<SEC-DOCUMENT>0001104659-24-129424.txt : 20241217
<SEC-HEADER>0001104659-24-129424.hdr.sgml : 20241217
<ACCEPTANCE-DATETIME>20241217170939
ACCESSION NUMBER:		0001104659-24-129424
CONFORMED SUBMISSION TYPE:	F-1/A
PUBLIC DOCUMENT COUNT:		62
FILED AS OF DATE:		20241217
DATE AS OF CHANGE:		20241217

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Evaxion Biotech A/S
		CENTRAL INDEX KEY:			0001828253
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			G7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283304
		FILM NUMBER:		241556626

	BUSINESS ADDRESS:	
		STREET 1:		DR NEERGAARDS VEJ 5F
		CITY:			HOERSHOLM
		STATE:			G7
		ZIP:			2970
		BUSINESS PHONE:		004531262615

	MAIL ADDRESS:	
		STREET 1:		DR NEERGAARDS VEJ 5F
		CITY:			HOERSHOLM
		STATE:			G7
		ZIP:			2970
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-1/A
<SEQUENCE>1
<FILENAME>tm2427973-5_f1a.htm
<DESCRIPTION>F-1/A
<TEXT>
<html>
  <head>
    <title>tm2427973-5_f1a - block - 17.0625664s</title>
  </head>
  <body style="margin-left:auto;margin-right:auto;width:595.31pt;">
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:27pt;width:541.31pt;">

          <div style="text-align:center; width:541.31pt; line-height:10pt;font-weight:bold;">
            <font style="letter-spacing:-0.18pt;">As filed with the Securities and Exchange Commission on December 17, 2024</font><font style="font-weight:normal;letter-spacing:0.18pt;"> </font>
          </div>

        <div style="margin-left:20pt; margin-top:2.3pt; text-align:right; width:521.31pt; line-height:10pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">Registration Statement No. 333-283304</font>&#8203;</div>
        <div style="margin-top:2.2pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 2.2pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:1.7pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 1.7pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:7.7pt; text-align:center; width:541.31pt; line-height:16.5pt;font-weight:bold;font-size:16pt;">
          <font style="letter-spacing:-0.32pt;">UNITED STATES </font>
          <br >
          <font style="letter-spacing:-0.32pt;">SECURITIES AND EXCHANGE COMMISSION </font>
          <br >
          <font style="font-size:9pt;letter-spacing:-0.18pt;">Washington, D.C. 20549</font><font style="font-weight:normal;letter-spacing:0.32pt;"> </font>
        </div>
        <div style="margin-top:8.5pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 8.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>

          <div style="margin-top:4.7pt; text-align:center; width:541.31pt; line-height:14.5pt;font-weight:bold;font-size:14pt;">
            <font style="letter-spacing:-0.28pt;">Amendment No. 2</font>
            <br >
            <font style="letter-spacing:-0.28pt;">to</font>
          </div>

        <div style="margin-top:3pt; text-align:center; width:541.31pt; line-height:17pt;font-weight:bold;font-size:16pt;">
          <font style="letter-spacing:-0.32pt;">FORM F-1</font><font style="font-weight:normal;letter-spacing:0.32pt;"> </font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:541.31pt; line-height:10pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</font><font style="font-weight:normal;letter-spacing:0.18pt;"> </font>
        </div>
        <div style="margin-top:6.5pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 6.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:7pt; text-align:center; width:541.31pt; line-height:10.5pt;font-size:16pt;">
          <font style="font-weight:bold;letter-spacing:-0.32pt;">Evaxion Biotech A/S </font>
          <br >
          <font style="font-size:8pt;letter-spacing:0.16pt;">(Exact name of Registrant as specified in its charter)</font><font style="letter-spacing:0.32pt;"> </font>
        </div>
        <div style="margin-top:10.5pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 10.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <table style="width:541.31pt;margin-top:4.5pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
          <tr style="line-height:9pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:172.44pt;">
              <div style="text-align:center;font-weight:bold;font-size:9pt;">
                <font style="letter-spacing:-0.18pt;">The Kingdom of Denmark</font>
              </div>
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">(State or other jurisdiction of </font>
                <br >
                <font style="letter-spacing:0.16pt;">incorporation or organization)</font><font style="font-size:9pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:172.44pt;white-space:nowrap;">
              <div style="text-align:center;font-size:9pt;">
                <font style="letter-spacing:0.18pt;">&#8199;</font>
                <br >
                <font style="font-size:8pt;letter-spacing:0.16pt;">(Primary Standard Industrial</font>
                <br >
                <font style="font-size:8pt;letter-spacing:0.16pt;">Classification Code Number)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:172.43pt;">
              <div style="text-align:center;font-weight:bold;font-size:9pt;">
                <font style="letter-spacing:-0.18pt;">Not applicable</font>
              </div>
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">(IRS Employer</font>
                <br >
                <font style="letter-spacing:0.16pt;">Identification Number)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:7.21pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6.7pt; text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">Dr.&#160;Neergaards Vej 5F 2970</font>
          <br >
          <font style="letter-spacing:-0.18pt;">H&#248;rsholm Denmark </font>
          <br >
          <font style="letter-spacing:-0.18pt;">Telephone: +45 31 31 97 53 </font>
        </div>
        <div style="margin-top:0.7pt; text-align:center; width:541.31pt; line-height:9pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</font><font style="font-size:9pt;">&#8203;<font style="letter-spacing:0.18pt;"> </font></font>
        </div>
        <div style="margin-top:6.5pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 6.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:5pt; text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">Christian Kanstrup Chief</font>
          <br >
          <font style="letter-spacing:-0.18pt;">Executive Officer Evaxion</font>
          <br >
          <font style="letter-spacing:-0.18pt;">Biotech A/S Dr.&#160;Neergaards</font>
          <br >
          <font style="letter-spacing:-0.18pt;">Vej 5F 2970 H&#248;rsholm</font>
          <br >
          <font style="letter-spacing:-0.18pt;">Denmark </font>
          <br >
          <font style="letter-spacing:-0.18pt;">Telephone: +45 31 31 97 53 </font>
        </div>
        <div style="margin-top:0.7pt; text-align:center; width:541.31pt; line-height:9pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</font><font style="font-size:9pt;">&#8203;<font style="letter-spacing:0.18pt;"> </font></font>
        </div>
        <div style="margin-top:8.5pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 8.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:5pt; text-align:center; width:541.31pt; line-height:10pt;">
          <font style="letter-spacing:0.18pt;">Copy of all communications including communications sent to agent for service, should be sent to: </font>
        </div>
        <table style="width:541.31pt;margin-top:3.30000000000001pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:172.44pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.18pt;">Michael D. Baird</font>
                <br >
                <font style="letter-spacing:-0.18pt;">Duane Morris LLP</font>
                <br >
                <font style="letter-spacing:-0.18pt;">230 Park Avenue</font>
                <br >
                <font style="letter-spacing:-0.18pt;">Suite 1130</font>
                <br >
                <font style="letter-spacing:-0.18pt;">New York, NY 10169</font>
                <br >
                <font style="letter-spacing:-0.18pt;">Telephone: (212) 818-9200</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:172.44pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.18pt;">Lars L&#252;thjohan</font>
                <br >
                <font style="letter-spacing:-0.18pt;">Mazanti-Andersen</font>
                <br >
                <font style="letter-spacing:-0.18pt;">AdvokatPartnerselskab</font>
                <br >
                <font style="letter-spacing:-0.18pt;">Amaliegade 10</font>
                <br >
                <font style="letter-spacing:-0.18pt;">DK-1256 Copenhagen K</font>
                <br >
                <font style="letter-spacing:-0.18pt;">Denmark</font>
                <br >
                <font style="letter-spacing:-0.18pt;">Telephone: +45 3314 3536</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:172.43pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.18pt;">David Danovitch</font>
                <br >
                <font style="letter-spacing:-0.18pt;">Aaron Schleicher</font>
                <br >
                <font style="letter-spacing:-0.18pt;">Sullivan &amp; Worcester LLP</font>
                <br >
                <font style="letter-spacing:-0.18pt;">1251 Avenue of the Americas</font>
                <br >
                <font style="letter-spacing:-0.18pt;">New York, NY 10020</font>
                <br >
                <font style="letter-spacing:-0.18pt;">Telephone: (212) 660-3000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:7.2pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:541.31pt; line-height:9.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.18pt;">Approximate date of commencement of proposed sale to the public:</font><font style="letter-spacing:0.18pt;"> As soon as practicable after this registration statement becomes effective. </font>
        </div>
        <div style="text-indent:20pt; margin-top:2.3pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under the Securities Act of 1933 (as amended, the &#8220;Securities Act&#8221;), check the following box. &#9746; </font>
        </div>
        <div style="text-indent:20pt; margin-top:2.3pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If this Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:2.3pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If this Form is a post-effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:2.3pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If this Form is a post-effective amendment filed pursuant to Rule&#160;462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:2.3pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act. Emerging growth company &#9746; </font>
        </div>
        <div style="text-indent:20pt; margin-top:2.3pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:2.3pt; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act, or until this registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&#160;8(a) may determine.</font>
        </div>
        <div style="margin-top:8.3pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 8.29999999999995pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:4.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.18pt;">&#8224;</font>
          <br >
        </div>
        <div style=" margin-top:4.6pt; margin-bottom:0pt; line-height:9.5pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.18pt;">The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April&#160;5, 2012. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:2.81pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 2.81000000000006pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:1.8pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 1.79999999999995pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
    <div style="position:relative;overflow:hidden;min-height:775.71pt;page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="position:absolute;top:738.83pt;left:24pt;height:30.02pt;width:706pt;transform-origin:0pt -0pt;transform:rotate(-90deg) translate(0%, 0%);">
        <div style="text-align:justify; width:706pt; line-height:9.5pt;font-weight:bold;color:#FC0014;font-family:Helvetica, Arial, sans-serif;font-size:8pt;">
          <font style="letter-spacing:-0.08pt;">The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</font><font style="color:#000000;letter-spacing:-0.08pt;"> </font>
          <br >
        </div>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:63pt;width:505.31pt;">

          <div style="text-align:center; width:505.31pt; line-height:11.5pt;font-weight:bold;color:#FC0014;font-size:10pt;">
            <font style="letter-spacing:-0.2pt;">PRELIMINARY PROSPECTUS</font>
            <br >
            <font style="letter-spacing:-0.2pt;">(Subject to completion, Dated December 17, 2024)</font><font style="font-weight:normal;color:#000000;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="margin-top:3pt; text-align:center; width:505.31pt; line-height:11.5pt;font-weight:bold;font-size:10pt;">
            <font style="letter-spacing:-0.2pt;">UP TO 7,640,845&#160;AMERICAN DEPOSITARY SHARES REPRESENTING 76,408,450 ORDINARY </font>
            <br >
            <font style="letter-spacing:-0.2pt;">SHARES AND&#160;UP TO 7,640,845 PRE-FUNDED WARRANTS TO PURCHASE UP TO 7,640,845 </font>
            <br >
            <font style="letter-spacing:-0.2pt;">AMERICAN DEPOSITARY SHARES AND UP TO 7,640,845 WARRANTS TO PURCHASE </font>
            <br >
            <font style="letter-spacing:-0.2pt;">UP TO 7,640,845 AMERICAN DEPOSITARY SHARES </font>
            <br >
            <font style="letter-spacing:-0.2pt;">(and 7,640,845 American Depositary Shares representing 76,408,450 ordinary shares issuable upon exercise </font>
            <br >
            <font style="letter-spacing:-0.2pt;">of the Pre-Funded Warrants and 7,640,845 American Depositary Shares representing 76,408,450 </font>
            <br >
            <font style="letter-spacing:-0.2pt;">ordinary shares issuable upon exercise of the Warrants)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="position:relative;margin-top:4.5pt; text-align:center; width:505.31pt;">
          <img src="lg_evaxion-bwlr.jpg" alt="[MISSING IMAGE: lg_evaxion-bwlr.jpg]" height="39" width="224" >
        </div>
        <div style="margin-top:5.2pt; text-align:center; width:505.31pt; line-height:18pt;font-weight:bold;font-size:16pt;">
          <font style="letter-spacing:-0.32pt;">Evaxion Biotech A/S</font><font style="font-weight:normal;letter-spacing:0.32pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:2.5pt; width:505.31pt; line-height:7.5pt;">
            <font style="letter-spacing:0.136pt;">We are offering on a best efforts basis up to 7,640,845 American Depositary Shares (&#8220;ADSs&#8221;) representing an aggregate of 76,408,450 ordinary shares, DKK 1 nominal value per share, together with warrants to purchase up to 7,640,845 ADSs representing 76,408,450 ordinary shares (the &#8220;Warrants&#8221;). The ADSs and Warrants will be sold in a fixed combination, with each ADS accompanied by one Warrant to purchase one ADS. The ADSs and Warrants are immediately separable and will be issued separately in this offering, but must be purchased together in this offering. The Warrants will have an exercise price per share of $&#8199;&#8199;&#8199;&#8199;&#8199; and will be immediately exercisable for a term of five&#160;(5) years from the date of issuance. The assumed public offering price for each ADS and accompanying Warrant is $1.42, which is based upon the DKK 1 nominal value of each of the ten ordinary shares underlying each ADS. The actual public offering per ADS (or pre-funded warrants in lieu thereof) and accompanying warrant will be determined through negotiation between us, the Placement Agent and investors based upon a number of factors, including our history and our prospects, the industry in which we operate, our past and present operating results, the previous experience of our executive officers and the general condition of the securities markets at the time of this offering. </font>
          </div>


          <div style="text-indent:20pt; margin-top:2.5pt; width:505.31pt; line-height:7.5pt;">
            <font style="letter-spacing:0.136pt;">We are also offering to certain purchasers whose purchase of ADSs in this offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding ordinary shares, including ordinary shares represented by ADSs immediately, following the consummation of this offering, the opportunity to purchase, if any such purchaser so chooses, 7,640,845 pre-funded warrants, in lieu of ADSs that would otherwise result in such purchaser&#8217;s beneficial ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of the ADSs. The public offering price of each pre-funded warrant will be equal to the price at which an ADS is sold to the public in this offering, minus an amount in US dollars equal to DKK 10 at the time of pricing of this offering, which amount is equal to $1.42 as of the date of this prospectus, and the exercise price of each pre-funded warrant will be DKK 10 equal to $1.42 per ADS, provided that such exercise price shall not be less than the USD equivalent to DKK 10 at the time of exercise, and such exercise price may be pre-funded and held in escrow until exercise thereof. The pre-funded warrants will be immediately exercisable and may be exercised at any time until all of the pre-funded warrants are exercised in full. For each pre-funded warrant we sell, the number of ADSs we are offering will be decreased on a one-for-one basis. This prospectus also relates to the ADSs issuable upon exercise of the Warrants and any pre-funded warrants sold in this offering. </font>
          </div>


          <div style="text-indent:20pt; margin-top:2.5pt; width:505.31pt; line-height:7.5pt;">
            <font style="letter-spacing:0.136pt;">There is no established public trading market for the Warrants or pre-funded warrants, and we do not expect a market to develop. We do not intend to apply for listing of the Warrants or pre-funded warrants on any securities exchange or other nationally recognized trading system. Without an active trading market, the liquidity of the warrants will be limited.</font>
          </div>


          <div style="text-indent:20pt; margin-top:2.5pt; width:505.31pt; line-height:7.5pt;">
            <font style="letter-spacing:0.136pt;">This offering will terminate on January 31, 2025, unless we decide to terminate the offering (which we may do at any time in our discretion) prior to that date. We will have one closing for all the securities purchased in this offering. </font>
          </div>


          <div style="text-indent:20pt; margin-top:2.5pt; width:505.31pt; line-height:7.5pt;">
            <font style="letter-spacing:0.136pt;">The ADSs are listed on the Nasdaq Capital Market, or Nasdaq, under the symbol &#8220;EVAX&#8221;. On December&#160;13, 2024, the closing trading price for the ADSs, as reported on Nasdaq, was $1.14 per ADS. </font>
          </div>

        <div style="text-indent:20pt; margin-top:2.5pt; width:505.31pt; line-height:7.5pt;">
          <font style="letter-spacing:0.136pt;">We have engaged Lake Street Capital Markets, LLC (the &#8220;Placement Agent&#8221;) to act as our exclusive Placement Agent in connection with this offering. The Placement Agent has agreed to use its reasonable best efforts to arrange for the sale of the securities offered by this prospectus. The Placement Agent is not purchasing or selling any of the securities we are offering and the Placement Agent is not required to arrange the purchase or sale of any specific number of securities or dollar amount. We have agreed to pay to the Placement Agent the Placement Agent Fees set forth in the table below, which assumes that we sell all of the securities offered by this prospectus. There is no minimum offering requirement as a condition of closing of this offering. Because there is no minimum offering amount required as a condition to closing this offering, we may sell fewer than all of the securities offered hereby, which may significantly reduce the amount of proceeds received by us. The investors in this offering will not receive a refund in the event that we do not sell an amount of securities sufficient to pursue our business goals described in this prospectus. In addition, investors could be in a position where they have invested in our company, but we are unable to fulfill all of our contemplated objectives due to a lack of interest in this offering. Further, any proceeds from the sale of securities offered by us will be available for our immediate use, despite uncertainty about whether we would be able to use such funds to effectively implement our business plan. We will bear all costs associated with the offering. See &#8220;Plan of Distribution&#8221; on page &#8199;&#8199; of this prospectus for more information regarding these arrangements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:2.5pt; width:505.31pt; line-height:7.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.136pt;">We are a &#8220;foreign private issuer,&#8221; and an &#8220;emerging growth company&#8221; each as defined under the federal securities laws, and, as such, we are subject to reduced public company reporting requirements. See the section entitled &#8220;Prospectus Summary&#8201;&#8212;&#8201;Implications of Being an Emerging Growth Company and a Foreign Private Issuer&#8221; for additional information.</font><font style="font-weight:normal;letter-spacing:0.136pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:2.5pt; width:505.31pt; line-height:7.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.136pt;">Investing in our securities involves a high degree of risk. Before buying any ADSs, you should carefully read the discussion of material risks of investing in the ADSs and the company. See &#8220;Risk Factor Summary&#8221; beginning on page <a href="#tRIFA">20</a> for a discussion of information that should be considered in connection with an investment in our securities.</font><font style="font-weight:normal;letter-spacing:0.136pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:2.5pt; width:505.31pt; line-height:7.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.136pt;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</font><font style="font-weight:normal;letter-spacing:0.136pt;"> </font>
        </div>

          <table style="width:505.31pt;height:56.4800000000001pt;margin-top:3.5pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.8pt;">
            <tr style="line-height:7.64pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:299.21pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.72pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.136pt;">Per ADS and accompanying Warrant</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.72pt 0pt;" colspan="4">
                <div style="text-align:center; line-height:7.63999999999999pt;">
                  <font style="letter-spacing:-0.136pt;">Per Pre-Funded</font>
                  <br >
                  <font style="letter-spacing:-0.136pt;">Warrant and</font>
                  <br >
                  <font style="letter-spacing:-0.136pt;">accompanying </font>
                  <br >
                  <font style="letter-spacing:-0.136pt;">Warrant</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.72pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.136pt;">Total</font><font style=" position:relative; bottom:2.75pt;line-height:4.5pt;font-size:4.5pt;letter-spacing:-0.1pt;">(4)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:6.78999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.8pt;">
              <td style="padding:1.257pt 0pt 0.5pt 0pt; width:299.21pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.136pt;">Public offering price </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:42.265pt;width:0pt;">&#8203;</td>
              <td style="padding:1.257pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
              <td style="padding:1.257pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8199;&#8199;&#8199;&#8199;&#8199;</td>
              <td style="padding:0pt;padding-left:42.265pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:10.34pt;width:0pt;">&#8203;</td>
              <td style="padding:1.257pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
              <td style="padding:1.257pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;</td>
              <td style="padding:0pt;padding-left:10.34pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.164999999999999pt;width:0pt;">&#8203;</td>
              <td style="padding:1.257pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
              <td style="padding:1.257pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8199;&#8199;&#8199;&#8199;&#8199;</td>
              <td style="padding:0pt;padding-left:0.164999999999999pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:6.78999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.8pt;">
              <td style="padding:1.507pt 0pt 0.5pt 0pt; width:299.21pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.136pt;">Placement Agent Fees</font><font style=" position:relative; bottom:2.75pt;font-size:4.5pt;letter-spacing:0.1pt;">(1)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:42.265pt;width:0pt;">&#8203;</td>
              <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
              <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;"> </td>
              <td style="padding:0pt;padding-left:42.265pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:10.34pt;width:0pt;">&#8203;</td>
              <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
              <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;"> </td>
              <td style="padding:0pt;padding-left:10.34pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.164999999999999pt;width:0pt;">&#8203;</td>
              <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
              <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;"> </td>
              <td style="padding:0pt;padding-left:0.164999999999999pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:6.78999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.8pt;">
              <td style="padding:1.517pt 0pt 0.5pt 0pt; width:299.21pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.136pt;">Proceeds to us (before expenses)</font><font style=" position:relative; bottom:2.75pt;font-size:4.5pt;letter-spacing:0.1pt;">(2)(3)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:42.265pt;width:0pt;">&#8203;</td>
              <td style="padding:1.517pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
              <td style="padding:1.517pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;"> </td>
              <td style="padding:0pt;padding-left:42.265pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:10.34pt;width:0pt;">&#8203;</td>
              <td style="padding:1.517pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
              <td style="padding:1.517pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;"> </td>
              <td style="padding:0pt;padding-left:10.34pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.164999999999999pt;width:0pt;">&#8203;</td>
              <td style="padding:1.517pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
              <td style="padding:1.517pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.164999999999999pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:7.26pt; width:505.31pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.136pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:8.8pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.136pt;">Pre-Funded Warrant public offering price of $&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; calculated to include the exercise price of DKK 10 equal to $&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; in addition to the public offering price of $&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:8.8pt; margin-top:0.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.136pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:0.8pt; margin-bottom:0pt; line-height:8.8pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.136pt;">We have agreed to pay the Placement Agent cash fee equal to 7.0% of the gross proceeds raised in this offering. We have also agreed to reimburse the Placement Agent its legal fees and expenses in an amount up to $100,000, See &#8220;Plan of Distribution&#8221; for additional information and a description of the compensation payable to the Placement Agent. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:8.8pt; margin-top:0.79pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.136pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:0.79pt; margin-bottom:0pt; line-height:8.8pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.136pt;">We estimate the total expenses of this offering payable by us, excluding the Placement Agent fee, will be approximately $0.7&#160;million. Because there is no minimum number of securities or amount of proceeds required as a condition to closing in this offering, the actual public offering amount, Placement Agent fees, and proceeds to us, if any, are not presently determinable and may be substantially less than the total maximum offering amounts set forth above. For more information, see &#8220;Plan of Distribution.&#8221; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:8.8pt; margin-top:0.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.136pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:0.8pt; margin-bottom:0pt; line-height:8.8pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.136pt;">Gross proceeds assumes exercise in full of Pre-Funded Warrants. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:2.5pt; width:505.31pt; line-height:7.5pt;">
          <font style="letter-spacing:0.136pt;">We anticipate that delivery of the securities against payment will be made on or about &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2024, subject to satisfaction of customary closing conditions. </font>
        </div>
        <div style="margin-top:4pt; text-align:center; width:505.31pt; line-height:18pt;font-weight:bold;font-size:16pt;">
          <font style="letter-spacing:-0.32pt;">Lake Street</font><font style="font-weight:normal;letter-spacing:0.32pt;"> </font>
        </div>
        <div style="margin-top:2.5pt; text-align:center; width:505.31pt; line-height:7.5pt;">
          <font style="letter-spacing:0.136pt;">Prospectus dated, &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199; 2024</font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:254pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:337pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tATP"><font style="letter-spacing:0.2pt;">ABOUT THIS PROSPECTUS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tATP">v</a></font> <a href="#tATP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSNRF"><font style="letter-spacing:0.2pt;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSNRF">vii</a></font> <a href="#tSNRF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPRSU"><font style="letter-spacing:0.2pt;">PROSPECTUS SUMMARY </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPRSU">1</a></font> <a href="#tPRSU"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tRIFA"><font style="letter-spacing:0.2pt;">RISK FACTORS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRIFA">20</a></font> <a href="#tRIFA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDIPO"><font style="letter-spacing:0.2pt;">DIVIDEND POLICY </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDIPO">40</a></font> <a href="#tDIPO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMIAO"><font style="letter-spacing:0.2pt;">MARKET, INDUSTRY AND OTHER DATA </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMIAO">40</a></font> <a href="#tMIAO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUOP"><font style="letter-spacing:0.2pt;">USE OF PROCEEDS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUOP">41</a></font> <a href="#tUOP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCAP"><font style="letter-spacing:0.2pt;">CAPITALIZATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCAP">42</a></font> <a href="#tCAP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDIL"><font style="letter-spacing:0.2pt;">DILUTION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDIL">44</a></font> <a href="#tDIL"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tBUOV"><font style="letter-spacing:0.2pt;">BUSINESS OVERVIEW </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tBUOV">45</a></font> <a href="#tBUOV"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMAN"><font style="letter-spacing:0.2pt;">MANAGEMENT </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMAN">108</a></font> <a href="#tMAN"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSHOW"><font style="letter-spacing:0.2pt;">SHARE OWNERSHIP </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSHOW">111</a></font> <a href="#tSHOW"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOSC"><font style="letter-spacing:0.2pt;">DESCRIPTION OF SHARE CAPITAL AND ARTICLES OF ASSOCIATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOSC">114</a></font> <a href="#tDOSC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOAD"><font style="letter-spacing:0.2pt;">DESCRIPTION OF AMERICAN DEPOSITARY SHARES </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOAD">132</a></font> <a href="#tDOAD"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMITC"><font style="letter-spacing:0.2pt;">MATERIAL INCOME TAX CONSIDERATIONS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMITC">140</a></font> <a href="#tMITC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOSW"><font style="letter-spacing:0.2pt;">DESCRIPTION OF SECURITIES WE ARE OFFERING </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOSW">151</a></font> <a href="#tDOSW"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPOD"><font style="letter-spacing:0.2pt;">PLAN OF DISTRIBUTION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPOD">154</a></font> <a href="#tPOD"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEOTO"><font style="letter-spacing:0.2pt;">EXPENSES OF THE OFFERING </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tEOTO">157</a></font> <a href="#tEOTO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tLEMA"><font style="letter-spacing:0.2pt;">LEGAL MATTERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tLEMA">157</a></font> <a href="#tLEMA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEXP"><font style="letter-spacing:0.2pt;">EXPERTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tEXP">157</a></font> <a href="#tEXP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tWYCF"><font style="letter-spacing:0.2pt;">WHERE YOU CAN FIND MORE INFORMATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWYCF">157</a></font> <a href="#tWYCF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:429pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tDOCP"><font style="letter-spacing:0.2pt;">DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOCP">159</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF FIGURES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tF1CD"><font style="letter-spacing:0.2pt;">Figure 1</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tF1CD"><font style="letter-spacing:0.2pt;">A clearly differentiated position with AI based drug discovery and development</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tF1CD">2</a></font> <a href="#tF1CD"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tF2ET"><font style="letter-spacing:0.2pt;">Figure 2</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tF2ET"><font style="letter-spacing:0.2pt;">The Evaxion Three-Pronged Business Model</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tF2ET">3</a></font> <a href="#tF2ET"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG"><font style="letter-spacing:0.2pt;">Figure 3</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG"><font style="letter-spacing:0.2pt;">2024 company milestones</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG">4</a></font> <a href="#tFIG"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG1"><font style="letter-spacing:0.2pt;">Figure 4</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG1"><font style="letter-spacing:0.2pt;">Preliminary 2025 company milestones</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG1">5</a></font> <a href="#tFIG1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG2"><font style="letter-spacing:0.2pt;">Figure 5</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG2"><font style="letter-spacing:0.2pt;">The AI-Immunology&#8482; platform</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG2">6</a></font> <a href="#tFIG2"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG3"><font style="letter-spacing:0.2pt;">Figure 6</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG3"><font style="letter-spacing:0.2pt;">The Evaxion pipeline</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG3">9</a></font> <a href="#tFIG3"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG4"><font style="letter-spacing:0.2pt;">Figure 7</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG4"><font style="letter-spacing:0.2pt;">Our AI models and vaccine pipeline</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG4">46</a></font> <a href="#tFIG4"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG5"><font style="letter-spacing:0.2pt;">Figure 8</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG5"><font style="letter-spacing:0.2pt;">A clearly differentiated position with AI based drug discovery and development</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG5">50</a></font> <a href="#tFIG5"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG6"><font style="letter-spacing:0.2pt;">Figure 9</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG6"><font style="letter-spacing:0.2pt;">The Evaxion Three-Pronged Business Model</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG6">51</a></font> <a href="#tFIG6"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG7"><font style="letter-spacing:0.2pt;">Figure 10</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG7"><font style="letter-spacing:0.2pt;">2024 milestones</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG7">52</a></font> <a href="#tFIG7"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG8"><font style="letter-spacing:0.2pt;">Figure 11</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG8"><font style="letter-spacing:0.2pt;">Preliminary 2025 company milestones</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG8">53</a></font> <a href="#tFIG8"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG9"><font style="letter-spacing:0.2pt;">Figure 12</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG9"><font style="letter-spacing:0.2pt;">Illustration of mechanisms within the tumor cell that are required for a neoantigen to have </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">a clinical effect in patients </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG9">56</a></font> <a href="#tFIG9"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG10"><font style="letter-spacing:0.2pt;">Figure 13</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG10"><font style="letter-spacing:0.2pt;">Benchmark study of PIONEER&#8482; against state-of-the-art, public tools for number of hits </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">identified in the top 10 best-ranked neoantigens</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG10">57</a></font> <a href="#tFIG10"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG11"><font style="letter-spacing:0.2pt;">Figure 14</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG11"><font style="letter-spacing:0.2pt;">PIONEER&#8482; improvement demonstrated in a preclinical study</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG11">58</a></font> <a href="#tFIG11"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG12"><font style="letter-spacing:0.2pt;">Figure 15</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG12"><font style="letter-spacing:0.2pt;">Our process for manufacturing a personalized cancer vaccine </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG12">60</a></font> <a href="#tFIG12"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG13"><font style="letter-spacing:0.2pt;">Figure 16</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG13"><font style="letter-spacing:0.2pt;">Our immuno-oncology product candidates derived from PIONEER&#8482; and ObsERV&#8482;</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG13">61</a></font> <a href="#tFIG13"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG14"><font style="letter-spacing:0.2pt;">Figure 17</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG14"><font style="letter-spacing:0.2pt;">Clinical design of the first-in-human Phase&#160;1/2a clinical trial in the EVX-01 program</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG14">63</a></font> <a href="#tFIG14"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG15"><font style="letter-spacing:0.2pt;">Figure 18</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG15"><font style="letter-spacing:0.2pt;">Patient disease status, treatment outcome and immune response from the EVX-01 </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">Phase&#160;1/2a clinical trial</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG15">64</a></font> <a href="#tFIG15"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG16"><font style="letter-spacing:0.2pt;">Figure 19</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG16"><font style="letter-spacing:0.2pt;">% change in target lesion size for patients treated with EVX-01</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG16">64</a></font> <a href="#tFIG16"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG17"><font style="letter-spacing:0.2pt;">Figure 20</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG17"><font style="letter-spacing:0.2pt;">Dose-responsiveness of immunogenic neoantigens. Pre, immune responses to EVX-01 </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">neopeptides before vaccination, Post; Immune responses to EVX-01 neopeptides after </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">vaccination</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG17">65</a></font> <a href="#tFIG17"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG18"><font style="letter-spacing:0.2pt;">Figure 21</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG18"><font style="letter-spacing:0.2pt;">Frequency of immunogenic neoantigens in patients</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG18">66</a></font> <a href="#tFIG18"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG19"><font style="letter-spacing:0.2pt;">Figure 22</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG19"><font style="letter-spacing:0.2pt;">Correlation between PIONEER quality score and immunogenicity</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG19">67</a></font> <a href="#tFIG19"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG20"><font style="letter-spacing:0.2pt;">Figure 23</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG20"><font style="letter-spacing:0.2pt;">Kaplan-Meier plots displaying PFS of patients based on TMB high/low calculated FDA </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">guidelines (left) Median PIONEER score (right)</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG20">67</a></font> <a href="#tFIG20"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG21"><font style="letter-spacing:0.2pt;">Figure 24</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG21"><font style="letter-spacing:0.2pt;">Schematic presentation of the EVX-01 Phase&#160;2 clinical trial design. Each patient receives </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">18 cycles with pembrolizumab (approximately two&#160;years)</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG21">68</a></font> <a href="#tFIG21"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG22"><font style="letter-spacing:0.2pt;">Figure 25</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG22"><font style="letter-spacing:0.2pt;">Vaccine neoantigen-specific T-cell responses induced during the priming</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG22">68</a></font> <a href="#tFIG22"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG23"><font style="letter-spacing:0.2pt;">Figure 26</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG23"><font style="letter-spacing:0.2pt;">Vaccine-specific CD4+ and CD8+ T-cells were analyzed by intracellular cytokine staining </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">(ICS) and flow cytometry after in vitro expansion</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG23">69</a></font> <a href="#tFIG23"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG24"><font style="letter-spacing:0.2pt;">Figure 27</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG24"><font style="letter-spacing:0.2pt;">Immunogenicity of individual EVX-01 neoantigen (neoAg) and correlation with neoAg </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">quality score</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG24">69</a></font> <a href="#tFIG24"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG25"><font style="letter-spacing:0.2pt;">Figure 28</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG25"><font style="letter-spacing:0.2pt;">Clinical event timeline and change in tumor target lesion size</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG25">70</a></font> <a href="#tFIG25"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG26"><font style="letter-spacing:0.2pt;">Figure 29</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG26"><font style="letter-spacing:0.2pt;">Immunogenicity and correlation analysis between AI-Immunology&#8482; and immune </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">response</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG26">71</a></font> <a href="#tFIG26"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG27"><font style="letter-spacing:0.2pt;">Figure 30</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG27"><font style="letter-spacing:0.2pt;">Illustration of our two neoantigen targeting DNA therapies, EVX-02 and EVX-03</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG27">72</a></font> <a href="#tFIG27"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG28"><font style="letter-spacing:0.2pt;">Figure 31</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG28"><font style="letter-spacing:0.2pt;">Anti-tumor effect of the mouse EVX-02 surrogate vaccine</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG28">73</a></font> <a href="#tFIG28"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG29"><font style="letter-spacing:0.2pt;">Figure 32</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG29"><font style="letter-spacing:0.2pt;">In vivo tumor study investigating the combinatorial effect of mEVX-02 and anti-mPD-1 </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">antibody. P-values were calculated using log-rank (Mantel-Cox) test P&lt;0.01</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG29">74</a></font> <a href="#tFIG29"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG30"><font style="letter-spacing:0.2pt;">Figure 33</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG30"><font style="letter-spacing:0.2pt;">In vivo pre-clinical data for EVX-03</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG30">75</a></font> <a href="#tFIG30"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC3">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG31"><font style="letter-spacing:0.2pt;">Figure 34</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG31"><font style="letter-spacing:0.2pt;">mEVX-02 A) and mEVX-03 B) dose-dependently inhibited the growth of subcutaneous </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">CT26 tumors. Antitumor of EVX-02 and EVX-03 was obtained at doses as low as 5 and </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">0.25 &#956;g, respectively</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG31">76</a></font> <a href="#tFIG31"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG32"><font style="letter-spacing:0.2pt;">Figure 35</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG32"><font style="letter-spacing:0.2pt;">Pre-clinical data for mEVX-03 containing ObsERV&#8482; identified ERV antigens </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">(mEVX-03_ERV_CT26)</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG32">76</a></font> <a href="#tFIG32"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG33"><font style="letter-spacing:0.2pt;">Figure 36</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG33"><font style="letter-spacing:0.2pt;">Results obtained in GLP toxicology study of EVX-03 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG33">77</a></font> <a href="#tFIG33"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG34"><font style="letter-spacing:0.2pt;">Figure 37</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG34"><font style="letter-spacing:0.2pt;">Prediction of patient response to immunotherapy from immunogenomic profiles in </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">baseline tumor biopsy</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG34">78</a></font> <a href="#tFIG34"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG35"><font style="letter-spacing:0.2pt;">Figure 38</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG35"><font style="letter-spacing:0.2pt;">Prediction of patient response to immunotherapy from genomic profiles, neoantigen and </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">ERV antigen signatures in baseline tumor biopsy</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG35">79</a></font> <a href="#tFIG35"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG36"><font style="letter-spacing:0.2pt;">Figure 39</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG36"><font style="letter-spacing:0.2pt;">EDEN&#8482; is a self-taught AI model that provides important insight into what makes </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">antigens elicit a protective immune response. EDEN&#8482; identifies novel protective </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">proteins by recognizing abstract features shared with known highly protective </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">proteins</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG36">81</a></font> <a href="#tFIG36"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG37"><font style="letter-spacing:0.2pt;">Figure 40</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG37"><font style="letter-spacing:0.2pt;">Our approach to bacterial vaccine discovery and design</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG37">82</a></font> <a href="#tFIG37"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG38"><font style="letter-spacing:0.2pt;">Figure 41</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG38"><font style="letter-spacing:0.2pt;">Correlation between EDEN prediction and protection</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG38">84</a></font> <a href="#tFIG38"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG39"><font style="letter-spacing:0.2pt;">Figure 42</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG39"><font style="letter-spacing:0.2pt;">EDEN&#8482; outperform Reverse Vaccinology</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG39">85</a></font> <a href="#tFIG39"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG40"><font style="letter-spacing:0.2pt;">Figure 43</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG40"><font style="letter-spacing:0.2pt;">Multicomponent approach to the development of EVX-B1</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG40">86</a></font> <a href="#tFIG40"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG41"><font style="letter-spacing:0.2pt;">Figure 44</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG41"><font style="letter-spacing:0.2pt;">Assessing protection of EVX-B1 in a mouse sepsis model</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG41">88</a></font> <a href="#tFIG41"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG42"><font style="letter-spacing:0.2pt;">Figure 45</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG42"><font style="letter-spacing:0.2pt;">Assessing protection of EVX-B1 in a mouse skin infection model</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG42">88</a></font> <a href="#tFIG42"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG43"><font style="letter-spacing:0.2pt;">Figure 46</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG43"><font style="letter-spacing:0.2pt;">IgG titers. Mice were immunized with EVX-B1</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG43">89</a></font> <a href="#tFIG43"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG44"><font style="letter-spacing:0.2pt;">Figure 47</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG44"><font style="letter-spacing:0.2pt;">EVX-B1 prevents both disease and infection as the bacterial burden in the kidneys is </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">blocked for at least 30&#160;days post infection</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG44">89</a></font> <a href="#tFIG44"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG45"><font style="letter-spacing:0.2pt;">Figure 48</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG45"><font style="letter-spacing:0.2pt;">EVX-B2 is composed of a fusion protein of NGO0265 and NGO1549 formulated with </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">adjuvant GLA-SE</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG45">91</a></font> <a href="#tFIG45"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG46"><font style="letter-spacing:0.2pt;">Figure 49</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG46"><font style="letter-spacing:0.2pt;">EVX-B2 induce significant protection against challenge in a </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;"> vaginal </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">colonization model</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG46">92</a></font> <a href="#tFIG46"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG47"><font style="letter-spacing:0.2pt;">Figure 50</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG47"><font style="letter-spacing:0.2pt;">Both antigens used in the product candidate induce protection, which was enhanced when </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">the antigens were fused together, as was the case in EVX-B2</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG47">93</a></font> <a href="#tFIG47"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG48"><font style="letter-spacing:0.2pt;">Figure 51</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG48"><font style="letter-spacing:0.2pt;">EVX-B2 demonstrates high level of immunogenicity as specific antibodies can be detected </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">already after one immunization</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG48">93</a></font> <a href="#tFIG48"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG49"><font style="letter-spacing:0.2pt;">Figure 52</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG49"><font style="letter-spacing:0.2pt;">Cellular immune response induced by EVX-B2</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG49">94</a></font> <a href="#tFIG49"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG50"><font style="letter-spacing:0.2pt;">Figure 53</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG50"><font style="letter-spacing:0.2pt;">EVX-B2 immune sera demonstrate broad bacterial killing activity</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG50">94</a></font> <a href="#tFIG50"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG51"><font style="letter-spacing:0.2pt;">Figure 54</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG51"><font style="letter-spacing:0.2pt;">RAVEN&#8482; workflow with EDEN&#8482; integration</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG51">96</a></font> <a href="#tFIG51"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG52"><font style="letter-spacing:0.2pt;">Figure 55</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tFIG52"><font style="letter-spacing:0.2pt;">Vaccination with RAVEN&#8482; identified SARS-CoV-2 T-cell epitopes protects against lethal </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">disease</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG52">98</a></font> <a href="#tFIG52"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:48pt;vertical-align:top;">
              <a href="#tFIG53"><font style="letter-spacing:0.2pt;">Figure 56</font></a>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:384pt;">
              <div style="white-space:nowrap;">
                <a href="#tFIG53"><font style="letter-spacing:0.2pt;">Engraftment of CD4+ T-cell epitope in the influenza hemagglutinin antigen</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIG53">98</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:16.99pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Neither we nor the Placement Agent have authorized anyone to provide information different from that contained in this prospectus, any amendment or supplement to this prospectus or in any free writing prospectus prepared by us or on our behalf. Neither we nor the Placement Agent take any responsibility for, and can provide no assurance as to the reliability of, any information other than the information in this prospectus, any amendment or supplement to this prospectus, and any free writing prospectus prepared by us or on our behalf. Neither the delivery of this prospectus nor the sale of the ADSs means that information contained in this prospectus is correct after the date of this prospectus. This prospectus is not an offer to sell or the solicitation of an offer to buy the ADSs in any circumstances under which such offer or solicitation is unlawful. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You should rely only on the information contained in this prospectus and any free writing prospectus prepared by or on behalf of us or to which we have referred you. Neither we nor the Placement Agent have </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">iii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:512pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">authorized anyone to provide you with information that is different. We and the Placement Agent are offering to sell the ADSs, and seeking offers to buy the ADSs, only in jurisdictions where offers and sales are permitted. The information in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of the ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For investors outside of the United States: Neither we nor the Placement Agent have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about and observe any restrictions relating to this offering and the distribution of this prospectus outside the United States.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">iv</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tATP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ABOUT THIS PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless the context requires otherwise, in this prospectus Evaxion Biotech A/S and its subsidiaries (&#8220;Subsidiar(y/ies)&#8221;) shall collectively be referred to as &#8220;EVAX,&#8221;, &#8220;Evaxion&#8221;, &#8220;the Company,&#8221; &#8220;the Group&#8221;, &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; unless otherwise noted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus contains our audited consolidated financial statements as of December&#160;31, 2023 and 2022 and for the&#160;years ended December&#160;31, 2023, 2022 and 2021 and the related notes, prepared in accordance with International Financial Reporting Standards or IFRS, as issued by the International Accounting Standards Board, or IASB and our unaudited condensed consolidated interim financial statements as of June&#160;30, 2024, and for the three and six&#160;months ended June&#160;30, 2024 and 2023 and the related notes and our unaudited condensed consolidated financial information as of September&#160;30, 2024, for the three and nine&#160;months ended September&#160;30, 2024 and 2023. The unaudited condensed consolidated interim financial statements of the Company are prepared in accordance with International Accounting Standard 34, &#8220;Interim Financial Reporting&#8221;. Certain information and disclosures normally included in the annual consolidated financial statements prepared in accordance with IFRS have been condensed or omitted. Accordingly, these unaudited condensed consolidated interim financial statements should be read in conjunction with the Company&#8217;s audited annual consolidated financial statements as of and for the year ended December&#160;31, 2023. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All references in this Prospectus to &#8220;$&#8221; mean U.S. dollars and all references to &#8220;DKK&#8221; mean Danish Kroner. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our financial information is presented in our presentation currency, U.S. Dollar, or USD. Our functional currency is the Danish Krone, or DKK. Certain Danish Krone amounts in this prospectus have been translated solely for convenience into USD at an assumed exchange rate of DKK 6.7447 per $1.00, which was the rounded official exchange rate of such currencies as of December&#160;31, 2023. We used an assumed exchange rate of DKK 6.9664 per $1.00, which was the official rounded exchange rate of such currencies as of June&#160;30, 2024 for the unaudited interim periods ended June&#160;30, 2024 and an assumed exchange rate of DKK 6.6595 per $1.00, which was the official rounded exchange rate of such currencies as of September&#160;30, 2024 for the unaudited interim periods ended September&#160;30, 2024. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Foreign currency transactions are translated into our functional currency, DKK, using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized as financial income or financial expenses in the consolidated statements of comprehensive loss. Non-monetary items in foreign currency, which are measured at cost at the consolidated statements of financial position date are translated into our functional currency, DKK, using the exchange rates at the date of the transaction. Such DKK translated amounts are not necessarily indicative of the amounts of DKK that could have actually been purchased with the underlying currency being exchanged into DKK at the dates indicated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Assets and liabilities in our functional currency are translated to our presentation currency, USD, at the exchange rates applicable on December&#160;31, 2023, June&#160;30, 2024 and September&#160;30, 2024 for the respective period. Income and expenses in our functional currency are translated to USD at the average exchange rate, which corresponds to an approximation of the exchange rates prevailing on each individual transaction date. Translation differences arising in the translation to presentation currency are recognized in other comprehensive income. Such USD amounts are not necessarily indicative of the amounts of USD that could actually have been purchased upon exchange of DKK at the dates indicated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have made rounding adjustments to some of the figures contained in this prospectus. Accordingly, numerical figures shown as totals in some tables may not be exact arithmetic aggregations of the figures that preceded them. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;22, 2024, we effected a change to the ratio of the ADSs to our ordinary shares from one ADS representing one (1)&#160;ordinary share to one ADS representing ten (10) ordinary shares (the &#8220;ADS Ratio Change&#8221;). Except as otherwise indicated, all information in this prospectus gives retroactive effect to the ADS Ratio Change. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">v</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:372pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have made rounding adjustments to reach some of the figures included in this prospectus. As a result, numerical figures shown as totals in some tables may not be an arithmetic aggregation of the figures that precede them. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus includes statistical, market and industry data and forecasts which we obtained from publicly available information and independent industry publications and reports that we believe to be reliable sources. These publicly available industry publications and reports generally state that they obtain their information from sources that they believe to be reliable, but they do not guarantee the accuracy or completeness of the information. Although we believe that these sources are reliable, we have not independently verified the information contained in such publications. In addition, assumptions and estimates of our and our industry&#8217;s future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in the &#8220;Risk Factor Summary&#8221; and in the Form 20-F for the fiscal year ended December&#160;31, 2023 as filed with the Securities and Exchange Commission (the &#8220;2023 Form 20-F&#8221;) incorporated by reference in this prospectus. These and other factors could cause our future performance to differ materially from our assumptions and estimates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Some of our trademarks and trade names are used in this prospectus, which are intellectual property owned by the Company. This prospectus also includes trademarks, trade names, and service marks that are the property of other organizations. Solely for convenience, our trademarks and trade names referred to in this prospectus appear without the </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> symbol, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights, or the right of the applicable licensor to these trademarks and trade names. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">vi</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSNRF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:252pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company discusses in this prospectus its business strategy, market opportunity, capital requirements, product introductions and development plans and the adequacy of the Company&#8217;s funding. Other statements contained in this prospectus, which are not historical facts, are also forward-looking statements. The Company has tried, wherever possible, to identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221; &#8220;estimates&#8221; and other comparable terminology. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company cautions investors that any forward-looking statements presented in this prospectus, or that the Company may make orally or in writing from time to time, are based on the beliefs of, assumptions made by, and information currently available to, the Company. These statements are based on assumptions, and the actual outcome will be affected by known and unknown risks, trends, uncertainties and factors that are beyond its control or ability to predict. Although the Company believes that its assumptions are reasonable, they are not a guarantee of future performance, and some will inevitably prove to be incorrect. As a result, its actual future results can be expected to differ from its expectations, and those differences may be material. Accordingly, investors should use caution in relying on forward-looking statements, which are based only on known results and trends at the time they are made, to anticipate future results or trends. Certain risks are discussed in this prospectus and also from time to time in the Company&#8217;s other filings with the Securities and Exchange Commission (&#8220;SEC&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus and all subsequent written and oral forward-looking statements attributable to the Company or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. The Company does not undertake any obligation to release publicly any revisions to its forward-looking statements to reflect events or circumstances after the date of this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In particular, you should consider the risks provided under &#8220;Risk Factors Summary&#8221; in this prospectus and in the 2023 Form 20-F incorporated by reference in this prospectus. </font>
        </div>
        <div style="margin-top:22pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8201; </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">vii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPRSU">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">PROSPECTUS SUMMARY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
              <font style="letter-spacing:0.2pt;">The following summary highlights selected information contained elsewhere in this prospectus. This summary does not contain all the information you should consider before investing in our securities. Before&#160;deciding to invest in the ADSs, you should read this entire prospectus carefully, including information incorporated by reference in this prospectus and any free writing prospectus prepared by us or on our behalf, including the section entitled &#8220;Risk Factor Summary&#8221; in this prospectus, &#8220;Item&#160;3. Key Information&#8221;, Item&#160;5 &#8220;Operating and Financial Review and Prospects&#8221;; Item&#160;7 Major Shareholders and Related Party Transactions; Item&#160;8, &#8220;Financial Information&#8221; in our 2023 Form 20-F and incorporated by reference in this prospectus; the sections titled &#8220;Business&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and the other sections of the documents incorporated by reference in this prospectus and the financial statements and the related notes incorporated by reference in this prospectus,. Unless otherwise indicated, all share amounts and prices assume the consummation of the ADS Ratio Change.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
            </div>

          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The Company</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Corporate Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Evaxion Biotech A/S is a pioneering clinical-stage TechBio company based upon the Artificial Intelligence (AI) platform: AI-Immunology&#8482;. The AI-Immunology&#8482; platform consists of five proprietary and scalable AI prediction models harnessing the power of data, machine learning and artificial intelligence to decode the human immune system. This enables the development of novel vaccines for the treatment of cancer as well as bacterial and viral infections. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We believe we are the first in the world to demonstrate a correlation between the predictive power of AI and clinical response in patients, as evidenced by a clear association between AI-Immunology&#8482; predictions and progression free survival in metastatic melanoma cancer patients. AI-Immunology&#8482; allows&#160;for fast and effective discovery, design and development of novel vaccines and offers a strong value&#160;proposition to both existing and potential pharma partners. The value proposition is supported by AI-Immunology&#8482; being preclinically and clinically validated, adaptable, scalable to other disease areas and, we believe, significantly reduces development costs and risks. Partnerships are essential to realizing the full value of the opportunities AI-Immunology&#8482; offers and we have a strong focus on partnering as part of our strategy execution. Our recently announced significantly expanded partnership with MSD validates this approach and confirms the value of the AI-Immunology&#8482; platform seen from an external perspective. Further, we have developed a clinical-stage cancer pipeline of novel personalized therapeutic vaccines and a preclinical prophylactic vaccine pipeline for bacterial and viral diseases with high unmet medical needs based on AI-Immunology&#8482; identified vaccine targets. Evaxion is committed to transforming patients&#8217; lives by providing innovative and targeted treatment options through AI-Immunology&#8482;. Our purpose is saving and improving lives with AI-Immunology&#8482;. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The Evaxion Strategy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">The Evaxion strategy centers around our AI-Immunology&#8482; platform, which has been continuously developed and refined over the past 15&#160;years. This has provided us with a pioneering and differentiated position within AI-based vaccine target discovery and further led to the design and development of novel vaccine candidates. The strong potential of AI-Immunology&#8482; is evidenced by both the preclinical and clinical data we have generated as well as through existing partnerships. The AI-Immunology&#8482; platform holds the potential to generate one new vaccine target every 24 hours, is delivery modality-agnostic, and easily adaptable to partner needs. The platform is currently trained in cancer and infectious diseases and is scalable to other therapeutic areas. The high throughput, combined with a very flexible model, offers a strong value proposition for both existing and future partners. </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The AI-Immunology&#8482; platform contains five interrelated proprietary AI prediction models: (i)&#160;PIONEER&#8482;, our cancer neoantigen prediction model, (ii)&#160;ObsERV&#8482;, our endogenous retrovirus (ERV) tumor antigen prediction model, (iii)&#160;EDEN&#8482;, our B-cell antigen prediction model, (iv)&#160;RAVEN&#8482;, our T-cell antigen prediction model and (v)&#160;AI-DeeP&#8482; our responder prediction model. The platform features a unique modular architecture where the same building blocks are used across different AI prediction models. This means that improvements in individual building blocks will lead to improvements in all the AI </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tF1CD">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">prediction models where the building block is used. This, we believe, serves to further enhance the predictive capabilities of AI-Immunology&#8482; and to ensure we will retain a differentiated position going forward. The building block-based architecture also gives a high scalability to other therapeutic areas which is offering attractive long-term opportunities for Evaxion. </font>
          </div>
          <div style="text-indent:20pt; margin-top:11.19pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">In parallel with the AI-Immunology&#8482; platform development, we have been building a strong multidisciplinary capability set spanning the full value chain from target discovery to early clinical development. Our state of art wet-lab and animal facility gives us a unique opportunity for rapidly validating our AI predictions in pre-clinical models thereby, generating proprietary data as well as new pipeline assets. Further, it offers partners a flexible and adaptable one stop shop for discovery and development of new vaccine candidates. </font>
          </div>
          <div style="text-indent:20pt; margin-top:11.19pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">The AI-Immunology&#8482; platform together with our multidisciplinary capability set drives a clear differentiation for our AI driven approach to development of novel vaccine candidates and provides a strong value proposition towards potential partners. The differentiation is illustrated in Figure 1 below. </font>
          </div>
          <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
            <img src="fc_immun-4c.jpg" alt="[MISSING IMAGE: fc_immun-4c.jpg]" height="307" width="576" >
          </div>
          <div style=" float:left; line-height:12pt; margin-top:14.69pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Figure 1</font>
            <br >
          </div>
          <div style=" margin-top:14.69pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">A clearly differentiated position with AI based drug discovery and development.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:11.19pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">With AI-Immunology&#8482; at the core, and further building upon our strong multidisciplinary capability set, our focus is on pursuing value realization of our AI platform and pipeline via a multi-partner approach. This is being executed through our three-pronged business model focusing on vaccine target discovery collaborations using our AI-Immunology&#8482; platform (Targets), advancing our proprietary pipeline of vaccine candidates (Pipeline) and using our core data and predictive capabilities to develop responder models (Responders). Please see Figure 2 below for an overview of the Evaxion three-pronged business model. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tF2ET">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:18pt;margin-left:12pt;width:456pt;">
          <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
            <img src="fc_strategy-4c.jpg" alt="[MISSING IMAGE: fc_strategy-4c.jpg]" height="330" width="576" >
          </div>
          <div style=" float:left; line-height:12pt; margin-top:12.6pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Figure 2</font>
            <br >
          </div>
          <div style=" margin-top:12.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The Evaxion three-pronged business model.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">For the </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Target</font><font style="letter-spacing:0.2pt;"> part of our three-pronged business model, the multi-partner approach to value realization means that we have a strong focus on establishing partnerships where we bring our multidisciplinary capabilities and the unique predictive capabilities of AI-Immunology&#8482; to partners with the objective of developing novel vaccine candidates. The EVX-B3 agreement with MSD from September&#160;2023, which in September&#160;2024 resulted in a significantly expanded collaboration with an option and license agreement, covering both EVX-B3 and EVX-B2, with potential milestones of USD 592&#160;million per product, is a good example of what we aim at achieving in the Target part of our three-pronged business model. For EVX-B3, we teamed up with MSD in September&#160;2023 to utilize AI-Immunology&#8482; to discover and develop a novel vaccine for a bacterial infectious disease, where no vaccine is available today. We are excited about this collaboration with MSD and are thrilled to see it continuing into the next phase, a collaboration which now also includes EVX-B2. We are also very pleased with the level of interest we are seeing from other potential partners in establishing similar partnerships within other infectious disease areas and are excited about the potential for addressing significant unmet needs in collaboration with partners within the Target part of our strategy. To further develop the predictive capabilities of AI-Immunology&#8482;, and hence further strengthen the value proposition to existing and potential partners, we are excited to have launched an upgraded version of EDEN&#8482;, EDEN&#8482; 5.0, which took place at the European Conference on Computational Biology (ECCB) conference in September&#160;2024. </font>
          </div>

            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">Within the </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Pipeline</font><font style="letter-spacing:0.2pt;"> part of our three-pronged business model, we are advancing our own select high value programs to key value inflection points following which we will pursue partnering. With our multidisciplinary capabilities and the predictive capabilities of AI-Immunology&#8482;, we have strong potential for quickly advancing proprietary high value programs into preclinical and clinical development. However, we do not intend to run larger scale clinical trials ourselves. Within the Pipeline part of the strategy, we are very excited about the convincing EVX-01 Phase&#160;2 one-year clinical data we presented at ESMO in September. The convincing data already makes us look forward to the two-year clinical readout in Q3, 2025. The one-year clinical data was a very important milestone for our lead pipeline candidate, and we are excited about the commercial potential of EVX-01. We will also partner pipeline assets before entering clinical development if this makes sense from a strategic and financial point of view. The agreement with MSD on EVX-B2 (as well as EVX-B3), containing potential milestones of up to USD 592&#160;million per product, which we announced in September&#160;2024 is a good example of such early partnering strategy. </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Within the </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Responder</font><font style="letter-spacing:0.2pt;"> part of our strategy, which focuses on harnessing our data and predictive capabilities to develop responder models, we obtained Proof of Principle for our Checkpoint Inhibitor </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">responder model in late 2023. We have now defined a high-level development plan and a preliminary commercial model. The plan remains to bring our Checkpoint Inhibitor responder model forward in a partnership-based structure. </font>
          </div>
          <div style="text-indent:20pt; margin-top:11.2pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Hence, in summary, we are seeing continued strong progress on our strategy as executed via our three-pronged business model. We are excited about having delivered successfully on most of our 2024 key milestones as can be seen in Figure 3 below. We are also thrilled about the interest we are seeing from potential partners in both the establishment of new vaccine discovery and development collaborations as well as in our existing pipeline assets and excited about our significantly expanded vaccine collaboration with MSD and the financial and strategic value it brings While we will not be able to meet the original business development ambition of generating USD 14&#160;million in business development income or cash in for 2024, due to certain business development discussions moving into 2025, we are pleased with the USD 3.2&#160;million already secured in 2024 via the MSD agreement as well as the potential up to USD 10&#160;million for 2025, contingent upon if MSD exercises the option for one or both vaccine candidates. Further, the business development discussions having moved into 2025 enhances the potential for generation of business development income in 2025. Finally, we remain on track for meeting our milestone on preclinical Proof-of-Concept for our ERV based precision vaccine in 2024. </font>
          </div>
          <div style="position:relative;margin-top:11.2pt; text-align:center; width:456pt;">
            <img src="tb_milestones-4c.jpg" alt="[MISSING IMAGE: tb_milestones-4c.jpg]" height="285" width="595" >
          </div>
          <div style=" float:left; line-height:12pt; margin-top:14.68pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Figure 3</font>
            <br >
          </div>
          <div style=" margin-top:14.68pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">2024 company milestones.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:11.2pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">The strong strategy execution in 2024 makes us excited about the prospects for 2025. Focus for 2025 will be a continuation of the multi-partner approach to value realization via execution upon our business development strategy, continuation of the ongoing EVX-01 phase 2 trial, the ongoing strengthening of our AI-Immunology&#8482; platform and further advancement of our research activities, including progressing our ERV based precision vaccine concept towards clinical development. Finally, the focus is of course on advancing our existing partnerships including bringing the MSD collaboration to option exercise. Please see the table below for an overview of 2025 company milestones. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG1">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:18pt;margin-left:12pt;width:456pt;">
          <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
            <img src="fc_aiimmunology-4c.jpg" alt="[MISSING IMAGE: fc_aiimmunology-4c.jpg]" height="301" width="608" >
          </div>
          <div style=" float:left; line-height:12pt; margin-top:12.6pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Figure 4</font>
            <br >
          </div>
          <div style=" margin-top:12.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">2025 company milestones.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Financial Update</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our cash and cash equivalents were $4.6&#160;million as of September&#160;30, 2024, not including the $3.2&#160;million upfront from the MSD agreement received in October&#160;2024. The amount is unaudited and is not necessarily indicative of any future period and should be read together with &#8220;Risk Factors Summary,&#8221; &#8220;Cautionary Note Regarding Forward-Looking Statements,&#8221; and our financial statements and related notes contained in this prospectus and our 2023 Form 20-F. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our AI-Immunology&#8482; Platform</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our AI-Immunology&#8482; platform is the core of Evaxion. The platform has been developed and refined over the past 15&#160;years. The AI-Immunology&#8482; platform holds following key features: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Consists of five AI prediction models and has a unique modular architecture based upon building blocks used across models </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">AI prediction models applied in cancer and infectious diseases with a demonstrated correlation between the predictive power of AI and clinical response in patients </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Vaccine target discovery, design and development of personalized and precision therapeutic cancer vaccine candidates </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Vaccine target discovery, design and development of prophylactic bacterial and viral vaccine candidates </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Potential for one new target every 24 hours </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Platform is delivery modality agnostic </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Unique predictive capabilities </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Adaptability to partner needs </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Scalable to other therapeutic areas </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">90%+ cheaper target discovery vs. reverse vaccinology </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">80% fewer targets needs testing </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The AI prediction models in AI-Immunology&#8482; each offer unique predictive capabilities in their respective areas and an overview can be seen below. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG2">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:18pt;margin-left:12pt;width:456pt;">
          <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
            <img src="fc_cancer-4c.jpg" alt="[MISSING IMAGE: fc_cancer-4c.jpg]" height="275" width="608" >
          </div>
          <div style=" float:left; line-height:12pt; margin-top:12.6pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Figure 5</font>
            <br >
          </div>
          <div style=" margin-top:12.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The AI-Immunology&#8482; platform.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our PIONEER&#8482; Model</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">PIONEER&#8482; is our proprietary AI prediction model for the rapid discovery and design of patient-specific neoantigens used to derive cancer vaccines. It has been shown that neoantigens, which arise from patient-specific tumor mutations, play a critical role in T-cell mediated antitumor immune response. Neoantigens, being absent in normal tissues, are, we believe, ideal cancer vaccine targets because they distinguish themselves from germline proteins and can be recognized as non-self by the immune system. We believe our AI building blocks within PIONEER&#8482; enable us to efficiently identify and select those neoantigens that will generate a de novo T-cell response leading to significant antitumor effect in each patient. By combining these neoantigens with a purposefully selected delivery modality believed to further enhance this antitumor effect, we design and deliver our vaccines to patients, effectively training their immune systems to target and kill cancer cells with no or very limited adverse effects on healthy non-cancer cells. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our proprietary AI building blocks identifying neoantigens within PIONEER&#8482; have been trained using gradient-boosted decision trees, transformers and a conditional generative adversarial network approach on our internally generated data as well as other data, including, but not limited to, next generation sequencing data from tumor samples, mass spectrometry immunopeptidomics, peptide-MHC-binding affinity data, T-cell immunogenicity data and peptide-MHC-binding stability data. We have demonstrated that development and iterative training of our AI building blocks improves its predictive power in identifying and selecting therapeutic neoantigens. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The strong predictive capabilities of PIONEER&#8482; have been proven in a clinical trial setting, where we in the EVX-01 Phase&#160;1 trial demonstrated a clear link between quality of the predictions from PIONEER&#8482; and Progression Free Survival in metastatic melanoma patients. We believe that we are the first in the world to establish a link between AI prediction and clinical outcomes. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our ObsERV&#8482; Model</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">ObsERV&#8482; is our proprietary AI model for the discovery of patient-specific virus-derived sequences, so-called ERVs (endogenous retroviruses), expressed in cancer. Targeting this novel class of tumor antigens may allow for developing a completely new type of immunotherapy against immunologically cold tumors with low response rates to immunotherapy. ObsERV&#8482; can rapidly discover ERV tumor antigens and design personalized and precision vaccines containing these antigens. Our proprietary AI building blocks within ObsERV&#8482;, for the prediction of antigen-specific T-cell responses have been trained using transformers and a conditional generative adversarial network approach. This allows us to efficiently identify and select those ERV- antigens that we believe are most likely to generate a strong, </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> T-cell response leading to significant antitumor effect in each patient. The goal of our ObsERV&#8482; model derived cancer vaccines is to </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">deliver therapeutic ERV-antigens to patients in a way that trains the patients&#8217; own immune system to target and kill tumor cells with no or very limited adverse effects on healthy non-cancer cells. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We have preclinically demonstrated complete tumor eradication in animal models when targeting ObsERV&#8482; identified ERVs. Hence, we believe such ERV-based therapies will induce a directed T-cell dependent immune response leading to tumor eradication. Our EVX-03 development candidate contains a combination of PIONEER predicted neoantigens and ObsERV&#8482; predicted ERV-antigens. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We believe that ObsERV&#8482; will allow us to develop therapeutic cancer vaccines benefitting a broader range of cancer patients for which no or limited treatment options exist. This includes providing novel treatment solutions for cancer patients that are unlike to respond to immunotherapy and cancer vaccines that targets neoantigens. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At the ASH conference in December&#160;2023, we showcased a novel usage of ERVs for hematological cancers offering potential for a completely novel treatment paradigm. A key 2024 milestone is to establish preclinical proof-of-concept for an ERV based precision vaccine candidate, which we remain on track to deliver. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our EDEN&#8482; Model</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">EDEN&#8482; is our proprietary AI prediction model that rapidly identifies novel, highly protective B-cell targets for use in pathogen-specific prophylactic vaccines against bacteria and virus, including antimicrobial resistant bacteria. Our proprietary algorithms in EDEN&#8482; allow us to predict and identify antigens that we believe will trigger a robust, protective immune response against almost any pathogen. The core of our EDEN&#8482; model is a proprietary machine learning ensemble of artificial neural networks trained using a feed-forward backpropagation approach to interpret immunological-relevant information in relation to bacterial antigens that incur protection in a vaccine setting. EDEN&#8482; has been trained on our own curated data set derived by trawling through publicly available patents and publications with reported truly protective and non-protective antigens tested in clinical and pre-clinical settings. The input to the artificial neural network ensemble is a feature transformation of the protein data set, in which several global and sequence-resolved properties are extracted. These structural and functional features have been selected for their relevance in protein chemistry, immunology and protein structure and their ability to guide the network in discriminating protective versus non-protective antigens. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We believe our approach can be used to target almost any pathogenic infection and rapidly enables the discovery and development of vaccine product candidates. We have applied EDEN&#8482; in seven bacteria pathogens to test its predictive power. For each pathogen, EDEN&#8482; identified novel vaccine antigens which were subsequently expressed as proteins and tested in pre-clinical, mouse infection models, demonstrating protection against all seven pathogens. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">EDEN&#8482; forms the basis for several pipeline compounds. The EDEN&#8482; AI prediction model is already the basis for three existing partnerships, and we see great potential for further partnerships based upon the unique predictive capabilities of EDEN&#8482;. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our RAVEN&#8482; Model</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">RAVEN&#8482; is our AI model that rapidly identifies T-cell epitopes in pathogenic virus and bacteria for the use in prophylactic infectious disease vaccines. The RAVEN&#8482; model synergizes with EDEN&#8482; as RAVEN&#8482; identified T-cell antigens can be used either as a stand-alone or incorporated into known or novel EDEN&#8482; identified B-cell antigens. We believe that a vaccine comprising both RAVEN&#8482; and EDEN&#8482; identified antigens will elicit both an antibody and a T-cell response. This may result in highly efficacious and broadly protective vaccines through robust memory T-cell populations. The RAVEN&#8482; model is a transformer-based neural network, trained using a conditional generative adversarial network approach. The algorithm is adjustable and can be used to ensure the broadest possible response across human tissue types and entire virus species, or alternatively to target specific human populations with common tissue types and/or selected viral strains in outbreaks. In a study using 17 T-cell epitopes identified by RAVEN&#8482; across the SARS-CoV-2 genome, 15 epitopes (88%) induced T-cell activation and provided significant protection against lethal SARS-CoV-2 challenge in a mouse model. Moreover, T-cell epitope enrichment </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:22.05pt; margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">involving engraftment of CD4+ T-cell epitopes from hemagglutinin genetic information across numerous influenza species improved antibody response in pre-clinical studies. Hemagglutinin, a viral fusion protein like the spike protein in coronaviruses, plays a crucial role in cellular entry. Enrichment of hemagglutinin significantly enhanced antibody response, resulting in 5-10 times better neutralization compared to non-enriched hemagglutinin. These identified antigens can be administered by any established vaccine delivery technology such as protein, DNA or mRNA. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">We have applied RAVEN&#8482; in our current pre-clinical vaccine program; EVX-V1, targeting CMV and in our EVX-B3 bacteria vaccine development. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our AI-DeeP&#8482; Model</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">AI-DeeP&#8482; is our proprietary AI model designed to predict if patients respond to cancer immunotherapies and is an instrumental part for the Responder part of our strategy. It utilizes immunogenomic expression profiles as well as neoantigen and ERV-antigen burden to differentiate between patients who could benefit from these therapies and those who may not.</font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Initially, the model&#8217;s effectiveness was highlighted through a clinical trial (EVX-01) where it successfully retrospectively predicted patient outcomes based on immunogenomic profiles from tumor biopsies. This prediction was statistically significant and shows promise in identifying patient response to immunotherapy. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Furthermore, AI-DeeP&#8482; was improved by incorporating additional features, including neoantigen and ERV- antigen burden, resulting AI-DeeP&#8482; outperforming classical biomarkers in identifying non-responding patients. It showcased the ability to pinpoint 10&#8201;&#8211;&#8201;30% of non-responsive cases with a precision of 95%, compared to 70&#8201;&#8211;&#8201;80% precision achieved by traditional biomarkers tumor mutational burden, or TMB and PD-L1 tumor expression. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">This AI model shows promise in reducing clinical development risks and enhancing benefits for patients and healthcare payers by stratifying patients based on their predicted likelihood to respond to immunotherapy. Hence, it holds great promise for improving outcomes and addressing the significant healthcare burden. Ongoing efforts aim to further refine and validate AI-DeeP&#8482; by accumulating more data, enhancing its sensitivity, and increasing predictive accuracy. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We presented Proof of Principle for our Responding model in November&#160;2023 at Biomarkers &amp; Precision Oncology Europe conference. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our Pipeline</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">The immune system is generally considered nature&#8217;s strongest weapon to fight disease. When the immune system is engaged, people are often able to fully eliminate a disease or infection from the body. Using our deep understanding of the human immune system and our proprietary AI-Immunology&#8482; technology, we can mimic the human immune system in silico and predict whether certain stimuli induce an immune response. Our predictive power relies on our ability to process and interpret vast amounts of immune-related data, a process known as computational immunology. Using our in-silico AI models, we are able to transform such data into advanced algorithms that we believe can accurately predict cellular interactions within the immune system and identify the right vaccine targets that will stimulate a relevant response. To translate the identified targets into product candidates, we test multiple delivery modalities and move the most promising forward. We believe this process allows us to discover new product candidates and move them into the clinic without spending time and resources on clinical development of product candidates that may ultimately fail to produce a therapeutic or prophylactic response. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Based upon the AI-Immunology&#8482; platform we have established a broad pre-clinical and clinical pipeline within cancer and infectious diseases. Our pipeline candidates are a mix of proprietary and partnered programs. Please see the chart below for an overview of the current Evaxion pipeline. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG3">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:18pt;margin-left:12pt;width:456pt;">
          <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
            <img src="fc_stageofdevelop-4c.jpg" alt="[MISSING IMAGE: fc_stageofdevelop-4c.jpg]" height="337" width="608" >
          </div>
          <div style=" float:left; line-height:12pt; margin-top:12.2pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Figure 6</font>
            <br >
          </div>
          <div style=" margin-top:12.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The Evaxion pipeline.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Patent Portfolio and Intellectual Property</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">To protect and maintain exclusivity to our products and AI-Immunology&#8482; platform, we have developed what we believe is a strong portfolio of patents and trade-secrets. Our strategy for protecting our AI-Immunology&#8482; platform is to pursue patent protection on some essential features while keep other essential features as trade secrets. The strategy allows us to obtain patent protection on essential features and protect our technology against copying. We believe this strategy effectively protects our proprietary position and exclude competitors from utilizing our technology. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In addition, we pursue patent protection for our pipeline products focusing on obtaining patent rights covering; composition of matter, methods, and use of same. We own thirty (30) patent families; twenty-six (27) granted patents and seventy (82) patent applications. In general, our strategy is to file a priority document with the European Patent office (EPO) followed by a Patent Co-operation Treaty (PCT) application and subsequently national or regional filings, e.g. Unites States, Europe (EPO), Japan, China, Australia, and Canada. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We will continue to capture value of our innovation by patenting and trade-secrets following our strategy on intellectual property. These assets will continue to build and strengthen our position within AI, infectious disease, cancer vaccines and cancer treatment response predictions. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our Management Team</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">To deliver on our objectives, we have built an experienced and broadly skilled management team. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our Chief Executive Officer, Christian Kanstrup joined on September&#160;1, 2023. Christian Kanstrup has more than 25&#160;years of experience in the life science industry, coming from a position of Executive Vice President at Mediq before joining Evaxion. Prior to that, Christian held a broad range of senior management roles at Novo Nordisk A/S, most recently as Senior Vice President and global head of Biopharm Operations, and previously held other senior leadership roles within commercial, strategy and corporate development roles. Christian also holds various board and advisory positions in the life science industry, advising on corporate strategy and company growth. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our Chief Science Officer Dr.&#160;Birgitte R&#248;n&#248; joined in 2017 and was appointed CSO in 2021. Dr.&#160;R&#248;n&#248; has more than 20&#160;years&#8217; experience in biopharmaceutical drug discovery from academia and industry and </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">received her PhD in experimental oncology and immunology from National Institutes of Health, Bethesda, USA, and Copenhagen University Hospital, Denmark. Prior to joining Evaxion, Birgitte R&#248;n&#248; served as a specialist, team leader and project manager at Novo Nordisk A/S, where she led early drug discovery projects, evaluating in-licensing opportunities, and supporting drug development projects with pre-clinical and biomarker expertise. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Jesper Nyegaard Nissen joined as Chief Operating Officer in 2022 and was also appointed interim Chief Financial Officer in 2023. For over 25&#160;years, Jesper Nyegaard Nissen has worked broadly across the pharma value chain in global operations positions at Novo Nordisk anchored in research, development and finance. He has covered business areas across a variety of focus points, including finance operation, external innovation and collaborations, digitalization of business process optimization, development and shaping of organizational capacities, and implementation of performance and process improvement structures. On July&#160;31, 2024, he tendered his resignation as the Interim Chief Financial Officer and Chief Operating Officer, to be effective October&#160;31, 2024. Mr.&#160;Nissen&#8217;s resignation was for personal reasons and was not a result of any disagreement with the Company on any matter relating to the Company&#8217;s operations, policies or practices. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The Company has appointed Thomas Frederik Schmidt to assume Mr.&#160;Nissen&#8217;s responsibilities as the Interim Chief Financial Officer. Mr.&#160;Schmidt brings more than 29&#160;years of financial management experience from across different industries with more than 25&#160;years of these being based in the life science industry including roles as country Managing Director and country Chief Financial Officer in Roche and Group CFO in Ambu, a MedTech company listed on the Nasdaq Copenhagen Stock Exchange. Mr.&#160;Schmidt holds a Master of Science in Business Economics and Auditing from Copenhagen Business School and has undergone training and preparation for State Authorized Public Accountant (CPA) exam. Mr.&#160;Schmidt has succeeded Mr.&#160;Nissen as the Company&#8217;s Interim CFO as of November&#160;1, 2024. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Andreas Holm Mattsson serves as Chief AI Officer at Evaxion Biotech, where he&#8217;s been at the&#160;forefront in silico-based vaccine target discovery. He has played a key role in developing Evaxion&#8217;s innovative AI-Immunology platform, a proprietary AI technology for identifying novel vaccine targets for cancer and infectious diseases. Andreas brings a strong educational background in bioinformatics from the Technical University of Denmark and has previously worked at Novo Nordisk. Since founding Evaxion in 2008, he has been an essential part of the company&#8217;s growth, serving in various executive roles. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Company Structure</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We have been building strong in-house multidisciplinary capabilities spanning the full value chain from&#160;AI target discovery to early clinical development. However, a lot of our development is done via CDMOs/CROs to focus our limited internal resources in strategic core areas where we have an edge over our competitors. The research we do in-house is mainly focused on AI-Immunology&#8482; platform development, pre-clinical mouse studies and clinical translational activities, i.e. our core scientific areas. Other scientific activities, like manufacturing of new drug product leads, toxicology studies, clinical trial management and regulatory affairs are outsourced to CDMOs/CROs, where we internally have experienced managers/scientists to manage these. Our organizational strategy for now, is to continue with this setup to maintain flexibility and limit our fixed cash burn rate and at the same time develop and stay at the forefront within AI-Immunology&#8482;. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our Strengths</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Since our inception, we have applied our advanced data, AI, and machine learning capabilities to transform complex biological data into tangible AI-Immunology&#8482; powered vaccines. We believe that we&#160;were one of the first companies to challenge status quo in drug discovery and development using AI&#160;technology. By building our multidisciplinary capabilities, gathering data and developing our AI prediction models, we hold a pioneering position with our AI-Immunology&#8482; platform. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our key strengths include:</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Our flexible, modular, scalable and adaptable AI-Immunology&#8482; platform offers a strong value proposition toward existing and potential partners </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Our five AI models PIONEER&#8482;, ObsERV&#8482;, AI-DEEP&#8482;, EDEN&#8482; and RAVEN&#8482; ingrained in the AI-Immunology&#8482; platform, have allowed us to generate numerous pipeline candidates within both cancer and infectious diseases, all with first-in-class potential and with our first two cancer product candidates in clinical development </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">We are seeing a strong external interest in both our AI-Immunology&#8482; platform and our pipeline and the significantly expanded vaccine collaboration with MSD signed in September&#160;2024, containing potential milestones of USD $592&#160;million for each of EVX-B2 and EVX-B3, validates our approach </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Our AI-Immunology&#8482; platform offers the potential to expand our partnerships and product candidate portfolio and allows for entering into additional therapy areas </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Our AI-Immunology&#8482; platform facilitates the identification of novel effective vaccine targets, enhancing the potential for clinical success </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Our in-house capabilities for experimental screening and testing of novel targets/product leads allow us to move rapidly from target/product lead identification to pre-clinical development and further into clinical development </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Our model for iterative training allows for continuous improvement of our AI-Immunology&#8482; platform as data are generated throughout the drug development stages </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">We have established a direct link between the predictive power of our AI-Immunology&#8482; platform and preclinical and clinical outcome </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Our existing collaborations are confirming the strength of our AI-Immunology&#8482; platform </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Our strong ties with MSD Global Health Innovation Fund (MSD GHI), a corporate venture capital&#160;arm of Merck &amp; Co., Inc., Rahway, NJ, USA as our single largest shareholder holding approximately&#160;13% (see Share Ownership&#8201;&#8212;&#8201;Major Shareholders) </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Risks Associated with Our Business</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our business is subject to several risks of which you should be aware before making an investment decision. These risks are discussed more fully in the section of this prospectus titled &#8220;Risk Factors&#8221; immediately following this prospectus summary. These risks include, but are not limited to, the following: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">On May&#160;7, 2024, we received a notification from Nasdaq that we are not in compliance with the Nasdaq requirement to maintain a minimum equity of USD $2.5&#160;million. We were granted an extension until November&#160;4, 2024, to demonstrate compliance with the Nasdaq listing requirements. On November&#160;11, 2024 we received a delisting notice from Nasdaq Capital Markets, which we appealed on November&#160;12, 2024 and will pursue an additional 180-day exemption allowing time for securing compliance in a balanced way. The appeal will stay any trading suspension of the ADSs until completion of the Nasdaq hearing process and expiration of any additional extension period granted by the panel following the hearing. During any additional extension, we intend to regain compliance and maintain our Nasdaq listing, however there is no guarantee that we will be able to regain compliance. We are in constructive dialogue with Nasdaq on the matter, however no guarantees can be made that additional 180-days exemption will be given. If appeal isn&#8217;t successful, the continued non-compliance would result in delisting from Nasdaq Capital Markets. Such a delisting would likely have a negative effect on the price of the ADSs and would impair your ability to sell or purchase the ADSs when you wish to do so. In the event of a delisting, any action taken by us to restore compliance with listing requirements may not i) allow the ADSs to become listed again, ii) stabilize the market price or iii) improve the liquidity of the ADSs, iv) prevent the ADSs from dropping below the Nasdaq minimum bid price requirement or v) prevent future non-compliance with the listing requirements of Nasdaq. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">We are a clinical stage AI-Immunology company with only two product candidates in the early stages of clinical trials. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">We have incurred significant losses since our inception, and we anticipate that we will continue to incur significant losses for the foreseeable future, however reduced due to our strategic focus on partnerships. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">We will require substantial additional financing to achieve our goals which may not be available. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">We will need to develop our company, and we may encounter difficulties in managing this development and expansion, which could disrupt our operations. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Pharmaceutical product development is inherently uncertain, and there is no guarantee that any of our product candidates will receive marketing approval. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">No vaccine has been approved using our technology, and none may ever be approved. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Our product candidates may not work as intended, may cause undesirable side effects or may have other properties that could delay or prevent their regulatory approval, limit the commercial profile of an approved label or result in significant negative consequences following marketing approval, if any. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Our business model is based upon partnering and there is no guarantee that we will be able to secure needed partnerships to be able to monetize our platform and assets. Our future partners, if any, may not be able to obtain regulatory approval for products, if any, derived from our product candidates under applicable US, European and other international regulatory requirements. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">We face significant competition in an environment of rapid technological and scientific change, and our failure to effectively compete would prevent us from achieving our goals. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Even if products derived from our product candidates receive regulatory approval, such products may not gain market acceptance and our future partners, if any, may not be able to effectively commercialize them. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">If we are not successful in developing our product candidates and our future partners, if any, are not successful in commercializing any products derived from our product candidates, our ability to expand our business and achieve our strategic objectives will be impaired. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">We rely on third parties in the conduct of significant aspects of our pre-clinical studies and clinical trials and intend to rely on pharma partners in the conduct of future clinical trials. If these third parties/pharma partners do not successfully carry out their contractual duties, fail to comply with applicable regulatory requirements and/or fail to meet expected deadlines, we may face delays and/or be unable to obtain regulatory approval for our product candidates. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Enrolling patients in clinical trials may be difficult for many reasons, including high screen failure, manufacturing capacity for personalized products, timing, proximity and availability of clinical sites, perceived risks, and publicity about the success or lack of success in the methods of treatment. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Our future partners, if any, may encounter difficulties in manufacturing to supply clinical studies and the market. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Certain of our product candidates may be uniquely manufactured for each patient and we and/or our future partners may encounter difficulties in manufacturing, particularly with respect to the scaling-up of manufacturing capabilities. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">If our efforts to obtain, maintain, protect, defend and/or enforce the intellectual property related to our product candidates and technologies are not adequate, we may not be able to compete effectively in our market. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">We may be involved in lawsuits to protect or enforce our intellectual property or the intellectual property of our licensors, or to defend against third-party claims that we infringe, misappropriate or otherwise violate such third party&#8217;s intellectual property. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Corporate Information</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We were incorporated under the laws of the Kingdom of Denmark on August&#160;11, 2008, as a private limited liability company (in Danish: </font><font style="font-style:italic;letter-spacing:0.2pt;">Anpartsselskab</font><font style="letter-spacing:0.2pt;">, or </font><font style="font-style:italic;letter-spacing:0.2pt;">ApS</font><font style="letter-spacing:0.2pt;">) and are registered with the Danish Business Authority (in Danish: </font><font style="font-style:italic;letter-spacing:0.2pt;">Erhvervsstyrelsen</font><font style="letter-spacing:0.2pt;">) in Copenhagen, Denmark under registration number 31762863. On March&#160;29, 2019, our company was converted into a public limited liability company (in Danish: </font><font style="font-style:italic;letter-spacing:0.2pt;">Aktieselskab</font><font style="letter-spacing:0.2pt;">, or </font><font style="font-style:italic;letter-spacing:0.2pt;">A/S)</font><font style="letter-spacing:0.2pt;">. Our principal executive offices are located at Dr.&#160;Neergaards Vej 5F, 2970 H&#248;rsholm, </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Denmark and our telephone number is +45 31 31 97 53. Our website address is www.evaxion-biotech.com. The information on, or that can be accessed through, our website is not part of and is not incorporated by reference into this prospectus. We have included our website address as an inactive textual reference only. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Implications of Being an &#8220;Emerging Growth Company&#8221;</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We are an &#8220;emerging growth company,&#8221; as defined in Section&#160;2(a) of the Securities Act of 1933, as amended, or the Securities Act. As such, we are eligible to, and intend to, take advantage of certain exemptions from various reporting requirements applicable to other public companies that are not &#8220;emerging growth companies&#8221; such as not being required to comply with the auditor attestation requirements in the assessment of our internal control over financial reporting of Section&#160;404 of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act. We could remain an &#8220;emerging growth company&#8221; for up to five&#160;years, or until the earliest of (a)&#160;the last day of the first fiscal year in which our annual gross revenue exceeds $1.235&#160;billion, (b)&#160;the date that we become a &#8220;large accelerated filer&#8221; as defined in Rule&#160;12b-2 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, which would occur if the market value of all our ordinary shares, including those represented by the ADSs, that are held by non- affiliates exceeds $700&#160;million as of the last business day of our most recently completed second fiscal quarter, or (c)&#160;the date on which we have issued more than $1&#160;billion in nonconvertible debt during the preceding three-year period. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Recent Developments</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">ADS Ratio Change</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our board of directors approved the change in the ratio of ADSs evidencing ordinary shares from one (1) ADS representing one (1)&#160;ordinary share to one (1)&#160;ADS representing ten (10) ordinary shares, which resulted in a one for ten (10) reverse split of the issued and outstanding ADSs (the &#8220;ADS Ratio Change&#8221;). The ADS Ratio Change was effective on January&#160;22, 2024. All ADS and related warrant information presented in this prospectus, including our financial statements and accompanying footnotes, has been retroactively adjusted to reflect the reduced number of ADSs resulting from the ADS Ratio Change, unless otherwise noted. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">Receipt of Nasdaq Notification</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On May&#160;7, 2024, the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) Listing Qualifications Department notified us that the Company no longer complied with Nasdaq Listing Rule&#160;5550(b)(1) (the &#8220;Rule&#8221;). Under the Rule, companies listed on Nasdaq must maintain stockholders&#8217; equity of at least $2,500,000 (the &#8220;Stockholders&#8217; Equity Requirement&#8221;). The Company&#8217;s stockholders&#8217; equity of $(4,729,000) for the period ended December&#160;31, 2023 was below the Stockholders&#8217; Equity Requirement for continued listing. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On May&#160;31, 2024, we submitted a plan to the staff at the Nasdaq Listing Qualifications Department (the &#8220;Staff&#8221;) to regain compliance with the Stockholders&#8217; Equity Requirement (the &#8220;Compliance Plan&#8221;), and on June&#160;13, 2024, the Staff notified the Company (the &#8220;Letter&#8221;) that it would be granted an extension until November&#160;4, 2024, to demonstrate compliance with the Rule to meet the continued listing requirements of Nasdaq, conditioned upon the Company evidencing compliance with the Rule. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On November&#160;11, 2024 we received a delisting notice from Nasdaq Capital Markets, which we appealed on November&#160;12, 2024 and will pursue an additional 180-day exemption allowing time for securing compliance in a balanced way. The appeal will stay any trading suspension of the ADSs until completion of the Nasdaq hearing process and expiration of any additional extension period granted by the panel following the hearing. During any additional extension, we intend to regain compliance and maintain our Nasdaq listing, however there is no guarantee that we will be able to regain compliance. We are in constructive dialogue with Nasdaq on the matter, however no guarantees can be made that additional 180-days exemption will be given. If appeal isn&#8217;t successful, the continued non-compliance would result in delisting from Nasdaq Capital Markets. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">Business Updates</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On September&#160;9, 2024, Evaxion announced it had obtained pre-clinical Proof-of-Concept (PoC) for novel mRNA Gonorrhea vaccine candidate EVX-B2, achieving another company milestone. New pre-clinical </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">data demonstrated the ability of EVX-B2 in eliminating gonorrhea bacteria by triggering a targeted immune response, providing strong PoC for the mRNA-based version of EVX-B2 in a pre-clinical setting. EVX-B2 was initially designed as a protein-based prophylactic vaccine candidate for which pre-clinical PoC had already been obtained. The novel pre-clinical data for the mRNA-version of the vaccine substantiates that AI-Immunology&#8482; identified vaccine antigens are delivery modality agnostic and can be applied across different vaccine modalities. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On September&#160;16, 2024, Evaxion announced convincing one-year data from an ongoing phase 2 trial on its lead clinical asset, AI-designed personalized cancer vaccine EVX-01. Presenting phase 2 efficacy data for an AI-designed vaccine was a major milestone for Evaxion. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The data demonstrated 69% Overall Response Rate, reduction in tumor target lesions in 15 out of 16&#160;patients, an immunogenicity rate of 79%, and a positive correlation between our AI-Immunology&#8482; platform predictions and immune responses induced by the individual neoantigens in the EVX-01 vaccine (p=0.00013). The observed immunogenicity rate means that 79% of EVX-01&#8217;s vaccine targets triggered a targeted immune response, which compares very favorably to what is seen with other approaches. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">These clinical findings underscore the significant therapeutic potential of EVX-01 and are yet another validation of the AI-Immunology&#8482; platform as a leading AI technology for fast and effective vaccine target discovery and design. The data was presented at the renowned European Society for Medical Oncology (ESMO) Congress 2024. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On September&#160;19, 2024, Evaxion launched an improved version of its AI-Immunology&#8482; platform for vaccine antigen prediction. Among other improvements, the platform can now predict toxin antigens, allowing for the development of improved bacterial vaccines. The upgrade will expectedly improve Evaxion&#8217;s ability to fast and effectively discover AI-derived novel vaccines and is expected to further solidify the strong interest seen in AI-Immunology&#8482; from potential partners. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On September&#160;26, 2024, Evaxion announced a significant expansion of its vaccine development collaboration with MSD (tradename of Merck &amp; Co., Inc., Rahway, NJ, USA) in a transformative deal carrying substantial value for Evaxion. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Under the terms of the agreement, Evaxion has granted MSD an option to exclusively license Evaxion&#8217;s preclinical vaccine candidates EVX-B2 and EVX-B3. EVX-B2 is a protein-based candidate for Gonorrhea and EVX-B3 targets an undisclosed infectious agent. In return, Evaxion receives an upfront payment of $3.2&#160;million and up to $10&#160;million in 2025, contingent upon MSD exercising its option to license either one or both candidates. In addition, Evaxion is eligible for development, regulatory and sales milestone payments with a potential value of up to $592&#160;million per product, as well as royalties on net sales. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Evaxion and MSD have been collaborating on EVX-B3 since 2023. Also in 2023, MSD, through its Global Health Innovation Fund (MGHIF), led a private placement round of financing for Evaxion to become the company&#8217;s single largest shareholder. MGHIF also participated in Evaxion&#8217;s public offering in February&#160;2024. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">On November&#160;12, 2024, Evaxion announced positive preclinical data for its cytomegalovirus (CMV) vaccine program EVX-V1. The data demonstrates that CMV antigens identified with Evaxion&#8217;s AI-Immunology&#8482; platform trigger targeted immune responses. Results also showcases the successful design of a proprietary prefusion glycoprotein B (gB) antigen with ability to neutralize the virus. Evaxion is advancing these new findings to develop a multi-component CMV vaccine candidate. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">On December 2, 2024, Evaxion announced that it would present data from preclinical studies with its precision cancer vaccine concept targeting non-conventional ERV (endogenous retrovirus) tumor antigens shared across patients at the ESMO Immuno-Oncology Congress, taking place from December 11-13, 2024, in Geneva, Switzerland. The data provides preclinical Proof-of-Concept for the concept. </font>
          </div>

            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">On December&#160;17, 2024, Evaxion announced that it is currently in advanced discussions with the European Investment Bank (EIB) about conversion of &euro;3.5&#160;million out of Evaxion&#8217;s &euro;7&#160;million loan with EIB into an equity-type instrument. A conversion is expected to increase Evaxion&#8217;s equity by $3.7&#160;million (&euro;3.5&#160;million) immediately upon completion and constitutes an important part of Evaxion&#8217;s plan to ensure </font>
            </div>

        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">

            <div style="width:456pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">ongoing compliance with the Nasdaq listing requirements, although there is no guarantee that a final agreement will be reached. Evaxion has no debt besides the EIB-loan, so the conversion would also substantially reduce the company&#8217;s overall liabilities, simplify its balance sheet and improve its financial flexibility and cash flow. </font>
            </div>


            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">An agreement between Evaxion and EIB would be subject to certain conditions. Such agreement is expected to be finalized and implemented in the first quarter of 2025. </font>
            </div>

        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:40pt; margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The Offering</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;font-weight:bold;">
              <font style="letter-spacing:-0.2pt;">Securities offered by us</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
            </div>
          </div>

            <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Up to 7,640,845 ADSs representing 76,408,450 ordinary shares or up to 7,640,845 pre-funded warrants to purchase 7,640,845 ADSs representing 76,408,450 ordinary shares, and accompanying Warrants to purchase up to 7,640,845 ADSs representing 7,640,845 ordinary shares. The ADSs and Warrants are immediately separable and will be issued separately in this offering but must initially be purchased together in this offering. Each Warrant has an exercise price of $&#8199;&#8199;&#8199;&#8199; per ADS, is immediately exercisable and will expire 5&#160;years from the date of issuance. See &#8220;Description of Securities&#8221;. We are also registering the ADSs issuable upon exercise of the pre-funded warrants and the Warrants.</font>
            </div>

          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;font-weight:bold;">
              <font style="letter-spacing:-0.2pt;">ADSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Each ADS represents 10 ordinary shares. As a holder of ADSs, we will not treat you as one of our shareholders. The depositary will be the holder of the ordinary shares underlying the ADSs, and you will have the rights of a holder of ADSs or beneficial owner (as applicable) as provided in the deposit agreement among us, the depositary and owners and holders of ADSs from time to time. To better understand the terms of the ADSs you should read the section herein entitled &#8220;Description of Share Capital and Articles of Association&#8221; in this prospectus. We also encourage you to read the deposit agreement, the form of which is filed as an exhibit to the registration statement of which this prospectus forms a part. </font>
          </div>

            <div style="width:144pt;">
              <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Warrants</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
              </div>
            </div>


            <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Each Warrant will be immediately exercisable, will expire five&#160;(5) years from the date of issuance and have an exercise price of $&#8199;&#8199;&#8199;&#8199;, subject to adjustment as set forth therein. </font>
            </div>

          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;font-weight:bold;">
              <font style="letter-spacing:-0.2pt;">Pre-Funded Warrants Offered</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
            </div>
          </div>

            <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">We are also offering to certain purchasers whose purchase of ADSs in this offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding ADSs immediately following the closing of this offering, the opportunity to purchase, if such purchasers so choose, pre-funded warrants, in lieu of ADSs that would otherwise result in any such purchaser&#8217;s beneficial ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding ADSs. Each pre-funded warrant will be exercisable for one ADS. The purchase price of each pre-funded warrant and accompanying Warrant will be equal to the price at which an ADS and accompanying Warrant is being sold to the public in this offering, minus an amount in US dollars equal to DKK 10 at the time of pricing of this offering, which amount is equal to $1.42 as of the date of the prospectus, and the exercise price of each pre-funded warrant will be DKK 10 equal to $1.42, provided that such exercise price shall not be less than the USD equivalent to DKK 10 at the time of exercise. The pre-funded warrants will be exercisable immediately and may be exercised at any time until all of the pre-funded warrants are exercised in full. This prospectus also relates to the ADSs issuable upon exercise of any pre-funded warrants sold in this offering. For each pre-funded warrant we sell, the number of ADSs we are offering will be decreased on a one-for-one basis. </font>
            </div>

        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; line-height:12pt;font-weight:bold;">
              <font style="letter-spacing:-0.2pt;">Term of the offering</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
            </div>
          </div>

            <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">This offering will terminate on January&#160;31, 2024, unless we decide to terminate the offering (which we may do at any time in our discretion) prior to that date. </font>
            </div>

          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;font-weight:bold;">
              <font style="letter-spacing:-0.2pt;">Ordinary shares outstanding before this Offering</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">58,660,556 ordinary shares </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;font-weight:bold;">
              <font style="letter-spacing:-0.2pt;">ADSs outstanding before this Offering</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">4,087,351 ADSs. To date, not all of the holders of outstanding ordinary shares have converted their ordinary shares to ADSs. </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;font-weight:bold;">
              <font style="letter-spacing:-0.2pt;">Ordinary shares and ADSs to be outstanding after this offering, including ordinary shares represented by ADSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
            </div>
          </div>

            <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">135,069,006 ordinary shares, and 11,728,196 ADSs, assuming no issuance of any pre-funded warrants and no exercise of the Warrants. As noted above, to date, not all of the holders of outstanding ordinary shares have converted their ordinary shares to ADSs. </font>
            </div>

          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;font-weight:bold;">
              <font style="letter-spacing:-0.2pt;">Use of proceeds</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
            </div>
          </div>

            <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">We estimate that our net proceeds from this offering will be approximately $9.4&#160;million. This is based on an assumed public offering price of $1.42 per ADS (based on the DKK 1&#160;nominal value of each of the ten underlying ordinary shares per ADS), assuming no issuance of pre-funded warrants, no exercise of the Warrants and after deducting the estimated Placement Agent fees and commissions and estimated offering expenses payable by us. We intend to use the net proceeds of this offering to advance our preclinical and clinical pipeline, and for continuing operating expenses and working capital. </font>
            </div>

          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;font-weight:bold;">
              <font style="letter-spacing:-0.2pt;">Risk factors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">You should read the &#8220;Risk Factor Summary&#8221; section within this prospectus and in Item&#160;3D (&#8220;Risk Factors&#8221;) in our 2023 Form 20-F included by reference in this prospectus, for a discussion of factors to consider carefully before deciding to invest in our securities. </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;font-weight:bold;">
              <font style="letter-spacing:-0.2pt;">Nasdaq Capital market symbol</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The ADSs trade on the Nasdaq Capital Market under the symbol &#8220;EVAX.&#8221;</font>
          </div>

            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">The number of our ordinary shares (including shares represented by ADSs in proportion to the designated ratio or ten (10) ordinary shares to one (1)&#160;ADS, as described in this registration statement) to be outstanding after this offering is based on 58,660,556 ordinary shares outstanding as of December&#160;13, 2024, and excludes: </font>
            </div>

          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">3,107,061 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, pursuant to our Warrant Incentive Plans, at a weighted average exercise price of $1.00 per warrant; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">69,455,025 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, based on warrants issued to investors and placement agent, at a weighted average exercise price of $0.37 per warrant; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">50,000 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, based on warrants issued to a consultant, at an exercise price equal to $1.50 per warrant, 50,000 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, based on warrants issued to a consultant at an exercise price equal to $0.39 per warrant, 50,000 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, based on warrants issued to a consultant related to the Company, at an exercise price equal to $0.25 per warrant issued and 1,400,000 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, based on warrants issued to a consultant related to the Company, at an exercise price equal to DKK 1, or approximately USD $0.14 per warrant issued. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:10pt; margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">95,073,413 ordinary shares reserved for future issuance under our warrant plans. Includes 9,461,540 ordinary shares reserved for future issuance to directors, officers and key employees, 706,873 ordinary shares reserved for future issuance under the EIB Warrants, as described below in the section entitled &#8220;EIB Warrants&#8221; ), and 84,905,000 shares reserved for future issuance under warrants the may be issued to future investors, lenders, consultants and/or advisors, if any. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">For the description of the Warrant Incentive Plan see &#8220;Warrant Incentive Plan&#8221; herein. </font>
          </div>

            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Unless otherwise stated, all information in this prospectus assumes no exercise of the outstanding options and warrants described above into ordinary shares, no exercise of the Warrants in this offering into ADSs, treats all restricted shares issued with outstanding restrictions to be vested as issued and outstanding ordinary shares and the exercise in full of pre-funded warrants in this offering. </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Except as otherwise indicated all references to our articles of association in this prospectus refer to our articles of association, as amended as currently in force for the Company at the date of this prospectus. </font>
          </div>
          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Summary Consolidated Financial Data</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The following tables set forth our summary financial data for the periods indicated. The consolidated financial statements as of December&#160;31, 2023, have been audited in accordance with the standards of the Public Company Accounting Oversight Board (Unites States). Our financial statements are prepared and presented in accordance with IFRS, as issued by the IASB. IFRS differ in certain significant respects from U.S. GAAP. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We have derived the summary consolidated statements of comprehensive loss for the six&#160;months ended June&#160;30, 2024, 2023 and 2023 2022, and the summary consolidated statements of financial position as of June&#160;30, 2024, 2023 and 2022, from the unaudited condensed consolidated interim financial statements. We have prepared the unaudited condensed consolidated interim financial statements on the same basis as the audited financial statements, and the unaudited condensed consolidated financial data include all adjustments, that we consider necessary for a fair presentation of our financial position and results of operations as of and for the periods presented. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Our historical results are not necessarily indicative of results expected for future periods and our consolidated operating results for the nine&#160;months ended September&#160;2024 and six&#160;months ended June&#160;30, 2024 are not necessarily indicative of the results that may be expected for the entire year ended December&#160;31, 2024. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The summary financial data below should be read together with our financial statements and related notes, and our unaudited condensed consolidated interim financial statements and related notes incorporated by reference in this prospectus. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Summary Statements of Comprehensive Loss (USD in thousands)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <table style="width:456pt;height:168pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:291.36pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.25pt 0pt; width:0pt;text-align:center;" colspan="16">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">For The Year Ended December&#160;31, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:291.36pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2pt 0pt 1.25pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2023 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2pt 0pt 1.25pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2022 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2pt 0pt 1.25pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2021 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:291.36pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2pt 0pt 0.5pt 0pt; width:0pt;text-align:center;" colspan="16">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(USD in thousands, except per&#160;share&#160;amounts) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2pt 0pt 0.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Revenue </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">73</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.25pt 0pt 0.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Research and development </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(11,916<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(17,056<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(19,583<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.25pt 0pt 0.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">General and administrative </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(10,354<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,208<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(6,251<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.25pt 0pt 0.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Operating loss</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(22,197<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(25,264<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(25,834<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.25pt 0pt 0.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Finance income </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">963</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,831</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,039</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.25pt 0pt 0.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Finance expense </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,681<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,508<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(915<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.25pt 0pt 0.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Net loss before tax</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(22,915<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(23,941<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(24,710<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.25pt 0pt 0.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Income tax benefit </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">790</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">772</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">178</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.25pt 0pt 0.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Net loss for the year</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(22,125<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(23,169<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(24,532<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.25pt 0pt 0.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Net loss attributable to shareholders of Evaxion Biotech A/S.</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(22,125<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(23,169<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(24,532<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.25pt 0pt 0.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Loss per share&#8201;&#8211;&#8201;basic and diluted </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(0,81<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(0,98<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,26<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:28.5pt; margin-left:12pt;width:456pt;">
          <table style="width:456pt;height:200.5pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:291.36pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Six Months Ended June&#160;30, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:291.36pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2024 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2023 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2022 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:291.36pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(USD&#160;in&#160;thousands,&#160;except&#160;per&#160;share&#160;amounts) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Revenue </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">205</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Research and development </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(5,588<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(6,788<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,916<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">General and administrative </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(3,594<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(5,283<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(3,742<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Operating loss</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(8,977<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,071<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,658<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Finance income </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">5,838</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">332</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,058</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Finance expense </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,282<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(604<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(383<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Net loss before tax</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(5,421<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,343<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(10,983<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Income tax benefit </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">417</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">419</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">424</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Net loss for the year</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(5,004<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(11,924<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(10,559<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Net loss attributable to shareholders of Evaxion Biotech A/S.</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(5,004<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(11,924<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(10,559<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Loss per share&#8201;&#8211;&#8201;basic and diluted </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(0.10<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(0.46<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(0.45<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
          <table style="width:456pt;height:200.5pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:291.36pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Nine Months Ended September&#160;30, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:291.36pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2024 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2023 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2022 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:291.36pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(USD in thousands, except per share amounts) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Revenue </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">3.222</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Research and development </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,202<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(9,618<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,983<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">General and administrative </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(5,728<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,215<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(5,756<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Operating loss</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(10,708<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(17,833<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(18,739<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Finance income </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">5,922</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">404</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,761</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Finance expense </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(2,665<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(786<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(918<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Net loss before tax</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(7,451<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(18,215<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(16,896<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Income tax benefit </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">513</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">613</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">599</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Net loss for the year</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(6,938<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(17,602<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(16,297<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Net loss attributable to shareholders of Evaxion Biotech A/S.</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(6,938<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(17,602<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(16,297<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.36pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Loss per share&#8201;&#8211;&#8201;basic and diluted </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(0.13<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(0.66<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(0.69<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Summary Consolidated Statement of Financial Position (USD in thousands)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <table style="width:456pt;height:167.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:268.85pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Sep 30,</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">2024 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Jun 30</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">2024 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Dec 31,</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">2023 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Dec 31, </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">2022 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:268.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,576</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7,993</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,583</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">13,184</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:268.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total assets </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">15,185</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">15,231</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">12,889</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">22,025</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:268.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total liabilities </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">15,111</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">13,978</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">17,618</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">13,772</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:268.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Share capital </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,732</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,244</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,899</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">3,886</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:268.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Other reserves </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">106,245</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">105,983</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">99,946</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">90,262</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:268.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Accumulated deficit </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(114,903<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(112,974<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(107,860<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(85,845<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:268.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total equity before derivative warrant liability </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">74</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,253</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(2,015<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">8,303</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:268.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Effect from derivative liabilities from investor warrants </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(2,714<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:268.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total equity </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">74</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,253</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(4,729<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">8,303</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:268.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total liabilities and equity </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">15,185</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">15,231</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">12,889</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">22,025</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRIFA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RISK FACTORS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Our business is subject to a number of risks and uncertainties, including those risks discussed at length in Section&#160;3.D&#8201;&#8212;&#8201;Risk Factors in our 2023 Form 20-F incorporated into this prospectus by reference. Below are risks that are updated or new risks since our 2023 Form 20-F, as well as a summary of risks. Investing in our company and its securities involves a high degree of risk. You should carefully consider the risks and uncertainties described below, together with all of the other information in this prospectus, including the information incorporated by reference to our 2023 Form 20-F, before investing in our company and our securities. If any of these risks materialize, our business, financial condition, operating results and prospects could be materially and adversely affected. In that event, the price or value of the ADSs in the public market could decline, and you could lose part or all of your investment. This registration statement also contains forward-looking statements that involve risks and uncertainties. Our results could materially differ from those anticipated in these forward-looking statements, as a result of certain factors including the risks described below and elsewhere in this registration statement. See &#8220;Special Note Regarding Forward-Looking Statements&#8221; above.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The following is a summary of some of the principal risks we face. The list below is not exhaustive, and investors should read the risks described under the heading &#8220;Risk Factors&#8221; in our 2023 Form 20-F incorporated by reference herein, as well as the additional risks set forth in this section, in full.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The principal risks and uncertainties affecting our business include the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">We are a clinical stage TechBio company with only product candidates currently in clinical development. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">We have a limited operating history and no vaccine has been approved using our technology, and none may ever be approved. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">We are dependent upon successfully concluding partnerships to advance our product candidates to monetize our assets. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">We have incurred significant losses since our inception, and we anticipate that we will continue to incur significant losses for the foreseeable future. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">We will require substantial additional financing to achieve our goals, and a failure to obtain this capital on acceptable terms, or at all, could force us to delay, limit, scale back or cease our product development activities or any other or all operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">We will need to develop and expand our company, and we may encounter difficulties in managing this development and expansion, which could disrupt our operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">We are substantially dependent on the success of product candidates, which may not be successful in nonclinical studies or clinical trials, receive regulatory approval or be successfully commercialized. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Clinical drug development involves a lengthy and expensive process with uncertain outcomes, and we may encounter substantial delays in our clinical studies. Furthermore, results of earlier studies and trials may not be predictive of results of future trials. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Interim and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Pharmaceutical product development is inherently uncertain, and there is no guarantee that any of our product candidates will receive marketing approval. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Competition in the biotechnology and pharmaceutical industries is intense and our competitors may discover, develop or commercialize products faster or more successfully than us. If we are unable to compete effectively our business, results of operations and prospects will suffer. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The effects of the invasion of Ukraine by Russia, the resulting conflict and retaliatory measures by the global community have created global security concerns, including the possibility of expanded regional or global conflict, which have had, are likely to continue to have, short-term and likely longer- term adverse impacts on Ukraine and Europe and around the globe, which could adversely affect our business and results of operations. The same applies to other global conflicts such as the ongoing conflict in the Middle East. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Our failure to meet Nasdaq&#8217;s continued listing requirements could result in a delisting of the ADSs. If we fail to satisfy the applicable continued listing requirements of Nasdaq, such as certain corporate governance requirements, minimum equity or minimum closing bid price requirement, Nasdaq may take steps to delist the ADSs. Such a delisting would likely have a negative effect on the price of the ADSs and would impair your ability to sell or purchase the ADSs when you wish to do so. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Our product candidates may not work as intended, may cause undesirable side effects or may have other properties that could delay or prevent their regulatory approval, limit the commercial profile of an approved label or result in significant negative consequences following marketing approval, if any. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The regulatory approval processes of the U.S. Food and Drug Administration, the European Medicines Agency and comparable authorities are lengthy, time consuming, and inherently unpredictable. If we are ultimately unable to obtain regulatory approval for our product candidates, our business will be substantially harmed. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Our future partners, if any, may not be able to obtain regulatory approval for products, if any, derived from our product candidates under applicable United States, European and other international regulatory requirements. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Even if products derived from our product candidates receive regulatory approval, such products may not gain market acceptance and our future partners, if any, may not be able to effectively commercialize them. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">If we are not successful in developing our product candidates and our future partners, if any, are not successful in commercializing any products derived from our product candidates, our ability to expand our business and achieve our strategic objectives will be impaired. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">We rely on third-parties to manufacture preclinical, clinical and commercial supplies of our products, product candidates and their components. In addition, we rely on third-parties in the conduct of significant aspects of our pre-clinical studies and clinical trials, and we intend to rely on third parties in the conduct of future clinical trials. If these third parties do not successfully carry out their contractual duties, fail to comply with applicable regulatory requirements and/or fail to meet expected deadlines, we may be unable to obtain regulatory approval for our product candidates. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Our future partners, if any, may encounter difficulties in manufacturing, product release, shelf life, testing, storage, supply chain management and/or shipping, and/or all of which could materially adversely affect our business operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Certain of our product candidates may be uniquely manufactured for each patient and we and/or our future partners may encounter difficulties in production, particularly with respect to the scaling of manufacturing capabilities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">If our and our future partners&#8217;, if any, efforts to obtain, maintain, protect, defend and/or enforce the intellectual property related to our product candidates and technologies are not adequate, we may not be able to compete effectively in our market. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">We may be involved in lawsuits to protect or enforce our intellectual property or the intellectual property of our licensors, or to defend against third-party claims that we infringe, misappropriate or otherwise violate such third party&#8217;s intellectual property. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to our Financial Condition and Capital Requirements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have incurred significant losses since our inception, and we anticipate that we will continue to incur significant losses for the foreseeable future, which makes it difficult to assess our future viability. We have not generated significant revenue and may never be profitable.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have incurred net losses in each year since our inception in 2008, including net losses of $22.1&#160;million, $23.2&#160;million, and $24.5&#160;million for the&#160;years ended December&#160;31, 2023, 2022, and 2021, respectively. As of December&#160;31, 2023, we had an accumulated deficit of $108.0&#160;million. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have devoted most of our financial resources to research and development, including our pre- clinical and clinical development activities and the development of our AI-Immunology&#8482; platform. The amount of our future net losses will depend, in part, on the rate of our future expenditures and our ability to obtain funding through equity or debt financings, sales of assets, collaborations, including our out-licensing arrangements, if any, and grants. We believe that the cost and expense of most late stage clinical testing, regulatory and marketing approval and commercialization of our product candidates are beyond the resources of all but the large biopharmaceutical and pharmaceutical companies. Therefore, we currently intend to develop our vaccines through pre-clinical or clinical proof of concept, or PoC, and then enter into partnership arrangements with large biopharmaceutical and pharmaceutical companies to conduct clinical trials, regulatory and marketing approval and commercialization of our product candidates. We have not yet entered into any such partnership arrangements and may be unable to do so on economically viable terms, if at all. As a result, clinical trials, including late stage clinical trials as well as pivotal clinical trials for our product candidates have not been commenced under any such partnership arrangements and even if such trials are commenced in the near future, it will be several&#160;years, if ever, before we, or our partners, if any, have a product candidate ready for commercialization. Even if our future partners, if any, obtain regulatory approval to market a product candidate, our future revenues will depend upon the size of any markets in which our product candidates receive such approval, upfront, milestone and any other payments we receive from our future partners, if any, and our future partners&#8217;, if any, ability to achieve sufficient market acceptance, reimbursement from third-party payors, and adequate market share in those markets. We may never achieve profitability. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our ability to generate revenue and achieve profitability depends on our and our partners ability to successfully complete the development of, and our partners&#8217; ability to obtain the regulatory approvals necessary to commercialize, our product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We expect to continue to incur significant expenses and operating losses for the foreseeable future, however reduced due to the strategic focus on partnerships. For the next year the primary cost drivers are: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">continue our research or development of our programs in pre-clinical and early stage clinical development; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">continue to invest in our AI-Immunology&#8482; platform to improve its predictive capabilities and identify novel vaccines; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">invest in generation of needed pre-clinical evidence to support our partnership strategy </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">attract and retain skilled personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">make milestone or other payments under any in-license agreements; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">maintain, protect, defend, enforce and expand our intellectual property portfolio. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our ability to generate future revenues from our potential commercialization partnerships depends heavily on our success in: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">completing research and pre-clinical development, and successfully entering into partnership arrangements with large biopharmaceutical and pharmaceutical companies to conduct clinical trials, regulatory and marketing approval and commercialization of our product candidates for both our immuno-oncology and infectious disease product candidates to validate our AI-Immunology&#8482; platform; and other business efforts </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">seeking, negotiating and obtaining agreements with future partners, if any, on favorable terms for the completion of clinical trials, and United States and non-United States marketing approvals and commercialization of our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our relationships with our third-party manufacturers in order to provide adequate (in amount and quality) products in time and services to support clinical development of our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our future partners, if any, obtaining market acceptance of our product candidates as treatment options; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our future partners, if any, launching and commercializing our product candidates for which marketing approval and reimbursement have been obtained; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">addressing any competing technological and market developments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">implementing additional internal systems and infrastructure; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">maintaining, defending, protecting, enforcing and expanding our portfolio of intellectual property rights, including patents, trade secrets and know-how; and attracting, hiring and retaining qualified personnel. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our operating results may fluctuate significantly, which makes our future operating results difficult to predict. If our operating results fall below expectations, the market price of the ADSs could decline. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our financial condition and operating results have varied in the past and will continue to fluctuate from one financial period to the next due to a variety of factors, many of which are beyond our control. Factors relating to our business that may contribute to these fluctuations include the following, as well as other factors described elsewhere in this prospectus: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">delays or failures in advancement of existing or future product candidates into pre-clinical studies or clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">failures in further development of our AI-Immunology&#8482; platform; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the ability of our future partners, if any, to manufacture and successfully commercialize our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to manage our growth; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the outcomes of research programs, pre-clinical studies and clinical trials, and other product development or approval processes conducted by us and/or our future partners, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our relationships, and any associated exclusivity terms, with partners; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our contractual or other obligations to provide resources to fund our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our operations in a net loss position for the foreseeable future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">risks associated with the international aspects of our business outside of Denmark, including the conduct of clinical trials in multiple locations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our and our partners&#8217;, to the extent relevant, consistent ability to have our products and product candidates manufactured by third parties; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to develop programs to fit into a clinical work-flow and treatment regimen; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to accurately report our financial results in a timely manner; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our dependence on, and the need to attract and retain, key management and other personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our and our partners&#8217; ability to obtain, protect, maintain, defend and enforce our intellectual property rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our and our partners&#8217; ability to prevent the theft or infringement, misappropriation or other violation of our intellectual property, trade secrets, know-how or technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">potential advantages that our competitors and potential competitors may have in securing funding, obtaining the rights to critical intellectual property or developing competing technologies or products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to obtain additional capital that may be necessary to expand our business; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our future partners, if any, ability to obtain additional capital that may be necessary to develop and commercialize products under any future collaboration or licensing agreements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">business interruptions such as power outages, strikes, acts of terrorism, pandemics or natural disasters; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the effects of climate change on our operations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the effects of the continuing conflict between Russian and the Ukraine and in the Middle East may have on our business and operations; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to use our net operating loss, or NOL, carryforwards to offset future taxable income. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Due to the various factors mentioned above, and others, the projected financial information included in this should not be relied upon as indications of our future operating performance. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We will need substantial additional financing to achieve our goals, which may not be available on acceptable terms, or at all. Failure to obtain this necessary capital could force us to delay, limit, reduce or terminate our product development programs, commercialization efforts or other operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our cash and cash equivalents were $4.6&#160;million as of September&#160;30, 2024, which does not include the $3.2&#160;million upfront from the MSD agreement received in October&#160;2024. The net proceeds from our IPO completed in February&#160;2021 was $25.3&#160;million, based on the initial public offering price of $10.00 per ADS, after deducting underwriting discounts and commissions and offering expenses. The net proceeds from our follow-on offering completed in November&#160;2021 was $24.9&#160;million, based on the public offering price of $7.00 per ADS after deducting underwriting discounts and commissions and offering expenses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2020, we executed a loan agreement, or the EIB Loan Agreement, with the European Investment Bank, or EIB, for a principal amount of &euro;20.0&#160;million, divided into three tranches of tranche 1 in the amount of &euro;7.0&#160;million, tranche 2 in the amount of &euro;6.0&#160;million and tranche 3 in the amount of &euro;7.0&#160;million, or the EIB Loan. Under the EIB Loan Agreement, the EIB Loan tranche balances are due six&#160;years from their respective disbursement dates. In connection with disbursement of each tranche, EIB is entitled to receive certain warrants, or the EIB Warrants. In November&#160;2020, we initiated the process to receive the funds from the disbursement of tranche 1 of the EIB Loan in the aggregate amount of &euro;7.0&#160;million but due to the timing of our IPO we did not finalize a disbursement offer. In connection therewith, EIB received 351,036 EIB Warrants, which vested immediately, pursuant to the terms of a separate warrant agreement, or the EIB Warrant Agreement. We received the proceeds from the drawdown of the first tranche of the EIB loan of &euro;7.0&#160;million on February&#160;17, 2022. As of the date of this registration statement, we have not initiated a drawdown on any additional tranches of the EIB Loan and under the present business plans we do not expect to draw the remaining 2 tranches. The remaining two tranches have become void. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2022, we entered into a purchase agreement, or the LPC Purchase Agreement, with Lincoln Park Capital Fund, LLC, or Lincoln Park, pursuant to which we may, from time to time and at our sole discretion, for a period of 36-months, direct Lincoln Park to purchase up to 4,649,250 of our ordinary shares represented by the ADSs, subject to the development in the ADS price. If the ADS price is between $5.00 and $40.00 (as adjusted to take into account, the ADS ratio change) the number of purchase shares is limited to 50,000. If the price is not below $40.00 the purchase share limit may be increased to 60,000 purchase shares and if the price is not below $6.00 the purchase shares limit may be increased to 70,000 purchase shares. Under the terms of the LPC Purchase Agreement, we may receive up to $40,000,000 in aggregate gross proceeds from any sales of our ordinary shares represented by ADSs that we make to Lincoln Park thereunder. In connection with the LPC Purchase Agreement, we issued 428,572 ADSs representing ordinary shares to Lincoln Park as consideration for a commitment fee of $1,200,000 for Lincoln Park&#8217;s agreement to purchase ordinary shares represented by ADSs under the LPC Purchase Agreement, or the Commitment Shares. As of the date of this prospectus, Lincoln Park has not purchased any additional ordinary shares represented by the ADSs and we have not received any proceeds therefrom. At current, the closing conditions to make the LPC Purchase Agreement operational have not yet been met. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In October&#160;2022, we initiated an at-the-market, or ATM, program with JonesTrading Institutional Services LLC, or JonesTrading, acting as sales agent, relating to the sale of up to $14,439,000 of the ADSs. As of the date of this prospectus, we have raised gross proceeds of $9,414,825 from the sale of ADSs under this ATM program. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;31, 2023, we entered into an agreement with Global Growth Holding Limited, or GGH, for the issuance of, and subscription to, convertible notes, or the Notes, convertible into new ordinary shares, nominal value DKK 1, or the ordinary shares, or the GGH Agreement, with ten shares represented by one&#160;(1)&#160;American Depositary Share, or the ADSs. Pursuant to the GGH Agreement, we may elect to sell to GGH up to $20,000,000 in such Notes, subject to certain limitations and conditions set forth in therein. The Notes are subject to conversion into new ordinary shares at any time upon submission of a request for conversion by GGH. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the GGH Agreement, on any business day over the 36-month term of the GGH Agreement, we have the right, but not the obligation, at our sole discretion and subject to certain conditions, to direct GGH to purchase tranches of up to $700,000 in aggregate value of Notes, or a Tranche. The Notes carry a zero coupon and will be issued at a subscription price corresponding to their par value. The conversion price of the Notes will be determined as 83.5% of the second lowest closing volume weighted average share price (VWAP) of the ADSs for the eight (8)&#160;trading days immediately preceding the issuance of each conversion request by GGH, unless the lowest closing VWAP of the ADSs over the such eight (8)&#160;trading days is the most recent trading day in which case the conversion price will be 85% of the lowest closing VWAP of the ADSs over such eight (8)&#160;day period. The closing conditions to the GGH Agreement, which will include filing a registration statement, have not yet been met and the facility is not yet available to us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;18, 2023, we entered into a securities purchase agreement, or the Securities Purchase Agreement, and an Investment Agreement, or the Investment Agreement, with certain Institutional Accredited Investors, Qualified Institution Buyers and other Accredited Investors, including all members of the Company&#8217;s Management and Board of Directors and MSD GHI, or MSD, a subsidiary of Merck Inc., for the issuance and sale in a private placement of 9,726,898 of the Company&#8217;s ordinary shares, DKK&#160;1 nominal value represented by American Depositary Shares and accompanying warrants to purchase up to 9,726,898 Ordinary Shares represented by ADSs at a purchase price of $0.544 per Ordinary Share. The Warrants are exercisable immediately upon issuance, expire three (3)&#160;years after the closing date and have an exercise price equal to $0.707 per Ordinary Share. The above number of ordinary shares and neither the purchase price thereof nor the exercise price of the warrants reflect the one (1)&#160;ADS for ten (10) ordinary shares Ratio Change effected on January&#160;22, 2024, described herein. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On February&#160;5, 2024, we closed a public offering with net proceeds of $12.6&#160;million of 3,750,000 of the ADSs (or pre-funded warrants in lieu thereof) and warrants to purchase up to 3,750,000 ADSs at a combined public offering price of $4.00 per ADS (or pre-funded warrant in lieu thereof) and accompanying warrant. The warrants have an exercise price of $4.00 per ADS (amended to 27.52 DKK as of May&#160;23, 2024), are exercisable immediately upon issuance and will expire five&#160;years following the date of issuance. Each ADS represents ten ordinary shares of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We expect that the net proceeds from our IPO, our follow-on offering, our private placement in December&#160;2023, our Public Offering in February&#160;2024 (excluded positive cash contribution from exercise of pre-funded warrants of 2.9&#160;million USD) and the net proceeds, we have received and may receive in the future under the ATM program and our existing cash and cash equivalents will be sufficient to fund our operating expenses and capital expenditures into March&#160;2025. However, our operating plan may change as a result of many factors currently unknown to us, and we may need to seek additional funds sooner than planned, through public or private equity or debt financings, government or other third-party funding, sales of assets, other collaborations and licensing arrangements, or a combination of these approaches. In any event, we will require additional capital to achieve our goals. We will seek additional capital if market conditions are favorable or if we have specific strategic considerations. Our spending will vary based on new and ongoing development and corporate activities. Due to high uncertainty of the length of time and activities associated with discovery and development of our product candidates, we are unable to estimate the actual funds we will require for our development activities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our future funding requirements, both near and long term, will depend on many factors, including, without limitation: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the initiation, progress, timing, costs, and results of pre-clinical or nonclinical studies and clinical trials for our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the results of research and our other platform activities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the clinical development plans we establish for our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the terms of any agreements with our future partners, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number and characteristics of any technology that we develop or may in-license; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the outcome, timing and cost of meeting regulatory requirements established by the FDA, the EMA, the TGA and other comparable regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the cost of filing, prosecuting, obtaining, maintaining, protecting, defending and enforcing our patent claims and other intellectual property rights, including actions for patent and other intellectual property infringement, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">misappropriation and other violations brought by third parties against us regarding our product candidates or actions by us challenging the patent or intellectual property rights of others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the effect of competing technological and market developments, including other products that may compete with one or more of our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the cost and timing of completion and further expansion of clinical scale manufacturing activities by third parties sufficient to support all of our current and future programs. the impact and duration of the COVID-19 pandemic and its effect on the global economy and our business; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the effects of climate change on the global economy and our business; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the effects of the continued conflict between Russia and the Ukraine and in the Israel-Gaza region on the global economy and our business. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To date, we have financed our operations primarily through the sale of equity securities, the EIB loan and from private and governmental grants and we cannot be certain that additional funding will be available on favorable terms, or at all. Until we can generate sufficient upfront fees, milestone payments and royalty revenues from our agreements with future partners, if any, to finance our operations, which we may never do, we expect to finance our future cash needs through a combination of public or private equity offerings, debt financings, sales of assets, out-licensing arrangements, and other product development arrangements. Any fundraising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to develop our product candidates, the AI-Immunology&#8482; platform as well as establishing partnerships. In addition, we cannot guarantee that future financing will be available in sufficient amounts, at the right time, on favorable terms, or at all. Negative clinical trial data or setbacks, or perceived setbacks, in our programs or with respect to our technology could impair our ability to raise additional financing on favorable terms, or at all. Moreover, the terms of any financing may adversely affect the holdings or the rights of our shareholders, and the issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance, may cause the market price of the ADSs to decline. If we raise additional funds through public or private equity offerings, the terms of these securities may include liquidation or other preferences that may adversely affect our securityholders&#8217; rights. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may not be in compliance with the EIB Loan&#8217;s beneficial ownership requirements following this offering</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The EIB Loan contains a requirement that, while the EIB Loan is outstanding, Niels Iverson Moller, one of our co-founders, and Andreas Holm Mattsson, our Chief AI and Culture Officer, and MSD Global Health Innovation Fund (&#8220;MSD GHIF&#8221;), must beneficially own and Control directly or indirectly at least 14% of our issued and outstanding ordinary shares. Currently, Messrs. Moller and Mattsson together with MSD GHIF beneficially own approximately 28% of our issued and outstanding ordinary shares. Depending on the beneficial ownerships level of participation and share price at time of this offering, we could be in non-compliance with the EIB Ownership Requirement, requiring us to obtain a waiver from EIB. While we believe we would be able to obtain such a waiver if required, we cannot give you any assurance that we will obtain such. If we are unable to obtain a waiver, EIB may have rights to demand repayment of the EIB Loan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">This offering is being made on a best efforts basis and we may sell fewer than all of the securities offered hereby and may receive significantly less in net proceeds from this offering, which will provide us only limited working capital.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">This offering is being made on a best efforts basis and we may sell fewer than all of the securities offered hereby and may receive significantly less in net proceeds from this offering. Assuming that we receive net proceeds of approximately $9.4&#160;million from this offering (assuming an offering with gross proceeds of $10.85&#160;million, and assuming no issuance of pre-funded warrants), we believe that the net proceeds from this offering, together with our existing cash and cash equivalents, will satisfy our capital into end 2025 under our current business plan. Without giving effect to the receipt of any proceeds from this </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">offering, we currently estimate that our existing cash and cash equivalents are sufficient to fund business operations into March&#160;2025 assuming no further income from ongoing business development discussions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We will need to develop our company, and we may encounter difficulties in managing this development, which could disrupt our operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">As of December 13, 2024, we have 44 fulltime employees and, in connection with the development and advancement of our pipeline, partnerships and becoming a public company, we expect to keep developing our operations. To manage our anticipated development, we must continue to implement and improve our managerial, operational, legal, compliance and financial systems, and retain as well as recruit and train additional qualified personnel. Also, our management may need to divert a disproportionate amount of its attention away from its day-to-day activities and devote a substantial amount of time to managing these development activities. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a developing TechBio company, we are actively pursuing technologies, drug classes, platforms and product candidates in more therapeutic areas and across a wide range of diseases. Successfully developing product candidates for and fully understanding the regulatory and manufacturing pathways to all of these therapeutic areas and disease states requires significant human capital resources with a depth of talent, and corporate processes in order to allow simultaneous execution across multiple areas. Due to our limited resources, we may not be able to effectively manage this simultaneous execution and the development of our operations or recruit and train additional qualified personnel. This may result in weaknesses in our infrastructure, give rise to operational mistakes, legal or regulatory compliance failures, loss of business opportunities, loss of employees and reduced productivity among remaining employees. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, the commitments in being Nasdaq listed and low liquidity in the capital markets may lead to significant costs and may divert financial resources from other projects, such as the development of our product candidates. If our management is unable to effectively manage our expected development, our expenses may increase more than expected, our ability to generate or increase our revenue could be reduced and we may not be able to implement our business strategy. Our future financial performance and our ability to compete effectively and develop our product candidates will depend in part on our ability to effectively manage the future development of our company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Enrolling patients in clinical trials may be difficult for many reasons, including high screen failure, manufacturing capacity for personalized products, timing, proximity and availability of clinical sites, perceived risks, and publicity about the success or lack of success in the methods of treatment.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Screen failures</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The fundamental purpose of patient screening is to enable the successful enrollment of the target patient: in other words, ensuring the patient is qualified as a &#8220;good fit&#8221; for the study. Getting this process right while minimizing screen failure rates is a key industry challenge that is fundamental to efficient, effective, and successful enrollment. According to a commonly cited statistic from the Tufts Center for the Study of Drug Development (Tufts CSDD), some 11% of active sites will fail to enroll a single patient. The consequences of high screen failure rates are enrollment delays, increased cost due to longer delivery timelines, delays to endpoint generation, and in some cases termination of the study. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Manufacturing capacity for personalized products</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A unique product has to manufactured for each patient. So, if more patients are enrolled at the same time, manufacturing might become a bottleneck delaying patient treatment and potentially causing disease progression and patient drop out. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Clinical sites</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Preferred clinical sites might not be available due to e.g. competing studies ongoing at the clinical site or the investigator is not interested in participating because of the time, staff, and resources their participation would require. This might have a negative effect on patient recruitment rate. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Inaccurate enrollment projections</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Most enrollment projections in a clinical trial are based on best-case scenarios. Trial sites tend to over commit and are overly optimistic about their enrollment rates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Safety</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">People have become accustomed to hearing the multitude of possible side effects in drug advertisements for approved drugs. As a result, they may think the worst when it comes to drugs or therapies that are not yet approved for market. This might prevent patient for accepting to participate in a clinical study. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">A future pandemic, epidemic, or outbreak of an infectious disease, such as the COVID-19 pandemic, may materially and adversely affect our business operations, including the manufacturing, clinical trial and other business activities performed by us, our future partners, if any, or by suppliers or third parties with whom we conduct business, including our CDMOs, CROs, shippers and others.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our business has been and could be further adversely affected by health epidemics wherever we have clinical trial sites or other business operations. In addition, health epidemics could cause significant disruption in the operations of third-party CDMOs, CROs and other third parties upon whom we rely. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If there is a future pandemic, other aspects of our ongoing clinical trials and future planned clinical trials may be adversely affected, delayed or interrupted, including, for example, site initiation, patient recruitment and enrollment, availability of clinical trial materials, clinical trial site data monitoring and efficacy, safety and translational data collection, and data analysis. Some patients and clinical investigators may not be able to comply with clinical trial protocols and patients may choose to withdraw from our trials or we may have to pause enrollment or we may choose to or be required to pause enrollment and/or patient dosing in our ongoing or planned clinical trials in order to preserve health resources and protect trial participants. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, we depend on a global supply chain, including timely shipment of patient specimens and ingredients, to manufacture product candidates used in our pre-clinical studies and clinical trials. Quarantines, &#8220;shelter-in-place&#8221; and similar government orders, or the expectation that such orders, shutdowns or other restrictions could occur, whether related to epidemics, could impact personnel at third-party manufacturing facilities in the United States, Europe and other countries, or the availability or cost of materials, any of which factors, either individually or collectively, could disrupt our supply chain. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, it has been widely reported that there has been a global shortage of microchips that has been affecting almost every industry, which has impacted the production of machinery and final products. This shortage could adversely impact our suppliers&#8217; ability to meet their contractual obligations to provide us with necessary products and materials. If our relationships with our suppliers or other vendors are terminated or scaled back as a result of epidemics, we may not be able to enter into arrangements with alternative suppliers or vendors or do so on commercially reasonable terms or in a timely manner. Replacing or adding additional suppliers or vendors involves substantial cost and requires management time and focus. In addition, there is a natural transition period when a new supplier or vendor commences work. As a result, delays may occur, which could adversely impact our ability to meet our desired clinical development and any future commercialization timelines. Although we carefully manage our relationships with our suppliers and vendors, there can be no assurance that we will not encounter challenges or delays in the future or that these delays or challenges will not harm our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to the Manufacturing of our Product Candidates and Future Pipeline</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We and/or our future partners, if any, may encounter difficulties in manufacturing, product release, shelf life, testing, storage, supply chain management or shipping. If we, and/or our future partners, if any, or any of the third-party manufacturers we and/or our future partners&#8217;, if any, work with encounter such difficulties, our and/or our future partners, if any,&#8217; ability to supply materials for clinical trials or any approved product could be delayed or stopped.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At early-stage development product knowledge is limited. Specifically, due to the nature of our personalized immunotherapies and novel delivery technologies, we and/or our future partners, if any, may </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">encounter difficulties in manufacturing, product release, shelf life, testing, storage and supply chain management, or shipping. These difficulties could be due to any number of reasons including, but not limited to, complexities of personalized manufacturing at large scale (a unique product is manufactured for each patient with short manufacturing turn-around-times), equipment failure, choice and quality of raw materials and excipients, analytical testing technology, and product instability. In an effort to optimize product features, we have in the past and we and/or our future partners, if any, may in the future make changes to our product candidates in their manufacturing and stability formulation and conditions. This may in the future result in our and/or our future partners&#8217;, if any, having to resupply batches for pre-clinical or clinical activities when there is insufficient product stability during storage and insufficient supply. Insufficient stability or shelf life of our product candidates could materially delay our and/or our future partners&#8217;, if any, ability to continue the clinical trial for that product candidate or require us and/or our future partners, if any, to begin a new clinical trial with a newly formulated drug product, due to the need to manufacture additional pre-clinical or clinical supply. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For our personalized therapies, we and/or our future partners, if any, may encounter issues with our and/or our future partners&#8217;, if any, ability to timely and efficiently manufacture product given the on-demand requirements of such therapies, thereby potentially impacting clinical and commercial supply. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As we and/or our future partners, if any, continue developing new manufacturing processes for our drug substances and drug products, the changes we and/or our future partners, if any, implement to manufacturing process may in turn impact specification and stability of our drug products. Changes in our manufacturing processes may lead to failure of lots and this could lead to substantial delays in our clinical trials. Our product candidates may prove to have a stability profile that leads to a lower than desired shelf life of the final approved immunotherapy. This poses risk in supply requirements, wasted stock and higher cost of goods. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We and/or our future partners, if any, may be dependent on a number of equipment providers who are also implementing novel technology. Further, we and/or our future partners, if any, may develop custom manufacturing equipment for certain of our product candidates. If such equipment malfunctions or we and/or our future partners, if any, encounter unexpected performance issues, we and/or our future partners, if any, could encounter delays or interruptions to clinical and commercial supply. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Due to the potential number of different products being manufactured in the same facility, we and/or our future partners, if any, may have cross contamination of products in the manufacturing facility, or in in the pharmacy during preparation of the final drug for patient administration that affect the integrity of our product candidates. Additionally supplied raw materials and consumables can be contaminated or/or adulterated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As we and/or our future partners, if any, scale the manufacturing output for particular programs, we plan to continuously improve process robustness, yield, purity, and the stability profile and shelf-life of our product candidates from clinical stage studies through commercial launch. Due to continuous improvement in manufacturing processes, we and/or our future partners, if any, may introduce changes to the manufacturing process, raw materials and/or manufacturing facilities for a particular program during development. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">However, such changes might require extended pharmaceutical property testing, such as six- or 12-month stability testing that could delay clinical trials. Additionally, there is always the risk of unexpected problems when introducing changes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We and/or our future partners, if any, may utilize a number of raw materials and excipients that are either new to the pharmaceutical industry or are being employed in a novel manner. Some of these raw materials and excipients may not have been scaled to a level to support commercial supply and could experience unexpected manufacturing or testing failures, or supply shortages. Such issues with raw materials and excipients could cause delays or interruptions to clinical and commercial supply of our product candidates. Further, one or more of our programs may have a single source of supply for raw materials and excipients. Additionally, we and our manufacturers may experience manufacturing difficulties due to resource constraints or as a result of labor disputes or supply chain issues, such as those experienced due to the COVID-19 pandemic, or as a result of climate change, or unstable political environments, such as recent events in Ukraine and Russia or in the Israel-Gaza region, or other geopolitical uncertainty. If we and/or our future partners, if any, and manufacturers were to encounter any of these difficulties, or otherwise </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">fail to comply with their contractual obligations, our ability to manufacture our products, or to make our product candidates available for clinical trials could be jeopardized. Any such delay or interruption in the supply of clinical trial supplies could delay the completion of clinical trials, increase the costs associated with maintaining clinical trial programs and, depending upon the period of delay, require us to commence new clinical trials at additional expense or terminate clinical trials completely. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We and/or our future partners, if any, may learn that any or all of our product candidates are less stable than desired. We and/or our future partners, if any, may also find that transportation conditions negatively impact product quality. This may require changes to the formulation or manufacturing process for one or more of our product candidates and result in delays or interruptions to clinical or commercial supply. In addition, the cost associated with such transportation services and the limited pool of vendors may also add additional risks of supply disruptions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The occurrence of any of these factors could materially harm our business, financial condition, results of operations, and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have entered into in-licensing arrangements and may form or seek to enter into additional licensing arrangements in the future, and we may not realize the benefits of such licensing arrangements.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may obtain licenses that give us rights to third-party intellectual property, including patents and patent applications that are necessary or useful for our business. In particular, we have entered into license agreements with Statens Serum Institut, or SSI, and PharmaJet, Inc. or PharmaJet to obtain licenses for intellectual property useful in pharmaceutical formulations and delivery devices. We may enter into additional licenses to third-party intellectual property in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The success of products developed based on in-licensed technology will depend in part on the ability of our current and future licensors to prosecute, obtain, maintain, protect, enforce and defend patent protection for our in-licensed intellectual property. Our current and future licensors may not successfully prosecute any patent applications we may license. Even if patents were issued in respect of these patent applications, our licensors may fail to maintain these patents, may determine not to pursue litigation against other companies that are infringing these patents, or may pursue such litigation less aggressively than we would. Without protection for the intellectual property we license, other companies might be able to offer substantially identical products for sale, which could adversely affect our competitive business position and harm our business prospects. In addition, we may sublicense our rights under various third-party licenses to our partners. Any impairment of these sublicensed rights could result in reduced revenues under our collaboration agreements or result in termination of an agreement by one or more of our partners. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Disputes may also arise between us and our licensors regarding intellectual property subject to a license agreement, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the scope of rights granted under the license agreement and other interpretation-related issues; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">whether and the extent to which our technology and processes infringe, misappropriate or otherwise violate the intellectual property of the licensor that is not subject to the licensing agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our right to sublicense patent and other intellectual property rights to third parties under collaborative relationships; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our diligence obligations with respect to the use of the licensed intellectual property and technology in relation to our development and commercialization of our product candidates, and what activities satisfy those diligence obligations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the ownership of inventions, trade secrets, know-how and other intellectual property resulting from the joint creation or use of intellectual property by our licensors and us and our partners; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the priority of invention of patented technology. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For instance, in April&#160;2022, SSI initiated a legal proceeding against us in The Danish Maritime and Commercial High Court (S&#248; og Handelsretten), claiming sole ownership of a patent application we filed related to a method for treating malignant neoplasm by administering a composition comprising a high dose of neopeptides, a solvent and SSI&#8217;s liposomal adjuvant, CAF</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">09b, or the Invention, for which we have an </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">exclusive, royalty-bearing sub-licensable license to use in formulation with PIONEER identified neopeptides, from SSI. We believe that we and our employees are the sole inventors of the Invention and that we have strong defenses against SSI&#8217;s claim and that SSI&#8217;s claim is without merit. In December&#160;2023 terms were agreed between us and SSI which results in a situation where we retain all commercial rights to EVX-01 and the patent application. In June&#160;2024 agreements were signed with SSI that reflects the terms agreed upon in December, and the law-suit lifted on a walk-away basis and no compensation by Evaxion to SSI. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If disputes over intellectual property that we have in-licensed or other related contractual rights prevent or impair our ability to maintain our current licensing arrangements on favorable terms, we may be unable to successfully develop our product candidates and the commercialization of any products derived from such product candidates may be adversely affected. We are generally also subject to all of the same risks with respect to protection of intellectual property that we license, as we are for intellectual property that we own, which are described herein. If we, our co- owners or our licensors fail to adequately protect, defend, maintain or enforce this intellectual property, our ability to commercialize products could suffer and our business, financial condition, results of operations and prospects would be materially harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We rely on third parties to manufacture certain of our clinical product supplies, and we will rely on third parties to produce and process our product candidates, if approved.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We rely on external vendors to manufacture supplies and process our product candidates. None of our product candidates have been manufactured at large scale for supply of late-stage clinical trial or the marked and large scale manufacturing at our third party CDMOs and our future partners, if any, may not be successful and/or may be unable to create an inventory product to satisfy demands for our product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We do not yet have sufficient information to reliably estimate the cost of the commercial manufacturing and processing of our product candidates, and the actual cost and rights to manufacture and process our product candidates could materially and adversely affect the availability of our product candidates in sufficient quantities to conduct our clinical trials or the commercial viability of any products derived from our product candidates. As a result, we and/or our future partners, if any, may never be able to develop a commercially viable product. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, our reliance on a limited number of third-party manufacturers exposes us to the following risks: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we may be unable to identify manufacturers on acceptable terms or at all because the number of potential manufacturers is limited and the FDA, the EMA, the TGA or other regulatory authorities may have questions regarding any replacement contractor. This may require new studies and regulatory interactions. In addition, a new manufacturer would have to be educated in, or develop substantially equivalent processes for, production of our product candidates or any products derived from our product candidates after receipt of regulatory authority questions, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our third-party CDMOs might not be able to timely formulate and manufacture our product candidates or any products derived from our product candidates or produce the quantity and quality required to meet our and our partners&#8217; clinical and commercial needs, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">CDMOs may not be able to execute our manufacturing procedures appropriately; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our future CDMOs may not perform as agreed or may not remain in the contract manufacturing business for the time required to supply our clinical trials or to successfully produce, store and distribute our product candidates or any products derived from our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">manufacturers are subject to ongoing periodic unannounced inspection by the FDA, the United States Drug Enforcement Administration, or the DEA, and corresponding state agencies and by regulatory authorities in other jurisdictions to ensure strict compliance with GMP and other government regulations and corresponding standards in other jurisdictions. We do not have control over third-party CDMOs or our future partners, if any, compliance with these regulations and standards; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we may not own, or may have to share, the intellectual property rights to any improvements made by our third-party CDMOs in the manufacturing process for our products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our third-party CDMOs could breach or terminate their agreement with us; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our third-party CDMOs would also be subject to the same risks we face in developing our own manufacturing capabilities, as described above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each of these risks could delay our clinical trials, the approval, if any, of our product candidates or any products derived from our product candidates by the FDA, the EMA, the TGA or regulatory authorities in other jurisdictions or the commercialization of our product candidates or result in higher costs or deprive us of potential product sales revenue. In addition, we will rely on third parties to perform release tests on our product candidates, or any products derived from our product candidates prior to delivery to patients. If these tests are not appropriately done and test data are not reliable, patients could be put at risk of serious harm. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other companies or organizations may challenge our intellectual property rights or may assert intellectual property rights that prevent us from developing our product candidates and other technologies, and may prevent our future partners, if any, from commercializing any products derived from our product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our business involves new and evolving scientific fields, the continued development and potential use of which has resulted in many different patents and patent applications from organizations and individuals seeking to obtain intellectual property protection in the fields. We own and in-license patent applications and issued patents that describe and/or claim certain technologies, including products, reagents, formulations and methods including uses and manufacturing methods, or features or aspects of any of these. These issued patents and pending patent applications claim certain compositions of matter and methods relating to the discovery, development, manufacture and commercialization of therapeutic modalities and our delivery technologies, including LNPs. If we, our co-owners, our licensors, including our future partners, if any, are unable to obtain, maintain, protect, defend or enforce patent protection with respect to our product candidates and other technology and any product candidates and technology we develop, our business, financial condition, results of operations and prospects could be materially harmed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As the scientific fields mature, our known competitors and other third parties have filed, and will continue to file, patent applications claiming inventions in the field in the United States and in other countries. There is uncertainty about which patents will issue, and, if they do, as to when, to whom and with what claims. With respect to both in-licensed and owned intellectual property, we cannot predict whether the patent applications we and our licensors are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient protection from competitors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We, our co-owners or our licensors, including our future partners, if any, may in the future become a party to patent proceedings or priority disputes in the United States, Europe or other jurisdictions. For instance, in April&#160;2022, SSI initiated a legal proceeding against us in The Danish Maritime and Commercial High Court (S&#248; og Handelsretten), claiming sole ownership of a patent application we filed related to a method for treating malignant neoplasm by administering a composition comprising a high dose of neopeptides, a solvent and SSI&#8217;s liposomal adjuvant, CAF</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">09b, or the Invention, for which we have an exclusive, royalty-bearing sub-licensable license to use in formulation with PIONEER identified neopeptides, from SSI. We believe that we and our employees are the sole inventors of the Invention and that we have strong defenses against SSI&#8217;s claim and that SSI&#8217;s claim is without merit. We have since come to agreement with SSI where we retain all commercial rights to EVX-01 and the patent application. In June 2024 agreements were signed with SSI that reflects the terms agreed upon in December, and the law-suit lifted on a walk-away basis and no compensation by Evaxion to SSI. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If disputes such as the SSI dispute, over intellectual property that we have in-licensed or other related contractual rights prevent or impair our ability to maintain our current licensing arrangements on favorable terms, we may be unable to successfully develop our product candidates and the commercialization of any products derived from such product candidates may be adversely affected. In any event, if it is determined that that SSI are co-owners of part of the subject matter of the patent application, such a determination would not, in and of itself, prevent us from carrying on with EVX-01. However, if co-ownership of part of the patented subject matter is the end result of the court proceedings, our practical use of such part of the patented subject matter in any enforcement proceeding or as an object of licensing could be problematic. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Leahy-Smith America Invents Act, or the America Invents Act, enacted in September&#160;2011, included a number of significant changes that affect the way patent applications will be prosecuted and also may affect patent litigation. These include allowing third-party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent through USPTO- administered post-grant proceedings, including post-grant review, inter partes review and derivation proceedings. We expect that our competitors and other third parties may institute litigation and other proceedings, such as interference, reexamination and opposition proceedings, as well as inter partes and post- grant review proceedings against us and the patents and patent applications that we own and in-license. We expect that we may be subject to similar proceedings or priority disputes, including oppositions, in Europe or other foreign jurisdictions relating to patents and patent applications in our portfolio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we, our co-owners or our licensors, including our future partners, if any, are unsuccessful in any interference proceedings or other priority or validity disputes, including any derivations, post-grant review, inter parties review or oppositions, to which we or they are subject, we may lose valuable intellectual property rights through the narrowing or loss of one or more patents owned or in-licensed, or our owned or in- licensed patent claims may be narrowed, invalidated or held unenforceable. In many cases, the possibility of appeal exists for either us or our opponents, and it may be&#160;years before final, unappealable rulings are made with respect to these patents in certain jurisdictions. The timing and outcome of these and other proceedings is uncertain and may adversely affect our business if we are not successful in defending the patentability and scope of our pending and issued patent claims. In addition, third parties may attempt to invalidate our intellectual property rights. Even if our rights are not directly challenged, disputes could lead to the weakening of our intellectual property rights. Our defense against any attempt by third parties to circumvent or invalidate our intellectual property rights could be costly to us, could require significant time and attention of our management and could have a material adverse impact on our business and our ability to successfully compete against our current and future competitors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There are many issued and pending patent filings that claim aspects of technologies that we or our future partners, if any, may need for our product candidates or any products derived from our product candidates, including patent filings that relate to relevant delivery technologies. There are also many issued patents that claim targeting genes or portions of genes that may be relevant for vaccines we wish to develop. In addition, there may be issued and pending patent applications that may be asserted against us in a court proceeding or otherwise based upon the asserting party&#8217;s belief that we or our future partners, if any, may need such patents for the development, manufacturing and commercialization of our product candidates or any products derived from our product candidates. Thus, it is possible that one or more organizations, ranging from our competitors to non-practicing entities or patent assertion entities, has or will hold patent rights to which we may need a license, or hold patent rights which could be asserted against us. Such licenses may not be available on commercially reasonable terms or at all, or may be non-exclusive. If those organizations refuse to grant us a license to such patent rights on reasonable terms or a court rules that we need such patent rights that have been asserted against us and we are not able to obtain a license on reasonable terms or at all, we may be unable to perform research and development or other activities or market products covered by such patents, and we or our future partners, if any, may need to cease the development, manufacture and commercialization of one or more of the product candidates or any products derived from our product candidates we or our future partners, if any, may develop. Any of the foregoing could materially harm our business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have been and may, in the future, be, subject to claims that current or former employees, consultants, independent contractors, collaborators, future partners, if any, or other third parties have an interest in our patents or other intellectual property as an inventor or co-inventor. While it is our policy to require our employees, consultants, independent contractors, future partners, if any, and other third parties who may be involved in the conception, development or reduction to practice of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who, in fact, conceives, develops or reduces to practice such intellectual property that we regard as our own. The assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached. For example, we may have inventorship disputes arise from conflicting </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">obligations of employees, consultants, independent contractors, future partners, if any, or other third parties who are involved in developing and commercializing our product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For instance, in April&#160;2022, SSI initiated a legal proceeding against us in The Danish Maritime and Commercial High Court (S&#248; og Handelsretten), claiming sole ownership of a patent application we filed related to a method for treating malignant neoplasm by administering a composition comprising a high dose of neopeptides, a solvent and SSI&#8217;s liposomal adjuvant, CAF</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">09b, or the Invention, for which we have an exclusive, royalty-bearing sub-licensable license to use in formulation with PIONEER identified neopeptides, from SSI. We believe that we and our employees are the sole inventors of the Invention and that we have strong defenses against SSI&#8217;s claim and that SSI&#8217;s claim is without merit. In December&#160;2023 terms were agreed between us and SSI which results in a situation where we retain all commercial rights to EVX-01 and the patent application. In June&#160;2024 agreements were signed with SSI that reflects the terms agreed upon in December, and the law-suit lifted on a walk-away basis and no compensation by Evaxion to SSI. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If disputes such as the SSI dispute, over intellectual property that we have in-licensed or other related contractual rights prevent or impair our ability to maintain our current licensing arrangements on favorable terms, we may be unable to successfully develop our product candidates and the commercialization of any products derived from such product candidates may be adversely affected. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Litigation may be necessary to defend against these and other claims challenging inventorship. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could materially harm our business, financial condition, results of operations and prospects. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, the laws of some countries do not protect intellectual property and other proprietary rights or establish ownership of inventions to the same extent or in the same manner as the laws of the United States. A majority of our employees work in Denmark and are subject to Danish employment law. Employees&#8217; inventions that are either patentable or registrable as Danish utility models are subject to the provisions of the Danish Act on Employee Inventions, which regulates the ownership of, and compensation for, inventions made by employees. We face the risk that disputes can occur between us and our employees or former employees pertaining to alleged non-adherence to the provisions of this act. Such disputes may be costly to defend and may take up our management&#8217;s time and efforts regardless of whether we prevail or fail in any such dispute. There is a risk that the compensation we provided to employees who have assigned the rights to inventions to us may be deemed to be insufficient and we may under Danish law be required to increase the compensation due to such employees for the assignment of rights to such inventions. In those cases where rights to employees&#8217; inventions have not been assigned to us, we may need to agree with the respective employees on the assignment of such inventions, including i.e. by paying suitable compensation for the use of those patents. If we are required to pay additional compensation or face other disputes under the Danish Act on Employee Inventions, our business, financial condition, results of operations and prospects could be materially harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to this Offering and Ownership of ADSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our failure to meet Nasdaq&#8217;s continued listing requirements could result in a delisting of the ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;7, 2024, we received a notification from Nasdaq that we are not in compliance with the Nasdaq requirement to maintain a minimum equity of USD $2.5&#160;million. We were granted an extension until November&#160;4, 2024, to demonstrate compliance with the Nasdaq listing requirements. On November&#160;11, 2024 we received a delisting notice from Nasdaq Capital Markets, which we appealed on November&#160;12, 2024 and will pursue an additional 180-day exemption allowing time for securing compliance in a balanced way. The appeal will stay any trading suspension of the ADSs until completion of the Nasdaq hearing process and expiration of any additional extension period granted by the panel following the hearing. During any additional extension, we intend to regain compliance and maintain our Nasdaq listing, however there is no guarantee that we will be able to regain compliance. We are in constructive dialogue with Nasdaq on the matter, however no guarantees can be made that additional 180-days exemption will be given. If appeal is not successful, the continued non-compliance would result in delisting from Nasdaq Capital Markets. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Such a delisting would likely have a negative effect on the price of the ADSs and would impair your ability to sell or purchase the ADSs when you wish to do so. In the event of a delisting, any action taken by us to restore compliance with listing requirements may not i) allow the ADSs to become listed again, ii)&#160;stabilize the market price or iii) improve the liquidity of the ADSs, iv) prevent the ADSs from dropping below the Nasdaq minimum bid price requirement or v) prevent future non-compliance with the listing requirements of Nasdaq. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">A significant portion of our total outstanding ordinary shares may be sold in the near future. The large number of shares eligible for sale or subject to rights requiring us to register them for sale could cause the market price of the ADSs to drop significantly, even if our business is performing well.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Sales of a substantial number of ordinary shares or the ADSs could occur at any time. These sales, or the perception in the market that holders of a large number of shares intend to sell shares, could reduce the market price of the ADSs. We had 58,660,556 ordinary shares outstanding and 5,866,055 ADSs outstanding as of December 13, 2024. To date, not all of the holders of outstanding ordinary shares have converted their ordinary shares to ADSs. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">You will experience immediate dilution. As of December 13, 2024, there were 74,112,086 warrants outstanding. If these warrants are exercised then an additional 74,112,086 ordinary shares, which are convertible into 7,411,208 ADSs, will become eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules and Rule&#160;144 and Rule&#160;701 under the Securities Act. If these additional ordinary shares are sold, or if it is perceived that they will be sold, in the public market, the trading price of the ADSs could decline. Any sales of securities by these security holders could have a negative effect on the trading price of our ordinary shares and the ADSs. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For a more detailed description of the EIB warrants see the section herein entitled &#8220;EIB warrants.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, on November&#160;28, 2021, we entered into a Share Sale and Restriction Agreement with, Dr.&#160;Lars Staal Wegner, our former Chief Executive Officer, Dr.&#160;Niels Iversen M&#248;ller our Co-Founder, and Andreas Mattsson, our Co-Founder and Chief AI Officer, pursuant to which Dr.&#160;Wegner agreed to exercise 211,849 warrants in each of the two week exercise windows established under our Articles of Association that are expected to open two trading days following publication of our annual report and interim quarterly financial reports in March&#160;2022, May&#160;2022, August&#160;2022 and November&#160;2022, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of this agreement, Dr.&#160;Wegner, Dr.&#160;M&#248;ller and Mr.&#160;Mattsson further agreed with us that in the corresponding open trading window related to each such exercise consisting of the four-week period commencing on the third full trading day after the date of publication of our annual report or interim financial reports in March&#160;2022, May&#160;2022, August&#160;2022 and November&#160;2022, each a Trading Window, Dr.&#160;Wegner would sell such Ordinary Shares and Dr.&#160;M&#248;ller and Mr.&#160;Mattsson will purchase such ordinary shares, with each of Dr.&#160;M&#248;ller and Mr.&#160;Mattsson purchasing fifty per cent (50%) of such shares, at a purchase price per share equal to the Volume Weighted Average Price, or VWAP, of the ADSs at the close of the market on the date of exercise as reported on Nasdaq. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of the agreement, Dr.&#160;M&#248;ller and Mr.&#160;Mattsson agreed that during each Trading Window each of them will sell 328,731 ADSs representing ordinary shares at a price equal to the prevailing market price thereof on the date of such sale as reported on Nasdaq. Furthermore, pursuant the terms of the agreement, Dr.&#160;M&#248;ller and Mr.&#160;Mattsson are required to sell such shares and are prohibited from exercising any subsequent influence over how, when, or whether to affect the trade(s). As of December&#160;31, 2022, due to market conditions, Dr.&#160;M&#248;ller and Mr.&#160;Mattsson had only sold 43,196 of such ADSs representing ordinary shares, thereby, leaving a total of 285,535 ADSs subject to future sale under this arrangement. The number of ADSs referred to in this section do not reflect the one to ten ratio change effective January&#160;22, 2024. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, on June&#160;7, 2022, we entered into the LPC Purchase Agreement pursuant to which we issued 428,572 ordinary shares represented by ADSs (&#8220;Commitment Shares&#8221;) to Lincoln Park as consideration for a commitment fee of $1,200,000 for Lincoln Park&#8217;s agreement to purchase ordinary shares represented by ADSs under the LPC Purchase Agreement. As of the date of this prospectus we have not issued any additional ordinary shares represented by ADSs to Lincoln Park. In accordance with the terms of the LPC Purchase Agreement, we filed a selling shareholder Form F-1 Registration Statement with the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SEC on July&#160;7, 2002, which was declared effective by the SEC on August&#160;26, 2022 registering the potential future sale by Lincoln Park of up to 4,649,250 ADSs represented ordinary shares inclusive of the 428,572 Commitment Shares. As of the date of this prospectus, Lincoln Park has only sold an aggregate of 102,000 of such Commitment Shares thereby leaving 326,572 of such Commitment Shares available for sale. The number of ADSs referred to in this section do not reflect the one to ten ratio change effective January&#160;22, 2024. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, on October&#160;3, 2022, we entered into a Capital on Demand&#8482; Sales Agreement, or the Sales Agreement, with JonesTrading Institutional Services LLC, or JonesTrading, pursuant to which we may sell from time to time, at our option, ADSs representing ordinary shares through or to JonesTrading, as sales agent or principal. The ADSs are offered pursuant to a prospectus supplement, dated October&#160;3, 2022, or the Prospectus Supplement, which was filed with the SEC on such date and our Form F-3 (Registration No. 333-265132) shelf registration statement filed with the SEC on May&#160;20, 2022 and declared effective by the SEC on June&#160;3, 2022. Pursuant to the Prospectus Supplement, we may offer and sell up to an aggregate of $14,439,000 of ADSs. Sales of the ADSs made pursuant to the Sales Agreement, are made by any method deemed to be an &#8220;at the market offering&#8221;, or ATM, as defined in Rule&#160;415(a)(4) promulgated under the Securities Act. JonesTrading is not required to sell any specific number or dollar amount of ADSs but has agreed to use its commercially reasonable efforts to sell the ADSs from time to time, based upon our instructions, including any price, time or size limits or other customary parameters or conditions we may impose. As of the date of this prospectus, we have sold a total of 703,137ADSs under this ATM program for an aggregate purchase price of $9,414,825, thereby leaving up to an aggregate $5.0&#160;million of ADSs available for future sale under this ATM program, depending in the development in the share price. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, on July&#160;31, 2023 we entered into a financing agreement with Global Growth Holding Limited (&#8220;GGH&#8221;), for the issuance of convertible notes into our ordinary shares represented by ADSs, DKK 1 nominal value, with each ordinary share represented by one ADSs. Pursuant to the agreement, we may elect to sell to GGH up to $20.0&#160;million in such notes on any business day over the 36 month term of the agreement. We have under certain circumstances the right, but not the obligation, to direct GGH to purchase traches of up to $0.7&#160;million, subject to certain limitations and conditions set forth in the agreement. In connection with the agreement, we are obligated to pay GGH a commitment fee totaling $1.1&#160;million. At any time, GGH may, in its sole discretion, convert the notes into ordinary shares at specified conversion prices upon submission of a request for conversion by GGH to us. The financing agreement between us and GGH is subject to approval by the SEC through the date of this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In February 2024, we completed a public offering through which we sold 757,500 ADSs representing an aggregated 7,575,000 ordinary shares, DKK 1 nominal value per share, together with warrants to purchase up to 757,500 ADSs representing 7,575,000 ordinary shares. The public offering price for each ADS and accompanying warrant was $4.00. The warrants have an exercise price per ADS of $4.00 (amended to 27.52 DKK as of May 23, 2024) and are immediately exercisable for a term of five years from the date of&#160;issuance. Additionally, as part of the public offering, we offered prefunded warrants to purchase up to 2,992,500 ADSs representing 29,925,000 ordinary shares. The public offering price for each ADS and accompanying&#160;prefunded warrant was $4.00. The prefunded warrants have an exercise price per ADS of $1,4537 and are immediately exercisable for a term of five years from the date of issuance. Additionally, we issued Placement Agent warrants to purchase up to 187,500 ADSs representing 1,875,000 ordinary shares. The Placement Agent warrants have an exercise price per ADS of $5.40 and are immediately exercisable for a term of five years from the date of issuance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sales of ADSs or our ordinary shares as restrictions end or pursuant to the above described agreements or pursuant to registration rights may make it more difficult for us to finance our operations through the sale of equity securities in the future at a time and at a price that we deem appropriate. These sales also could cause the trading price of the ADSs to fall and make it more difficult for holders of ADSs to sell the ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our principal shareholders and executive management own a significant&#160;percentage of our ordinary shares and will be able to exert significant control over matters subject to shareholder approval.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As of December 13, 2024, our executive management, directors, holders of 5% or more of our ordinary shares and their respective affiliates beneficially own 15.1% of our outstanding voting securities. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a result, these security holders will have the ability either alone or voting together as a group to determine and/or significantly influence the outcome of matters submitted to our shareholders for approval, including the election and removal of directors, payment of dividends, amendments to our articles of association, including changes to our share capital or any mergers, demergers, liquidations and similar transactions. This may prevent or discourage unsolicited acquisition proposals or offers for our ordinary shares or ADSs that holders of ADSs may feel are in their best interest as a holder of ADSs. In addition, this group of shareholders may have the ability to control our management and affairs. Such control and concentration of ownership may affect the market price of the ADSs and may discourage certain types of transactions, including those involving actual or potential change of control of us (whether through merger, consolidation, take-over or other business combination), which might otherwise have a positive effect on the market price of the ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may not have sufficient funds available to pay amounts due and owing European Investment Bank upon the exercise of certain warrants and may be required to use our cash, cash equivalents and investments to make such payments.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In August&#160;2020, we executed a loan agreement, or the EIB Loan Agreement, with the European Investment Bank, or EIB, for a principal amount of &euro;20.0&#160;million, divided into three tranches of tranche 1 in the amount of &euro;7.0&#160;million, tranche 2 in the amount of &euro;6.0&#160;million and tranche 3 in the amount of &euro;7.0&#160;million, or the EIB Loan. Under the EIB Loan Agreement, the EIB Loan tranche balances are due six&#160;years from their respective disbursement dates. In connection with disbursement of each tranche, EIB is entitled to receive certain warrants, or the EIB Warrants. In November&#160;2020, we initiated the process to receive the funds from the disbursement of tranche 1 of the EIB Loan in the aggregate amount of &euro;7.0&#160;million but due to the timing of the IPO we did not finalize a disbursement offer. In connection therewith, EIB received 351,036 EIB Warrants, which vested immediately, pursuant to the terms of a separate warrant agreement, or the EIB Warrant Agreement. As of December&#160;31, 2021, we initiated the drawdown of the first tranche of the EIB Loan Agreement amounting to &euro;7.0&#160;million. We received the first tranche of &euro;7.0&#160;million on February&#160;17, 2022. While we are in advanced discussions with EIB to convert up to &euro;3.5 million of the EIB Loan to some form of equity, there is no guarantee that a final agreement will be reached.</font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under Article&#160;18, Paragraph 2 of the Statute of the European Investment Bank, or the EIB Statute, establishing EIB, a direct equity investment by EIB requires a separate authorization from the EIB Board of Governors pursuant to which the EIB Board of Directors, acting by qualified majority, has to establish the terms and conditions of such direct equity investment. Under the EIB Statute, in the absence of a separate authorization from the EIB Board of Governors, commercial shareholdings financed from EIB&#8217;s own resources are not allowed. Since the EIB Loan is being made from EIB&#8217;s own resources, the EIB Statute does not allow EIB to acquire any of our ordinary shares, therefore, we fully expect that if and when EIB exercises the EIB Warrants, it will do so on either a net cash settlement basis at a price equal to the market price on the date of exercise thereof, or by means of exercising its right to cause us to purchase the EIB Warrants at a purchase price equal to the volume weighted average price per ordinary share, or VWAP, for a period of six&#160;months following the exercise of such Put Right. Since we fully expect the EIB Warrants to be cash settled, we do not expect them to affect our share capital at any time. However, since the amount of cash that we will need in order to meet our obligations to pay the amounts due and payable to EIB upon the exercise of the EIB Warrants is based on valuations to be determined in the future and, therefore, cannot be determined as of the date of this prospectus, we may not have sufficient funds on hand to pay such amounts in which case we may be required to use a portion of our investments for such payments. For a more detailed discussion of the terms of the EIB Warrants see &#8220;Description of Share Capital&#8201;&#8212;&#8201;EIB Warrants.&#8221; </font>
        </div>

          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">There is no public market for the Warrants or pre-funded warrants being offered by us in this offering.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">There is no established public trading market for the Warrants or pre-funded warrants, and we do not expect a market to develop. In addition, we do not intend to apply to list the Warrants or pre-funded warrants on any national securities exchange or other nationally recognized trading system. Without an active market, the liquidity of the Warrants or pre-funded warrants will be limited. </font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The Warrants and pre-funded warrants are speculative in nature.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The Warrants and pre-funded warrants offered hereby do not confer any rights of ADS ownership on their holders, such as voting rights, but rather merely represent the right to acquire ADSs representing </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">ordinary shares at a fixed price. Specifically, holders of the pre-funded warrants may acquire the ADSs issuable upon exercise of such warrants at an exercise price of $1.42 per ADS or the USD equivalent to DKK&#160;10 at the time of exercise and holders of the Warrants may acquire the ADSs issuable upon exercise of such warrants at an exercise price of $&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; per ADS. Moreover, following this offering, the market value of the pre-funded warrants is uncertain and there can be no assurance that the market value of the pre-funded warrants will equal or exceed their public offering prices. There can be no assurance that the market price of the ADSs will ever equal or exceed the exercise price of the Warrants and pre-funded warrants, and consequently, whether it will ever be profitable to exercise the Warrants and pre-funded warrants. </font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Holders of the Warrants and pre-funded warrants offered hereby will have no rights as ADS holders with respect to the ADSs deliverable upon exercise of the Warrants or pre-funded warrants until such holders exercise their Warrants or pre-funded warrants and acquire our ADSs, except as otherwise provided in the Warrants or pre-funded warrants.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Until holders of the Warrants and pre-funded warrants acquire ADSs upon exercise thereof, such holders will have no rights with respect to the ADSs underlying such Warrants or pre-funded warrants, except as otherwise provided in the Warrants or pre-funded warrants. Upon exercise of the Warrants or pre-funded warrants, the holders will be entitled to exercise the rights of an ADS holder only as to matters for which the record date occurs after the exercise date. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">This is a best efforts offering, no minimum amount of securities is required to be sold, and we may not raise the amount of capital we believe is required for our business plans, including our near-term business plans.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The Placement Agent has agreed to use its reasonable best efforts to solicit offers to purchase the securities in this offering. The Placement Agent has no obligation to buy any of the securities from us or to arrange for the purchase or sale of any specific number or dollar amount of the securities. There is no required minimum number of securities that must be sold as a condition to completion of this offering. Because there is no minimum offering amount required as a condition to the closing of this offering, the actual offering amount, Placement Agent fees and proceeds to us are not presently determinable and may be substantially less than the maximum amounts set forth above. We may sell fewer than all of the securities offered hereby, which may significantly reduce the amount of proceeds received by us, and investors in this offering will not receive a refund in the event that we do not sell an amount of securities sufficient to support our continued operations, including our near-term continued operations. Thus, we may not raise the amount of capital we believe is required for our operations in the short-term and may need to raise additional funds, which may not be available or available on terms acceptable to us. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">You will experience immediate dilution in the book value per ADS purchased in the offering.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:11pt;">
            <font style="letter-spacing:0.2pt;">Because the price per share of the ADSs being offered may be higher than the net tangible book value per ADS, you will experience dilution to the extent of the difference between the offering price per ADS you pay in this offering and the net tangible book value per ADS immediately after this offering. Our net tangible book value as of September&#160;30, 2024, was approximately $0.1&#160;million, or $0.01 per ADS. Net tangible book value per ADS is equal to our total tangible assets minus total liabilities, all divided by the number of ADSs outstanding. See the section titled &#8220;Dilution&#8221; for a more detailed discussion of the dilution you will incur if you purchase shares in this offering. You may suffer immediate and substantial dilution in the net tangible book value of the ordinary shares you purchase in this offering. After giving further effect to 7,640,845 ADSs in this offering at an assumed public offering price of $1.42 per ADS, and after deducting the Placement Agent commission and estimated offering expenses payable by us, our pro&#160;forma as adjusted net tangible book value at September&#160;30, 2024 would have been $9.5&#160;million, $0.71 per ADS. This represents an immediate increase in pro&#160;forma as adjusted net tangible book value of $0.70 per ADS to existing investors and immediate dilution of $0.71 per ADS to new investors in this offering. See the section of this prospectus titled &#8220;Dilution&#8221; for a more detailed description of these factors. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If you purchase our securities in this offering you may experience future dilution as a result of future equity offerings or other equity issuances.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to raise additional capital, we believe that we will offer and issue additional ADSs or other securities convertible into or exchangeable for the ADSs in the future. We cannot assure you that we will be </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:386pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">able to sell ADSs or other securities in any other offering at a price per ADS that is equal to or greater than the price per ADS paid by investors in this offering, and investors purchasing other securities in the future could have rights superior to existing stockholders. The price per ADS at which we sell additional ADSs or other securities convertible into or exchangeable for the ADSs in future transactions may be higher or lower than the price per ADS in this offering. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, we have a significant number of share options and warrants outstanding. To the extent that outstanding share options or warrants have been or may be exercised or other shares issued, you may experience further dilution. Further, we may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Purchasers who purchase our securities in this offering pursuant to a securities purchase agreement may have rights not available to purchasers that purchase without the benefit of a securities purchase agreement.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to rights and remedies available to all purchasers in this offering under federal securities and state law, the purchasers that enter into a securities purchase agreement will also be able to bring claims of breach of contract against us. The ability to pursue a claim for breach of contract provides those investors with the means to enforce the covenants uniquely available to them under the securities purchase agreement including: (i)&#160;timely delivery of shares; (ii)&#160;agreement to not enter into variable rate financings for &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; from closing, subject to certain exceptions; (iii)&#160;agreement to not issue any ordinary shares or ADSs or securities convertible into ordinary shares or ADSs for&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;days from closing, subject to certain exceptions; and (iv)&#160;indemnification for breach of contract.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDIPO">&#8203;</a><a name="tMIAO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:228pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DIVIDEND POLICY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have never declared or paid any cash dividends on our ordinary shares. We do not anticipate paying cash dividends on our equity securities in the foreseeable future and intend to retain all available funds and any future earnings for use in the operation and expansion of our business. If we pay any dividends on our ordinary shares, we will pay those dividends, which shall be payable in respect of the ordinary shares represented by the ADSs, to the depositary, as the registered holder of such ordinary shares, and the depositary then will pay such amounts to the ADS holders in proportion to the ordinary shares underlying the ADSs held by such ADS holders, subject to the terms of the deposit agreement, including the fees and expenses payable thereunder. See the section entitled &#8220;Description of American Depositary Shares&#8221; in this prospectus. Cash dividends on our ordinary shares, if any, will be paid in USD. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MARKET, INDUSTRY AND OTHER DATA</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus contains statistics, estimates, projections and other information concerning our industry, our business, and the markets for our product candidates, including data regarding the total sales of product in those markets, the estimated patient population in those markets, their projected growth rates, the perceptions and preferences of patients and physicians regarding the disease indications that we are pursuing or may pursue, as well as data regarding market research, statistics, estimates and forecasts prepared by our management. Information that is based on statistics, estimates, forecasts, projections, market&#160;research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may&#160;differ materially from events and circumstances that are assumed in this information. Unless otherwise expressly stated, we obtained this industry, business, market and other data from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data and similar sources. For example, certain information contained in this prospectus regarding industry and market data was obtained from Medtrack, a database of private and&#160;public biotechnology companies. In some cases, we do not expressly refer to the sources from which this data is derived. In that regard, when we refer to one or more sources of this type of data in any paragraph, you should assume that other data of this type appearing in the same paragraph is derived from the same sources,&#160;unless otherwise expressly stated or the context otherwise requires. In addition, assumptions and estimates of our and our industry&#8217;s future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in &#8220;Risk Factors.&#8221; These and other factors could cause our future performance to differ materially from our assumptions and estimates. See &#8220;Cautionary Note Regarding Forward-Looking Statements.&#8221; </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tUOP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">USE OF PROCEEDS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We estimate that our net proceeds from this offering will be approximately $9.4&#160;million, after deducting placement agent fees and estimated offering expenses of approximately $1.45&#160;million (based on a public offering price per ADS of $1.42 per ADS and accompanying warrant, based on an offering with aggregate gross proceeds of $10.85&#160;million. However, because this is a best effort offering and there is no minimum offering amount required as a condition to the closing of this offering, the actual offering amount, the placement agent&#8217;s fees and net proceeds to us are not presently determinable and may be substantially less than the maximum amounts set forth on the cover page of this prospectus. </font>
          </div>

        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We intend to use the net proceeds of this offering for continuing operating expenses and working&#160;capital. More specifically the net proceeds will be used to drive forward the remaining 2024 milestone as laid out in Figure 3 as well as coming 2025 key milestones in Figure 4. This includes both progressing our AI-Immunology&#8482; platform as well as our clinical and pre-clinical pipeline, while advancing ongoing&#160;business development discussions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table presents our approximate use of proceeds if 100% of the securities in this offering are sold. </font>
        </div>
        <table style="width:416pt;height:108.5pt;margin-left:20pt;margin-top:7pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt; width:355.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">$m </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt; width:19pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">100% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">% of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:355.47pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Gross Proceeds from Offering</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:19pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8199;&#8199;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">100<font style="position:absolute;">%</font></div>
            </td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.47pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Use of Proceeds</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Placement Agent Fees and Expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">7<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Offering Expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">6<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research &amp; Development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">50<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General &amp; Administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">37<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Total Use of Proceeds</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>

          <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">If Gross Proceeds of this offering amounts to $10.85&#160;million we expect to be able to fund current operations until end of 2025 based on the offering net proceeds, assuming no issuance of pre-funded warrants if such are part of the offering. This is excluding any further income from ongoing business development activities which would extend the runway. For our expected January&#160;2025 to December&#160;2025 operating loss excluding financing activities, 57% is consumed by R&amp;D related expenses and 43% for General&#160;&amp; Administrative expenses. </font>
          </div>


          <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">In addition, we expect to use the At-The-Market facility in place with JonesTrading. This tool is dependent upon the liquidity in the EVAX share. Further, we expect to generate business development income in 2025 which will be used to fund operations. Via the MSD agreement signed in September&#160;2024, we have secured a potential up to $10&#160;million in 2025 already. </font>
          </div>

        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In common with many clinical development stage biotechnology companies our future liquidity needs, and ability to address them, will largely be determined by the availability of capital, both generally and in particular to fund our product candidates and key development and regulatory projects. As a pre-revenue biotechnology company, we have financed our operations though continuously raising capital; and we expect to continue having to raise capital routinely on the capital markets, taking advantage of our public listing. We are constantly formulating and implementing potential funding initiatives to ensure we have adequate working capital. These initiatives could be in the form of further equity raises, as noted earlier and/or non- dilutive financings arising from collaborations or licensing arrangements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The amounts and timing of our actual expenditures will depend on numerous factors, including the progress of our clinical trials, the potential for achieving accelerated regulatory approval and the amount of cash used in our operations. We therefore cannot estimate with certainty the amount of net proceeds to be used for the purposes described above. We may find it necessary or advisable to use the net proceeds for other purposes, and we will have broad discretion in the application of the net proceeds. Our shareholders may not agree with the manner in which our management chooses to allocate and spend the net proceeds. Moreover, our management may use the net proceeds for corporate purposes that may not result in our being profitable or increase our market value. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCAP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAPITALIZATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table below sets forth our cash and cash equivalents and our total capitalization as of September&#160;30, 2024 on: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">an actual basis and; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">an adjusted basis to give effect to the exercise of pre-funded warrants of 124,000 ADS on October&#160;25, 2024, at an aggregate exercise price of $0.2&#160;million. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(3)</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:0.2pt;">a pro&#160;forma basis as adjusted to give effect to the sale of 7,640,845 ADSs and Warrants pursuant to this prospectus at a public offering price of $1.42 per ADS, assuming no sale of pre-funded warrants and no Warrants are exercised, after deducting the Placement Agent commission and estimated offering expenses payable by us. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You should read this information together with our unaudited interim financial statements and related notes appearing at the end of this prospectus and the information set forth under the &#8220;Prospectus Summary&#8201;&#8212;&#8201;Summary Financial Data,&#8221; &#8220;Use of Proceeds&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; sections. </font>
        </div>

          <table style="width:416pt;height:136pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:262.61pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Sep 30,</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">2024 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">As adjusted </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Pro&#160;forma as </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">adjusted </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:262.61pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">USD in thousands </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:262.61pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,576</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.1pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,751</td>
              <td style="padding:0pt;padding-left:1.1pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.54pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">14,141</td>
              <td style="padding:0pt;padding-left:3.54pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:262.61pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total assets </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">15,185</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.1pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">15,360</td>
              <td style="padding:0pt;padding-left:1.1pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.54pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">24,750</td>
              <td style="padding:0pt;padding-left:3.54pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:262.61pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total liabilities </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">15,111</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.1pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">15,111</td>
              <td style="padding:0pt;padding-left:1.1pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.54pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">15,111</td>
              <td style="padding:0pt;padding-left:3.54pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:262.61pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Share capital </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,732</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.1pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,907</td>
              <td style="padding:0pt;padding-left:1.1pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.54pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">19,661</td>
              <td style="padding:0pt;padding-left:3.54pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:262.61pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Other reserves </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">106,245</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.1pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">106,245</td>
              <td style="padding:0pt;padding-left:1.1pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.54pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">104,881</td>
              <td style="padding:0pt;padding-left:3.54pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:262.61pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Accumulated deficit </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(114,903<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.1pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(114,903<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:1.1pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.54pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(114,903<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:3.54pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:262.61pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total equity </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">74</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.1pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">249 </td>
              <td style="padding:0pt;padding-left:1.1pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.54pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">9,639</td>
              <td style="padding:0pt;padding-left:3.54pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The number of our ordinary shares (including shares represented by ADSs in proportion to the designated ratio, as described in this registration statement) to be outstanding after this offering is based on 57,420,556 ordinary shares outstanding as of September&#160;30, 2024 and excludes: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">3,107,061 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, pursuant to our Warrant Incentive Plan, at a weighted average exercise price of $1.00 per warrant; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">70,695,025 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, based on Warrants issued to investors and placement agent, at a weighted average exercise price of $0.37 per warrant; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">50,000 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, at an exercise price equal to $1.50 per warrant, 50,000 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, based on warrants issued to a consultant, based on warrants issued to a consultant, at an exercise price equal to $0.39 per warrant, 50,000 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, based on warrants issued to a consultant related to the Company, at an exercise price equal to $0.25 per warrant issued and 1,400,000 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, based on warrants issued to a consultant related to the Company, at an exercise price equal to DKK 1, or approximately USD $0.14 per warrant issued. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">108,690,504 ordinary shares reserved for future issuance under our warrant plans, including 9,461,540 ordinary shares reserved for future issuance to key-employees, officers and directors, 728,964&#160;ordinary shares reserved for future issuance under the EIB Warrants, and 98,500,000 shares reserved for future issuance under warrants they may be issued to future investors, lenders, consultants and/or advisors, if any. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:448pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the description of the Warrant Incentive Plan see &#8220;Warrant Incentive Plan&#8221; herein. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Unless otherwise stated, all information in this prospectus assumes no exercise of the outstanding options and warrants described above or the Warrants into ordinary shares or ADSs, treats all restricted shares issued with outstanding restrictions to be vested as issued and outstanding shares and the exercise in full of pre-funded warrants in this offering. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise indicated all references to our articles of association in this prospectus refer to our articles of association, as amended as currently in force for Evaxion Biotech A/S at the date of this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the extent these outstanding options or any newly issued options are exercised, or we issue additional ordinary shares in the future, there will be further dilution to the new investors purchasing ordinary shares represented by ADSs in this offering. In addition, we may choose to raise additional capital because of market conditions or strategic considerations, even if we believe that we have sufficient funds for our current or future operating plans. If we raise additional capital through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our shareholders. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDIL">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DILUTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">If you invest in the ADSs in this offering, your ownership interest of our ordinary shares will be immediately diluted to the extent of the difference between the public offering price per ADS in this&#160;offering and the pro&#160;forma as adjusted net tangible book value per ADS after this offering. For the purposes of calculating the potential impact of dilution, the full value of the public offering price of $1.42 per ADS has been ascribed to the ADSs. Dilution results from the fact that the public offering price per ADS is substantially in excess of the net tangible book value per ADS after this offering. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of September&#160;30, 2024, we had a historical net tangible book value of $0.1&#160;million, or $0.01 per ADS. Our net tangible book value per ADS represents total tangible assets less total liabilities, divided by the number of ordinary shares outstanding on September&#160;30, 2024. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">After giving further effect to 7,640,845 ADSs at a public offering price of $1.42 per ADS, and after deducting the Placement Agent commission and estimated offering expenses payable by us, our pro&#160;forma as adjusted net tangible book value at September&#160;30, 2024 would have been $9.5&#160;million, or $0.71 per ADS. This represents an immediate increase in pro&#160;forma as adjusted net tangible book value of $0.70 per ADS to existing investors and immediate dilution of $0.71 per ADS to new investors in this offering. The following table illustrates this dilution to new investors purchasing ADSs in this offering: </font>
          </div>


          <table style="width:416pt;height:82pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 1pt 0pt; width:381.29pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Public offering price per ADS </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:0pt 0pt 1pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">1.42 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:381.29pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Historical net tangible book value per ADS as at September&#160;30, 2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">0.01</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:381.29pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Increase in net tangible book value per ADS attributable to transactions in the period through the present offering, as described above </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">0.70 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:381.29pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Pro&#160;forma net tangible book value per ADS as of September&#160;30, 2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">0.71 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:381.29pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Dilution per ADS to new investors purchasing ADSs in this offering </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">0.71</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>


          <div style="text-indent:20pt; margin-top:7.71pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The number of our ordinary shares (including shares represented by ADSs in proportion to the designated ratio, as described in this registration statement) to be outstanding after this offering is based on 58,660,556 ordinary shares outstanding as of December 13, 2024 and excludes: </font>
          </div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">3,107,061 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, pursuant to our Warrant Incentive Plan, at a weighted average exercise price of $1.00 per warrant; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">69,455,025 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, based on Warrants issued to investors and placement agent, at a weighted average exercise price of $0.37 per warrant; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">50,000 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, at an exercise price equal to $1.50 per warrant, 50,000 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, based on warrants issued to a consultant, based on warrants issued to a consultant, at an exercise price equal to $0.39 per warrant, 50,000 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, based on warrants issued to a consultant related to the Company, at an exercise price equal to $0.25 per warrant issued and 1,400,000 ordinary shares issuable upon the exercise of warrants outstanding as of the date of this prospectus, based on warrants issued to a consultant related to the Company, at an exercise price equal to DKK 1, or approximately USD $0.14 per warrant issued. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">95,073,413 ordinary shares reserved for future issuance under our warrant plans, including 9,461,540 ordinary shares reserved for future issuance to key-employees, officers and directors, 706,873&#160;ordinary shares reserved for future issuance under the EIB Warrants, and 84,905,000 shares reserved for future issuance under warrants they may be issued to future investors, lenders, consultants and/or advisors, if any. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Unless otherwise stated, all information in this prospectus assumes no exercise of the outstanding options and warrants described above or the Warrants into ordinary shares or ADSs, treats all restricted shares issued with outstanding restrictions to be vested as issued and outstanding shares, issued in this offering and the exercise in full of pre-funded warrants in this offering.</font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tBUOV">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">BUSINESS OVERVIEW</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are a clinical-stage TechBio company that aspires to lead the exploration of artificial intelligence, or AI, to develop vaccines with improved efficacy when compared to currently marketed products for patients with unmet medical needs. We were founded in 2008 as an AI company and over the&#160;years have developed into an AI-TechBio company with a robust clinical pipeline of personalized cancer vaccines and a broad pre- clinical pipeline of vaccines for various infectious diseases. Our pipeline programs are derived from our proprietary AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform, consisting of several models: PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, AI-DeeP</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, EDEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, and RAVEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> and we are utilizing these unique AI models to build a strong drug development pipeline. Drug development is a long and costly process with high attrition rates. We believe our unique AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform, trained to translate vast amounts of data to identify novel targets for the development of unique vaccines, have the potential to significantly reduce drug development timelines, costs and attrition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We aim to capture the value from the predictive power of our proprietary AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform and its ability to identify novel targets for drug development by building a solid pipeline of AI-powered vaccines within the areas of cancer and infectious diseases, both attractive markets with high unmet medical needs. The associated business model is to partner our vaccines after pre-clinical or clinical Proof of Concept, or PoC, with large biopharmaceutical and pharmaceutical companies to conduct clinical trials, regulatory and marketing approval and commercialization of our product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are currently advancing our first two product vaccine candidates, EVX-01 and EVX-02, for the treatment of various solid cancers. Our third cancer vaccine candidate, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is a clinically ready asset. We are actively seeking partnership opportunities to further advance the development of the EVX-03 vaccine candidate. In addition, we are currently developing three pre-clinical bacterial vaccine product candidates, EVX-B1, EVX-B2 and EVX-B3, targeting </font><font style="font-style:italic;letter-spacing:0.2pt;">Staphylococcus aureus</font><font style="letter-spacing:0.2pt;">, or </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;">, and </font><font style="font-style:italic;letter-spacing:0.2pt;">Neisseria gonorrhoeae</font><font style="letter-spacing:0.2pt;">, or </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;"> infections, and an undisclosed bacteria target respectively, and one viral vaccine product candidate, EVX-V1, targeting cytomegalovirus, or CMV. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.15pt;">&#8482;</font><font style="letter-spacing:-0.2pt;"> Platform and Product Development Pipeline</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The immune system is widely regarded as a highly important defense system. We use the power of AI to decode the immune system and to direct it towards internal or external threats such as cancer and infectious diseases. Our AI technologies include the immuno-oncology AI models PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> &amp; ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, the bacterial and viral disease AI models EDEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> &amp; RAVEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, and our Immune Checkpoint Inhibitor responder AI model AI-DeeP</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">. These AI technologies are based on the current understanding of the human immune system and can transform large amounts of biological data into algorithms that may accurately predict cellular interactions within the immune system and potentially more accurately identify targets that will stimulate a relevant immune response. We believe that the predictive power of our AI models will reduce both the development time and risk of failure during the various stages of drug development. Our AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> allows for a cost reduction of up to 90%+ when deploying the model for target identification compared to reverse vaccinology. Further, given the strong predictive capabilities of AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> we only need to test 20% of targets compared to what is needed with reverse vaccinology. We have demonstrated that our AI models are able to identify novel targets in just days, rather than&#160;years as is common for standard drug discovery methods. We believe that this predictive accuracy can significantly decrease the risk of failure by reducing the risk of low efficacy or unacceptable toxicity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> is our AI model for the discovery of patient-specific cancer targets which we use to develop truly personalized cancer vaccines. PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> identifies patient-specific tumor mutations, so called neoantigens, that can induce strong T-cell dependent immune responses leading to tumor eradication. We believe such neoantigen-based therapies will induce a directed immune response to each patient&#8217;s tumor that can eradicate the cancer cells from the body. We are currently developing three programs for personalized cancer vaccines; EVX-01, EVX-02, and EVX-03, of which the first two are currently in clinical development. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG4">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> is our AI model for the discovery of patient- or indication-specific virus-derived targets, so-called ERVs (endogenous retroviruses), selectively expressed in cancer. We have preclinically demonstrated complete tumor eradication in animal models when targeting ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> identified ERVs. We believe that ERV-based therapies will induce a directed T-cell dependent immune response leading to tumor eradication. Our EVX-03 vaccine candidate contains a combination of PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> predicted neoantigens and ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> predicted ERV antigens. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">AI-DeeP</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> is our AI model for predicting patient responses to cancer checkpoint inhibitor immunotherapy. The AI model can predict patient immunotherapy treatment outcomes with high precision and may inform decision on treatment. AI-DeeP</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> is part of the &#8216;Responder&#8217; leg of our corporate strategy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">EDEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> is our AI model for the discovery of B-cell antigen vaccine targets. EDEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> has been designed to identify novel infectious disease B-cell antigen targets that, we believe, have the potential to be more effective than what have previously been identified using standard drug discovery methods. We apply EDEN in our current development of three pre-clinical bacterial vaccine programs; EVX-B1, targeting </font><font style="font-style:italic;letter-spacing:0.2pt;">Staphylococcus aureus</font><font style="letter-spacing:0.2pt;">, or </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus infections</font><font style="letter-spacing:0.2pt;">, EVX-B2/EVX-B2-mRNA targeting </font><font style="font-style:italic;letter-spacing:0.2pt;">Neisseria gonorrhoeae</font><font style="letter-spacing:0.2pt;">, or </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;"> infections, and EVX-B3, targeting an undisclosed bacterial pathogen with a high medical need where no vaccine is currently available. We believe EDEN is applicable for virus vaccine development, hence it is applied in the development of our EVX-V1 virus vaccine against cytomegalovirus (CMV). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">RAVEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> is our AI model for the discovery of vaccine antigen targets, that can induce strong T-cell immune responses for infectious diseases. We apply RAVEN in our current development of the pre-clinical viral vaccine program; EVX-V1, targeting cytomegalovirus (CMV). We believe RAVEN is also applicable for bacterial vaccine development, hence it is applied in the development of EVX-B3. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Product Development Pipeline</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our AI-identified targets can be delivered using any delivery modality, such as peptides, recombinant proteins, mRNA and our proprietary DNA-targeting technology, and we are building a diverse vaccine pipeline utilizing such different delivery modalities. </font>
        </div>
        <div style="position:relative;margin-top:8.7pt; text-align:center; width:456pt;">
          <img src="fc_stageofdevelop-4c.jpg" alt="[MISSING IMAGE: fc_stageofdevelop-4c.jpg]" height="337" width="608" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:11.11pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 7</font>
          <br >
        </div>
        <div style=" margin-top:11.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our AI models and vaccine pipeline.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">EVX-01</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">EVX-01 is a novel liposomal, peptide-based cancer vaccine designed to engage a patient&#8217;s own immune system to fight their cancer by mounting a targeted response towards the tumor. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2023 we reported complete clinical data from the Phase&#160;1/2a trial of EVX-01 in metastatic or unresectable melanoma demonstrated an overall response rate of 67% across all 12 patients compared with a historical overall response rate of 40% with anti-PD-1 treatment alone. In addition, the data showed induction of neoantigen-specific T cells in 100% of patients. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">EVX-01 is currently in a Phase&#160;2 global multi-center clinical trial for the treatment of metastatic melanoma and is administered in combination with KEYTRUDA</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> (pembrolizumab), a humanized anti- human PD-1 monoclonal antibody developed by Merck &amp; Co., Inc., or Merck. A Clinical Trial Collaboration and Supply Agreement, or CTCSA, is in place with MSD International GmbH and MSD International Business GmbH (known collectively as MSD outside the United States and Canada), both of which are subsidiaries of Merck, to evaluate the combination of EVX-01 with MSD&#8217;s KEYTRUDA</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The first patient in the EVX-01 Phase&#160;2 trial was dosed in Australia in September&#160;2022. In November&#160;2022, we submitted an Investigational New Drug Application, or IND, along with a Fast Track designation request to the U.S. Food and Drug Administration, or FDA, for the Phase&#160;2 clinical trial of EVX-01 in combination with KEYTRUDA</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> for the treatment of patients with metastatic melanoma. On December&#160;22, 2022, the FDA notified us that it had reviewed our IND and determined that we could proceed with our Phase&#160;2 trial. In January&#160;2023, we received Fast Track designation from the FDA for the study. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, we have received approval of our Clinical Trial Applications, or CTAs, for the Phase&#160;2 trial from regulatory authorities in Australia and Italy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The initial data from five patients from the Phase&#160;2 clinical study were presented at the annual meeting of the Society of Cancer Immunotherapy, or SITC, in San Diego, California November&#160;2023. In June&#160;2024, immune data from a total of 12 patients was presented at American Society for Clinical Oncology, or ASCO, Annual Meeting in Chicago, Illinois. The data demonstrated neoantigen-specific T-cell reactivity induced by EVX-01 in all 12 patients. In Septemeber 2024, one-year clinical efficacy data was presented at the European Society for Medical Oncology Congress in Barcelona, Spain. The data demonstrated an overall response rate of 68.8% as per RECIST 1.1 with 15 out of the 16 patients experiencing a tumor target lesion reduction. Full Phase&#160;2 study readout is expected in 2025. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">EVX-02</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">EVX-02 is a DNA-based cancer vaccine designed to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma, when administered in combination with a PD-1 inhibitor. In March&#160;2022, we reported completion of recruitment of the EVX-02 Phase&#160;1/2a clinical trial and in November&#160;2022, we announced an interim study readout from eight patients. The data demonstrates activation of neoantigen-specific T cells with tumor killing potential and that T-cell responses were robust and long lasting indicating potential for a clinically relevant anti-tumor immune attack. The treatment appeared to be well tolerated in all patients, with only very mild AEs, observed in relation to EVX-02 treatment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On April&#160;18, 2023, we presented final clinical data from the Phase&#160;1/2a study. Data were presented in the Late Breaking Research: Clinical Research 2 session at the 2023 AACR (American Association for Cancer Research) meeting in Orlando, Florida. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The study showed that: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">All 10 patients who received the full dosing schedule of eight immunizations with EVX-02 were relapse- free at their last assessment </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Of these 10 patients, nine completed the full study and were relapse-free at the 12-month end of study visit. One patient was prematurely terminated due to non-EVX-02 related adverse events, or AEs, and was relapse-free at the last visit at nine&#160;months </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The combination of EVX-02 and nivolumab was well tolerated and only mild EVX-02-associated AEs were observed </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Robust and long-lasting neoantigen-specific T-cell immune responses were confirmed in all EVX-02 completers </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The induced T-cell immune responses involved both CD4+ and CD8+ T cells </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe the data serve as a validation of our PIONEER platform and provide proof of mechanism for our DNA-based approach to personalized cancer therapies. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">EVX-03</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">EVX-03 is an improved, next generation DNA-based cancer vaccine with a proprietary antigen- presenting cell, or APC, targeting unit, for the treatment of various cancers. We believe our DNA technology has the potential to improve antigen presentation, anti-tumor immunity and hence clinical response. The goal of our EVX-03 cancer vaccine is to promote T-cell priming and expansion of effector T cells for direct and specific tumor killing, and we intend to develop EVX-03 for the treatment of multiple cancers, including non-small cell lung cancer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our EVX-03 product candidate is clinically ready asset with pre-clinical data demonstrating that adding our APC-targeting unit leads to high levels of neoantigen-reactive T cells, significant tumor reduction even at very low doses and a favorable toxicology profile. We believe the promising clinical, immune and safety data from the EVX-02 Phase&#160;1/2a clinical trial together with the superior EVX-03 pre-clinical data, support moving EVX-03 into clinical development. We are actively seeking partnership opportunities to further advance the development of EVX-03. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">EVX-B1</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">EVX-B1 is a prophylactic multi-component vaccine initially in development for the prevention of</font><font style="font-style:italic;letter-spacing:0.2pt;"> S.&#160;aureus</font><font style="letter-spacing:0.2pt;">-induced skin and soft tissue infections, or SSTI, in patients undergoing elective abdominal hernia surgery. EVX-B1 includes two proprietary and highly protective antigens identified by EDEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> as well as a chimeric toxoid, formulated with a potent adjuvant. We believe that the predictive power of EDEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> and our unique approach to vaccine design will result in a highly protective vaccine. EVX-B1 has now completed pre-clinical development. We have concluded the testing of the protein antigens in a final MTA study with a potential partner, where we could demonstrate that the protein antigens induce protection against </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> infection in a non-rodent surgical site infection model. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">EVX-B2</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">EVX-B2 is a prophylactic vaccine being developed to target diseases caused by </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;">. EVX-B2 is composed of a fusion protein with two antigen subunits, identified by EDEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> and formulated with a potent adjuvant. We believe that our EVX-B2 vaccine candidate will induce a protective immune response against </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;"> and thereby minimize the risk of infection for the general population and groups at risk. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2022, together with UMass Chan Medical School, we received a grant from the U.S. National Institutes of Health, or NIH, to support the evaluation of our EVX-B2 candidate using DNA and mRNA vaccine delivery platforms and to progress the development of our EVX-B2 vaccine candidate. In September&#160;2023, we initiated a collaboration with Afrigen Biologics with the goal of developing an mRNA- based gonorrhea vaccine for low- and middle-income countries (LMICs). The mRNA vaccine will be based on the same two EDEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> discovered antigens having demonstrated high levels of protection in preclinical studies. In September&#160;2024 initial data from the Afrigen collaboration was presented at the 18</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> Vaccine Congress in Lisbon, Portugal. The results presented included Proof-of-Concept data, demonstrating the ability of the EVX-B2 mRNA vaccine to induce a specific immune response and that the immune sera from vaccinated mice could induce bacterial killing in vitro. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">EVX-B3</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2023, we initiated a new collaboration with MSD to address a serious global medical issue by targeting a pathogen associated with repeated infections, increasing incidence, and often serious medical complications for which no vaccines are currently available. Our proprietary AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform, with the EDEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> and the RAVEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> models, will be utilized for the rapid design of a completely </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">novel vaccine candidate, EVX-B3, with the goal to be capable of eliciting both a strong humoral (antibody) and cellular immune response to the bacterial pathogen. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">EVX-B2 and EVX-B3 were partnered with MSD in September&#160;2024 as part of a significantly expanded vaccine collaboration with MSD. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">EVX-V1</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2022, we announced the development of our first viral vaccine product candidate, targeting Cytomegalovirus, or CMV. We are utilizing our AI models RAVEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> and EDEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> to design a next- generation vaccine candidate that elicits both cellular and humoral responses. Ten EDEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> predicted novel B-cell antigens have been selected and are now being produced as recombinant proteins for further evaluation in preclinical models. In addition, antigens described in literature, but with novel design by Evaxion, are also being investigated and evaluated for efficacy in preclinical models. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">EVX-V1 is being developed in collaboration with ExpreS</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;">ion Biotechnologies AB, or ExpreS2ion. We believe this partnership has the potential to deliver a truly differentiated, highly immunogenic vaccine for protection against CMV infections. EVX-V1 is currently in a pre-clinical discovery phase. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On November&#160;12, 2024, we announced positive preclinical data for EVX-V1. The data demonstrates that CMV antigens identified with Evaxion&#8217;s AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform trigger targeted immune responses. Results also showcases the successful design of a proprietary prefusion glycoprotein B (gB) antigen with ability to neutralize the virus. We are advancing these new findings to develop a multi-component CMV vaccine candidate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;2, 2024, Evaxion announced that it would present data from preclinical studies with its precision cancer vaccine concept targeting non-conventional ERV (endogenous retrovirus) tumor antigens shared across patients at the ESMO Immuno-Oncology Congress, taking place from December&#160;11&#8201;&#8211;&#8201;13, 2024, in Geneva, Switzerland. The data provides preclinical Proof-of-Concept for the concept. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Strengths</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Our flexible, scalable and adaptable AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform offers a strong value proposition toward existing and potential partners </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Our five AI models PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, AI-DeeP</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, EDEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> and RAVEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> ingrained in the AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform, have allowed us to generate numerous pipeline candidates within both cancer and infectious diseases, all with positive potential and with our first two oncology product candidates currently in clinical development </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Our AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform offers the potential to expand our partnerships and product candidate portfolio and allows for entering into additional therapy areas </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Our AI immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform facilitates the identification of novel effective vaccine targets, enhancing the potential for clinical success </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Our in-house capabilities for experimental screening and testing of novel targets allow us to move rapidly from target identification to pre-clinical development </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Our model for iterative training allows for continuous improvement of our AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform as data are generated throughout the drug development stages </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">We have established a direct link between the predictive power of our AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform and preclinical and clinical outcome </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Our existing collaborations are confirming the strength of our AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Strategy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Evaxion strategy centers around our AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform, which has been continuously developed and refined over the past 15&#160;years. This has provided us with a pioneering and differentiated position within AI-based vaccine target discovery, and further led to the design and development of novel </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG5">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">vaccine candidates. The strong potential of AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> is evidenced by both the preclinical and clinical data we have generated as well as through existing partnerships. The AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform holds the potential to generateone new vaccine target every 24 hours, is delivery modality-agnostic, and easily adaptable to partner needs. The platform is currently trained in cancer and infectious diseases and is scalable to other therapeutic areas. The high throughput, combined with a very flexible model, offers a strong value proposition for both existing and future partners. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform contains five interrelated proprietary AI prediction models: (i)&#160;PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, our cancer neoantigen prediction model, (ii)&#160;ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, our endogenous retrovirus (ERV) tumor antigen prediction model, (iii)&#160;EDEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, our B-cell antigen prediction model, (iv)&#160;RAVEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, our T-cell antigen prediction model and (v)&#160;AI-DeeP</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> our responder prediction model. The platform features a unique modular architecture where the same building blocks are used across different AI prediction models. This means that improvements in individual building blocks will lead to improvements in all the AI prediction models where the building block is used This, we believe, serves to further enhance the predictive capabilities of AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> and to ensure we will retain a differentiated position going forward. The building block-based architecture also gives a high scalability to other therapeutic areas which is offering attractive long-term opportunities for Evaxion. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In parallel with the AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform development, we have been building a strong multidisciplinary capability set spanning the full value chain from target discovery to early clinical development. Our state of art wet-lab and animal facility gives us a unique opportunity for rapidly validating our AI predictions in pre-clinical models thereby, generating proprietary data as well as new pipeline assets. Further, it offers partners a flexible and adaptable one stop shop for discovery and development of new vaccine candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform together with our multidisciplinary capability set drives a clear differentiation for our AI driven approach to development of novel vaccine candidates and provides a strong value proposition towards potential partners. The differentiation is illustrated in Figure 8 below. </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="fc_immun-4c.jpg" alt="[MISSING IMAGE: fc_immun-4c.jpg]" height="307" width="576" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:13pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 8</font>
          <br >
        </div>
        <div style=" margin-top:13pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">A clearly differentiated position with AI based drug discovery and development.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">With AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> at the core, and further building upon our strong multidisciplinary capability set, our focus is on pursuing value realization of our AI platform and pipeline via a multi-partner approach. This is being executed through our three-pronged business model focusing on vaccine target discovery collaborations using our AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform (Targets), advancing our proprietary pipeline of vaccine candidates (Pipeline) and using our core data and predictive capabilities to develop responder models (Responders). Please see Figure 9 below for an overview of the Evaxion three-pronged business model. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG6">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="fc_strategy-4c.jpg" alt="[MISSING IMAGE: fc_strategy-4c.jpg]" height="330" width="576" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:17pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 9</font>
          <br >
        </div>
        <div style=" margin-top:17pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Evaxion Three-Pronged Business Model.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the Target part of our three-pronged business model, the multi-partner approach to value realization means that we have a strong focus on establishing partnerships where we bring our multidisciplinary capabilities and the unique predictive capabilities of AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> to partners with the objective of developing novel vaccine candidates. The agreement around EVX-B3 with MSD from September&#160;2023, which in September&#160;2024 resulted in a significantly expanded collaboration with an option and license agreement, covering both EVX-B3 and EVX-B2, with potential milestones of USD 592&#160;million per product, is a good example of what we aim at achieving in the Target part of our three-pronged business model. For EVX-B3, we teamed up with MSD in September&#160;2023 to utilize AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> to discover and develop a novel vaccine for a bacterial infectious disease, where no vaccine is available today. We are excited about this collaboration with MSD and are thrilled to see it continuing into the next phase which now also includes EVX-B2.. We are also very pleased with the level of interest we are seeing from other potential partners in establishing similar partnerships within other infectious disease areas and are excited about the potential for addressing significant unmet needs in collaboration with partners within the Target part of our strategy. To further develop the predictive capabilities of AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, and hence further strengthen the value proposition to existing and potential partners, we are excited to have launched an upgraded version of EDEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, EDEN</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> 5.0, which took place at the European Conference on Computational Biology (ECCB) conference in September&#160;2024. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Within the Pipeline part of our three-pronged business model, we are advancingour own select high value programs to key value inflection points following which we will pursue partnering. With our multidisciplinary capabilities and the predictive capabilities of AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, we have strong potential for quickly advancing proprietary high value programs into preclinical and clinical development. However, we do not intend to run larger scale clinical trials ourselves. Within the Pipeline part of the strategy, we are very excited about the convincing EVX-01 Phase&#160;2 one-year clinical data we presented at ESMO in September. The convincing data already makes us look forward to the two-year clinical readout in Q3, 2025. The one-year clinical data was a very important milestone for our lead pipeline candidate and we are excited about the commercial potential of EVX-01. We will also partner pipeline assets before entering clinical development if this makes sense from a strategic and financial point of view. The agreement with MSD on EVX-B2 (as well as EVX-B3), containing potential milestones of up to USD 592&#160;million per product, which we announced in September&#160;2024 is a good example of such early partnering strategy. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG7">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:41.49pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Within the Responder part of our strategy, which focuses on harnessing our data and predictive capabilities to develop responder models, we obtained Proof of Principle for our Checkpoint Inhibitor responder model in late 2023. We have now defined a high-level development plan and a preliminary commercial model. The plan remains to bring our Checkpoint Inhibitor responder model forward in a partnership-based structure. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Hence, in summary we are seeing a continued strong progress on our strategy as executed via our three-pronged business model. We are excited about having delivered successfully on most of our 2024 key milestones as can be seen in Figure 10 below. We are also thrilled about the interest we are seeing from potential partners in both the establishment of new vaccine discovery and development collaborations as well as in our existing pipeline assets and excited about our significantly expanded vaccine collaboration with MSD and the financial and strategic value it brings While we will not be able to meet the original business development ambition of generating USD 14&#160;million in business development income or cash in for 2024, due to certain business development discussions moving into 2025, we are pleased with the USD 3.2&#160;million already secured in 2024 via the MSD agreement as well as the potential up to USD 10&#160;million for 2025, contingent upon if MSD exercises the option for one or both vaccine candidates. Further, the business development discussions having moved into 2025 enhances the potential for generation of business development income in 2025. Finally, we remain on track for meeting our milestone on preclinical Proof-of-Concept for our ERV based precision vaccine in 2024. </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tb_milestones-4c.jpg" alt="[MISSING IMAGE: tb_milestones-4c.jpg]" height="291" width="608" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:18.69pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 10</font>
          <br >
        </div>
        <div style=" margin-top:18.69pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2024 milestones.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The strong strategy execution in 2024 makes us excited about the prospects for 2025. Focus for 2025 will be a continuation of the multi-partner approach to value realization via execution upon our business development strategy, continuation of the ongoing EVX-01 phase 2 trial, the ongoing strengthening of our AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform and further advancement of our research activities, including progressing our ERV based precision vaccine concept towards clinical development. Finally, focus is of course on advancing our existing partnerships including bringing the MSD collaboration to option exercise. Please the table below for an overview of preliminary 2025 company milestones. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG8">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="fc_aiimmunology-4c.jpg" alt="[MISSING IMAGE: fc_aiimmunology-4c.jpg]" height="301" width="608" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:16.01pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 11</font>
          <br >
        </div>
        <div style=" margin-top:16.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preliminary 2025 company milestones.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Management Team</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe that our fully AI-driven approach and our AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform places us at the forefront of effectively translating the immune system into novel vaccine candidates that trigger the immune system to treat a variety of diseases. To deliver on our objectives, we have built an experienced and broadly skilled management team. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Chief Executive Officer, Christian Kanstrup joined us on September&#160;1, 2023. Christian Kanstrup has more than 25&#160;years of experience in the life science industry, coming from a position of Executive Vice President at Mediq before joining Evaxion. Prior to that, Christian held a broad range of senior management roles at Novo Nordisk A/S, latest as Senior Vice President and global head of Biopharm Operations. Prior to that Christian among others held senior leadership roles within the commercial part of the business as well as within strategy and corporate development. Christian also holds various board and advisory positions in the life science industry, advising on corporate strategy and company growth. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Chief Science Officer Birgitte R&#248;n&#248; joined in 2017 and was appointed CSO in 2021. Dr.&#160;R&#248;n&#248; has more than 20&#160;years&#8217; experience in biopharmaceutical drug discovery from academia and industry and received her PhD in experimental oncology and immunology from National Institutes of Health, Bethesda, USA, and Copenhagen University Hospital, Denmark. Prior to joining Evaxion, Birgitte R&#248;n&#248; served as a specialist, team leader and project manager at Novo Nordisk A/S, where she was leading early drug discovery projects, evaluating in-licensing opportunities, and supporting drug development projects with pre-clinical and biomarker expertise. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Jesper Nyegaard Nissen joined as Chief Operating Officer in 2022 and was also appointed interim Chief Financial Officer in 2023. For over 25&#160;years, Jesper Nyegaard Nissen has worked broadly across the pharma value chain in global operations positions in Novo Nordisk anchored in research, development and finance. He has covered business areas across a variety of focus points, including finance operation, external innovation and collaborations, digitalization of business process optimization, development and shaping of organizational capacities, and implementation of performance and process improvement structures. On July&#160;31, 2024, Jesper Nissen tendered his resignation as Chief Operating Officer and Interim Chief Financial Officer of the Company, to be effective October&#160;31, 2024. Mr.&#160;Nissen&#8217;s resignation was for personal reasons and was not a result of any disagreement with the Company on any matter relating to the Company&#8217;s operations, policies or practices. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has appointed Thomas Frederik Schmidt to assume Mr.&#160;Nissen&#8217;s responsibilities as the Interim Chief Financial Officer. Mr.&#160;Schmidt brings more than 30&#160;years of financial management experience </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">from across different industries with more than 25&#160;years of these being based in the life science industry including roles as country Managing Director and country Chief Financial Officer in Roche and Group CFO in Ambu. Ambu is a MedTech company listed on the Nasdaq Copenhagen Stock Exchange. Mr.&#160;Schmidt holds a Master of Science in Business Economics and Auditing from Copenhagen Business School and a has undergone training and preparation for State Authorized Public Accountant (CPA) exam. Mr.&#160;Schmidt has succeeded Mr.&#160;Nissen as the Company&#8217;s Interim CFO as of November&#160;1, 2024. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Andreas Holm Mattsson serves as Chief AI Officer at Evaxion Biotech, where he&#8217;s been at the forefront </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;">-based vaccine target discovery. He has played a key role in developing Evaxion&#8217;s innovative AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform, a proprietary AI technology for identifying novel vaccine targets for cancer and infectious diseases. Andreas brings a strong educational background in bioinformatics from the Technical University of Denmark and has previously worked at Novo Nordisk. Since founding Evaxion in 2008, he has been an essential part of the company&#8217;s growth, serving in various executive roles. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Background on Cancer Vaccines and the Role of Neoantigens and ERVs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The immune system is our body&#8217;s natural defense system that protects us against infection and diseases. It keeps track of all of the substances normally found in the body and raises an alarm if an unfamiliar substance is found, launching an attack against it. However, cancer cells can present a more challenging target for the immune system. Cancer cells are altered normal cells and therefore the immune system doesn&#8217;t always recognize them as foreign. In fact, cancer cells possess several mechanisms through which they escape immune surveillance as they: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Harbor genetic changes that make them less visible to the immune system </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Express proteins on their cell surface that inhibit immune cell effector functions </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Induce changes in the normal cells around the tumor thus interfering with how the immune system responds to the cancer cells </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To overcome this, vaccines use different ways to seek the power of the patient&#8217;s own immune system to fight cancerous cells. The regulatory approval of immune checkpoint inhibitors, or CPIs, has been a major breakthrough in treatment of patients suffering from advanced solid cancers by demonstrating beneficial clinical responses, durable disease control and improved survival in subsets of patients. Detailed mapping of the underlying mechanisms has revealed that the CPI-induced antitumor effect is associated with the patient&#8217;s ability to mount a tumor-specific T-cell response. To further improve clinical efficacy, different co-targeting strategies are currently being explored, including the combination of CPI and T-cell vaccines capable of directing and improving the patients&#8217; immune response specifically towards essential functions in the cancer cells. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The Role of T Cells in Cancer Vaccines</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">T cells are a type of white blood cells that play a central role in the immune system. T cells are involved in both detecting and killing infected or abnormal cells, such as cancer cells, as well as coordinating immune responses. T cells can be classified into two major subsets, CD4+ T cells and CD8+ T cells, each possessing different functionalities. CD8+ T cells are considered the main effectors in T-cell mediated tumor killing, however, several reports have highlighted the importance of inducing both CD4+ and CD8+ T cells as T&#160;helper 1, or Th1, CD4+ T cells support CD8+ T-cell priming as well as promote the desired effects via secretion of effector cytokines. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">T cells recognize cancer cells using T-cell receptors, or TCRs, that interact with specific immune targets, or epitopes, presented by a molecular structure on the surface of cells known as the major histocompatibility complex, or MHC. The MHC molecules bind to peptides from protein degradation inside the cell before being transported to the cell surface to present the peptide to TCRs. If a peptide bound to the MHC molecule is recognized by T cells, it is called an epitope. There are two classes of MHC molecules, class I and class II, that activate CD8+ and CD4+ T cells, respectively. In humans, MHC is encoded by the genes of the HLA locus. HLA genes show high allelic variation, resulting in MHC molecules that have different peptide binding preferences. Each person expresses a unique combination of molecularly distinct class I and class II MHC molecules that bind a specific set of peptides and epitopes. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Mutated genes in cancer cells lead to expression of altered proteins which are, like all proteins, processed by the cellular machinery into protein fragments known as peptides. When these mutated peptides are presented on MHC molecules, by either tumor cells or antigen presenting cells, and recognized by T cells, they are known as neoantigens. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Another class of tumor antigens are derived from endogenous viral elements, hereunder endogenous retroviruses (ERVs). ERVs are found in the genome of all cells but their expression is tightly regulated in healthy cells. Due to the way cancer cells evolve, this tight transcriptional regulation of ERVs is often compromised, leading to expression and production of cancer-specific, ERV-derived antigens. As a limited number of somatic mutations and ERVs are shared among two different tumors, no general cancer vaccine can be produced, making it necessary to design and produce a new personalized or precision product specific for each patient or for groups of patients. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The immune system refrains from targeting the body&#8217;s own healthy cells principally through processes known as central and peripheral tolerance, by which T cells are educated not to respond to MHCs displaying peptides from normal proteins and, therefore, T cells avoid targeting normal cells for destruction. The TCR-peptide-MHC interaction is a vital immune mechanism that allows the body both to respond against threats, including cancer, as well as to avoid targeting the body&#8217;s own healthy cells. Understanding the interactions between TCRs, peptides and specific MHC alleles is critical to directing and activating an immune response to cancer. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Neoantigen- and Endogenous Retrovirus-based Cancer Vaccines</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The common feature of cancer is accumulation of mutations in the genes, which manifests as tumors with uncontrolled growth. Cancer is a complex, extremely heterogeneous condition. Despite this complexity and variability, patients with the same type and stage of cancer have historically been administered the same treatment. This approach has been altered in recent&#160;years with the introduction of precision medicine cancer vaccines, a tailored approach for selecting therapy at the individual patient or groups of patients&#8217; level based on the genetic makeup of the patient&#8217;s cancer. Discovery of molecular cancer biomarkers (i.e., cancer oncogenes) has paved the way for the first generation of personalized and precision therapies. Genomic screening approaches have been commonly employed to identify tumor-specific, overexpressed proteins or genetic mutations that may confer targets for an effective cancer vaccine. We believe a truly personalized or precision approach, incorporating the entirety of the tumor ecosystem, while taking a more unbiased approach to drug design, is required to advert the inherent complexities of the tumor microenvironment and heterogeneous cellular landscape, and to improve the clinical outcome of cancer vaccines. We believe such approach can be achieved by directing vaccines towards cancer-exclusive peptide sequences, so called neoantigens and endogenous retroviruses, or ERVs, displayed on the surface of tumor cell originating from patient-specific mutations and highly expressed ERV sequences, respectively. Neoantigen-targeting vaccines have shown great promise in pre-clinical animal models as well as in early clinical trials. Of note, Moderna and Merck recently announced their personalized neoantigen targeting therapy met the primary endpoint in a Phase&#160;2b trial in melanoma patients. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Neoantigens and ERVs provide an avenue for tumor-specific immune cell recognition, a prerequisite for a beneficial clinical response of a neoantigen/ERV based vaccine. Antigen presenting cells, or APCs, educate the immune system by presenting neoantigens and the ERVs to T cells. Tumor cells often present neoantigens and ERV-derived sequences on their cell surface, providing accessible targets for T cells. T cells recognize and kill neoantigen and/or ERV-presenting cancer cells and effect a positive feedback loop to heighten and broaden the cancer specific immune response as more epitopes will be available for APC uptake upon T-cell mediated tumor cell lysis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Once patient-specific neoantigens and/or ERVs are administered to the patient, APCs will process the neoantigens and ERVs by the MHC epitope presentation machinery, migrate to the lymph node and present neoantigens and ERVs to T cells. TCRs on circulating CD4+ and CD8+ T cells bind to the presented neoantigens and ERVs triggering initial T-cell activation. Once activated, the T cells will enter the circulation to reach distant organs, including the tumor. In the tumor, reactive T cells will encounter tumor cell surface displayed neoantigens and/or ERVs, resulting in T cell mediated tumor cell killing. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG9">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Cancer patients normally do not have a meaningful numbers of T cells that recognize their tumor. We believe a neoantigen and ERV-targeting approach will generate a strong, </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> tumor-specific T-cell response which will lead to killing of tumor cells and thereby an improved clinical response. Further, we believe such approach has encouraging therapeutic potential because neoantigens and ERVs represent foreign elements to the immune system and are unique to each person&#8217;s tumor cells which means neither self- tolerance nor adverse side effects are likely to limit the clinical application of a neoantigen and/or ERV- based vaccine. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe our truly personalized or precision approaches targeting neoantigens and ERVs will allow us to harness the natural power of a patient&#8217;s own immune system to elicit a strong, cancer-specific immune response, potentially holding the key to long-lasting tumor control or even a possible cure for many cancer patients. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.15pt;">&#8482;</font><font style="letter-spacing:-0.2pt;">&#8201;&#8212;&#8201;Our AI model for the Discovery of Novel, Personalized Neoantigen-targeting Cancer&#160;Vaccines </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Overview</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> is our proprietary AI model for the rapid discovery and design of personalized neoantigen- targeting therapies. Our proprietary PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> model allow us to efficiently identify and select those neoantigens that we believe are most likely to generate a strong, </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> T-cell response leading to significant antitumor effect in each patient. The goal of our PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> derived cancer vaccines is to deliver therapeutic neoantigens to patients in a way that trains the patients&#8217; own immune system to target and kill tumor cells with no or very limited adverse effects on healthy non-cancer cells. As shown in Figure 12 below, PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> simulates the key biological steps in presenting each neoantigen to the patient&#8217;s immune system with our high-performance, AI-based </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;"> modules. </font>
        </div>
        <div style="position:relative;margin-top:10.09pt; text-align:center; width:456pt;">
          <img src="fc_cells-4c.jpg" alt="[MISSING IMAGE: fc_cells-4c.jpg]" height="160" width="595" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:15.1pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 12</font>
          <br >
        </div>
        <div style=" margin-top:15.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Illustration of mechanisms within the tumor cell that are required for a neoantigen to have a clinical effect in patients</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Key biological steps simulated by PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> include: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Step 1&#8201;&#8212;&#8201;Mutation:&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> identifies cancer-specific mutations by comparing DNA sequencing data from the tumor sample(s) and normal tissue sample using our proprietary AI-based somatic variant caller. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Step 2&#8201;&#8212;&#8201;Expression:&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">Only a subset of the cancer-specific mutations is found in genes that are expressed in the tumor cells. The expression levels of each gene are determined by analyzing tumor RNA sequencing data. In addition, PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> calculates the mutation-specific expression levels using an in-house developed computational module. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Step 3&#8201;&#8212;&#8201;Translation:&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">Not all cancer-specific mutations result in altered protein sequences. Some mutations may be found in regions that do not code for protein sequences or they may simply be synonymous mutations (where the DNA sequence is altered, but the encoded amino acid is the same). PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> determines the effects of each cancer-specific mutation. The coding regions around non- synonymous mutations are then translated into amino acid sequences, generating cancer-specific neoantigen sequences. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">56</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG10">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Step 4&#8201;&#8212;&#8201;Presentation on MHC Class&#160;I and Class&#160;II Molecules:&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">To induce an immune response, neoantigens must contain subsequences that are bound by MHC molecules and presented on the cell surface. The identified neoantigens are given as input to our proprietary AI-based tool suite, EvaxMHC, along with the patient&#8217;s HLA type to identify neoantigens containing MHC ligands bound by the patient&#8217;s MHC molecules specifically. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Step 5&#8201;&#8212;&#8201;T-cell Response:&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">Neoantigens presented by MHC class I and class II molecules are recognized by T cells, triggering an immune response and T cell mediated tumor cell death. However, while being presented as MHC ligands is a prerequisite for generating an immune response, not all MHC ligands are recognized by T cells. PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> includes an </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;"> module that predicts the likelihood of a given mutated MHC ligand eliciting a T-cells response. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Step 6&#8201;&#8212;&#8201;Clonal Neoantigens:&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">Tumors are extremely heterogeneous, meaning that not all tumor cells necessarily encode and express the same neoantigens. Targeting clonal neoantigens, defined as neoantigens arising from clonal mutations that are present in all cancer cells, allows for systemic eradication of the whole tumor, as well as potential metastases in the patient. Multiple reports suggest that targeting clonal neoantigens result in a more effective treatment. PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> determines the clonal status of a neoantigen by analyzing the DNA sequencing data using </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;"> AI modules. For patients where DNA sequencing data from multiple tumor biopsies is available, PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> seamlessly integrates the information from each biopsy to improve the clonality estimate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Identifying those neoantigens that will induce a strong antitumor immune response capable of eradicating all tumor cells in the patient requires sophisticated AI-based </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;"> tools. Such tools must be capable of accurately identifying tumor specific mutations along with all steps involved in neoantigen processing, presentation and TCR recognition. State-of-the-art, publicly available </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;"> tools for neoantigen prediction return a vast number of candidates, of which only a handful are ever found to trigger bona fide antitumor responses in patients. We have benchmarked our proprietary </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;"> tools from PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> against state-of-the-art public tools (Mutect2, MixMHCpred-v2.1/MixMHC2pred-v1.2, RSEM-v1.2.0 quantified expression) and we believe our platform produces superior results: </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="bc_bestranked-4c.jpg" alt="[MISSING IMAGE: bc_bestranked-4c.jpg]" height="358" width="576" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:15pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 13</font>
          <br >
        </div>
        <div style=" margin-top:15pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Benchmark study of PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.15pt;">&#8482;</font><font style="letter-spacing:-0.2pt;"> against state-of-the-art, public tools for number of hits identified in the top 10 best-ranked neoantigens. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">57</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG11">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:3.70000000000005pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To compare PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> to a pipeline of state-of-the-art public tools, we designed a simulation study with 3,000 patients. Each patient was assigned 500 potential neoantigens in a 1:5 positive to negative ratio. Both pipelines were tasked with selecting a set of 10 neoantigens for each patient and the average number of positive neoantigens was assessed. Results are depicted in Figure 13 above. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our benchmark study demonstrates that the publicly available tools are only capable of identifying 2.6 correct neoantigens in the top 10, which, we believe, in a neoantigen-based cancer vaccine is not sufficient to reach a strong antitumor effect. In comparison, PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> was able to identify 8.7 correct neoantigens in the top 10, which we anticipate is optimal to drive an enhanced antitumor immune response. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> include several </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;"> modules, some of which are AI-based, corresponding to each biological step in neoantigen presentation to the immune system. We believe that our multi-parameter improvements incorporated across our </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;"> AI modules will translate into better antitumor effect. In pre- clinical studies, we have already demonstrated that enhanced neoantigen prediction directly links to improved antitumor effect in mice (see Figure 14 below). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Improved Neoantigen Prediction Directly Translate into Better Antitumor Effect</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our proprietary </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;"> AI modules identifying neoantigens within PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> have been trained using gradient-boosted decision trees, transformers and a conditional generative adversarial network approach on our internally generated data as well as other data, including, but not limited to, next generation sequencing data from tumor samples, mass spectrometry immunopeptidomics, peptide-MHC-binding affinity data, T-cell immunogenicity data, peptide-MHC-binding stability data. We have demonstrated that development and iterative training of our AI model directly translates into improved antitumor effect in pre- clinical studies. In a pre-clinical tumor study, the efficacy of three versions of PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> version 0.1, 1.0 and 2.0), each with increasing number of new features were directly compared (see Figure 14 below). Mice treated with neoantigens predicted by PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> 2.0 developed statistically significant smaller tumors compared to mice treated with neoantigens predicted by earlier versions of PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, thereby demonstrating that improved neoantigen prediction directly translates into improved antitumor effect. </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lc_cellinoculation-4c.jpg" alt="[MISSING IMAGE: lc_cellinoculation-4c.jpg]" height="335" width="467" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:17pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 14</font>
          <br >
        </div>
        <div style=" margin-top:17pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.15pt;">&#8482;</font><font style="letter-spacing:-0.2pt;"> improvement demonstrated in a preclinical study. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">58</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:48pt; width:408pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">To explore the biological impact of different improvements, three versions of PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.15pt;">&#8482;</font><font style="letter-spacing:-0.2pt;"> were evaluated in the CT26 mouse tumor model. For each version, the top 10 ranked neoantigens were encoded in separate DNA constructs, designated PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.15pt;">&#8482;</font><font style="letter-spacing:-0.2pt;"> 0.1, PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.15pt;">&#8482;</font><font style="letter-spacing:-0.2pt;"> 1.0, and PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.15pt;">&#8482;</font><font style="letter-spacing:-0.2pt;"> 2.0. Mice were intramuscularly treated twice with the various DNA constructs prior to CT26 cells inoculation. A &#8220;mock&#8221; DNA plasmid without neoantigens was included as control.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will continue to train and incorporate more data into PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> model to ensure that our nested AI modules remain state-of-the-art. In addition, we continue to include new features in the model to further increase its predictive power. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Key Advantages of Our PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> model</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Identification of Therapeutic Neoantigens:&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> can identify therapeutic neoantigens that drive a T-cell response with higher accuracy compared to predictions done by state-of-the-art public tools. Clinical data from the Phase&#160;1/2a trial of EVX-01 demonstrated induction of neoantigen- specific T cells in 100% of patients with an overall response rate of 67% compared with a historical overall response rate of 40% with anti-PD-1 treatment alone. Further, clinical data from the Phase&#160;1/2a trial of EVX-02 demonstrated activation of neoantigen-specific T cells with tumor killing potential in patients, and that T-cell responses were robust and long lasting. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Identification of Multiple Neoantigens:&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> identifies multiple neoantigens that can be incorporated in the cancer vaccine to increase therapeutic effect and overcome issues related to cancer clonal heterogenicity and tumor immune escape. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">World Wide Clinical Applicability:&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> is clinically applicable, automated and deployable anywhere in the world and has been through a process of validation according to the International Society for Pharmacoepidemiology, ISPE&#8217;s, latest revised guide for Good Manufacturing Practice, or GAMP5, to ensure compliance with legislature and good practice regulations to maintain a high standard of quality in the system. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe we are uniquely positioned to develop a neoantigen-based cancer vaccine and address the shortcomings from competing approaches through our proprietary algorithms and AI modules contained in the PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> model. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.15pt;">&#8482;</font><font style="letter-spacing:-0.2pt;">&#8201;&#8212;&#8201;Our AI model for the Design of Personalized or Precision ERV-based Cancer Targets</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Overview</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> is our proprietary AI model for the discovery of patient-specific virus-derived sequences, so- called ERVs (endogenous retroviruses), expressed in cancer. Targeting this novel class of tumor antigens mayallow for developing a completely new type of immunotherapy against immunologically cold tumors with low response rates to immunotherapy. ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> can rapidly discover ERV tumor antigens and design of personalized or precision vaccine containing these antigens. Our proprietary AI modules within ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, for the prediction of antigen-specific T-cell responses, have been trained using transformers and a conditional generative adversarial network approach. This allows us to efficiently identify and select those ERV-antigens that we believe are most likely to generate a strong, de novo T-cell response leading to significant antitumor effect in each patient. The goal of our ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> model derived cancer vaccines is to deliver therapeutic ERV-antigens to patients in a way that trains the patients&#8217; own immune system to target and kill tumor cells with no or very limited adverse effects on healthy non-cancer cells. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have preclinically demonstrated complete tumor eradication in animal models when targeting ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> identified ERVs. Hence, we believe such ERV-based therapies will induce a directed T-cell dependent immune response leading to tumor eradication. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe that ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> will allow us to develop therapeutic cancer vaccines benefitting a broader range of cancer patients for which no or limited treatment options exist. This includes providing novel treatment solutions for cancer patients that are unlike to respond to immunotherapy and cancer vaccines that targets neoantigens. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">59</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG12">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Key Advantages of Our ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> Model</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Identification of Therapeutic ERV-antigens</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;We believe ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> can identify therapeutically relevant ERV-antigens that drive a T-cell response with a state-of-the-art high accuracy and effect. While previous published reports highlight some success with retroviral therapy against specific antigens, our in silico-designed cancer vaccine using ERV-antigens is the first to show lasting tumor protection and a robust, diverse T-cell response. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Identification of Multiple ERV-antigens</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> identifies multiple ERV-antigens that can be incorporated in the cancer vaccine to increase therapeutic effect and overcome issues related to cancer clonal heterogenicity and tumor immune escape. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.29pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Worldwide Clinical Applicability:&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">As with PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> is designed to be clinically applicable, automated and deployable anywhere in the world and has been through a process of validation according to the International Society for Pharmacoepidemiology, ISPE&#8217;s, latest revised guide for Good Manufacturing Practice, or GAMP5, to ensure compliance with legislature and good practice regulations to maintain a high standard of quality in the system. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe we are uniquely positioned to develop ERV-antigen based cancer vaccines and address the shortcomings from competing approaches through our proprietary algorithms and AI modules contained in ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Using PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> and ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> to Design Our Cancer Vaccine Candidates</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="fc_pioneerrna-4c.jpg" alt="[MISSING IMAGE: fc_pioneerrna-4c.jpg]" height="217" width="608" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:15.2pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 15</font>
          <br >
        </div>
        <div style=" margin-top:15.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our process for manufacturing a personalized cancer vaccine. As shown in Figure 15 above, the following steps describe our process for designing a personalized cancer vaccine:</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Step 1&#8201;&#8212;&#8201;Tissue Biopsy:&nbsp;&nbsp;&nbsp;</font><font style="font-weight:normal;letter-spacing:0.2pt;">Tumor tissue sample(s) and a blood sample are collected from the patient. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Step 2&#8201;&#8212;&#8201;DNA and RNA sequencing:&nbsp;&nbsp;&nbsp;</font><font style="font-weight:normal;letter-spacing:0.2pt;">We then apply deep-sequencing to the patient&#8217;s tumor biopsy specimen and blood to derive high-quality DNA and RNA sequence information. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Step 3A&#8201;&#8212;&#8201;Identify Critical Neoantigens:&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> uses this sequence information to identify tumor mutations. Next, PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> identifies potential neoantigens from the tumor mutations and selects the top 10-20 neoantigen candidates and designs the final cancer vaccine. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Step 3B&#8201;&#8212;&#8201;Identify Critical ERV antigens:&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> uses tumor RNA sequence data from tumor biopsies to identify and rank the most vaccine-relevant ERV antigens. The top 10-20 ERV antigen candidate are selected for the final cancer vaccine design. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Step 4&#8201;&#8212;&#8201;Manufacturing:&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">The PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> and ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> antigen cancer vaccines are manufactured. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Step 5&#8201;&#8212;&#8201;Administer cancer vaccine to Patient:&nbsp;&nbsp;&nbsp;</font><font style="font-weight:normal;letter-spacing:0.2pt;">The manufactured cancer vaccines are administered to the patient. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">60</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG13">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Initially, our personalized vaccines are intended for the use as a combination therapy with CPIs. Evidence suggests that in patients responding well to CPI treatment, the response is partly mediated by tumor antigen-reactive T cells. Induction of </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> tumor antigen-specific T cells in combination with CPIs may increase the number of patients responding to treatment as well as improve the long-term clinical outcome. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Our PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> and ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> Derived Cancer Vaccine Programs</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are currently advancing a clinical pipeline of personalized cancer vaccines derived from our PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> and ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> models (see Figure 16). </font>
        </div>
        <div style="position:relative;margin-top:9.11pt; text-align:center; width:456pt;">
          <img src="fc_cancervaccines-4c.jpg" alt="[MISSING IMAGE: fc_cancervaccines-4c.jpg]" height="117" width="608" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:15.41pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 16</font>
          <br >
        </div>
        <div style=" margin-top:15.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our immuno-oncology product candidates derived from PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.15pt;">&#8482;</font><font style="letter-spacing:-0.2pt;"> and ObsERV</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.15pt;">&#8482;</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:48pt; margin-top:10pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note: The role of MERCK in the EVX-01 clinical trial is to supply KEYTRUDA</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.15pt;">&#174;</font><font style="letter-spacing:-0.2pt;"> (pembrolizumab). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our EVX-01 Product Candidate</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Overview</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our EVX-01 product candidate is a liposomal, peptide-based therapeutic cancer vaccine designed to engage a patient&#8217;s own immune system to fight their cancer by mounting a targeted response towards the tumor. EVX-01, in combination with anti-PD-1 or other CPIs, is intended for the first-line treatment of a variety of metastatic and unresectable cancers amenable to PD-1 inhibition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">EVX-01 consists of five to 10 PIONEER identified neoantigens formulated as peptides (neopeptides) together with a strong CD8+ and CD4+ T-cell inducing adjuvant, CAF09, in-licensed from Statens Serum Institute, or SSI. When administered to the patient, we believe EVX-01 will induce neoantigen-specific T cells that will migrate to the tumor site and induce tumor killing or target circulating tumor cells to eliminate these before becoming metastatic. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The development and Phase&#160;1/2a clinical trial of EVX-01 was partly funded through a $3&#160;million grant from the Innovation Fund&#160;Denmark and conducted in collaboration with a consortium consisting of Center for Cancer Immune Therapy at Herlev Hospital, Department of Health Technology at Danish Technical University, Center for Genomic Medicine at University Hospital Copenhagen and the Center for Vaccine Research at SSI. Evaxion retains all of the commercial development rights to EVX-01. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A clinical Phase&#160;1/2a trial was conducted from 2019 to 2022. Results from this trial was presented at American Society of Clinical Oncology, or ASCO, Annual Meeting in June&#160;2023 and showed that EVX-01 in combination with anti-PD-1 treatment induced strong anti-tumor response in 67% of patients. 8 patients had a clinical response to treatment i.e. tumor shrinkage with 2 patients having a complete response i.e. no sign of disease. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">EVX-01 is currently in clinical Phase&#160;2 development in a global multi-center trial in metastatic melanoma, administered in combination with KEYTRUDA</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> (NCT05309421). The trial is currently conducted globally at clinical sites across in Europe and Australia in collaboration with Merck. Patients enrolled in the Phase&#160;2 clinical trial receive KEYTRUDA</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> in combination with EVX- 01, or in the event of progression, another standard of care treatment in combination with EVX-01. We are responsible for the conduct of the trial. We will continue to collaborate with Merck as the data mature. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The first patient in the Phase&#160;2 trial was dosed in Australia in September&#160;2022. Initial readout from the first five patients was presented at the 38th annual meeting of SITC in November&#160;2023 in San Diego, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">61</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:9.44000000000005pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">California. The initial data demonstrated that the EVX-01 therapy was well tolerated, induced an EVX-01- specific immune response in all five patients and further promising signs were observed as three out of the five patients experienced improved clinical outcome upon EVX-01 and pembrolizumab treatment. In June&#160;2024, immune data from 12 patients was presented at the American Society of Clinical Oncology in Chicago, Illinois. Data demonstrated EVX-01 induced T-cell responses in all 12 assessed patients. The T-cell responses were mediated by both CD4+ and CD8+ T cells. Single vaccine neoantigen responses were induced by 71% of the administered neoantigens and correlation analysis between the AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> prediction scores and the neoantigen T-cell responses demonstrated a significant positive correlation, underlining the precision and predictive power of the proprietary AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform. In September&#160;2024, one-year clinical efficacy data was presented at the European Society for Medical Oncology Congress in Barcelona, Spain. The data demonstrated an overall response rate of 68.8% as per RECIST 1.1 with 15 out of the 16 patients experiencing a tumor target lesion reduction. Furthermore, additional immune monitoring analyses of single neoantigens revealed an even higher neoatigen hitrate of 78.8% with additional data generated from the timepoint of the ASCO presentation. Similarly with the additional immune data generated, the p value for positive correlation between AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> prediction scores and the immune response induced by the single neoatigens was improved, underlining the precision the proprietary AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> platform. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Addressable Market for EVX-01</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We are currently developing EVX-01 for the treatment of advanced or metastatic unresectable melanoma with the potential to expand into other solid tumor types such as non-small cell lung cancer, or NSCLC, and bladder cancer. According to the American Cancer Society, in 2023 there will be in the U.S.: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">97,610 new melanoma cases and 7,990 deaths from melanoma; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">238,340 new lung cancer cases and 127,070 deaths from lung cancer. NSCLC makes up on average 84% of all lung cancer cases; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">82,290 new cases of bladder cancer and 16,710 deaths from bladder cancer. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The treatment paradigm for metastatic and unresectable melanoma, NSCLC and bladder cancer has been revolutionized over the last few&#160;years with the approval of PD-1/PD-L1 CPIs across treatment lines, including first line for metastatic and unresectable melanoma and in NSCLC as monotherapy or in combination with chemotherapy/other CPIs depending on a patient&#8217;s status. In bladder cancer, PD-1/PD-L1 CPIs are approved in the first line setting for cisplatin ineligible patients as well as later line treatments. Only a minority of patients in these three indications have durable responses to PD-1/PD-L1 CPIs with a majority of patients ultimately showing progressive disease. We believe that our therapeutic neoantigens and ERV-antigens could change the treatment paradigm in combination with PD-1/PD-L1 CPIs across these three indications by expanding the patient population responding to PD-1/PD-L1 inhibitor treatment (CPI-resistant patients) and potentially increasing the effect in patients already responding to PD-1/PD- L1inhibitor treatment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Data Readout from our EVX-01 Phase&#160;1/2a Clinical Trial</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our EVX-01 Phase&#160;1/2a clinical trial was a first-in-human clinical trial of EVX-01 in combination with anti-PD-1 or anti-PD-L1 (NCT03715985). The trial commenced in January&#160;2019 and was an open-label, single-arm trial. The objectives of the trial were to evaluate the safety/tolerability (primary endpoint) and immunogenicity and feasibility of manufacturing (secondary endpoint) and establish a recommended Phase&#160;2b dose, or RP2D. The trial was initially intended as a basket trial for three indications: metastatic melanoma, NSCLC and bladder cancer. The indications were subsequently changed to advanced or metastatic unresectable melanoma. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">62</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG14">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:95.16pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="fc_vaccinetreat-4clr.jpg" alt="[MISSING IMAGE: fc_vaccinetreat-4clr.jpg]" height="348" width="578" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:18.69pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 17</font>
          <br >
        </div>
        <div style=" margin-top:18.69pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical design of the first-in-human Phase&#160;1/2a clinical trial in the EVX-01 program.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:48pt; margin-top:10pt; width:408pt; line-height:12.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(a) biopsy, Positron emission tomography/computed tomography scan, or PET/CT scan, and blood samples were collected at baseline (T1). Treatment with anti-PD-1 was either initiated at time of first biopsy (group A) or had already been initiated &gt;4&#160;months before biopsy (group B). EVX-01 vaccine was administered at week 6-8 and every 2nd week for 6 total vaccinations:3x IP followed by 3 x IM. (b)&#160;Dose escalation of administered peptide pool and number of patients at each dose level. CPI: checkpoint inhibitor, IP: intraperitoneal, IM: intramuscular, ORR: overall response rate, PFS: progression free survival, T: timepoint, FU: follow-up.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:11.2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2023, we announced data readout from the Phase&#160;1/2a clinical trial showing that EVX-01 in combination with anti-PD-1 compares favorably to anti-PD-1 treatment alone. The data demonstrated an overall response rate, or ORR, of 67% across all 12 patients compared with a historical ORR of 40% with anti- PD-1 treatment alone. The study also demonstrated a complete response, or CR, of 17%, compared with a historical CR of 7% with anti-PD-1 treatment alone. Among the four patients on the highest doses, all had a clinical response (ORR of 100%). Two patients with stable disease, or SD, for 10 and eight&#160;months on anti- PD-1 treatment alone, achieved CR and a partial response, or PR, respectively, following EVX-01 administration. In addition, the data showed induction of neoantigen-specific T cells in 100% of patients. 58% of the administered neoantigens induced reactive T cells in patients, of which 85% were </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> responses. Data from the trial also showed that EVX-01 appeared to be well-tolerated with only Grade 1 and 2 adverse events such as fatigue and fever (see Figure 18). </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">63</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG15">&#8203;</a><a name="tFIG16">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:17.4pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tb_diseasestage-4c.jpg" alt="[MISSING IMAGE: tb_diseasestage-4c.jpg]" height="249" width="605" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:15pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 18</font>
          <br >
        </div>
        <div style=" margin-top:15pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Patient disease status, treatment outcome and immune response from the EVX-01 Phase&#160;1/2a clinical trial.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As shown in Figure 19 below, a benefit of the combination therapy was observed for nine patients. Of these, two patients had a CR, six patients had a PR, one patient had SD, and three patients had progressive disease, or PD, as best outcome. Furthermore, a complete remission of target tumor lesions was observed in 4 patients (33%). </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="bc_changetrg-4c.jpg" alt="[MISSING IMAGE: bc_changetrg-4c.jpg]" height="328" width="448" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:17pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 19</font>
          <br >
        </div>
        <div style=" margin-top:17pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">% change in target lesion size for patients treated with EVX-01.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:48pt; margin-top:10pt; width:408pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Disease development determined according to RECIST criteria. PD: Progressive disease, SD: Stable disease, PR: Partial response, CR: Complete response. % change for lymph-node target lesions was set to <font style="white-space:nowrap;">-100%</font> when lymph-node was normal size (10 mm or below). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">64</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG17">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="lc_prepost-bw.jpg" alt="[MISSING IMAGE: lc_prepost-bw.jpg]" height="355" width="435" >
        </div>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Data from our clinical trial, as depicted in Figure 20, prove that patients treated with higher dose levels of EVX-01 neopeptides (dose level three, 200 ug/peptide) have an increased T-cell response compared to lower doses. When investigating the effect of peptide dose on T-cell response in general, we found that higher dose levels increase ORR in patients i.e. all patients at dose level 3 has an objective clinical response. The data supported the selection of the Phase&#160;2 dose as dose level 3 i.e. 200 ug/peptide. </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lc_prepost-bw.jpg" alt="[MISSING IMAGE: lc_prepost-bw.jpg]" height="355" width="435" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:15pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Figure 20</font>
          <br >
        </div>
        <div style=" margin-top:15pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Dose-responsiveness of immunogenic neoantigens. Pre, immune responses to EVX-01 neopeptides before vaccination, Post; Immune responses to EVX-01 neopeptides after vaccination. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">65</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG18">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">When investigating the safety profile, we found that increasing the dose level of EVX-01 does not affect the safety profile. Only grade 1 and 2 treatment related adverse events, or TRAEs, were observed across the three dose levels. Most frequently observed TRAEs include fatigue, stomach pain and fever&#8201;&#8212;&#8201;see table below of the TRAE: </font>
        </div>
        <table style="width:416pt;height:70pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:363.91pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Grade 1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 1pt 0pt; width:40.09pt;text-align:right;">
              <div style="white-space:nowrap; text-align:right;">
                <font style="letter-spacing:0.2pt;">8 (88.8)%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.91pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Grade 2 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:40.09pt;text-align:right;">
              <div style="white-space:nowrap; text-align:right;">
                <font style="letter-spacing:0.2pt;">4 (44.4)%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.91pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Grade 3 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:40.09pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">0 (0)%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.91pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Leading to drug discontinuation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:40.09pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">0 (0)%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.91pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Leading to death </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:40.09pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">0 (0)%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.1pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Neoantigen and Clinical Response Correlations</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As shown in Figure 21 below, we observed a correlation between broadness of immune response and clinical benefit when investigated if responding patients had a higher frequency of neoantigens resulting in a tumor-specific immune response as measured in blood by ELISpot. As seen in Figure 21, responding patients in general had a higher frequency of immunogenic neoantigens after treatment with EVX-01&#8201;&#8212;&#8201;a trend not observed pre EVX-01 treatment (see &#8220;Pre&#8221; boxplot to the left in Figure 21). Furthermore, the prevalence for immunogenic neoantigens in patients with clinical response increases in the follow-up samples. We interpret the increased profile of more immunogenic neoantigens in responders post EVX-01 treatment as indirect evidence of effect for EVX-01. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical outcome correlates with neoantigen immunogenicity</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lc_prepostfollow-bw.jpg" alt="[MISSING IMAGE: lc_prepostfollow-bw.jpg]" height="282" width="512" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:13.2pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 21</font>
          <br >
        </div>
        <div style=" margin-top:13.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Frequency of immunogenic neoantigens in patients.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pre-; before EVX-01 treatment but after initiation of PD-1 CPI treatment, Post: After 3 and 6 rounds of EVX-01 treatment and Follow up: After end EVX-01 treatment until progression. Clinical response as defined by RECIST, immunogenic neoantigens are defined as neoantigens where the T-cell response (SFU) is at least 3 times the standard deviation of the response induced by irrelevant peptides at the same timepoint, frequency of immunogenic neoantigens is calculated per patient.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We also observed a significant correlation between PIONEER quality score (prediction scores), immunogenicity, clinical response and Progression Free Survival, or PSF, as seen in Figure 21 and Figure&#160;22. PIONEER (v4.2) assigns significantly higher quality scores to immunogenic compared to non-immunogenic neoantigens and significantly higher quality scores to neoantigens administered to patients responding to treatment compared non-responding patients. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">66</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG19">&#8203;</a><a name="tFIG20">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="lc_pioneerscore-bw.jpg" alt="[MISSING IMAGE: lc_pioneerscore-bw.jpg]" height="231" width="448" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12.1pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 22</font>
          <br >
        </div>
        <div style=" margin-top:12.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Correlation between PIONEER quality score and immunogenicity.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Left: PIONEER quality scores for EVX-01 peptides inducing functional responses detected by ELISpot (immunogenic) compared to non-immunogenic EVX-01 peptides. Right: PIONEER quality scores for EVX-01 administered neopeptides in responders (CR/PR) and non-responders (SD/PD). P-value by t-test.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We further investigated if PIONEER quality score impacted PFS, i.e. time from treatment start to disease progression or death, of patients treated with EVX-01 by dividing patients in high and low PIONEER quality groups (n=6 in each). As seen from Figure 23, the high-quality group have significant longer time to progression compared to the low-quality group. To investigate if the longer PSF in the high score group was driven by a higher mutational load, the same analysis using TMB was conducted. As depicted in Figure&#160;23, TMB did not seem to be the determining factor for PSF in this patient cohort, indicating that the quality of administered EVX-01 neopeptides is important for clinical benefit. </font>
        </div>
        <div style="position:relative;margin-top:9.31pt; text-align:center; width:456pt;">
          <img src="lc_shortlong-4c.jpg" alt="[MISSING IMAGE: lc_shortlong-4c.jpg]" height="228" width="448" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10.2pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 23</font>
          <br >
        </div>
        <div style=" margin-top:10.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Kaplan-Meier plots displaying PFS of patients based on TMB high/low calculated FDA guidelines (left) Median PIONEER score (right).</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Our Phase&#160;2 Clinical Trial</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Based on our Phase&#160;1/2a clinical trial interim data readout on October&#160;21, 2021, we entered into the Merck CTCSA to evaluate in a new Phase&#160;2 clinical trial, the combination of our personalized cancer vaccine, EVX-01, with MSD&#8217;s anti-PD-1 therapy KEYTRUDA</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> (pembrolizumab), a humanized anti- human PD-1 monoclonal antibody. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Phase&#160;2 clinical trial is an open-label, multi-center, single arm trial evaluating the efficacy (best objective response, overall response rate, progression free survival and overall survival) and safety of EVX-01 </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">67</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG21">&#8203;</a><a name="tFIG22">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">in adults with advanced or metastatic unresectable melanoma on pembrolizumab. The trial is designed to show an improvement in the best overall response of patients with SD or PR after 12 weeks on pembrolizumab. treatment. The trial design is guided by recently published KEYNOTE-001 and 006 data from MSD which demonstrates that advanced melanoma patients with SD at week 12 and subsequent progression had poor survival outcomes. We believe EVX-01 in combination with pembrolizumab has the potential to significantly improve patient outcomes. The trial design is developed in collaboration with world leading KOLs; Georgina Long (Melanoma Institute Australia, AU), Patrick Ott (Dana-Faber Cancer Institute, USA) and Inge-Marie Svane (Center for Cancer Immune Therapy, Denmark), and is conducted in partnership with MSD. </font>
        </div>
        <div style="position:relative;margin-top:9.5pt; text-align:center; width:456pt;">
          <img src="fc_screening-4c.jpg" alt="[MISSING IMAGE: fc_screening-4c.jpg]" height="110" width="568" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10.51pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 24</font>
          <br >
        </div>
        <div style=" margin-top:10.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Schematic presentation of the EVX-01 Phase&#160;2 clinical trial design. Each patient receives 18 cycles with pembrolizumab (approximately two&#160;years).</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, we received regulatory clearance from the Australia Therapeutic Goods Administration, or the TGA, to initiate the Phase&#160;2 clinical trial of EVX-01, and in September&#160;2022, we announced enrollment of the first patient in our Phase&#160;2 trial in Australia. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2022, we submitted a CTA to the Italian Medicines Agency, which was approved on September&#160;16, 2022. Further, on November&#160;23, 2022, we submitted an IND to the FDA, which was granted approval on December&#160;22, 2022. Further, we received Fast Track designation from the FDA on January&#160;17, 2023. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of November&#160;2023, 16 patients were enrolled the Phase&#160;2 study and commenced the combination treatment with EVX-01 and pembrolizumab. Initial readout from the first five patients was presented at the 38</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> annual meeting of SITC in November&#160;2023 in San Diego, California. Few AEs related to EVX-01 have been reported and these were either grade 1 or 2. No SAEs have been reported in this patient cohort at the time of safety data cut-off on 30-Sep-2023. For all five patients EVX-01 induced a specific immune response over time as evidenced by an increase in magnitude of vaccine neoantigen-specific T cells. Further, a clinical benefit was observed in 3 out 5 patients. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2024, immune data from a total of 12 patients was presented at American Society for Clinical Oncology Annual Meeting in Chicago, Illinois. The data demonstrated neoantigen-specific T-cell reactivity induced by EVX-01 in all 12 patients and that the response was driven by both CD4+ and CD8+ T cells. All 12 patients had a CD4</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">+</font><font style="letter-spacing:0.2pt;"> T-cell response to their antigen pool and CD8+ T-cell reactivity to vaccine neoantigens was observed in three patients after the six priming vaccinations (Figure 25). </font>
        </div>
        <div style="position:relative;margin-top:9.6pt; text-align:center; width:456pt;">
          <img src="bc_sfupbmc-4c.jpg" alt="[MISSING IMAGE: bc_sfupbmc-4c.jpg]" height="176" width="448" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12.2pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 25</font>
          <br >
        </div>
        <div style=" margin-top:12.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Vaccine neoantigen-specific T-cell responses induced during the priming.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">A: IFN&#947; ELISPOT response at four different timepoint in PBMCs after in vitro stimulation towards each individual patient&#8217;s neoantigen pool. B: Vaccine-specific CD4+ and CD8+ T-cells </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">68</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG23">&#8203;</a><a name="tFIG24">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:49pt; width:407pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.2pt;">were analyzed by intracellular cytokine staining (ICS) and flow cytometry after in vitro expansion. T-cell responses were defined as %cytokine-positivevaccine_pool STIMULATED &gt; 2.5 x %cytokine-positiveUNSTIMULATED and at least 0.1% of CD4/CD8.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">With booster immunizations, analyses of a limited patient subset demonstrated CD8+ T-cell reactivity in two additional patients (Figure 26). </font>
        </div>
        <div style="position:relative;margin-top:9.5pt; text-align:center; width:456pt;">
          <img src="fc_cd4cd8cells-4c.jpg" alt="[MISSING IMAGE: fc_cd4cd8cells-4c.jpg]" height="189" width="448" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10.5pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:-0.2pt;">Figure 26</font>
          <br >
        </div>
        <div style=" margin-top:10.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;">
          <font style="letter-spacing:-0.2pt;">Vaccine-specific CD4+ and CD8+ T-cells were analyzed by intracellular cytokine staining (ICS) and flow cytometry after in vitro expansion.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.2pt;">T-cell responses were defined as %cytokine-positivevaccine_pool STIMULATED &gt; 2.5 x %cytokine-positiveUNSTIMULATED and at least 0.1% of CD4/CD8</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">In general, booster immunizations tended to increase the immune response and did not impose any safety concerns. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">Assessment of individual neoantigen reactivity revealed that 64 out of the 90 neoantigens administered to the 12 patients induced a significant T-cell response with an overall neoantigen response of 71%. Neoantigen PIONEER</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> quality score correlates positively with T-cell responses, underlining the precision and predictive power of the PIONEER&#8482; model (Figure 27). </font>
        </div>
        <div style="position:relative;margin-top:9.4pt; text-align:center; width:456pt;">
          <img src="lc_neoagspearson-4c.jpg" alt="[MISSING IMAGE: lc_neoagspearson-4c.jpg]" height="215" width="512" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10.41pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:-0.2pt;">Figure 27</font>
          <br >
        </div>
        <div style=" margin-top:10.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;">
          <font style="letter-spacing:-0.2pt;">Immunogenicity of individual EVX-01 neoantigen (neoAg) and correlation with neoAg quality score.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.2pt;">A: Number of immunogenic neoAgs per patient at each sample timepoint during EVX-01 priming. Immunogenic neoAgs were determined in an IFN&#947; ELISpot assay using the criteria: [Mean SFUneoAg STIMULATED] &gt; 2 x [Mean SFUUNSTIMULATED]+ 10 SFU. 64 out of 90 tested neoAgs were immunogenic. B: Correlation between IFN&#947; ELISpot responses and AI-Immunology&#8482; neoAg quality scores assessed at week 30 after completion of EVX-01 priming (6x&#160;EVX-01) demonstrated a significant positive correlation between neoAgs quality score and IFN&#947; responses.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">69</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG25">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:54.28pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2024, one-year clinical efficacy data was presented at the European Society for Medical Oncology (ESMO) 2024 Congress in Barcelona. The combination of EVX-01 and anti-PD-1 therapy led to an encouraging overall response rate of 68.8% (11 patients out of 16 patients) as per RECIST 1.1 with three out of the 16 patients achieved complete remission of their tumor target lesion. Further, a decrease in&#160;tumor target leasion size was observed in 15 out of 16 patients (Figure 28 A and B). Data cutoff: 21-Aug-2024. </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="bc_patient-4c.jpg" alt="[MISSING IMAGE: bc_patient-4c.jpg]" height="181" width="448" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:14.69pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 28</font>
          <br >
        </div>
        <div style=" margin-top:14.69pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical event timeline and change in tumor target lesion size.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:49pt; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:17pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">A)</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:66pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview of clinical response assessments and EVX-01 dosing. Week 0 is defined as the date of first Pembrolizumab treatment. Circles indicate the day of each clinical response assessment and are colored according to the assessment per RECIST 1.1. The arrows indicate the day of each EVX-01 administration. Early termination (ET) is indicated with a black square and a cross indicates early termination due to death. Patient 4 had PD at week 12 but experienced tumor reduction later. B) Largest reduction in target lesion size for each patient compared to baseline. Bars are colored according to each patient&#8217;s best overall response at the data cut-off date as assessed by RECIST 1.1. *Patients not included in the primary analysis as they were not SD or PR at week 12. # Increased response category after week 12.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The clinical efficacy data from the one-year interim analysis are summarized in the table below: </font>
        </div>
        <table style="width:416pt;height:113.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:336.3pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Assessments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:67.7pt;text-align:center;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.3pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Improvement from SD to PR/CR </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:67.7pt;">
              <font style="letter-spacing:0.2pt;">2/5 (40.0%) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.3pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Improvement from PR to CR </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:67.7pt;">
              <font style="letter-spacing:0.2pt;">2/9 (22.2%) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.3pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Overall improvement in response </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:67.7pt;">
              <font style="letter-spacing:0.2pt;">4/16 (25%) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.3pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">ORR </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:67.7pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">*11/16 (68.8%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.3pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Median follow up (months) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:67.7pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">14.8 (4.7&#8201;&#8211;&#8201;21.3) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.3pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Median OS </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:67.7pt;">
              <font style="letter-spacing:0.2pt;">NR </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.3pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Median PFS </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:67.7pt;">
              <font style="letter-spacing:0.2pt;">NR</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:9.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Immune motoring data demonstrated that out the 103 EVX-01 administered neoantigens analyzed to date, 81 gave rise to a specific T-cell response, totalling a hit-rate of 78.6%. Addionally, a positive correlation was observed between AI-Immunology&#8482; predictions and the immune response elicited by the specific neoantigens (Figure 29). </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">70</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG26">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="bc_preexisting-4c.jpg" alt="[MISSING IMAGE: bc_preexisting-4c.jpg]" height="218" width="512" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12.8pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 29</font>
          <br >
        </div>
        <div style=" margin-top:12.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Immunogenicity and correlation analysis between AI-Immunology&#8482; and immune response.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">A) Immunogenicity of individual neoantigens after six or more EVX-01 vaccinations. In total 103 peptides were analyzed, of which 81 were immunogenic (78.6%). B) Predicted neoantigen (neoAg) quality correlates positively with T-cell responses. Linear regression and Pearson correlation analysis of predicted neoantigen quality score and best observed immune response in IFNy ELISpot. Background signals are subtracted from all ELISpot data. PCC: Pearsson correlation coefficient. These data include the data depicted in Figure 27 as well as data generated from the time of the ASCO presentation in June&#160;2024 until the ESMO presentation in September&#160;2024.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In conclusion, the one-year data presented at ESMO indicate that EVX-01 holds the promise as a safe and effective therapeutic approach when used in combination with anti-PD-1 therapy. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Manufacturing of Our EVX-01 Drug Product</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The peptide-based format used to deliver PIONEER-identified neoantigens in EVX-01 is able to specifically stimulate neoantigen-specific T cells and has a turnaround time of approximately seven weeks from collection of patient-specific biopsies to administration of the therapy. We believe that this seven-week turnaround time is significantly shorter as compared to other current patient-specific, peptide-based, cancer vaccines, which have been shown to have turnaround times of 20 or more weeks. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our EVX-02 and EVX-03 DNA Product Candidates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Overview</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our additional two personalized cancer vaccines, EVX-02 and EVX-03, developed based on our PIONEER AI model, are in early clinical and late pre-clinical development, respectively. EVX-02 comprise PIONEER top-ranked neoantigens contained in a plasmid DNA and EVX-03 contains a combination of PIONEER predicted neoantigens and ERV antigens. EVX-02 is our product candidate for adjuvant treatment of resectable melanoma, whereas EVX-03 is an improved, next generation vaccine with a proprietary APC targeting unit, intended for the treatment of patients with locally advanced or metastatic solid tumors, including non-small cell lung cancer. The goal of the two cancer vaccines is to promote T-cell priming and expansion of cancer-specific effector T cells for direct and specific tumor killing. Both personalized vaccine candidates will be administered to patients in combination with CPI. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Summary</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our pre-clinical studies demonstrated that both EVX-02 and EVX-03 inhibited tumor growth in mice and induced functional therapy-specific T cells. Direct comparison of the potency of EVX-02 and EVX-03 in mice clearly indicated a beneficial effect of the APC targeting unit, as evidenced by a lower tumor protective dose of EVX-03 compared to EVX-02 and higher levels of neoantigen-specific T cells induced by EVX-03 compared to EVX-02. Further, the combination of our EVX-02 DNA therapy and CPI treatment of mice enhanced the antitumor effect, which we believe indicates a positive interplay of the two therapies. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">71</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG27">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Final data from a first-in-human Phase&#160;1/2a clinical trial investigating the safety, tolerability and pharmacodynamic response of EVX-02, substantiated the ability to activate neoantigen-specific T cells as well as indicated encouraging clinical outcome data of our first-generation neoantigen DNA therapy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.51pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe that the data from the EVX-02 Phase&#160;1/2a trial substantiates the clinical relevance of DNA- mediated delivery of neoantigens. We believe that the clinical data from our EVX-02 DNA therapy in combination with the improved EVX-03 anti-tumor effect in pre-clinical models, support moving into a first- in-human Phase&#160;1 clinical trial, investigating the safety and pharmacodynamic effect of EVX-03. To expedite the development of EVX-03, we are actively exploring partnership opportunities. </font>
        </div>
        <div style="margin-top:10.52pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Background</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have chosen to use a DNA-based vaccine format for several reasons: It is well-established that DNA vaccines harbor self-adjuvating capacities as they can activate the innate DNA sensing machinery inmammalian cells. This directs the immune response towards Th1-like immunity which is generally considered to be preferable in cancer therapies. Further, the DNA plasmid allows for full inclusion of highest ranking immunogenic neoantigens. Moreover, with the recent approval of a plasmid DNA vaccine for prevention of severe COVID-19 disease, it is now established that DNA vaccines can induce a clinically relevant immune response. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.51pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">When administered to the patient, we expect that the EVX-02 and EVX-03 DNA therapies (see Figure&#160;30) will be taken up by APCs and will be expressed as peptides, processed into smaller components, and loaded onto the MHC molecules on the cell surface eliciting an antigen-specific immune response. The APC unit is believed to mediate effective recruitment and activation of APCs to the local site of injection, thus further enhancing the antigen-specific immune response. </font>
        </div>
        <div style="position:relative;margin-top:7.52pt; text-align:center; width:456pt;">
          <img src="fc_evx02-4clr.jpg" alt="[MISSING IMAGE: fc_evx02-4clr.jpg]" height="218" width="448" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10.01pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 30</font>
          <br >
        </div>
        <div style=" margin-top:10.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Illustration of our two neoantigen targeting DNA therapies, EVX-02 and EVX-03.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:7.52pt; width:407pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EVX-03 also includes ERV antigen in the antigen unit. Both candidates comprise PIONEER-identified neoantigens inserted as a neoantigen unit into a backbone plasmid with immune stimulating elements. Furthermore, EVX-03 comprises an APC-targeting unit linked to the antigen unit via a dimerization unit, illustrated in dark blue.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:10.52pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Our EVX-02 Phase&#160;1/2a Clinical Trial</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The EVX-02 clinical trial is a first-in-human, open label, safety and pharmacodynamic multi-center trial in resectable Stage III/IV melanoma patients (NCT04455503), initiated in the third quarter of 2020. Each patient received, upon tumor resection, a unique EVX-02 vaccine designed based on their tumor genomic fingerprint in combination with PD-1 CPI. Each patient was treated with eight doses of EVX-02 at a two-week interval. Anti-PD-1 therapy was administered before, during and after administration of EVX-02 to unleash the potential of the EVX-02-specific T cells to mediate tumor killing. </font>
        </div>
        <div style="margin-top:10.52pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Data Readout from Our EVX-02 Phase&#160;1/2a Clinical Trial</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On April&#160;18, 2023, we presented clinical data from our Phase&#160;1/2a first-in-human study of its DNA- based personalized cancer vaccine, EVX-02 in combination with the checkpoint inhibitor nivolumab. Data </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">72</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG28">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">were presented in the Late Breaking Research: Clinical Research 2 session at the 2023 AACR (American Association for Cancer Research) annual meeting in Orlando, Florida. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The information shared during the 2023 AACR meeting was initially deemed preliminary since, at the time of presentation, the clinical database had not been locked. Final data cleaning and subsequent database lock on 14</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> of July&#160;2023 did not result in any modifications to the data presented at the AACR meeting. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The study, in patients with resected melanoma, showed that: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">All 10 patients who received the full dosing schedule of 8 immunizations with EVX-02 were relapse- free at their last assessment. Of these 10 patients, 9 completed the full study and were relapse-free at the 12-month end of study visit. One patient was prematurely terminated due to non-EVX-02 related adverse events (AEs), and was relapse-free at the last visit at 9&#160;months </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The combination of EVX-02 and nivolumab was well tolerated and only mild EVX-02-associated AEs were observed </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Robust and long-lasting neoantigen-specific T-cell immune responses were confirmed in all EVX-02 completers </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The induced T-cell immune responses involved both CD4+ and CD8+ T cells </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe the data serve as a validation of our PIONEER platform and provide proof of mechanism for our DNA-based approach to personalized cancer therapies. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Our EVX-02 and EVX-03 Pre-Clinical Data</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The pharmacological effect of EVX-02 and EVX-03 was addressed in the well-established CT26 syngeneic mouse model of colorectal cancer. As both vaccines are truly personalized and the therapy design is based on each patient&#8217;s individual tumor mutational profile, pre-clinical efficacy testing of personalized EVX-02 and EVX-03 therapies is not feasible. Instead, mouse surrogate compounds were designed by PIONEER through identification of CT26 tumor-specific neoantigens. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In several in vivo pharmacology studies, treatment with mouse specific EVX-02 and EVX-03 vaccines, or mEVX-02 and mEVX-03, induced robust, antitumor immunity in the CT26 tumor model (see Figure&#160;31A and A). Further, detailed complementary ex vivo analyses, unravelling the mEVX-02 and mEVX-03 induced T-cell responses, demonstrated neoantigen-reactive T cells in immunized mice as evidenced by cytokine positive CD4+ and CD8+ T cells (See Figure 31B-C and Figure 33B-C) </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lc_empty-4c.jpg" alt="[MISSING IMAGE: lc_empty-4c.jpg]" height="219" width="527" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:13pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 31</font>
          <br >
        </div>
        <div style=" margin-top:13pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Anti-tumor effect of the mouse EVX-02 surrogate vaccine.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">In vivo pharmacology study testing the antitumor effect of a mouse EVX-02 surrogate compound, mEVX-02. P-values were calculated using unpaired t-test with Welch&#8217;s correction. A: P&lt;0.001 (tumor volume AUC of Empty plasmid vs mEVX-02); B: P&lt;0.05 Empty plasmid vs mEVX-02, C:&#160;P&lt;0.05 Empty plasmid vs mEVX-02.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">73</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG29">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As shown in Figure 31 above, groups of BALB/c mice were intramuscular, or IM, administered with 100 &#956;g empty plasmid or mEVX-02 plasmids encoding 13 top ranked PIONEER identified CT26 neoantigens. (n=13-14 in both groups). The mice were prophylactically immunized once a week starting two weeks prior to CT26 tumor cell inoculation and the diameters of the tumors were recorded three times a week. Splenocytes from immunized mice were collected at endpoint and restimulated with vaccine relevant peptides for 10 hours. Subsequently the splenocytes were stained with antibodies for detection of intracellular cytokines (IFN</font><font style="font-family:Arial, Helvetica, sans-serif;letter-spacing:-0.067pt;">&#611;</font><font style="letter-spacing:0.2pt;"> and TNF</font><font style="font-family:Times New Roman, Times, serif;letter-spacing:0.35pt;">&#593;</font><font style="letter-spacing:0.2pt;">).</font><font style="font-family:Times New Roman, Times, serif;letter-spacing:0.35pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In an additional </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> pharmacology study, co-treatment with a suboptimal mEVX-02 dose and an anti- mouse PD-1, or mPD-1, antibody led to a combinatorial antitumor effect in a syngeneic tumor model illustrated by an increase in time to reach humane endpoints in mEVX-02 + anti-mPD-1 administered mice compared to single compound treatment groups (see Figure 32). In vivo tumor study investigating the combinatorial effect of mEVX-02 and anti-mPD-1 antibody. P-values were calculated using log-rank (Mantel-Cox) test P&lt;0.01. (Figure 31B-C and Figure 33B-C below). </font>
        </div>
        <div style="position:relative;margin-top:9.8pt; text-align:center; width:456pt;">
          <img src="lc_tumar-4c.jpg" alt="[MISSING IMAGE: lc_tumar-4c.jpg]" height="298" width="483" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10.8pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 32</font>
          <br >
        </div>
        <div style=" margin-top:10.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">In vivo tumor study investigating the combinatorial effect of mEVX-02 and anti-mPD-1 antibody. P-values were calculated using log-rank (Mantel-Cox) test P&lt;0.01.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In Figure 32, the time to reach either tumor ulceration or a tumor diameter of more than 12 mm, was increased in CT26 tumor bearing BALB/c mice receiving IM injections of a sub-optimal mEVX-02 dose and intraperitoneal, or IP, injections of 200 &#956;g anti-mPD-1 antibody compared to mEVX-02 and anti-PD-1 monotherapy. The anti-PD-1 antibody treatment was initiated when the tumors reached a mean volume 80&#8201;&#8211;&#8201;100 mm</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">3</font><font style="letter-spacing:0.2pt;"> in the groups receiving mEVX-02 treatment. As control for unspecific antibody mediated antitumor effect, parallel isotype control antibody groups were included (n=12&#8201;&#8211;&#8201;13 in all groups). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our next-generation DNA vaccine, EVX-03, is, we believe, further optimized by including an APC targeting unit to enhance the antitumor effect. APC-targeting is accomplished by introducing a Chemokine (C-C motif) ligand 19, or CCL19, that selectively engage cell surface receptors on APC populations and additionally directs the neoantigens to the APCs. We believe that this dual mechanism induces an effective and specific immune response. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To address if APC targeting of the neoantigens potentiated the effect of our EVX-03 product candidate, we immunized mice with neoantigen vaccines with and without a targeting unit. Figure 33A below shows that tumor establishment in the majority of mice treated with mouse mEVX-03 was completely prevented compared to mice immunized with a non-APC targeted neoantigen vaccine. Figure 33B below shows that higher levels of neoantigen-reactive T cells were obtained in the mEVX-03 APC targeted group compared to mEVX-03 without an APC targeted unit. Figure 33B and C demonstrate that mEVX-03 induces both a CD4+ and CD8+ neoantigen-specific T-cell response detected by intracellular cytokine staining. We </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">74</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIG30">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:146.3pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">believe that the data clearly demonstrate that the inclusion of the APC targeting unit potentiated the effect of the neoantigen DNA therapy. </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lc_tumarvalume-4c.jpg" alt="[MISSING IMAGE: lc_tumarvalume-4c.jpg]" height="262" width="449" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:13pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 33</font>
          <br >
        </div>
        <div style=" margin-top:13pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">In vivo pre-clinical data for EVX-03.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">A: Antitumor effect of mEVX-03 containing 13 PIONEER predicted neoantigens, P&lt;0.0001 (tumor volume AUC of Untreated vs mEVX-03) and P&lt;0.05 tumor volume AUC of mEVX-03 without targeting unit vs mEVX-03. B-C: mEVX-03 induces neoantigen-reactive CD4+ and CD8+ T cells detected by intracellular cytokine staining.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As shown in Figure 33 above, groups of BALB/c mice were intramuscularly, or IM, administered with 5 &#956;g empty plasmid or mEVX-03 plasmids with and without targeting unit (n=13&#8201;&#8211;&#8201;14 in all groups). The mice were prophylactically immunized once a week starting two weeks prior to CT26 tumor cell inoculation and the diameters of the tumors were recorded three times a week. Splenocytes from immunized mice were collected at endpoint and restimulated with vaccine relevant peptides for 10 hours. Subsequently the splenocytes were stained with antibodies for detection of intracellular cytokines (IFN</font><font style="font-family:Arial, Helvetica, sans-serif;letter-spacing:-0.067pt;">&#611;</font><font style="letter-spacing:0.2pt;"> and TNF</font><font style="font-family:Times New Roman, Times, serif;letter-spacing:0.35pt;">&#593;</font><font style="letter-spacing:0.2pt;">).</font><font style="font-family:Times New Roman, Times, serif;letter-spacing:0.35pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To directly compare the efficacy of mEVX-02 and mEVX-03, we conducted a dose titration study in which mice were immunized with 0.25-5 &#956;g mEVX-02 or mEVX-03. Both DNA therapies reduced the tumor growth dose dependently. With a mEVX-03 dose as low as 0.25 &#956;g, a significant antitumor response was obtained, whereas a dose of 5 &#956;g was required to mediate a similar effect with mEVX-02. The 20-fold difference in pharmacological effective dose of the two DNA therapies and the superior levels of neoantigen- specific T cells induced by EVX-03, clearly substantiate that the addition of the APC targeting unit significantly increases the potency of the DNA therapy. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">75</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG31">&#8203;</a><a name="tFIG32">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="lc_emptyplasmid-4c.jpg" alt="[MISSING IMAGE: lc_emptyplasmid-4c.jpg]" height="230" width="515" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10.8pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 34</font>
          <br >
        </div>
        <div style=" margin-top:10.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">mEVX-02 A) and mEVX-03 B) dose-dependently inhibited the growth of subcutaneous CT26 tumors. Antitumor of EVX-02 and EVX-03 was obtained at doses as low as 5 and 0.25 &#181;g, respectively.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As shown in Figure 34 above, in BALB/c mice IM administered with either 0.25, 2 or 5 &#956;g mEVX-02 or mEVX-03 encoding 13 PIONEER identified CT26 neoantigens, a clear dose-response effect was obtained (n=13&#8201;&#8211;&#8201;14 in all groups). BALB/c mice were prophylactically treated once a week starting two weeks prior to CT26 tumor cell inoculation and the diameters of the tumors were subsequently recorded three times a week. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To assess if ObsERV identified mouse ERV antigens can induce antitumor effects in preclinical models, mice were prophylactically immunized with a mEVX-03 vaccine containing 13 ERV antigens (mEVX- 03_ERV13_CT26) derived from the CT26 mouse tumor cell line. The immunized mice developed smaller tumor over time compared to mice administered with a plasmid without ERV antigens (mEVX-03 backbone) (see Figure 35 A and B). Complementary immune analyses demonstrated induction of ERV-reactive CD4+ and CD8+ T cells detected by intracellular cytokine staining (see Figure 35 C and D). Collectively, these data qualify ERV-derived sequences as relevant tumor vaccine targets. </font>
        </div>
        <div style="position:relative;margin-top:9.8pt; text-align:center; width:456pt;">
          <img src="lc_tumorvolume-4c.jpg" alt="[MISSING IMAGE: lc_tumorvolume-4c.jpg]" height="222" width="577" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10.8pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 35</font>
          <br >
        </div>
        <div style=" margin-top:10.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pre-clinical data for mEVX-03 containing ObsERV&#8482; identified ERV antigens (mEVX-03_ERV_CT26).</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">A-B: Antitumor effect of mEVX-03 with ERV antigens, ** p&lt;0.005, Kruskal-Wallis analysis (tumor volume AUC of mEVX-03 backbone vs mEVX-03_ERV13_CT26). C-D: mEVX-03 induces ERV-reactive CD8+ and CD4+ T cells detected by intracellular cytokine staining.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As shown in Figure 35 above, in BALB/c mice immunized IM with 25 &#956;g mEVX-03 containing 13 ERV antigens (mEVX-03_ERV13_CT26) a clear tumor growth delay was observed compared to mice administered </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">76</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG33">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a plasmid without ERV antigens (mEVX-03 backbone) (n=12 in both groups). BALB/c mice were prophylactically treated once a week starting two weeks prior to CT26 tumor inoculation, and the tumor diameters were subsequently measured three times a week. Splenocytes from immunized mice were collected at endpoint and restimulated with vaccine relevant peptides for 10 hours. Subsequently the splenocytes were stained with antibodies for detection of intracellular cytokines (IFN</font><font style="font-family:Arial, Helvetica, sans-serif;letter-spacing:-0.067pt;">&#611;</font><font style="letter-spacing:0.2pt;"> and TNF</font><font style="font-family:Times New Roman, Times, serif;letter-spacing:0.35pt;">&#593;</font><font style="letter-spacing:0.2pt;">). (n = 2 technical replicates from a pool of splenocytes from 5 mice per group). Group mean was &#177; SD.</font><font style="font-family:Times New Roman, Times, serif;letter-spacing:0.35pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">EVX-03 GLP toxicology study</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In a toxicology study, performed under GLP standards, no organ weight, no macroscopic nor microscopic changes were observed in a repeated dose study in mice. </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="fc_vehiclecontrol-4c.jpg" alt="[MISSING IMAGE: fc_vehiclecontrol-4c.jpg]" height="172" width="426" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:11pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 36</font>
          <br >
        </div>
        <div style=" margin-top:11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Results obtained in GLP toxicology study of EVX-03. The final report from the GLP toxicology study concluded that EVX-03 administered intramuscularly to BABL/c mice on eight dosing occasions with 2-week intervals was well tolerated and did not cause any adverse changes at local or systemic level.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe that the comprehensive </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> pharmacology data package provides clear evidence of complete mEVX-02 and mEVX-03 induced antitumor responses accompanied by induction of reactive CD4+ and CD8+ T cells. Moreover, a beneficial effect was obtained in mice by combining our DNA therapy with CPI treatment, holding great promise for a combination therapy approach in humans. We further believe that our EVX-03 pre-clinical data demonstrates that adding an APC-targeting unit leads to high levels of neoantigen-reactive T cells and significant tumor reduction even at very low doses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Manufacturing</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The production process of a personalized drug consists of multiple steps. For our EVX-02 drug product, DNA plasmids are designed to encode 13 PIONEER identified neoantigens. We have established a manufacturing process with a number of different contract development and manufacturing organizations, or CDMOs, and the entire process from the time of patient biopsy to the time of treatment takes approximately 10 to 12 weeks. With the release of our final batch for EVX-02, we have confirmed our manufacturing process, which we believe will allow us to progress our DNA-based cancer vaccine programs into larger global trials to explore the clinical benefits of the compounds further. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Our EVX-03 Clinical Development Plans</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based on the readout from our Phase&#160;1/2a EVX-02 study, induction of a robust and long-lasting CD4+ and CD8+ specific T-cell responses as well as a favorable clinical outcome in all patients, we believe we have validated our PIONEER&#8482; AI model, DNA technology and manufacturing process of the DNA therapy. Our next-generation DNA vaccine, EVX-03, is further optimized by including an APC targeting unit thereby leading to improved anti-tumor effect in pre-clinical models. Collectively, we believe these data constitute an attractive out-licensing package for potential partners, supporting progression into a first-in human Phase&#160;1 clinical trial to assess the safety, tolerability and pharmacodynamic effect of EVX-03. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">77</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG34">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:96.8pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AI-DeeP&#8482;, Our Proprietary Immuno-Oncology AI Model for Prediction of Drug Response</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have developed AI-DeeP&#8482;, an AI drug response prediction model, that is based on genomic signatures in the tumor microenvironment, neoantigen and ERV burden and seeks to identify patients who may or may not benefit from cancer immunotherapies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As shown in Figure 37 below, we believe AI-DeeP&#8482; identifies patients responding to therapy with high precision from the immunogenomic signatures alone. </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lc_clinical-4c.jpg" alt="[MISSING IMAGE: lc_clinical-4c.jpg]" height="254" width="254" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:11pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 37</font>
          <br >
        </div>
        <div style=" margin-top:11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Prediction of patient response to immunotherapy from immunogenomic profiles in baseline tumor biopsy.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">At enrollment to the Phase&#160;1/2a EVX-01 clinical trial, tumor biopsies were collected from malignant melanoma patients. Immunogenetic profiling was performed on the tumor biopsies using RNA sequencing. Leave- one-patient-out analysis demonstrated that patient outcomes can be successfully predicted on the 18 patients in the EVX-01 clinical trial. The prediction of patient outcome was found statistically significant (p=0.01) using the permutation test.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We further developed AI-DeeP&#8482; by including additional genomic signatures as well as neoantigen and ERV burden. We developed a training dataset of 937 patients treated with CPI and used this dataset for model training. When applied to genomic data from CPI treated cancer patients not included in the training dataset, AI-DeeP&#8482; outperforms stratification of patients by classical biomarkers; &#8216;TMB &amp; PD-L1&#8217; (see Figure 37). For the three CPI treated cohorts, we can identify 10&#8201;&#8211;&#8201;30% of the non-responding patients with (progressive disease) with 95% precision versus 70&#8201;&#8211;&#8201;80% precision with classical biomarkers. Hence, AI-DeeP&#8482; predicts progressive disease patients with high precision thus effectively identifying patients that will not benefit from CPI treatment. We believe this AI model can decrease clinical development risk and increase patient and payer benefit through patient stratification based on predicted likelihood of response to immunotherapy. We continue to generate and acquire data to further develop, validate and increase sensitivity and precision of AI-DeeP&#8482;. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">78</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG35">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="lc_liuhugoanti-4c.jpg" alt="[MISSING IMAGE: lc_liuhugoanti-4c.jpg]" height="185" width="589" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:11.1pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 38</font>
          <br >
        </div>
        <div style=" margin-top:11.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Prediction of patient response to immunotherapy from genomic profiles, neoantigen and ERV antigen signatures in baseline tumor biopsy.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Genomic data of baseline biopsies from 937 CPI treated cancer patients were curated from 14 studies and divided in 3 cohorts. AI-DeeP&#8482; (blue line) predicts a subset of progressive disease patients with high precision. In the anti-PD1 &amp; anti-CTLA4 treated cohort, AI-DeeP&#8482; can identify 10% of the non-responding patients with 95% precision, versus with classical biomarkers (&#8216;TMB &amp; PD-L1&#8217;, red line) with 70% precision. In the anti-PD1 treated cohort, AI-DeeP&#8482; can identify 25% of the non-responding patients with 95% precision, versus with classical biomarkers with 80% precision. In the anti-CTLA4 treated cohort, AI-DeeP&#8482; can identify 30% of the non-responding patients with 95% precision, versus with classical biomarkers with 70% precision.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Bacterial Diseases</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Drug-resistant bacteria pose a major medical and societal issue as bacteria are rapidly becoming resistant to many of the antibiotics that are currently used as standard of care. According to the World Health Organization, or the WHO, antibiotic resistance is one of the biggest threats to global health and it is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common bacterial diseases. A misuse of antibiotics is accelerating this process. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe the development of prophylactic vaccines is the sustainable solution to address and counteract drug-resistant bacterial infections for several reasons, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Vaccines can be used for decades without generating significant resistance </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Vaccines reduce antimicrobial use to further diminish pressure toward resistance </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Vaccines are cost-effective </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The market for combatting drug-resistant bacteria is projected to increase significantly. According to The World Bank, drug-resistant infections could by 2050 cause global economic damage on par with the 2008 financial crisis. In a recent report by Data Bridges Market Research Group, the Global Bacterial Vaccines Market was valued at $19.68&#160;billion in 2021 and is projected to reach $36.97&#160;billion by 2029, growing at a CAGR of 8.2% from 2022 to 2029. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Bacterial Vaccinology</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Vaccines work by training the immune system to recognize and combat pathogens, such as bacteria, viruses or parasites. To do this, certain molecules, called antigens, from the pathogen must be introduced into the body to trigger a protective immune response. By injecting vaccines containing antigens, the immune system will safely recognize them and trigger an immune response that leads to protective immunity. If the antigen-harboring bacteria or virus appears in the body during an early infection, the immune system will recognize the antigens displayed and immediately attack the pathogen before it can invade and establish a persistent infection and cause disease. The antigens can be surface exposed molecules, secreted toxins or specific virulence factors and by targeting them, the pathogen can more easily be neutralized. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">79</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:120pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The adaptive immune response following vaccination protects the body from infections by mounting a specific antibody-mediated immune response (B-cell response) and/or a cellular immune response (T-cell response). Antibodies can have different functions, but in general they either lead to neutralization of the pathogen (blocking function of important surface molecules or toxins), opsonization (antibodies bind to pathogen surface and flag them for phagocytosis and killing by immune cells) or complement activation (bound antibodies trigger a cascade of proteins that bind to the pathogen and form a pore that eventually lyses the bacteria or enhances opsonization further). On the other hand, the cellular immune response involves cell-mediated cytotoxicity (killing of infected cells), release of cytokines and chemokines as well as phagocytosis (pathogens are taken up and neutralized by macrophages). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to provoke the correct type of immunity as well as receive long-lasting and high protection, many vaccines include adjuvants as part of the formulation. Different adjuvants systems trigger different parts of the immune system. Even though adjuvants are critical components of the vaccines, they typically do not have protective properties by themselves in the absence of the specific antigens. The use of correct adjuvants in combination with the selected vaccine antigen(s) is important for the vaccine design. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A typical bacterial pathogen consists of thousands of unique proteins, where only a few elicit a protective immune response in a vaccine setting. Modern sequencing technology has enabled detailed insight into the entire genome of several clinical isolates of the same pathogen. This in turn has paved the way for computational antigen selection tools that can select a limited number of vaccine antigen candidates from whole bacterial genomes as a starting point for vaccine development. A challenge in computational, or bioinformatic, predictions, however, is to correctly identify posttranslational modifications and other molecular mechanisms that can change the structure and potential antigenic properties of bacterial antigens and optimize antigens in terms of stability, epitope presentation, ease of production and safety. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EDEN&#8482;&#8201;&#8212;&#8201;Our AI model for the Discovery and Design of Novel Prophylactic B-cell antigen Vaccines for Infectious Diseases</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Overview</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe that our AI model EDEN&#8482;, can rapidly identify novel, highly protective antigens for the use in pathogen-specific prophylactic vaccines against drug-resistant bacteria. Within EDEN&#8482;, our proprietary algorithms allow us to predict and identify those antigens that we believe will trigger a robust, protective immune response against almost any pathogen. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The core of our EDEN&#8482; technology is a proprietary machine learning ensemble of artificial neural networks trained using a feed-forward backpropagation approach to interpret immunological-relevant information in relation to infectious disease antigens that incur protection in a vaccine setting. EDEN&#8482; has been trained on our own curated data set derived by trawling through publicly available patents and publications reported to identify truly protective and non-protective antigens tested in clinical and pre- clinical settings. The input to the artificial neural network ensemble is a feature transformation of the protein data set, in which several global and sequence-resolved properties are extracted. These structural andfunctional features have been selected for their relevance in protein chemistry, immunology and protein structure and ability to guide the network in discriminating protective versus non-protective antigens. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">80</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG36">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:71.2pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="fc_datacuration-4c.jpg" alt="[MISSING IMAGE: fc_datacuration-4c.jpg]" height="200" width="575" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12.19pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 39</font>
          <br >
        </div>
        <div style=" margin-top:12.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EDEN</font><font style="font-weight:normal;letter-spacing:0.2pt;">&#8482; </font><font style="letter-spacing:-0.2pt;">is a self-taught AI model that provides important insight into what makes antigens elicit a protective immune response. EDEN&#8482; identifies novel protective proteins by recognizing abstract features shared with known highly protective proteins.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:11.2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We believe our approach can be used to target almost any bacterial infection and rapidly enable the discovery and development of vaccine product candidates. We have applied EDEN&#8482; to seven bacterial pathogens to test its predictive power. For each pathogen, EDEN&#8482; identified novel vaccine antigens which were subsequently expressed as proteins and tested in pre-clinical, mouse infection models, demonstrating protection against all seven pathogens. Within these studies, where vaccine formulations were distinguished by variations in EDEN&#8482; scores, we demonstrated the precision of EDEN&#8482;. This precision is evident through the correlation observed between EDEN&#8482; prediction scores and the level of protection in pre-clinical infection models. Notably, EDEN&#8482; outperforms reverse vaccinology (RV) by not only identifying the same bacterial vaccine antigens as RV but also uncovering numerous additional potential vaccine antigens that RV has overlooked, all through computation. By employing proteome-wide AI predictions, this tool not only identifies protective proteins but also predicts the level of protection each protein offers. We intend to develop a broad pipeline of vaccine product candidates using this AI model. EVX-B1, our vaccine candidate for the prevention of </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;">, has completed pre-clinical development and is ready for out-licensing. We are currently focused on the development of EVX-B2/EVX-B2-mRNA, our vaccine candidate for the prevention of </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;"> infections, and EVX-B3, a vaccine against an undisclosed bacterial pathogen with a high medical need where no vaccine is currently available. Furthermore, we believe EDEN&#8482; is applicable in virus vaccine development, hence is applied in the development of a virus vaccine EVX-V1 against cytomegalovirus (CMV). We develop our vaccine candidates through pre-clinical development with the ambition to enter co-development or out-licensing partnerships prior to clinical development. EVX-B2-mRNA, EVX-B3 and EVX-V1 are being co-developed with the pharmaceutical company Afrigen Biologics, with MSD and the company Expres2ion Biotechnologies, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:11.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2024 we launched an update of the EDEN model at the 23rd European Conference on Computational Biology, or ECCB. The updated. The updated version 5.0 of the AI model EDEN&#8482; features a novel toxin antigen predictor, is trained on an expanded dataset and includes an advanced protein prediction feature. The launch will expectedly improve Evaxion&#8217;s ability to fast and effectively discover AI-derived novel vaccines and is expected to further solidify the strong interest seen in AI-Immunology&#8482; from potential partners. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">81</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG37">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="fc_discovery-4c.jpg" alt="[MISSING IMAGE: fc_discovery-4c.jpg]" height="346" width="389" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 40</font>
          <br >
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our approach to bacterial vaccine discovery and design.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">To identify novel, broadly protective antigens for bacterial vaccines, EDEN&#8482; utilizes proteomes from clinically relevant bacterial strains as input. EDEN&#8482; then identifies unique feature combinations and ranks all proteins according to their predicted probability of eliciting a protective immune response. The EDEN&#8482; output is a ranked list of protective antigens, of which the highest ranking are selected, and constructs are designed and produced. Verification of protection and immunogenicity is conducted with pre-clinical models and assays, and if needed, further optimization steps follow, to finally derive at a CMC ready, potent product candidate.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Key Advantages of our EDEN</font><font style="letter-spacing:0.2pt;">&#8482; </font><font style="font-style:italic;letter-spacing:0.2pt;">Model</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe that our AI-based vaccine discovery and design approach for bacterial diseases has several advantages over more traditional approaches, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Ability to Predict Protective Vaccine Antigens:&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">The ability of EDEN&#8482; to predict protective vaccine antigens has been shown in pre-clinical models. Once clinically validated, we believe our approach may have the ability to improve on the attrition rates for new vaccine product candidates. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Identification of Novel and Unbiased Targets</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;EDEN&#8482; has been trained to identify the underlying feature patterns (e.g. structural or immunological elements) that we believe are important for protection to enable discovery of novel and unbiased targets that are not necessarily homologous to existing products. Traditional reverse vaccinology, or RV, relies heavily on sequence homology (proteins identical to previously tested antigens) in antigen identification. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Data Driven Precision</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;With carefully curated data, we believe EDEN&#8482; has learned to filter away irrelevant proteins, narrowing the field of candidates substantially from thousands to a few dozen proteins, reducing the burden on pre-clinical development. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Ability to Provide Broad Protection</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;The rapid &#8220;evolution&#8221; of the genome that can occur in some bacterial pathogens makes it difficult to capture all pathogen strains by a single vaccine. EDEN&#8482; is capable of leveraging genomic sequencing data to find important targets or domains that are present in the majority of clinical strains. By combining the correct antigens, we believe that most, if not all, relevant strains can be covered. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Speed</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;Traditionally, developing and verifying the safety and efficacy of a novel vaccine takes between 10 to 15&#160;years, often resulting in a new vaccine arriving too late on the market to influence </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">82</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:94.48pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">the spread of infections to the general population. We believe that EDEN&#8482; is capable of identifying vaccine antigens in a matter of weeks instead of&#160;years thus potentially lowering the overall development time significantly. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We are continuously improving our EDEN&#8482; model to ensure it remains state-of-the-art and incorporates multiple aspects of vaccine development from discovery to clinical testing. We explore among other improvements, incorporation of new translational features and data into EDEN&#8482;, novel machine learning architectures such as deep learning and probabilistic programming to enhance protein structure and function prediction, generation of novel high-throughput data to be incorporated into our AI technology for assessment of solubility and CMC-readiness and methods for determining broadness of protection across strains. By continuous improvement in all aspects of vaccine development, we believe the EDEN&#8482; model will continue to produce potent vaccine product candidates with minimal testing required before entering clinical development. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">EDEN</font><font style="letter-spacing:0.2pt;">&#8482; </font><font style="font-style:italic;letter-spacing:0.2pt;">Prospective In Vivo PoC Showing Remarkable Predictive Precision</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">To obtain initial </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> PoC, EDEN&#8482; was applied to seven bacterial pathogens reported to exhibit resistance to standard antibiotics, identifying both novel and known antigens. For each pathogen, EDEN&#8482; identified vaccine antigens were expressed as proteins and their protective ability tested in pre-clinical infection models. IP rights have been filed for all identified targets conferring significant protection. See table below for overview: </font>
        </div>
        <table style="width:456pt;height:158.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:192pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Bacterial species </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:21.86pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">In vivo </font>
                <br >
                <font style="letter-spacing:-0.16pt;">PoC </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:191.81pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">In vivo model (mouse challenge models) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:14.33pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">IP </font>
                <br >
                <font style="letter-spacing:-0.16pt;">filed </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:192pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Staphylococcus aureus</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:21.86pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#10003; </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:191.81pt;">
              <font style="letter-spacing:0.2pt;">Lethal peritonitis and skin abscess model </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:14.33pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#10003; </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:192pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Pseudomonas aeruginosa</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:21.86pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#10003; </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:191.81pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Lethal peritonitis and lethal acute pneumonia model </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:14.33pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#10003; </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:192pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Non-typeable Haemophilus influenzae</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:21.86pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#10003; </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:191.81pt;">
              <font style="letter-spacing:0.2pt;">Lung colonization model </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:14.33pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#10003; </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:192pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Moraxella catarrhalis</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:21.86pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#10003; </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:191.81pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Lethal peritonitis and lung colonization model </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:14.33pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#10003; </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:192pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Neisseria gonorrhoeae</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:21.86pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#10003; </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:191.81pt;">
              <font style="letter-spacing:0.2pt;">Vaginal colonization model </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:14.33pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#10003; </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:192pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Acinetobacter baumannii</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:21.86pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#10003; </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:191.81pt;">
              <font style="letter-spacing:0.2pt;">Lethal acute pneumonia model </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:14.33pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#10003; </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:192pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Klebsiella pneumoniae</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:21.86pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#10003; </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:191.81pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Lethal peritonitis and lethal acute pneumonia model </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:14.33pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#10003;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:9.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In the protective PoC studies, where vaccine formulations could be distinguished by variations in EDEN&#8482; scores, the results are depicted in Figure 41. This illustration demonstrates the precision of EDEN&#8482;, showing that the EDEN&#8482; prediction score correlates with the level of protection in pre-clinical infection models. There exists a significant correlation between the protein-specific EDEN&#8482; prediction score and the actual in vivo and in vitro protection in mice across four bacteria, encompassing gram-positive and gram-negative strains. This correlation strongly supports the notion that the top EDEN&#8482; antigens are indeed the most optimal B-cell antigens for use in a given bacterial vaccine. This discovery holds promise for reducing risk and cost in the development of infectious disease vaccines. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">83</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG38">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:53.76pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="lc_bacteria-4c.jpg" alt="[MISSING IMAGE: lc_bacteria-4c.jpg]" height="442" width="512" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:14.69pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 41</font>
          <br >
        </div>
        <div style=" margin-top:14.69pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Correlation between EDEN prediction and protection.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:12.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The EDEN&#8482; score shows a strong correlation with both the in vivo and in vitro efficacy of vaccine targets. This correlation is evident in various instances, such as the EDEN&#8482; score&#8217;s association with increased in vivo bacterial clearance across multiple N. gonorrhea strains in a mouse vaginal colonization model, as well as its correlation with in vitro bacteria killing. Furthermore, the EDEN&#8482; score demonstrates a correlation with a reduced p-value for in vivo survival in challenge models involving S. aureus, A. baumannii, and K. pneumoniae, signifying increased survival.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">EDEN&#8482; Retrospective Proof of Concept</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our retrospective Proof of Concept of EDEN&#8482; utilized a published reverse vaccinology (RV) study. Figure 42 demonstrates EDEN&#8482; model&#8217;s superior computational approach, not only identifying the same bacterial vaccine antigens as RV but also uncovering numerous additional potential antigens overlooked by RV. Specifically, EDEN&#8482; swiftly analyzed the </font><font style="font-style:italic;letter-spacing:0.2pt;">S. pyogenes</font><font style="letter-spacing:0.2pt;"> proteome, identifying all six highly protective antigens within days, a process that took&#160;years using RV. Additionally, EDEN&#8482; uncovered the &#8216;M protein&#8217; and 15 novel potential vaccine antigens among its top-ranked proteins, overlooked by RV. We believe this discovery approach promises cost-effective infectious disease vaccine development, surpassing RV by revealing known and overlooked antigens solely through computational methods. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">84</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG39">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="fc_proteins-4c.jpg" alt="[MISSING IMAGE: fc_proteins-4c.jpg]" height="256" width="366" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:13.8pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 42</font>
          <br >
        </div>
        <div style=" margin-top:13.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EDEN&#8482; outperform Reverse Vaccinology.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Group A Streptococcus (GAS) proteome, consisting of approximately 1700 proteins, underwent EDEN&#8482; processing. Within days of computational processing, EDEN&#8482; ranked all proteins in the proteome based on the probability of being optimal vaccine antigens. Among the top 30 EDEN&#8482; ranked proteins, the same six best-performing antigens identified by reverse vaccinology could be found, along with the well-known highly protective M protein as well as 15 novel antigens.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our EVX-B1 Product Candidate</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Overview</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our EVX-B1 product candidate is a multi-component subunit prophylactic vaccine, initially being developed for the prevention of SSTI in patients undergoing elective hernia surgery. EVX-B1 includes two proprietary and protective antigens identified by EDEN&#8482; in combination with two known toxins that play a key role in </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> pathogenesis formulated together with an adjuvant, CAF01. EVX-B1 is intended to be administered prior to surgery. Upon administration to the patient, we believe that EVX-B1 will significantly reduce </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> related SSTI. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">EVX-B1 has completed pre-clinical development. We intend to partner EVX-B1 prior to start of manufacturing and clinical assessment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Previous attempts to design vaccines to combat </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> have not been successful. We believe EVX-B1 is a highly competitive vaccine capable of out-performing other programs in clinical development as it has been designed to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Include Novel Antigens with High Protection Abilities</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our proprietary AI model EDEN&#8482; has identified several novel vaccine antigens and of these, two have been selected based on protection levels observed in different pre-clinical animal models such as sepsis and skin abscess, and when using multiple challenge strains. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Induce Broad and Effective Protection</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;By including antigens widely present and highly conserved among multiple clinically relevant strains, the vaccine will have a broad coverage and effectively address the medical need. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Include Multiple Antigens</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;By including multiple antigens with conserved B- and T-cell epitopes, the infecting bacteria is attacked from several angles and critical functions needed for bacterial pathogenicity, persistence and growth are targeted. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Target Critical Toxins</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;To increase protection even further, EVX-B1 includes a proprietary designed toxoid fusion protein targeting two critical toxins released by the bacteria during infection. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">85</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG40">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Include a Potent Adjuvant</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;By including the liposomal adjuvant CAF01, driving a balanced Th1 and Th17 type of immune response, we believe the vaccine induces the most optimal response needed to combat the pathogen. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Addressable Market for EVX-B1</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> is responsible for significant morbidity and mortality worldwide and antibiotic-resistant. </font><font style="font-style:italic;letter-spacing:0.2pt;">S.&#160;aureus</font><font style="letter-spacing:0.2pt;">, and in particular MRSA infections, are, according to the CDC, of critical concern and remain a prevention priority. In the United States, </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> is estimated to cause 20,000 deaths and amount to a total bill of $15&#160;billion on the health service annually. According to an IMARC Group Research Report, the global MRSA drugs market size reached US$ 3.6&#160;billion in 2022. Looking forward, it is expected that the global market will reach US$ 4.5&#160;billion by 2028, exhibiting a CAGR of 3.6% during 2023&#8201;&#8211;&#8201;2028. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are initially developing EVX-B1 for the prevention of </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> induced SSTI in patients undergoing hernia surgery. To date, no prophylactic vaccine for the prevention of </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> infections has received marketing authorization. With the development of EVX-B1, we are addressing this unmet medical need and believe our candidate has the potential to be the first vaccine to receive approval for the prevention of </font><font style="font-style:italic;letter-spacing:0.2pt;">S.&#160;aureus</font><font style="letter-spacing:0.2pt;"> infections. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Our EVX-B1 Pre-Clinical Data</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">EVX-B1 is a multicomponent vaccine, consisting of three components to derive a strong vaccine candidate: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Novel, EDEN&#8482;-identified vaccine antigens evaluated in pre-clinical protection and challenge studies and with critical functions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Uniquely designed toxoids selected from a long list of relevant toxins and pre-clinically evaluated as single proteins and fusion protein constructs. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Adjuvant selected based on pre-clinical tests and optimal profile for clinical indication. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each component has been carefully tested and evaluated pre-clinically as outlined in Figure 43 below. </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="fc_evxb1-4c.jpg" alt="[MISSING IMAGE: fc_evxb1-4c.jpg]" height="207" width="426" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:13pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 43</font>
          <br >
        </div>
        <div style=" margin-top:13pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Multicomponent approach to the development of EVX-B1.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Evaluation and Selection of Vaccine Antigens</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We applied EDEN&#8482; to the proteome of </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> to predict the antigens most likely to induce protective immunity. Forty-four (44) novel vaccine antigens were identified, expressed as recombinant proteins and assessed for protection in a </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> mouse sepsis model. Of these, 13 antigens demonstrated consistent high and significant protection in this model. The protection data is summarized in the table below: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">86</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:221.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:95.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;"># ID </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:43.12pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Proteins </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">No. of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Experiments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">No. of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Test</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Mice </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">No. of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Control</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Mice </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">% Survival of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Test Mice </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">% Survival of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Control Mice </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Difference in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Survival (Test vs.</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Control) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:95.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:43.12pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EDEN-1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">59</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">60</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">76<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">28<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">48<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:95.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:43.12pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EDEN-2 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">24</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">24</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">58<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">13<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">46<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:95.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">3 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:43.12pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EDEN-3 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">43</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">44</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">77<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">32<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">45<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:95.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">4 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:43.12pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EDEN-4 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">68<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">25<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">43<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:95.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">5 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:43.12pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EDEN-5 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">68<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">25<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">43<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:95.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">6 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:43.12pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EDEN-6 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">27</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">85<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">43<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">42<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:95.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">7 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:43.12pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EDEN-7 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">36</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">36</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">61<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">19<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">42<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:95.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">8 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:43.12pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EDEN-8 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">61</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">64</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">51<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">9<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">41<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:95.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">9 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:43.12pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EDEN-9 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">43</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">44</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">63<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">30<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">33<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:95.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">10 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:43.12pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EDEN-10 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">36</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">36</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">69<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">36<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">33<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:95.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">11 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:43.12pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EDEN-11 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">32</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">35</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">53<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">20<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">33<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:95.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">12 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:43.12pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EDEN-12 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">42</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">42</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">62<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">31<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">31<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:95.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">13 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:43.12pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EDEN-13 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:18.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">36</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">36</td>
            <td style="padding:0pt;padding-left:7.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">47<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">28<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:17.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">19<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:23.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.5pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The 13 antigens were further subject to extensive bioinformatic analyses to determine their function. Also, early production and formulation characteristics were addressed. Two antigens were selected based on the following parameters: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Level of protection in different challenge models and against different </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> challenge strains as single antigens and as part of a fusion protein construct. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Virulence functions critical for </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> pathogenicity and infection, including evasion of innate and adaptive immunity, secretion of virulence factors and toxins and replication, verified by functional assays. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Attractive CMC profile of the individual constructs </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:11.92pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Evaluation and Selection of EDEN&#8482; Identified Virulence Factors</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Evaxion&#8217;s extensive antigen discovery process, facilitated by EDEN&#8482;, identified many promising vaccine antigens and ultimately enabled the selection of two virulence factors Aureolysin (Aur) and </font><font style="font-style:italic;letter-spacing:0.2pt;">S.&#160;aureus</font><font style="letter-spacing:0.2pt;"> protein A (SpA). Aur and SpA demonstrate high level of immunogenicity and protection in preclinical models. The two lead antigens were designed and expressed as one fusion protein, EDEN-Fusion-1. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Evaluation and Selection of Toxins</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have evaluated multiple </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> toxins and selected the two most promising candidates for our proprietary toxoid fusion protein, which has demonstrated protection in sepsis models and skin abscess models of infection using two different challenge strains. Our toxoid fusion protein, Hla-LukE, includes inactivated forms of &alpha;-hemolysin (Hla) and Leukotoxin E (LukE), two toxoids having demonstrated high levels of protection when assessed in animal models amongst publicly described </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> toxins. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Evaluation and Selection of Adjuvant</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The vaccine antigens will be formulated with CAF01, a potent cationic liposomal adjuvant. The hallmark for CAF01 is its ability to induce CD4+ T-cell responses, especially Th1 cells and Th17 cells after parenteral vaccination with strong antibody response. CAF01 has been used in other vaccine programs undergoing clinical testing (in Tuberculosis and Chlamydia) and has an attractive safety and immunogenicity profile. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Our EVX-B1 Product Candidate</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">EVX-B1 will include two EDEN&#8482; predicted antigens as one fusion protein (EDEN-Fusion-1), two toxins as one toxoid fusion protein (Hla-LukE). EVX-B1 will therefore comprise a total of four antigens </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">87</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG41">&#8203;</a><a name="tFIG42">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">expressed as two fusion protein constructs and formulated with CAF01. All protein constructs are engineered to be proprietary to Evaxion. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pre-clinical data testing our EVX-B1 product demonstrated highly significant levels of protection in two different challenge models (Figure 43 and Figure 44) and high IgG titers (Figure 45) suggesting good overall immunogenicity. </font>
        </div>
        <div style="position:relative;margin-top:7.11pt; text-align:center; width:456pt;">
          <img src="lc_postinfection-4c.jpg" alt="[MISSING IMAGE: lc_postinfection-4c.jpg]" height="233" width="433" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.62pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 44</font>
          <br >
        </div>
        <div style=" margin-top:9.62pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Assessing protection of EVX-B1 in a mouse sepsis model.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:7.12pt; width:407pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Survival proportions of mice having received EVX-B1 product or PBS was followed for 7&#160;days post infection (p.i.). Statistical analysis was performed using Log-rank Mantel-Cox test (p-value &lt;0.0001****).</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Figure 44 above shows that EVX-B1 is inducing 79% protection compared to control (PBS) in a mouse sepsis model using </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> USA300 for challenge. </font>
        </div>
        <div style="position:relative;margin-top:7.12pt; text-align:center; width:456pt;">
          <img src="lc_abcessarea-4c.jpg" alt="[MISSING IMAGE: lc_abcessarea-4c.jpg]" height="353" width="267" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.62pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 45</font>
          <br >
        </div>
        <div style=" margin-top:9.62pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Assessing protection of EVX-B1 in a mouse skin infection model.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:7.11pt; width:407pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Abscess sizes are presented as area under the curve (AUC) for individual mice and mean with standard deviation. Statistical significance was calculated with Mann-Whitney test (p-value &lt;0.0001****).</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">88</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG43">&#8203;</a><a name="tFIG44">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Figure 45 above shows that EVX-B1 is inducing highly significant protection compared to control (PBS) in an abscess mouse model of infection using </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> USA300 for challenge. </font>
        </div>
        <div style="position:relative;margin-top:9.9pt; text-align:center; width:456pt;">
          <img src="lc_halfmaxtiter-4c.jpg" alt="[MISSING IMAGE: lc_halfmaxtiter-4c.jpg]" height="238" width="257" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12.8pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 46</font>
          <br >
        </div>
        <div style=" margin-top:12.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IgG titers. Mice were immunized with EVX-B1.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IgG titers are shown as half-max titers for individual mice, groups median values and 95% confidence interwall are shown.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to study the immune response following immunization, IgG titers were investigated. Figure 46 above shows that the EVX-B1 product induce high IgG titers specific for both of the two fusion protein constructs, EDEN-Fusion-1 and Hla-LukE, and holds promise for continued development. </font>
        </div>
        <div style="position:relative;margin-top:9.9pt; text-align:center; width:456pt;">
          <img src="lc_kidneys-4c.jpg" alt="[MISSING IMAGE: lc_kidneys-4c.jpg]" height="233" width="245" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10.9pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 47</font>
          <br >
        </div>
        <div style=" margin-top:10.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EVX-B1 prevents both disease and infection as the bacterial burden in the kidneys is blocked for at least 30&#160;days post infection.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:49pt; margin-top:8pt; width:407pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EVX-B1 immunized mice having survived a lethal challenge with S. aureus USA300 have also cleared the infection from internal organs (kidneys) 30&#160;days after infection. This is not observed for mice having received only the adjuvant CAF01. This demonstrates that EVX-B1 not only prevents disease but also prevents infection. Bacterial numbers as colony forming&#160;units (CFU) in individual kidneys from mice are shown.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To study if EVX-B1 can not only prevent disease but also prevent infection, we challenged CAF01 and EVX-B1 immunized mice with </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> USA300 in a sepsis model. Surviving mice were left for 30&#160;days before they were sacrificed, and several organs tested for presence of </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> bacteria. None of the organs collected (kidneys, heart and spleens) from EVX-B1 immunized mice (5 mice) showed any presence of bacteria, suggesting that EVX-B1 not only prevents disease but also prevents infection (See Figure 47). In </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">89</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">contrast three of five mice having received only the adjuvant CAF01 showed high numbers of bacteria in organs. We believe this important data holds much promise for the future EVX-B1 product. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Our EVX-B1 Development Plan</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We believe the pre-clinical data package demonstrates that our EDEN&#8482; platform is capable of identifying highly protective antigens based on the bacterium proteome. A finding we believe holds true for multiple bacteria with diverse pathogenicity, emphasizing the broad usability of the AI model. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We have recently completed the testing of the EVX-B1 fusion proteins for protection in a non-rodent surgical site infection model. This was done in collaboration with an undisclosed pharma company. The EVX-B1 fusion protein antigens significantly reduced </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> bacterial burden at the site of surgery. Also, the antigens inducted meaningful antigen-specific antibody titers in all immunized animals. Immune blood collected from vaccinated animals showed killing of clinically relevant </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> in a neutralization assay, holding promise for translational readout in early clinical development. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">EVX-B1 is currently in pre-clinical development, and we plan to assess the final formulation of EVX-B1 in a non-clinical, repeat dose toxicity study and to partner the candidate prior to start of manufacturing and clinical assessment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our EVX-B2 Product Candidate</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Overview</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our EVX-B2 prophylactic vaccine candidate is being developed to target all diseases caused by </font><font style="font-style:italic;letter-spacing:0.2pt;">N.&#160;gonorrhoeae</font><font style="letter-spacing:0.2pt;">. Gonorrhea is a sexually transmitted bacterial infection which has developed resistance to many commonly used antibiotics and represents a large unmet medical need. EVX-B2 is currently in pre- clinical development. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">EVX-B2 is a gonorrhea vaccine candidate composed of one fusion protein with two antigen subunits and formulated with the adjuvant GLA-SE. We believe that our EVX-B2 vaccine candidate will induce a protective immune response against </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;"> and thereby minimize the risk of infection for the general population and groups at risk. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, the EVX-B2 vaccine candidate is currently being evaluated for suitability in DNA and mRNA vaccine delivery platforms. In September&#160;2022, together with UMass Chan Medical School, we received a grant from the NIH to support this strategy and the further development of our EVX-B2 vaccine candidate. Furthermore, in September&#160;2023, we initiated a collaboration with Afrigen Biologics with the goal of developing an mRNA-based gonorrhea vaccine for low- and middle-income countries, or LMICs. The mRNA vaccine will be based on the same EDEN&#8482; discovered antigens having demonstrated high levels of protection in preclinical studies. This partnership will explore the expression and biological activity of the antigens in mRNA format. Following the validation phase, Evaxion and Afrigen Biologics will negotiate a subsequent agreement for clinical development and commercialization, with the opportunity to bring in additional partners. In September&#160;2024, initial data from the Afrigen collaboration was presented at the 18</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> Vaccine Congress in Lisbon, Portical. The data demonstrated the ability of the EVX-B2 mRNA vaccine to elicit a specific immune response in mice and further the ability of the immune sera from EVX-B2 mRNA vaccinated mice to induce bacterial killing. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Addressable Market for EVX-B2</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Identified by the CDC as one of the five most urgent antibiotic resistance threats, gonorrhea can result in ectopic pregnancy, infertility, newborn blindness and life-threatening sepsis. Each year, more than 80&#160;million global cases of gonorrhea infections show resistance to at least one of the commonly used antibiotics. As one of the world&#8217;s most urgent antibiotic-resistance threats with no vaccine available, we believe that the development of a safe and efficacious gonorrhea vaccine is critical, fills a major unmet medical need and addresses a global public health concern. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">90</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG45">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Evaluation and Selection of Vaccine Antigens</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">EVX-B2 was developed using our, proprietary AI model EDEN&#8482; for B-cell antigen discovery, to identify novel B-cell antigen vaccine targets. Ten proteomes of </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;"> were processed through EDEN&#8482;. The strains were selected to represent the </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;"> phylogenetic landscape and include several different antibiotic resistance profiles. EDEN&#8482; identified several </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;"> vaccine antigens. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Out of the 30 top-ranking antigens identified by EDEN&#8482;, 26 were successfully expressed and purified as recombinant proteins and tested for their protection and immunogenicity in mice in collaboration with UMass Chan Medical School. The proteins were tested in 11 combinations each comprising two to three antigens formulated together with the adjuvant Glucopyranosyl Lipid A Stable oil-in-water Emulsion, or GLA-SE. Further, the ability of immune sera to neutralize different </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;"> strains in a bactericidal assay was studied. The data demonstrated a total of 11 antigens that showed significant protection in a mouse vaginal colonization model and induced immune sera with demonstrated bactericidal activity against at least two </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;"> strains. One combination with two EDEN&#8482; identified antigens (NGO0265 and NGO1549) induced immune sera capable of killing all four tested </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;"> strains and showed protection against a highly antibiotic resistant challenge strain in mice. Based on these promising results, NGO0265 and NGO1549 were selected for further evaluation as vaccine antigens. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Evaluation and Selection of Adjuvant</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have evaluated different adjuvants together with the antigens and their combined effect to induce antigen-specific antibody responses, bactericidal activity and protection </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;">. GLA-SE was identified to have the highest adjuvanting capacity on the antigens, resulting in a formulation with high immunogenicity </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">GLA-SE is a synthetic analog of Monophosphoryl Lipid A (MPL). GLA-SE has been included in multiple vaccine formulations and the adjuvant has been confirmed to have a favorable immunogenicity. The adjuvant induces a Th1 skewed immune response. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Fusion Protein Generation and Pre-Clinical Development</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To reduce the number of proteins required for vaccine production and thereby the associated costs, a fusion protein construct combining the two lead antigen candidates, NGO0265 and NGO1549, was produced. The EVX-B2 formulation (see 46), consisting of the fusion protein together with the adjuvant GLA-SE was tested for protection in the vaginal colonization model. </font>
        </div>
        <div style="position:relative;margin-top:6.6pt; text-align:center; width:456pt;">
          <img src="fc_ngo265-4c.jpg" alt="[MISSING IMAGE: fc_ngo265-4c.jpg]" height="317" width="304" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10.49pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 48</font>
          <br >
        </div>
        <div style=" margin-top:10.49pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EVX-B2 is composed of a fusion protein of NGO0265 and NGO1549 formulated with adjuvant GLA-SE.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">91</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG46">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Immunization with EVX-B2 enhanced the bacterial clearance rate with a strong reduction of bacterial burden from three days and complete bacterial clearance seven days after challenge compared to adjuvant controls where infection was still detectable 10&#160;days after challenge (Figure 48) </font>
        </div>
        <div style="position:relative;margin-top:8.11pt; text-align:center; width:456pt;">
          <img src="lc_postinfections-4c.jpg" alt="[MISSING IMAGE: lc_postinfections-4c.jpg]" height="320" width="307" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.11pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 49</font>
          <br >
        </div>
        <div style=" margin-top:9.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EVX-B2 induce significant protection against challenge in a </font><font style="font-style:italic;letter-spacing:-0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:-0.2pt;"> vaginal colonization model.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:48pt; margin-top:8pt; width:408pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Mice received three immunizations and were challenged intravaginally two weeks after the last booster. Vaginal bacterial burden was measured daily to determine bacterial clearance rate. Statistical significance was calculated with Kruskal-Wallis test (Dunn&#8217;s multiple comparison test) (p-value&#160;=&#160;0.0029**).</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have also tested the antigen&#8217;s protective capacity when given individually to mice in a vaginal colonization model. below, mice were immunized with NGO0265, NGO1549, the combination of both proteins or the EVX-B2 product candidate, including the fusion protein. Mice were challenged with </font><font style="font-style:italic;letter-spacing:0.2pt;">N.&#160;gonorrhoeae,</font><font style="letter-spacing:0.2pt;"> and the number of bacteria was followed over time. Both proteins individually induced protection compared to the control group, having received only adjuvant GLA-SE. The protection was even enhanced for the fusion protein, which is included in the EVX-B2 product candidate. </font>
        </div>
        <div style="position:relative;margin-top:8.01pt; text-align:center; width:456pt;">
          <img src="lc_auccfu-4c.jpg" alt="[MISSING IMAGE: lc_auccfu-4c.jpg]" height="281" width="236" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">92</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG47">&#8203;</a><a name="tFIG48">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:93.4pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 50</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Both antigens used in the product candidate induce protection, which was enhanced when the antigens were fused together, as was the case in EVX-B2.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:48pt; margin-top:8pt; width:408pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Female BALB/c mice were immunized with three intramuscular injections of NGO0265, NGO1549, both proteins combined, or EVX-B2 including the fusion protein, using a 3-week schedule. Mice were challenged intravaginally with N. gonorrhoeae and the bacterial burden in vaginal swabs was monitored for eight days. Bacterial clearance was determined as log10 colony forming&#160;units (CFU) detected over time and the resulting area under the curve (AUC) was calculated. Statistical significance was calculated with Kruskal-Wallis test (p-value &lt;0.01**, p-value &lt;0.001***)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">EVX-B2 was also shown to be highly immunogenic in mice, inducing fusion-protein specific antibody responses already after one dose. This antibody was further increased with subsequent second and third immunization doses (See Figure 50) </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lc_immunizations-4c.jpg" alt="[MISSING IMAGE: lc_immunizations-4c.jpg]" height="290" width="332" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:11pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 51</font>
          <br >
        </div>
        <div style=" margin-top:11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EVX-B2 demonstrates high level of immunogenicity as specific antibodies can be detected already after one immunization.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:48pt; margin-top:8pt; width:408pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Furthermore, a significant booster effect after the second and the third immunization can be detected. The bars represent median values of OD</font><font style=" position:relative; bottom:-2.25pt;font-size:7.5pt;letter-spacing:-0.15pt;">405</font><font style="letter-spacing:-0.2pt;"> nm measured with a 1/100 sera dilution.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The EVX-B2 formulation has also been shown to induce a strong cellular immune response. Antigen- specific IFN</font><font style="font-family:Arial, Helvetica, sans-serif;letter-spacing:-0.067pt;">&#611;</font><font style="letter-spacing:0.2pt;"> T-cell responses against both antigen candidates (NGO0265 and NGO1549) were induced in mice immunized with EVX-B2 (see Figure 51). Also, three immunizations with the vaccine candidate EVX-B2 (CHIM_0265_1549 formulated in GLA-SE) raised a higher IFN</font><font style="font-family:Arial, Helvetica, sans-serif;letter-spacing:-0.067pt;">&#611;</font><font style="letter-spacing:0.2pt;"> T-cell response than immunization with a combination of individual NGO0265 and NGO1549 formulated with GLA-SE. We believe these data are very promising as they suggest that a strong Th1 type of immune response is induced following immunization with EVX-B2. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">93</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG49">&#8203;</a><a name="tFIG50">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="bc_splenocytes-4c.jpg" alt="[MISSING IMAGE: bc_splenocytes-4c.jpg]" height="170" width="580" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:13.2pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 52</font>
          <br >
        </div>
        <div style=" margin-top:13.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cellular immune response induced by EVX-B2.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:48pt; margin-top:8pt; width:408pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Female BALB/c mice were administered three intramuscular immunizations with either a combination of NGO0265 and NGO1549 or EVX-B2 (CHIM_0265_1549) using a 3-week schedule. Both formulations included adjuvant GLA-SE. Spleens were collected two weeks after the last immunization, and splenocytes were restimulated with full-length protein as indicated on the x-axis (NGO0265, NGO1549, or CHIM_0265_1549). Antigen-specific IFN</font><font style="font-family:Arial, Helvetica, sans-serif;">&#611;</font><font style="letter-spacing:-0.2pt;"> T-cell responses against both antigen candidates (NGO0265 and NGO1549) were induced by EVX-B2 (CHIM_0265_1549). Furthermore, three immunizations with EVX-B2 raised a higher IFN</font><font style="font-family:Arial, Helvetica, sans-serif;">&#611;</font><font style="letter-spacing:-0.2pt;"> T-cell response than immunization with a combination of NGO0265 and NGO1549.</font><font style="font-weight:normal;font-family:Arial, Helvetica, sans-serif;letter-spacing:-0.067pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, the EVX-B2 induced antibody response demonstrated a high level of bacterial killing activity against a large number of clinically relevant </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;"> isolates. As shown in Figure 52, all 50 (100%) different </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;"> strains tested were efficiently killed by EVX-B2 immune sera, using either 20% or 40% immune serum. We therefore believe the vaccine has the potential to present protection against a majority of global </font><font style="font-style:italic;letter-spacing:0.2pt;">N. gonorrhoeae</font><font style="letter-spacing:0.2pt;"> strains. </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="bc_killing-4c.jpg" alt="[MISSING IMAGE: bc_killing-4c.jpg]" height="169" width="577" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12.99pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 53</font>
          <br >
        </div>
        <div style=" margin-top:12.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EVX-B2 immune sera demonstrate broad bacterial killing activity.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:48pt; margin-top:8pt; width:408pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EVX-B2 demonstrates broad protection in a bactericidal assay using a panel of 50 different relevant clinical isolates with &gt;50% bactericidal killing. Two different immune serum concentrations were used, 20% and 40%, together with 20% normal human serum as a source of complement and bacterial survival was assessed after 30 min.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe the pre-clinical and bactericidal data generated to date holds great promise for future vaccine development and the population at risk. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our EVX-B3 Product Candidate</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have expanded Evaxion&#8217;s preclinical bacterial vaccine pipeline through a new collaboration with a leading pharmaceutical company. The EVX-B3 project is a collaboration with a company that has strong scientific alignment and complementary skill sets and capabilities. EVX-B3 is a vaccine discovery project addressing a serious global medical issue by targeting a pathogen associated with repeated infections, increasing incidence, and often serious medical complications for which no vaccines are currently available. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">94</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Evaxion&#8217;s proprietary AI-Immunology&#8482; platform, with the EDEN&#8482; and the RAVEN&#8482; models, will be utilized for the rapid design of a completely novel vaccine candidate capable of eliciting both a strong humoral (antibody) and cellular (T cell) immune response to the bacterial pathogen. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Viral disease Background</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Newly emerging and reemerging infectious viral diseases have threatened humanity throughout history and the advent of globalization have accelerated both the emergence and spread of human and animal viruses as existential human threats. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the coronavirus disease 2019 (COVID-19) pandemic engulfed the entire world in less than six&#160;months with high mortality in the elderly and those with associated comorbidities, and severely disrupted the world economy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While the challenges posed by the COVID-19 pandemic have highlighted the need for effective vaccines to prevent viral diseases and control future pandemics, the number of new and improved human viral vaccines licensed in recent&#160;years remain few despite the high need. Over the past 20&#160;years, great concerns have been expressed by the World Health Organization, or WHO, and other bodies following disease outbreaks by avian influenza A subtypes H5N1, H7N9, H9N2, and H3N2v and the SARS and MERS coronaviruses, Ebola filoviruses and the Zika flaviviruses. Further, according to the WHO, various disease vaccines are being added to pipelines round the globe with a number of these currently undergoing clinical trials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe our AI-approach to the design of viral vaccine candidates holds great promise for the development of novel, effective vaccines against hard-to-treat viral infections and emerging viral diseases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The global viral vaccines market was valued at $35.5&#160;billion in 2020 and is projected to reach $74.4&#160;billion by 2029, growing by at a CAGR of 8.49% from 2020 to 2026. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Viral Vaccinology</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Vaccines work by training the immune system to recognize and combat pathogens, such as bacteria, viruses or parasites. To do this, certain molecules, called antigens, from the pathogen must be introduced into the body to trigger a protective immune response. By injecting vaccines containing antigens, the immune system will safely recognize them and trigger an immune response that leads to protective immunity. If the antigen-harboring pathogen appears in the body during an early infection, the immune system will recognize the antigens displayed and immediately attack the pathogen before it can invade and establish an infection and cause disease. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The adaptive immune response following vaccination protects the body from infections by mounting a specific antibody-mediated immune response (B-cell response) and/or a cellular immune response (T-cell response). Antibodies can have different functions, but key to protect against a viral disease is their ability to bind to surface molecules and thereby prevent function or virus uptake by the target cell, while the key cellular immune response involves cell-mediated cytotoxicity (killing of infected cells). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A virus is fully dependent on the host cell machinery to successfully establish an infection. With the many ways of the host immune system to recognize and prevent infection, viruses have established various strategies to manipulate the cellular environment to prevent recognition or limit any immune responses against it. In addition, when a virus replicates, &#8220;copying errors&#8221; of its genome, i.e., mutations, can cause the virus to further evade the immune system by gaining new traits preventing them from being recognized by an otherwise trained immune system. Viral evasion strategies pose a great challenge for the vaccine development and calls for new strategies to target the virus from multiple angles, i.e., by combining B-cell and T-cell antigens for activation of both humoral and cellular pathways and targeting selected viral strains and/or human populations for specific or broad coverage. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our approach to viral vaccine design is an unbiased and fully AI-based target discovery approach, which traditionally, to a large extent, has been a manual process. In addition, while many licensed viral vaccines in the past have been focused on generation of a neutralizing antibody (B-cell) response, our AI model RAVEN&#8482; allows integration of a T-cell component in the vaccine design. We believe our approach </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">95</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG51">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">will help combat some of the historic challenges with viral vaccines, most recently observed in relation to vaccines developed to protect against the SARS-CoV-2 pandemic, including durability and breadth of response. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RAVEN&#8482;&#8201;&#8212;&#8201;Our AI Model for the Discovery and Design of Novel Prophylactic Vaccines for Infectious Diseases</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Overview</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">RAVEN&#8482; is our AI-Immunology&#8482; model that rapidly identifies T-cell antigens in infectious virus and bacteria for the use in pathogen-specific prophylactic vaccines. RAVEN&#8482; combines essential AI modules from our PIONEER&#8482; model to discover novel T-cell antigens. The RAVEN&#8482; model synergizes with EDEN&#8482; as RAVEN&#8482; identified T-cell antigens can be used either as a stand-alone or incorporated into known or novel EDEN&#8482; identified B-cell antigens. To construct a combined T- and B-cell antigen vaccine, we have generated a range of novel structural design tools, which graft T-cell epitopes into the B-cell antigens while maintaining the overall structural integrity of the B-cell antigen essential for eliciting the humoral response. We believe that a vaccine comprising both RAVEN&#8482; and EDEN&#8482; identified antigens, separately or in one integrated antigen, will elicit both a humoral/antibody response and cytotoxic T-cell responses, which may result in highly efficacious and broadly protective vaccines through robust memory T-cell populations. The schematic workflow for RAVEN&#8482; integration in EDEN&#8482; is shown in Figure 54. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The ability of RAVEN&#8482; to include T-cell epitopes in the vaccine design serves multiple purposes, both in the cellular response as cytotoxic T cells clearing pathogen-infected cells from the body and helper T-cells boosting both the cellular and humoral responses. The high-throughput nature of the RAVEN&#8482; model enables rapid identification of vaccine antigens for any viral or bacterial pathogen. </font>
        </div>
        <div style="position:relative;margin-top:9.9pt; text-align:center; width:456pt;">
          <img src="fc_identification-4c.jpg" alt="[MISSING IMAGE: fc_identification-4c.jpg]" height="243" width="608" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12.9pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Figure 54</font>
          <br >
        </div>
        <div style=" margin-top:12.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RAVEN</font><font style="font-weight:normal;letter-spacing:0.2pt;">&#8482; </font><font style="letter-spacing:-0.2pt;">workflow with EDEN&#8482; integration.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The input to RAVEN&#8482; is genomic and proteomic data from any pathogen target as well as MHC data on the indented human population. The cross-protective B-cell antigens are identified either from literature, if known, or by our EDEN&#8482; model. In order to predict the protective B-cell antigenicity of a given full length protein sequence, the models receive the proteome of a given pathogen as input and generate an output list ranking the proteins based on prediction scores (see above). The models leverage genomic sequencing data to find important targets or domains that are present in the majority of clinical strains for a given pathogen in order to capture a majority of pathogen strains by a single vaccine. Proteins are ranked by predicting B-cell antigen protection level by calculating an antigen prediction score ranging from 1 to 0, where 1 is highest predicted level of protection and 0 is the lowest. Adaptation of the EDEN&#8482; approach have been successfully applied to several viral targets where verified antigens rank high. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The protective T-cell epitopes are identified using a proprietary model composed of several computational features which identifies peptides presented on MHC class I and II molecules on the surface </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">96</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">of cells, a model adapted from our PIONEER&#8482; model. The model is a transformer-based neural network with seven million parameters, trained using a conditional generative adversarial network approach. A second model is subsequently applied to down select the full pool of T-cell epitopes to a set of peptides containing epitopes covering a target human population defined by MHC allele distribution, anywhere from a single individual to a world-wide population and a virus population defined by the genomes of the desired virus population. The algorithm is adjustable and can be used to ensure the broadest possible response across human tissue types (MHC-I and -II alleles) and entire virus species, or alternatively to target specific human populations and/or selected viral strains in outbreaks. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The identified B- and T-cell antigens can be administered as individual components or combined. A third ensemble of RAVEN&#8482; is further capable of examining the B-cell antigen structure and identify sites where the T-cell epitopes can be grafted into the protein thus preserving the B-cell mediated antibody generation whilst also eliciting a T-cell response. We expect that such T-cell epitope enrichment of the B-cell antigen will increase B-cell activation, resulting in increased breadth, avidity, magnitude and duration of the generated antibody response or can be designed to elicit a broadly protective cytotoxic T-cell response alongside the antibody response. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">These identified antigens can be administered by any established vaccine delivery technology such as protein, DNA or mRNA. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Key Advantages of our RAVEN&#8482; Model</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We believe, the combination of EDEN&#8482; and RAVEN&#8482; models results in several unique features of a vaccine design: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Promiscuous T-cell Epitopes</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;The AI modules of our RAVEN&#8482; model enable the identification and combination of T-cell epitopes that cover the immunological diversity of the human populations (HLA type). </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Multiple Hits on Target</font><font style="letter-spacing:0.2pt;">: By combining multiple potent epitopes in one vaccine, we believe different T cells will be able to target the infected cells, avoiding antigenic drift and curtail spread of the infection more effectively. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Potential Coverage of Entire Viral Cycle</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;By selecting epitopes from multiple proteins in the viral genome, vaccine generated T cells may be able to kill infected cells at selected stages of the viral replication cycle. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Mutation Proof</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;Combining multiple epitopes ensures covering of several variants of a strain, hence new mutations are likely to have little effect on the vaccine efficacy. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Neutralizing Focused</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;Design of minimal constructs from viral fusogens for the generation of neutralizing antibodies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Cross-reactive Antibodies</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;The RAVEN&#8482; and EDEN&#8482; viral fusion protein antigen is designed using information from all available variants of the target strain to ensure that the generated antibodies offer cross-reactive neutralization. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Broadly Applicable</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;The RAVEN&#8482; model can be applied to any known pathogen and is delivery platform agnostic. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Early Pre-clinical PoC for RAVEN&#8482;</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We have already demonstrated the predictive capabilities of our AI model PIONEER&#8482; and EDEN&#8482; to identify T- and B-cell antigens, respectively. We have further demonstrated that when integrated into RAVEN, T-cell epitope prediction capabilities are maintained. In an </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> study with 17 T-cell epitopes identified by RAVEN&#8482; across the entire SARS-CoV-2 genome, we found that 15 of the 17 (88%) epitopes induced T-cell activation and provided significant protection against lethal SARS-CoV-2 challenge in a K18-hACE2 mouse model (Figure 55). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">97</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFIG52">&#8203;</a><a name="tFIG53">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="bc_sarsgenome-4c.jpg" alt="[MISSING IMAGE: bc_sarsgenome-4c.jpg]" height="240" width="517" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.62pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:-0.2pt;">Figure 55</font>
          <br >
        </div>
        <div style=" margin-top:9.62pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;">
          <font style="letter-spacing:-0.2pt;">Vaccination with RAVEN&#8482; identified SARS-CoV-2 T-cell epitopes protects against lethal disease.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:48pt; margin-top:7.12pt; width:408pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.2pt;">Seventeen RAVEN&#8482; predicted T-cell epitopes from SARS-CoV-2 ORF1a/b, ORF3a, ORF6, ORF8, S, M, and N was incorporated into a plasmid DNA delivery platform containing an antigen-presenting cell targeting unit (APCt), a dimerization domain and the 17 T-cell epitopes. To evaluate immunogenicity and protection, mice were immunized intramuscularly five times with one-week intervals with 25 ug plasmid DNA expressing the RAVEN&#8482; predicted SARS-CoV-2 T-cell epitopes as &#8216;beads-on-a-string&#8217;. Figure 55A: Splenocytes from female C57BL/6 mice (n=2) immunized with the plasmid showed IFN-</font><font style="font-family:Arial, Helvetica, sans-serif;">&#611;</font><font style="letter-spacing:-0.2pt;"> response against 15 of the 17 included epitopes upon restimulation. Figure 55B: K18-hACE2 transgenic mice, carrying the human ACE2 receptor immunized with our RAVEN&#8482; predicted SARS-CoV-2 T-cell vaccine, were protected against lethal infection of SARS-CoV-2 (WA1/USA 2020) compared to APCt-Mock DNA immunized mice (n=8).</font><font style="font-weight:normal;font-family:Arial, Helvetica, sans-serif;letter-spacing:-0.067pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">We have further demonstrated that our approach to T-cell epitope enrichment using CD4+ T-cell epitope engraftment of hemagglutinin resulted in an improved antibody response in a pre-clinical study. Hemagglutinin is a viral fusion protein located on the surface of the influenza virus where it facilitates cellular entry, serving the same purpose as the spike protein in coronaviruses and its neutralization is therefore key in the development of an effective vaccine. As seen in Figure 56 below, the antibody response towards the enriched hemagglutinin was significantly enhanced, evidenced by a 5-10-fold better neutralization compared to non-enriched hemagglutinin. </font>
        </div>
        <div style="position:relative;margin-top:7.12pt; text-align:center; width:456pt;">
          <img src="bc_antibody-4c.jpg" alt="[MISSING IMAGE: bc_antibody-4c.jpg]" height="255" width="157" >
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.62pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:-0.2pt;">Figure 56</font>
          <br >
        </div>
        <div style=" margin-top:9.62pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;">
          <font style="letter-spacing:-0.2pt;">Engraftment of CD4+ T-cell epitope in the influenza hemagglutinin antigen.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:48pt; margin-top:7.12pt; width:408pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.2pt;">Six Influenza CD4+ T-cell epitopes were integrated into a hemagglutinin antigen. Subsequent immunization with the supercharged hemagglutinin antigen induced higher antigen-specific antibody titers compared to the standard antigen.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">98</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our first viral candidate, EVX-V1, entered our pipeline in 2022. Once we achieve PoC on our RAVEN&#8482; model, we plan to target other viruses that display seasonal recurrence and/or pandemic potential or general medical need, either through co-development or other partnership arrangements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our EVX-V1 Product Candidate</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2022, we announced our first viral target, Cytomegalovirus (CMV), against which we will use our RAVEN&#8482; and EDEN&#8482; AI models to identify promising vaccine targets. Our EVX-V1 vaccine candidate will be developed in collaboration with ExpreS</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;">ion Biotechnologies, or ExpreS2ion. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On November&#160;12, 2024, we announced positive preclinical data for EVX-V1. The data demonstrates that CMV antigens identified with Evaxion&#8217;s AI-Immunology&#8482; platform trigger targeted immune responses. Results also showcases the successful design of a proprietary prefusion glycoprotein B (gB) antigen with ability to neutralize the virus. We are advancing these new findings to develop a multi-component CMV vaccine candidate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">CMV is a member of the herpesvirus family and is a widespread infection with approximately half of the US population estimated to be infected by age 40. The virus is transmitted in body fluids, and once infected, the virus stays for life. People with weakened immune systems, including organ transplant patients, can develop severe symptoms affecting for example, eyes, lungs and liver. CMV can also be passed from a pregnant woman to her unborn child, and congenitally infected babies may suffer from intellectual disability and loss of vision and hearing. As there are currently no commercially available vaccines or other effective treatment options against CMV, it represents a critical unmet medical need. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the discovery phase of the collaboration, we utilized both EDEN&#8482; and RAVEN&#8482; models to find the most optimal vaccine candidate eliciting both a potent antibody and cellular response. By using EDEN&#8482;, we were able to identify novel B-cell antigens not pursued by other competing programs. We believe that including novel EDEN&#8482; antigens and RAVEN&#8482; T-cell epitopes in the final vaccine is a differentiator for us and a critical competitive edge. The CMV vaccine field has long focused on the same few antigens, yet without being able to develop a successful vaccine. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The antigen constructs derived from our AI platform will be produced by ExpreS2ion using their proprietary ExpreS2 platform, a protein expression system utilizing fruit fly cells, and subsequently process through our pre-clinical models. We believe this partnership has the potential to deliver a truly differentiated, highly immunogenic vaccine for protection against CMV infections. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The project has completed the vaccine discovery activities using the EDEN&#8482; model. Fifteen (15) potential targets were identified, and a detailed assessment resulted in a final selection of 10 new targets toinvestigate further. The antigens are present and well-conserved across multiple globally collected clinical isolates. The 10 new vaccine targets have been the basis for vaccine antigen design activities and are now being expressed using the ExpreS2 platform. We believe the new EDEN&#8482; antigens, together with RAVEN- identified T-cell epitopes, constitute a new and promising strategy to pursue in the development of a much- needed CMV vaccine. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Third-Party Collaborations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are collaborating with MSD on the Phase&#160;2 clinical trial which combines our patient-specific neoantigen cancer vaccine compound, EVX-01, with MSD&#8217;s anti-PD-1 therapy KEYTRUDA</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> compound, a humanized anti-human PD-1 monoclonal antibody. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The ongoing multi-center Phase&#160;2 clinical trial has enrolled patients (all patients enrolled) with Stage&#160;III and IV advanced or metastatic unresectable melanoma and will investigate EVX-01 in combination with KEYTRUDA</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">. We will act as the sponsor of the clinical trial and MSD supplies all the necessary KEYTRUDA</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">. We will continue to collaborate with MSD as the data mature. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are also collaborating with the National Center for Cancer Immune Therapy (CCIT-DK) at Herlev Hospital, Department of Health Technology at Danish Technical University, Center for Genomic Medicine at University Hospital Copenhagen and the Center for Vaccine Research at SSI on the development and Phase&#160;1/2a clinical trial of our EVX-01 product candidate. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">99</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We retain the commercial rights to EVX-01 and our other clinical stage programs. We plan to continue to identify potential collaborators who can contribute meaningful resources and insights to our programs and allow us to more rapidly expand our impact to broader patient populations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are also collaborating with ExpreS</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;">ion Biotechnologies, or ExpreS2ion, on the joint development of a novel CMV vaccine candidate, EVX-V1. Under the terms of the agreement, ExpreS2ion will have the exclusive right to license the CMV vaccine candidate under a potential Development and Commercialization Agreement. The research and intellectual property licensing costs for the collaboration project will be divided 50:50 between us and ExpreS2ion until 2025. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the EVX-B2 we are collaborating with Afrigen Biologics to develop an mRNA-based gonorrhea vaccine for LMICs. Following the validation phase, the partners will negotiate a subsequent agreement for clinical development and commercialization, with the opportunity to bring in additional partners. Afrigen will be responsible for the development and commercialization of the resulting mRNA vaccine in LMICs and African territories. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our latest vaccine project, EVX-B3, targets a bacterial pathogen for which no vaccine is yet available. The new vaccine project is a co-funded effort between us and MSD. The collaboration is leveraging unique assets and know-how from both organizations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual Property</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Introduction</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We actively seek to protect the intellectual property (IP) and proprietary technology that we believe is important to our business. Further, we seek to protect our proprietary position by, amongst other methods, filing patent applications in Europe, the United States and potentially other relevant jurisdictions relating to our inventions, improvements and product candidates. We also pursue IP protection for assets that may be used in future development programs and/or that may be of interest to our collaborators, or otherwise may prove valuable in the field. We pursue a patent strategy which seeks to protect marketed products and methods of their production, as well as therapy methods enabled by our proprietary AI-Immunology&#8482; platform without disclosure to the public the core elements in our technology. Following this strategy, we have filed patent protection of aspects of our PIONEER&#8482;, EDEN&#8482;, AI-DeeP&#8482; and RAVEN&#8482; models, however, we do not believe that the value of obtaining patent protection for all component of our platform technologies outweighs the risks of disclosing such information. We rely on trade secrets and know-how relating to our proprietary technologies to develop, maintain and strengthen our proprietary position in AI-based drug discovery and development. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Patent applications that relate to the PIONEER&#8482; technology cannot meaningfully be directed to single antigens and their various uses. Neoantigens identified by PIONEER&#8482; are by nature unique for each patient, therefore, the precise nature of each neoantigen has no relevance as an object for intellectual property rights. We are therefore establishing patent portfolio around the PIONEER&#8482; model which protects generally applicable aspects of the model, enabling personalized cancer vaccine, i.e. protection of additional features and elements which characterize the PIONEER-enabled therapy compositions, and which could be applied to other anti-cancer therapies that are based on immunization against neoantigens. The focus on the patent protection in the PIONEER&#8482; setting is therefore aiming at securing patent protection for 1)&#160;specific essential elements/ features needed to identify neoantigens not specific to the PIONEER&#8482; system, 2) specific features characterizing the composition of the designed therapy, and 3) specific features related to patient safety of the administered composition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the AI-Immunology&#8482; model; EDEN&#8482;, we file patents to protect vaccine antigens identified, vaccine compositions, antibodies, and antibody compositions as well as methods for prophylactic treatment of infectious diseases where the vaccine antigens and antibodies constitute the active ingredient. We file applications relating to several vaccine targets for each infectious agent causing the diseases and prosecute those antigens that have shown greatest promise as protective antigens in animal models. Our patent strategy for the EDEN technology also entails identification of optimal combinations of vaccine antigens as well as identification of specific vaccine formulations and modes of immunization that can be made the subject of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">100</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">second- and later generation patent applications that protect the final marketed product. Furthermore, we have one patent family pending covering the EDEN&#8482; method itself. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the AI-Immunology&#8482; model; RAVEN&#8482;, we have filed patent applications related to some aspects of the method for viral vaccine design as well as product claims related to viral vaccines designed by RAVEN thus harboring unique features of the RAVEN&#8482; design. However, the core functionality of RAVEN&#8482; is protected by trade-secret and not patents as we have assessed that disclosure of methods do not outweigh the benefit of obtaining patent protection. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Most of our IP assets were developed and are owned solely by us. In the few cases where our IP assets are jointly owned or in-licensed from third parties, we retain full rights to the commercial exploitation of such assets. We expect that we will continue to make additional patent application filings and will continue to pursue opportunities to acquire and license additional IP assets. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Regardless, given the early stage of prosecution for some of our patent application, we cannot be certain that any of the patent filings or other IP rights that we have pursued or obtained will provide protection for any product candidates that may ultimately be commercialized. Our most advanced product candidates are currently in clinical testing, with no certainty that they will be successful, or that significant modification or adjustment may not be required for successful commercialization. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our success will depend on our ability to obtain and maintain patent and other proprietary protection for commercially important technologies, inventions, and know-how related to our business, defend and enforce our patents, preserve the confidentiality of our trade secrets and operate without infringing valid and enforceable patents and proprietary rights of third parties. For more information, please see &#8220;Risk Factors&#8201;&#8212;&#8201;Risk Related to Our Intellectual Property&#8221;. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An issued patent provides its owner (or possibly its licensee) with a right to exclude others from making, using or selling that which is claimed in the patent, for a specified period of time (the &#8220;term&#8221; of the patent), in the jurisdiction in which the patent is issued. In the United States, and in many other countries, patents have a presumptive term of 20&#160;years from their accorded filing date (which is the earliest filing date to which the patent claims lineage, excluding filing dates claimed as priorities under the Paris Convention Priorities and/or priorities claimed from provisional patent applications). We believe that due to the patient- specific nature of our PIONEER&#8482; based cancer vaccines, in which our PIONEER&#8482; model is an inherent part of the product, and the platform predicted neoantigens cannot, we believe, be copied, such therapies will not be subject to competition from generic products even when the patent protection expires. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Patent Portfolio</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of August&#160;1st, 2024, we owned a total of 30 patent families, of which 10 are currently in their priority year or international phase and we own several granted patents in the United States (12), Germany (4), France (4), Spain (1), Great Britain (5)&#160;and 1 European unitary patent (in force 17 EU-member states) and have 68 pending national/regional applications. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">So far none of our granted patents has been subject to opposition, administrative reexamination, inter partes review, invalidity actions, or similar actions aiming at revoking or restricting the scope of a granted patent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The patent portfolio related to our most advanced product candidates and technologies as of August&#160;1st, 2024 are summarized below. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">EVX-01</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">EVX-01 is protected by trade secrets, patent applications related to, and the proprietary nature of the AI-Immunology model; PIONEER. In addition to IP protection of the PIONEER&#8482; model, our patent portfolio related to EVX-01 currently includes one patent family directed to a method of treating cancer in a patient using neopeptides (EVX-01). The patent application has entered national phase in CA, CN, US, EP, JP and AU. We expect the patent family to lapse in January&#160;2040. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">101</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">EVX-02</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">EVX-02 is protected by trade secrets, patent applications related to, and the proprietary nature of the PIONEER&#8482; models. In addition to IP protection of the PIONEER&#8482; model, our patent portfolio related to EVX-02 currently includes two patent families. The first patent family is claiming a method directed at inducing an anti-cancer immune response in patients by administrating the EVX-02 vaccine concept comprising DNA plasmid and polaxomer 188, a novel adjuvant. The second patent family is directed at a method of inducing and anti-cancer immune response in patients by administrating the EVX-02 plasmid alone. As of December&#160;1st, 2023, both patent families are in national phase in EP, CA, CN, US, JP and AU. The first patent family is expected to lapse in March&#160;2040 and the second in December&#160;2040. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">EVX-03</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">EVX-03 is protected by trade secrets, patent applications related to, and the proprietary nature of the PIONEER model. Furthermore, due to the similarities between our two DNA-based cancer vaccines, EVX-03 and EVX-02, our patent families covering EVX-02 also applies to EVX-03. In addition, one patent family has been filed that specifically relates to the targeting unit, unique to EVX-03. The patent family is a composition of matter application directed to the EVX-03 product concept. The patent family has national applications pending in the following Juristrictions: AU, CA, CN, EP, JP and US. We expect that the patent rights will lapse in April&#160;2041. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">EVX-B1</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our patent portfolio related to EVX-B1 includes five patent families. The patent families are composition of matter patents, or methods for inducing anti </font><font style="font-style:italic;letter-spacing:0.2pt;">s. aureus</font><font style="letter-spacing:0.2pt;"> immunity, directed against compositions comprising one or more </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> antigens. The first patent family comprise five issued patents in the US, one in DE, one in FR and one in GB as well as one pending application in US and one pending application in EP. The patent family is expected to expire in April&#160;2032. The second patent family comprises one US patent, one US and one EP pending application. We expect the patent family to lapse in December&#160;2034. The third patent family comprises one US, one GB, one DE and one FR registered patents. We expect the family to lapse in February&#160;2037. Our fourth EVX-B1 related patent family comprises one issued US patent as well as pending applications in EP and US. We expect this patent family to lapse in July&#160;2037. The fifth family claims a composition used for vaccination against </font><font style="font-style:italic;letter-spacing:0.2pt;">S. aureus</font><font style="letter-spacing:0.2pt;"> comprising our EVX-B1 vaccine. The application is in international phase and upon entry into national stage, we expect this patent family to lapse in 2042. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">EVX-B2</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Patent portfolio related to EVX-B2 comprise two patent families. Both families are directed against antigens useful in vaccines against N. gonorrhoeae. The first patent family is at national stage and contains pending applications in EP and the US. Subject to grant, we expect these patents to expire in 2041. The second family is in national stage and have pending applications in: AU, CA, CN, EP, JP, US and ZA. We expect that patent rights will expire in 2042. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">EVX-V1</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Together with our development partner for EVX-V1 we have filed one PCT application claiming variants of a specific antigen useful for vaccine against CMV. Subject to national stage entry we expect the patent family to expire in September&#160;2044. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">PIONEER</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The AI-Immunology&#8482; model: PIONEER&#8482; is mainly protected as a trade secret as computational methods are complicated to patent and protect from infringement. However, our current patent portfolio comprises two patent families related to PIONEER&#8482; covering some aspects that are important for neoantigen selection. The first patent family is directed against a method for selecting and de- selection of neoantigens for the treatment of cancer comprising the SLICE model used in PIONEER for epitope prioritization. The patent family have pending applications in AU, CA, CN, EP, JP and US. We expect the family to lapse in July&#160;2041. The second family is directed against as method for identifying antigens (including neoantigens) using the AI-framework used in PIONEER&#8482; for MHC ligand identification. The patent family is currently in priority year. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">102</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">ObsERV</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The AI-Immunology&#8482; model: ObsERV&#8482; is, like the PIONEER&#8482; model, protected by trade-secrets and additionally to patents protecting PIONEER&#8482; the ObsERV&#8482; models is protected by one patent family. The family supplements the identification of neoantigens with a system for identifying highly immunogenic epitopes from human endogenous retroviral sequences, or hERVs, and other normally non-expressed tumor specific epitopes found in the human genome and use these to treat cancer. The patent discloses a method for deselecting potentially harmful and non-immunogenic hERV epitopes. This patent application is in international stage. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">RAVEN</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our AI-Immunology&#8482; model; RAVEN&#8482;, is in addition to trade secrets and the proprietary nature of the model, protected by two patent families. The first patent family is a composition of matter family directed to the vaccine delivery concept that can be utilized together with the RAVEN&#8482; model. The family comprise one AU, one CA, one CN, one, EP, one JP and one US patent application. We expect the patent family to lapse in July&#160;2041. The second patent family also a matter of composition patent aimed at a vaccine product designed from analyzing genomes of pathogens by the RAVEN model. This patent family comprise one EP and one US patent application. We expect the patent family to lapse in 2042. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">AI-DeeP</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our AI-Immunology&#8482; model; AI-DeeP&#8482;, is in addition to trade-secret and the proprietary nature of the model, protected by one patent family. The patent family discloses a method for identifying patients&#8217; response to immunotherapy comprising measuring and relating HLA expression in patient&#8217;s tumor sample. The method disclosed is comprised in the AI-DeeP&#8482; model. The patent family is in national phase with one EP and one US patent pending. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">EDEN</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our AI-Immunology&#8482; model EDEN&#8482;, has provided input for multiple patent applications within our bacterial vaccine portfolio. The model itself is been kept as trade-secret, however one patent application has been filed to cover the EDEN&#8482; method. The application is in priority year and is expected to lapse in 2044. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">In-Licensing</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have pursued a strategy of identifying and in-licensing third-party patents that we believe are complementary to or otherwise interact synergistically with our own intellectual property portfolio. On November&#160;30, 2020 we entered into a CAF</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">09b Supply, Patent Know How Trademark License Agreement and on June&#160;27, 2024 we entered into an updated CAF</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">09b Patent Know How Trademark License Agreement with Statens Serum Institut, or SSI, which will grant us an exclusive, royalty-bearing sub-licensable license to a product comprising SSI&#8217;s adjuvant technology CAF</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">09b and PIONEER identified neopeptides. Pursuant to the terms of the agreement, we or our affiliates may import, have imported, export, have exported, formulate or have formulated, commercialize, market, use, offer for sale, sell, have sold, supply, or have supplied PIONEER derived cancer vaccines administered together or in combination with licensed adjuvant, but not, on a stand-alone basis, the licensed adjuvant. The license specifically excludes any manufacturing rights to the licensed adjuvant and the license further excludes any research and development in relation to the licensed adjuvant other than where such research and development is in connection with and for the purpose of research and development in respect of PIONEER derived cancer vaccines administered together or in combination with licensed adjuvant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the SSI agreement, we have rights to three issued United States patents and other patents and patent applications in jurisdictions outside the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event we commercialize any PIONEER derived cancer vaccines administered together or in combination with licensed adjuvant on our own, we are required to pay SSI a royalty on net sales in the low teens. The royalty term extends for a fixed period of 10&#160;years commencing on the first calendar day of the calendar month following the first commercial sale of a PIONEER&#8482; derived cancer vaccine administered </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">103</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">together or in combination with the licensed adjuvant or when patent protection of SSI licensed patents expires, whichever comes last. Upon expiration thereof, the SSI license shall be deemed to be fully paid up, royalty-free, irrevocable and perpetual with respect to such vaccine. However, if any PIONEER&#8482; derived cancer vaccine administered together or in combination with licensed adjuvant are commercialized by one of our partners, if any, we are required to pay SSI a&#160;percentage of any out-licensing revenue (milestones and royalties) earned by us and our affiliates. The size of the income share due to SSI shall be determined and reflect the extent to which we have invested in carrying out the Phase&#160;2 and Phase&#160;3 clinical trials in respect of the PIONEER&#8482; derived cancer vaccines administered together or in combination with licensed adjuvant prior to entering into a sub-license agreement. If we enter into a sublicense agreement with a partner on our EVX-01 product candidate subsequent to the initiation of a Phase&#160;2 clinical trial, we are required to pay to SSI a&#160;percentage of any sublicensing income in an amount in the low double-digit range. If we enter into a sublicense agreement with a partner on our EVX-01 product candidate subsequent to the initiation of a Phase&#160;3 trial, we are required to pay to SSI a&#160;percentage of any sublicensing income in the low double-digit range. Prior to any out-licensing or commercialization of EVX-01, we are not required to make any additional payments to SSI. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The SSI license will terminate on the earlier of (i)&#160;a fixed period of 10&#160;years commencing on the first calendar day of the calendar month following the first commercial sale of a PIONEER&#8482; derived cancer vaccine administered together or in combination with licensed adjuvant or when patent rights expires, whichever comes last and (ii)&#160;the effective date of termination. In this connection, we or SSI may terminate the license upon prior written notice in the event of (a)&#160;a material breach which is not capable of remedy, or if capable of being remedied, such remedy does not occur within a specified time after notification or (b)&#160;an order is made, or a resolution passed for the winding up of either SSI or us. In addition, we may terminate the SSI License upon prior written notice if we are not able to reach a supply agreement with SSI&#8217;s designated commercial supplier of the licensed adjuvant. Apart from such causes, SSI may not terminate the license agreement and we may only terminate the SSI license on (c)&#160;the grounds of lack of efficacy of a PIONEER&#8482; derived cancer vaccine administered together or in combination with licensed adjuvant, as a result of which we determine not to progress with the development and commercialization of such product or (d)&#160;due to safety concerns, market and/or competitive situation that would prevent commercialization of a PIONEER&#8482; derived cancer vaccine administered together or in combination with licensed adjuvant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On April&#160;28, 2022, we received formal notice that on April&#160;21, 2022, SSI, had initiated a legal proceeding against us in The Danish Maritime and Commercial High Court (S. og Handelsretten), claiming sole ownership of a patent application (PCT/EP2020/050058 and subsequently national filings, EP3906045), we had filed related to a method for treating malignant neoplasm by administering a composition comprising a high dose of neopeptides, a solvent and an liposomal adjuvant, e.g. CAF.09b, for which we have a license agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The patent application for the Invention relates solely to the use of the adjuvant CAF</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">09b in conjunction with a high dose of neopeptides in our EVX-01 product candidate. SSI&#8217;s claim to the patent application does not relate to any other aspect of our patent portfolio covering EVX-01 or the PIONEER&#8482; model. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2023 terms were agreed between us and SSI which results in a situation where we retain all commercial rights to EVX-01 and the patent application, the law-suit will be lifted on a walk-away basis and no compensation by Evaxion to SSI. These terms were effectuated on the 27&#8217;th of June&#160;2024 and the court case lifted by SSI. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On June&#160;29, 2020, we entered into a license agreement with PharmaJet or the PharmaJet License Agreement, which grants us non-exclusive, sub-licensable license to certain intellectual property of PharmaJet and supply of the Stratis</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> device and disposable needle-free syringes and filling adapter items for use with any products derived from one or more of our product candidates in the field of prophylaxis, diagnosis prediction, and/or treatment of cancer in humans and/or animals. Subject to meeting certain development milestones, additional consideration of up to $320,000 is to be transferred to the seller. Further, $250,000 is to be transferred to the seller upon each regulatory approval of an Evaxion product utilizing the in-licensed technology. Also, we will owe PharmaJet customary royalties in the low single digits based on net commercial sales of any products derived from our product candidates for so long as we continue to use in our product candidates the intellectual property and products licensed from PharmaJet pursuant to the PharmaJet License Agreement. The PharmaJet License Agreement will remain in effect for an initial period until successful </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">104</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">completion of the first Phase&#160;1/2a clinical study of our product candidate in combination with the PharmaJet product with the option to extend the term for additional 10&#160;years, after which the term will automatically extend for successive periods of 24&#160;months if not terminated prior to the beginning of each such subsequent extension. Either party may terminate the agreement upon six&#160;months prior notice with effect immediately prior to a subsequent extension term. Either party may terminate the agreement with immediate effect upon written notice to the other party due to a material breach by the other party. Moreover, we may terminate the agreement in the event of i) change of control or divestment, ii) regulatory action taken by the FDA or EMA, iii) termination of development of our product in combination with PharmaJet product or iv) if PharmaJet undergoes a change of control to a third party who does not agree to continue to supply us PharmaJet product. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Trade secret protection</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain of our technologies, including in particular certain proprietary manufacturing processes or technologies and/or AI-based prediction technologies, are protected as trade secrets. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to patent protection, we rely upon unpatented trade secrets and confidential know-how and continuing technological innovation to develop and maintain our competitive position. We protect certain of our technologies, including but not limited to algorithms and software, from becoming public knowledge. However, trade secrets and confidential know-how are difficult to protect. We seek to protect our proprietary information, in part, by using confidentiality agreements with any future collaborators, scientific advisors, employees and consultants, invention assignment agreements with our employees and internal processes for handling trade-secrets. These agreements may not provide meaningful protection. These agreements may also be breached, and we may not have an adequate remedy for any such breach. In addition, our trade secrets and/or confidential know-how may become known or be independently developed by a third party or misused by any collaborator to whom we disclose such information. Despite any measures taken to protect our intellectual property, unauthorized parties may attempt to copy aspects of our products or to obtain or use information that we regard as proprietary. Although we take steps to protect our proprietary information, third parties may independently develop the same or similar proprietary information or may otherwise gain access to our proprietary information. As a result, we may be unable to meaningfully protect our trade secrets and proprietary information. See &#8220;Risk Factors&#8201;&#8212;&#8201;Risks Related to our Intellectual Property&#8221; for a more comprehensive description of risks related to our intellectual property. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Competition</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We compete in an industry characterized by rapidly advancing technologies, intense competition and a complex intellectual property landscape. We face substantial competition from many different sources, including large and specialty pharmaceutical and biotechnology companies, academic research institutions and governmental agencies and public and private research institutions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">AI-Immunology&#8482; platform</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We face competition from several companies developing AI platforms and software including Schrodinger, BenevolentAI, Atomwise, AI Therapeutics, Insilico Medicine, Recursion Pharmaceuticals, Lantern Pharma, Adaptive Biotechnologies, Immatics, BIOVIA, and Citrine, among others. However, because most of these companies are not focused on developing therapeutic drug candidates centered around neoantigens, ERV antigens or bacteria or viral antigens, we do not consider the majority of them to be our direct competitors. Below is a description of the companies we consider to be our main competitors for each of our three AI models and their respective indications. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">PIONEER&#8482;&#8201;&#8212;&#8201;Neoantigen vaccines</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The immuno-oncology therapeutics landscape in general is highly competitive and includes large and specialty pharmaceutical and biotechnology companies, academic research institutions and governmental agencies and public and private research institutions. It includes both competition from marketed therapies as well as potential new therapeutics in development. We may compete with products with different mechanisms of action as well as against established standards of care. Well-established companies such as AstraZeneca, Amgen, Bristol-Myers Squibb, Celgene, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceuticals, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">105</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:72pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Merck &amp; Co., Novartis, Pfizer, Roche and Sanofi are developing diversified immuno-oncology programs and have substantial resources. Smaller companies are also developing immuno-oncology drugs, such as Jounce Therapeutics, Arcus Biosciences, ALX Oncology, iTeos Therapeutics and Five Prime Therapeutics, among others. We expect our vaccine candidates for the treatment of solid tumors to face direct competition from companies such as Moderna in collaboration with Merck &amp; Co., BioNTech SE in collaboration with Roche and Nykode in collaboration with Roche. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We also expect to face competition from smaller specialized oncology companies active in the neoantigen/ personalized cancer therapy space including Agenus, Gritstone Bio, Achilles Therapeutics, NousCom, Immunetune, ISA Pharmaceuticals, PACT Pharma, PersImmune, and Geneos Therapeutics. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">EDEN&#8482;&#8201;&#8212;&#8201;B-cell antigen vaccines</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our main competitors taking a prophylactic approach to bacterial diseases are BioNTech SE, GlaxoSmithKline, Pfizer and Sanofi Pasteur. Additional competitors within the bacterial disease space include well-established pharmaceutical companies including AbbVie, Bayer, Gilead, Janssen Pharmaceuticals, Merck &amp; Co. and Novartis. In addition, Seqirus UK, Biomedical Corp. of Quebec and AstraZeneca produce vaccines. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">RAVEN&#8482;&#8201;&#8212;&#8201;T-cell antigen vaccines</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our plans to leverage our RAVEN platform to develop vaccines against viral diseases will put us in competition with several other companies focused on viral vaccines including Moderna, BioNTech, CureVac, Novavax, Johnson &amp; Johnson, GSK, Merck &amp; Co. and AstraZeneca. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Many of our competitors and potential competitors, either alone or with their collaborators, have greater scientific, research and product development capabilities as well as greater financial, marketing, sales and human resources and experience than we do. In addition, smaller or early-stage companies, including immunotherapy-focused therapeutics companies, may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. Some of our collaborators may also be competitors within the same market or other markets. Accordingly, our competitors may be more successful than us in developing and potentially commercializing technologies and achieving widespread market acceptance. In addition, our competitors may design technologies that are more efficacious, safer or more effectively marketed than ours or have fewer side effects or may obtain regulatory approvals more quickly than we are able to, which could eliminate or reduce our commercial potential. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We anticipate that the key competitive factors affecting our technologies will be efficacy, safety, cost, speed and convenience. The availability of reimbursement from government and other third-party payors will also significantly affect the pricing and competitiveness of our products. The timing of market introduction of our products and competitive products will also affect competition among products. We expect the relative speed with which we can develop our products, complete the clinical trials and approval processes, and supply commercial quantities of the products to the market to be important competitive factors. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">106</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:155.5pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employees</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">As of December&#160;13, 2024, we had 44 full-time employees. The following tables provide breakdowns of our full-time equivalent employees as of December&#160;13, 2024 by function: </font>
          </div>


          <table style="width:416pt;height:83.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:377.08pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.16pt;">Function </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Number </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:377.08pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Clinical Research &amp; Development </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">4</td>
              <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:377.08pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Scientific Research &amp; Development </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">20 </td>
              <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:377.08pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Supporting Functions </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">17</td>
              <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:377.08pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Commercial &amp; Business Development </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">3</td>
              <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:377.08pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">TOTAL</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">44</td>
              <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">None of our employees have engaged in any labor strikes. We have no collective bargaining agreements with our employees. We consider our relationship with our employees to be positive and have not experienced any major labor disputes. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Organizational Structure</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Evaxion was formed as a private limited liability company organized under Danish law on August&#160;11, 2008 and re-registered as a public limited liability company on March&#160;29, 2019. Certain of our operations are conducted through our wholly owned subsidiaries, Evaxion Biotech Australia PTY LTD (Australia) and Evaxion Biotech, Inc., in Australia and the United States, respectively, both of which are listed in Exhibit&#160;8.1 to this prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Property and Equipment</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In October&#160;2020, the Company entered into a lease for approximately 1,356 square meters, which is allocated on 839 square meters of office space, and 518 square meters of laboratory space in H&#248;rsholm, Denmark. The commencement date for the lease of the 839 square meters of office space was February&#160;1, 2021 and the lease continues for a term of 10&#160;years from that date. The commencement date for the lease of the laboratory space is August&#160;13, 2021 and the lease continues for a term of 10&#160;years. Both leases have a subsequent 12-month cancellation notice period. The lease agreement contains an early termination provision which would trigger a termination fee of $2.7&#160;million. Through-out the term, the lease is subject to annual increases ranging from two to four&#160;percent on the annual lease payment amount. As of January&#160;1</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">st</font><font style="letter-spacing:0.2pt;">, 2024, the monthly payment is approximately $28,221, which consists of $11,740 for the office space and approximately $16,481 for the laboratory space. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Unresolved Staff Comments</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">None.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">107</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMAN">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MANAGEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Directors, Senior Management and Employees</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Directors and Senior Management</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have a two-tier governance structure consisting of a board of directors and an executive management team. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Executive Management</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth certain information relating to our executive management as of the date of November 01, 2024. </font>
        </div>
        <table style="width:416pt;height:83.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222.75pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:13.25pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Age </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:156pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Position(s) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:222.75pt;">
              <font style="letter-spacing:-0.2pt;">Executive Management:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:13.25pt;text-align:center;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:156pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:222.75pt;">
              <font style="letter-spacing:0.2pt;">Christian Kanstrup, MSc</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:13.25pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">52 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:156pt;">
              <font style="letter-spacing:0.2pt;">Chief Executive Officer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:222.75pt;">
              <font style="letter-spacing:0.2pt;">Thomas Frederik Schmidt, MSc</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:13.25pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">53 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:156pt;">
              <font style="letter-spacing:0.2pt;">Chief Financial Officer (interim) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:222.75pt;">
              <font style="letter-spacing:0.2pt;">Birgitte R&#248;n&#248;, Ph.D. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:13.25pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">47 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:156pt;">
              <font style="letter-spacing:0.2pt;">Chief Scientific Officer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:222.75pt;">
              <font style="letter-spacing:0.2pt;">Andreas Holm Mattsson </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:13.25pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">49 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:156pt;">
              <font style="letter-spacing:0.2pt;">Chief AI Officer</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Mr.&#160;Kanstrup entered into an agreement to join us on August&#160;24, 2023, and joined us on September&#160;1, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(2)</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Mr.&#160;Schmidt joined us on November 01, 2024. Mr.&#160;Jesper Nissen held the position before, Mr.&#160;Nissen resigned, which resignation was effective on October&#160;31, 2024. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a brief summary of the prior business experience of the members of our executive management: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our Chief Executive Officer, Christian Kanstrup joined us on September&#160;1, 2023. Christian Kanstrup has more than 25&#160;years of experience in the life science industry, coming from a position of Executive Vice President at Mediq before joining Evaxion. Prior to that, Christian held a broad range of senior management roles at Novo Nordisk A/S, latest as Senior Vice President and global head of Biopharm Operations. Prior to that Christian among others held senior leadership roles within the commercial part of the business as well as within strategy and corporate development. Christian also holds various board and advisory positions in the life science industry, advising on corporate strategy and company growth. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Jesper Nyegaard Nissen joined as Chief Operating Officer in 2022 and was also appointed interim Chief Financial Officer in 2023. For over 25&#160;years, Jesper Nyegaard Nissen has worked broadly across the pharma value chain in global operations positions at Novo Nordisk anchored in research and finance. He has covered business areas across a variety of focus points, including finance operation, external innovation&#160;and collaborations, digitalization of business process optimization, development and shaping of organizational capacities, and implementation of performance and process improvement structures. On July&#160;31, 2024, Mr.&#160;Nissen tendered his resignation as the Chief Operating Officer and Interim Chief Financial Officer, to be effective October&#160;31, 2024. Mr.&#160;Nissen&#8217;s resignation was for personal reasons and was not a result of any disagreement with the Company on any matter relating to the Company&#8217;s operations, policies or practices. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has appointed Thomas Frederik Schmidt to assume Mr.&#160;Nissen&#8217;s responsibilities as the Interim Chief Financial Officer. Mr.&#160;Schmidt brings more than 30&#160;years of financial management experience from across different industries with more than 25&#160;years of these being based in the life science industry including roles as country Managing Director and country Chief Financial Officer in Roche and Group CFO in Ambu. Ambu is a MedTech company listed on the Nasdaq Copenhagen Stock Exchange. Mr.&#160;Schmidt holds a Master of Science in Business Economics and Auditing from Copenhagen Business School and has undergone training and preparation for State Authorized Public Accountant (CPA) exam. Mr.&#160;Schmidt succeeded Mr.&#160;Nissen as the Company&#8217;s Interim CFO as of November&#160;1, 2024. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">108</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:39.79pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our Chief Science Officer, Birgitte R&#248;n&#248;, joined in 2017 and was appointed CSO in 2021. Dr.&#160;R&#248;n&#248; has more than 20&#160;years&#8217; of experience in biopharmaceutical drug discovery from academia and industry and received her PhD in experimental oncology and immunology from National Institutes of Health, Bethesda, USA, and Copenhagen University Hospital, Denmark. Prior to joining Evaxion, Birgitte R&#248;n&#248; served as a specialist, team leader and project manager at Novo Nordisk A/S, where she was leading early drug discovery projects, evaluating in-licensing opportunities, and supporting drug development projects with pre-clinical and biomarker expertise. Andreas Holm Mattsson serves as Chief AI Officer at Evaxion Biotech, where he&#8217;s been at the forefront in silico-based vaccine target discovery. He has played a key role in developing Evaxion&#8217;s innovative AI-Immunology</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> platform, a proprietary AI technology for identifying novel vaccine targets for cancer and infectious diseases. Andreas brings a strong educational background in bioinformatics from the Technical University of Denmark and has previously worked at Novo Nordisk. Since founding Evaxion in 2008, he has been an essential part of the company&#8217;s growth, serving in various executive roles. In August&#160;2023, Per Norl&#233;n, our Chief Executive Officer, or CEO, stepped down and Christian Kanstrup assumed Per Norl&#233;n duties as CEO. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In July&#160;2023 Bo Karmark, our Chief Financial Officer, or CFO, stepped down and Jesper Nyegaard Nissen assumed Bo Karmarks duties as CFO. In March&#160;2023, Dr.&#160;Erik Deichmann Heegaard, our Chief Medical Officer, or CMO, at the time stepped down and Dr.&#160;Norl&#233;n along with our Vice President of Clinical Development assumed Dr.&#160;Heegaard&#8217;s duties as CMO. In August&#160;2023, Birgitte R&#248;n&#248; our Chief Scientific Officer assumed the duties as CMO along with an external consultant. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Family Relationships</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There are no family relationships among any of our directors and/or executive management. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compensation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compensation of Executive Management and Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Please refer to Item&#160;6. Directors, Senior Management and Employees from our 2023 Form 20-F, which has been incorporated by reference in this prospectus for further information including regarding the compensation of our executive management and directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Further to this in May&#160;2024, all employees, management and board members were granted additional warrants. Details for Management and Board warrants are provided below. In January&#160;2024, cash bonuses related to 2023 performance were paid out. Overview of these is also included below. </font>
        </div>
        <table style="width:416pt;height:62.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:256.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Management </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:31.14pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Warrants</font>
                <br >
                <font style="letter-spacing:-0.16pt;">granted </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:46.38pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exercise price</font>
                <br >
                <font style="letter-spacing:-0.16pt;">USD </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:45.62pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Expiration</font>
                <br >
                <font style="letter-spacing:-0.16pt;">date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:256.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Andreas Holm Matsson (CAIO) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">25,000</td>
            <td style="padding:0pt;padding-left:1.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">0.4</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">31/12/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:256.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Birgitte R&#248;n&#248; (CSO) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">50,000</td>
            <td style="padding:0pt;padding-left:1.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">0.4</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">31/12/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:256.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Christian Kanstrup (CEO) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,668</td>
            <td style="padding:0pt;padding-left:1.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">0.4</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">31/12/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:416pt;height:77.5pt;margin-left:20pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:256.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Board </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:31.14pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Warrants</font>
                <br >
                <font style="letter-spacing:-0.16pt;">granted </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:46.38pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exercise price</font>
                <br >
                <font style="letter-spacing:-0.16pt;">USD </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:45.62pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Expiration</font>
                <br >
                <font style="letter-spacing:-0.16pt;">date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:256.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Marianne S&#248;egaard </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:1.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">0.4</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">31/12/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:256.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Roberto Prego Pineda </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">20,000</td>
            <td style="padding:0pt;padding-left:1.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">0.4</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">31/12/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:256.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lars Holtug </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">20,000</td>
            <td style="padding:0pt;padding-left:1.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">0.4</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">31/12/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:256.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Niels Iversen M&#248;ller </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">20,000</td>
            <td style="padding:0pt;padding-left:1.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">0.4</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">31/12/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">109</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:416pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Management 2023 Performance Bonus (Thousand USD)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:416pt;height:175pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:394pt;">
              <font style="letter-spacing:-0.2pt;">Christian Kanstrup (CEO)</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:10pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:394pt;">
              <font style="letter-spacing:0.2pt;">Bonus </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:10pt;">
              <font style="letter-spacing:0.2pt;">12 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:394pt;">
              <font style="letter-spacing:-0.2pt;">Bo Karmark (CFO)</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:10pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:394pt;">
              <font style="letter-spacing:0.2pt;">Bonus </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:10pt;">
              <font style="letter-spacing:0.2pt;">65 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:394pt;">
              <font style="letter-spacing:-0.2pt;">Jesper Nygaard Nissen (COO and CFO)</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:10pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:394pt;">
              <font style="letter-spacing:0.2pt;">Bonus </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:10pt;">
              <font style="letter-spacing:0.2pt;">27 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:394pt;">
              <font style="letter-spacing:-0.2pt;">Andreas Holm Mattsson (CAIO)</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:10pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:394pt;">
              <font style="letter-spacing:0.2pt;">Bonus </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:10pt;">
              <font style="letter-spacing:0.2pt;">12 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:394pt;">
              <font style="letter-spacing:-0.2pt;">Erik Deichmann Heegaard, Ph.D., DMSc (CMO)</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:10pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:394pt;">
              <font style="letter-spacing:0.2pt;">Bonus </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:10pt;">
              <font style="letter-spacing:0.2pt;">29 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:394pt;">
              <font style="letter-spacing:-0.2pt;">Birgitte R&#248;n&#248;, Ph.D. (CSO)</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:10pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:394pt;">
              <font style="letter-spacing:0.2pt;">Bonus </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:10pt;">
              <font style="letter-spacing:0.2pt;">23</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">110</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSHOW">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SHARE OWNERSHIP</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Major Shareholders</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The following table presents information, as of December&#160;13, 2024, regarding the beneficial ownership of our ordinary shares: (i)&#160;prior to the consummation of the offering and (ii)&#160;as adjusted to reflect the sale of the ADSs representing ordinary shares in the offering (assuming none of the persons or entities listed below purchases any ADSs in this offering), for: </font>
          </div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">each person, or group of affiliated persons, known by us to own beneficially 5% or more of our outstanding ordinary shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">each of our directors and members of our executive management individually; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">each of our directors and members of our executive management as a group. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The number of ordinary shares beneficially owned by each entity, person, and member of our board of directors or members of our executive management is determined in accordance with the rules of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any ordinary shares over which the individual has sole or shared voting power or investment power as well as any ordinary shares that the individual has the right to acquire within 60&#160;days of December&#160;13, 2024 through the exercise of any option, warrant or other right. Except as otherwise indicated, and subject to applicable community property laws, the people named in the table have sole voting and investment power with respect to all ordinary shares held by that person. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The&#160;percentage of outstanding ordinary shares is computed on the basis of ordinary shares, DKK 1 nominal value per share, each outstanding as of December&#160;13, 2024. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The&#160;percentage of shares beneficially owned on an as adjusted basis after the offering is based on shares to be outstanding after the offering after giving effect to the completion of this offering, assuming no issuance of pre-funded warrants in this offering, Ordinary shares that a person has the right to acquire within 60&#160;days of December&#160;13, 2024 are deemed outstanding for purposes of computing the&#160;percentage ownership of the person holding such rights, but are not deemed outstanding for purposes of computing the&#160;percentage ownership of any other person, except with respect to the&#160;percentage ownership of all members of our board of directors or executive management as a group. None of our shareholders have different voting rights from other shareholders. We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our company. Unless otherwise indicated, the business address for each beneficial owner is Dr.&#160;Neergaards Vej 5F, 2970 H&#248;rsholm, Denmark. </font>
          </div>


          <table style="width:456pt;height:227pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;" colspan="10">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Before Offering </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;" colspan="10">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">After Offering </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt; width:277.02pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.16pt;">Name of Beneficial Owner </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Number </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Percent </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Number </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Percent </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.25pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">5</font><font style="font-style:italic;letter-spacing:0.2pt;">% or Greater Shareholders</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Niels M&#248;ller</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,329,017</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">7.4</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,329,017</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">3.2 </td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Mattsson Holding af 2008 ApS</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,142,521</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">7.1</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,142,521</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">3.1 </td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Merck Global Innovation Fund&#160;LLC</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">7,720,588</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">12.7</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">7,720,588</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">5.6 </td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Armistice Capital LLC</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">5,552,770</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">9.5</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">5,552,770</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">4.1 </td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">Executive Management</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Christian Kanstrup</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,544,181</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.6</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,544,181</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">1.1 </td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Andreas Holm Mattsson</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,285,657</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">7.3</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,285,657</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">3.2 </td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Birgitte R&#248;n&#248;</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(6)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">182,306</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">182,306</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">Directors</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Roberto Prego</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(7)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">557,822</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.0</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">557,822</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">0.4 </td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Lars Holtug</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(8)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">176,644</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">176,644</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Marianne S&#248;gaard</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(9)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,770,803</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.0</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,770,803</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">1.3 </td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Lars Staal Wegner</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(10)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">681,842</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.2</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">681,842</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">0.5 </td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2pt 0pt 0.5pt 0pt; width:277.02pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">All current directors and executive management, as a group </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">(7 persons) </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">9,272,785</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">15.1</td>
              <td style="padding:0pt;padding-left:3.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">9,272,785</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">6.7</td>
              <td style="padding:0pt;padding-left:6.18pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">111</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Represents beneficial ownership of less than 1% </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 4,232,893 ordinary shares held by NIMedical Holding ApS, which is a personal investment company wholly-owned by Dr.&#160;M&#248;ller. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 4,142,521 ordinary shares held by Mattsson Holding af 2008 ApS, which is a personal investment company wholly-owned by Mr.&#160;Mattsson. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(3)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Includes 2,297,704 shares subject to Warrants that are exercisable within 60&#160;days of December&#160;13,&#160;2024. Does not include 3,125,000 shares subject to Series&#160;A Warrants that are not exercisable within 60&#160;days of December&#160;13, 2024, due to a beneficial ownership blocker in the Series&#160;A Warrants limiting beneficial ownership to 9.99%. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 5,552,770 ordinary shares held by Armistice Capital LLC. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(5)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Include 808,887 shares subject to Warrants that are exercisable within 60&#160;days of December&#160;13, 2024. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(6)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Include 145,541 shares subject to Warrants that are exercisable within 60&#160;days of December&#160;13, 2024. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(7)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Include 155,662 shares subject to Warrants that are exercisable within 60&#160;days of December&#160;13, 2024. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(8)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Include 103,115 shares subject to Warrants that are exercisable within 60&#160;days of December&#160;13, 2024. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(9)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Include 953,788 shares subject to Warrants that are exercisable within 60&#160;days of December&#160;13, 2024. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(10)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Include 644,953 shares subject to Warrants that are exercisable within 60&#160;days of December&#160;13, 2024. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Holdings by United States Shareholders</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">As of December&#160;13, 2024, approximately four&#160;percent (4%) of our issued and outstanding ordinary shares were held by ten (10) United States record holders. The number of individual holders of record is based exclusively upon our share register and does not address whether a share or shares may be held by the holder of record on behalf of more than one person or institution who may be deemed to be the beneficial owner of a share or shares in our company. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Significant Changes in Percentage Ownership</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our company. To Evaxion&#8217;s knowledge, and other than changes in&#160;percentage ownership as a result of the shares issued in connection with Evaxion&#8217;s initial public offering in the United States, there has been no significant change in the&#160;percentage ownership held by the major shareholders listed above in the last three&#160;years, except as discussed below in &#8220;Related Party Transactions.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Related Party Transactions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Below is a summary of our grants, agreements, and transactions since January&#160;1, 2021 in which the amount involved exceeded or will exceed $120,000, and in which any of our then directors, executive management or holders of more than 10% of any class of our voting securities at the time of such transaction, or any members of their immediate family, had or will have a direct or indirect material interest. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Share-based Awards to Directors and Executive Management </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have granted share-based awards to certain of our directors and executive management. For more information regarding the warrants granted to our executive management and directors see the section herein entitled &#8220;Warrant Incentive Plan&#8221;. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Employment Agreements and Indemnification Agreements </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have entered employment agreements with each member of our executive management and intend to enter into indemnification agreements with each member of our executive management and each of our directors. For more information see the sections herein entitled &#8220;Compensation of Executive Officers and Directors&#8221; and &#8220;Insurance and indemnification.&#8221; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">112</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:408pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Policies and Procedures for Related Person Transactions </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to our IPO, we have not had a formal policy regarding approval of transactions with related parties. We have adopted a related person transaction policy setting forth the policies and procedures for the identification, review and approval or ratification of related person transactions. This policy covers, with certain exceptions set forth in Item&#160;404 of Regulation&#160;S-K under the Securities Act, any transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships, in which we and a related person were or will be participants and the amount involved exceeds $120,000, including purchases of goods or services by or from the related person or entities in which the related person has a material interest, indebtedness and guarantees of indebtedness. In reviewing and approving any such transactions, our audit committee will consider all relevant facts and circumstances as appropriate, such as the purpose of the transaction, the availability of other sources of comparable products or services, whether the transaction is on terms comparable to those that could be obtained in an arm&#8217;s length transaction, management&#8217;s recommendation with respect to the proposed related person transaction, and the extent of the related person&#8217;s interest in the transaction. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interests of Experts and Counsel</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Not applicable.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">113</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOSC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF SHARE CAPITAL AND ARTICLES OF ASSOCIATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The following describes our issued share capital, summarizes the material provisions of our articles of association and highlights certain differences in corporate law in the Kingdom of Denmark and Delaware corporate law, the law under which many publicly listed companies in the United States are incorporated. Please note that this summary is not intended to be exhaustive. For further information, please refer to the full version of our articles of association, which are included as an exhibit to the registration statement of which this prospectus is a part.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Introduction</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Set forth below is a summary of certain information concerning our share capital as well as a description of certain provisions of our articles of association and relevant provisions of the Danish Companies Act. The summary includes certain references to and descriptions of material provisions of our articles of association to be effective in connection with the consummation of the offering and Danish law in force as of the date of this prospectus. The summary below contains only material information concerning our share capital and corporate status and does not purport to be complete and is qualified in its entirety by reference to our articles of association. Further, please note that as an ADS holder you will not be treated as one of our shareholders and will not have any shareholder rights. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We were incorporated under the laws of Denmark on August&#160;11, 2008, as a private limited liability company (in Danish: </font><font style="font-style:italic;letter-spacing:0.2pt;">Anpartsselskab</font><font style="letter-spacing:0.2pt;">, or </font><font style="font-style:italic;letter-spacing:0.2pt;">ApS</font><font style="letter-spacing:0.2pt;">) and are registered with the Danish Business Authority (in Danish: </font><font style="font-style:italic;letter-spacing:0.2pt;">Erhvervsstyrelsen</font><font style="letter-spacing:0.2pt;">) in Copenhagen, Denmark under registration number 31762863. On March&#160;29, 2019, our company was converted into a public limited liability company (in Danish: </font><font style="font-style:italic;letter-spacing:0.2pt;">Aktieselskab</font><font style="letter-spacing:0.2pt;">, or </font><font style="font-style:italic;letter-spacing:0.2pt;">A/S</font><font style="letter-spacing:0.2pt;">). The ADSs were publicly listed for trading on The Nasdaq Capital Market under the symbol &#8220;EVAX&#8221; on February&#160;5, 2021. Our principal executive offices are located at Dr.&#160;Neergaards Vej 5f, DK-2970 H&#248;rsholm, Denmark and our telephone number is + 45 53 53 18 50. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our website address is www.evaxion-biotech.com. The information on, or that can be accessed through, our website is not part of and is not incorporated by reference into this prospectus. We have included our website address as an inactive textual reference only. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Development of the Share Capital</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As December&#160;13, 2024, our registered, issued and outstanding share capital was nominal DKK 58,660,556 divided into 58,660,556 ordinary shares of DKK 1. The development of our share capital since December&#160;31, 2016 to December&#160;13, 2024 is set forth in the table below. The below Price Per Share (DKK) is based on the registrations with the Danish Business Authority. </font>
          </div>

        <table style="width:456pt;height:191.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:240pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Transaction </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Share Capital</font>
                <br >
                <font style="letter-spacing:-0.16pt;">After</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Transaction </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Price Per</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Share (DKK)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Rounded) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">August&#160;2008 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Formation (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">250,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">March&#160;2014 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">268,148</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">120.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">December&#160;2014 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">316,751</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">178.22</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">December&#160;2015 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">336,549</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">435.76</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">March&#160;2016 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">342,880</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">432.12</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">September&#160;2017 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">358,806</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,034.75</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">March&#160;2019 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Transfer of reserves (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">717,612</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">July&#160;2019 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:justify;">
              <div style="white-space:nowrap; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Cash contribution and debt conversion (Nominal DKK&#160;2) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">836,994</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">914.71(avg<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">December&#160;2019 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">843,564</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,037.50</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">September&#160;2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">884,974</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,002.90</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">October&#160;2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">899,926</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,008.45</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">114</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:653.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:240pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Transaction </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Share Capital</font>
                <br >
                <font style="letter-spacing:-0.16pt;">After</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Transaction </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Price Per</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Share (DKK)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Rounded) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">January&#160;2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Share split 2-for-1 (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">899,926</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">January&#160;2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Bonus share issuance 17-for-1(Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">16,198,668</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Initial public offering (3,000,000 ADSs / 3,000,000 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">19,198,668</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">61.99</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">November&#160;2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Follow-on public offering (3,942,856 ADSs / 3,942,856 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">23,141,524</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">45.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">November&#160;2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">23,184,656</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">November&#160;2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">23,203,808</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">April&#160;2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">23,257,880</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">June&#160;2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">23,350,193</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">June&#160;2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash Contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">23,387,858</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">June&#160;2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Conversion of Debt (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">23,816,430</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">19.54</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">June&#160;2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash Contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">23,833,694</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">August&#160;2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash Contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">23,926,007</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">August&#160;2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash Contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">23,967,092</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">September&#160;2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash Contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">23,977,928</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">October&#160;2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">JonesTrading Sales Agreement (23,405 ADSs / 23,405 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">24,001,333</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">21.67</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">October&#160;2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">JonesTrading Sales Agreement (26,396 ADSs / 26,396 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">24,027,729</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">21.83</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">October&#160;2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">JonesTrading Sales Agreement (64,601 ADSs / 64,601 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">24,092,330</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">22.60</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">December&#160;2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">24,134,963</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">December&#160;2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">JonesTrading Sales Agreement (4,450 ADSs / 4,450 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">24,139,413</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">15.62</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">January&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">JonesTrading Sales Agreement (186,584 ADSs / 186,584 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">24,325,997,</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">13.82</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">January&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">JonesTrading Sales Agreement (447,829 ADSs / 447,829 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">24,773,826,</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">13.40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">January&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">JonesTrading Sales Agreement (94,278 ADSs / 94,278 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">24,868,104</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">12.59</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">January&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">JonesTrading Sales Agreement (259,407 ADSs / 259,407 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">25,127,511</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">12.24</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">January&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">JonesTrading Sales Agreement (79,657 ADSs / 79,657 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">25,207,168</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">11.47</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">January&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">JonesTrading Sales Agreement (71,678 ADSs / 61,678 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">25,278,846</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">11.19</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">JonesTrading Sales Agreement (96,271 ADSs / 96,271 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">25,375,117</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">12.42</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">JonesTrading Sales Agreement (1,003,802 ADSs / 1,003,802 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">26,378,919</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">13.86</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">JonesTrading Sales Agreement (42,808 ADSs / 42,808 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">26,421,727</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">11.79</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">March&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">JonesTrading Sales Agreement (16,280 ADSs 16,280 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">26,438,007</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.94</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">115</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:635.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:240pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Transaction </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Share Capital</font>
                <br >
                <font style="letter-spacing:-0.16pt;">After</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Transaction </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Price Per</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Share (DKK)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Rounded) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">May&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash Contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">26,572,737</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">May&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash Contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">26,623,862</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">June&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash Contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">26,773,862</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">June&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">JonesTrading Sales Agreement (861,614 ADSs* / 861,614 new share issue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">27,635,476</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">12.03</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">June&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash Contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">27,640,300</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">July&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (11,348 ADSs* / 11,348 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">27,651,648</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8,43</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">September&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash Contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">27,662,484</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">September&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (54,099 ADSs* / 54,099 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">27,716,583</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.50</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">September&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (51,750 ADSs* / 51,750 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">27,768,333</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.33</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">September&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (45,807 ADSs* / 45,807 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">27,814,140</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.29</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">October&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (54,829 ADSs* / 54,829 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">27,868,969</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.04</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">November&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (50,281 ADSs* / 50,281 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">27,919,250</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7.92</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">November&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (19,387 ADSs* / 19,387 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">27,938,637</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4.95</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">November&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (77,119 ADSs* / 77,119 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">27,015,756</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5,08</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">November&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (43,950 ADSs* / 43,950 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">28,059,706</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.19</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">November&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (21,136 ADSs* / 21,136 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">28,080,842</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">November&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (24,316 ADSs* / 24,316 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">28,105,158</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.61</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">December&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (65,724 ADSs* / 65,724 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">28,170,882</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.63</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">December&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Capital Increase (PIPE) (9,726,898 ADSs* / 9,726,898 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">37,897,780</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3.71</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">January&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash Contribution (Nominal DKK1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">37,906,996</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">January&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (263,355 ADSs / 2,633,550 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">40,540,546</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.73</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Public offering (445,000 ADSs / 4,450,000 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">44,990,546</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.76</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Public offering (312,500 ADSs / 3,125,000 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">48,115,546</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.74</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">50,090,546</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">52,150,546</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">April&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash contribution (Nominal DKK 1) </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">54,110,546</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">July&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Prefunded Warrant Exercise </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">55,750,546</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">116</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:191.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:240pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Transaction </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Share Capital</font>
                <br >
                <font style="letter-spacing:-0.16pt;">After</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Transaction </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6.43pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Price Per</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Share (DKK)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Rounded) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">August&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (1,000 ADSs / 10,000 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">55,760,546</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.75</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">September&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (1,000 ADSs / 10,000 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">55,770,546</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.67</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">September&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (1,000 ADSs / 10,000 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">55,780,546</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">September&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Prefunded Warrant Exercise </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">56,850,546</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">September&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (31,618 ADSs / 316,180 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">57,166,726</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.08</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">September&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:240pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jones Trading Sales Agreement (25,383 ADSs / 253,830 new share issue) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">57,420,556</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.08</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">October&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:240pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Prefunded Warrant Exercise </font>
            </td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">58,660,556</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt; width:6.43pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.6pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Does not take into account ADS Ratio Change of January&#160;22, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Authorizations to the Board of Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">As of December&#160;13, 2024, our board of directors is authorized to increase the share capital as follows: </font>
          </div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The board of directors is until November&#160;23, 2025, authorized, on or more occasions, to issue warrants to the company&#8217;s investors entitling the holder to subscribe shares for a total of up to nominal value of DKK 706,873 without pre-emptive rights for the company&#8217;s shareholders. The exercise price for the warrants shall be equal to the nominal value of the company&#8217;s shares, currently DKK 1. The board of directors shall determine the terms for the warrants issued and distribution hereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The board of directors is until January&#160;3, 2026, authorized at one or more times to increase the company&#8217;s share capital by the issuance of new shares with up to nominal DKK 11,000,000 with pre- emptive subscription rights for the company&#8217;s shareholders. Capital increases according to this authorization shall be carried out by the board of directors by way of cash contributions. The shares may be issued at market price or at a discount price as determined by the board of directors. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The board of directors is until January&#160;3, 2026, authorized at one or more times to obtain loans against issuance of convertible loan notes which give the right to subscribe for shares for a total of up to nominal value of DKK 14,700,000 without pre-emptive subscription rights for the company&#8217;s shareholders. The conversion shall be carried out at a price that corresponds in aggregate to at least the market price at the time of the decision of the board of directors. Shares shall be considered issued at market price if the shares are issued at +/-10 of the listed price for the company&#8217;s shares on a relevant stock exchange in Europe or the USA. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The board of directors is until April&#160;15, 2029, authorized at one or more times to issue warrants to members of our board of directors and executive management, as well as to key employees, and to increase our share capital by up to nominal DKK 9,461,540 without preemptive subscription rights for existing shareholders in connection with the exercise, if any, of said warrants and to determine the terms and conditions thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The board of directors is until 15 April&#160;2029 authorized at one or more times to issue warrants to investors, lenders, consultants and/or advisors in the company or its subsidiaries entitling the holder to subscribe for shares for a total of up to nominal value of DKK 84,905,000 without pre-emptive subscription rights for the company&#8217;s shareholders. The exercise price for the warrants issued shall at the time of issuance be determined by the board of directors at market price or at a discount price. The board of directors shall determine the terms for the warrants issued and the distribution hereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The board of directors is until May&#160;1, 2027, authorized at one or more times to increase the company&#8217;s share capital by up to nominal DKK 76,689,990 without pre-emptive subscription rights </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">117</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">for the company&#8217;s shareholders. Capital increases according to this authorization must be carried out by the board of directors by way of cash contributions. The shares may be issued at market price or at a discount to the listed price of the ADSs as determined by the board of directors. The board of directors is authorized to make the required amendments to the articles of association if the authorization to increase the share capital is used and to cause such shares to be deposited with a depositary bank and the simultaneous issuance of ADSs representing such shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The ADSs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Trades in ADSs are settled through The Depository Trust Company, or DTC, in accordance with its customary settlement procedures for equity securities. Each person owning ADSs held through DTC must rely on the procedures thereof and on institutions that have accounts therewith to exercise any rights of a holder of the ADSs. The ADSs are listed for trading on The Nasdaq Capital Market under the symbol &#8220;EVAX.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Warrants</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have established warrant programs for members of our board of directors, our executive management, other employees, consultants and advisors. Under the terms of our warrant plans, warrants are issued to our directors, executive management and employees, on a discretionary basis following consultation with and recommendation from our Compensation Committee. All warrants have been issued by the general meeting or by our board of directors pursuant to valid authorizations in our articles of association and the terms and conditions have, in accordance with the Danish Companies Act, been incorporated in our articles of association. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The description below merely contains a summary of the applicable terms and conditions and does not purport to be complete. As of December&#160;13, 2024, we have issued and outstanding 3,107,061 warrants (excluding (1)&#160;the 373,127 warrants issued to the European Investment Bank, or EIB, as described below and in the section herein entitled &#8220;EIB Warrants&#8221; and (2)&#160;50,000 warrants issued to an consultant related to the Company on September&#160;19, 2023, (3)&#160;9,726,898 warrants to investors as part of a direct offering in December&#160;2023 described below in the section entitled &#8220;Investor warrants, December&#160;21, 2023&#8221;, and (4)&#160;39,375,000 ordinary warrants and 19,980,000 prefunded warrants to investors and placement agent as part of a public offering in February&#160;2024 described below in the section entitled &#8220;Public Offering Investor warrants, February, 2024&#8221;, (5)&#160;50,000 warrants issued to an consultant related to the Company on May&#160;7, 2024, and (6)&#160;1,450,000 warrants issued to consultants related to the Company on August&#160;20, 2024). Each such warrant confers upon the holder thereof the right to subscribe to nominal DKK 1 share. Our warrants have previously been granted, on the dates, and with exercise prices as set forth below: </font>
          </div>


          <table style="width:456pt;height:212.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:126.91pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.16pt;">Grant Date </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:117.45pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Vesting Period </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:81.04pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Expiration</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Date </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:42.18pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Exercise</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Price </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Number of</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">warrants </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 0.5pt 0pt; width:126.91pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;19, 2016 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; width:117.45pt;">
                <font style="letter-spacing:0.2pt;">Upon IPO Event </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2036 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">DKK 1.0 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:24.75pt; white-space:nowrap;text-align:center;">758,448</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:126.91pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;10, 2017 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:117.45pt;">
                <font style="letter-spacing:0.2pt;">Upon IPO Event </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2036 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">DKK 1.0 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; white-space:nowrap;text-align:center;">632,700</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:126.91pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;19, 2017 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:117.45pt;">
                <font style="letter-spacing:0.2pt;">Upon IPO Event </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2036 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">DKK 1.0 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; white-space:nowrap;text-align:center;">141,804</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:126.91pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;17, 2020 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:117.45pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">See vesting principles below </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2031 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">DKK 1.0 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; white-space:nowrap;text-align:center;">757,620</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:126.91pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">June&#160;2021 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:117.45pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">See vesting principles below </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2031 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">DKK 1.0 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; white-space:nowrap;text-align:center;">62,147</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:126.91pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;7, 2021 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:117.45pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">See vesting principles below </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2031 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">USD 5.38 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; white-space:nowrap;text-align:center;">523,599</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:126.91pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">March&#160;11 2022 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:117.45pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">See vesting principles below </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2031 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">USD 2.96 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; white-space:nowrap;text-align:center;">35,000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:126.91pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">June&#160;14, 2022 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:117.45pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">See vesting principles below </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2031 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">USD 1.83 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; white-space:nowrap;text-align:center;">65,000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:126.91pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">September&#160;2022 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:117.45pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">See vesting principles below </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2031 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">USD 2.42 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; white-space:nowrap;text-align:center;">11.000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:126.91pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;2022 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:117.45pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">See vesting principles below </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2031 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">USD 2.23 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; white-space:nowrap;text-align:center;">380,612</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:126.91pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">March&#160;2023 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:117.45pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">See vesting principles below </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2031 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">USD 1.90 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; white-space:nowrap;text-align:center;">10,000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:126.91pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">September&#160;2023 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:117.45pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">See vesting principles below </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2031 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">USD 1.02 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; white-space:nowrap;text-align:center;">100,000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:126.91pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;2023 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:117.45pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">See vesting principles below </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2031 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">USD 0.75 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; white-space:nowrap;text-align:center;">216,074</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">118</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;height:131.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:126.91pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.16pt;">Grant Date </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:117.45pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Vesting Period </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:81.04pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Expiration</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Date </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:42.18pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Exercise</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Price </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Number of</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">warrants </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:justify;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:126.91pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">December&#160;2023 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:117.45pt;">
                <div style="white-space:nowrap; text-align:justify;">
                  <font style="letter-spacing:0.2pt;">See vesting principles below </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap; text-align:justify;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2031 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap; text-align:justify;">
                  <font style="letter-spacing:0.2pt;">USD 0.75 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; white-space:nowrap;text-align:center;">90,000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:justify;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.91pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">May&#160;2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:117.45pt;">
                <div style="white-space:nowrap; text-align:justify;">
                  <font style="letter-spacing:0.2pt;">See vesting principles below </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap; text-align:justify;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2031 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap; text-align:justify;">
                  <font style="letter-spacing:0.2pt;">USD 0.40 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; white-space:nowrap;text-align:center;">438,460</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:justify;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.91pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">May&#160;2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:117.45pt;">
                <div style="white-space:nowrap; text-align:justify;">
                  <font style="letter-spacing:0.2pt;">See vesting principles below </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
                <div style="white-space:nowrap; text-align:justify;">
                  <font style="letter-spacing:0.2pt;">December&#160;31, 2031 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:42.18pt;">
                <div style="white-space:nowrap; text-align:justify;">
                  <font style="letter-spacing:0.2pt;">USD 0.40 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; white-space:nowrap;text-align:center;">100,000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.91pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Exercised </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:117.45pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:81.04pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:42.18pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; white-space:nowrap;text-align:center;">(811,196<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:126.91pt;white-space:normal;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Lapsed or annulled without exercise </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:117.45pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:81.04pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:42.18pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; white-space:nowrap;text-align:center;">(404,207<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:126.91pt;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Total issued and outstanding </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">as of December&#160;13, 2024</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:117.45pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:81.04pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:42.18pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:center;">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; white-space:nowrap;text-align:center;">
                <div style="border-bottom:1px #000000 solid;padding-bottom:1pt;font-weight:bold;">3,107,061</div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-left:20pt; margin-top:16.1pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;17, 2020, we issued 757,620 warrants related to 2018&#8201;&#8211;&#8201;2020. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Vesting Principles Generally</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Warrants granted for the&#160;years 2016&#8201;&#8211;&#8201;2018 vested upon the closing of our initial public offering. Warrants granted for the&#160;years 2019 and 2020 generally vest at a rate of 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month. Vested warrants may be exercised in four annual exercise windows of two weeks each that each commence two trading days following publication of our annual report, the six-month report and the interim quarterly reports. However, our board of directors determined that the first such exercise window began November&#160;2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the 331,632 warrants granted in 2019 (issued in 2020), 117,612 warrants were fully vested on the date of grant and 214,020 warrants vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from date of grant. For the 236,196 warrants granted and issued in 2020, 120,888 warrants were fully vested on the date of issuance, 6,084 vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month starting on January&#160;1, 2020, 19,008 warrants vest three&#160;years from the date of joining us, 90,216 warrants vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month starting on January&#160;1, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">62,147 warrants granted on June&#160;17, 2021 and on October&#160;21, 2021 formally issued shall vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month and vesting shall be calculated from April&#160;1, 2021. For warrants granted on December&#160;7, 2021, 500,683 warrants vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from January&#160;1, 2022 and 22,916 warrants shall be deemed fully vested at the time of issuance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">35,000 warrants granted on March&#160;11, 2022, vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from April&#160;1, 2022. 65,000 warrants were granted on June&#160;14, 2022. 10,000 warrants vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from February&#160;1, 2022, 10,000 warrants vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from April&#160;1, 2022, and 45,000 warrants vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from June&#160;1, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11,000 warrants were granted on September&#160;15, 2022. 5,000 warrants vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from August&#160;1, 2022 and 6,000 warrants vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from August&#160;8, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For 380,612 warrants granted on December&#160;12, 2022, 2,500 warrants were fully vested per December&#160;7, 2022, 50,000 warrants vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from December&#160;7, 2022, 299,362 warrants vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from January&#160;1, 2023 and 28,750 warrants vest with 1/12 per month from January&#160;1, 2023. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10,000 warrants were granted on March&#160;15, 2023. The warrants vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from January&#160;1, 2023. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">100,000 warrants were granted on September&#160;1, 2023. The warrants vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from September&#160;1, 2023. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">90,000 warrants granted on December&#160;11, 2023. The warrants vest with 1/12</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from January&#160;1, 2024. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">216,074 warrants granted on December&#160;11, 2023. The warrants vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from January&#160;1, 2024. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">438,460 warrants granted on May&#160;1, 2024. The warrants vest with 1/36</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from May&#160;1, 2024. 100,000 warrants granted on May&#160;1, 2024. The warrants vest with 1/12</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per month from May&#160;1, 2024. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">119</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There are certain restrictions on exercise in the event that warrant holders terminate their employment or are dismissed for prior to exercise. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Adjustments</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Warrant holders are entitled to an adjustment of the number of warrants issued and/or the exercise price applicable in the event of certain changes to our share capital at a price other than the market price. Events giving rise to an adjustment include, among other things, increases or decreases to our share capital at a price below or above market value, respectively, and issuance of bonus shares. For the purpose of implementing the capital increases necessary in connection with the exercise of warrants, our board of directors has been authorized to increase our share capital by one or more issuances of shares with a total nominal value corresponding to the number of warrants issued upon cash payment of the exercise price without any preemptive subscription rights to existing shareholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Public offering Investor warrants February, 2024</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In February&#160;2024, we completed a public offering through which we offered 757,500 ADSs representing an aggregated 7,575,000 ordinary shares, DKK 1 nominal value per share, together with warrants to purchase up to 757,500 ADSs representing 7,575,000 ordinary shares. The public offering price for each ADS and accompanying warrant was $4.00. The warrants have an exercise price per ADS of $4.00 (amended to 27.52 DKK as of May&#160;23, 2024) and are immediately exercisable for a term of five&#160;years from the date of issuance. Additionally, as part of the public offering, the Company offered prefunded warrants to purchase up to 2,992,500 ADSs representing 29,925,000 ordinary shares, together with ordinary warrants to purchase up to 2,992,500 ADSs representing 29,925,000 ordinary shares. The public offering price for each ADS and accompanying prefunded warrant was $4.00. The prefunded warrants have an exercise price per ADS of $1.4537 and 9,945,000 prefunded warrants have been exercised. Ordinary warrants have an exercise price of $4.00 and are immediately exercisable for a term of five&#160;years from the date of issuance. Additionally, the Company issued placement agent warrants for consultants to purchase up to 187,500 ADSs representing 1,875,000 ordinary shares. The placement agent warrants have an exercise price per ADS of $5.40 and are immediately exercisable for a term of five&#160;years from the date of issuance. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Investor warrants December&#160;21, 2023</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with Private Placement, on December&#160;21, 2023 we issued 9,726,898 warrants to purchase 9,726,898 ordinary shares to a group of investors. The warrants vested immediately upon issue with an exercise price of $0.707 (amended to 4.799 DKK as of June&#160;12, 2024) and an expiration date on December&#160;21, 2026. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Warrants issued to a consultant related to the Company on September&#160;19, 2023</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;19, 2023 the Company issued 150,000 warrants to a consultant related to the Company of which 100,000 warants have lapsed. The warrants vest with </font><font style=" position:relative; bottom:2.66pt;font-size:7pt;letter-spacing:0.14pt;">1</font><font style="letter-spacing:0.2pt;">&#8725;</font><font style="font-size:7pt;letter-spacing:0.14pt;">4</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> per quarter with an exercise price of $1.50. Vested warrants may be exercised until and including September&#160;19, 2026. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Warrants issued to a consultant related to the Company on May&#160;7, 2024</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;7, 2024 the Company issued 50,000 warrants to a consultant related to the Company. The warrants vested immediately upon issue with an exercise price of $0.391. The warrants may be exercised in a period of 12&#160;months from the date of issuance. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Warrants issued to consultants related to the Company on August&#160;20, 2024</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;20, 2024, the Company issued 1,450,000 warrants to consultants related to the Company. 50,000 warrants were deemed to be granted on August&#160;5, 2024 and vested immediately upon granting with an exercise price of $0.25 per share of nominal 1. The warrants may be exercised in a period of 12&#160;months from the date of issuance. 1,400,000 warrants were deemed to be granted on August&#160;1, 2024 and vest with 1/6 per month and may be exercised for a period of 1 month after the expiration of the 6&#160;months&#8217; vesting period with an exercise price of DKK 1 per share of nominal 1. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">120</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EIB Warrants</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the EIB Loan Agreement, we agreed to issue the EIB Warrants to EIB in the event we make draws on the EIB Loan. Under the terms of the EIB Warrant Agreement, we are obligated to issue up to an aggregate of 1,047,744 EIB Warrants in three separate tranches with each tranche of EIB Warrants to be issued upon a drawdown of a tranche of the EIB Loan in accordance with the following schedule: (i)&#160;351,036 EIB Warrants upon a drawdown of the first tranche of the EIB Loan in the amount of &euro;7.0&#160;million; (ii)&#160;345,672 EIB Warrants upon a drawdown of the second tranche of the EIB Loan in the amount of &euro;6.0&#160;million, upon shareholders&#8217; approval and (iii)&#160;351,036 EIB Warrants upon a drawdown of the third and final tranche of the EIB Loan in the amount of &euro;7.0&#160;million, upon shareholders&#8217; approval. In November&#160;2020, we initiated the process of making a draw down on the first tranche of the EIB Loan in the amount of &euro;7.0&#160;million and, in connection therewith, on December&#160;17, 2020 and through the date of the annual report, our board of directors approved the issuance of 351,036 EIB Warrants to EIB. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of the EIB Warrant Agreement, each EIB Warrant entitles EIB to subscribe for one ordinary share, nominal DKK 1, at an exercise price of DKK 1 per ordinary share. In addition, EIB has the right to cause us to net settle the exercise of the EIB Warrants in cash based on the value of our ordinary shares on the date of exercise thereof. Finally, upon the occurrence of certain events, including the completion of our initial public offering, the prepayment of the EIB Loan, the sale of all or substantially all of our issued share capital or assets, a change in control transaction, or Messrs. Mattsson and Moller cease to own and control directly or indirectly 25% or more of the voting rights or economic interest of our company, EIB has the right, but not the obligation, to cause us to purchase any EIB Warrant, or the Put Right. If EIB exercise its Put Right, we are required to pay EIB an amount equal to the volume weighted average price per ordinary share, or VWAP, for a period of six&#160;months following the exercise of such Put Right. In the first six&#160;months following the completion of our initial public offering, the VWAP price to be paid by us is calculated for the entire period from the completion of our initial public offering until the exercise of the Put Right. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under Article&#160;18, Paragraph 2 of the Statute of the European Investment Bank, or the EIB Statute, establishing EIB, a direct equity investment by EIB requires a separate authorization from the EIB Board of Governors pursuant to which the EIB Board of Directors, acting by qualified majority, has to establish the terms and conditions of such direct equity investment. As of the date of this prospectus, the EIB Board of Governors has not granted any such special authorization to the EIB Board of Directors. Under the EIB Statute, in the absence of a separate authorization from the EIB Board of Governors, commercial shareholdings financed from EIB&#8217;s own resources are not allowed. Since the EIB Loan is being made from EIB&#8217;s own resources, the EIB Statute does not allow EIB to acquire any of our ordinary shares, therefore, we fully expect that if and when EIB exercises the EIB Warrants it will do so on either a net cash settlement basis or by means of exercising its Put Right. In either case, we may not have sufficient funds on hand to pay such amounts in which case we may be required to use a portion of the proceeds from our initial public offering and this offering in order to meet our obligations to pay the amounts due and payable to EIB upon the exercise of the EIB Warrants. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of the EIB Warrant Agreement, EIB may not exercise the EIB Warrants and cause us to settle the exercise of the EIB Warrants on a net cash basis or pursuant to its Put Right, for a period of 180&#160;days from the date of the completion of our initial public offering, provided that such lock-up arrangement shall cease to be effective in the event there is a material adverse event relating to our company as determined in accordance with ordinary principles of Danish law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The number of our ordinary shares that may be subject to either net cash settlement or EIB&#8217;s Put Right upon the exercise of the EIB Warrants are subject to adjustment in the event of changes to our capital structure which are not carried out at the then current market price, provided that there shall be no such adjustment as a result of the issuance of additional shares or warrants to employees as well as for any future exercise of such warrants. In addition, the EIB Warrants are not subject to any adjustment in the event of any capital increases in directed issuances or our ordinary shares following the completion of our initial public offering with customary discounts of up to 10% of the market price. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to a board resolution dated October&#160;3, 2024 the number of shares issuable upon exercise of warrants previously granted to EIB was adjusted from 351,036 to 373,127. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">121</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Shareholders&#8217; Register</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are obligated to maintain an owners&#8217; register (DK: </font><font style="font-style:italic;letter-spacing:0.2pt;">ejerbog</font><font style="letter-spacing:0.2pt;">). The owners&#8217; register is maintained by Computershare A/S (company registration number (CVR) no.&#160;27088899), Lottenborgvej 26 D, 1., DK-2800&#160;Kgs. Lyngby, Denmark, our Danish share registrar and transfer agent. It is mandatory that the owners&#8217; register is maintained within the European Union and that it is available to public authorities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Danish Companies Act public and private limited liability companies are required to register with the Danish Business Authority information regarding shareholders who own at least 5% of the share capital or the voting rights. Pursuant to the Danish Companies Act, we will file registrations with the Public Owners&#8217; Register of the Danish Business Authority. Shareholders that exceed or fall below the ownership threshold must notify us and we will subsequently file the information with the Danish Business Authority. Reporting is further required upon passing or falling below thresholds of 5, 10, 15, 20, 25, 50, 90, and 100% or 1/3 or 2/3. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Articles of Association and Danish Corporate Law</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Objects Clause</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our corporate object, as set out in article 1.2 of our articles of association, is to create advanced software that enables the development of novel immune therapies and vaccines. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Summary of Provisions Regarding the Board of Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to our articles of association, our board of directors shall be elected by our shareholders at the general meeting and shall be composed of not less than three and no more than seven members. With respect to the duration of the term which our directors severally hold office, the board of directors is elected to serve for a term of one year subject to re-election at the next annual general meeting of shareholders or until their successors have been duly elected and qualified, subject to their earlier removal, retirement or death. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Currently, the board of directors consists of four members who are elected by the shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The board of directors shall appoint and employ an executive management consisting of one to seven members to attend to our day-to-day management, and the board of directors shall determine the terms and conditions of their employment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting Rights</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each shareholder is entitled to one vote for each share owned at the time of any general meeting. As compared with Danish citizens, there are no limitations under the articles of association or under Danish law on the rights of foreigners or non-Danish citizens to hold or vote our ordinary shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividend Rights</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our shareholders may at general meetings authorize the distribution of ordinary and extraordinary dividends. Our shareholders may not distribute dividends in excess of the recommendation from our board of directors and may only pay out dividends from our distributable reserves, which are defined as results from operations carried forward and reserves that are not bound by law or our company&#8217;s articles of association after deduction of loss carried forward. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our shareholders are eligible to receive any dividends declared and paid out. However, we have not to date declared or paid any dividends and we currently intend to retain all available financial resources and any earnings generated by our operations for use in the business and we do not anticipate paying any dividends in the foreseeable future. The payment of any dividends in the future will depend on a number of factors, including our future earnings, capital requirements, financial condition and future prospects, applicable restrictions on the payment of dividends under Danish law and other factors that our board of directors may consider relevant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">See &#8220;Certain Material Tax Considerations&#8221; for a summary of certain tax consequences in respect of dividends or distributions to holders of our ordinary shares or ADSs. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">122</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pre-emptive Subscription Rights</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under Danish law, all shareholders have pre-emptive subscription rights in connection with capital increases that are carried out as cash contributions. An increase in share capital can be resolved by the shareholders at a general meeting or by the board of directors pursuant to an authorization given by the shareholders. In connection with an increase of a company&#8217;s share capital, the shareholders may, by resolution at a general meeting, approve deviations from the general Danish pre-emptive rights of the shareholders. Under the Danish Companies Act, such resolution must be adopted by the affirmative vote of shareholders holding at least a two-thirds majority of the votes cast and the share capital represented at the general meeting, and requires that such capital increases will be carried out as a cash contribution at market price. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The board of directors may resolve to increase our share capital without pre-emptive subscription rights for existing shareholders pursuant to the authorizations set forth above under the caption &#8220;Authorizations to the Board of Directors&#8221;. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unless future issuances of new shares and/or pre-emptive rights are registered under the Securities Act or with any authority outside Denmark, United States shareholders and shareholders in jurisdictions outside Denmark may be unable to exercise their pre-emptive subscription rights. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Rights on Liquidation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon a liquidation or winding-up of the Company, shareholders will be entitled to participate, in proportion to their respective shareholdings, in any surplus assets remaining after payment of our creditors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Limitations on Holding of Shares</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There are no limitations on the right to hold shares under the articles of association or Danish law. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Disclosure Requirements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to Section&#160;55 of the Danish Companies Act, a shareholder is required to notify us when such shareholder&#8217;s stake represents 5% or more of the voting rights in our company or the nominal value accounts for 5% or more of the share capital, and when a change of a holding already notified entails that the limits of 5, 10, 15, 20, 25, 50, 90 or 100% and the limits of one-third and two-thirds of the share capital&#8217;s voting rights or nominal value are reached or are no longer reached. The notification shall be given within two weeks following the date when the limits are reached or are no longer reached. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The notification shall provide information on the date of the acquisition or disposal of the shares, the full name, civil registration (CPR) number, and address of the shareholder or, in the case of an enterprise, registered office and business registration (CVR) number, the number of shares and their nominal value and share classes (if applicable) as well as information about the basis on which the calculation of the holdings has been made. In the event that the shareholder is a non-resident company or citizen of Denmark, the notification shall include documentation, which clearly identifies the owner. The company shall cause the notification to be entered in the owners&#8217; register. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to The Danish Companies Act, section 58a, we are obligated to collect and store for a period of at least five&#160;years certain information regarding the beneficial owners of shares in the Company. A beneficial owner is a physical person who ultimately holds or controls, directly or indirectly, a sufficient part of the ownership interests or voting rights or exercises control by other means, except for owners of companies whose ownership interests are traded on a regulated market or a similar market which is subject to a duty of disclosure in accordance with EU law or similar international standards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The legal status of the notification obligations is not fully clarified in relation to ADS holders and an ADS holder may be subject to such obligations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General Meetings</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The general meeting of shareholders is the highest authority in all matters, subject to the limitations provided by Danish law and the articles of association. The annual general meeting shall be held at our home address or in the Greater Copenhagen area not later than the end of May in each year. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">123</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the annual general meeting, the audited annual report is submitted for approval, together with the proposed appropriations of profit/treatment of loss, the election of the board of directors and election of our auditors. In addition, the board of directors reports on our activities during the past year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">General meetings are convened by the board of directors with a minimum of two weeks&#8217; notice and a maximum of four weeks&#8217; notice. A convening notice will also be forwarded to shareholders recorded in our owners&#8217; register, who have requested such notification and by publication in the Danish Business Authority&#8217;s computerized information system and on the company&#8217;s website. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the latest, two weeks before a general meeting (inclusive of the day of the general meeting), we shall make the following information and documents available at our website. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the convening notice, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the documents that shall be presented at the general meeting, and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the agenda and the complete proposals. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Shareholders are entitled to attend general meetings, either in person or by proxy and they or their proxy may be accompanied by one advisor. A shareholder&#8217;s right to attend general meetings and to vote at general meetings is determined on the basis of the shares that the shareholder holds on the registration date. The registration date shall be one week before the general meeting is held. The shares which the individual shareholder holds are calculated on the registration date on the basis of the registration of ownership in the owners&#8217; register as well as notifications concerning ownership which the Company has received with a view to update the ownership in the owners&#8217; register. In addition, any shareholder who is entitled to attend a general meeting and who wishes to attend must have requested an admission card from us no later than three days in advance of the general meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any shareholder is entitled to submit proposals to be discussed at the general meetings. However, proposals by the shareholders to be considered at the annual general meeting must be submitted in writing to the board of directors not later than six weeks prior the general meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Extraordinary general meetings must be held upon resolution of a general meeting to hold such a meeting or upon request of, the board of directors, our auditors or shareholders representing at least 1/20 of the registered share capital or such lower&#160;percentage as our articles of association may provide. Our articles of association do not state such lower&#160;percentage. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Holders of ADSs are not entitled to directly receive notices or other materials and may not attend or vote at general meetings. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Resolutions in General Meetings</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Resolutions made by the general meeting generally may be adopted by a simple majority of the votes cast, subject only to the mandatory provisions of the Danish Companies Act and our articles of association. Resolutions concerning all amendments to the articles of association must be passed by two-thirds of the votes cast as well as two-thirds of the share capital represented at the general meeting. Certain resolutions, which limit a shareholder&#8217;s ownership or voting rights, are subject to approval by a nine-tenth majority of the votes cast and the share capital represented at the general meeting. Decisions to impose or increase any obligations of the shareholders towards the company require unanimity. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Quorum Requirements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There are no quorum requirements generally applicable to general meetings of shareholders. To this extent, our practice varies from the requirement of Nasdaq Listing Rule&#160;5620(c), which requires an issuer to provide in its bylaws for a generally applicable quorum, and that such quorum may not be less than one-third of the outstanding voting shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Squeeze out</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to Section&#160;73 of the Danish Companies Act, a minority shareholder may require a majority shareholder that holds more than 90% of the company&#8217;s registered share capital and the corresponding voting </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">124</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">rights to redeem his or her shares. Similarly, a majority shareholder holding more than 90% of the company&#8217;s share capital and the corresponding voting rights may, according to Section&#160;70 of the same act, redeem the minority shareholder&#8217;s shares. In the event that the parties cannot agree to the terms of redemption and the valuation basis of the redemption price, this shall be determined by an independent evaluator appointed by the court for the district in which the registered office of the company is situated. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of Danish Corporate Law and our Articles of Association and Delaware Corporate Law</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following comparison between Danish corporate law, which applies to us, and Delaware corporate law, the law under which many publicly listed companies in the United States are incorporated, discusses additional matters not otherwise described in this prospectus. This summary is subject to Danish law, including the Danish Companies Act, and Delaware corporation law, including the Delaware General Corporation Law. Further, please note that as an ADS holder you will not be treated as one of our shareholders and will not have any shareholder rights. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Duties of Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Public limited liability companies in Denmark are usually subject to a two-tier governance structure with the board of directors having the ultimate responsibility for the overall supervision and strategic management of the company in question and with an executive board/management being responsible for the day-to-day operations. Each Director and member of the executive board/management is under a fiduciary duty to act in the interest of the company but shall also take into account the interests of the creditors and the shareholders. Under Danish law, the members of the board of directors and executive management of a limited liability company are liable for losses caused by negligence whether shareholders, creditors or the company itself suffers such losses. They may also be liable for wrongful information given in the annual financial statements or any other public announcements from the company. An investor suing for damages is required to prove its claim with regard to the incurred loss, negligence and causation. Danish courts, when assessing negligence, have been reluctant to impose liability unless the directors and officers neglected clear and specific duties. This is also the case when it comes to liability with regard to public offerings or liability with regard to any other public information issued by the company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The board of directors bears the ultimate responsibility for managing the business and affairs of a corporation. In discharging this function, directors of a Delaware corporation owe fiduciary duties of care and loyalty to the corporation and to its stockholders. Delaware courts have decided that the directors of a Delaware corporation are required to exercise informed business judgment in the performance of their duties. Informed business judgment means that the directors have informed themselves of all material information reasonably available to them. Delaware courts have also imposed a heightened standard of conduct upon directors of a Delaware corporation who take any action designed to defeat a threatened change in control of the corporation. In addition, under Delaware law, when the board of directors of a Delaware corporation approves the sale or break-up of a corporation, the board of directors may, in certain circumstances, have a duty to obtain the highest value reasonably available to the shareholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Terms of the Members of our Board of Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under Danish law, the members of the board of directors of a limited liability company are generally appointed for an individual term of one year (terms may have a maximum period of four&#160;years). There is no limit in the number of consecutive terms the directors may serve. Pursuant to our articles of association, our directors are appointed by the general meeting of shareholders for a term of one year. Election of directors is, according to our articles of association, an item that shall be included on the agenda for the annual general meeting. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Pursuant to the Danish Companies Act, in a limited liability company that employed an average of at least 35 employees in the preceding three&#160;years, the employees are entitled to elect a minimum of two representatives and alternate members to the company&#8217;s board of directors and up to one half the number of the shareholder elected directors. If the number of representatives to be elected by the employees is not a whole number, such number must be rounded up. However, as of December&#160;13, 2024, our company had 44&#160;full time employees. As of the date of this prospectus, our employees have not demanded representation on our board of directors. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">125</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Delaware General Corporation Law generally provides for a one-year term for directors, but permits directorships to be divided into up to three classes, of relatively equal size, with up to three-year terms, with the&#160;years for each class expiring in different&#160;years, if permitted by the certificate of incorporation, an initial bylaw or a bylaw adopted by the stockholders. A director elected to serve a term on a &#8220;classified&#8221; board may not be removed by stockholders without cause. There is no limit in the number of terms a director may serve. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director Vacancies</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under Danish law, new directors are elected by the shareholders in a general meeting also in the event of vacancies. A general meeting will thus have to be convened in order to fill a vacancy on the board of directors. However, the board of directors may choose to wait to fill vacancies until the next annual general meeting of the company, provided that the number of remaining directors is more than two, and provided that the remaining directors can still constitute a quorum. It is only a statutory requirement to convene a general meeting to fill vacancies if the number of remaining members on the board is less than three. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Delaware General Corporation Law provides that vacancies and newly created directorships may be filled by a majority of the directors then in office (even though less than a quorum) unless (1)&#160;otherwise provided in the certificate of incorporation or bylaws of the corporation or (2)&#160;the certificate of incorporation directs that a particular class of stock is to elect such director, in which case any other directors elected by such class, or a sole remaining director elected by such class, will fill such vacancy. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conflict-of-interest Transactions</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under Danish law, directors may not take part in any matter or decision-making that involves a subject or transaction in relation to which the director has a conflict of interest with us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Delaware General Corporation Law generally permits transactions involving a Delaware corporation and an interested director of that corporation if: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the material facts as to the director&#8217;s relationship or interest are disclosed and a majority of disinterested directors consent; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the material facts are disclosed as to the director&#8217;s relationship or interest and a majority of shares entitled to vote thereon consent; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the transaction is fair to the corporation at the time it is authorized by the board of directors, a committee of the board of directors or the stockholders. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proxy Voting by Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In the event that a director in a Danish limited liability company is unable to participate in a board meeting, the elected alternate, if any, shall be given access to participate in the board meeting. Unless the board of directors has decided otherwise, or as otherwise is set out in the articles of association, the director in question may in special cases grant a power of attorney to another director, provided that this is considered safe considering the agenda in question. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A director of a Delaware corporation may not issue a proxy representing the director&#8217;s voting rights as a director. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stockholder Rights</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Notice of Meeting</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;According to the Danish Companies Act, general meetings in limited liability companies shall be convened by the board of directors with a minimum of two weeks&#8217; notice and a maximum of four weeks&#8217; notice as set forth in the articles of association. A convening notice shall also be forwarded to shareholders recorded in our owners&#8217; register, who have requested such notification. There are specific </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">126</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">requirements as to the information and documentation required to be disclosed in connection with the convening notice. </font><font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">. Under Delaware law, unless otherwise provided in the certificate of incorporation or bylaws, written notice of any meeting of the stockholders must be given to each stockholder entitled to vote at the meeting not less than ten nor more than 60&#160;days before the date of the meeting and shall specify the place, date, hour, and purpose or purposes of the meeting. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Voting Rights</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each ordinary share confers the right to cast one vote at the general meeting of shareholders, unless the articles of association provide otherwise. Each holder of ordinary shares may cast as many votes as it holds shares. Shares that are held by us or our subsidiaries do not confer the right to vote. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, each stockholder is entitled to one vote per share of stock, unless the certificate of incorporation provides otherwise. In addition, the certificate of incorporation may provide for cumulative voting at all elections of directors of the corporation, or at elections held under specified circumstances. Either the certificate of incorporation or the bylaws may specify the number of shares and/or the amount of other securities that must be represented at a meeting in order to constitute a quorum, but in no event can a quorum consist of less than one third of the shares entitled to vote at a meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Stockholders as of the record date for the meeting are entitled to vote at the meeting, and the board of directors may fix a record date that is no more than 60 nor less than ten days before the date of the meeting, and if no record date is set then the record date is the close of business on the day next preceding the day on which notice is given, or if notice is waived then the record date is the close of business on the day next preceding the day on which the meeting is held. The determination of the stockholders of record entitled to notice or to vote at a meeting of stockholders shall apply to any adjournment of the meeting, but the board of directors may fix a new record date for the adjourned meeting. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Shareholder Proposals</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;According to the Danish Companies Act, extraordinary general meetings of shareholders will be held whenever our board of directors or our appointed auditor requires. In addition, one or more shareholders representing at least 1/20</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> of the registered share capital of the company may, in writing, require that a general meeting be convened. If such a demand is forwarded, the board of directors shall convene the general meeting within two weeks thereafter. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All shareholders have the right to present proposals for adoption at the annual general meeting, provided that the proposals are made in writing and forwarded at the latest six weeks prior thereto. In the event that the proposal is received at a later date, the board of directors will decide whether the proposal has been forwarded in due time to be included on the agenda. Any business not included on the agenda may be transacted by the general meeting only if all shareholders&#8217; consent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Delaware law does not specifically grant stockholders the right to bring business before an annual or special meeting of stockholders. However, if a Delaware corporation is subject to the SEC&#8217;s proxy rules, a stockholder who owns at least $2,000 in market value, or 1% of the corporation&#8217;s securities entitled to vote, may propose a matter for a vote at an annual or special meeting in accordance with those rules. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Action by Written Consent</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under Danish law, it is permissible for shareholders to take action and pass resolutions by written consent in the event of unanimity; however, this will normally not be the case in listed companies and for a listed company, this method of adopting resolutions is generally not feasible. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Although permitted by Delaware law, publicly listed companies do not typically permit stockholders of a corporation to take action by written consent. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Appraisal Rights</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The concept of appraisal rights does not exist under Danish law, except in connection with statutory redemptions rights according to the Danish Companies Act. According to Section&#160;73 of the Danish </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">127</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Companies Act, a minority shareholder may require a majority shareholder that holds more than 90% of the company&#8217;s registered share capital to redeem his or her shares. Similarly, a majority shareholder holding more than 90% of the company&#8217;s share capital may, according to Section&#160;70 of the same act, squeeze out the minority shareholders. In the event that the parties cannot agree to the redemption squeeze out price, this shall be determined by an independent evaluator appointed by the court. Additionally, there are specific regulations in Sections&#160;249, 267, 285 and 305 of the Danish Companies Act that require compensation in the event of national or cross-border mergers and demergers. Moreover, shareholders who vote against a cross-border merger or demerger or cross-border conversion are, according to Sections&#160;286, 306 and 318 m of the Danish Companies Act, entitled to have their shares redeemed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Delaware General Corporation Law provides for stockholder appraisal rights, or the right to demand payment in cash of the judicially determined fair value of the stockholder&#8217;s shares, in connection with certain mergers and consolidations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Shareholder Suits</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under Danish law, only a company itself can bring a civil action against a third party; an individual shareholder does not have the right to bring an action on behalf of a company. An individual shareholder may, in its own name, have an individual right to take action against such third party in the event that the cause for the liability of that third party also constitutes a negligent act directly against such individual shareholder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a stockholder may bring a derivative action on behalf of the corporation to enforce the rights of the corporation. An individual also may commence a class action suit on behalf of himself and other similarly situated stockholders where the requirements for maintaining a class action under Delaware law have been met. A person may institute and maintain such a suit only if that person was a stockholder at the time of the transaction which is the subject of the suit. In addition, under Delaware case law, the plaintiff normally must be a stockholder at the time of the transaction that is the subject of the suit and throughout the duration of the derivative suit. Delaware law also requires that the derivative plaintiff make a demand on the directors of the corporation to assert the corporate claim before the suit may be prosecuted by the derivative plaintiff in court, unless such a demand would be futile. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Repurchase of Shares</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Danish limited liability companies may not subscribe for newly issued shares in their own capital. Such company may, however, according to the Danish Companies Act Sections&#160;196-201, acquire fully paid shares of its own capital provided that the board of directors has been authorized thereto by the shareholders acting in a general meeting. Such authorization can only be given for a maximum period of five&#160;years and the authorization shall fix (i)&#160;the maximum value of the shares and (ii)&#160;the minimum and the highest amount that the company may pay for the shares. Shares may generally only be acquired using distributable reserves. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a corporation may purchase or redeem its own shares unless the capital of the corporation is impaired, or the purchase or redemption would cause an impairment of the capital of the corporation. A Delaware corporation may, however, purchase or redeem out of capital any of its preferred shares or, if no preferred shares are outstanding, any of its own shares if such shares will be retired upon acquisition and the capital of the corporation will be reduced in accordance with specified limitations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Anti-takeover Provisions</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under Danish law, it is possible to implement limited protective anti-takeover measures. Such provisions may include, among other things, (i)&#160;different share classes with different voting rights, (ii)&#160;specific requirements to register the shares on name in the company&#8217;s owners register and (iii)&#160;notification requirements concerning participation in general meetings. We have currently not adopted any such provisions. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">128</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In addition to other aspects of Delaware law governing fiduciary duties of directors during a potential takeover, the Delaware General Corporation Law also contains a business combination statute that protects Delaware companies from hostile takeovers and from actions following the takeover by prohibiting some transactions once an acquirer has gained a significant holding in the corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;203 of the Delaware General Corporation Law prohibits &#8220;business combinations,&#8221; including mergers, sales and leases of assets, issuances of securities and similar transactions by a corporation or a subsidiary with an interested stockholder that beneficially owns 15% or more of a corporation&#8217;s voting stock, within three&#160;years after the person becomes an interested stockholder, unless: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the transaction that will cause the person to become an interested stockholder is approved by the board of directors of the target prior to the transaction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">after the completion of the transaction in which the person becomes an interested stockholder, the interested stockholder holds at least 85% of the voting stock of the corporation not including shares owned by persons who are directors and officers of interested stockholders and shares owned by specified employee benefit plans; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">after the person becomes an interested stockholder, the business combination is approved by the board of directors of the corporation and holders of at least 66.67% of the outstanding voting stock, excluding shares held by the interested stockholder. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A Delaware corporation may elect not to be governed by Section&#160;203 by a provision contained in the original certificate of incorporation of the corporation or an amendment to the original certificate of incorporation or to the bylaws of the company, which amendment must be approved by a majority of the shares entitled to vote and may not be further amended by the board of directors of the corporation. Such an amendment is not effective until 12&#160;months following its adoption. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Inspection of Books and Records</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;According to Section&#160;150 of the Danish Companies Act, a shareholder may request an inspection of the company&#8217;s books regarding specific issues concerning the management of the company or specific annual reports. If approved by shareholders with simple majority, one or more investigators are elected. If the proposal is not approved by simple majority but 25% of the share capital votes in favor, then a shareholder can request the court to appoint an investigator. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, any stockholder may inspect certain of the corporation&#8217;s books and records, for any proper purpose, during the corporation&#8217;s usual hours of business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pre-emptive Rights</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under Danish law, all shareholders have pre-emptive subscription rights in connection with capital increases that are carried out as cash contributions. In connection with an increase of a company&#8217;s share capital, the shareholders may, by resolution at a general meeting, approve deviations from the general Danish pre-emptive rights of the shareholders. Under the Danish Companies Act, such resolution must be adopted by the affirmative vote of shareholders holding at least a two-thirds majority of the votes cast and the share capital represented at the general meeting and requires that such capital increases will be carried out as a cash contribution at market price. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The board of directors may resolve to increase our share capital without pre-emptive subscription rights for existing shareholders pursuant to the authorizations described above under the caption &#8220;Development of the Share Capital.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unless future issuances of new shares are registered under the Securities Act or with any authority outside Denmark, United States shareholders and shareholders in jurisdictions outside Denmark may be unable to exercise their pre-emptive subscription rights under United States securities law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, stockholders have no pre-emptive rights to subscribe for additional issues of stock or to any security convertible into such stock unless, and to the extent that, such rights are expressly provided for in the certificate of incorporation. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">129</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under Danish law, the distribution of ordinary and extraordinary dividends requires the approval of a company&#8217;s shareholders at a company&#8217;s general meeting. Under the Danish Companies Act the general meeting may authorize the board of directors to resolve to distribute extraordinary dividends after presentation of a company&#8217;s first financial statements. The authorization may be subject to financial and time restrictions. The shareholders may not distribute dividends in excess of the recommendation from the board of directors and may only pay out dividends from our distributable reserves, which are defined as amounts stated as retained earnings in the Company&#8217;s latest approved financial statements, and reserves not being non-distributable under a statute or the Company&#8217;s articles of association, less retained earnings. The decision to pay out extraordinary dividends shall be accompanied by a balance sheet, and the board of directors determine whether it will be sufficient to use the balance sheet from the annual report or if an interim balance sheet for the period from the annual report period until the extraordinary dividend payment shall be prepared. If extraordinary dividends are paid out later than six&#160;months following the financial year for the latest annual report, an interim balance sheet showing that there are sufficient funds shall always be prepared. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, it is possible under Danish law to distribute assets other than cash as dividends. If assets other than cash are distributed as dividends, a valuation report must be prepared. The valuation report must be prepared by one or more impartial valuation experts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a Delaware corporation may pay dividends out of its surplus (the excess of net assets over capital), or in case there is no surplus, out of its net profits for the fiscal year in which the dividend is declared and/or the preceding fiscal year (provided that the amount of the capital of the corporation is not less than the aggregate amount of the capital represented by the issued and outstanding stock of all classes having a preference upon the distribution of assets). In determining the amount of surplus of a Delaware corporation, the assets of the corporation, including stock of subsidiaries owned by the corporation, must be valued at their fair market value as determined by the board of directors, without regard to their historical book value. Dividends may be paid in the form of shares, property or cash. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Shareholder Vote on Certain Reorganizations</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under Danish law, all amendments to the articles of association shall be approved by the general meeting of shareholders with a minimum of two-thirds of the votes cast and two-thirds of the represented share capital. The same applies to solvent liquidations, mergers with the company as the discontinuing entity, mergers with the company as the continuing entity if shares are issued in connection therewith and demergers with the company as the transferor company and demergers with the company as the existing transferee if amendment of the articles of association for any purpose other than the adoption of the transferor company&#8217;s name or secondary name as the transferee company&#8217;s secondary name is required to be made. Under Danish law, it is debatable whether the shareholders must approve a decision to sell all or virtually all of the company&#8217;s business/assets. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, the vote of a majority of the outstanding shares of capital stock entitled to vote thereon generally is necessary to approve a merger or consolidation or the sale of all or substantially all of the assets of a corporation. The Delaware General Corporation Law permits a corporation to include in its certificate of incorporation a provision requiring for any corporate action the vote of a larger portion of the stock or of any class or series of stock than would otherwise be required. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the Delaware General Corporation Law, no vote of the stockholders of a surviving corporation to a merger is needed, however, unless required by the certificate of incorporation, if (1)&#160;the agreement of merger does not amend in any respect the certificate of incorporation of the surviving corporation, (2)&#160;the shares of stock of the surviving corporation are not changed in the merger and (3)&#160;the number of shares of common stock of the surviving corporation into which any other shares, securities or obligations to be issued in the merger may be converted does not exceed 20% of the surviving corporation&#8217;s common stock outstanding immediately prior to the effective date of the merger. In addition, stockholders may not be </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">130</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:352pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">entitled to vote in certain mergers with other corporations that own 90% or more of the outstanding shares of each class of stock of such corporation, but the stockholders will be entitled to appraisal rights. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Amendments to Governing Documents</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Denmark</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;All resolutions made by the general meeting may be adopted by a simple majority of the votes, subject only to the mandatory provisions of the Danish Companies Act and the articles of association. Resolutions concerning all amendments to the articles of association must be passed by two-thirds of the votes cast as well as two-thirds of the share capital represented at the general meeting. Certain resolutions, which limit a shareholder&#8217;s ownership or voting rights, are subject to approval by a nine-tenth majority of the votes cast and the share capital represented at the general meeting. Decisions to impose any or increase any obligations of the shareholders towards the company require unanimity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a corporation&#8217;s certificate of incorporation may be amended only if adopted and declared advisable by the board of directors and approved by a majority of the outstanding shares entitled to vote, and the bylaws may be amended with the approval of a majority of the outstanding shares entitled to vote and may, if so provided in the certificate of incorporation, also be amended by the board of directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Transfer Agent and Registrar</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The transfer agent and registrar for our shares is Computershare A/S, Lottenborgvej 26 D, 1., DK-2800&#160;Kgs. Lyngby, Denmark. The Bank of New York Mellon serves as the depositary, registrar and transfer agent for the ADSs. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">131</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOAD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF AMERICAN DEPOSITARY SHARES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">American Depositary Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of that certain Deposit Agreement, dated as of February&#160;4, 2021, as amended and supplemented from time to time, or the Deposit Agreement, by and among us, The Bank of New York Mellon as the depositary, and all owners and holders of the ADSs, the depositary will register and deliver the ADSs. As of the effectiveness of the Ratio Change on January&#160;22, 2024, each ADS represents ten ordinary shares (or a right to receive ten ordinary shares) deposited with the depositary, acting through an office located in the United Kingdom, as custodian for the depositary. Each ADS will also represent any other securities, cash or other property which may be held by the depositary. The deposited shares together with any other securities, cash or other property held by the depositary are referred to as the deposited securities. The depositary&#8217;s office at which the ADSs will be administered and its principal executive office are located at 240 Greenwich Street, New York, New York 10286. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may hold ADSs either (i)&#160;directly (a)&#160;by having an American Depositary Receipt, or an ADR, which is a certificate evidencing a specific number of ADSs registered in your name, or (b)&#160;by having uncertificated ADSs registered in your name, or (ii)&#160;indirectly by holding a security entitlement in ADSs through your broker or other financial institution that is a direct or indirect participant in The Depository Trust Company, or DTC. If you hold ADSs directly, you are a registered ADS holder, or an ADS holder. This description assumes you are an ADS holder. If you hold the ADSs indirectly, you must rely on the procedures of your broker or other financial institution to assert the rights of ADS holders described in this section. You should consult with your broker or financial institution to find out what those procedures are. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Registered holders of uncertificated ADSs will receive statements from the depositary confirming their holdings. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As an ADS holder, we will not treat you as one of our shareholders and you will not have shareholder rights. European and Danish law governs shareholder rights. The depositary will be the holder of the shares underlying the ADSs. As a registered holder of ADSs, you will have ADS holder rights. A deposit agreement among us, the depositary, ADS holders and all other persons indirectly or beneficially holding ADSs sets out ADS holder rights as well as the rights and obligations of the depositary. New York law governs the deposit agreement and the ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of the material provisions of the deposit agreement. For more complete information, you should read the entire deposit agreement and the form of ADR. Those documents are filed as exhibits to the registration statement of which this prospectus forms a part. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends and Other Distributions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How will ADS holders receive dividends and other distributions on the ordinary shares?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary has agreed to pay or distribute to ADS holders the cash dividends or other distributions it or the custodian receives on shares or other deposited securities, upon payment or deduction of its fees and expenses. You will receive these distributions in proportion to the number of ordinary shares your ADSs represent. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary will convert any cash dividend or other cash distribution we pay on the shares into United States dollars, if it can do so on a reasonable basis. If that is not possible or if any government approval is needed and cannot be obtained, the deposit agreement allows the depositary to distribute the foreign currency only to those ADS holders to whom it is possible to do so. It will hold the foreign currency it cannot convert for the account of the ADS holders who have not been paid. It will not invest the foreign currency and it will not be liable for any interest. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Before making a distribution, any withholding taxes, or other governmental charges that must be paid will be deducted. See &#8220;Taxation&#8221; included elsewhere in this prospectus. The depositary will distribute only </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">132</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">whole United States dollars and cents and will round fractional cents to the nearest whole cent. If the exchange rates fluctuate during a time when the depositary cannot convert the foreign currency, you may lose some of the value of the distribution. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Shares</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary may distribute additional ADSs representing any shares we distribute as a dividend or free distribution. The depositary will only distribute whole ADSs. It will sell shares which would require it to deliver a fraction of an ADS (or ADSs representing those shares) and distribute the net proceeds in the same way as it does with cash. If the depositary does not distribute additional ADSs, the outstanding ADSs will also represent the new shares. The depositary may sell a portion of the distributed shares (or ADSs representing those shares) sufficient to pay its fees and expenses in connection with that distribution. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Rights to purchase additional shares</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we offer holders of our securities any rights to subscribe for additional shares or any other rights, the depositary may (i)&#160;exercise those rights on behalf of ADS holders, (ii)&#160;distribute those rights to ADS holders or (iii)&#160;sell those rights and distribute the net proceeds to ADS holders, in each case after deduction or upon payment of its fees and expenses. To the extent the depositary does not do any of those things, it will allow the rights to lapse. </font><font style="font-style:italic;letter-spacing:0.2pt;">In that case, you will receive no value for them.</font><font style="letter-spacing:0.2pt;"> The depositary will exercise or distribute rights only if we ask it to and provide satisfactory assurances to the depositary that it is legal to do so. If the depositary will exercise rights, it will purchase the securities to which the rights relate and distribute those securities or, in the case of shares, new ADSs representing the new shares, to subscribing ADS holders, but only if ADS holders have paid the exercise price to the depositary. United States securities laws may restrict the ability of the depositary to distribute rights or ADSs or other securities issued on exercise of rights to all or certain ADS holders, and the securities distributed may be subject to restrictions on transfer. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Distributions</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary will send to ADS holders anything else we distribute on deposited securities by any means it thinks is legal, fair and practical. If it cannot make the distribution in that way, the depositary has a choice. It may decide to sell what we distributed and distribute the net proceeds, in the same way as it does with cash. Or, it may decide to hold what we distributed, in which case ADSs will also represent the newly distributed property. However, the depositary is not required to distribute any securities (other than ADSs) to ADS holders unless it receives satisfactory evidence from us that it is legal to make that distribution. The depositary may sell a portion of the distributed securities or property sufficient to pay its fees and expenses in connection with that distribution. United States securities laws may restrict the ability of the depositary to distribute securities to all or certain ADS holders, and the securities distributed may be subject to restrictions on transfer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any ADS holders. We have no obligation to register ADSs, shares, rights or other securities under the Securities Act. We also have no obligation to take any other action to permit the distribution of ADSs, shares, rights or anything else to ADS holders. </font><font style="font-style:italic;letter-spacing:0.2pt;">This means that you may not receive the distributions we make on our ordinary shares or any value for them if it is illegal or impractical for us to make them available to you.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Deposit, Withdrawal and Cancellation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How are ADSs issued?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary will deliver ADSs if you or your broker deposits shares or evidence of rights to receive shares with the custodian. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will register the appropriate number of ADSs in the names you request and will deliver the ADSs to or upon the order of the person or persons that made the deposit. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">133</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:64pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How can ADS holders withdraw the deposited securities?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may surrender the ADSs to the depositary for the purpose of withdrawal. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer will deliver the shares and any other deposited securities underlying the ADSs to the ADS holder or a person the ADS holder designates at the office of the custodian. Or, at your request, risk and expense, the depositary will deliver the deposited securities at its office, if feasible. However, the depositary is not required to accept surrender of ADSs to the extent it would require delivery of a fraction of a deposited share or other security. The depositary may charge you a fee and its expenses for instructing the custodian regarding delivery of deposited securities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How do ADS holders interchange between certificated ADSs and uncertificated ADSs?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may surrender your ADR to the depositary for the purpose of exchanging your ADR for uncertificated ADSs. The depositary will cancel that ADR and will send to the ADS holder a statement confirming that the ADS holder is the registered holder of uncertificated ADSs. Upon receipt by the depositary of a proper instruction from a registered holder of uncertificated ADSs requesting the exchange of uncertificated ADSs for certificated ADSs, the depositary will execute and deliver to the ADS holder an ADR evidencing those ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting Rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How do ADS holders vote?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ADS holders may instruct the depositary how to vote the number of deposited shares their ADSs represent. If we request the depositary to solicit your voting instructions (and we are not required to do so), the depositary will notify you of a shareholders&#8217; meeting and send or make voting materials available to you. Those materials will describe the matters to be voted on and explain how ADS holders may instruct the depositary how to vote. For instructions to be valid, they must reach the depositary by a date set by the depositary. The depositary will try, as far as practical, subject to the laws of the Denmark and the provisions of our articles of association or similar documents, to vote or to have its agents vote the shares or other deposited securities as instructed by ADS holders. If we do not request the depositary to solicit your voting instructions, you can still send voting instructions, and, in that case, the depositary may try to vote as you instruct, but it is not required to do so. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except by instructing the depositary as described above, you won&#8217;t be able to exercise voting rights unless you surrender the ADSs and withdraw the shares. However, you may not know about the meeting enough in advance to withdraw the shares. In any event, the depositary will not exercise any discretion in voting deposited securities and it will only vote or attempt to vote as instructed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We cannot assure you that you will receive the voting materials in time to ensure that you can instruct the depositary to vote your ordinary shares. In addition, the depositary and its agents are not responsible for failing to carry out voting instructions or for the manner of carrying out voting instructions. </font><font style="font-style:italic;letter-spacing:0.2pt;">This means that you may not be able to exercise voting rights and there may be nothing you can do if your ordinary shares are not voted as you requested.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to give you a reasonable opportunity to instruct the depositary as to the exercise of voting rights relating to deposited securities, if we request the depositary to act, we agree to give the depositary notice of any such meeting and details concerning the matters to be voted upon at least 45&#160;days in advance of the meeting date. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">134</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fees and Expenses</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:101.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:225pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Persons depositing or withdrawing shares or ADS holders must pay: </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:219pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">For: </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:225pt;">
              <font style="letter-spacing:0.2pt;">$5.00 (or less) per 100 ADSs (or portion of 100 ADSs) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:219pt;">
              <font style="letter-spacing:0.2pt;">Issuance of ADSs, including issuances resulting from a distribution of shares or rights or other property </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:225pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:219pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Cancellation of ADSs for the purpose of withdrawal, including if the deposit agreement terminates </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:225pt;">
              <font style="letter-spacing:0.2pt;">$0.05 (or less) per ADS </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:219pt;">
              <font style="letter-spacing:0.2pt;">Any cash distribution to ADS holders</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:218.5pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:225pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Persons depositing or withdrawing shares or ADS holders must pay: </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:219pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">For: </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:225pt;">
              <font style="letter-spacing:0.2pt;">A fee equivalent to the fee that would be payable if securities distributed to you had been shares and the shares had been deposited for issuance of ADSs </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:219pt;">
              <font style="letter-spacing:0.2pt;">Distribution of securities distributed to holders of deposited securities (including rights) that are distributed by the depositary to ADS holders </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225pt;">
              <font style="letter-spacing:0.2pt;">$0.05 (or less) per ADS per calendar year </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:219pt;">
              <font style="letter-spacing:0.2pt;">Depositary services </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:225pt;">
              <font style="letter-spacing:0.2pt;">Registration or transfer fees </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:219pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Transfer and registration of shares on our share register to or from the name of the depositary or its agent when you deposit or withdraw shares </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:225pt;">
              <font style="letter-spacing:0.2pt;">Expenses of the depositary </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:219pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Cable and facsimile transmissions (when expressly provided in the deposit agreement) Converting foreign currency to United States dollars </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:225pt;">
              <font style="letter-spacing:0.2pt;">Taxes and other governmental charges the depositary or the custodian has to pay on any ADSs or shares underlying ADSs, such as stock transfer taxes, stamp duty or withholding taxes </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:219pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">As necessary </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:225pt;">
              <font style="letter-spacing:0.2pt;">Any charges incurred by the depositary or its agents for servicing the deposited securities </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:219pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">As necessary</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary collects its fees for delivery and surrender of ADSs directly from investors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of distributable property to pay the fees. The depositary may collect its annual fee for depositary services by deduction from cash distributions or by directly billing investors or by charging the book-entry system accounts of participants acting for them. The depositary may collect any of its fees by deduction from any cash distribution payable (or by selling a portion of securities or other property distributable) to ADS holders that are obligated to pay those fees. The depositary may generally refuse to provide fee-attracting services until its fees for those services are paid. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From time to time, the depositary may make payments to us to reimburse us for costs and expenses generally arising out of establishment and maintenance of the ADS program, waive fees and expenses for services provided to us by the depositary or share revenue from the fees collected from ADS holders. In performing its duties under the deposit agreement, the depositary may use brokers, dealers, foreign currency dealers or other service providers that are owned by or affiliated with the depositary and that may earn or share fees, spreads or commissions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary may convert currency itself or through any of its affiliates and, the custodian or we may convert currency and pay U.S. dollars to the depositary. Where the depositary converts currency itself or through any of its affiliates, the depositary acts as principal for its own account and not as agent, advisor, broker or fiduciary on behalf of any other person and earns revenue, including, without limitation, transaction spreads, that it will retain for its own account. The revenue is based on, among other things, the difference between the exchange rate assigned to the currency conversion made under the deposit agreement and the rate that the depositary or its affiliate receives when buying or selling foreign currency for its own account. The depositary makes no representation that the exchange rate used or obtained in any currency conversion under the deposit agreement will be the most favorable rate that could be obtained at the time or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">135</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">that the method by which that rate will be determined will be the most favorable to ADS holders, subject to the depositary&#8217;s obligations under the deposit agreement. The methodology used to determine exchange rates used in currency conversions made by the depositary is available upon request. Where the custodian converts currency, the custodian has no obligation to obtain the most favorable rate that could be obtained at the time or to ensure that the method by which that rate will be determined will be the most favorable to ADS holders, and the depositary makes no representation that the rate is the most favorable rate and will not be liable for any direct or indirect losses associated with the rate. In certain instances, the depositary may receive dividends or other distributions from us in U.S. dollars that represent the proceeds of a conversion of foreign currency or translation from foreign currency at a rate that was obtained or determined by us and, in such cases, the depositary will not engage in, or be responsible for, any foreign currency transactions and neither it nor we make any representation that the rate obtained or determined by us is the most favorable rate and neither it nor we will be liable for any direct or indirect losses associated with the rate. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Payment of Taxes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You will be responsible for any taxes or other governmental charges payable on or with respect to the ADSs or the deposited securities represented by any of the ADSs. The depositary may refuse to register any transfer of the ADSs or allow you to withdraw the deposited securities represented by the ADSs until those taxes or other charges are paid. It may apply payments owed to you or sell deposited securities represented by the ADSs to pay any taxes owed and you will remain liable for any deficiency. If the depositary sells deposited securities, it will, if appropriate, reduce the number of ADSs to reflect the sale and pay to ADS holders any proceeds, or send to ADS holders any property, remaining after it has paid the taxes. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Tender and Exchange Offers; Redemption, Replacement or Cancellation of Deposited Securities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary will not tender deposited securities in any voluntary tender or exchange offer unless instructed to do by an ADS holder surrendering ADSs and subject to any conditions or procedures the depositary may establish. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If deposited securities are redeemed for cash in a transaction that is mandatory for the depositary as a holder of deposited securities, the depositary will call for surrender of a corresponding number of ADSs and distribute the net redemption money to the holders of called ADSs upon surrender of those ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If there is any change in the deposited securities such as a sub-division, combination or other reclassification, or any merger, consolidation, recapitalization or reorganization affecting the issuer of deposited securities in which the depositary receives new securities in exchange for or in lieu of the old deposited securities, the depositary will hold those replacement securities as deposited securities under the deposit agreement. However, if the depositary decides it would not be lawful and practical to hold the replacement securities because those securities could not be distributed to ADS holders or for any other reason, the depositary may instead sell the replacement securities and distribute the net proceeds upon surrender of the ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If there is a replacement of the deposited securities and the depositary will continue to hold the replacement securities, the depositary may distribute new ADSs representing the new deposited securities or ask you to surrender your outstanding ADRs, if any, in exchange for new ADRs identifying the new deposited securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If there are no deposited securities underlying ADSs, including if the deposited securities are cancelled, or if the deposited securities underlying ADSs have become apparently worthless, the depositary may call for surrender or of those ADSs or cancel those ADSs upon notice to the ADS holders. Amendment and Termination </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How may the deposit agreement be amended?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may agree with the depositary to amend the deposit agreement and the ADRs without your consent for any reason. If an amendment adds or increases fees or charges, except for taxes and other governmental charges or expenses of the depositary for registration fees, facsimile costs, delivery charges or similar items, or prejudices a substantial right of ADS holders, it will not become effective for outstanding </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">136</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">ADSs until 30&#160;days after the depositary notifies ADS holders of the amendment. At the time an amendment becomes effective, you are considered, by continuing to hold the ADSs, to agree to the amendment and to be bound by the ADRs and the deposit agreement as amended. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How may the deposit agreement be terminated?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary will initiate termination of the deposit agreement if we instruct it to do so. The depositary may initiate termination of the deposit agreement if: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">60&#160;days have passed since the depositary told us it wants to resign but a successor depositary has not been appointed and accepted its appointment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we delist the ADSs from an exchange in the United States on which they were listed and do not list the ADSs on another exchange in the United States or make arrangements for trading of ADSs on the United States over-the-counter market; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we delist our ordinary shares from an exchange outside the United States on which they were listed and do not list the shares on another exchange outside the United States; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the depositary has reason to believe the ADSs have become, or will become, ineligible for registration on Form F-6 under the Securities Act; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we appear to be insolvent or enter insolvency proceedings </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">all or substantially all the value of the deposited securities has been distributed either in cash or in the form of securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">there are no deposited securities underlying the ADSs or the underlying deposited securities have become apparently worthless; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">there has been a replacement of deposited securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the deposit agreement will terminate, the depositary will notify ADS holders at least 90&#160;days before the termination date. At any time after the termination date, the depositary may sell the deposited securities. After that, the depositary will hold the money it received on the sale, as well as any other cash it is holding under the deposit agreement, unsegregated and without liability for interest, for the pro&#160;rata benefit of the ADS holders that have not surrendered their ADSs. Normally, the depositary will sell as soon as practicable after the termination date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After the termination date and before the depositary sells, ADS holders can still surrender their ADSs and receive delivery of deposited securities, except that the depositary may refuse to accept a surrender for the purpose of withdrawing deposited securities or reverse previously accepted surrenders of that kind that have not settled if it would interfere with the selling process. The depositary may refuse to accept a surrender for the purpose of withdrawing sale proceeds until all the deposited securities have been sold. The depositary will continue to collect distributions on deposited securities, but, after the termination date, the depositary is not required to register any transfer of ADSs or distribute any dividends or other distributions on deposited securities to the ADSs holder (until they surrender their ADSs) or give any notices or perform any other duties under the deposit agreement except as described in this paragraph. Limitations on Obligations and Liability </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Limits on our Obligations and the Obligations of the Depositary; Limits on Liability to Holders of ADSs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The deposit agreement expressly limits our obligations and the obligations of the depositary. It also limits our liability and the liability of the depositary. We and the depositary: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">are only obligated to take the actions specifically set forth in the deposit agreement without negligence or bad faith, and the depositary will not be a fiduciary or have any fiduciary duty to holders of ADSs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">are not liable if we are or it is prevented or delayed by law or by events or circumstances beyond our or its control from performing our or its obligations under the deposit agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">are not liable if we or it exercises discretion permitted under the deposit agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">137</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">are not liable for the inability of any holder of ADSs to benefit from any distribution on deposited securities that is not made available to holders of ADSs under the terms of the deposit agreement, or for any special, consequential or punitive damages for any breach of the terms of the deposit agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">have no obligation to become involved in a lawsuit or other proceeding related to the ADSs or the deposit agreement on your behalf or on behalf of any other person; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">may rely upon any documents we believe or it believes in good faith to be genuine and to have been signed or presented by the proper person; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">are not liable for the acts or omissions of any securities depository, clearing agency or settlement system; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the depositary has no duty to make any determination or provide any information as to our tax status, or any liability for any tax consequences that may be incurred by ADS holders as a result of owning or holding ADSs or be liable for the inability or failure of an ADS holder to obtain the benefit of a foreign tax credit, reduced rate of withholding or refund of amounts withheld in respect of tax or any other tax benefit. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the deposit agreement, we and the depositary agree to indemnify each other under certain circumstances. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Requirements for Depositary Actions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Before the depositary will deliver or register a transfer of ADSs, make a distribution on ADSs, or permit withdrawal of shares, the depositary may require: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">payment of stock transfer or other taxes or other governmental charges and transfer or registration fees charged by third parties for the transfer of any shares or other deposited securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">satisfactory proof of the identity and genuineness of any signature or other information it deems necessary; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">compliance with regulations it may establish, from time to time, consistent with the deposit agreement, including presentation of transfer documents. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary may refuse to deliver ADSs or register transfers of ADSs when the transfer books of the depositary or our transfer books are closed or at any time if the depositary or we think it advisable to do so. Your Right to Receive the Shares Underlying the ADSs </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">ADS holders have the right to cancel their ADSs and withdraw the underlying shares at any time except: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">when temporary delays arise because (i)&#160;the depositary has closed its transfer books or we have closed our transfer books, (ii)&#160;the transfer of shares is blocked to permit voting at a shareholders&#8217; meeting or (iii)&#160;we are paying a dividend on our ordinary shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">when you owe money to pay fees, taxes and similar charges; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">when it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADSs or to the withdrawal of shares or other deposited securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This right of withdrawal may not be limited by any other provision of the deposit agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Direct Registration System</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the deposit agreement, all parties to the deposit agreement acknowledge that the Direct Registration System, or DRS, and Profile Modification System, or Profile, will apply to the ADSs. DRS is a system administered by DTC that facilitates interchange between registered holding of uncertificated ADSs and holding of security entitlements in ADSs through DTC and a DTC participant. Profile is a feature of DRS that allows a DTC participant, claiming to act on behalf of a registered holder of uncertificated ADSs, to direct the depositary to register a transfer of those ADSs to DTC or its nominee and to deliver those ADSs </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">138</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:260pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">to the DTC account of that DTC participant without receipt by the depositary of prior authorization from the ADS holder to register that transfer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with and in accordance with the arrangements and procedures relating to DRS/Profile, the parties to the deposit agreement understand that the depositary will not determine whether the DTC participant that is claiming to be acting on behalf of an ADS holder in requesting registration of transfer and delivery as described in the paragraph above has the actual authority to act on behalf of the ADS holder (notwithstanding any requirements under the Uniform Commercial Code). In the deposit agreement, the parties agree that the depositary&#8217;s reliance on and compliance with instructions received by the depositary through the DRS/Profile system and in accordance with the deposit agreement will not constitute negligence or bad faith on the part of the depositary. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Shareholder Communications; Inspection of Register of Holders of ADSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary will make available for your inspection at its office all communications that it receives from us as a holder of deposited securities that we make generally available to holders of deposited securities. The depositary will send you copies of those communications or otherwise make those communications available to you if we ask it to. You have a right to inspect the register of holders of ADSs, but not for the purpose of contacting those holders about a matter unrelated to our business or the ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Jury Trial Waiver</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The deposit agreement provides that, to the extent permitted by law, ADS holders waive the right to a jury trial of any claim they may have against us or the depositary arising out of or relating to our ordinary shares, the ADSs or the deposit agreement, including any claim under the United States federal securities laws. If we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable in the facts and circumstances of that case in accordance with applicable case law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You will not, by agreeing to the terms of the deposit agreement, be deemed to have waived our or the depositary&#8217;s compliance with United States federal securities laws and the rules and regulations promulgated thereunder.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">139</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMITC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MATERIAL INCOME TAX CONSIDERATIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The following summary contains a description of material Danish and U.S. federal income tax consequences of the acquisition, ownership and disposition of our ordinary shares. This summary should not be considered a comprehensive description of all the tax considerations that may be relevant to the decision to acquire our ordinary shares.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Danish Tax Considerations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following discussion describes the material Danish tax consequences under present law of an investment in the ADSs. The summary is for general information only and does not purport to constitute tax or legal advice. It is specifically noted that the summary does not address all possible tax consequences relating to an investment in the ADSs. The summary is based solely on the tax laws of Denmark in effect on the date of this prospectus. Danish tax laws may be subject to change, possibly with retroactive effect. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The summary does not cover investors to whom special tax rules apply, and, therefore, may not be relevant, for example, to investors subject to the Danish Tax on Pension Yields Act (</font><font style="font-style:italic;letter-spacing:0.2pt;">i.e.</font><font style="letter-spacing:0.2pt;">, pension savings), professional investors, certain institutional investors, insurance companies, pension companies, banks, stockbrokers and investors with tax liability on return on pension investments. The summary does not cover taxation of individuals and companies who carry on a business of purchasing and selling shares. The summary only sets out the tax position of the direct owners of the ADSs and further assumes that the direct investors are the beneficial owners of the ADSs and any dividends thereon. Sales are assumed to be sales to a third party. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Potential investors in the ADSs are advised to consult their tax advisors regarding the applicable tax consequences of acquiring, holding and disposing of the ADSs based on their particular circumstances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Investors who may be affected by the tax laws of other jurisdictions should consult their tax advisors with respect to the tax consequences applicable to their particular circumstances as such consequences may differ significantly from those described herein. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Taxation of Danish Tax Resident Holders of the ADSs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">It is currently not clear under the current Danish tax legislation or case law how listed ADSs issued by Danish resident companies in general are to be treated for tax purposes, and therefore no level of assurance can be given on this matter. For the purpose of the below comments, it is assumed that Danish tax resident holders of the ADSs should be treated as holders of listed shares in the company for both Danish corporate law purpose and Danish tax purposes, even though the company&#8217;s ordinary shares are not admitted to trading on a regulated market. Recent communications and binding rulings from the Danish Tax Assessment Council indicate that the holders of ADSs for Danish tax purposes are treated as holders of listed ordinary shares. The same communications and rulings indicate that the actual distribution of dividends on ADSs to Danish investors are considered dividends for Danish tax purposes. However, it should be emphasized that these communications and binding rulings are based on the actual facts and circumstances and terms and conditions of the depositary agreement implying that a holder of ADSs might not be able to rely on said rulings, the position cannot therefore be said to be clear. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event that the holders of ADSs are not treated as holding listed shares, it is likely that they will be treated as either holding unlisted shares or financial instruments for tax purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As described above, the below summary assumes that the holders of ADSs listed in the U.S. should be treated as holding listed ordinary shares in the company for Danish tax purposes, but if this is not the case, then this will impact the Danish tax treatment of the holders of ADSs, including in respect of the taxation of dividends paid to holders of ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Sale of the ADSs (Individuals) assuming treatment as listed shares under Danish tax law</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For individual investor in 2024, gains from the sale of shares are include in the computation of the annual share income subject to 27% tax on the first DKK 61,000 (for cohabiting spouses, a total of DKK&#160;122,000) and at a rate of 42% on share income exceeding DKK 61,000 (for cohabiting spouses over </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">140</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">DKK&#160;122,000). Such amounts are subject to annual adjustments and include all share income (</font><font style="font-style:italic;letter-spacing:0.2pt;">i.e.</font><font style="letter-spacing:0.2pt;">, all capital gains and dividends derived by the individual or cohabiting spouses, respectively). The realization principle applies; i.e., the gains or losses are included in the income in the year of disposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Gains and losses on the sale of shares are calculated as the difference between the purchase price and the sales price. The purchase price is generally determined using the average method (in Danish &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">gennemsnitsmetoden</font><font style="letter-spacing:0.2pt;">&#8221;) as a proportionate part of the aggregate purchase price for all the shareholder&#8217;s shares in a company (</font><font style="font-style:italic;letter-spacing:0.2pt;">i.e.</font><font style="letter-spacing:0.2pt;"> not the purchase price paid for each share). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As the ADSs, for the purpose of this tax description, are considered listed shares for Danish tax purposes, losses on the sale of listed shares may be offset against other share income deriving from listed shares (</font><font style="font-style:italic;letter-spacing:0.2pt;">i.e.</font><font style="letter-spacing:0.2pt;">, dividends and capital gains on the sale of listed shares) and subject to the Danish tax authorities having received certain information concerning the ownership of the shares in due time. Unused losses will automatically be offset against a cohabiting spouse&#8217;s share income deriving from listed shares and any additional losses can be carried forward and offset against future share income deriving from listed shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Sale of the ADSs (Companies) assuming treatment as unlisted shares under Danish tax law</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the purpose of taxation of sales of shares made by shareholders (companies), a distinction is made between Subsidiary Shares, Group Shares, Tax-Exempt Portfolio Shares and Taxable Portfolio Shares (note that the ownership threshold described below is applied on the basis of the number of all shares issued by a company, and not on the basis of the number of the ADSs issued): </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Subsidiary Shares</font><font style="letter-spacing:0.2pt;">&#8221; are generally defined as shares owned by a shareholder holding at least 10% of the nominal share capital of the issuing company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Group Shares</font><font style="letter-spacing:0.2pt;">&#8221; are generally defined as shares in a company in which the shareholder of the company and the issuing company are subject to Danish joint taxation or fulfill the requirements for international joint taxation under Danish law (</font><font style="font-style:italic;letter-spacing:0.2pt;">i.e.</font><font style="letter-spacing:0.2pt;">, the company is controlled by the shareholder). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Tax-Exempt Portfolio Shares</font><font style="letter-spacing:0.2pt;">&#8221; are defined as shares not admitted to trading on a regulated market owned by a shareholder holding less than 10% of the nominal share capital of the issuing company. As the ADSs are listed on Nasdaq, the rules on Tax-Exempt Portfolio Shares are not applicable to the ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Taxable Portfolio Shares,</font><font style="letter-spacing:0.2pt;">&#8221; are defined as shares that do not qualify as Subsidiary Shares, Group Shares or Tax-Exempt Portfolio Shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Gains or losses on disposal of Subsidiary Shares and Group Shares and Tax-Exempt Portfolio Shares are not included in the taxable income of the shareholder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Special rules apply with respect to Subsidiary Shares and Group Shares to prevent exemption through certain holding company structures just as other anti-avoidance rules may apply. These rules will not be described in further detail. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Capital gains from the sale of Taxable Portfolio Shares are taxable at a rate of 22% irrespective of ownership period and losses on such shares are generally deductible. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Gains and losses from the sale of listed Taxable Portfolio Shares are generally taxable according to the mark-to-market principle (in Danish &#8220;lagerprincippet&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the mark to market principle, each year&#8217;s taxable gain or loss on Taxable Portfolio Shares is calculated as the difference between the market value of the shares at the beginning of the tax year and the market value of the shares at the end of the tax year. Hence, taxation will take place on an accrual basis even if no shares have been disposed of and no gains or losses have been realized. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the Taxable Portfolio Shares are sold or otherwise disposed before the end of the income year, the taxable income of that income year equals the difference between the value of the Taxable Portfolio Shares at the beginning of the income year and the value of the Taxable Portfolio Shares at realization. If the Taxable Portfolio Shares are acquired and realized in the same income year, the taxable income equals the difference between the acquisition sum and the realization sum. If the Taxable Portfolio Shares are acquired in the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">141</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">income year and not realized in the same income year, the taxable income equals the difference between the acquisition sum and the value of the shares at the end of the income&#160;years. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A change of status from Subsidiary Shares/Group Shares/Tax-Exempt Portfolio Shares to Taxable Portfolio Shares (or vice versa) is for tax purposes considered a disposal of the shares and a reacquisition of the shares at market value at the time of change of status. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Dividends (Individuals)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As described above, the recent communications and binding rulings from the Danish Tax Assessment Council indicate that the holders of ADSs for Danish tax purposes are treated as holders of listed ordinary shares. The same communications and rulings indicate that the actual distribution of dividends on ADSs to Danish investors are considered dividends for Danish tax purposes. Provided that such distributions to Danish tax resident individual investors are treated as dividends, taxation as share income, as described above, will take place. All share income must be included when calculating whether the amounts described above are exceeded. Dividends paid to individuals are generally subject to 27% withholding tax. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Dividends (Companies)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For corporate investors, dividends paid (subject to the same uncertainty as described immediately above) on Subsidiary Shares and Group Shares are tax-exempt irrespective of ownership period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Dividends paid on Taxable Portfolio Shares are taxable at the standard corporate rate of 22% irrespective of ownership period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Tax applies at the standard corporate income tax rate of 22 %, which is withheld at source by the distributing company. If the distributing company withholds a higher amount, the Danish corporate shareholder can claim a refund of excess tax. A claim for repayment must be filed within two&#160;months. Otherwise, the excess tax will be credited in the corporate income tax for the year. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Taxation of Shareholders Residing Outside Denmark</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">It is currently not clear under current Danish tax legislation or case law how the listed ADSs are to be treated for tax purposes, and therefore no level of assurance can be given on this matter. For the purpose of the below comments, it is assumed that non-Danish tax resident holders of the ADSs should be treated as holders of listed shares in our company for Danish tax purposes, even though our company&#8217;s ordinary shares are not admitted to trading on a regulated market. Recent communications and binding rulings from the Danish Tax Assessment Council indicates that the holders of ADSs for Danish tax purposes are treated as holders of listed ordinary shares. The same communications and rulings indicate that the actual distribution of dividends on ADSs to Danish investors are considered dividends for Danish tax purposes. However, it should be emphasized that these communications and binding rulings are based on an individual analysis based on the actual facts and circumstances and terms and conditions of the depositary agreement implying that a holder of ADSs might not be able to rely on said rulings. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event that the holders of ADSs are not treated as holding listed shares in our company, it is likely that they will be treated as either holding unlisted shares or financial instruments for Danish tax purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As described above, the below summary assumes that the holders of ADSs listed in the U.S. should be treated as holding listed ordinary shares in our company for Danish tax purposes, but if this is not the case, then this will impact the Danish tax treatment of the holders of ADSs, including in respect of the taxation of dividends paid to holders of ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Sale of the ADSs (Individuals and Companies)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Holders of the ADSs not resident in Denmark are normally not subject to Danish taxation on any gains realized on the sale of ADSs, irrespective of the ownership period, subject to certain anti-avoidance rules seeking to prevent that taxable dividend payments are converted to tax exempt capital gains. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">142</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No Danish share transfer tax or stamp duties should be payable on transfer of ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If an investor holds the ADSs in connection with a trade or business conducted from a permanent establishment in Denmark, gains on shares may be included in the taxable income of such activities pursuant to the rules applying to Danish tax residents as described above. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Dividends (Individuals)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As described above, the recent communications and binding rulings from the Danish Tax Assessment Council indicate that the holders of ADSs for Danish tax purposes are treated as holders of listed ordinary shares in the company. The same communications and rulings indicate that the actual distribution of dividends on ADSs to investors are considered dividends for Danish tax purposes. In principle the holders of the ADSs should therefore be entitled to apply for a refund of Danish withholding tax on dividends paid by the company. However, it remains uncertain how the Danish tax authorities will accept/handle this in practice and whether. the holders of ADSs will in fact be entitled to apply for a refund of Danish withholding tax on dividends paid by the company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the holders of ADS for Danish purposes are treated as holders of the ordinary shares in the company and are entitled to apply for a refund of Danish withholding tax on dividends paid by the company, then the below should apply: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Dividends paid to individuals are generally subject to 27% withholding tax. The withholding tax is 44% for dividends paid to beneficial owners in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Blacklisted Jurisdictions</font><font style="letter-spacing:0.2pt;">&#8221;. The 44% rate only applies to &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Main Shareholders</font><font style="letter-spacing:0.2pt;">&#8221; which generally encompass individual shareholders holding more than 25% of the shares or 50% of the votes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Non-residents of Denmark are not subject to additional Danish income tax in respect to dividends received on shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the holders of the ADSs are considered beneficial owners of the dividends according to the applicable double tax treaty between Denmark and the tax residence country of the ADS holder, the withholding tax rate under such double tax treaty may apply to the extent the tax residency of the ADS holder can be documented and to the extent it can be documented that the dividends are in fact paid onwards to the holder of the ADSs as the beneficial owner. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For holders of ADSs (as the beneficial owners of the dividends on the ordinary shares), if the withholding tax rate applied is higher than the applicable final tax rate (as reduced according to domestic law or an applicable double tax treaty) for the holder of ADSs, a request for a refund of Danish tax in excess hereof can be made in the following situations: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Reduction According to Tax Treaty</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event that the ADS holder is a resident of a state with which Denmark has entered into a tax treaty, the holder may generally, through certain certification procedures, seek a refund from the Danish tax authorities of the tax withheld in excess of the applicable treaty rate, which is typically 15%. Denmark has entered into tax treaties with approximately 80 countries, including the United States, Switzerland and almost all members of the European Union. The tax treaty between Denmark and the United States generally provides for a 15% tax rate. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Reduction According to Danish Tax Law</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the ADS holder holds less than 10% of the nominal share capital (in the form of ordinary shares in the company and not on the basis of the number of the ADSs issued) of the company and the ADS holder is tax resident in a state which has a double tax treaty or an international agreement, convention or other administrative agreement on assistance in tax matters according to which the competent authority in the state of the ADS holder is obligated to exchange information with Denmark, dividends are subject to tax at a rate of 15%. If the ADS holder is tax resident outside the European Union, it is an additional requirement for eligibility for the 15% tax rate that the ADS holder together with related ADS holders holds less than 10% of the nominal share capital of the company. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">143</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Note that the reduced tax rate does not affect the withholding rate, which is why the holder must claim a refund as described above in order to benefit from the reduced rate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Where a non-resident of Denmark holds shares which can be attributed to a permanent establishment in Denmark, dividends are taxable pursuant to the rules applying to Danish tax residents described above. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The recent communications and binding rulings from the Danish Tax Assessment Council indicates that a holder of ADSs selling such ADSs back to the company should be exempt from withholding tax on the basis of a specific exception applying to shares in listed companies. It should be emphasized that these rulings are based on an individual analysis based on the actual facts and circumstances and terms and conditions of the depositary agreement implying that a holder of ADSs might not be able to rely on said rulings. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends (Companies)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">As described above, the recent communications and binding rulings from the Danish Tax Assessment Council indicates that holders of ADSs for Danish tax purposes are treated as holders of listed ordinary shares. The same communications and rulings indicate that the actual distribution of dividends on ADSs to investors are considered dividends for Danish tax purposes. In principle the holders of the ADSs should therefore be entitled to apply for a refund of Danish withholding tax on dividends paid by the company. However, it remains uncertain how the Danish tax authorities will accept/handle this in practice and whether the holders of ADSs will in fact be entitled to apply for a refund of Danish withholding tax on dividends paid by the company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">If the holders of ADS for Danish purposes are treated as holders of the ordinary shares in the company and are entitled to apply for a refund of Danish withholding tax on dividends paid by the company, then the below should apply: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Dividends paid to companies are generally subject to 27% withholding tax. Companies residing in certain black-listed countries and holding Group Shares or Subsidiary Shares are subject to 44% withholding tax and not eligible to for any refund of such 44% withholding tax. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Non-residents of Denmark are not subject to additional Danish income tax in respect to dividends received on shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">If the holder of the ADSs is considered the beneficial owner of the dividends according to the applicable double tax treaty between Denmark and the tax residence country of the ADS holder, the withholding tax rate under such double tax treaty may apply to the extent the tax residency of the ADS holder can be documented. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Dividends from Subsidiary Shares are tax exempt provided the taxation of the dividends is to be waived or reduced in accordance with the Parent-Subsidiary Directive (2011/96/EEC) or in accordance with a tax treaty with the jurisdiction in which the company investor is resident. If Denmark is to reduce taxation of dividends to a foreign company under a tax treaty, Denmark will not&#8201;&#8212;&#8201;as a matter of domestic law&#8201;&#8212;&#8201;exercise such right and will in general not impose any tax at all. Further, dividends from Group Shares &#8212; not also being Subsidiary Shares&#8201;&#8212;&#8201;are exempt from Danish tax provided the company investor is a resident of the European Union or the EEA and provided the taxation of dividends should have been waived or reduced in accordance with the Parent-Subsidiary Directive (2011/96/EEC) or in accordance with a tax treaty with the country in which the company investor is resident had the shares been Subsidiary Shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Dividend payments on both Tax-Exempt and Taxable Portfolio Shares will generally be subject to a tax rate of 22% irrespective of ownership period. While the actual withholding tax rate is as a starting point 27%, it can be reduced if certain requirements are met. If the withholding tax rate applied is higher than the applicable final tax rate for the ADS holder, a request for a refund of Danish tax in excess hereof can be made by the ADS holder in the following situations: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Reduction According to Tax Treaty</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event that the shareholder is a resident of a state with which Denmark has entered into a double taxation treaty, the shareholder may generally, through certain certification procedures, seek a refund from </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">144</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the Danish tax authorities of the tax withheld in excess of the applicable treaty rate, which is typically 15%. Denmark has entered into tax treaties with a large number of countries, including the United States and almost all members of the European Union. The tax treaty between Denmark and the United States generally provides for a 15% rate. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Reduction According to Danish Tax law</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A corporate ADS holder to whom the 44% withholding tax rate mentioned above does not apply can always request a refund of at least 5% corresponding to the difference between a 27% withholding tax and the Danish CIT rate of 22%. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the ADS holder holds less than 10% of the nominal share capital (in the form of ordinary shares in the company and not on the basis of the number of the ADSs issued) in the company and the ADS holder is resident in a jurisdiction which has a tax treaty or an international agreement, convention or other administrative agreement on assistance in tax according to which the competent authority in the state of the ADS holder is obligated to exchange information with Denmark, dividends are generally subject to a tax rate of 15%. If the ADS holder is tax resident outside the European Union, it is an additional requirement for eligibility for the 15% tax rate that the ADS holder together with related ADS and shareholders holds less than 10% of the nominal share capital of the company. Note that the reduced tax rate does not affect the withholding rate, hence, in this situation the ADS holder must also in this situation claim a refund as described above in order to benefit from the reduced rate. Where a non-resident company of Denmark holds ADSs which can be attributed to a permanent establishment in Denmark, dividends are taxable pursuant to the rules applying to Danish tax residents described above. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The recent communications and binding rulings from the Danish Tax Assessment Council indicate that a holder of ADSs selling such ADSs back to the company should be exempt from withholding tax on the basis of a specific exception applying to shares in listed companies. It should be emphasized that these rulings are based on an individual analysis based on the actual facts and circumstances and terms and conditions of the depositary agreement implying that a holder of ADSs might not be able to rely on said rulings. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Share Transfer Tax and Stamp Duties</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No Danish share transfer tax or stamp duties should be payable on transfer of the shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Certain Material U.S. Federal Income Tax Considerations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following discussion describes certain material United States federal income tax considerations relating to the acquisition, ownership and disposition of ADSs by a United States Holder (as defined below) that acquires the ADSs and holds them as a capital asset (generally property held for investment) under the Internal Revenue Code of 1986, as amended from time to time, or the &#8220;Code&#8221;. This discussion is based upon existing U.S. tax law (including the Code, its legislative history, existing, temporary and proposed United States Department of the Treasury Regulations promulgated thereunder, or the &#8220;Treasury Regulations&#8221;, administrative and judicial interpretations thereof, and other published rulings, guidance, and court decisions) in effect on the date hereof. These tax laws are subject to change, possibly with retroactive effect, and subject to differing interpretations that could affect the tax consequences described herein. No ruling has been sought from the Internal Revenue Service, or the &#8220;IRS&#8221;, or any other taxing authority, with respect to any United States federal income tax consequences described below. In addition, because the authorities upon which this summary is based are subject to various interpretations, the IRS, other taxing authorities, and the U.S. courts could disagree with one or more of the positions taken in this summary. This summary is not binding on the IRS or any other taxing authority or court, none of which are precluded from taking a position that is different from or contrary to, any position taken in this summary and there can be no assurance that the IRS, other taxing authority, or a court will not take a contrary position. No opinion from U.S. legal counsel has been requested, or will be obtained, regarding the U.S. federal income tax consequences of the acquisition, ownership and disposition of the ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This discussion does not address all aspects of United States federal income taxation that may be applicable to U.S. Holders in light of their particular circumstances or status including investors subject to special tax rules (such as, bank thrifts, and other financial institutions, insurance companies, broker-dealers in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">145</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">stocks, securities, currencies, or notional principal contracts, traders that have elected to mark securities to market, regulated investment companies, real estate investment trusts, partnerships or other pass-through entities, tax-exempt organizations including private foundations and charitable remainder trusts, pension plans, persons that hold the ADSs or ordinary shares as part of a straddle, hedge, conversion, constructive sale, or other integrated investment or transaction as determined for U.S. federal income tax purposes, persons subject to alternative minimum tax or whose &#8220;functional currency&#8221; is not the USD, U.S. expatriates or former long-term residents of the United States, persons that directly, indirectly or constructively own 10% or more (by vote or value) of the Company, persons who acquired interests in the Company pursuant to the exercise of any employee share option or otherwise as compensation, or persons holding interests in the Company through partnerships or other pass-through entities). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">This section does not address the treatment of a non-U.S. holder, nor does it address the tax treatment under the laws of any U.S. state or local state or non-U.S. taxing jurisdiction or any U.S. estate or alternative minimum tax consequences. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">This summary is for general information purposes only and does not purport to be a complete analysis or listing of all potential U.S. federal income tax considerations that may apply to a U.S. Holder as a result of the acquisition, ownership and disposition of the ADSs. In addition, this summary does not take into account the individual facts and circumstances of any particular U.S. Holder that may affect the U.S. federal income tax consequences to such U.S. Holder. Accordingly, this summary is not intended to be, and should not be construed as, legal or U.S. federal income tax advice with respect to any particular U.S. Holder. Except as specifically set forth below, this summary does not discuss applicable tax reporting requirements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this discussion, a &#8220;U.S. Holder&#8221; is a beneficial owner of the ADSs that, for United States federal income tax purposes, is: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an individual who is a citizen or resident of the United States; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States or of any State thereof or the District of Columbia; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an estate the income of which is subject to United States federal income taxation regardless of its source; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a trust if (i)&#160;a court within the United States is able to exercise primary supervision over the trust&#8217;s administration and one or more United States persons have the authority to control all substantial decisions of the trust or (ii)&#160;a valid election under the Treasury regulations is in effect for the trust to be treated as a United States person. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If a partnership or other pass-through entity (including any entity or arrangement treated as a partnership or other pass-through entity for U.S. federal income tax purposes) holds the ADSs, the tax treatment of a person treated as a partner or other owner in the partnership or other pass-through entity for U.S. federal income tax purposes generally will depend on the status of the partner or other owner and the activities of the partnership or other pass-through entity. Partnerships (and other entities or arrangements so treated for U.S. federal income tax purposes) and their future partners should consult their own tax advisors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In general, and taking into account the earlier assumptions, for U.S. federal income tax purposes, a holder of ADSs will be treated as the owner of the shares represented by those ADSs. Exchanges of shares for ADSs, and ADSs for shares, generally will not be subject to United States federal income tax. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">This discussion addresses only U.S. Holders and does not discuss any tax considerations other than United States federal income tax considerations. Prospective investors are urged to consult their own tax advisors regarding the United States federal, state and local, and non-U.S. income and other tax consequences of the purchase, ownership, and disposition of ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the United States federal income tax laws, and subject to the PFIC rules discussed below under &#8220;&#8212; Passive Foreign Investment Company Considerations&#8221;, any distributions of cash or other property with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">146</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">respect to the ADSs (including any amounts withheld in respect thereof), generally will, to the extent made out of our current and accumulated earnings and profits as determined for U.S. federal income tax purposes, constitute dividends for U.S. federal income tax purposes. Generally, the gross amount of any dividend we pay out of our current or accumulated earnings and profits (as determined for United States federal income tax purposes) is includible in income for a U.S. Holder and subject to U.S. federal income taxation. Dividends paid to a non-corporate U.S. Holder that constitute dividend income from a &#8220;qualified foreign corporation&#8221; will be taxable at a preferential tax rate applicable to long-term capital gains, provided that the U.S. Holder holds the ADSs for more than 60&#160;days during the 121-day period beginning 60&#160;days before the ex-dividend date and meets other holding period requirements. A non-United States corporation (other than a corporation that is classified as a PFIC for the taxable year in which the dividend is paid or the preceding taxable year) generally will be considered to be a qualified foreign corporation (i)&#160;if it is eligible for the benefits of a comprehensive tax treaty with the United States which the Secretary of Treasury of the United States determines is satisfactory for purposes of this provision and which includes an exchange of information program, or (ii)&#160;with respect to any dividend it pays on stock (or ADSs in respect of such stock) which is readily tradable on an established securities market in the United States. The ADSs are listed on The Nasdaq Capital Market, which is an established securities market in the United States. We therefore expect that dividends we pay with respect to the ADSs generally will constitute qualified dividend income. There can be no assurance, however, that the ADSs will be considered readily tradeable on an established securities market in later&#160;years. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A U.S. Holder must include any Danish tax withheld from the dividend payment, as described above under &#8220;&#8212; Danish Tax Considerations&#8201;&#8212;&#8201;Taxation of Shareholders Residing Outside Denmark,&#8221; in the gross amount of dividend paid even though the holder does not in fact receive it. The dividend is taxable to the holder when the depositary receives the dividend, actually or constructively. Because we are not a United States corporation and do not expect to meet the dividends-received deduction eligibility criteria for non-U.S. corporations, the dividend is not expected to be eligible for the dividends-received deduction generally allowed to U.S. corporations in respect of dividends received from other United States corporations. The amount of the dividend distribution includible in a U.S. Holder&#8217;s income will be the USD value of the Danish Krone payments made, determined at the spot Danish Krone/USD rate on the date the dividend distribution is includible in income, regardless of whether the payment is in fact converted into USD. Generally, any gain or loss resulting from currency exchange fluctuations during the period from the date the dividend payment is included in income to the date the payment is converted into USD will be treated as ordinary income or loss to the U.S. Holder and will not be eligible for the special tax rate applicable to qualified dividend income. The currency gain or loss generally will be income or loss from sources within the United States for foreign tax credit limitation purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the extent a distribution with respect to ADSs exceeds our current or accumulated earnings and profits, as determined under U.S. federal income tax principles, the distribution will be treated, first, as a tax-free return of the U.S. Holder&#8217;s capital invested in the Company, up to the holder&#8217;s adjusted tax basis in its ADSs, and, thereafter, as capital gain, which is subject to the tax treatment described below in &#8220;&#8212; Gain on Sale, Exchange or Other Taxable Disposition.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Because we do not intend to determine our earnings and profits on the basis of United States federal income tax principles, all distributions paid will generally be treated as &#8220;dividends&#8221; for United States federal income tax purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Dividends paid by the Company generally will be treated as income from foreign sources for United States foreign tax credit purposes and generally will constitute passive category income. A U.S. Holder may be eligible, subject to a number of complex limitations, to claim a foreign tax credit in respect of any foreign withholding taxes imposed on dividends received on the ADSs, including the Danish tax withheld in accordance with the Treaty and paid over to the Danish taxing authority, which may, subject to such limitations, be creditable against a U.S. Holder&#8217;s United States federal income tax liability. A U.S. Holder who does not elect to claim a foreign tax credit for foreign tax withheld, may instead claim a deduction, for United States federal income tax purposes, in respect of such withholdings, but only for a year in which such U.S. Holder elects to do so for all creditable foreign income taxes. To the extent a refund of the tax withheld is available to a U.S. Holder under Danish law or under the Treaty, the amount of tax withheld that is refundable will not be eligible for credit against a U.S. Holder&#8217;s U.S. federal income tax liability. See &#8220;&#8212; Danish </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">147</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Taxation&#8201;&#8212;&#8201;Withholding Tax Refund for United States Treaty Beneficiaries&#8221; above for the procedures for obtaining a tax refund. Investors are urged to consult their own tax advisors about the availability of any foreign tax credits or deductions in respect to their specific tax situations. Gain on Sale, Exchange or Other Taxable Disposition </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to the PFIC rules described below under &#8220;&#8212; Passive Foreign Investment Company Considerations&#8221;, a U.S. Holder that sells, exchanges or otherwise disposes of ADSs in a taxable disposition generally will recognize capital gain or loss for United States federal income tax purposes equal to the difference between the United States dollar value of the amount realized and the holder&#8217;s adjusted tax basis, determined in United States dollars, in the ADSs. Gain or loss recognized on such a sale, exchange or other disposition of ADSs generally will be long-term capital gain if the U.S. Holder&#8217;s holding period in the ADSs exceeds one year. Long-term capital gains of non-corporate U.S. Holders are generally taxed at preferential rates. The gain or loss generally will be income or loss from sources within the United States for foreign tax credit limitation purposes. A U.S. Holder&#8217;s ability to deduct capital losses is subject to limitations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Passive Foreign Investment Company Considerations</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have not made a determination as to whether the Company will or will not be treated as a PFIC in the current taxable year and subsequent taxable&#160;years. The determination of PFIC status is inherently factual, is subject to a number of uncertainties, and can be determined only annually after the close of the tax year in question. Additionally, the analysis depends, in part, on the application of complex U.S. federal income tax rules, which are subject to differing interpretations. There can be no assurance that the Company will or will not be determined to be a PFIC for the current tax year or any prior or future tax year, and no opinion of legal counsel or ruling from the IRS concerning the status of the Company as a PFIC has been obtained or will be requested. U.S. Holders should consult their own U.S. tax advisors regarding our PFIC status. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we were classified as a &#8220;passive foreign investment company&#8221;, or a &#8220;PFIC&#8221;, for U.S. federal income tax purposes in any taxable year, a U.S. Holder would be subject to special rules with respect to distributions on and sales, exchanges and other dispositions of the ADSs. A non-U.S. corporation, such as the Company, will be classified as a PFIC for United States federal income tax purposes for any taxable year, if either (i)&#160;75% or more of its gross income for such year consists of certain types of &#8220;passive&#8221; income (the &#8220;income test&#8221;) or (ii)&#160;50% or more of the value of its assets (generally determined on the basis of a quarterly average) during such year is attributable to assets that produce or are held for the production of passive income (the &#8220;asset test&#8221;). For this purpose, cash and assets readily convertible into cash are categorized as passive assets and the company&#8217;s goodwill and other unbooked intangibles are taken into account. Passive income generally includes, among other things, dividends, interest, rents, royalties, and gains from the disposition of passive assets. However, certain rents and royalties received from unrelated parties in connection with the active conduct of a trade or business are not considered passive income for purposes of the PFIC test. For purposes of the PFIC test, we will be treated as owning a proportionate share of the assets and earning a proportionate share of the income of any other corporation in which we own, directly or indirectly, at least 25% (by value) of the stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we were a PFIC with respect to a U.S. Holder, then unless such U.S. Holder makes one of the elections described below, a special tax regime would apply to the U.S. Holder with respect to (i)&#160;any &#8220;excess distribution&#8221; &#8203;(generally, aggregate distributions in any year that are greater than 125% of the average annual distribution received by the holder in the shorter of the three preceding&#160;years or the holder&#8217;s holding period for the ADSs) and (ii)&#160;any gain realized on the sale or other disposition of the ADSs. Under this regime, any excess distribution and realized gain will be treated as ordinary income and will be subject to tax as if (a)&#160;the excess distribution or gain had been realized ratably over the U.S. Holder&#8217;s holding period, (b)&#160;the amount deemed realized in each year had been subject to tax in each year of that holding period at the highest marginal rate for such year (other than income allocated to the current period or any taxable period before we became a PFIC, which would be subject to tax at the U.S. Holder&#8217;s regular ordinary income rate for the current year and would not be subject to the interest charge discussed below), and (c)&#160;the interest charge generally applicable to underpayments of tax had been imposed on the taxes deemed to have been payable in those&#160;years. If we were determined to be a PFIC, this tax treatment for U.S. Holders would apply also to indirect distributions and gains deemed realized by U.S. Holders in respect of stock of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">148</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">any of our subsidiaries determined to be PFICs. In addition, dividend distributions would not qualify for the lower rates of taxation applicable to long-term capital gains discussed above under &#8220;&#8212; Taxation of Dividends.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A U.S. Holder that holds the ADSs at any time during a taxable year in which we are classified as a PFIC generally will continue to treat such ADSs as ADSs in a PFIC, even if we no longer satisfy the PFIC income and asset tests described above, unless the U.S. Holder elects to recognize gain, which will be taxed under the excess distribution rules as if such ADSs had been sold on the last day of the last taxable year for which we were a PFIC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain elections by a U.S. Holder would alleviate some of the adverse consequences of PFIC status and would result in an alternative treatment of the ADSs, as described below. These elections include a &#8220;qualified electing fund&#8221; or &#8220;QEF&#8221; election and a &#8220;mark-to-market&#8221; election, which is described in more detail below. We do not expect that a U.S. Holder would be able to make a QEF election with respect to the ADSs because we do not intend to provide to U.S. Holders the required information to make a valid QEF election. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event we are determined to be a PFIC, the rules applicable to PFICs described above would not apply to a U.S. Holder that makes a &#8220;mark-to-market&#8221; election with respect to the ADSs, but this election will be available with respect to the ADSs only if they meet certain minimum trading requirements to be considered &#8220;marketable stock&#8221; for purposes of the PFIC rules. Generally, shares of ADSs will be treated as marketable stock if they are &#8220;regularly traded&#8221; on a &#8220;qualified exchange&#8221; within the meaning of applicable Treasury Regulations. ADSs generally will be considered regularly traded during any calendar year during which they are traded, other than in </font><font style="font-style:italic;letter-spacing:0.2pt;">de minimis</font><font style="letter-spacing:0.2pt;"> quantities, on at least 15&#160;days during each calendar quarter. Any trades that have as their principal purpose meeting this requirement will be disregarded. The ADSs will be considered marketable stock as long as they remain listed on The Nasdaq Capital Market and are regularly traded. We anticipate that the ADSs should qualify as being regularly traded, but no assurances may be given in this regard. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A U.S. Holder that makes a valid mark-to-market election for the first tax year in which the holder holds (or is deemed to hold) ADSs and for which we are a PFIC will be required to include each year an amount equal to the excess, if any, of the fair market value of such ADSs the holder owns as of the close of the taxable year over the holder&#8217;s adjusted tax basis in such ADSs. The U.S. Holder will be entitled to a deduction for the excess, if any, of the holder&#8217;s adjusted tax basis in the ADSs over the fair market value of such ADSs as of the close of the taxable year, but only to the extent of any net mark-to-market gains with respect to such ADSs included by the U.S. Holder under the election for prior taxable&#160;years and may be subject to certain other limitations. The U.S. Holder&#8217;s adjusted tax basis in such ADSs will be adjusted to reflect the amounts included or deducted pursuant to the election. Amounts included in income pursuant to a mark-to-market election, as well as gain on the sale, exchange or other taxable disposition of such ADSs, will be treated as ordinary income. The deductible portion of any mark-to-market loss, as well as loss on a sale, exchange or other disposition of ADSs to the extent that the amount of such loss does not exceed net mark- to-market gains previously included in income, will be treated as ordinary loss. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Because a mark-to-market election cannot be made for any lower-tier PFICs that we may own, a U.S. Holder may continue to be subject to the PFIC rules with respect to such U.S. Holder&#8217;s indirect interest in any investments held by us that are treated as an equity interest in a PFIC for U.S. federal income tax purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The mark-to-market election applies to the taxable year for which the election is made and all subsequent taxable&#160;years, unless the ADSs cease to be treated as marketable stock for purposes of the PFIC rules or the IRS consents to its revocation. The excess distribution rules described above generally will not apply to a U.S. Holder for tax&#160;years for which a mark-to-market election is in effect. However, if we were a PFIC for any year in which the U.S. Holder owns the ADSs but before a mark-to-market election is made, the interest charge rules described above would apply to any mark-to-market gain recognized in the year the election is made. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A U.S. Holder of PFIC shares must generally file an annual information return on IRS Form 8621 (Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund). The failure to file IRS Form 8621 could result in the imposition of penalties and the extension of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">149</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:104pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the statute of limitations with respect to U.S. federal income tax. U.S. Holders are urged to consult their tax advisors as to our status as a PFIC, and the tax consequences to them if we were a PFIC, including the reporting requirements and the desirability of making, and the availability of, a mark-to-market election with respect to the ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Net Investment Income Tax</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Non-corporate U.S. Holders that are individuals, estates or trusts and whose income exceeds certain thresholds generally are subject to a 3.8% tax on all or a portion of their net investment income, which may include their gross dividend income and net gains from the disposition of ADSs. A U.S. person that is an individual, estate or trust is encouraged to consult its tax advisors regarding the applicability of this net investment income tax to its income and gains in respect of any investment in ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Information Reporting with Respect to Foreign Financial Assets</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Individual U.S. Holders may be subject to certain reporting obligations on IRS Form 8938 (Statement of Specified Foreign Financial Assets) with respect to the ADSs for any taxable year during which the U.S. Holder&#8217;s aggregate value of these and certain other &#8220;specified foreign financial assets&#8221; exceed a threshold amount that varies with the filing status of the individual. This reporting obligation also applies to domestic entities formed or availed of to hold, directly or indirectly, specified foreign financial assets, including the ADSs. Significant penalties can apply if U.S. Holders are required to make this disclosure and fail to do so. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">U.S. Holders who acquire ADSs for cash may be required to file IRS Form 926 (Return by a U.S. Transferor of Property to a Foreign Corporation) with the IRS and to supply certain additional information to the IRS if (i)&#160;immediately after the transfer, the U.S. Holder owns directly or indirectly (or by attribution) at least 10% of our total voting power or value or (ii)&#160;the amount of cash transferred to us in exchange for ADSs, when aggregated with all related transfers under applicable regulations, exceeds $100,000. Substantial penalties may be imposed on a U.S. Holder that fails to comply with this reporting requirement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Information Reporting and Backup Withholding</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Dividend payments with respect to the ADSs and proceeds from the sale, exchange or redemption of the ADSs may be subject to information reporting to the IRS and possible United States backup withholding tax. In general, information reporting, including IRS Form 1099 reporting, will apply to dividends in respect of ADSs and the proceeds from the sale, exchange or redemption of ADSs that are paid to a holder of ADSs within the United States (and in certain cases, outside the United States), unless such holder is an exempt recipient such as a corporation. Backup withholding will not apply, however, to a U.S. Holder who furnishes a correct taxpayer identification number and makes other required certifications, or who is otherwise exempt from backup withholding. U.S. Holders that are required to establish their exempt status generally must provide such certification on IRS Form W-9. Backup withholding is not an additional tax. A U.S. Holder generally may obtain a refund of any amounts withheld under the backup withholding rules that exceed the U.S. Holder&#8217;s income tax liability by filing a refund claim with the IRS. U.S. Holders are urged to consult their tax advisors regarding the application of the United States information reporting and backup withholding rules. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">150</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOSW">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF SECURITIES WE ARE OFFERING</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We are offering up to 7,640,845 ADSs, and pre-funded warrants to purchase up to 7,640,845 ADSs in lieu thereof. For each pre-funded warrant we sell, the number of ADSs we are offering will be decreased on a one-for-one basis. We are also registering the ADSs issuable from time to time upon exercise of the pre-funded warrants offered hereby. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">American Depositary Shares (&#8216;ADSs&#8217;)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For a description of the ADSs see the section &#8220;Description of American Depositary Shares&#8221;. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;22, 2024, we effected a change to the ratio of the ADSs to our ordinary shares from one ADS representing one (1)&#160;ordinary share to one ADS representing ten (10) ordinary shares, or the ADS Ratio Change. Except as otherwise indicated, all information in this prospectus, including the number of ADSs being offered and the offering price gives retroactive effect to the ADS Ratio Change. </font>
        </div>

          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Warrants</font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Duration and Exercise Price</font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Each Warrant will have an exercise price equal to $&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; per ADS. The Warrants will be immediately exercisable from the date of issuance until the five (5) year anniversary of the initial exercise date. The exercise price and number of ADSs issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, subsequent rights offerings, pro rate distributions, reorganizations, or similar events affecting the Company&#8217;s ordinary shares and ADSs and the exercise price. </font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Exercisability</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to the Company a duly executed exercise notice accompanied by payment in full for the number of ADSs purchased upon such exercise. A holder (together with its affiliates) may not exercise any portion of such holder&#8217;s Warrants to the extent that the holder would own more than 4.99% (or, at the election of the holder, 9.99%) of the outstanding ordinary shares represented by ADSs immediately after exercise, except that upon prior notice from the holder to the Company, the holder may increase or decrease the amount of ownership of outstanding ADSs after exercising the holder&#8217;s Warrants up to 9.99% of the number of the Company&#8217;s ordinary shares outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Warrants, provided that any increase will not be effective until 61 days following notice to us. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At the time a holder exercises its Warrants, if a registration statement registering the issuance or resale of the ordinary shares represented by ADSs issuable upon exercise of the Warrants under the Securities Act is not then effective or available for the issuance of such ordinary shares represented by ADSs, we shall be obligated to pay certain liquidated damages of up to $20 per day per $1,000 of Warrant ADSs subject to exercise as further described in Section 2(c) of the Warrants. </font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Trading Market</font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">There is no established trading market for the Warrants, and the Company does not expect an active trading market to develop. The Company does not intend to apply to list the Warrants on any securities exchange or other trading market. Without a trading market, the liquidity of the Warrants will be extremely limited. </font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Rights as a Stockholder</font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Except as otherwise provided in the Warrants or by virtue of the holder&#8217;s ownership of the Company&#8217;s ADSs, such holder of Warrants does not have the rights or privileges of a holder of the Company&#8217;s ADSs, including any voting rights, until such holder exercises such holder&#8217;s Warrants. The Warrants will provide that the holders of the Warrants have the right to participate in distributions or dividends paid on the Company&#8217;s ADSs. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">151</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Fundamental Transactions</font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">If at any time the Warrants are outstanding, the Company, either directly or indirectly, in one or more related transactions effects a Fundamental Transaction (as defined in the Warrant), a Holder of Warrants will be entitled to receive, upon exercise of the Warrants, the kind and amount of securities, cash or other property that such holder would have received had they exercised the Warrants immediately prior to the Fundamental Transaction. Notwithstanding the foregoing, in the event of a fundamental transaction, the holders of the Warrants have the right to require us or a successor entity to redeem the Warrants for cash in the amount of the Black-Scholes Value (as defined in each Warrant) of the unexercised portion of the Warrants concurrently with or within 30 days following the consummation of a fundamental transaction. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">However, in the event of a fundamental transaction which is not in our control, including a fundamental transaction not approved by our board of directors, the holders of the Warrants will only be entitled to receive from us or our successor entity, as of the date of consummation of such fundamental transaction the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of the Warrants that is being offered and paid to the holders of our ADSs in connection with the fundamental transaction, whether that consideration is in the form of cash, stock or any combination of cash and stock, or whether the holders of our ADSs are given the choice to receive alternative forms of consideration in connection with the fundamental transaction. </font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Waivers and Amendments</font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The Warrants may be modified or amended or the provisions of the Warrants waived with the Company&#8217;s and the holder&#8217;s written consent. </font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Pre-Funded Warrants</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The term &#8220;pre-funded&#8221; refers to the fact that the purchase price of the pre-funded warrants in this offering includes almost the entire exercise price that will be paid under the pre-funded warrants, except for an amount in US dollars equal to DKK 10 at the time of pricing of this offering, which amount is equal to $1.42 as of the date of the prospectus, provided that such exercise price shall not be less than the USD equivalent to DKK 10 at the time of exercise. The purpose of the pre-funded warrants is to enable investors that may have restrictions on their ability to beneficially own more than 4.99% (or, at the election of such purchaser, 9.99%) of our outstanding ordinary shares represented by ADSs following the consummation of this offering the opportunity to invest capital into the Company without triggering their ownership restrictions, by receiving pre-funded warrants in lieu of ADSs which would result in such ownership of more than 4.99% or 9.99%, as applicable, and receiving the ability to exercise their option to purchase the ADSs underlying the pre-funded warrants at a price at a later date. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The following is a brief summary of certain terms and conditions of the pre-funded warrants being offered by us. The following description is subject in all respects to the provisions contained in the form of pre-funded warrant, the form of which will be filed as an exhibit to the registration statement of which this prospectus forms a part. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exercise Price</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The pre-funded warrants will have an exercise price of DKK 10 equal to $1.42, provided that such exercise price shall not be less than the USD equivalent to DKK 10 at the time of exercise. The exercise price is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting the ADSs and also upon any distributions of assets, including cash, stock or other property to our stockholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exercisability</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The pre-funded warrants are exercisable at any time after their original issuance and until exercised in full. The pre-funded warrants will be exercisable, at the option of each holder, in whole or in part by delivering </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">152</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to us a duly executed exercise notice and by payment in full of the exercise price in immediately available funds for the number of ADSs purchased upon such exercise. No fractional ADSs will be issued in connection with the exercise of a pre-funded warrant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the time a holder exercises its pre-funded warrants, if a registration statement registering the issuance or resale of the ordinary shares represented by ADSs issuable upon exercise of the pre-funded warrants under the Securities Act is not then effective or available for the issuance of such ordinary shares represented by ADSs, we shall be obligated to pay certain liquidated damages of up to $20 per day per $1,000 of pre-funded warrants ADSs subject to exercise as further described in Section&#160;2(c) of the pre-funded warrants. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As set forth in the pre-funded warrant that is an exhibit to this registration statement, investors who purchase pre-funded warrants may, at the option of the investor, deliver the aggregate exercise price at closing of the offering to our Danish counsel, which shall be held in trust by our Danish counsel until the time of exercise of the pre-funded warrants by the investors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exercise Limitations</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The pre-funded warrants may not be exercised by the holder to the extent that the holder, together with its affiliates, would beneficially own, after such exercise more than 4.99% of the ADSs then outstanding (including for such purpose the ADSs issuable upon such exercise). However, any holder may increase or decrease such beneficial ownership limitation upon notice to us, provided that such limitation cannot exceed 9.99%, and provided that any increase in the beneficial ownership limitation shall not be effective until 61&#160;days after such notice is delivered. Purchasers of pre-funded warrants in this offering may also elect prior to the issuance of the pre-funded warrants to have the initial exercise limitation set at 9.99% of our outstanding ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Transferability</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to applicable laws, the pre-funded warrants may be offered for sale, sold, transferred or assigned without our consent. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Trading Market</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">There is no established trading market for the pre-funded warrants and we do not expect a market to develop. In addition, we do not intend to apply for the listing of the pre-funded warrants on any national securities exchange or other trading market. Without an active trading market, the liquidity of the pre-funded warrants will be limited. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fundamental Transactions</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event of a fundamental transaction, as described in the pre-funded warrants and generally including any reorganization, recapitalization or reclassification of the ADSs, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding ADSs, or any person or group becoming the beneficial owner of more than 50% of the voting power represented by our outstanding ADSs, upon consummation of such a fundamental transaction, the holders of the pre-funded warrants will be entitled to receive upon exercise of the pre-funded warrants the kind and amount of securities, cash or other property that the holders would have received had they exercised the pre-funded warrants immediately prior to such fundamental transaction without regard to any limitations on exercise contained in the pre-funded warrants. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Rights as a Shareholder</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in the pre-funded warrant or by virtue of such holder&#8217;s ownership of shares of the ADSs, the holder of a pre-funded warrant does not have the rights or privileges of a holder of the ADSs, including any voting rights, until the holder exercises the pre-funded warrant. The pre-funded warrants will provide that holders have the right to participate in distributions or dividends paid on the ADSs. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">153</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPOD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PLAN OF DISTRIBUTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have engaged Lake Street Capital Markets, LLC, or the Placement Agent, to act as our exclusive Placement Agent to solicit offers to purchase the securities offered pursuant to this prospectus on a reasonable best efforts basis. The engagement agreement does not give rise to any commitment by the Placement&#160;Agent to purchase any of our securities, and the Placement Agent will have no authority to bind us by virtue of the engagement agreement. The Placement Agent is not purchasing or selling any of the securities offered by us under this prospectus, nor is it required to arrange for the purchase or sale of any specific number or dollar amount of securities, other than to use its &#8220;reasonable best efforts&#8221; to arrange for the sale of such securities by us. Therefore, we may not sell all of the securities being offered. The terms of this offering were subject to market conditions and negotiations between us, the Placement Agent and prospective investors. This is a best efforts offering and there is no minimum offering amount required as a condition to the closing of this offering. Because there is no minimum offering amount required as a condition to closing this offering, we may sell fewer than all of the securities offered hereby, which may significantly reduce the amount of proceeds received by us. The Placement Agent does not guarantee that it will be able to raise new capital in any prospective offering. The Placement Agent may engage sub-agents or selected dealers to assist with the offering. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Investors purchasing securities offered hereby will have the option to execute a securities purchase agreement with us. In addition to rights and remedies available to all purchasers in this offering under federal securities and state law, the purchasers which enter into a securities purchase agreement will also be able to bring claims of breach of contract against us. The ability to pursue a claim for breach of contract is material to larger purchasers in this offering as a means to enforce the following covenants uniquely&#160;available to them under the securities purchase agreement: (i)&#160;a covenant to not enter into variable rate financings for a period of&#8199;&#8199;&#8199;&#8199;&#8199; following the closing of the offering, subject to certain exceptions; and (ii)&#160;a covenant to not issue any ordinary shares or ADSs or securities convertible into ordinary shares or ADSs for &#8199;&#8199;&#8199;&#8199;&#8199; from closing of the offering, subject to certain exceptions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The nature of the representations, warranties and covenants in the securities purchase agreements shall include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">standard issuer representations and warranties on matters such as organization, qualification, authorization, no conflict, no governmental filings required, current in SEC filings, no litigation, labor or other compliance issues, environmental, intellectual property and title matters and compliance with various laws such as the Foreign Corrupt Practices Act; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">covenants regarding matters such as registration of warrant shares, no integration with other offerings, filing of a 6-K to disclose entering into these securities purchase agreements, no shareholder rights plans, no material nonpublic information, use of proceeds, indemnification of purchasers, reservation and listing of ADSs, and no issuance of any ordinary shares or ADSs or securities convertible into ordinary shares or ADSs for &#8199;&#8199;&#8199;&#8199; days from closing of the offering, subject to certain exceptions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We expect to deliver the securities being offered pursuant to this prospectus on or about&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;, 2024, subject to satisfaction of certain customary closing conditions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fees and Expenses</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The following table shows the per ADS and Warrant and per pre-funded warrant and Warrant proceeds and total Placement Agent fees we will pay in connection with the sale of the securities in this offering. </font>
          </div>


          <table style="width:416pt;height:80.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:255.57pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Per ADS And </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">accompanying </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Warrant</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Per Pre-Funded</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Warrant and </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">accompanying </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Warrant</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Total </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 0.5pt 0pt; width:255.57pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Public offering price </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8199;&#8199;&#8199;&#8199;</td>
              <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.66pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8199;&#8199;&#8199;&#8199;</td>
              <td style="padding:0pt;padding-left:13.66pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8199;&#8199;&#8199;&#8199;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:255.57pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Placement Agent Fees </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;"> </td>
              <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.66pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;"> </td>
              <td style="padding:0pt;padding-left:13.66pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;"> </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:255.57pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Proceeds to us (before expenses) </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;"> </td>
              <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.66pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;"> </td>
              <td style="padding:0pt;padding-left:13.66pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">154</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Pre-Funded Warrant public offering price of $&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; calculated to include the exercise price of DKK&#160;10 equal to $1.42 in addition to the public offering price of $&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:3.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(2)</font>
            <br >
          </div>
          <div style=" margin-top:3.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Gross proceeds assumes exercise in full of Pre-Funded Warrants and no exercise of the Warrants. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have agreed to pay the Placement Agent cash fee equal to 7.0% of the gross proceeds raised in this offering. We have also agreed to reimburse the Placement Agent for certain of its offering-related expenses, including for its legal fees and expenses and other out-of-pocket expenses in an amount up to $100,000. We estimate the total expenses of this offering payable by us, excluding the Placement Agent fees, will be approximately $0.7&#160;million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have agreed to pay an investment banking firm that we engaged in a prior financing a cash fee of up to seven and a half&#160;percent (7.5%) of the gross proceeds received by us in this offering (the &#8220;Fee Tail&#8221;) from certain investors previously brought over-the-wall by such firm (the &#8220;Tail Investors&#8221;). To the extent such Tail Investors represent one-quarter of the gross proceeds received in this offering, we would be obligated to pay to such investment banking firm, and our net proceeds in this offering would be reduced by, approximately $235,000. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Lock-up Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We and each of our officers and directors have agreed with the Placement Agent to be subject to a lock-up period of TBD days following the date of closing of the offering pursuant to this prospectus. This means that, during the applicable lock-up period, we and such persons may not offer for sale, contract to sell, sell, distribute, grant any option, right or warrant to purchase, pledge, hypothecate or otherwise dispose of, directly or indirectly, any of the ADSs or any securities convertible into, or exercisable or exchangeable for, ADSs, subject to customary exceptions. The Placement Agent may waive the terms of these lock-up agreements in its sole discretion and without notice. In addition, we have agreed to not issue any securities that are subject to a price reset based on the trading prices of our ADSs or upon a specified or contingent event in the future, or enter into any agreement to issue securities at a future determined price for a period of &#8199;&#8199;&#8199;&#8199; following the closing date of this offering, subject to certain exceptions. The Placement Agent may waive this prohibition in its sole discretion and without notice. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Tail</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have also agreed to pay the Placement Agent a tail fee equal to the cash compensation in this offering, if any investor, who was brought over-the-wall by the Placement Agent during the term of its engagement, provides us with capital in any public or private offering or other financing or capital raising transaction during the 6-month period following expiration or termination of our engagement of the Placement Agent. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regulation&#160;M</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Placement Agent may be deemed to be an underwriter within the meaning of Section&#160;2(a)(11) of the Securities Act, and any commissions received by it and any profit realized on the resale of the securities sold by it while acting as principal might be deemed to be underwriting discounts or commissions under the Securities Act. As an underwriter, the Placement Agent would be required to comply with the requirements of the Securities Act and the Exchange Act, including, without limitation, Rule&#160;10b-5 and Regulation&#160;M under the Exchange Act. These rules and regulations may limit the timing of purchases and sales of our securities by the Placement Agent acting as principal. Under these rules and regulations, the Placement Agent (i)&#160;may not engage in any stabilization activity in connection with our securities and (ii)&#160;may not bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities, other than as permitted under the Exchange Act, until it has completed its participation in the distribution. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indemnification</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have agreed to indemnify the Placement Agent against certain liabilities, including certain liabilities arising under the Securities Act and to contribute to payments that the Placement Agent may be required to make for these liabilities. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">155</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:264pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Determination of Offering Price</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The actual offering price of the securities we are offering has been negotiated between us and the investors in the offering based on the trading of the ADSs prior to the offering, among other things. Other factors considered in determining the public offering price of the securities we are offering include our history and prospects, the stage of development of our business, our business plans for the future and the extent to which they have been implemented, an assessment of our management, the general conditions of the securities markets at the time of the offering and such other factors as were deemed relevant. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Electronic Offer, Sale and Distribution of Securities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A prospectus in electronic format may be made available on the websites maintained by the Placement Agent, if any, participating in this offering and the Placement Agent may distribute prospectuses electronically. Other than the prospectus in electronic format, the information on these websites is not part of this prospectus or the registration statement of which this prospectus forms a part, has not been approved or endorsed by us or the Placement Agent, and should not be relied upon by investors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Relationships</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From time to time, the Placement Agent or its affiliates have in the past or may in the future provide in the future, various advisory, investment and commercial banking and other services to us in the ordinary course of business, for which they have received and may continue to receive customary fees and commissions. However, except as disclosed in this prospectus, we have no present arrangements with the Placement Agent for any further services. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Listing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The ADSs are listed on The Nasdaq Capital Market under the symbol &#8220;EVAX.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Depositary</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary for the ADSs is The Bank of New York Mellon. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">156</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tEOTO">&#8203;</a><a name="tLEMA">&#8203;</a><a name="tEXP">&#8203;</a><a name="tWYCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPENSES OF THE OFFERING</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Set forth below is an itemization of the total anticipated expenses, excluding Placement Agent commissions, expected to be incurred in connection with the offer and sale of the ADSs by us. With the exception of the SEC registration fee and the FINRA filing fee, all amounts are estimates, in United States dollars: </font>
        </div>
        <table style="width:416pt;height:100pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:366.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">SEC registration fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,914</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">FINRA filing fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,375</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Printing and engraving expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">90,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.99999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Legal fees and expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">540,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accounting fees and expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">45,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Miscellaneous expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:366.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">722,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.9pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LEGAL MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are being represented by Duane Morris LLP, New York, New York with respect to certain legal matters of United States federal securities and New York state law. We are being represented by Mazanti- Andersen AdvokatPartnerselskab, Denmark with respect to certain legal matters of the law of Denmark. Sullivan &amp; Worcester, LLP, New York, New York, is acting as counsel to the placement agent in connection with certain legal matters related to this offering. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPERTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The consolidated financial statements of Evaxion Biotech A/S appearing in Evaxion Biotech A/S&#8217;s Annual Report (Form 20-F) for the year ended December 31, 2023 have been audited by EY Godkendt Revisionspartnerselskab, independent registered public accounting firm, as set forth in their report thereon (which contains an explanatory paragraph describing conditions that raise substantial doubt about the Company&#8217;s ability to continue as a going concern as described in Note 2 to the consolidated financial statements) included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The registered business address of EY Godkendt Revisionspartnerselskab is Dirch Passers All&#233; 36, 2000 Frederiksberg, Denmark. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WHERE YOU CAN FIND MORE INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have filed with the SEC a registration statement on Form F-1 under the Securities Act relating to this offering. This prospectus does not contain all of the information contained in the registration statement. The rules and regulations of the SEC allow us to omit certain information from this prospectus that is included in the registration statement. Statements made in this prospectus concerning the contents of any contract, agreement or other document are summaries of all material information about the documents summarized, but are not complete descriptions of all terms of these documents. If we filed any of these documents as an exhibit to the registration statement, you may read the document itself for a complete description of its terms. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may read and copy the registration statement, including the related exhibits and schedules, and any document we file with the SEC without charge at the SEC&#8217;s public reference room at 100 F Street, N.E., Room 1580, Washington, DC 20549. You may also obtain copies of the documents at prescribed rates by writing to the Public Reference Section of the SEC at 100 F Street, N.E., Room 1580, Washington, DC 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room. The SEC also maintains an Internet website that contains reports and other information regarding issuers that file electronically with the SEC. Our filings with the SEC are also available to the public through the SEC&#8217;s website at </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">157</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We are subject to the information reporting requirements of the Exchange Act that are applicable to foreign private issuers, and under those requirements are filing reports with the SEC. Those other reports or other information may be inspected without charge at the locations described above. As a foreign private issuer, we are exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and short- swing profit recovery provisions contained in Section&#160;16 of the Exchange Act. In addition, we are not required under the Exchange Act to file annual, quarterly and current reports and financial statements with the SEC as frequently or as promptly as U.S. registrants whose securities are registered under the Exchange Act. However, we are required to file with the SEC, within 120&#160;days after the end of each fiscal year, or such applicable time as required by the SEC, an annual report on Form 20-F containing financial statements audited by an independent registered public accounting firm, and will furnish to the SEC, on Form&#160;6-K, unaudited interim financial information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We maintain a corporate website at www.evaxion-biotech.com. Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference. We will post on our website any materials required to be so posted on such website under applicable corporate or securities laws and regulations, including, posting any XBRL interactive financial data required to be filed with the SEC and any notices of general meetings of our shareholders. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INFORMATION INCORPORATED BY REFERENCE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The rules of the SEC allow us to incorporate information into this prospectus by reference. The information incorporated by reference is considered to be a part of this prospectus. This prospectus incorporates by reference the documents listed below (including any exhibits, except where otherwise noted): </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;"><a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f.htm">our Annual Report on Form 20-F for the year ended December&#160;31, 2023 filed with the SEC on March&#160;26, 2024;</a> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;"><a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924002087/tm242312d1_6k.htm">our reports on Form 6-K filed with the SEC on January&#160;8, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924002818/tm242578d1_6k.htm">January&#160;10, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924003545/tm243239d1_6k.htm">January&#160;12, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924005593/tm243814d1_6k.htm">January&#160;22, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924006204/tm244046d1_6k.htm">January&#160;24, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924007286/tm244277d1_6k.htm">January&#160;26, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924009200/tm2334005d10_6k.htm">February&#160;1, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924010345/tm2334005d11_6k.htm">February&#160;5, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924010952/tm2334005d12_6k.htm">February&#160;6, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924011401/tm245386d2_6k.htm">February&#160;7, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924011634/tm245386d1_6k.htm">February&#160;7, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324000857/f6k_022024.htm">February&#160;20, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324001069/f6k_022924.htm">February&#160;29, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924033948/tm248683d1_6k.htm">March&#160;13, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324001433/f6k_031924.htm">March&#160;19, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324001636/f6k_032724.htm">March&#160;27, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924040866/tm2410083d1_6k.htm">March&#160;29, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324001751/f6k_040224.htm">April&#160;2, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324002048/f6k_041724.htm">April&#160;17, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324002249/f6k_042324.htm">April&#160;25, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324002767/f6k_051024.htm">May&#160;10, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003087/f6k_052324.htm">May&#160;23, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003093/f6k_052424.htm">May&#160;24, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003119/f6k_052824.htm">May&#160;28, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003213/f6k_060324.htm">June&#160;3, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003215/f6k_053024.htm">June&#160;3, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003344/f6k_060724.htm">June&#160;7, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003468/f6k_061724.htm">June&#160;17, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003502/f6k_061824.htm">June&#160;18, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003612/f6k_062424.htm">June&#160;24, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003651/f6k_062624.htm">June&#160;26, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003784/f6k_070224.htm">July&#160;2, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003786/f6k_070224.htm">July&#160;2, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003794/f6k_070324.htm">July&#160;3, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003804/f6k_070324.htm">July&#160;3, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003965/f6k_071624.htm">July&#160;16, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324004406/f6k_080224.htm">August&#160;2, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324004563/f6k_080824.htm">August&#160;8, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324004668/f6k_081224.htm">August&#160;12, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1828253/000117184324004774/evax20240805_6k.htm">August&#160;14, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324004776/f6k_081424.htm">August&#160;14, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324004853/f6k_081924.htm">August&#160;19, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324005111/f6k_090924.htm">September&#160;9, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324005113/f6k_090924.htm">September&#160;9, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324005195/f6k_091624.htm">September&#160;16, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324005264/f6k_091924.htm">September&#160;19, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324005295/f6k_092024.htm">September&#160;20, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324005365/f6k_092624.htm">September&#160;26, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324005434/f6k_100124.htm">October&#160;1, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324005470/f6k_100224.htm">October&#160;3, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324005502/f6k_100424.htm">October&#160;4, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324005571/f6k_100924.htm">October&#160;9, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324005840/f6k_102824.htm">October&#160;28, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324005932/f6k_103124.htm">October&#160;31, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324006312/f6k_111324.htm">November&#160;13, 2024</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324006313/f6k_111224.htm">November&#160;13, 2024</a>; <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324006317/f6k_111324.htm">November&#160;13, 2024</a>; <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324006675/f6k_120324.htm">December 3, 2024</a>; December 9, 2024; December 12, 2024; and December 17, 2024;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the description of our securities contained in our registration statement on <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465921007674/tm2031352d20_8a12b.htm">Form 8-A filed with the SEC on January&#160;26, 2021</a>, including all amendments and reports filed for the purpose of updating such description. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Any statement made in a document incorporated by reference into this prospectus will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus modifies or supersedes that statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">You can obtain any of the filings incorporated by reference into this prospectus through us or from the SEC through the SEC&#8217;s website at http://www.sec.gov. We will provide, without charge, to each person, including any beneficial owner, to whom a copy of this prospectus is delivered, upon written or oral request </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">158</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOCP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:456pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of such person, a copy of any or all of the reports and documents referred to above which have been or may be incorporated by reference into this prospectus. You should direct requests for those documents to: </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Evaxion Biotech A/S</font>
          <br >
          <font style="letter-spacing:0.2pt;">Dr.&#160;Neergaards Vej 5F</font>
          <br >
          <font style="letter-spacing:0.2pt;">2970 H&#248;rsholm</font>
          <br >
          <font style="letter-spacing:0.2pt;">Denmark</font>
          <br >
          <font style="letter-spacing:0.2pt;">Tel:+ 45 53 53 18 50 </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In so far as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons, we have been informed that in the opinion of the SEC this indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">159</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:14pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 2.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:39.26pt; text-align:justify; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#8199;</font>
        </div>

          <div style="margin-top:10.92pt; text-align:center; width:456pt; line-height:15.5pt;font-weight:bold;">
            <font style="letter-spacing:-0.28pt;">UP TO 7,640,845&#160;AMERICAN DEPOSITARY SHARES REPRESENTING 76,408,450 ORDINARY SHARES </font>
            <br >
            <font style="letter-spacing:-0.28pt;">AND UP TO 7,640,845 PRE-FUNDED WARRANTS TO PURCHASE </font>
            <br >
            <font style="letter-spacing:-0.28pt;">UP TO 7,640,845&#160;AMERICAN DEPOSITARY SHARES </font>
            <br >
            <font style="letter-spacing:-0.28pt;">AND UP TO 7,640,845 WARRANTS TO PURCHASE UP TO</font>
            <br >
            <font style="letter-spacing:-0.28pt;">7,640,845 AMERICAN DEPOSITARY SHARES</font>
          </div>


          <div style="margin-top:2pt; text-align:center; width:456pt; line-height:11.5pt;font-size:10pt;">
            <font style="letter-spacing:0.2pt;">(and 7,640,845 American Depositary Shares representing 76,408,450 ordinary shares issuable upon exercise of the Pre-Funded Warrants and 7,640,845 American Depositary Shares representing 76,408,450 ordinary shares issuable upon exercise of the Warrants) </font>
          </div>

        <div style="position:relative;margin-top:39.16pt; text-align:center; width:456pt;">
          <img src="lg_evaxion-bwlr.jpg" alt="[MISSING IMAGE: lg_evaxion-bwlr.jpg]" height="56" width="320" >
        </div>
        <div style="margin-top:41.67pt; text-align:center; width:456pt; line-height:20pt;font-weight:bold;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">EVAXION BIOTECH A/S</font><font style="font-weight:normal;letter-spacing:0.36pt;"> </font>
        </div>
        <div style="margin-top:60pt; text-align:center; width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">PRELIMINARY</font><font style="font-weight:normal;letter-spacing:0.24pt;"> </font>
        </div>
        <div style="margin-top:24pt; text-align:center; width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.24pt;"> </font>
        </div>
        <div style="margin-top:72pt; text-align:center; width:456pt; line-height:20pt;font-weight:bold;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">Lake Street</font><font style="font-weight:normal;letter-spacing:0.36pt;"> </font>
        </div>
        <div style="margin-top:72pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2024</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:74.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 74.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 2.5pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tITFS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PART II</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INFORMATION NOT REQUIRED IN PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;6.&nbsp;&nbsp;&nbsp;Indemnification of Directors and Officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The general meeting is allowed to discharge our board members and members of our executive management from liability for any particular financial year based on a resolution relating to the financial statements. This discharge means that the general meeting will discharge such board members and members of our executive management from liability to our company. However, the general meeting cannot discharge any claims by individual shareholders or other third parties. In addition, the discharge can be set aside in case the general meeting prior to its decision to discharge was not presented with all reasonable information necessary for the general meeting to assess the matter at hand. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additionally, we have agreed to indemnify our board members and members of our executive management and employees, in relation to certain claims. We will not, however, indemnify our board members, executive management and employees, in respect of: (i)&#160;claims against a person pursuant to Danish law raised before the Danish Courts, except claims arising from the offer, sale and listing of the our securities in the United States and/or its subsequent status as a listed company in the United States, including in respect of our reports filed with or furnished to the U.S. Securities and Exchange Commission; (ii)&#160;claims against a person for damages and legal costs related to criminal and/or grossly negligent or willful acts or omissions committed by the indemnified person; (iii)&#160;claims against an indemnified person, which is attributable to the gaining or purported gaining of any profit or advantage to which the indemnified person or any related natural or legal person was not legally entitled; (iv)&#160;claims covered by insurance; (v)&#160;claims brought against the indemnified person by us or any subsidiary of ours; and (vi)&#160;any sum payable to a regulatory authority by way of a penalty in respect of the indemnified person&#8217;s personal non-compliance with any requirement of a regulatory nature howsoever arising. The indemnification is limited to a maximum amount of DKK 534.5&#160;million per claim per person. The indemnification shall remain in force for a period of five&#160;years after the resignation of the indemnified person from us or our subsidiaries, if the claims made within such period are related to such person&#8217;s services to us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There is a risk that such indemnification will be deemed void under Danish law, either because the indemnification is deemed contrary to the rules on discharge of liability in the Danish Company Act, as set forth above, because the indemnification is deemed contrary to sections 19 and 23 of the Danish Liability and Compensation Act, which contain mandatory provisions on recourse claims between an employee (including members of our executive management) and the company, or because the indemnification is deemed contrary to the general provisions of the Danish Contracts Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, we provide our board members and executive management with directors&#8217; and officers&#8217; liability insurance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended, or the Securities Act, may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;7.&nbsp;&nbsp;&nbsp;Recent Sales of Unregistered Securities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">2022 Sales of Unregistered Securities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Lincoln Park Purchase Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On June&#160;7, 2022, we completed a private placement to Lincoln Park Capital Fund, LLC pursuant to which we have the right to sell to Lincoln Park up to $40,000,000 of our ordinary shares represented by American Depositary Shares (the &#8220;ADSs&#8221;), subject to certain limitations, from time to time over the 36- month period commencing on the date that a registration statement covering the resale of the ADSs is declared effective by the SEC. We issued 428,572 ordinary shares to Lincoln Park as consideration for its commitment to purchase our shares under the Purchase Agreement. In the Purchase Agreement, LincolnII-1 Park </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">represented to the Company, among other things, that it was an &#8220;accredited investor&#8221; &#8203;(as such term is defined in Rule&#160;501(a) of Regulation&#160;D under the Securities Act of 1933, or the Securities Act). The securities were sold by the Company under the Purchase Agreement in reliance upon an exemption from the registration requirements under the Securities Act afforded by Section&#160;4(a)(2) of the Securities Act. </font>
        </div>
        <div style="margin-left:20pt; margin-top:10.02pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">2023 Securities Purchase Agreement and Investment Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;18, 2023, the Company, entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) and an Investment Agreement (the &#8220;Investment Agreement&#8221;; and, together with the Purchase Agreement referred to herein as the &#8220;Purchase Agreements&#8221;), with certain Institutional Accredited Investors, Qualified Institution Buyers and other Accredited Investors, including all members of the Company&#8217;s Management and Board of Directors and MSD GHI (&#8220;MSD&#8221;), a subsidiary of Merck Inc. New Brunswick (collectively, the &#8220;Purchasers&#8221;), for the issuance and sale in a private placement (the &#8220;Private Placement&#8221;) of 9,726,898 of the Company&#8217;s ordinary shares, represented by American Depositary Shares, and accompanying warrants to purchase up to 9,726,898 Ordinary Shares represented by ADSs at a purchase price of $0.544 per ordinary share. The Warrants are exercisable immediately upon issuance, expire three&#160;(3)&#160;years after the closing date of the Private Placement and have an exercise price equal to $0.707 per Ordinary Share. </font>
        </div>
        <div style="margin-left:20pt; margin-top:7.22pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">MSD participated in the Private Placement accounting for some 25% of the full offering amount. Further, the Private Placement included significant participation by all members of the Company&#8217;s management and board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.22pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The gross proceeds to the Company from the Private Placement were approximately $5.3&#160;million</font><font style="font-weight:bold;letter-spacing:-0.2pt;">,</font><font style="letter-spacing:0.2pt;"> with up to an additional $6.8&#160;million of gross proceeds upon cash exercise of the Warrants, before deducting offering expenses payable by the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Private Placement was subject to the satisfaction of customary closing conditions and closed on December&#160;21, 2023. </font>
        </div>
        <div style="margin-top:9.93pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;8.&nbsp;&nbsp;&nbsp;Exhibits and Financial Statement Schedules</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <table style="width:456pt;height:316.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:32.71pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Exhibit</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Number </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:225.09pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Exhibit Description </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:25.51pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Form </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:45.62pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Date </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Incorporated</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">by Reference</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Number </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">File</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Number </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">1.1** </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2427973d6_ex1-1.htm">Form of Placement Agency Agreement for this Offering</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:25.51pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:45.62pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:42.74pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:48.33pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">3.1 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324006313/exh_11.htm">Articles of Association currently in effect (including English translation)</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">11/13/2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">1.1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-39950</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.1 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1201935/000101915521000011/evaxionda.htm">Form of Deposit Agreement among the Registrant, the depositary and holders and beneficial owners of the American Depositary Shares</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">F-6 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">01/12/2021 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">333-252038 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.2 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1201935/000101915521000011/evaxionda.htm">Form of Specimen American Depositary Receipt (included in Exhibit&#160;4.1)</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:25.51pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:45.62pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:42.74pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:48.33pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.3 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465923128269/tm2333217d2_ex10-1.htm">Form of Securities Purchase Agreement</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">12/21/2023 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10.1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-39950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.4 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465923128269/tm2333217d2_ex10-2.htm">Form of Investment Agreement</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">12/21/2023 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10.2 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-39950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.5 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465923128269/tm2333217d2_ex10-3.htm">Form of Registration Rights Agreement</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">12/21/2023 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10.3 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-39950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.6 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465923128269/tm2333217d2_ex4-1.htm">Form of Warrant Certificate</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">12/21/2023 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">4.1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-39950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.7** </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2427973d6_ex4-7.htm">Form of Pre-Funded Warrant for this Offering</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:25.51pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:45.62pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:42.74pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:48.33pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:32.71pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.8**</font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:225.09pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2427973d6_ex4-8.htm">Form of Ordinary Warrant</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td colspan="3">&#8203;</td>
              <td colspan="3">&#8203;</td>
              <td colspan="3">&#8203;</td>
              <td colspan="3">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">5.1** </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2427973d6_ex5-1.htm">Form of Opinion of Mazanti-Andersen regarding the validity of the Ordinary Shares being registered</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:25.51pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:45.62pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:42.74pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:48.33pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">8.1</font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/tm2427973d4_ex8-1.htm">Form of Tax Opinion of Mazanti-Andersen</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">F-1</font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">12/05/2024</font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">8.1</font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">333-283304</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.1 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465921002525/tm2031352d12_ex10-1.htm">CAF</a><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;"><a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465921002525/tm2031352d12_ex10-1.htm">&#174;</a></font><a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465921002525/tm2031352d12_ex10-1.htm">09b Supply, Patent Know How &amp; Trademark License Agreement dated November&#160;30, 2020, between Statens Serum Institut and Evaxion Biotech A/S</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">F-1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">01/08/2021 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10.1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">333-251982 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:20.5pt;margin-left:69.66pt;width:456pt;">

          <table style="width:463.2pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:32.71pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Exhibit</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Number </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:225.09pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Exhibit Description </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:25.51pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Form </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:45.62pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Date </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Incorporated</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">by Reference</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Number </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">File</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Number </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.6pt;">&#8203;</td>
              <td colspan="3">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.2 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465921002525/tm2031352d12_ex10-2.htm">Finance Contract between European Investment Bank and Evaxion Biotech A/S dated August&#160;6, 2020</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">F-1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">01/08/2021 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 0.5pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10.2 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">333-251982</font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td colspan="3">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.3 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465921002525/tm2031352d12_ex10-3.htm">Lease Agreement dated October&#160;2, 2020 between Evaxion Biotech A/S and DTU Science Park A/S.</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">F-1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">01/08/2021 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10.3 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">333-251982 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.4 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465921129167/tm2130750d1_ex99-2.htm">Clinical Trial Collaboration and Supply Agreement by and among Evaxion Biotech A/S, MSD International GmbH and MSD International Business GmbH, subsidiaries of Merck &amp; Co., Inc., (known collectively as MSD outside the United States and Canada) (Incorporate by Reference to Exhibit&#160;99.2 to Form 6-K filed with the Commission on October&#160;25, 2021).</a>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10/25/2021 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">99.2 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-39950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.5 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465922069014/tm2217679d1_ex10-1.htm">Purchase Agreement dated June&#160;7, 2022, between Evaxion Biotech A/S and Lincoln Park Capital Fund, LLC</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">06/07/2022 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10.1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-3950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.6 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465922069014/tm2217679d1_ex10-2.htm">Registration Rights Agreement dated June&#160;7, 2022, between Evaxion Biotech A/S and Lincoln Park Capital Fund, LLC</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">06/07/2022 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10.2 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-3950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.7 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465922105614/tm2217325d5_ex1-1.htm">Capital on DemandTM Sales Agreement dated October&#160;3, 2022 between Evaxion Biotech A./S and JonesTrading Institutional Services LLC</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10/04/2022 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">1.1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-3950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.8 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465923087892/tm2322907d1_ex10-1.htm">Agreement for the Issuance and Subscription of Notes</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">08/04/2023 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10.1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-39950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.9 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324005434/exh_101.htm">Option and License agreement</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10/03/2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10.1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-39950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.10 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924008168/tm2334005d4_ex4-4.htm">Form of Placement Agent Warrant</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">F-1/A </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">1/30/2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">4.4 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">333-276505 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.11 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924010345/tm2334005d11_99-1.htm">Form of Securities Purchase Agreement</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">02/05/2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">99.1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-39950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.12 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924010345/tm2334005d11_99-2.htm">Form of Pre-Funded Warrant</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">02/05/2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">99.2 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-39950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.13 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924010345/tm2334005d11_99-3.htm">Form of Series&#160;A Ordinary Warrant</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">02/05/2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">99.3 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-39950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.14 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003093/exh_101.htm">Amendment to Series&#160;A Warrant</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">05/24/2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10.1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-39950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.15 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003612/exh_101.htm">Amendment to Warrant</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">06/24/2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10.1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-39950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.16 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003784/exh_101.htm">Co-Ownership Agreement</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">07/02/2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10.1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-39950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">10.17 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000117184324003786/exh_101.htm">License Agreement</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6-K </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">07/02/2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">10.1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">001-39950 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <div style="text-align:justify;">
                  <font style="letter-spacing:0.2pt;">10.18** </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2427973d6_ex10-18.htm">Form of Securities Purchase Agreement for this Offering</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:25.51pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:45.62pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:42.74pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:48.33pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">21.1 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465921133373/tm2119736d11_ex21-1.htm">List of Subsidiaries of the Registrant</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">F-1/A </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">11/03/2021 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:42.74pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">21.1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">333-260493 </font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">23.1** </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2427973d6_ex23-1.htm">Consent of independent registered public accounting firm</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:25.51pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:45.62pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:42.74pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:48.33pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">23.2** </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2427973d6_ex5-1.htm">Consent of Mazanti-Andersen (included in Exhibit&#160;5.1).</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:25.51pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:45.62pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:42.74pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:48.33pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">24.1 </font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:225.09pt;white-space:normal;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/tm2427973-1_f1.htm#tPOATT">Power of Attorney (included on signature page to this registration statement).</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:25.51pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">F-1</font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:45.62pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">11/18/2024</font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:42.74pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:48.33pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">333-283304</font>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:32.71pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">107**</font>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:225.09pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2427973d6_ex-filingfees.htm">Filing Fee Table</a>
                </div>
              </td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:25.51pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:45.62pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:42.74pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:48.33pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt; width:3.6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">**</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Filed herewith </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;9.&nbsp;&nbsp;&nbsp;Undertakings</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(A)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">The undersigned registrant hereby undertakes: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">To include any prospectus required by Section&#160;10(a)(3) of the Securities Act of 1933, as amended, or the Securities Act; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or any decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule&#160;424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:7.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply if the registration statement is on Form F-3 and the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the SEC by the registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Securities Exchange Act of 1934, as amended, or Exchange Act, that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule&#160;424(b) that is part of the registration statement. </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">That, for the purpose of determining any liability under the Securities Act, each such post- effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">To file a post-effective amendment to the registration statement to include any financial statements required by Item&#160;8.A of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section&#160;10(a)(3) of the Exchange Act need not be furnished, provided that the registrant includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements. Notwithstanding the foregoing, with respect to registration statements on Form F-3, a post- effective amendment need not be filed to include financial statements and information required by Section&#160;10(a)(3) of the Exchange Act or Rule&#160;3-19 of Regulation&#160;S-K if such financial statements and information are contained in periodic reports filed with or furnished to the SEC by the registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Exchange Act that are incorporated by reference in this Form F-1. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">That, for the purpose of determining liability under the Securities Act to any purchaser: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">Each prospectus filed by the registrant pursuant to Rule&#160;424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:8pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:60pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">Each prospectus required to be filed pursuant to Rule&#160;424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule&#160;430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (vii), or (x)&#160;for the purpose of providing the information required by section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule&#160;430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </font>
        </div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iv)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(B)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:556pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(C)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:40pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant&#8217;s annual report pursuant to Section&#160;13(a) or Section&#160;15(d) of the Exchange Act that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">II-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPOATT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:128.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SIGNATURES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies it has reasonable grounds to believe that it meets all of the requirements for filing this amended registration statement on Form F-1 with the Securities and Exchange Commission and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Copenhagen, Denmark, on December&#160;17, 2024. </font>
          </div>

        <div style="margin-left:220pt; margin-top:12pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EVAXION BIOTECH A/S</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:18pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:18pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">/s/ Christian Kanstrup</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:240pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:32pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Name:</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:272pt;">
          <font style="letter-spacing:0.2pt;">Christian Kanstrup </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:240pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:32pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Title:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:272pt;">
          <font style="letter-spacing:0.2pt;">Chief Executive Officer </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated. </font>
        </div>

          <table style="width:456pt;height:282.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Signature </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:168pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Title </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:96pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Date </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:47.25pt; white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:19.917pt 0pt 0.5pt 0pt; width:0pt;white-space:normal;" colspan="4">
                <div>
                  <font style="letter-spacing:0.2pt;">/s/ Christian Kanstrup </font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 168pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Christian Kanstrup </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.917pt 0pt 0.5pt 0pt; width:168pt;">
                <font style="letter-spacing:0.2pt;">Chief Executive Officer </font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">(Principal Executive Officer)</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.917pt 0pt 0.5pt 0pt; width:96pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">December&#160;17, 2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:43pt; white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:16.167pt 0pt 0.5pt 0pt; width:0pt;white-space:normal;" colspan="4">
                <div>
                  <font style="letter-spacing:0.2pt;">/s/ * </font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 168pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Thomas Frederik Schmidt </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:16.167pt 0pt 0.5pt 0pt; width:168pt;">
                <font style="letter-spacing:0.2pt;">Interim Financial Officer </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:16.167pt 0pt 0.5pt 0pt; width:96pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">December&#160;17, 2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:43pt; white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:16.167pt 0pt 0.5pt 0pt; width:0pt;white-space:normal;" colspan="4">
                <div>
                  <font style="letter-spacing:0.2pt;">/s/ * </font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 168pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Marianne S&#248;gaard </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:16.167pt 0pt 0.5pt 0pt; width:168pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:16.167pt 0pt 0.5pt 0pt; width:96pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">December&#160;17, 2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:43pt; white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:16.167pt 0pt 0.5pt 0pt; width:0pt;white-space:normal;" colspan="4">
                <div>
                  <font style="letter-spacing:0.2pt;">/s/ * </font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 168pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Roberto Prego </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:16.167pt 0pt 0.5pt 0pt; width:168pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:16.167pt 0pt 0.5pt 0pt; width:96pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">December&#160;17, 2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:43pt; white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:16.167pt 0pt 0.5pt 0pt; width:0pt;white-space:normal;" colspan="4">
                <div>
                  <font style="letter-spacing:0.2pt;">/s/ * </font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 168pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Lars Wegner </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:16.167pt 0pt 0.5pt 0pt; width:168pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:16.167pt 0pt 0.5pt 0pt; width:96pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">December&#160;17, 2024 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:24pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:16.167pt 0pt 0.5pt 0pt; width:18pt;">
                <font style="letter-spacing:0.2pt;">*By: </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:16.167pt 0pt 0.5pt 0pt; width:138pt;white-space:normal;vertical-align:middle;">
                <div>
                  <font style="letter-spacing:0.2pt;">/s/ Christian Kanstrup</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 138pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Christian Kanstrup</font>
                  <br >
                  <font style="letter-spacing:0.2pt;">Attorney-In-Fact</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="3">&#8203;</td>
              <td colspan="3">&#8203;</td>
            </tr>
          </table>

        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style=" width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:492pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SIGNATURE OF AUTHORIZED U.S. REPRESENTATIVE OF THE REGISTRANT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Evaxion Biotech A/S, has signed this Form F-1 Registration Statement in New York, New York on December&#160;17, 2024. </font>
          </div>

        <div style="margin-left:220pt; margin-top:12pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EVAXION BIOTECH, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:18pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:18pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;">
          <font style="letter-spacing:0.2pt;">/s/ Roberto Prego </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Roberto Prego </font>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Director</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm2427973d6_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 1.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLACEMENT AGENCY AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 504.75pt">[&bull;], 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Christian Kanstrup</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Evaxion Biotech A/S<BR>
Dr.&nbsp;Neergaards Vej 5F</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2970 Horsholm</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Denmark</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mr.&nbsp;Kanstrup:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This letter agreement (the &ldquo;<B>Agreement</B>&rdquo;)
constitutes the agreement between Lake Street Capital Markets, LLC (&ldquo;<B>Lake Street</B>&rdquo;), as placement agent (the &ldquo;<B>Placement
Agent</B>&rdquo;) and Evaxion Biotech A/S, a public limited liability company incorporated under the laws of the Kingdom of Denmark (the
 &ldquo;<B>Company</B>&rdquo;), pursuant to which the Placement Agent shall serve as the exclusive placement agent for the Company, on
a &ldquo;reasonable best efforts&rdquo; basis, in connection with the proposed placement (the &ldquo;<B>Placement</B>&rdquo;) of American
Depositary Shares of the Company (the &ldquo;<B>ADSs</B>&rdquo;), each of which represents 10 ordinary shares of the Company, DKK 1 nominal
value per ordinary share (&ldquo;<B>Ordinary Shares</B>&rdquo;), pre-funded warrants to purchase ADSs (the &ldquo;<B>Pre-Funded Warrants</B>&rdquo;)
and, warrants to purchase ADSs (the &ldquo;<B>Ordinary Warrants</B>&rdquo; and, together with the ADSs and Pre-Funded Warrants, the &ldquo;<B>Securities</B>&rdquo;).
The terms of the Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a &ldquo;<B>Purchaser</B>&rdquo;
and, collectively, the &ldquo;<B>Purchasers</B>&rdquo;) and nothing herein constitutes that the Placement Agent would have the power or
authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the Placement. This
Agreement and the documents executed and delivered by the Company and the Purchasers in connection with the Placement, which may include
a securities purchase agreement between the Company and one or more of such Purchasers in a form mutually agreed upon by the Company and
the Placement Agent (the &ldquo;<B>Purchase Agreement</B>&rdquo;), shall be collectively referred to herein as the &ldquo;<B>Transaction
Documents</B>.&rdquo; The date of the closing of the Placement shall be referred to herein as the &ldquo;<B>Closing Date</B>.&rdquo; The
Company expressly acknowledges and agrees that the Placement Agent&rsquo;s obligations hereunder are on a reasonable best efforts basis
only and that the execution of this Agreement does not constitute a commitment by the Placement Agent to purchase the Securities and does
not ensure the successful placement of the Securities or any portion thereof or the success of the Placement Agent with respect to securing
any other financing on behalf of the Company. With the prior written consent of the Company, the Placement Agent may retain other brokers
or dealers to act as sub-agents or selected-dealers on its behalf in connection with the Placement. Capitalized terms that are not otherwise
defined herein have the meanings given to such terms in the Purchase Agreement. Prior to the signing of any Purchase Agreement, executive
officers of the Company will be available upon reasonable notice and during normal business hours to answer inquiries from prospective
Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;1.
REPRESENTATIONS AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Representations
of the Company</U>. Each of the representations and warranties (together with any related disclosure schedules thereto) and covenants
made by the Company to the Purchasers in the Purchase Agreement in connection with the Placement is hereby incorporated herein by reference
into this Agreement (as though fully restated herein) and is, as of the date of this Agreement and as of the Closing Date, hereby made
to, and in favor of, the Placement Agent. In addition to the foregoing, the Company represents and warrants that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">1. The Company has prepared and filed
with the Commission a registration statement on Form&nbsp;F-1 (Registration No.&nbsp;333-283304), and amendments thereto, and related
preliminary prospectuses, for the registration under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;),
of up to $[&bull;] of the securities of the Company identified therein, which registration statement, as so amended (including post-effective
amendments, if any) became effective on [&bull;], 2024. The Company will file with the Commission pursuant to Rule&nbsp;424(b)&nbsp;under
the Securities Act, and the rules&nbsp;and regulations (the &ldquo;<B>Rules&nbsp;and Regulations</B>&rdquo;) of the Commission promulgated
thereunder, a final prospectus included in such registration statement relating to the placement of the Securities and the plan of distribution
thereof and has advised the Placement Agent of all further information (financial and other) with respect to the Company required to be
set forth therein. Any reference in this Agreement to the Registration Statement, the Preliminary Prospectus, the Pricing Prospectus or
the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein (the &ldquo;<B>Incorporated Documents</B>&rdquo;),
on or before the date of this Agreement, or the issue date of the Preliminary Prospectus, the Pricing Prospectus or the Prospectus, as
the case may be; and any reference in this Agreement to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo; or &ldquo;supplement&rdquo;
with respect to the Registration Statement, the Preliminary Prospectus, the Pricing Prospectus or the Prospectus shall be deemed to refer
to and include the filing of any document under the Exchange Act after the date of this Agreement, or the issue date of the Preliminary
Prospectus, the Pricing Prospectus or the Prospectus, as the case may be, deemed to be incorporated therein by reference. All references
in this Agreement to financial statements and schedules and other information which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo;
 &ldquo;described,&rdquo; &ldquo;referenced,&rdquo; &ldquo;set forth&rdquo; or &ldquo;stated&rdquo; in the Registration Statement, the
Preliminary Prospectus, the Pricing Prospectus or the Prospectus (and all other references of like import) shall be deemed to mean and
include all such financial statements and schedules and other information which is or is deemed to be incorporated by reference in the
Registration Statement, the Preliminary Prospectus, the Pricing Prospectus or the Prospectus, as the case may be. The Company has not
received any notice that the Commission has issued or intends to issue a stop order suspending the effectiveness of the Registration Statement
or the use of the Pricing Prospectus or the Prospectus, or intends to commence a proceeding for any such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">2. The Registration Statement (and any
further documents to be filed with the Commission) contains all exhibits and schedules as required by the Securities Act. Each of the
Registration Statement and any post-effective amendment thereto, at the time it became effective, complied in all material respects with
the Securities Act and the Exchange Act and the applicable Rules&nbsp;and Regulations and did not and, as amended or supplemented, if
applicable, will not, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading. The Pricing Prospectus, and the Prospectus, each as of its respective date, comply
in all material respects with the Securities Act and the Exchange Act and the applicable Rules&nbsp;and Regulations. Each of the Pricing
Prospectus, and the Prospectus, as amended or supplemented, did not and will not contain as of the date thereof any untrue statement of
a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading. The Incorporated Documents, when they were filed with the Commission, conformed in all material
respects to the requirements of the Exchange Act and the applicable Rules&nbsp;and Regulations, and none of such documents, when they
were filed with the Commission, contained any untrue statement of a material fact or omitted to state a material fact necessary to make
the statements therein (with respect to Incorporated Documents incorporated by reference in the Pricing Prospectus or Prospectus), in
the light of the circumstances under which they were made not misleading; and any further documents so filed and incorporated by reference
in the Pricing Prospectus or Prospectus, when such documents are filed with the Commission, will conform in all material respects to the
requirements of the Exchange Act and the applicable Rules&nbsp;and Regulations, as applicable, and will not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading. No post-effective amendment to the Registration Statement reflecting any facts or events arising
after the date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein is
required to be filed with the Commission. There are no documents required to be filed with the Commission in connection with the transaction
contemplated hereby that (x)&nbsp;have not been filed as required pursuant to the Securities Act or (y)&nbsp;will not be filed within
the requisite time period. There are no contracts or other documents required to be described in the Pricing Prospectus, or Prospectus,
or to be filed as exhibits or schedules to the Registration Statement, which (x)&nbsp;have not been described or filed as required or
(y)&nbsp;will not be filed within the requisite time period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Covenants
of the Company</U>. The Company has delivered or made available, or will as promptly as practicable deliver or make available, to the
Placement Agent complete conformed copies of the Registration Statement and of each consent and certificate of experts, as applicable,
filed as a part thereof, and conformed copies of the Registration Statement (without exhibits), the Pricing Prospectus, and the Prospectus,
as amended or supplemented, in such quantities and at such places as the Placement Agent reasonably requests. Neither the Company nor
any of its directors and officers has distributed and none of them will distribute, prior to the Closing Date, any offering material in
connection with the offering and sale of the Securities pursuant to the Placement other than the Pricing Prospectus, the Prospectus, the
Registration Statement, copies of the documents incorporated by reference therein and any other materials permitted by the Securities
Act. In addition, the Company agrees that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">1. From the date hereof until 30 days
after the Closing Date, without prior written consent of the Placement Agent, neither the Company nor any Subsidiary shall, other than
for Exempt Issuances set forth in Section&nbsp;1(B)(3)&nbsp;below, (i)&nbsp;issue, enter into any agreement to issue or announce the issuance
or proposed issuance of any ADSs, Ordinary Shares or Ordinary Share Equivalents or (ii)&nbsp;file any registration statement or any amendment
or supplement thereto, other than the Prospectus or filing a registration statement on Form&nbsp;S-8 in connection with any employee benefit
plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">2. From the date hereof until six (6)&nbsp;months
after the Closing Date, without the prior written consent of the Placement Agent, the Company shall be prohibited from effecting or entering
into an agreement to effect any issuance by the Company or any of its Subsidiaries of ADSs, Ordinary Shares or Ordinary Share Equivalents
(or a combination of units thereof) involving a Variable Rate Transaction. &ldquo;<B>Variable Rate Transaction</B>&rdquo; means a transaction
in which the Company (i)&nbsp;issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for,
or include the right to receive additional ADSs and/or Ordinary Shares either (A)&nbsp;at a conversion price, exercise price or exchange
rate or other price that is based upon and/or varies with the trading prices of or quotations for ADSs and/or Ordinary Shares at any time
after the initial issuance of such debt or equity securities, or (B)&nbsp;with a conversion, exercise or exchange price that is subject
to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent
events directly or indirectly related to the business of the Company or the market for the ADSs and/or Ordinary Shares or (ii)&nbsp;enters
into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit or an &ldquo;at-the-market
offering&rdquo;, whereby the Company may issue securities at a future determined price regardless of whether ADSs or Ordinary Shares pursuant
to such agreement have actually been issued and regardless of whether such agreement is subsequently canceled; provided however, that
after two (2) months after the Closing Date, the Company&rsquo;s issuance of ADSs in the Existing ATM shall not constitute a Variable
Rate Transaction. &ldquo;Existing ATM&rdquo; means the Company&rsquo;s at-the-market offering pursuant to the Capital on DemandTM Sales
Agreement, dated as of October&nbsp;3, 2022, between the Company and JonesTrading Institutional Services LLC as sales agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">3. Notwithstanding the foregoing, Sections
1 (B)(1)&nbsp;and 1(B)(2)&nbsp;shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be an
Exempt Issuance. &ldquo;<B>Exempt Issuance</B>&rdquo; means the issuance of (a)&nbsp;Ordinary Shares, ADSs or options to employees, officers,
directors or consultants of the Company pursuant to any stock or option plan duly adopted for such purpose, which issuance was approved
by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors
established for such purpose for services rendered to the Company, (b)&nbsp;ADSs or Ordinary Shares upon the exercise or exchange of or
conversion of any Securities issued pursuant to the transaction contemplated hereunder and/or other securities exercisable or exchangeable
for or convertible into ADSs or Ordinary Shares issued and outstanding on the date of this Agreement, provided that such securities have
not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange
price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term of such
securities, (c)&nbsp;securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested
directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule&nbsp;144)
and carry no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition
period in Section&nbsp;1(B)(1)&nbsp;herein, and provided that any such issuance shall only be to a Person (or to the equityholders of
a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the
business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include
a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business
is investing in securities, and (d)&nbsp;Ordinary Shares, ADSs, options, <U>warrants, preferred shares</U> or other securities issued
primarily in exchange for up to $3,700,000 of outstanding indebtedness of the Company held by the European Investment Bank (&ldquo;EIB&rdquo;),
which conversion price shall not be lower than the Per ADS Purchase Price paid by Purchasing Parties, and provided that any such issuance
of securities in exchange of indebtedness to EIB shall be subject to a customary written lock-up agreement with the Company pursuant to
which EIB agrees to not sell or transfer any of the securities issued under this clause (d)&nbsp;during the prohibition period in Section&nbsp;1(B)(1)&nbsp;herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;2</U></FONT>.
<U>REPRESENTATIONS OF THE PLACEMENT AGENT</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Placement Agent represents and warrants that
it (i)&nbsp;is a member in good standing of FINRA, (ii)&nbsp;is registered as a broker/dealer under the Exchange Act, (iii)&nbsp;is licensed
as a broker/dealer under the laws of the States applicable to the offers and sales of the Securities by the Placement Agent, (iv)&nbsp;is
and will be a corporate entity validly existing under the laws of its place of incorporation, and (v)&nbsp;has full power and authority
to enter into and perform its obligations under this Agreement. The Placement Agent will immediately notify the Company in writing of
any change in its status as such. The Placement Agent covenants that it will use its reasonable best efforts to conduct the Placement
hereunder in compliance with the provisions of this Agreement and the requirements of applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;3</U></FONT>.
<U>COMPENSATION</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>In
consideration of the services to be provided for hereunder, the Company shall pay to the Placement Agent or its respective designees,
the following compensation with respect to the placement of the Securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">1. A cash fee (the &ldquo;<B>Cash Fee</B>&rdquo;)
equal to an aggregate of seven percent (7.0%) of the gross proceeds from the sale of Securities in the Placement to all Purchasers. The
Cash Fee shall be paid to the Placement Agent at the Closing of the Placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">2. Subject to compliance with FINRA
Rule&nbsp;5110(g)(5), the Company also agrees to reimburse the Placement Agent for all reasonable and documented out-of-pocket expenses
incurred by the Placement Agent in connection with the Placement, including the fees and disbursements of legal counsel, in an aggregate
amount not to exceed $100,000. The Company will reimburse the Placement Agent directly out of the Closing of the Placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">3. The Placement Agent reserves the
right to reduce any item of its compensation or adjust the terms thereof as specified herein in the event that a determination shall be
made by FINRA to the effect that the Placement Agent&rsquo;s aggregate compensation is in excess of FINRA Rules&nbsp;or that the terms
thereof require adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;4</U></FONT>.
<U>INDEMNIFICATION</U>.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The Company agrees to the indemnification
and other agreements set forth in the Indemnification Provisions (the &ldquo;<B>Indemnification Provisions</B>&rdquo;) attached hereto
as <U>Addendum A</U>, the provisions of which are incorporated herein by reference and shall survive the termination or expiration of
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;5</U></FONT>.
<U>ENGAGEMENT TERM</U>.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The Placement Agent&rsquo;s engagement hereunder
shall be until the earlier of (i)&nbsp;the final closing date of the Placement and (ii)&nbsp;the date a party terminates the engagement
according to the terms of the next sentence (such date, the &ldquo;<B>Termination Date</B>&rdquo; and the period of time during which
this Agreement remains in effect is referred to herein as the &ldquo;<B>Term</B>&rdquo;). The engagement may be terminated at any time
by either party upon five (5)&nbsp;days written notice to the other party, effective upon receipt of written notice to that effect by
the other party. Notwithstanding anything to the contrary contained herein, the provisions concerning the Company&rsquo;s obligation to
pay any fees actually earned pursuant to Section&nbsp;3 hereof and the provisions concerning confidentiality, indemnification and contribution
contained herein and the Company&rsquo;s obligations contained in the Indemnification Provisions will survive any expiration or termination
of this Agreement. If this Agreement is terminated prior to the completion of the Placement, all fees due to the Placement Agent shall
be paid by the Company to the Placement Agent on or before the Termination Date (in the event such fees are earned or owed as of the Termination
Date). The Placement Agent agrees not to use any confidential information concerning the Company provided to the Placement Agent by the
Company for any purposes other than those contemplated under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;6</U></FONT>.
<U>PLACEMENT AGENT INFORMATION</U>.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The Company agrees that any
information or advice rendered by the Placement Agent in connection with this engagement is for the confidential use of the Company only
in their evaluation of the Placement and, except as otherwise required by law, the Company will not disclose or otherwise refer to the
advice or information in any manner without the Placement Agent&rsquo;s prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;7</U></FONT>.
<U>NO FIDUCIARY RELATIONSHIP</U>.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>This Agreement does not create,
and shall not be construed as creating rights enforceable by any person or entity not a party hereto, except those entitled hereto by
virtue of the Indemnification Provisions hereof. The Company acknowledges and agrees that the Placement Agent is not and shall not be
construed as a fiduciary of the Company and shall have no duties or liabilities to the equity holders or the creditors of the Company
or any other person by virtue of this Agreement or the retention of the Placement Agent hereunder, all of which are hereby expressly waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;8</U></FONT>.
<U>CLOSING</U>.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The obligations of the Placement Agent, and the
closing of the sale of the Securities hereunder are subject to the accuracy, when made and on the Closing Date, of the representations
and warranties on the part of the Company contained herein and in the Purchase Agreement, to the accuracy of the statements of the Company
made in any certificates pursuant to the provisions hereof, to the performance by the Company of their obligations hereunder, and to each
of the following additional terms and conditions, except as otherwise disclosed to and acknowledged and waived by the Placement Agent
by the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>No
stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall
have been initiated or threatened by the Commission, and any request for additional information on the part of the Commission (to be included
in the Registration Statement, the Pricing Prospectus, the Prospectus or otherwise) shall have been complied with to the reasonable satisfaction
of the Placement Agent. Any filings required to be made by the Company in connection with the Placement shall have been timely filed with
the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Placement Agent shall not have discovered and disclosed to the Company on or prior to the Closing Date that the Registration Statement,
the Preliminary Prospectus, the Pricing Prospectus, the Prospectus or any amendment or supplement thereto contains an untrue statement
of a fact which, in the reasonable opinion of counsel for the Placement Agent, is material or omits to state any fact which, in the reasonable
opinion of such counsel, is material and is required to be stated therein or is necessary to make the statements therein not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>All
corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this Agreement,
the Securities, the Registration Statement, the Preliminary Prospectus, the Pricing Prospectus and the Prospectus and all other legal
matters relating to this Agreement and the transactions contemplated hereby shall be reasonably satisfactory in all material respects
to counsel for the Placement Agent, and the Company shall have furnished to such counsel all documents and information that they may reasonably
request to enable them to pass upon such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Placement Agent shall have received from Duane Morris LLP, outside US counsel to the Company, such counsel&rsquo;s written opinion, addressed
to the Placement Agent and the Purchasers and dated as of the Closing Date, in form and substance reasonably satisfactory to the Placement
Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Placement Agent shall have received from Mazanti-Andersen, outside Danish counsel to the Company, such counsel&rsquo;s written opinion,
addressed to the Placement Agent and the Purchasers and dated as of the Closing Date, in form and substance reasonably satisfactory to
the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>On
the Closing Date, the Placement Agent shall have received a certificate of the Chief Executive Officer of the Company, in his capacity
as such, dated, as applicable, as of the date of such Closing, certifying to certain regulatory matters, in form and substance reasonably
satisfactory to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>On
the Closing Date, the Placement Agent shall have received a certificate of the Chief Financial Officer of the Company, in his capacity
as such, dated, as applicable, as of the date of such Closing, certifying to certain financial matters, in form and substance reasonably
satisfactory to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>On
the Closing Date, the Placement Agent shall have received a certificate of the Chief Executive Officer of the Company, in his capacity
as such, dated as of the date of such Closing, to the effect that, as of the date of this Agreement and as of the applicable date, the
representations and warranties of the Company contained herein and in the Purchase Agreement were and are accurate in all material respects,
except for such changes as are contemplated by this Agreement and except as to representations and warranties that were expressly limited
to a state of facts existing at a time prior to the applicable Closing Date, and that, as of the applicable date, the obligations to be
performed by the Company hereunder on or prior thereto have been fully performed in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>On
the Closing Date, the Placement Agent shall have received a certificate of the Chief Executive Officer of the Company, in his capacity
as such, dated as of the date of such Closing, certifying to the organizational documents, Danish Business Authority Certificate of Registration
in Denmark and board resolutions relating to the Placement of the Securities from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">K.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>On
the date hereof, the Placement Agent shall have received a &ldquo;comfort&rdquo; letter from Ernst&nbsp;&amp; Young DK (the &ldquo;<B>Auditors</B>&rdquo;),
addressed to the Placement Agent and in form and substance reasonably satisfactory to the Placement Agent. On the Closing Date, the Placement
Agent shall have received a bring-down &ldquo;comfort&rdquo; letter from the Auditors, addressed to the Placement Agent and in form and
substance reasonably satisfactory to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Company (i)&nbsp;shall not have sustained since the date of the latest audited financial statements included or incorporated by reference
in the Registration Statement, the Pricing Prospectus and the Prospectus, any loss or interference with its business from fire, explosion,
flood, terrorist act or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action,
order or decree, otherwise than as set forth in or contemplated by the Registration Statement, the Pricing Prospectus and the Prospectus,
and (ii)&nbsp;since the date of the latest audited financial statements included or incorporated by reference in the Registration Statement,
the Pricing Prospectus and the Prospectus there shall not have been any change in the capital stock or long-term debt of the Company or
any change, or any development involving a prospective change, in or affecting the business, general affairs, management, financial position,
shareholders&rsquo; equity, results of operations or prospects of the Company, otherwise than as set forth in or contemplated by the Registration
Statement, the Pricing Prospectus and the Prospectus, the effect of which, in any such case described in clause (i)&nbsp;or (ii), is,
in the judgment of the Placement Agent, so material and adverse as to make it impracticable or inadvisable to proceed with the sale or
delivery of the Securities on the terms and in the manner contemplated by the Pricing Prospectus, Prospectus and the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">M.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
ADSs are registered under the Exchange Act and, as of the Closing Date, the ADSs shall be listed for trading on the Trading Market or
other applicable U.S. national exchange and reasonable evidence of such action, if available, shall have been provided to the Placement
Agent upon its request. The Company shall have taken no action designed to, or likely to have the effect of terminating the registration
of the ADSs under the Exchange Act or delisting or suspending from trading the ADSs from the Trading Market or other applicable U.S. national
exchange, nor has the Company received any information suggesting that the Commission or the Trading Market or other U.S. applicable national
exchange is contemplating terminating such registration or listing, other than as set forth in Schedule 8(M)&nbsp;hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>No
action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental
agency or body which would, as of the Closing Date, prevent the issuance or sale of the Securities or materially and adversely affect
or potentially and adversely affect the business or operations of the Company; and no injunction, restraining order or order of any other
nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing Date which would prevent the issuance
or sale of the Securities or materially and adversely affect or potentially and adversely affect the business or operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">O.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Company shall have prepared for filing with the Commission a Current Report on Form&nbsp;6-K with respect to the Placement, including
as an exhibit thereto this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Any
Purchase Agreement entered into by the Company with a Purchaser shall be in full force and effect and shall contain representations, warranties
and covenants of the Company as agreed between the Company and the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>FINRA
shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition, the Company
shall, if requested by the Placement Agent, make or authorize Placement Agent&rsquo;s counsel to make on the Company&rsquo;s behalf, any
filing with the FINRA Corporate Financing Department pursuant to FINRA Rule&nbsp;5110 with respect to the Placement and pay all filing
fees required in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">R.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Prior
to the Closing Date, the Company shall have furnished to the Placement Agent such further information, certificates and documents as the
Placement Agent may reasonably request. If any of the conditions specified in this Section&nbsp;8 shall not have been fulfilled when and
as required by this Agreement, or if any of the certificates, opinions, written statements or letters furnished to the Placement Agent
pursuant to this Section&nbsp;8 shall not be reasonably satisfactory in form and substance to the Placement Agent, all obligations of
the Placement Agent hereunder may be cancelled by the Placement Agent at, or at any time prior to, the consummation of the Closing. Notice
of such cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in
writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;9</U></FONT>.
[RESERVED].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;10</U></FONT>.
<U>GOVERNING LAW</U>.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>This Agreement will be governed by, and construed
in accordance with, the laws of the State of New York applicable to agreements made and to be performed entirely in such State without
regard to the conflicts of laws principles thereof. This Agreement may not be assigned by either party without the prior written consent
of the other party. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their respective successors
and permitted assigns. Any right to trial by jury with respect to any dispute arising under this Agreement or any transaction or conduct
in connection herewith is waived. Any dispute arising under this Agreement may be brought into the courts of the State of New York or
into the Federal Court located in New York, New York and, by execution and delivery of this Agreement, the Company hereby accepts for
itself and in respect of its property, generally and unconditionally, the jurisdiction of aforesaid courts. Each party hereto hereby irrevocably
waives personal service of process and consents to process being served in any such suit, action or proceeding by delivering a copy thereof
via overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees
that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any manner permitted by law. If either party shall commence an action or proceeding
to enforce any provisions of a Transaction Document, then the prevailing party in such action or proceeding shall be reimbursed by the
other party for its attorney&rsquo;s fees and other costs and expenses incurred with the investigation, preparation and prosecution of
such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;11</U></FONT>.
<U>ENTIRE AGREEMENT/MISC</U>.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>This Agreement (including the attached
Indemnification Provisions) embodies the entire agreement and understanding between the parties hereto, and supersedes all prior agreements
and understandings, relating to the subject matter hereof. If any provision of this Agreement is determined to be invalid or unenforceable
in any respect, such determination will not affect such provision in any other respect or any other provision of this Agreement, which
will remain in full force and effect. This Agreement may not be amended or otherwise modified or waived except by an instrument in writing
signed by the Placement Agent and the Company. The representations, warranties, agreements and covenants contained herein shall survive
the closing of the Placement and delivery of the Securities. This Agreement may be executed in two or more counterparts, all of which
when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each
party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any
signature is delivered by facsimile transmission or a .pdf format file, such signature shall create a valid and binding obligation of
the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or .pdf signature
page&nbsp;were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;12</U></FONT>.
<U>CONFIDENTIALITY</U>.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The Placement Agent (i)&nbsp;will keep the
Confidential Information (as such term is defined below) confidential and will not (except as required by applicable law or stock exchange
requirement, regulation or legal process (&ldquo;<B>Legal Requirement</B>&rdquo;)), without the Company&rsquo;s prior written consent,
disclose to any person any Confidential Information, and (ii)&nbsp;will not use any Confidential Information other than in connection
with the Placement. The Placement Agent further agrees to disclose the Confidential Information only to its Representatives (as such term
is defined below) who need to know the Confidential Information for the purpose of the Placement, and who are informed by the Placement
Agent of the confidential nature of the Confidential Information. The term &ldquo;<B>Confidential Information</B>&rdquo; shall mean, all
confidential, proprietary and non-public information (whether written, oral or electronic communications) furnished by the Company to
a Placement Agent or its Representatives in connection with the Placement Agent&rsquo;s evaluation of the Placement. The term &ldquo;<B>Confidential
Information</B>&rdquo; will not, however, include information which (i)&nbsp;is or becomes publicly available other than as a result of
a disclosure by a Placement Agent or its Representatives in violation of this Agreement, (ii)&nbsp;is or becomes available to a Placement
Agent or any of its Representatives on a non-confidential basis from a third-party, (iii)&nbsp;is known to a Placement Agent or any of
its Representatives prior to disclosure by the Company or any of its Representatives, or (iv)&nbsp;is or has been independently developed
by a Placement Agent and/or the Representatives without use of any Confidential Information furnished to it by the Company. The term &ldquo;<B>Representatives</B>&rdquo;
shall mean the Placement Agent&rsquo;s directors, board committees, officers, employees, financial advisors, attorneys and accountants.
This provision shall be in full force until the earlier of (a)&nbsp;the date that the Confidential Information ceases to be confidential
and (b)&nbsp;two years from the date hereof. Notwithstanding any of the foregoing, in the event that the Placement Agent or any of its
Representatives are required by Legal Requirement to disclose any of the Confidential Information, the Placement Agent and its Representatives
will furnish only that portion of the Confidential Information which the Placement Agent or its Representative, as applicable, is required
to disclose by Legal Requirement as advised by counsel, and will use reasonable efforts to obtain reliable assurance that confidential
treatment will be accorded the Confidential Information so disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;13</U></FONT>.
<U>NOTICES</U>.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Any and all notices or other communications or deliveries
required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a)&nbsp;the
date of transmission, if such notice or communication is sent to the email address specified on the signature pages&nbsp;attached hereto
prior to 6:30 p.m.&nbsp;(New York City time) on a business day, (b)&nbsp;the next business day after the date of transmission, if such
notice or communication is sent to the email address on the signature pages&nbsp;attached hereto on a day that is not a business day or
later than 6:30 p.m.&nbsp;(New York City time) on any business day, (c)&nbsp;the third business day following the date of mailing, if
sent by U.S. internationally recognized air courier service, or (d)&nbsp;upon actual receipt by the party to whom such notice is required
to be given. The address for such notices and communications shall be as set forth on the signature pages&nbsp;hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;14</U></FONT>.
<U>PRESS ANNOUNCEMENTS</U>.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The Company agrees that the Placement
Agent shall, from and after any Closing, have the right to reference the Placement and the Placement Agent&rsquo;s role in connection
therewith in the Placement Agent&rsquo;s marketing materials and on its website and to place advertisements in financial and other newspapers
and journals, in each case at its own expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>The remainder of this page&nbsp;has been intentionally
left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Please confirm that the foregoing correctly sets forth our agreement
by signing and returning to Lake Street the enclosed copy of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAKE STREET CAPITAL MARKETS, LLC</B></FONT></TD></TR>
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 37%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Michael Townley</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Head of Investment Banking</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address for notice:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">920 Second Avenue South, Suite&nbsp;700</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minneapolis, Minnesota 55402</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Michael Townley, Head of Investment Banking</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: mike.townley@lakestreetcm.com</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted and Agreed to as of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">the date first written above:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EVAXION BIOTECH A/S</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; width: 37%">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT>Christian Kantrup</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
for notice</U></FONT>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Evaxion Biotech A/S</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dr.&nbsp;Neergaards Vej 5F</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2970 Horsholm</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Christian Kantrup, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: cka@evaxion-biotech.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Placement Agency Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ADDENDUM A</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><U>INDEMNIFICATION PROVISIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the engagement
of Lake Street Capital Markets, LLC (the &ldquo;Placement Agent&rdquo;) by Evaxion Biotech A/S (the &ldquo;Company&rdquo;) pursuant to
a placement agency agreement dated as of the date hereof, between the Company and the Placement Agent, as it may be amended from time
to time in writing (the &ldquo;Agreement&rdquo;), the Company hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>To
the extent permitted by law, the Company will indemnify the Placement Agent and its affiliates, directors, officers, employees and controlling
persons (within the meaning of Section&nbsp;15 of the Securities Act of 1933, as amended, or Section&nbsp;20 of the Securities Exchange
Act of 1934, as amended) against all losses, claims, damages, expenses and liabilities, as the same are incurred (including the reasonable
and documented fees and expenses of counsel), relating to or arising out of its activities hereunder or pursuant to the Agreement, except
to the extent that any losses, claims, damages, expenses or liabilities (or actions in respect thereof) are found in a final judgment
(not subject to appeal) by a court of law to have resulted primarily and directly from the Placement Agent&rsquo;s willful misconduct,
bad faith or gross negligence in performing the services described herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Promptly
after receipt by the Placement Agent of notice of any claim or the commencement of any action or proceeding with respect to which the
Placement Agent is entitled to indemnity hereunder, the Placement Agent will notify the Company in writing of such claim or of the commencement
of such action or proceeding, and the Company will assume the defense of such action or proceeding and will employ counsel reasonably
satisfactory to the Placement Agent and will pay the reasonable fees and expenses of such counsel. Notwithstanding the preceding sentence,
the Placement Agent will be entitled to employ counsel separate from counsel for the Company and from any other party in such action if
counsel for the Placement Agent reasonably determines that it would be inappropriate under the applicable rules&nbsp;of professional responsibility
for the same counsel to represent both the Company and the Placement Agent. In such event, the reasonable and documented fees and disbursements
of no more than one such separate counsel will be paid by the Company. The Company will have the exclusive right to settle the claim or
proceeding provided that the Company will not settle any such claim, action or proceeding without the prior written consent of the Placement
Agent, which will not be unreasonably withheld, unless such settlement includes an unconditional release of the Placement Agent from all
liability arising out of such claim, action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Company agrees to notify the Placement Agent promptly of the assertion against it or any other person of any claim or the commencement
of any action or proceeding relating to a transaction contemplated by the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>If
for any reason the foregoing indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent harmless, then
the Company shall contribute to the amount paid or payable by the Placement Agent, as the case may be, as a result of such losses, claims,
damages or liabilities in such proportion as is appropriate to reflect not only the relative benefits received by the Company on the one
hand, and the Placement Agent on the other, but also the relative fault of the Company on the one hand and the Placement Agent on the
other that resulted in such losses, claims, damages or liabilities, as well as any relevant equitable considerations. The amounts paid
or payable by a party in respect of losses, claims, damages and liabilities referred to above shall be deemed to include any legal or
other fees and expenses incurred in defending any litigation, proceeding or other action or claim. Notwithstanding the provisions hereof,
the Placement Agent&rsquo;s share of the liability hereunder shall not be in excess of the amount of fees actually received, or to be
received, by the Placement Agent under the Agreement (excluding any amounts received as reimbursement of expenses incurred by the Placement
Agent).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>These
Indemnification Provisions shall remain in full force and effect whether or not the transaction contemplated by the Agreement is completed
and shall survive the termination of the Agreement, and shall be in addition to any liability that the Company might otherwise have to
any indemnified party under the Agreement or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>The remainder of this page&nbsp;has been intentionally
left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAKE STREET CAPITAL MARKETS, LLC</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; width: 37%">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Michael Townley</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Head of Investment Banking</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address for notice:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">920 Second Avenue South, Suite&nbsp;700</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minneapolis, Minnesota 55402</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Michael Townley, Head of Investment Banking</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: mike.townley@lakestreetcm.com</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted and Agreed to as of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">the date first written above:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EVAXION BIOTECH A/S</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 37%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Christian Kanstrup</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
for notice</U></FONT>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Evaxion Biotech A/S</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dr.&nbsp;Neergaards Vej 5F</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2970 Horsholm</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Christian Kantrup, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: cka@evaxion-biotech.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Indemnification Provisions</I></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pursuant
to Placement Agency Agreement</I></FONT>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Schedule 8M</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May&nbsp;7, 2024, we received a notification from Nasdaq that we
are not in compliance with the Nasdaq requirement to maintain a minimum equity of USD $2.5&nbsp;million. We were granted an extension
until November&nbsp;4, 2024, to demonstrate compliance with the Nasdaq listing requirements. On November&nbsp;11, 2024 we received a delisting
notice from Nasdaq Capital Markets, which we appealed on November&nbsp;12, 2024 and will pursue an additional 180-day exemption allowing
time for securing compliance in a balanced way. The appeal will stay any trading suspension of our ADSs until completion of the Nasdaq
hearing process and expiration of any additional extension period granted by the panel following the hearing. During any additional extension,
we intend to regain compliance and maintain our Nasdaq listing, however there is no guarantee that we will be able to regain compliance.
We are in constructive dialogue with Nasdaq on the matter, however no guarantees can be made that additional 180-days exemption will be
given. If appeal isn&rsquo;t successful, the continued non-compliance would result in delisting from Nasdaq Capital Markets. Such a delisting
would likely have a negative effect on the price of our ADSs and would impair your ability to sell or purchase our ADSs when you wish
to do so. In the event of a delisting, any action taken by us to restore compliance with listing requirements may not i) allow our ADSs
to become listed again, ii) stabilize the market price or iii) improve the liquidity of our ADSs, iv) prevent our ADSs from dropping below
the Nasdaq minimum bid price requirement or v) prevent future non-compliance with the listing requirements of Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.7
<SEQUENCE>3
<FILENAME>tm2427973d6_ex4-7.htm
<DESCRIPTION>EXHIBIT 4.7
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.7</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PREFUNDED WARRANT TO SUBSCRIBE FOR ORDINARY
SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPRESENTED BY AMERICAN DEPOSITARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>EVAXION
BIOTECH A/S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 50%">Warrant ADSs: ______&#8239;</TD>
  <TD STYLE="text-align: right; width: 50%">Initial Exercise Date: ______, 2024</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS PREFUNDED WARRANT TO SUBSCRIBE
FOR ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the &#8220;<U>Warrant</U>&#8221;) certifies that, for value received, ______
or its assigns (the &#8220;<U>Holder</U>&#8221;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the date hereof (the &#8220;<U>Initial Exercise Date</U>&#8221;) until this Warrant is
exercised in full (the &#8220;<U>Termination Date</U>&#8221;) but not thereafter, to subscribe for and purchase from Evaxion Biotech A/S,
a public limited liability company incorporated under the laws of the Kingdom of Denmark (the &#8220;<U>Company</U>&#8221;), up to ______
Ordinary Shares (the &#8220;<U>Warrant Shares</U>&#8221;) represented by _______ ADSs (the &#8220;<U>Warrant ADSs</U>&#8221;), as subject
to adjustment hereunder. The subscription price of one Warrant ADS under this Warrant shall be equal to the Exercise Price, as defined
in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this
Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>ADS(s)</U>&#8221;
means American Depositary Shares issued pursuant to the Deposit Agreement, each representing ten (10) Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Affiliate</U>&#8221;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Board
of Directors</U>&#8221; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Business
Day</U>&#8221; means any day except any Saturday, any Sunday, any day which is a federal legal or national holiday in the United States
or Denmark or any day on which banking institutions in the State of New York or Denmark are authorized or required by law to remain closed;
provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to
 &#8220;stay at home&#8221;, &#8220;shelter-in-place&#8221;, &#8220;non-essential employee&#8221; or any other similar orders or restrictions
or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer
systems (including for wire transfers) of commercial banks in The City of New York and Copenhagen, Denmark are generally open for use
by customers on such day or other governmental action to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Commission</U>&#8221;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Company
Danish Counsel</U>&#8221; means Mazanti-Andersen, Amaliegade 10 1256 Copenhagen K, Denmark, or any successor Danish counsel to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Deposit
Agreement</U>&#8221; means the Deposit Agreement, dated as of February 4, 2021, among the Company, The Bank of New York Mellon as Depositary
and the owners and holders of ADSs from time to time, as such agreement may be amended or supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Depositary</U>&#8221;
means The Bank of New York Mellon and any successor depositary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Exchange
Act</U>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Liens</U>&#8221;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Ordinary
Share(s)</U>&#8221; means the ordinary shares of the Company, DKK 1 nominal value per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Person</U>&#8221;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Proceeding</U>&#8221;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Purchase
Agreement</U>&#8221; means the securities purchase agreement, dated as of [_____], 2024, by and between the Company and each of the purchasers
signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Registration
Statement</U>&#8221; means the Company&#8217;s registration statement on Form F-1 (File No. 333-283304).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Securities
Act</U>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Subsidiary</U>&#8221;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Trading
Day</U>&#8221; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Trading
Market</U>&#8221; means any of the following markets or exchanges on which the Ordinary Shares and/or ADSs are listed or quoted for trading
on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the
New York Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Transfer
Agent</U>&#8221; means Computershare A/S, the current transfer agent of the Company, with a mailing address of Lottenborgvej 26 D, 1.,
DK-2800 Kgs. Lyngby, Denmark and company registration number (CVR) no. 27088899, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>VWAP</U>&#8221;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the ADSs are then listed or quoted
on a Trading Market, the daily volume weighted average price of the ADSs for such date (or the nearest preceding date) on the Trading
Market on which the ADSs are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b) if OTCQB Venture Market (&#8220;<U>OTCQB</U>&#8221;) or OTCQX Best Market (&#8220;<U>OTCQX</U>&#8221;)
is not a Trading Market, the volume weighted average price of the ADSs for such date (or the nearest preceding date) on OTCQB or OTCQX
as applicable, (c) if the ADSs are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the ADSs are then reported
in the &#8220;Pink&#8221; Open Market (&#8220;<U>Pink Market</U>&#8221;) operated by OTC Markets, Inc. (or a similar organization or agency
succeeding to its functions of reporting prices), the most recent bid price per ADS so reported, or (d) in all other cases, the fair market
value of an ADS as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants
then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
of Warrant</U>. This Warrant may be exercised, in whole or in part, at any time or times on or after the Initial Exercise Date and
on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment)
of the Notice of Exercise in the form annexed hereto (the &#8220;<U>Notice of Exercise</U>&#8221;). On the Trading Day (based on New
York City time) on which the delivery of the Notice of Exercise occurs, the Holder shall deliver to the Company Danish Counsel the
aggregate Exercise Price for the Warrant ADSs specified in the applicable Notice of Exercise by wire transfer to the Company Danish
Counsel pursuant to the bank wire transfer instructions set forth on the Notice of Exercise attached hereto. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has subscribed for all of the Warrant ADSs available hereunder and the Warrant has been
exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably
practicable following the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant
resulting in the subscription of a portion of the total number of Warrant ADSs available hereunder shall have the effect of reducing
the outstanding number of Warrant ADSs purchasable hereunder in an amount equal to the applicable number of Warrant ADSs subscribed.
The Company shall record the number of Warrants issued to the Holder and the number of Warrant ADSs subscribed through exercise and
the date of such subscription of the Warrant ADSs. The Company shall deliver any objection to any Notice of Exercise within one (1)
Trading Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by
reason of the provisions of this paragraph, following the subscription for a portion of the Warrant ADSs hereunder, the number of
Warrant ADSs available for subscription hereunder at any given time may be less than the amount stated on the face hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of DKK 10, or $[&#8226;] per Warrant ADS,
was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the
nominal exercise price of DKK 10 or $[&#8226;] per Warrant ADS) shall be required to be paid by the Holder to any Person to effect any
exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate
exercise price under any circumstance or for any reason whatsoever. The remaining unpaid exercise price per Warrant ADS under this Warrant
shall be DKK 10 or $[&#8226;], subject to adjustment hereunder (the &#8220;<U>Exercise Price</U>&#8221;), <U>provided</U>, <U>however</U>,
that in no event shall the Exercise Price paid by the Holder be less than the amount in US dollars (rounded to four decimal places) equal
to 10 Danish Krone, at the exchange rate published by the Danish National Bank, on the date of the Holder&#8217;s delivery of the Notice
of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Unavailability
of Registration Statement</U>. Notwithstanding anything to the contrary contained herein, if there is no effective registration
statement registering, or the prospectus contained therein is not available for, the sale of all of Warrant ADSs, representing the
underlying Warrant Shares, issuable under this Warrant at any time following the Initial Exercise Date and ending on the Termination
Date, the Holder shall be permitted to exercise this Warrant by delivery of a Notice of Exercise to the Company, and, within one (1)
Trading Day (based on New York City time) following the delivery of such Notice of Exercise, deliver to the Company Danish Counsel
the aggregate Exercise Price with respect to such exercise of this Warrant. Upon delivery by the Holder of a Notice of Exercise
during a Registration Failure Period (as defined below) and the timely payment by the Holder of the aggregate Exercise Price, the
Company shall be required to (1) pay in cash to the Holder on each Trading Day during the Registration Failure Period an amount
equal to 1.0% of the product of (A) the number of Warrant ADSs subject to the exercise by the Holder pursuant to the immediately
preceding sentence and (B) the VWAP of the ADSs on the date of delivery of the Notice of Exercise to the Company, and (2) on the
Trading Day immediately following the date on which the Registration Failure Period ends, deliver all of the Warrant ADSs required
to be delivered pursuant to such Notice of Exercise by crediting the account of the Holder&#8217;s prime broker with The Depository
Trust Company through DWAC (as defined below). The Company shall pay any cash amounts owed pursuant to clause (1) of the immediately
preceding sentence on each corresponding Trading Day during the Registration Failure Period. As used herein, &#8220;<U>Registration
Failure Period</U>&#8221; means the period (x) beginning on the date of delivery of a Notice of Exercise at a time when there is no
registration statement registering, or the prospectus contained therein is not available for, the sale of all of the Warrant ADSs,
representing the underlying Warrant Shares, issuable under this Warrant, and (y) ending on the later of (A) the date that there is
an effective registration statement registering, and the prospectus contained therein is available for, the sale of all of the
Warrant ADSs, representing the underlying Warrant Shares, issuable hereunder and (B) the date of delivery of all of the Warrant ADSs
required to be delivered pursuant to the Notice of Exercise by crediting the account of the Holder&#8217;s prime broker with The
Depository Trust Company through DWAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Delivery
of Warrant ADSs Upon Exercise</U>. Upon the exercise of this Warrant, the Company shall enter the Warrant Shares in the name of the Holder
in the Company&#8217;s share register, deposit the Warrant Shares in connection with such exercise with the Depositary for the ADSs, and
instruct the Depositary to transmit the Warrant ADSs purchased hereunder to the Holder by crediting the account of the Holder&#8217;s
or its designee&#8217;s balance account with The Depository Trust Company through its Deposit/Withdrawal At Custodian system (&#8220;<U>DWAC</U>&#8221;)
if the Depositary is then a participant in such system and there is an effective registration statement permitting the issuance of the
Warrant ADSs, representing the underlying Warrant Shares, to the Holder, by the date that is the earlier of (i) two (2) Trading Days after
the delivery to the Company of the notice of Exercise and (ii) the number of Trading Days comprising the Standard Settlement Period after
the delivery to the Company of the Notice of Exercise (such date, the &#8220;<U>Warrant ADS Delivery Date</U>&#8221;), provided that the
Company shall not be obligated to deliver the Warrant ADSs hereunder unless the Company Danish Counsel has received the aggregate Exercise
Price on or before the Trading Day (based on New York City time) immediately prior to the Warrant ADS Delivery Date by 9:00am CET. Upon
delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant
ADSs with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant ADSs, provided that payment
of the aggregate Exercise Price is received by the Warrant ADS Delivery Date by 9:00am CET. If the Company fails for any reason to cause
the Depositary to deliver to the Holder the Warrant ADSs subject to a Notice of Exercise by the Warrant ADS Delivery Date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant ADSs subject to such exercise
(based on the VWAP of the ADSs on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day
on the third Trading Day after the Warrant ADS Delivery Date) for each Trading Day, after such Warrant ADS Delivery Date until such Warrant
ADSs are delivered or the Holder rescinds such exercise. The Company agrees to maintain a depositary and a transfer agent that each are
a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, the &#8220;<U>Standard
Settlement Period</U>&#8221; means the standard settlement period, expressed in number of Trading Days, on the Company&#8217;s primary
Trading Market with respect to the ADSs as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing,
with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Trading Day prior to the Initial
Exercise Date, which may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver
the Warrant ADSs subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date
shall be the Warrant ADS Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price is delivered to Company
Danish Counsel by 12:00 p.m. (New York City time) on the Trading Day prior to the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant ADSs, deliver to the Holder a new Warrant certificate
evidencing the rights of the Holder to subscribe for the unsubscribed Warrant ADSs called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Rescission
Rights</U>. If the Company fails to cause the Depositary to transmit to the Holder the Warrant ADSs pursuant to Section 2(d)(i) by
the Warrant ADS Delivery Date, then the Holder will have the right to rescind such exercise prior to the delivery of such Warrant
ADSs hereunder (with the effect that the Holder&#8217;s right to acquire such Warrant ADSs pursuant to this Warrant shall be
restored) and the Company shall return to the Holder the aggregate Exercise Price paid to the Company Danish Counsel for such
Warrant ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant ADSs Upon Exercise</U>. In addition to any other rights available to the Holder, if the
Company fails to cause the Depositary to deliver to the Holder the Warrant ADSs in accordance with the provisions of Section 2(d)(i) above
pursuant to an exercise on or before the Warrant ADS Delivery Date, and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, ADSs to deliver in satisfaction
of a sale by the Holder of the Warrant ADSs which the Holder anticipated receiving upon such exercise (a &#8220;<U>Buy-In</U>&#8221;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including
brokerage commissions, if any) for the ADSs so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant ADSs
that the Company failed to deliver to the Holder in connection with the exercise at issue by (2) the price at which the sell order giving
rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant in respect
of the equivalent number of Warrant ADSs for which such exercise was not honored and return any amount received by the Company Danish
Counsel in respect of the Exercise Price for those Warrant ADSs (in which case such exercise shall be deemed rescinded) or deliver to
the Holder the number of Warrant ADSs that would have been issued had the Company timely complied with its exercise and delivery obligations
hereunder. For example, if the Holder purchases ADSs having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted
exercise of Warrants for ADSs with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the
immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice
indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such
loss. Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including,
without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#8217;s failure to timely deliver
Warrant ADSs upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Fractional Ordinary Shares or Warrant ADSs</U>. No fractional Warrant Shares or Warrant ADSs shall be issued upon the exercise of this
Warrant. As to any fraction of a Warrant ADS which the Holder would otherwise be entitled to subscribe upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole ADS, provided that the fraction of an ADS shall not be rounded up to the next whole
ADS if such rounding would result in the issue price being lower than the nominal value of the Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant ADSs shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant ADSs, all of which taxes and expenses shall be paid by the Company,
and such Warrant ADSs shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant ADSs are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a
condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay
all Depositary and Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic issuance
and delivery of the Warrant ADSs. The Company shall pay all applicable fees and expenses of the Depositary and Transfer Agent in
connection with the issuance of the Warrants ADSs hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Closing
of Books</U>. The Company will not close its shareholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Holder&#8217;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to
exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates, and any
other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates (such Persons,
 &#8220;<U>Attribution Parties</U>&#8221;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined
below). For purposes of the foregoing sentence, the number of Ordinary Shares beneficially owned by the Holder and its Affiliates
and Attribution Parties shall include the number of Ordinary Shares underlying such Warrant ADSs issuable upon exercise of this
Warrant with respect to which such determination is being made, but shall exclude the number of Ordinary Shares underlying Warrant
ADSs which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the
Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of
any other securities of the Company (including, without limitation, any other Ordinary Share Equivalents) subject to a limitation on
conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or
Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be
calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To
the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to
be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder
together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to
the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such
determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with
Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in
determining the number of outstanding Ordinary Shares, a Holder may rely on the number of outstanding Ordinary Shares as reflected
in (A) the Company&#8217;s most recent annual report on Form 20-F, Report on Form 6-K or other public filings filed with the
Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the
Company or the Depositary or the Transfer Agent setting forth the number of Ordinary Shares outstanding. Upon the written or oral
request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of Ordinary
Shares then outstanding. In any case, the number of outstanding Ordinary Shares shall be determined after giving effect to the
conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties
since the date as of which such number of outstanding Ordinary Shares was reported. The &#8220;<U>Beneficial Ownership
Limitation</U>&#8221; shall be [4.99%] [9.99%] of the number of Ordinary Shares outstanding immediately after giving effect to the
issuance of the Ordinary Shares issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or
decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in
no event exceeds 9.99% of the number of Ordinary Shares outstanding immediately after giving effect to the issuance of Ordinary
Shares upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61<FONT STYLE="font-size: 10pt"><SUP>st</SUP></FONT>
day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner
otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may
be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a
successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Share
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a share dividend or otherwise makes
a distribution or distributions on its ADSs or Ordinary Shares or any other equity or equity equivalent securities payable in ADSs or
Ordinary Shares (which, for avoidance of doubt, shall not include any Warrant Shares or Warrant ADSs issued by the Company upon exercise
of this Warrant), (ii) subdivides outstanding Ordinary Shares or ADSs into a larger number of Ordinary Shares or ADSs, as applicable,
(iii) combines (including by way of reverse share split) outstanding ADSs or Ordinary Shares into a smaller number of Ordinary Shares
or ADSs, as applicable, or (iv) issues by reclassification of ADSs, Ordinary Shares or any shares of capital stock of the Company, then
in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Ordinary Shares or ADSs
as applicable (excluding treasury Ordinary Shares, if any) outstanding immediately before such event and of which the denominator shall
be the number of Ordinary Shares or ADSs, as applicable, outstanding immediately after such event, and the number of ADSs issuable upon
exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged,
provided that any reduction in the nominal value of the Ordinary Shares without any dividend or distribution shall not lead to any such
adjustment and provided, further, that the Exercise Price cannot be adjusted to a price that is less than the nominal value of the Ordinary
Shares. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination
of shareholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the
case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, exclusive license, assignment, transfer, conveyance or other disposition of all or
substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender
offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Ordinary Shares
(including Ordinary Shares underlying the ADSs) are permitted to sell, tender or exchange their shares for other securities, cash or
property and has been accepted by the holders of 50% or more of the outstanding Ordinary Shares (including Ordinary Shares
underlying the ADSs) or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or
indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Ordinary
Shares or any compulsory share exchange pursuant to which the Ordinary Shares effectively converted into or exchanged for other
securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a share
purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of
the outstanding Ordinary Shares (including Ordinary Shares underlying the ADSs) or 50% or more of the voting power of the common
equity of the Company (each a &#8220;<U>Fundamental Transaction</U>&#8221;), then, upon any subsequent exercise of this Warrant, the
Holder shall have the right to receive, for each Warrant Share represented by the Warrant ADSs that would have been issuable upon
such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to
any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of capital stock of the successor or acquiring
corporation or of the Company, if the Company is the surviving corporation, and any additional consideration (the
 &#8220;<U>Alternate Consideration</U>&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of
Warrant Shares represented by the Warrant ADSs for which this Warrant is exercisable immediately prior to such Fundamental
Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise,
the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount
of Alternate Consideration issuable in respect of one Ordinary Share (including any Warrant Shares underlying the ADSs), in such
Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner
reflecting the relative value of any different components of the Alternate Consideration. If holders of Ordinary Shares are given
any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the
same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the
 &#8220;<U>Successor Entity</U>&#8221;) to assume in writing all of the obligations of the Company under this Warrant in accordance
with the provisions of this Section 3(b) pursuant to written agreements in form and substance reasonably satisfactory to the Holder
and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the
Holder, deliver to the Holder in exchange for this Warrant, a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the Warrant Shares underlying the Warrant ADSs acquirable and
receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such
Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but
taking into account the relative value of the Ordinary Shares underlying the Warrant ADSs pursuant to such Fundamental Transaction
and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose
of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which
is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the
Successor Entity shall be added to the term &#8220;Company&#8221; under this Warrant (so that from and after the occurrence or
consummation of such Fundamental Transaction, each and every provision of this Warrant referring to the &#8220;Company&#8221; shall
refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior
thereto and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this
Warrant with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been
named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(b) regardless of (i) whether the Company has sufficient authorized Ordinary Shares for the issuance of Warrant Shares
represented by Warrant ADSs and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADS, as the case may be. For purposes
of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number
of Ordinary Shares (including Ordinary Shares underlying ADSs, but excluding treasury shares, if any) issued and outstanding. Irrespective
of any right of adjustment no adjustment can be made that gives an exercise price below DKK 10 per Warrant ADS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
 &#8239;&#8239;&#8239;&#8239;<U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant ADSs and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
Ordinary Shares or ADSs, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Ordinary
Shares or ADSs, (C) the Company shall authorize the granting to all holders of the Ordinary Shares or ADSs rights or warrants to
subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any shareholders of the
Company shall be required in connection with any reclassification of the Ordinary Shares or ADSs, any consolidation or merger to
which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share
exchange whereby the Ordinary Shares are converted into other securities, cash or property, or (E) the Company shall authorize the
voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall
cause to be delivered by email to the Holder at its last email address as it shall appear upon the Warrant Register of the Company,
at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on
which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not
to be taken, the date as of which the holders of the Ordinary Shares or ADSs of record to be entitled to such dividend,
distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer, share exchange or action is expected to become effective or close, and the date as of which it is expected
that holders of the Ordinary Shares (including Warrant Shares underlying Warrant ADSs) of record shall be entitled to exchange their
Ordinary Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale,
transfer, share exchange or action; provided that the failure to deliver such notice or any defect therein or in the delivery
thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice
provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the
Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Report on Form 6-K. The Holder
shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the
event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall take no action that would result in the Exercise Price per ADS being adjusted hereunder to less than ten (10) Danish Krone,
the nominal amount per share of the Ordinary Shares for ten (10) Ordinary Shares, as expressed in United States dollars at the applicable
exchange rate published by the Danish National Bank.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transferability</U>.
This Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office of
the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly
executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.
Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the
assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue
to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the subscription for Warrant ADSs without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical with this
Warrant except as to the number of Warrant ADSs issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
 &#8220;<U>Warrant Register</U>&#8221;), in the name of the record Holder hereof from time to time. The Company may deem and treat
the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the
Holder, and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Rights as Shareholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv)
herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant ADSs, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
 &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Authorized Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period that the Warrant is outstanding, it shall allot a sufficient number of shares to provide for the issuance of the
Warrant ADSs and the underlying Ordinary Shares upon the exercise of any subscription rights under this Warrant. The Company further covenants
that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the requisite
Warrant Shares for the Depositary to issue the necessary Warrant ADSs upon the exercise of the subscription rights under this Warrant.
The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares and Warrant ADSs may be issued
as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the
ADSs and/or Ordinary Shares may be listed. The Company covenants that all Warrant Shares represented by Warrant ADSs which may be issued
upon the exercise of the subscription rights represented by this Warrant will, upon exercise of the subscription rights represented by
this Warrant and payment for such Warrant ADSs in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than any taxes in respect of
any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its articles
of association or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any
other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times
in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to
protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company
will (i) not increase the nominal value of any Warrant Shares represented by Warrant ADSs above the amount payable therefor upon such
exercise immediately prior to such increase in nominal value, (ii) take all such action as may be necessary or appropriate in order that
the Company may validly and legally issue fully paid and nonassessable Warrant Shares represented by Warrant ADSs upon the exercise of
this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory
body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant ADSs for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law</U>.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP></SUP></FONT> All questions concerning the construction,
validity, enforcement and interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal
laws of the Kingdom of Denmark, without regard to the principles of conflict of laws thereof. Each party agrees that all legal proceedings
concerning the interpretation, enforcement and defense of this Warrant shall be commenced in the state and federal courts sitting in the
City of New York, Borough of Manhattan (the &#8220;<U>New York Courts</U>&#8221;). Each party hereto hereby irrevocably submits to the
exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any
claim that it is not personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient
venue for such proceeding. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all
right to trial by jury in any legal proceeding arising out of or relating to this Warrant. Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Warrant and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an action
or proceeding to enforce any provisions of this Warrant, then the prevailing party in such action or proceeding shall be reimbursed by
the other party for its attorneys&#8217; fees and other costs and expenses incurred in the investigation, preparation and prosecution
of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares represented by Warrant ADSs acquired upon the exercise of this Warrant, if not registered,
will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies. Without limiting any other provision of this
Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&#8217; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any
Notice of Exercise, shall be in writing and delivered personally, by email, or sent by a nationally recognized overnight courier
service, addressed to the Company, at Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark, Attention: <B>Flemming Pedersen </B>and <B>Susanne
Bech</B>, email addresses <B>fap@evaxion-biotech.com</B> and <B>sbe@evaxion-biotech.com</B> and <B>investor@evaxion-biotech.com</B>
or such other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or
other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by email,
or sent by a nationally recognized overnight courier service addressed to each Holder at the email number or address of such Holder
appearing on the books of the Company, or if no such email number or address appears on the books of the Company, then to the most
recent email, number or address such Holder has provided to Company. Any notice or other communication or deliveries hereunder shall
be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via
email at the email address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day
after the time of transmission, if such notice or communication is delivered via email at the email address set forth in this
Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading
Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by
the party to whom such notice is required to be given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to subscribe for
Warrant ADSs, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for
the subscription price of any Warrant Shares or Warrant ADSs or as a shareholder of the Company, whether such liability is asserted by
the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Company
Acknowledgement; Notice of Successor Danish Counsel; Payment of Aggregate Exercise Price</U>. The Company acknowledges and agrees that
the Holder&#8217;s payment of the aggregate Exercise Price to Company Danish Counsel in connection with any exercise hereunder shall be
deemed to be the delivery by the Holder of the aggregate Exercise Price to the Company and shall satisfy the Holder&#8217;s obligations
under this Warrant for the payment of the aggregate Exercise Price in connection with any exercise hereunder and shall require the Company
to deliver the Warrant ADSs upon such exercise to the Holder pursuant to the terms hereunder. If the Company changes its Company Danish
Counsel after the Initial Exercise Date, the Company shall promptly deliver notice of the successor Company Danish Counsel (including
the bank wire transfer instructions of such successor Company Danish Counsel) to the Holder (including, without limitation, any successor
holder of this Warrant) on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer of the Company, with
instructions in writing to pay the aggregate Exercise Price of this Warrant to such successor Company Danish Counsel. The Company acknowledges
that, if the Company Danish Counsel has received from the Holder the aggregate Exercise Price of the Warrant ADSs issuable upon exercise
of this Warrant pursuant to Section 2.2(b)(ii) of the Purchase Agreement, the Company Danish Counsel shall convert such aggregate Exercise
Price of this Warrant into Danish Krone on the Initial Exercise Date and shall hold such amount in trust for the Holder and shall release
the applicable portion of such amount to the Company to apply it in connection with exercises of this Warrant pursuant to Section 2 herein
by the Holder or any subsequent assignee of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reimbursement</U>.
The Company shall reimburse the Holder for any fees charged to the Holder by the Depositary in connection with the issuance or holding
or sale of the Warrant ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&#8239;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&#8239;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>


<P STYLE="margin: 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&#8239;</TD><TD COLSPAN="2" STYLE="text-align: left"><B>EVAXION BIOTECH A/S</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="text-align: left; width: 5%">&#8239;</TD><TD STYLE="text-align: justify; width: 45%"><B>&#8239;</B></TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD></TD><TD STYLE="text-align: left">By:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify"></TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD></TD><TD STYLE="text-align: left">Name:</TD><TD STYLE="text-align: justify"></TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&#8239;</TD><TD STYLE="text-align: left">Title:</TD><TD STYLE="text-align: justify">&#8239;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&#8239;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">To:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>EVAXION
BIOTECH A/S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Payment
shall be in lawful money of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 30%">&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid; width: 40%; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify; width: 30%">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Warrant Shares shall be delivered to the following DWAC Account
Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 30%">&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid; width: 40%; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify; width: 30%">&nbsp;</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
<TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
<TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">[SIGNATURE OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 18%; text-align: left">Name of Investing Entity:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 82%">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 35%"><I>Signature of Authorized Signatory of Investing Entity</I>:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 65%">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20%">Name of Authorized Signatory: </TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 80%">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20%">Title of Authorized Signatory:</TD><TD STYLE="border-bottom: Black 1pt solid; width: 80%; text-align: left">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 6%">Date:</TD><TD STYLE="border-bottom: Black 1pt solid; width: 94%; text-align: left">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 49%">Name:</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid; width: 49%"></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>(Please Print)</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>Address:</TD>
    <TD>&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>(Please Print)</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 10%">Phone Number:</TD><TD STYLE="width: 39%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 49%">&nbsp;</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>Email Address:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">Dated:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 22%"></TD>
    <TD STYLE="width: 22%">,</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%">Holder&rsquo;s Signature:<U></U></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Holder&rsquo;s Address:<U></U></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.8
<SEQUENCE>4
<FILENAME>tm2427973d6_ex4-8.htm
<DESCRIPTION>EXHIBIT 4.8
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.8</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WARRANT TO SUBSCRIBE FOR ORDINARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPRESENTED BY AMERICAN DEPOSITARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>EVAXION
BIOTECH A/S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%">Warrant ADSs: ________</TD><TD STYLE="width: 50%; text-align: right">Initial
Exercise Date: ______, 2024</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS WARRANT TO SUBSCRIBE FOR
ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _______
or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00
p.m.&nbsp;(New York City time) on _______, 2030<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT>
(the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Evaxion Biotech A/S, a public limited
liability company incorporated under the laws of the Kingdom of Denmark (the &ldquo;<U>Company</U>&rdquo;), up to ______ Ordinary Shares
(the &ldquo;<U>Warrant Shares</U>&rdquo;) represented by _______ ADSs (the &ldquo;<U>Warrant ADSs</U>&rdquo;), as subject to adjustment
hereunder. The subscription price of one Warrant ADS under this Warrant shall be equal to the Exercise Price, as defined in Section&nbsp;2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section&nbsp;1</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section&nbsp;1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>ADS(s)</U>&rdquo;
means American Depositary Shares issued pursuant to the Deposit Agreement, each representing ten (10)&nbsp;Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal or national holiday in the United States
or Denmark or any day on which banking institutions in the State of New York or Denmark are authorized or required by law to remain closed;
provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to
 &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other similar orders or restrictions
or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer
systems (including for wire transfers) of commercial banks in The City of New York and Copenhagen, Denmark are generally open for use
by customers on such day or other governmental action to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Danish Counsel</U>&rdquo; means Mazanti-Andersen, Amaliegade 10 1256 Copenhagen K, Denmark, or any successor Danish counsel to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Deposit
Agreement</U>&rdquo; means the Deposit Agreement, dated as of February&nbsp;4, 2021, among the Company, The Bank of New York Mellon as
Depositary and the owners and holders of ADSs from time to time, as such agreement may be amended or supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Depositary</U>&rdquo;
means The Bank of New York Mellon and any successor depositary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1 </SUP>Insert the date that is the five (5) year anniversary
of the Initial Exercise Date, provided that, if such date is not a Trading Day, insert the immediately following Trading Day</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Ordinary
Share(s)</U>&rdquo; means the ordinary shares of the Company, DKK 1 nominal value per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchase
Agreement</U>&rdquo; means the securities purchase agreement, dated as of _______, 2024, by and between the Company and each of the purchasers
signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form&nbsp;F-1 (File No.&nbsp;333-283304).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Ordinary Shares and/or ADSs are listed or quoted for trading
on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the
New York Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Computershare A/S, the current transfer agent of the Company, with a mailing address of Lottenborgvej 26 D, 1.,
DK-2800 Kgs. Lyngby, Denmark and company registration number (CVR) no. 27088899, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the ADSs are then listed or
quoted on a Trading Market, the daily volume weighted average price of the ADSs for such date (or the nearest preceding date) on the Trading
Market on which the ADSs are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m.&nbsp;(New York
City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or OTCQX Best Market
(&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the ADSs for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the ADSs are not then listed or quoted for trading on OTCQB or OTCQX and if prices
for the ADSs are then reported in the &ldquo;Pink&rdquo; Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by OTC Markets,&nbsp;Inc.
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per ADS so reported,
or (d)&nbsp;in all other cases, the fair market value of an ADS as determined by an independent appraiser selected in good faith by the
Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of
which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section&nbsp;2</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
of Warrant</U>. This Warrant may be exercised, in whole or in part, at any time or times on or after the Initial Exercise Date and on
or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the
Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). On the Trading Day (based on New York City
time) on which the delivery of the Notice of Exercise occurs, the Holder shall deliver to the Company Danish Counsel the aggregate Exercise
Price for the Warrant ADSs specified in the applicable Notice of Exercise by wire transfer to the Company Danish Counsel pursuant to the
bank wire transfer instructions set forth on the Notice of Exercise attached hereto. No ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has subscribed for all of the Warrant ADSs available hereunder and the Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation as soon as reasonably practicable following the date on which the final Notice
of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in the subscription of a portion of the total number
of Warrant ADSs available hereunder shall have the effect of reducing the outstanding number of Warrant ADSs purchasable hereunder in
an amount equal to the applicable number of Warrant ADSs subscribed. The Company shall record the number of Warrants issued to the Holder
and the number of Warrant ADSs subscribed through exercise and the date of such subscription of the Warrant ADSs. The Company shall deliver
any objection to any Notice of Exercise within one (1)&nbsp;Trading Day of receipt of such notice. The Holder and any assignee, by acceptance
of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the subscription for a portion of
the Warrant ADSs hereunder, the number of Warrant ADSs available for subscription hereunder at any given time may be less than the amount
stated on the face hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
Price</U>. The exercise price per ADS under this Warrant shall be <B>$</B>_______<B>,</B> subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Unavailability
of Registration Statement</U>. Notwithstanding anything to the contrary contained herein, if there is no effective registration statement
registering, or the prospectus contained therein is not available for, the sale of all of Warrant ADSs, representing the underlying Warrant
Shares, issuable under this Warrant at any time following the Initial Exercise Date and ending on the Termination Date, the Holder shall
be permitted to exercise this Warrant by delivery of a Notice of Exercise to the Company, and, within one (1)&nbsp;Trading Day (based
on New York City time) following the delivery of such Notice of Exercise, deliver to the Company Danish Counsel the aggregate Exercise
Price with respect to such exercise of this Warrant. Upon delivery by the Holder of a Notice of Exercise during a Registration Failure
Period (as defined below) and the timely payment by the Holder of the aggregate Exercise Price, the Company shall be required to (1)&nbsp;pay
in cash to the Holder on each Trading Day during the Registration Failure Period an amount equal to 1.0% of the product of (A)&nbsp;the
number of Warrant ADSs subject to the exercise by the Holder pursuant to the immediately preceding sentence and (B)&nbsp;the VWAP of the
ADSs on the date of delivery of the Notice of Exercise to the Company, and (2)&nbsp;on the Trading Day immediately following the date
on which the Registration Failure Period ends, deliver all of the Warrant ADSs required to be delivered pursuant to such Notice of Exercise
by crediting the account of the Holder&rsquo;s prime broker with The Depository Trust Company through DWAC (as defined below). The Company
shall pay any cash amounts owed pursuant to clause (1)&nbsp;of the immediately preceding sentence on each corresponding Trading Day during
the Registration Failure Period. As used herein, &ldquo;<U>Registration Failure Period</U>&rdquo; means the period (x)&nbsp;beginning
on the date of delivery of a Notice of Exercise at a time when there is no registration statement registering, or the prospectus contained
therein is not available for, the sale of all of the Warrant ADSs, representing the underlying Warrant Shares, issuable under this Warrant,
and (y)&nbsp;ending on the later of (A)&nbsp;the date that there is an effective registration statement registering, and the prospectus
contained therein is available for, the sale of all of the Warrant ADSs, representing the underlying Warrant Shares, issuable hereunder
and (B)&nbsp;the date of delivery of all of the Warrant ADSs required to be delivered pursuant to the Notice of Exercise by crediting
the account of the Holder&rsquo;s prime broker with The Depository Trust Company through DWAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<U>Mechanics of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Delivery
of Warrant ADSs Upon Exercise</U>. Upon the exercise of this Warrant, the Company shall enter the Warrant Shares in the name of the Holder
in the Company&rsquo;s share register, deposit the Warrant Shares in connection with such exercise with the Depositary for the ADSs, and
instruct the Depositary to transmit the Warrant ADSs purchased hereunder to the Holder by crediting the account of the Holder&rsquo;s
or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit/Withdrawal At Custodian system (&ldquo;<U>DWAC</U>&rdquo;)
if the Depositary is then a participant in such system and there is an effective registration statement permitting the issuance of the
Warrant ADSs, representing the underlying Warrant Shares, to the Holder, by the date that is the earlier of (i)&nbsp;two (2)&nbsp;Trading
Days after the delivery to the Company of the Notice of Exercise and (ii)&nbsp;the number of Trading Days comprising the Standard Settlement
Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant ADS Delivery Date</U>&rdquo;), provided
that the Company shall not be obligated to deliver the Warrant ADSs hereunder unless the Company Danish Counsel has received the aggregate
Exercise Price on or before the Trading Day (based on New York City time) immediately prior to the Warrant ADS Delivery Date. Upon delivery
of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant ADSs
with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant ADSs, provided that payment
of the aggregate Exercise Price is received by the Warrant ADS Delivery Date. If the Company fails for any reason to cause the Depositary
to deliver to the Holder the Warrant ADSs subject to a Notice of Exercise by the Warrant ADS Delivery Date, the Company shall pay to the
Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant ADSs subject to such exercise (based on the VWAP
of the ADSs on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading
Day after the Warrant ADS Delivery Date) for each Trading Day after such Warrant ADS Delivery Date until such Warrant ADSs are delivered
or the Holder rescinds such exercise. The Company agrees to maintain a depositary and a transfer agent that each are a participant in
the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the ADSs as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s)&nbsp;of
Exercise delivered on or prior to 12:00 p.m.&nbsp;(New York City time) on the Trading Day prior to the Initial Exercise Date, which may
be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver the Warrant ADSs subject
to such notice(s)&nbsp;by 4:00 p.m.&nbsp;(New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the
Warrant ADS Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price is delivered to Company Danish
Counsel by 12:00 p.m.&nbsp;(New York City time) on the Trading Day prior to the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant ADSs, deliver to the Holder a new Warrant certificate
evidencing the rights of the Holder to subscribe for the unsubscribed Warrant ADSs called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Rescission
Rights</U>. If the Company fails to cause the Depositary to transmit to the Holder the Warrant ADSs pursuant to Section&nbsp;2(d)(i)&nbsp;by
the Warrant ADS Delivery Date, then the Holder will have the right to rescind such exercise prior to the delivery of such Warrant ADSs
hereunder (with the effect that the Holder&rsquo;s right to acquire such Warrant ADSs pursuant to this Warrant shall be restored) and
the Company shall return to the Holder the aggregate Exercise Price paid to the Company Danish Counsel for such Warrant ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant ADSs Upon Exercise</U>. In addition to any other rights available to the Holder, if the
Company fails to cause the Depositary to deliver to the Holder the Warrant ADSs in accordance with the provisions of Section&nbsp;2(d)(i)&nbsp;above
pursuant to an exercise on or before the Warrant ADS Delivery Date, and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, ADSs to deliver in satisfaction
of a sale by the Holder of the Warrant ADSs which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A)&nbsp;pay in cash to the Holder the amount, if any, by which (x)&nbsp;the Holder&rsquo;s total purchase price
(including brokerage commissions, if any) for the ADSs so purchased exceeds (y)&nbsp;the amount obtained by multiplying (1)&nbsp;the number
of Warrant ADSs that the Company failed to deliver to the Holder in connection with the exercise at issue by (2)&nbsp;the price at which
the sell order giving rise to such purchase obligation was executed, and (B)&nbsp;at the option of the Holder, either reinstate the portion
of the Warrant in respect of the equivalent number of Warrant ADSs for which such exercise was not honored and return any amount received
by the Company Danish Counsel in respect of the Exercise Price for those Warrant ADSs (in which case such exercise shall be deemed rescinded)
or deliver to the Holder the number of Warrant ADSs that would have been issued had the Company timely complied with its exercise and
delivery obligations hereunder. For example, if the Holder purchases ADSs having a total purchase price of $11,000 to cover a Buy-In with
respect to an attempted exercise of Warrants for ADSs with an aggregate sale price giving rise to such purchase obligation of $10,000,
under clause (A)&nbsp;of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide
the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence
of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder,
at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s
failure to timely deliver Warrant ADSs upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Fractional Ordinary Shares or Warrant ADSs</U>. No fractional Warrant Shares or Warrant ADSs shall be issued upon the exercise of this
Warrant. As to any fraction of a Warrant ADS which the Holder would otherwise be entitled to subscribe upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole ADS, provided that the fraction of an ADS shall not be rounded up to the next whole
ADS if such rounding would result in the issue price being lower than the nominal value of the Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant ADSs shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant ADSs, all of which taxes and expenses shall be paid by the Company, and such Warrant
ADSs shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant ADSs are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise
shall be accompanied by the Assignment Form&nbsp;attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Depositary
and Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another
established clearing corporation performing similar functions) required for same-day electronic issuance and delivery of the Warrant ADSs.
The Company shall pay all applicable fees and expenses of the Depositary and Transfer Agent in connection with the issuance of the Warrants
ADSs hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Closing
of Books</U>. The Company will not close its shareholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section&nbsp;2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of Ordinary Shares beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Ordinary
Shares underlying such Warrant ADSs issuable upon exercise of this Warrant with respect to which such determination is being made, but
shall exclude the number of Ordinary Shares underlying Warrant ADSs which would be issuable upon (i)&nbsp;exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)&nbsp;exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Ordinary Share
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section&nbsp;2(e),
beneficial ownership shall be calculated in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and regulations
promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is
in compliance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the Holder is solely responsible for any schedules required to be filed
in accordance therewith. To the extent that the limitation contained in this Section&nbsp;2(e)&nbsp;applies, the determination of whether
this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise
shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by
the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject
to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section&nbsp;13(d)&nbsp;of
the Exchange Act and the rules&nbsp;and regulations promulgated thereunder. For purposes of this Section&nbsp;2(e), in determining the
number of outstanding Ordinary Shares, a Holder may rely on the number of outstanding Ordinary Shares as reflected in (A)&nbsp;the Company&rsquo;s
most recent annual report on Form&nbsp;20-F, Report on Form&nbsp;6-K or other public filings filed with the Commission, as the case may
be, (B)&nbsp;a more recent public announcement by the Company or (C)&nbsp;a more recent written notice by the Company or the Depositary
or the Transfer Agent setting forth the number of Ordinary Shares outstanding. Upon the written or oral request of a Holder, the Company
shall within one (1)&nbsp;Trading Day confirm orally and in writing to the Holder the number of Ordinary Shares then outstanding. In any
case, the number of outstanding Ordinary Shares shall be determined after giving effect to the conversion or exercise of securities of
the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of
outstanding Ordinary Shares was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by
a Holder prior to the issuance of any Warrants, 9.99%) of the number of Ordinary Shares outstanding immediately after giving effect to
the issuance of the Ordinary Shares issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease
the Beneficial Ownership Limitation provisions of this Section&nbsp;2(e), provided that the Beneficial Ownership Limitation in no event
exceeds 9.99% of the number of Ordinary Shares outstanding immediately after giving effect to the issuance of Ordinary Shares upon exercise
of this Warrant held by the Holder and the provisions of this Section&nbsp;2(e)&nbsp;shall continue to apply. Any increase in the Beneficial
Ownership Limitation will not be effective until the 61<FONT STYLE="font-size: 10pt"><SUP>st</SUP></FONT> day after such notice is delivered
to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section&nbsp;2(e)&nbsp;to correct this paragraph (or any portion hereof) which may be defective or inconsistent with
the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give
effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section&nbsp;3</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Share
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i)&nbsp;pays a share dividend or otherwise makes
a distribution or distributions on its ADSs or Ordinary Shares or any other equity or equity equivalent securities payable in ADSs or
Ordinary Shares (which, for avoidance of doubt, shall not include any Warrant Shares or Warrant ADSs issued by the Company upon exercise
of this Warrant), (ii)&nbsp;subdivides outstanding Ordinary Shares or ADSs into a larger number of Ordinary Shares or ADSs, as applicable,
(iii)&nbsp;combines (including by way of reverse share split) outstanding ADSs or Ordinary Shares into a smaller number of Ordinary Shares
or ADSs, as applicable, or (iv)&nbsp;issues by reclassification of ADSs, Ordinary Shares or any shares of capital stock of the Company,
then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Ordinary Shares or
ADSs as applicable (excluding treasury Ordinary Shares, if any) outstanding immediately before such event and of which the denominator
shall be the number of Ordinary Shares or ADSs, as applicable, outstanding immediately after such event, and the number of ADSs issuable
upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged,
provided that any reduction in the nominal value of the Ordinary Shares without any dividend or distribution shall not lead to any such
adjustment and provided, further, that the Exercise Price cannot be adjusted to a price that is less than the nominal value of the Ordinary
Shares. Any adjustment made pursuant to this Section&nbsp;3(a)&nbsp;shall become effective immediately after the record date for the determination
of shareholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the
case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i)&nbsp;the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii)&nbsp;the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, exclusive license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii)&nbsp;any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Ordinary Shares (including Ordinary Shares
underlying the ADSs) are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted
by the holders of 50% or more of the outstanding Ordinary Shares (including Ordinary Shares underlying the ADSs) or 50% or more of the
voting power of the common equity of the Company, (iv)&nbsp;the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Ordinary Shares or any compulsory share exchange pursuant to which the
Ordinary Shares effectively converted into or exchanged for other securities, cash or property, or (v)&nbsp;the Company, directly or indirectly,
in one or more related transactions consummates a share purchase agreement or other business combination (including, without limitation,
a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other
Person or group acquires 50% or more of the outstanding Ordinary Shares (including Ordinary Shares underlying the ADSs) or 50% or more
of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share represented by the Warrant ADSs that would
have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder
(without regard to any limitation in Section&nbsp;2(e)&nbsp;on the exercise of this Warrant), the number of shares of capital stock of
the successor or acquiring corporation or of the Company, if the Company is the surviving corporation, and any additional consideration
(the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of
Warrant Shares represented by the Warrant ADSs for which this Warrant is exercisable immediately prior to such Fundamental Transaction
(without regard to any limitation in Section&nbsp;2(e)&nbsp;on the exercise of this Warrant). For purposes of any such exercise, the determination
of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one Ordinary Share (including any Warrant Shares underlying the ADSs), in such Fundamental Transaction, and the
Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any
different components of the Alternate Consideration. If holders of Ordinary Shares are given any choice as to the securities, cash or
property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company's control,
including not approved by the Company's Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor
Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this
Warrant, that is being offered and paid to the holders of Ordinary Shares (including Ordinary Shares underlying ADSs) of the Company in
connection with the Fundamental Transaction, whether that consideration be in the form of cash, shares or any combination thereof, or
whether the holders of Ordinary Shares (including Ordinary Shares underlying ADSs) are given the choice to receive from among alternative
forms of consideration in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>, that, if holders of Ordinary Shares
(including any Ordinary Shares underlying ADSs) of the Company are not offered or paid any consideration in such Fundamental Transaction,
such holders of Ordinary Shares (including any Ordinary Shares underlying ADSs) will be deemed to have received common equity of the Successor
Entity (which Successor Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black
Scholes Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting
(A)&nbsp;a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public
announcement of the applicable contemplated Fundamental Transaction and the Termination Date, (B)&nbsp;an expected volatility equal to
the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization
factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C)&nbsp;the
underlying price per share used in such calculation shall be the greater of (i)&nbsp;the sum of the price per Ordinary Share being offered
in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii)&nbsp;the
highest VWAP during the period beginning on the Trading Day immediately preceding the public announcement of the applicable contemplated
Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the
Holder&rsquo;s request pursuant to this Section&nbsp;3(b), (D)&nbsp;a remaining option time equal to the time between the date of the
public announcement of the applicable contemplated Fundamental Transaction and the Termination Date and (E)&nbsp;a zero cost of borrow.
The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within
the later of (i)&nbsp;five Business Days of the Holder&rsquo;s election and (ii)&nbsp;the date of consummation of the Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of
this Section&nbsp;3(b)&nbsp;pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by
the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder
in exchange for this Warrant, a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance
to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the Warrant Shares underlying the Warrant ADSs acquirable and receivable upon exercise of this Warrant (without regard to
any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise
price hereunder to such shares of capital stock (but taking into account the relative value of the Ordinary Shares underlying the Warrant
ADSs pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and
such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such
Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental
Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence
or consummation of such Fundamental Transaction, each and every provision of this Warrant referring to the &ldquo;Company&rdquo; shall
refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity
or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the
Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant with the same
effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein.
For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section&nbsp;3(b)&nbsp;regardless of
(i)&nbsp;whether the Company has sufficient authorized Ordinary Shares for the issuance of Warrant Shares represented by Warrant ADSs
and/or (ii)&nbsp;whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Calculations</U>.
All calculations under this Section&nbsp;3 shall be made to the nearest cent or the nearest 1/100th of an ADS, as the case may be. For
purposes of this Section&nbsp;3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum
of the number of Ordinary Shares (including Ordinary Shares underlying ADSs, but excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section&nbsp;3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant ADSs and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notice
to Allow Exercise by Holder</U>. If (A)&nbsp;the Company shall declare a dividend (or any other distribution in whatever form) on the
Ordinary Shares or ADSs, (B)&nbsp;the Company shall declare a special nonrecurring cash dividend on or a redemption of the Ordinary Shares
or ADSs, (C)&nbsp;the Company shall authorize the granting to all holders of the Ordinary Shares or ADSs rights or warrants to subscribe
for or purchase any shares of capital stock of any class or of any rights, (D)&nbsp;the approval of any shareholders of the Company shall
be required in connection with any reclassification of the Ordinary Shares or ADSs, any consolidation or merger to which the Company is
a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Ordinary
Shares are converted into other securities, cash or property, or (E)&nbsp;the Company shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder
at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable
record or effective date hereinafter specified, a notice stating (x)&nbsp;the date on which a record is to be taken for the purpose of
such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the
Ordinary Shares or ADSs of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y)&nbsp;the date on which such reclassification, consolidation, merger, sale, transfer, share exchange or action is expected to become
effective or close, and the date as of which it is expected that holders of the Ordinary Shares (including Warrant Shares underlying Warrant
ADSs) of record shall be entitled to exchange their Ordinary Shares for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer, share exchange or action; provided that the failure to deliver such notice or any defect therein
or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent
that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the
Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Report on Form&nbsp;6-K. The Holder
shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event
triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Voluntary
Adjustment By Company</U>. Subject to the rules&nbsp;and regulations of the Trading Market, the Company may at any time during the term
of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall take no action that would result in the Exercise Price per ADS being adjusted hereunder to less than ten (10)&nbsp;Danish
Krone, the nominal amount per share of the Ordinary Shares for ten (10)&nbsp;Ordinary Shares, as expressed in United States dollars at
the applicable exchange rate published by the Danish National Bank.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section&nbsp;4</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transferability</U>.
This Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office of
the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly
executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.
Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the
assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue
to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3)&nbsp;Trading
Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly
assigned in accordance herewith, may be exercised by a new holder for the subscription for Warrant ADSs without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section&nbsp;4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical with this
Warrant except as to the number of Warrant ADSs issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section&nbsp;5</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Rights as Shareholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section&nbsp;2(d)(i), except as expressly
set forth in Section&nbsp;3. Without limiting any rights of a Holder to receive cash payments pursuant to Section&nbsp;2(d)(i)&nbsp;and
Section&nbsp;2(d)(iv)&nbsp;herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant ADSs, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Saturdays,
Sundays, Holidays,&nbsp;etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period that the Warrant is outstanding, it shall allot a sufficient number of shares to provide for the issuance of the
Warrant ADSs and the underlying Ordinary Shares upon the exercise of any subscription rights under this Warrant. The Company further covenants
that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the requisite
Warrant Shares for the Depositary to issue the necessary Warrant ADSs upon the exercise of the subscription rights under this Warrant.
The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares and Warrant ADSs may be issued
as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the
ADSs and/or Ordinary Shares may be listed. The Company covenants that all Warrant Shares represented by Warrant ADSs which may be issued
upon the exercise of the subscription rights represented by this Warrant will, upon exercise of the subscription rights represented by
this Warrant and payment for such Warrant ADSs in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than any taxes in respect of
any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its articles
of association or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any
other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times
in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to
protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company
will (i)&nbsp;not increase the nominal value of any Warrant Shares represented by Warrant ADSs above the amount payable therefor upon
such exercise immediately prior to such increase in nominal value, (ii)&nbsp;take all such action as may be necessary or appropriate in
order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares represented by Warrant ADSs upon the
exercise of this Warrant and (iii)&nbsp;use commercially reasonable efforts to obtain all such authorizations, exemptions or consents
from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under
this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant ADSs for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law</U>.<SUP></SUP> All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the Kingdom of Denmark, without regard to the principles of conflict
of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense of this Warrant
shall be commenced in the state and federal courts sitting in the City of New York, Borough of Manhattan (the &ldquo;<U>New York Courts</U>&rdquo;).
Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and
agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such New York
Courts, or such New York Courts are improper or inconvenient venue for such proceeding. Each party hereto hereby irrevocably waives,
to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating
to this Warrant. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to
such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If any party shall commence an action or proceeding to enforce any provisions of this Warrant, then the
prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys&rsquo; fees and other costs and
expenses incurred in the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares represented by Warrant ADSs acquired upon the exercise of this Warrant, if not registered,
will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally, by email, or sent by a nationally recognized overnight courier service, addressed
to the Company, at Dr.&nbsp;Neergaards Vej 5f, DK-2970 Hoersholm, Denmark, Attention: <B>: Flemming Pedersen and Susanne Bech, email addresses
fap@evaxion-biotech.com and sbe@evaxion-biotech.com and investor@evaxion-biotech.com</B> or such other email address or address as the
Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries to be provided
by the Company hereunder shall be in writing and delivered personally, by email, or sent by a nationally recognized overnight courier
service addressed to each Holder at the email, number or address of such Holder appearing on the books of the Company, or if no such email,
number or address appears on the books of the Company, then to the most recent email, number or address such Holder has provided to Company.
Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i)&nbsp;the time of
transmission, if such notice or communication is delivered via email at the email address set forth in this Section&nbsp;prior to 5:30
p.m.&nbsp;(New York City time) on any date, (ii)&nbsp;the next Trading Day after the time of transmission, if such notice or communication
is delivered via email at the email address set forth in this Section&nbsp;on a day that is not a Trading Day or later than 5:30 p.m.&nbsp;(New
York City time) on any Trading Day, (iii)&nbsp;the second Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (iv)&nbsp;upon actual receipt by the party to whom such notice is required to be given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to subscribe for
Warrant ADSs, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for
the subscription price of any Warrant Shares or Warrant ADSs or as a shareholder of the Company, whether such liability is asserted by
the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Company
Acknowledgement; Notice of Successor Danish Counsel</U>. The Company acknowledges and agrees that the Holder&rsquo;s payment of the aggregate
Exercise Price to Company Danish Counsel in connection with any exercise hereunder shall be deemed to be the delivery by the Holder of
the aggregate Exercise Price to the Company and shall satisfy the Holder&rsquo;s obligations under this Warrant for the payment of the
aggregate Exercise Price in connection with any exercise hereunder and shall require the Company to deliver the Warrant ADSs upon such
exercise to the Holder pursuant to the terms hereunder. If the Company changes its Company Danish Counsel after the Initial Exercise Date,
the Company shall promptly deliver notice of the successor Company Danish Counsel ((including the bank wire transfer instructions of such
successor Company Danish Counsel) to the Holder (including, without limitation, any successor holder of this Warrant) on Company letterhead
and executed by the Chief Executive Officer or Chief Financial Officer of the Company, with instructions in writing to pay the aggregate
Exercise Price of this Warrant to such successor Company Danish Counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reimbursement</U>.
The Company shall reimburse the Holder for any fees charged to the Holder by the Depositary in connection with the issuance or holding
or sale of the Warrant ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page&nbsp;Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD></TD><TD COLSPAN="2" STYLE="text-align: left"><B>EVAXION BIOTECH A/S</B></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="text-align: left; width: 5%">&nbsp;</TD><TD STYLE="text-align: justify; width: 45%">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">By: </TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Name:</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Title:</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">To:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>EVAXION
BIOTECH A/S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Payment
shall be in lawful money of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 30%">&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid; width: 40%; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify; width: 30%">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Warrant Shares shall be delivered to the following DWAC Account
Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 30%">&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid; width: 40%; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify; width: 30%">&nbsp;</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
<TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
<TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">[SIGNATURE OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 18%; text-align: left">Name of Investing Entity:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 82%">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 35%"><I>Signature of Authorized Signatory of Investing Entity</I>:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 65%">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20%">Name of Authorized Signatory: </TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 80%">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20%">Title of Authorized Signatory:</TD><TD STYLE="border-bottom: Black 1pt solid; width: 80%; text-align: left">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 6%">Date:</TD><TD STYLE="border-bottom: Black 1pt solid; width: 94%; text-align: left">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 49%">Name:</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid; width: 49%"></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>(Please Print)</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>Address:</TD>
    <TD>&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>(Please Print)</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 10%">Phone Number:</TD><TD STYLE="width: 39%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 49%">&nbsp;</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>Email Address:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Dated: _______________________ , _______________</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%">Holder&rsquo;s Signature:<U></U></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Holder&rsquo;s Address:<U></U></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>tm2427973d6_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit&nbsp;5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="7" STYLE="width: 50%"><IMG SRC="tm2427973d4_ex5-1img001.jpg" ALT=""></TD>
    <TD STYLE="width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mazanti-Andersen</FONT></TD>
    <TD STYLE="width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amaliegade 10</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advokatpartnerselskab</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DK-1256 K&oslash;benhavn K</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VAT: DK35892052</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+45 3314 3536</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">www.mazanti.dk</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Klosterbakken 12</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DK-5000 Odense C</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+45 6314 1414</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaxion Biotech A/S</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr Neergaards Vej 5F</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DK-2970 H&oslash;rsholm</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denmark</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.12.2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ref.
70451/LLJ</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ID
3159</FONT></P>
</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re.
Evaxion Biotech A/S &ndash; Form&nbsp;F-1 Registration Statement (File No.&nbsp;333-283304)</B></FONT></FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 20%; vertical-align: bottom"><IMG SRC="tm2427973d4_ex5-1img02.jpg" ALT=""></TD><TD STYLE="text-align: justify">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #656565"><FONT STYLE="color: Black"><B>Lars
                                         L&uuml;thjohan&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #656565"><FONT STYLE="color: Black">Attorney-at-law&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #656565"><FONT STYLE="color: Black">D: +45 3319 3749&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #656565"><FONT STYLE="color: Black">M: +45 4028 3536&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #656565"><FONT STYLE="color: Black">llj@mazanti.dk</FONT></P>

</TD>
    <TD STYLE="width: 7%"><FONT STYLE="text-transform: uppercase"><B>1.</B></FONT></TD><TD STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="text-transform: uppercase"><B>Introduction</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">I act as Danish legal adviser to Evaxion Biotech A/S (the &ldquo;Company&rdquo;), in
                                                                                connection with the Registration Statement on Form F-1/A (File No. 333-283304) (the &ldquo;Registration Statement&rdquo;) filed by
                                                                                the Company with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) on December 17, 2024 for purposes of
                                                                                registering under the Securities Act of 1933 (the &ldquo;Securities Act&rdquo;) the offer and sale of the Company&rsquo;s ordinary
                                                                                shares, DKK 1 nominal value (the &ldquo;Ordinary Shares&rdquo;), represented by American Depositary Shares (&ldquo;ADSs&rdquo;),
                                                                                with each ADS representing ten (10) ordinary shares (&ldquo;Placement Shares&rdquo;) as well as ordinary Warrants (the
                                                                                &ldquo;Ordinary Warrants&rdquo;) and Pre-Funded Warrants (the &ldquo;Pre-Funded Warrants&rdquo;; along with the Ordinary Warrants
                                                                                sometimes hereinafter collectively referred to as the &ldquo;Warrants&rdquo;) , each such Warrant conferring the right to purchase
                                                                                ADSs with each ADS representing ten (10) Ordinary Shares.</P></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD>
    <TD>1.1</TD><TD STYLE="text-align: justify">This
opinion is being rendered in connection with the filing of the Registration Statement with the Commission. Certain terms used in this
opinion are defined in Annex 1 (Definitions).</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD>
    <TD><FONT STYLE="text-transform: uppercase"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Danish
                                            Law</B></FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD>
    <TD>2.1</TD><TD STYLE="text-align: justify">This
opinion is limited to Danish law in effect on the date of this opinion and we express no opinion with regard to the laws of any other
jurisdiction. The opinion (including all terms used in it) is in all respects to be construed in accordance with Danish law. This opinion
does not include an assessment or opinion as to whether the Shares and the Warrants have been subscribed at market price in accordance
with the Danish Companies Act.</TD></TR>
     </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="tm2427973d4_ex5-1img001.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><B>3.</B></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><B>SCOPE
                                            OF INQUIRY</B></TD></TR>
                                                                                                                                          <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
                                                                                                                                          <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            the purpose of this opinion,&nbsp;I have examined, and relied upon the accuracy of the factual
                                            statements and compliance with the undertakings in, the following documents:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            copy of the Registration Statement, in the form filed and to be filed with the Commission,
                                            and the exhibits filed or to be filed in connection therewith.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            copy of:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 27%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Company&rsquo;s deed of incorporation and articles of association as in effect on today&rsquo;s
                                            date;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 27%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            compiled summary from the Danish Business Authority dated as of today&rsquo;s date; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 27%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Owners&rsquo; Register.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            copy of:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 27%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            form of Placement Agency Agreement dated [&#9679;] between the Company and Lake Street Capital
                                            Markets, LLC (the &rdquo;PAA&rdquo;) filed as Exhibit&nbsp;1.1 to the Registration Statement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 27%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            form of Securities Purchase Agreement dated [&#9679;] between the Company and the purchasers
                                            signatory thereto (the &rdquo;SPA&rdquo;) filed as Exhibit&nbsp;10.18 to the Registration
                                            Statement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 27%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            form of Pre-Funded Warrants between the Company and the purchasers thereof to purchase ADSs
                                            representing Ordinary Shares filed as Exhibit&nbsp;4.7 to the Registration Statement; </FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
                                                                                                                                                      <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">(d)</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">the form of Warrant between the Company and the purchasers thereof
to purchase ADSs representing Ordinary Shares filed as Exhibit 4.8 to the Registration Statement; and</TD></TR>
                                                                                                                                                      </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            addition,&nbsp;I have examined such documents, and performed such other investigations, as
                                            I consider necessary for the purpose of this opinion. My examination has been limited to
                                            the text of the documents. With your consent I have relied upon certificates and other assurances
                                            of officers of the Company and others as to factual matters without having independently
                                            verified such factual matters.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="tm2427973d4_ex5-1img001.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><B>4.</B></TD>
    <TD STYLE="text-align: justify"><B>Assumptions</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">In giving this opinion we have assumed, without further verification,
the completeness and accuracy of all documentation that we have reviewed. We have also relied upon the following assumptions, which we
have not independently verified:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 7%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Copies of documents, conformed copies or drafts of documents
    provided to us are true and complete copies of, or in the final forms of, the originals.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 7%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">That the final forms of the PAA, SPA, the Warrant and the Pre-Funded Warrant
    instrument as signed by the parties thereto will conform in all material respects to the drafts thereof as filed with the
    Registration Statement.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 7%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All signatures, initials and seals are genuine.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 7%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accuracy and completeness of all factual
representations expressed in or implied by the documents we have examined.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 7%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
    <TD>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">That all public records of the Company which we have examined
are accurate, true and complete and that such information has not since then been altered and did not fail to disclose any information
which had been delivered for registration but did not appear on the public records.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 7%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board Resolutions remain in full force and effect and have
not been revoked.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 7%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD>
    <TD>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There is nothing under any law (other than the law of the Kingdom
of Denmark) which would or might affect the opinions hereinafter appearing.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>Specifically, we have made no independent investigation of
the laws of the USA.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD><B>5.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Opinion</B></FONT></TD></TR>
                                                                                                                                          <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                          <TR STYLE="vertical-align: top">
<TD STYLE="width: 20%"></TD><TD STYLE="width: 7%">5.1</TD><TD STYLE="text-align: justify">Based on the documents and investigations referred to in paragraph 3 above,&nbsp;I am of the following
opinion:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27%"></TD><TD STYLE="width: 3%">1.</TD><TD STYLE="text-align: justify">upon issuance of the Placement Shares and Warrants against full payment therefor in the circumstances
contemplated by the SPA and the Warrant agreements,</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="tm2427973d4_ex5-1img001.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27%"></TD><TD STYLE="width: 3%">2.</TD><TD STYLE="text-align: justify">registration of the Board of Directors&rsquo; resolutions to increase the share capital and issue the
Warrants with the Danish Business Authority, and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27%"></TD><TD STYLE="width: 3%">3.</TD><TD STYLE="text-align: justify">the due entry into the Owners&rsquo; Register of the Placement Shares by the Company&rsquo;s share registrar
and the entry of the Warrants in the Company&rsquo;s warrant register</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 27%">&nbsp;</TD>
    <TD STYLE="text-align: justify">the Company is authorised to issue
the Placement Shares to be issued by the Company for issuance in connection with the ADSs and when issued, the Placement Shares will have
been validly issued and will be fully paid and nonassessable. Nonassessable shall in this context mean, in relation to a share, that the
issuer of the share has no right to require the holder of the share to pay to the issuer any amount (in addition to the amount required
for the share to be fully paid) solely as a result of his shareholding. The Warrants will have been validly issued and will be exercisable
pursuant to the terms and conditions set out in the Warrant Agreements.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><B>&nbsp;</B></TD>
    <TD STYLE="width: 7%"><B>6.</B></TD>
    <TD STYLE="text-align: justify"><B>&#8239;<FONT STYLE="text-transform: uppercase">Reliance</FONT></B></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20%"></TD><TD STYLE="width: 7%">6.1</TD><TD STYLE="text-align: justify">This opinion is for your benefit in connection with the Registration Statement and may be relied upon
by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Securities Act. It may not be supplied, and
its contents or existence may not be disclosed, to any person other than as an exhibit to the Registration Statement and may not be relied
upon for any purpose other than the Registration.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20%"></TD><TD STYLE="width: 7%">6.2</TD><TD STYLE="text-align: justify">Any and all liability and other matters relating to this opinion shall be governed exclusively by Danish
law and the Danish courts shall have exclusive jurisdiction to settle any dispute relating to this opinion.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                     <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>6.3 </TD><TD STYLE="text-align: justify">The Company may:</TD></TR>
                                                                                                                     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27%"></TD><TD STYLE="width: 3%">(a)</TD><TD STYLE="text-align: justify">file this opinion as an exhibit to the Registration Statement; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27%"></TD><TD STYLE="width: 3%">(b)</TD><TD STYLE="text-align: justify">refer to Mazanti-Andersen Law Firm giving this opinion under the heading &ldquo;Legal Matters&rdquo; in
the Registration Statement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20%"></TD><TD STYLE="width: 7%">6.4</TD><TD STYLE="text-align: justify">The previous sentence is no admittance from me (or Mazanti-Andersen Law Firm) that I am (or Mazanti-Andersen
Law Firm is) in the category of persons whose consent for the filing and reference in that paragraph is required under Section&nbsp;7
of the Securities Act or any rules&nbsp;or regulations of the SEC promulgated under it.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2427973d4_ex5-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
                                                                                                 <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
sincerely,</FONT></TD></TR>
                                                                                                 <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD COLSPAN="2">&nbsp;</TD></TR>
                                                                                                 <TR STYLE="vertical-align: top">
<TD STYLE="width: 1.75in">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; width: 3.5in">/s/ Lars L&uuml;thjohan</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                 <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lars
L&uuml;thjohan</FONT></TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                 </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="tm2427973d4_ex5-1img001.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annex
1 &ndash; Definitions&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this opinion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Danish
law</B>&rdquo; means the law directly applicable in Denmark.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company</B>&rdquo;
means Evaxion Biotech A/S, with corporate seat in H&oslash;rsholm, Denmark.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Owners&rsquo;
Register</B>&rdquo; means the Company&rsquo;s owners&rsquo; register.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Registration</B>&rdquo;
means the registration of the ADSs, Placement Shares and Warrants with the SEC under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Registration Statement</B>&rdquo; means the registration
statement on Form F--1 (Registration No. 333-283304) filed with the SEC on November 18, 2024, as amended by Amendment No. 1 to Form F-1
Registration Statement filed with the SEC on December 5, 2024, as amended by Amendment No. 2 to Form F-1 Registration Statement filed
with the SEC on December 17, 2024, in relation to the Registration, as amended and supplemented to the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>SEC</B>&rdquo;
means the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Securities
Act</B>&rdquo; means the U.S. Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.18
<SEQUENCE>6
<FILENAME>tm2427973d6_ex10-18.htm
<DESCRIPTION>EXHIBIT 10.18
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.18</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase
Agreement (this &ldquo;<U>Agreement</U>&rdquo;), dated as of [<FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT>], 2024,
is between Evaxion Biotech A/S, a public limited liability company incorporated under the laws of the Kingdom of Denmark (the &ldquo;<U>Company</U>&rdquo;),
and each purchaser identified on the signature pages&nbsp;hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below),
the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the
Company, securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE,&nbsp;IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;I.<BR>
DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
set forth in this Section&nbsp;1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>ADS(s)</U>&rdquo;
means American Depositary Shares issued pursuant to the Deposit Agreement (as defined below), each representing ten (10)&nbsp;Ordinary
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal or national holiday in the United States
and Denmark or any day on which banking institutions in the State of New York or Denmark are authorized or required by law to remain
closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized or required by law
to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other
similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long
as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York and Copenhagen, Denmark
are generally open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section&nbsp;2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i)&nbsp;the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii)&nbsp;the
Company&rsquo;s obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the first
(1<FONT STYLE="font-size: 10pt"><SUP>st</SUP></FONT>) Trading Day following the date hereof (except, with respect to any Purchaser, as
otherwise agreed pursuant to a written agreement between the Company and such Purchaser for a later date).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Danish Counsel</U>&rdquo; means Mazanti-Andersen, Amaliegade 10 1256 Copenhagen K, Denmark, or any successor Danish counsel to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
US Counsel</U>&rdquo; means Duane Morris LLP, 230 Park Avenue, Suite&nbsp;1130, New York, New York 10169-0079.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Deposit
Agreement</U>&rdquo; means the Deposit Agreement, dated as of February&nbsp;4, 2021, among the Company, The Bank of New York Mellon as
Depositary and the owners and holders of ADSs from time to time, as such agreement may be amended or supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Depositary</U>&rdquo;
means The Bank of New York Mellon and any successor depositary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i)&nbsp;if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m.&nbsp;(New York City
time) and before midnight (New York City time) on any Trading Day, 9:01 a.m.&nbsp;(New York City time) on the Trading Day immediately
following the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii)&nbsp;if this Agreement
is signed between midnight (New York City time) and 9:00 a.m.&nbsp;(New York City time) on any Trading Day, no later than 9:01 a.m.&nbsp;(New
York City time) on the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FDA</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(hh).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FDCA</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(hh).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>IFRS</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(aa).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors and officers
of the Company, in the form of <U>Exhibit&nbsp;C</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section&nbsp;3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Ordinary
Share(s)</U>&rdquo; means the ordinary shares of the Company, DKK 1 nominal value per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Ordinary
Share Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Ordinary Shares or ADSs, including, without limitation, any debt, preferred share, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Ordinary
Shares or ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Ordinary
Warrant ADSs</U>&rdquo; means the ADSs issuable upon exercise of the Ordinary Warrants and the Company&rsquo;s deposit of the Ordinary
Warrant Shares with the Depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Ordinary
Warrant Shares</U>&rdquo; means the Ordinary Shares issuable upon exercise of the Ordinary Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Ordinary Warrants</U>&rdquo; means, collectively, the ADS
purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, which Ordinary Warrants shall be
exercisable immediately, have a term of exercise equal to five (5) years and be in the form of <U>Exhibit A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per ADS
Purchase Price</U>&rdquo; equals $[__] (inclusive of any Depositary ADS issuance fee), subject to adjustment for reverse and forward
stock splits, stock dividends, stock combinations and other similar transactions of the ADSs and/or the Ordinary Shares, as applicable,
that occur after the date of this Agreement, provided that the purchase price per Prefunded Warrant shall be the Per ADS Purchase Price
minus $[<FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT>].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pharmaceutical
Product</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means Lake Street Capital Markets, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agency Agreement</U>&rdquo; means the placement agency agreement, dated as of the date hereof, by and between the Company and the Placement
Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prefunded
Warrant Aggregate Exercise Price Amount</U>&rdquo; means, as to each Purchaser, an amount equal to the aggregate Exercise Price of the
Prefunded Warrants purchased by such Purchaser, which aggregate Exercise Price shall be paid in United States dollars and in immediately
available funds by the Purchaser at Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prefunded
Warrants</U>&rdquo; means, collectively, the Prefunded ADS purchase warrants delivered to the Purchasers at the Closing in accordance
with Section&nbsp;2.2(a)&nbsp;hereof, which Prefunded Warrants shall be exercisable immediately and will expire when exercised in full,
in the form of <U>Exhibit&nbsp;B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prefunded
Warrant ADSs</U>&rdquo; means the ADSs issuable upon the exercise of the Prefunded Warrants and the Company&rsquo;s deposit of the Prefunded
Warrant Shares with the Depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prefunded
Warrant Shares</U>&rdquo; means the Ordinary Shares issuable upon the exercise of the Prefunded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Preliminary
Prospectus</U>&rdquo; means any preliminary prospectus included in the Registration Statement, as originally filed or as part of any
amendment thereto, or filed with the Commission pursuant to Rule&nbsp;424(a)&nbsp;of the rules&nbsp;and regulations of the Commission
under the Securities Act, including all information, documents and exhibits filed with or incorporated by reference into such preliminary
prospectus, including all information, documents and exhibits filed with or incorporated by reference into such preliminary prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pricing
Prospectus</U>&rdquo; means (i)&nbsp;the Preliminary Prospectus relating to the Securities that was included in the Registration Statement
immediately prior to [<FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT>] [a.m./p.m.] (New York City time) on the date
hereof and (ii)&nbsp;any free writing prospectus (as defined in the Securities Act) identified on <U>Schedule I</U> hereto, taken together.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement on Form&nbsp;F-1 (File No.&nbsp;333-283304) which registers the sale
of the Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;144</U>&rdquo;
means Rule&nbsp;144 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted from
time to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;424</U>&rdquo;
means Rule&nbsp;424 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted from
time to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the ADSs, the Prefunded Warrants, the Prefunded Warrant Shares and the Prefunded Warrant ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the Ordinary Shares, as represented by ADSs issued pursuant to the Deposit Agreement, each ADS representing ten (10)&nbsp;Ordinary
Shares, issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule&nbsp;200 of Regulation SHO under the Exchange Act (but shall
not be deemed to include locating and/or borrowing Ordinary Shares and/or ADSs).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for ADSs and Prefunded Warrants purchased hereunder as
specified below such Purchaser&rsquo;s name on the signature page&nbsp;of this Agreement and next to the heading &ldquo;Subscription
Amount,&rdquo; in United States dollars and in immediately available funds (minus, if applicable, a Purchaser&rsquo;s aggregate exercise
price of the Prefunded Warrants, which amounts shall be paid as and when such Prefunded Warrants are exercised).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U>, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Sullivan</U>&rdquo;
means Sullivan&nbsp;&amp; Worcester LLP, with offices located at 1251 Avenue of the Americas, New York, New York 10020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Ordinary Shares and/or ADSs are listed or quoted for trading
on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or
the New York Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Prefunded Warrants, the Ordinary Warrants, the Lock-Up Agreement, all exhibits and schedules
thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Computershare A/S, the current transfer agent of the Company, with a mailing address of Lottenborgvej 26 D, 1.,
DK-2800 Kgs. Lyngby, Denmark and company registration number (CVR) no. 27088899, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
ADSs</U>&rdquo; means, collectively, the Ordinary Warrant ADSs and the Prefunded Warrant ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means, collectively, the Ordinary Warrant Shares and the Prefunded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Ordinary Warrants and the Prefunded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;II.<BR>
PURCHASE AND SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell and issue, and the Purchasers,
severally and not jointly, agree to purchase and subscribe for, up to an aggregate of $[________] of ADSs and Ordinary Warrants. Notwithstanding
anything herein to the contrary, to the extent that the Purchaser determines, in its sole discretion, that the Purchaser&rsquo;s Subscription
Amount would cause the Purchaser&rsquo;s beneficial ownership of Ordinary Shares (including any Ordinary Shares underlying any ADSs) to
exceed the Beneficial Ownership Limitation, or, as the Purchaser may otherwise choose in its sole discretion, the Purchaser may elect
to purchase Prefunded Warrants in lieu of the ADSs as determined pursuant to Section 2.2(a). The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% (or, at the election of the Purchaser at Closing, 9.99%) of the number of Ordinary Shares (including any Ordinary Shares
underlying any ADSs) outstanding immediately after giving effect to the issuance of the Securities on the Closing Date. Each Purchaser&rsquo;s
Subscription Amount as set forth on the signature page hereto executed by such Purchaser shall be made available for &ldquo;Delivery Versus
Payment&rdquo; (&ldquo;DVP&rdquo;) settlement with the Company or its designee, except as otherwise directed by the Placement Agent. The
Company shall deliver to each Purchaser its respective ADSs and/or a Prefunded Warrant and an Ordinary Warrant (as applicable to the Purchaser),
as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable
at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall take place remotely
by electronic transfer of the Closing documentation. Unless otherwise directed by the Placement Agent, settlement of the ADSs shall occur
via DVP (i.e., on the Closing Date, the Company shall issue the ADSs registered in the Purchasers&rsquo; names and addresses and released
by the Transfer Agent directly to the account(s) at the Placement Agent identified by each Purchaser; upon receipt of such ADSs, the Placement
Agent shall promptly electronically deliver such ADSs to the applicable Purchaser, and payment therefor shall be made by the Placement
Agent (or its clearing firm) by wire transfer to the Company); provided, however, that for those Purchasers electing &ldquo;Company Escrow
Settlement&rdquo; on the signature pages hereto, such Purchasers shall wire their respective Subscription Amount in immediately available
funds to the account specified in writing by the Company within the time period required in Section 2.2(b) below, and on the Closing Date,
the Company shall deliver the Shares registered in the name of the applicable Purchaser through the Transfer Agent via DRS book-entry
procedure or, if elected by such Purchaser, otherwise via the Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;)
for the account of the applicable Purchaser. For purposes of clarity, the issuance of the Securities at the Closing hereunder shall occur
upon the receipt by the Company Danish Counsel (on behalf of the Company) of the aggregate net proceeds to the Company from the sale of
the Securities from the Placement Agent (or its clearing firm) and/or the Purchasers, as directed by the Placement Agent. Notwithstanding
anything herein to the contrary, if at any time on or after the time of execution of this Agreement by the Company and an applicable Purchaser,
through, and including the time immediately prior to the Closing (the &ldquo;<U>Pre-Settlement Period</U>&rdquo;), such Purchaser sells
to any Person all, or any portion, of the ADSs to be issued hereunder to such Purchaser at the Closing (collectively, the &ldquo;<U>Pre-Settlement
ADSs</U>&rdquo;), such Purchaser shall, automatically hereunder (without any additional required actions by such Purchaser or the Company),
be deemed to be unconditionally bound to purchase, such Pre-Settlement ADSs at the Closing; provided, that the Company shall not be required
to deliver any Pre-Settlement ADSs to such Purchaser prior to the Company&rsquo;s receipt of the purchase price of such Pre-Settlement
ADSs hereunder; and provided further that the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation
or covenant by such Purchaser as to whether or not during the Pre-Settlement Period such Purchaser shall sell any Ordinary Shares to any
Person and that any such decision to sell any Ordinary Shares by such Purchaser shall solely be made at the time such Purchaser elects
to effect any such sale, if any. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise (as defined in the Prefunded
Warrants) delivered on or prior to 12:00 p.m. (New York City time) on the Trading Day prior to the Closing Date, which may be delivered
at any time after the time of execution of this Agreement, the Company agrees to deliver the Prefunded Warrant ADSs subject to such notice(s)
by 4:00 p.m. (New York City time) on the Closing Date and the Closing Date shall be the Prefunded Warrant ADS Delivery Date (as defined
in the Prefunded Warrants) for purposes thereunder, provided that payment of the aggregate Exercise Price is delivered to Company Danish
Counsel by 12:00 p.m. (New York City time) on the Trading Day prior to the Closing Date.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;this
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;legal
opinions of Company US Counsel and Company Danish Counsel, respectively, addressed to the Placement Agent and the Purchasers, each in
the form reasonably acceptable to the Placement Agent and the Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;subject
to Section&nbsp;2.1, a copy of the irrevocable instructions to the Depositary instructing the Depositary to deliver on an expedited basis
via DRS book-entry transfer or DWAC, as elected by the Purchaser on the signature page&nbsp;hereto, ADSs equal to such Purchaser&rsquo;s
Subscription Amount (minus the portion of such Subscription Amount applicable to Prefunded Warrants) divided by the Per ADS Purchase
Price, registered in the name of such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
applicable, a Prefunded Warrant certificate registered in the name of such Purchaser to purchase up to a number of ADSs equal to the
portion of such Purchaser&rsquo;s Subscription Amount applicable to the Prefunded Warrants divided by the Per ADS Purchase Price minus
$[<FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT>], with an exercise price equal to 10 DKK, or $[<FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT>],
subject to adjustment therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;an
Ordinary Warrant certificate registered in the name of such Purchaser to purchase up to a number of ADSs equal to 100% of the sum of such
Purchaser&rsquo;s ADSs and Prefunded Warrants on the date hereof, with an exercise price equal to $[<FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT>], subject to adjustment therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;subject
to Section&nbsp;2.1, the Company shall have provided each Purchaser with the Company Danish Counsel&rsquo;s wire instructions, on Company
letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;on
the date hereof, the Lock-Up Agreements;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(viii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
Preliminary Prospectus and the Prospectus (which may be delivered in accordance with Rule&nbsp;172 under the Securities Act); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ix)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;an
officer&rsquo;s certificate executed by the Company&rsquo;s Chief Executive Officer or Chief Financial Officer certifying that all Purchasers
under this Agreement have executed and delivered this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;this
Agreement duly executed by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;such
Purchaser&rsquo;s Subscription Amount (less the aggregate exercise price of the Prefunded Warrants issuable to such Purchaser hereunder,
if applicable), which shall be (i)&nbsp;funded to the Company no later than close of business on [<FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT>]<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT>,
2024 and held in escrow by the Company prior to Closing, or (ii)&nbsp;made available for &ldquo;Delivery Versus Payment&rdquo; settlement
with the Company or its designee, and, at such Purchaser&rsquo;s election, such Purchaser&rsquo;s Prefunded Warrant Aggregate Exercise
Price Amount, which shall be included in such Purchaser&rsquo;s Subscription Amount to be made available for &ldquo;Delivery Versus Payment&rdquo;
settlement with the Company or shall be separately delivered to the Company Danish Counsel pursuant to the Company Danish Counsel&rsquo;s
wire instructions as provided pursuant to Section&nbsp;2.2(a)(v)&nbsp;herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Closing
Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
accuracy in all material respects (or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and
warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall be accurate in all material
respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as
of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP> The funds needs to be deposited at 9am CET on Closing.
To insert the business day prior to Closing in brackets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
delivery by each Purchaser of the items set forth in Section&nbsp;2.2(b)&nbsp;of this Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
Registration Statement has been declared effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
a specific date therein in which case they shall be accurate in all material respects or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
delivery by the Company of the items set forth in Section&nbsp;2.2(a)&nbsp;of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;there
shall have been no Material Adverse Effect with respect to the Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;from
the date hereof to the Closing Date, trading in the ADSs and/or Ordinary Shares shall not have been suspended by the Commission or any
Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have
been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service,
or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;III.<BR>
REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company that are wholly owned (directly or indirectly) by the Company or that constitute
significant subsidiaries within the meaning of Item 601(b)(21)(ii)&nbsp;of Regulation S-K are set forth on <U>Schedule 3.1(a)</U>. The
Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens,
and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable
and free of preemptive and similar rights to subscribe for or purchase securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Organization
and Qualification</U>. The Company is a public limited liability company duly organized under the laws of the Kingdom of Denmark. Each
of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and, if the concept of good standing is applicable
under the laws of the applicable jurisdiction, in good standing under the laws of the jurisdiction of its incorporation or organization.
Each of the Company and its Subsidiaries have the requisite power and authority to own and use its properties and assets and to carry
on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of
its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and
the Subsidiaries is duly qualified to conduct business and, if the concept of good standing is applicable under the laws of the applicable
jurisdiction, is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted
or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case
may be, would not have or reasonably be expected to result in: (i)&nbsp;a material adverse effect on the legality, validity or enforceability
of any Transaction Document, (ii)&nbsp;a material adverse effect on the results of operations, assets, business, prospects or condition
(financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii)&nbsp;a material adverse effect on the Company&rsquo;s
ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii)&nbsp;or
(iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting
or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action on the part of the Company and
no further action is required by the Company, the Board of Directors or the Company&rsquo;s shareholders in connection herewith or therewith
other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been
(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof and
assuming the due authorization, execution and delivery by the Purchaser, will constitute the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms, except (i)&nbsp;as limited by general equitable principles and applicable
bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights
generally, (ii)&nbsp;as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies
and (iii)&nbsp;insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which
it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i)&nbsp;conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of association, bylaws or other organizational or charter documents, or (ii)&nbsp;conflict with, or constitute a default (or an event
that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties
or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii)&nbsp;subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii)&nbsp;and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in
connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i)&nbsp;the filings
required pursuant to Section&nbsp;4.4 of this Agreement, (ii)&nbsp;the filing with the Commission of the Prospectus, (iii)&nbsp;the notice
and/or application(s)&nbsp;to each applicable Trading Market for the issuance and sale of the Securities and the listing of the ADSs
and Warrant ADSs for trading thereon in the time and manner required thereby, and (iv)&nbsp;such filings as are required to
be made under applicable state securities laws and the laws of the Kingdom of Denmark (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Issuance
of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.
The Warrant Shares and the Warrant ADSs, when issued in accordance with the terms of the Warrants, will be validly issued, fully paid
and nonassessable, free and clear of all Liens imposed by the Company. The Company has received the necessary authorization to issue the
Warrants and the Ordinary Shares and ADSs issuable upon the exercise of the Warrants and the Ordinary Shares and ADSs issuable pursuant
to this Agreement. The Company and the Depositary have prepared and filed with the Commission a registration statement relating to ADSs
on Form F-6 (File No. 333-252038) for registration under the Securities Act (the &ldquo;<U>ADS Registration Statement</U>&rdquo;) which
became effective on February 4, 2021, and the ADS Registration Statement is effective as of the date hereof. The Company has prepared
and filed the Registration Statement in conformity with the requirements of the Securities Act, which became effective on December [<FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT>],
2024, including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this Agreement. The
Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration
Statement or suspending or preventing the use of any Preliminary Prospectus or the Prospectus has been issued by the Commission and no
proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission. The Company,
if required by the rules and regulations of the Commission, shall file the Prospectus with the Commission pursuant to Rule 424(b). At
the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the Closing Date,
the Registration Statement and any amendments thereto conformed and will conform in all material respects to the requirements of the Securities
Act and did not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated
therein or necessary to make the statements therein not misleading; and the Pricing Prospectus and the Prospectus and any amendments or
supplements thereto, at the time the Pricing Prospectus and the Prospectus or any amendment or supplement thereto was issued and at the
Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain
an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading. The Company was at the time of the filing of the Registration Statement
eligible to use Form F-1 and is eligible to use Form F-1 on the date hereof and on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>. The Company has not issued any capital
stock since its most recently filed Form&nbsp;6-K under the Exchange Act, other than pursuant to the exercise of employee warrants under
the Company&rsquo;s warrant plans, the issuance of Ordinary Shares to employees pursuant to the Company&rsquo;s employee stock purchase
plans and pursuant to the conversion and/or exercise of Ordinary Share Equivalents outstanding as of the date of the most recently filed
Form&nbsp;6-K under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar
right to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the
Securities or as set forth on <U>Schedule 3.1(g)</U>, there are no outstanding options, warrants, scrip rights to subscribe to, calls
or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable
for, or giving any Person any right to subscribe for or acquire, any ADSs, Ordinary Shares, Ordinary Share Equivalents, warrants or the
capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is
or may become bound to issue additional ADSs, Ordinary Shares, Ordinary Share Equivalents, warrants or capital stock of any Subsidiary.
The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue ADSs, Ordinary Shares, Ordinary Share
Equivalents, warrants or other securities to any Person (other than the Purchasers). There are no outstanding securities or instruments
of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or
instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments of the
Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary.
The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement.
All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have
been issued in compliance with all applicable federal and state securities laws, and none of such outstanding shares was issued in violation
of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any shareholder,
the Board of Directors or others is required for the issuance and sale of the Securities. There are no shareholders agreements, voting
agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge
of the Company, between or among any of the Company&rsquo;s shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;thereof,
for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Pricing Prospectus
and the Prospectus, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received
a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their
respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act,
as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The Company has never been an issuer subject to Rule&nbsp;144(i)&nbsp;under the Securities Act. The financial
statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the
rules&nbsp;and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have
been prepared in accordance with International Financial Reporting Standards applied on a consistent basis during the periods involved
(&ldquo;<U>IFRS</U>&rdquo;), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited
financial statements may not contain all footnotes required by IFRS, and fairly present in all material respects the financial position
of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the
periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, (i)&nbsp;there has been no event, occurrence or development that has had or that could reasonably be expected to result
in a Material Adverse Effect, (ii)&nbsp;the Company has not incurred any liabilities (contingent or otherwise) other than (A)&nbsp;trade
payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B)&nbsp;liabilities not
required to be reflected in the Company&rsquo;s financial statements pursuant to IFRS or disclosed in filings made with the Commission,
(iii)&nbsp;the Company has not altered its method of accounting, (iv)&nbsp;the Company has not declared or made any dividend or distribution
of cash or other property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital
stock and (v)&nbsp;the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing
Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment of information.
Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development
has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective
businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under
applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least 1 Trading
Day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Litigation</U>.
There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened
against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental
or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;).
None of the Actions set forth on <U>Schedule 3.1(j)</U>, (i)&nbsp;adversely affects or challenges the legality, validity or enforceability
of any of the Transaction Documents or the Securities or (ii)&nbsp;could, if there were an unfavorable decision, have or reasonably be
expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has
been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach
of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by
the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop
order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange
Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which could reasonably be expected to result in a Material Adverse Effect. Except as set forth on <U>Schedule 3.1(k)</U>, none of the
Company&rsquo;s or its Subsidiaries&rsquo; employees is a member of a union that relates to such employee&rsquo;s relationship with the
Company or such Subsidiary. Neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the
Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company, no executive
officer of the Company or any Subsidiary is, or is now expected to be, in violation of any material term of any employment contract,
confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or
any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the
Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are
in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms
and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compliance</U>.
Neither the Company nor any Subsidiary: (i)&nbsp;is in default under or in violation of (and no event has occurred that has not been
waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company
or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit
agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not
such default or violation has been waived), (ii)&nbsp;is in violation of any judgment, decree or order of any court, arbitrator or other
governmental authority or (iii)&nbsp;is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority,
including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health
and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected
to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Environmental
Laws</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The Company and its Subsidiaries (i)&nbsp;are in compliance
with all applicable federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including
ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases
or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous
Materials</U>&rdquo;) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage,
disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions,
judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder
(&ldquo;<U>Environmental Laws</U>&rdquo;); (ii)&nbsp;have received all permits licenses or other approvals required of them under applicable
Environmental Laws to conduct their respective businesses; and (iii)&nbsp;are in compliance with all terms and conditions of any such
permit, license or approval where in each clause (i), (ii)&nbsp;and (iii), the failure to so comply could be reasonably expected to have,
individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any written notice of proceedings relating to the revocation
or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in
each case free and clear of all Liens, except for (i)&nbsp;Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii)&nbsp;Liens for the
payment of federal, state, foreign or other taxes, for which appropriate reserves have been made therefor in accordance with IFRS and,
the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company
and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are
in compliance in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Intellectual
Property</U>. The Company and the Subsidiaries own, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither
the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2)&nbsp;years from the date of this
Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within
the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights are invalid or unenforceable
or violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse
Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement
by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures
to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect. Except as set forth in the SEC Reports, (i)<B>&#8239;t</B>he
Company has no knowledge of any facts that would preclude it from having valid license rights or clear title to the Intellectual Property
Rights and (II)&#8239;the Company has no knowledge that it lacks or will be unable to obtain any rights or licenses to use all Intellectual
Property Rights that are necessary to conduct its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(q)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in
such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not
limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. After giving effect to the
receipt by the Company of the proceeds from the sale of the Securities hereunder, neither the Company nor any Subsidiary has any reason
to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage
from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(r)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transactions
with Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of the Company or
any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any
transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to
or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, shareholder, member or partner, in each case in excess of $120,000 other than for (i)&nbsp;payment
of salary or consulting fees for services rendered, (ii)&nbsp;reimbursement for expenses incurred on behalf of the Company and (iii)&nbsp;other
employee benefits, including stock option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(s)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Sarbanes-Oxley;
Internal Accounting Controls</U>. Except as set forth on <U>Schedule 3.1(s)</U>, the Company and the Subsidiaries are in compliance in
all material respects with any and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of
the date hereof and as of the Closing Date, and any and all applicable rules&nbsp;and regulations promulgated by the Commission thereunder
that are effective as of the date hereof and as of the Closing Date and apply to the Company given its status as a foreign private issuer
(as such term is defined under the Securities Act). The Company and the Subsidiaries maintain a system of internal accounting controls
sufficient to provide reasonable assurance that: (i)&nbsp;transactions are executed in accordance with management&rsquo;s general or
specific authorizations, (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity
with IFRS and to maintain asset accountability, (iii)&nbsp;access to assets is permitted only in accordance with management&rsquo;s general
or specific authorization, and (iv)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls
and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and 15d-15(e)) for the Company and the Subsidiaries and designed
such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or
submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s
rules&nbsp;and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures
of the Company and the Subsidiaries as of the end of the period covered by the most recently filed Form&nbsp;20-F under the Exchange
Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed Form&nbsp;20-F under the
Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their
evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting
(as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely
to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(t)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Fees</U>. Except as set forth in the Pricing Prospectus and the Prospectus, no brokerage or finder&rsquo;s fees or commissions are or
will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no
obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated
in this Section&nbsp;that may be due in connection with the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(u)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The
Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
Rights</U>. Except as set forth on <U>Schedule 3.1(v)</U>, no Person has any right to cause the Company or any Subsidiary to effect the
registration under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(w)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Listing
and Maintenance Requirements</U>. The Ordinary Shares and ADSs are registered pursuant to Section&nbsp;12(b)&nbsp;or 12(g)&nbsp;of the
Exchange Act, and the Company has taken no action designed to, or which to its knowledge is reasonably likely to have the effect of,
terminating the registration of the Ordinary Shares and/or ADSs under the Exchange Act nor has the Company received any written notification
that the Commission is contemplating terminating such registration. Except as set forth on <U>Schedule 3.1(w)</U>, the Company has not,
in the 12 months preceding the date hereof, received notice from any Trading Market on which the ADSs and/or Ordinary Shares are or have
been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading
Market. Except as set forth on <U>Schedule 3.1(w)</U>, the Company is, and has no reason to believe that it will not in the foreseeable
future continue to be, in compliance with all such listing and maintenance requirements. The ADSs are currently eligible for electronic
transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the
fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its jurisdiction
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their
obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s
issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(y)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Pricing Prospectus
and the Prospectus. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions
in securities of the Company. All of the written disclosure furnished by or on behalf of the Company to the Purchasers regarding the
Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules
to this Agreement, taken as a whole, is true and correct and does not contain any untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made,
not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as
a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
in order to make the statements therein, in the light of the circumstances under which they were made and when made, not misleading.
The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in Section&nbsp;3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(z)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section&nbsp;3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market
on which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(aa)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Solvency</U>.
Except as set forth on <U>Schedule 3.1(aa)</U>, based on the consolidated financial condition of the Company as of the Closing Date,
after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i)&nbsp;the fair saleable
value of the Company&rsquo;s assets exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing
debts and other liabilities (including known contingent liabilities) as they mature, (ii)&nbsp;the Company&rsquo;s assets do not constitute
unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking
into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements
and capital availability thereof, and (iii)&nbsp;the current cash position of the Company, together with the proceeds the Company would
receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay
all amounts on or in respect of its liabilities when such amounts are required to be paid. <U>Schedule 3.1(aa)</U> sets forth as of the
date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary
has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x)&nbsp;any liabilities for borrowed money
or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y)&nbsp;all guaranties,
endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected
in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments
for deposit or collection or similar transactions in the ordinary course of business; and (z)&nbsp;the present value of any lease payments
in excess of $50,000 due under leases required to be capitalized in accordance with IFRS. As of the date hereof and as of the Closing
Date, neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(bb)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Tax
Status</U>. Except for tax matters that are being challenged on a good faith basis by the Company and tax matters that would not, individually
or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i)&nbsp;has
made or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations
required by any jurisdiction to which it is subject, (ii)&nbsp;has paid all taxes and other governmental assessments and charges that
are material in amount, shown or determined to be due on such returns, reports and declarations and (iii)&nbsp;has set aside on its books
provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports
or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction,
and the officers of the Company or of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(cc)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Foreign
Corrupt Practices.</U> Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other
person acting on behalf of the Company or any Subsidiary, has (i)&nbsp;directly or indirectly, used any funds for unlawful contributions,
gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii)&nbsp;made any unlawful payment
to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii)&nbsp;failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its
behalf of which the Company is aware) which is in violation of law, or (iv)&nbsp;violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(dd)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Accountants</U>.
The Company&rsquo;s accounting firm is set forth in the Pricing Prospectus and the Prospectus. To the knowledge and belief of the Company,
such accounting firm (i)&nbsp;is a registered public accounting firm as required by the Exchange Act and (ii)&nbsp;shall express its
opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report on Form&nbsp;20-F for the fiscal
year ending December&nbsp;31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ee)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.
The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives. The Company further represents that, except for the fact that
some purchasers of Securities hereunder may purchase Prefunded Warrants instead of ADSs, all purchasers of Securities under this Agreement
are receiving the same economic terms in connection with their purchase of Securities under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ff)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity.</U> Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except
for Sections 3.2(f)&nbsp;and 4.14 hereof), it is understood and acknowledged by the Company that: (i)&nbsp;none of the Purchasers has
been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities
of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term; (ii)&nbsp;past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short
Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities; (iii)&nbsp;any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
ADSs and/or Ordinary Shares, and (iv)&nbsp;each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s
length counter-party in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y)&nbsp;one
or more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding, including,
without limitation, during the periods that the value of the  Warrant ADSs deliverable with respect to Securities are being
determined, and (z)&nbsp;such hedging activities (if any) could reduce the value of the existing shareholders' equity interests in the
Company at and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging
activities do not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(gg)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Regulation
M Compliance.</U> The Company has not, and to its knowledge no one acting on its behalf has, (i)&nbsp;taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the ADSs or Ordinary Shares, (ii)&nbsp;sold, bid for, purchased, or, paid any compensation for soliciting
purchases of, any of the ADSs or Ordinary Shares, or (iii)&nbsp;paid or agreed to pay to any Person any compensation for soliciting another
to purchase any other securities of the Company, other than, in the case of clauses (ii)&nbsp;and (iii), compensation paid to the Placement
Agent in connection with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(hh)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>FDA</U>.
As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (&ldquo;<U>FDA</U>&rdquo;) under the Federal
Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&ldquo;<U>FDCA</U>&rdquo;) that is manufactured, packaged, labeled,
tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a &ldquo;<U>Pharmaceutical Product</U>&rdquo;),
such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance
with all applicable requirements under FDCA and similar laws, rules&nbsp;and regulations relating to registration, investigational use,
premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices,
product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would
not have a Material Adverse Effect. There is no pending, completed or, to the Company's knowledge, threatened, action (including any
lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or
any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter or other communication
from the FDA or any other governmental entity, which (i)&nbsp;contests the premarket clearance, licensure, registration, or approval
of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of
any Pharmaceutical Product, (ii)&nbsp;withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders
the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii)&nbsp;imposes a clinical hold
on any clinical investigation by the Company or any of its Subsidiaries, (iv)&nbsp;enjoins production at any facility of the Company
or any of its Subsidiaries, (v)&nbsp;enters or proposes to enter into a consent decree of permanent injunction with the Company or any
of its Subsidiaries, or (vi)&nbsp;otherwise alleges any violation of any laws, rules&nbsp;or regulations by the Company or any of its
Subsidiaries, and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and
operations of the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules&nbsp;and
regulations of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in
the United States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern
as to approving or clearing for marketing any product being developed or proposed to be developed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Warrant
Plans</U>. Each warrant granted by the Company under the Company&rsquo;s warrant plans was granted (i)&nbsp;in accordance with the terms
of the Company&rsquo;s warrant plans adopted as an integral part of the Articles of Association and (ii)&nbsp;with an exercise price
at least equal to the fair market value of the Ordinary Shares on the date such warrants would be considered granted under IFRS and applicable
law. No warrant granted under the Company&rsquo;s warrant plans has been backdated. The Company has not knowingly granted, and there
is no and has been no Company policy or practice to knowingly grant, warrants prior to, or otherwise knowingly coordinate the grant of
warrants with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial
results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(jj)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Cybersecurity</U>.
(i)(x)&nbsp;There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s
information technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees,
suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems
and Data</U>&rdquo;) and (y)&nbsp;the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition
that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and Data; (ii)&nbsp;the Company
and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules&nbsp;and regulations
of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy
and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation
or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii)&nbsp;the Company and the
Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information
and the integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv)&nbsp;the Company and the Subsidiaries
have implemented backup and disaster recovery technology consistent with industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(kk)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compliance
with Data Privacy Laws</U>. (i)&nbsp;To the Company&rsquo;s knowledge, the Company and the Subsidiaries are, and at all times during
the last three (3)&nbsp;years were, in compliance with all applicable state, federal and foreign data privacy and security laws and regulations,
including, without limitation, the European Union General Data Protection Regulation (&ldquo;<U>GDPR</U>&rdquo;) (EU 2016/679) (collectively,
 &ldquo;<U>Privacy Laws</U>&rdquo;); (ii)&nbsp;the Company and the Subsidiaries have in place, comply with, and take appropriate steps
reasonably designed to ensure compliance with their policies and procedures relating to data privacy and security and the collection,
storage, use, disclosure, handling and analysis of Personal Data (as defined below) (the &ldquo;<U>Policies</U>&rdquo;); (iii)&nbsp;the
Company provides accurate notice of its applicable Policies to its customers, employees, third party vendors and representatives as required
by the Privacy Laws; and (iv)&nbsp;applicable Policies provide accurate and sufficient notice of the Company&rsquo;s then-current privacy
practices relating to its subject matter, and do not contain any material omissions of the Company&rsquo;s then-current privacy practices,
as required by Privacy Laws. &ldquo;<U>Personal Data</U>&rdquo; means (i)&nbsp;a natural person&rsquo;s name, street address, telephone
number, email address, photograph, social security number, bank information, or customer or account number; (ii)&nbsp;any information
which would qualify as &ldquo;personally identifying information&rdquo; under the Federal Trade Commission Act, as amended; (iii)&nbsp;&ldquo;personal
data&rdquo; as defined by GDPR; and (iv)&nbsp;any other piece of information that allows the identification of such natural person, or
his or her family, or permits the collection or analysis of any identifiable data related to an identified person&rsquo;s health or sexual
orientation. (i)&nbsp;None of such disclosures made or contained in any of the Policies have been inaccurate, misleading, or deceptive
in violation of any Privacy Laws and (ii)&nbsp;the execution, delivery and performance of the Transaction Documents will not result in
a breach of any Privacy Laws or Policies. Neither the Company nor the Subsidiaries (i)&nbsp;to the knowledge of the Company, has received
written notice of any actual or potential liability of the Company or the Subsidiaries under, or actual or potential violation by the
Company or the Subsidiaries of, any of the Privacy Laws; (ii)&nbsp;is currently conducting or paying for, in whole or in part, any investigation,
remediation or other corrective action pursuant to any regulatory request or demand pursuant to any Privacy Law; or (iii)&nbsp;is a party
to any order, decree, or agreement by or with any court or arbitrator or governmental or regulatory authority that imposed any obligation
or liability under any Privacy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ll)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Office
of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer, agent,
employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign
Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(mm)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>U.S.
Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning
of Section&nbsp;897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(nn)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of
1956, as amended (the &ldquo;BHCA&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;Federal
Reserve&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or
Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(oo)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable
financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable
money laundering statutes and applicable rules&nbsp;and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(pp)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Disagreements with Accountants and Lawyers</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;There are no disagreements
of any kind presently existing, or reasonably anticipated by the Company to arise, between the Company and the accountants and the Company&rsquo;s
lawyers formerly or presently employed by the Company, including the Accountants, and the Company is current with respect to any fees
owed to its accountants and lawyers, including the Accountants, which could affect the Company&rsquo;s ability to perform any of its
obligations under any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i)&nbsp;as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii)&nbsp;as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions may be limited by
applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Understandings
or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with
applicable federal and state securities laws). Such Purchaser is acquiring such Securities hereunder in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
it exercises any&#8239;Warrants, it will be, an &ldquo;accredited investor&rdquo; as defined in Rule&nbsp;501(a)(1), (a)(2), (a)(3),
(a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Access
to Information</U>. Such Purchaser acknowledges that it has not been provide access to  data room (virtual or otherwise) in
connection with the transactions contemplated hereunder, but that it has otherwise had the opportunity to review the Transaction
Documents (including all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i)&nbsp;the opportunity to ask
such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and
conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii)&nbsp;access to
information about the Company and its financial condition, results of operations, business, properties, management and prospects
sufficient to enable it to evaluate its investment; and (iii)&nbsp;the opportunity to obtain such additional information that the
Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision
with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the
Placement Agent has provided such Purchaser with any information or advice with respect to the Securities nor is such information or
advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes any representation as to the Company or
the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information with respect to the
Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the Securities to such Purchaser,
neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first
received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material pricing
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company acknowledges and agrees that the
representations contained in this Section&nbsp;3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s
representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document
or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions
contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;IV.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Warrant
ADSs</U>. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the issuance
or resale of the Warrant Shares represented by the Warrant ADSs, the Warrant ADSs issued pursuant to any such exercise shall be issued
free of all legends. If at any time following the date hereof the Registration Statement (or any subsequent registration statement registering
the sale or resale of the Warrant ADSs) is not effective or is not otherwise available for the sale or resale of the Warrant ADSs, the
Company shall immediately notify the holders of the Warrants in writing that such registration statement is not then effective and thereafter
shall promptly notify such holders when the registration statement is effective again and available for the sale or resale of the Warrant
Shares represented by the Warrant ADSs (it being understood and agreed that the foregoing shall not limit the ability of the Company to
issue, or any Purchaser to sell, any of the Warrant ADSs in compliance with applicable federal and state securities laws). The Company
shall use best efforts to keep a registration statement (including the Registration Statement) registering the issuance or resale of the
Warrant Shares represented by the Warrant ADSs effective during the term of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Furnishing
of Information</U>. Until the earlier of the time that (i)&nbsp;no Purchaser owns Securities or (ii)&nbsp;the Warrants have
expired, the Company covenants to maintain the registration of the Ordinary Shares and ADSs under Section&nbsp;12(b)&nbsp;or 12(g)&nbsp;of
the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports
required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the
reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in
Section&nbsp;2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the rules&nbsp;and
regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless
shareholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a)&nbsp;by the Disclosure Time, issue a press release disclosing the material terms
of the transactions contemplated hereby, and (b)&nbsp;file a Report on Form&nbsp;6-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act, provided that the Company shall not be required to file such
a Current Report on Form&nbsp;6-K if the Transaction Documents have been previously filed with the Commission as exhibits to a pre-effective
or post-effective amendment to the Registration Statement. From and after the issuance of such press release, the Company represents
to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the
Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without
limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In addition, effective
upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors,
agents, employees, Affiliates or agents, including , without limitation, the Placement Agent, on the one hand, and any of the Purchasers
or any of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and
each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby,
and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the
prior consent of the Company, with respect to any press release of any Purchaser, or without the prior written consent of each Purchaser,
with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure
is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name
of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except (a)&nbsp;as required by federal securities law in connection with the filing of final Transaction Documents with the
Commission and (b)&nbsp;to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall
provide the Purchasers with prior notice of such disclosure permitted under this clause (b)&nbsp;and reasonably cooperate with such Purchaser
regarding such disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser
is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Non-Public
Information</U>. Except with respect to the material pricing terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section&nbsp;4.4, the Company covenants and agrees that neither the Company, nor any
other Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company
reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing
to the receipt of such information and agreed in writing with the Company to keep such information confidential. The Company understands
and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To
the extent that the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates
delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and
agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective
officers, directors, employees, Affiliates or agents , including, without limitation, the Placement Agent, or a duty to the Company,
any of its Subsidiaries or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation,
the Placement Agent, not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject
to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public
information regarding the Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice
with the Commission pursuant to a Report on Form&nbsp;6-K. The Company understands and confirms that each Purchaser shall be relying
on the foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Use
of Proceeds</U>. Except as set forth in the Pricing Prospectus and the Prospectus, the Company shall use the net proceeds from the sale
of the Securities hereunder for working capital purposes and shall not use such proceeds: (a)&nbsp;for the satisfaction of any portion
of the Company&rsquo;s debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices),
(b)&nbsp;for the redemption of any ADSs, Ordinary Shares or Ordinary Share Equivalents, (c)&nbsp;for the settlement of any outstanding
litigation or (d)&nbsp;in violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section&nbsp;4.8, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section&nbsp;15 of the Securities Act and Section&nbsp;20 of the Exchange Act), and the directors, officers, shareholders, agents,
members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or
incur as a result of or relating to (a)&nbsp;any breach of any of the representations, warranties, covenants or agreements made by the
Company in this Agreement or in the other Transaction Documents or (b)&nbsp;any action instituted against the Purchaser Parties in any
capacity, or any of them or their respective Affiliates, by any shareholder of the Company who is not an Affiliate of such Purchaser
Party, with respect to any of the transactions contemplated by the Transaction Documents unless such action is solely based upon a material
breach of such Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any agreements or
understandings such Purchaser Party may have with any such shareholder or any violations by such Purchaser Party of state or federal
securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or
willful misconduct. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to
this Agreement, such Purchaser Party shall promptly notify the Company in writing, and, the Company shall have the right to assume the
defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right
to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall
be at the expense of such Purchaser Party except to the extent that (i)&nbsp;the employment thereof has been specifically authorized
by the Company in writing, (ii)&nbsp;the Company has failed after a reasonable period of time to assume such defense and to employ counsel
or (iii)&nbsp;in such action there is, in the reasonable opinion of counsel a material conflict on any material issue between the position
of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses
of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y)&nbsp;for any
settlement by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld
or delayed; or (z)&nbsp;to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser
Party&rsquo;s breach of any of the representations made by such Purchaser Party in this Agreement or in the other Transaction Documents.
The indemnification required by this Section&nbsp;4.8 shall be made by periodic payments of the amount thereof during the course of the
investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition
to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject
to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reservation
of Ordinary Shares</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available
at all times, free of preemptive rights, a sufficient number of Ordinary Shares and ADSs for the purpose of enabling the Company to issue
ADSs pursuant to this Agreement and Warrant ADSs pursuant to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Listing
of ADSs and Warrant ADSs</U>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of
the ADSs and Warrant ADSs on the Trading Market on which the ADSs are currently listed, and concurrently with the Closing, the Company
shall apply to list or quote, as applicable, all of the ADSs and Warrant ADSs, on such Trading Market and promptly secure the listing
of all of the ADSs and Warrant ADSs on such Trading Market. The Company further agrees, if the Company applies to have the Ordinary Shares
and/or ADSs traded on any other Trading Market, it will then include in such application all of the ADSs and Warrant ADSs (and/or, if
applicable, the Ordinary Shares represented by such ADSs or Warrant ADSs), and will take such other action as is necessary to cause all
of the ADSs and Warrant ADSs to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all
action reasonably necessary to continue the listing and trading of ADSs and/or Ordinary Shares on a Trading Market and will comply in
all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company
agrees to maintain the eligibility of the ADSs for electronic transfer through the Depository Trust Company or another established clearing
corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing
corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
[RESERVED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.12&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[RESERVED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of this Agreement) shall be offered or paid to any Person to
amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration is also offered to all
of the parties to this Agreement. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by
the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall
not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of
Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it
nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short
Sales of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time
that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described
in Section&nbsp;4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the pricing
terms of the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release
as described in Section&nbsp;4.4, such Purchaser will maintain the confidentiality of the pricing terms of this transaction (other than
as disclosed to its legal and other representatives). Notwithstanding the foregoing and notwithstanding anything contained in this Agreement
to the contrary, the Company expressly acknowledges and agrees that (i)&nbsp;no Purchaser makes any representation, warranty or covenant
hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated
by this Agreement are first publicly announced pursuant to the initial press release as described in Section&nbsp;4.4, (ii)&nbsp;no Purchaser
shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities
laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial
press release as described in Section&nbsp;4.4 and (iii)&nbsp;no Purchaser shall have any duty of confidentiality or duty not to trade
in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees,
Affiliates or agent, including, without limitation, the Placement Agent, after the issuance of the initial press release as described
in Section&nbsp;4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the
investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth
above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.15&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers
in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers
to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required in order to exercise the Warrants.
The Company shall honor exercises of the Warrants and shall deliver Warrant ADSs in accordance with the terms, conditions and time periods
set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.16&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Lock-Up
Agreements</U>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except to extend
the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If any party
to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific
performance of the terms of such Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.17&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Capital
Changes</U>.&#8239;From the date hereof until the one year anniversary
of the Closing Date, the Company shall not undertake a reverse or forward stock split or reclassification of the Ordinary Shares without
the prior written consent of the Purchasers holding a majority in interest of the ADSs and Prefunded Warrants purchased hereunder, other
than a reverse stock split that is required, in the good faith determination of the board of directors of the Company, or requested by
any Trading Market, to maintain the listing of the ADSs on the Trading Market or remain in compliance with any applicable listing rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;V.<BR>
MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination</U>.
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been
consummated on or before the fifth (5<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>) Trading Day following the date hereof; <U>provided</U>,
<U>however</U>, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Fees
and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Depositary fees and Transfer Agent fees
(including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company to issue
ADSs or Warrant ADSs (including in connection with any exercise notice delivered by a Purchaser to the Company)), stamp taxes
and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers and shall reimburse the Purchasers
for any fees charged to the Purchasers by the Depositary in connection with the issuance or holding or sale of the ADSs, Warrant
ADSs and/or Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Pricing Prospectus and the Prospectus,
contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements
and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a)&nbsp;the time of transmission, if such notice or communication is delivered via
email attachment at the email address as set forth on the signature pages&nbsp;attached hereto at or prior to 5:30 p.m.&nbsp;(New York
City time) on a Trading Day, (b)&nbsp;the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages&nbsp;attached hereto on a day that is not a Trading Day
or later than 5:30 p.m.&nbsp;(New York City time) on any Trading Day, (c)&nbsp;the second (2<FONT STYLE="font-size: 10pt"><SUP>nd</SUP></FONT>)
Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d)&nbsp;upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
signature pages&nbsp;attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains,
material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
Commission pursuant to a Report on Form&#8239;6-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the ADSs and Prefunded Warrants
purchased hereunder based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or,
in the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment,
modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of at least 50.1% in
interest of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with
respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver
of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any
party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately,
materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the
other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with
this Section&nbsp;5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser
(other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns
or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities,
by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations, warranties, and covenants
of the Company in this Agreement and the representations, warranties, and covenants of the Purchasers in this Agreement. This Agreement
is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of,
nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section&nbsp;4.8 and this Section&nbsp;5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents (other than
the Warrants) shall be governed by and construed and enforced in accordance with the internal laws of the State of New York,
without regard to the principles of conflicts of law thereof, and the Warrants shall be governed by and construed and enforced
in accordance with the internal laws of the Kingdom of Denmark. Each party agrees that all legal Proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against
a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced
exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient
venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company under Section&nbsp;4.8, the prevailing party in such Action or Proceeding
shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file or any electronic signature complying with the U.S. federal ESIGN Act of 2000 (e.g., www.docusign.com), such signature
shall be deemed to have been duly and validly delivered and shall create a valid and binding obligation of the party executing (or on
whose behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page&nbsp;were an original
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any
of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document
and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind
or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in
whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission
of an exercise of a Warrant, the applicable Purchaser shall be required to return any Warrant ADSs subject to any
such rescinded exercise notice and such Purchaser shall be entitled to the return to such Purchaser by the Company of the aggregate exercise
price paid to the Company for such Warrant ADSs and the restoration of such Purchaser&rsquo;s right to acquire such Warrant ADSs pursuant to such Purchaser&rsquo;s  Warrant (including, issuance of a replacement warrant certificate evidencing
such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company
of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and
hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law
would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a
Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or
any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or
are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several
and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
Sullivan. Sullivan does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to provide
all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested
to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each
other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively
and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Liquidated
Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents
is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have
been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Company
Acknowledgement; Notice of Successor Danish Counsel; Aggregate Exercise Price of Prefunded Warrants</U>. The Company acknowledges and
agrees that the Purchaser&rsquo;s payment of any amounts of funds to the Company Danish Counsel under the Transaction Documents pursuant
to the bank wire transfer instructions for Company Danish Counsel provided to the Purchasers and/or the Placement Agent in writing by
the Company (and such bank wire transfer instructions for Company Danish Counsel included on the form of Notice of Exercise in the Warrants)
shall be deemed to be the delivery by the Purchaser of such amount of funds to the Company and shall satisfy the Purchaser&rsquo;s obligations
for the payment of such amount of funds under the Transaction Documents. If the Company changes its Company Danish Counsel, the Company
shall promptly deliver notice of the successor Company Danish Counsel (including the bank wire transfer instructions of such successor
Company Danish Counsel) to the Purchasers (including, without limitation, any successor holder of the Prefunded Warrants or Ordinary Warrants)
on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer of the Company, with instructions in writing
to pay the exercise price of the Prefunded Warrants and Ordinary Warrants to such successor Company Danish Counsel. The Company acknowledges
and agrees that, with respect to each Purchaser that has paid its applicable Prefunded Warrant Aggregate Exercise Price Amount for the
Prefunded Warrant ADSs issuable upon exercise of such Purchaser&rsquo;s Prefunded Warrants to Company Danish Counsel, Company Danish Counsel
shall convert such Prefunded Warrant Aggregate Exercise Price Amount into Danish Krone on the date of Closing and shall hold such amount
in trust for such Purchaser and shall release the applicable portion of such amount to the Company to apply it in connection with exercises
of the Prefunded Warrants pursuant to Section 2 therein by such Purchaser or any assignee of the Prefunded Warrants. Notwithstanding the
foregoing, each Purchaser shall have the right, upon three (3) Trading Days&rsquo; notice to the Company, to require the Company Danish
Counsel to return to such Purchaser all or any portion of the remaining amount of the Prefunded Warrant Aggregate Exercise Price Amount
in United States dollars that was paid by such Purchaser, provided that, following such return of such funds, any future exercise of such
Prefunded Warrants pursuant to Section 2 therein by such Purchaser shall require delivery of such aggregate nominal amount of the Ordinary
Shares before the Warrant ADSs are issued thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Saturdays,
Sundays, Holidays,&nbsp;etc.</U>&#8239;If the last or appointed day for
the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may
be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.21&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule&nbsp;of construction to the effect that any ambiguities are to be resolved against the drafting party
shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference
to share prices, Ordinary Shares and ADSs in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the ADSs or Ordinary Shares that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.22&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>WAIVER
OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,&nbsp;IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages&nbsp;Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2"><B>EVAXION BIOTECH A/S</B></TD>
    <TD>&nbsp;</TD>
  <TD><U>Address for Notice:</U></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 3%">By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 40%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
  <TD STYLE="width: 37%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2">Name:</TD>
    <TD>&nbsp;</TD>
  <TD>E-mail:</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2">Title:</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy to (which shall not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">evax
</FONT>SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 13%; text-align: left">Name of Purchaser:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 87%"></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 32%; text-align: left"><I>Signature of Authorized Signatory of Purchaser</I>:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 68%"></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20%; text-align: left">Name of Authorized Signatory:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 80%"></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20%; text-align: left">Title of Authorized Signatory:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 80%"></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 26%; text-align: left">Email Address of Authorized Signatory:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 74%"></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Securities to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 17%; text-align: left">Subscription Amount:</TD><TD STYLE="text-align: justify; width: 83%">$&nbsp;_________________</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">Settlement Election:</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;&#8239;
                                            DVP Settlement</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;&#8239;&#8239;Book
                                        Entry Settlement</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;&#8239;&#8239;DWAC
                                        Company Escrow Settlement (Input DWAC Details here: _____________)</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">ADSs:</TD><TD STYLE="text-align: justify">_________________</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 17%">Prefunded Warrant ADSs:</TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 13%">&nbsp;</TD>
  <TD STYLE="width: 20%">&nbsp;</TD>
  <TD STYLE="width: 50%">Beneficial Ownership Blocker <FONT STYLE="font-family: Wingdings">&#168;</FONT> 4.99% or&#8239;<FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;9.99%</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Ordinary Warrant ADSs:</TD>
  <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>Beneficial Ownership Blocker <FONT STYLE="font-family: Wingdings">&#168;</FONT> 4.99% or&#8239;<FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;9.99%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EIN Number: _______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;Notwithstanding
anything contained in this Agreement to the contrary, by checking this box (i)&nbsp;the obligations of the above-signed to purchase the
securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company to sell
such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)&nbsp;the Closing
shall occur on the first (1<FONT STYLE="font-size: 10pt"><SUP>st</SUP></FONT>) Trading Day following the date of this Agreement and (iii)&nbsp;any
condition to Closing contemplated by this Agreement (but prior to being disregarded by clause (i)&nbsp;above) that required delivery
by the Company or the above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer
be a condition and shall instead be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement,
instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>tm2427973d6_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Consent of Independent Registered Public Accounting Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We consent to the reference to our firm under the caption &quot;Experts&quot;
in Amendment No.&nbsp;2 to the Registration Statement (Form&nbsp;F-1 No.&nbsp;333-283304) and related Prospectus of Evaxion Biotech A/S
for the registration of American Depositary Shares representing ordinary shares and warrants and to the incorporation by reference
therein of our report dated March&nbsp;26, 2024, with respect to the consolidated financial statements of Evaxion Biotech A/S included
in its Annual Report (Form&nbsp;20-F) for the year ended December&nbsp;31, 2023 filed with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ EY Godkendt Revisionspartnerselskab&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Copenhagen, Denmark&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">December&nbsp;17, 2024</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>8
<FILENAME>tm2427973d6_ex-filingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;107</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Calculation of Filing Fee Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;F-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Form&nbsp;Type)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Evaxion Biotech A/S</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its
Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Table 1: Newly Registered Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Security<BR> Type</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Security<BR> Class<BR>
    Title</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Fee<BR> Calculation<BR>
    Rate</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount<BR> Registered</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Proposed<BR> Maximum<BR>
    Offering<BR> Price Per<BR> Unit</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Maximum<BR>
    Aggregate<BR> Offering<BR> Price</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Fee Rate</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount
    of<BR> Registration<BR> Fee</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 9%">Fees to be paid</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%">Equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 15%">Ordinary Shares DKK 1 nominal value (1)(2)(3)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">457(o)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">10,850,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">0.00015310</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">1,661.14</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fees to be Paid</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Other</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Warrants to purchase American Depositary Shares (4)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">457(g)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fees to be Paid</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Ordinary Shares issuable upon exercise of Warrants (1)(2)(5)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">457(o)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">16,275,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.00015310</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,491.70</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fees to be Paid</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Other</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Pre-Funded Warrants to purchase American Depositary Shares
    (4)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">457(g)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fees to be Paid</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Ordinary Shares issuable upon exercise of Pre-Funded Warrants
    (1)(2)(3)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">457(o)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fees Previously&nbsp;&nbsp;paid</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Ordinary Shares DKK 1 nominal value (1)(2)(3)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">457(o)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12,500,000.00</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.00015310</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,913.75</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fees Previously&nbsp;&nbsp;Paid</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Other</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Warrants to purchase American Depositary Shares (4)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">457(g)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fees Previously&nbsp;&nbsp;Paid</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Ordinary Shares issuable upon exercise of Warrants (1)(2)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">457(o)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fees Previously&nbsp;&nbsp;Paid</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Other</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Pre-Funded Warrants to purchase American Depositary Shares
    (4)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">457(g)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Fees Previously&nbsp;&nbsp;Paid</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Ordinary Shares issuable upon exercise
    of Pre-Funded Warrants (1)(2)(3)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">457(o)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Offering Amount</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">27,125,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,152.84</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Fees Previously Paid</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,913.75</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Fee Offsets</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Net Fee Due</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,239.09</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Represents
the maximum number of ordinary shares, represented by American Depositary Shares (&ldquo;ADSs&rdquo;), each representing ten ordinary
shares, offered in this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Registration Statement includes an indeterminate number of additional ordinary shares issuable for no additional consideration pursuant
to any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration, which
results in an increase in the number of outstanding ordinary shares. In the event of a stock split, stock dividend or similar transaction
involving our common stock, in order to prevent dilution, the number of shares registered shall be automatically increased to cover the
additional shares in accordance with Rule&nbsp;416(a)&nbsp;under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
proposed maximum aggregate offering price of the ADSs will be reduced on a dollar-for-dollar basis based on the offering price of any
pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued
in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any ADS issued in the offering. Accordingly,
the proposed maximum aggregate offering price of the ADSs and pre-funded warrants (including the ordinary shares issuable upon exercise
of the pre-funded warrants), if any, is $12,500,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(4)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No
separate registration fee required pursuant to Rule&nbsp;457(g)&nbsp;under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(5)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Estimated
solely for the purpose of calculating the registration fee pursuant to Rule&nbsp;457(g)&nbsp;under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>lg_evaxion-bwlr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_evaxion-bwlr.jpg
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M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !7 ?0# 1$  A$! Q$!_\0
MFP   P # 0$! 0            @)!08'! ," 0$! 0
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M$BEH4VM2%I*5I)2I*AH01T$$&@J/R+[[M[@X*G;>_P DKS'$64HC*=)4N7:
M0AI>I)U4SJ&E?4\![30-K03X](-O@7Y,;9''I!#48M7#*W&R1Q.%(7&BGP@
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MG NDQKO+5B+*[T_[4R$$-Q@?4<6'/K*"M- 4!02EY\=R59IO.[C$-[O+-AC
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MC$ Z'N >E77Q**?8T"D4%1/1[W3!7]H9EJL"0UF,6>X[E2'"DONJ=)\U=20
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MP[K BW2W/HDV^:RW)B26SQ(<9>2%H6D]H4D@B@B#O/\ .]GGYP77X8[08C_
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M!I*@V2>O@6"6U_4G7K H(QWJS7/';O.L-ZBKA7>VON1)T1X<+C3[*BA:5 ^
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MTQ0,OZ-+\-;A>];;]LD4%#J H%WYPMC7=Y-M%R+#%#^<8R5S[,E(U=D-%/\
M.(B3J.EP *0/;I [:"1CC;C+BVG4%#J"4K0H%*DJ2=""#T@@T%'.4+F_M-XM
M-OVNW3N"860P4)C6._RU\+,YE.B6V'W%="'D#R4J4='!V\?K@=_KZ1U4!0%
M4"7\V_.!;,1M<S;G:RY(F9E,2IBZWR&L+:MC2NA2&G$]"I*AT>2?L?7Z_30)
MI^6\YVK<6?&I143_ .)-!6;DPV(<VBV[^_F01NZSC+$MR[@AQ(#L2&!K'BGM
M"@%%QP>V5PGUM RU 4$P?2+?/)9OQ$S\(>H-.Y%OVD,<]ZW+X$[05OH"@*!6
M.=G8$[IX1\=L;BEW.L496M#38U<FVP'C>8T'6IOI=:'NDCI502\QS(+OB=^M
MN2V"2J'>;3(;F09*#H4.LJ"DGQ@Z:*'41T&@^V7Y&_F&57K*Y3"(TJ^3I%RD
M1V=>[0[+<4ZM*-?8A2CIXJ#[_P"!O[V_HU!CK]^';G[[?^V*H&OY4N:S!MB<
M#NN,9+:[C-N$ZZKN#;L(-*:#2X[+0!XUI/$"V:#O'^XUM+\G[W^\C_=: _W&
MMI?D_>_WD?[K0'^XUM+\G[W^\C_=: _W&MI?D_>_WD?[K0,]MQG5NW+P>RYW
M:8[T2W7MCSF/'E!(>0D+4@A7 5#75/8:#:: H"@*"3W/;MXG"M[Y5\B-ANUY
MA'1=V^'702@>ZE#I[2M/>'W= M34^:Q$D0&7W$0I:FUR8Z5$-N*9XN[*DCH)
M3Q*X=>K6@W/9C;^3NCNAC.#QTJ+=TFH$U:1Q=W#9U=D+/N6D*H+?18T>%&9A
MQ&TLQ8Z$LL,H&B4-M@)2D#L  T%!]: H)W>D;W*$R]8YM5 >);MK9O-Y0E1T
M+\@%N,A0ZM4-A:_KQ0*1M!@<G<S<O&<(C)447:<TW+6D%7=Q$'O)#AT]JVE1
MH+A0XD:!$CP8;89B16T,1VD]"4-MI"4I'B &E!]J H"@*"5G/QMO\3]Y/C7#
M9X+1F49,[B2DA(GL:,R4Z]6IT0Z?=T&B<I.Y0VRWPQ^XRWBS9+PLV6[:J*4=
MS.(2A:O$VZ&U^H*"QU!B,IR:S8;CESRK(9*8EEM$=R7-?5IT-M#70 D:J4?)
M2GM) H(H[P;EW7=S<.]YW=N)!N3Y\RBJ/$(T)OR6&!IH/(0!J1UJU/;0,ER"
M;)?&S,7]U[]&*K#BK@;LP<!X'[NI.H6.PB.D\7NU(\%!3.@*#PWJS6S(K1.L
M-ZC(F6BYL.1)T5P:H<8>24+2?5!H(N;];/7?9+<:XX=/XWK:3YU8K@I)2)5O
M=4>[7X.).A0X!U*2:#?.4#?D[,;BHAWN26\#R4MP[V%$]W&=!(8EZ=G=E7"O
MZ@GM H*Z)4E:0M!"D* *5 Z@@]1!H/[0%!%KF>_:!W$_'4GZ8H&7]&E^&MPO
M>MM^V2*"AU 4!0(]S=<G4O+YLO<_:B&A60.A3V08ZT @S%@:F1&'5WQ]FW[,
M](\K4*"=$J+)@R78<UER/+866WX[R"VXVM)T*5)4 00>L&@[IM3S?;S[4L,V
MN'=4W['&0$MVB]!4E#:!KHEIT*2ZV.GUH7P^*@8ZS>DLMYC)&0X \F8!Y:X%
MP2IHGPA+K*2/4XC0?2[>DLM*8RA8MOY#DP^L,VX(;;'C(;963^Z*!==T^<G>
MG="._:U7)&.8](!0[;+*%1RXA0T*7'R5.J![4\02?!0< :9=D.ML,(4Z\ZH(
M::0"I2EJ.@2D#I))Z *"@W*1R:2[5,A;H;OP.ZFQU)D8]BT@:J;=3HI$F8D]
M2DGI;9/4?*5TZ"@?6@* H)@^D6^>2S?B)GX0]0:=R+?M(8Y[UN7P)V@K?0%
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M"TK ('$.(:IZB:"3TK86^,R7V6,PPB0PVXM#4A.76-"7$)) 6$KEA0"ATZ*
D/AH,I^A+(?BEYG\9<-_"/>]]\;;%W7\1P\/'YWIQ>+76@__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>fc_immun-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_immun-4c.jpg
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M%!04%/_  !$( A8#Z ,!$0 "$0$#$0'_Q #(  $  @(# 0$
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MP +M-%HT;:[G7$-!7=T[9=.J5J3(MWA#.[ER;Q7C6>W>,Q#N5\CF_(C1-_8
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M3;[W:L0L%KR:;]IY)"ML.->+BBJ229K+  ^[J2(J[S0BU5.M9&>H% H% H%
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MWF?:OL=H8[%ZNUBO,AAM$0!E2Y+:/DB?2XX!.E_G&M;[#<_S1_5ISC_H6_\
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M*IJ+P\8/U?>//Z&8_P#'6:-./%;]=7.__6Y+_O%*WMT'I#7,></@!_QVS_\
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MJ= DR[BR,=N+\L+XF;4<FVQ%$-MM10^FN[5/A4HT_P#NT_\ M#R%_P!3MO\
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M ,"TFT!:%!$4/1-/HZ5,B1<Q<+8=SA8(6.9J4P;?;YB7".L!X6'.\+9M>Y2
MT5-KA=-*2X$FPC#[3@&*6G#;$KJV>RQ@APUDFCCW;;UTWDB"BKU^A*@KKE7Q
M>X?YBN27W+;0XUD6P6G+Q;7BB276VTT%'=$)MQ1304(P4D%$371-*LHR?#/
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MMP+&SQ<#<NTI71D_(G?QCZV<9&NQ15_?OVH?L5U&NW^5NV>ZK@;#5 H% H%
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M9W?L5K4=G[MCYW]!LW[F_P"SOM:-V-==G>^6_.Z?AV]O7]BIL--> 6FWO(;
M0=%#%,F@FB+U3<$H2%?V%1%KI69T>T]<6GBSY%@+7D'R"C0H"?I#,/V]/<3R
MDJ_C55UKMJSMT>T4=5)AM2755 555^G1*X1IR50H% H% H% H% H% H% H%
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M'VVFST<%MS7W/EIJ*^Q27JBT;Z^1\=B'X]<@18S8,Q6;#):89;%&VVVP;VB
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M\@^Z_+?MT5UYQSI[C,VU(BZ>JK5S1)433HE0?M H% H% H% H% H% H% H%
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M^4,:N>.S^4\ CX[@F67"/:(<V)<OG+C:Y<]52*-Q95L!1'%Z&39:-_'KHBS
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M9/XW7K%L=M;]RR)^/908M48$)\BC7"&ZZ*#JB>P&R)?P)5UN*EF7>\G,:O\
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M5]S8E$;!1_@]/5%JVP9SAK#N7(O'>>YCD5@B'RYD4>#9F+#D&YR#+A8Y ;@
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MZ*Y^F9V=*[O)<^X,>&#US8F/MW),.M;J3 =,9'<)B,I'W$7=N77JNO6FL_\
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M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!05KY LY/+X9S.WX;
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MF<=V00;-L>Z7:1H11"3W;EZ]*BL?;/'R#;N<Y7+HW<RM!I)N%OQ86U"/&O\
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M=.NOD/$M$I_%+G 96/+7'1A.?-+);E#J#9,*TVPCB(9/H/;Z[J17[R _P@>
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MM;7&8#SZR38$M5783J]Q4_;=:#)_HO8OTD_3#Y!C]*?D?LC[7V?[3]G][O\
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M^OV^/%Z,L!B8H8+N%>J*GI7ELP]LN7U44H% H% H% H% H% H% H% H% H%
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MX;ZX5BEOP;$K+A]I1$MUDA,0&"04!31@$%3)$U]QKJ9?A6O#M<W+M)AGJBE
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M.BU8-A\2N-WNV-VNYY!:RLE^EQ67KG:"<%]8LHP17&4<!50T$M40D]4K(S5
MH% H% H% H% H% H% H%!3?._CQ9>=SQUVZWZX6)W'"EG%=MG;0S68C2%J1H
MJIM[2:;?I6NOK]G@S=<U3S?W?.)M..O-<A9(V\^J*^Z!,";BIZ*9(&I:?AKK
M_P#T7XB>$;.<<83'XYPFS83%GR+G'L[*L-SIBHLAU"<)S4U3IZEHGX*\^US<
MM)365:VYW^N#@']6)W\]J:_R1GV?HJ[:^D^84"@4"@4"@4"@4"@4"@4"@4"@
M4"@4&1B7%1T:D+J/H+GT?C_RUPW]7>/3Z_=CBLHBHJ:IU1?1:\KV% H% H%
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M,3RQCGD[S3@S^*2\5LF(Q([\&3.C)=TN+M[=C2FG.VR0M $5@-I/EW%)Q2
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M6+G7Y8VG.6'YI\PN&LJXJO&,88[(R?*<L@.VJ!8D@OB;3TT>TA/=P$'<"EN
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M9+]8EZK7D=7:H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M^JVOM1!T-%7=JSR*\PVW)SUG'";_ "BT[.^<P.X3+U$-QQD+G\G<$9864C1
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M4&?H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H%!K#YDGQ!%LN+3.2<8G9CD)RGX6(V"VR7H;K[LCL_,;C9U7:B"TGU"+<
MHHB=55._I\L\,;8:W6D_"8<<O5QSW!KSB&6V20D1[#GI\Z1/><-%449W&SZ:
M+O[J!M^GJFOHO[F>.C/'UEO'X]O6>3PWB,C'K$[C-C=B$<"QR7G)3T=I7W%3
M<ZZ(D:G^^:JGY73I7CWZND696%:VYW^N#@']6)W\]J:_R1GV?HJ[:^D^84"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@ICRSGS[=X[YP];T+NO,1(
MCY@6U1C29C+;J_A117:J?0M)SM'7U\/*KTKVN10;8?=\S[FQS+>H$5".VR\?
M><N H6@BK$ICM&J?%44U!/HW+7C_ .U)XO5Z*VX\S]/\-.;Z_M;;I^/[5B:?
M^&O)Z/UQW]G1*./[OS%?)<B!R?B%FL^-.051F1;[F5R-]XE$>T;9MBFP@4U4
MM?@B==:QM-9TK4RU^LF<W+@CB;F3BQLW2R' +C\EA"ZJKKD++24K6K?Q(VS<
M<<+3T]*ZV>5E^?K_ ,,])]?7W3+D$F_&OQ%;QF$X,>__ &<U8([Z$(BMXO.Y
M93R'T1-BF^\)+Z(-9GY]\KTB"\#WCCGB_G.T8#Q_DMLO>-9MB\2)/.UR0>;'
M)K"T2&Z>BKI\RVCAIZ;C+TZ5OV2[:YLZ).'UY@R/T/S6%D.!3I=OS3([#,MO
M( 6V-\T0X@A T=Q=%-.VXR2JVV[T5=-$(=G6>KF<K4QY:LF*8]BGCG9<(V+A
M\;/,92S.MJA"]%<:><%Y21$W$[N[A%I[B)5IZ\_FS\5G?I/Q9GQGBP+IE?,F
M679 >Y%7,[C:9[SWODQ[5#V#!8!2]PL[4+;IT+:GKM33'LXQCX:U<7)T>)9/
M*3AR[XP(M99D+5X@90TQH)2[+'C"XV<D1TU1HT)6R+U443KM1$:_HI>JC>&O
MG^)<4B>0=B9==QT;[=K%RG;F5)TG[2L\OE;BVWU_.0S<5"V]2;73VIO6NN]\
MKBDX7WXKRHLZZ<U3H3S<F%+Y NDF+)9)'&G67FV3;,"%511(5145*Y^WM^!J
MV*K@V4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4&KW*^7->/'+URY0>;[F+<@X[
M(CS6="VGE.-L$[;T,T14'YJ.JQFQ3U)-5]*U.1"W\'C<=,>/?]K"B6.2[Q>;
M[R+-N8BD1<PO43YB <_5%'<TZ3C(N%H*;-2]NM7*)-Y'WKCBY<G<&MP)ENF<
MD!FEI('(KC3TD+(KBJZ+I-JNT#=)I64<]5W[/RZDE*@%_5.YE^OI_;Y9M?\
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M=V?<9)(W'AQ&R??<,NB" -HJJJUNV1GPKTX\-_'VX<28]<,HRT ;SG(P:!Z
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M% H-;<[_ %P./_ZL3_YY4U_DC/L_15VU])\PH% H% H% H% H% H% H% H%
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M\EEG5[I9>8^JBE H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MS-F-JDQ^''5KWM,J#BAW%$G4'H@ZI3 GN4\Z:EBEGXMQ]S-\PS*V!D-JMWS
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M/59;+F,M$G@_HVY[7O\ P%^+_)7DW]>.9T>WU^V;<7J[M<7<H% H% H% H%
MH% H% H% H% H% H% H%!B\C&\'8KF&/. UD!PY VEU[16AFJT78(T5%110]
MNNJ4% <56ZYQLPQ9RPV3*+1,"#*3E69D12EBS9G806O=*-QM^2LK\ZV[$T!&
M2)-=I"*:J1LG65*#7_(X&9<1<IY'RCC6-3,SP?.(\%,KM%EV.7F!<K4VL=F5
M%C.$"/M.M*@N-BN_=[M=$T6C(6'/^5N2\LLWZ-8E<\!X[MKJR<DN>80VX]TN
M&U-!@PX7<<)L25=3D$J=/JZ*.AK,"(X7D&6^.D6[<<7?CW),NL(72=<</O\
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M-]7OJ.1]B(.FHH*DB*-PZR% H% H% H% H% H%!K;G?ZX''_ /5B?_/*FO\
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MABA)JGHNBHOI5LRDN'U^&@^!:9#38T ;4T#: CM1?5$T3HGX$J87-?=5DH%
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MU<",TVR)ET54:%!U7\>E!V:!0-$H% H% H% ]*!0*!0-$H% H% H% H% H%
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MY61K!)D-RYHT:Q0DE/<)&5=TVHXHKJ@:ZZ+5O^6)?R?7W1+/+5=&^6>8KZ[
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M% H% H% H% H% H% H% H% H% H% H% H% H% H% H%!K;G?ZX''_P#5B?\
MSRIK_)&?9^BKMKZ3YA0*!0?HD0+J!**KZJBZ4LRLN'XO5=5ZK]-$?6\]G;W+
MV_VFJZ?\E3$7-QA^(JHBBB]%]4^"U015TVI]55UV_#7\5!4_+W+'$-CL5_P+
M,LX@V.YWFVS;8ZPVCEPDQ5FL&QW'(\4345'?NV'M5:SUZ1VUTVG+L<%YCQU.
MP6PX1@F:0<I>QJVQ[>_\NI193HQ005>6&\J."*_@0D3Z:G?-B[S99XJHJA"N
MBIU14Z5MP?2F9*JD2JI="U777\=,0S4?RW.</P6(L[-K_!L4=!W#]H2!;=,4
M73\VUJKA_B %K,OPW-+5(S>9\ \E4R'@_C[(9MIG7:WDKN32(2]B1 :>;^<C
MQ&G'6W",V=R:F@IL4NE++.;'777'*FLR@>7&4Y/=>',$C2+-@&)F-E@.6C2S
MVTK8RT"1B>GNDCCI$SL(Q%Q>I+[?A6IX3F]6\K"X$\.I?&.56WD+)\M-_*;>
M1N!;;,*C#+OMJ#@2)#Z;WA)")"$0'7]M5VV\N,<.=WD^[::/;K=%GR;M&AQV
M;M-!MJ;<&F@"4^VRFC8..HF\Q!.@H2Z)6?&.7E<.S58*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*#]$B$D(5423T5/5*+T96)<!=T;>T%WX%Z"7^1:\N_JQ
MS'L]?NSQ>KOUP>@H% H% H% H% H% H% H% H%!4SGDWP2UDBXHYFD0;L,K[
M/)Q6I/R"2_X)9W9^50OI3O5<43&%G5MG9Q=L";@W!NYV>''GR)SL4@MSC<I=
M!!F0J[3-/RAT^GUT72"44"@Q]]N[%@LMQODIE^1&MD5^:\Q$;5^2X$9LG"!I
ML>IF2#H(IU5>E!7V0\[XKCV+XMD3MIO<^X9F"'CF*P(!/WZ3HUWW42*IB@]E
MM=SJD:"*?&K@2O'\WM^19'DF,18-PBSL7*&$Z1,C$Q%>*>RKX?+.JJH[L1-K
MFGU5_ J+4$FH% H%!A8N68_.R*X8E$GMNY):F&)=PMPZ]UEB5N[1ETTT+:NF
MBT'2PW/+#G19$%B5Y5QB\R\;NG?;[6D^ +9.H'5=P:.CH7QH)/0*!0*"+Y1G
M]@Q&]XOC]W5_[0RZ:Y;;0C+?<#OM-*\O<+5-H[4]>M!**!0*!0*",97G%NQ"
MX8Y;IT&X2W<FN(6F&Y;XI26F'G!4D<DD*IVFDTZFOIZ^B*J!)Z!0*#I7>[6^
MPVN;>[O("):K;'>FSY;BZ S'C@KCCA::]!$55:"+9'RMA^-8SC^7RY#LJP9/
M+MT&S2X;:O(\5XT6,YHJBJ-DBH6Y?A\*";4"@4"@4"@B^%Y]8,]7(DL"O+^C
M%ZF8U=.^VK6EPMR KR!JJ[@_.#M+XU;!**@4"@4'4N=S@V:W2[O='PBVV P[
M+FRG%T;:88!7''"7X((HJK01CC7D>W<H6-S)+-:+O;+,3NRW2+U#6#\_&)L7
M&Y<42,B..X)IL,D'7Z*HF50*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0:VYW^N!
MQ_\ U8G_ ,\J:_R1GV?HJ[:^D^84"@4"@4"@4&O/EWS1=N)L$@V[%I"Q,ORQ
MU^)#GC^^1(4<$62^TNOM=53!MLM/;J1)H2)2:^5QV==..7F41&XX;KA$;SI*
M;KAJI&9DNJD1+U555?5:]DF&+;>KMVFZW2PW6'?;',=MUZM[HOP9\8E;>9=!
M=4(23K^Q\:EUEG*Z[W5N*7W@UQ8QNW1F<,9EYIV6PN<Z3*5JWG)'VDXS&8'N
M*AZ;MN]-%54^%>;]J_+KC6\_7U_5;GC!RSS1R7>,AF<H8^[ Q=R.S)QZ8W;C
MMT$'!=V/1VG'$WNJ8&A"1$6FQ>J5SVDG$JV2<_"MH/@-(NV3W*ZYIFYK93F/
M% 8@@<NY.0E=)6N])E*@MN;--=HN=:Z3V7M$NTPV)XX\>N)N*9#=RQ&QZ9 T
M)@-^GO'+G[7!4#1"7: ;A517MMCJE8YO6L7V<8BT%)51!5541^JGP3\55S?E
M$*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#O1+@36C;Z[F_1#]53\
M?TI7'?U9YCT>OVXXO1EA)"1"%=17JBIZ5Y;'LER_:BE H% H% H% H% H*6\
MI.0N1.,N+7<EXSM?VE??G6(TIU6"EI"A.BX1R5:'ZVA@VW[NB;]5]*L@E/".
M49=FO%F-93GEK^QLLN48G+C;^V;*)M><;:=1L]2#O-"#VU?3=I2BP*@ZMPC)
M-AOPB<-H9+3C*NM%M<%'!4=PK\%375%H-3H\3)>$N*CXIYBXY9S+A*UMN,3<
MMQIT#_V!Q]7Q?F6H^V^!MFO=>?9<78J;T553<6NHY\AY;N''^7<KWS'YSUTQ
M/&L%L-QQ2T./NOVX'9>K3#P@1?5+<V3A(J$0^JU!EKGQ)R)8N-KCR(UR]E#O
M*$6SR+U*-Z<#V-NR/E2>=CC;5;1EMA4W T;>TFUT<'JFVKD07%)'(7).3</X
MD?(&06>TWGC@+SE3]OFDW-F$W)%$,'G$-6WR<5M#D"G<[:$.Y-RU!+WI^6<6
MY;R-Q-'RR\9!83X[GYQCUSO<HI=WM<QAQR$;3<Q='#!5VNAN^HJ:#^4I:QGE
M,H+.Q*9R'EWBW<+SEV2Q+IE.)W#YZX6VZNQI+3T*S1GR?CN:$3;LDG524?JZ
MB"B^E6=*5+LPY6S; [IY"/VBXNS9MDEX?:,28N3I/PX$B\06&#?03W"/O<5\
M_;M,T]R=5K,BINYP5R/C#5OR#!>5<ANN=PWFG9T;+K@[,QRY-F8_--.0P;/Y
M<5%2[*LZDWT'7\M&1B+1:<EY_P [S^7<<UO^*83A-[>Q.R6/%IY6E]V7!:;.
M7,F/MBINH9.#V1Z"*)Z:ZJ3H*GS7).4\#LOD;89N?W>[2L,@X@.,WA7UCRV&
M)LC<BEV=HH^K9"U(= 15_;N)/=3KA%@\F8GF_!V&,\SQ>2<ER#*;),MKF46J
MZS4?L5T:N4QF)*9:@" M1A0G]6.U^]BFB:KH2)R..P\:1[IY9\@NKE>40S@1
M+'?$;AWAUAE]7WGG5AO@@>^(.B VPJZ".Y/CT9X5$8MZR/!+?R%RO8YTQNUX
M9S+>7LLM,9PU8FV"X-08DI7(X]'7&5,'6E+HW[B_%;_A%X%?KOG7D5&L5BNT
MAG">.;,ERR!N#(((\^\Y /\ L,:2 J@NM-1A64"]40B3\%9[*Q/D]R1=<6D8
M-@MLN5RL+&:S)R7>_6&(=PO#%MM+ OO-0F6A,T>>5P 1X1+M#J>BU9! ./\
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M;;8^TOK:IHJ%>@@F9!D\+%^;N"LDRR\7NV8UB3F6XQD+DGMW@H11GU.WW&0
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MF,LIHG#('/K B]$3X+UK,_-<0FGRU@G^>'*>1&<3 L%@1WG%T979,O$A$U^
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M3-8N60[;:[Y+^;CP7X\Q]YM" 1(20=H>J+HB*O2FGL\9AJXVYQ_;_P /O _
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M=5T]F)B\PL8O _&C-9_)4#EGGW,V\RR6Q**X];(+2Q[=%=!=P.Z;&DU$O>@
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M2V1D("M*YV^Z ,=%VJG6M_F_LSPRO$4+@F/<H*\;W*7*G)BSK<09 SD1<?\
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1OY=&%'Y=#'1:D\LS^R\/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>fc_strategy-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_strategy-4c.jpg
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M%!04%!04%!04_\  $0@"/@/H P$1  (1 0,1 ?_$ -<  0 " @,! 0
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MGW<>4VCK9?9$DK(IGNOYSF<%<=L7FPA&>RZ[3&X-G8F"3C0B**[(>)L2!20
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MU^'U-:OBCT$[>>=[!SWAIY#;6%MU\M[@Q;]9R/U%COD.X2 M$4FG$15 E1/
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M$1HWO3(T5"T<-!$U1=VU5T5%ZUJ]E>N=PX]P>ZXT6&S\=MKN)JVK(V9(C01
M!45/P;8"B J:^4@T4?%%UKD/&_E?&UX=YJR"PXQ+=:3%[OZMDEJ6K[0MF,B,
MJDB)J;:*&I:=536NL[#8OO\ <]N.2AQ?;E3W>W3;$.2NQ@55%9-RVBB+KX^F
M+9(/[Y:FL1:W85PIA[/'+7+%VM[%RRJ\RI+=NDRFQ>2%$A/*QHR)HJ X;C9D
M3B==NB)IUUSM52WO3X3PS*.)K[G;-MC0LUQIH;@Q=H[0,O2([9B+S$A01/4%
M052#=U$D3141214HU&[!_P"\/;_ZKN/\DE:V'2[YLIFY#W#7VW/N*4''(T*U
M6]OP0 ]W"4YT^%77W.OP:? E76=$6APMWC<,\+8+;<2L6"73W\&&COET H@O
M3I^W5UTRW;E%"4D:0E\H:)6;%4-W'<F<9\L95$RW ,6D8O<'VG!R%MU6!9E/
MH2*V\(,=$<5%)'2^Z\J^.JK8-M^$,BN%_P"PC.(]P<]7Z#M>1VJ*2_.2.$0I
M "J^W;ZZBG[E$3V5/\41KWV%?WB;7_5MR_D%J[*]8ZYA0*!0*!0*!0*#23#^
M\W+X//$[BOF:#9,<QZ-.F6M;I':DQR8DMFONKCSS\EP$9<1$3U/31/.)JHCK
M6L=!N/<<BL=GL[F0W:Y1(-@9;1]VZ2'VVHHM*FJ&KI*@[53P76LCSA[8@@99
MWIWK*,!C;,(CR+]<@5IKT60M\H76&%0%1/3$W'FU -$5$Z:)HNG2]D6[]9(P
M\7&^'21!5CMWLVS<]B&Y$<44^R@%^I6=57IVRY%8[IP/@'T?<(\A8EFAPI0M
MN@I-28[:-.-&FNHD)#IHM2]QK3]9?_T+C7_.WG^#"K6OJGJW/XU_L[Q'^I+;
M_1&ZS>ZM._K&N.[G-L^*\FVYMQZ'95=M-Y($U1EN48G&=73J(^IO;4EZ;B!/
M;UUK1?W;AW 8GS+A%I1NY,MYY#BMQ[_9'3%N7[RP"";[;:Z*;3FGJ"0:H.NT
MM"14K-F [C.X+$^&,+NBN7%AW/)49QBP6-HQ<E+)>#:#SK::[&F]?4(CT0M-
MH^942DF1J!]6]TY2RW7V6!?Z;'K6PD7UED=Y+KQS*4%]W./=FQ/V;Q<BDJ?J
M$E-1O!Q[D5DON$XY<+/<(\V')MT1676'0<0E] -1\JKYD7HH^*+6!Y^=UV/,
M<6=TUGY2R.QMWW <B=A7"7"DL-R8KZ16PB38R@\B@3B "/"A=-3%?9TW.PW)
MP[C7MAS^QQ\DP[#,1O%DE"A-2HMKA%HJIJH."K2$V:?= :(0^"I6<T:]=PG)
MW;3P]>H.*XIQ1B&8Y,2FMXC,PX;;4%$T%MLS;C.HKQKKJWX@B>;YPUJ9%R<D
M\;7'/^U.=AENQB/BV02+0Q=(6(VT!%J).CN!</<FQ$ 3>9"K1>5$WDORUF=Q
M0W89SWC&/62=P[FDYJS7 )KLW'Y,XT88=1]!1Z*1GH(."8*8(2^?<J)U1$75
M@W?R[-\2P.RNY#F-XBV:S,BIE*ENH"%HFNUL>I.&OW(-B1%[$K \JAY+_.[W
MC8QGK;!1H%RS"Q!;6'$1'!A19D>.QO1-4WD#:$?5="54UTKKZ)7KDZT#PJVZ
M*&T2*)@2(0D))HJ*B^Q:Y*\N[!D!=FG<_EENEMF6'OQ9S<9E$)SU84II9EMT
MT\2%X6F#-/#SUOO!;?U?>"S[S-S/G;)-9%UO,EVVP)3O4C<><27/>Z]?.9-"
MA)\!I4V&YV8YIB_']@DY1F-S9M%@AZ>\39"EHA&J"(B((1&1*O0 %27V)61Q
MX1G>(\CX^QE.$W5F\6&01-MRV-PJCC:Z$#C;@B;9IT51,47147314H)%0*#R
M7[\/[QM[_F-M_HH5TU[#TCX"_L/XX_V:M/\ 0VJQ>]2=E(_6(?V$0/\ :.#_
M $695U%?_5H?_*^2/YQ:/X$RKL-D>ZS^[OR#_5B_RS=9BM$?J]O[?'OZAG_R
ML>M;]B,_]9!_:SBW^SK?].E5=4;>=FW]VK _\Q._UE*K.W<BD/K&.-[C=<<Q
MGDNV,&^Q8"=MM[4$4O2C3" F'2T^: NH3:K]\X*4UJJ<[5,][9X]@DX?SCC5
MI;O+,AR3;,FN$+WD'V'4%5CO& &0&VJ*H$7D45TZ*GFU<HD_,_-?:KB4V%:^
M)^,<:S&1YCNMP?A%'@M#HFQME=@DX:KU(D38*:(BDJKMDE5=/;%;[9RUQ7F]
MT9X\LO'MJRV+)QV%,LK1BY,8-EUA]PD/34&S<VBHKU)#3[FI;@>?^)G%X?Y>
MCQ^4,7;O,''YSL+),<FM"ZCC1"3#A +F@D0(7K,+J@DJ"NNU=:WZ(W@O/(78
M!;<5>R.%C]@NDQ&/5BV*/:S">Z\J:BRHN-(+:Z]"(RVI\*^W/55,<3<HXMRE
MR+8,)L? 6'!(N4L/7D@RZONT-LM[[Y+II^#;12Z^*Z)[=*7,'I]6 H%!3O=7
M_=XY!_JQ?Y5NK!Y6<$\KRN%N3+1GC$;WZ)%]2-<X*+M)^%)%6W1%5\#%%0P]
MFX4UZ:UTL1Z07/OK[>X6,+?H-YE7"YDVI,X\W"D-SE=TU1LR<!&1T7Q+U5'X
M-U8\:KS;G2,M[A>9'9#$?U,HS>Z_@HS6IML"\6@CJO7TH[0]2+P -5K?:(W,
M^L/MC-EXRXWLT95*-;YCD1E51$508A@V/1.G@-9U5G?JW?[+\L_K_P#_ ,-B
MIL+C[LN-KERCPA?[!8F"E9!"5F[6J*WJIO/0BW&T(IU(S:5P0'VDJ5)1YX=I
MG/-NX(SZ;)R:.\[B=_C)!NQQQWOQG&CWLOH"JF] 52$P1==I*J:J*"N[,HW2
MY3[Z>'<=Q.7(X_NZY/E\E@QM,5B-(989><'0'9)R6VT0 5=RMCJ9:;=!UW)G
MQ5I'VF<<WCDSG/'I(,F[:L>FM9!?9JHOIMA#<1YL27HFYYT1 1\5U5? 5K=J
M+?\ K)/[1L._J1S^EN5-1M+V2?W:<._?7+_64FL[=TU[*C^LG_[D8/\ UK*_
MHR5=6G6^K^LL?).%>1<=EDH1;O<'K>^8]21N5;@:)4^-$*IMW&EECN66=OO,
M,:?)A^ED^%70ADP7M0%U&E5MP-VB^1YHE03'7420DUZ5OO$>DT'OK[>9.,)?
MY5ZEP[DC>YS'3@R#GH[IKZ8D *P7Q%ZVWX52L>-5YM<X\JS>9^2[SGTJ-[DQ
M-)MFW0-V_P!"'&!&F@4O:2HF\U\-Y+IHFB5N3$1Z#VG )G)O8A:\/MC?JWB3
MCS,JV-)U)R7 D>]MM#X=7%:]-/WU<_56B/;YE_&^"\A$G,>,,7W$)K#D"<$N
M*DIZ ^AB02!9/JJB0;'!3S;254U5-I=*C;3DSDKL=Q+$Y%TPW$L;RW)W1V6N
MT1K>;8*X7W<APVA1ML/$D^>7@B>*IGJK"=K&<V#ECE2#%LO"F+6*)8FSNEPR
M. RXC\)6Q48ZM$2;?4-Y1017KMW$GS5I12?>MQW<,'YUO=U-DTLF6DEZMDHD
M\AFZB)*!"3IN![=J/B@D*^U*NHVNX+[Y.+KAA%NMG*-S/'<NM,5N++?=CR),
M:<D<$!'VRC-NJAFB(I@:#YM=NJ5FP:Q]X/<G:><KQ:+%AS3P85CJO.LRY(*T
M]-ER$$2=5M5U!L!':VA:%YB4O%$36L&P'U:__<W.OZSB?T<JSMW&\-9'G#]9
M1_WWP?\ JJ5_24K>HQW9KW6XKQ19)?''(Y.P\>>EG/M-[9:.0,=Q\1%UE]MI
M"/TU4$," "5"4M>FFBP3KNK[S,"R' KEQUQ5+<O4R_M^Z76](R]&C1X1*BNM
MM^N+9N..(FQ?)L057KK200/ZN_C^Y73D>[<C.M&%BQZ"Y!:D*/D<N$[:GIB2
M^.QI#(]OAN'7YW5L(3WVXS.L7<)>+J^PK<#(HD&XP'NJBX+<8(CG7PU1Q@M1
M]B:+[:NO9&U/!/>GPX7&ECM.?7HL<RBPV^/;YS+\:2\U(2&VC(OL'';=W;Q$
M2(%T)"U1$5$0ES8-,.ZOFJV<X\I%D6/LNLXU:H35HM!2!]-Y]IEQQXWS#4MN
M]QTMJ>.Q!U1"U1-R8&\_ N09#B?9/9<GQ2W-W:_6>VW2=$MKV_8^C%RE&X.C
M>AJNQ"44'Q7I6+W(I#&>\G .7,EC8WW"X+86L3D,N,,7I8[LUR'(54(%(C0W
M&VRT45)K11545?+JJ7'LJKNZK$^V6P#:IO!E\&5>ICY+<K- D'<+:U$5M21Q
M'W%(FW-^@^EO+HJ] V^:S(VJ^KMN-_E\,76)<E,[+ O;[-D-Q57:#C#+KS8(
MO@".&I]/NC*L[=QHKP%_>(P+_::%_2AK=1NS]9#_ &4XK_M"/]"DUG56*^K6
M_P"YN=?UG#_HYU-A=_>/_=KSS^;PO]8QJ:]QI_\ 5P?VN9/_ +.._P!.B5K9
M%4]V/'URXWYXR4Y,;6U7Z:YD-H>,%5A]F>XK[@)\/IND;1#\7P*E64;4X/R-
MV'Y/BT:]Y%C6.XU?$9$KK9IEL)3:D(**XC*M-&CK>[7TU#S*FFHBO2L]10]_
M[AN(GLHEVW!.!,9N%D<D)'LI3(I^_2454 55IE%1"<+J(#JJ:HG5:8JMP^7.
M2<P[<N$,2O\ C.%VIIN.4:'D%B85Y(-K=ELDXJ,JTJ?@TD;F]Y+U(A^^K,ZB
MD\!Y[[>.X63<X7<3B>/8]D&\#MUX478J262':8N3@4' ,%1--[J"J+TZHM:Q
M8-5>?[#Q%CO(+]NX7O3U[Q-&&S=>=576F9A$6]EE]1%76T% 5#T\55-Q::UJ
M=D>@=RYBY,XR[3<%Y-"RM7V_MPK8%]"X*]J,!]H@:EF3:H2F:^[[E+[]56L8
MZJJ/ ^X_@GG^ZW*U]R&(8]9)Z@RMFOA-NCZJ)J+K+TU%1UI11 4%5Q 5-454
M5!W6RP:U=R..<)8SF[,/@Z]N7BQ.1O4N(>HLJ-&E>H2(VQ)(45P=B"OB>GWZ
MZZ#J(]-NU.X7RZ=O6!3,C)P[F5O)M#>U4RBLR'6HI*J]5U8%M47VI7.JN.H/
M%SN<_O \A_UU)_92NVJ5[,6O_P"71/\ ,M?P$KC%>7OUA?\ ;U&_V?@_R\JN
MFO8;U]JG]W?C[^K$_E7*Q1K9]9A_T#C7_/7G^#!K6J,_V8XNUF_:?F.&O$+8
MW^X7FVHZ>NULY5OC-B:[>OE)4*I>XTMXOS&_]N?-4*^7FUG])8S+D0+Y9W-
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M/M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M5.E)<">U H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M)>RD@U>^KGXP]SLN1<LW!G;(N9_0=D,DZ^ZL$+LHQZ=1-U&PU^%LJUM1O96
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H%!\7P6@TW[0.W;DSAK.\
MIO\ G$6&Q;KK!]VAG%E!)(G?>A=ZB*:HFT?%:U;DDZ-R:R% H% H% H% H%
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M3CUFN97/7:VMPJ\SH4"@4"@4"@4"@IO'.YGCK*.6)?#5L9N:9="DSH3SCT8
MA^K;$-7M'$=4M/(NU=G7[-=+QV3+,VE7)7-HH% H% H% H% H% H% H% H%
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M\:02(/J)L$UW'J2*.FJHO3GS<6LGEJNFUSBMYZ\;LAI<M\5MN&TYG./ ZV1
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M)(C;F=/@!:Z<=\O+6N=Z25]X0M-QY=R;F[N%R!D@&)9[V-L$B4T:F7*$\(M
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MNJ*(H*(@BFE3\_9?"*8^LF54N/':HNBHQ=]%^18U>CXO:N?)WGZ>L64UV/\
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M*0 @2'ZK+J*F@IIHB5RTWNO9JS*<8CC-OPO%[/B5J-URV62&Q;X9R20WE9C
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MWK^'TUT3P^.NN^_EAG77"#8/V:81'G9-D'+WN^?Y/D=R=N:S7&GX;<='E4R
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MMW(E=;RS'28RGBVMKSME H% H% H% H% H% H% H% H% H% H% H% H% H%
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M6MF=5S5EHH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MRZ\+45LXSQ1W!(ST35'!4-/:71-:GC<X,L3B'-/%N>M7!W$<HA7-+2R4JXM
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M  B((B*(B(B=$IT.K8GB&VYG:.-L=MO(<DY>:QHVR[ONO#*<)WU#4=[P]#)
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M%:F^T[5+)6=E8O8)TFTS)EMC/2;":NV5PFAUAF3:LJK'WFH+LZ>SI6<U5?\
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M4"@4"@C-U;.PW [ZR"G:Y6@WA@$U4%%-!D"B? G0_BZU]#BQS:?EW\4_#_\
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M,A>6W0;I&L-RF;[2P^XVCFP&$;0D;$M- WZ:)H6J=*Z\G+<V1C37I$:O!?\
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M!01NYY_AMER2TX?=+U%BY5?=RVFSFXBRWQ!"521L=50?(6A%HBZ+IX4$DH%
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M .R?JI_4\O\ U7]<_B?3MZ_\/2?^=9_QJ?T_'_V3]5/ZGE_ZK^N?Q/IV\_\
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MJO1%:%U3%5Z;D36K!C;?VJ\(1\:7'[IB\:]S) [KEDERW/7R5*)-7))3MR/
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MO"2"K2B0[=>J:5(M<'X[]Q?Z);3^5;?_ .SZN)[IF^Q^._<5KUXEM/Y5M_\
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M2+B;USM@2%9;>?$D%I#$G'%45-=4%%0=:8DBL<WSOGF'\=<@P,A6)DW)V$Y
MQB=IN",^YQ;H[=2:2!*DLM*(MDB.D3S;:HGDVH77=3 XN587<9Q)QE?N0XO*
M8Y)=(,-2NMKF6>#&BM*\HM>O;R:%" XZEN$'MX.)KN372G09#+N3LSM6598Q
M$N#;;5LX<=S"*X,6.KH7H'9&CZ&0;E%-B+Z)%Z>OW-63^U&#EW#N$L7#D+N
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MYMI^SK^Y(*\+Z)0*!0*!0*!0*!0*##WZU/3FF9< T:O$$E=A.KT155-";/\
M<FG1:]7Q^::6Z[?AV[_Q^N/%\G@N\FVO3?7K/X7Z*X[=<0NC/OT459FL*K4^
M$?0VW!^<!)_!7VUCGX;Q[8[R]K[QT^/SSEUSVL[SUE9=B0V^.X/%.A"OB*_
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M1Q>;QBY9I PLIM,:2U?L@4F"&+">%YPF&#E'HW(1M"/Q'1/,M7H+>X[XQO\
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MJJ?\1%_!BJ?*J$M>_P"5]V:\?\LZ_7>KYWP_OW?D_FO3ZM>G\4AKP/HE H%
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MZF08]9,AO4>;*>FL-W.*I/G$=E./>B\:,HTWL3:.[HB+HM:[U')R;QKC/;E
ML')?$BSK/>6[Y;;=>;65PES6+]$N+XL.L/M2G7D5[1?4;< =PJBKIX;9G*KB
M[A'7(_!O(C[)DV\WCUR)MQLE$Q)(YJBHJ*BIHM2#7;.N*;7QYP''YYQV[7=G
MFZU6NU7E[,WKE*E/RWI"L"\P^R^X;!QU%Q0%KTM$%!1=4W;M3K<(SG)W$UFX
M/Q>R\N87<;F'(]NN]F'(K]*N$N2=^9GRVHTIN<VZX31"XKN_00';IY=*DN59
M3$N/<?[B,OY(R/E@IEYAXKE<_$\9QL)TR# M\:TBTB20;BNLDK\A7-YN$J^S
M;X)I;T3NJV_P+GB&(]U>/!DEQO8V,,<8MUTFRC>E-L%'$@95Q"ZFT!(R9]"/
M;J76B^JV)5CB\V\N7#CK/94ES ,,QRSSF,88E/PV[K.NX$IRY)QS;<=!A 1L
M0W[4)=?:2+GL,%=HCW$V0\I<08S/FO<?2>,+GF%JM<V6_+*SS&B>@DQ$>=(G
M19=1?5VD:Z&*J/MK4ZLU9';1QG8\;X_QO._>9]US;*\>M,B\WNZ37YCQM.1F
MWVHX"9^F#3._8WM!"VHFY5J58ZDFX)Q7W&2Y%SEFSA7*%D=G$X\9FS%ON*LJ
MY(5$7RM-N055PE^Z(/BZ3T53\.7E^18_BMPN5UGXX?<3F+LF[36WB:EP\7C,
M&MNML=S51;*0RV.UQM$(D/1=4Z51FN:>&<2X@:P"Z<:2KCC<.Z9MC]NO5D"Y
M2Y,*XBY)5T7#"4ZZ2/-JWJA 2:BI[D7V,Y1'N2)+\-[N$E1WSC*UF6$*X^V9
M-J#:^Y"2J0JFB:+HM(J\NZ*6]$Q;"O0D''<>SG&V?P9JVIB4O4@\JIJBHBJJ
M5(*:R^YQ>2^7\_M_(V"Y?G^,XC,CV?';!C1>E:X?X 7G9,A&YL-PY#Q%J!%J
M*!T371-NH5;7;+)RV.F9XQ=HEYAX=9YL0\.C96\P]?HL.9'4W8<CTGWR1MDQ
M_P!']4MRM$G731$S1C,TF2F^?\[CH^ZD5OB5R0+ N&(([](2TWH**B(6B:;D
MZU8BN,;X0QJ3VS1.7YMSO+G+4#%#O]IRY+K,25#*#$*1%CLM^KZ*, +8-$'I
M^8=>N[142^A7;B89B/+/-G%>5YA;#DW/+^/&<ENZLS9L42N+205:,4COMH(@
MA*FP= +Q)%7K5[#!7[*;]CF,\@VRPNW-G\;^<96.71RP;!O*V^1"8>>:@&X0
M"$EU&O3;(E]JTQU^P9"QVQ,+SG"KEQ!QSFN G,OD.W9:&2R6_H6YVF:2MR%=
M&3<9!%,;U1QCTDW+YNA=$H)QB/'N/]P^5<D9)RPLN\Q,8RRX8GC./-SYD*WV
MZ+9Q:1) -Q7&561(5SU''"(ON=NB>"]#NAG+G%=@2P<=8[D&3'GK5MY.MF-0
MI3DMT9T"RW,T)VUS'(TC4Y#: GX<D%T15-NQ*NO[F=DYGPX/%W.MELN)1GQQ
M_'N-KW,@64I,F2)N,W 'D12?-PR(B54W$JKUT^"LMNAQIP3B?+_'5EY1SB[W
M6Y\HY5$^EDS"%=)<1^UOR=2;9@-,NBPT,9= 0%;5-PKKTT1&3"!XO*O'/-RX
M';S:\S5C7NPY2QE(VN6];TNT:T3AC +Q1S!=LA60<=V*F[JB*FM7LBV,$QNW
M\/\ <(G%^$N28G'>0XH]?DQU^2_,CP[I"G-Q_6C%)-PVQ<;-4,$+12T7P042
M6Y5V^[0;E(L?&=KM5WDV*7=N0;';4N\(_3?C#+9EMDX'BBDFNHH2:;M*:^J5
M%>5>+L9[><>A\N<5R)]IRNUW2VLW6._<IDX,BCSYC45^-+;E.N"9DCBNH8"A
M"HJJ> J+.59#'L$L/<5FO(]UY6.5=;3B&1R,4QO$VYLJ#"A,6]EDUF[(CK)&
M]))Q2WFJZ(.@]$':SA.ZN,_O.08WQ=SSQ0%ZG7.R\>W7$DQF\RGS<GM0[W-A
M2"@E(1=QI%75L2(MVU=%Z:(ED$XB\6XWR]W%<U6S/SGW/%+(N,%$QL;A+C6X
MY<JT(2R7&H[C:JXV(;6]"T3<2JBKHJ.TB=U7<H62,G"G-_'UUDS+S:^+<AMA
MX7(GRGW'XD:ZG%TC$:&BO R+S@-^MOT0OW(Z77N;7$;KX+@&*<;64L=PV$<"
MSD^<I6'94J:7K.H*&7J2W7CZH*=-VGQ5BM)-4"@4"@4"@4"@4"@4"@4"@4%5
M=RG]AF:_S(?Y=NM:]V=^U6K66B@4"@4"@IGMY^;RG_O$R+^$Q6MF=5S5EHH%
M H%!T;O%67!< 4U<#\(VG[H>OZZ5VX=_'9Y^?3RTJ'(NJ:U]=\5]J"0X[,U
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MZH3QLP618 C44%%)1!%+1$36LT1CF#A_%^:\6;Q3*794:(S*;G,2[>8-26W
M$VB02,#3:XVXXV::=4*K+@=O-.*\/SO#V,'O$0H]E@K&<LYV]PHLJW/P4VQG
MX;H=6G&DZ J>S5%1454ID5T_VMV6\3+3=,SS?*,KN]@G0Y]CEW6:T0P_<7@?
MVMLML@VI/* B\Z8DX0HB(HU<B72N#,)N:\AM7L'[I;^2W(KU_@R2'TFRA,"R
MTL=0$2!14!<0E(E0T14\*F1#S[6;1<9%E?RO/LMR=,9G0[CCC=UGLN!%."\+
MH[A!@$>,T'TS==12VKY=J]:N1*,SX.MV2Y4[G6.Y)><(S&6PW"NMSQ]YIL;A
M&914:&6P^VZVX;:+M;<VH8ITU5$322B1<<<98WQA:)-LL*RI<NXR3GWF]W-Y
M9=SN,UWYS\I]4'<:_ (B*>Q.JTHZMUXIL5XS.\9O)ERQN=[QHL/DL-DVC P2
M><?5T$4%)'=SJIJI*.GW-,CEM_&%EMW%2<1-2I1X\ED<QSWLB#WQ8KL<HRGN
M0$#U-I:HNS37V5,CH8_PWCN.7S#[]"F3#E87C:8A;&W3;5MV"*,HCCR"VBJ[
M^!'J*B/5?+X5<CI.< X+,L&9XW=DDW"VYM?7\IFDZZC;\.YOBT@N0G6A FE:
M5D2;5=5\455%5&F1T\=X MUNR.UY/EV6Y!GL['U4\;8R22R_%@/:;4DHTPRR
M+LE!U1'G=RI\Y$0D146CDRC@6WWC)[AF&*Y7?L%OM[!MO(3QV0TU'N'I#L!U
MYE]EX4?$?*+S>U4Z^*KK3(2.W3C]SCUCCR&5PM[$:Y!D+&0QI2I?/IYL_4^D
MSEF)*<E25=3,533H*(@CHR,IC_$,.R938\UG9!=;[DMDLLG'AG7-QDRDQY<I
M):N/^FT&K@JB *CHFWQ15ZT$0E=KN/BDZT8]F648S@5T==>GX59YX,VM?>"(
MWFF-[)N,,NJ1>HTT:"J*J)HE7(FT7A[$K=D^(Y+9P<MHX5:Y5CLMJC**0TB3
M$;$MZ$)&1"C::%OZJJJ6JUD9!_CNTR>2H/*#DF0E\@6=^P,Q1(/=5C29 R",
MA4=V]"'1-#TT]E!6'=98X.3VKB_'+M%*;9;KR#985TC"K@[XDB/-;<U-I1,/
M'YXDBBNBZUK7U2LQ:.W2ULW^SWO+LSR;.&,;?&;CEIR.<W)AQ9;6OI23%MIL
MGWV]5]-UXB5*F5=[+N![;?LIF9MC&4WW!LGNS34>_2L=DMLLW((XJVT4EA]M
MULG6P51;=1$(45:2CC?[=,$/B^[<5LOW%NVWZ8S=+Y?')"2;Q.N#4MF84F1(
M> T-QPV 0UV>'@B4SU$OQ[CVT8WF^99Y#D2'+KFZVTKFPZ0K':6T15B->BB"
MA)N%=3W$O7PTID1NX<"X5>(_(L*\'+FP.37H\B^QR=$$9<AM VRL90!%%14!
M<3?N\R?!TID2K L0EX38ULLS);ME3B/&Z%TO[S<B:@$@HC2N-MM(HCMU34==
M57K4$HH% H% H% H% H% H% H% H*J[E/[#,U_F0_P NW6M>[._:K5K+10*!
M0*!04SV\_-Y3_P!XF1?PF*ULSJN:LM% H% H%!#KM$]SFF(IHR[^$:^#1?%/
ML+7U^'?RU^E\3GX_#?Z*Z5=7!R1WW(K[<AKY[:ZHGPI[4^RE3;6;3%:UVNME
MB:QWVY+(/M+JV::I]K[%?&VUNMQ7WM-IM,QRUEHH&B4'&['8?T]9H'-O4=XH
M6GR:T&,R7&;%E]AFXQDD!FY6&XM+'FP7QU;-M?DT45%40A(="%4145%2@\K>
MY7M*R;AB;(R3&FW[YQDZ2FW<$'?(M^XM$:F(*>":Z"\B;2]NTE1%Z39%"XKE
MN2X1?(N2XE<W[1?(9;H\V*>PTU\15.J$)>! 2*))T5*U9D;_ '"?U@MBN;<>
MQ<SQ/HBY^5M,E@-DY!=7HFZ0P&XVB7Q4FT(?B!*YW4;H6#);!E=L:O.,W.+>
M+2^B*U-@/-R62Z:Z;FU5-4UZIXUE65H% H% H% H% H%!Q-QH[)$;30-F7SB
M$4%5^542@Y:!0*#\F8MBIFNT!15(E]B)5DREN.J%SI93I1R%Z"OE;%?8">'Z
MOC7V./3PUP^'R\GGMEUZVY.>'%6;*;CI\TEU<7X 3QK&^_CKETX]//:1-A%!
M1!%-!1$1$3V(E?'M?=DPCS__ ,6R=F-\Z'90]X>^!9;R*C8_X(ZE]FO=K_M\
M-OKOT^R=WSMO]WY$GIQ];_FO;]42*O ^D4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4%5=RG]AF:_S(?Y=NM:]V=^U6K66B@4"@
M4"@IGMY^;RG_ +Q,B_A,5K9G5<U9:*!0*!0*#'W>#[[%5 3_ $AKSM?&OM3[
M*5WX>3PV^AYOD<7GKT[Q$/&OK/C/M096QW#W5WW5U=&'E\BKX":_M+7FY^/R
MF9WCV?&Y?&^-[5*:^8^L4"@4"@XI$=F4RY&D-@[&> FWF7!0VS TT(2%>BHJ
M+HJ+0:7\Z]@N-9,LC(N'WF<;O9;G'<>?4OHM\M-=&23<4<E7[G0F_8B E:FR
M- L\XUSKC*[G9,ZL<JS3D54;5\-67D%53<R\.K;@]/G 2I727(ZF*9QF."ST
MNF'7V=8Y_@3T"0XPI)\!H"HA)\1(J4P-B,/[_>=<<$&+Z=MRF, H.MPC>A(T
M3V^K$5E%7XR JSXBW;/]97!)H1R#CYT'_NW(%R$Q7Y =8%4_X53Q$A3ZR3CG
MT]2PV]H[]ZCD11U^7U$_8J>-5A;K]959A;)+)Q_)>>^X*;<6VA^R+;#B_KU?
M%%3Y;]81S5?!)G&XMJQ=I=41V.PLR3U_=RE,.GQ-59J+0[&.X#,<SSS),-Y#
MO\J]S[Q%&Y6=Z<ZIJ#T)51YEH?F@AMGZFT41/P:K6=H-^:RI0*!0*!0*!01V
M_P!QWK[@R71.KY)\/B@_;KZ'Q^+'WK]CYGRN7/W)]K!U['@?/#K5$HL,'W>.
MLEQ-'WT143VB'L3[/C7S?D<GE<3M'U?B\7CKY7O7:N]Q:M-N?N#W461U$$\3
M->@BGQJJHE<N'BO)O-9ZNW/RSBTN]]'6QZW.V^WHLM=UREDLF<?PO.=53Y!3
M04^2NGR>6;[]/PSI/J<OB<5X]/O?BVZ[?7?X=F6KRO84"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%5=RG]AF:_S(?Y=NM:]V=^
MU6K66B@4"@4"@IGMY^;RG_O$R+^$Q6MF=5S5EHH% H% H%!%K[ ]V?\ >FQ_
M /+YT3[EQ?VEKZ?Q^3RF+WCY/R>+QOE.U8JO2\;XJ:]%JB362Z>N*0Y!?Z0"
M?@S7[L4_;2OG<_#C[T[/J?&Y_+[M[LS7C>XH% H% H,7D&.6#*K8[9LEM<2[
MVE_^-@SV DLET5$78XBIJFO1?&@U>Y!^K\XARAQV;B$N;AT]Q=WHQU]^@(NG
ML9?)#3K]Z\B?%6IM4:YY3]7AS':2(\9N=HR..BKL$7C@R51/#4'Q]--?\[6O
M(55=>T[N(L[IM2< N+VS[N&K,P5^18[AZU?*##+VZ<\H>Q>.,AW?"EMD*GZN
MS2F1D[=VK=PUT<%N/Q]=&U)=-90-Q!3Y5D&VB4\H+/QCZOGF^\F)7]^T8Y'5
M-223*64_]@(H."J_*XE3R&T'"G8WB/%&2VS-I^37"]93:7$>AE'$+?#$U @-
M";173,20E%45Q$5/%*S;D;6UE2@4"@4"@4&+N]S2$UZ3*ZRG$\O[E/OE_:KT
M\/%YW-[/)\CF\)B=T5ZJJJJZJO557Q55]M?3?(*#OVF![])133_1F50G%]BK
M[!^S[:X\W)X:_37HX.+SV^B)?7R7VD;=_P#CU_&.GFM=E)''U^Y<G*GD#XT;
M1=R_&J5]"?[/%G_%O^S7^]\S;_?YL?X>/O\ 3MZ?J_M22OGOIE H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H*J[E/[#,U_F0_R
M[=:U[L[]JM6LM% H% H%!3/;S\WE/_>)D7\)BM;,ZKFK+10*!0*!0*#C?8;D
MM&PZFYLTT)*UKM=;F,[:S:8J&3(CL%\F'>OM;/V$/P_;KZ^F\WF8^'R<=TVQ
M7!6W,12$D(543%=1).BHJ>U*"56F[#-'T7M!F"G5/!#1/:G[:5\SFX?'K.SZ
M_!S^?2]V4KS/64"@4"@4"@4"@4"@4"@4"@4"@4"@Z%SN;4!OV'))/P37[9?
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M?+,;>E]-OJ_@SU>)] H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%!57<I_89FO\
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MS7^9#_+MUK7NSOVJU:RT4"@4"@4%,]O/S>4_]XF1?PF*ULSJN:LM% H% H%
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MML_5_>]4_J-9C737'U_W)+[SF7_9\'_K#G^)3Q^/_-M^K^]?/Y7\NO\ JO\
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MT_\ %Z>M:U]F=O=<8ENUT\/8OPUEI]H% H% H% H% H% H% H% H% H% H%
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MB6O?P_[O'>/UG77]\?,Y_P#9Y9R_X;]W;]U_<R\8UCN+%/YBZDROQ>*C]JO
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M6WWRVP[S:)#<RU7!AJ7!F,EN:>CO@CC;@+[1(514J*[E H% H% H% H% H%
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MTK,K;>[]AV47%EN->+EBMP6W'<&F!V,I* @=;,FA\H.;$-$Z;M$32S>R82Q
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M>YF^Q^<+FC]#;_Y16G[=,3W,WV/SA<T?H;?_ "BM/VZ8GN9OL?G"YH_0V_\
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DC_FZ6T_BIJONOT![O]'Z]-VSW7\'K\.E9K<2.H% H% H/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tb_milestones-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tb_milestones-4c.jpg
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M%!04%!04_\  $0@!X /H P$1  (1 0,1 ?_$ ,@  0 " @,! 0
M   &!P0% @,( 0D! 0$! 0$! 0$            ! @,$!0<&$   !0," @8%
M" 8(! 0#!@<! @,$!0 &!Q$2(1,Q(A34%U=!E1:6"%$RTB/3E!5684*25;6F
M<=$S<R0U-W>!4F(TD4.T&+&"4\%R8T3$)?"ALE2D-H81 0 " 0,# @('!P(%
M P4    !$0(A,0-!41)A!!,%\'&!(C)"4I&AL<'18A0C!N'Q<C,5@J+BDK+2
M)!;_V@ , P$  A$#$0 _ /?U H% H% H% H% H% H% H% H% H% H*=QNLL?
M.N;$CJG.BDK;'*2,<QB$W1(B.PHCH74>(Z=-:G:$A<594H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M4Q3!J @(<! 0Z!K#;LH% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M]O7!#W5"L;BM]V1]"22)7+%XF!@(JB?YI@ P (:_I"N<Q3M#9U H% H% H%
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ML@BE#WE<RNS'O-9[0!T9LL<BC=4J8\G<!RFW!H!O2.H5B=<8EK&8CDRCK/\
MQ57"71B.W/AYN;%EX6RIXW'=NFIV*S QI-21.K]0N1P)!,4J6@%,4#:FX@ #
MO$1W,3.5]'&)B,)QF/O?2ED6G:*PYZP7:>1F2<A*1V/][Q@_("O+7;F>&0*H
MFH @)T2B4O$.!B_HK$S]V:[NV.$>47&T?U:N0M=^I?7Q/V1CIGV=9Q$-%FT.
MP^K X\Q-5<B9":<3D,J4I"A^MM ..E6],9EF,=<Z5NQ- WI;MB6/%W7VFX0=
M-086Y!6>DE,13Q =#"Y?"NB8Q 'K'/O-NTWF HA6]IF:_>Q$7$1>OU)1EJ8M
M2S;WR?\ A3\C>2DI'M%PX[O:"!TWFEC',;F1;YN8RQ$C[N80=R(Z&+H(Z!IC
M&+B'7*8B9_A]OT[/>&,U>=CVUE?P@8 #Q+$2P8B8W8B\@H @ GZVA ZH;NM\
MO&O/EO+TX?AC2DKK+90*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!04WGS_,L/?[AQ?\/D:U'47)60H% H% H%
M H% H% H% H%!Y@R$<O_ +UL4E$0 PV](Z!Z?FO*ZQ^"7#+\<?3NAN4I&T[
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M=1<E9"@4"@4"@4"@4"@4"@4"@4&(>-8JNTWZK9$[Y$HD1=&3**Q"FZ0*<0W
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M\-VT>L%16LR#EJW;#L&1O],Q)UA'I,W0-HUPBHHLW?NR-$U4S;MHD$QQ$#=
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M0'CHB!8=0*!0*!0*!0*!0*!0*!0*!0*!04SES,A+=!>V;55(I<&@E?/^!DF
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M1 W9^5\X=!. WKIL+"PK:%L7)E:(D[BB&DF^@L968>*.Y1*LDW56(J)E4R'
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MKIKTZ4'(0 P"4P:E'@(#Q 0H.)$44M>6F4FO =H '_PH/H)IE,8Y2 !S?.,
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MMIP 0 Q=>@=!'C0<"LFA71GQ4$P>G("1W($*"IDP'4"B?340U]&M!V@FF &
M"@ '$1.  '$1Z=?EH.!VS=4J9%$2'*B8ITBF* @0Y/FF+J' 0] A0?%6K==
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M=T>G3=QKC\''R\JU?&_\/[;_ "?\CQ^]V_+Y?JK]7K_-,Z[/LE H%!K/:*
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M%Q=D(@BZEHM,3"JV1<AJD*@Z;0$P" [=V[00$0T$*@D5 H% H% H% H% H%
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M>(ZW2AC$R-E%I%GQJ6XT5+Q&_P#V";7TY9H\U.,-&EEBN5&^G(.\Y8BW( D
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M_P"6X[[2EP'L#FSS?_EN.^TI<![ YL\W_P"6X[[2EP'L#FSS?_EN.^TI<![
MYL\W_P"6X[[2EP'L#FSS?_EN.^TI<![ YL\W_P"6X[[2EP'L#FSS?_EN.^TI
M<![ YL\W_P"6X[[2EP'L#FSS?_EN.^TI<![ YL\W_P"6X[[2EP'L#FSS?_EN
M.^TI<"KK#L_*CC,.6V;/)8-)5HI;WXE)?@3)3MG,C-R7U1C[4^67J]7YW36I
MJH2%H^P.;/-_^6X[[2LW"GL#FSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?
M_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#
MFSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?_EN.^TI<![ YL\W_ .6X[[2E
MP'L#FSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?_EN.^TI<![ YL\W_ .6X
M[[2EP'L#FSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?_EN.^TI<![ YL\W_
M .6X[[2EP'L#FSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?_EN.^TI<![ Y
ML\W_ .6X[[2EP'L#FSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?_EN.^TI<
M![ YL\W_ .6X[[2EP'L#FSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?_EN.
M^TI<![ YL\W_ .6X[[2EP'L#FSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?
M_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#
MFSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?_EN.^TI<![ YL\W_ .6X[[2E
MP'L#FSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?_EN.^TI<![ YL\W_ .6X
M[[2EP'L#FSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?_EN.^TI<![ YL\W_
M .6X[[2EP'L#FSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?_EN.^TI<![ Y
ML\W_ .6X[[2EP'L#FSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?_EN.^TI<
M![ YL\W_ .6X[[2EP'L#FSS?_EN.^TI<![ YL\W_ .6X[[2EP'L#FSS?_EN.
M^TI<![ YL\W_ .6X[[2EP*OS'9^5&,AB\);)?XF9S>T>W8&_ 6*'979V+\2.
M-"'^LV@!B[#<.MKZ K45J+/]@<V>;_\ +<=]I6;@??8'-GF__+<=]I2X#V!S
M9YO_ ,MQWVE+@/8'-GF__+<=]I2X#V!S9YO_ ,MQWVE+@/8'-GF__+<=]I2X
M#V!S9YO_ ,MQWVE+@?/8'-GF_P#RW'?:4N!S]@,R>;RWN]%_U4N%/8#,GF^M
M[O1?]5+@/8#,GF^M[O1?]5+@/8#,GF^M[O1?]5+@/8#,GF^M[O1?]5+@/8#,
MGF^M[O1?]5+@/8#,GF^M[O1?]5+@/8#,GF^M[O1?]5+@/8#,GF^M[O1?]5+@
M/8#,GF^M[O1?]5+@/8#,GF^M[O1?]5+@/8#,GF^M[O1?]5+@/8#,GF^M[O1?
M]5+@/8#,GF^M[O1?]5+@/8#,GF^M[O1?]5+@/8#,GF^M[O1?]5+@/8#,GF^M
M[O1?]5+@/8#,GF^M[O1?]5+@/8#,GF^M[O1?]5+@/8#,GF^M[O1?]5+@/8#,
MGF^M[O1?]5+@/8#,GF^M[O1?]5+@/8#,GF^M[O1?]5+@/8#,GF^M[O1?]5+@
M/8#,GF^M[O1?]5+@/8#,GF^M[O1?]5+@/8#,GF^M[O1?]5+@/8#,GF^M[O1?
M]5+@/8#,GF^M[O1?]5+@26S[;OB%7=J79>I[J06(0&J)XUI'<@Y1$3& S;B?
M< @&ANC2DB85 H% H% H% H% H% H% H% H% H% H% H% H*:QK_ *\9O_O;
M7_A(UJ=H2%RUE2@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%-Y\_S+#W^X<7_#Y&
MM1U%R5D*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"FL:_Z\9O_ +VU_P"$C6IV
MA(7+65*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!04WGS_,L/?[AQ?\/D:U'47)60
MH% H% H% H% H% H% H(+F6]W6-\775?#%N5U(0L>JX9(J:BF+@=$TA. " B
M0IS 8X (=4!JQ%R*WD,$RD5:CFZ$\AW(?+C)F>1-=9Y17L*L@DD*PI&CC +0
M& J!IV?D\$^&[7C5L:.XFT?E3'UHYEOR'N6[8-] LQ2QG:I5TTTY9V4RJ\AH
M@Y;JJZ ')2WJ""9!W  F-J"-$6+\-CZ2DL(6H^DID)U^L@X,#TZYW:B:?:EN
M2U76.1(YUFQ-K=8QB .\ANGIJ3NJIY2PC6#>.,R,;AD)_P"(2?N%%Y=4LD\=
M #RVP44/*"X9**F;HLDT0(@W("91 Y2 GU@-6K*:22MXT]AZ\OB4&8E&V5&+
M^;EK>DP?N2)QK*#DEFR$:1J50&YFYDFYB*D.D83\PVX1X:7K20E^9[0M]>W[
MJR]D2<D3N'+!JGB^'8/'C%Q$R*K,!029)-%2 N^<O! XG.0_5*4!T3*:LQ*M
M_<5Y7HX@K-PZWDR,,O3L*R<7W/E43(6"8E133?O0,7J]I66W(,R%#3>;?J4I
M.(;GX4Y-Q+8!LMV[=*/'8M5B+++JBNOU':Y2@H<1$1-M O33+<7+60H% H%
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M>\<2_#7&Y3MZ3;%O:75CKIO=R^8E=*2SBX7")3H&."A.4" .BD3$H" $3V@
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M: $NA%[/PG>:UQ6BA-V(E!EMB192<Q<KVZI&>8/#Q7$@Q<:9?<1190"J$.[
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M@(' !34*015$BA2CM#7TA5B-:29;N2SEB:'M:-O62NMBWMF9,H2(>G,?5V9
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MZ <1*/'H3KH52:X_"3R#F63S,G#O82SFUN$M.!"7;'9/I05'O;UG@(*@51-
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MMC19' D44*9)4BJ1&R^Q/8(' >N-6-1A1D<EBRX, )W?;LI(I6U;]QO7K=1
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MJ(W7J+ N.T\9V!-XA-=\$S880;13D1(=L48A*['*+4C=W+%VB10ZB!52)+.
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M:&WB.H\.CIH.*[5JY%(7*":PH'!9$5"%/L4+T'+J Z&#7@(4'81--,!!,H$
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MTA2\?309B8(B(K) 750"B*A0#K  =7B'3PZ*#D1,B10(F4"$#70I0  XCJ/
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M$,6K6.ECD;<;EM%!8KQ!H0ZQ%TWI#"8'178*=H!QJ(ZK\WF"&H";01I8Q6&
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M@4"@IK&O^O&;_P"]M?\ A(UJ=H2$E5QVX6S*7)JKQ$\7[*JVLI%'2$RAE%9
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M% H% H% H% H% H% H% H% H*=SU_P!_B+_<&*_]#(58%Q5 H% H% H% H%
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M3RT:C"IM#;8^%>Z&<W,7'<UU1KF8<6_(VVR5B(E.+!W^(HG2[5)@B8 75+N
MW -1'CNX<=3R0Q'&R6_PTWQ;$=8\SC^]T(3(]JP?LS(/EF?:8V08 J=4H&1,
M.H&(8_ 1W:\.C;4\XZK/'K<;B_PIO@L=A!)W0#V[7%W-;UNJX7Z!A%ZY;@<#
M)IID/U  #]43"/I$>G0+\35(XM(UZVLL^+7YL\DR_P#B2/X<6WA@/POEFYW,
M%<5N;S-VW;IPTTK'E]VFOA_?\O2D5R%AO)DMEDF5,<W='V](A"E@C)OV OQ%
M/G&6.8 $P%XCMTX:\*U&<>-2D\<^?E$]*?)GX?9.]+UCKHO^79RS52S5K2N1
MNDTY1W+MP<YSNT-PF*CH)@,30-2F#A4C.HT[K/'<W/9NK2P].(84?X<R%-HW
M&W4:N8EA)E24(H6/.31J"I5#FW*(#IM$!TT*4/14G+[UPL8SXU+J^'G"+W#4
M+,DGIDMP7/..4E'LH4ATP%JS1*@U2T4,8>H7=Z?3IZ*N>?DG'Q^*Y:YNI0*!
M0*!04UC7_7C-_P#>VO\ PD:U.T)#1Y.O.\4LQ,L?Q%_,,?0(6NI<"TF_9,W@
M+NRR'9>5J\42   @[NJ;7A2(T&!:_P 2LH:W+6;/[:<W=>USN9Z/A#6P"2<=
M*>SCI-N+Y,[M8@(MER*<P%#&$I=IOT4I4OF<\+(2\RPM&Q9R\8ZU%NRW?*P_
M9!29NBIE44:MB*K$4>.$2F#G)(%ZFH!J(CI4H=\MG:/<N8B,QG;[_(,S+Q:-
MQ$;QAT&3=O$.A$$5G+E\=%-,ZHE,"2 _6#M-J!=*4(Z?,3N[\@8C;VLN^AX.
MX75T1]SP<DU(W?)/(>/WE0<$.!Q(H@KUNH<2C\HA5K1&NM/X@0:VM8,1"0UQ
MY"NJ\(EU)Q"JY(]FZ7*T<BF<7QP5(@W H&_M-1+H !Q,-/%6X=9EC[H;6>Y3
M4G;3EPO=O:4];W9VAW!)(&JRYFCPRAC%%H<A04*NV,83 )1+Z=LH=[SXCV:1
M7]Q1MESTMBN(=*L)._&2;=1J"C9445UVS0%>TN6B)P,55PDF)0VGT P%UJT-
MO/YL.VN=_;%D6=+WRO )(.;I=1!FJ*+%-TGSB))B\61[2Y%(04!!'4=! -=W
M"I$"&Q6='&0K\P^YM [N-LRZ7=W,Y2/>HID6=?@;8 0.8!W&3T4 3@4# /H-
M5K1+U;K-EWW;%7WCZSK>O!G8\;<3>=<RDV]:-7I0&+3:&03*#LZ9"[A6/KQU
M&D;",6M\24C'P(-IU@I?EP*W/)6?;\C:2)"HS1HUHDZ3=@FJKL3*?F&36.FH
M=(AB&, [*4J<RV;9)&84M>V+"E[HNN(9,W]X1L>NQ33A^VH@L5L=PX6337<[
M1W$10W;R\0&I0^NOB!MIW;]KR5EQ4C=4_>?:0@+::)D:O-T>;8][8=R9-)L5
MLI]4J90_SQ#;N#C2A!LH?$#< 8HNYU:,'(6_DZVWD=$3T2^!F=U#_BZQ$TGA
M-53(.4E $2MSIF,!C"!A "@:K$:I,I[!98Q_9<-'6U?MX(0UVL6R(24;<\JP
M5FDSJ%WE%V=N8$C',4P&W)AM$!#2GC);MNC,YX^YG=FV+:4E?=Q1+9O(7 E%
M*M&S:/:NRB=$%%WBR13.%2!O20( F,7CPJ1"JUR)FF?O57&D5B]I-EAKR>OR
MS"T:=A&SJ*T*BJ=>,,61$0;JI*$W.!$O$A!*F8V[C8A+7''YGQ-+2Z-OQ=ZP
MKR;<KBT;QR+Y [A1P B'+*0#:B;4!#2I4EP@,=-98S#+7$^L.Z6EB6/;LJ[@
M(UP,6E,OY9W'F!)TX4[0J5-)L54!31*F&\^AC&$O5"KI"MH7*UWV/;3%GDVW
M!?Y*DI->&MR%M<R;@9[D)\T'J":B@=E1!/4[CM!PY(%$P_.*%2ATN/B,BH2
MNM[>MLREM759C1"3F+7="V5<+1[I;D)NF+A)4R+E'?J0QRG#:<HE$ '350VE
ML9J5E;MC;2NRS9BS'-R).7-H+RW9SED4F:?.534(W54,U<%2^M%!< ': \=0
MTI0TB?Q*1RJ!+K):$T;$*KKL"60B%;G:&4%;D X[&547?9!/U0<<K_Y:4-E.
M9V4;S4W'6=8TY>L7::XM+LF(<&O):N2$*=1NU366(H\<)%-]:D@74FH!J(CI
M2ATR?Q#12T[&VO8-MR=[SDY M+J@RQHMVS16,>+*I<Q=P[42*W @IZ#S UW&
M FFZE"-7[\1<JAC5>YK)MMZG=D5<$?;URP$H5NB[BUW#E IB*D45 JA7!%"D
M;K(F,0>84^NA3 %B-1<AKR0B;+5O2]VA[5;,6BC^9:O%$G"C--$!$P&,U,J1
M0V@< 2$V[4 #4>%00.$SV+B6@FMWV1.6;!W>X39VE.2W9!1=.5BB9)!RD@LH
MJS66 /J4UB]?B&H"&E*$"Q[\0EWHVG+R4Q:,_>#2VY>:0NJXV2;)!)DV;/UP
M12;(G524>"B@!!5Y*?4#I$PZU9@29YFRYG>7K9MFS;=5N:PKBML)]M(M%VB!
ME$UG38@/ %RJF8$44U=JB0E!0QC!M =!I6@[7_Q*M46,M=L18T_-XMA#.T7E
M[,"M3ME%6 G*LHV;&7!=9J0Q#$.Z*3840-^J435*&"ZSK!P;NY[X>N)IU#1]
MI0%S*6V*;,&S=O+J'*4R"@' YEQ_\TIQV<.J(^A0E=L9K4E+LC;3NVS9>RW-
MR).75H+RXMCED$61.<L10K=50S5P5+ZT4%P =H#QU#2E#2?^Y:,!N2[3VC-$
MP\HY!D3(A@;@RW&5Y(.A:"KVH&0F_P#S(I:?]-*&VELYG3N&8B+0LF<O&,M9
MQV.[9J(!KR&CH"%4.W;IK+$4>+I%. K)(%$2:@'$PZ4H=_PVW7/7SA:V+LN9
M_P#B<U)@]4</Q(1+FD3?N$TAV)E*4-$RD#33T<>-)W2%JU%*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*"G<]?\ ?XB_W!BO_0R%6!<50*!0*!0*!0*!0*!0
M*!0*!0>8;<^)!F[^&]W>4S>-OHY91A9=VG&G=-$%?Q!H9R#8G8C*[MQN6F )
MZ:F$?TUN<=6;;F?>YSF(N5O!.ZVM@V? VZTE8]T5DSD?Q9V+#MKU9X5<#G;-
MT3!R03( ''K'UX%J:-+)M2[KDN;$L1?*,,0]VRL C+H0/,[.DK(+M 63;@HH
M(\LBB@@4#''JE'K>FH*RC[@R[8-Y8\99&O!K.FOLLB$];18]LS3B3L6!GZJK
M%PW'>HBU,4K=05SGW@8#!UC5=!'HS(&96ED6U\0$Y=#9>S9Z18'E;"+'-R(,
M8.:>D9(F;O2@#A1PB"J:IA4-M,(F#30 UM=$;;)\_GBSH*],KN[B:6]"6Q(;
M+;L@6;5^VE8Q-PF@DHZ=AJX(N^,?1--(Q>5U2CQ$U2*5O?B"R[<MJ0CZW<<$
M2+D%"%>7/)/'0$5;0L+'(G54<+$$#@=9<Y.S-4MH@8XB8VA2#K(@7#:[]>5M
MN'E70ZN7S%JY6$   YBR)3FX!P#B-)&VJ!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!04O+_%5A6#NU6T)"<4(X;..POI4K98\4V>:B')6=@784P"&@])0](\!TZ?#
MFG/XF+/OOXD,3XYN9O:5R2JOXRH1-=X1DV6>)LFZP )%G1TBF!,A@'=Z1V\1
M#00UD83,6L\F,337G^*G#R%OPMTNI%VW@9YZ]C6#P[)8P<Z. HJB<I ,8"CN
M+L$ '=KT5?AY73/Q<:NVZLSX@<77Q;TY<L;+"QC[9 37 G*)'9.&1  1*=5)
M0-=#;1V[==1X=/"I.$PU')C-^C L'XE\29&F%X&#E56DHF@H\;HRS=2.!TT1
M 3*+H&6 "G(4I1.;B [=1TT =$X3"1R8RZK7^*##]WW2VM2(E' .I%4[:&D'
M3-=M'2"Z8Z"FU<*% IS?('#7H#B(:V<)@CDB6;;'Q$8RN^]O#R#>.EKK*Y?M
M%69VJJ8)C%AJJH<XAM AAU*F.O6$!X5)PF(LQY,9FH2&.RI:,C>=RV$599M<
M5J-DG\LFZ2,BD#18H'*LFH/ Y  0U$.BIXS5M>4(*]^*_$#"TXF[W#I_V&>7
M<-X1F1BJ=\[*S4Y2JR2 <11*?J[QTU$! .(#6OARS\3'3U;VVOB(Q-=<3=%P
MQ4YI;MH$;JS4LY15;MR$=D,<FSF% YQU*)!*!=V_J@ CI4G"8,>3'+6)8MA?
M$KB7(CQ]'P\JHP?Q[4\BHVF$#QQU&")=QW*7.T Z92]8P@.H%XZ:4G"86,XE
MBVC\3N([_N4MH6W,*IS+T%2PB[]HNV:2!T@'46JB@%!3337;P$?1QI.$Q%D9
MQ.R)X_\ B/@X#&D+=&6;J3E5IN8D(MO-1\6X:MR=D,([54=@&#8 ?. G'4 X
MCQ'4X3,U$,?$B,;F4]L_XBL47G"3\^RF#1S.UR<Z>2ED5&#AJ@.NU4R2H;A*
M?30NW41'0--1 *S.$PW&<2ZK#^)'%>0I-Q#Q$@X822+8\@BA,-58[M+%(!,=
MPW%8 !1,I0W#H.NWCIH TG"8(SB=G&R_B5Q1?MT)6C 2+@)-Z"IX99XT6:-9
M,C?7F&9*JE %0*!1'T#2<)@C.)6Y6&R@4%-8U_UXS?\ WMK_ ,)&M3M"0YW'
MB5I=^<&U[77"14[9+6U#PZ+:402>F3EADBN2G(@NF<H!RMP<P!U]%+T*U;.9
ML.24RY8-W12+9O:UKP\S&.$"""1DQ? U*W(BB4NFPH(B'#0"A4O15*71\.,V
MQO&[W\+9</>B%XR;B;C9N6G)&'-#O'X *Y'C5IH#IN53KI\@2J[=2F'YI@U:
M4FL9C7(V')9M.XYBHJ[F4E 1$#<D"=Q^ '*^@RJE0>,E#$<)D0."Z@*H&#<
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M^(7,S53 C%)0#'%(AS$3#>("(!OX:[0MI2]$K?@$'!7:,4S3=$-S"KD;I%4
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MC7_7C-_][:_\)&M3M"0N6LJ4"@4"@4#0*!0*!H% T >F@4"@4#0*!0-*!H%
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M!1$0$*4-+?5]WRC>##'N-K?:R-PK1YYN1EYQ5PSAF;,%A023%5NBJ91=8Y3
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MMB[N6)AU,(B-213-C7#(V?ANX\736*KE<W5<#B?!B@E$G4:39I9TX(DNZ<
M$;["F335[2("5$A3EW%$H5JA*8IG<N$+OLN>NJ#E)^#1QU%V;(2=NM%IA5O-
M13@RQBJHH%%3E*@IM25V\3!H;376FZ4@;6#G"1Y[[FK1NZV)?V^NB<B;CBF9
M7,Q (2Z+<$A<19DW .VSH@"1<4RF*02:;N/&V1"369#Y$D[PQ!<D]:*L:9H_
MOA>1D6T4,4*R3QB1-K(R3,@G*S=/C%$QTC&XJ?TZ5.DDOI;$N1K\%5MVNUMM
MXE>4::%>)0Y&APD6[LD^@X75*CMYA% 3,JH<V@#M$PCPUI>JM1,1-_8]O')+
M%TZNOLMXS3N;C$[;MJ/N9A,,7R*:2;11PZ16,DJB!5$3HN1(D4@;B=4PZD=$
MW:=Q8UAK<:,XN[H>ZT+.:0H/8MDWO:)E13,LH,'*-"H@0#H"KRD5R\LATSG
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M((=I,H<A0$W53XB  (T&RCY!I*,6DE'G!=@]13<M%R@( =%8H'(8 , "&I1
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MR$A<&;D4$C=9114I UV#T&JV/18C^C6L@(Z= :T !Z>&E!';WO6%Q_ 'N6X
M6"-(Y:,S"W3YRG-D'*;5+JZAPWJEU_102(/Z-*"-O+XA&-ZQ5@K M[03#%W*
M,P*GJAV=B=--7<?7@;54N@:4$CW#K\WC0?>B@^;A_P"7_P#@*#Z']&E!5^7+
MUN.+?6GC^Q54FM]7P]509R3E+M"$=%QQ <2#XR0Z%4,FF)2))G,4#*'+QX:#
M8@6<4!*  .IQX:FX!KIZ:@Y .O'3IH/@#\@?+T4$=&]H0M]I8Z$%O:-:(4N
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M@2+Q*/PK<4&ZEWK=M)+%C9B[N2R &CQR5<1 ")"==-#FE*=0 #0VFVK:TLW
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MU3=:I'595LO'8RGOA_NW*>0KA4;Y^,SG&TP^4E%FLJTF2F<MTX@&0+;4T3%
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MT*'3\@!H/3+.*J'+#CF[FM.STE7%W*!0*!0*!0*!0*!04UC7_7C-_P#>VO\
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M8^JR91*&AQI4$RL?!=^S=\'GF,C=4/?MO- 1!":8L5(61277WE69OXIP)CI
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MR1D2G.T4&0?HMC%4Y9BF !!0>L4=0K,"O)";^(B$OF(Q.O=$ _>W>T=2S2\
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MY9SF,D8"@)!$>FI:MG&X MJ+96V@A*2"[Z#N0;SD)1VH1=W+3!VZK<ZKLPE
M-!*IH )E+M*4 "EB6EL%D3)BV3@=K#)K02-M&8CM[.#=!XH\!4.&[>)E1+TZ
M:4Z#1WQB9:Y+D:WQ:UTR%F7NW9C$KRT<FW=).HX5!5*BX:O$U4CBF<QS)'
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M^&\:W46NNY(W*+6+MD<66:P;'+$3:#B-:'4.X1(B1)<57!G)'/,,3LY2]7H
M*BPF$=)Y#CYN/OPUUSSER^RN\LUQ;JZIEX0EOKOG"&TC?9_Y8% R;G=PZ.BF
MB,K.MW3L7?%V,[ANVXK/1CX%)UB5G;B:HMIN4,@L9V#GEMUBN%4URH) W54(
M!4S;].L)P0(:,]E%:T[QR*K>5R-YFRHVR'D/%)'.:/67D(>.5?\ :6PICVGF
MJ**"<H_-,(CTU=+-:=5XSS^;NEBQNFYKA/DI/(L:E)6 *"IH%I;[>8)V-PD4
M$ (5(4 05!X4^\YS"40'4:D+*<9]5?L,KSDDP(JFJ%H6L@9VFASM$E+V2*L4
M-Q#E$03,8=-!$ XTC8:RWKUO1>9D5D;KN9S\0(&N4)/&1V9G%MMR-$70QI-A
MT2)-F_49"B[(X,9<RF@B;F&VIC]B*^B\@Y35M"Y%X6])ITO^"1"MP*BN_DG4
M;<#F:9('*D9Q&,R,E1(HY(=BF90H$+KKH76K6IJF]_2EYV2XO>QBW]<"-K0<
MM;+UO-R:[P71V\JT>F=L59EHU<*M$3JH(BFOR3E3/HD;0B@U(5%;AR9E-:/A
M'S^X;AMU,]ML'F/>VJ.6;^5E5%5"K=J;L(IZE)K%4*W3!NJ9 IT#E4VAS3F*
MI)7=FRXIZ,;XW1O*X92SK%DDW(WY<=M%6;KHRJ;5$S-N*Q"JJMT%E17U$"#J
M)2D,(:U(54MOWU<#Y"%)D>_;N@\8J/;A*PNQHFX:RSV8;2!$HYF^Y314R!18
M:KI-]A2K*;M=PDV5JD?,>W1FJZH-K/L+AG).Y(;'SN<C8C?M;R,^::F&9!=I
M 4P**)I$3VMMV@G(0HZ@6I,00UL-D#+06C=KFQ[IDY^'1AHM6=?+.)&6>QCM
M=ZF1^N@Y<Q386ZI&@J&4:)(K<G3F$XEVU=%;RTIB^[O?P=JL[ZG#6%+W8+)C
M/QD@]=/^R)0CET\;A*/&+,SA+M)$P*IR %$1,0#&ZHA$;2,?Y.MX8^YT;PN*
M=DXW(B^.FD3*J%-'.X)!59J@=TDFBF!US"!#'?#UA'B(TW-E?,<D9<+ 7"^;
MW;+K72E;DL[O>+66?N%8R834*5L"+<\8T1C5$EQ43*@BNL59,/T <;H)EE^$
MF;9=2UD2EXW9,6:Q1M&^'$T[=J*R#!4L^9B_426;-A.")&Y0= B!3<I4A5"!
MH E&1*K,S7<(QB6-T7EVSEO8>D$'1K@O*'.J#\ZR39 T65=VFF=5(CC54QS@
M3KG "FTUJ0*RA'F4;Y<J,YJ\;KB8^*L>2G8)RS$T6\D :S#M&+>/B EH*RS4
MB9E$?_,#:8W35$ES9-.YS"N#KKNH\>#MY+04I.N9R/5>1)%W$&\.J9TR0 #;
M#*'T H:;3"'12.J-;?!YFW4HZ>Q:DU799HMEK9":L"S49Q;:X4E 19OR$..]
MNB5HN\ @?J\DF[TC2!@7A;5FVIDF-BX2,D?!FTC6U%Y:Y9 ,P=/V20E@3K$,
MD N :B*!Y 4SF*8AT0,03$$*"P\\0^5T\0Y*/=4Y%3%NK0[H&,;%1;AF^3.*
MZ9DC'6,Z7 Y2$ 04 $@W=/"D4*:AIG&D,%[WA=<.SNZT$%8!U#H6A%.X6W'=
MQ,R.P09]B6+M.N4AN:NJ<ZB()[-Y0.!2BD6;:CV>M[X7+NF\0/4)B\U7LE)\
MB$:*]ACG;]X19XVBVKDB8G(S04,*!=NBARZZ=;;3KJ*\=7G)JN;@BL4Y+NZX
M;14A;>[+/R2BZKMO(O[I9,W@MU7#9$3F!JIU@$@@3<8O1J4HA([EG+NLRX+@
MQW,7I<R&(X:X(O\ 'KWYBKJ?8,)2(.Z21[<1!0X-E'Y")G6*3<F!@3$P :@R
MK&(9Y\./Q#'9+R$NU>/[K/%R4@@9"0D&AX5N5!PH42$,H90@!]9L**@<1 !&
MKUA&L@'4+'XYMC+EJ! /Y7%\NV<W 6SXAS&F5@I)DFRDDE&ZXASG()&!?>(@
M7ZH/FC45KKFLZY$+"M9S;T<__P#<5>"L_>TJO#B=)5O%3*!AD6RAU2*%((H'
M:LVI#!J5R5,Q!+M&EZCT!8C.XWT7:$CBJ9B(O#!64?V* =Q+@\F5FD4"K)"X
M[64"JCH8!$R1A ^N[</$8KR=CYO%.+@@FJD6E<"[&0O$MQ6O;D4Z;75^&NOQ
M$% DY 0*DZ1.4Q$TT=Z1C'42*01$HUN1=WPV&@7F3[SE;.22=VDO$1B+&0C8
MH]O,& )+N#$B7#4Q?KWB"9RF.Y$YS;1 @[> 5B=A6B-[9,%'(S2(NNZ9^Z&+
M,TH[4;E6229D:3S<5$CQSAHD>.=D:<X@(-EUD7"0&,'$H5="6VR#FE_<-S3$
MG:=XS;'&ZUQV7'#+1:*Z?+CGC.6&4%D11$3F_LR&5,5,PE,0# 41+5B-$8$O
M?M^)1B#>%NN;>_#[[1JM6N19%X\C)59 L:17LZDFC'N'(-"R J(IN>R&WB'*
M%3:&M*&]L:7RI=,O$DEKRN)L2*L%_<,6LQ:N%1?.$I1VTCEW3-9NV,]4[/RU
M.4)$A<Z$,(!NXR1$(O(N0?8-9"/NZ>D;9;3D.VO"\3O7AFJ;=PQ445.RDSQ8
M/V1%7!4B.T3LU!:"8I2J;5#"%H;R%OFZUF-L)90ORX(+$BQID]NWE" ]!](O
M6[M(D>S>O3QX++$!L*RB*AFR)78AQ QB;1@@$-=61+?Q]:4:XFY.THDD#)/+
M8.W4>1!GMR*3;X5@609QS[M*Q1Y'^ 4,F0Q3CH;K"(:G<7"SO6^6^>;9C;BN
M*:=3$D$,B]MB,3<-&C,%HD%'JBL:Y;&079'7!0YWA'95VY_JQ(.P*ST5'_B0
MC"(7?E_M+R5"1F[2@58&($RZ\:]*U?*).SE0*D*9S,]4U2$,H D.H<P%,!QV
MW'HS*1W.I>-DY%8V(WN*<N&WT;JLF2;NIK9(ND_Q4\FB]1*N*(#RA[,B< #3
MEFU HE U2%EMOA<NZX)FZ+CAI>XYRZ3-F:3E_)OA6/&E?'=*D%,4'C5LM&NP
M*&AV)!51VAN*?@&LE42MEKD.9MS'-PNL@W>@_P @7%*6[<30KD.0WBT'$@9,
M6I%$!,V5 &210<%-OT.;CH( %$2OV4NV3M*]K6GG4A.,K=:73 -GS] 5WSMK
M$73  S575!(#*J@DNH43EX* 7=IKJ-6-TG9+O;?*1\Z.(Y:?D&MQ)WDLP0M;
MFO5FJEGD$035+%$8=F$IV_UW;C/@,"G 2AT5-*5!59R<N>QKN83UW75.LX%Y
M;LW-SJ"KPK= 4YXB;DW(48IN6#IN@)ECL$P623Y0+$..P $)LG?%W^U3HK&\
M+D7R@A<#!GCVR3%64@YBS#F;@F^=!V<R:H+M#.7#EXHL0Z2A?U!( &M([H"8
MRM$VM9V0[?N>?G[KNU[=,0:W)E7GQ1@:)2IXW8@HF445"JLV^BFX!/N,41VF
MT"30W/PQW;>T[>9V[JY7T]#FM]-U=C:2</I$64^*Q0 A3N8UB1DJ.JQ3,4SJ
M% I=0'J@-,AZUK"E H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H*XS3F"$PK
M:B=U3C!W(HK.2,T6S("B<5% $VIA$=0*!2CQ H\= X:ZU8BQH&GQ'6D^R9"8
MR1C)()&=CFTFU?'(D"! >H%<I$4T4$ 'EB.[CKN  *!@$!I1;:W7F-6)N9_:
M-GVC*7M-P39%_<R<49JB2/;N"B=),3NE4P5<J$#>FW3U,8O'4*4.U[\0&*(B
M/@']PSY8,UQMP=L64FBNW=I(BH")CNDM@BV(1013,HMM3W /6$ UI$3(U]\?
M$IB6Q/Q)"1F>V2L.NT0DXQBDLNN@#U=)$ISB4FP"E!7F_.U,4!V 8= %$2,Z
M1^(;"\/))Q,E=[)M(JMF[WDG!;4B3PH'0*J()B":JA1 Q45!*IH(#MTI4B)3
MV3L5-IR"O[)TDC;=PVN_N6)MULV=JR1%TDE2,GJATVJ&HG*"9!.EM$41UU$0
MXU8B>@M64R#9<+:(W])S;1O9G9TWA9L52F;*(+:<HR9B:BH*FH 0I $QA$
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M04Q-L'0#:#2AEM,OV9<%C7!?EEOBW QMQL\<NVB(*-W'.9(&7% Z:Y"*)F.
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M.J9A2'M"I03T*D4"B?B.H:4H:Q7XG,+'@[AFX>YD9@+<CCR[MHS36YZS<@[
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MB4Q&9A/'MNXFL_-PK*3>HQ#4QR&>C#MEG2Q&RQT^6H7:@8.:F)B?II4C5/\
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M:)B@;37I"@J6?L'*%O7S<5Z8FD8,P7FFS-/1MT$=B1N_C6X-$7311F.IBG1
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M90\K W4B!'".J3^9<3**['0! 3[E@34(KH  74!'6DS8W(XKR)#W1<#:UI&
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M29%P5 H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
,H% H% H% H% H/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>fc_aiimmunology-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_aiimmunology-4c.jpg
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M%!04%!04_\  $0@!\ /H P$1  (1 0,1 ?_$ +<  0 " @,! 0
M   &!P0% 0(#" D! 0$! 0                 ! @,0   % P("! @+!08$
M! , $P$" P0%  8'$1(A$]075P@Q(M,4E)46ED$R4I+2DU05U58842-3M%5A
M0G0U=CAQ,R1E@6*U-I&A0[%R-#?PP:)CLZ0E=41DA,2E)@D1 0$! 0 " P$
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MU 0J#UH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H%!3./O]P^:?\ !6A_*OJU?$%S5D*!0*!0*!0*!0*!0*!0*!0?)TQW
MU9""GV5L2N&[M:3LHH=.)CUTN4Y>;#B35!,R>Y3P?W-:U@O>"RA%+6!&7Y?C
M<<>(O]Y58ZZ%DX]=LH510A2*"N*8 8Y4^84OAVCX*F#;,\@V)(+IM6%T0[MT
MLU&1110D&RJAV)=1%P4I3B(I  #JH'B\/#3*.T5?MD3KEHS@[DBI1W()*N&*
M#%\W<J+HH&V**)E2.83$(8-IC!P >%,&O)EO%BGGNR][?,$9I]XB$LST;[C
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MCXVW30A0\'@"LJTG4;B8+05L$MIL"6:N\&25AR$,1 SP=/WOBF V[0 *''@
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MH\\,59LARA%@J4Q%$S 40 PG*80.<P"<VO$:NCLXQTWM7'$G96(DV5J.5$'
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MZ;B.# 7]Z!M UWZZ@ !4T8]I8QQ]82KM>RK9C(!R^'_JUXYHDW44+KJ!!,0
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MSQ4G]]=)(Y2B8?[QB[1,/$VHC31+FV&[ :7J>_6\65.;/#%MGD (_=X1)-H
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M+3E)1I=A(5%N\CKTBV#J+;/4'!CD.BY;."Z).DC%U$$CF(8ABCP$#:YL%[5
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M5*8I?& NW:4-M-'G;?=]19W#<5S7M=<C>DC=\">VKC)()HMFZK950PF!NFV
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M_47B/^KOO4DST*GK33]1>(_ZN]]23/0J>M-/U%XC_J[WU),]"IZTT_47B/\
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MT%O=:U[,F(2RHV+BV$DH\N%J]D59![)-$7A&B8,T5@3*4JP)F,8H>,41W:"
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M#MOOAXZN*8?V\,%<<5/1$,^GY>/DF"399LC&I"NHB8IE]PJG3#>GH&T0$-3
M(Z P5YD#OS1KG&<E=>)8"56DV2L>BH_F(W=%-SO3J;TUSHN \8I4A+J4VW><
M@ (ZU?46$^[VMH6W"6.]N:V+H;S-\-W*D?#$C""^!9D<$=@MA<;_ /J#B'FV
MS=N*8!-MJ8-E ][+%$Q8]S7Q(&D(!.SUDVEP0DLVY,J@Z<"8B"0($,<#&5.0
MY"ANX"4V_: "-,'-J]Z>R+A=RT5+0%Q6E<$9%.;A1AKCCP8.WT8T3,J=5H45
M#%..T@Z%$Q==!TU IA!@T41WV<22]L2UWIL9Q"$AD6HN%%F:8'5?O5#)IL$
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M&M<";A:U9";8 U92Z;/<*HM%2**:Z 0P^, !PTU WBTL%[5 H% H% H% H%
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M>JA,5A//SC$N5[47B747!3[5BA9&/Y2>;3KIJN@NB=<2/Q%-)-(2D-L()B_
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M%90ZRFQ(H%+N44$QCCH'$QA$1^&HK*H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H*EP%_EM^_Z[N?\ GS5J_"1;594H% H% H% H% H% H% H%
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MK*E H(ABVP6V+[ @["9O5)%K!H&;IO%B%344 RAU-1*74 ^/I5MT2^H% H%
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MW$9I_P %:'\J^K5\07-60H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH*EP%_EM^_Z[N?\ GS5J_"1;594H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%!3./O]Q&:?\%:
M'\J^K5\07-60H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MI4X&G>H^7C_YLU]*G T[U'R\?_-FOI4XKC3O3_*Q_P#,FOI4XCG3O3_+Q_\
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M=8-A5# / VA@DW."$NX^R;M7OHMG1P*8/N:[[$8($:(F;P[^3(^!.7.R3*!
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M*!0*!0*!0*!0*!0*!0*!0:NXGLU'0SIW;L829FDR@+2,5<@Q(L83  @*YB*
M30HB;42#X-*"O?;;.G90Q]Z4.@U<BGMMG7LH8^]*'0:9 ]MLZ]E#'WI0Z#3@
M>VV=>RAC[TH=!ID#VVSIV4,?>E#H-7(A[;9U[*&/O2AT&IQ3VVSKV4,?>E#H
M-,@>VV=>RAC[TH=!ID#VVSKV4,?>E#H-,@>VV=>RAC[TH=!ID#VVSKV4,?>E
M#H-.![;9T[*&/O2AT&F0/;;.O90Q]Z4.@TR![;9U[*&/O2AT&F0/;;.O90Q]
MZ4.@TX'MMG3LH8^]*'0:<#VVSKV4,?>E#H-,@>VV=>RAC[TH=!ID#VVSKV4,
M?>E#H-,@>VV=.RAC[TH=!JY$/;;.O90Q]Z4.@U.*>VV=>RAC[TH=!ID#VVSI
MV4,?>E#H-,@>VV=>RAC[TH=!ID#VVSKV4,?>E#H-,@>VV=>RAC[TH=!ID#VV
MSKV4,?>E#H-,@>VV=.RAC[TH=!IP5OAJZLO-(^\0B,<,Y JUXW"L[$UQHM^0
MZ.],*J  +,VX$S>*!^&[PZ!6KB19'MMG7LH8^]*'0:SD4]MLZ]E#'WI0Z#3(
M'MMG7LH8^]*'0:9 ]MLZ]E#'WI0Z#3('MMG3LH8^]*'0:9!Q[;YT[*&/O2AT
M&F0<^VV=>RAC[TH=!ID#VVSKV4,?>E#H-7('MMG7LH8^]*'0:F0/;;.G90Q]
MZ4.@TR![;9U[*&/O2AT&F0/;;.O90Q]Z4.@TR![;9U[*&/O2AT&F0/;;.O90
MQ]Z4.@TR![;9U[*&/O2AT&F0/;;.O90Q]Z4.@TR![;9T[*&/O2AT&G##VVSK
MV4,?>E#H-,@>VV=>RAC[TH=!ID#VVSKV4,?>E#H-,@>VV=>RAC[TH=!ID#VV
MSKV4,?>E#H-.![;9U[*&/O2AT&F0/;;.O90Q]Z4.@TX'MMG7LH8^]*'0:9!Q
M[;9T[*&/O2AT&G$<^VV=>RAC[TH=!IQ3VVSKV4,?>E#H-,@>VV=.RAC[TH=!
MID#VVSKV4,?>E#H-,@>VV=>RAC[TH=!ID#VVSKV4,?>E#H-,@>VV=>RAC[TH
M=!IP/;;.O90Q]Z4.@TX'MMG7LH8^]*'0:9 ]MLZ]E#'WI0Z#3('MMG7LH8^]
M*'0:9 ]MLZ]E#'WI0Z#3('MMG7LH8^]*'0:9 ]MLZ]E#'WI0Z#3('MMG3LH8
M^]*'0:N1#VVSKV4,?>E#H-3BGMMG7LH8^]*'0:9 ]MLZ]E#'WI0Z#3('MMG7
MLH8^]*'0:9 ]MLZ=E#'WI0Z#5R(>VV=>RAC[TH=!J9%/;;.O90Q]Z4.@TR![
M;9U[*&/O2AT&G ]MLZ]E#'WI0Z#3('MMG7LH8^]*'0:9 ]MLZ]E#'WI0Z#3(
M'MMG7LH8^]*'0:9 ]MLZ]E#'WI0Z#3@>VV=.RAC[TH=!ID%665=66T<WY6>,
ML=,W,NY9VO\ >4<-PHID:E3;/ 1$JPLQ!3F )A$ *7;I\.M:N9$6G[;9U[*&
M/O2AT&L\4]MLZ]E#'WI0Z#3('MMG7LH8^]*'0:9 ]MLZ]E#'WI0Z#3('MMG3
MLH8^]*'0:9 ]MLZ]E#'WI0Z#3('MMG7LH8^]*'0:N0/;;.G90Q]Z4.@U,@>V
MV=>RAC[TH=!ID#VVSKV4,?>E#H-7('MMG7LH8^]*'0:F0/;;.O90Q]Z4.@U<
M@>VV=.RAC[TH=!J9 ]MLZ]E#'WI0Z#3('MMG7LH8^]*'0:9 ]MLZ=E#'WI0Z
M#3('MMG7LH8^]*'0:9 ]MLZ]E#'WI0Z#3('MMG7LH8^]*'0:9 ]MLZ=E#'WI
M0Z#5R(>VV=>RAC[TH=!J<4]MLZ]E#'WI0Z#5R![;9U[*&/O2AT&ID#VVSKV4
M,?>E#H-,@>VV=>RAC[TH=!ID#VVSKV4,?>E#H-,@>VV=.RAC[TH=!JY$/;;.
MO90Q]Z4.@U.*>VV=>RAC[TH=!ID#VVSKV4,?>E#H-,@>VV=>RAC[TH=!ID#V
MVSIV4,?>E#H-,@>VV=>RAC[TH=!ID#VVSKV4,?>E#H-,@>VV=.RAC[TH=!ID
M#VVSKV4,?>E#H-.![;9U[*&/O2AT&F0<#>V=0#_[U#'WI0Z!3(++BW#YU'-'
M$FT*PD544U';(BH."(K&* G3!4"E X%'ANVAKX=*B,R@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@J7 7^6W[_KNY_Y\U:OPD6U65*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!04SCW_ '#YI_P5H?RKZM7Q!<U9"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@Q).380S!Q*RKE)E&,TS+NWC@Y
M4D444PW&.<YA "E .(B-!#6>;L.R(.1CK]@'@,VYWCOS>3:JBDV2TWJG AQV
MD+J&XP\ JY1(UKMMEM;WM<XF&2=J<@KS[\,Y2!AYL< $JO/W;-AM0VFW<:@Q
M8C(%DW!*!"0=PQTC,"T2DBQ[9TDJY%BX*0Z;@J91W"D<JA!*< V^,''C3!DP
M%WVM=2D@E;4RREU(I?S22!@X3<@W<!KJDH*8B!3AH.I1XA0;)\_:1C1>0D%T
MFL>U3.NZ=N#E21112*)CJ*'.(%*4H (F,(Z %!7MH]X'#=]N)%I:=WL9%S$H
M*/'Z(<U Y&J :J+%!8A!4(0/C&3W '#]M7!N[!RIC[*"#YS8,\WG$8TZ:;X[
M<%"\HRP"8@&!0A!\8"CII^RH)A0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"I,!?
MY;?O^N[G_GS5J_"1O)C-^(;>DGL-.WO"QLO''Y;YBZ?(I+I'T =IB&, ZZ#K
MI4]:;$UCI%E+,&TI&KD=1SU)-RT=(F Z2J*Q0.0Y#!P$IBB @-1650*!0*!0
M*!0*!0:5O=<"ZN1Y9[=X12YH]JA(/8X .!TVKHQR)*"82[1 QB&#0#:_MH-U
M0*!0*#0WA>MJV!"J7%>,JWAX9,Y4A=.3: 94_P 5-,I0$QSFT'0A"B8=!X4"
MS[TM:_H5.XK/E6\O#*F,D5TV,([52?&34*8"F(<NH:D.4#!KX*#?4$8F<@VC
M;T@\B9F2(VDF$.YN9XUV*J'3AV1P(NY_=D-J!#" ;2ZG'X &F#<PTO'W!$,)
MZ)6\XB91LB^8.-IR<QLY3!5,^TX%,7<4P#H8 $/A"@P)N\K<MV8@8"7>^;R]
MS+JM(-MRU3^<+MTA64+N3(8I-" )M5!*'_C0;V@4&FD[JM^'G(2VI%\1O.W&
M9R2$9& XG<F8H^<+@42E$H;$_&'<(?V4&YH-7<5Q0MIPKZX[C>I1T'&HF<OG
MRYMJ:21/A'PB(B/ I2@(F'0  1&@BZ69,>++6VT)**>?W<BH[@6)F;LKI1JC
MKO751%$#MT@T_P"8X*0H_!QH)':EU05[6^PNJV'7GT!*) X8/.6HB"J0B)==
MBQ2'+Q >!BA0;F@4"@4"@4"@4&OG9R+MJ&?W#-N"LX:+;JO9!V<#&*DW0*)U
M#B! ,8="@(Z &M![L'[649-Y%BH"S)VDFX;+%U #I+% Y#  @ Z"40&@R:#&
MD)!E%,UY&2<I,X]J0RKIVY4*B@DF0-3'.<X@4I0#PB(T'LDJFNF55(Q3I' #
M)J$$#%,4P:@("' 0$*#O0*!0*!0*!0*!0*!0*!04SC[_ '$9I_P5H?RKZM7Q
M!<U9"@4"@4"@4"@4"@4"@4"@4"@4&ODYN(ACL4I5Z@S4DW)6$<1=0J8N':A3
M'*BD!A\8XE(80*''0!H.'$[$-95G!N'J"<U(IK+L8\ZA2N%TFVWFG3((ZF*3
M>7<(>#4*")VOFK%EZW YM6U+I82T^U XG9MU!$5"I#M4,@<Q0(N4NGC"B8P!
M5P3VH% H% H% H% H% H% H% H% H% H%!6G>(_^\1D?_3DG_+'JSR/G_NL8
M^D9ZPF+6[,?VE'6=/6JNP0NN*(E[1O2/M$3E<GVB;0Z9E!/QX&*'_A;13[:=
MN"=Q?!]S1PZ$EZI7RK;<J">HB%O,5?/#.!X#J0%3"<GA\1+_ (5?L6;WS6<;
M8#_'D[B@SB)S+'(.8V$:0J(+KFMIHR4*L*B>AQ B!=03,)?BBI\C<2?D6%B!
MJ^MKNT6HX[L[&+GY=^*3F5/.G,V*L[5 2OSKBD8@\Y-4H)%*)Q "%  $P  B
MHB^=97O!/^[?D\<IPL+"BFC$_=8VZNLNHJB>21!X"W,44T*">G@TX;J3R-#)
M,L<$S1W:D\2I1II!S&N23:<4"9N9"F8D !=@3XPB076HJ>,/C;N-5$Z[I3%E
M&9%[P,?&MDF<>UNXR+5HW3*BBDDFJ[*4A"$ "E* !H  %3]$?5%94H% H% H
M% H% H% H% H% H% H% H*EP%_EM^_Z[N?\ GS5J_"1I\L1T>;-F#][1 XN9
M2?\ .!,D0W,T@G&F_4..G]M(J(9&O2[K+N^_\=QLTHG)WTTM[JQ*J8XECUY9
MS]R/BMQ*("06^A7I2%X%XC21$4ZX[_+#QZ2<BLO<^)+8NJ0OYL03*H2$O"JF
MAF!7@E. B!S$4D% W:"700JX)+.1USXMLZU\Q,\F3]V3;Y[!EEX9^\2<P\\E
M.N$$ET8YD4A"-SZ+&6:BWUV$)H('#4:BK68F[PH7&B$FA906CYY_U!FRTJ,E
MYAO'B0ITN5SMFG 1V[O[*G!3DC?=]1$3<F $9QZIE->ZVT!:UP*'%>0"VI\3
MR1)$ZAMICF:-$G:*BB8?NS)D^&KGR-;+SMYWM?=ZQZRF2!C[/D_9R#;6(Z9-
M4$4VS9%3SQ\9RX15<KKF/S !5/E;/ )M1VU&?9=S9%S9*698MXW.YMDI;04N
MF:=6>]1:O)9Z276BTQ\\:"J0B1$T2K+)MC@7FK;1\4I0!>*CMR7%DBTF>;[4
MCLARTDZM60L..MB>=J)+.F2<JZ("Q%-A"$54VGV+F,&JN@;_ (:N1GY?6MIV
MJ-FVT6"";EI\Z7.4-*SKKSZ14,L8QQW*[2!H41T(4I0*4. !I7.UI\HV?'WS
M*=VY'/SS+EQFO6,A7DPS+YZF,$)HD5BD9N67+V+F.*/*5.J)E!4'7X-M;OG!
MOXRWW^7\W/7[R?G+-1?6%;,K)LK<>&C79G;M1R<B9W(%%4J:.\X"F40W&T$W
MQ=*>!B0EW7W>+ZU,*R=YOH](;CO. EKK8G3:7!)M+-,B+5$C@"""2JI5]RZB
M9>88J(^-XQQ%F#:H&O:Q,LWG849DAY(1T?CM>:@'5W.TG#>)DW#XR:9WS@Q
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MS $0#AKIPJRX-HOB3'JYS'&#11*: 7LX$6QE&Z)8!T8IE6A$TCE(4HB4-#%
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M:OB"YJR% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H-9<$D_B(=U(1<4M-OT"@9&*:J(I+KB)@ 0(=P=-,! !U\8P>"@@G65?_
M &33OIT-TVKD0ZRK_P"R:=].ANFTR!UE7_V33OIT-TVF0.LF_P#LFG?3H;IM
M,@=95_\ 9-.^G0W3:9 ZRK_[)IWTZ&Z;3('65?\ V33OIT-TVF0.LJ_^R:=]
M.ANFTR!UE7_V33OIT-TVF0.LJ_\ LFG?3H;IM,@=95_]DT[Z=#=-ID#K*O\
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MZ&Z;3('65?\ V33OIT-TVF0.LJ_^R:=].ANFTR!UE7_V33OIT-TVF0.LJ_\
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M5'+MRH5%%(A?"8YSB!2@'[1&@]6SE!X@FZ:J$6;+$*JBND8#IJ)G#4IBF+J
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MX]_W$9I_P5H?RKZM7Q$7-65*!0*!0*!0*!0*!0!H% H% H% H% H% H% H%
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M46EE?O W5:!<FQ-I6W,VB99^"=NLWCYO<*B$<\69F!(RB2C<ZNJ)CE)J&X.
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MI%&TT?"1F13:W'7Q5#" &X[==!IE$MM&[[;ORWF5UVC()2MO2)!49/D-P%.
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MG+X XB&E+,&/;G>(QA=$ZQ@XYZ]1"84,A;TN^CGC**E5D]=R;)XND1)4P:"
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MS$C*%,7>4.%27!4ML1]QENY')J=MY'N%C943)&9-KZ6;I/W,A*)IH@S8,FZ
M&.4X% 5EE#"0NW4 $0XVD:R&P7D"+L#)&&E8=LA(7_%(7'&7''I&)&LWZ0I
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M(N50)H)"^(7PZ^&KN+BS<WV[+7"]Q8:+CE)!*(OJ+E9+E%W@W9MVCTIG!]?
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M^7J;6"31?>_PO,QLS+,'<F=C L2RLBJ:+=D K0[A%J!RB8@ ;QUR< _NZF\
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MHF<-#%,4> @(#H(#01B+Q=C2"?I2L%9L%&2B ZH/F46S;N$QTTU*HFD4P?\
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MKXB+GK*E H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H-/=$=.RL"\86S,%@)U8I093!VI'Y6Y@.41,+=0Q"GU* ET$WPZT%9=7?
M>![:D/=-CTJM;/XG7/5WW@>VI#W38]*IL_AUQU=]X'MJ0]TV/2J;/X=.KOO
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MBQ0\V>O0(*"*FGQ3J <HE ?@&@E%!K8"X(:Z(IM.V\^0DH5Z45&;]J<%4%2
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MT#IL3<-I5!%0J1CBF!A'Q=.%-&]4P?9"JPKF!YO&[R9#X.! /OQ-(J(#X/\
MD[2A^Z_^=-&^?8]MN3O U[2* NI52%<6PNW6$%&2L8\<$<JIJ(F 0,)C)@ Z
M_P!W4!"H(7;_ '<+"M^6BG_GTY+1-NKE>6M;$Q*.'T+$.4M015:-E!^.B4QB
MHBL93EZZET'00NB;7[C^W,CPA(2Y$EN6V<)OXU^S6.T?L9!OJ*+MHX2$#I+)
MB([3%_:(" @(A241FW\#6)#-)U&6\^NZ0N9K]VSDQ<[H\G(.(\-=K4%1 @)I
M%$=P%2*7QM##J)2B#1I([NQ6(S?0T@_F;EG%K:?-)&UTYB9</$8LS%4%2)-D
MS:%Y9MI"'Y@',)"@4# %7V$\@L<V[;K2Z6,=S_-[QDGLS,@JJ)Q%W))$16Y0
MZ!L+M3+M+\%31#GW=RL9>.MMM$2$W;DQ:T:2!C+D@I$[&6-$D'=YHNL4HE52
MW_O *=/Q3<2[=1U:.8[NW8TB8"6MI@G()Q<W)Q\[( =ZJLLI(QADE"+"JKO.
M)E3I HL(B(F,(^#AHT=K@[NMB3\])S7GLW$LK@5\XNFW8>3780TPL( 10[QL
MF/$RI0 JHI&)S ^-J(B(M3'HX[O-@JV=;%GM%9.-&S.:-JW#'O3MIN/%P(\X
M$G1 UVJ%-L.0Y1(8NFI?% 0:KI =W+'$$:XE50D9IS=T9]S74ZF7Z[U>21$Q
MQ%590P@8%MI]@'3$NTI2[0+I31PMW>K4<V]#PR\]<9Y6W5EEK>NT950+@8$<
M@4BB"+P"@(H&(4$Q24*8HE\/'C31+,?XVMO&[!XU@Q=.W\FOYY,S<HX.]E'[
MG:! 4<N%.)A H 4I0 "E#P &HU!+Z!0*!0*"F,??[BLT_P"!L_\ E7]:OB(N
M>LJ4"@4"@4"@4"@4"@4"@4"@4"@B-MXXMVU;=E+7BA<?=<NZD7KSG*[U>;+J
M'57VF  T#4X[>'#^V@@4GW8K(?J6JLUG;DB%[+BTX6WE8R3\V,V0(0R9U"?N
MC 594IMJJA  3  !X JZ+*LNTRV7"%A"S4M/@5517[PGWAI!\/,'7:*QBE$2
ME_NAIPJ"0T"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@J'N[?\ M6Y_]971_P"K+UK],_GPMZLM% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MJFX=NNPVEGYJ:E5R=X'&-J*L6TJ_=J/GS%*8%BQC7[YTUC%B[@<NT6Z!SMR
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MI6[MV5N?$4M?EH/<<S-T+73<LI<5OR4&V3<14@E.J 8B+]TH<"M3HC^X6,X
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M0H;C#\ 591V[RT'-7'AB?AK>CUY277<Q!D&+0@JK'*A+LU5!*4/#M(0QS?V
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M^%O5EHH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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F!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>fc_cancer-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_cancer-4c.jpg
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M%!04%/_  !$( <4#Z ,!$0 "$0$#$0'_Q #(  $  04! 0$
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MP]F(%VCA&.CF1,+ZZ,M&EI=&KK\&RR/3_ Y7)6LM;GO^?9"*&KE#BM/&URI
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M &%8VI5L=TI?S*O_ ,H/]UE\=7]4_-]O1],?)[K!F(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MV]=TMMAJ-;I9N4AS4&&A%XK&/S[C'!9:$!#E>M8CC"33G^]R,X@#"ZF*NIJ
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MVS;#(;>Q.1B@&K%<I5K 50XA$,L0FP"^C<!9^5N"YIC!Z&.+:H" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(""(X3_ #!W;^:8C[%M93L3O2Y8J("
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M?J/]<?8FP;/[;79F?W6@3UJ32W/!3ZCW6_N-)@]/SV7\0GK4FEN>"R;Z#G7
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MQS-JO$JC"<'OTSC$2]5BR$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MCT=L?E^._2P[R=1L^)TV]X;_ ,E"V[8Y2_E^.[C_ /G [R=1L^*3_&WO#?\
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MFOQM$TQ5 LP!7K-'SR&7:"TC<S-&SL^I:Z+'!75% 0$! 0$! 0$!!$L*SMU
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MXB<QDGQ].O4ED#7D(X(AC=QUXZ.X\-5RR]"&T4! 0$! 0$! 0$! 0$! 0$!
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MS,!W50$! 0$! 0$! 0$! 0$! 0$!!#=Z?T_L;^N9/[OMK*.])3)8J(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @((CA/\ ,'=OYIB/L6UE.Q.]+EBH
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MQU2KEC?^1ZR+GQ?'Y4O%3IM/-Y)U2KEC?^3;Y+=MBCA<7E1J 9W^)1.;LP>
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M @(&C(" @(" @(" @(" @(" @(" @(""&[T_I_8W]<R?W?;64=Z2F2Q40$!
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M4< 5I6[*8Y)-.;WO,I@-#N#KI)F,3MZ7:@7-O;@CWO@-K[NV]FZ@19*I!D[
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M.RSHO<4X82UUV9IC'L2'E;VF70TX*$(\I<&[C_82$F.Q*MWLST=NZM_Y)O\
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M@]$! 0$! 0$! 0$! 00W>G]/[&_KF3^[[:RCO24R6*B @(" @(" @(" @("
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M8BQ"')(SB[.#&PD[,3\KDSN&K\NBOH4Y)J*N9NJM3'TBG*I''"5J1IK#@_\
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M$8,[IC]&ZYT\WE@=T2;E?*0X"G;PU"K+$3/!B)X8BAJ1ES/JT=DK,KF>KN)
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ME1E&X^#L?^20^3'O)ZE6<[STJ,HW'P=C_P DA\F/>3U*LYWGI491N/@W'O\
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MUWELN#QL\TL(2FPB[,["+EHVO=[JDQ@,"B[_  A1_.JW\<"BOU$7<T" @("
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M&5=CD",NZ'A<)P7(V;%BNU/U=LLZ7%=2GDF\YESLTK6^?/S4,C5AJV\?YR1
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M"[.SL_<=<%6V7L4?3'R3%8LQ 0$$-WI_3^QOZYD_N^VLH[TE,EBH@(" @("
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MS758R/TGV?\ X2P']74_X@%VT[&J=K=*H(" @(" @(" @(" @(" @(" @("
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MYY]Y\G*7-I&VNFG'V$TLD>ZI?>VUI*$VW,1+BNT?%24:IT7GX2O7*$7CY_\
M6Y=.;]E3##L;L<6W0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M*JVO?C8D:BB @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @AN]/Z?V-_7,G]WVUE'>DIDL5$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$$1PG^8.[?S3$?8MK*=B=Z7+%1 0$! 0$!
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M&QOU%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$!!#-Z<=P[&;_O$K^YCK2RCO24S6*B @(" @(" @(" @("
M@(" @(" @(" @(" @(" @("")X8.7?VZBUU<JF)U_P!#6F64[$[TL6*B @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((9O/_
M !%L7^MY?[NM+*.])3-8J(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M<6'WFK:LM]JJN:HQV.:]11%,\,OJ6C_,JW_*#_=9?,5_5/S?7T?3'R>ZP9B
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(""+8C_ !YNC\SQ/_W:RG8G
M>E*Q40$! 0$! 0$! 0$! 0$!!%][8J[EJE2*DT;G',YGVIM&VG([<'?N\77H
M>ROT6JIFK)YOOK%=VF(I[I0WT-SWM5OT@>\O4U]G.=SR>G7\HWGH;GO:K?I
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)(" @(" @(/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>fc_stageofdevelop-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_stageofdevelop-4c.jpg
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M%!04%/_  !$( BL#Z ,!$0 "$0$#$0'_Q #%  $  @(# 0$
M! 4#!@$"!P@) 0$! 0$! 0$!             0(#! 8%!Q    8  P,%"0P'
M! D$ @ '  $" P0%$1(&(1,',114%19!T2*3TY155@A1D;$R<I*RTC.5%QAA
M<8(C4W,T0E+"1(&#LR1TM#5U-J%B0S=C)?#!X>)D9281 0 ! @0$! 0%! ("
M @,    !$0)1D1(#(3$3%$%A4@1QH045@;$B,C/PP>%BT4*2!B,D\=(T_]H
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M3+LZ6MIRS@H<0J2\:5)5);(R,L^TC(]HS,<&[+IU0H^^?PC3G/.?B @
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MF\0L9D&QG/SZRN13U\E1.1JMIYV4B.@TEX"77C-Q98[<5[1U>::5X<D4$
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M)*34<5:N0G2))GD]P@K"3$PKA60  2ZG_J]9_P ;%_VZ EJWG#BT_P"JV/\
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M<W:3>-*9>-H\<V*"4>3,?ZPT\*)U)U3.+2$()M"4$>))(DD9_H+ ;<G8
M                        !:Z7_P#*M/\ _=:__FFA)Y-V?NA5=\_A%9GG
M/Q 0 98T25828]? 1O)\QUN-$1L+%Y]1-H+;L^,H@6E7U;KZ%I:[T7JOA!I_
M6%5;N: K*^9I6@CM2(\IF=IUM2;I:GGVD,NG)WSR\K3RC,R+ MACS6UB:S'-
M[KXMNMFV)XP\1XF.M.Z7X1;I:5Y-'95DDR,TF=I+5@>'(>!D>!CK;SGXN&[R
MM^#U;2U75Z[X%:$X0S9T&LL-2O7EII^XE.9>96M1/0:T/&DS-#;\-U\DD9;5
MI2,732Z9;LB+MN+<:_FL]3ZYT [J3@#JR0RQ'X;4UC<0(#.Q9L5=5*;API4E
MLLRB4:D)D+Q+;REB)$32Z/%JZZW59/AQ:WIK2VOM WFL=:\6+!"]#6M3<,64
M]^R:GQM3/SV5IA-P4-N.&^HW5H<2I*"W)%X1I%F8FD1S6V+K:S=/#\V.#H[B
M+<T? _4^BY'5D*CHFV[/4[E@S!@USC=M(=<.2M;J=FZ/$TY3SD>&!B5B*Q+<
MQ,TFWDOZ=C3>NZWB\K2NE9>L:"?KJ%85%)36)4+YQN;R2.6A2FU'NL58[O(7
MQR/9@)-8I7!J)BZ)TQXM+T[H_4VJ> >H=,Z;JW9]_!U\S*E5+;K2I+$>-6O-
M.*6:UIS$A2DH4LN4QTFZ(NK.#R19-UDQ'J>'D9'R?I+_ $EL,=7G  !+J?\
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MU"_Z2J/O)@*FGSC,ZA?])5'WDP%33YQF=0O^DJC[R8"II\XS.H7_ $E4?>3
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M!4T^<9G4+_I*H^\F J:?.,SJ%_TE4?>3 5-/G&9U"_Z2J/O)@*FGSC,ZA?\
M251]Y,!4T^<9G4+_ *2J/O)@*FGSC,ZA?])5'WDP%33YQF=0O^DJC[R8"II\
MXS96],3W67Y#4ZJ6Q%)!R7"LH^#9.JR(,]O]I6S8)5=$SAFQ=0O^DJC[R8%J
MFGSC,ZA?])5'WDP%33YQF=0O^DJC[R8"II\XS.H7_251]Y,!4T^<9G4+_I*H
M^\F J:?.,SJ%_P!)5'WDP%33YQF=0O\ I*H^\F J:?.,SJ%_TE4?>3 5-/G&
M9U"_Z2J/O)@*FGSC,ZA?])5'WDP%33YQF=0O^DJC[R8"II\XS.H7_251]Y,!
M4T^<9G4+_I*H^\F J:?.,SJ%_P!)5'WDP%33YQF=0O\ I*H^\F J:?.,SJ%_
MTE4?>3 5-/G&;-&TM837%-1)M4\ZAMU]:4V4?$FF$&XXK:9;$I2:C$JL6S.&
M;#U"_P"DJC[R8%JFGSC,ZA?])5'WDP%33YQF=0O^DJC[R8"II\XS.H7_ $E4
M?>3 5-/G&9U"_P"DJC[R8"II\XS.H7_251]Y,!4T^<9G4+_I*H^\F J:?.,S
MJ%_TE4?>3 5-/G&9U"_Z2J/O)@*FGSC,ZA?])5'WDP%33YQF=0O^DJC[R8"I
MI\XS.H7_ $E4?>3 5-/G&9U"_P"DJC[R8"II\XS.H7_251]Y,!4T^<9G4+_I
M*H^\F J:?.,SJ%_TE4?>3 5-/G&:UTQ1/IU10*ZQJ3RVD \$V+"C/"4V>!$7
M*8S=/!O;M_5'&&K=\_A&G.><_$!  Y2,NX>P!QE3E2G#P4X92]S#W *.2(BQ
M,BP,SQ/]8#J:$*S9DD>;#-CW<.05*.221&:B+ U<I^[@(KJEII!DI*"(R^+@
M7)C[GN?Z *"F65&:E(2HSVGB6(M4I#E;:'#(UI)1E[H5)BKA33:\,R"/ L"_
M4%2D.XB@  EU/_5ZS_C8O^W0$M6\X<6G_5;'_C)7^W6$%W.44&0!ZUPTN]*U
M/";B>QJJLB:@9ES=-FQIR5-<KW)6Z>D9G&U,&3JB9S$:LFS;MP'.^)F8>C9N
MBV+IGR7/#[6U9?\ $>WXMZWEQ=-P-(426*&%!;YTIB03'5E:W$C/.D[)7'):
MGU'GQQ3B9I(2ZVD4AK;NU7:IX44/'J3IO5,'2FMZ&^[1RK"HZBU))E,\SLGK
M.D3N42I,-3KRD;]DT959U$HT<N.P7;K%8E-Z8F8NAL\BVHD^U)H6[1/AE4QD
MZ4*59)>:YLV4:L80Z2WB5D3NU)-*L3\$RP,9I^B6YG_Y81&]8:2MN&/&>LK=
M,4NE+&2S7IC*@S9CK]GEN26I"439#I*(DI-P]RDL"/$_!#3-8)OMFVZG#DLM
M65+'$CB34\7-+ZNI:'2#350^N1+LV85CIOJAAI+T5,)9I?4I"FE&R4=!I<-7
M+RA$TBDQQ*:KM43P_)S*U+ICBG6ZZT_0N08%A::\/6<6HO)14S&H:939M<T7
M*,TI:<0HC>R+<3]IBGPB$I-M/@1=;?6*TXU7-59</J#BSP;KH$B'63Z.9)?U
M*W"NY-QIVI:D(4IB)'ES7%()9%X4C=*W9+/ E'W)QFV6HFV+X_Y4F@X=?I?C
MWI.=/K--Z'KUQ+=6\T_>-V,(G2A2B;?=DN2I),O&I:$MI4LB/9@G$6>-DI2F
MY:QW&LM,:PX%:PU,Y,9B<3+^=IV/JVE\!DY4NI6ZDK2.WB1JYTTXDY!)3X+J
M5*/XPL6S%T1X,W7Q=9,^/!X".SR   N[;_QS2O\ +L_^>,2.<MSRC\5(*P
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M_D4">+?_ %_'^RH%8  !)KJZPMY\:JJ8KLZTFN)8APHZ36\\ZOXJ$)+E4?N
ML1,\(7*= :Z7='IQ.G+ [XHYSCK]S@[S-)X&^1F>4VB/8:R5ACL&=44K5K1=
M6E'$#06N+.;9UU?IRP?L*5:6KB+N#;<AN+,R2E\G#3D-64\I'RX; U019=,T
MHQ4^B]8ZBKY-K0:?L+2LAJ6B3+B1UNMI6TG.XDC+:M2$^$M*,QI3M/8+-T01
M9=/*%<55:&Q722A/<WMUK;J7<AY);C;A,K2R?]HTN*)!_P#N/ 6K-)S27-,Z
MD92E;U/,0A=BNB2M3*B2=NUAGA8\F_+,7[OE$K"Z9P8WJ*\CJ90_62D+DS'J
MR,@V5FMV?%4EMZ,A*2,U.MJ6E*D$6)&9!6";9CG#/J'2FI](N,M:JIYE,N2E
M:X_/6C;2XEH\',BMJ3-![%I(\4GRD01,3R+K9MYNB]-ZC:MCH':B8W>DSSHZ
MQ;*DRN;[CG6]W9[<FY_>X_W-H5@TS6E.*J(R41*2>*3+$C+ND8K+D   %M6?
M]"U)_*K_ /G2$GG#<<I_!4BL     "QI-/WNI9IUNG:Y^TL$M+D+C14YUI8:
MPSN*Q,B)*<2Q,S$F8CFU;;-TTAQ-H;VM3.795DJ$FKE(KK,Y#*VN;374K6AA
MTE$1I<4EM:DI/E))F%8)MF.<.Y:;U$=C8U":B8JVJ&GY%M!2RHWXC$0B4^X\
M@MJ$MD9&LSY K!IG!DJ=*ZHOX,VTHJ6;9UM<DUSY<1E3S;*4HWBC,T\N5!9U
M$G$TI\(]@3,01;,Q6()&E=31*&-JF5426--3<AP[5Q))CO$XI2$&V>.*B4I*
MDD9%AB1A6*T6;+HBLPCJI+=-&C4RH3G9YR6JM19;#9.:A&\-D\#Q)>3PMI;2
MY!:\:,TFE?! !     !>:3_ZI+_[3;?\@\)+5O/\)42?BE^H5ER     L:2@
MO-2SNK-.US]I8DTN0J-%3G6EADL7'%8F1$A./A*,\"$F8CFU;;,S2'$ZAO:L
MIZK.KE0DU,AN#:<Y96US64^E:FV7B4195K2VM2"_M$DS((F))MF.;OV<U%UE
M-I>J9?7-:T](L:\F5'(C,14$X\XZ@MJ4MH,E+,^0@K!IGE1DI]*:HU%#FV.G
MZ6;:P*Y.>=)ALJ>;:22#</$T\ID@C69)Q,DD:CV!,Q'-8MF>4#NEM2L4$?5;
M]3):TQ+R\TMUI(HSI+6IM)H/'%1&M*DXD7*1A6*T)LNB*S#+3:,U;J*NG6]%
M32K"KK<2F2F$$:$K0TI]2$YC(W%I:2IU2&R4I*"-1E@$W1',MLF[C$*,C)1$
MI)XI/:1ER&1BL     "UTO\ ^5:?_P"ZU_\ S30D\F[/W0JN^?PBLSSGX@(
M                )=3_ -7K/^-B_P"W0$M6\X<6G_5;'_C)7^W6$%W.44&0
M!Q@1F2C(LR?BGW2QY<  TI,R49$:D_%/#:6/N !)22LY$1+,L#5AMP+](!D0
M23022R'RIP+ \?T &5)FDS(L4_%/#D[FSW '!MMJ42U(2:RY%&1&9?J,!RI*
M5I-*R)23Y2,L2_\ 4 R(R;O*6[Y,F!9?> =2::))I)M))5\9))+ \.3$@'8T
MI-1*,B-1<BNZ6/N& Y   !=VW_CFE?Y=G_SQB1SEN>4?BI!6
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MG!LP@
M
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M=?$:1'APXS:66&&&DDE#;;:")*4)(L"21"#,
M
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MD:?(I[R!)+!34MI)/-*26!&DE-FI*D'C@I&)'@K8F!2C*@
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MQ,3%870B@                  QR/L'/DJ^ P!C[%OY*?@(!D
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M6)I:::3@68S4:E'W, F11C*@
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MO#?B9?:EMG8&@.;<3'+/>Z;XI:=GIJ815I.$IM=@T3QJ6\V@E)61HQ5LP_\
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M0\\RN.O>L'E661PB/9[H@VX    !CD?8.?)5\!@#'V+?R4_ 0#(
M          ".Q_4R?V/H@)                               ^3>._![
MB1K;B1,O],4R9U2N)$83(.5&8,W&DJSEE=<2K9B6W >>^R9ETB:/-_RX\:?5
MM'G\+RHQT[EU0?EQXT^K://X7E0Z=QJ@_+CQI]6T>?PO*AT[C5!^7'C3ZMH\
M_A>5#IW&J#\N/&GU;1Y_"\J'3N-4'Y<>-'JVCS^%Y4.G<:H/RX\:?5M'G\+R
MH=.XU0?EQXT^K://X7E0Z=QJ@_+CQI]6T>?PO*AT[C5!^7'C3ZMH\_A>5#IW
M&J#\N/&GU;1Y_"\J'3N-4'Y<>-'JVCS^%Y4.G<:H/RX\:?5M'G\+RH=.XU0?
MEQXT^K://X7E0Z=QJ@_+CQH]6T>?PO*AT[C5!^7'C3ZMH\_A>5#IW&J''Y<N
M-&.'9M&/+_7PO*AT[C5#G\N/&GU;1Y_"\J'3N-4'Y<>-/JVCS^%Y4.G<:H/R
MX\:?5M'G\+RH=.XU0?EQXT^K://X7E0Z=QJ@_+CQI]6T>?PO*AT[C5!^7'C3
MZMH\_A>5#IW&J#\N/&GU;1Y_"\J'3N-4'Y<>-/JVCS^%Y4.G<:H/RX\:?5M'
MG\+RH=.XU0?EQXT^K://X7E0Z=QJ@_+CQI]6T>?PO*AT[C5!^7'C3ZMH\_A>
M5#IW&J#\N/&GU;1Y_"\J'3N-4'Y<>-/JVCS^%Y4.G<:H/RX\:?5M'G\+RH=.
MXU0?EQXT^K://X7E0Z=QJAP?LY\:",B/3:,3Y/\ ?X7E0Z=QJAS^7'C3ZMH\
M_A>5#IW&J#\N/&GU;1Y_"\J'3N-4'Y<>-/JVCS^%Y4.G<:H/RX\:?5M'G\+R
MH=.XU0?EQXT^K://X7E0Z=QJ@_+CQI]6T>?PO*AT[C5!^7'C3ZMH\_A>5#IW
M&J#\N/&GU;1Y_"\J'3N-4'Y<>-/JVCS^%Y4.G<:H/RX\:?5M'G\+RH=.XU0?
MEQXT^K://X7E0Z=QJ@_+CQI]6T>?PO*AT[C5!^7'C3ZMH\_A>5#IW&J#\N/&
MGU;1Y_"\J'3N-4'Y<>-/JVCS^%Y4.G<:H/RX\:?5M'G\+RH=.XU0X5[.?&=)
M8GIM&&)%_7PN4]A?_*'3N-4.?RX\:?5M'G\+RH=.XU0?EQXT^K://X7E0Z=Q
MJ@_+CQI]6T>?PO*AT[C5!^7'C3ZMH\_A>5#IW&J#\N/&GU;1Y_"\J'3N-4'Y
M<>-/JVCS^%Y4.G<:H<'[.7&DBQ[-)/\ 5/A>5#IW&J'T%P)X"-Z%0C5.K6VW
M]:N),F&$F3K-<VLL#2VHMBG5%\=PN3XJ=F)GVLLIS8F7O(ZL@#RW7' +0VO+
MD[^><NOM'<A37:]U+12"064C<2M"RS8;,R<#'>S?NLBD/PO>_1/;^ZOUW5MN
M\=,TK\>;>=+:6I-&TL?3^GXQ1:V,1Y48FI:UJ/%:W%GM4M1[3,_@'*ZZ;IK+
M];V_M[-BR++(I$+D9=P      ?F3P\X0<0^-ECQCT=IFZI:C2+^K5+U Y8Q#
MDV.*)C[C2XJDMGEPR'B1.(S<F8B,QNHS\2="W*.*?&[AWH53\VPI>'U##CM(
M\*7)@5!4!OHP1M-:V6S,TI+POBD7A"_U^:0A:^X@<#==^SMHOA7PXTR<CB^M
M5;#9KHM:IN;'L&B2F8ZJ0E!;[G*LY%E6HU9B4LDFG9.-5A.UAPWUSJCVD=9-
MZ?LG#XN:!TM0:CK7V5$X<RVJ8-2AYHR41YC=WJC1CL4K*2O!48O@CR6?J)[4
MO"+B!J>8VW6S;CB-46;[#:3-J.[+AW+ZTH0K$\J#,\$GB>!"Q_7R)\'K7''6
M$;4OL[I)7$F#Q#LH6N:]3UO I4T:8K+U9-W3:V$,,DZ>+;B\V57]W'8)',GP
M=^->KXVI_9Y-I?$RNXA6,37%6;UI#I44*(C+U=-W3;C*&&2<VMN+S95;,2QV
M!',EN? +2DC6_'7BI'XL6;-3Q5@U<G394E1$:KX[D"6T4=R>QE).]P1D4G,C
MD<2LS/82<S*O6KWV(^'^IH6G8-Y>6<EK3=#&TW"46Y0HVHU@J:;V))V+6AQR
M/LV$A6);2"+I@H]BX1\*Z7@[I->CZ"2])JSG2Y[/."22FREN9]TG(1%E06"2
M&1O@    #&_]BY\E7P #'V+>']U/P ,@                   ([.'.9/NX
MHQ^: D                              #"SAO7_=S%C\T@&8
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M_>+022<,DY_B_&PV]P21NP@ ([']3)_8^B D
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MEN-+D1F9");++JVFY;6)-O(0HR)Q&;;E46TL1E6$0
M                                  &Z\'?_ +7T;_W1KZ*QNSG"3R?H
MN/8X@                           ,,J*Q-CNQ);2'XKZ%-/L.I)QMQM9
M95)4E6)&1D>!D8!&C,0V&HL5M#,5A"6F&&DDVVVV@LJ4I2G B(B+ B(!F
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ME$WAG3BD_C!4HU^0^],D/S):][*E.+>D.F1$:W'5&M1F7Z3,]@BL8@
M                                                #=>#O_VOHW_N
MC7T5C=G.$GD_1<>QQ                                         &.
M1]@Y\E7P& ,?8M_)3\! ,@                   ([']3)_8^B D
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MYP]Y .E)J@_*=Q3Z34></>0#I2:H/RG<4^DU'G#WD Z4FJ#\IW%/I-1YP]Y
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M ,;&6_DI^ @&0                   $=DL),@_=R?1 2
M                !A9^U?/_ -Q?1(!F                     1_\X9__
M (O\0"0                     P._U$?\ ;^B S@
M  (\S[-'\QOZ1 )                        /S[X>\05^R1J/B7HKB?HZ
MTMI>HK!VSH[F PA]FW962TM-N..&19%9\VS.:%+6E2<Q8'NE1XYJ7ASJ'2'"
M;ADWKC34\XVH]8VEXYI:(AQN<FK=9KF3CI3E-33KR6EY",L2+*>&.(HW/2%!
M2ZKU+QGN>$FD=1UG!67I7JU^LAMKY\Y.-R(K",TZZLEK2IMYU31NJ,VLZ?!W
MB4B#4N'[;/9SB+#IJ5$Z+'T _&DZIBU\NI>CN;UI7,I\<UJC//K4DD[Q)*69
MI)9+,DJPLJV;AS?P)G!'7.E(^K=67%TWH>0IS2ELPM-%!./)84LX:C<7X2"/
M*CP$XI-7ZA$2.#=+9L\4N!L3C%;V5GHLZMFTX:$VR;,.%;J>3DB2"W9J,D/,
M$G,2L3/<F9DV9D5\!UXTZ9UIHSBIK[@)I. OL_QFN:6TKI*4J2TREZ2MQQ))
M264FRD+4E>TL$-%R$) ^ZG^!>A),K1<QQN2E[055*HJ%#3N[;3#G0N8/;Q))
M\)1M<A[,#VC-1J-)['_!73UI3W=57RVK6DF55C"E'),UG(HR63)KP26).9R-
MXBPSFA/)AM5D>\B      QR/L'/DJ^ P!C[%OY*?@(!X!;^T=JC3R+]5_H.-
M ZBN*_3JWEZAC<V.?:I9=;4\\<=*664LOI6MU?(KP,,=HU0=*;VEM0:JD0Z_
M1W#QV\LE5TZVGLL7$1+1L5UBJN6<!_(;4Q"UI-33B5(2KDQQ(*#VG1NK:?7>
MEZK5^GW%.4UQ&1+B*<3D<)*RVH<3B>5:%$:%IQV*(QD7H
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MF/\ K7]$!G                     1YGV:/YK?TB 2
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MU!M)=6X3-BQ"DM2%QW#QP2X3:C-.TC+;W2,N4C 70       ,<C[!SY*O@,
M8^Q;^2GX" >4:LX$5^I6]0K9O),"PO;^MU2W(-B/*;C3:EAEAI&Y>2:'6U$R
M1J2YCM,6HUZO]F9='.:M-,Z_N*2UE1)L'4$^''@$_*;LY93)!QB4P;<(\Y8-
M;AO!LMI%FQ4=U#V/2FEZ?16G*S2FGF.;4E1&;AP6,34:6VBPQ4H]JE*/PE*/
M:HS,S&1<@               CL?U,G]CZ("0
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MN(E/$JIM0UB*2_M:=IQ3S,"4ZPRZLB):VDJQ0:L-F;*99OTB3%)56B
M                 !ECAM,C(R,C(S(R,CQ(R,MI&1[2,4?7WL_\?%:D.-H3
M6KQKU,2<E1:J(SY^ALL=V[@6Q]*2QS<BRV_&Y?19?7A+G=#Z'=_J(_ZU_1'9
MAG                     1YGV:/YK?TB 2
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M5\!@#'V+?R4_ 0#(                   ".Q_4R?V/H@)
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M6_I$ D                                          #'(^P<^2KX#
M&/L6_DI^ @&0                   $=C^ID_L?1 2
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M+*,S-7KPZ,L#O]1'_6OZ(#.                     CS/LT?S6_I$ D
M                                       #&_\ 8N?)5\!@#'V+?R4_
M  R                    CLE_O,C]CZ("0
M      ,+/VKY^ZHOHD S                     (_^<,__ ,7^(!(
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MNH02EJ2G!2B29XD1'M(CVA,#<Q        !&8_J9/['T0$D
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MS(6A7_J1D>PR/:1[#VCTQ-7)/%        $?_.?ZK_$ D
M      ,#O]1'_6OZ(#.                     CS/LT?S6_I$ D
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MDI2B-Q2$H(U>%M,DEB,C8P        $=C^ID_L?1 2
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MM?T0&<                    !'F?9H_FM_2(!(
M                      &.1]@Y\E7P& ,?8M_)3\! ,@
M     ([']3)_8^B D                              #X+]I;_[GO/\
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M:CT.8       "/\ YS_5?X@$@                    !@=_J(_ZU_1 9P
M                   $>9]FC^:W](@$@
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M]0HO-;6$:\CPC2Y K6&EI85((\2<?WAGG)'*E'(9[3Y,!NW;IS2;GTD.S
M       C_P"<_P!5_B 2                     &!W^HC_ *U_1 9P
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M&7<V$ X0P^X@W&VEK;3CF6E)FDL-IXF0#&
M
M                                         #E/QT?*3\) "_C+^4KX
M3 ?,'$N=)9T![43G.'T<UU%3-1UMN*2MEMPZXE$T>)9=BCV%L]T;B.,$SP6+
M.IM3+XT</N'>L9#AZVT7$UA%NY:26TU;P'JIA59:Y2,T*W[:%$X68\CZ'/BG
M@0#7.#.F6XO N[UI(T:NCN']#7+L?7)WKMB]8K<BR#4HH6]/FYD:"7F-.PTX
M%@$\R5UH&'><//9^ON(FGM 'IK5IZ/ASZ^\7;JNSMU\V2\N<<5:EICFT1G*W
M:D[>0_!29!/,;=!X7\,]+UNE^(59JZ=47<UZN<;UX[9R):M1OST$I4:2S)=<
M9DIF&9_NVVR4C#$MB3&:BNU=PMT)8>T/IMB=3J4W?TU[?7#!39Z$/6<*2QN7
MC2B0DDFC%7@H(D[3Q+DPM> H[W4=Y4U?%-J);R*6OL^+$/3UUJ1EW=OTU%8M
M0VI4EEYS,E@R(R;)SD1GQ+ \#%&UV>C*#@QQ#X;M\-T2:N7JR]72WNEESY4V
M/:4Y177W[!QJ6Z\>\@J0VX4AO+\<R5B1X"5J-)N[&2S[,O'*4J:XW+@ZMU'$
M)XW5)<8<.YAI:9)6;%!F2L$HV?&V%M%B.,"WXV:9YUK34^K+R))UAIG3E-"=
ME1=/WYTVH]$)CLN2'Y[$-2T,OJD)3SA"W/"4;9IPREMD2/7K^P:F<*[FYK)K
MLJ-)TI,G0+)S]W(>;=J5NLR%X$G*ZLC2XK BP5CR">(\.J--U7#70'!G7^BG
M)5;K;53FE85I6\\ER(^HF;J.T<]MV-(=<;S():GDNMH3NC_9PLJDNU]OJ;27
M%*CAW3$.0_Q?G1$5ME8NU;-U$0B&M5"B8V>\8.7M2V3?*99=A&8L_P!D4NKG
M*VE]GWC!I:EKKK2EY03J-%MHJRLRLVJEVRG07&VJR<THS.++:,U*)2\4J-6P
MDGM1S27HMA,+@3P4UGJJ-H?L!;LDOJRCZU5J'?V4M*(<&03RUJ+[1S,;*?[+
M9GW1.<JU?@AJ:%^'W$CAG4:Y.0O1\9R31Z^FDXP3,2[@*<5+5OTMN9(4U+^9
MPR\$C+#D()@2>#]5!T1?N:>LJF?IG55KI23,0]"N^T.F-3-14)-RW:4LU.M2
MLRB6C'*6[6?+B6*1W]E?2ZX6CJC5DG0RZ279TS1'K-RZ<LE6YO.DM1'"4M11
MS5E)S$R[F4@N&Y<1+.+P_P"(NA^)UG+.)I&<F1HG63CBU[AIB82YU;*-..1&
M[DM.-K=/;E61?H$B*C2V]8W&A?9VU5Q?M%.,ZTX@2)%S617G,YQ7-0.%#J&&
MBVGEC1,LDDI+' C%IQ%3P]XA2=.<$>*E'H:\5JRXX7-OR=,7KS3F^?JK-LI+
M,E;<E"5*7$6<HU$I&0LB2\) 3 W:'PNX9Z3@Z8X@5.KIU1<S7Z];.NW;.1,5
MJ5Z>@E'&DLR77&9)3<3/(VV2D88E@23"HPU^BZ#C'Q!XD,<1VI-I+T?=-TE!
MI1$^5"8K*<XC3[%@AJ(ZRK>SE+6X<AW-\0B3@18!R&.2_%9D<!8E)K&1K6I1
MJZ9"1J1YU#KTUAB%(23;[S.")!LF6ZWFW/EQ$'D=AJO4>D>''%M=Q8/OZ(UA
M:ZPKJN<HEJ53:D@R7%LQR<)69+$]A!);PV)>;PP(EF9VBMSU'I=[6'&QB _H
M9S7T6)HK3KZHJKQRD3 6\Z\2Y&!+3OE*).U/+L_2*C+Q>HD'KK6.N;Y$W5&E
M*)BL5UEI>^ZMU)H1$=A+CCJ*]Q1-N%)/_>4J,LQIQV;,1(Y*^D6'D26&933I
M/LR&FGVGR3DWC;K:5H<RX%@:TF2C+ L,>091W
M
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MIWJ8YD;29#;;B&Y"48%E*0A>!;.38%1N"E&HS4H\5'RF(.
M
M                                                    !RGXZ/E)
M^$@&Q'IE!F9\Z5M,S^(7=/$%<=F$=*5\P@#LPCI2OF$ =F$=*5\P@#LPCI2O
MF$ =F$=*5\P@#LPCI2OF$ =F$=*5\P@#LPCI2OF$ =F$=*5\P@#LPCI2OF$
M=F$=*5\P@#LPCI2OF$ =F$=*5\P@#LPCI2OF$ ZN::;0A2SDJ/*1GAE3W"Q
M&]--K0E925%F(CPRI[I8@.W9A'2E?,( [,(Z4KYA '9A'2E?,( [,(Z4KYA
M'9A'2E?,( [,(Z4KYA '9A'2E?,( [,(Z4KYA '9A'2E?,( [,(Z4KYA '9A
M'2E?,( [,(Z4KYA '9A'2E?,( [,(Z4KYA '9A'2E?,(!C1IUM;CC925D;>&
M)Y4[<Q8@,G9A'2E?,( [,(Z4KYA '9A'2E?,( [,(Z4KYA '9A'2E?,( [,(
MZ4KYA '9A'2E?,( [,(Z4KYA '9A'2E?,( [,(Z4KYA '9A'2E?,( [,(Z4K
MYA '9A'2E?,( [,(Z4KYA '9A'2E?,( [,(Z4KYA '9A'2E?,( [,(Z4KYA
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MF$ =F$=*5\P@#LPCI2OF$ =F$=*5\P@#LPCI2OF$ =F$=*5\P@#LPCI2OF$
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MJ(_ZU_1&6F<                    !'F?9H_FM_2(!(
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MW:Y$)?61LIR-*4P23RK-32#29)0K,I)*-;===2O.J7V6VZJ<J?-[*/TWY0
M                           V_04BU*8Y%CIWE3M5)SF9):69;,A_WE=U
M/^D?E_4+;-,3/[O#S?L?3+]S5-L?L\?+X?\ #T!W^HC_ *U_1'X#Z1G
M                1YGV:/YK?TB 2
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MR^[R@,3C+3LA$MQM"Y;:%--R%I)3J6UF1J2E9^$25&DLQ$>W A-,+6>3N-(
M                           M**BE7LO<LXMQF\.<R<,201]PO=4?<+_2
M/-O[]NU;6>?A#U>V]M=OW4CE'.?Z\7K-? BUD5N'";)MALMA<IF?=,S[IGW3
M'S.YN7;EVJ[F^MVMJW;MBVV.#L[_ %$?]:_HCFZLX
M "/,^S1_-;^D0"0                                          ,<C
M[!SY*O@, 8^Q;^2GX" 9                    1V/ZF3^Q]$!(
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M?T0&<                    !'F?9H_FM_2(!(
M                     &-_#<N8_P!U7P& ,?8MX?W4_ 0#(
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MZU_1 9P                    $>7]FC^8W](@$@
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M&6I[36F@M/ZLNJHZ6TN(34N16&X3Q-&YC@:%IQ)2%E@M'=RJ+':)*MM$
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M>)?J%WMC1Q\'/Z/];CWLS9=&FZ(KPY3#VDSP'F?3!F?N .#422Q5L(N4SV$
M<ID9EM+NGW '8                    !'F?9H_FM_2(!(
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MHG2,N&5%8RW3D.Q52VC4]!-Y6*E[I18<NS _='._E$NFWPF8\(?08Y.P
M              (\S[-'\UOZ1 )
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MRD6)X)(L3]P9$@                        !Y1K7_ ,EE?RV?H#Z;V/\
M#'XOD_J/\\_"%%G7ER9CR?W<=GO#V/SS>.8FK,>8S(S/$\<2Y#"@)6I!XH4:
M3/E,CP,!R;CAD:36HTGCB1F>&W:84$5$&&W->LFV$(L)#2(S\I*<'7&6C-2$
M+,OC$DU&:<>3$9TQ6OBUJFE/!)2M:3(TJ,C(L",CPV>X-,N2=<(\26K':?*?
M*?+[X4'!K6HC(U&9'RD9G[N/P@(]A$BVT-=?:,HFU[BD*=B2"WC2S;63B<R3
MV'@I)*V]T9FV)YM6W3;-89S,U&:E'BHSQ,SY3,QIEP*
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M6L\/C*,8F9GFZ1;$12&QB*                  "/,^S1_-;^D0"0
M                                    ,<C[!SY*O@, 8^Q;^2GX" 9
M                   1V/ZF3^Q]$!(
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M+GC5]\._W<8R/MNQA.<G873O\%SQJ^^'?[N,9'VW8PG.3L+IW^"YXU??#O\
M=QC(^V[&$YR=A=._P7/&K[X=_NXQD?;=C"<Y.PNG?X+GC5]\._W<8R/MNQA.
M<G873O\ !<\:OOAW^[C&1]MV,)SED8T7I^.^W(3'4M;2B4E+CBEHQ+DQ29X'
M@,W>^W9BE6K?I^S;,33EYM@'A?H         # Z9\X8(C,B//B7[(#.
M                CS/LT?S6_I$ D
M           #&_\ 8N?)5\!@#'V+>']U/P$ R                    CLX
M<YD\N.*,?F@)                               JW+BJA2GV)<QIE_%*
MC;<6258&DL#P_2.UFQN716+9F'"_W&W9-+KHB3M'0^D8_C$C?;;OIECN]GU1
MF=HZ'TC'\8D.VW?3)W>SZHS.T=#Z1C^,2';;OID[O9]49G:.A](Q_&)#MMWT
MR=WL^J,SM'0^D8_C$AVV[Z9.[V?5&9VCH?2,?QB0[;=],G=[/JC,[1T/I&/X
MQ(=MN^F3N]GU1F=HZ'TC'\8D.VW?3)W>SZHS.T=#Z1C^,2';;OID[O9]49G:
M.A](Q_&)#MMWTR=WL^J,SM'0^D8_C$AVV[Z9.[V?5&9VCH?2,?QB0[;=],G=
M[/JC,[1T/I&/XQ(=MN^F3N]GU1F=I*'TC'\8D.VW?3)W>SZHS6:5$HL2VD>T
MC+:1D8\[TN1%8-G//T[O_$ S@.N=.&)&1E[N(#AMYM[-NUI7D4:%93)6"BY2
M/#D,A(F)68F.;N*@               # [_41_UK^B S@
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MRG*>5/6E:YNM>9Q>?[SX_.=PC>YOTY\V/Z1^AMUTQ5^;N4U33DF#HP
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MM^XW=ZM>KHX4Y:8IS\:ME'B?I        ,#O]1'_ %K^B S@
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M@                   ([']3)_8^B D
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M_=6NKXUXUYUXIPY/0                 ,#O]1'_6OZ(#.
M        CS/LT?S6_I$ D                        X)"2-1DDB-6U1X<
MIELV@!I2HTFHB,TGBDS+' \#+$O]!@&5)*-9)+.9$1JPVF18F18_HQ,!R ZI
M0A)XI21'@2<2+#8GD+]18@-&UMPGTWKR<U86\NTB/%'.NG(J["1!:G5JUFM<
M24VTHDK:4:E8X$2\#,B41&+$C<H4")71H\.$PW'B1&D1HC+2"0AIALB2EM)%
MR)(B(B(A!GR((R422Q+' \-OA'B?O@.P       ,;_V+F/)E5\!@#'V+?R4_
M  R                    CLX<YDX<O@8_- 2
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MZ'(#!LYY^G=_X@&<                    !@>_J(_NXKP^: S@
M            (\O#=HQ_B-_2(!(
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MLTE]1[+W=GNMJ-RWE+9AA[0!QC^@!R             P._U$?]:_H@,X
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M(SM\2>'CT>++9U;2N19TLZV$^BRBJ;?G)PQC-*)S!;I9DXMI\+:6P*#:!
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M9:,T,XRRWK:"24,XQJRJE+>_WK>$C+@>8ARMF[5;S=K[;-%W*CW ?K/QP
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M]1'_ %K^B S@                    (\S[-'\UOZ1 )
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M<0DVR\)QF/&0@\"Q-)DK B()NJ1#[P&0      &.1]@Y\E7P& ,?8M_)3\!
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M2$(0@LJ4I26PB(BP(B'-V90         !@=_J(_ZU_1 9P
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M'3?#S34'26DX15NFJM"TP89...I:2MQ3R\7'UK6>*EJ5BI1B3(V# @
M  &.1]@Y\E7P& ,?8M_)3\! ,@                   ([']3)_8^B D
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MMX<F5/P$ R                    CLX<YD^[X&/S0$@
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M3NO\0#.                     P/?U$?\ ;^B S@
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M9MN&&(D\QZB(        ([']3)_8^B D
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M7U?M?=6[UN%T<X_KP78\;W        (_^<_U7^(!(
M  8'?ZB/^M?T0&<                    !'F?9H_FM_2(!(
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MF'6E&I"VFLN5"DF>*326)& LF&&(S26(S2&64XY6VTDA)8GB>!%@7*8#(
M      CL?U,G]CZ("0                              /*-:_P#DLK^6
MS] ?3>Q_AC\7R?U'^>?A#S2UI.'EAJ-F-<I@N:LF9Y46(]*R3%YXBH"G&VMX
M1[8YJ06!=S,7A)S%TNMVYNX\W"V_=BWA6G]2H3I^"3I/W?6-:N(T3K#JTVZC
MALKD,\V>-+1/Y$.OMLDE2DIS.$C,7=,<].SS==>_RXY,&KZ+A>Q&:9F6$>*[
M:2HMDW%:EKD/RHLFQ9DK3#:2\2D-OR$H<);.!)5F6G^T,WV[>*[=^[/AR9'J
MKA&PS6Q92=Q<VYQS@LN37%7RGYLS>-2C43ZG=\;ZLQODHSRXEM01D&G:I$+K
MWJS/A&2_AZLX;Z:JH\"#>US-3$D-5;*&9?.]W(D.*2A#BB4XOPW,V+BSPQQV
MCM;N;=L4B7"[:W;YK,<5RO4^F6DV*W+J E-.HD6QG*:PBJ/81/>%X)F?@E^G
M9R[!TZMN+ETK^'">*Q8?8E,MR8KJ'XSR4N,OLK2XVXVLL4J0M)F2DF6TC(QN
M)B>3$Q,<V0:1+JU6*;&.=1FZRS?N"3W?=)7<R8?&Q'+=T:)U_M_KYNNSKUQT
M_P!WA_6&+V=C>[E'.,N_REO2;QR9\-N7';AB/D[J5X<GVMM:<>;(,M
M C_YS_5?X@$@                    !@=_J(_ZU_1 9P
M      $>9]FC^:W](@$@
M  8Y'V#GR5? 8 Q]BW\E/P$ R                    CL?U,G]CZ("0
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M?T0&<                    !'F?9H_FM_2(!(
M                     &.1]@Y\E7P& ,?8M_)3\! ,@
M    ([']3)_8^B D                              "ED:>I;.;(E3HB
M7I!FE)N&:B/*E)8%L,AZ-OW.Y9&FV:0\NY[3:W+M5UM9=>QVFO1Z/G+^L.G>
M[WJ<^PV/3!V.TUZ/1\Y?U@[W>]1V&QZ8.QVFO1Z/G+^L'>[WJ.PV/3!V.TUZ
M/1\Y?U@[W>]1V&QZ8.QVFO1Z/G+^L'>[WJ.PV/3!V.TUZ/1\Y?U@[W>]1V&Q
MZ8.QVFO1Z/G+^L'>[WJ.PV/3"97T=35+6Y7Q4,..$25K+$U&1=S$S/ ARW-_
M<W.%TU=MKVVWM36R*56 X/0         (_\ G/\ 5?X@$@
M      !@=_J(_P"M?T0&<                    !'F?9H_FM_2(!(
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M,)3B30LX\MI+S9J2>U)Y5%B7<$%D P._U$?]:_H@,X
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MUJ80TVA"6U.F:EFDDD6!J-1FK#EQ =T1(C>ZW;#:-SFW.5"2R9_C9<"V8]W
M!BB5=9 :8CP83$9B*2BBM,M(;0T3AXJ)!)(B3F/EPY0'=%? :<:>;BLH>80I
MIEQ+:24AMPR-24F18D1F1&9%R@.Z8T9*LZ64$LEFZ2B21'O%%E-6.'*9'@9@
M,)UE::FEG#8-3"3;84;2,4(49*-*=FPC-)'@7=(@&5<.(XV\TY';6U(/%]"D
M)-+AX$6*B,MNPBY0$9JCI6&W66*V*TR\G=O-H8;2E:",SRJ(DX&6)GL,!K^A
MN&NF.'U3)IJ5IQ^+*DS9;KDTT/O8V3ZI#S6;(G]UG6>"/?Q/: V=4&$M4=2X
MS2E0SQB*-"3-D\N3%O9X/@[/![@#LW%BLOO26F&VY,G*<AY*$I6YNRRISJ(L
M592V%CR ,;M;7/H<;?AL.-O+2\ZA;:%)6X@R-*U$9;5$9%@9@.RX,)TW3<C-
M+-\T&^:D)/.;7Q#5B6W+AX./( D    ^7N,7_P!B6?\ )B?[$A\C]1_GGX0J
MHBWS4&NI51EDJ?5NNJ=CK)\C<;>>4I2",E;DT+;49*S)S?I'"W=TVVTYV_''
M+D)\'45/737F8S\E-*Q';K:C]V6]9\);AV)I/83[*UJ-"2\)6;E+ =;-ZRV[
MA732D?\ [?&!25EE";DIC3H[<:IE,.0;1<,G#<<8=(OWN#BUXK0M*7$\FT>?
M;OB)I,4B8I-/Z_$=[>Z3:Q%)5F2[U@[(:8V[MJ)S=MAE*3Y-B6R+ 7<W=<?C
M\J4A5,/.                 "375<^[G,5-9'5*GRE9&6$[,<-IJ4?]E*>5
M2CY!JS;NONBVV*S*/KG2U;9U%%"K;BP.SL8[9(>F*++F/N%[IDGXI*5M/E/:
M/MMBRZRR+;IU3'BCY$X-7VD(?&?6%-9\2KBEU6_Q"U&<+AXSF*KG-N2%FVXX
M1Q5[7"Q49[\B\$L,.[ZIC@D)?'>4WJ3C!'U[2Z<;O-/\"D1']>R"2]SB;SR2
MU)YFPE.5#W5K23L%$I>5*]BB+D5/!6X<=&;C6G%#@(OA]J+J"?:'J.55:J:A
M-V:&([E.AW.4>1E;5OFCR)S_ !<V.!X8!'*4E6\:^&_X>\(>$O#CA],<B3:W
M7%#'I;B6WSM35@^[)>YV^WAE41ON&XM.&7;R=P6)28-"=7_E>XKPU)E.\1N:
M:H=XE0[ D'*/5;\)WG9DB.E#6Y=)*%1MR67=92QS9@\2>29[)-_HRRIXE=0<
M3KC6-U%H:SK/3=F9JBU"D-(0M,?&,SL2O]T7[Q9Y2VX\HES4-NTI;PUZJBT.
MEES4U%HY8(U3HNP;-2*G#.:G4.8?N4N.']F2S2O/BG 1E7<9J6OH]4<#*VFB
M)BP&=:(4AAA*LB".#)QP+;@00T@7.JZ3@OQ^U;K+B8IR#I36]341M,ZK<8<?
MAPG:HGDRJUUUM*ULJ>4M,E)&1(7ARYBP%YBSX+2DZYXK<0N,.FHCT3A[J")4
MU57.?97&Z[E5:72<L$-NDE>[;2XF.VM2?#(CP^*9%)'SOHW0FL*+V87>)7#R
M.Y,>U)3:CJ.(FDUFIHY\-4NPBL6<8E)5EF1$&DU)R_OF2,BP619MS,59CC#[
M/X.D2>$F@4),E$G3=.1++81X06BY#VC$\UANPBL#O]1'_6OZ(#.
M            CS/LT?S6_I$ D
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MJZ7=0*;S'!L4*WYLG_O!GB@G%))6Q&/A)(C(S\%..W8)U?\ 6W)KMO\ :_\
M\O\ #ED]0[Q34EF:V69A)NI?<<2:75.9S(B1CX!)27Z#5B>P.KY6Y';1ZK__
M "_PZ;S42FU[VLL$I-"S-*I:7TDI..!*23?A$9$1^#^KE#J_ZVY)'MZ?][__
M "_P[[R^6;*2AV6\6LDNES@TEE4VE995&C!.TS^/L+#*?A&+UO*,CMO]K_\
MR_PZ(>U"M$=2H=BE;N]WRC?4DD;M"U(P22#46924IVEW?U"=;RMR.VCU7_\
ME_AN=6I:JZ*IUHV'39;-QE18*0HTEBD\/<,<9>J(HE@K [_41_UK^B S@
M                 (\S[-'\UOZ1 )
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M'::69934VA*3PY<,2(6+8CE SC0                  # [_41_UK^B S@
M                   (\S[-'\UOZ1 )
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M0TA1MJ6RM+B26GE29I,]I8\@#(B0PXZXPAQ"GV<N^:)1&M&<L4YB+:6)%LQ
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M_1N:)Y7?F/HP?4(                  "/_ )S_ %7^(!(
M        8'?ZB/\ K7]$!6ZETM3:M@M5UVTIZ*R\W)0E"U-GO6CQ2>*3(_\
M0 I]6:<EV-I56%?$:=>@QYZ.<KW9.MNN1\L?*I18['.0R^+R@-4>TIK1DHK+
M*9<MY$>N*).*S4CFCB'$KL">2M9&\IX\QF>"B4GP? (A41G](ZX>><?;8>;L
MFV)+<JP<L"=3.4[)96?-T9B-C>,MJ01^!E+!'_N 3&=):S7$WC[LM+\2,I51
M'Y_D)F1SPW$(425J2K*SX)&M2_!/+B8##,TQK]Y][FY2VI3G/2GVC=GD;F$\
M\V<<VF<W[HVV\R"\%.3:7A8X@+%S1FIHB9CE'+D19RIDMFO>?FN.M-5CD11-
M(R*-18$_@I.)&M)[<<-@BNU10:UC:5O(:'GH-C*-LZJ,])2M;1)2G?Y'DK>-
M!O'FRJ-9X*/-@GD%1VT]I6W;U#6V\Z"N+60%3N80Y,SG;\)N0TP@DFLEKSDX
MM#BB3F5D(^7;@4%?*T5JA<B?#8:;.CFVZ]0*:WQ$HY3<Q)MMF1G@;:T$F0HC
M_M(R]T4HPU^D->+F;NTD2>:KEL*M'&YN1$QI,A:UNHRN&M*=WE0:")O%/@Y=
MF(!)TAKF9$>90VXU?E(;><NI$\GHLAQN2:TNLQC)6Z-+7@H/*DT;,$JPQ 6N
MJ-/WUG5Z=:@527CKFU..5\QYB4:)>[)M"92WS43K!I-Q+JFSWF)I6G:0@EV%
M5J2P@:;L+>N:MI]<MYVWHS6RAI;KR#;0MK.>Z5N?_CSF1FD\=B@%--TOJQ91
MRJJSJM*F\:V-7V.YC5$MR2MUQYY!$1/$M"R(TMI4DL%()."LP#:;,[?4M1NR
MJ7(,N):QE$Q)6C]XS$D-N*>29'@:3(CR^[@"M6>TGJR)&AM).7-@NL0W=005
MV1D_,F(<63J6WG%%D,R4@U95(2M*23B1BHVRE>N&XG9Z=5RFEMP5.%-D2BF(
M-:SP2P;Y$DU.%F,C,RY$]W89Q6D5>A]4U+#+4B(4Z)_N)384!]JM5(89C.)2
MTI31MXKCO+-2UJ7^^3E_N914HE4VB=4-MIG6JI!7F%6TJ0F<:W%--/.)E[Q1
M&1.J)A>7,LL3P++@9" O2_$I;#C96CC;SC;I$OG:CW;E>DX\/+RX<Z;4;KQX
M'E<(C,419%;JZJS.0DRZ9-E.C5E17/SUSMTS-C*:DKQ0IS*;*RYRC%9[4GM\
M+ !L]G2S=45U VTU)KT5DMQUJ1)61RV3BLNLQI*B5@:C4K*:DGRH4>/*(JIA
M0]754"A3/T\3BZ9V18O<PDMNDM^5SALV&VS(E%X3R5DOXI-XYMI8"HL]44-]
M+LK1JNA(D0[UJN:<G*=0A,14!]:U&XVHR4LC2O%.3$\=AX<HBJ!O1&HG(=G3
MLU4:+5V;C+$A4QYM;JH9.N//MF_%)#CK2RRH0;A$ZG.>.PL14H]#TBQ<1*"'
M!O20=G$1S9QUI69MU#*C0VXD^7PT$E6![?=$5>
M       ,<C[!SY*O@, 8^Q;^2GX" <DTTEQ;J4))U>4EK(BS*)/Q<3[N&.P!
MRMM#J%-.I);:R-*T*(C2I)E@9&1\I& +;;<2M"T$I#A&2TJ(C)1&6!D9'RXD
M ZFPR:FU&VDU,X[DS26*,2RGE]S8>&P!V-MM1H-2$F;9YFS,B/*>!IQ+W#P,
MR <)::2M;J4))US EK(B)2LO)B?=PQ <$PP32&":03+>7=MDDLJ=V9&C N0L
MID6'N ,A$1<A8=WWP         !'8_J9/['T0$@
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MNM+:K;U.4[+!>@KA.[I3<@T;PR/$BSH2HU-J\$\4++W,#,@5L(
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MX'M+:1\AEM(!8@                   QR/L'/DJ^ P!C[%OY*?@(!D
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M6./<_4 LM':-;TFF6LY9S94PF&UO&TEG]U%0:&DX$:C,R(SQ,U8>X1$ V@
M                 &-_[%SY*O@ &/L6_DI^ @&0                   $
M=G^ID_L?1 2                              !A9^U?^47T2 9@
M               $?_-G_+_Q )                     # [_41_V_H@,X
M      X/_1_I <@            (\O[-'\QOZ1 ,Y?Z '(
'      #_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>fc_cells-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_cells-4c.jpg
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M<" S+C  .$))300$       /' %:  ,;)4<< @   @ " #A"24T$)0
M$/SA'XG(M\EX+S1B- =8=^O_[@ .061O8F4 9,     !_]L A  $ P,# P,$
M P,$!@0#! 8'!00$!0<(!@8'!@8("@@)"0D)" H*# P,# P*# P-#0P,$1$1
M$1$4%!04%!04%!04 00%!0@'" \*"@\4#@X.%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $' ],# 1$
M A$! Q$!_\0 RP !  (# 0$! 0            8'! 4( P(!"0$!  (# 0$!
M              $% @,$!@<($  ! P,# 00&! H$!PT&!P$! @,$  4&$1('
M(3%!(A-187$R% B!D2,5H;%"4F*R,W,U%G*2=!=#TR0TE#96P8+"TE-C@Y.S
M5'5&-]'A)54FEO#QHF1%5QA8$0$  @$" P0'!P,$ @(#     0(#$00A,1)!
M47$%88&1(C(3,_"AL<'14A3A0@9B<B-3\16"!Y+20__:  P# 0 "$0,1 #\
M[LR"SIR"R3K(J=,MJ9S*F#/MCZHDUG=^6R\G4H6.Y0H*S^5R^WK)N!,+OF0W
M"1=;S+C2#*GS'%/2'2B8^VDK6K4J(2D#4^B@QN0KSE.7\IVWA3&;Y(Q2 +&K
M*<GO]O2V;FY#5+,&/#AN.I6AE2W$K6X[L4H)2 G34ZA[VVUY;PP+]?\ (LVD
MY1Q%;;3(NDG^8-).0PI4,%Q89D,MM(?9<;"O Z-X6$A)ZG4(?>.?.7<;Q.!G
M^0<:PV,1OTBW-6OR;N79T%FYR&VFG+DV8R4I\Q+@*?)6K8LI0L==02V,SFKE
M>Z9'GMGP/ ;?=H''T[X>=,G7<PESVQ%1(+$9 C.;7R"?$XKRQTZGKH&:KGJZ
MYA_*=GXAQ]F[91E5A1EC@ODI5O@VNU+<# 5)6RV^MQQ;VYE#;([4E>NT=0^;
M[S[?,9Q. K(\0^Y>2+G=W\>A6.Z7!B%:G7HK7Q#MP1<G@E)@I9\87Y>]2_L@
M@JZT$;D?-1-LF.9NF_6FSS,UPZTL7]AO'[NFYV:Y6^1*3$*VY*&@XPXTXK8M
MIUO=[JAJE70)\KFE>(62!<>8;*_C-UO+TA=LM-ICSL@6W#9#93\4Y!C+2A[Q
M^)/N^@G0Z!K,W^82WVS&L8O.'1F73E\]^V6ZZY29&.V>&N(VMQ:YSLED.M[R
MV4,H\O[578?2&MO'/N=6.T8:9/'A?RO*+V_CR;2S<FOAGRW&4^S-A2_+*7(C
MHVK\Q:4E*=W0E/4:-@QSG?<-G7RS<VX_'L-PM=CE93 GV*4JXP)]O@*2B0TT
M7VXZTR6U.-CRU#1>[74#M#18U\RMV<R'&8>:6O'X=FS2:S:[0FQ9"Q>+I;IL
MI),=FXQD-H!\TC:7&%*2VKHKM!H,^W\X\E9%;O[P\1X\3>N)!*<BQE1IQ5DT
MZ*Q(5&<GQ8'DALMA25%#"W@XM*=W0*%!7',F:7J'C7.#&#-R[==X>1X[:;U<
MG[T^=T6Y(C(4J @-?Y*5>:AAQ"%'PJ4X%:I":"4N<AV?B+)KW][8].;NF*X1
M8D+MT"\2;E!6],N"H,2#&:DMI*EEY2$F8XK>H$[D]"2%DXCFG+9R>#8.1\%8
MML&\L/28-ZL$U=TB0G&$A9BW$N,L^6X4]$.HW(6KPB@M*B"@4"@4$>SJT9%?
M\0O%DQ.\_P O9#/CJCP;WY1?,53A 4XE 4@[@G=L.X:*T/=04C@^,6?"N?8^
M(<63;D_9;;8I#_*"9MPDW.,9\I;1MBG#(<<#<YS:^ZL)VZM== #1*RN?+K<[
M'PMGEXLTQZWW:#9)K\.;&6IIYEUMHE*T+204J!["*(51QG<+PWAUXR3CAK,K
MUGL>R0Y+=OY =NHM$YP[7G40U2B$><X$K2VM!T!4G=X-:)>MT^9C)9G&>5\P
MX=C;*\)LR+3#L;=V#\>;<;K+FQX\]O:--C<<O_#)5M.Y]"B%% H)0CD?E[#L
MHQEGE:RV%K$LTN2+);7; _*>FVNY2FUNQ69GG@(?2ORU-EUE*$I5UTT(U"%V
M7YDN0F>*IO,67V*QQL:D.JL^+V^++?:E3+M]Y.0 [)=?^QCQ1L)45%2P$*5V
M%(H,_$/F.OJ\G9Q/()&*YK<KO;KE.L?]W<UV6XF79XWQ2X<IF2I:D^>C41WP
M0E2DE)3Z ].*>>N0\W2_=)%LQV_VW[KF7&19,8FNIR"S3HK?F-V^XPYQ2XMQ
MU6K"7&6PD.I.HVE)(8&"<XYOR)9+O(O$+%KOCLFPW*9<[99)\AB[V*0RPI0@
MW:-)6A\ES53/G1T)"5I5W;5$/7 ^2,TN.+\>\=\.X]9K;>'<0@9/<7KY(G/V
MFVVV42Q&C-)0M<IYUQ:%$%QX;$)U)45#0,B[_,+GUML;-H&-6P<KPLSM^"WJ
MTKDO?=;B[I'7(CS8KX2'$LO(V+2'4;TC<%))TU":X#G_ ")_>//XKY1@V?[]
M%F1DMINN-JE"$[!,KX-UEYJ9JXAY#A204J*5)/<011"W:!0*!0*!04?SKQ]8
MKPX,URJP7[D.! BH@6O K,Z6V&I+BUN.3RA#S"E.%.UO?N5L3[J2>H);KY:Y
M,V7PAB#UQO0O\PQW@Y/\QQY: F4\$17%O)0M3D5&V,X5I!*FS1"%?-5B<!..
M1LWC3[O!OYNECLY<M]VGPF/@Y=R:9>26&'D-;E(<6G?LW>OI1,,O*;QG'&^6
MX3PKP\Q;W4Y!!N\]5RRV5<;BN*82VG"LN%]3KH/F*2&RKM(ZI2#09,7D#FG.
M[]E4GC.)CK6)8;=9./+8O@EFX7>XVT)$SRW&%I;BMA:O+:4I+A*AN4-O2@BM
MDYZY9S6V\21L8MU@A9#R1"R&5<7;BB8J) 59'D(06T-O!:_"2%()\2M/$E.M
M!LI7.7)U@QC/K;>;';KAR%@%SMMON5RMC4YZRIMMW9;E(NCL9H.2]D=A97)9
M9WJ&WPJT[ A/(/(>4YQPC=9=SNMAOD&)DF--V?*L3D+0Q-;?N+!<:?AK==>B
MOLG3>EQ?B"AH!I4"TFL_YCSS)LJ/%L7'XV(X9='L??3?Q+7-NMSA(0J6EI<=
M:41FD%P-MK4EPJ4-Q&GAJ4*P1R?S-R+<. LEL$ZU8_/RI[)VYMG=1.<MZI%N
M9EH*9*&I"2ZA#3(\L$]'O'[OAHE(8?)\_%[ER#$PW&+8C,+]R*WB-F6X[);B
MR)[\!N0N=<27'%;6FTK4I,=*=V@2$[B54&_G\L<H\=2[UC7);%DGWA>,7C)\
M1O=F:E1X<AZQL^;(ARHSSKBPI.]"PM#@"D=.BJ##LW+7-%MC<;9EG,/''L+Y
M&F6JUIMEG3,1<[<_?&/-BO%Y]U33J=>CR @%.HVJ5H20Z.H@H% H% H% H%!
MJ,HR>QX9CMRRK)9B(%BM$=<N=*<[$MMC70#M4I1T2A*?$I1"0"2*#FK ;ODE
MX^8#%LRRZXKBW',+!>Y$;$S)1\/:+9'?@I@12VE9W2UI<6_)4H:[U;$@!%$N
MA^1'Y$7C_*Y41U3$MBSW!QA]M10M#B(KA2I*AU!!&H-$.3N'W[C//$=QXT&:
MN9-*3;G^29][5=7,;?MCD$JFK*[BI3"W5/$&(8WI)[*)2VT_,=R5%XDF<S9=
M;L?:L,U]=FQ6V1%2VGGKF;FY #\QYU;B&HZ0VI2DI!5HDG=U"0&1@_S(9++R
MYG$I\W'>09-WMMRG6I6%(F1'(]PM<8RC"DHFJ='ER$@HCOA8.].BD=0:#TXT
M^8?,;VU<+]E#V.W*QVRS3[UD]CLXDV[(L<>MS/G*BRH=P=+D@'0L^:VVA/FZ
M]=NV@CV-?-AD3\W&KS>;KB-RL^23(<:5A]C,]R^VIBYJ2AE9D.?8R5L>8GXI
M"64#H=ATH)*[RYSO=+7R/F>.Q<6;Q3C>]WZW.6Z<B>9]SB6!16YHZV[Y;#A:
M!"%%*@ISM2E':0];=EO).4_,9CDK';K$BX/><%@Y"JQ3D2E[;?)G,EX[&WDM
M?&ZK*6WMNT-^$@]M$O%',7.F0<?7KG#$+9C9XZC1KC.LN/3_ (TWB3;K<74?
M%.R&UI:0XHLET,!L^#P[]W6@^<>RSEC*.?<1DP[O;H^-WCC^W9!<;(XW,5'^
M'DRV/BE--A_8)6]:DLNJ!"6O"H$]:#6\8\HY$_Q[QSA'%=@LMERK+5Y)-*91
MEN6:U6ZT75]EY\MEY4AUQY:D[$!W3>5$[4 "@VV4\^<D<?XKR#;<IMEGE<EX
M2BQS8#T+XA%HNMNOT]N$AP-N.>:RXVHK0XE3A 5HI.J:"7V7.>6,;Y-QS!>3
MV[!.A9M&N3]EEXZB6PY"DVEMM]UB0):UAUM3;GV;J A6X'<D BB%TT"@4'#&
M!WNXVNV6C-^3GN48]KCW=YN^92N]/,V!A_[T<:CI7!4_YRH826FW%AK9KJG0
MU"7<]2AS+<\,R/\ O[@\?HY-S-K'[GCT_)G$-W&,'&Y<>XL,H:;5\(0E@(>4
M-FA/0=:)7+RAR&WQOCL>Z-6UR]7RZW")8\>LC+J(ZIMUN*_+89+[FJ&D]%*6
MXOHE*2=#V40AB>7LXPB)D$OFC#V[1;++:';\SD./257*U/I96ELP5*?;CK;E
ME2T^6E0V.=2%)VT2CV-?,A>59/C=JSFUX_#M>8S$6RTG'\ACWNX6Z>^A2V(]
MQ8;0D'S=I1YT=2FT+T"O>!H(+Q/EV6SYGR]HGWZXRDWB\<@M7=+\IYP3&X7Q
MWPZ7]RCY@9V)\L*UV:#32A*[>5N4<JPO*L-PK#,99R7(,T;NWP:),T6]F.NU
M-,.^8ZLMN:M[75%0'BZ )ZFB$,R'YB\C1D5[LF(6K&Y+>)/)@7U=^R./97I]
MT;:0[(B6UIU"E:-;TH^(D[&U+.@]U1HEYW3YGWKP[B,7C>U6QU_*K%_,T5[*
M[F+(P^E,A49=KB+#;J79X<2K<G<$(2-VJ@K4!M;MS?R&_EV/8'B?'WF91D&-
M?S&_&O4X04VI:97PSJ9FQITJ;0K0 M J6HIT !) ?)^8N?9[1?K5E6)+:Y8L
M-TM>/MXG;YC;T:Y3\@256U<6:ZAM"67TH<6I3J06@A04"H:$AD)YGSO$[F]C
MG*V*0;5>IUHNEZQ:;9[@J=;IR[,Q\1(A.^8RTZR\ALI7N*"A:==IU3H26JQW
MGSD9Z#@N99A@L*T\>9[(MEM@R8ET,NYQ95Y $5]]E3#;9CNK4D#:YO0E04H:
MZIH,NW\^97>^0+M8+#B\"?8+#?5XW=[>BZI3E3:6GDM+NPMJF@#!U4"G1TK4
MCQ]FH :6_P#S1W%B?D5SQ>UV"9A>)RI,*<FYY!'MU\N2H!*)3EOB*0M)0VI*
MPWYRTE[;X=-10T=!XW?[=E6/6G*+.M3EIO<*/<H"UIV+5'F-)>;*DGL.U0U%
M$-G0*#F;GIZZY3R]C'&_\KRLTL;=@F7\XNQ<!:(4F:)C,5#UQD$_L8[>_P M
M 2K<ZX.E$IO\N4V ,3O.-QF+I;)N-WJ5;YV-7J6BXNV=PH;>3#C2T@%^(E+@
M5&<7JK8K:2=M!Y\RW.^W?-./N(K5=Y6/6[-%W67?+Q;7/(N/P-DCM/&+&>T)
M:4^MY.]Q'C2A)T[:(;'&.&#@.50+Q@N47:'BY2\W?\3NLN5>H<LK1]D\PY,?
M6Y&>0O0J4@J#B1M(';04MPMR%F</BKC+CG &H,C.,G<RB<Y=;ZIYV# MMLO4
MI+CKC;2DNO.+4ZAME"5@:ZE1"11*393SYR1Q_BO(-MRFV6>5R7A*+'-@/0OB
M$6BZVZ_3VX2' VXYYK+C:BM#B5.$!6BDZIH) KE#DOCK,[=9.8$V*;8<AMEY
MNL";C34MIZ"O'XZ9DAEY,M:@\A3*OLW$;%%8.Y(!%!$LAYF^82Q\32.=?NC%
MCB,R%'NENQQ?QRKE#M\];?PSS\E+B6WU!MU*WFD-M_HG4$$)UQFXXKYA.=&U
M.+4VC^4_+0I1*4ZVMTG:"=!KWZ40P9V=<WY3R;R!@O'(QB!;\'5:MDV_,SWW
M93ETMZ9?DJ3&=0$I"B=SHZA.@"5'4@(A=?FODS\9P!=H79L2OV86Z3=KI<LF
M+\BW6YB#(,)Q#3<8MKD.N/A7E#>D!"=RJ)9%E^9W(;GC4NU6^'9[_P B?S%;
M,1LEVMSDIK%YTB]QURF):E.H+[:&&FGOB64[U;T;4*.X$!)7N7.0>+KM+LO,
M\>TW-AZP7?);%=\9;?C!X8ZRF1.AO1Y3KI#@;<2IIT+"2.A&NM!'[_RG\QN(
M8-;^3+Y:\4?L-Y>M07:(OQPEVB/=Y+#3:GG5.[)*@'@TX&THT<4%)W(!%!LG
M>2>=\HR?DBVX(SBT2T<?3_A6579N:[(N!$1$GR5>4^A+7O=7NO:-$]":".L\
MB\E<A<I\0Y#AMSA6?'LKQ:;=7;!/3,>;!;<B_%AX,NMMNN)W;8KFT;?$5#Q:
M4'WCG*=WM:[YAW'6.6F)GN5\DY39K69"Y0MNVT 2)MSF@NK<6X6T]6F5-I4H
MC;MTT(;][FOD?CS++_CG+$*S3+=C^%3\T1=; F2RN>84MJ.AA+4EQP,J.\I4
M"I0*E)4% :B@B^'_ #09)*R7$F+Y=\3OT#+[A%M3^/8T)PN]F=N/1AQ;KZE-
M26VU;425)2WM)W)U2*#.3S-SU.Q+-.3+;!Q48G@=TO4679WQ.3/N,&QO*#RD
M/AU3;#@:2=FJ%[UCL (%!E\A_,#F=KRF+:\?<L&+6B7:(5XQZ5F;<MMG(7YC
M9=7#CS6G&HL53(VH7YZU*WJ20G9J:"ZOYDR__95'\ ^]OXG&_B__ ,L]WL__
M '7[/U40EU!4G$O&.;<88Q@F&MY%#E8[CD6XL9"P(:@[.>DO*>BK9<4LEH-%
M9WCKN_$&QY#XTO%]R&U<A8'>F\=Y%LL=VWMRY4<S;?/MCZTNKA364K;66_,2
MEQ"VUA2%:D:T&I@<49EE7W])YFRI-W9OMID6!.+X^AZW6*)%F)*7GDH>=><>
ME$>X^Z?L^H2*)0N]\%\V9/B5OX\OW(%J<Q"P2+<[;GH]K>;N-S8MDEIUINY+
M5(4V-B6QIY"!O6$J4>AU"R<0XPFXU=^3;D]<6I",]N)N$5M#:DF*DPT1=JR3
MXCJG7I00:R<"9M@=NPF\X!D5M1G^+8__ "G<S=HK[UHNEL\_XE"5)9=0\TME
MTE;:T*/:4D;2:#-R#@/(\LQ."K*LJ8OO)5LO#V10+E=+:S,L;*Y+(CN6M-O=
M*O\ ("T-@U<+J5_:A05X:#22_EMR.^8)G-FNMPQZS7[,(3%MBP<8LZ+;9+>S
M'?0\5:#60^XZ4:K6XYH.@2G0"@Z/9;+3+;1.I0E*2?3H-*(0/E7#<KR^V0D8
MI=8,9^&ZM4VQWZ$FY6*[1W  6)K/18"2 XVMM6J5#L.O0.<<JXFOG'J^(<4A
MY"Q;<AN^>7&]L2K5!TM5JD2X#K@AP83SITA)*=I;4X"H*4?"3H"5ML\(9)G,
MZ^WOG"]PKI.NECE8K;K7CD=V%;X$">I*Y#[9E+?<5)<4VV=RCM1MTT4#T#68
M/P!E-DR2PS+],Q5JT8NX'H\[',=CVV]7=;:=K1N#ZO,0T$^\M,4#>KO'2@]K
M9PKRMC%I/&F&YW%LG$WQ3LB',8AN?S5;X4B0J2Y!C22Z8Y3N4I*'W&BM"5=A
MVIH/W+/EZNV1Q.3X[-[C1U9_>['>8I4PLB*W95Q5+0O17B4Y\.="-.VAJV6>
M< _S_EN87J?>E0;;DU@MEGB"*V?BH<^SSS<(\L*4=J@ET(.SIN (U&M!N\1Q
M3F-S)H-]Y)S" _;K,P['AV7&HKT*-/>?3L,JXF0XZ5*2GJAIK:A*O%KTT(6C
M1!0*!0*#2Y=:;U?<:N5GQZ]KQR\S&2S%O;3")3D52B-5H:<*4E6W4#4]-=>Z
M@J7CO@[D+CBVR+)9^2V_NA]F<I8&/1!,=NLUE247&3*6^XN0^API=7YNOF;0
M@Z)["5@Y9@LS,^+KEQW>[TIVX7>T&TW#($QFT+<?<9#3DGX="DH25JU7Y:5
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M4-- M8\ [R*"C9O]X!X%L7 HXVR4Y7CTNSQKQ<TQ JS_  ULNK+ZI,66%Z2
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MVT/,K2XRXD+;<00I*DJ&H((Z$$50S&CT#[J H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H/PD)!4H@ =I/04-7XA:'!N0H*3Z4G4?@
MJ9B81$Q/)]5"2@4"@4'RAQMS78H*T[=I!_%4S$PB)B>3ZJ$E H% H% H% H%
M H,>?.BVR#(N,UP-1(K:WGW#^2AL%1/U"L;6BL3,\H'/-UO$W)+HY?KCJEUP
M%,&,KLBQ5'5+8'YZAU<5WGIV 5Y+-FMEMU3ZO1'VYMK!DRHT)DORW4LLCIN6
M>T^@#M)]0K3,Q'&1IU9;:@=$HD*3^<&]!] *@:U?-JG1L8%VM]RU$1[<ZD:J
M96"AP#T[3W>L5G6T6Y(2[!,B<QJ_-1UJTLEX>2S+;)\+4MSPM/I'8-YT0YZ?
M"KNJQV6><=]/[;?CW_JB87K7IFLH% H% H% H% H% H% H% H% H% H% H%
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M.YR7$8></Z;C:5*_":]GBMU4BW?$-<\VRK:@H% H% H% H% H% H% H% H%
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MW>/-EVJ=%MLCX2XOQWFHDO37RGEH*4.:=^U1!K*LQ$Q,\D6B9C@Y^'$GS)@
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ML'4Z&^4?(I@N&1X@M97;DH3<HR">C;@6&7-O],*1K_1JZ\KR3U33LTU?*O\
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M6QM*!0*!0*!0*!0*!04C\Q7-;_%=DAQL;D07LMN#Q084D*=<9AEIS60$(4D
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M2SJ/SR=RA]&M>ZVM>G%'IG5\(WM^K-/^F-&M';70Y$OPK^#*/ID.G\-5._\
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M0*!0*!0*!0*!0*!0*!05/R7?F+E.9QZ*UJNUOHDRYIZ!+A;.C#8[RI*_M#V
M=.WLX<]XF=.YZ_R3:6K'SIGA:)B(_/\ 1#.O30Z>GUUS/3OP*U44Z$;=.I'0
MZ^@T'RXXTV6RXH)*E!#>O>M78![:A,1JRK=/EV6Z1[Q;0V9L?>%-.>%#S3H
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M5"\\M^EZY2*J]9E H% H% H% H% H**Y0/Q>9/LR@'F8L6.([;@W)1YA4I1
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M4A0;.A]0436C/;II+FW-^G',JEX4N&'8]]XWF_7&+!N2RF)":>7HXB.D!2U
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M>+OQ9,>2-:3$^"25H;B@4"@4"@4"@4"@4"@4"@4"@4"@4'X2$@J40$@:DGH
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M0AMM "4I2D:  #H !6U8/J@4"@4"@4"@A'+[3CW'-\#>I*&VG% =Z6WD*5^
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M&L,^BVFNDMB=P*0D#9UW'7J!ITTK)@U]W0F8VFTA*BY*T65CHEMMI:5*43^
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M0*!05ARC;>>IUPMZ^(+UCUKMJ&5BYMW^/(?=6^5#86RRE0"0GMU[Z"!_R_\
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M),QEQGBZ?;;=EA>:+4F]-N/0PP%?:@I:"E;B/=Z4%0?R_P#.Q_M=@G^A3O\
M%T2?R_\ .Q_M=@G^A3O\70<[\F6SYA)7/&&VZUWS&;CSE#"GG)6+1I,=R':E
M!'6\.NI#:HY2?"VM*E[5=GC0%!_0Z,) C,B6I"I80D/J;!""YH-Q2#U U[*(
M>M H(?R>6AATQ+CY:6M;(9:&I^(<\P%+! ZD+TT/JZ]E<^?X%OY1K_)KI&OY
M>GU*A?4&VU.E>QMK5QP@!6J$ DCZ17 ]_"NKC.7=I:YCPT0O0,LJ.H0V.P:=
MFO>?77-:VLK/'CZ(T[6.0"-#U!Z$=VE8MR8XK.5)BJB.+4IZ( A"2=06E$E)
M].H]WZJZ*3K"MSTZ;>B6P;>;>NRU,GS&V8Y:?<'N)<\S<$[NPG374=U9=K5I
MP];.W>+;H=--=WY/L]M2Q1_+)GDQD0T*4'9B2EP D)#*2"KIZ5'1/LUK7>=(
M;\%>JWHA$*TK%^H4MMU#[1V/M*"VW.\*2=1_[Z1P1:-8TE85KFBY1$3P"@NC
M:MC75"%MDA6WVFNF)UXJJU>F=.YXR6[>N5-^+C^=='&$,VE*04JTZE3F\::;
M%GQ%78---=:<&NW7K&DZ1VOD6V>]UG3?"HZOH8*PA;8 ^ST4= .G50&XU&DM
MFL:\'NU##!=2SO<@N()BL,O_  X8>5^7N"5E;??Y8*?;UJ6K)%YTTG2>W6-=
M8_*?2L+C/(,=L,%FPSPN->9#J@]<WT?9S'"LAK<^"?'L( 2O;UZ"NO!>M8TG
MF\OYQL\^2\Y(XTCE'[8[>'BLR)=+9/>D1X,QF2_%5LDMLN)6IM1[E!).GTUU
MQ:)Y2\S?%>D1-HF(GEZ676344"@4"@K[FV<N!QC?E-**7)#;<4*'0Z/NH0KZ
MTDUC;DTYITI*J>!,GPK$;7>)>0W:/!NDZ0AMMIW=Y@CL(U21HD]"I:OJK"LQ
M#GP6K6)UE;QYCXQ'_F2+]3G_ !*SZH=/SJ=ZNLUA\-9'YDZT7^+9[TK51<:;
M<,9U7_.-! '7\Y.A]M5^6,5N,3I*MS1@OQBT1*$X9GEXX_N2FHSR;A8_,(E0
MFEE3#@[W8Y4!M5IU[!KV$5SX\LXY[X<F'/;#/#C'VY.I[/=H%]MD6\6QT/09
MC8=9<'3H>T$=Q!Z$=QJXK:+1K#T%+1:(F.4LVLF10?#K@9:6ZI*E!M)64H25
M*(2-= D=2?0!0<O##,Y^9K-!=^4+/.Q3@W&Y.^QX3<$JBS[U,:[)5P;UU2T/
MR6SW=!^4HDNH(\=B*PU%BM(8C,(2TRRTD(;0V@;4I2E.@  &@ HAZ4"@AW*]
MQ>M?'.23(YVO"&MI*O1YY#1_ NL;<FK+.E)4I\O-UQ/'!?+I?KE%M\YXL1(@
MDNI;66$ K7M![BHC^K6%9AR[>:QK,KO5R=QWH0K);?H>A'GH/^[6?5#K^97O
MA6N:X_Q)D =G6/(;?9[RK51\MQ/PCJO^<;3[I/YR/J-<&6F*W&)B)5N;'AOQ
MBT1*$85R!>>/;BJ$71/L <*9<)IP/-::]78RQT![]!T5[:Y\66<<Z=CDPY[8
M9TYQ]N3J.V7*%>+?&NEN>2_!EMI=8=3V%*OQ$=A'=5O6T6C6%_6T6C6.3+K)
MD4"@AO)\SD>)B<E/%=LAW',))#$1RY/B/$BA8.LA8()<V=S8[3V] 00C'"7"
M,#BJ%.O-WFJR/D[(U"1EF62=5/27E'<6F=W5#"#[J1INT!/8E*0MF@4"@4"@
MI')<4^9:7D%SD8UFMEAXZ](<5;84B*E;K48GP(63$7J0.WQ&K3'EVL5CJI,S
M]O2K\F/<3;W;1$?;T*!Y ^63E*TQ+KR ]/M$B9 3]X/QK&AR([JSXUNLMH8:
M0E20/,\&G9TZU=;?S+#;3'I.D\./_EY[=^59M9RQ,:QQX?\ AT!\M7+C_)V'
MN0KVZ',KL!;8N#IT!DL. ^3(T_.5M4E?Z0U_*TJF\QVGR,FM?AMR7?EF\_D8
M^/Q5YKLJJ6Q0*!0:+,LD7B.-7#(&K1/OS\-O<Q:+0PJ5.DN$Z)0VVGTD]2>B
M1U-!1W%?$V6YSEK?._/L=)R?JK"L'6?,AX[$4=4+6A714M0 )44ZH/4^/:EH
M.CJ!0*!0*!0:^9>K;!66G7MT@?X!H%QS^JG4CZ:WTP7OQB.#1DSTIPF>/<UZ
M\E=)^PMZRC\YYQ#1_JC<:WQM8[;.:=YW5>8R*X DJ@MJ'<$OZ'\*-*R_C5_=
M]S'^7;]OW_T0N4U.BWMZ1#8+<.>Z9(<?<2TEB2KJI/FIW#:3U23IZ*TVVUHY
M>]X?HWUW5)^+W?'E[4^QNT.VN(XJ4XAV7*7YKI:U+8&FB4I)ZGIWGM-<KK;J
M@4"@4"@4"@4"@4"@4"@I?FS%>7.2I4+CO%9+.,<<7%.N896U("KJ]%.H7"AL
M!/@W@;5N*5U"M/="DK"R,)PC&..\:@XCA]O;MMBMZ-C##8ZJ5^4XXH]5N+/5
M:U=2:"04"@4'ROW%>PU,(GDJF+^P3[5?C->HMS>.IR>U8LR@\W?\'^];_7%3
M';X2QGL\8_%(<S6I5R@,D_9H:<<"?TM0-?JJOV,>Y:?2L_,9_P"2L>B6BKO5
MQ0.WH>P]#4"9X:XM=C;2HZAIQQM'J2E1T%4^^C3+/J7OETS.&/1,M_7"LB@4
M"@4% \D<8\D<V9JG&LN>;Q[@6U+0_(M\"45W'(GD*"DHD%L)\B.DCW-2KIK[
MQ26R5YVRV6ZRVZ+:+1%:@VN$TB/#AQT!MEIIL;4H0E(   '91#+H% H%!1/)
M/^N\W^S1?Q+HF$7':*A*0S?_ $XQO_Q.5^-^I0CM0E/N(O\ 6"Z_V-C_ +1=
M2B5PT04"@4$%Y7D<HHQA<+B.#"?RN>KX9%RN;X9C6YM8ZR2V4++RD_D(TTUZ
MG<!M4&JX6X4L?#]GE%,IV^9K>W/B\IRR=JN;<)2B5$E2BHI;22=B-Q])U42:
M"SZ!0*#09CCJ\FLJH+#J6)K3B),1Q8);\YK70+ Z[5 E)T[-=:U9:=<:+#8;
MO^-EB^FL<I\)46KRY<=0?!:2L+96-PZ*.K2T]P.A'3TU6/HT3KQCQ_-7DJ([
M DNPGB"XP=A4.Q0TU2H>T5SS&DZ+6E^JNKRJ&:1X=JXY.2D'RM&E%Y!T\22?
M!J/2.IK;C<6YYPWL4.P7(T%;B783J5HC*V;%)4CQ!*NNBBI.O<-2*V0YIXZS
MVLY*E)0%.[4J';MZITUZ=M&**9A]FN T0?+T>6'EG4E2B/!J?0.NE:\CKVW&
M91RM3M-%$A*!N6HA*4^E2CH!]9HB9TC58=JMXMT-F&%!V0UKYI2=!O=.Y1T]
M'HUKIB-."JM;JF9[WS&67W3=WG U%#:FF$$@#R]_5Q:CV$E/0=PIZ2>'!]O7
M2WQT%V1+82PK0-D+"RKT]$ZZ_136$169Y0R&'67VFW8JT+C*&J%(ZI([!IIV
M:41/I?JT;@X'/M&5@)\DI!'K]NM!+^*V(+>23U*<3'E-0T,PHJ0$^:PM86XY
MZ]BDI3IW:Z_E5T[?3J]3SGGUK_*K&GNZZS/=/9'L^W!;]=[QA0*!0*"$\O6A
MV]\<W^''3OD-Q_BFD^N*M+QT]H016-N35EC6DJ/X&L&"Y<;K:,EMC,Z[,[)<
M)QQ3B5*BJ 0L#:H#PJT_K5A6(ER8*UMK$PNP<-<8CLQN-_6=/_#K/IAU_)IW
M,L<6<>C_ ,OQ?J4?^%6KY&/N:_XV+]L-!FW$^+OXQ<%8_:V8-XCMF1$=9!!4
MID;BV>W4+ *:UY=O7IG2.+5FVM)I/3&DHQ\O-_<6+KC3BB64)3<8@/Y 6=CH
M^D[5?76G9WYU<^PR<Z^M>M6*V*!0*!0*!013DRT.WS ,AMC'[=V$XMH=NJV?
MM4@>THTK&W)KR1K68<]<$8]@V7S+K:,IMR)MQ2VU+MQ<6XW]@-4.I'EK3J0H
MI/TUKK$2XL%:VUB87A_<CQ8/_+C/_72/\;6SIAU_)IW,L<1<<#_^ 8_KO?\
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M5%2DA*2&R-W73T5U;;;6SVZ:N3=;JFWIU7^W#7\G-7RB6"YY+GF4<HW1L^4
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M.Y]Y45H^[%C*T('Z;G:3Z=N@JQKCI3E&L]\_HJKYKWYSI'='ZL=N.PRHK;0
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M4>CF^2_Y1_@NS\LR5OAB9Q9->$SK-9_;KVQVQKQYK_P?Y;N../\ )H>68_\
M>'WK!#J6/B)(<:T?:4RK<D(3KX5G3KVUV9O,,N6DUMII+R&'R_#BM%JQI*WJ
MKEB4"@4"@4'X0>FAT]/KH(?;.1[)+Q6XYK/!MV,PI4AB//</FIDL,/>0E]"6
MP5;7'-4H3IK]==U]G>,D8HXVF(X=W;IZE5C\SQ6P6SV]W'69CJ[XB=-8T[YY
M=J6^<UO0V5@.N J0V3HL@::D ]>FHUKBT6FL(;>"NWWN074GX>=L=95^<I*
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MI\I<"+')0?><+24C_ID?[NE<VXMI73OF/Q8VG28\70U>N8E H% H% H% H%
MH% H% H% H% H(AGW^:P?WROU#5KY=\5O!2^:_#7Q_)DX-_!W/[0O]5-:_,/
MJ1X-OEGTI\92:JY:E H% H% H% H% H% H% H% H*[O7\9G_ +Q/ZB:]!M_I
MU>8W/UK>/Y,&M[G;:+/D0<=6F*LMO2)JVO-':E.T*)'KZ:5R7QQ?-QY15VTR
MVI@]WA,VT:HN/$ZE]TD]I+J]?QUU:1W1[''U6[Y]LI#BMRE?&FWO.J>8<;4X
MWYA*E(4@C4 GKH0>RJ_>8J]/5$:2LMCFMU]$SK&B854KPH% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H%!RSSO:[%C>3)=LSZ?O"ZI5)G6Q(U$=1
M.GG:CH Z=?!Z03V&N#)MXFVO8I]S@KUZQV\X5_AMBL=YO##64W-5GLBSJN4A
M!6IPZCP;M"&PK_E% @5E.6D3I,L:WIU:6G1V5BN-XUC5K;B8O%9CP' E?FLD
M++W3HM;FI*R=>TFNR-.Q;TK$1P;RI9E H% H% H% H%!S+\P-OL-BO[$ZV/A
M-\NJ2].MR4ZI2$^$221V%1&W;^41KZ:X<N")MK[53NL%>O7OYPK'$K/9+I=X
MZ<KGNVNQ+5J])9;WN*.ONZ]=B3UU7M.GHI.6E9TEJB](MI:=(=E8C8,6Q^T-
M,8E'CM6QT!8?CD.>?ITWJ=U)6>WJ379733@N*16(]WDWU9,R@4"@4"@4"@4"
M@4"@YDY=Y3QZ^S;M@^5<5WC((=LDNQX]R8;4"%I\/G1G4ME2->T:*Z]^HJ\V
MNVM6(O7)%=5/N\])UI?':T>#FFUWC+^*LJ<R_!H%ZM%E96D%-YCK2AV.I0^P
MEJ0E#:TD] KPG70C:JK^U,>XIT7FLV]'Y/+Q?)M,DWQUM%/]4._^,.1K-RCB
M,3*+1]DI9+%PA*.Y<:6V 7&E$=O:%)5WI(/3LKQNYV]L%YK+V^VW%,](O5,J
MYG24"@4"@4"@T&;6-W),5NEFCG25(9)BDZ >>T0ZUJ3V#>E.M<VZQ?-Q6IWP
MF%-6J[)E1FW'4EO=JE:5#1;3J#M<:6.T%"@4FO*XLVG"S32_3[MFV!"AN20I
M)[QU%=L3KR=,3J5(4"@\WGFV$ZN'KW)'::UWR12.+&UHKS8!G25J\&B1W) U
MKAG<7GDY9RV?:9SZ1]HV%#TZ%-9QN;1SAE&:7V;DC3HT=?61I6?\F.YE\[T/
M&!!?R?)+;8T)\P%YJ;<AIX&8,98<\7H+BTI0CT]3W4V]+9\T:\HXSX0BDS:W
M5/8Z!KV+:4"@4"@4"@4"@4"@4"@4"@4"@4"@B&??YK!_?*_4-6OEWQ6\%+YK
M\-?'\F3@W\'<_M"_U4UK\P^I'@V^6?2GQE)JKEJ4"@4"@4"@4"@4"@4"@4"@
M4"@KN]?QF?\ O$_J)KT&W^G5YC<_6MX_DP:WN=F'^!,_^(.?]G6B/JS_ +8_
M%OGZ,?[Y_!AUO:&VQC^.-?N7?^#7)N_I3XP[=E]:/"4\JC>B*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#&N,YBV6^7<I)(CPV7)#Q';L:25J_
M *(F=''F+XY>N:<RNLIZ8(CSZ53Y<IQ)=#:%*"&64IU'8/".O0)K3$:RK:5G
M+:5HJ^7>X>23_,:'903T+D8A*E@=-Q#A('T5RVVDS,SJQML)F9GJ^Y%&IO(_
M#TY,=T*9MRUG:P[J_;'^S78H>XH^K:KU5SQ.3#/VT<L3EV\Z=GW?T77@G*=B
MS4B"0;??DIW+M[R@=X':IE?0+ [Q[P]%=^+/6_#E*TP;FN3ARGN3NNEUE H%
M H% H%!Y29#42,]+D*VL,(4ZZKT(0"HGZA0<>8_9;GS;R!<WWY9AHE)<G2)6
MWSO(C((;8:2@J3KT*4]OI-:8C6596)RVE:I^731G3^9G'9 3H%N1$Z*4!TW:
M.DZ5S6VFLS.J+;'69GJ0QV+R-P[.\UM1:MJU_M6]7[9(Z]BTG38H^O:KUUS:
M9,,_;1R3&7;SZ/N_HN3 ^6;+F*DVV4C[LO\ ITB.*W-O:#J65]-?Z)\7MKNQ
M;B+\.4K/!NJY.'*5A5U.PH% H% H% H% H%!CSYT6UP)5SG.>5"A,N29+I!.
MQIE)6M6@!)T )Z5E6LVG2.U$S$1K*E[[\POR^Y/9)]@N^1)?MESCKC26U0YG
M5MU.TD:L'10UU2>X]:LJ;'<TM%HKQCTQ^JNOO=O:)K,\_1/Z*2^3G(3:N1+_
M (>S),FTW.(X_'< (0X] = 0X$JZC<TM9/T:U;^;X^K%6_;'YJ+R7+TYKXXX
MQ^D]WKEV[7E'KR@4"@4"@4"@KC,^.I$R8]D&*EMNY/\ CN%L>.R/+6D:!Q*P
M#Y3V@V[M-JNF[TU3[SR_YD]=.%OQ_JQM6+*U>FJM<CX2[-O6:=_R$Y/D;M#I
MJASJVL:]A2LZUYVU;XITM$UEHFEJL]$R44A25^8@]BM H'Z1649[]Y&6W>^O
MCI/H3_5K+^1?T,OG6?#LR0$%;B_*;[U=$#ZS6%LUY[6,Y+3VL&+(<NLDP[%'
M=O,\Z:M0AO0G7H"X^?LD)U[2I7T5&/'?+.E8ZOMWD4M*PK#Q,T^VF7FCYF/*
M&HM$5:VH37J6I)2MY0_.5HGT)J_V_E=8C7)[T]W9_5OK6*MR_P 38*XG2-;E
M6][\E^$^\PX/ZJ]#](-=5O+MO/\ ;IX,IX\V#_<]9?=^^KQL]'Q#.O\ 6\G=
M^&M'_J<7?;V_T8]->Y+<>QBR8O%7%LL4,!Y07)>4I3C[S@&F]UQ9*E'VGIW5
M8X<%,4:5C1DV];PH% H% H% H% H% H% H% H% H%!$,^_S6#^^5^H:M?+OB
MMX*7S7X:^/Y,G!OX.Y_:%_JIK7YA]2/!M\L^E/C*357+4H% H% H% H% H%
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M&A,IC0V6X\='1#+20VA/L2D "NV(B(TA#UJ0H% H% H% H% H% H% H% H%
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MLMI7;8^F.?:LRN%WE H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MGF\%YEYC_)F*UC2M?;*8UT*8H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H'37U]U!7,_$L0F9!<)\R_(;:>65/VUJ0TR6Y6T)6I
M2PK?W:[#W]:Y)QTFTSJ])AWN[K@K2F.>'*W3,\/P];YCX?QS#6MV?>4SF3T0
MU,GM!M!/9^S+>I]:B:1CQQSG[V=]]YA>-*TFO^VD_P!7LY8.)'6_)$BWHV'S
M'%-SP'"@=5!:O-W%!'O G32IZ,7H]K3&X\RB==+_ /X_T6 C9L3Y>FS0;=.S
J3NTKJ>>?5 H% H% H% H% H% H% H% H% H% H% H% H% H% H% H/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>bc_bestranked-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_bestranked-4c.jpg
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M%!04%!04%!04_\  $0@";0/H P$1  (1 0,1 ?_$ +0  0$  @,! 0$
M       (!@<!! 4# @D! 0$! 0$! 0             " 00%!@,0  $# @,"
M!PP'!@0$! 0'   ! @,$!1$&!Q(((=(3DQ655C&1T2(45-15%A=7&$%RM'6U
M-SA183+BE"9"(W.S<8%B"5(S)#2A@E,VP9)T1:5V.1$!  $"! 4$  <! 0$
M      %1 B$Q$Q0101(#!*%2!17PL<%"<H(S<6&!_]H # ,!  (1 Q$ /P"_
M@                 !&^1-&---6=<]=9M0;$EYEM5ZM\= Y]35T_),GII%>
MB)3S1(N*L;W<2^/"!M7Y.=V[L/'UC=/2S.J6'R<[MW8>/K&Z>ECJD/DYW;NP
M\?6-T]+'5(?)SNW=AX^L;IZ6.J0^3G=N[#Q]8W3TL=4A\G.[=V'CZQNGI8ZI
M#Y.=V[L/'UC=/2QU2'R<[MW8>/K&Z>ECJD/DYW;NP\?6-T]+'5(?)SNW=AX^
ML;IZ6.J0^3G=N[#Q]8W3TL=4A\G.[=V'CZQNGI8ZI#Y.=V[L/'UC=/2QU2'R
M<[MW8>/K&Z>ECJD/DYW;NP\?6-T]+'5(?)SNW=AX^L;IZ6.J0^3G=N[#Q]8W
M3TL=4A\G.[=V'CZQNGI8ZI#Y.=V[L/'UC=/2QU2'R<[MW8>/K&Z>ECJD/DYW
M;NP\?6-T]+'5(?)SNW=AX^L;IZ6.J0^3G=N[#Q]8W3TL=4A\G.[=V'CZQNGI
M8ZI#Y.=V[L/'UC=/2QU2'R<[MW8>/K&Z>ECJD/DYW;NP\?6-T]+'5(?)SNW=
MAX^L;IZ6.J0^3G=N[#Q]8W3TL=4A\G.[=V'CZQNGI8ZI#Y.=V[L/'UC=/2QU
M2'R<[MW8>/K&Z>ECJD/DYW;NP\?6-T]+'5(?)SNW=AX^L;IZ6.J0^3G=N[#Q
M]8W3TL=4A\G.[=V'CZQNGI8ZI#Y.=V[L/'UC=/2QU2'R<[MW8>/K&Z>ECJD/
MDYW;NP\?6-T]+'5(?)SNW=AX^L;IZ6.J0^3G=N[#Q]8W3TL=4A\G.[=V'CZQ
MNGI8ZI#Y.=V[L/'UC=/2QU2'R<[MW8>/K&Z>ECJD/DYW;NP\?6-T]+'5(?)S
MNW=AX^L;IZ6.J0^3G=N[#Q]8W3TL=4A\G.[=V'CZQNGI8ZI#Y.=V[L/'UC=/
M2QU2'R<[MW8>/K&Z>ECJD/DYW;NP\?6-T]+'5(?)SNW=AX^L;IZ6.J0^3G=N
M[#Q]8W3TL=4A\G.[=V'CZQNGI8ZI#Y.=V[L/'UC=/2QU2'R<[MW8>/K&Z>EC
MJD/DYW;NP\?6-T]+'5(?)SNW=AX^L;IZ6.J0^3G=N[#Q]8W3TL=4A\G.[=V'
MCZQNGI8ZI#Y.=V[L/'UC=/2QU2'R<[MW8>/K&Z>ECJD/DYW;NP\?6-T]+'5(
M?)SNW=AX^L;IZ6.J0^3G=N[#Q]8W3TL=4A\G.[=V'CZQNGI8ZI#Y.=V[L/'U
MC=/2QU2'R<[MW8>/K&Z>ECJD/DYW;NP\?6-T]+'5(?)SNW=AX^L;IZ6.J0^3
MG=N[#Q]8W3TL=4A\G.[=V'CZQNGI8ZI#Y.=V[L/'UC=/2QU2'R<[MW8>/K&Z
M>ECJD/DYW;NP\?6-T]+'5(?)SNW=AX^L;IZ6.J0^3G=N[#Q]8W3TL=4A\G.[
M=V'CZQNGI8ZI#Y.=V[L/'UC=/2QU2'R<[MW8>/K&Z>ECJD/DYW;NP\?6-T]+
M'5(?)SNW=AX^L;IZ6.J0^3G=N[#Q]8W3TL=4A\G.[=V'CZQNGI8ZI#Y.=V[L
M/'UC=/2QU2'R<[MW8>/K&Z>ECJD/DYW;NP\?6-T]+'5(?)SNW=AX^L;IZ6.J
M0^3G=N[#Q]8W3TL=4A\G.[=V'CZQNGI8ZI#Y.=V[L/'UC=/2QU2'R<[MW8>/
MK&Z>ECJD/DYW;NP\?6-T]+'5(?)SNW=AX^L;IZ6.J0^3G=N[#Q]8W3TL=4A\
MG.[=V'CZQNGI8ZI#Y.=V[L/'UC=/2QU2'R<[MW8>/K&Z>ECJD/DYW;NP\?6-
MT]+'5(?)SNW=AX^L;IZ6.J0^3G=N[#Q]8W3TL=4A\G.[=V'CZQNGI8ZI#Y.=
MV[L/'UC=/2QU2'R<[MW8>/K&Z>ECJD/DYW;NP\?6-T]+'5(?)SNW=AX^L;IZ
M6.J1B>[ME#+N0=?M><GY2HNCLN6UN4_(:%)99FQ^46V:>3!TSWO7:D>YW"[Z
M?V&SE#5/D                   )SW?_P [MX;[]M7V68J<A1A(
M
M                                                      $^:3_J
MCWA_J9-_"'E3E H,D                  !.>[_ /G=O#??MJ^RS%3D*,)
M
M
M  GS2?\ 5'O#_4R;^$/*G*!09(                  "<]W_P#.[>&^_;5]
MEF*G(482
M
M          !/FD_ZH]X?ZF3?PAY4Y0*#)                   3GN__G=O
M#??MJ^RS%3D*,)
M
M                 GS2?]4>\/\ 4R;^$/*G*!09(                  "
M<]W_ /.[>&^_;5]EF*G(482
M
M                         !/FD_ZH]X?ZF3?PAY4Y0*#)
M       3GN__ )W;PWW[:OLLQ4Y"C"0
M
M                                 )\TG_5'O#_4R;^$/*G*!09(
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M=F]8TO/Q\8!TW9O6-+S\?& =-V;UC2\_'Q@'3=F]8TO/Q\8!TW9O6-+S\?&
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M3[#;(;>^JFN*5"PH[QTCI<6X[2KW,5.3R+(MX<';XO<NNF>*@#D=X
M     $^:3_JCWA_J9-_"'E3E H,D                  !*.D7YY[PGWS:/
ML]0=_C/.\SDW:=KS0
M
M   !C%U_,K3O_7N?V1#B\KD]#P\Y;H.!Z8            $^:3_JCWA_J9-_
M"'E3E H,D                  !*.D7YY[PGWS:/L]0=_C/.\SDW:=KS0
M
M                                            !C%U_,K3O_7N?V1#
MB\KD]#P\Y;H.!Z8            $^:3_ *H]X?ZF3?PAY4Y0*#)
M          2CI%^>>\)]\VC[/4'?XSSO,Y-VG:\T
M
M                           8Q=?S*T[_ ->Y_9$.+RN3T/#SEN@X'I@
M           3YI/^J/>'^IDW\(>5.4"@R0                  $HZ1?GGO
M"??-H^SU!W^,\[S.3=IVO-
M
M         &,77\RM._\ 7N?V1#B\KD]#P\Y;H.!Z8            $^:3_JC
MWA_J9-_"'E3E H,D                  !*.D7YY[PGWS:/L]0=_C/.\SDW
M:=KS0
M                                                   !C%U_,K3O
M_7N?V1#B\KD]#P\Y;H.!Z8            $^:3_JCWA_J9-_"'E3E H,D
M               !*.D7YY[PGWS:/L]0=_C/.\SDW:=KS0
M
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M[3KOD&/.%OI5MU?!.Z@O-K<_E?)ZR)K7KL/P:KHWM>US'8)^SNHI,QP&U3
ME'2+\\]X3[YM'V>H._QGG>9R;M.UYH
M
M                 QBZ_F5IW_KW/[(AQ>5R>AX><MT' ]-,F]UJ]G[)#<D:
M>Z8/919RU#KWVZFN\K6KY,Q)(*=&QJ]KFM?))4L3E,%V&HN";2M<E6P-7:FY
M$WEMWS)WO;MVM%=FQ;)) Z_V2ZMF?1K'4S,@PB9433MD;MR(U4V8W;/C-5%1
M$-B8EBP]-LVLS]D++>=F4ZTB7^VTMP=2KBO)25$:/>Q%7NHURJB+]*<),M:M
MUCTNUVSKFJFNNF.IOL9E^*ACII[5R;W\I5MEE>^?%J*GC-<QO_RFQ(F;66CW
MHM(JG*UE=K/4Y@S5G&O2W6:R4,;HYGXJUBRN<]JHC4DDC8G[=K@_A4J. _H+
M9J>MI+91TEQJ/++A!3PQ5=7AARL[(T;))A_U.15/S'?     "?-)_P!4>\/]
M3)OX0\J<H%!DC^8VZ=J/K;DK)^8*/3#3/VTM55=W2UERY9T7)5*4\3>1P141
M<&[+\?\ J/UNC$43H%HUJG7:Q7W>)UM@IK/F>Z4ZTEIRY1O9(L$;HHX4?(L;
MY&M1D,:1L8KW/<JN<_95.&)D:%T&J;I2;ON\O/9E<E:U'(KH_P")L#XZEL[D
MP[F$2O7'Z.Z5.8IW<8I++3;N.79;3L>55=3<9[PYO\2UJ5<D7C_O2%D*)_TX
M$W9C*MZREM=7N]9_9>&L6ECM;YH5DPP2KBD8^F5%_P#%RJ,P,C,1?GJHNE3_
M -O;3YUTVE6/,;HJ-S_XEI8Y;FV/_DF"M;_THA?,;#O\%?NMZ@Y4UVL<"KI1
MJ!14%%G^UTC,(Z6MEIV2+4,C:B(BN7:J(\/\7*LQ:DC3,QZ>BL\-5OYZHUE+
M*R>DJ[%)54M1$Y)(Y8*A;5+%(QS55%:]CFN:J?0ILY,YM:Z67/7BV:\:Y/T,
ML=GO=9)?ZQMY9>I$CY*-+G6+"L6-338XKM[7\7T=PV> KBV7#5VY:$9[GUJM
M-NLV;DM]Y9!2VAZ24[J%*!5C>N$TZ(]7K(BIM]Q$(PXX-29NL7[>LMVEBTVC
M.5\OW?*/2=6]U9=9495>5JR))&*BUM/XJ(C=GQ/I[I4\!O#>UGS74[HD\^>J
M6GHLXR.L[KW1T2[5-%5K5Q\HV-4?)XJ+_P!;O^*DQF-.4N]=K'D+33(60*?3
MJ"Q3WFR4-JRAF>Z5BMIJJ-M/#3QU;4D;'$W@DCD7E)=EFTBN\4J8Q%/;J&AU
M=H7IO)9;]/'49JO-4MSO"0+MPT[G1LCCIV/X-ODVLQ<[##;<Y$Q:B*3,\1O<
MD )1TB_//>$^^;1]GJ#O\9YWF<F[3M>:
M
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M;@DD\=&?Y<FTN*N;M?XN#)&WS  E'2+\\]X3[YM'V>H._P 9YWF<F[3M>:
M
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M5.4"@R0                  $HZ1?GGO"??-H^SU!W^,\[S.3=IVO-
M
M                                          &,77\RM._]>Y_9$.+R
MN3T/#SEN@X'I@            3YI/^J/>'^IDW\(>5.4"@R0
M      $HZ1?GGO"??-H^SU!W^,\[S.3=IVO-
M
M                       &,77\RM._]>Y_9$.+RN3T/#SEN@X'I@
M      3YI/\ JCWA_J9-_"'E3E H,D                  !*.D7YY[PGWS
M:/L]0=_C/.\SDW:=KS0
M
M     !C%U_,K3O\ U[G]D0XO*Y/0\/.6Z#@>F            !/FD_ZH]X?Z
MF3?PAY4Y0*#)                   2CI%^>>\)]\VC[/4'?XSSO,Y-VG:\
MT
M                                                8Q=?S*T[_P!>
MY_9$.+RN3T/#SEN@X'I@            3YI/^J/>'^IDW\(>5.4"@R0
M             $HZ1?GGO"??-H^SU!W^,\[S.3=IVO-
M
M                              &,77\RM._]>Y_9$.+RN3T/#SEN@X'I
M@            3YI/^J/>'^IDW\(>5.4"@R0                  $HZ1?G
MGO"??-H^SU!W^,\[S.3=IVO-
M
M           &,77\RM._]>Y_9$.+RN3T/#SEN@X'I@            3YI/\
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MFX#\70            !/FD_ZH]X?ZF3?PAY4Y0*#)
M3GN__G=O#??MJ^RS%3D*,)
M
M                         GS2?]4>\/\ 4R;^$/*G*!09(
M       "<]W_ /.[>&^_;5]EF*G(482
M
M                                 !/FD_ZH]X?ZF3?PAY4Y0*#)
M               3GN__ )W;PWW[:OLLQ4Y"C"0
M
M                                         )\TG_5'O#_4R;^$/*G*
M!09(                  "<]W_\[MX;[]M7V68J<A1A(
M
M                                               $^:3_ *H]X?ZF
M3?PAY4Y0*#)                   3GN_\ YW;PWW[:OLLQ4Y"C"0
M
M                                                        )\TG
M_5'O#_4R;^$/*G*!09(                  "<]W_\ .[>&^_;5]EF*G(48
M2
M
M   !/FD_ZH]X?ZF3?PAY4Y0*#)                   3GN_P#YW;PWW[:O
MLLQ4Y"C"0
M
M           )\TG_ %1[P_U,F_A#RIR@4&2                   G/=_\
MSNWAOOVU?99BIR%&$@
M
M                    3YI/^J/>'^IDW\(>5.4"@R0
M $Y[O_YW;PWW[:OLLQ4Y"C"0
M
M                          )\TG_5'O#_ %,F_A#RIR@4&2
M         G/=_P#SNWAOOVU?99BIR%&$@
M
M                                   3YI/^J/>'^IDW\(>5.4"@R0
M                $Y[O_P"=V\-]^VK[+,5.0HPD
M
M                                          "?-)_U1[P_U,F_A#RI
MR@4&2                   G/=__.[>&^_;5]EF*G(482
M
M                                                !/FD_P"J/>'^
MIDW\(>5.4"@R0                  $Y[O_ .=V\-]^VK[+,5.0HPD
M
M                                                         "?-
M)_U1[P_U,F_A#RIR@4&2                   G/=__ #NWAOOVU?99BIR%
M&$@
M
M     3YI/^J/>'^IDW\(>5.4"@R0                  $Y[O\ ^=V\-]^V
MK[+,5.0HPD
M
M            "?-)_P!4>\/]3)OX0\J<H%!D@                  )SW?_
M ,[MX;[\M7V68J<A1A(
M
M                     $^:3_JCWA_J9-_"'E3E H,D
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M^_;OZH>)\AXEOC7VVVS,\8XX_P#5!GZ/-
M
M"?-)_P!4>\/]3)OX0\J<H%!D@                  (GRM^>6N_WU;/LTQS
M^1R_%'TWPG[_ .OZM@G(^E                                !WL@?F
MY:?NFM_W&'7V,I?)_-_ZV?QG\U$G0\
M                                                          )\
MTG_5'O#_ %,F_A#RIR@4&2                   B?*WYY:[_?5L^S3'/Y'
M+\4?3?"?O_K^K8)R/I0                                =[('YN6G[
MIK?]QAU]C*7R?S?^MG\9_-1)T/
M                                                      "?-)_U
M1[P_U,F_A#RIR@4&2                   B?*WYY:[_?5L^S3'/Y'+\4?3
M?"?O_K^K8)R/I0                                =[('YN6G[IK?\
M<8=?8RE\G\W_ *V?QG\U$G0\
M                                                    )\TG_5'O
M#_4R;^$/*G*!09(                  ")\K?GEKO\ ?5L^S3'/Y'+\4?3?
M"?O_ *_JV"<CZ4                                '>R!^;EI^Z:W_<
M8=?8RE\G\W_K9_&?S42=#P
M                                                  GS2?\ 5'O#
M_4R;^$/*G*!09(                  ")\K?GEKO]]6S[-,<_D<OQ1]-\)^
M_P#K^K8)R/I0                                =[('YN6G[IK?]QAU
M]C*7R?S?^MG\9_-1)T/
M                                               "?-)_U1[P_P!3
M)OX0\J<H%!D@            'Y9(UZN1JHKF+LO1%15:Y41V"_L7!44#]
M ")\K?GEKO\ ?5L^S3'/Y'+\4?3?"?O_ *_JV"<CZ4
M              '>R!^;EI^Z:W_<8=?8RE\G\W_K9_&?S42=#P
M
M                  GS2?\ 5'O#_4R;^$/*G*!09(   $N[[.JVH6E.4\J5
M^GEXZ&N%SNKZ2KFY"GJ$?$D"N1JI41RHB;7#XJ8EVC$,\0;[^DN6J_4*MS]8
M<UVFQ1^5W.S^0PL5]+&J+([@I*=RHU.%VQ,UVSCAPC"6-MV'>FTX31S+&KV=
M*IU@MV8I'4#J=D,]:L5R@65LT2<A&]VSC"]S'.:GBX8\*F=+6YZJ\4-':IKW
M42;-M@IW5LLV"KLP,8LCG8(F*X-3'#NDC2V=-7,J:G;N6H^==-+O-445!:;K
M2,KXXZBBFBK(*1)5V>5;&]%:DC%1R?M*B,1J?=_WEM.],-WW*3]4LU2SYEN$
MEQFBH\9KG<G4[;A/&Q\C6[;HV>+@Q95;BB>+B;,"E--M9-.=7;=-<M/[Y#=F
MTJM2MI,'P5=.K_X>5@F:Q[47!4:[9V78+@JX$S' 3MH7?;Y6[YFLEIK+G5U%
MJI*6H6EH)JB62GB5*ND1%9&YRM;@BJB8)W%*G(>YNKY1R'9,_P"JE?DW46OS
ME<I*]L5]MU925%'Y',ZHJ%19I)L6U,RNCD9RT>"8(O!XW!DC8&H6];H?IE>I
M,N9DS'RE^IW;%906Z"6M?3N^ELSHFJQKD^EBNVD_89P&;Z>:JY!U6M#[YD&]
M07BAA<V.J;'MQ3P2/3%&S0RM9(Q5P7#:;@N"X8B8&9& !$^5OSRUW^^K9]FF
M.?R.7XH^F^$_?_7]6P3D?2@                                [V0/S
M<M/W36_[C#K[&4OD_F_];/XS^:B3H> B[.>HNM^N&N&8]&]&LP1Y+RMDM'-O
MM_<S&JFJ(G-BD\9&N>G^:JLCCC5FTC7.<[N-2^'"!V]*=3-8M,M>Z;=ZUGO<
M6;:2_4BUN6\Q(U&3M_RY96;3D:USF/6"6)S9-IS7HFR[9[J8P%C$",KKG#7'
M>/U3S=DO2+-;<BZ<9#J$M]POL3-NJK*Y'OC56N;@]R*Z.39:Q[6;#4<Y55S4
M+P@9CHK6[QF2=2JW2S5I*K.63I*9:JR:@Q4[DABD:SE.2GFV6XH[QF;,BN>U
MZ(B*K'(ID\!3A(
M                                  $^:3_JCWA_J9-_"'E3E H,D
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M> GB-P& !$^5OSRUW^^K9]FF.?R.7XH^F^$_?_7]6P3D?2@
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M&K$D?(L;DFB<Q[6OV',>C\-K@3,X%OD
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M\M=_OJV?9ICG\CE^*/IOA/W_ -?U;!.1]*
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M_DY)D:UG+/D\:5SW2*F.RUJ()F!71
M                                                  $^:3_JCWA_
MJ9-_"'E3E H,D        &"      P0    1/E;\\M=_OJV?9ICG\CE^*/IO
MA/W_ -?U;!.1]*                                #O9 _-RT_=-;_N
M,.OL92^3^;_UL_C/YJ).AX   8(  8(
M                                                     $^:3_JC
MWA_J9-_"'E3E H,D                  !$^5OSRUW^^K9]FF.?R.7XH^F^
M$_?_ %_5L$Y'TH                                .]D#\W+3]TUO\
MN,.OL92^3^;_ -;/XS^:B3H>
M                                                    $^:3_JCW
MA_J9-_"'E3E H,D                  !$^5OSRUW^^K9]FF.?R.7XH^F^$
M_?\ U_5L$Y'TH                                .]D#\W+3]TUO^XP
MZ^QE+Y/YO_6S^,_FHDZ'@
M                                                !/FD_P"J/>'^
MIDW\(>5.4"@R0                  $3Y6_/+7?[ZMGV:8Y_(Y?BCZ;X3]_
M]?U;!.1]*                                #O9 _-RT_=-;_N,.OL9
M2^3^;_UL_C/YJ).AX
M                                             3YI/^J/>'^IDW\(
M>5.4"@R0                  $3Y6_/+7?[ZMGV:8Y_(Y?BCZ;X3]_]?U;!
M.1]*                                #O9 _-RT_=-;_N,.OL92^3^;
M_P!;/XS^:B3H>
M                                         $^:3_JCWA_J9-_"'E3E
M H,D                  !$^5OSRUW^^K9]FF.?R.7XH^F^$_?_ %_5L$Y'
MTH                                .]D#\W+3]TUO\ N,.OL92^3^;_
M -;/XS^:B3H>
M                                        $^:3_JCWA_J9-_"'E3E
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M(YCFIM(JIPX'[]NSIAXOR'EV^3?;=;$QPCAC_P!4$?H\T
M
M            )\TG_5'O#_4R;^$/*G*!09(                  "<]W_\
M.[>&^_+5]EF*G(482
M
M                   !/FD_ZH]X?ZF3?PAY4Y0*#)
M 3GN_P#YW;PWW[:OLLQ4Y"C"0
M
M                           )\TG_ %1[P_U,F_A#RIR@4&2
M          G/=_\ SNWAOOVU?99BIR%&$@
M
M                                    3YI/^J/>'^IDW\(>5.4"@R0
M                 $Y[O_YW;PWW[:OLLQ4Y"C"0
M
M                                          )\TG_5'O#_ %,F_A#R
MIR@4&2                   G/=_P#SNWAOOVU?99BIR%&$@
M
M                                                   3YI/^J/>'
M^IDW\(>5.4"@R0                  $Y[O_P"=V\-]^VK[+,5.0HPD
M
M                                                          "?
M-)_U1[P_U,F_A#RIR@4&2                   G/=__.[>&^_;5]EF*G(4
M82
M
M    !/FD_P"J/>'^IDW\(>5.4"@R0                  $Y[O_ .=V\-]^
MVK[+,5.0HPD
M
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MG_4_-MQK*6HH,\7.DN%M@I^4Y:&.F@=&YL^VUJ(Y5=P;"K_^!LR-J&
M                !X.=[-49ER;F'+5'(R&LO-LK;=3S2X\DR2KIWPM<_9Q7
M917XK@; \;1_)UPT^TRRODBZSPU5RL5OAHJFHI5<L#Y(T7%6*]K78</TM3_@
M9(S<                      !JO*FFMXL.MFH.IU55TTMFS=26BEH*.+E/
M*HGVR#DI%E16HS!R\+=ER_OP-XX#:A@                      :NUNTUN
M^IE#DNEL]92T;\MYLM.9JQ:SE$22EMO*\I''R;7?YCN439VN#]JH;$C:)@
M                    %QPX.Z!K'=\TXNVD>D>7]/+W54]=<[,M;RU51*]:
M=_E==/5-V>4:QW V5$7%O=0VZ>,C9Q@                      :ZRCIG4
M99U7U'U(DN3*FGSVVR-AM[8E8^EZ%HW4KMJ3:5'\HKMI/%3#N<)LS@-BF
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MM:\B3Y"S5>T3H.J61[Z6I?(JMCC5KVHJ;;FN8U['O17^*J-[HF!49(
M                3WO$[UV5M JNU666U/S'F6Y,=4S6N&I;2>2T:*K62RR+
M'+PR.148U&\*-<JX<&UL1Q&Y\EYA;F_)^7\VLIW4;+_;:*ZMHWO21T*5M.R?
MDU>B(CE;M[.*)PB1[I@                     DW,>]9GW,><+UE3=]TZD
MSU2Y9F=3WC,$TKF4:SM5S59#L[#<,6.V'++C)@JM;A@JUP&P] =X>CUD?>\N
MWBR394U%RR]([[ENJ>KW-1'<FZ6)7LC?@UZ;+VN;BQ5:BJN**N3' ;O,
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M<6N55<-W++\52[:;05=QI*=5[O))5R2HG_)9%1/W&R*/)
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M;R?K%EV6GS%F:OHTH;CD1.56Y/@=%+2I4PNCCD:QKV>(W:\;;;P->U7;-QC
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M(4O-^J+93-J*ZI5=AKG(VK561,5R\E"W'915_B>KG.V8F6+X/S:
M            GO>4W:;CO!5&6WPYQ=ERDR^E2[R1:):Z.::H=&J2X>40(US4
M9L\*.X%^CZ:B> FW>9T+U9T_TEN>8LUZUWG.5F\JHX)LOUL=2RGF66=-ESED
MKIV^(Y$>B<GW4^@J)ABGMT_(N:,G:86NOS%G.LS72YBMMIN5HHZQLC66FEDH
MF.;2P\I--BQJ.1OBHQ/%3Q4)NS(;X):                   !U;C04UTH:
MFW5C=NDK(9*>H9W%6.9BL<F/[T4"#]'=8J7<\CO^B^LEAN4%/!<ZBY9?S#;X
M&S4U?2SM9&CFH]T>+7<EM->U5PQ5CT8YG#<QQ&0[OS+YK9O+YEWD8[)5V+($
M=!T;8G5K4;+62\A%2MX4\5WB,DDD5BN:Q5:S:=PN$X1P%LD
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M0
M
M
M                             .$7'Z, .0   !PBJO=3 #D
M                                  !PBX_0!R
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M1 _6[CO"Y6U8RS9++59BANFJ;;6E?F*@AI9J;86.1L<CL>29#XJR,148[Z>
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MAGE:Q,7+"VJCBY143QE:S%V"*N&"*)@;6,
M                                      "<-][45<AZ%76WTDW)7G-T
MC;#2(UV#TIYT5]6[#NJU8&/B5?H5Z%6B6]6;?I9:MV'3FBR9G>R56I>0)X;K
M+!0U]/)5NGN[VRUS8FL<KGOBJ%A5%^B.+N<'!7,63=::W;S>[:_D6QI)G*QM
MJ*9,<(Z>[PHCV-578\$-7%LNX>%$7A(RD:#T/U[ERKN>9KFN,JP9NTX2IL-)
M%(N$Z35S]FW.<UW_ -.29T>RG^&%?^)4QB,3@LM[T4W#J^]T224F:=1JFGJ+
MG6-Q;/%;KD]&1-V^[LR4T?T]SEW?3PCF/*TNS?EG*FFMLRW)NNWC-25]%'-<
MLQ55 ^JDN,E3$CG3PS.M[W-A=CC D;\&MP5%5V+EJ8&6;J]LS_EBDUCL-QRC
M?LJZ;W&U5UWR]0W^EJHFP3;$D;8V33Q1))(L+FI(YJ8NY-JF2&XAH9IKF_(-
MQU!S;9(;UF"*]OHZ!U6KGQ4L5%#3S-='&BHFVY\JJKG8\"-1,.'')D?K3_*E
MEUXWQ]3J[4Z%MYHLE25%)9K'5^/2K'0U?D<&W$N*.B:U'2.9_"Z23:=CBN*<
M('<W\]$].+!IY0:AY9LM%E[,%-<H+=.VVPQTD%735,<J[+X8FM:LC'1M<UZ)
MCL[2+CP;*)'@;REPN-^R=NV:2OK)+=EC,]#:'76I:N#7/=%0TL;EQX%Y%LTC
M\%X,7(OT(;',5+?=UO0ZYY$ER+%E"VVZB;3/AH[O! QMRII48J,J/*UPED>U
M?&7E)%1^&#L6\!'5(CO=GS1>,C;KNN.8[!.Z.\T$L4=%60*NU%)41-I^7C5,
M%16))RC5_:F)<YCS- LVV/)60(/*-W.[:@W&\+-/6YJJ*%U?3U;.5?&UE,LE
M#.UL3$;L.1KEVGHY7?L398V-NFT.=\O:_P"8Y[1IYF+(^DF:J&69MKO-+5MI
M*6I@2.2-6U$L,3'*C^69$G=2-^'"J8DSDU:FH7_V#FG[HN'V60F!'.X/I!IU
MF#32\9VS+EZAOM^JKM/;6R72GCK8H:2G@@>C(XYFN:U7.E<KW(F*I@G<0J9'
M&E^7;9I7OXYCR/DF-;=E.YVE\TUJ8Y5@9RM)!7;+&JJX(V5%6/\ \#55J< G
M(=_=XIJ>LWO]>J.LA944E0VNBG@E:CXY(WU\;7,<UR*BM<BX*B]T3D/%W:\C
MY*N^\UKE9+KEJU5UFMM=5MMMOJJ&GFIJ9L=SD8U(8GL5L:(U,$V$3@-F<&/6
MW@=+M0<N[P%)KO;<A1:J9(\D@II\L.9Y1+2.@I^15K*;9E54Q19HWMAD:USE
MQ:B[*KD2U]] [ONZ9[UU;F[*MMO.G6K5/33LJ,CRMIZ*TU>,#V5"LBBBQ>YK
M%25S%=$JN;RFPNRYPGCP8MDAJ(]R3_[DW@?O>+_>NA<C&?\ M^:3Y!S3E?-&
M<\TV&BOEWAN3;51I<Z>.KA@@93QS.6..5',1[UEP5V&.#<$PQ7';IQ'KY<RQ
M:-+-_P"H\LY%@;9LN9AL\\U=::7%E*B/H)JAS&,[B,Y:F9*C4X&KP-P3!#,X
M%UD"*+S_ /Z.9=^Y)/PBK+Y,?2WHE-_W&;OY5P>66)OD6U_BPM=/CL\W)_\
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MJ*HJF2L?!%4N=2L=CRC=ACE@CX';*O[B)N+'] C\V@
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M4=+R36JYTC6L3QD8J\!O&(%MD
M                             !QP <@<)A] #@_<!R  X7#Z< .0'_$#
MCQ?W 35ON,TFETEACU0GK*69U<Q,M5%HABJKDRNV';3F0S2P,?"D>URS7RL1
M4V<%1^P5 F"X0;YRZ5R17>OS.W2'R5R554^BMKKZEJV%VUEA6J2NY/D\=IKY
MOX>ZNR7@Q7FY^W2]FBEM9I3)536AM3.EXFN4;(;@^[(C.6=41Q/DC8Y6<DK&
ML>Y$BV$VE7%3\Y:WQP>$P<@<+A]('*8?0!QP8?1@ 7#Z< ' !SP?2!QXO[L
M.0"8?0 X/H X\7]P'(''B_1A^\#D#CQ?W <@<>+^X!P>$#D!P  ' !QP .#Z
M0.0 '"8?1A^\#G@^D#C@ >+^X F'T %V?IP <&/T8@$P^@#D F'T $P^@#C@
M Y B_<W90MUHU_6FGEEE6\_Y[986Q-:O2%Q_A5LKU=PX]U$+NR%G\'@('*X?
M2  C#_N!LHWT>F'E<\L*)>I^3Y*%LV*[,'=VI8\,/^9=HL\@.#Z ..#]P!-G
IZ, 'B_N +A]. '*X?2!QP8_O Y                         '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>lc_cellinoculation-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_cellinoculation-4c.jpg
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M$ ,!$0 "$0$#$0'_Q #B  $  P # 0$!            !@<( P0% @$) 0$
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M%6IEU1)+L)9IYA%W$J@*RL4$
M
M
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M=2T7(;0C8]IY=D5"4=S-IFW.EYUS54J<TC47D4];P A3?OM_:!_XB5][6+^
M"=B*Y)O9U<[?WVSVK/;LY:7+HM"F&7H5I7S&2=)"S(V654[:=I&!2']& 5
M
M
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M22N\D&OEI/O)) K*Q 0 ,*=<_P I>WGM=7NQ(+0W6"H
M
M
M                     /PR)14452\!@/T  ?A$22HDJ%X" ?H#\H1&9D7$
M^TP'Z   #"G7/\I>WGM=7NQ(+0W6"H
M
M
M                    ,*=<_P I>WGM=7NQ(+0W6"H
M
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M":/6;WWW 6ZAL]E,I+4HDFJL>A5.E:F9%\TZ 47F0(
M        !A3KG^4O;SVNKW8D%H;K!4
M
M                             !1L/]+VX_T?L_SN0)X+R!
M        HGJJ_(_$/SRL?VQP$PO8$                            ,*=
M<_RE[>>UU>[$@M#=8*@        #\,R21J49$1=IGP( 2I*R)2#)23[#(ZD"
M9BC]!      ROU3=06X6S^56*RX8U!=C7*WKEOE,CKD.<Q#RD>2:'$4(DI\
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M"RYZ;&QB4AE;3I/-.&3"5.FXHEG4B951/KU$? %IAL0%0
M                                                         !1L
M/]+ZX_T?L_SN0)X+R!                  HCJJ_(_$/SRL?VQP$PO<$
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M4M
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MUO34]*C:64>439JI5"J-.MD7:2E*!,MB J
M                                              HV'^E]<?Z/V?YW
M($\%Y @                 41U5?D?B'YY6/[8X"87N"
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MU<>XFJ^P0
M                     HV'^E]<?Z/V?YW($\%Y @                 4
M1U5?D?B'YY6/[8X"87N"                            &%.N?Y2]O/:Z
MO=B06ANL%0
M
M         %&P_P!+ZX_T?L_SN0)X+R!                  HCJJ_(_$/SR
ML?VQP$PO<$                            ,*=<_RE[>>UU>[$@M#=8*@
M
M                                                           *
M-A_I?7'^C]G^=R!/!>0(                 %$=57Y'XA^>5C^V. F%[@@
M                          !A3KG^4O;SVNKW8D%H;K!4
M
M                                               !1L/]+ZX_T?L_
MSN0)X+R!                  HCJJ_(_$/SRL?VQP$PO<$
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M^%2E&1$0#[0M#B$N-J);:R)2%I.I&1\2,C+M(P'T
M                                             HV'^E]<?Z/V?YW(
M$\%Y @                 41U5?D?B'YY6/[8X"87N"
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M1%__  S8*I&
M              #BDR8\-AR5*=2S':+4XZLR2E)>,S"(7LLNOFEL5F5%1[C;
M6^HB7N <HOQ;?Q1NPI?-"R5YZFX><'Y.FNC1[+P]W>,GAW.K^DZGEKR^V%[1
MY#$ME$F,XEYATM3;B#)25$?>1D,;DW6S;-)BDPY 5                43U
M"KB97:+!8K1*;=G6O([9=9I%J4E$:$M9N^41&1K(CX)K\P9(QS+J8>F:C);S
M1;L[YHN6T7VU7U@Y%KDI?2G@XGBE:#/Z))T,A6;9C>U,^FR89I?%'HBK6
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MEMIM"6I%$I0DB(B+P$"87Y@'Y"8O_P!(@>YFP0D0
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M78IMY1),C+Q5KZ0I?%8<[J&*W)@NKPBOJ:"&D^>@
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M_P"MPOM4@$PO; /R$Q?_ *1 ]S-@A(@
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M=Y8                          &%.N?Y2]O/:ZO=B06ANL%0
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MW0X]O@M)8A1&D1XS""HEMII)(0DB\!$1$0#G
M                                      '!-F1[?$>FRUDW&80;CBS[
MDI*OIGX!,15DQX[K[HMMWRJ>P0Y&?Y6]>[B@_>N*HE<H^*=*:\IDO#]$KT_"
M-BZ>2VD/6ZK);H=/&.S[I\IGX?)YD/\ 2]N/]'[/\[D-9X_@O($
M        "B>JK\C\0_/*Q_;' 3"]@0                            PI
MUS_*7MY[75[L2"T-U@J
M
M                *MW%O<B[7%C$+35Q1N(\Z))^O>5ZQ%? GURO'Z V,=M(
MK+U72M/&*R<]_9L\W;Z?+>GN.V2/CUI8MK%%&@M3[O9S'5>N5ZGBH,-UU9J\
M_JM1.?)-\^CS*BA_I?7'^C]G^=R%6MP7D"                 !1'55^1^(
M?GE8_MC@)A>X(                            84ZY_E+V\]KJ]V)!:&Z
MP5
M                                                          >!
ME^1-XW9W)9&1S7?K4-L^-7#+M,O GM/YG>+V6UET-#I9U&6+>$;_ #(MMECK
ME',IN)&N5)-11#7Q5I49ZW3KWJ/@7BKX1DR7<(=7J^JC9ALW1O\ PCT+(&!Y
MI1L/]+ZX_P!'[/\ .Y G@O($                 "B.JK\C\0_/*Q_;' 3"
M]P0                            PIUS_ "E[>>UU>[$@M#=8*@
M
M                                                ^5K0VA3CBB2V
M@C4I2CH1$7$S,P3$3,TA3[JG]R,P2T@U)LD3L/B6F.D^)^)3A]G_ &#9^RWO
M>QMB.GZ:O\=WO^$>6];[33;#2&64DAIM)(;0DJ$E*2H1$7B(:SQUTS,UG>^P
M0HV'^E]<?Z/V?YW($\%Y @                 41U5?D?B'YY6/[8X"87N"
M        $+W4W*LVTV%S<TOC#\J)%4VRW%BDDW'7WE:6TU49$DC/URC["[C[
M &3I>==8^]RC>PJQO8;BKU38<;T0%*;["4<N7I=<[?7,)27B!;8\S^JOU4S-
M4V7GC29A^49/7RYK=-7C4EE15_= 5AZ$2P]<NU.F5#ENY=;&?LD5<EN\I4DN
M--$@T2J?YJA@;%][#[_.;M/W/&\@QV3C6<6-I#US@O)43*D+5HU()TDN(.O:
MA:>'T2@1,+M!            #"G7/\I>WGM=7NQ(+0W6"H
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M[-VBX2K5<LUM4>XP75QY<=<A.IMYI1I6A5*\4F5#\8)HZW]8G8[X>6C[X+U
M*)/B.XF#9Z4L\,O\*]^8&@IA0W2<4US=6@U%VD2M*J'XC!"3     *[W-R14
M>.C&X"C5,F$1RM'%1-&="05.]9_.]$9\=O%Z+H^DYI\6[=;N\_;Z/+<D.%XV
MG&[.AEPB]\)%'9BR^CIP17P)+AZ-3[QCONK+G]0U?^1EK'VQN\N](Q1S0!1L
M/]+ZX_T?L_SN0)X+R!                  HCJJ_(_$/SRL?VQP$PO<$
M     ,97;JUR^]W2X9%9-N47W97'9Z&I]W=8=>D%REE20APS)EM9$9+2DT'I
MU)U**M06HZ<_?;JGNMOE[O8IC$=&T<=QU^+"?986ZNW1UF1O.D3OG)T2DS6X
MW1!<3+R2J!2&KMM,Z@;EX+9,XMK2F(UWC\U491ZC9>;6IIYO50M6AQ"DZJ%6
ME: JE8#@*%#*8=P*.T4]39,'*T)YQLDK42#735I(SKIK2H#G
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MDD7=J!;@UZ"H
M C<G;S )DEZ9,Q2SR)<A:G7Y#MOBN...+.JE*4ILS-1GQ,S 4ALCA&%W#.MX
MXT_&[7*CP<F)F$T]!CN(9:Y-=#9*09)37N3P!,K^LV,XWCO._%^SP;3YQI.1
MYA&9B\S173KY24ZJ5.E00]4   'G7V\1K#:Y%SD\4M)^MMUH:W#X)27HGZHM
M;%9HV=-@NSY(LCBKO;^SR;_>)&7WCZX2'#4QJ+@M_P )$?L6RX)\=/ ,V2:1
M2'H^IY[<&*,&/LV^;Y^6]:HUWDP  4;#_2^N/]'[/\[D">"\@0
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M L;8;>6'!F'_ #H[2P:7Y5-).R'G%/O+21\22;CBM)'V%0$)D
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MFU<AYSM2E;3$*,:*^'7JX>(P6X-= J
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MNUVR:X%>-PLH?*9D%R2:EH)6I2R:0M9$I7E+6M:S(M2C[*$0(F5S@@
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M_ 23C;1J;+G+2DBJJGH@2UN"H             PIUS_*7MY[75[L2"T-U@J
M
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MUV:_>>9YN'$R:P\E:#MC-GCP%\XZ:%DZT9&6GCPXU!"T 0
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ME+V\]KJ]V)!:&ZP5
M
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M.X688K,W1Q_W@GPS0U;VO,95NYK*Y"5*5IE*4:J**E4\ 2_JF"@
M
M                                     *)V%^4#>S\Z?Y $RO8$(_F&
M1HQNSN2DF1SGJM0VSXU<,O7&7@27$_F=XO9;670T&DG498C^&-_EWHQMECBT
MH<R>XD:I<K440U\5:%'Y;AU[UGP(_!Z(R9+N#J=7U<3,8;-T;_AZ/+<L<8'F
MP      4=$,SZO;B1]A;?LT_"X)X+Q!                  HGJJ,RQ#$#+
MM_'*Q_;' 3"]@0         ,H==6(7>]X=C63Q&79-DQN:\=\9C_ &1$:832
M2>H?<DV]%>[61]E06AZF,8QT3W>S0Y-M+&#8-E!DBXSDLS4E0OLR)+R7"7X=
M1=H(VI]@6*=.5JR5B9MRG&_QJ0V[YN=JF,2)9-*3I<TH0ZLZ:3\HZ=@"W00B
M.Y^"L[EX'><&?FJMS5X;;:5-0V3RF^4\AZI(4:2.NBG: RM.Z ;)"@R9AYS*
M5YNTX[I][VRKRTFJE>?X@6JIWI*V@B;GYF]>)%V<MKF&R;9=F66V4O%)-,A3
MFA1FM.DOK)%4B/M!,IIOE;KYL1U-0MX4VYR7BUQF(N3+J"HA:W6.1-C&NE$N
MF1N+17N41\:&"(>%N+E4OJ]WGQNSX7:ID2PQ&6X;CLE*>:S'4Z;LJ6]RU+0V
MDDF24IUG4TD7KE$D#<N7KDVNN=[Q7'LSQR&N2UBY/0[G'82:UMP'R0:'=)<=
M#2FZ*IV$NI\",R$*=W2ZG6]U-GK!M;:[',3E+JH+-Y>HAQEY<)))249+9J<4
MIYPDKHI):?6^5V@4;-Z==OYNVFT6/8U=F^5>S;<G71JI&;<F8X;IMG3A5M)I
M;53A5((E:0( &%.N<S^,K;PN[S=7NQ(+0W6"H                  .M)N$
M"&I*)DIF.M952EUQ+9F1=Y$HR <2;U9EJ)*;C&4H^!))YLS/^Z =U*B41*29
M&D^)&7$C(!PNS83#S<9Z0TW(=^Q,K6E*UU.GDI,ZGQ\ #G >==+_ &*R$@[U
M=(EN)S[&<Q]J/JIX.8I-0'/;[G;;M'*5:IC$Z*9T)^*ZAYNO@U(,R =A:T-H
M4XXHD-H(U*4HZ$1%Q,S,P''&EQ9C?.B/MR&JZ>8TM*TU+NJDS(!S ."--AS"
M4<.0U()!Z5FTM*R2?@/29T,!USO=F29I5<8I*29DHC?;(R,N!D?E 'OY9?\
MF47^/;_A .PQ-ARFU/19#3[2#,EN-K2M)&15,C-)F1< '7]_;(?$KE%_CV_X
M0![^67_F47^/;_A .PB9#=CG+;D-KB)(S4^E:3;(D]IFHCIP[P'7]_+)_P R
MB_Q[?\(!S1[A F&:8DIE]1=I-.)69?O3,!V0 !\//,QVU/2'$M,HXK<<424D
M7C,^! /B/*BS&^;$?;?:K36TM*TU+NJDS <P  Z[L^"P\B,_)::D.?8V5N)2
MM5>'!)G4P'8
M    43L+\H&]GYT_R )E>CCB&D*=<42&T$:EK4="))%4S,_$!$3,TA3ZC?W(
MS DEJ38XGHEICI/B?B6X?I_O1L_9;WO8Q3I^F_GN]_PCRWK@;;;9;0RTDD--
MI)"$)*A)2DJ$1%XB&L\=,S,UG>^@0      "C8?Z7UQ_H_9_G<@3P7D"
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M,U&:C06MI;>HS,DK--:)20(EI\$
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MLDXPE#'7IEJ8ZJ)=LZ3>214*IP(*C(_#Q(C!;@UV"H
M                               =@#/FU%Q3C63[VWB<V:67<EYD$E>3
MYQ5FB>6?>53H9EV<? +6VS,MS3Z6_-?%D1O2_;ZS2;[=I&7WCZYI<4<?47!;
MY]JB(_8H+@GQ_4C-DFD4AW^J:BW#CC!C[-OF^?EO6H-=Y0         4;#_2
M^N/]'[/\[D">"\@0                 **ZJ4J7B&'I255'F=C(B+M,S<<!
M,+U!        "![OX-?-P<)DV#&;Z[C>0)>8F6ZZLJ<0:'XR]:4FII25I2KL
M-2>SMH?8"897F;T]5^QJC@;C8ZUE%E8JE%Z6RI;:T)[#*9#TI+A_CV]?A!-(
M=EC^T*9Y)><[?J\XIQY=U+09T\<2I 4=9GJ\WTW)=.V;4[?-)?</1YRE#]S-
MKQJ<HPRBGA<*@%%X[$;>;P6.Z73-]Y,H5=K_ '>,B*Q96U\QB$VEPW#IR]+*
M5&?#2RC3],8(E>8(            84ZY_E+V\]KJ]V)!:&ZP5         &2
M=T>F7(47J5>-OFFYUIEK4][U&XAA^.M9U4A!N&E"FZGY/E$9%PH=*G@NQ]CY
MKU3]LY8R3?IXYK9_AW3'KV4=#;WI@RNXW6/+SII%JL3*R<?B$ZAV5())UY9<
ME2DH2KL4HU5+N(1;CGBP]/\ VQGOOB<\<MD<*[9]6YL-"$-(2VVDD-H(DH0D
MJ$22*A$1%W$-A]/B*12'T"0   &/>IPS+J/V0,N!E/A4/_ZHR"T-A J ,<=1
M/Z5VS/\ G+;_ #HL%HW)EU<[6Y'D]HL6Y6"-+=S+!W_.D,1TZGW8I+0]J;25
M34MAQLEI07:DUTJ=",B'N;9=66U>;6*.]D5YBXKDS:"3<K9<W/-FDO$7E*9>
M<HA:#/UOE:B[R HA^_/5%B[N.S, VEE'E.<9$VJVL.VM*WV8Z))&VM2%H+ZZ
M\:3-+:6JT,]1GP(E"(>[@>U4C:/I>RFPW1*2R.X62\72]D@R42),B"M)-$HJ
MD?*;0A!T,RU$HRX& _>B3Y"HG_4Y_P#?I E%.J;;V]X9D-LZD]MD\C(;$XU^
M,C#:3-+S!%R4R%I30S3H/D/EWMF1\-*C!,.#H&?\YQC-Y)()LGKLRYRTU,DZ
MV3.A5X\*@2AO2[N=@6W.8;K'F]]8LQW&YL^8E()P^;R'YW,TZ$J];K36OA E
MI7^LYL+\.(/[U_[D"*/;A;D8/N+B>2R,)O3%Y9@0WVYBXY++EJ=8<-)'K2GM
M(C 94Z--V]M]O,%O]NS3(HUGGRKMYQ'CODX:E,^;-(UEH0HJ:DF7I F6D/ZS
MFPOPX@_O7_N0(HX-Q,YQ+<#8/<.]8;=6;O:V;/=(CLEC424OHAFM2#UI2=22
MM)]G> C?15\@MK]O7#[>8$OOJMV4/<W#?QEQU@RS_%T*DVU;)&3TJ*@];L8C
M3Q-1?9&?I_)*FLS B7<Z6=ZRW<P-,6\/DO-L>)N)>24?ER&S*C,LB[^81&2_
MITJX$1I F%ZF9)(U*,B215,SX$1$"'\_<_W=L'4+N0]C.3Y@UA^R%A=-9%5?
MG%U4TO23B22E55+,JMZRTM(\K2:^!EMS2&*;X=,>#V&)C6+91;+;982=+$9E
M#_:?KEJ,VS-:U'Q4M1FI1]H(HGV;[L81M[BD'-<EGJ;QRXN,,PI<=ER1S%2F
ME/-&26TF=%(09U,@0JOJMQ=>Z>PJ;]C+2YJ[<J)DL!"4*)UV&IE1.42=#J3+
MQN&D^/DT[03#W-L^H_:[(-M[=D%YR>!:;C A,HOMOFOH9DLR6D$AS0TH];B5
MJ(S;-M*M1&1>NJ1"BL^F9B5N3O1N-OX<5UC'IRE6FPK?3I4ZDU-<2+CY3;,=
MHE]Q&NG&A@F6N05
M    %0[FY-,=N:[!%=4U"C)3YRE!TYKBTDNBC+M21&7#P^D-G';LJ]AT?1VQ
MC\68K,[NY71)2FNDB*O$Z<*C.]'5?.WES;N6,1DH;2TN&9Q7$-E1)F@B,E4\
M*B41GXZC3R127@>J89QYYVUYMJ5#&Y0         HV'^E]<?Z/V?YW($\%Y
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MQ&E',<IJ5Q,^)T >K,AQ;A$?@3F4284IM;$F.ZDEMN-.I-*T+2=2-*B,R,C
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MJLBTVBUV&VQK/9(3-OM4-!-1845M+++:"XT2A)$1<>((=T
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ML%0
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M?.^M-.2;7Q"8Q2+%E/3WV&3CLODF"N,Y()JB=*7'G&RXD1J/RC*J@.#=H*@
M           #"G7/\I>WGM=7NQ(+0W6"H
M
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M:&ZP5
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M0$             #"G7/\I>WGM=7NQ(+0W6"H
M
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MT;3"E'P)*U.:C\.CP5!:%50N@7<=<5M<K*+1%D+22G6$>=.$A1EQ+43::T]
M"JTMA^D[+MI=QH6:7;(H%Q@QH\EA<6,E\G5'(:-!&6LB3P,ZF!,M9@J
M        ,*=<_P I>WGM=7NQ(+0W6"H
M
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MO$TBAFJE"KQ FC6@*@            #"G7/\I>WGM=7NQ(+0W6"H
M
M                       #R<H_)F\^T97VE0"M.E?Y ,)]JR/=CX)E<((
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MOV!AF9G>V(MB-T/L0L            HCJJ_(_$/SRL?VQP$PO<$
M"C>I?.MV,%LEBE[46QVYSY<IUJXMLV]RY&AI+9*09I;(]/'O,@3#-B^HCK#:
M0;CF+2T(3Q4I6.22(O1,T FD)]TV;][W;H[BE9LGCLNXM#;D%=WH\#DG'D$V
MHV4.+(_K9J6FA$HN-#("8;'!4             84ZY_E+V\]KJ]V)!:&ZP5
M
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M%H;K!4
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MU/C7[/MC<Z73-%&FQ4G[KM_P]"JX?Z7UQ_H_9_G<AH.MP7D"
M     !1'55^1^(?GE8_MC@)A>X(        >!FF9X]M_C<W+<JE'#L-OY7G4
ME+;CQIY[J&4>0TE2CJM:2X$ SCN-OATA[KPH-OSFZR;A%MSJGXB$1;M&-+CB
M="CJPV@SX>$%J2KO_P#Y]?\ QG_\_ VKHV(S+I?CWT\2V8;1'O\ <FEK=,XD
M\GW6HY&XHE29B#/27;IUT\0(FK1((             &%.N?Y2]O/:ZO=B06A
MNL%0
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M11>A'4J@@      $<SS"+#N-BL_#LF0ZY9;CRO.4,.&RX?(>0^BBRXEY2$U
M4?.Z,NGVV0Y%QN2)T2WQ6U/293]R4VTTTV6I2UK41$E)$53,P3505QC]"EON
M*H#;N0SFT*-"IT53ZH]2[R-PD+,O&E!@G:T5L1M#T_1ID7<[:.;(N+C*78R7
ME2W'";-Y&E;;S#B4*0O2JNE:2[C\ (EH8$             #"G7/\I>WGM=7
MNQ(+0W6"H
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M^S_.Y G@O($                 "B>JFOXH8?I[?QRL=*?YQP$PO8$
M    #(W7ODUUMV&8QBL)Y3%OR":^Y<C)1I2XB EHVVUG]!K=)=/"@C[@6A)\
M8Z*=EH&.1H5]B2;W>ELH.5>//'V-3IE52F6V5I0E%3\DE)4=.TS!%51;+663
MLCU<W':FR7%R?C=U8=:>)9D:N44$[C'-XDT3S6J<O50N"C,B+50$SN;O!4
M           84ZY_E+V\]KJ]V)!:&ZP5
M
M    >7DR5+QR\(255*A24I(N\S:41$"85%T^7=C%^G+$)=R2I#C49]"(RO)<
M6ZJ6^:44/B5>WQ%Q%K;9F:-K3Z:[/DBRW_2'K8C8YF97AW*+^7,A(<JAM1>0
MXXGL01'_ (-'?X>SCQ&>^[EBD/1Z[4VZ3%&'%OIZN_SSY<%MC6>1
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MZP5
M                                 !T[M*FPK5.FVV$JY7&/'=>B6Y#B
M&527FT&I#)..42@UJ(DZE<"K4P&0,KWLW2R!]QV9M[*C0&R\F$B[0U-H(NVM
M"+6JO?3T!L6UMC<]7I(R::RL8)F=\W5^6Q%K1NGF-ZMT:Y6O I,FUR2YK"_?
M*(@ED?"NE9$95IWD+Q?,\&[9K\V2WFMPS,3QK\FR=MKS<+_A=KNERQY6+/O-
MGHLRI+<PVFDJ,FU<UHB)6M-%\2KQX\1JS6NUXW-S\\\_W5V^=*Q#"
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M^\%\8Q"58Y5FREYEQY!(6F5!63"#6NCGD+2="J1*;IW:@1,-$@@
M    84ZY_E+V\]KJ]V)!:&ZP5
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M7[SO/\ZM]_L!,K3[W1+4W#<-Y5-"N:DR,B3QX<:@A9X(
M41U5?D?B'YY6/[8X"87N"        $<SS.+#MQBEPS/)5NHLML)LY!QVS>=,
MWW4,H)*"I4S6M)=M/" QQFW7Q=YJUV_;3%TQC</EL3[NHY#ZC4="TQF#))*\
M%75^@"U$28P#J[Z@%<[))<^WX]+]?[[NG:;?RU'W0FDI4LJ=A\@Z^$#8T-L1
MTE6O:#((^9W'('[QDS++K"&F&DQH*"D)T+\E6M:S(CX'J3]2")EI$$
M       #"G7/\I>WGM=7NQ(+0W6"H
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MY;WO8M846&VI941'->HN4LOHNY)'X$]GSQH:S4SFOKPC<ZO3M%&FQ4_BG?\
M#T/<&BZ@   "C8?Z7UQ_H_9_G<@3P7D"                 !1'55^1^(?G
ME8_MC@)A>X(        1C<+!++N7B4["\B6^BS7%3"I1Q%DT\91GVY"4DI25
M4(U-D2N'97L >;@VSNV>W#:"P_&X<"4DB2<\T<^:JA4XR'C6YQ\&JGB JG(
M               #"G7/\I>WGM=7NQ(+0W6"H
M
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M/\I>WGM=7NQ(+0W6"H
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M,/W(A7S<:_2+ABS4>2W(C/7E^>DW'&C2V?)6I1'15/0 EK<%0
M !A3KG^4O;SVNKW8D%H;K!4
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M*--BI_%._P NY[8TG3      !1L/]+ZX_P!'[/\ .Y G@O($
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M=B06ANL%0
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M[NXC20$[F[ 5             &%.N?Y2]O/:ZO=B06ANL%0
M
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M[OC/EN6<RTVPTAAE)(9;22&T)X$24E0B(>9NNFZ:SO>WMMBV(B-D0^Q58
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M0Q';2RPV6E#;:22A)> B*A$+N[;;%L4C<Y 2 *(ZJOR/Q#\\K']L<!,+W!
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M)U4<SU&R^A1MO-&JA5Y;B5(K3C2H*I4  ,*=<_RE[>>UU>[$@M#=8*@
M
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ML#PW%$D6.V.' 67^';:2;Y]W%U55GZ:ADB(AZ;3Z#3Z?^W9%OHV^O>D(EO
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MZ[OO7F&*W.[V)NQNVM2(S;;;CCG-2Y(2O4?,2FE*4X FC^J0*
M
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ME):Y9*2?$E5($2N$$ #"G7/\I>WGM=7NQ(+0W6"H
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MO/:ZO=B06ANL%0
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M3HHJ*!,PT[A>7V[.L=BY-:H\R+!EFXEMBXQUQ))&TLVSU-KXD1FG@?>0*O?
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M%+4AI9EF-C,]*TG0B<<XGQ!,+T*="-1(*2T:S/2226FIF?"E*@AV
M %'=2N/[TY!9;"SLO*E1;DS+=5=%0YS5O,V#:HC4IUQO46KN(P3#.*MN.N]*
M35[[795"KI*_Q*GXB_UD$[$@Z7[QOA<]XYMDW R><M&.LOIO6,W><HY576Z-
M/(CJJ3B$K4CRTG0M23K115$MO@J             ,*=<_P I>WGM=7NQ(+0W
M6"H
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MQ$_3N5S/]F4":OUOI!Z>FG$.HQ$]2#)2:W*YF52.O_B@*KP(B(J%V$"
M   %0;^[[,[%VFS71ZQJOA7>2[&)I$HHAM\IO7JJ;3NJM:4H0)B%$?K"H'_V
M_>_"J?\ = 31'MB\PRO>[JJ+<]FU^]EHA0GD7)M@U.,M1?,UQF&G'C2DEN+<
M4E7$B,])T*B> G<WN"H             PIUS_*7MY[75[L2"T-U@J
M
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MA/M61[L?!,KA!   (9DV;MPC5;K,9/W ST+>(M2&S[*%]$KYQ?.'9TG3YO\
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MT^/!9%F..6V'J"6P *-A_I?7'^C]G^=R!/!>0(
M      4MU93)EOV"RR7 D.Q);?O?RWV%J:<36XQB.BD&1E4CH8)A$NFFX85D
M&Q&,-;@3+5=;@T_<'";OKL:4\@SFOI(],DU*29I(J?2^("5I>]&Q'_@,1_B;
M9Z@"28]-P>.E-HQ21:FDG5:8%K7&27 N*B;8/P%Q.@(2               8
M4ZY_E+V\]KJ]V)!:&ZP5
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M24D7 B(NPAF?0(B(BD;GV"0  4;#_2^N/]'[/\[D">"\@0
M              I#J]_1ZR__ .G?SE&!,,B;3=(%[W7P.VYU"RF);H]R5(0F
M$[&==6V<:0XP=5)6DCKHU</""U4V_5]9-\-H/WD]]T!%5C[&=(U[VCW$A9M.
MR6)=(\5B2P<5J,XTX9R&C;(R4I9D5*@3+5H*@            #"G7/\ *7MY
M[75[L2"T-U@J
M                      #\4I*4FI1DE*2J9GP(B+O,"(JH7>ZY6K<3'F\5
MMSJVRC7&'<//])*;4<%XG#0E)FDS)1%354J=M#&:,4O18.BY+K:W3%O=O2&^
M[BR[_$:M&/Q76)<SZV_V*</5PT-FGP]ZN O;CIMEN:;I5N"Z;\LQ,6[OC*68
M5A3&-L%+EDEV\NI^N.=J6DG[!'[9]_H#%??5R>H=0G43RV[+(]O?*7#&XX
M "-YKFUGP>T+N=S7K>55,.$@R)U]TB]:GP$7LE=A>C0CV=/I[LUU+?7V*W71
M;"C<9Q?)-ZL@7E65.*8QQE>A"452E24G]@CD?8DO9K\/A5V=[-FLT=G)9]WE
MMEKVVS?-9:.A0HEMB,P(#*(\..@FV&&RTH2A/81$/-773=-9WMIV!4    =.
M[P7;G:IUM8F/6Y^9'=CM7"*:2D1UNH-!.M&HE)UH,]2:D95(!0MZV#RV+9+C
M(=WES!]#,5]Q;2Y*#0LDMJ,TF5.P^P$U0C879G)<EVBQ>^0=T\HL468PZINT
MVY]"(C!)DNH-+:3*I$9EJ]$P3,M(8]!+;O$XUMO^13L@?C&X9W6Z+2[-?4XL
MUDCR2*NDCTEXNTQFPX;\MW+;#4U.IQX+>:^:1[_,C;TF_9[-./&3YO:6E$9D
M=>6DO"L_9*\!?_B/16V8=%;6=MT^7HAX^_)J.IW\MOTV1ZO3VRGMDL%OL,?D
MQ$5=41<Z0K[(LR\)]Q> AP=1J;\UU;MW8]7H]%CTUM+8V\9XR]0:K>
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MSE')>6^JO+2E/ UF1< $Q                 84ZY_E+V\]KJ]V)!:&ZP5
M
M         !&\^=D,XE<E1ZZS0A"S+MY:W$I7_<F8R8_N=/IEL3J;:^6Q0(W'
MT![&*O/L9):EQC/F^=-(X=Z5J)*B] TF=12[=+3UML3@OB=U):*&D^<    (
MMG6=VC!+2<^X'S9CM4P8"#(G'G"^;1)5\I7=Z-"/;TVFNSW4C=QE2ZZ+84GB
M>'Y#O%?U9AF"UMX^E>E"$U03J4'P88+M2VD_7+]'B:JF7<SY[-)9X>/[O+;+
M!;;-\UEH^)#BP(K,*$RB/$823;+#:22A"$\"(B+L'FKKINFL[VTYA4
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MIUS_ "E[>>UU>[$@M#=8*@
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M#/$4>PTNEQZ;'%F.*1'EM>R);0
M                        ,*=<_P I>WGM=7NQ(+0W6"H
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M_$DAMHS+Q&MM8V<>Y]7_ &MCNMT=;MUUTS'FV1[XE=PR/6@
M                                              ,*=<_RE[>>UU>[
M$@M#=8*@
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M"X
M #"G7/\ *7MY[75[L2"T-U@J
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M87Y0-[/SI_D 3*]@0
M                  ,*=<_RE[>>UU>[$@M#=8*@
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MEV$E*2(B+T!F>VMLMMBEL4B',"P  *)V%^4#>S\Z?Y $RO8$
M                                                 #"G7/\ *7MY
M[75[L2"T-U@J
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M@1#EW73=-9FLN];9;;%+8I#[%5@          >5D_'&KS3O@ROM*@%9]+'R
M83[5D>['P3*U[C<[=:(3URNLIJ% 83K>DR%I;;0GPFI1D0,63)9CMFZ^8B(X
MRSMGW4]S)!V#:V$JXW!U7*1='6E+(UF=*1X]-2S\!K+]R8PW9.QX?7_N:L^'
MI8YI_-3_ .,<?3ZGD8IT\YCG=P+*MW+I(94_11P363D]:"XDE:CJAE/@0DC,
MNRB1$63.V6MI?V]GU5WBZNZ=O#^+X6^;W-)8WBV/XA;46G'+>U;X**50TGRE
MJ+V3BSJI:OIE&9C-$4>[TVEQ:>SDQVQ;'EO[7L"6T     *)V%^4#>S\Z?Y
M$RO8$
M      #"G7/\I>WGM=7NQ(+0W6"H
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MML%HM!%YC%0ASO=/RG#_ '2JF/&9=3DR_=+M:?18<'V6Q$]O'UO2&LW0
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M0=W(17$MT[K9;F:S:]Z_>1A]@T$1*YO--VA'7R--"\/$!.P0
M                                                PIUS_*7MY[75
M[L2"T-U@J
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M
M            #"G7/\I>WGM=7NQ(+0W6"H
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MG%(4F0ZU]:)Q2B;\E-/)H?C$19$,6EZ1I=-=S8[*3V[9]55^"[K
M
M      PIUS_*7MY[75[L2"T-U@J
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M(L)DH\)AN.PGUK3*$MH+T"21$+NS;9;;%+8I#F!8     >3E'Y,WGVC*^TJ
M5ITK_(!A/M61[L?!,KA!
M                                   ,*=<_RE[>>UU>[$@M#=8*@
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M85ET+.<<BY+;X4ZWQ)9N$B+=8ZH<M/*6;9FIM1G0C--4G7B0*I
M
M     ,*=<_RE[>>UU>[$@M#=8*@
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M:(&9[<
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M6D^'G)>,$PO/S^#73YTSJK2G,36OS00[
M
M        ,*=<_P I>WGM=7NQ(+0W6"H
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MP0E*$)0@J)21$DO 1< 0_0
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M4:B_-=6YW])H\>FLY;/3/&7I#6;@
M
M               #"G7/\I>WGM=7NQ(+0W6"H
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M;;9F7:HN4V?H54D=&>MY)BD6;7.P:Z<N2++,&:;N^R(]<S,1'IEH#IXVWO\
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MFX^1W=-M6ISWMEOGYN]J0I&EPC6JJ?*J94 JOX$
M
M                           ,*=<_RE[>>UU>[$@M#=8*@
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M=:FN3;XZ&$^R-)>4KZI1\3],QQ<N:_)-;IJ]+@TV/#%++8AW!A;(
M
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MC7WW7S6Z:R])CQ6XXY;8B([G,*,@
M
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M$_I%GYI)RW/D^I2\GQ1C[!E_G7?V22'Z19^:?8>)?V>R7Y_64OOP>C_QKW\
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M#KG]\1_4 H?K \/^!US^^(_J 4/U@>'_  .N?WQ']0"A^L#P_P"!US^^(_J
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M#KG]\1_4 H?K \/^!US^^(_J 4/U@>'_  .N?WQ']0"A^L#P_P"!US^^(_J
M4/U@>'_ ZY_?$?U *'ZP/#_@=<_OB/Z@%#]8'A_P.N?WQ']0"A^L#P_X'7/[
MXC^H!1IO;G-8VXN$V?-8<1R#%O#)OM1'U)6X@DN*;H9HX'734%4H
M      &(_P"T"Q6:XG#\T8:-<!DI-JFND7!MQPTO,5/Z8B=^9XP6AUM_NH/
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MN/@?9/P;$^Y@'Q:;<? ^R?@V)]S /BTVX^!]D_!L3[F ?%IMQ\#[)^#8GW,
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MH;L!4          &9^NDR+9-BI]M[A4_BI )A8G389'L5@M/^6H_OU@2M0$
M        "OM]?D7S_P#Z!<O<RP3"D.@/Y+LB_P"ON>XHH)EK %0
M 83Z-#(]]]QZ&7&--,O&7OFV"TMV J          #">5F7]?RV\2X2;>1^C[
MT(!;@W8"H          ,)_V@9D5_P&ITI&N!G_&QP6ANEK[$CZDOV 5?8
M       S;UQ&1;'JKWW>#3YCH)A..F(R/87!Z<?]15]O= E;0(
M          >+><0Q/(Y,>9D%AMUVEQ2TQ7Y\1B4XT6HE40IU"C3Q*O ![0
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M)J7<= '-;K;;K/!9MEIB,P+;&3HCPXK:&&&TUK1"$$24E4^X@':
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M=Y$Z"U&NK->;9D-IA7VRR43+3<6&Y4*4W72XRZDE)45:&52/L,JEW@J[P
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M<Y+$Q3);(_BERGNE'A2')"9<14A9Z4-N+Y;*FS69DE)F@TU[3("C3X(
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MZ )E'=O.1@?6[-LMD04:T2[K<H"HC1:&TL3&''DMI27 DH<T&DNPM) <']#
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MLV,;=MMS,A93'L]PFQ"*CMQ5(51)K1Z[D),B6OV-#(_6 F']& 5
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M XOGH#O%ZFX-D]HF.N.V6V7!D[62S,TMKDMJ6^V@S[$U2A>DN]1G[("6NP5
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M1;08ILSC)X[C*7'G)#GG%RN4FAR)3]-)*5I(B2E)<$(3P3XS-1F0L $
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M%JM=V6S6O';3"L5DBHA6BW,HC0HC140VTT6E*2K4SX%VGQ/M,%7>
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M1$I)_M< 0R@K^S^MOOB:6\\EIQPW"<.$<%!R:%P*KI/DWJH?K^3Z0+5:JP+
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M5
M
M
M
M
M
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M;1%Q\($)#M)FTS<;;NQ9K<(*;;,N[3CKL)M2EI;-M]QHJ&LDF=217L[P0F@
M
M                                   "@.L[Y ;[[:MWNML$PZ?1(?\
M_8J'XKE/_OT@2I_KXP>R6Z5B^<6V(W%NES7)@79QI!(*0;24.,K7II59$:TF
MH^)E0O8D"86?DN\NYMJZ>,'R7!+!+R#,+Y;HZ9US9BN3VH?F[24OR'4-DJJW
M%EY!*+3ZXS];0R**ER:Z=:^!X:6Z&09(E%H:)B1-@+3"7(CHDK2A!/1CCDDO
M*<2E24&:DUXTH="=B;9#OQNKD?37;=X<.EM6>_VBX*@Y2PS&9DL.LZN23R$R
M$.FFBELJH79J5QH0%%P;";M_&!LS%SK)92/?*V(E,Y)(2E+:$NP:K4X:4$24
MZF30X9$1$6H$2I'8CJ"W2SR^9WFN47#7MKAUMFW=RT,1(J%F:B<<C1R>2V2S
M-+;3AU-9U-)5[03,(QA6Y'4_U"7"ZS\)S&SXS&@N&3-C4MEAS2HM220DX[[S
MA4X&XL]-?F ;%Q=/F;=1+^3W'#=Y<<EO6V-SFXV4JBHBH3(CGZTUMDVV^TXG
M[&ZVGMIVDJJ2):3!#$N[G4GNY@?4+<\,QU3=XL4=R''MN-'&9U/R)T!HVT<Y
M#?//Z^[KHE9&?K>! M1X6>9YUD[.+@9QFMP8D62:^E#L%#<.3!:<41J*.\EA
M"5MU(C(E(7W>OKVC8T#>.IK'+=L-"WF:B:Y-S(H<&R*<\H[MJ6A;"ET+R&S;
M<6:Z$9MIJ15,B!%&?\>RKK8W8M#VX&*32AV&KAV^*PW!BM/\HS):8[<A"UN$
M2B-.IQ9U/@1G0P3L6MTR]2]WW)N<W;[<2,B)G%O;<=8E-M^;^=)CJTO-NLG3
M0^WVF22(C*ODIT\2)A5EJWMW\Z@\YNEIVRR6V899HAFY A3%LLO.,&HTH,U*
M9?>=<,BJLFRT)KZ%2:+*V@R[JCL&Y!X-NM8Y.0XP:B9=R5B,VAF.;B-;;S4E
MM#3;S5?)<29:TU[C3I,C8S#OPC=HM]XI9>XRK,52(QXRIOS;040YKGF.KE$2
M."NWF<?H@6A_0O9].YR,)CIW=6TO-.>_SU,>;Z.1K^M?]V(F_6^#CX059^Z[
M$[A'BL!5N6V6VI&T5Z0?(YIW$WCY!EJ+FTI] =/""8>%TH2=[[;@;ES4\PC:
M*+:+R_9.$13R;DT\M1*,J<XR)TG>"ST^E0"4PZ/-Y]Q-V)>7,YW=$7)NTM6]
M4'1&CQC0<A4@G#,V&T:J\M/:")AY>\.^>YN)=25@V]L5W1'Q.?)LK4F$J)&=
M4I$Y]*'BYJVU.%J(S[%<.X$Q#I]274/N=M7O-;+!C$M#N.%#@S9%E5&86<I3
MCSI.-\Y32W4\PD$GR#J7=Q B$0W.W$ZPMK4VG/\ +[K$@VJ[/DTU98[<5Z+'
M<4@W2C/-Z#41FE*O*)U2N!^74#8]2\[G=5NYV&3=V\*1'Q/ +4PY(;A1ULN2
MI+<)/^M/I4^TI3B4*0YP\@J%I(EJ*IC8MCIFZ@+AN)MUD-ZW!=9:GX=]<NMV
M;033;L(V5O$\MM!4):2;<U:"(CH5"!$PIEC?/J2Z@\JN5OV7;38,<MWEF9)C
MI4VRHU$T<J2^E?UQS2=&VJ=_ R2:@31[& ]26[6VFY$?;'J#92\Q+=:8*ZK0
MRV_&*0>EE\G(Y):>CF?!2J:D\>-4F@Q1WNICJ*W-VGW@@63&IS1XTW!A3Y-I
M=C,+*0:GG>8@WE-J=22TH)-4*(R[N($0EVQ:NJJX[A^^N[+CD'")L!Z?Y@MJ
M%RN:X:4L1T):J\PM&O719UHFBJF8(FC25XNT"PVF??+JZ3%LMD=V9-?/B2&(
MZ#<6KTDI,P0PU;=Y>IKJ(R>[-;0N-8YC-K,E::1T$VVX9DR3\AY#BE.K)*CT
MMD2>WA0J@M1-]B-[]Y(^YTG:'>. ]/E-K7&*\-14DN+)2CFMD\Y&232F74>L
M<I7BDZT,Z"8>!E^_F\^[VZ<[;/8)QNVVRV+>0[==+1K>;BJY;LEUUY#A-,ZS
M)+9(3J.I=ZM)"CLX9OQO-M/NG;MK=_5-7&!=ULMQ;PE+25M)E+-ME]#K*6TN
ML\PM#G,3K3Q.ODZ3%$-ZO/TF,0]I6?\ G&0!#EZ^_E Q#_I2_=2P(;[:^Q(^
MI+]@%6;NK_=G/-J+)B\W!;DBW/W*5*9F*7'8DZT--H4DJ/H614,S[ 3#R=[=
MY]Q<-Z?MN<[Q^Z(C9/D";8=VF'%CNI=.5;5R'*-N-J0FKB2/R4E3L[ (A"&L
MYZOMU<!8SO#EL63'+;"HM311T3[N_"1IDR6TN-*+REI7I;1RT>Q3J,@3L6'T
MD;_9-NK;[]9<[=9?O%@0Q*;NR$(C\Z*]K2KG)024$IM2/7)(B,E=G"ID3"M;
MUU$;X;W9_+PW8!";=9(AK4W.)MGG.QFE:#DR'I*5):0LS+0A*25Q(O*,$T?%
MLZA=]=BL[AXKOZV5UL$PDN+EDVP;Z(SBM'G$9Z,E*7209'J;61J[O).@%%L]
M3W4C*VHMUHLF$)8EY9D#'GL>8X7.8C03/2AU*".BU.JJ3?L?),SKP(R(A3>0
MY%UL[:6&-N-DMS*19UK9\\MSK4*0;/G"B2A,AAII)H)2E$CZVJJ5&1'0P3L6
MANAU 9HWTZ6;=#%V7,6RF7<F(%RB2XJ7.6HDO$Z2$RD*(T+-"5H52NDZ=M01
M1;73[EM_SO9_&,KRB2F9?;BW)5+DI;0P2S:F/-)\AHDI*B$)+@0$J4Z6=[MR
M]R]Q\IQ_,[LB?:K9"=?ALHBQHYH<1+0T1ZF6T*/R5&5%&8)F%9]-'Z6^6_YS
M(/=@$[E@9UG753N#N?<,*VTM4K#,<@F[YM<;A#*,B0Q'5RSDKE267",G%'];
M0P5=)E4CHHP-B-XCO?OWM=O19]K]X)S-[AW:5#ANF:&%&ANXK)IJ0P^PVVHR
M2H_*2X1\",J$?$"BJ^JA&Z"=YB+-5M+>-QS\33:\W(BL_G[_ )GKY1%Y5:UY
MOE>$$PT%N-N)U$[6;",9#F-QCP]Q'<D1#\X:8@R$':W8KBTITMH-HCYC9\=.
MJ@(32T;^2L6Z9K-NYFZRNV1S65M,,H2W%\\GKD/-LMT;224$2&]2S2GUJ5&1
M&? $44;CV8]:>\5NE9UALI-OQ]"W"@Q6$0HC#RFC/4B.4I*UNZ3+3J<6:=7#
M54CH3L6ETT=2]^W O\O;+<R,B)G$-+QQ):6_-E25Q3,I##S' D/MD1J\DB(T
MI5P2:?*(F%:+ZD]^U[V91MUC/(R!U=SNMFQNU.QX[*(ZF9"TM/K<0A*UDPTV
MHU:W*>R4? $T>9FN[G55L'EUL?W$NT>\0+H1R40R1&7 DMM*23S2%M,M+:6C
M4GUM*:B/RB V-[VBY,7FU0;Q%(RC7".S+9)7!7+?03B:^.A@J[@
M
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M-@JD0
M                                   ANZ6V]HW8PV7A5\E28=NF.,.N
M/PC;2^1QW$NI(C<0M-#-/'R0% _U ]KOA%?_ .,A?[J"U5B[8=+.U&UMS:OU
MLB2+OD$?C%N5W<2^MA7T33;:&VTJ\"M!J+N,$52+>/9'#MZ[-&MF3$]&G6]:
MW+9=89I3(8-PB):?+2I*D+TIU),NXJ&1\0(E4]AZ&MLX$68Q?KM=+ZX[&=BV
M]3KB&$03>(RYS2$$9&XDSU)UF:*]J3 JGV&8MM_TM81*BW')I3>*R[@3J)-W
MTN<F5(;)&A)QF4T2LFB/B5*^B!O8KSYK'.H7J?;AX TXNR7R5$8F3TI4WSFH
MK22ERTH41&A)--J,M155IJ=#50%N#^ER;= 3;BM/FS1VLF?-?,U()3)Q]&CE
MF@ZD:=/DT/N!1F/(^A;;>Y79ZYXW>;IC;+YJ4J!'4W(81J.NEHW")Q*?$I:@
M358&SG31M]LS+=O-H\XNN2NMFS[[7 T*6TVOUR6&VTI2@E4XGQ5W:J&9 3*Y
M00_G=NC8K3DW6XK'K[%3-L]SN%JBS8JS4DEM.VV.DRJ@TJ(^-2,C[06X+DA=
M!6V,>^%.EWN[3+*EPW$VE:F6S4FM2;6^A!*-/ATDE7C+M!%6DI>(8Q.Q=6$R
M[5'=Q-45,#WH-!%'**VDDH0E)4TZ2(M)EQ29$9<2!#-%WZ!MN)EQ<DVG(;M;
M8"U:B@GR).CCQ2AQ:253P:M1^,P6JO3:K9S!]G;,[:</B+2[*-*KC<Y2B=F2
MEMU))N+(DE1-3TH0E*2J?"IF9D553GG17MGEM^?R*R3IV+393BGI,:W\M43F
M+XJ4VVM-6S,SK1*]/@20%7L[3])FW6UM];RKSB7D&21S4J'+N)MDU'6HC+F-
MM-I(N90S\I:E4[2H?$"KT-[>FC#M[;A!OETG2[1?X+)0RFP]"TNQ26IQ*'&W
M",C-*EJ-*DF7:=:\*")2W9[:JU;.8<G#[1/DW&-YR[,7)EZ"6;CY))1)2V1$
M22TE0N/?Q >ON%@5@W-Q&XX7DJ'%6JXI1K6PKEO-.-+2XVXVHR,B4E22/B1D
M?89&1F0(5)L]TGXQL_F!9E;L@N%RFHCO16HSZ&6V=#Y$2M>A)FJE"I0RX@FJ
M.Y1T+[:7W(7[U:;M<;##E.F\]:XI,N,MJ6JJB8-::MIX\$GJT]W#@!5[K?1M
MM5"R+&LALK]QM;F,G$=9CL.,K1+D0Y!R>=)4XTI:EK,R2K2I):2(DDF@%4@W
M#Z;,0W(W"MNX]WNERBW>V)B)9BQ%L%&44%XWD:B<96KB:J'10%4EWBV@L&].
M-1,7R*;,@PHDU%Q;=MZFDNFZVTZR23YK;A::.F?9VT AWL?VUL^.;9(VMB2I
M+ME1;Y%J*6ZI'G7)E$XE2JI02-1<PZ>30$(]LML-C&QS-Y9QNXSYZ;VJ,N2=
MQ4RHT'$)TDZ.2TWV\TZUKW F90/</HLVNS>\OWZUR)F,3I;BG9C%OY:X:UK.
MJE)9<3Y!F?&B%$GZ4"J0[0=+.W.T5R+(89R+WDZ$J3'N=Q-!^;DLM*N0TA*4
MH,R.AJ/4JE2(R(S("9=G</ILQ#<C<*V[CW>Z7*+=[8F(EF+$6P49107C>1J)
MQE:N)JH=% 57." !FC/^B;;',KY(O]HF3,9?F.*=EPX)-.0S<7Q4IMIQ-6ZG
MQ,DJT^!) FJ:;-]->W^S$AV[6?SBZY*^V;*[O<#0IQMI7KD,(0E*6R50M1\5
M'V:J< )EY.[72;MSNK>G,H6]*L&2R#2<R9;C0;4A22IK=9<29:Z$7E(-->^H
M%7!M3TC;=;87]K*G)$O(L@BJ-<!^X\M+$9SN=0TVDJN%W*6I5.TB(^(%7L[E
M]-F(;H9Y;=P+U=+E$NMK:BL,QH:V$QU)AOK?2:B<96JIFLR.BNP"KZWDZ;L1
MWKO-MO>1W2Y0)%LC'$9;MZV$H4@W#<JKFM.'6I]Q@1*Y$I)*22781$7S 0K#
M>?8W&M[X-IM^27"= :M#SK["K>IE*E*>2E)DOFMN%0M/"@)B73SOI[Q7/]N<
M9VTNERN$>SXL44H4J,MDI+GF4541'--;2TG5*JGI27$"J;X7A5NPC"K9@UM?
M?D6VUQ3ALR)!I-]2#KQ4:$I37RNY((0'9GIQQ'9&Z7.ZXY<[E/?NL=$5Y%P4
MPI"4-KUD:>2TV=:^$$S+P]U.D7;+<Z\/Y(A<K'<AEKYLZ3;3;-B2XHZJ<=9<
M29:U=ZD&FI\55/B!5\[5=(>VNV-[9R9QV5D5_B+YD!^X\LF(SB3JEQMEM)$;
MB>Y2S50^*2(RJ!59>YVU.&;N6 L?S&&IYEI9NPIK"B:EQ73*AK9<H=*EP4E1
M&E7>1T($* MO0)MW&N+<BY9)=IUN0K4J$DF&#61'P2IQ*%'3PZ2(_ 9 M5H6
M\;7X/>\ 7MC*M3;6&G'1$9@,&;?)2T9*;6VOB9+2LB7J.IFKBJM3J54+C_0A
MMI:;XS<KI>;G>;7'=)U-I?Y+3;NDZI0\MM!*4GZ+1HKX@359.U/3GANT&57C
M*L:FSG9%Y9<CN0I!L>:LM./I?TM);:09$DTDE-5'P JX<#Z;,0V_W(N.YUJN
MERDWFYJFJ>B25L'&2=P=YJ])(92O@?K:J JAF9]$^WV2Y3*RBRWBXXV[-=7)
MDPX7+6REYU1J6IG41*;)1F?DU,B[J%P JYG.B7:MEZR3++<;Q:+E9=#A3H[[
M+CLF2V[S4/O<UE:=9'P(FR2FA%P JF.]W3EB.]Z[;.O$V5:[Y;&U1V;A#T*U
MQU*UFVXVX1D9$HS-)D9&53[0(E'8O2+A;6UBMJI%]NKMJ<O19$Y-0<=M_P Z
M*,470DC:6DF]!$=#J>KO[@*K1Q;:_&<9VXB[6NMJO.+QXSL-UNXDAQ3[+[BW
M%$YH2A/:O@:2*G#O!"@KUT$;;3KBY*L]^NMJ@N'J* ?)E)1]*AQ:253P:S4?
MC!:J[MI]EL%V;M3UNQ&*LY4S2=QNLM1.S))H+R26LDI(DIJ=$(2E)5K2IF8(
MJCF)]-N(8ANK<-VX%TN3U]N,B?*>A/K8.(E=S4M3A))+25T2:STU6!5W=ZM@
M,6WQ]Y3R2XW"WG8_.O-O>Y3*=?GG*U:^<TY6G)32E.\")679K6S9+/;[+&6M
MR/;HS,-EQRAK4B.VEM)J,B(JF2>/ $.\
M
M         S_UG?(3=?L/_?8'V?\ SY>L^F_:J"84YT&_\2O_ .3_ /W;V'Y0
M_9$^M_\ A?H_I] )EN,%0   &*\L_3&C?DY_Q6T_9_\ B_\ W*/_ '?^+\6D
M%N#:@*@
F                                               #_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>fc_pioneerrna-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_pioneerrna-4c.jpg
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M;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (  @ X0DE-!"4
M !#\X1^)R+?)>"\T8C0'6'?K_^X #D%D;V)E &3      ?_; (0 ! ,# P,#
M! ,#! 8$ P0&!P4$! 4'" 8&!P8&" H("0D)"0@*"@P,# P,"@P,#0T,#!$1
M$1$1%!04%!04%!04% $$!04(!P@/"@H/% X.#A04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@!8@/G P$1
M  (1 0,1 ?_$ +<  0 !!0$! 0             & P0%!P@" 0D! 0 # 0$
M               ! @,$!1    8! @($!PP%" 8)! ,   $" P0%!A$2(0<Q
M(A,505%QD114"&&QT3)"DK(C,W,T%H%2TC48H<%R@J)3TU5B0R24E1?"8Y.S
M='56-SCC)39VM-1%$0$!  (! P0! P,%  ,!     1$" R$Q$D%181-Q@2(R
MD:'!\+%",Q31X?%2_]H # ,!  (1 Q$ /P#OX
M                                        $"YV&9<J,K,N!^@KX_UD
MC/D_C5].[47L?J4J)F&IF?UT#IX_ZMX8\'JOR.FAU,7$_*U:C]HY!&H].\[?
MAK_U<@<.G\W1M_%VP.YSN,O:L6I/,B&1*,B[J8Z#_P"N='%S?R=''V=@U/[J
M@_\ AVOH$.R=F%7@E
M
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M4)W*3H7E,:3EUO16Z5L\:J
M
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MX;8&R@
M
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M[%VM2H75
M
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M23N,B\&ID03:7LBZV) +(
M
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M+V7HY,;?K$N;M26K7XN@GCX_&FVV6X!LS
M
M
M     >'?LE_T3]X!Q;[,'_NLO_P$S_O$#AX?Y.C?LZMYA8G*SC$I^+1K-505
MB26GYJ&B?63)*)2DDDU(^-IM/CT#KWU\IACK<5DL7Q^%BF.UF-U_X.KC-Q6U
M&6AJ[-.AK,O&H]5'[IBVLQ,(MS48YA\LT9S8XY=1;-=/=XU+],ARVV4O[TF:
M34THC4G@9I+CKX^ IOIY8OLMKMA4YH<N&^9=575;EDJL*OGLV).H9)\UFSKU
M-#4G377I#?3RB-=L)R-%7%-C_P#*-O\ _9(__1'#?^S]73_Q=K#N<P
M
M
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MF]F.CH =#(
M
M                                         !Y6G<A22Z3(R\X#CU?L
ME\P%*4??--HI2E%UY7A,S_N1Q_1LZ/LCS_"1GW^<4WSY7^"(^C9'V0_A(S[_
M #BF^?*_P0^C8^R'\)&??YQ3?/E?X(?1L?9#^$C/O\XIOGRO\$/HV/LA_"1G
MW^<4WSY7^"'T;'V1GL*]F7-\:R^AR";:U3L*JG,RWVF523=4AI6IDC<R1:G[
MIBVO#992[S#J@=;
M           !X<>99))O.);)2B0DUF2=5*Z"+7PF ]@
M                       +>=.B5L-^PL'D1H,5M3TA]P]J$-H+52C,_ 1$
M Y8S#VF<LR&W*DY5UZFV5+-$>4ICTN=*TU+<VQH:4(/P;B,_)T#EVYK;C5M-
M)ZL;)R_VJ*B.=I,CV)14%O<WU\9U*4])[D-M[B(5SR1.-&Q.4/M&Q\PGQ\7S
M&.W79!(,FH,UC4HLIWH[,TJ,S;=/P%KHH^!:'P&NG+GI5-M,-^C=F
M               #P\\U':<??63;+236XXH]$I2DM3,S/H(B 8BCR[%LF4\C
M';F':KCDE3Z8;[;YH2O7::MAGH1Z<!6;2]DV6,T+( &$C9CB<RY7CL6[A/7S
M:G&W*UN0VJ2E;)&:TFV1[B-)%QX<!7RF<)Q6;%D                    (
M7S<L;"HY:Y+954IR%8QH:G(\ID]KC:R47%)^ QGR7&M6U[M8>RYEF493&RE6
M2W$JV5%=A%&.6OM#;)Q#IJ)/ M-="U&7#M;G*_))'08Z63D?ESGN<67/E%#8
M9#.DTAV%HT=>Z[N8[-EM\T)VZ="326GD''IM?/&6^TF'7 [&#E#VDLZS7&\]
MBP,>R";5P55S+JH\5W8V;BGG"-1EH?$R(AR<VUEZ5OI)8ZEK%K=K8;CBC6XM
MAI2U'TFHT$9F8ZIV8U="4
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MY9]FZML<MYI76?S4&EN*4E]Y>G5.79*/1O7W$&HQR\4SM:VWZ3#KP=;
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MS+$\ET[@NH5BLR,^SCOH6YH7AV$>[^06FTO96RQG!9
M        L;BYJ\?K)5S=2VX-7#0;LF4\>U"$E_*9GT$1<3/@7$1;@0[EKS>Q
M?F<W-34&N)8PG%$Y72M$R%1]VC;Z2+I0HNG3XI\#\&M==YMV6NMB?BZKEOGU
MSZ[;TG!L%E&:-5,75RP>NI_%5&CJ+I,^A:T_T2'+R\GI&VFGK6L[3D5GU#A$
M;.7HRD+0?I$JJ:)13H4=)$I#ZM..J>E:2ZR"XGX=,[Q;297\YG#I3V?,]R?.
ML06]DL1:EUZTQHUXHMJ+!!$>JM/"M&FU:BX&?NZCIXMK9U8[R2MN#50
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M\B:230<JL=AS$&W*>95,<0KI24IQ3J"T\'44D:\<QK%-N[8HT5
M            !S][0W)>7E9%FV)1U/9)'0ENP@-<%RV6^"%M]'US?@_63[I%
MKS\O'GK.[73;'2IKC^4VW+WEQ#LN<]G&9MF$["4V9N27DD7U;:B+[5_3@HT<
M#Z3\)C27&O[E;,WHYVR;+L[]HW*F,9QR(J+CT9SM68:C/L64%P]+FN%PW$1]
M1!='0G51F8YK;R7$[-))KUKJSE[@E1RZQF-CE3JX2-79DM9:.2)*]-[JO%KI
MHE/R4D1#KUU\9AC;E*19
M          XGY:<QJ?EEE>>W=FA<F2^MUBO@-F9*?>]*6K3<>I)21<5*,<.F
M\UMKHVF66:3SS]H%TWR=.FPYQ6B=#7&@;=3Z"+ZR09=&O1Y!/[]_PCIJV!0^
MR7AD-HE7]I.LI1D1J[ T1&M?"6A$M1_.&LX)ZJWDK.K]E_E2I&U,::@_UTRU
MZ_RD9?R"?IU1]E0O(_9-89W3L$OWHLYL]S,>?QXEXGV22I)^+JBEX/:K3D]V
M#H^;_-'E!;LXWS3A/V-.9[427=%R2;+AO8?+JO)+]51Z^#4A6<FVEQLFZR]G
M4./9'2Y74Q[R@F(FULDM6WFSZ#+I2HCXI47A2?$=<LLS&-F&4$H
M             !%N8EWB%#B-C*SCLG*!QLV7H;I$M4E2RZK3:.E2U'\73H^-
MJ6FI5VLDZIDN>C@6MM[*BNUY;AR)-8S6RM\-XS.1Z,AY1]DQ(=)))7N26U1*
M(M_B'GSI<QU7VKL+$\\@<]\"LZ*)8N8YERHW8V+457UK)JT+MF=W%;*SZI\=
M2U-)F1Z&?;KMYZN>SQJ,\EO9W7BED>39REF3;PG5)IX+2B=CM$@S(I*C,NLM
M72@OD=/QNBG'Q8ZU;;?/9T,9$HC2HB-)EH9'Q(R,=#)1B0XE?&;AP([<6&R6
MUF.PA+;:$].B4I(B(O( K@                .-_:T:DISZL>=(SC.5*"8/
MP=1]W>1>[QU_2./G[M^/LZQQ61#EXQ32:XTG =@QEQC1\7LS:3M(M/$0Z]>S
M&]V7$H8'-I$.)AN02)ZDIA-UTLWS69$1H[%1&7'Q] KMVJ9W<M^R(U(/,KIU
M)&4=%2A#IGT;U/H-!>71*AR\'>MN1V$.Q@             ,)EV*U.:X].QJ
M[;-R!.1M-2>#C:RXH<0?@4A1$9? (LS,)EPY$DX]SB]GRZDS:/M9="\HM\QA
ME4F!);2?4](9+4VW"+AKP\.BM!QV;<?;LVS-N[(R?:IYE6$=4&MIJ^-8.%L2
M^PS)D.I4?A0TI1EK_2U$_=;VAX1D.6O(_+L[R,LXYJ^D-P3=3(7%F\)DYQ'Q
M$K1_JF"T^+P,RX$1%Q%M..VYV1MM)TCK1*221)21$DBT(BX$1$.IB^@
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M8>20TI[UJC/4T&?#M6M>*FE'T'X.@_!KU:;S:,=M<-B#14
M    &K>>7*Q7,O&4=V;$914FI^J4X>U#I*(NT84KH(G"(MIGT*(O!J,N33RB
M^NV*T'RLYX7?*E3F%9G6R7Z>(XI)1E%LGP%*5JM*4.:$MO4S,DZET\#T'/IR
M73I6FVN>L;M/VG.4Q1?2/3Y9N::^C>AO=KY.C;_:&_W:J?76C^9_.O(.;CK6
M%8?62&*:4ZDO0D?639ZTJU03A(U)#9&1*VZ^ZH^ QWY+OTB^NLUZUT+R2Y8?
M\M,6-B?L<R2T6F3;.MGN2E1)T;92?A2V1GQ\*C,QT<>GC&>VV:V8-%
M      %-]]B*RN1)=0S':(U..N*)"$I+I,U'H1$ @LWG9RIKWUQI.50NU09I
M432E/IU+_2:2HOY13SU]UO&K?_GURA_]51OF/_X8C[-?<\:\)YZ\G$+4XC)H
MB7%?&433Q&?E/L@^S7W/&O?_ #ZY0_\ JJ-\Q_\ PP^S7W/&LS0\T.7N32"B
M4>1PI4M1D2(_:]FZHSX$24.;3,_(0M-I>Q=;$M%E0
M  Z.)] #BIB-)]H+G@^F4XL\<CK7NVF?U=1"7M2A/ZIO+/B?C49CC_GO^&_\
M8[.APXM=$8@0641X49M+,=ALB2A#:"VI2DBZ"(B'8P1'FER[K>9&*R::4A"+
M-HE/5$XRZ[$HBZID?3M7IM67A+W2(4WUFTPMK<5HOV5<MFP+BXY<V:C0C1R;
M#87KJU)963<EM)> CX+\I'XQAP[=;&F\]75(ZF(             Q&1?@D?>
ME]%0IMV3$8&:X                  )#C?V<CRI]XQIHK6=%U0
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M'F#F2<ONZ);AN3L>=*'N4>JCBN%O8,S/Q%N1Y$BO#MF83R3JW6-V8
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M7(ZV  X]Y9*:D>U!9O0.,,YMTLC3T=F:7"U\FXR''I_V5OM_%V$.Q@
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MHM#(_*.ADY6]EPU5V?YI1I5HPAI1I;\9QI1MZ_H)8Y.'^5C?D[.JQUL
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M>%4<;'L>C%&KHI</"XXX?QG'%?*6H^)G_-H0[)))B,+<LT)0
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M&9GX1,DG2%N61$H        <E9\1*]JBC(^)%.J?Y&D&.3;_ +(WG\76HZV
M  (7G_,_'^7!0#O8T^1WB;A,=WQE2M.Q))JW[3+;\;@*;;S7NM-<H7_$[R__
M ,MOO^&.?M#/[M?E;ZZV+A&;4?,"@;R/'U.G 6XXP:)".R>0XR>BDK3J>A^'
MIZ!M+F94LPYLYIR;S*LZRCF!0.ZQ>4YP&HB"3J;L@GNTDDG3]7K&H_U2'+O;
M;;/1KKTGY=34=Q#R"F@7E>HEPK&.W*8,CUZCJ241'IX2UT,=4N9EE9AD!*
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M3"M(D*<Y8JLI"7CD/(2VM+32-J&SVF9'H9J/=PUUZ!333Q6VVRV&-%
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M6(10W9.^*AQ+F]M22(M5K46G6\0MQ\EVN*KMI)'0PZ60
M UIS7YKL8(Q'I*2.=OGMOHU34S1&M6Y9[2==)/$D$?07RO)J99;[^/;NMKKE
M3Y1\L['$2GY5ET]RSY@9"25W$@W#4RTDCW)801'M/9T;M/<3U>EQZV=;W-KE
M*LEY>X1F#K<C)J*)926RT0^\V7:[?%O3HHR]PST%[K+W1+8RM+14V.0$5=#
M8KJ]LS-,>,VEI&X]"-1DDBU,].)GQ$R8+60$H                    6EI
M^[)OW#OT#$7L.4?9'_\ R[(__+FO^_')P?RK?D[.N1V,     !^>.=99EUGG
M-O9VEE,C6\.>^RPAI]QKT0H[JDH;:))EMVD1>4^)CSMMK:ZI)A[S3FAF6>)K
MV[RP<2Q7QFXY,1EK9;>>;+14EQ*3(C<7X? 7@(@VWNW<FLCI[V8,@R"]P*4W
M=R'9C%;.7#KI<A1N.&REM"C;-:M3439JT29^#AX!U<-MC'DG5NT;LP
M '.7-GD)FF<YW+RJCL($6*\W'2R3[S[3Z5,M)09_5LK(N)<#)0YM^*[;9:Z[
MR3"(?PR<VO\ U'"_WZ=_@BGT[>ZWG#^&3FU_ZCA?[]._P0^G;W/.'\,G-GPY
M'"_WZ=_@A].WN?9&^.3&#Y!R_P 2>H\EFM3K!R<]*2\RZZ^DFG4MDE.YY*%:
MD:3X::#HX];K,5EM<UL0:*M,<YN2LSF7D&/W%?+9BMQ"]#NB>4M*G(':I=T;
M)"%$I7%?!1D7$8\G'Y6--=L1N1EEJ.RW'803;+24MMH3P)*4EH1%Y"&S-[
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M+1#0LM.P9TX%H754I/#3JIZOQHTTQUO=.VWHVN-5
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M7%;BSXK<6?A4M1FI1_S#OUUDF(YK<LT+(
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MDJ,R1N(M%;?)T&>M/"9SZK>5QA*1=4
M     !X;9:9W$RVELEJ-:]A$G<M7$U'ITF?A,![
M                                    >5JV(4LDFHTD9[4])Z> M?"
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M2U4DE%P/3734N YMKFNS28UD3456
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M<CRI]XQIHK6=%U0    !&\C_ !37W?\ .8SV6C"BBP
M)?2_NUG^M](QKKV4J_%D     "&VG[PD?TQC>Z\68A(
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MWNO%F(2                  ">-_9H\A>\-V;T      ((Y]HORG[XP:/
M                 ^D 'TF ^   ?!*E?JI4KYI&?\P#4U'[17+J9BM/DV42
M3Q5R\1-=@5DDG9KJVJ]]4=Q25QVC(S-2>JG34;7AVSB=6,Y=<2WIE(YW./E9
M5X]49;891&;QN^=4S4S&VWGEOK;,B=)++:#<+LM?K-R2V_I(5G'MG&.JUY-<
M9ST02AY^3,F7CLJ#%JX=1:9/98\^;SLF0_*@UT=M],B#V2-#=6E>NQ?#H(NG
MA>\6,_A77D\NORGY<U<#DU%#;UMRU(9RTY3&*&;3^DR3$2HW$J23>]M*#+ZQ
M2R+0AGX7-GLO-Y9T]4:Q_GKB$;!\7R/F1?U57;9*F0J.W5IEOQ7$1WULFXA*
MFU.I;3MVK6LMN[73H%[Q7-DG96<DDEM7W+#G%4<P:R@5/;;J,GR9ZR13TK:G
M)"7F*IS8XZE[822X=;11E[FHC?CNM^#3DFT7LWG7RKKZ%K)YN2--4LB<_4QW
MNQD*==FPS)+[:&4MFXHF]2W+).WW1'U[9QA:[ZR9K$S.>6-2I^%,X6MG(ZK*
M\A<QB58H4ZPF(\RRV\:T$M!=KP=3_H^Z)^N]<],3*)R2]NK:9](R:/@  NJW
M\?'^\3[XF=T5-!LH     +*W_=TCR%](A7;LF(<,EWME1(=;6KXJ5$9^0C <
MO%RUYWO8UGG*Z+C]9#QG.KV78R<JFV+;AQX$EYM1[(C1J4IS:TDT^'CT>$=?
MGIF;9ZR.7QWZR8ZU=W/(#(["YSRUJ]*ZXCMU!\M[XY".U>.NKC@2F'TI,S0W
M);ZBR66FNA]!&(G+,3^Y>*VV_P!%K6<F>;4^MY9XW(*LHJO!:6:3[]FEJVC+
MM[)UUMQOT9I9FO9'6G:X?5)6NG$3>33K?<^O?I\1*\%Y)O6/+VHPCFTS+*1A
MLN=%QZ746CD9$JKD+2MIQ?HZMW#B1(=ZR2T%-N3]V=?5IKQ_MQLSW,WE0_><
MEGN66$.*0N$J,]6L64E;OI2(KYOJC2)#A[C)S<?67PU))<"Z*:;XW\JMOIG7
M$:GM^4',W(GN85LU@M3B;F48DQ35E+538ILG/8F17#[0TFA*%*0RI6NFTB))
M&9JXC?[-9CKG%8SCVMMLQF,SE_(/(;>Q.+BL"%05LWE\C'9\N,MF.VNZ;<;>
M[)]#6BEI6;>U3VAEX3/@*SEGK[IO%<]/;"\Y<\NL]A<UL5S.ZP:IPZEIL=DT
M4U%3+COK?DDR;;;[R&M#-3AGU3ZQDGXR@WWUNMDN>J=-+Y9LDZ,/F?(_F!<Y
M=G63Q8BY]1:Y-7V+>*JLRBP+^F;(^W1(2A:=CC:B2;?:&1Z&K03KRZR2?']$
M7BMMJZR;D+E5_<<SLGK6FZG)9EDS8<OYJ7FT]O#7#7%F07B29DVVZVHF]%\"
M41?)U"<LF)Z>IMQ7K9W4&.2G-2Z8P*BE*KJ&FPO&'J\WK-+=LPY:6AN-2TIC
MLKUW(96DDNGPU+5(G[=9F^]1]>W3XC;G)2CR_%>7%9B6;,):MJ!Q^OAOMO(D
M)DUK:]T9W<@ST/:HT[5<2))#GY++MF-])9KBM@#-=F,=_&K^Z/Z21?7NK4F&
MBH     Q&1?@D?>E]%0IMV3$8&:X                  )#C?V<CRI]XQIH
MK6=%U0    !&\C_%-?=_SF,]EHPHHL                  "7TO[M9_K?2,
M:Z]E*OQ9      AMI^\)'],8WNO%F(2                  ">-_9H\A>\-
MV;T      ((Y]HORG[XP:/                   ^D 'TF ^   KBA:?"I"
MTEY5),B]\!H?ECR3RG#,@Y96MS(KI$7"XMY'M4,+6XM;EL^ZZR;!+;(E;4N%
MO-6W0^@=&_+-I<>N'/IQV8^,L/CG(CF1AK>)Y!CTRB?S'%[6[D)@V)ON5;M?
M=N)4E1*0VE27FM#U(B+P;3X"UY=;F7.*?7>EGHN<0Y#YO02L*DV4ZJ=<QW-+
M'*[,X:G&VW(D]EAM*([?9D1+)3:OJST(DZ<1%Y9<_@UX[)U]U_AG(:[QG/;:
MWE6,9[":]F\_(-:VM9OQ)&1<'3?2:"2DDIU3JE1^X&W++/GU3KQV;9]/1B<9
MY&<S<';PNXQF=C\G)Z:EG8U>1;=+TBO*--EOR$R(RB;)2E)2]M6@R+=T<4F8
MF\NMSG.%->+;63&,R85,5Y(<S<'A<O[3'K&B>R[#9%RW(8GG).M>AW3F[M$*
M:0E9+;+4S1H7@T,-N77;.<XIKQ;:R=LS/]U*AY%<S,3AXC>TUA12\ZQ2YNY_
MHT_MU54F)>*0>\C)!+;=0:35H1:EPT5J07EUN>^*GZ]NEZ9BOC'(?.*A_%)%
MG-J'7Z7.IN8V1PC<997#F,,-DB.WV1$E9+;5]6>A$G3B(VY9<_C"VG'9W]\N
MB3Z1S-WP  75;^/C_>)]\3.Z*F@V4     %E;_NZ1Y"^D0KMV3$.&2X ^D1F
M9$7$SX$0#7L+G3@MAE[V&13L5RF)SM0Y<^@N=S%9QT[W(QRB,R2I)$?66DD^
M[X1K]>V,LYR2W"ACW/?ESDUTS309$Z*U.*4=1=6,-<2IL?0"-4CT62L]%[$I
M-7626I%X^ 7BVDR3DUM6%)[1O+3(;JIHJM%R;]]*7#I9C]:MB%+[,E;G6GEK
MT4UJDRU(M==-2$WAVDRB<NMN&;K^<.&6=5AES%*=Z#GT]RJQ[M(Q)7Z2TI2%
M>D%VA]FC5)];50K>.YL]EIO+)?=85//OEQ=W;=)!=L21+<E1ZFY?@K9JK&3
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M=? *?3MC*?MF?[-OJ2I"E(66BTF9*+Q&72,6RXK?Q\?[Q/OB9W14T&R@
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M9\#-)F6OF >5*4M1J49J4H]34?$S,!\  &8QW\:O[H_I)%]>ZM28:*@
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MHT[75J,]A$1(X:BVTDUQZHUMMSZ-IC%HS&._C5_='])(OKW5J3#14
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M725XD<O<+R-EF:4N;+;<BE639\"W?+O6$P:D^CSW8[FDE*3-:#-1[RXIW:<
M\[#QE5;GE?A-]*>E383["9<5JNLX<"7(@PY\..CLV&I;+"TI=2RD]K>NAD7
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MVV]?9\S/,,GQ_(KC#8<TN^LM16'RW><:2HHS\EXH=BA75T64;0Y9;]VB3X\
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M$LQCOXU?W1_22+Z]U:DPT5     &(R+\$C[TOHJ%-NR8C S7
M      !(<;^SD>5/O&--%:SHNJ     (WD?XIK[O^<QGLM&%%%@
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M8WNO%F(2                  ">-_9H\A>\-V;T      ((Y]HORG[XP:/
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M)ZSBNA)<3# S-?8U]O!CVE3+9GU<Q!.Q)T5Q+S#S9\"6VX@S2I)Z=)&(%R
M "0XW]G(\J?>,::*UG1=4     1O(_Q37W?\YC/9:,**+
M    E]+^[6?ZWTC&NO92K\60     (;:?O"1_3&-[KQ9B$@
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MT_"'C3)W18^KGYT_"'C3)W18^KGYT_"'C3)W18^KGYT_"'C3*8#50
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MH5G%8G1>T+:YV,II+K>Y.IZ*VJ+4M>!A9@B5XW]G(\J?>,7T16=%U0
M
M
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MBPKY)PI\,W.W:W[26E;;FB=R5)/PI(R/A[HSWU\:UX]_.9;5%&@
M
M
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MKJ48N@
M
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MK;>ZKSD4E&@G%(/BDE&1[=W$RX]!D->2RUCQ:V2Y]W10R;
M
M
M  ,1D7X)O[TOHJ%-NR8C S7         'TC,C(R/0RXD9=)&0"DU&B1UO.1H
MK$=V2K?)<89;:6\HN.KBD)(UG[JM0%0      2'&_LY'E3[QC316LZ+JN?,D
MY(Y;S5YNO77-:;'D\J,>4V[B>-0UK[*6ZHM5.3$'IUDGP5QZW06B===9O).G
M=C=+MMU[.@&66H[3;##:6F&DDAII!$E"4)+0DI(N!$1=!#)L]]/ P
M
M
M            8C(OP2/O2^BH4V[)B,#-<                  $AQO[.1Y4
M^\8TT5K.BZH
M
M                                 ,1D7X)'WI?14*;=DQ&!FN
M            "0XW]G(\J?>,::*UG1=4
M
M                                                      &(R+\$
MC[TOHJ%-NR8C S7                  !(<;^SD>5/O&--%:SHNJ
M
M
M               #$9#^#;Z/M2Z?Z*A3;LF(UYAFL>8 \P!Y@#S 'F /, >8
M \P!Y@#S 'F /, >8 \P"08Y\21T=*>CR&--45G!=4
M
(       ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>fc_cancervaccines-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_cancervaccines-4c.jpg
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M%!04%/_  !$( , #Z ,!$0 "$0$#$0'_Q #"  $  @(# 0$
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M'[9!\T!ZX;M_ZU1/,4G9[8T\+$W3ZJRQD1?TVT\X0;&>E(_>;CG;$CYTAO@
M!%/>)9BYL!#@XX[:>%_-/JK543NQ*4&#5\[)S@*@W&*,9V5YOS=A/<".?./@
MY<:>$K=NU5W\RU451=/7R"Z!C)KI*N'":B9R#@8IRF. E, [! =M*)E.J1?Q
MM]1,>VEI9I.1\2]PYF_=E?-VRV/8R*J92CC_ "T\-3G'NK*RA-0I)@:6C8^X
M'L24IE#2#9-^LV B>.<PJDQ)@7*.8<=F T\$9SZJAO.LEES^<G>3#'-SI;##
MY<<]*,Y3JE7<;?4?$H3TBTG6<"Z$ ;2KDCY%FJ(]C(L? @]VGAJ<H\S5EBX/
M4.=;\[@HZX)5F!A)SE@F_=)9B[#!G2S!B ]D,:GC8_//JJ*1>3;E=-JV>/UG
M2IP22;I+N#JG4$< (4A3"(F$=F ;:OAG*6]+,+W@"HFGVTY$D<[&YY KUJ50
M>SP!5R@/^RD4E9FZ/=89FT)J$]C33+*.N!U#%3,L:203?J- 23Q$QQ6+B3*7
M*.)L< P&GC9?S[HYTO<+$$1?.)%J#E(CEJ*ZSE+?-U/H*IYC!G(;\TQ=@TI#
M.4QJD6T+J$]?+Q;*/N!S)M0(+MB@F_5<(@H7,3>)EQ,3,7:7,&T*>%K=NU5T
M;N:JOD'19=!:+P\ZIJF=D.SSB!2\X P@*6(B !GPQIX*W;L<;ZT3+Y*+A32L
MG)K_ +%BR.Z<N#X>"FD)C#W*>")NGU5V=)W8QDQA'X2S2;*<J0QC@SM)WO#C
M@4NY.('Q$=@!AMIX*W1JS2S&]K?!$UP-YN((XQ%N:1!ZT*IAM'(*V4#?[*12
M29NCW6&H]6N&-6%M)KR3%R4A5#(.E7*"@)J%S$-E.8!RF#:4>V%/!6[ZU;:3
M"]UY L0@WFU9@Z95R1Q >F="B< ,50$0X>00$! V&%/!6[=W=1=^,7QHMZSG
M6TH1 SL[!8KY-R5J0!$RPI&P/NPP'$^&%/!6[=HIKW"LT-((N)%2/(HF@=X1
M9R9 JRP8IIBH!LH'.'T2XXCVJ>"MVZ7>6UJ9'-W#N2A[D9-&A=X[<.4)%%)%
M,?SE#G  *7YS#4K&R_GW_F@?.<IZ1>=*7X]6C.4ZGG.4](O.E+\>E#*=3SG*
M>D7G2E^/2AE.IYSE/2+SI2_'I0RG4\YRGI%YTI?CTH93J><Y3TB\Z4OQZ4,I
MU/.<IZ1>=*7X]*&4ZGG.4](O.E+\>E#*=3SG*>D7G2E^/2AE.IYSE/2+SI2_
M'I0RG4\YRGI%YTI?CTH93J><Y3TB\Z4OQZ4,IU/.<IZ1>=*7X]*&4ZGG.4](
MO.E+\>E#*=3SG*>D7G2E^/2AE.IYSE/2+SI2_'I0RG4\YRGI%YTI?CTH93J>
M<Y3TB\Z4OQZ4,IU/.<IZ1>=*7X]*&4ZGG.4](O.E+\>E#*=3SG*>D7G2E^/2
MAE.IYSE/2+SI2_'I0RG5<]('3QYJW831X[<.&B]P1J:Z"JZJB:A#."XE,4QA
M 0'Y!K-_Z9=..Z<H^ZA=LWZ9_P">-:CTYW>Y^\N:J% H'9HA0*!17&(8X=L.
MS1#$.QVZ!V.S0,0H.:*4"@D;>_U%"_\ <67^93J3Z:L_5#/=W^K[C_[M(?YI
M2I;Z@O\ U3]T/6F7OEK6;:CQ3X;2NHALKZV.Y(ERB<@CYP(C)'13*OMP,!2!
ME+7&9G\SU66Q.'CW5M2NFEHDCM2K\M>.YYIZ^MIU(VHHX)BI"R[641:NF)AS
M")%D1,;=XB.9(Q=HX#4BZ?$.D\=OF:>*(R0G++L>U]*VTCIW 7$QN>$2?7"Y
M=)N$I=91204;&%!TBL7(?(4,O 'A?_A?,S/EF<;8MBGN&:Z],;;LJW?B!C4D
M223NS)*WF]MRKGANFK>174.<N<N4,PD$J:@X<+#L!2+IF;?Q8OLBV+OP+VD[
M#T:N=KIN&GD)=4?'L8U>YIF8,N>5DUI!N1TJ9HNF<I6I !3=H@0AMI=N-+8F
MZ*U:OFWCFE*_Q]%5TEM:!N[4MZ\&&=N+!MMK(71(0:X\Z=FCH],QT6:ABE+O
M#**"1+$"XF#M5J^9B-W/CMBZ_P!>(9-6(J/TZU):7)"V^V&U9V.:73 VY,H&
M49E;2"'VC5=$#)FP06 Y0+B A@ TLFL');C?6GA9=55K;)>UD6A%V7;\/'2*
M5L3+]S'-%4G2QY4I#N&QCF6,'-S;P0R9<< #A5FVM)FKKR4RB*0RRMMV79<I
MK%?2]MM)QO:=UDMNV+9=[P(AL+M50W.'221B&.F0A-VF3.!<P_R8(NF:0MW'
M%M;E=N)E;=Z:9--4&-NLK6GH^YVELS+*&(HE$2*+M+?D5(BH<^Z63RB50A!P
M$HXU:S$T8BV+XK2CV>5T<T]?ZU.I2T(--:Q8LTW!W=;2I"BC&3+&*6<M' )@
M;$&[D"E.F;L J4P;,< YQ?./EWGBMSK3P\-TF4/!:;:JWWO2D=$A6EJ1PG#$
MYG5PKE!;(/:$$$CX_,-=;O,Q#R\?BVZ=J/+@ "@!2["@& !\P5T>=S15DGO]
M(V3_ %$M_P"XC6(]RZW?HC\?]U;K;D4"@4"@4"@XQ#L=NB.>Q0.QV:!\_:H.
M,0^6@8]OM4#$ [(T#$ H.:*4"@4"@4"@4%KO'_HM@?\ QS_[D[K%OU^[IR?X
M_95*VYE H% H% H% H% H% H% H% H% H% H%!]6Z-JWG+V=IO LFURVONWD
M@E:%\6D9"2B55UUQ%;S_ !HB(!N^&&=80Q)M , $:\U]*R]_#6;(B/&Z@:$R
MUQ1-VW]#M)IP5HVMF[%U"1SE5)@=X@B( Z233,4@")B@9,X%Q#9AV K=\12'
M/BF<KHK])<_#DRE7D[<^JSN2:EE+4B5#1<Q<3PB+0]QRR8M60N7#H1 <I1.?
MA#CL -E7D]49X/,S=,^M5WE[>MIA\35A7I<ZT8ZM6^T$IH7C94KF$-<B;8S=
M8F_+B0Z8/R$.; <.&&-8B9PF(^CI,1VQ,^I;,!&:A/8:_O>S<-Z0;T&$@K>I
MYV/9.[1.DFI_ATF9WJF&^4^S!N+5/,&S)LP&I-*Q2CI&5)RK_3^/XA$+BIU:
M-,1%&\S+^;;CYL-IG,6,*?GZO_50 IA%/'LX"' S5K_.?3G/_CCW]?3QG1X;
M:#5*RAO#<>K'G5KS_?Y.:88_9[W/P-SO,F?-P<O9V5UOK2:/-Q4SBKW:R UR
M#6&X!UC\Z^[\2R?O#&:WWJX,5NUMWN<WV.&.7FNXX7R;,:XSCCX]O7;GG.7K
MZZ*HPN"&@/ARLP7TK<\4Y<3%SA!&MIV1FF=0@I;OG^<Q3'(&)?H;0X7;JTF;
MI],S=$<<>_P>;:-YAU@T[$^&<;EB1.(=@3"[3$1V_*-=;_TR\O'^N/N]Q(&H
M7GK6PNI82GN>%"X! ;BYQS#SIOQ\V>;Q<_T^\RY-SLRX8]JN/CQ3V]49?FS_
M $^?[(B9%</A]TVR)7J9YZM2>[4MTYBV\4>?JY_.12E$1##Z> A]G2/U3Z:Y
M/_'XK^']6QI7;T9J[9ED2D\HD9OHY)+DNTZF)C*VB"*DJVS#CPBD5;G;E*7L
M%-\E6Z<9FGU9XZ7VQ7_%SI'<SZ](#7J[Y@)Y5><<0K]RE:)A+-EW\@H9--J8
M0-@4A,"'##]F TOBF,,\5\W3=/GZ>E9M%A*RMN:_Q\:RFGK]>/C 092A%',Z
M8I98@E!T0A1,98"!B; O8^:K,TF$LB9B[W_5WL5M=+/1&\V6G:#]MJFA<+=.
M[VL>11*<3MDK80(5,A0!8J0.,=^"89O"V4NIE%?2<>463C[K_):F7K*#'0,-
M20<CJ8%[I^8RRNR6]5]^CN^=9_MLG.,=QOMN7Z.RL^/-/5'6:TMR]U06MNIE
MOMXO4C3>->7#<4G-7*HY?*W.*0,H52-=J"8D60JJI\5!$4A.;)]F !EK5ED^
M)<^?EBDVQ7^)>J:JVG:6H%W,[CEQ(U:Z1LXX^H2*I@*H^@#1))=H*8&$N8YW
M!56@@ X\,*YVS,1]WIOLMNFL_P"/_JU%9A6XOB7F[A5;OFYI;3,7ZK2*,/G)
M/G46144VAL/VP";!(</IX4I2W\69FO)7_P"*B:43$A;VL%PW#&(W%SF'L>7D
M(U&^S&4DQ.U:@J4%AP+B@*@<$ ^?MUNZ*VQ]W*V9CDF?/J??\>G2]8:W2?#W
M-WU9!TD+/O.Z824:0Q%!,O$OTVS@CUBI@!0 $EMJ(^+,7YAI;7*DM7Q$63-O
MJJNWW<]U._A^TOYY.R3@)*1N9%_OGCA0'2*2R&0BV8X[PA<392FQ -M:MB,I
M<;KYGCM\ZO%:ZO.4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%WT8_\QZ>__(HS
M_,%K%_Z9=.+]<?=1^V;],_\ /&M1Z8N]S]Y<U4*"4MFWGUW7)#6I&;)"<>MX
MYN;M%,X4 HG$>T!2XF$?FJ3-(JU;;E,0]@^(ZSK28Q4;>FG,"M VVS?25G22
M9T3H@J_B1SMWN)RE$>=)"80'#\WY<:Y<=TSXEZ.>R(I,13Z*EKI"0]O:C*1D
M$Q1CHT(B$< U;ER)@JYCTE53X?*<YA,-:LFL.?-;$74A=+@TQ@YO0"P;BLUD
MF;4I!N#J>8MR#SB0CI*25CD7!]O#%%P5(@Y0Q I]NRLQ=,737T[3Q1-D4]K/
M>.BEA^N>BFG,*HFFVE3OXN[9UKB1=\^BUBD>Y5#AM$%4U4DC9>#CV\*D7S29
M6[BMRMB-ZJU8\A8NL5\&TG'3V%MB&E"R2-N2\45<DS%K,$E54E73@ZAN<EP2
MRKE4*'9V859K;%:LVXWW8XT199BV[#T3T^N)>R+=N60N)Y/HSCF9;JG751C5
MDRI@BNDJF9,<JA@ P8_F_P"V^9NGRS$Q;9;XB:KK;&FEEQ6K5\1S6-CEX)&Q
MB79;K&[3"JQBW+T&JQ"/#XE'(CO#DS&VY!#''LUB;YI'W=+>*(NG2GU^BIP4
M+"SMRZLFF(VV71H6QG3^,]50$\&B^1%L4CEH(F$=Z4%! YL?IXUNM*>_;E2)
MR]>(GT\+(.)"B.W$ VUU>:':BE!(V]_J*%_[BR_S*=2?35GZH9[N_P!7W'_W
M:0_S2E2WU!?^J?NAZTRNL;JG<T4:P3-D69O=LJX6MX%$SCO#.W N3@Y$#@)P
MSCP<F7 *S-L37=TCDNBFS%#:G77!6S=]FLEDC6[>XBI,,EBF,":XJ;P5FV!@
MR'$. ;'$!* 8[0 :3;$S$Z$<MT1,:IZ(USN&%B;?CT+<MIU)VJU!C;MQ2$<9
MY)LTP4,J4Q!45W68#F$Q1%(<!VAMK,\<3JU'/=$4I"L)Z@W*6!O& =KD?HWX
MX:/+B?/ ,J\4<,%CN"'(IB  )C'-GQ*.S8&%:QCQLYS?-)C59X?7>[(MC%(O
M(B N"7M](K:W+CFXX'DK'HI_LR)JYRE4!+^BWQ3Y.U69XX=(Y[HTE#PNK=^6
M^C=1HF3.WGKR70<S5SIF.G,XMU#+"1!PF8NZ(H<V*@%#:  &P*U-L3^#,<MT
M5W:=X:CW7?L'!PEWN_.RT +P&4TZ$ZLJJB_,!SHN'!S"*I"&#%/$,2]C'"D6
MQ'I+N2;HB)^C'.WY-W%<4/=#])L22@VT8S9$1(8$13A0*#<5"F,(B(Y0S[0Q
M[6%(MB(H3R3,Q.B7CM8;MCKIN>Z2I1[U&]%E%[IMU\WYU"OMXJ*P$.@<V8,A
MA$4SE.!RXC@;;4PBE&HY;HF9U:5WZE3EXHQ4:=E&P5M0:O.8JVX)MS..2<")
M1.L8HF.=50^7 3J'$<,<,,:L6Q"7<DW4V2\;KE?<1?-SZ@1YFB4I>**[:>8;
MLXQZJ;@H%#!,3Y@,GAF3-GQ#$0'$!$*F$4HU'-=$S.J-7NR*0T<BM.HT%1E%
M+@<3]P*J) 1,2I-BM6*::F(BIE*)SF# ,!&K3\U6<HPIO52JTYE!9)[_ $C9
M/]1+?^XC6(]RZW?HC\?]U;K;D4"@4"@4"@^H]/+9L\FF&F,S-05F'AIEU+EO
MN7NI<K23,P:/,H&CS;Y-0ZA$A,4-T4W"R ->>^9RGV]G%;&$3-/Q^ZD:/VY8
MQ[EOF_I.$=75I;9IMU&Q2B1EG#P95Z#9CO$P*(B9-#,L;@[, QK=\S2(^K'#
M;$S,TK$)"T-,8^VOB3G=.YV.9RD9%-IIW&M9K &2J!61GC!5P(F*!2 429AS
M!EP':%2;JVU:LXXCDF):&KL=$V>WL63D[=MJ-U0,921GK<@<[F <1&!!8*.4
MP4.D(K"!]B"N!B;<0V4LF9KH<UMMM)I%?Y,&MDO"H6K8[>'LRW81Q==O-+AD
MI",9'0=INS.UDC$0.*I@(D8J89B" ]O;6N.)K/ESYYB+8I$>8>QRNC&G[_7"
MW3VM")*0<1(,8?42T01$[9$TA'<Z92!"%$W^'7SY#B.&50@8]FN,7SCY>KJL
MF_Q]/<//M-H*%2T85NDL=9"D]ZVR4<=[?F)4S,6[5)4C=L(&+B<#".!?DK<S
M.5//X.<6Q%E:1^+9T4LI:Y]+!D;9LZU[DO9Y=ZT<9.ZL"$\U Q(X.DVQ53,(
MICB;*GF.4F(X4OFD^Y])PVY6UI%:_P!'C6IZ-D-]0KB0TV4,K8R;L2PYC"8Q
M0*!"[TJ9C\(4BJYRIB;;E ,:ZVUIY]O-R4RFGI4ZTP4"@4"@4"@M-YF L-8&
M./\ ISM (_\ ^D\^2L6^Y^[?)_C]E3WA/G[@]ZMT<JP;PGS]P>]2A6#>$^?N
M#WJ4*P;PGS]P>]2A6#>$^?N#WJ4*P;PGS]P>]2A6#>$^?N#WJ4*P;PGS]P>]
M2A6#>$^?N#WJ4*P;PGS]P>]2A6#>$^?N#WJ4*P;PGS]P>]2A6#>$^?N#WJ4*
MP;PGS]P>]2A6#>$^?N#WJ4*P;PGS]P>]2A6#>$^?N#WJ4*P;PGS]P>]2A6#>
M$^?N#WJ4*P;PGS]P>]2A6#>$^?N#WJ4*P;PGS_JCWJ4*PD8^Y9Z(9O(Z(F)"
M.CI$,L@S9N7#=!P79L533,4I^QVPI18NIZEJ-)!RP,<\>Y6:'42.W4,W,HD)
MD% RG3,),,2&#88H[!I0R ?N2LE(PKE8L6JH5=5B!C@V.LF E(H9(.")B@.!
M3"&(4H9"L@Z<,F\8X<KK1C,5#,V2AE#MT!6'%04DQQ*3.(8FR@&/;I0JW']S
MW#+,&L5+3<C(13'^!8/'3APV0P\6FH8Q2_[ I2%F^9]S+,RO&ZXU@:*C;AE6
M428IDS1[5XY1:B13'.44B' F!LPY@PVXC3&#.8]3*&SIY<F' PPRY1PP^3#"
MK1*I1W=%Q2$4W@9&<DGD"T$!:Q3ETY69I"'8R(G,) [E2BS?,^)F6D>0=*M4
M6*KE91@W.=5NT.90R"2BN&\,0@\$ICX!F$ V]NE$R=$7:C99-RV540<HF!1!
M=(3D434*.)3$,7 2F >P(4HE6_+7/<,^5$D_-2,L1MM;$D'3AV5,>QB0JIC
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M:JA5U6!3J V,L0,I5#)?0$Y0V ;#&E#(4D72K5!BLZ748-3'.U:',H9%$ZN
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MYQ,1X^KXN((B41'PC!W##7JE\R/3M1HH+)/?Z1LG^HEO_<1K$>Y=;OT1^/\
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MNRFJ*JH4"@4"@4"@]&F+RNZW;;L-C 3;N-9*0 KG;MC@4@JC(.RB80$!VB
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M">F548H@*2JA.$1H05 1 RX@3 @"H()XF_.V4PM.WDUEML;IUOE(A]<$7(7
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MC6W&'-%*"R3W^D;)_J);_P!Q&L1[EUN_1'X_[JW6W(H% H% H% H% H% H%
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MX^]=.F-\VV0KQIYNB[9GX:2>'=S#FW-_*-G!&C%H9R!GY&Q=X!5E"X<,QA(
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M .QALK5)R2;HFR/4S"<NB?@;AE!OV+U"-;R'J\VB$K2;)/#2S<S9@1F>,22
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M"C@I$AX9Q2*8#' @#E"E!@<0;YK.#;*K0!N %B-!CDA(JKSE7*!4L""(9\3
M!@_-'8/8&E!(/K)FXYN[=N$&AVC- KM5=LZ;N4SH&<"T$Z)DC""@$7#=*9/H
M&[.P:4*NHVLJ,(UE4\%7;I%Y(\Q*0H;N)CS B=T<XB'TE<Q")E 1P*)ODI0:
M(PC[9N&1W9=P1T<[1([@B:2A<_#,0@@40#Z0#V*E%:_,%^:%D 9J#'G4W*;P
M$3"@97P"J9<HF_X0'&@S#"R0.%F8Q3GGC9/?.6W-5=\DEACG.3)F*7 ?I"&%
M* C"R3E)!=M%N5D'1]VU52:JG(J<0S 5,Q2"!AP#'@TH,1(YTJDX72CUU46@
MX.SI-U% 1-MX*F4HY1V=@V T$NK:+IHUFE9 I4GD2=@W3:HE!QSAQ)@*I"%,
M3'L(E,J.&/R5:(C AI$7A(X(MR,BH4%$V7-E.<&((9LQ4\F82X;<<,*E%8PC
MG0M%7X,%A8(?MW0-U!13'-EP,<"Y0'-P=H]G902$A:<Y$N.8R48HVD]^1J6-
M,F879E%4@6()$BE$3%$H_2+CMV5:(Q.;;F&BA$5HQ45SM"21DDT3*G2:*"8"
MG6*0HBGM*.(' ,*45VDH1NRCX>6:JE=,)=!0Y3"0"'1=-C[MP@8 $0'*(E.0
MX?2(8!V#B%*(C-VGX!>X%13=I^ 7N!0-VGX!>X% W:?@%[@4#=I^ 7N!0-VG
MX!>X% W:?@%[@4#=I^ 7N!0-VGX!>X% W:?@%[@4#=I^ 7N!0-VGX!>X% W:
M?@%[@4#=I^ 7N!0-VGX!>X% W:?@%[@4#=I^ 7N!0-VGX!>X% W:?@%[@4#=
MI^ 7N!0-VGX!>X% W:?@%[@4#=I^ 7N!0-VGX!>X% W:?@%[@4#=I^ 7N!0-
MVGX!>X% W:?@%[@4#=I^ 7N!0-VGX!>X% W:?@%[@4#=I^ 7N!0-VGX!>X%
MW:?@%[@4#=I^ 7N!0-VGX!>X% W:?@%[@4#=I^ 7N!0-VGX!>X% W:?@%[@4
M#=I^ 7N!0-VGX!>X%!:]/-0)_3.?).V^8#)GP3DHPXB5N\0 ?H'P[!PQX!\,
M2C\V(5JVZ8E)BK[\L._+?U%M]&X;>6SH'^S<MCX NV7 .$DJ7M&#N"&T-E>J
MV:N4Q14-4-:[?L=X6UB*&&YGB92@N!0,VCP<\!-PY$1[!1'>;LH"82AVME>G
MCXIN\_1\'_L?^VXOVUW77\\_7Z6U]3/_  \B4^$^ZWJIWCJZ&#ITX,*RSM1%
M=150YQS"<5!-B(B(XXXUZ/E1'T?GY_\ S')=-9Y(F?M,_P ZO2-.M7(IC,(:
M37+(&?W1&&\UDN H8LW[E$/V>8PB<JI0^S'/],Y1VXB 5QY.*:91'A]C]A_V
M=EM\?M;[LK[?RY?2Z8_&?/TFON4WK?K,VT5@8Z=<PJTV60=BS*W;K)MS$$$C
M*YA%0! ?HX85QLMR?H;[\85C4CXH[3L.#M&981RMP#>#?G[-JV721.BTRDX:
M@FS!CG/N\H?G ;Y*MO',I=RQ%-W>Y/B0+$S%Q-[?LJ5N:W;+6(VO"=8*(E*S
M6' 52(H''>.!2*.)\F';[6VD6>/9-_GQ#!-?$F]:W=+6W;.GTO=+.&:L)%Y(
M1BB6\*SDFQ'*9^;* 53' ^&3LX@/8JQ9XK5)Y/-(B9>IZ?Z@6UJ9;#6[+57,
MM&.1,F8BQ=TN@NF."B*R8B.50@]D,?G#$!KG,3$TETMNBZ*PM%1I\L71\;MO
M6S=EUVT-AW#*-[->*LYV5CB)+MT"(JBCOC\( (4QBCEWABX_+6J"[POQ063<
M>HEEV)",W3EO>\(>XHZ<,9--NBW2*\$Z:Q#&S%.0S)4A^T!OFVU*#S^:^/73
MMC+O205KSUQ6C%+ WE+K8($YD01-ES)@<P9BC^:*ADQ-V@[=6@M%]_&-IE9!
M+%DQ2=2MJWTB=TTG68%W35!)8J"HJI'P/F2,804( 9BB40PQV5*"P7)\1]M6
M]JDUTO",<R#EY KW*WEVBJ)VAVK=JX=@4O"Q-G(W'*8-G"#M4H*EIC\79=4I
MB'8PFF5T)PDL[YB-RBW!6+;G+],5%TP$@ 39FX6RE!I6?\9J%]3:<7;>F%TR
M#'SDE$O)AHW!RR:J*J@GG742 Q2 4HYQ P_1I0:$E\=MK1<Q/LSV)<3R%MF1
M4C)F=8IHN&J(IKG1!0QLQ2ESB01(4YRXU:"SRWQ9Q3:ZK>@H*S9:>A[I8%EX
M.?:G02;N&)$-^Z5 BHE,7FP 8%2FP, E$,.QBH*Q"_'KIS.(6NFTA'WGJY)D
MT*>*WR K,RYFY2.51 =J:@N  F ;1(</S:8CZQK(4"@4'1;]BI^B;\E!PW_A
MTOT"_DH/* ^&[2X&H-N9.!4+$R]OINC.#&<$83[E5TZ IS .!\ZZQ2'[)2',
M7L#5K(WV6A5D1]VJW6W4D036<*R)[=YZJ$%YS<I"@L]%D7 @KJ)F,4^81((F
M$V7-MI40:GPPZ>'8,(\DA/H)1[5:'(LC+.$UU8!<PF\SK*APSL4\<$DQ',0.
MP?:.-RD2C#X?;!CYF!EDCR:S:W&J#:,A'#]9:**LU9!&INA;'$2[_FH;DPE$
MI#!PC%$W"J5$2K\+^GJL<SB@DKA29-&*\&<B4NX(9S +"<213@X<)1FCG,5$
M@CF(4<,P@(U<A))?#MIVA+1\NW\X(FCR0G^#(\.#1=>V=V6/<+I" @95--,J
M(FV 8F("&W&I42%CZ)6=I_,GF8)Q**@BFJVA8M](.'4;$-7)P4608-C&R)$4
M,4N.8#& "@4H@7929J-MMI!9[3S?N2N0\V7$[O!KBN8?_57^_P!Z)OE3_P 2
M? G8#92HKTG\-^GLDN+E-Q,1KA=5^:36C)%9DJ_9RKL[URQ='2P,=L950QBD
M 2F)B(%,&(TJ-J1^'ZQGRXR#1S+0\T$JXFD9B)D%6;Y)1\B@W<MR*EQ$&ZJ;
M9(#I_-B @.VE1VA?A]T[M^&>P$4B\1C'UO+6>JF+HYS%B7+ATY.4IC8B"F=X
MK@IV<,/DI61A)\.^GB=P-YTOG'FZ"R,@: YZH,,M+M42H)2:K,> 9V!"$^T[
M F*!Q*)^%2HFX;2"SX+U?%@5T'JU"KVS&;QP8V$>Z%(5 4\(_P!B7 _:I45&
M6^%K3"78IQ2BDPUB31;.$E(]E)+-6\FVBTP38F?$3PWRK<"ANS[![1LP  5<
MI'M0!@ !\E9&NA_%NO[/^;00H65#!>_O"^U]8O-/F#-O!W',><\ZPW?8S[S\
M_P"3904];0"Q5KCDKA!:511E%7;US H2"R4.$G(H';N7Y6I1 O.%$U#@)A$2
MXB)LN;;5J)1OH[9S8&94BNLK&UC6*@ N##_Z*;=XE'Y5?LB_:]FE15U/A?TR
M4=E7SRY&2J<4WEX@DBL$=*-X!JBT8I/V_P!%4J142F[68V.;$!PJY2E$U*:%
M67)0;6(27DXQ['23^:B;@C7IVLNQ>2ZJBKL6[DH<$BH+'3.F)1()!PPQ !"5
M5@:?#SIM'JQ*K!L[;#"I1Z3($W2FTT7(J2J:J@FS"=4[E8ZBIS#B?';2LB*B
M_AELJ(MSU9:3UR@U:O"2<"[&6.#R'=E%?>'8+$(44]^#A4%P-G!3-MVU:C<M
MC0S2]A&/&%OJN'+%2'E+->*!('=F!J^?N'3U,R@B8><%<+*@8QAS%^B/8I4+
MLT5TR\T&E)T7S9K;]O-8EO)-W*Q',>R@%>?-7;<R("H5TW.7.54@"8?HY3 (
ME&5%1/I7H:C$Q1O6R61?R4XD[C9T)AP6:-<<]&I(HJ&4$-X1PNV*10J:A +@
M;Z %'"K647^2T[T]M+3%S;#Z0<0-JM!&1?7&:259R)'PK X-(K2&<IQ<&7'>
M&.<1*8>")<G!J*I4EH?H@6(MJ&5N!W&^=T'D2R>MIH6[NXVLT8SQTW64*.#M
M-<ZAE\J8  9N#@4<!M9%1@;,T-4E;LNRY=0XQ_:S":CCKQC&X "&,TC&;-G%
MI338# D=1%9H8Z>W(H;#-GPRU:HS6=IOI"SLU6^+XOMM-1;A_-JK.64\=Q;*
M<G-.70 [02QR%?E:N=T(X< 1,8I0'A5*R/1K2T?C8_4^/U!: T4MV M)A:=G
MBF<73I1$@B91VLJ)0+B"0$12,0QA,0QQ$0 0"I7PM'L=0*!0*!0*!0*#X*^)
M3_S//?\ +Q_^5)7EY/U.MOI2RW"T&QRVL;G*+Y%TY=I+I)M3H'%R* DS'4+O
MTA3%''[$W"QVUBOA4XMJ63UCC;H9QID'\0DN^9MQ5Q;GN1Z("Y?+ 7 PI'$,
M02*..P $<N-:R\I1$)WFM'339S#)G+;C&1))LX=WN5%"B"N_,D=T1,%3!F,<
M"GS8X88UFJLKRZ(9*&<V[",G9(HS!5DU5>J(F< LYDDI!513=% F0 2*D0"[
M?SA[.%6I1F8W!!)1,;YP,N=8D1)6Q(,VF4')$'*PN6[Q(50W9B_:&3.01 <2
M_/C2HF6%\0K:#CEEE)-)6,E8U9LRCW:;==4(9@5(AW&("&Z5-P0,7$2#FV#C
M5B1I-M1F[<I'I6[Y&6%LW8':-'*:,6W1;/0>@NS3$AQ3< (<#,02E.)C[<<M
M,BC..HD*+DH%;R[=FW=,)-!=DY2;.EG<=O1W2I<3D2;G%7$I4C#NSYC 7A8
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MVY7QER'=%*7+SD@)@!A%0W!#:(8J%4OIWK$?4"^[@MZ-@UBVM'QD+,1%R9B
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MCFP*!2@7:(VI1R34_=-VSOS,DM<J;(K)T\4543:K+"]*]7=Y43$4*JN*20*
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M0;- H% H% H% H% H% H% H% H% H% H% H%!^?&O/\ YANS_F$?\LE7DO\
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MYQ[& @-*"$C/B+82L_)-3,RPENP\FDQ?NILCQH^*D6"<S+P#-MSBFLV!N8#
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M7K10JS1PF19NL0<2G34#,4Q1^00'$*]3DST"@4"@4"@UR?QBG]63\IJ#8H%
MH% H% H% H% H% H% H%!KJ_Q3?^0_Y H-B@4"@4"@4"@4"@4"@4"@4"@4&N
MZ_H/ZTO^^@V*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0=
M%OV*GZ)OR4'#?^'2_0+^2@\52^'8B3OF'K<^-8$>M)R%LVES9J"4=)3"3E-5
M870$WRY$A>.#()*#P<P8F-E"M5'$S\-\9,-[7'UC>M92SK>8P4!(HHH"HA(1
M3ALY:R64X&*8X&;93HF 2'(<P;-@@J.T7\/CI.67N*X;VD):Y7L@26?RB;5J
MR4%=.%<PI01(F4Q$BD(YWI RFP,7A9@$:E1"07PO/K::(OX._G3&^8^05D(:
M90C&2<:S2=-09ND$XDF#8"N2%*HL),F94I3@!<! UR1,2OPZA*+-Y@]YR9KR
MCVL5YKN5PD@X=I2D.N]7([4*(%35*H#Y1$Z E FZ "@.(8TJ414O\+RLPQ9
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MR@4H !0  *4 P  #M!A7H<W:@4"@4"@4&N3^,4_JR?E-0;% H% H% H% H%
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M)^4U!GH% H% H% H% H% H% H% H%!KJ_P 4W_D/^0*#8H% H% H% H% H%
FH% H% H%!KNOZ#^M+_OH-B@4"@4"@4"@4"@4"@4"@4"@4"@__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>fc_vaccinetreat-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_vaccinetreat-4clr.jpg
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M;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (  @ X0DE-!"4
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M P$  A$#$0 _ /?P
M
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MG],+MY=_3CR#Y?[2ORCV'GZ-/.KK\/C>#Q> R\L<^[P5SL>YAILH
M
M                                                      -![+_K
MVW\_M"P_\"\,U_+56-\M^#"L
M    _/[_ ,8_^YO_ #0WOY_8P^#] 1HLP
M
M                                   -![+_ *]M_/[0L/\ P+PS7\M5
M8WRWX,*P                                       #\_O_ !C_ .YO
M_-#>_G]C#X/T!&BS,6YW.W66W2KM=Y34&UPFER)DR0LFV6F6RU*6M2C(B(B+
MB9@/.LCSZM@6+P=K*=<GHJ5Z#N[4!9P^!TU$1J)XT]W@R FYGG@;+QLRC80Q
M.EW"Y3)$.+$F06$R(+JK@39M*0\ESBG\:G4=.!U+N -\@
M
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M\IMC41]PR-PV')+#S9+-)$1K2E9)49$7$CX$ _7P
M
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M9FE/.CV8E;U[9NV6S&A.56F0FYV3FJ)M#KS:%(6PI9\$DZA9DDSH6LDU,BJ
M\,;:;A>=)LJJ7MCC%@FF[(D*)FTS;:N84>6[P4N.ZGJ%KH1\5J;/QJ<3,P@X
M^V^[EJWZLSF<VJ;,R$\AM<V^7)M!RH_/E/L25FJ2R1LU23E%Z5:4F1ET$ _6
MX
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MT68
M
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MUY#MIY(;)Y <9D[IV4C3'*6:"-TFB,U'H)5234^@60D0       ?G]_XQ_\
M<W_FAO?S^QA\'Z C19@            !P9D1&9G0BXF9@*U+SNQQ7U,)-U_0
M=%.,HU(X=XZE4!,VR[0;NQVB Z3B".BTGP6D^\HCZ &:
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M<L?L#R);J[*]-7,4TIF'$O<YEEKFDA=5+<:6:DI1734J@-U
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M7&O#[UODQW+=>8Q:GH$CQS1]^@RX*3Z@Q:FE-8S&V.*];YV>*PEQ*HPL@
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M@(N+M_MUFUIL]UMRY#MD7$MW9FF'W&&I4:UN)=AJ?;,B-7+4V6DU4,!LL
M            $%?8JRE0+LDDJ:AJ4F6DTZE<EPJ&:?4,!C2)>AJ09&E9N)T0
M$H-*C4M?521)254^$P$Q9X)VVV1H2M)N-(+F&DJ$:SXJIZY@,X  <"!1KE2Z
MY^Q#DIU1[/#*6PV?%*GWE:=1E_!+H&[I_#IS,>+7O/Q0L1G4ZGTC%"06
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MMRAGH.A=/ ^ 9@$I6KQ2-7?H5?M!D";6JI$DS,N!T(^ 91A'7Z\VS%[/-O\
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M'%$?=#&U&=CT&,BH             _/[_P 8_P#N;_S0WOY_8P^#] 1HLP
M   T?GV Y+>-R7KY:K/S3DQ+5'MF1)E):.WO0IIOOK4UJ)1ER^C@>KQ0$2>W
M.<):;9?MBI-T?22+)=NVDDK(ZBXNR#=,M5550I+G5(S53EF AK7@N2Y%#7/L
MEKF6^.;%W8O5P8FH9D7I;\[4PEM+VM*.4:5.:EIH?B=!@,FW8CD)7K#\7GQ(
M\1=R>E.9+;6''$*.QPI)3(KRVDN.(:6X\1H6AM>GK433H!+TK7C0$/AYYMAM
M3KAT0G[/J$ PES9:DF;3)-E]R:SU*/\ R2I0_ 9@,%)-542VS<=+\9K=2536
M?27J .UEV6RLSBIUM+4:UMO=4B4?C&E1?:,!F1;D3SQ17VCCR3(U(09DI*DE
M]ZHN!T[I ,X!YSNVVN?RDY1#CPE>6)R[ZXYD7;-*;C#N2%)B123JJC01I10R
M)*-%4GQ!+869;=3+MB%JQ7'2C1;);D*5(L4A3O9Y1MM'R&7'$J-9MI=,EJ)1
MGJH500UO"V;R4[LKRW98LIFZ,XBN>^R\E"$>06N3,969&E9U,R6G3P41 +9^
MA.7VO;2?;++%(\CLM^FW7$8"Y/XLHR;@XY&:-:S,B3V=Q1)2L^'"O0"5-N>R
M^X4>U/VR'<)3UKML^WH9)F0R<N?9F>;)D()+Y+;)927E*)#O!:2(NX0#O;VC
MS9O)XC\F;>Y-J9@06K,HI<#5&5&:<)]B8I36JCBU$9]GHE2>'20"Y[$81EN"
M65RU9<E,N:Y'C+:N?,)2FVTI-/8#;(S2E,<_$4C@LE5/K5!#;P
M    QI$Q+*N4A)N/F6HD%PH7?,SX$ PI#\EVB72Y<?I4EGKK.G$B,SI3CW@'
M15I2*FR:%.$?,-M-%$9'PI]L!WMSKDV1ZV$OH3XIDHD.'X3(^ #/BRV9C1.L
MF=*Z5)45%)4722B[A@.\ ,1(HI?K(N']F,_AF-Z/H^UKW\RP])#$M+D2@
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M<JM:[O-6MJ)"3,9-UQUMPVE())*KJUI-.GI,RH09A.%K$H     'Y_?^,?\
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M1%0@PG+G$-D,*PV[VR]19-UNTJP,N1<:9O,YR<Q:F'DZ%IBH7T53U=2JF2>
M8&&UYO.W#5Q;?2FXJL#,\[TQB"YKBK"BY&LU\\HO\8]>@ST5[@80E+ALO@%T
M;R5J9$D+1EERC7N]TD*3KFPJ<HT4+JI*G%)!A.5CN6'V"[9=:<XGL*<R&RQ9
M4" YKHR4>>1$\E;?0JI%P#E1E3+?L!@5JN##T%^[M6&+-.[0\33<7BLC,XU&
MOF(8(R,B)1F9-ZM)=X,)7C+L6LN=XW=,2R:.<NR7=DV)K25&VNAGJ)2%EQ2I
M*B)25%T&)PKE!6?:W&K/=<<OZI%PNE^Q:!(M-KN=QDF^\<27363IT+69$1$D
M^X083E&9-L?AF2WZY9&F7=K%/OK2(^1HL<YR"Q=&FR-)=I;14C5I/2:TT49"
M,&7WD>R6$Y#,M5Q9>N=AN-GMZ;&Q+LLYV(\[:44TQ7UU4:TE3@H^MX0PG+I1
ML+MNQ@$C;.'$EQ<8>G%=F.5*7VN+.)9.)>CO*JI*DJ*I5KW0P96>S8/9++D1
MY:PN5*R-=L8LDB?+>-U;T2*K4A2RH1&X9\5+[H81E%%M'A"<&OVW28T@L6R2
M1+F79KG*YRGI[I//&ERE4D:BX%W P98V1[,X?D-U@9"Q(N>/9+ @IM"+U89B
MX4MZW-T),=\RJEQ)4X&95(,)RS[3M7A=D<Q1ZW1GT.86W):L*G)#CQI[<7X]
M3JG#4;BE])F9](8,OJ=M=A5R+,47"$N0WGK;;62-J=5I=2RV;2.72F@R(Z\.
MZ&$93&*8W'Q#'H.-0YLVX1+>CE,2KF]VF6;9'U4K<,BJ22ZI> 60F0
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M?K(N/]F,_AF-Z/I>UKW\RPET$,:9<@        'A[@#FATZ '
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M:[->;)8II/\ ;\@<?9MYM1W7F27&:-Y?-<0DTM%I+JFX95/@0C*<)D2@
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M]\;_ &/U?9+7[CR-489_BRS?G2!U^Y^C;U-#2\\/2(\RZX
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MP+B9]!?O /AIYE_6;#J'B;6IEPVEI6274>,A1I,Z*+NI/B09'V
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MGSF5$9*22:<4'U08]2TUC,1E'V7>1YE*6\GM]6E'5-Q@'S$&W3I4V?$C]0Z
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MF?YRS^^-_L?J^R6OW'D:HPS_ !99OSI Z_<_1MZFAI>>'I$>9=<
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MVZ^22):T(,STDH^-*C)#'*N[@_X=1^?POZ0QL=MYI]4L>IY8]<-@CGML
M 0"DH>MR]/42ZE:^'?,SJ EHR$IM[3=*I)E)4/O:0$$I)RK(VZO\IR4NI,CX
M:J +$Q7D-5Z=":^K0!66GY&.S[BA^!)EQYSZI;$B&USE'KI5"B+B6GN (US!
MK7ESDFYY-"-!R%:H#"5&VZPBA5<,TGXZNZ"MJ5MOC+%C[96^V7=EFS,KBXZ2
M-4A@G#-"WJU-1E6IF?A[IU!,1$-BD5"H7070"7(
M                           #&DP(<Q;+DEHEN1UDZRJID:5I.I'P,OL
M.YUIIYM3+J"6TX1I6@^)&2N!D8"!1B<8C2RY,E/6QM1+:@+<JT1D=:&?2:>\
MDP%@(B(J%P(N!$0#D  1"=+<B8V1EU'.8OP&XDC+[0#OLI&5N;6HJ*<-2U%Z
MJC 8[*33*F-4,B2]J*O=YB249EZ_ !W6$T+MC3K?0X:U'ZNLR/[0"2   !1=
MVO\ "9_G+/[XW^Q^K[):_<>1JC#/\66;\Z0.OW/T;>IH:7GAZ1'F77
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M1QZ#(P$OB.:L9;/O\-B,;";'*9B\[62TO$_&;DDM-"*A4<H M0
M                             (>9I;DS3I0E,$XM7J$I/V@&?;FN3 C-
M&K7I;26H^[PZ0&%+(V9LAXUF9+CD9(/H2;9JXEX3J R[8V35NBH)))_%I4:2
MZ-2BJ?[I@,L   %%W:_PF?YRS^^-_L?J^R6OW'D:HPS_ !99OSI'[XZ_<S_X
M;>IH:,?'#TB/,NN                 /AU)K:6@BJ:DF1%X3(!",:U/6M)D
M1F1K-WND1I30J>H8"=4DE)-)]"B,C]<!7V2;=*VM*/3^.JWX39)1T^P0"P@
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M;\HY*:SDS9/%N&Y)/H-,<NJ26^ALO7.IAB<8SL1F%Z,S49FKB9])AA$[070
M   5[H"M9?<9"X;N+69"GLFO,9QJ*EM9M=D:<(T'+=<(C-"&ZU+NK,J$*Y6Q
M"J6C9NWNQ8YYF\S<KE%9:AQUVQ+D",F*SQ,E(U&I:WE54ZI2CZ:),B$1!;W\
M/0V8TRTPPW&C-I9CLI)MEIM))0A">!)21=!$+81F8VYVNP2@ "(S,B+B9]%
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M&LB_> 3X"NNON2$3ED1$N-*TEI^]:TG]FAF L*5$HB4DZI,JD?@,!R
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MW)UD[:X1%&A$PE.IF/0B-2"6I1:S,]5" ;"
M              !PK5I/3353A7HJ JB3OM'(J[<K2[KUO:T'UG#IJK7P][N
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M2OO2Z3H C[!CR+-VF;*D*N%_N2B=NER=Z5J(N#;2?N&4="$%Z_$1$)F4R)0
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M,DV:+(:AQE$3<E[E&AU)F9%4FUK4VLJ=9IXDK3PJD!<@
M                               85TM[%U@2+;**K$ELVU>"O0?K&)K?
MDM$HM7FC#7NV>'R;3<+C<;FUID1G%0HE2/B1'UUEX#*A$8Z/>=Q%XB(:VCI\
MLRV>.:V@                 H        (%%+]9%Q_LQG\,QO1]'VM>\?$L
M)=%._P#:&):=[D2@
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MJ6:&S,TZC0E',69F>IUS4M7=4 N0
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M >EEL']+6_DTGX( ]++8/Z6M_)I/P0!Z66P?TM;^32?@@#TLM@_I:W\FD_!
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MBP3=^UN7/"K@J3V?24R*ZVIIZ.L^&E9&5*\/N3,!?0
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MOB,?WI'L 'DFU?$8_O2/8 /)-J^(Q_>D>P >2;5\1C^](]@ \DVKXC']Z1[
M!Y)M7Q&/[TCV #R3:OB,?WI'L 'DFU_$8_O2/8 47,,0P2X9Q@]SO$QFWWRU
MOS%V*VI)I!37'F=+J30::JT)ZW#H 7KR3:_B,?WI'L 'DFU?$8_O2/8 /)-J
M^(Q_>D>P >2;5\1C^](]@ \DVKXC']Z1[ !Y)M7Q&/[TCV #R3:OB,?WI'L
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MG6>*49M<9!.):2E1%4C6DU([@(;J*O=  'RM:$(4M:B2A!&I:E'0B(N)F9F
M\QX9&M.Y6:;U;B7.7V;;6YPV<5CW0E$VAV/;FE%*D-N'4M"350E!,#8&WMLQ
M^R2[39L3E=NQ:!C,"-9INLG>?#;.C;FM)$2JEW2(;L?2QZ6O?S-C%P(8LK3
M)0                     9<IK4Z=-#(_4,N(B12MJ+%AV.85&M6!7+RMC2
M),MQB=S$O5>=>4IY.I)$7569D(A,[%T%D9                     "O ,H
MWJKN$HOT>1^?POZ09NV\\^J5=6/AB/2[,<L&$0MT<RO]HN7/S6Z1K:WD-MYJ
M5]F9CMK*,KED54ZTF9\3XC0;2_                         *%F-@PJY9
MQ@]VR"Y=DR:U2):\:A<U*.U.NLZ7DZ#(S7I1QX& OH
M                                    UWO1:-N[WA[4/<^<=OQI-R@O
M-R$N*:,YK;Q*CIU)2H^LOA2@"RY=AN-YYCDK%LHA(GV68@B6TNI*2I/%#C:B
MXI6D^*5%Q(!J*W;;><)@R/)6%;AP;]C3/5@1<LB*=F,-%XK9R8Y:G"275(U&
M7 N@!G=@\ZWYWPWY-.]D [!YUOSOAOR:=[(!V#SK?G?#?DT[V0#L'G6_.^&_
M)IWL@'8/.M^=\-^33O9 .P>=;\[X;\FG>R =@\ZWYWPWY-.]D [!YUI<?*^&
MGX.S3N/[H#!>WEW&VQDQBWVQN)'QB4ZB.C,\;6Z_ CNNJTH*6R[5QI)G]W6G
M@ ;BO^6X[C&-R<NO=Q9BXY$8*4[<%*(VC:41&DTF5=6JI::=-> #3\+<#?S<
M=M%WVZQ:V8UA[_6@7'+5/G/E-'T.IB,&1M)5TEKJ9D8#,\G^=;\\8:?_ .6G
M>R =@\ZWYWPWY-.]D [!YUOSOAOR:=[(!V#SK?G?#?DT[V0#L'G6_.^&_)IW
ML@'8/.M^=\-^33O9 .P>=;\[X;\FG>R =@\ZWYWPWY-.]D!@7#:;>O<.EMW.
MW CP,1<,BGV/$XRHJY;?W33DITN8E"BX*(J@-EW7$\&L.V\_$GF&[+@,6W/1
M9#4>K2&(6@R<,C(E'6E3,^)UXA.T5:T6ZP8GC6(W[!EKN.!P;2Q;4/(,W7%6
MM*2-A^ID1JT]W@0W-&8M6:3O\&#4KXKS"N-ON329$"4T^RHB42D+(Z5[Y5J7
MKC':DUV3"L2RJI^_3[8O9!;)5/WZ?;%[(&2J?OT^V+V0,E4_?I]L7L@9*I^_
M3[8O9 R53]^GVQ>R!DJG[]/MB]D#)5/WZ?;%[(&2J?OT^V+V0,E4_?I]L7L@
M9*I^_3[8O9 R53]^GVQ>R!DJG[]/MB]D#)5/WZ?;%[(&2J?OT^V+V0,E4_?I
M]L7L@9*I^^3[8O9$F341'34D^!\-1=[CW>\()E2MJ;=@MHPJ- VZG=OQ5,F6
MMB2MPUJ-];RE/%J423X+J70(A,RNM4_?)]L7LBR,E4_?I]L7LB#)5/WZ?;%[
M(&2J?OT^V+V0,E4_?I]L7L@9*I^_3[8O9 R53]^GVQ>R!DJG[]/MB]D#)5/W
MZ?;%[(&2J?OT^V+V0,E4_?I]L7L@9*I^_3[8O9 R53]^GVQ>R!DJG[]/MB]D
M#)5/WZ?;%[(&2J?OT^V+V0,E4_?I]L7L@9?*W6FDFXZZVAM/%2E+2E)>J9F&
M,[DY564^C,;S$L]K/G6:WOHEW6:GBRI;)U;:0?W1F?309ZXTJS;QG8I6)F7=
MCEKP&-NAF5ULDU3V>3(]M1DT(UJ43+#3:RBF2#21)U)-70HQH-E?@
M                 %#S&UX%,SC!Y^2S3CY7!?EJQ6,2U))]YQDB>(TDDR51
M''B9 +X
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M&TS;>O$84;&F-O$;J9H_8GE*W!=C6TLH:/F:4,);642FHB1Q3JKI/U1"6P0
M                       % S-C;US.\$=R=U2,O;D3#Q%M)N46\;)<^N@C
M3P1]^9 +^   C("0
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MC;<?HI^@6.?H*9GAOD^/Y",]=3A<LN5^4ZWBT\;B M
M      /EQ:&T*6XHDMI*JE*.A$7A,P&MMK[UM9:,.BQ<$D''QPY$I3#+J7^;
MS3?4;QF3I&NAK,S*O#O"T5F496O],K.;BD(3)62?_43'=-!^H=!;IRCFAUO9
MQ8V$&M9232GI-$=U7X*3$]*QS0-YWBRT$XY/*/7[E]"VU?8-(="_@CGA)1<@
MLDS3V:X,.:^*")Q)&?K&*SIVCP3S0D$+0XG6VHEI^^29&7#PD*XPME]"
M              4#&_J[^M+,_(1J/<'LUM_2DCYNGD<M?9*:NIXNKQ/7 7\
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M;H9E"L<3EY_'C6T\HEZ%%S6%H6<0M1J-)Z4ZN@B 7X
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MT()QILHU2-DD+6E)II3HH8[6II4O69F/!R=/5F+1#?1<!YN';<B0
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M&_55T#TL;(R\_F9MCBWY!0M$**A?C):;)7JDDJCRUI^*7?KN9(A(
M       #7V-7G Y6ZF:6>S6U4?.H$:VKR2XFV24R&7FUG%(EZSU:$D9>*7K@
M-@@                      (R-?7664&%+DF6HR-:4)Z=2U*H7[HR4IS26
MMRPZ;-;DP(A&L]<R11<EXSJI2CXTKWB#5M%I]'AZ$Z=(C;.]\W>Y'$8>9B+2
M5S-!\C4G6A"S+JJ652X>"HQ3&?%>9SO94!V6Y!BO3VU-ONH+4X:.6VXLNDT$
M1G0C[A!B/6B+.NZVU%TAKC*X.EUX[G=0X7$CJ,FGJ32W')?,PP%7)<S&9,MS
M_:&VEM/]_F(X']GI&:*<FK$1NSEBFV:6]2M6UA,FXP8JNAU]HO7)1'^\.[JS
MBDSZ'%T_BO'H;W'F7<!(
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M*D7ZU(2=#1*;=/U&^)D.OW,XTY<GM]MV\!YQW
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MC8KD&+VR5#A$>DWWFFTGX347L#NZNS3GU.+I;;QGBWT/,N\
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MK/["#'3[SZ4N;VL?^1N4AY]VG(
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MY*06HXS!&\Z95IP2@C%ZZ=IW*S:(0\C<1!U3;;1)?,CIS))IBMF7?*IJ5_\
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MO/H+JDVTE,5G@9\22FGVQ@F^62(<)YI%^*0W%(RH9MIUN4+HJI=>CN4$3=.
MVDN'J=,W5=]Q1J_</NBHDK?;<E.'VZT*UL.K4E$=224@C(Z&JE>YX1FK;3\:
MJSS.QQW(U&A"GF(NHC):G4<M22+AK+5T4,3_ .'/BCXYW,F)9&FE]MDOJF3U
M$1MRU]"?"V71ZXK;4F8Q'PPM73QMEDRG3\GRC66E:&UDLN\=.GUQBC?&-^5[
MSLS"FV%#KMZM3,=&MSM#2U((J_BTG52C\!$/1Z]HC3G/!P=.DSJ1+>8\X[@
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MTWQM]&7(R+M2",VXK+A.J+H)2Z$23/HKX.D;_?6CEPTNTK.<ML#B0Z@)
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MK'+M1,Y2%IQZU61"DVV.EI2Z<UTZJ<70J=91\1DOJ6O.9E2M8C<E!18
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MR)@VVXMICNW.4E"4F3)4:29%]TL^'V!927TS:<AOCO*G2%)2K_\ 3;:1FLO
MMSN>$$+SCVV;4,B=E(1";,NLRP>N0K^.\=:?Y/V0'WLGD$C+L&CY'/L;=AN$
MB3+9<AH2X2M,=]325&;M5GJ2DCXF V,                         H..9
MO>;ONAF6%2[24:SX['MK\"ZDE9'*7.;6IQ)F?5/0::=4!?@
M    !K/*/TEC9!+E6DVGHQDV9VY?!:Z(XN%6E:]'5/N M"'DYC <@RX=U9<M
MDTVU)T.E5"E> Z"$J^>0N2?Q-BA.3W2*AOJ+EQTF1=U1](E1VP\;O60.\N?(
M<F\>,*#^+83_ !W3IZX#8%AVWB0&T]LT,M%Q[)%ZI'7^4</K*/U*$ Z<FR:7
MB&:8+B=DL;3UKR-^6S/G$A>J(F.SS$J)2>%5'PZX#8H
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MIR?,L-CWW+[+Y O;DB4RY;=#K>EMA];;:M+W6ZZ2)0"[
M         *-C^5Y3<]RLNQ6Y63L>+V2/;W;->]#I=M<EH6I]&I1:#Y1D1=3O
M\0%Y                  &+-MT*X-\N6R3A4ZJNA:?XJBH9>L8"IW_#I,^$
M[$9-F>@]/+*8DN:BBB/QR+CT G+LM>!QVB2JZN$\A/BPV"Y;!=[52AJ^T"%M
MCQV(K1,QFD,LIZ$-I)*2]8@': I&6Y5E%ES3#+#9[+Y0L5]?E-7RYZ'5=A;8
M9UMJU(ZI:U=7K@+N
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M=R;+[AN;F&-72UG&Q*T1[<[8[GREH*2[);6J0GF'U5:#(O%Z %\
M                47+\ERVT9OA-EL=K.9C]Z?EMY!.Y2UE%;99);1ZT\$:E
M<.MT@+T
M /(GG1;Z;S[-99#C6 [?^B5X9YUOEOQN8ZVZQ0GF5&9F1])*K0N!@-S>;[D^
MX6;[=P\QW$1&8GWE2I%NAQ&C:)N#T-J74S,U+H:O4H VJ
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M;;3;KO6Y9),SXH(R2?A 60
M             '!G0!K?>K:"S;SXHQCEU<.,[$FL3X<Q)$:D*967,1W]+B-2
M5%ZG> ; A18UOBL6Z$P3$**VAF.TBA)0VV1)2DB[Q$0#OU<:4"2'T
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MNEE6ZD%!'=<C98:1&)"4HC&@O]86@_OGU$DU'W*>$(&RR76G#IZ?  ^@
M                 1,C@S#(UMGNR^+;AYOAN;7MLE3<0>=>;:-)&F2E1:FV
MW*]*4.%S"(^ D;)(ZF9=[O@.0
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M,YE\?_,:4:7=WK$8C*]CI..
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MIVLZ>GJ1>V8W/5=")/'B1<1[.=LOF.,/LCJ1'WQ(
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MO60TDNDA[_M:371K$QMBL/CW?:E=3N+VKNFTS^U81M-,
M   !\J+OGP 4S=:S3L@V_O-HMK?.FR&T\IJI%70XE1E4_ 0Y_>Z<WT9B-[J?
MB]>NCW-+VV1#R:K;O*XSQNN6B<E:3H:39/3WO&_?'A9_']U/P].?<^L_Y?L,
M\W6K^O8]5;.V6Y6#!(%MNC/(D)4XXELSU&3;BM2:T'M_QFE;3T(BT8E\L_-:
M^GK=U:])S"^CIN*
M     #Y652Z*@/+^X._F083E=XQRVPH_*BS7%%(62EK5K)*J&70-'N->U9Q&
M/!ZS\7^'TNXT>>UIVYW-D[$YU.W%L=UR2XQFXTKMIQ>6S73I930CX]TZC8T;
M\]<XPY'Y7LZ=KK\E9F?AB<SZ6US(NBG2,SE/H
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M_6?D/YXK\!(X_=>=](_ _P#K>V6_/-%_P#=/[4>^T0W>U^G[?^'FO]B_]O\
M^M?XO00VWG                           >1_.X_Q%8_S4_PU#F][X/;?
MZUNOZ_X,+S1O\=W_ /LM/].@.S\63_9/)1[$/H'3AX27(A(
M        TAYTGZO6/SU'X"QK=SY'<_"?^U'J_P"'E/:[]9F'_P!K1?PAR]#S
MP]U^3_\ 6OZGZ-CN/E()                     !0-Z?U69+^;H_IFQCU/
M+/J;?9?7I_VA^?,O\LK^?3_2D.'3S0^KZ_TK?]9_<_3JU?U9"_-VOP"'H)WO
MCL,L                      163_X;O'YE)_HE")W,FEYX]</S2NOY>;_&
M<_?'G[>;VOK]/IQ_U_@_1_;[_ N-?V9$_H4CO4\L/DW=_6MZY6,7:H
M                                            .# > M]?UGY#^>*_
M 2./W7G?2/P/_K>V6_/-%_P#=/[4>^T0W>U^G[?^'FO]B_\ ;_\ K7^+T$-M
MYP                          'D?SN/\ $5C_ #4_PU#F][X/;?ZUNOZ_
MX,+S1O\ '=__ ++3_3I#L_%D_P!D\E'L0^@=.'A)<B$@
M    #2'G2?J]8_/4?@+&MW/D=S\)_P"U'J_X>4]KN&Y>'G__ ):+^$.7H>>'
MNOR?_K7]3]&QW'RD$@                     H&]/ZK,E_-T?TS8QZGEGU
M-OLOKT_[0_/F7^65_/I_I2'#IYH?5]?Z5O\ K/[GZ=6K^K(7YNU^ 0]!.]\=
MAE@                     "*R?_#=X_,I/]$H1.YDTO/'KA^:5U_+S?XSG
M[X\_;S>U]?I]./\ K_!^C^WW^!<:_LR'_0I'>IY8?)N[^M;URL8NU0
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M +0_/F9^65_/I_I2'#IYH?5]?Z5O^L_N?IS:OZKA?F[7X!#T$[WQV&8
M                 (K)_P##=X_,I/\ 1*$3N9-+SQZX?FE=?R\W^,Y^^//V
M\WM?7Z?3C_K_  ?H]M[_ ($QK^S(G]"D=ZGEA\F[OZUO7*R"[5
M                                        !PKN>J \ []I>C;KY"S*
M0;1+>2^P:BIK;6A/6+O] X_=1/,^D?@)B>UV;\M^>:&HE8!=#*M#NCQE4NDC
M(J&1]TC&]VOT_;_P\S_L,Q/=[/EK_%Z#&T\Z
M .%=!\:>$!Y%\[M1MY)C^LC2V[$7RW#\4UI<.I?8,<[O(G#VO^MS\-XC>Q?-
M$2IS-<B?;(S:;MB$*671K4\DR*O?H)[*-DLG^S6CEI'B]A$2N%3]4=!X9]@
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ME2;9$)1&5#(^2GA0QW*>6'R7N9SJV]:R"[7
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MS<7"-)/NK4\IM*NDF]?BBM=.M9S#:UN]UM6.6]IF&P4T+@14(7:;Z
M              <'7N .I]E$EER.\V2V7$FAQM9$:5)45#(R/N&0$2U[8=BM
MLL;R-65VFRH:NVHUMZUJ<:;6KI-"%<",4C3K$Y;UN^U[5Y)M.&QBJ9\2Z.Z+
MM%]                       ?'@ UF_L)M;)RA66NV)!W93IOK02U%'4Z?
M$U&UXO3Q&.=.LSEO5[_7BG)%IY6R6TDDM)%I(J$22Z"+N$0R-%]@
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MR4NDV48V&#?UFDTGKK2E*D OA%0
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MC7$LMCVZXPY3N?K4EV7/D3&*JB2G4&:%NQ"22?Q>DB2KQ2,!Z(
M            &A_/!4E&QUS-1D1>4;253.A<9[("Q[^,9]=,09QS!;0]<F[U
M)1$R)Z))9BRF+1XT@F%/&1<QTBY1'W",S :RV3N5V8\X'.K*6&/8];FK+8(I
MQ#EQWD6YB)&6B.@R;,S43B2ZND^'= >H@                     !YFW,L
MU_R#SI\7MN-9.]BES_0R:Z=PC1H\QQ;:9]#;-N22DDDSXUI4!E;O6R\X3BVW
MMPS;*'<BCV?/+3<+KD<R,Q"3%@FM22-U,9)(2VV9\5GW^(#MW<O5GR?>;8RW
M8W<(UWG1+Q/N<MB \B2IF"F"I)ON<HU:&ZF1$I5",^@!Z*
M                                       8-NLUIM"YCEKA,PW+C(7-
MG*90E!O27"(E.N4\91T*IF 2K/:IUP@W69#9?N5LYODZ6X@E.Q^T))#O+4?%
M.M)$2J=(#.                           !',V&RQ[Q)R%B PW?)C*(TN
MXI;24AUAHZH0M9%4TIKP(! 7O:G;;)+F_>;_ (K;+E=I.CM$V5%;<><Y:20G
M4I15.B2(B 3E@QNP8K;DVC&[;'M5K0I3B(D1M+31+7XQDE-"J8"4
M              &%.L]JN4B%+N$-F3)MKIR(#SJ"6MAXTFDUMF?BG0Z5(!AY
M-B>,YG:W+)E=IBWBU.'J5%F-)=02BZ%)U%5*BKP4FA@/O',7QW$+4U8\7MD:
MT6ADS-N'#;2TWJ5TJ,DEQ4=.*CXF E@                     !@7FQV?(
MH"K7?8+%QMRU(<7%E(2ZT:VE$M!FE1&5241&0#/ 8,>S6F+<YEYC0F6KM<$M
M-SIJ$))YY#!&39+615,DD?5KT ,X                      8"['9W+PUD
M+D%A5\885$9N)H2<A$=:M:FR72I)-7&@#OG6^!=(;UNN<5F;;Y*#;D1)+:7F
M7$'TI6A9&E1'WC(!7,0VSP# 5R7<,QR#97IG^U/1&4H<61GJTFOBK37CIK3P
M +6
M
M                             *=>=U]N,?F+M]VR6#'FMF:76"<YJT*+
MI)9-DK2?@,8YU*QOE:*S*.^O+:7Z50_])[@1UJ<4\ECZ\MI?I5#_ -)[@.M3
MB<ECZ\MI?I5#_P!)[@.M3B<ECZ\MI?I5#_TGN ZU.)R6/KRVE^E4/_2>X#K4
MXG)8^O+:7Z50_P#2>X#K4XG)8^O+:7Z50_\ 2>X#K4XG)8^O+:7Z50_])[@.
MM3B<ECZ\MI?I5#_TGN ZU.)R6/KRVE^E4/\ TGN ZU.)R6/KRVE^E4/_ $GN
M ZU.)R6/KRVE^E4/_2>X#K4XG)8^O+:7Z50_])[@.M3B<ECZ\MI?I5#_ -)[
M@.M3B<ECZ\MI?I5#_P!)[@.M3B<ECZ\MI?I5#_TGN ZU.)R6/KRVE^E4/_2>
MX#K4XG)9,X_N3@>52>Q6#((<V8?BQD.$EY5.)Z4+TJ53P$+5O6VZ43686D75
M
M
M                    :)\ZK<J=MYMX96QQQB9=3=0Y)9/0XB,P@E.DA1<4
MJ6:D(U=PC/NC'?,S%8_FE:-D3,^#\NY^37^YR%29$]YLU&9I986III!'W$I2
M9?9/B8Z=-"E(Q$.=?5M:<Y8OE6[?.,KW]SW0R=.O"%.>W&3RK=OG&5[^Y[H.
MG7A!SVXR>5;M\XRO?W/=!TZ\(.>W&3RK=OG&5[^Y[H.G7A!SVXR>5;M\XRO?
MW/=!TZ\(.>W&3RK=OG&5[^Y[H.G7A!SVXR>5;M\XRO?W/=!TZ\(.>W&3RK=O
MG&5[^Y[H.G7A!SVXR>5;M\XRO?W/=!TZ\(.>W&3RK=OG&5[^Y[H.G7A!SVXR
M>5;M\XRO?W/=!TZ\(.>W&3RK=OG&5[^Y[H.G7A!SVXR>5;M\XRO?W/=!TZ\(
M.>W&3RK=OG&5[^Y[H.G7A!SVXR>5;M\XRO?W/=!TZ\(.>W&3RK=OG&5[^Y[H
M.G7A!SVXR>5;M\XRO?W/=!TZ\(.>W&4G8\SO^/SV9[,Y]UME:7%M+<49]4ZZ
MD*,]2%ETI4D^D8=7MZ7C=B>+)IZUJSOR_6C8G.)F?[<6Z\W)9NW)A2X4N09$
M1O*9))I=,B[JD*0:OX51SM.TS&W?#HVC$MDC(H
M
M                                                        #R?Y
M]Z"5@%O6?2A$ZGKE'(5CZM/6F?)9^< [#D@#X6\RV>EQQ*%=-%&1'3UP6B)E
MRE:%EJ0HE)[Y'4OW 1,8?0(    <I0M=2;0M9EQ,D)4LR+OGI(Z F(RX!
M #DDK,C4E"E(3XRR29I+U3(J%ZX)PX[I$1&:E'I2DBJ9F?01$7$S <K0XTX;
M3S:VGB(C-MU*FUD1]!Z5$1T!,Q,. 5 'P[^37_%/[0)?JYYHR"1M!&I]U+6H
M_5..P.+3Q]<NM;P]3>PR*@                          Q+I=;99+?(NU
MYF,6^UQ$<R5-EN(88:07#4MQ9DE)>$S 1F-YOAF9=I_1'(;;?NQZ.U^2YC$S
MD\W5HYG)6K3JTJTUZ:& G@
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MC'WCR)AMQANW1D+M<61(+\4RLE(4:M:DJ2WJ<2:^D]-2JZMIVQ&PZ-5?V_\
M-<C2KGN2UN#*NLY.V\IF$]8L.CHE7>Y')2;C;S"'JT0I!I6E&DS5UN):>,VU
M=V/%$:,>**MGF\XUG>\5NV^VPRQ^9CLJ&NYWJ3<X3L>ZV5IE1)<CR&7$-)6Z
M9K0E"BH6HSKP*ISU)B,S".E$SL6/,?-?Q61@.3YCMA(RAJ=A:5/76W9=;504
M7"(TE2W)$%:FFCTDA"UEP/HHJE2K6NK.<2FVC$1L?'F/J+]*-QUD?#]$'S(_
M_OB$Z_@G0W,/;GS;<4<VRQ_<;<R3DTE&5K45FLN&VY<]^-%2HR*3+633M$F1
M:C(B+JFFFHZD2VK.<0B-&,;4W"\T.RQMVKUM+?LAEG-E6$\AP.YLDW'*62%J
M:<8EM+2NBVUD1F2#*J",^'04=:<93T8RUO8ME[6>P=\W9RB5-CY*5Y+'<5LD
M;0AF5-)Q#*N8:TJ,RYAN^*I/!LQ>=3XL0K&CLVMQQO,XP:!<K7M_DMZRE>X5
MUBI?<OUIM"G\7@R%H-9,.O&V9'XBB(S=37@:M%:#'UIW^"_1JB\+Q:YX-YNG
MG*8=>5-KN=CN#<&0ZQ4VG%,\M).(U$2M*RHI-2K0PM;FM65Z5Y8PTIL?N:YM
M9EZ[Q;[!;KUD=S;;M5DEW9SELVV1)=2GM":I,B.IIU*JDR21E6AF,UZ\T-;2
MMB<-\^=X[=4[5[<,[A(BY!NB[(?>D9S96-%I7"+GUBI?2A"5K,C:5H))>(I1
M$51AT=\XW,NMY7CL;33 'P[^37_%/[0)?J[YI/ZH(OYTK_AV!Q:>/KEUK>'J
M;U&14                          &I/.?X[ 9]7YK7_2( >(?-"WNP;8^
MQY_>LP>=7)N*[2S:[5"03LR4MDIBEZ24I*4H1K3J6M1%QX5/@ ]/[:>?!M5N
M!D$;&;A%G8Q<9[J6+>_<>4N&ZZLZ(0;K2CT*4? M:23_  @'IH
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M&AQG:H ^'?R:_P"*?V@2_5WS2?U01?SI7_#L#BT\?7+K6\/4WJ,BH
M                   -2^<_^H#/_P"RU_AH >*?,<V=P/<Z_91>,XA-W=O'
M6H:8-H?,^0MR<;^IYQ!&6O03.E*3JGK5,JD0".\]O:3!]K\UL,C!XJ+7$O\
M#>?EVAE1FTR[&<2@G&TJ,S0EPE4TEPJDZ /T'V6OEPR7:/"+[=EF[<Y]D@/2
MWE&9J<=-A!*<,S[JS+4?J@+T
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M5BT3NE:=.8C*KBS&  #W7_\ 3]_)7K^:?_XAL<K6^M/JAT]+Z<>M[D$+
M                /*/GV_J^@_Q)O_+BL?4IZTSY+>I^;P[#D@
M            ^'?R:_XI_:!+])/-PGS8^V$5$>2ZTCM"CTH6I)?D&>\8Q_C]
M.MJ6F8B?BEB_(:EJZD1$S'PPVSY6NOQU_P!]7[(Z?1I\L>YSNOJ?-/O/*UU^
M.O\ OJ_9#HT^6/<=?4^:?>>5KK\=?]]7[(=&GRQ[CKZGS3[SRM=?CK_OJ_9#
MHT^6/<=?4^:?>D+=E-SAN)Y[ARH]>NAPZJIX%=-1@U.TI:-FR6QI=YJ4G;.8
M7^+)9F1VY3"M33I:DG^\?A(<.]9K.)=^EXO$3&Z7<*K@
M  UIYPEDN^2;+9I8K#"=N-XG6]3,.%'3K==<-:#HDNZ=" ?G]MALKYUF %=<
MZP.T7&P7VV$Q'=M[S;:7I\62:U+Y;+Y*;?2TII.M"BU%J2::GT!E6O8+SD?.
M$W!;O&Y\2XVQAQ2&[G?KVP4,H\1M53;BQC2W4^*M"&T$C4=5&53,!^FEDL\#
M'K-;K!:FN1:[5&9@PF:UT,1FR:;37P)21 ,X
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M$1=/A&VT'(  ]U__ $_?R5Z_FG_^(;'*UOK3ZH=/2^G'K>Y!"P
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M+D.@T0    !?<*<4JUNH4=4MO*)/@(TI/[9CB=]'QQZG>_'SG3GUK(.>Z0
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MS>HVE'533J%&AQLS+I-*TFFO=Z1AK;FC+-,8G"<%D
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MR?5E@'S"Q[=[X0/\=V_R0??:_P \GU98!\PL>W>^$#_'=O\ )!]]K_/)]66
M?,+'MWOA _QW;_)!]]K_ #R?5E@'S"Q[=[X0/\=V_P D'WVO\\GU98!\PL>W
M>^$#_'=O\D'WVO\ /)]66 ?,+'MWOA _QW;_ "0??:_SR?5E@'S"Q[=[X0/\
M=V_R0??:_P \GU98!\PL>W>^$#_'=O\ )!]]K_/)]66 ?,+'MWOA _QW;_)!
M]]K_ #R?5E@'S"Q[=[X0/\=V_P D'WVO\\GU98!\PL>W>^$#_'=O\D'WVO\
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MQ^J;(_XD;_BV1AUO)*]/-#\>I/\ M4G^>=_#4.W7=#DVWRZQ*H
M            /87F7.NM1;J;:U(,V7ZFDS(_]I1WAA[>(GN;9^6$]W,QH5Q\
MW\'K+M<K^7<]NKV1V.2O!QN>W&3M<K^7<]NKV0Y*\#GMQD[7*_EW/;J]D.2O
M Y[<9.UROY=SVZO9#DKP.>W&7?%N]RAK)QB2X1ETI4HU)/U2.I"EM&EHVPR4
MU[UG,3+8%BO*+Q%-PR)$EHR2\V714^@R\!CA]QHSI6QX._VVO&K7/BE!K-H
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M$SA-M&8C.8=,/<IU>X>48=<;/*B63'HL67^D*FM,1MMQAY]YV6ZIRB&C)O\
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M-2\6C,,%Z32<2VIA']6O_P ^?X"1R>^\\>IV?Q_DGUK,.<Z8
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MF&\8ECB5 !\._DU>H8D?K7YK7ZH;;_/._@H'#T]T^N78O_!N<95
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MDW*8K]MR*_Q)LA4IJWN-N):AV^,N.EMF.V:ZZ-55*JM9J52FM&G;Q;5M6O\
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MC<IJ3\3&$L8 ^'?R:O4,2/UK\UK]4-M_GG?P4#AZ>Z?7+L7_ (-SC*H
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MYES\$P'XS-?E$?QB^V.@Y3]EFX$$VT&<5FNDO_33WO4'/=1]^3X'Q5GWM/L
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M,>*]#,P "]X1_5K_ //G^ D<7OO/'J=W\?Y)]:S#G.F
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M4A7!23+I(R/H,AV7**D""I %2 *D 5( J0!4@"I %2 *D 5( J0!4@"I %2
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MOM#GNJ^P       4#-$F5W29EP4R@R/UU$.YV/T_:X'?_4]BNC?<X
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M$'9(G\@W[1/L!SVXG)7A#L2A"$Z4))*2Z"(J%^X*S.5HC#Z$)
M                           !KS,/ZZ7_ #:/M#N]E]-Y[OOJ^Q C>:
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MC<-[\H=#(12LY6U-2N)W/3 Z+EMB8A_4C?\ '7^$.#WGU)>B['Z4)T:3>
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MDS !( ++A*3.YO*IU28,C/PFM(YW?>2/6Z?X_P"I/J7P<5W0
M
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M%CUE*T15$X9*EO44\HN@J="2]0<+N=?J6V;H>@[7M^E7;OE,#5;@
M
M                  ->9A_72_YM'VAW>R^F\]WWU?8@1O-   %'WDA3;EM1
MF%OML9V9/DVUQN/%CH-UYQ9K09)0A-3,^'00PZL9JS:,XM"CW-BPV#*\X<W
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M55*TH)2CH7>(:<1ENS.&KO2FV$^F3/R2?_\ +B_3LQ]6O$]*;83Z9,_))_\
M\N'3L=6O$]*;83Z9,_))_P#\N'3L=6O$]*;83Z9,_))__P N'3L=6O$]*;83
MZ9,_))__ ,N'3L=6O%XK\ZG.,5W!W.:OV'W%-TM*;7&C*DH;=:(GFW'C4G2\
MA"N!*+N#8TXF(VM35M$VV/4'F._J=G?V[+_X:*,.KO;&AY7I486P
M .*%W@"A=X H7> *%W@"A=X H7> *%W@"A=X H7> *%W@"A=X H7> *%W@"A
M=X H7> *%W@"A=X H7> *%W@'(
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M21FFM#Z#J0K-8F,+UM-9S#/^P1%P(B*A$1<"(B+H(A94$H &Q,0_J1O^.O\
M"'![SZCT78_2A#[O6:YY#M?EMCLL=4N[7"UR8T.,@TI4XZXV9)21J,BXGWS&
MI6<2V[QFLOSK]&+??Z&2O?XGPPVNI7BT>E;@>C%OO]#)7O\ $^&#J5XG2MP/
M1BWW^ADKW^)\,'4KQ.E;@>C%OO\ 0R5[_$^&#J5XG2MP/1BWW^ADKW^)\,'4
MKQ.E;@>C%OO]#)7O\3X8.I7B=*W![3\TW",KP#;.99,PMCEJNB[O)DHC.J;6
MHV7&(Z4KJVI14,T*+I[@U]28F=C;TJS$;6]AC9@
M
M                                           !4\QM#KY(N4=)K-I.
MA])<3T$=253P5XCI]EK1'PRY7?:$V^./#>I0[#B
M    #MCQGY;R(\=!N/+.B4D*6M%8S*]:3:<1O;0M<%-M@,0R.IMIZZB[JC.J
MC^R8\YJZG/:;/3Z.GTZ15F#$S
M
M                                          "M3_T.YRNU\KG5ZW*U
M]/AY7"HZ&G]QC9G'ZXN;J?;9^+&?;_!B_P#0G@_W@9?[K]<K%_:?KF/^A/!_
MO ?W7ZY3^T_7,?\ 0G@_W@/[K]<I_:?KF/\ H3P?[P']U^N4_M/US'_0G@_W
M@/[K]<I_:?KF/^A/!_O ?W7ZY3^T_7,?]">#_> _NOURG]I^N8_Z$\'^\!_=
M?KE/[3]<Q_T)X/\ > _NOURG]I^N8_Z$\'^\!_=?KE/[3]<Q_P!">#_> _NO
MURG]I^N8_P"A/!_O ?W7ZY3^T_7,?]">#_> _NOURG]I^N8_Z$\'^\!_=?KE
M/[3]<Q_T)X/]X#^Z_7*?VGZYC_H3P?[P']U^N4_M/US'_0G@_P!X#^Z_7*?V
MGZYC_H3P?[P']U^N4_M/US'_ $)X/]X#^Z_7*?VGZYD[:/(FA7DCE4^[T>/3
MPUZWV1I:W4S\>6]H=+'P820UVR
M
3                      __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>tb_diseasestage-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tb_diseasestage-4c.jpg
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M;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (  @ X0DE-!"4
M !#\X1^)R+?)>"\T8C0'6'?K_^X #D%D;V)E &3      ?_; (0 ! ,# P,#
M! ,#! 8$ P0&!P4$! 4'" 8&!P8&" H("0D)"0@*"@P,# P,"@P,#0T,#!$1
M$1$1%!04%!04%!04% $$!04(!P@/"@H/% X.#A04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@"*P5& P$1
M  (1 0,1 ?_$ *   0 " P$! 0             %!@,$!P(!" $! 0$! 0$
M              $" P0%$   !@ # P@'!P0" 00" 04  0(#! 41$@8A$P<Q
MD=%24Y,4%4%1(I+28U2AX3*BTR2587$C"$(6,X%R-!=B0[&")37!&!$!  $#
M!  ' 0$! 0$!      $140)AD1(3\+'A(I(#(Z$Q,D$A@?_:  P# 0 "$0,1
M #\ _?P
M
M
M
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MNGN(FCXVHY5:Y53C=>BS(;B7"1O8ZS0;C*GFVE*:<+!:%&@CP/ ]I&"+F
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MY01.@
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M[7PSUA+U[H:GU985+]%86#2_%U4I*D.LO,NK966"R2K*HT&I!F18I,C!%L
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MQ].&&)@5=&J:FNH:N%25$=$2JKF&XL**WCD:8922$)+'$]A%Z01N
M  #E=S_KSPUU!?6VH+9BQ>D7SR7[J(BTFLPY:FTDA"7F&G4)4E*2P))[,-@+
M5*ZDX-:&U*_727&)=2]6P2IFU4<V14[VH2>)0'?"+;SQR,MC?H]&&)@53FI-
M#:<U91Q--W,=;M+"?B268J'5H(U0%I<92LR/%224E.*5'MPV@B(M>#^@KO\
M[8=K7*E+UHY$>O75O.DXIRM03<532DJ(VC9))&C(9;0&M!X*:!A::U!IAR+)
MG,:J22-1V5A+?EV4[(G(V;LIU2G#W9;&R(R)/H+:8+5MW7"/0]UI>FTDN$[
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M[9L$Y$-I,8W%FE9.+WR6VS6\Z:,IH2 \L_[!<0V(-G12Z^&6JRU/2:4J;2?
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M8 M4IJ_@SPYUS+BS]04^:7%B^6I=AR)$ W*_',<1WPKC6\8Q_P#UKQ27HY3
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M::XA-PZ6PL(DF5$HW*Z9"D&Y&=(OV4TWI$6<P3?M*<0I"L>1)EC@'? 0
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MU8F9>RD\"P(@$N
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M#.4X4_\ D3OZ+C&=?_LQMZMD<W4
M
M
M
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M?63E@QI^:I^55+;;L(K[#\20SOTFMI2FI+;:\CB2-3:\N56!X&>!@BQ
M ".O;8Z.IDVB8,NS6P2<D"N:)Z4\I:B026T&:2Y3VFI1)26)F9$1F @N&.L)
M6OM#U>K9L%%;+L/$;V VYOTLJCR76,F\P3F,MWM,BPQY-@"W
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M@@
M
M
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M@).%(_V-VL?LB9I2=FP.;H
M
M
M
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M?U 8XEM7SIL^OBO$Y,JUMM3FLJB-M;S27D$9F1$>*%I5[.(#=
M  :\*="LHR)E=):EPW#42)$=:76U&A1H41*09D>"B-)_U(!L
M        J%9Q2T%<ZH?T95W3<O4D9U^._":;>,D/1,=\@W=WN\R#29*+/REA
MR@)R!J*CM+2SI:Z>S*M:4V4VL5I69<94E!K:2YAL(U)+-ARX ),
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MO+J9"*!<=#;:D-+<7&D*=62U%_D6:CQ<7F-6/XC ==!
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ML] T,Z)K)ER.[&.O=.$Q!.,\:TI3G=DM&M*",\Q-FO\ #@9A^D 0
M     <AXQ:>KEZBX=ZG9KM]?HU35056*&U.O-023*<4@E$1[MLU'BLRP(]F8
M]A L*-/=5$<UEPZE(?5KN^U_7W=+&2P\M3M<J772FYJ'4H-!-1V8KB5KS>P;
M1I/;E(P4CSLC_H_#N.3YZ\T]KJSN+Z.<=YLV*\I%F^Y+<=-!(W4AF6TEM>?_
M ";TB+$\V 9+G3[.B[)]BCDO653HTJ)J3+M_;B0U)D>'JH[A1T-9XU4Q*?L'
MC4K.HS9-3A8&9!VWA]J*?JO2,"]LV6V9<E4A!JCDXF.^AB0XRW)92[[9-/H0
MEYLE8GE66T^4$68                   $8O3FGG)13EU,)4TE[TI*H[1N[
MS-FS9S3CFQVXX\H"3         8UL,N.-NN-I6ZR9FRM22-2#464S29[2Q(\
M-@##85M=;15P;6&Q.@N8&Y&E-H>:5E/$L4+(R/ _Z /7@87)X9K#=>'_  )_
M\'9\GX/_ ,>0!\=KJ]Y"VGHC+C;C)Q7$+;0I*HY\K1D9;4?_ (\@#''IZF&T
MTQ$@1F&6"03#;3*$);)K'(2221$67,K+AR8F ^QZFJB3)-C$@QV+"9AXR6TT
MA#SV7DWBTD2E8>C,8#<         1\NBI)\A,N=6Q94M&&1]]AMQPLNTL%*2
M9E@ D          !\4E*TJ0M)*0HC)23+$C(^4C(!@\!!-.4XS64VO#&6[3A
MN.SY/P?_ (\@#(<>.K=9FD'N#S,8I+V#(C3BGU;#,MGH 8/*ZSS'S?P3'FV[
MW'C]TCQ&YQQR;S#-EQVY<< &V          ,;+#,=LF8[:6F4XY6VTDE)8GB
M>!%LVF8#PF'#2AEM,=M*(QYHZ20DB;/ TXH+#V3P,RV ,X
M    ^&1'L,L2Y=O] # L<V'M%L(_3@8#Z
M   ,;+#,=LF8[:6F4XY6VTDE)8GB>!%@6TS 9
M                   !HRJ:GG3(UC-KXTFPAGC$EO,MN/,GRXMK4DU)_P#Z
M3 ;26&$.N/H;0E]W*3KA)(EK)&))S'RGACLQ ?&8\>,2RCM(:)Q:G7";22<S
MBSQ4H\,,5&?*8#*                                           #Y
ME29&6!8*_$6'+CLV@/H
M
M
M
M                 T_*H)F9[L\3V_C7Z?\ ^H=>W)QZ<+/GE4#LS]]?Q!VY
M'3A;S/*H'9G[Z_B#MR.G"WF>50.S/WU_$';D=.%O,\J@=F?OK^(.W(Z<+>9Y
M5 [,_?7\0=N1TX6\SRJ!V9^^OX@[<CIPMYGE4#LS]]?Q!VY'3A;S/*H'9G[Z
M_B#MR.G"WF>50.S/WU_$';D=.%O,\J@=F?OK^(.W(Z<+>9Y5 [,_?7\0=N1T
MX6\SRJ!V9^^OX@[<CIPMYGE4#LS]]?Q!VY'3A;S/*H'9G[Z_B#MR.G"WF>50
M.S/WU_$';D=.%O,\J@=F?OK^(.W(Z<+>9Y5 [,_?7\0=N1TX6\SRJ!V9^^OX
M@[<CIPMYGE4#LS]]?Q!VY'3A;S/*H'9G[Z_B#MR.G"WF>50.S/WU_$';D=.%
MO,\J@=F?OK^(.W(Z<+>9Y5 [,_?7\0=N1TX6\SRJ!V9^^OX@[<CIPMYGE4#L
MS]]?Q!VY'3A;S/*H'9G[Z_B#MR.G"WF>50.S/WU_$';D=.%O,\J@=F?OK^(.
MW(Z<+>9Y5 [,_?7\0=N1TX6\SRJ!V9^^OX@[<CIPMYGE4#LS]]?Q!VY'3A;S
M/*H'9G[Z_B#MR.G"WF>50.S/WU_$';D=.%O,\J@=F?OK^(.W(Z<+>9Y5 [,_
M?7\0=N1TX6\SRJ!V9^^OX@[<CIPMYGE4#LS]]?Q!VY'3A;S/*H'9G[Z_B#MR
M.G"WF>50.S/WU_$';D=.%O,\J@=F?OK^(.W(Z<+>9Y5 [,_?7\0=N1TX6\SR
MJ!V9^^OX@[<CIPMYGE4#LS]]?Q!VY'3A;S/*H'9G[Z_B#MR.G"WF>50.S/WU
M_$';D=.%O,\J@=F?OK^(.W(Z<+>9Y5 [,_?7\0=N1TX6\SRJ!V9^^OX@[<CI
MPMYGE4#LS]]?Q!VY'3A;S/*H'9G[Z_B#MR.G"WF>50.S/WU_$';D=.%O,\J@
M=F?OK^(.W(Z<+>9Y5 [,_?7\0=N1TX6\SRJ!V9^^OX@[<CIPMYGE4#LS]]?Q
M!VY'3A;S/*H'9G[Z_B#MR.G"WF>50.S/WU_$';D=.%O,\J@=F?OK^(.W(Z<+
M>9Y5 [,_?7\0=N1TX6\SRJ!V9^^OX@[<CIPMYGE4#LS]]?Q!VY'3A;S/*H'9
MG[Z_B#MR.G"WF>50.S/WU_$';D=.%O,\J@=F?OK^(.W(Z<+>9Y5 [,_?7\0=
MN1TX6\SRJ!V9^^OX@[<CIPMYGE4#LS]]?Q!VY'3A;S/*H'9G[Z_B#MR.G"WF
M>50.S/WU_$';D=.%O,\J@=F?OK^(.W(Z<+>9Y5 [,_?7\0=N1TX6\SRJ!V9^
M^OX@[<CIPMYGE4#LS]]?Q!VY'3A;S/*H'9G[Z_B#MR.G"WF>50.S/WU_$';D
M=.%O,\J@=F?OK^(.W(Z<+>9Y5 [,_?7\0=N1TX6\SRJ!V9^^OX@[<CIPMYGE
M4#LS]]?Q!VY'3A;S/*H'9G[Z_B#MR.G"WF>50.S/WU_$';D=.%O,\J@=F?OK
M^(.W(Z<+>9Y5 [,_?7\0=N1TX6\SRJ!V9^^OX@[<CIPMYGE4#LS]]?Q!VY'3
MA;S/*H'9G[Z_B#MR.G"WF>50.S/WU_$';D=.%O,\J@=F?OK^(.W(Z<+>9Y5
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M.W(Z<+>;(S BQW"=:0:5D1EB:E'L/^AF8F7V93%):Q^O'&:PV1S=
M
M
M
M                                             !P[6Q:ITGK.@U$W
M?VS]99ZBCQ[2Q4XD]/U]7(7X5NN<@MK5BXZZI#:)6[S)=42EK))905W$$
M      '*N*?$>\T)J_0T6(W'7I>S=EJU4MY)FZQ"0Y$C(D(62B)*6G9:5.8I
M/%/JP!6F7%NS3Q=U!IQ4;?:&HJ&1,2N'&=E3Y-K!D1DR$,I:-1K)"92&MVE&
M)N>D!GN.,$AYIR!454JHU+!MM-Q+&MN6V#64#4-BB(3B#BR'D8F1.I(C7F0H
MO:3AAB$O5\9=)VUS"K&&IC<"TG2:FGO74-%739\/>$XRTI+JG2,S9=)"G&DH
M6:#R*/V<11T,$         '%>.O$F[TI*JZ/25O!K+QF),U//3/4PE,JOJ,A
M% 3OS+!<UUPFDJ0>9))49 L.M4-U7ZDHZW4-2X;M7;169T)PRRFIB2V3B#,O
M0>518D")         !'7\]RJHK2S9(C>A1)$ELE%B69EI2RQ+9B6) ."_P#W
MKK!O@"_J]Z''_P#L]APZ\XJ6U>".0<?S)+^7/CN_+S\3^+#_ - 6B[66O]9L
M:@X=PV*N.UIG4SK#-G<.NDIUU^16RIA,QHZ3-222;!&MUP_224D>TR":C<5:
M69J!=)#J[:3 ;LUT+FH68F\JTV;23-;)K2LW2)*R-I3NZW1.>R:\0%[!
M    &E;)M5UDI%&ZPS;J;44)Z8A;L=#IE[*G$-J0I22Y<I*+'UD X,=EQ'<X
M#ZLG0]6*+4%+,U05AJ-^.2ICL>IDS"2F*VE:6XZE[I*$G[1-(_"68B,BL?$J
MZUA/LJ2FTZ]>6;K>D7[=ZJTW*\#.8L%[M$29)D.*0EYM2DNH0QBHU+2I1MK+
MD#M>AK95[HO3MRY8-6ST^MB2'K.,V;+,EUQE)K=0VHB-"5JQ42#(C3R&")\
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MR0B4U<6D5UE3TB ALUE$2TAU1+8Q0E1+3D1@@U .U @
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MKW)\MV!%56TC5E,=F-5D!9H-4>&EPSR(/=MI-1YEY4)3FRE@"+P
M          "&H=+U&FWKE^J;6AR^L'+>Q-:U.$J6ZTTRI2<WX2RLH]DM@#'"
MTA0P;/45JW'WLC52V5W3;YFZR]X>,B(E.[7BDDFT@DJ3A@?I >])Z7K-%Z>@
MZ7I5/G45J#9@HE/+DN-,9C4AHG'#-1H;(\C9&?LH(B] ":
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M+ G&V%&TG R3EP]G%)&07,
M
M
M
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MPV[LE9L?_4Q,N-/_ )5K'G7_ .T;(YN@
M
M
M
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M,B2FRD[DT1$DXMB*TDW),QU)F1DQ'06=U18X$9; %U(R,L2VD?(8
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M3K8#=A:6%=;'8HBKDK-,9AU*HD<R==)"W"3CL01*/\2<0Z8"
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MS4E%%X6-3CA;S1K]R]<;E:E$?F;$EMO<&;:<QYGBSYLOIY0'9@0
M,,>4!1.#6G;G2?#FIH=01RBVT9R<J0REQ+I$3\Y]Y!YT&9'BA:3!97L$
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M(S(@1=P
M
M
M
M    !I';02,R-2\2V?\ B=^$=NG+Q,./=CXB3S:#UG.Y=^$.G+Q,)WX>(D\V
M@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(
MD\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!W
MX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\
M3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#
MIR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7
M?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9
MSN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V
M@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(
MD\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!W
MX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\
M3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#
MIR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7
M?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9
MSN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V
M@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(
MD\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!W
MX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\
M3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#
MIR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7
M?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9
MSN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V
M@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(
MD\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!W
MX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\
M3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#
MIR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7
M?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9
MSN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V
M@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(
MD\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!W
MX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\
M3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#
MIR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7
M?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9
MSN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V
M@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(
MD\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!W
MX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\
M3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#
MIR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7
M?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9
MSN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V
M@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(
MD\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!W
MX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\
M3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#
MIR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7
M?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9
MSN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V
M@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(
MD\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!W
MX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\
M3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#
MIR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7
M?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9
MSN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V
M@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(
MD\V@]9SN7?A#IR\3!WX>(D\V@]9SN7?A#IR\3!WX>(ED8L(LAS=-*4:S(S]I
MMQ);/ZJ21#.7UY1%9:Q^W'*:1Y2V1S=0
M
M
M
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M9$%F5AR$ ]5UI76S+DBLE-3&&GGHKKC"R6E+\9Q33K9F7(I"TJ2HO09 -L
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MC4GUD WP            &-B0Q);)Z,ZAYDS,B<;42TF:3-*BQ+$MAD9& R
M                  @(>N-'V&H9&DX5Y"D:EB$HY%6V^A4A.[_&60CQ,T8^
MV1;4^G !]H=;Z0U3,G5^G+N%:3:U62<Q$>0ZMH\33B9)/DS$:<Q;,2,N4@$\
M                                      -2TM*VDKY%M<2V8%9$0;LJ
M9)6EIEM!<JE+49$1 -;3^I*'5=:BXTY8L6=8XI2$R8RR<02T;%)/#:2B]*3V
M@)0!C??8BL.RI3J&8S*%.//.*)"$(06*E*4>!$1$6)F8#TVXV\VAUI9.-.$2
MD+29*2I*BQ(R,N4C(!&:BU+0Z2JG;O4E@S653*D(<E2%94YW%$A"2])J49X$
MDBQ,!AO]7Z8TM5-W>HK6/6U3IH0S)DK)!.+<+%*4$>U2C+;@DL<",^0C 2D.
M;#L8C$^OD-RX,E"7HTEA:76G&UEBE:%I,R4DR/$C(P&<              :5
MC<550<0K28S$5826X,$GED@WI3I&:&FR,_:6HDF9)+U& CI&M](1-2,:0E7<
M)G5$E)+8JEO(3)42B-22)!GCBHB-24\ID1F6P@"+K?2$W4<C2,2[A/:GBI-4
MBJ0^A4E!)(C41H(\<4D9&HN5)&6/* UXG$/0\^OM+:'?PGZVE=W%I);=2I##
MF.!$H_3F,\$&6)*/\.("S                     /S-/\ !4&MK?7T2QT[
MJ:SE:UB5+U&_6).\:6Z<2O2S&EO+)U+T9M)2$I2WNC02E$>W,"OTR"
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M@-32-8:4@W\IAMB1(5(:7X=:G(SIQ9#D??L+41&IE[=[UHS+:A1 BR@
M              C#TYIX[DM1'4PSU E.[*U..UXPD9<F7?9<^&7V<,W)L 28
M        #X9$9D9EM+D/U /+S+,AI3,AM+K*_P 3;B24D\-NTCV /1I29XF1
M&9EA_P"GJ ?%-MJ2:5()25%E,C(C(TGZ/[ /B&66TI0VVE"$$E*$I(B)*4[$
MD1%R$7H ?$,,H<<>0VE+SN&]<2DB4O*6!9C+:>!<F(#(
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M^)1X>D_28(^H::;3D;0E*,,,J2(BP]6! /CK++Z20^VEU!&2B2M)*+,D\2/
M_21\@#(           #!#A0Z^.B) CM18C>8T,,(2TVDUJ-2L$I(B+$S,S_J
M S@                   \)990ZMY#:4O.$DG'"(B4HD8Y2,^4\,3P &V6F
MC6IIM*%.JSN&DB(U*P(L3PY3P(BQ >P
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M >@
M
M
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MY_9E,Q_]EU^O#&)_^0E1YGI1"N4_[CU/*^
M
M
M
M               -B'_YB_L8QG_C>'^I <'=$*Y3_N/4\KX      .+MZKNY
MFII-Q*FVL*F@ZB51)>CM1UTZ&VGTQDLOM+,GEF\LS)4E.QM:DIY",17:!4
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M]1SU5WFD E(BR30TA:\J5J6:5MJ6;3J24HB6D]OH(+8
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MD9&1D98D>P]HJ-L        !L0__ #%_8QC/_&\/]2 X.Z(5RG_<>IY7P
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MJ+!%8U$BX-UT>GCO1F6V2+:2B>==,U&K$S5CM].W: L0
M   *7#X9TL&2V[&FSTPX:I3M37;\O#0'YJ5H<=CIR8DHB<63>=2B1F/*1 M6
M32'#R)HM,:/67=M)K8C2F6:Z8^T[']L\QK4264*4X:L5&M2\3,S,\3 JN (
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MK B+%:UJ5L(BV[ $B         V(?_F+^QC&?^-X?ZD!P=T0KE/^X]3RO@
M
M
M
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M*#2?.:C'/[.-/_CK]<95_P#LI8>9Z40KE/\ N/4\KX
M
M
M
M                       V(?\ YB_L8QG_ (WA_J0'!W1"N4_[CU/*^
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M#H_#C3TS2NB:>BL,"G165'(0E9NY''G%.J1O#_&:37E-?_(RQ%25I
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M2A)$3:$%@2$I))%LQ!970$                  !QN-P]M)\RNA.:8KM,G
M5:>8WM8XV:)C,]A]DFVFR_RF3BWD/N%(_"I&S,>!B+5MZ!T/;TMS1ON4;% W
M25;E9:S8[Z'CN'CW*6W#)'MFE.Z4X2G_ /(1KRE_R,"7614
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MO@
M                                         ,#<.&U(<EM1VD2WB(GG
MTH23BR+D)2B+$\/Z@,X
M
M                  -B'_YB_L8QG_C>'^I <'= JEM$HRR/<O9+Z![8PG3=
MXN<:[/GC&NH]W2^@.$Z;ISC78\8UU'NZ7T!PG3<YQKL>,:ZCW=+Z X3IN<XU
MV/&-=1[NE] <)TW.<:['C&NH]W2^@.$Z;G.-=CQC74>[I?0'"=-SG&NQXQKJ
M/=TOH#A.FYSC78\8UU'NZ7T!PG3<YQKL>,:ZCW=+Z X3IN<XUV/&-=1[NE]
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M>E$*Y3_N/4\KX
M
M
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MU#JV7-OLN$@S-)[#V* ;@
M,;,F/))9QWD/$VM33AMJ)>5Q!X*2>!G@HCV&7H 9 'Q2DI2:E&24I+$S/81$
M7I, 2HE$2DF1I,L2,MI&1@-:QLJZHAN6%K+9@P&<#=E27$LM(Q/ LRUF1%B9
MX /,ZWJ:N*F=9SX\*$LTI1)DO(9:4I98I(EK,B,S(M@#+#FP[&,U-KY#4N&\
M69F0PM+K2T\F*5),R,O[ ,X              UYT^#615S;*4U#A-8;R1(<2
MTTG,9)+,M9D18F> #29U1IF1$D3V+F"[!B93E2D2F5--$L\$[Q9*P3B?)B8
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MSDN1I==03)AO:=J+%:W)<:$3:$8KWIJ6V3KB5NI94>+9*P/ \4D65Y!
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MM)+5@H]NT!Z@:4TU5V;]S75,6+:R<V^EM,H0X><\5X&1;,Q[5X?B/:>)@)@
M       !H2Z*DGOE*G5L65*21$3[[#;CA$GDP4I)GL ;X          Q28T>
M9'>B2FDO19"%-/LN$2D+;61I4E1'L,C(\#(!H.Z:T\^4@GJN*YXJ*W7R34R@
MS<ALFHT,K/#:VDU*P2>PL0&X[ A/R(LIZ.VY)A&HXCJDD:VC<2:%&@SY,4GE
M/#T (MK1FDV;!RU:I8:+)QY,I4HF4;PI"<3WB3P]E1X^TI.!GZ<0$X
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MI*=ZA*\"66"B+,1\I;# 9R+#87( PJAQ%FLUL-J-U27'#-"3S+;PRJ5LVFG
ML#] #%*JZR:TZQ-A,2&)"DK?:>:0XAQ:,,JE$HC(S+ L#,!Z.MKC-A1Q&35&
M6;L8]VC%MQ1&DU(V>RHR,R,R 8HU)30VU,PZZ+':62R4VTPVA)D[AG(R2DB]
MK#VO6 ^G3U!PUUYP(QP'$I0Y%-EO<J0V1$E)HPRF22(L"PV ,S4*''2REB.T
MTF,@VXY(0E)-H/ C2C O9+86P@&1EEF.VEF.VEIE/X6VTDE)8GCL(M@#V
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M)QIPC2M"B)25)46!D9'L,C(!C?AQ),54*3';>A+3D7&<0E;1H+_B:#(R,OZ
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M!XGN5!?XU?W,?4A\N?\ 7P$
M
M
M
M   ;]/\ _-+_ -JAQ^[_ )=OI_Z6$>%[U07^-7]S'U(?+G_7P$     '.Y.J
M["):R')%@2)#-LW7)T\;22S0G7$-I?S89\5$K>DYCD_XX#-6J.B#3(
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M/,FS)$=^&MS?SU)4B7*;6@UKC$C'=I02CS(/ MJ<I;#,4G_%U%9
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M.7-M_H)1:K"*@       "/FU+,ZQK+);BT.5:W7&D)PRK-YI31DK$L=A*QV
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MLS_H%%JRT=.S0UY5D9Q;D1MQU<=*\/\ $VZLUDV6!%[*,V"<?0$),U20
M    #2N(3EE43ZYI1(=EQGHZ%JQ-*5.MF@C/#T%B!"H3=!V$E-FA,UG=3*_<
M1FU(5@U.=90P^\9ERI4AI!$7+^+UC-&JK+.J7I5K2ST.)2W6*?4Z@R/,O?,*
M:++_ &,\=HTE4(SI:Z4]'B3),4Z:-:.V[:FDK*2HS>6^VT9'[)$2EXJ7CB>&
M&'I$HM5R%9         %;+1[#-7 @PYCT>95NNOP; B0IQ"WS7G)23+*I*B<
M-)D9?:)1:O'_ $_<-,.5]I(BVS2Y#CUB26G%/'-4E;V=M2<F!J0DTD1>SE+
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M>DS!&4        !H6U;YI$)A,EZ&^VXAYB3'5@M#K1YDF9'BE2?0I*B,E%L
MAAI:4JGQ3[TE<VRGN$[,F.DE!K-"";01(01)2E*2(B(@692H(
M       "O0]&4T-]#B3?=C,;XXD%YU3D9@Y!&3F[0?K)2DEB9X$9D6!"46K+
M4Z5K:B0U):=D2%QFCC04RGE/)C,*,C-#1'R$>5)8GBK B+' 6A,IP$
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MO_4B%2);%96Q*B"U7P4FF.R1X9E&M2E*4:E*4I6)FI2C-2C/E,!M@
M      #2L*N+9G$.42C.%(1,8RJ-/^5HC)..'*7M'L :#VE:Q^R.R6I\B6\W
M+>A)=-,5R2R1$AU;9<JBRI/EP,TD9D9D%%J,:5K(]D5BA;ZB;><E,0ENFJ*U
M)?(R<=0WZ%'F5_0LQX$6(4*LTS3T*:N8Z\X\4B6;"B>2LB6SX16\:W6PR+*O
MV\#(\3,\=FP*%6W6U[%7#;A1S4IM!K4I;AYEK6XHUK6H]F)J4HS,$;8
M   #?I__ )I?^U0X_=_R[?3_ -+"/"]ZH+_&K^YCZD/ES_KX"
M
M
M
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M[=3W:)&EW_CBWF[RY5?@S8_:.'WTXN_T5Y?_ &BR#P/H*@O\:O[F/J0^7/\
MKX"
M
M
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MQP$JM'N1J_3\6E*^DRR9@&9MD3B5)>-Y*C0IK=&6;>$HC2:<,1:E$X"
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M7%"B/8%2B8@3XEI"8L(#I/PY*"<8=3C@I*N0]N!E_8Q4;(
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M)++B?_H8LR1#;H[9N\J8MJVTMA,E&;<N89DF1FDRQ+898EL46PRVA"3"1
M           $%<ZE;J;*LK"B/2';"0VPMY*32PPEW-@I;AE@9F:3)*"V_P!B
M"JQ#5>U:ZW-?W<#>4D.8U6S+#>DE:9#QH3BEHRVH0IQ*5*S8[=A8$)4H1M6.
MO38^\@;NDFRWJ^%8;TE+7(8-98J:P]E"S;6E!YC/86)%B05*->#K5R;%4XF$
MCQ;_ (0ZYAM[>$X4_.:$N&2?86A+:UNIP/*1<IA5:+>*R         -^G_\
MFE_[5#C]W_+M]/\ TL(\+WJ@O\:O[F/J0^7/^O@(    ^&1'R[?N 4=FFMX-
M933/"*?F5-E,EO0D+1O%QY2Y"#-!F9)-1)=2LDF98\G*(U5-Z6A38L>?+GM>
M'?LYSTXHQF2E--K)*$)6:3,LV5!&K ]AG@$)*>%0      %=U'IU-]8TBI+#
M4FLA//NS&7MI&2V%H1@G \3)1D),+$T1M_I):%U4C3L?=,UA24'!BOG 692\
MAFIMQ)&1&1HVD?*1F$PL2U8FCK2.PX@FF&U.4TV"24NK=RRILA3^&=Q.8T^U
M[2O7Z!*%7N9I>]0AM=:3+;[-/#KTD2DD>\C2$N.)0:D*2DS01DVLTGE5@> M
M"K7@Z2ODV!SWTI23EA7S#)^2J4^345EUIS.X:2Q7BHC(B]G 2A5[TQI"UJY]
M6B<UFC4R'4-2U3774+-;9M$;,?*1-YB/VR49X>C'E"()ET :9        4^V
MT[:Z@OICKTA4"K8AG7Q<$,O^(3++-)5E62LFQ*$%Z3P/T"4:K1+Z5:M(U'&@
MW*<)\+-$4[B2B>;84:&WL2,_QH)*CQVXXBPDID$        :UBPY*KY<9K#>
MO,N-HQV%F6DR+'G 416BKLXKL+.R<1=5B368_P#_ #/@O YOP_\ CR;<W+FV
MC-&JK))IYKJ=-$C)C5/H=EXJ_P"*8KC)Y=FWVEE_Z"I5HP*F]@37("(D-ZK<
MLG;,[)X\[A(>6;AH)K CWQ&>5+F; D_UV M5N%9        0^IK*5552Y<"N
M<LYQ+0B-';0;F5:SP)Q9)(U$A!>TK+M]!;3"5A4(C#T5ZMOE,V4QV-/?>NWG
MH;C+[JY44V$NM,8&K=-D2$$E&)I3ZSQ,9:9GJ:7(T9?/J@+.PL)$Z9 BK;(Y
M3:)2\$EAM-*U)+$R+UX&'_B5_P#KH"?PE_8:9?0       5*1HJ!;:DL[2[B
MHDQ'V8C4,MXLE%NB<WI*2DTE@>9.&.(E%K_\)E9<U>HV[2AK8\FO*M17)CF^
M40FC:>4LLI$VLLN!X; 5[J])RVVRDV-B^Q9/37;&8W7.FU&6XZ:,&U$I.*T)
M0VE&)X8[?6%$J\:88U-3LM5$JKCG"3(DK5.;E[2;??<>29-&UR^V189@@FB3
MKJR5%U#=V;N7PL],0H^4\5?X&U)7F+#9M/8*,=QIA&H'G&KB8Z_1K))>3H)+
M;*C+E-U9%G7B>TBS$1"4(FB&N].VMB]*KF*^ B+*=C.L7:/\<J.B/NS]I.4U
M+<3D,FU$LBP,L<,-JBQ+TUIZ[\0Q4*;9121+5=NB>EPS<6@WER$L;K+L43B\
M#5FPREZS"A5GM]/3),B;(@1FV&VB0<5EE26%27'G$*EK4M!$:5K:3N$+/:6*
MCQVA0B6[%KKI.E7Z\G$-VSC4E,0I)^*;9)U2S9;<4K'>$VDTH49XXX>D/_$_
M]5)W1FHYZ9;K[9$N1!:B$F9,.6Z;C<QM]6*B;2A*#21Y4H3_ '$HU6$U;:;M
MG;J5=PFV'E-R*^9%CN*R;XXC3[3B%*RGE/!W%"MNTA:)$I72]=8P4VK]DRU'
M>L9[DU##"]XE*%M-((E*P3BO%!YL A)4^GT3;Q6:J*=1 @6$"2A][43+^:2M
MM+IK<)*4M),S=09MJ):\,#/E$HU,MY?#XUUK\MIB,SJIF?)L8$A6+C2\\A;C
M;;Q&6U*D&2%;,4\J=I$%$Y-J1HN3J%=S,O)4B"[9I1&:BPW\6D166\&R7[/M
M*WBG%[/60M"M'V!H]=E8.66L8,2;)<@0HZC/_*12&-[OS3B18)7F2HON"A6R
M<U'4NV=2W7PT(Q1)ANY%[$;N-(;<47(?_%!X$+*1*OWFE;:78S;.(1'A/CSH
M[33ZHSKJ&X1Q5D3B4GD61JQ3Z#Y#PQ$F%B4<B*]I&57VTOPS$R0J=O8TV4ZI
MO+)-E9K.6M"DD\1-%F3@6<L<O)MG^+_K5K:#4TZ@K4QFB:B28#S1LMO'!)MY
MYYY9*=P;-Q;)I6G(V1D9;<2Q/8H5A*)TI?-QG(26V#;?ATR#=)W+NWZMU)N(
MRY=I*21FE1?VP"B5;+VBIDFQND+>;13R8\ORK\2G&I=JC+)6HMA8$:<48'_S
M4+0JR:5T[:0;-$ZSCFT<6(<)IQ<YV8:LRD&K=I-*4H:]@C(C]K^WI1!,KH*R
M        CKJ6_!A>(9A.SB):$NMQ\-\AI1X*<0GE4:"/'*G:?HVA)"%T1$D1
M46O^.0FM?EF]!>L",IKQ*;03BW<V"C+.1DWG+-E(O1@)"RM8J
M        KL6A>>=U([98$NY7X=I2%9C3";8)ILMI%@>93BL/6H2BU:5'37A3
MJI=PRS'8H(;D*.METW3DN.);;-W TIR)RM_A/$\5?TVH696\5D
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MX;0E(EO:7K9=121J^:M*GVLYDAM2EMM(6XI2&4*5M-+:3)M)GZ"%@E, @
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M?XU?W,?4A\N?]? 0
M                                                      'PR)18
M&6)>HP'T
M
M       &_3__ #2_]JAQ^[_EV^G_ *6$>%[U,6][:O\ "]RG_P /O'UHQ_\
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M3[*MJTX%SXCA]\>UZ/HFN7^2LH^>^@J"_P :O[F/J0^7/^O@(
M
M
M
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M' PJ4>(^L*J3$>EH1(2AK<&TVMHTN/HEJ-#"V2Q]I+AD9)^W 2I1/BH
M    -^G_ /FE_P"U0X_=_P NWT_]+"/"]ZH+_&K^YCZD/ES_ *^ @   #PZR
MT^VIE]"765EE6VLB4E1'Z#(]AD J#-5(5IC4$=Z&9RUR+5V"TI!&LS=4Z32F
MR]&8E>R9>L1K_P!6.D:<8IJYEY!MO-Q64.(5L4E26TD9'_4C%AF6^
M"I:MBS9=WIAN ^Y#>*1*,YC327MV7A'.4EI4DB5^'VO_ $VB2U"*U@U=0VZ>
M/,L/%5N:2=A+D(=996Z>4V$NE!)*B(BSY?\ B:B+';@))"+3'LIT1)39,^04
M>AF2HZT^*C$I]N2HXRC29DM2TH).3/[2BVF6T%9'_&53#ZT'/=:F4L&3./?/
MI4J6Y(2VXZ:R2LV\$&9NDVG'(6PN0!JU?C%S6V")QVN9N:UZ*329*HR26P]G
M4TJ1BO)F(LQ_AQ ;.BW;E=Y \7+5Y@:'CO(^[F*<4LD'L?-T]RWE7ANS;+:6
MQ/LA!+J8TP        H>I*^TU1>2JZ&PRJ!705QG%S-ZVGQ5BG:MHT),E*:;
M26WT&OUB3_\ 6H_^+%I2QEV5'&=L6U-6C&:+8(6DTGXF,HVW%%B18I4:<R3+
MT&0L)*:!        $5J=1ITU<J+E*#*,O_1E02L?ZY9:H3_U>=I$DJ*OJ(AW
M#2<IDDXKC25Q6\>0\'U.;/4V0Q_XW_[5>+.OB-:RTS9I;,YT@Y+2WE&I1DTB
M(HR0DC,R21GM/*18GRC7_K/_ (KT?4,IW4->]'GOY95N[">C29*5+-DB=2:#
MAH;RLI2I!9%K7G/8>W,)5:.HC3        "!U?84E54%87K12(\=]E<9@\,5
MRR7_ (2+,9)QS;<5;"Y3Y!)6%<A5]7=Z=U!+G28MC(G..3+"- =-<1IQM@DM
MLF:#+>8)2DUFK\:MN&&!"*^0I4*!(TI873K;-8= IEEZ1@329*D1U*+,K82E
M-I5ACRD1D L&@VGF=(U;;Z%-GNE&VVLC)265+4IHC(^3!!IV>@6/\2?]6(5
M    !6-;U\RSA5<>"3Q.)M(3CC\<DFXRVAS%3I9B,O9+UD8DK",U%IA<*IF3
MV7)MU;NNP"<<<RNO^&BS&WC0TAM+:2(O:4>!8F?*$PL2SJ.RU)?PK"##D5;%
M5&EI;EV#.[-<F6E"$)2R:B4I"22:E8F18X$0'^,+[EM2ZHAV-I&DVQ'5O1G9
ME;$4:-X<E#B4FV2UFGV2ZVT#_P 2%['<M$Z?L8<%TGCL8CTC.UD?;CH2X?\
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M2%"JV:??L)-3'>LR44M1KQ-:-TM39.*)M:D?\5*025*3Z#,:AF4F
M WZ?_P":7_M4./W?\NWT_P#2PCPO>J"_QJ_N8^I#Y<_Z^ @
M                                ^&1&6![2/E(!\-"3+ TD9&6!EAZ/
M4 ^X$9D9D6)<A^H!Y)EHEK<)M)+<P-:B(L5&GDQ/TX>@![         >5(0L
MLJTDHO498D ^(:;01DA"4D?*22(B/F %LM.HW;C:5ME@9(41&6*=I;#]0#V
M                C;.@I;I3:[2"U*6T1DVIQ.*B2KE3B7*D\-J3V&%"J02E
M*$I0A))0DB)*2+ B(MA$1$ ]              ##%BQX4=N)$:2S&:+*TT@L
MJ4I+T$1 ,P              ^*22B-*B(TF6!D>TC(P'Q#:&D);:22&TE@E"
M2(B(OZ$0#T                                          /"F6EK0X
MMM*G&_P+,B,TX^H_0 ]$1$9F1%B?*?I/  2E*<<I$6)XG@6&)GZ0'T
M                                                 &_3_P#S2_\
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MD1$./W3[7?Z8]RQ#P/>J"_QJ_N8^I#Y<_P"O@(
M
M  8@
M
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MJ?,7/*7"CU*+)VL\ ^2DNJ2RM368G<W_ )E++%+>7#+_ %V@46P5D
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M?$*0VEQQDTI__9(02L$N>SR\JB(A%G_U)6-^XWJ=S5!(EG7UDQ-4;B6W/!>
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MC3#<         ;]/_P#-+_VJ''[O^7;Z?^EA'A>]4%_C5_<Q]2'RY_U\!
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MD:?_ .E1I :O_7*/S3SGP+?F6;>;[ __ "9<N?+CESY=F?#-AZ0HM4H"
M    (V\HX&H815]B3AQB<;>P:<4T>=I69&)I,L2(R(\ F")HTE:0K7(Z679,
MUUYM[Q,:8Y*=7)8=R&@S:<4HS21I,R4GD/':0E%J^+T;3''BLL'(BO1#=-J9
M'?<;E'XE1*>SND>96\41*5F].WT!0JF(,&)60V:^ TEB''03;+2>1*2_OM/^
MYBHV         &O"@Q*YCPT%E+#&=;F[06!9W5FXL_[FI1F8")7HK2KDY=DY
M5,KF.NG(<6HC4E3QGB:S09Y3/$L<<!*+64O-A1+&(] G-)?AR$&V^RLL4K0K
M89&*C0J=,T5$ZX_4PTQG7DDVXI*EJQ2D\2+VE'ZPHM6]#A1*^.F)"92Q&0:E
M):06"2-Q1K4?_JHS,$;')L+D 8&X45J4].;:2F7)2A#[Q%[2TM9LA'_;,>']
MP&E(T[32HRXK\4E-./JEK,EK2LWW,24O.E1*(S(S3L/\/L\FP*+5GE5-;-@>
M5RHR'*\DH2F/A@E)-X9,N&&7+@64RY 2K5C:7T_#42XT!I#A.MR,^!FLWV4J
M0APU&9F:B2HRS'M"BU?9.F*&6A2)$%M1+D*FFHL4+\0LLJG"4DR,C418'@>T
M@H5;#%/5QJLZ6/$;;J3;6R<-*<&MV[CG3AZCS&"5:-=H[3-2Z;\"M::>-LV=
MY[2U$VHL#2DUF>4C+EP"BUENN4E2[7,U#D1LZV-NO#Q\/9;\.9*:-/I(T&DC
M29!1*OJ*>K;K%TR(K953B'&G(F'^-2'L361EZ<V8\?[@59(5?"KTNIA,I9)]
M>]>R_P#-S(E&8\>4\J$E_P"@#0OM.Q=0.5Q33)46"^J0M@R/_(9M+;+!25)-
M)I->8C+U!,+$T?7]*Z>D08U<[ ;\)#,SC(1F0ILU8DHTK29*]K'VMOM>G$*%
M7F1I+3<HXYO5K)E%:3'92DC0DF$'B39D@R)2"/\ XJQ(*%99W=.TCRDK<A-F
MM$KQZ5EBE12LI(WF)&1XFDLI^L@HE7M%%3MG7FB$T1U.8JT\O_@):#;5D]6*
M3P"A5A/3% =GYP<!H[$E[XGC(\-]ER[S+CESX;,^&;^H46J6!         !I
M6E5"N8APYR#4V2T.MK0HVW&W6SS(<0M)D:5),L2,@*O%330Z9IU$7>+=D.;Z
M5)?6IUYUS DYEK5M/ B(B+D(N0"92                    (J'IJAKYR[*
M' :9FKSGO$D>"3=/%9H29Y49CVJRD6/I"BU?:W3M)42'I=;";CR'B-*UH(]B
M35F-*",S)"3/;E3@04*I0$                  !J0:V)7+EKBH-*ISZI<@
MS4:L75I2@S+'DV(+80#RS506),^6AO%VS-"IF8S4E9MMDT7LGL(LI$0%2IJX
ME+7L5< E)A1B-##:UJ<-",3,D$:C,\J<<$EZ"V 2W0             !%3--
M4-A.193(#3TU&3_*HC]K='F1G21X+RGM3F(\/0%%JVK*K@6\;P=DPF1'S)62
M58D:5H/%*DJ+ TJ+T&1X@C1<TGIQV%'KUU[7A(BS>CI+,E27%8YE9R,E&:L?
M:Q/VO3B%%K++'T[1Q'H3\6"TP[7(<:A*;+)NFWMJTD18%E,]N![ H5?)^FJ*
MTF(GSX+;\I!)+.HC]HFU9D$M)&1+))[4DLCP"A5O1X46*Y(=CM);<EN;Z2I/
M*MS*E&8_ZY4D7_H"/APHAS2L3:3XY+1QR?P]LFE*)9IQ]1F1& U*_3M)52GI
MM=";CR7\2<<1CR*5G,DD9F22-7M&2<",PH528              UY4&)--@Y
M;*7CC.ID,9BQR/(Q)*R_J6)@-1W3M(_:(NGH3:[-LTFE\\<<R"-*5&G'*:DD
M>"5&6)>@*%1G3U)'M'+EF$VBS<-1J?(CQS+(B4HBQRDI1%@I1%B?I"A5[D4E
M7**83\<E^/-M4I1FHE*-DBW9DHC(TFC#%.7# ]I;0H5;,.'%KXK<.&V349HL
M$-EB>&)XF9F>)F9F>)F>TS 9P        &_3_P#S2_\ :H<?N_Y=OI_Z6$>%
M[U07^-7]S'U(?+G_ %\!
M
M
M
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>bc_changetrg-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_changetrg-4c.jpg
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M="!E;F0](G(B/S[_[0!(4&AO=&]S:&]P(#,N,  X0DE-! 0       \< 5H
M QLE1QP"   "  ( .$))300E       0_.$?B<BWR7@O-&(T!UAWZ__N  Y!
M9&]B90!DP     '_VP"$  0# P,# P0# P0&! ,$!@<%! 0%!P@&!@<&!@@*
M" D)"0D("@H,# P,# H,# T-# P1$1$1$104%!04%!04%!0!! 4%" <(#PH*
M#Q0.#@X4%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%/_  !$( MP#Z ,!$0 "$0$#$0'_Q #0  $  P$! 0$!
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MUN#>FKE6.Q"CIFKU1<LI[:.].:HS/*6NQTC"MQ)Y4E&HVI)*I1_-Z[F@LO\
M':.&.&ZNYB=;/QV(F?P:1OF<G<W,VJ9E%28T:!9UG=[7%F1-2T1T/C9E_5TZ
MD*]BHOQBIWQ&3IL1-U''/8E?A"7YYN>DY"&D6=F(4M"<NBCXSVPVJOL8N5$Q
M _/!KE&F8S9>6J,K'F'XZ$*''AO>[#=7!K7*J@=
M
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M]W0.XG\)0UV<)
M
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M0T$<I
M                                                   (]&J=8GIZ
M9E*)#@M@R;D9&F)A57&)TVM1/8"'NA>7RDE\%X2:%Y?*27P7@-"\OE)+X+P&
MA>7RDE\%X#0O+Y22^"\!H7E\I)?!> T+R^4DO@O :%Y?*27P7@-"\OE)+X+P
M&A>7RDE\%X#0O+Y22^"\!H7E\I)?!> T+R^4DO@O"'VI=5G8D]%I55@LA3T-
MB18;X2XPXD/H8ICTPEV@                   S[G9Z_-GOZ2N'ZM8=19*&
M@CE(
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M/M:KUD&/= F]%NZKD@1VPXBM3IJC<!L$_(' C_;&5\2?PP.^
M       &?<[/7YL]_25P_5K#J+)0T$<I
M
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M2AH(Y2
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MY<?[8ROB3^&!WP                   S[G9Z_-GOZ2N'ZM8=19*&@CE(
M
M                                           !'[9Y>L>.OW@.S$DI
M.,]8D:7A1(B[BO>QKG;GZ50YFB)MA](Q:XC9$S#^?-U/_E(/S;/V$?!3W0GY
MV)XI]YYNI_\ *0?FV?L'P4]T'SL3Q3[SS=3_ .4@_-L_8/@I[H/G8GBGWGFZ
MG_RD'YMG[!\%/=!\[$\4^\\W4_\ E(/S;/V#X*>Z#YV)XI][[0H4."Q(<)C6
M0TZ#6HC6I[2(=1$18XJJF9VR_LER     !P(_P!L97Q)_# [X
M        9]SL]?FSW])7#]6L.HLE#01RD
M
M                   C]L\O6/'7[P$@          /RP:C(S,9\O+3,&-,0
MMR+"AQ&/>U?^)J*JH!]W1H3-Q[VM5>@CE1-\#UKFO3%JHYOLHN* ?T!P(_VQ
ME?$G\,#O@                  !GW.SU^;/?TE</U:PZBR4-!'*0
M
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MZ2@
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MH-_V50;30;_LJ@VM/Y4IAE_1$3Y)_=7FFT>53[=K\DZ]Z[$OCA"9'K40
M
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M6ZGC*EBF;T    '@&GLJOL!1=4_NKS3:/*I]NU^2==]=B7QPA,CUJ,
M
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MQPA,CUJ,
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M7QPA,CUJ,
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MG7?78E\<(3(]:C
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M.$)D>M1@
M                                       $?MGEZQXZ_> D
M       ' C_;&5\2?PP.^                   &?<[/7YL]_25P_5K#J+)
M0T$<I   "F<_N1M[6S7 84_4OV[VZ^T[<6ZGC*EBF;T    '@&GLJOL!1=4_
MNKS3:/*I]NU^2==]=B7QPA,CUJ,
M                                                           C
M]L\O6/'7[P$;NK-VD6G7(]"FZ?-3$> R&]T6#Q>@J16Z28:3D7<*O'ZA1@US
M1,3(XWY@+?\ Z3/>["[<^'U;#\,_HG8?F M_^DSWNPNW'U;#\,_H;#\P%O\
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M3:/*I]NU^2==]=B7QPA,CUJ,
M                                                        C]L\
MO6/'7[P% 9R>L*HZF5[DAD>HY\W0E!"N2    #463_J\H_M1^[Q#7=.R*?;M
M<IP6(RQMMQ8L[1<L[1F7*VW;DO*G2E;:F*-B0$542&]4_=725^'LM3V"8&HX
M$"%+0F0(#&PI>$UL.#"AM1C&,8F#6M1-Q$1-Q$0@99VUXR4FBY73\M(Q9V+
MORF3?>$BQ.^9J(R'&?Q<)NXCHL14T6X]%28$.S@S J>?MTY?Y+U&TZEEM GJ
MU!K:UB\8:242.E.:]O>\@UG&-?'>D54;\8G58-_>)V;$-MG*7 C_ &QE?$G\
M,#O@                  !GW.SU^;/?TE</U:PZBR4-!'*0   IG/[D;>UL
MUP&%/U+]N]NOM.W%NIXRI8IF]    !X!I[*K[ 475/[J\TVCRJ?;M?DG7?78
ME\<(3(]:C
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M1Y5/MVOR3KOKL2^.$)D>M1@
M                                                      $?MGEZ
MSXZ_>0"0               <"/\ ;&5\2?PP.^                   &?<
M[/7YL]_25P_5K#J+)0T$<I   "F<_N1M[6S7 84_4OV[VZ^T[<6ZGC*EBF;T
M    '@&GLJOL!1=4_NKS3:/*I]NU^2==]=B7QPA,CUJ,
M
M                CT:E5>2G9B:HD>"D*;=QD:7F$7!(G35JH T;S]_)>X\!
MHWG[^2]QX#1O/W\E[CP&C>?OY+W'@-&\_?R7N/ :-Y^_DO<> T;S]_)>X\!H
MWG[^2]QX#1O/W\E[CP&C>?OY+W'@-&\_?R7N/ :-Y^_DO<> T;S]_)>X\(?>
MF4F<AST2JU6.V///8D)C8:*V'#9T<$QZ:@=H)                  !GW.S
MU^;/?TE</U:PZBR4-!'*0   IG/[D;>ULUP&%/U+]N]NOM.W%NIXRI8IF]
M  !X!I[*K[ 475/[J\TVCRJ?;M?DG7?78E\<(3(]:C
M
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MFSW])7#]6L.HLE#01RD   *9S^Y&WM;-<!A3]2_;O;K[3MQ;J>,J6*9O0
M > :>RJ^P%%U3^ZO--H\JGV[7Y)UWUV)?'"$R/6HP
M
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M$OCA"9'K48
M
M         !7.9N7MY7C,4JHV3F#4+%J5,;'8_O27@S\I-MCZ.''RT=48Y8>B
MN@O2TE)A"*V;L]S<E?,GF7F?>T]F'>5)A.@4")-R\&GT^GI%16Q(D&4EU5G&
M.3<T\?TJBN1JHF2'1S,R-B7?==/S'LJZ9JQ,R:?+.IRUV2@0IR%-2#ETN(FI
M:,J,BHUVZU57<Z>.#=%$DOW939+R66DQ7+AJ=:FKKS NB(R+<%TU!C(4:.V
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M5YIM'E4^W:_).N^NQ+XX0F1ZU&
M
M                                   &?<[/7YL]_25P_5K#J+)0T$<I
M   "F<_N1M[6S7 84_4OV[VZ^T[<6ZGC*EBF;T    '@&GLJOL!1=4_NKS3:
M/*I]NU^2==]=B7QPA,CUJ,
M
M                               ,^YV>OS9[^DKA^K6'462AH(Y2   %
M,Y_<C;VMFN PI^I?MWMU]IVXMU/&5+%,WH    / -/95?8"BZI_=7FFT>53[
M=K\DZ[Z[$OCA"9'K48
M
M        %#[75>J]O92PYJF5*9H\M,5RD2E8JDG%=+Q8%.C3*)&=QK%16(N#
M6JN/3PZ9,"(W]3:?M#YZP<JTKTW]V=F4!M9KC:%-\4D>LS\7BY6%%BP])%T(
M'QS/\?94F/P0F6R9<-<KN5464KU1BUB/;M:J= DZM,N5\>:DZ?&T8#XCEZY4
M:[0Q]AJ8D2E>A               S[G9Z_-GOZ2N'ZM8=19*&@CE(   4SG]
MR-O:V:X#"GZE^W>W7VG;BW4\94L4S>@    \ T]E5]@*+JG]U>:;1Y5/MVOR
M3KOKL2^.$)D>M1@
M
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MUV)?'"$R/6HP
M
M  *&VOY*!,Y-3$V]D>-/4JIT^ITR5EY5\\R8G)6-IPX,>%#ZKBHB8L<[]W%%
MP7H$P.'3MM.Q)B1EX]2LZ\9&?>QJS,FE&?'2%$5.J:V(UZ(Y$7H.P3'V$&P7
M3ESF%2,S;:9=-$DY^1D8D:++I+U:6=)S2.@K@JK#<J]2O27$@2P
M     #/N=GK\V>_I*X?JUAU%DH:".4@  !3.?W(V]K9K@,*?J7[=[=?:=N+=
M3QE2Q3-Z    #P#3V57V HNJ?W5YIM'E4^W:_).N^NQ+XX0F1ZU&
M
M                                          !!,W\S*=E)8L]><]*1
M:C'@OA2E,I4NN$:<GYIZ0X$!JX.PTG+BYV"X-151%7<68%.)4-NE9;TD\W60
MU.62SE?,]]\5T>*X_3XOC,-S'C]''W"?P0N')W,V1S;L:4O"4DXM,FWQ(TE5
M:1,+I19*H2CUAQX#G8-TL%W6K@F+53%$7%$B4IZ0              ,^YV>O
MS9[^DKA^K6'462AH(Y2   %,Y_<C;VMFN PI^I?MWMU]IVXMU/&5+%,WH
M / -/95?8"BZI_=7FFT>53[=K\DZ[Z[$OCA"9'K48
M
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M95?8"BZI_=7FFT>53[=K\DZ[Z[$OCA"9'K48
M
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M\JGV[7Y)UWUV)?'"$R/6HP
M
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M2XQ[MS<.Z*IE$PN ^KD
M
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MZY/$(_!/358I(8:9UC?:0\KZ/0     OC9@Y\N+Q6!PW'UPK7-32Y]W
M
M                                     5QGCEE%S9R_F[6D9_S778,>
M7J=!J3FZ<.!4I"(D6 Z(U$7%BJBL=N+@BXHBX8$P,XR4SM:T[-NOWE RGD5N
M6NT23H*U!:K 6C0HLDYS^_$ZO35CL>15R.3H8JI/X(:.R-RQBY39?2EK3T_Y
MUK\:/,52OU-$5K)BI3SUBQW,143J$7!C<4151N*HF.!$I6.0     S]M.9=9
MQ9I4FCVKE[.TN!:+XKHUVR50FIF2B5!D)['0I98DO#>Y(+D1_&(U6JJX>P3&
MP?KR^DMI*@SE"H%7MZPJ3E[(:$M'EZ'&J7?,"3AM5$279%1&:2;G7=$?@.M?
MDWM(TVYX\SEQ3[7KMFQX,%($E5XTU)U&7F&HJ155\-.+<QR[J;N/2]M^"''R
MGR@OB!F-6,[,X:C(3=_U*22CTNDT5(GFVETU'(_08^,B/>]RINJO0Q=NNTMQ
M*4DSLLN[,RJ;1K!I<6'(V35YQJWY4$C+#FUI$LJ15DY9&ICI33D1CGX]2S''
M%'8"!QLVLK[NC5RQLP<H$IL"ZK"9,R,I0:GIP*;-TJ>@M@1(".A)C#=#1B<5
MA@GL]#!42AT,C,M;HLUUW7=?TU*1[\ONI-JM8EZ9IK(2D.%#XN7EH3HB(Y_%
MM5=)Z]'H;N&DJ92MT@9]SL]?FSW])7#]6L.HLE#01RD   *9S^Y&WM;-<!A3
M]2_;O;K[3MQ;J>,J6*9O0    > :>RJ^P%%U3^ZO--H\JGV[7Y)UWUV)?'"'
MWS.]7UR>(1^">FJQ20PTSK&^TAY7T>@    !?&S!SY<7BL#AN/KA6N:FES[N
M
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MG6-]I#ROH]     "^-F#GRXO%8'#<?7"M<U-+GW<
M
M                     !$LQ<Q;<ROMYMS70L=*8^;EI!.]87'1..G(B0X?
M4XIN8KNJ2):0(EEWF+;N9]"C7%;''^;H$[,TV)WU"XF)Q\D_BXG4XKU./04"
M6@              9]SL]?FSW])7#]6L.HLE#01RD   *9S^Y&WM;-<!A3]2
M_;O;K[3MQ;J>,J6*9O0    > :>RJ^P%%U3^ZO--H\JGV[7Y)UWUV)?'"'WS
M.]7UR>(1^">FJQ20PTSK&^TAY7T>@    !?&S!SY<7BL#AN/KA6N:FES[N
M
M                                        R]M#;/V;^9/?\>U\QHSJ
M3.3]/F92S9J7@P9*5;*N9I16S.DKW.8YJQD;HIBNY[!,2/STW+3,2OSL[3Z-
MM3S%2G)!JNJ,M(R=.C19=F*M58B0IE5AX+N8JB8#<A=N3=A6UEKE]2[5M2?=
M5Z7!XV8?67Q61WSLS,Q'1(T=SV*K5TGJJ(B*N"(B8KAB)2GA
M   S[G9Z_-GOZ2N'ZM8=19*&@CE(   4SG]R-O:V:X#"GZE^W>W7VG;BW4\9
M4L4S>@    \ T]E5]@*+JG]U>:;1Y5/MVOR3KOKL2^.$/OF=ZOKD\0C\$]-5
MBDAAIG6-]I#ROH]     "^-F#GRXO%8'#<?7"M<U-+GW<
M
M                          !1&U[5JO2<EIUU.G(].IT[4:=3[BJ4HJMC
M2]'FYEL*9<CDQ5J.16L<OL.PZ9,"'946M8>7FT9?%.M*3DJ/8\O95(FFQ83T
M[T=!?%>YTP^,]SD>CFMQ=$<Y=)$Q50)'L8X_<W%651S;;=<%:=;&DBM8M*6;
M<L-6(O[NGQG^.(D:%(              &?<[/7YL]_25P_5K#J+)0T$<I
M"F<_N1M[6S7 84_4OV[VZ^T[<6ZGC*EBF;T    '@&GLJOL!1=4_NKS3:/*I
M]NU^2==]=B7QPA]\SO5]<GB$?@GIJL4D,-,ZQOM(>5]'H     7QLP<^7%XK
M X;CZX5KFII<^[@
M                                                        (1FU
M=MA698]0JN9FBZS)A$D*E"B2T2>AQ63?Q>@^##:]5:O3W-PF(GL&'%=__GLM
M5=/)<%P)3WJUKZ(GG?S>Z%#?IM@KC XU8;5Z#>.W#K94C\&NLH\],BKT66LC
M+*M2T*/3H"0I"WG2T:FQ&RTNU.I@0IB'#TT:W=P9BN&ZIS,3"=JX"
M       !GW.SU^;/?TE</U:PZBR4-!'*0   IG/[D;>ULUP&%/U+]N]NOM.W
M%NIXRI8IF]    !X!I[*K[ 475/[J\TVCRJ?;M?DG7?78E\<(??,[U?7)XA'
MX)Z:K%)##3.L;[2'E?1Z     %\;,'/EQ>*P.&X^N%:YJ:7/NX
M
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MU3^ZO--H\JGV[7Y)UWUV)?'"'WS.]7UR>(1^">FJQ20PTSK&^TAY7T>@
M!?&S!SY<7BL#AN/KA6N:FES[N
M
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MF=ZOKD\0C\$]-5BDAAIG6-]I#ROH]     "^-F#GRXO%8'#<?7"M<U-+GW<
M
M                                        !#LT867:V549O-6!(Q['
MD$;-U+SI#XZ6;Q3DT':&#E<[25$8UJ*Y7*B(BJH&08^;&Q1![\>F3DY$EI!L
M.).3+;;@-A0H<PW3@O>KXS58V(WJF*]$TD.MDHVM2Y$U>PJ[E[*57+6VH]JV
MG,1HSY6F3,DVGN<KE15C-A,<]JLB(J.:]'=4ARE90              &?<[/
M7YL]_25P_5K#J+)0T$<I   "F<_N1M[6S7 84_4OV[VZ^T[<6ZGC*EBF;T
M  '@&GLJOL!1=4_NKS3:/*I]NU^2==]=B7QPA]\SO5]<GB$?@GIJL4D,-,ZQ
MOM(>5]'H     7QLP<^7%XK X;CZX5KFII<^[@
M
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MXO%8'#<?7"M<U-+GW<
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M6<J-K4Z--6GDM0:;+1*A/U:9A]15:M*R\-,7Z>'$,B8HU(;5QP=AC&SL&D+
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M-K\T3;&VDH3W0HN2,=D1NXYCI6IHJ>VF@?2,&J8VQ#Y58U$3LF8?S^<K:/\
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M")/F:EV@\Q@^./? ?GIST_")/F:EV@\Q@^./? ?GIST_")/F:EV@\Q@^./?
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M*KM)4Z[=(2EH              &?<[/7YL]_25P_5K#J+)0T$<I
M              &8,U?M_5_:@=Q:9K69TOUOH7H:/_;BAYXUX    #]%/YQD
M?&8'=&G5-L/EC9=7]L\&QS7OPU%+Y\&D]:[@EIH+:KE1U/EIO0LME$     !
M8=I<Q2_9/X:E#K,V6ET&3&]V(_(1>P=O'EIMA[:K)5&WK4-3+&0](2    "3
M61SC-:EO#*[7\D7K7IO/5<G)3+]65P<]SW9IP4-%ILJEE=7G5>W8YIZ'E
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MH:+395+*ZO.J]NQS3T/*    #]$AX?*:^'PD.,3DFZ7UPN>F^%KF8:]36?\
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M8]/S=RP"B:-F#.3UAU'4RO<D,CU'/FZ$H(5R0    &\I#UC.$@&VC?N0
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MTNCR:?;M?DG7O78E\<(2J=\"F=4_@J>_#YHO9_$Y9N5,SK&^T:B6.BQZ0D
M  $CLKG6-J/]2'@UV7%ZSZ;F3<GA2-"RSFWZPJM[4OW)IC^H9]6[@F$+/ D
M   'Z*?SC)>,P>Z-.J.:+X&TC>N4;O7FN%KV[REAH>>;E7U'+B]!"Z9\
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MJ.3%O6XD3"5WD              #/N=GK\V>_I*X?JUAU%DH:".4@
M                         BE\^#2>M=P2TT%M5RHZGRTWH66RB      L
M.TN8I?LG\-2AUF;+2Z#)C>[$?D(O8.WCRTVP]M5DJC;UJ&IEC(>D)    !)K
M(YQFM2WAE=K^2+UKTWGJN3DIE^K*X.>Y[LTX*&BTV52RNKSJO;L<T]#R@
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M.MO"7OJ4J]-@,A1(L:WJ(Z:BS#FS$94TH4-D)6Z37X=%K53%N"!MTY2
M         S[G9Z_-GOZ2N'ZM8=19*&@CE(
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MA(    ._9W/*ZE^^AXM;E[UCT_-W+ *)HV8,Y/6'4=3*]R0R/4<^;H2@A7)
M    ;RD/6,X2 ;:-^Y    ! LXLSZ=E#9$S>,](QJK';&@R5,I,JNC&FYZ;?
MQ<&"UV"Z.*[JK@NXFXBK@BA3D"M[6DQ-,KT/)^S92HQDXQ(D>?8L]#TDZU\5
MD3KD3HX*3L@7EEO/Y@U*VF3.9U(D:+=2QHK8DC2XZS,LD!%^+=IJKNJ<G13$
M@2X              #/N=GK\V>_I*X?JUAU%DH:".4@
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M.ZBXI['Z% ] S[G9Z_-GOZ2N'ZM8=19*&@CE(
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MXE8BTJH5Q\^U)::EN+;'IR(Q<9F%"1<58[K<3KX9B)VHBJ)L:_.'0
M                         (I?/@TGK7<$M-!;5<J.I\M-Z%ELH@     +
M#M+F*7[)_#4H=9FRTN@R8WNQ'Y"+V#MX\M-L/;59*HV]:AJ98R'I"0    2:
MR.<9K4MX97:_DB]:]-YZKDY*9?JRN#GN>[-."AHM-E4LKJ\ZKV['-/0\H
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M&?<Z8<.'GYL]I#8UF-2N''11$_\ RUGL'462AH0Y2
M             "*7SX-)ZUW!+306U7*CJ?+3>A9;*(     "P[2YBE^R?PU*
M'69LM+H,F-[L1^0B]@[>/+3;#VU62J-O6H:F6,AZ0D    $FLCG&:U+>&5VO
MY(O6O3>>JY.2F7ZLK@Y[GNS3@H:+395+*ZO.J]NQS3T/*    #]$AX?*:^'P
MD.,3DFZ7UPN>F^%KF8:]36?_ "%O:Z:[FPI^I?MW_P!&[^T^;%NIXRI4IF\
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MX>P!ZJ(J8+T%   ,^YV>OS9[^DKA^K6'462AH(Y2
M            "*7SX-)ZUW!+306U7*CJ?+3>A9;*(     "P[2YBE^R?PU*'
M69LM+H,F-[L1^0B]@[>/+3;#VU62J-O6H:F6,AZ0D    $FLCG&:U+>&5VOY
M(O6O3>>JY.2F7ZLK@Y[GNS3@H:+395+*ZO.J]NQS3T/*    #]$AX?*:^'PD
M.,3DFZ7UPN>F^%KF8:]36?\ R%O:Z:[FPI^I?MW_ -&[^T^;%NIXRI4IF\
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MJHYO0]C=Z8E*UR              !GW.SU^;/?TE</U:PZBR4-!'*0
M                          12^?!I/6NX)::"VJY4=3Y:;T++91
M6':7,4OV3^&I0ZS-EI=!DQO=B/R$7L';QY:;8>VJR51MZU#4RQD/2$@    D
MUD<XS6I;PRNU_)%ZUZ;SU7)R4R_5E<'/<]V:<%#1:;*I975YU7MV.:>AY0
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MZZY49ZX:Q)051T.5F*G%XSB$<BJBZ#4;I8+AI8HBJFZJ1;Y
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M     !8=H\QP.RB<)2BUF;+2Z#)AV(_(Q.Q=O'DIMA[:K)5&G0-3+&/2$@
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MJ               H#-[^Y#9YUUV_5,,ZBR7,VPO\Y=
M                B-\\G(]G$X*%IH+:E-U.RG>AQ;*0     "Q[7YBD^Q=P
ME*#5YLM/HLFET9SP.8U;^"IYZ.:+WIQ.6;E3,ZUOM(:B6.BQZ0D    $IL?P
MN=U;-]2MU_+2M^F\U5T)L4Z]5M<W/LW_ ). AH-+E0R^MSI<D]3Q@    ^LM
MX5+ZV'PD.:N6;G='-%\+:,NV*H,_.;*)XU%[D5'4;*6V^U,S$_MCBH\I7Z"
M    !I3)[[!4_LX_=7&CT.5#\J^X?6U[N";S'@\7L';Q84VPS=5DJC;UJ&IE
MC(>D)    !(+-YY=J7;Z'AUN7O6/3\W<GY1M&R]G%ZPZGJI7N*&1ZCZB;HX)
MA!BN2    #ZRGADKKX7#0F+8O&U3?.4=O3F=NOA_K/?H<S<K>HY6^$"+MG0
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M-)RX)BY=T#](              % 9O?W(;/.NNWZIAG462YFV%_G+H
M                          $1OGDY'LXG!0M-!;4INIV4[T.+92
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MA%$TC,.<WK"GO%Y7@*9'J6?-T)0,KD@    -Y2'K&<) -M&_<@
M   /X?$9#P5[D:B[B8JB;X'B1X2K@U[7+[#515 \F)B#*PG1YB(V% AII1(L
M1R,8U/95RX(@'L&-#F(;8T%S8D%Z(Z'$8J.:YJ]!45,45 /X6;ETF$E.-9WV
MK.-27TF\:L/'#2T<<<,=S$#V:FY:2@NF9R,R!+LPTXT5S8;&XJB)BYRHB8JN
M 'VZ( "@,WO[D-GG77;]4PSJ+)<S;"_SET
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MTAD2M@V]+4%:K%NAM164TTXYLO2FK#1VDYW6J]V'MG<3^$N9MAK X=
M                                    /A.>!S&K?P5.Z.:+WSQ.6;E3
M,ZUOM(:B6.BQZ0D    $IL?PN=U;-]2MU_+2M^F\U5T)L4Z]5M<W/LW_ ).
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MTC,.<WK"GO%Y7@*9'J6?-T)0,KD@    -Y2'K&<) -M&_<@
M         "@,WO[D-GG77;]4PSJ+)<S;"_SET
M                   ^$YX',:M_!4[HYHO?/$Y9N5,SK6^TAJ)8Z+'I"0
M  2FQ_"YW5LWU*W7\M*WZ;S570FQ3KU6US<^S?\ DX"&@TN5#+ZW.ER3U/&
M   #ZRWA4OK8?"0YJY9N=T<T7PMHR[8J@S\YLHGC47N14=1LI;;[4S,3^V.*
MCRE?H(     &E,GOL%3^SC]U<:/0Y4/RK[A];7NX)O,>#Q>P=O%A3;#-U62J
M-O6H:F6,AZ0D    $@LWGEVI=OH>'6Y>]8]/S=R?E&T;+V<7K#J>JE>XH9'J
M/J)NC@F$&*Y(    /K*>&2NOA<-"8MB\;5-\Y1V].9VZ^'^L]^AS-RMZCE;X
M0(NV=      L&S^9(>LB<(HM;FRTF@R8WNW%Y)_8KO'CBU[YL5&AJI8P(
M  =VT.>VZF)OM/%K<K>L.GYNZ5A%$TC,.<WK"GO%Y7@*9'J6?-T)0,KD@
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MYS>L*>\7E> ID>I9\W0E RN2     WE(>L9PD VT;]R
M      * S>_N0V>===OU3#.HLES-L+_.70
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MZQG"0#;1OW(                       H#-[^Y#9YUUV_5,,ZBR7,VPO\
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MO?W(;/.NNWZIAG462YFV%_G+H
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M8<YO6%/>+RO 4R/4L^;H2@97)     ;RD/6,X2 ;:-^Y
M       % 9O?W(;/.NNWZIAG462YFV%_G+H
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M=LZ     !8-G\R0]9$X11:W-EI-!DQO=N+R3^Q7>/'%KWS8J-#52Q@0
M[MH<]MU,3?:>+6Y6]8=/S=TK"*)I&8<YO6%/>+RO 4R/4L^;H2@97)     ;
MRD/6,X2 ;:-^Y                       % 9O?W(;/.NNWZIAG462YFV%
M_G+H
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M811-(S#G-ZPI[Q>5X"F1ZEGS="4#*Y(    #>4AZQG"0#;1OW(
M             H#-[^Y#9YUUV_5,,ZBR7,VPO\Y=
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M*J>VGO3VL,S3E;H=(PK+2=5*2V$VII*)15D.FJP%X_H:6'588XO)[=@T3?\
M4:AFCFO3,G+>G9B4MFU5EKCS+GY**^"]R.ZNG4CC(:HJ+,*G'QDW/BFI@['%
M"!>Y"0"@,WD7\Q^SRO2XZ[4__289U%DN9M7^<N@
M                                        /PU*CTJL,APZK)09UD)R
MNA-CL;$1KE3!5321<-PXKPZ:^:-KT8.IQ<&9G#JFG;W3L<_T)M#^AR/D\/\
M8?/R^'X8>GZGJOY*O\I/0FT/Z'(^3P_V#R^'X8/J>J_DJ_RD]";0_H<CY/#_
M &#R^'X8/J>J_DJ_RD]";0_H<CY/#_8/+X?A@^IZK^2K_*3T)M#^AR/D\/\
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M1.XG\)<S;#81PZ
M                         /G,>#Q>P=O'5-L.:K)5&WK4-3+&0](2
M"06;SR[4NWT/#K<O>L>GYNY/RC:-E[.+UAU/52O<4,CU'U$W1P3"#%<D
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M)T$0@20"@,WO[D-GG77;]4PSJ+)<S;"_SET
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MJ+)<S;"_SET
M                      ?.8\'B]@[>.J;8<U62J-O6H:F6,AZ0D    $@L
MWGEVI=OH>'6Y>]8]/S=R?E&T;+V<7K#J>JE>XH9'J/J)NC@F$&*Y(    /K*
M>&2NOA<-"8MB\;5-\Y1V].9VZ^'^L]^AS-RMZCE;X0(NV=      L&S^9(>L
MB<(HM;FRTF@R8WNW%Y)_8KO'CBU[YL5&AJI8P(     =VT.>VZF)OM/%K<K>
ML.GYNZ5A%$TC,.<WK"GO%Y7@*9'J6?-T)0,KD@    -Y2'K&<) -M&_<@
M                   "@,WO[D-GG77;]4PSJ+)<S;"_SET
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MQ7)    !]93PR5U\+AH3%L7C:IOG*.WIS.W7P_UGOT.9N5O4<K?"!%VSH
M  %@V?S)#UD3A%%K<V6DT&3&]VXO)/[%=X\<6O?-BHT-5+&!     #NVASVW
M4Q-]IXM;E;UAT_-W2L(HFD9ASF]84]XO*\!3(]2SYNA*!E<D    !O*0]8SA
M(!MHW[D                       4!F]_<AL\ZZ[?JF&=19+F;87^<N@
M
M                   9>SB]8=3U4KW%#(]1]1-T<$P@Q7)    !]93PR5U\
M+AH3%L7C:IOG*.WIS.W7P_UGOT.9N5O4<K?"!%VSH     %@V?S)#UD3A%%K
M<V6DT&3&]VXO)/[%=X\<6O?-BHT-5+&!     #NVASVW4Q-]IXM;E;UAT_-W
M2L(HFD9ASF]84]XO*\!3(]2SYNA*!E<D    !O*0]8SA(!MHW[D
M              4!F]_<AL\ZZ[?JF&=19+F;87^<N@
M
M   9>SB]8=3U4KW%#(]1]1-T<$P@Q7)    !]93PR5U\+AH3%L7C:IOG*.WI
MS.W7P_UGOT.9N5O4<K?"!%VSH     %@V?S)#UD3A%%K<V6DT&3&]VXO)/[%
M=X\<6O?-BHT-5+&!     #NVASVW4Q-]IXM;E;UAT_-W2L(HFD9ASF]84]XO
M*\!3(]2SYNA*!E<D    !O*0]8SA(!MHW[D                       4!
MF]_<AL\ZZ[?JF&=19+F;87^<N@
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M9+F;87^<N@
M                               9>SB]8=3U4KW%#(]1]1-T<$P@Q7)
M   !]93PR5U\+AH3%L7C:IOG*.WIS.W7P_UGOT.9N5O4<K?"!%VSH     %@
MV?S)#UD3A%%K<V6DT&3&]VXO)/[%=X\<6O?-BHT-5+&!     #NVASVW4Q-]
MIXM;E;UAT_-W2L(HFD9ASF]84]XO*\!3(]2SYNA*!E<D    !O*0]8SA(!MH
MW[D                       4!F]_<AL\ZZ[?JF&=19+F;87^<N@
M
M               9>SB]8=3U4KW%#(]1]1-T<$P@Q7)    !]93PR5U\+AH3
M%L7C:IOG*.WIS.W7P_UGOT.9N5O4<K?"!%VSH     %@V?S)#UD3A%%K<V6D
MT&3&]VXO)/[%=X\<6O?-BHT-5+&!     #NVASVW4Q-]IXM;E;UAT_-W2L(H
MFD9ASF]84]XO*\!3(]2SYNA*!E<D    !O*0]8SA(!MHW[D
M          4!F]_<AL\ZZ[?JF&=19+F;87^<N@
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M1%:D><B80H:[JL:BNPPP5(2M\A(!0&;W]R&SSKKM^J89U%DN9MA?YRZ
M
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M\Y=
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M'W$63\K4/*$[0?2L'\_>'W$62BHO&U#%JHY/^8;T6KC[P?2L'\_>A9Q;@
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MG2ZS1T?W<-+J](B1>9
M
6                          ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>lc_prepost-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_prepost-bw.jpg
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M="!E;F0](G(B/S[_[0!(4&AO=&]S:&]P(#,N,  X0DE-! 0       \< 5H
M QLE1QP"   "  ( .$))300E       0_.$?B<BWR7@O-&(T!UAWZ__N  Y!
M9&]B90!DP     '_VP"$  0# P,# P0# P0&! ,$!@<%! 0%!P@&!@<&!@@*
M" D)"0D("@H,# P,# H,# T-# P1$1$1$104%!04%!04%!0!! 4%" <(#PH*
M#Q0.#@X4%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%/_  !$( R\#Z ,!$0 "$0$#$0'_Q "G  $!  (# 0$!
M        !P8( 00% P() 0$!                     1   0,# @(#" T'
M" 8'! @'  $" P0%!A$'$@@A$S<Q(A2TU'6U%T$RDE.SE)4V5G97&#A187&R
M<W05T4)RTB.$-1:!,],D5%61H<%2DY988H)#-+'B@T1E1@D9HF.C9(4F*!$!
M 0$                   $1_]H # ,!  (1 Q$ /P#?X
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M ,LVZW3P+=>SOOF!WF&[4<+TBJF,XF3P2*G$C98GHU[55.YJFB^PJ@9B
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M.>QJ.<KFOZ6:IT 5X
M                         /YY?_J 1U<N[VW$-OEZBXRT'5T4Z]"1U#J]
M$B>J]/0UVB@>Y>^6;G$SZB?CF=[GT=3C=0YJU5.^HGDC>C5U3BCBIXN/14U1
MKETU S;>K:>Q;+\G&1838I9*ML/45%=<)DTEJJN:JB6254151J+HB-:B]")_
MI [')OMC@U)LM9-Q9;#1UV:U#ZNX,O%1"R:KCDB<^*-D4CD5S&M:W1$:!K9R
M\WG,;AF&=YQ0[5,W9R2LK')7UM;54\7@"U$LCE:D=2UZ.63A]LB="-T_*!8N
M7C;O=S%^8RZ9M4;>38+@&34]2RX6J*KIJFEII.!)8T_LWHO3*G$U$8G#Q:=P
M#>0
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M8G<+':*2VUUYL]NJ;M44D+(9*J=*=O\ :3.:B*]W2O2[\H%8
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M%?G2+,^%\J44"3NXY7(C^'CD>J(G$K41K4T:GL@;%
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M@I:'&Z.VM76EIZ9'M<DDCHHE>KD5FFNJ]'= M@
M
M
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MR4!ZDYOM+SCY7A\E >I.;[2\X^5X?)0'J3F^TO./E>'R4!ZDYOM+SCY7A\E
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M#D
M    &-;B=G^5^9[AXK(!C7+UV(8#YEI/@T I0$NSOMAVE_:9!Z-0"H@
M                 /E45%/20OJ:J5D%/$G%)-*Y&,:GY5<[1$0#]0S0U$3)
MZ>1LL,B(Z.1BHYKFKW%14Z%0#]@
M    $1YK^R";SS8_2< %N          )?S%=C.4_LJ7QR "GL]HW]" <@
M                                                           Q
MO</L_P K\SW#Q60#&>7KL0P+S+2?J(!2@)=GG;#M+_3R#T:@%1
M             :D<XE\W6L5HN=MH+E8J_!<SI8\<MV(3,F2_S7"K[Q9:3JF+
MUCFN5%T<[@1.ZFJIJ'J<H^3;HYA9Z.MNUUL$. 6*WML#,2M\<W\7HJ^AX(D=
M6NE:BLD5&.5S=>%>)%1 -HP
M"(\U_9!-YYL?I.G MP         !+^8KL9RG]E3>.0 4]GM&_H0#D
M                                                       &-;B=
MG^5^9[AXK(!C7+UV(8#YEI/@T I0$NSSMAVE_:9!Z-0"H@
M        ,?O6#XED=[LF27RT4]=?,<E?/9*Z5JK+322MX7*Q45.[^1=>E$7N
MH Q[!\2Q2X7JZXY:*>W7'(JGPZ]5,#51]34Z+W[U55_*JZ)HFJJO=50,@
M                                   (CS7]D$WGFQ^DX +<
M  2_F*[&<I_94WCD %/9[1OZ$ Y
M                             !C>X?9_E?F>X>*R 8SR]=B&!>9:3]1
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M_:;GORXGDX&483MXN%5575?YKR+(O"XV1=3D%P\/BBX%5>*)O5LX7+KHJ_D
MS0                      !$>:_L@F\\V/TG3@6X          E_,5V,Y3
M^SI?'( *>SVK?T(!R
M                   #&MQ.S_*_,]P\5D QKEZ[$,!\RTGP: 4H"79WVP[2
M_P!/(/1J 5$
M              "(\U_9!-YYL?I. "W          $OYBNQG*?V5-XY !3V>
MT;^A .0
M         8WN'V?Y7YGN'BL@&,\O78A@7F6D^#0$4H"79WVP[2_T\@]&H!40
M
M   (CS7]D$WGFQ^DZ<"W          $OYBNQG*?V5-XY !3V>T;^A .0
M                                                          8W
MN'V?Y7YGN'BL@&,\O78A@7F6D^#0"E 2[/.V':7^GD'HU *B
M                                                   !$>:_IV@F
M\\V/TG3@6X          E_,3V,Y3^RIO'( *>SVK?T(!R
M                                               #&MQ.S_*_,]P\
M5D QKEZ[$,!\RTGP: 4H"79YVP[2_P!/(/1J 5$
M                                          "(\U_9!-YYL?I. "W
M         $OYBNQG*?V5-XY !3V>T;^A .0
M                                     8WN'V?Y7YGN'BL@&,<O78?@
M/F6D^#0$4L"79WVP[3?T\@]&H!40
M                               (CS7=D$WGFQ^DX +<          2_
MF)[&<I_9TOCD %/;[5OZ$ Y
M                         !C>X?9_E?F>X>*R 8SR]=B&!>9:3X- 12@)
M=G?;#M+_ $\@]&H!40
M                     (CS7]D$WGFQ^DX +<          2_F)[&<I_94W
MCD %.9[1OZ$ _0
M                ,;W#^8&5^9[AXK(!C'+UV(8%YEI/U$ I8$NSSMAVE_:9
M!Z-0"H@                                          8%N7N]B6UT-
M#'>DJKA?;JYS+1CUIA\+N57U::O>R+B:C8V)TODD<UC?RZZ(!X&%\P^'9;DT
M&(5MMNV+7ZO:Y]H@O],RFCKUC35[*>:*66-TC4Z5C5R.TZ414 K@
M          B/-?V03>>;'Z3@ MP         !+^8KL9RG]E3>.0 4]GM&_H0
M#D
M    &-;B=G^5^9[AXK(!C/+UV(8#YEI/@T I8$NSSMAVE_IY!Z-0"H@
M                                     :A;@==!O_F,=WZ+E66VU28Z
MLB=_):(HWI4-IE=JO VHXEF:Q?;:*J>R!AVXC9GX_34E#JF155TMC,9CCZ*I
MUU2LB=&M+[*2M:CUXF]QNNO0!O<                  (CS7]D$WGFQ^DX
M+<          2_F*[&<I_94WCD %/9[1OZ$ Y
M                                       !C>X?9_E?F>X>*R 8QR]=
MB&!>9:3X- *6!+L\[8=I?VF0>C4 J(
M            &'[A;88;NA;J:WY;0NF?02^$VNX4TLE)7T<ZIHKZ>HA5KV*J
M>V37A=T<2+H!X6$;"[>X'?\ _-=O@K;GDL<3J:DNEZK9[E/2PR=#V4_7N5L7
M'W'.8U'*BJFNBZ 4T                  1'FO[()O/-C])P 6X
M  E_,5V,Y3^RIO'( *>SVC?T(!R
M                             #&]P_F!E?F>X>*R 8SR]]B&!>9:3X-
M*4!+L[[8=I?Z>0>C4 J(
M                       $1YK^R";SS8_2< %N          )?S%=C.4_L
MJ;QR "GL]HW]" <@
M                  QO</Y@97YGN'BL@&,\O78A@7F6D_40"E 2[/.V':7^
MGD'HU *B
M           !$>:_L@F\\V/TG !;@         "7\Q78SE/[*F\<@ I[/:-_
M0@'(
M      ,:W$[/\K\SW#Q60#&N7KL0P'S+2?!H!2@)=G?;#M+^TR#T:@%1
M$5S[F'I,:R>HPW#L<J,ROML1JWY]/4P4-#;W2-XF0R5,^J.G5-'=4QJJB+WR
MIW /2VOWTMF?WBIQ*]6>HQ/-Z>):N*SULL53'5T:.X5GHZF'O)FM5421NB.8
MJ]*:=(%8
M     B/-?V03>>;'Z3@ MP         !+^8KL9RG]E3>.0 4]GM&_H0#D
M                                                           &
M-;B=G^5^9[AXK(!C7+UV(8#YEI/@T I0$NSOMAVE_:9!Z-0"H@   #1W'XI[
M1>\KP^[ZQY;;[W<:VX4\J=7+/!<*AT]/6,:OMHY8W-T<S5&Z</L >WBK)+SO
M9@=JM"+4W&P3UEWO38NGP.WRTCZ=JS/3H9ULCFHR-5U?W=.@#<<
M                                               "(\U_9!-YYL?I
M. "W          $OYB>QG*?V5+XY !3V^U;^A .0
M                                          8UN)V?Y7YGN'BL@&-<
MO78A@/F6D^#0"E 2[/.V':7]ID'HU *B    ,*SK:/;C<N6DJ,WQZGNM90(K
M:.L<LD%3&QVNK$F@?')P*JZ\"NX=>G0#NX/MS@^VUOFM>#V2GLU)4R=?5=2C
MGRSR^PZ6:1SY)%371.-RZ)W ,H
M                       B/-?V03>>;'Z3@ MP         !+^8KL9RG]E
M3>.0 4]GM&_H0#D
M                 &-[A]G^5^9[AXK(!C/+UV(8%YEI/@T I0$NSOMAVE_:
M9!Z-0"H@
M           1'FO[()O/-C])P 6X          E_,5V,Y3^RIO'( *>SVC?T
M(!R
M     #&MQ.S_ "OS/</%9 ,9Y>NQ# ?,M)\&@%+ EV=]L.TO]/(/1J 5$
M                                      'FY!D%DQ2RUV1Y'70VRQVV
M)T];75#N"*.-OLJOLJJ]#43I5=$355 C=/S9;9NF@?<;=D5GL4[T8W(KE:)Z
M>V,:]=(Y9)-7/CC?T:/>Q$375W"@%SAFAJ88ZBGD;-3S-;)%+&Y',>QR:M<U
MR:HJ*BZHJ ?L                  1'FO[()O/-C])P 6X          E_,
M5V,Y3^RI?'( *>SVC?T(!R
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M\73U?4\'5_\ L: 6                   1'FO[()O/-C])P 6X
M  E_,5V,Y3^RI?'( *>SVC?T(!R
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M-?V03>>;'Z3@ MP         !+^8GL9RG]E3>.0 4]OM6_H0#D
M                                                    &-[A]G^5
M^9[AXK(!C'+UV(8%YEI/@T I8$NSOMAVE_:9!Z-0"H@
M   @>2\RKXLCN%BV]Q-^6T5FF?172^2W"*UV]*Z-=)*>G>^*9T[HUZ)'-:C6
MKT:J!ENU&]%MW*FN%BK[9-C6<VAK9KECM7(V=5I95TCJJ:=B-9/ Y>]XVHBM
M=WKD1=-0IX            >)EF'XOG5FEQ[+[337FS3.:]])5L1[4D9[5[%[
MK'MU[U[51R>PH'A85L[MCMW75%TPS&J2UW.JC2&:N8CY:A8D77@269SW-:J]
M*M:J(J]T#.                         !$>:_L@F\\V/TG !;@
M  "7\Q78SE/[*E\<@ I[/:-_0@'(
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MZ>YW -D0  !W0&J=SV5[@ "7\Q/8SE/[*F\<@ I[/:-_0@'(
M                                                  ,:W$[/\K\S
MW#Q60#&N7KL0P'S+2?!H!2@)=GG;#M+_ $\@]&H!40
M  83F.T.V6X%=!=,QQBANUSIV+#%72QJRH2)>G@66-6N<U%Z4:Y51/8 ]W%L
M2QG";/%C^(VFFLUF@571T='&V*/C=[9[M.ESG:=\YVJK[*@>R
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M)2P/HJF-KIXZR)%;QO8C4]JO2J@;7-]JW]" <@
M                                        QK<3L_ROS/</%9 ,:Y>N
MQ# ?,M)\&@%* EV=]L.TW[3(/1J 5$
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M0#D
M     &-[A]G^5^9[AXK(!C/+UV(8%YEI/@T I0$NSOMAVF_IY!Z-0"H@
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M2FJJJ:J&P(      )?S%=C.4_LJ;QR "G,]HW]" ?H
M                                            &-;B=G^5^9[AXK(!
MC7+UV(8#YEI/@T I0$NSSMAVE_:9!Z-0"H@
M                            !KISF]FF/_6NS?"O"-BPH      "(\U_
M9!-YYL?I. #.]U]O+#NGM_>\'R21:>V7*'7PUO#QTTL+DECG;Q]']FYJ.Z>Z
MFJ :A+@_,Y#D%CW<H,LPO(;5B-DJK1;<XEGD2F?;$1Z2U52UK51TD7?\2MU3
M5JZ\7LAL3RW;<6W"L0K,B9DT6:Y%FU4MZOV5TSTDIZR=^NB0JBJG5LU<B=SI
MUZ$]J@6<      $OYBNQG*?V5-XY !3V>T;^A .0
M                                          8UN)V?Y7YGN'BL@&,\
MO78A@/F6D^#0$4L"79YVP[2_M,@]&H!40
M                           UTYS>S7'_ *UV;X5X&Q8       $1YK^R
M";SS8_2< '2YRY[]3\OF3OL2RM8YU(R[OIUTE;;'U#$J5;^EJZ._]G4#,< H
M-GHMIZ"Q8G);9]LI*!6]5).R:G?33M5\W7K(Y>^=Q.67C[BZZZ 2/D];;J:]
M;NVW"9'R[3TF1-;B;D>^2E:YS'>$MIG/UUC149THO<T7V0-I@      2_F)[
M&<I_94OCD %/9[5OZ$ Y
M                      !C6XG9_E?F>X>*R 8UR]=B&!>9:3X- *4!+L[[
M8=I?Z>0>C4 J(        "+<P6X61XU3V'"\+JH[=D^6R5#%O+V),MOM]%&D
ME1-'&NJ+,[B:R'C3AXE55[@$.2'<"T]5<L6W#R/_ ##0_P!M2MOEQEN=LJGM
MZ5BJZ:1.'JY.XKH^%S-=6]P#:S:_-F[C8!8,U;2K1/N]*DLU*J\21S,<Z*5K
M5]EJ/8[A7V6Z 9<                                         #73G
M,[-<>_)_FNS?"/ V+        B/-?V03>>;'Z3@ M%52TM=2S45;!'4T=2QT
M-13S-22*2-Z<+F/:Y%1S51=%1>Z!K_7\DO+U77*6X-L%31QS/222WTE?4PT:
MKT:HD2/71JZ=*(N@%NQ?%<=PNR4N-XI;8+38Z)O#345*W@C;KTJJ^RYRKTN<
MY55?94#V       2_F*[&<I_94WCD %/9[1OZ$ Y
M                                          !C6XG9_E?F>X>*R 8U
MR]=B&!>9:3]1 12@)=G?;#M+_3R#T:@%1         2#?C;.^YK0V?)L,6!^
M;8I+//;Z"K=U=-<*:J8D=32/D_\ AN>U$6*1>AKTZ>A55 A<-LW=O\D-EQ_;
MRZV:]UB]4^YW]*>&U6]%[U\\DD<KW3]7W6,C;J_] &UFW>%46W6$V3"K?.^J
MIK/3)!X5*FCY9%57R2*B*J-XWN<[A3VNN@&3@
M            ?B26.%BR3/;'&WVSWJC6IKT=*J!\/XE;O^+A_P#$9_* _B5N
M_P"+A_\ $9_* _B5N_XN'_Q&?R@/XE;O^+A_\1G\H&O'./54M1MMC[8)XY')
ME5F548]KE1.M=TZ(H&P_\2MW_%P_^(S^4!_$K=_Q<'_B,_E ?Q*W?\7!_P"(
MS^4!_$K=_P 7#_XC/Y0.4N-O541*N%57H1.L9W5_T@=D !$>:_L@F\\V/TG
M W(YF,8PC*'X#CECNV=[@0M;)5V+'X%G6E8]J/3PB7I1CE:O%PHCE_+IJ@&+
M2\TF>6]GAE[V&S&CM3$ZRHJHXTG='$WVSE8D;>XG3HJH!9MM-S\.W:QJ/*<+
MK5JJ!7N@J8)6+%4TU0Q$5T,\:]+7IK^=%[J*J 9B      "7\Q78SE/[*F\<
M@ I[/:-_0@'(
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MY(]$X72\>O<Z>E>YHH&R(      )?S$]C.4_LJ;QR "GL]HW]" <@
M                                                       QK<3L
M_P K\SW#Q60#&N7KL0P'S+2?!H!2@)=G?;#M+_3R#T:@%1
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MXFNT7A=HG<5%35 BE@      E_,3V,Y3^RIO'( *>SVC?T(!R
M                                                   #&MQ.S_*_
M,]P\5D QKEZ[$,!\RTGP: 4H"79WVP[3?T\@]&H!40
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MQJNNH%X      !+^8KL9RG]E3>.0 4]GM&_H0#D
M                                         &-;B=G^5^9[AXK(!C/+
MUV(8%YEI/U$ I8$NSOMAVF_IY!Z-0"H@
M                    ULYJ_G#LM]<:;]5 -DP         #7/G-[.<:^MM
ME^%>!L8  B/-?V03>>;'Z3@ Q"^;A;Y;O;@Y1A&R-5;L4Q3"ZG^%WS+KG"E9
M45%R1-7PT\*H]J-9HJ*JM_/Q)JB <>K#G'H$\,H]Y+3<*F-JO;15=HB9!(Y.
MXQ7-C<J(OY= ,\V!W<R#<>AR''L[M45FW(PFN2U9)24KN*ED>Y%6.>#5SE1L
MB-=T<2]S5%T5 +$      "7\Q78SE/[*F\<@ I[/:-_0@'(
M                                                 ,:W$[/\K\SW
M#Q60#&N7KL0P'S+2?!H!2@)=G?;#M+_3R#T:@%1
M                           !K9S6?.'9;ZY4WZJ ;)@         &N7.
M;V=8SI]+;+\*\#8T !$>:_L@F\\V/TG !B-]VWWRVEW R?-]BH[9DF,YI4_Q
M.^XC>)/!I8+DJ+UDU/-JQ%:_55TX_9TX5T10#MS.<>YL\#MVSUHM57(U42NK
M[Q'- Q?RJQDC%Z.[IJ!G6P6T%\VTH\AO^;7=E\W&S2N2YY)74[>"F8]J*D<,
M**C5X6(YW3HG=T1-$0"Q       E_,3V,Y3^RIO'( *>SVC?T(!R
M                                                      #&MQ.S
M_*_,]P\5D QKEZ[$,!\RTGP: 4H"79WVP[2_M,@]&H!40
M                                 :V<U?SAV6^N--^J@&R8
M !KGSF]G6-?6VR_"O V,  1'FO[()O/-C])P 6X#\-EB>JHQ[7*G=1%10,)P
MW%\WLF79E>,DR=;SCU[JH9L;M"M5J6R"-KD?&BKW>)53N?D SD      $OYB
MNQG*?V5-XY !3V>T;^A .0
M                        8UN)V?Y7YGN'BL@&-<O78A@/F6D^#0"E 2[.
M^V':7]ID'HU *B
M  #6SFL^<.RWUQIOU4 V3          -<^<WLZQKZVV7X5X&Q@ "(\U_9!-Y
MYL?I. "74V*WKFDW/W"I,QRRYV?;O [NM@MV)V6;P)T\D+7(ZIJ7Z*KN)R<3
M=47\B:(G2&33\CFT[87.M%ZR>UW)&KX/7P79ZR1R_P U^CF:*J+T^P!ZO+%E
M^95-9N!M;FMY7)J_;J[,MU'DCVZ355).U[F-F5%762-6*BZJKNG15734#80
M     $OYBNQG*?V5-XY !3V>T;^A .0
M                                 8UN)V?Y7YGN'BL@&,\O78A@7F6D
M^#0"E@2[.^V':;^GD'HU *B
M           #6SFK^<.RWUQIOU4 V3          -<^<WLZQKZVV7X5X&Q@
M"(\U_9!-YYL?I. #'MW]C[!1Y/5[K8MN3-M'E%T:D-XKF2Q-M]P>Q$1BRPS2
M1HLB:)JJ*NO=X==54)Q20Y_DT[;/<^;*S,I)>\<EHAHJ>K<J]"-:_K8UZ?S.
M V5V>VBQ'9W%OX#BKIJMU;*M;=+Q5R)-5U]5(B:S2O1$1=?YJ)T(GY]54*"
M     "7\Q78SE/[*E\<@ I[?:M_0@'(
M                                 ,;W#^8&5^9[AXK(!C/+WV(8%YFI
M/U$ I0$NSOMAVF_IY!Z-0"H@
M            ULYJ_G#LM]<:;]5 -DP         #7/G-[.L:^MME^%>!L8
M B/-?V03>>;'Z3@ DV$8-A>^V^NZU1O&YU[O.)W9;5C>)5E0Z.FI;2Q%1E1'
M3L<Q7=9HBJ[N:KJO2Y +)<.5;EWK*22"HP&UP1<#D6:!KZ>1J:+J[K(WM75/
MRJH&!\H%PDI:S<[ ;/>)[_MWB%\;28C<ZB5*CA@F:]TM.R5/;MC5K=-.CIU3
MVP&SX      )?S%=C.4_LJ;QR "GL]HW]" <@
M                                       QO</Y@97YGN'BL@&,<O78
M?@/F6D_40$4L"79WVP[2_M,@]&H!40
M                  :V<U?SAV6^N5-^J@&R8         !KGSF]G6-?6VR_
M"O V,  1'FO[()O/-C])P >-OSMWRW9%DENKMR[[38GGE8UL%#=*6Y-M=QFC
M35L?6=.CF(O0U\C?8TXO8 B&X> <M&V5\CQ7<[=K,;G4OC9)4V-;A45C(XY4
M1T;I^HA<C$<BZHBKJJ+K[* UMYM!;]L;=@5LCVA91I@\K72T4M JO9(]RZ/?
M(YVKUDU31_6=\G<7N: 9T      "7\Q78SE/[*F\<@ I[/:-_0@'(
M                                                       ,;W#[
M/\K\SW#Q60#&>7OL0P+S+2?!H!2@)=GG;#M+^TR#T:@%1
M                                 !K9S6?.'9;ZY4WZJ ;)@
M  &N?.;V<XU];;+\*\(V,"@$1YK^R";SS8_2< $:P6P;597OSO%C6^5+1UN?
MW6[-I,;I+WQ-62QO9_NS:!9%1$=P\'3&O'W-/9 I^P^SMJV5P'('[EQ6Q;A+
M7U4MQR"OF95-EM+."*E2:>I1%:QL:(WJW="+^D#'.3R6V5%ZW>JL(8YFT\V1
MM=BC6M>RFXNK=X2M,U_0D:KU>B)[&@&TX      )?S$]C.4_LJ;QR "GL]HW
M]" <@
M       QK<3L_P K\SW#Q60#&N7KL0P'S+2?!H!2@)=G?;#M+^TR#T:@%1
M                                              !K9S5_.'9;ZXTW
MZJ ;)@         &N?.;V=8U];;+\*\#8P !$>:_L@F\\V/TG !2KUM_A619
M!:,KO5BHZW);"_K+1=9(D\*IW)JJ<,B:*J(JZHU=4UZ=-0.[E&,6+,[!78OD
MU&VX6&Y1]374<BN:V1B.1VBJQ6N3I1%Z% ^F/X[8L4L]+C^-6^"U66B9U=+0
MTD:111M[O0UOLJO2J]U5Z5 ],      $OYB>QG*?V5-XY !3V>T;^A .0
M                                                           8
MWN'V?Y7YGN'BL@&,\O78A@7F6D^#0"E 2[/.V':7^GD'HU *B
M                                     #6SFL^<.RWUQIOU4 V3
M      -<^<WLZQKZVV7X5X&Q@ "(\U_9!-YYL?I. #UN9/*,VPO9^_91@-13
MT=\MG45$E75=4J14C9F]>YC9U2-[^'H:QR]]KHG3H!T[!S1;"72S45:NX=J;
M))#&LJ5LB4-1UG"G%QPR(U6+KW4[GY ,\P[<? ]P6U;L(R&AOS:!6)6+03-G
MZI9456<7#W.+A70#*       2_F*[&<I_94WCD %/9[1OZ$ Y
M                                                   !C>X?S RO
MS/</%9 ,8Y>NP_ O,M)^H@%+ EV>=L.TO]/(/1J 5$       ">[P[F.VRQF
M&NM]O_B^3WBJ9:\=M:OZJ*:NF:YR+-(OM(HVM=)(J=.B:)TJ! 6[B\Q%&K+G
M'EMHN]PC=UTF/26AE+;I]>E:>.J;*L[.[PQR.UZ?;(!LIMMGMNW+PZWY=;8)
M:-M6CXJNWU&BS4M73O6*>!ZMZ%5CVJWB3H7N@98
M                ULYJ_G#LM]<:?]5 -DP         #7/G-[.L:^MME^%>
M!L8  B/-?V03>>;'Z3@ H6YM1@M)@E[JMRXZ:;!X(.NN\5:SK87QQO:YK59_
M.<KT;PM3I5V@&F\61[9WNF=DF,\I];>,)T=)#>EHX8Y9H6KT2QP]6_5JITIH
M]0-E>7NKV5ON*5&4[-62EL=)7RI3WJAAIDI*J&KID7^QJ8TUT<SCZ.E45%U1
M0*^      "7\Q78SE/[*E\<@ I[?:M_0@'(
M                                     ,;W#[/\K\SW#Q60#&>7KL0P
M+S+2?!H!2@)=GG;#M+^TR#T:@%1        C?,1@V0Y/8;+D>)T:7/(,/KUN
MD=G1_5R5U*^)T-1!$Y>]256.XH]4Z7-X=4U US9N-9YUBI[-;KM=,EE>D5+C
M4=MJX[B^J1=.ID;)$C(U:J?VCG.X6HBJ!M3L9@MWV\VXMU@O[XEODLU3<;C#
M3NXX8)Z^=U0Z!C^CC2/CX.+V=-0*.
M      ULYJ_G#LM]<:;]5 -DP         #7/G-[.<:^MME^%>!L8  B/-?V
M03:_\YL?I. #K\X=DH[WR_Y1X=<66R&W>"W%LLS))8)9*:H8K()6Q(Y_#(Y4
M9T)T+HO<0#$,6YZM@I,4HJBZ5558KG!3QQSV!**:5T3V,1.KA=&U6.8FFC%U
M3H[J(!)MC>:/9;#,AW'S;);C56BISN\K<*3'*>BGG2DIJ?C:Q\KXV\"RS<:O
M<C-43\J@;UX[?K=E%AMN26A[I+7=J:*MHWO:L;G0SL1[%5KNE%T7N*!Z8
M  2_F*[&<I_94OCD %/9[1OZ$ Y
M                             !C6XG9_E?F>X>*R 8UR]=B& ^9:3X-
M*4!+L[[8=I?Z>0>C4 J(
M        -;.:OYP[+?7*F_50#9,          USYS>SK&?K;9?A7@;&  (CS
M7]D$WGFQ^DX +5/!!51.@J8F30/31\4C4>QR=WI1=44#I?P"Q?\ *Z3XO%_5
M ?Y?L/\ RND^+Q?U0:[\<<<3&Q1-1D;$1K&-1$:B)W$1$[@'Z     "7\Q78
MSE/[*F\<@ I[/:-_0@'(
M                      ,;W#^8&5^9[AXK(!C/+WV(8%YEI/@T I0$NSOM
MAVE_:9!Z-0"H@
M ULYJ_G#LM]<:;]5 -DP         #7/G-[.<:^MME^%>!L8  B/-=V03>>;
M'Z3@ RC?7=)NSNV=XSEE(E?<*5(J>V4+N+@FK:IZ11-=P]/"BKQ.TZ=$ D.Y
M&\&\]&FUVU6.PVZT;UYU!X5?*J1GA-%;8(459'M:O6(NO"_NH[3A5$U544#.
M^7[=#+<U3+<+W$AIF;@8%<4M=WJJ#O:6LCE:YT-0QB^UXT:NJ=SN="=Q M(
M     )?S%=C.4_LJ;QR "GL]HW]" <@
M                                 QK<3L_ROS/</%9 ,:Y>NQ# ?,M)
M\&@%* EV=]L.TO\ 3R#T:@%1
MQC/\^QW;7&:K*LFE>VB@5D-/34[%FJJNKF7AAIJ>)O3)+*[O6-3]*Z(BJ@0Y
M.9K/:3AN5XVQ5EC8Y9*R"ANT-9=H:9-55S:9(FMDD8WI=&R75>XW50-@\:R6
MQYA8;?D^-UK+A8KI"VIH:R+7A?&_\SD145%Z'-<B*B]"]('J@        -6N
M<V\Q8XFUV1U$3IZ>SY*E?-!&J-?(RFBXU:U7="*NG=4#QOO]XI]#+E\:I?Y0
M./O^8I]#+E\:I?Y0'W_,4^AER^-4O\H'/W^\4^AER^-4O\H#[_>*?0RY?&J7
M^4#C[_>*?0RY?&J7^4!]_P Q3Z&7+XU2_P H#[_F*?0RY?&J7^4!]_O%/H9<
MOC5+_*!.MX^9^Q;TV6PXE;L?K+54PY!;+AX34S0RQJRGFT5O#&NNJ\70!_00
M !$>:_L@F\\V/TG ![/,=AM@SG9_(;+D=Z@QNCC;#64]^K'<%/1U=/*UT$DB
MZIHU7Z,=^9WY0)GM;LWNW-GM?O?NC>;/=\RI[&ZSX9!:G2/H-%C5&54CE:Q-
M)===&]U'JO1T(![_ "QXE48U59]6Y;DUOO\ NW>[I%79O2VQR.BMTKXW+!3=
M#6Z:-<[V-/83N:J&P0      )?S%*B;,Y1K[,=*B?I6M@1$_TJ!3V]#43\R
M<@
M    Q[/89JG!LGIZ>-TM1-::^.*)B:N>]U-(C6HGLJJKH@&)<NLT-1L;@4D$
MC96)9Z9BN8NJ<<;>!Z?I:Y%:OYP*<!+<_P#[+=K::IE[RG\(OE/UJ]#.NFMJ
M]6S7_O.X7:)^90*D                                  #PLPS+&,!L
M%3D^77**UV2DX4EJ9>)55[UX6,8QB.>][EZ&L8U7+[" :E;[[_X+DL.%7)(;
MU::&S7R.KJ4N]IJ*."2&HIIJ=)62.:O?PK(UW!JFK7.7I5- /G593C5KMO\
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M:]I*2^7&+(:S+;[EE3'<+GD->K5DG:QBI%P\*NU31[G<7$O%K^30"M
M EG,?V,9+_</2%,!4P
M                     .C>?\'N'[M-\&H$LY5OP^X+^Y2^-3 6$"6[I?/;
M:CZPS^C*H"I                                   UCYB>LGW7P*ENJ
M-=966ZY5-DCE_P!4Z^1NC17-1W>K,R!7+%W51%<J(G= P++&6VHQ:^17Q(GV
M=:&I=6)5JG4<+8W*BN5W<5':*U>[KW.D"W;.[/;<MPG",LN.%VR+,_X5;ZRI
MK9**)E0VN=3,5\JM5NC9.)5=JB:H[I[H%K URQ[\:N8?4NA\9C V-
M ULYK/G#LM]<:;]5 -DP         #7/G-[.<:^MME^%>!L8  B/-?V03>>;
M'Z3@ _'-SE=_P_8G(;CC<TE'7U3Z6W2W&'B22DIJR=L4LR*WI31JJW5.YJ!T
ML8Y1N7B#$J*WOQ>EOOA--')+?JF262KJG2-1W7I,V1.'CUXDZO1 /!Y2):BQ
M77=/:V@N4UWPG![ZVDQFKJ)$F6&"H:]TE,DB=U(W,_Z=?R@;.       EG,=
MV,Y+_</2%,!4P
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MA5NB<.FFB: 4<      $LYCNQG)?[AZ0I@*F
M                                       !TKS_ (1</W:;X-0)7RK?
MA^P;]RE\:F L($MW2^>VU'UAG]&50%2
M          &N6/?C6S#ZE4/C48&QH       &MG-9\X=EOKE3?JH!LF
M     :Y\YO9UC7UMLOPKP-C  $1YK^R";SS8_2< 'SYO;1D%ZV#R>CQZ5(WM
M\'GN4?6L@?-;X9V/J(F/>J-XG-3H;_.]JFJKH!V< RGEKGVZMR8W78S38<ZD
MC:^BJWT<+FM1B(K:J*;1W6:MT?UB:JOY0)7RLY9M[C%QW/J+=DUJLNUERR!T
MV$VVNN$%*J11HYM1-##/(U[('NX4CXFIJC?S ;;TE725]+#74,\=515#&RT]
M3 ]LD4D;TU:YCVJJ.14Z45% ^P     2SF.[&,E_N'I"F J8
M                                                   '1O/^#W#]
MVF^#4"6<JWX?<%_<I?&I@+"!+=TOGMM1]89_1E4!4@
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M1VBVP1TM#21Z\$4$+4:QC=55=$1- .\     $LYCNQG)?[AZ0I@*F
M                                                        !TKS
M_A%P_=IO@U E?*M^'[!?W*7QJ8"P@2W=+Y[;4?6&?T95 5(
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MIU6ATCCF8]ZZ7"GUT1%50JP!
M                           '1O/^#W#]VF^#4"6<JWX?<%_<I?&I@+"!
M+=TOGOM/]89_1E4!4@         #A[V1L=)(Y&L:BN<YRZ(B)TJJJH'1M]\L
MMV>^.U7*EKGQHCI&TL\<RM:[H151CET10.^
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M[=>Z@&UX
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M",VQW</&:'+,7J5J;37-7AXVK'-%+&Y620S1KTLDC<BL>U>XJ 9"
M  :Y8]^-;,/J50>-, V-        ULYJ_G#LM]<J;]5 -DP         #7/G
M-Z=NL:^MME^%>!L8  B/-?V03>>;'Z3@ ]7F2W,N^TVTEXRS'HV29$KZ>WVA
M96I)&RJK96Q->YKNA>!%5R(O1JG3T :[U%/S5T.ZUAVIN.[\4-RR*Q3WVBN#
M+7 Z!*FF<J24CF\*+HB-5W6)['\T"E\I-VSVX/S^V[GY76WS.L?NS;5<[55(
MQ:6B2+K%CEI7,Z',J$777A;[0#922-DT;XI$XHY&JU[>YJUR:*G0!,5Y=-DE
M[N&4*_Z9O9Z?? ,OHL$P^WXLF$4UFIDQ-&.B_A$C.MI^"1RO<BMDXM>^7B_2
M!^,1V_PO H)Z;#[)2VB.I<CJA:=G?R*G<XGN57*B>PBKH@'3OVU6W.47N'(\
M@QF@N%[@X>&LGA1SW=7[7K$Z$DTTZ.-% R]K6M:C6HC6M31$3H1$0"6\QW8S
MDO\ </2%,!4P
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MHY51ZHYRZ+[")TKTJ!L$      "6<Q_8QDO]P](4P%3
M                                               Z-Y_P>X?NTWP;
M@)9RK?A]P7]RE\:F L($MW2^>VU'UAG]&50%2
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M,DFB]\]=7.Z?] 1;       2SF/[&,E_N'I"F J8
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MF.[&<E_N'I"F J8
M                  '1O/\ @]P_=IO@W 2SE6_#]@O[E+XU,!80);NE\]MJ
M/K#/Z,J@*D                       PG>+LFSCS#<O%9 /!Y:^P; /-$'
M_:!5           !T+E8K)>NK_C%MI;AU/%U7A<$<_!QZ<7#UC7::Z=.@'<B
MBB@B9! QL<,;49'&Q$:UK6IHB(B="(B=Q -=<>_&KF'U+H?&8P-C0
M-;.:OYP[+?7&F_50#9,          USYS>SG&OK;9?A7@;&  (CS7]&T$WGF
MQ^DZ<#K\X5ER*_; Y+28Y%+4RPNI:NXT4'$LL]OIJADE0QJ,15Z&MXU_,U0(
MNS=W:*MYB-K,SL5_MU!@MLPJN@E<^1E.R@5J2HVFEC718Y&HJ-X--5]C4*SW
ME'6*]Y#N]N#CU(^CV\RG(6RXTUT74,G2G;(D\\<?1HU[GI['=Z.Z@1M"
M  "6<QW8SDO]P](4P%3
M                       Z-Y_P>X?NTWP:@2SE6_#[@O[E+XU,!80);NE\
M]]J/K#/Z,J@*D                       PG>/LFSCS#<O%9 /"Y;.P? /
M-$'_ &@5,            ,*W4W&H]L,2ER*>CDNEQGGAMUDM$#FQR5MRJUX8
M($D?WK$545SWN]JU%7I7H4-.*O-,VQC<>NW1NF?8Q:]RKA;XJ&LQZJIT9:/
M8I$E93K(Z;PEJ:I_K].)>[IP@;B;2[EV_=;#:?**.F6AK&32T%WMKI&5'@MP
MIE1)8FS1*K)6=*/CD8NCF.1>A=40,X      !K9S5_.'9;ZXTWZJ ;)@
M     &N?.;V=8U];;+\*\#8P !$>:_L@F\\V/TG !CN8<T^08C>+]03;/935
MVFQ3U,4M\CC:RBEIZ1SD6H:]S.%(U:WC1RKW (Y!D^V.<TDFX%'RI76Z4%3_
M +TMS@IHFQ3)T.ZQD;$:V1%[NK6*BA6R7+YN_2;MX]55=EPRIQ+&[6L=+;DE
M6G\&E5JO;)%$R#1(UA5J(]BHFG$@180      2SF.[&<E_N'I"F J8
M                                                         '2O
M/^$7#]VF^#4"5\JWX?L%_<I?&I@+"!+=TOGOM1]89_1E4!4@
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M<+IN)%7\NFO<T4#8\      $LYCNQG)?[AZ0I@*F
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M@F\\V/TG3@6X#S:C'<?JZOP^JM5'/7(J.2JEIXGRZIW%XW-5>C]('I
M  2SF.[&<E_N'I"F J8
M                      '2O/\ A%P_=IO@U E?*M^'[!OW*7QJ8"P@2W=+
MY[;4?6&?T95 5(                      !A.\?9-G/F&Y>*R >#RU]@V
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M>;'Z3@ MP         !+.8[L9R7^X>D*8"I@
M                                       =&\_X/</W:;X-0)9RK?A]
MP7]RE\:F L($MW2^>VU'UAG]&50%2                       83O%V39Q
MYAN7BL@'@\M?8-@'FB#_ +0*H       !KG@GXQMV/J]8_U& ;&
M $-P?\4&Z_F;'/@Y@+D  ULYJ_G#LM]<:;]5 -DP,:SW!,=W(QBKQ3)X7R6Z
MJX9(YH'K#4TU3"O'%402MZ62QN1',<G^G5-4 A'W;-SY4_AE1N7 VU*Y8Y+I
M!:&1WEU-^:19EB;,J=[UB1]'MD34"_89AV/X!C5!B6,4W@MFMS."%CG+)(YS
ME5SY)'NU5[WN57/<O=50/>     #7/G-[.L:^MME^%>!L8  B/-?V03>>;'Z
M3@ MP         !+.8_L8R7^X>D*8"I@
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MQ@ "(\U_9!-YYL?I. "W          $LYCNQG)?[AZ0I@*F
M                                                  !TKS_A%P_=
MIO@U E?*M^'[!?W*7QJ8"P@2W=+Y[;4?6&?T95 5(
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MW.-?6VR_"O V-  1'FO[()O/-C])P 6X          EG,=V,Y+_</2%,!4P
M
M  .E>?\ "+A^[3?!J!*^5;\/V#?N4OC4P%A ENZ7SVVH^L,_HRJ J0
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M+\*\#8T !$>:_L@F\\V/TG !;@         "6<QW8SDO]P](4P%3
M                                                        Z5Y_
MPBX?NTWP:@2OE6_#]@O[E+XU,!80);NE\]MJ/K#/Z,J@*D
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M05EC@H[W;[K)7^'P5*(RDEU<W@1&=U'*NNOL ;C@ (CS7]D$WGFQ^DZ<"W
M        $LYCNQG)?[AZ0I@*F
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M4P
M     .C>?\'N'[M-\&H$LY5OP^X+^Y2^-3 6$"6[I?/;:CZPS^C*H"I
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MS 7(       #73G-[-<?^M=F^%>$;%A0      $1YK^R";SS8_2< %N
M     )9S'=C&2_W#TA3 5,
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MN          )9S'=C.2_W#TA3 5,
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M96:]6C(K72WNPUT%SL]<Q):.OI)&SP2QKT<3'L545-4T [P       $-P?\
M%!NOYFQSX.8"Y        :Z<YG9KCWUKLWPKPC8L*       B/-?V03>>;'Z
M3@ MP         !+.8[L8R7^X>D*8"I@
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ML?I.G MP         !+.8[L9R7^X>D*8"I@
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M[()O/-C])P 6X          EG,=V,Y+_ '#TA3 5,
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M<Y0,JR?F?WCP^UNOEQP:S72UPHBUSK57U+YJ5B__ !7QOA17L1?;*SVO=7H
MPI/_ -0"_KTIAMO5/85*^1477_[,&G_[@%_^AM!\?D_V8'1O7/7?+[9KC9)<
M0H8H[E2ST;Y&UTBN:VHC=&KD18TUTXM0:V4Y38^JY=\#BUUX**9NO<UTJYT
MLX #1'='9>X[W<S^>V*V76GM,UIMEGKGRU43YFR-EIHXN%$8J:*FFH'S^X'E
MOTPMGQ2?^N!RWD#RQ'(JYC;-->G_ '.?^N!\,0M:[61R[19=/%0Y+8):B6"2
MHTIJ>Y6^IF=+'6TCI':/:[56RHB\3'HJ*B ="MVV]<6>163;.XNM>2Q)X5FF
M46V:9M%%1LC<RGIZMU-(UDE3*_3JV]+VL:JNZ /49R Y8Q'(F96YW&YTDCGT
MU2][Y']+G.<Z15<Y?RJH'/W \M^F%L^*3_UP'W \M^F-L^*3_P!<!]P/+?IA
M;/BD_P#7!A]P/+?IA;/BD_\ 7 S[E9VZJ]J-U]Q,%KJZ*XU5#;;/4/JZ>-T4
M;O"UFD1J-<JKWH&V@       &NG.:NFVN/\ UKLWPKP-BP       (CS7]D$
MWGFQ^DX +<          2SF.[&<E_N'I"F J8
M                                        '2O/^$7#]VF^#4"5\JWX
M?L%_<I?&I@+"!+=TOGMM1]89_1E4!4@                #%-T.S3,_,5S\
M3E G/+#CN/UNP. U5;::*HJI+6Q9)I::)[W*CWIJKG-55[@%9_RGBW_([?\
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MO/-C])P 6X          EG,=V,Y+_</2%,!4P
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MX8UO%(D;6MXE1>'BUTZ$10+(  QS<#YAY3YHN'BT@$XY1_PY8!^X2^-3 6H
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M?I.G MP         !+.8_L8R7^X>D*8"I@
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MKP-BP       (CS7]D$WGFQ^DX +<          2SF.[&<E_N'I"F J8
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MX5X&Q8       $1YK^R";SS8_2< %N          )9S'=C&2_P!P](4P%3
M    !^998X8WS3/;'#&U7R2/5&M:UJ:JJJO0B(@&L^4<W$4M5_"=LL5J<@EN
M4TUNQW(JV2.DLU55P(YTTS45W72TL+45SI&-3C]JSNZ@8Q%N+S"VA[+M%E=M
MRBHIU66?&JBU0VZEJV]UT,-5$Y98GZ=$3Y.)-=.-%0#9_!,RM6X.(6C,K*DC
M+==X$GCBF3AEB>BJR2)Z=SBC>US':=&J= &1
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M5'0U<M/$LB.7558UG5\?\[AXO9 S3UC<W'V0V?Y;C_K <>L;FY^R&S?+<?\
M*!Z&RMBW5GW/S?</<S&:?&I;]06NCI::EK(ZV-SJ#K6JJ*U5<G0Y-=0+Z
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M)V?^&7*S6Z1RO91.NK)W5$,&NJM@5\7&V/N-5SM.A0-D
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M777N]('N@          #73G-[-<?^M=F^%>!L6       !$>:_L@F\\V/TG
M!;@         "6<Q_8QDO]P](4P%3  >3DF,8_F%HFL.3VZ"ZV:H5CIJ*J;Q
MQ.6-R.:JI^94U P7[N.Q7T LWQ9H#[N.Q7T LWQ9H#[N6Q7T LWQ9H#[N6Q2
M+K_D&SZIW%\&:!@.ZG*1@^0XW5T^V-LH\2RJIFIW+70SUM+2K#&_69'0TLG
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M6-M5-DUYH\<R.STZ)%;JV"M1[8YWPMT:RH@<W6.1B(KD56NU10-U@
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M)T@9ELK;KY<MYL"6BQ:OH(Z.[PU5;+$VYRL\'CUXGRK5.<UK&:ZJO_2!_40
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M@UC:B2*+_5T\,<:(R"!B]+8F>STN55TT"D@ (CS7]D$WGFQ^DX +<
M!'.6QU/'L]2=?T/BK+JEQX^ZDK:V;K.+\^G= ^_+0DJ[+V!7:I&]]<ZF5>E.
MI=6S*Q4_-IW )!NSM=O+8,&N][R7=RIR''Z:>EEJ[#);8(&5$3Z^%&Q+*UZJ
MU$XDZ43V -NP
M               .E>?\(N'[M-\&H$KY5OP_8+^Y2^-3 6$"6[I?/;:CZPS^
MC*H"I
M         1'FN[()O/-C])P 6X       "07S82DK[G=I;%EEYQO'<CE?49'
MCULEC;2U4LR<,SHW/:YT"RI_K.K7O@*C9;-;,>M-%8K-3MI+5;H64U'3,]JR
M*-.%J?G_ #JO= G7,?V,9+_</2%,!4P
M                                  .C>?\ ![A^[3?!J!+.5;\/N"_N
M4OC4P%A ENZ7SVVH^L,_HRJ J0
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MUO+_ /3.+XG</)@.?O6; ?3.+XG</)@'WK>7]>YFD#OR\-)7KI^G2G ?>LV
M^F<7Q.X>3 <?>MY?_IG%\3N'DP'/WK-@.Y_G.+XG</)@'WK-@/IG%\3N'DP#
M[UFP'TSB^)W#R8!]ZWE_3_\ .<7Q.X>3 /O6; ?3.+XG</)@'WK.7_Z9Q?$[
MAY, ^]9L!],XOB=P\F ?>MY?_IG%\3N'DP#[UO+_ /3.+XG</)@'WK>7_P"F
M<7Q.X>3 /O6\OWLYI BKW$6DKTU_1K3]/^@!]ZS8#Z9Q?$[AY, ^]9L!],XO
MB=P\F ?>LY?_ *9Q?$[AY, ^]9R__3.+XG</)@'WK-@/IG%\3N'DP#[UFP'T
MSB^)W#R8!]ZWE_\ IG%\3N'DP#[UO+_],XOB=P\F ?>LY?\ Z9Q?$[AY, ^]
M9L!],XOB=?Y, ^];R_\ =_SG%\3N'DP#[UO+_P#3.+XG</)@'WK.7_Z9Q?$[
MAY, ^];R_=U,TA<GY6TE>Y/^E*=4 ?>LY?\ Z9Q?$[AY, ^];R__ $SB^)W#
MR8!]ZS8#Z9Q?$[AY, ^];R__ $SB^)W#R8!]ZS8#Z9Q?$[AY, ^];R__ $SB
M^)W#R8#JW+FFV#J+=5T\691.EFADCC;X'7IJYS%1$Z:?\J@=WE714Y?L%1R*
MU? I%T<BM7IJ9EZ47I0"P@1G??([)A]YVUR?)*M*"PVZ_P KZVM<R25L:/MU
M2QNK8FO=TN5$Z$ _7WK-@/IG%\3N'DP#[UG+_P#3.+XG</)@./O6\O\ ],XO
MB=P\F Y^];R__3.+XG</)@'WK>7_ .F<7Q.X>3 /O6<O_P!,XOB=P\F ?>LY
M?_IG%\3N'DP#[UO+][.:0(J]Q%I*]%7]"+3]/^@!]ZS8#Z9Q?$[AY,!Q]ZWE
M_P#IG%\3N'DP'/WK-@/IG%\3N'DP#[UO+_\ 3.+XG</)@./O6\O_ -,XOB=P
M\F Y^];R_P#TSB^)W#R8!]ZS8#Z9Q?$[AY, ^];R_P#=_P YQ?$[AY, ^];R
M_P#TSB^)W#R8!]ZWE_\ IG%\3N'DP#[UO+_],XOB=P\F ?>MY?\ Z9Q?$[AY
M, ^];R_^SF<*)^5:.O1/%P./O6\OZ]*9I"J>PJ4=>J+^A4I^D#G[UFP'TSB^
M)W#R8!]ZWE_^F<7Q.X>3 /O6; ?3.+XG</)@'WK-@/IG%\3N'DP#[UO+_P#3
M.+XG</)@'WK.7_Z9Q?$[AY, ^]9L!],XOB=P\F ?>LV ^F<7Q.O\F ?>MY?_
M *9Q?$Z_R8!]ZS8#Z9Q?$[AY, 3FLY?U[F9Q?$[AY, ^];R__3.+XG</)@./
MO6\OW<_SI#Q?]WP2OXM/RZ>#ZZ <_>LV ^F<7Q.X>3 /O6; ?3.+XG</)@'W
MK>7_ .F<7Q.X>3 /O6\O_P!,XOB=P\F ?>MY?_IG%\3N'DP#[UO+_P#3.+XG
M</)@./O6\O\ ],XOB=P\F ?>MY?_ *9Q?$[AY,!S]ZS8#Z9Q?$[AY, ^];R_
M_3.+XG</)@'WK>7_ .F<7Q.X>3 /O6\O_P!,XOB=P\F ?>MY?D[N:0-3\KJ2
MO:G_ %TZ /O6; ?3.+XG</)@'WK-@/IG%\3N'DP#[UG+_P#3.+XG</)@'WK>
M7_Z9Q?$[AY, ^];R_P#TSB^)W#R8!]ZWE_\ IG%\3N'DP''WK>7_ .F<7Q.X
M>3 3#?[?G:7/MO?\M8CD;+G?:B[6>2GHHZ6L8Y[8KC ]^BR0L:FC45>E0-M
M         #AS6N16N1%:O=1>E /QX/3^],]R@#P>G]Z9[E '@]/[TSW* <>#
MT_O3/<H!SX/3^],]R@''@]/[TSW* <^#T_O3/<H!(N93 ,DW"VMJL9PRBAJK
MU+74,[89)8Z9JQ4\Z/>O&_1.A$[GL@5>EI(XZ6".6)G6LC8U_>HO?-:B+[ '
MU\'I_>F>Y3^0#GP>G]Z9[E '@]/[TSW* /!Z?WIGN4 >#T_O3/<H \'I_>F>
MY0!X/3^],]R@#P>G]Z9[E '@]/[TSW* /!Z?WIGN4 >#T_O3/<H 2G@1=4B9
MJGL\* 1S8#;S)\&ASAF6T4-.MZR6MNMM2.6.HXZ2?3@>O![55T]JO< L?@]/
M[TSW* /!Z?WIGN4 >#T_O3/<H \'I_>F>Y0!X/3^],]R@#P>G]Z9[E '@]/[
MTSW* /!Z?WIGN4 >#T_O3/<H \'I_>F>Y0!X/3^],]R@#P>G]Z9[E (WO3MW
MDV89AM1=L;HX9K?BV1)=+X]\L<*QTJ,:WB:U^BO]GO6](%D\'I_>F>Y0!X/3
M^],]R@#P>G]Z9[E '@]/[TSW* /!Z?WIGN4 X\'I_>F>Y0#GP>G]Z9[E '@]
M/[TSW* /!Z?WIGN4 X\'I_>F>Y3^0#GP>G]Z9[E '@]/[TSW* >5DUK?<,;O
M-OH(6.KJNAJJ>F:O"Q%EEA<QJ*Y>YJJ]T#!>7C![Y@.S6+8AEM)%3Y!:X9XZ
MV%CXZAK7/J99&Z2,U1VK7(O0H%/\'I_>F>Y0!X/3^],]R@#P>G]Z9[E '@]/
M[TSW* /!Z?WIGN4 >#T_O3/<H \'I_>F>Y0#]M:UJ(UJ(UJ=Q$Z$ Y _+V,D
M31[4<G=T<FO_ -('Y\'I_>F>Y0#CP>G]Z9[E/Y .?!Z?WIGN4 >#T_O3/<H
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MG]Z9[E '@]/[TSW* /!Z?WIGN4 X\&I_>F>Y3^0#GP>G]Z9[E '@]/[TSW*
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M%9?:<\QFWY395>E#7L5W52IPS12,<K)(I&].CV.16J@'O@        ,+W$W
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M97>VZW"7-H[K;[I:9L?R['ZAM'?;'4/;,Z%\C>.*2.5FC9(I6]\QZ=T#-P
M       "8VG>6V7[=RMVPLU+X3#:Z.2:OO"2:,2LB>UKZ>-G#H[@1VCW<70[
MHTZ /AD>ZN3.RBYXIMOB#LLK; V)^05<E;%;Z:"29O&RGC=(UW63*WI5.A&^
MR!VV;UXQZM)=R9Z>IABIWNHZBR.:GA[+HV3J5HN'719.L5&I[&G? =&Q;L93
M#DMIQ[<C#),39D;G1V"O96Q7"!]0UO&E-4+&UO52N;[5.E%7H K
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M]972I3Z?I<CN$(L&Z2K)NSM!!3KK5I7W25S6KWR4[:1J/5?S=P*L(
M #R,IR&CQ+'+IDU>R26CM5-)52Q0-5\KTC;KPM1.ZJKT(!IC>]P,+O&/-RF\
M7QM7N1?[_:[C=Z=E+5HRVVBBF5\=%#(^)&JV%O?/X%U>]5]MHBA%S6^6K(M_
M,$R&V3+562Z8O<76BI5KXFOD2=%?HR1K7(O!W=6HN@5\-PXZFIWQHX;:CEK6
M8->EEZM='(V63@AU_3(G1^<#O;<3T+>5VAF7A2CCQBK\(U7H1603)+JO])':
M@C*]C8ZF+9_"F5:.2=+12JJ/[O"K$5O_ /"J B@                ))E&U
M]-FNXM;>DSBMMDL-J@M=99;'-%2U\4#I75#'23HKY&,D=WW"D;>+3N@2[-:_
M)K9@>\FUMRNU1D5+B]%;JRV7BK5%KDHJ]S)GT]0]-$>L;6KH]>E6]T(HN_$U
M([EXNZTZIU,]#;64*-5.^<^HI^J1OY^YH%6"A;*RBIFSZ]<V)B2:]WB1J:Z_
MZ0/N          0S*[!9<8W:V=L^/4$%MMC)[_*VFIF)&SK)*-JO>NG=<Y>Z
MJ]('IOT9S.QK4_\ Q<,<E"KEZ.)EQUDX4_0J:A&([D))4[F[D1V[5T\6V53%
M4)&O2DLD\CHT7\ZLUT"LCN]3;6<JTL[7,2@7#F-8NJ</$ZB:Q$U_*KUT_2$4
M;;MD\6 8K'4HJ5#+10-E1WMD>E-&BZ_GU"LE         8?N#N)8MN[=%55\
M<M?>[D_P:QV&A9UM?<:K^;%"Q.GHU[YZ]ZU.[["*$>R;"LJM^S^Z6;9>K/\
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M17=_%1S-O::'_$)<PM:TJ-71_>=8K]/T)W0JP
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M9&=*@9]C.-V?$+#0XW8*=*6T6Z)(::%%551J=*JY5Z5<Y55SE7NJ!ZP
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MZ4"N]@&WEFV]H*NGM\]3<+G=)UK;S>KC)U];6U3DT5\K]$Z$3H:U$T:@&7
M       .'-:[H<U')^=-0,4EP.BEW%IMQ?"Y6UU-:WV=M"C6=0L;Y>MZQ5TX
MN+7H[H&/9=LU29!D4^56#([MB%\N$3*:\SV69D;*V&)%1G6LD:Y$D:B\+9&Z
M.1 /6AVFPB';Y^V:4+GXO+&YDK7R.=4OE>[C6H=-[99N/O\ C_+^;H \7%=E
M*&QY!19)?\EO&75]F8^+'V7J9DL5"R1.%SF-8QJ.DX4X>L?JN@%1
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M3Y'BMQANMCJ^-*:NIG<43^K<K':+T=QR*@'L
M
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M,!L&
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M<8W05]QY7^8#<3P2:DL^=W&Z7FQ4TK%8]U U[42;AT3H=WWN01V]W,CQ^_\
M)CA#+%=:2Y/MU3C-)<&4DS)G4]0QB<44K6JJL>G_ '7(B@9K><BM.TG-NW+,
M\F;:\4SK%Z:V6>^SZMHXJVC>Q7PRR*FC%5&(NJJB)Q-U Z>[.Z6$9QS#['X]
MA]SAODEFO-347&XT#FU%%$ZKIT2.%)V:L=(J1JY6M=T)IJ!,KO@V-1<Q>YF/
M;D[BW[;*HOM<R^8W5V^N2VVRY4DZ.55?,_O.LC5>!.)4[CD[J 9OLWB>T5'S
M"6RFQ;<3*]QLKL%OJZAURJ)XKG8J2"HC="^&2J3I:Y>)%3J]6*Y415UZ -O,
MKME1>L6O=FI'(VKN-OJJ2!SET1))X7QM55]CI<!K/RM;Q;=87L]3X%G-[H\4
MRW!I:V@OUJNTK*2='LJ)9>LC;)PK(CD=_,U75-/R:A.\695;N[0\SM1AU)/)
M)D-^FN-IHY(UBJ)H6MBJFIU:HCD?)&S5K5Z554 N.VG,OLK%L]8[Q<<JH;7+
M9;734ESLU5*V.XPU-'"R)\3:;7K'KQ-T9P-5'= $2P5N$6;E:O=\WJQ^Y2X#
MG655%QI*>EA5:BBIJZ5J4]8KD>WJFM5BJCT[O0FCD=TAC][2FV)2RY%L%OB_
M+8[C<J2&CVYJ*F.YK5P5+T:K$9"]W#HCNZZ*-4_+Q: >[O-B5G3FDKZG<3,;
MUMQC^862B=8\AM-7X'32U=&V.&6DJ9]%:G"K5<FNB)WJKW4 ^^-X1LO0[VX)
M8[7NKEVY.64E;_%+?!3U<%YM=$M.U'N?5RHJI&U[?;+&JKHG?::IJ&]8&MG+
M#V@;^_72;]5X&)<L&YV!8%1;FXOG-_H<;O=MRZ[UD]'=9V4DBP2O31[$E5O'
M[1>AFJ_]* 85A%//NYA7-4N&QS2/R*XI66:*6-T4T\7!+41HD;D1R=<QO>(J
M?SD L.VO,KLU;=AK/=+ID-#05=AL\5!<L=FD1EP;5T4"0N@92K_:/XW-[U6M
M5%1>[W= \CD[G;5<L5SJ61]4V:LOTC8O^XCU<O#_ *-0,HY)?PVXC_2K_'IP
M-@P
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MHK:JT27NNH(ZIT"U<RQZ(^9.MCU]HB\3?R>R!M=-_E[_ "^_PCP+_*O@??\
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M+&LC'5^JPRQSL76MF7H?$Y[5_P!"@7T
-             #__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>lc_prepostfollow-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_prepostfollow-bw.jpg
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M="!E;F0](G(B/S[_[0!(4&AO=&]S:&]P(#,N,  X0DE-! 0       \< 5H
M QLE1QP"   "  ( .$))300E       0_.$?B<BWR7@O-&(T!UAWZ__N  Y!
M9&]B90!DP     '_VP"$  0# P,# P0# P0&! ,$!@<%! 0%!P@&!@<&!@@*
M" D)"0D("@H,# P,# H,# T-# P1$1$1$104%!04%!04%!0!! 4%" <(#PH*
M#Q0.#@X4%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%/_  !$( B8#Z ,!$0 "$0$#$0'_Q "C  $! 0 # 0$! 0
M        !P8!!0@$ P() 0$!                     1   0,# @$%"0H+
M!08$ P4)  $" P0%!A$'$B$3%S<(,2*S%'2TM5970=&24W.3TY34=E&1,G+2
M%35UE18885(C-I9Q0C/C-%6!8D-4H8,DL<%D)3ACHT3$166%)D81 0$! 0
M               !$3'_V@ , P$  A$#$0 _ /?P
M        $F[3L\U-L!N!/3ROAGCM,KHY8W*Q[51S>5%:J*@'@BJCV>LNQELS
M:P;HWFCWUBIJ:H2STMSFF7Q]9$1T2Q(UJQHB=\JK)R:>[W KUC7]IK)\(I-O
M<-NV%UV2[DY=B]/=8*>ED9!)+='-5O,21*Q>;158LDC]=&)KWH1V]U[1&=_K
M:S;?8KMM)>=WIK3'>\HQYURA@HK-#)HK8YJQS.%TCD5-&HB:<3>50*%LUO!:
M=XL<J[M1T$]FO5HK9K5?[#6*UU115U.NCHW.;HCD7_==HG^Q%0"C
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MJ6U4MWC?&V3QY%3OFM>YRHC7]\F@%H
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M5$YR)QPSL:Q%5J.;KHBHO+HO(J(%N
M             3/M#V*\9-LEF]@Q^BEN-YN%LD@HJ*!.*661SFZ-:G)JH&4[
M/NRV)6+:_"JK*<%ME'GU%0QK7U-7;Z9;@RJ:]R\3Y%8KN/N+KQ:@=1N%A>6W
M+M:[99E;[-4U.*VJSU=/<KO&U%IH)9/&>%KW:\BKQ-_&!/\ ?'9.[T^]U=NE
M/MW+NEA614$%+56:@KI:"OH:^F8R-DJ<U(Q7L<UG]J)Q+KIHFH5_LQ;=W3!,
M-KJJ_8C:\+O-]JO&Y;-:9ZJJ<R!C=(4J9*B>=%F1%7BYMVGX>^UT"W@
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MO%POC56N35J*G(J:*!^?35M3ZV4'SB^\ Z:MJ?6R@^<7W@'35M3ZV4'SB^\
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M=<]L^[-=Y_2 ;P               !@K)UO9=^Z++X6N"MZ$
M           $GV_ZZMX?S\;]&. K $\V-ZL+-\K</2%0%JAA
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M:H80                                        "5YCUY[8^09'X&D
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M/D&1^!I *H!.\6ZWMP_(L?\ !U@%$
M          !+>T;U*Y9\A!YW"!4@        &$W5_95@^\ED\]C XJNN>V?=
MFN\_I -X                P5DZWLN_=%E\+7!6]"
M     "3X!UU;P?GXYZ,<!6 )YL=U86;Y6X>D*@+5#"
M        P&5[MV+&+ZN,4EKNV39## VJN%OQZD\=?10R:\TM2YSXV1K+HO-L
M5W&Y$UX=.4#08=F5@SNQQW_'9W2TCGR4]1!,QT%52U4"\,M/40O1'Q2QNY',
M<G]O*BHJAWX            2O,>O/;'R#(_ T@%4 G>+=;VX?D6/^#K *(
M                                       "6]HWJ5RSY"#SN$"I
M     ,)NK^RK!]Y+)Y[&!Q5=<]L^[-=Y_2 ;P               !@K)UO9=
M^Z++X6N"MZ$                       $GP#KJW@_/QST8X"L 3S8[JPLW
MRMP](5 6J&$                         ! ;]3Y%M_F6454^-7;(L9RJL
MBO%#=,?IVW*KAJ64L=-+25=.KXGM:U(D=3R-5S>%58NB@;;:&PY!0T^19-DE
M!^IZ_*[G^LXK*Z1LT]+31T\5-$E0]G>+.]L7.2HQ51JKPZKHH%(
M   "5YAUY[8^09'X*D J@$[Q;K>W#\BQ_P '6 40
M                     $M[1O4KEGR$'G<(%2         83=7]E6#[R63S
MV,#BJZY[9]V:[S^D W@ #\:JKI:&FEK*Z>.FI(6J^:HF>V.-C4[JN<Y41$3\
M*@?'9\AL&0Q23V"ZT=U@B<C)9:&HBJ6,<O*B.6)SD1?]H'9   &9RS<7 \#;
M"[-,EMMA\8_X#;C514[Y$UTU:U[D<J:^ZB: =C;<GQN\VAV06B[T5=8F-?(^
MYTU1%+2M9$G$]72L<K4X4Y7:KR>Z!TD>[&UDKVQQ9QC[Y'JB,8VZT2JJKW$1
M$EY0->US7M1[%1S'(BM<BZHJ+W%10.0  #!63K>R[]T67PM<%;T(
M               )/M_UU[P_GXWZ,<!6 )YL=U8V;Y6X>D*@+5#"
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MQ7):6B;=Z2V4<,*MD@=3R=XQRN[JJJ.Y%5-4>J@=AMM2[-UF.;V97LIDW_\
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M@$[Q;K>W#\BQ_P '6 40
M $M[1O4KEGR$'G<(%2         83=7]E6#[R63SV,#BJZY[9]V:[S^D W@
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MM[1O4KEGR$'G<(%2         83=7]E6#[R63SV,#BJZY[9]V:[S^D W@
M            #!63K>R[]T67PM<%;T(                       )/@'75
MO!^?CGHQP%8 GFQO5A9OE;AZ0J M4,(
M           !*\QZ\]L?(,C\#2 50"=XMUO;A^18_P"#K *(
M                             "6]HWJ5RSY"#SN$"I         ,)NK^
MRK!]Y+)Y[&!Q5=<]L^[-=Y_2 ;P               !@K)UO9=^Z++X6N"MZ
M$                       $GV_ZZMX?S\;]&. K $\V.ZL+-\K</2%0%JA
MA                                         )7F/7GMCY!D?@:0"J
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MY%[K7(B@=^   8*R=;V7?NBR^%K@K>A                       !)]O\
MKJWA_/QST8X"L 3S8WJPLWRMP](5 6J&$
M              E>8]>>V/D&1^"I *H!.\6ZW=P_(L?\'6 40
M                $+W-J6X7N?3Y_D%)4+C%58DLM-D%-3R5;;55MJW3R,F;
M Q\L4=4US&)*QJHKFHQVB*@'T;3.DRC/[[N-9Z:H@Q&LM5':6W*J@DHW7>NI
M9I)/&8XI6LE?'!&]*=LTK$XN5K.]:!I<\S*^X_N+MGC5M?$VU916W.GN[9(^
M.1T='0NGC2-VJ<*\:<OX0*.          2WM&]2N6?(0>=P@=-OI<L3O5\PW
M:;*<6I<FM^425MRN4U=,M-';+;9H4DGK(Y&(DB2ISB-9S;FKIQ(JZ 2GLQWJ
MP6')K2MGVYM6)8MNG3W.IPNYT534UEW=36*1$?#<75;I%:DD>DT:0N1B<B*F
MO<#V"      #";J_LJP?>2R>>Q@<577/;/NS7>?T@&\  >'=V9Y<D[1N6K?F
M\_\ R90VJEQ:DF1'1T\%Q@2HJ*J-J\G&^7_#X].)$;I^ #";G.6W8X_-*)_B
MN5XM+3W#'[M&G#40U3:B-K8D<W17,EUX'1KR._ !_HK033U-#2U%5%S%3+#'
M)- O_IR.:BN;_P""KH!]  #Q'9<]R+ ^U-OA/CV"77.7UJV5E1#9UC1:5(Z1
MJM67G$_W]5X=/P*%=YB^+9Y?LHW?WQRG#EV_M5VQ"KLE!8IY&/K:J6.%99*N
M=(T1$5.;1NKFIKJG=T55#HM@=YMQ<9V.Q:R6?9:^Y3;:.BG;3WBEG@2FJVNG
ME>JM:K'NTU<K--%7D"-_V&Z2CDVRR#)J:HA949)DEQN%;8J:.2*&T3*K&^)H
MV1K>5K4:[D33143W% ]/   &"LG6]EW[HLOA:X*WH0
M     2?;_KJWA_/QOT8X"L 3S8[JPLWRMP](5 6J&$
M                       E>8]>>V/D&1^!I *H!.\6ZW=P_(L?\'6 40
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MY[8^09'X&D J@$[Q;K>W#\BQ_P '6 40
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MSX#)DMF6#&4M3&5+6+51(UOCO.*[5']_Q<'*G>@;6JZY[9]V:[S^D W@
M           #!63K>R[]T67PM<%;T(                       )/@'75O
M!^?CGHQP%8 GFQW5A9OE;AZ0J M4,(
M          !*\QZ\]L?(,C\#2 50"=XMUO;A^18_X.L H@
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M!O                &"LG6[EW[HLOA:X*WH0
M2? .NK>'\['/1C@*P!/-CNK"S?*W#TA4!:H80
M                 "5YCUY[8^09'X&D J@$[Q;K>W#\BQ_P=8!1
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MSVQ\@R/P-(!5 )WBW6]N'Y%C_@ZP"B
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MZL9;DA5*5*5&]\J<+.5S^56\/N\0'K    P5DZWLN_=%E\+7!6]"
M               "3[?]=6\/Y^-^C' 5@">;&]6%F^5N'I"H"U0P@
M                                 $KS'KSVQ\@R/P-(!5 )WBW6]N'Y
M%C_@ZP"B                              (SNMUQ[)?O*]^BW 68
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MWA_/QOT8X"L 3S8WJPLWRMP](5 6J&$
M            E>8]>>V/D&1^!I *H!.\6ZWMP_(L?\'6 40
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M:UMRM26VSTSJN)LB1I.Q]:YT>KVMU<B.:Y=/<5 *F
M     2? .NK>'\_'/1C@*P!/-CNK&S?*W#TA4!:H80
M                      "5YCUY[8^09'X&D J@$[Q;K>W#\BQ_P=8!1
M                           $9W6ZX]DOWE>_1;@+,          2WM&]
M2N6?(0>=P@://-K-O]SX**FSVQ07R"VODDHHZETB-C?,B->J)&]NJJC4[H'2
M8?V?MF\ OT&3X=B-):;]3,DC@K8'3*]K)FJQZ(CY')RM73N 4H      &$W5
M_95@^\ED\]C W8                                          $GP#
MKJWA_.QOT8X"L 3S8[JPLWRMP](5 6J&$
M              E>8]>>V/D&1^!I *H!.\6ZWMP_(L?\'6 40
M                  !&=UNN/9+]Y7OT6X"S          $M[1O4KEGR$'G<
M('G3)\)JZC)KU.FWN[-2DM?5/2IHLCBBI)4=*Y>.%BS)PQN[K&^XW0*U^Q^*
M5-JW'M];+A>XUE:R"J:M?E%\CN%J;Q1*FDL+9'*KG=QGX':*!ZN"      83
M=7]E6#[R63SV,#=@                                          2?
M;_KJWA_/QOT8X"L 3S8[JQLWRMP](5 6J&$
M                E>8]>>V/D&1^!I *H!.\6ZWMP_(L?\'6 40
M                    !&=UNN/9+]Y7OT6X"S          $M[1O4KEGR$'
MG<(&([2]WD9?\#Q3(KY58UME?ENR7ZYT=6MM\8N%+2MDH*&:L;HL,<SED5>^
M3G%;P@3KLY996UN3;1V_'LBJ;Q)6854LW#LS:A:NBH(Z)Z+;:AZ(KDAJI))'
MQN15XG-[J)[H>S@      83=7]E6#[R63SV,#=@
M                     2?;_KJWA_/QOT8X"L 3S8WJPLWRMP](5 6J&$
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MMX?S\;]&. K $\V-ZL+-\K</2%0%JAA
M            )7F/7GMCY!D?@:0"J 3O%NMW</R+'_!U@%$
M                Z/,[G<;)A^07FSPI4W:W6VLJZ"G5JO22H@@?)&WA;RKJ
MY$31.Z!X*F>]E!#NFMZJJC-:.#]=T>8RU+WR>.OAUX6L<Y8$BDU\6\7;'P\V
MO-Z:A'^@&/UM=<;#:[A<Z?Q2Y5=)3U%92:.;S,\L37R1Z.Y4X7*J:+RA78@
M       );VC>I7+/D(/.X0-9FF!X5N795L.9VJGO=I21)61RZ\44\>J(^*2-
M6OC>FJIQ,<B^X!U6WVS>VNULE948/8(K;77!&LK:]\DU55RL8NJ,=/4ODDX$
MT3O4=P_V ;L      &$W4_95@^\=D\]C W8
M                 $GP#KJWA_.QOT8X"L 3S8[JQLWRMP](5 6J&$
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M0*J      #";J?LJP?>.R>>Q@;L
M         "3X!UU;P?GXYZ,<!6 )YL;U86;Y6X>D*@+5#"
M                           2O,>O/;'R#(_ T@%4 G>+=;NX?D6/^#K
M*(                              C.ZW7'LE^\KWZ+<!9@         "
M6]HWJ5RSY"#SN$#88;@^/8%;ZRUXW ^"CKZ^KNU2V21\RK5U\BRS.17JJHBN
M7D3W -$       !A-U?V58/O)9//8P-V
M              !)\ ZZMX?SL;]&. K $\V.ZL+-\K</2%0%JAA
M                                )7F/7GMCY!D?@J0"J 3O%NM[</R+
M'_!U@%$                              1G=;KCV2_>5[]%N LP
M    !+>T;U*Y9\A!YW"!(M]]W\&O><87AK=UV8UA#JJYTV95..7*.GND-?3Q
MM\4AGD9QOA@5Z2M>[AX4=HCM.10-'M+1;-0YU12X=O5>LSOZ15"08_79,VZT
MTS%C7C<ZF1J<2L:G$BZ\G= ]&       PFZG[*L'WCLGGL8&[
M                                D^W_ %U[P_GXWZ,<!6 )YL;U86;Y
M6X>D*@+5#"                                         2O,>O/;'R
M#(_ T@%4 G>+=;VX:_\ X''_  =8!1
M$9W6ZX]DOWE>_1;@+,          2WM&]2N6?(0>=P@1[<:FW8I-Q:.;%=M<
M&N.$OK;BVJN$[Z!K:]JQ(L?CTLT"R02LD7_TU=QOY%Y.4*T6V5!N+6[E6>XW
M/&<(PO'+?2UWCU/CDM%7W"X33L:R%C9&0-DB;$O$]RL<G%W':^X'I$(
M!A-U?V58/O)9//8P-V
M!)]O^NK>'\_&_1C@*P!/-C>K"S?*W#TA4!:H80
M                  "5YCUY[8^09'X&D J@$[Q;K>W#\BQ_P=8!1
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M      )7F/7GMCY!D?@:0"J 3O%NM[</R+'_  =8!1
M            $*WSN:6/<7:J^+"^I2U/R:X>+1\CY?%+)+-P(NBZ<7!IKIR
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M6HB+HW5P'U[J*J6JP:+W<CLB+]>C W8
M             $GP#KJW@_/QST8X"L 3S8WJPLWRMP](5 6J&$
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M/D]5BN.RUK:R-*B2V5M92OIZ&ZPT,O,5,MOG=JV=L3^]?W%_LTU4"I
M PFZO[*L'WDLGGL8&[
M D^W_75O#^?C?HQP%8 GFQW5A9OE;AZ0J M4,(
M       1K;+KSWL^5QOT:\"R@         $KS'KSVQ\@R/P-(!5 )WBW6]N'
MY%C_ (.L H@                             ",[K=<>R7[RO?HMP%F
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M;]&O LH         !*\QZ\]L?(,C\#2 50"=XMUO;A^18_X.L H@
M                     ",[K=<>R7[RO?HMP%F          );VC>I7+/D(
M/.X0.BWTQ3+Y,GPO<[$[*[*7XC'=Z2NQR&:.GK'0WJE;!XU1OF[SGH59^2O*
MYJJC>4"<]GG;_<>IN.VMPRS%9,0M&U]CK[2V:ODB6XW:NNB-:]$CB5592PM;
MQM61=5>O(G=T#UJ      #";J?LJP?>.R>?1@;L
M                     "3[?]=6\/Y^-^C' 5@">;'=6%F^5N'I"H"U0P@
M                           !&MLNO/>SY7&_1KP+*          2O,>O
M/;'R#(_ T@%4 G>+=;VX7D6/^#K *(
MC.ZW7)LE^\KWZ+<!9@         "7=HWJ5RSY"#SN$""[W[1;5X;N+AEUR-]
MVL>WV1U]SFR_(FW:XK E<Z-)*2DE7G7-IH9I'R*KVM3\E&HYB<H5]VV]JVFC
M[1UBEV*JY;_8Z:S7&7*Y(:^MN-JM;Y&LCHWPSRS/9S\[N<8^)SG][WR(U4U"
M/7H      ,)NK^RK!]Y+)Y[&!NP
M         )/M_P!=6\/Y^.>C' 5@">;'=6%F^5N'I"H"U0P@
M        #&[M9!=,4VQR[);)(V&[VJU5=712O:DC6311.<URM7D714[B@33'
MMIMQ[SC]IO#]Z,FC?<*.GJWQI!;U1KIXFR*B?X/<17 =ET*;B^VO)?J]O^A
M="FXOMKR;YBW_0@.A3<7VUY-\Q;_ *$!T*;B^VO)OJ]O^A ="FXOMKR7ZO;_
M *$#KJ+LZY5;;K=+[0[NY#!>+VL"W:L;!0\=0M)'S4/%K$J=XQ>%-$ ['H4W
M%]M>3?,6_P"A ="FXOMKR;ZO;_H0'0IN+[:\E^KV_P"A YZ%=Q?;7DOU>W_0
M@<="FXOMKR;YBW_0@9/.<<W'VPFQ"])NG?;Y#<,HM%GJ[=6Q4;()*:MG5LB.
M6.)'=Q/<4#TN   2O,>O/;'R#(_ T@%4 G>+=;VX?D6/^#K *(
M                    C.ZW7'LE^\KWZ+<!9@         "6]HWJ5RSY"#S
MN$"6;E;D6^BKJ';FY;\6BUWZLN=W9=9*JRVJMI8:6)$E@HJ^.>9&4_-)WC)'
MIK,[N@<[1Y32VO<>P8=:]X[3FU%>(;A4OQ_&,?M-)2-6E@1W.U55;Y56'E5.
M#5O^(J<('J0      &$W5_95@^\ED\]C W8
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MQ2(KVJC7M>UR.X%TT[O<#T,      #";J_LJP?>2R>>Q@;L
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M+'_!U@%$                       17L]4M-+0[BK+"R14SS($17-1R_\
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M<F>UK$<]W=<J-0#L@     PFZO[*L'WDLGGL8&[
M                      D^W_77O#^?C?HQP%8 GFQO5A9OE;AZ0J M4,(
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M8XH^;8B1PZJ[BU55[@'K@      &$W5_95@^\ED\]C W8
M                           $GP#KJW@_/QST8X"L 3S8WJPLWRMP](5
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MDB>B.8Y/=:H1V8     83=7]E6#[R63SV,#=@
M                   2?;_KJWA_/QOT8X"L 3S8WJPLWRMP](5 6J&$
M     $:V#_:.[7W\NW@:8"R@         $ZW]ZD\_P#W%7^ <$K28'_D;&?W
M30>;1A6A            ",]HW]CX%]^L=\X<!9@  "5YCUY[8^09'X&D J@$
M[Q;K>W#\BQ_P=8!1                       $:[.W_0;B_?W(/"1 64
M          .LR+_+]V\CJ/!. G'9BZ@L"_=C?"/!%:  2WM&]2N6?(0>=P@;
M;+,QQ;!+-+D.8W>ELMEB<V-U96R)$Q9'Z\+&Z\KG+HNC6HJJ!\V,[A85F+X8
ML9OE+<:B>AAN\5/$_AG=;ZISF15'-/1K^!SFJFO#_P#:@&E      !A-U/V5
M8/O'9//8P-V                                          !)\ ZZM
MX?SL;]&. K $\V-ZL+-\K</2%0%JAA         !&M@_VCNU]_+MX&F LH
M       !.M_>I//_ -Q5_@'!*TF!_P"1L9_=-!YM&%:$            (SVC
M?V/@7WZQ[SAP%F   )7F/7GMCY!D?@:0"J 3O%NM[</R+'_!U@%$
M               1KL[?]!N+]_<@\)$!90            ZS(_\ +UV\BJ/!
M. G'9AZ@L"_=C?"/!%:  2[M&]2N6_(0>=P@97M!8Y?W91@NX5%CM3F&/8NV
M[T]UL%!%'5UL4MTIF0T]?3TTBHV=T#FJBM_*1'<3?= G'9UQ',KA?=K[A7X=
M<<3I=M\;K[/?KO>J=:"JNM5<%:D5)#$Y><DIZ=6K*DCTX>)=$1/=#V$
M #";J_LJP?>2R>?1@;L      'DS(NV!>VY'4MPO&*2YXA23N@AJ*RKDIZZX
MI"]62R4Z-8Z.)CG(K8>>Y7:<2\*+H@>E<+R^S9[BMJS#'WODM%W@;4TW.MX)
M&ZJK7,>WET>QR.8[1535.150#O@
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MQJMC90U-.KD;K%+.L>CVJJ<3%UY.5/=T"X=+6U?KSC_\5HOI0'2UM7Z\8_\
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M((YUXU5'L:G>\2:IJ!ZH   )7F/7GMCY!D?@:0"J 3O%NM[</R+'_!U@%$
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M15X&(S\KOE7DT4/4W1/M9ZCX_P#PJB^B =$^UGJ/C_\ "J+Z(!T3[6>H^/\
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M5_#JY4:@'J@   E>8]>>V/D&1^!I *H!.\6ZW=P_(L?\'6 40
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M(;Q@SK]9J%U9<;19,=EM-T6FJX](I::JD1&2,1SF\[S;G</Y+M%4#TT$
M  PFZO[*L'WDLGGL8&[
M  D^W_75O#^?C?HQP%8 GFQO5A9OE;AZ0J M4,( 1GM4=2=Z\LL_I6E LP
M           (SO)UC[+?>.J]&S@68   G6_O4GG_ .XJ_P  X%:3 O\ (V,?
MNF@\VC T(            1GM&_L? OOUCWG#@+,   2O,>O/;'R#(_!4@%4
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MBSSPV2U17&E?=(LCLBR4*3Q>,)I6Q*O^%Q<6NBZZ:=SE"J2$
M                              2?;_KJWA_/QOT8X"L 3S8[JQLWRMP]
M(5 6J&$ (SVJ.I.]>66?TK2@68             $9WDZQ]EOO'5>C9P+,
M3G?WJ3S_ /<5?X!P*TN!?Y&QC]TT'FT8&A            ",]HW]CX%]^L=\
MX<!9@  "5YCUY[8^09'X&D J@$[Q;K=W#\BQ_P '6 40
M      !&NSM_T&XOW\R#PD0%E            #K,C_R]=O(JCP3@)QV8>H+
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M/G])C=#%FM3DMF?+?6Q:5:O?5Q1N=QZ]U6)P_P"P"S@
M                         2?;_KKWA_/QOT8X"L 3S8[JPLWRMP](5 6J
M&$ (UVJ.I.]>66?TK2@64             $9WDZQ]EOO'5^C9P+,   3K?WJ
M3S_]Q5_@' :3 _\ (V,_NF@\VC T(            1GM&_L? OOUCWAW 68
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M                                          2?;_KJWA_/QOT8X"L
M3S8WJPLWRMP](5 6J&$ (SVJ.I.]>66?TK2@68             $9WDZQ]EO
MO'5>C9P+,   3K?WJ3S_ /<5?X!P&DP/_(V,_NF@\VC T(            1G
MM&_L? OOUCOG#@+,   2O,>O/;'R#(_ T@%4 G>+=;VX?D6/^#K *(
M                 C79V_Z#<7[^Y!X2("R@           !UF1_Y>NWD51X
M)P$X[,/4%@7[L;X1X2*T% );VC>I7+/D(/.X0/KW>L>:7&VV^\8=EELQJ2PR
MOKJN+(*"&NM55P\*Q<_)(YLE/S3F\3987(Y-0)7L?O%;LDW.NN*5&&6-V7U4
M3YKUG^"/9<;)4NB3CX:JKYJ.1CU5.]:]\FKM /38      ,)NK^RK!]Y+)Y[
M&!NP         #S/O%VV-MMH\PDPEUNKLBN]%HEW=;UB9#2R.T5(N*5R<<B(
MNKD;R-[FNNJ(%SP'/,9W+Q.W9IB-7XY8[G&KX7JG!(Q[55KXI&?[KV.16N3\
M/<U3E TH                             "3X!UU;P_GXYZ,<!6 )YL=U
M86;Y6X>D*@+5#" $9[5*HFR5[<Y41J5EH557D1$2Z4NJJOX$ H72%@/K59_X
MA2_2 .D+ /6JS_Q"E^D =(6 >M5G_B%+]( Z0L ]:K/_ !"E^D =(6 >M5G_
M (A2_2 .D+ /6JS_ ,0I?I '2'@'K59_XA2_2 8;=;M([6[48N[([A=X+U/)
M)S%#:K1/#554\RHKM.]>J,:B)JY[UT3^U51%#.[+]KS:[>+Q^EYY<6O-O1)7
M4%ZFAA;+3JJ-YR&;B1CM%5$<WD<GX%3E K?2'@'K59_XA2_2 .D+ /6JS_Q"
ME^D =(> >M5G_B%+](!*=S\DQV^[D[-,L=WHKG)#D52Z9E%4PU#F-=;IT17)
M&YRHG]H%Z   )UO[U)Y_^XJ_P#@5I<$Y,'QE%Y%2U4.J+Y-&!H-4_" U3\(#
M5/P@0W*NTG;K-D=PL6.8Q79+!9IW4EVN-/-3TD254:ISL%*E0YJU#X^X_AX6
M\?>\6NN@5;$,MLF<XW;\JQZ9TUIN,:R0K*QT4K'-<K'QR1NT5DD;VN8]J]QR
M =WJGX0,=N1N19=M;)'=+G%-77"MF2CL]GHT:ZJK:IS5=P,XE1K6M:BODD>J
M-8U%5?<10R^VV^MMSJ^+BMVLU1C>22POJK=3SS15=-601:<[S-1"O"LD>NKX
MG-1W#HY-4UT"LZI^$#G5/P@-4_"!&>T;RV; U3ETSG'=?K#@+,   2O,>O/;
M'R#(_ T@%4 G>+=;VX?D6/\ @ZP"B                       /(V ;UP;
M?5NX%@I<:N.05G\Z7VKJY:1U/3P1-EEC1D;9*F1B2RJC556,_)Y-515T ]#8
MSNM@.5V.DOU!>Z:E@JVKQ4EPECHZR"5BJV2&>&5R.9(QR*UR+_M15315#M_Y
MTP[UAMGUVG_3 ?SIAWK#;/KM/^F!B\]WUQ##/$Z.VH[*K_<.)]/:K-+!*K((
ME1'SU$SGI'#&BJC45[M7NY&HO+H'Z8#OCAV;4]9'6O7&+];7M97V:\RPP2M;
M*BK'+%(CUCFB>B+H^-R\J*CD10-A_.F'>L-L^NT_Z8'RW+<7 K1;JJZW#);;
M%0T43ZBID2JBD5L<::KHQCG.<OX&M155>1$50)?9.U!CE?>*2EOF.W3'+!<9
M6P4=^N/B_,1OE72'QR..1TE,V551$=(G"U51'JT"M+FF'(NBY#;$7RVG_3 ?
MSIAWK#;/KM/^F!-<S[1>.X[?),>QNTU67UU(QDESGMDM/'14RRIQ1Q>,3R-8
M^9R=]S<>O"GY2H!H*'=;!<UP>KN]MNT%(ZII:J&2VW*2.CKZ>IC8YDD$\,CT
M5CV.Y%[J+W6JK515#J^S%U!8%K_VQOA'@BM  );VC>I7+/D(/.X0-!G>U>"[
MFRVEV=6I+S36662>BH9Y94I%EE1J*Z:%CVLET1O>I(CD3EY -+:K1:;%0Q6R
MR4%/;;; FD-'1PLIX&)_Y8XT:U/_  0#[0      83=7]E6#[R63SV,#=@
M       '^=':&[$NZF1[IWO+MO8Z6[V+(ZE]QD9/514D])43KQ2QO29R(YO$
MJN8YBKR<BIJG*'L3L\;3S[+;5VG!JVM;7W.%TU7<:B)%2'QFJ?QO9%JB*K&\
MC454U737D[@%3                              2?;_KKWA_/QOT8X"L
M 3S8[JQL_P K</2%0%JAA "+=J^)D^QF04TJ:PU%1:X)43D58Y;E3,<B+[BZ
M*H&1_H5V*_N7CZ__ ,L!_0IL7_=O'U__ )0#^A78O^[>/K__ "@']"FQ7]V\
M?7_^6 _H5V+_ +MX^O\ _* ?T*[%_P!V\?7_ /E /Z%-B_[MX^O_ /* FV]?
M8$L=7B\=5LY+.W*J.7B?07:K1T-53O31S&2*UJ1R(NCFJ[O5Y473N@9G8?L"
M7/QFX73?!5HH&L6"UVBUU;'S.D=IQ3RS1H]J-1.]:Q%U55U731-0M_\ 0IL7
M_=O'U_\ Y0#^A78O^[>/K_\ R@']"FQ?]V\?7_\ E 9RK[/NWNR^Z^U%TPMM
M<E9=;W44E4ZMJ?&&<RR@FDT:W@;HO$B<H'KH   ^"]V6UY)9ZZP7NF;66>Y0
MOI:ZE>KD;+#*WA>U5:J+RHON*!+T[+FQ*(C4Q-$1$1$1*^XHB(G<3_J0']+N
MQ7JFGU^X_:0']+NQ7JFGU^X_:0.4[+VQ2<J8HFOE]Q^T@1Z[[$[B8;<ZJR8/
MCD-_PY)I:BP3,N,-%)2P5$BR>*53:M5>[FG.=PRQJ_B9IJG$!1<2[*FVM-8X
M%SJTQ7O,*I\U9>KC3U5=3T[ZNJD=*]L,;)V(D;.+@8JM17(W5>50,=@VQ&U%
MXW8W2QNXV!9[)CTEC;9J1:VO1M.E;0NEGX52H1R\;TXEXE7^P#O,_P"R_CMO
MI:+(]H+/#1Y7:7RJ^WU-94K#<*.HCX)H$DJ))4BEY&OB?IP\2:.[U=4#H,-[
M/5]S'(*:KW:Q^.VXC9TEEI;0ZO2>KK:ZHCYI'ODH7HV.*)BNT1).)SEY4X4Y
M0J']+NQ7JFGU^X_:0./Z7=BO5-/K]Q^T@/Z7=BO5-/K]Q^T@?5;>S;LI:;E1
M7>@Q5D=PMT\=712OK*Z5(ZB!W$QZ-DJ'-56JFJ:H!50  "5YCUY[8^09'X&D
M J@$[Q;K>W#\BQ_P=8!1                       'ABTXCN+>[WG5;C>-
M_K^RLRV^PT\M-64U)/%4)4(]\4[*IS$T57:MDC54TY')KW0W=D[$V%7ZC=?]
MRYJW^=KM*^MNT-IJT910/DT1L,2OB5S^;8C6J]?RG:KHB =C_0CL?\9>_KS/
MH 8Y_H2V/^,O?UYGT &=OG95FVRK4NVSU%47ZW72-E+?[375L3*YBP.<^&II
MI96QQN:G$YDD3E:O<<U5Y4 _2P=DR#<::7(=XJ6ILTD$245BLMOK8G3QT_&Z
M22:JE8V2-7R.5.".->\:G*JN7D#O?Z$=C_C+W]>9] #'QW7L([5-M\\F-5MT
MI,AA1)K54UE2VHIF5<+DDB66-L35<SB:G$B+KIW ,NNQ^Z^:JN)Y%CC,?M-S
M5:?(KVMPIJJ&.D5R.E\39$JRR/E1.&/G&,1FNK^YHH;7^A+8_P",O?UYGT ,
M/Z$=C_C+W]>9] #&4NG9WRS;2LFLNW-DFR;!JE[ZVA7QVFAN%)52M:DT,_C"
MQ,D8]S>..1G*W56N3D15#ZZ;L:XM=['<\UW/DJVYU<&2W&LH;36(E%2I%"C8
M:='NB59',8QJ22<B.=KPIPZ 6+LR.<_83 W.[JVQNOSCP*P  EO:-ZE<L^0@
M\[A T6XNY^&[66B&\9A6N@963)2VZBIXGU5;5U+N5(J>")'/>[\.B:)[JH!B
M<,W.PK=W.;=)8[Y?;#D6+4]7-78-<H);4M93US61-GJ::9FLS87)K&YCN\<[
ME[J 68      &$W5_95@^\ED\^C W8
M            $GV_ZZMX?S\;]&. K $\V.ZL+-\K</2%0%JAA ",]JCJ3O7E
MEG]*TH%F             !&=Y.L?9;[QU7HV<"S           ",[9=>>]GR
MN-^C7@68          E>8]>>V/D&1^!I *H!.\6ZWMP_(L?\'6 40
M               !&NSM_P!!N+]_<@\)$!90            ZS(_\O7;R*H\
M$X"<=F'J"P+]V-\(\$5H !+>T;U*Y9\A!YW"!U6\V+9PW,<%W6P2SPY3<,+6
MY05N+S5#*.6HI+M"R-\U)-+_ (;9XN;31'?E-56@=3BUNW(W)W<Q_<K,,-3
M+)AU!<:.@I:JKIZVZ7.HNK8V/YQ:95:RGA:SB:URZ\:Z^[R!?0      83=7
M]E6#[R63SV,#=@                                          2?;_
M *ZMX?S\;]&. K $\V.ZL+-\K</2%0%JAA ",]JGJ3O7EEG]*TH%F
M      !&-Y.L?9;[QU?HV<"S@          "-;9=>>]GRN-^C7@64
M   E>8]>>V/D&1^"I *H!.\6ZWMP_(L?\'6 40
M!&NSM_T&XOW]R#PD0%E            #K,C_ ,O7;R*H\$X"<=F'J"P+]V-\
M(\$5H !+>T;U*Y9\A!YW"!,^U?/BU/DNVCMS)ZZHVKDJ+FV]V.V+5I)-5M@C
M6EJ)6T>DCXH5XD<U'(J<?(CN5 /EV4D[)#]QJ!-IZ.MASA(*KQ*2HBOK(^9Y
MI>>Y:[_!_(U_*Y?P<H'J@      &$W4_95@^\=D\]C W8
M                           $GV_ZZMX?S\;]&. K $\V.ZL+-\K</2%0
M%JAA ",]JGJ3O7EEG]*TH%F             !&=Y.L?9;[QU7HV<"S
M     ",[9=>>]GRN-^C7@68          E>8]>>V/D&1^!I *H!.\6ZW=P_(
ML?\ !U@%$                       1KL[?]!N+]_<@\)$!90
M   ZS(_\O7;R*H\$X"<=F'J"P+]V-\(\)%:"@$M[1O4KEGR$'G<(%2
M   83=7]E6#[R63SV,#=@
M   2? .NK>'\_'/1C@*P!/-CNK"S?*W#TA4!:H80 C/:HZD[UY99_2M*!9@
M            1C>3K'V6^\=5Z-G LX           C6V77GO9\KC?HUX%E
M        )7F/7GMCY!D?@:0"J 3O%NM[</R+'_!U@%$
M      1KL[?]!N+]_<@\)$!90            ZS(_P#+UV\BJ/!. G'9AZ@L
M"_=C?"/!%:  2WM&]2N6?(0>=P@5(        !A-U?V58/O)9//8P-V
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MH%(  =9D?^7KMY%4>"<!..S#U!8%^[&^$>$BM!0"7=HWJ5RSY"#SN$"H@
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M:7>S'<EN&.7"PV3&ZAU;<J^Z4\U$U6)&YG,Q\XUJO?)Q</"WN)JKN0#_ %2
M 33+\OO]IWAVWQ&@J&1V'(H;X^[T[HFO?(Z@I62P<,B\K.%SE5>'N@4L
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M]=6\/Y^-^C' 5@">;&]6%F^5N'I"H"U0P@
M              $KS'KSVQ\@R/P-(!5 )WBW6[N'Y%C_ (.L H@  !&ZWM,;
M>4URK[=1T5_N[;=4RT4]=:K-65E&ZHIW<$K631L5KN!VK':>Z@'X_P!3F#^K
M^6_Z>K_T ']3N$>K^6_Z>K_T .?ZG,(]7\M_T]7_ * '']3N$>K^6_Z>K_T
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M         83=7]E6#[R63SV,#=@
M         2? .NK>#\_'/1C@*P!/-CNK"S?*W#TA4!:H80
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MK]MYE^7.RRWTE@H[Q3U$EOIK<^.>HJI(7-1*?\I.%GNJ!;0
M         $GV_P"NK>'\_&_1C@*P!/-C>K"S?*W#TA4!:H80
M                            "5YCUY[8^09'X*D J@$[Q;K>W#\BQ_P=
M8!1   #PW@^TN^&:1Y)>]O\ <Z7%<>=DEZA99F/J&M9-%6R)(_\ P^][]>^
MU7]//:E]N-1\[6>^ _IX[4OMQJ/G:SWP']//:E]N,Z?_ #:P!_3QVI?;C4?.
MU@#^GGM2^W&H^=K ']//:E]N-1\[6 /Z>>U+[<:CYVL ?T\=J7VXU'SM8 _I
MY[4OMQG^<K/? ?T\=J7VXU'SM8 _IX[4OMQG^=K .IRC83M+V_&;U7W/>F>K
MMM+054]92+)5N26&.%[GQZ+R=\U%;R@>E=DU:[9[ G,;PM6P6Q6M_ BTL?(!
MNP         ",[K=<>R7[RO?HMP%F          )=VC>I7+/D(/.X0*B
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M%1471>Z!U%VW$P&PWF+';WE%JMU^FX.:ME76P05+N=_(TC>]'=]_N\G*!I0
M'PWF]6?';;47F_U]/:[32HCJFNK)64\$:*J-3B?(J-3551$Y>Z!\N.97C&84
M+KGBEXH[U;V2+"^IM\\=3&V5NBJQRQN=HY$5%T7E ^;)<[PG#74[,MR*VV-]
M7KXJRY5<-*Z5&_E*Q)7-543W50#O:>H@JX(JJEE9/33L;+#-$Y'QOC>G$US7
M-U145%U14 ST6X>!3Y$[$8<GM4F4L>Z)UF;6P+6I(Q-7,YE'\?$B=UNFH&E
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MP#2    "3X!UU;P_GXYZ,<!6 )YL=U86;Y6X>D*@+5#"
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M   C&_>VFX^;U.)7_:V^TEARC&*BM>RIK$=HL-P@2"3@5(Y4141.XK.5%[J
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M>^545K7*USDY.0(9@UVV[BW-;D5_\1FMM):THZ6^N@2>V4=VJ*GBB;4U#&K
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M*KWK_P#3P\BLY.ZH5:P  "3X!UU;P?GXYZ,<!6 )YL;U86;Y6X>D*@+5#"
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MEUYRE9$QL+N+N\3$3A77_8!^]-2TU% REHX8Z>FC32.&%J1QM15UY&M1$3E
M_.JMUOKGPR5M)#4R4[N.G?-&V18W\B\3%<B\*\B<J ?2!\\=!0Q54E=%2Q,K
MIDX9JEL;4E>U-.1ST354Y$[J@?NJ(J*BIJB]U /CAL]IIZ22WP4%-%02JKI:
M5D+&PN5=-5<Q$X5UT3NH!S):;5+1LM\M#3OH(]%CI71,="W3N:,5.%--?P ?
M6UK6-1C$1K&HB-:B:(B)W$1 /GDMUOEK([C+20ON$+>"&K=&U9F-Y>1KU3B1
M.^7N+[H'T@?/2V^@H72NHJ6&F=.[CG6&-L:O=^%W"B:KR]U0/H    $GV_ZZ
MMX?S\;]&. K $\V.ZL+-\K</2%0%JAA
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M\A!YW"!4@        &$W5_95@^\ED\]C W8
M                 $GP#KJWA_/QST8X"L 3S8[EVPLWRMP](5 6J&$
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MR.19+;)['D6YM]N%EK.!M;1.I[=&DK&/;)P\3*=')JK4[B@6,
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M=[97-N=MH[DR*2!E9!%4-AF3AE8DS$?PO3W')KHJ ?6
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MUF<V*NJKE!317.T7*JLU;+;I73T%1-1JU%FIGN1'+$Y')IQ<J+JGN ;<
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M#*]U0KH>*)O$[@AYE$<SD7W'!7=U3=F'[7;A-VM?0,JULU6ER>SGO&TCYEW
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-JON@48       #__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>lc_pioneerscore-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_pioneerscore-bw.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !&
M  #_X002:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 W+C(M8S P," W.2YD964S83<W,#,L(#(P,C(O,#@O
M,3@M,38Z-3 Z,S @(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T
M<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<$U-/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=%)E9CTB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@
M>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;6QN
M<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B('AM<$U-
M.D]R:6=I;F%L1&]C=6UE;G1)1#TB=75I9#HV-44V,SDP-C@V0T8Q,41"039%
M,D0X.#=#14%#0C0P-R(@>&UP34TZ1&]C=6UE;G1)1#TB>&UP+F1I9#HT,4$P
M1#@R,SE!-$$Q,45&.30Q1D$X-T)&,T)#,4-#-2(@>&UP34TZ26YS=&%N8V5)
M1#TB>&UP+FEI9#HT,4$P1#@R,CE!-$$Q,45&.30Q1D$X-T)&,T)#,4-#-2(@
M>&UP.D-R96%T;W)4;V]L/2)!9&]B92!);&QU<W1R871O<B R-RXS("A-86-I
M;G1O<V@I(CX@/'AM<$U-.D1E<FEV961&<F]M('-T4F5F.FEN<W1A;F-E240]
M(GAM<"YI:60Z-60Q93@S8C0M834R-RTT-V%E+3DS.#,M,S)A868U-C$U9C0W
M(B!S=%)E9CID;V-U;65N=$E$/2)A9&]B93ID;V-I9#IP:&]T;W-H;W Z.30T
M-&(Q,&,M,C%B82UF-S0U+3AF-C$M9F,W,69B93<S-F0T(B\^(#QD8SIT:71L
M93X@/')D9CI!;'0^(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^1FEG
M=7)E(#$W/"]R9&8Z;&D^(#PO<F1F.D%L=#X@/"]D8SIT:71L93X@/"]R9&8Z
M1&5S8W)I<'1I;VX^(#PO<F1F.E)$1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME
M="!E;F0](G(B/S[_[0!(4&AO=&]S:&]P(#,N,  X0DE-! 0       \< 5H
M QLE1QP"   "  ( .$))300E       0_.$?B<BWR7@O-&(T!UAWZ__N  Y!
M9&]B90!DP     '_VP"$  0# P,# P0# P0&! ,$!@<%! 0%!P@&!@<&!@@*
M" D)"0D("@H,# P,# H,# T-# P1$1$1$104%!04%!04%!0!! 4%" <(#PH*
M#Q0.#@X4%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%/_  !$( @0#Z ,!$0 "$0$#$0'_Q ";  $!  (# 0$
M        !@4' P0( 0(! 0$                    !$   !@$" P$'# X)
M P(%!0$  0(#! 4&$0<A$A,Q02(4M!46-E$RTM/4=956=A<W5V%"<B,S<[.4
M-56UEJ8(<9'14I)3DU1T@20TH6*Q@D,E&,&B@\,F)Q$! 0$
M      $1_]H # ,!  (1 Q$ /P#W\      ,;:W]11O5D>UE%&>N)::ZM2:5
MJZTM;:W4MERD>AFEM9ZJT+AV@,D
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M3U<=?>AM+<<49:<5*,S,!6
M                        #6F['Z8VR^5T?]GS@&RP
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MA,$9J)MB,@FVTZF9F>B4D7$!W0
M                           !K3=C],;9?*Z/^SYP#98
M
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M#CO\A]!#:3(E.*T/0!N4
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M=O\ T#Q;WHK_ !9L%48
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M_P G+;Q)T$K*[?\ H'BWO17^+-@JC
M                           $9E_I9@__ #Y7B3H"S
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MPPYJK!5-$1&5,4GD):B,U'R(U/E;29\K:-3Y4$1=P!5
M    )/!_PN4>_LO\DR K                                     $/O
M/]#^?_)RV\2=!*RNW_H'BWO17^+-@JC
M                             $7E_I9@_P#SY7B3H"T
M             &M-V/TQME\KH_[/G -E@
M         )/!_P +E/O[+_),@*P
M   !#[S_ $09_P#)RW\2= K*[?\ H'BWO17^+-@*,
M                                       1>7^EF#?\^5XDZ M
M                     !K3=C],[9?*Z/\ L^< V6
M                   D\'_"Y1[^R_R3("L
M            0^\_T/Y_\G+?Q)T"LKM_Z!XM[T5_BS8"C
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M#LN(<:0VA*$UTPS,GEMI:5ISIX)69@-U
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MBYC]5?#NZ 5L[ 4FG!<82K@I-3 (R[>)1FP%$
M                                   (O+_2S!_^?*\2= 6@
M              U-7?R^XG4S5RZRXNXK49FR:QR&W-24>C7=<WA+U<DVC-#F
MBU$V;AN$@C,DD0#L1=CZJ+FTO/"RG(GK>P4T4]EZ7'7'>BLEHF&9'&YTQM3-
M1M-N)(U'S=O$!W<2V<H<3OHU^5O<W3]9'>A8_&NIRIS%7%DJ2;C<;F22]3)*
M6^=U:U\B23S::ZAP;L&?EC;,NX>71M2_HKYP#98
M               "3P?\+E/O[+_),@*P
M   &@+C^7O)II7^%UN8-P]F\KM';JZHS@\]JV<M\I,N'%F$ZE"([[A&>JF34
M@E&DM0&?W"VZW:S''KK&JG.HM'7V5DE494>O4AYJB)@D*@=5I]M9*6YJ:GD*
M)7+P+34%<%+M1N-#P5S#O/*%CKM8]#?Q"3BE:NOCP2AFI2F9,=V2Z4IETS^^
M-K47/QYC,SU!&8P+;C*J[,9^Y&XU_%O,REUK=%#:JH:J^NA5K3YR%(0AQUY;
MCCKADM:UJX:<I%H0#+[S&9;09^9<#\W+?Q)T"LKM_P"@>+>]%?XLV HP
M                                                     !%Y?Z68
M-_SY7B3H"T                          &M-V/TSME\KH_P"SYP#98
M                                 "3P?\+E'O[+_),@*P
M                          !#[S_0_G_R<M_$G0&5V_\ 0/%O>BO\6; 4
M8                                                          B
M\O\ 2S!O^?*\2= 6@                          UINQ^F-LOE='_ &?.
M ;+                                     2>#_ (7*??V7^29 9YJY
MJ'[%VH9GQW+5A/.]!0\A4A"3TXJ;(^8BXEVD [P
M              (?>?Z'\_\ DY;>).@E97;_ - \6]Z*_P 6;!5&
M       "<RG/,2POP<LELVX+DO7P=HTK=<42=.97(VE2N4M>)Z: ,U76,&W@
MQ[.LD(E0)2"=CR&C)2%H5V&1D [(
M       (S+_2S!_^?*\2= 68                          UINQ^F-LOE
M='_9\X!LL                                    !)X/^%RGW]E_DF0
M$-CVQ\BDW->S=5P3M<4B3,CL$A12UN2R42D.N:Z&A/.?9Z[0M= &Y0
M                             0^\_P!#^?\ R<MO$G02LKM_Z!XM[T5_
MBS8*HP               :5WFVCO\VN8.08Z^PM]N.4*3#E+4T1)2XI:7$+(
ME?WCYDZ>H9 -@[=8DY@^(5^./R2ER8Q+7(>3J3?5>6IQ1-D?$D$:M"_K 5(
M                                      (O+_2S!_\ GRO$G0%H
M                      -:;L?IG;+Y71_V?. ;+
M                  2>#_A<I]_9?Y)D!6
M           (?>?Z'\_^3EMXDZ"5E=O_ $#Q;WHK_%FP51@
M                                            ",R_TLP?_GRO$G0%
MF                          -:;L?IG;+Y71_V?. ;+
M                       2>#_A<I]_9?Y)D!6
M                (?>?Z'\_^3EOXDZ!65V_] \6]Z*_Q9L!1@
M                                               ",R_TLP?_ )\K
MQ)T!9@                         #6F['Z8VR^5T?]GS@&RP
M                           $G@_X7*??V7^29 5@
M                    "'WG^A_/_DY;^).@5E=O_0/%O>BO\6; 48
M                                                    B\O]+,&_
MY\KQ)T!:                          #6F['Z9VR^5T?]GS@&RP
M                          '#+5(1%?7#0EV6EM9QVUGRI4X23Y2,^X1F
M TQLME&Z-YD%S&S5A_R8RV:E+DQ2BE'G$M)=!H^5/,GEU,R[[30CUX\0W: D
M\'_"Y3[^R_R3(#(9AE$'#,<G9)8MN.QH24GT62(W'%N*)"$%KH1:J41:GV ,
M/MON+ W&JI,^+$=@2H3W@\N(ZI+G*I226DTK3H2B4D_4(!:
M                     "'WG^A_/_DY;^).@5E=O_0/%O>BO\6; 48
M                                                   ">SN5>PL/
MNI>,MF[?,Q7%PD)3SJYR+B:4GZY1%J:2[I@/-&S]]DEMN'2LV=C-L(!2'WG/
M#'''4IDG&<+F(W/6K,M2-)=SN /7 #4V[N[\O;Z;!IJBO:F6LMDY;CDI2DL-
ML$LVR(B1WRE*41]TM"+NZ@*_;O-&L]Q>-D"(YQ'EK<8E1C/G)#[)\JB2K0M4
MGVD>@"J                      &M-V/TQME\KH_[/G -E@
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M($627WY#GDZ9H@X1,)-LC,U=]U5::?9 ;M
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M<E\/7:Z@._68UCM)+FSZ:HA5TZS7U;*5#C-1W9+FJE<SRVTI-Q6JE'JHS[3
M1&['Z9VR^5T?]GS@&RP                                &/L[VDI3C
ME<6,: <I?2C%)=0SU%^HGG,M>T!D  !!TEU7XY6YK>6KAM5\"XF/R%D1J/E2
MTSP(B[3,^!$ [6W^Y-#N+&F/4[;\=^ M*)464@D.))W4VU$:5*29*))]W@9:
M ,+E.RF.97F+.73I4EM9FRJ=!;-/2D*BD1-=\9<R."2)7+VD7<[0&S
M                       &L[/8+:^WRIS+IU2ZJ9)EM6<^N1+DMU4NQC\O
M3E2(*7"8<=3RD?,I'?&6JM3 ?<DV&VZRYN>S?QILMFQMTY$^WY1F(0FQ;9)A
M"T$ATB2E*2U2CUI*XZ=@*Y6-C]OTX_=XO81YUQ2Y IERQ8M[*;/5U(Q\S:VG
M'WE+96E7?$II23YB(^T@1E,"VOQ';A-@O'6)#EC;K;<MK:QE/V%A*-A)H:)V
M1(6M9I;29I0DCY4^IJ9@.'>CZ'\_^3EMXDZ"5E=O_0/%O>BO\6;!5&
M           U;NUM&YN&_ M*V>B#;P6U1S)]"EL.L+5SZ'RF2DJ2>ID9=NH"
MGV[PF/@&,LT#,@Y;W4<DRY)IY"6^\9<QI3J?*DB(B(M>X JP
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MT*[:+ YV 8NNMLY"'[&9)7-DI9,S9:4M*4$A!JT,]"27,K0M3 7P
M              UINQ^F-LOE='_9\X!LL
M         !)X/^%RCW]E_DF0%8  -67^Q]+?YXWFKUC(:;4ZQ)F5B4I-+K\7
MEY#)W7F0D^1/,G0_L&6H#:8                                "'WG^
MA_/_ ).6WB3H)65V_P#0/%O>BO\ %FP51@             #&9%21LDHK&@F
M*4B-8L.1G'$>N23B=.8OLD?$!J3;78F=AV5-Y'<6S,PH"745[,9M:#6IY)MF
MMTUGPT29]ZG7B?;P ;N
M1F7^EF#_ //E>).@+,                          :TW8_3&V7RNC_L^<
M V6                                     D\'_  N4^_LO\DR K
M                                  $/O1]#^?\ R<M_$G02LKM_Z!XM
M[T5_BS8*HP
M       !&9?Z68/_ ,^5XDZ LP                         !K3=C],;9
M?*Z/^SYP#98                               )S-\TJ<"HEWMNEUQGJ
M(CL,,))3CK[FII06ID1<",S,SX$0#]87F-3G5"U?TY.(86M;+S#R22ZT\V>B
MD*T,RX:D>I'Q(!K?>U&[*K:G\PCF^2^FHEE6FE*O#>?@<C7_ .ERZ>N[WMU
M;?K?#BKHA69I.RZ+?AAM^LZ_(74Y?L<VN@"=P?\ "Y3[^R_R3("L
M                   !U+.TK:6OD6MQ,8KZN(@W94V4XAAAIM/:I;BS)*2+
MU3,!C<;S/$LQCE)Q:[A7#/2;D&<)]#RB9>-26W#2DS,DK-"R29EH?*>G8 SH
M      A]Y_H?S_Y.6WB3H)65V_\ 0/%O>BO\6;!5&
M                                      P^5*N48U;+QU/->IB/'7I[
M3-_D/DT(^&NO9KW0'D;!LJM\=RN/D&2NV3]=7KD/3VY766I<Q3#B$IT>,B)U
M2CY>YH6O< >@MM-YJ_<*RDTSE:Y563+1R6$*=2^VZTE1)5HHDIT4G4M2T^R
MV>                         UINQ^F=LOE='_ &?. ;+
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M ).6_B3H%97;_P! \6]Z*_Q9L!1@
M                         #7>YM+7Y)98IC]JA3E=82Y;3Z4*-"BTAN&E
M:5%V*2HB4DP'ZV]VAH-O9DJSBR7["TD(Z"9,GD+IL<Q*Y4)01%J9D7,KM/3N
M -A                  #SIE/\ ,/D]+D^2IA554K%<87*8?C3)#K%O(<JW
MZYN2I!?@D=9-@7@:#(S=-!\2YB(!Z*(]2(^S7N& ^@   UINQ^F-LOE='_9\
MX!LL                                    !)X/^%RCW]E_DF0%8
M                        #3_\R=;2S=O&)USDR\2.DMH%K6V\:$FRGE8Q
MUJ*,U#8,R-3[BUDE/*1GIJ1ERFH!+[)9GEN0YK(I\JSJZ<LH<)<M>%9/BD3&
MYK\9Q24(F,N-*4;C:%]ZKD4>BCT41< 'H@      0^\_T/Y_\G+?Q)T"LKM_
MZ!XM[T5_BS8+5&"
M          ^$9'J1'J9<#^P?: ^@(O+_ $LP;_GRO$G0%H
M     #R5EEE$I-\)B[^+@EWDR;%AS&[&Z=DLVE='DI03,:2_'KW(R'.8E*BE
M(=)S12=#]:8#UJ     UINQ^F=LOE='_ &?. ;+
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M_P! \6]Z*_Q9L!1@
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M0E??$E9%S$1__ !6  "3P?\ "Y1[^R_R3("L
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M "<MO$G02LKM_P"@>+>]%?XLV"J,
M                      :QWUQG(\HPU$/'$*DK8E-R)E>V9$N0PA*BT+4R
MYC2HR5R?;:>KH P6P.,Y3B5/<RLE9<K*Z6XTJ#72E$A25H)25N&@ST;YS-*=
M.'-IJ?< :_QS>O<.;G\)F4\3T6?/3"=H"90E+;:W.0TH/3G);9=\:E*[G'@
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M WB                   #XI*5I-"TDI"BT4DRU(R/N&0#[V<"   !)X/\
MA<I]_9?Y)D!E<GR:HQ"ED7UX\;,"-H1\J36XM:SY4H0DN)J49Z$0#K8=F=%G
M-1Y9H7%JCI<4P\T\@VGFG4:&:5I/70]#(^!F6A@*
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MD^%.*)Q/5+AJ1=[W *V=@)D>"8N:2Y4G4P-$ZZZ%X,WPU 40
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MJW$*-,9$=2TN:RUH-M"TK3J:M &^BUT+4M#[I /H   -:;L?IC;+Y71_V?.
M;+              $CG^XM'MW!BS+A#\AV:X;42+%22G%F@N99]\:4D22,M=
M3[I ,WCM_6Y120L@J%J<KI[9.LFM/(LBU-)I4D^Q23(TG]D!DP
M         2>#_A<I]_9?Y)D!D\IQ>HS&DD4%VVIR#(Y3,VU<CB%H/F2M"B[%
M),N #KX9A5'@E/Y%HD.>#J<4^\\^OJ/.NKT(U+5H1=A$1$1$6A *$
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MQ/M 2.\_T/Y_\G+?Q)T"LKM_Z!XM[T5_BS8"C
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M:'RK3Q+F+@9=A@,M45-=15L6GJ(Z8M;#034:.C7E2@OLGJ9^J9GQ,!W0
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MNW_H'BWO17^+-@JC
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M6$B)$?\ !TH4ZM!$HWC0HS0GUO#N@/4@      A]Y_H?S_Y.6WB3H)65V_\
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M[  ^<NH_5=U\&2?8@'SEU'ZKNO@R3[  ^<NH_5=U\&2?8@'SE5'ZKN?@R3[
M ^<JH_5=S\&2?8@'SEU'ZKNO@R3[$!^'=T:".DG)4*UC,\R$&\_72&VTFXHD
M)YE*21%J9D M@   >+(F59-8[C,R\HO,-R:\8LU5U,_,*^1C=;*ZAI5%@J3"
M\"\+^UZKKJW%+(DDM)]Z"O:8(    UINQ^F-LOE='_9\X!LL
M              2F0>F>'_=V/BH"K   !!;L[A2-NL>8LX<),R;,D)BL=8U(
MCMF:5+-3AIX]B=$I+34P&6V]RU6<8E7Y(N(<)V42TN,:FI'.TLVU*;49%S(,
MTZI,!3@   Q>18]4Y53R:*[CE)KI1$3B-32HC29*2I*DZ&E23+4C(!U<1PZB
MPBI\CT#"FHREJ>><<6;CKKJM"-:UGVGH1$ SP    "3W)]#IOXZ%XXR K
M               !H7?G [6[M&\M.DVZDX[55Q(G7&?,RCD1S2ZM9D3S6C:&
M")1'WQZ\QF COY;:N\M<N=RV+MWAU'A349YB%F-'6S*N78K=Y3_[)N89.JC'
M]LZXV@E_::@/58      A]Y_H?S_ .3EOXDZ!65V_P#0/%O>BO\ %FP%&
M                                       (U'TKO?)YKQUP!9
M    #%Y'C];E5'-Q^W0I==/;Z;Q-JY%EH9*2I*NXI*B)1?9(! 8KM?0;31KG
M+&7I-O91X;ZTJ>Y$&F.TGJFVA*"TYE&@B-1_^@"&VXWURW(<T@5%VQ&=K;E9
MMLM16U(7&5R*<2:5&H^=.A:*YOZ?L /1@               (W=7T%L?QL+Q
MU@!9    \<O9M$F;?,;!NV.'LT:&X]4><LWT(XIP6'T*2^FM_P#)\.4E)$:#
MT1X0?4ZG* ]BD6A$7;IW3[0'T   &M-V/TQME\KH_P"SYP#98
M               E,@],\/\ N['Q4!5@   ZT^N@6L5<&SBM3(;FG4CR&TNM
MJT/4M4K(RX& Y6([$5EN-%:0S':22&F6TDA"$I+0B2DM"(B]0@'(
M   "3W*]#IOXZ%XXR K                  !YC_F?QVJMLEQ5^=D]^[;$E
M2J#;W'ZR+>^%28JE+<GKA2_O)])*TEU)'>(T+EXZ@,CL9<Y!<9E-A9%GV4O7
ME9$-^9@67TU?4RCC2%$AN:VJ(@R=:)9&CG:<,B5P5IJ6H>BP     !#[S_0_
MG_R<MO$G02LKM_Z!XM[T5_BS8*HP
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MQT/N15:GR&KU-2(^4^U.O<,!G0                $ID'IGA_W=CXJ JP
M               !)[E>AL[\="\<9 5@                  TEGTFSVZW>
MB;KR*"??X?88^6-63]+&7/GU;S$Q<Q#RX[>KBH[I+-+BFDJ-*D)-1:: .#';
M2=NUN[09]3T%E285A]991$7-S$<K9%M+MS823+$=XDNG'92QU#<61$;AD22X
M&8#>@      A]Y_H?S_Y.6_B3H%97;_T#Q;WHK_%FP%&
M                          (U'TKN_)YKQYP!9            'V /+-'
MOMGTW.8C<@VG:N;8)A*HD,))2&W'3:Y4+T)SJ(UYC,S[G$M 'J8
M      $;NIZ"V/XV%XZP L@         !K3=C],;9?*Z/^SYP#98      X)
M4.)/9./.CMR8YF1FT\A+B#-)ZD?*HC+@ YR(B(B(M"+L(
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M'\_^3EMXDZ"5E=O_ $#Q;WHK_%FP51@
M            "-1]*[OR>:\>< 60           /,.[>[6>4>>3JNJG>28%3
MTSC1NFVHI!+;)9NN\Y&:TJ,^4DEIIIZH#>F-4-#-17YJ_0Q(64V,5J1+?2RE
M+R'7VR4LN8RU(]3,C/UWJ@*H               $;NKZ"V/XV%XZP L@
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M "<MO$G02LKM_P"@>+>]%?XLV"J,
M          1J/I7>^3S7CK@"R           !CI^/T5K*CS;.LBS)D7_ ,:1
M(9;=<;TX]ZI1&9<3U_I 9$                !&[J^@MC^-A>.L +(
M :YS[=ZOP:S<J&Z2ROYD&M7D%Z58EDRKZ9M:FU27#><;YU&I*N1EOF6HDJ/3
MAQ#)6FYE'66&(,="1*J,S)U5;>L$@X39-0USTF\:UI6E*V6UK2HD&7#CH Q6
M#;QUV:VT2K716E$BZ@N7&+3+1MIMJUK65-H6ZUTW%J0HNJA?2=)*^FI*]-#X
M!^=V"/ROMF?<++HVI_TU\X!LL                          2F0>F>'_=
MV/BH"K           !JT][Z4MP_,+R=(T\+*M\J<R>3PPR]9TO7<O-WO/K_T
MTX@-I     )/<GT.F_CH7CC("L                      $!N=N!9X<>/T
M6+U+=YF^6S5UU%72'_!(J2887)D29#I)6:66&T&I1(2:E&9)3V@./;+<*WRV
M9DN+9;4-4F=8A)8C7,.(^<N$ZS.8*1%DQWE(0HVW4:]ZI/,@TF1@(:-_,)?-
MXOD$BTQ1KSYK<N1@510Q)W4C3K60AEQDSE+:23;9)=-3BC0?*2# 6.WVX>3V
MN57&W>X=+%I<UJ8<:W8562ES*^?63''&2>84XVVXA33K:FG$.)[=#(S(^ 9/
M><C/:#/R+B?FY;^).@E97;_T#Q;WHK_%FP51@
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M)(#AW'P/$JC</ LWKZU+.56>5,,SK$G7E*<;573",N12S;+4D)[$=P!NX
M                       2F0>F6'_=V/BH"K    ^QW0       3_F-B)Y
M)YW>2(_G'I_Y_*?/KR\O-IKR\VG#FTYOL@*     !)[E>AL[\="\<9 5@
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M:T250X;JF3Z33Z6CY3]5''NZ@5L[ 5&K!<84H]5'4P#,_LG&; 40
M                                  C4?2N[\GFO'G %D
M   ('*]G,(S*Z3?7$=XIQDA,KP=Y3*)*6RT23I%VZ%WNJ=#T[H"M9L**#(8Q
M]F7%8F-MI1'K"=;2\32$]Z26M>;0DEPX=@#(@            (W=7T%L?QL+
MQU@!9          #6F['Z9VR^5T?]GS@&RP
M!*9!Z9X?]W8^*@*L   &C<_VSW"R#<^!DM+8DU3MG%-F2<A3:H"6-#=2EK[;
MJ&1GP[>;17 !O(    !IG"][IV5;C/X<]3HC0%+E-1G4K4<II4/74WTF6A$K
ME[FFAF1<0&Y@     !)[D^ATW\="\<9 5@
M (?>?Z'\_P#DY;>).@E97;_T#Q;WHK_%FP51@
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M><+AP6LB)2NSNF [@      D]R?0Z;^.A>.,@*P
M      $/O/\ 0_G_ ,G+;Q)T$K*[?^@>+>]%?XLV"J,
M                         1J/I7>^3S7CK@"R           !\4E*DFE1
M$I*BT,CXD9'W# 3M%@6&XU8/VE#2QH-A)U)U]I.BB2H]32C4S)"3/M)&A /-
M68[=[FS=RK"3%KI<B9*L/"*V\;UZ#;/.1M*ZVOWLFDD1&C7N:$1Z@/6K1.):
M0EU1+=))$M9%H1J(N)Z=S4P'[             1NZOH+8_C87CK "R
M    &M-V/TQME\KH_P"SYP#98           )/ _P&0>_P!9?E@%8
M      E,@],\/^[L?%0%6                  )/<GT.F_CH7CC("L
M                      !#[S_0_G_R<MO$G02LKM_Z!XM[T5_BS8*HP
M                                      !&H^E=[Y/->/. +(
M                        1NZOH+9?C87CK "R          &M-V/TSME\
MKH_[/G -E@           D\#_ 9![^V7Y8!6             )3(/3/#_N['
MQ4!5@    .A97E+3''*WL(T Y:^E&*2ZAGJ+_NIYS+4^/< =\
M$GN3Z'3?QT+QQD!6                            A]Y_H?S_ .3EOXDZ
M!65V_P#0/%O>BO\ %FP%&
M   (U'TKO?)YKQUP!9             )S)L]Q##G([.2VS->]*(U,-+YEK4E
M)Z&KE;2HR3K]L? !GHLJ/-C-3(;J'XKZ$NL/MJ):%H66J5)47 R,@'*
M         (W=7T%L?QL+QU@!9          #6F['Z9VR^5T?]GS@&RP
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MO/\ 0_G_ ,G+;Q)T$K*[?^@>+>]%?XLV"J,
M                 1J/I7>^3S7CK@"R           !K_>/-+;!L/\ *E(A
M!V$B4U#;D.IYVV"=)1FX:>PS[WE21\-3+^@!YQ@U&>;T7$RS;6Q-MH#4=B6\
MZ916R;4I?3X(2:=2[XU$1%J7< >K,#QES#L0J<:=D%*>KV>1U])&E*EK4IQ7
M*1\>4C5HG[ "B 8[('[*+16<FG:Z]LS%?<@LZ<W/(2VHVTZ=W56G !YEV9S?
M/[7<*)"D6<VUB2R>5<QI2E+;90E!GU.4RT94E9)21%IKZW0!ZK
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M9&:#OBC->43:TY?".0N?3EX=O;IP]3@ R@   )/<GT.F_CH7CC("L
M                    !#[S_0_G_P G+;Q)T$K*[?\ H'BWO17^+-@JC
M                                       $:CZ5WOD\UX\X L@
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M_P"3EMXDZ"5E=O\ T#Q;WHK_ !9L%48
M             C4?2N]\GFO'7 %D             U_N9M36[D(@O.37*RS@
M<Z&I;:$O)4RYH:D+0HTZ\2(R,E%H S. X17X!CS=#7O.2=7%R94I[0ENONZ$
MI7*7!):)(B2781 *<!K+/-D\>SN[1?O3)-=/4A#4TXW(HGVV^"3T61\JR+O>
M8NYW %_35$"@JH=+5M=&O@M)8CMZZF2$%H6IGVF?:9@.\          (W=7T
M%L?QL+QU@!9          #6F['Z8VR^5T?\ 9\X!LL        !J3?/-LTPV
M#4N8HUTF);KB9ECX.<OD4@BZ;7+H9)ZFJN)EQY=" ;$Q:?:6F.5=C=Q/ +>5
M&;=F1.)=-U22-1:'Q+^@^)=@#!X?-AUU?DDVPD-Q8;-Y9*=D/K2VVA/6TU4I
M1D1=O= 5L65%G1VY<)]N3$>+F:?96EQM:3[J5),R,OZ ',           "4R
M#TSP_P"[L?%0%6                  )/<KT-G?CH7CC("L
M               !#[S_ $/Y_P#)RV\2=!*RNW_H'BWO17^+-@JC
M      'DN7O!N2WN&XA,I:5M67@",:Z:>DIHG^F31HY><UFGCU-=>[V /6@
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MV0\X@C2TE;QZFAI)\207<U[>)]T!8@           E,@],\/^[L?%0%6
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M,V H@             !TCIZA5B5NJOC';$7*4\V6_""3IRZ=33FTTX=H#N@
M                        #7=QD%+CFYQR[R:W!C/4+;33CIF1*64QQ1D6
MA'W &6^=';[XP1?ZU>Q /G1V^^,$7_$K^P ^=';[XP1?\2O[ #YT=OOC!%_Q
M*_L ?/G2V^^,$7^M7L0'WYT=OOC!%_Q*_L /G2V^^,$7^M7L0#YT=OOC!%_K
M5[$!H_>B+49K?0LAQK(JZ2;<9,)^%)D''4CE6I9+;4M/*:3YN_+M[#X]P-B[
M;9-A.$X;78Y.RB%)F12<4\MI2S92MUQ3AH;YDD?(GFT+U>T!5?.EM]\8(O\
M6KV(#[\Z.WWQ@B_UJ]B %NA@!ZF5_%/3MT-7#_\ : ^?.EM]\8(O]:O8@'SI
M;??&"+_6KV(#[\Z.WWQ@B_UJ]B ^?.EM]\8(O]:O8@/OSH[??&"+_B5_8 ?.
MCM]\8(O^)7]@!\Z6WWQ@B_XE?V 'SH[??&"+_B5_8 ^?.EM]\8(O]:O8@'SI
M;??&"+_6KV("9W!SW#[O%)E757$>582'89,QVS,U*-,ME1Z:EZA&8#:H
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M7><S[_CJ1EIV'P ;B         2>Y/H=-_'0O'&0%8
M   ^*2E:30LB4A1&2DGQ(R/M(P'GNI_E_P RBQ:';NRRB%*V6Q>V9N:N F&X
MF[D-PY!RXM?*?4X;)L-.FG5Q#9+6E"2[W4P%#D6VVYMX_29@C(JIG<C$K.T>
MH'CAO'5/4UHDFCA2VTN$YS\B$'U6U<%)[#[0'%6;-YE!QF^F,YH=?NQD=RUD
MMAD,"-R5_A$9M#+, XJUFIR"AE!-&E;G.KUYGKP 9C MO<PB9K9;F[E6T"QS
M"76M4,&'21W8U;#K67E25$776MQQQUT^=2EGWNG*7 !FMYC-.T&?F7Q<M_\
MU@N@,IM_Z!XM[T5_BS8"C
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MR6_\)?V '@L;_);_ ,)?V '@L;_);_PE_8 >"QO\E'^$O[ #P6-_DH_PE_8
MCMTF&$8/8J0TA*B=A:&22(__ #60%L          -:;L?IC;+Y71_P!GS@&R
MP$G>^G&(_<6?Y%L!6    U5DN^%5C6>-X6]6/OM)<CL3;%*TI)IV6231RM:&
M:R(EIYCU+[&N@#:H    #5V]^79CB-# EXDT:2?D&W/L"8\*..@DZH+D,E%W
MZN',9</Z3 5^!VEW=8?46N21? [N4P2Y<?E-O16ID2N0^*>9)$OE[FN@"B
M   2>Y/H=,_'P?'6 %8   "4R#TSP_[NQ\5 58       .O%@0()NG"BLQC?
M6;KYLMI;ZCA]JE<I%JH_5,!V         $GN3Z'3?QT+QQD!6
M                 A]Y_H?S_P"3EMXDZ"5E=O\ T#Q;WHK_ !9L%48
M           #1&XN_=KB>6R,?I:J/*BUO(4YV6MQ*W5K23BDM<NA)(DJ(N91
M'Q[F@#<]%;,7U+7W<9*D1[".U*;0OUR4O()9$?V2UT 9
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M'6 %8   "4R#TSP_[NQ\5 58                  D]R?0Z;^.A>.,@*P
M                         $/O/]#^?_)RV\2=!*RNW_H'BWO17^+-@JC
M                1&4[2X-F-NW=W<!3E@1)1(6TZXRF0AO@E+Q(,N8B+AZN
MG#70!9L,,Q6&XT9M+4=E"6VFD$24H0@M$I(B["(BT(!R
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MZQQN1"706L)+K\,CE2V64,(TEM'JLTO+,BX:<$@-E@
M         A]Y_H?S_P"3EMXDZ"5E=O\ T#Q;WHK_ !9L%48
M                             C4?2N]\GFO'7 %D             \V[
MK;SYOCN;S::C=9KZ^H)HS:?80Z<GG;)PUK4OB2#UY4\FGJZZ@-_X[9NW=!5W
M#S!QGI\5B4Y'/7O%/-DLT\>/#4!Y]W8WCSG'LXG4U+(:K*^I)HTM.L(=.1SM
MDX;CAK(SY#UY4\FG9ZH#T%CEF_=8_5V\E@XLB?$8DNQSU^]K=;)9IX\>!GW0
M&3           !&[J^@MC^-A>.L +(          :TW8_3.V7RNC_L^< V6
MD[[TXQ#[BS_(M@*P      <;S#$ELVI#2'FC,C-#B26G5)ZD>AZEP,!R
M      "3W)]#IGX^#XZP K    2F0>F>'_=V/BH"K       !J[>2YRK#\:9
MEX)#)A4F69VLV-&2^XRA23[\VR2HC-:M$FLTGI_U =BCW/@TV)8]+W.FM4V1
MVK2E*CNMK;6HDK-*75MH2HVR4GE4?-HDC/N -CH6AU"7&U$MM9$I"TGJDTGQ
M(R,NTC ?H      2FY/H=-_'0O'&0%6                           "'
MWG^A_/\ Y.6_B3H%97;_ - \6]Z*_P 6; 48
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M>T!MX    !KO+]FL3S3)(^2VBY+4E"6T3&&'"2U*0P>K9.:I,RT[#-)EJG@
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M[2-3_P#^@<-3T+S9E=FO @#SVD=W< OW9E 'GM(^/_\ #,H \]I/Q_\ X9E
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M3;3<RNW(@2WX\1ROL*]:$3(;BB<(B=(S0M"TD1*2KE/N$9&0"Y
M$;NKZ"V/XV%XZP L@         !K3=C],;9?*Z/^SYP#98"(S"P9J\MQ.;(;
M><:0FR2:(S2Y#NJF6^Q#9*49>J>@#O\ G[4?[*T^#9?M8!Y^U'^RM/@V7[6
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M ,L   "3W)]#IOXZ%XXR K                            0^\_T/Y_\
M)RW\2= K*[?^@>+>]%?XLV HP&*RCT:N?^#*_(J <&%^AV/>]D+Q= #.
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M9&A+<-LC)"22DB)*4D9Z$7JGQ 60          C=U/06Q_&PO'6 %D
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M#HV]'G]_!556,NG;@O.,K?7'9E$Z267D.][SNF6I\FG$@%T
M        X9CKK$1]YAOJOMMK6TU_>6E)F2?^I@/$]7CM/4[$[=;Z5;'/O!87
M]183LE2M1V%A(N+4HTR*^X1ZN-+;=6T;/K2)/ M2!6ZMXZJOS'=W:? <H8*?
MA=@F_M)U0^>L2;-JXT?P5+S? G":ZSCA)5PU[2X C3MM"9K)=_LM -QG:U[=
M/'J156AUQ+**NXKDV,RN;62N9#"Y"4ETD*+0EFDN!@-O8'04^WG\PN18-A,%
MNIPZSQ.!D,RGBZIALVJ9\B$3K31=ZT;K*")9((N<T<Q\0'/_ # Y7N% P[-Z
M6HV]>N,7<QZ>3^3(MH$9#278;I/*\%=5UE=$N)Z%WW< ;/P$B+!,7))\R2J8
M!$KLU+P9OCQ JB ="\BO3J2RA1R)4B3%?9:29D1&MQM24EJ?9Q,!&4=IGU12
M5M2O"E.K@16(JG2LXA$HV&TH-1%W-= &0\Y<\^(Z_A2& ><N>?$=?PI# /.7
M//B.OX4A@'G+GGQ'7\*0P#SESSXCK^%(8!YRYW\1U_"D, \Y<[^(Z_A2& Q]
MYE^X4*EL9D?"EMR(\9UUIPY\9\DK0@S)1MM]\O3MY4\3[" :8VHW2W(LLM*$
M3[V5-3&G7I4!Q33)-\A:DXAPTDEDB,^7E/@>NFFH"GLMJCL\D=R61A$XC??.
M9)JF[>"4-U_4EF9][SDE2BU4E*M-?Z@&KYF\FY2K"P==OWH;SYK9?A);:0B,
M25:<C:%(,VU(TY>;UWJGQ =).[.X2$K0662S)Q/349N-F9$9ZZI,TZD?_N+B
M ZD+<#-JME:(626$>/*6;JE*?4LEN%ZY25N\W_S<I_T@.KDF4Y%D\MNPR>>]
M+?-!'&-\NDTEM1$1&T@B2@DJY=3-)=\?$!OW9/)\O+!F8U;BR;.NB2'6(LYB
M1'@I<06BCYDN<5J)2C(W"X*_I(P&Q?.7._B.OX4A@'G+G?Q'7\*0P#SESSXC
MK^%(8!YRYY\1U_"D, \Y<\^(Z_A2& ><N>?$=?PI# /.7//B.OX4A@'G+GGQ
M'7\*0P'S#X60'D.27]Y5^24VA0$1HYR&I*C\%;<0LS4T>A<5%V@+,      =
M"=1TMHXEZSK8LUU">1#DEAMY1)UUT(UI,R+4P'5\T,3_ %#7?FC'L #S0Q/]
M0UWYHQ[  \T,3_4-=^:,>P /-#$_U#7?FC'L #S0Q/\ 4-=^:,>P 8.^I(=<
MMA-)@<"Y0X2C>6DH47I&6FA:.H[[74^P!B?!9_U50?SBM]@ ^>"V'U4P?SBL
M]@ T'O2RJ+EL=<C'6\7-^$VKP9MQMQI]25J(W"-G1LC26B32GCW3[@!MKD][
MUY]=$IHN41HM9(D,Q'XT=PXIL)(T.$LT<QIUX&V9ZK^UX@->S+#R@[)FRWVS
M?EFIV0XVE#*>9?;RMH)*4D7<21< 1L'<F9/\@X;'GXU'Q]E<!+Z9B$-I<F.D
MA+>JEI(C3WNBS;7WVJM3[ 5KI1QU:&LT&?VIZEK_ -#_ + &W=GLAO+:YE5:
MZ*-E\1N+U3:?:AM.1C2I*4J)]QLBT47#D4>O=+N@,/NG+R:)FBFG:GS=Z:6E
MT]9$996WHI)%SI4RCD?6I>I*]=IZT!O.LC71UD)4[:V"[.-AHY+G5KF>9WD+
MG/IFC5.I_:GV=@#M^#6'U4P?SBM]@ YH<&0],CLR]L(,6*XXE#\HWJYSI-J/
M12^1*-5:%QT+B K/-#$_U#7?FC'L #S0Q/\ 4-=^:,>P /-'$_U%7?FC'L #
MS0Q/]0UWYHQ[  \T,3_4-=^:,>P ?48GBS:DK;HZ]*TF2DJ3$9(R,N)&1D@!
MF      !$-;.[6L,7$9C$JQIC(%H7<-MQTH*0;3J7T$KETT23B2<Y4Z)YN^T
MU 9*+M]A$'*I&<0Z""SELI)H?MT,I*2HE%HH^;3@I1%HI1=\HN!F9 &-[>X/
MA\^QM,7Q^#4V-JKGL),1E+2W>/-RZD7!/,9JY$Z)YC,]-3 3.[/Z9VR^5T?]
MGS@&RP       -"    [.!
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MVD,DM9_;*Y"+4_LF [*FVUJ2I224I!ZH49$9I,RTU+U. #]
M         #6F['Z9VR^5T?\ 9\X!LL
M                                             $/O/]#^?_)RV\2=
M!*RNW_H'BWO17^+-@JC
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MCB_NI$]U@'F!O_\ 7'%_=2)[K /,'?\ ^N.+^ZD3W6 >8&__ -<<7]U(GNL
M\P-__KCB_NI$]U@'F#O_ /7'%_=2)[K /,#?_P"N.+^ZD3W6 _2,!W]):#5O
M%%4@E$:T^:L0M4D?$M?"^&I -O@         "'WAS.UV^VVOLPHX\>5;UK;)
MPX\TU%&6Z](;9(G#0I!D7WSMYBT :_1_,=%1>-%*JG4TOD)4J35L-+?O$Y*B
MX;J%5*&N9"%.$ZOD(M"UX+U)!Z@,O(W^B5S?DVVQ&ZBYR5I#I3Q-!17I)O6K
M#\B&^A]+_@ZH[A1W$J=)S[VI*B47#B'99_F(VZBTR+++'Y.,3D3IM1-JIL9Z
M0_'L:OI^$M&J$A]"DI)U"D.)5RK2HC+ND0=";O3Y'R:ZK6(EAE+DJTK*C&Z:
MNAL1W$/SJ8[0C4^_(22FE)0I:W7$HZ79H9<0'8HM_J^YL:N/)Q6ZJ*NTL',=
M3;6#<=MIG(F.ISU[C:7E.>N:6V3Y)-HW.]YNZ QE9_,@F[12'4X!D+K^71G)
MF&,O%!8.R;BD2I)J4J2:8Q-I42R-\RZB3(TZ]@"AIM]\2OXS\NOAV'1C8V]E
MKQ/,H:<3'C29$1Z,I!KU*0AV,XE2?6^HHR 81W^92@1X1-:QFZ>QZKC4\W(;
MI#<;H0(^0QFI,51H-_J.FGK))]+2%&V6JN) ,PO?*H;NS9<HK1.%IME8TK-C
M0R585PAXXYMFGJ]8F">+H>$]/I]7O=?M@'1@_P PU+(?J95AC5U58ED1RG,>
MRB8TPF%)BU\1Z:\^XA+RGF4J:CK<82XWS.IT-*0&$9_FRP8ZNRM9=5/:1$KD
MWM?%C/5\^3-K5R(\?F2W%E.=%]*I+9JCR#0O17J\Q)#(6F][BIM?428%AA][
M&R2FJ[BOL8L:;U:^Y1(<86EYJ3TT-NI87SNI4I32D*2:#[0%1A&['GM81$-8
MG>5F/W$=<['<BFQT>!38S>A\RNDM:XQN)/J,)D)0;J.^+CP ;%         :
MUW-W0>VZN\=:>AIDT,Z'?V-PM)*5+0S15RIQ%'3S)2:E\IIT6 G/_P B5*>.
M"WM[D:[=5:G)(U<28/5<QX^"IFOA/(EPC[WP52NJ:M"(N.I!^['^93&XBK"9
M QVZM<;I8-7<7E[$98Z$6NNXQ28SI-N/)><423+J-H;-2$]]Q 9.+OG"38%3
M7^+W%!=+L*B"Q G(CFM<;(7G6(<LE-/+3R$ME:7D:\[:BT,@'/?[V5U1=R,8
MKL>M+O(D6RJ")!@ICEUIA5B+3FYWGFTH9)I>BW%^M,CX: ,>WO\ P+%BMBXU
MBEU=99*:G2;+%V4QF9U:U4RCA2O"5/O(:)9/)4VTA"U&Z9=[PX@.O(_F1QE^
M(Y;8Q07.34==4-9!D<ZM:8(ZR));<<;;<:?>:4N1HTKJ,MZF@BU/U '4G?S3
M8%!G1VG8T@JI#5:Y=62Y$%LX*KEEA^.CP5<@I,CD3(;4^<9I9-D?VVAZ!EXV
M^D2PND5!8Y;5U7-M;#%J[*)+<9<%R^KUOMFRE"'S=-MPV%DT\:20I1<O !B<
M<WZ<DTU047'[O,Y;%366F5VE/!9:.(FW:ZL?_L_"%+<=4@R=<9CFX;:./$^
M#>*3)224789:EW.W^D!]
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MA"B4I"C[BB(^!_T@/J'V'%$AMU"UFA+A)2HC/D5KHK0NX>G P'(
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M%6MWI&MAWD(FW'(YH-:.'V0&X4I)*22781:%W>P!]
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M.:3Y%ZEIR<W$%=6TC5U'49'A4\I;&Q6-;GE&RBMC+D+:AX](K&Y#;*^0S4F
M4Y9*>0G@DCX< '%/3C7SCYLG^6 OOI[96?DXZ7J^ ^5O*<;J>33/O.OTM.;P
M;O>?D^WU!''LU&I'-R,#5@-GC$:P:2^J[;Q&)>.SY%44=SPAN^5,6;;9F[R<
MJY1=4G^7D[H*W/\ R=8=CE/LQCN6081)R7(8AJN;-Q3BWWR8E/I:0?.9\J&R
M/1"$D1$"/08
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M<-0")Y,Z\KP'H>%<Y>&]'DZG4TX=7EXZZ?W@'.QT.BCP;DZ&G>=/3DT^QIP
-<@            #_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>lc_shortlong-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_shortlong-4c.jpg
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M="!E;F0](G(B/S[_[0!(4&AO=&]S:&]P(#,N,  X0DE-! 0       \< 5H
M QLE1QP"   "  ( .$))300E       0_.$?B<BWR7@O-&(T!UAWZ__N  Y!
M9&]B90!DP     '_VP"$  0# P,# P0# P0&! ,$!@<%! 0%!P@&!@<&!@@*
M" D)"0D("@H,# P,# H,# T-# P1$1$1$104%!04%!04%!0!! 4%" <(#PH*
M#Q0.#@X4%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%/_  !$( ?T#Z ,!$0 "$0$#$0'_Q #<  $  @(# 0$
M        !@<$!0(#" $) 0$! 0$! 0$!             0(% P8$!Q    8!
M P$#! H*#@<%!@0'  $" P0%!A$2!R$Q$PA!(A0543+2M'655A<W&&$C5)34
M5;46-G9Q@;'10I*R,U.3TW26.%)R<[,E-5>18J(D-*&"0\-$A&.#A68GHT4F
M1B@)$0$  0(" PH, P<%  (#     1$" P0Q$@4A05%QT7*2,S05D;'!X5*R
MTA-3<Q14,L*38:$BXD,U!H%"HF,E8H+P(R3_V@ , P$  A$#$0 _ /?P
M                   *%Y_YXN^&[.C@5-/%M$6S+[SJY3KC9H-E:4D2201Z
MZ[ABZZC40E_"7+4#ES$O72&D0KV&YZ-=U;:S63#W4T*29Z&;;B?.09E[)>06
MVZJ3%%59=XGLBQSEQ[CB/CT%^O9M(E:4YQYU+QHE&V2E[2+;J7>&,S?NT6CT
M^9Z?OCT98\>PA3%+1$DLR%M_SB6G$K-/[)),] &2 Q9%C!AK0W+DLQW'/:)=
M<2@U?L$HR,P&21Z_L>R ZY,J/#:-^4ZAADO;..J)"2U]DU&1 .)2XQM(>)YO
MN7.K;F].U1?8/70P'+TAGN^])Q/=%_#W%M]CM[ 'STJ.;:W2=;-MLM5KWIVI
M+[)^0!]8D,R6R>CN(=:5V+;42TG^V6I * YT\2$[A[)8>/P*!BY;DUWK!;ZY
M2F30OOG&N[VI0O\ T-==?*/.ZZC40L;)96395Q5-EX5(;K\PMJAN17*)U*>X
M?D-)<VDX?1*M#-*5GIH>AC6\BH/"[BG,^-VMZ[R&N;'QMYA*8L"TEE+>58$X
M1F^VG>X:4[-4J5J1+/3MT&;8F-*S1Z6E38D)*5RWVHZ%GM2IY:6R,_8+<9:F
M/1ER5)CHT-QU""46J=RB+4O9(!S2HEI)23(TGU(R/4C =!V$$I/H1R6?2_N?
MO$][_%UU 9!F22U/L\I@.M$AAU6UEU#BM-=$J(ST]GH ^,2XTG>49YMXVSVK
M[M:5[3]@]#/0!W /BE$A)J/H1=3,^A$1?9 =#4Z(\T;[+[;C"3T-Q"TJ01^P
M9D>@#FB0RXE2D.(4E/MC2HC(OV3+L $2&'3T:<0X9=3)"B49%^T +DQVCVNN
MH0K3712B(]/VS =A*U+4NI>0P&.Q80I7>>C2&GNZ/1WNG$KV'_WM#/3]L!VM
MR&'3VM.H</34R2HE'I^T \?\4\_\H97S5$PN[L(KN//3+%AQAN(TVX;<5#QM
MD3A=>FPOV1Y1=-6YA]O\'\2+_/:[NLG2TT1VB'8%GZ:DJIFH[TOM#D?>78C5
M*FN[W*5UZZZA,753<6)SOXBIO#F00*:!0LW*)T%<U;RY)L&A2'5-[-J4+]C4
M:NNH1"X\9R!B\QRHO73:CNV<*-,<CDX2B;5)92Z:-3TUTW::C42C<MNMNIW-
MJ2M.NFY)DHM?VA4<5R8[1[774-JTUT4HB/3]L!V)4E9$I)D:3+4C(]2,C =,
MJ9%A-][+?;CMF>F]U:6TZ_LJ,@'8TZV^VEUI27&EEJA:#)23+V2,N@ ZZAE"
MG'5$AM)&:EJ,DI(B]DS =<6;$G(-R&^U(;(]#6RM+B=?V4F8#O 8OK&!Z5Z%
MZ4SZ9]S]XCO?XFNH#)49)+4^PNTP'6B0PZ>UIU#BNTR2HC/3]H!]:?:?(U,K
M2X@C-.Y"B46I=#+4O*0#J]8P?2?0O26?3/N?O$=Y_%UU 9(  QI%A"B+0U*D
M-,..?S:'7$H4K]@E&1F []Y$6I]"[=?)H \,\S<U\HY1RE+X^X_LI-3#A3RI
MJZ-6.)8D3)A'L6XY(/0R2:S,DEN)))+4QXS=-:0W$+$Y5Y-Y XAX9PRD=E?_
M ,1[AGT6QMGW43G8_HZ"6\X2S-25N*W)2E9ZD74^W0:F9B$B&3X4E\K6S5IE
MF<VLZTQJVC-^HG+"84@U+:>6EQ:&=3-LNFFID6H65)>DY4Z'")*IDAJ.E9Z(
M4\XELC/V"W&6H]&7<A:7$DM!DI"BU2HC(R,C\NI /CCB&D*<<426TD9J6HR2
MDB+RF9@.J+.AS4J<AR&I#:3T4IE:7"(_LFDS 5OSIRJ_Q'B<3(XM:W;/R+!F
M <1QXV-$/-NK-PC)*CZ&WIV>49NFD+$.[A3D]WE?#"RB5 :J92I<B(F$A[O]
M2CZ:+U,DGUU[- MFL$PH;B["/$=6\UHM\IFS#I"D/KN["1.2_72XBDKV(9:)
M9D9^UV$E">[TZZ:#$1-5W'KU$J,XHDMO(6HRU(DJ(ST+[!&/5ES<=;:3N<6E
M"3/351DDM?VP!MUMXC4TM*TD>AFDR46OL= '3ZQ@^D^A'*9],^Y^\1WG\777
M_P!@#"RB;(K,;N+.&HDRX4&5)CJ46Y).LLJ6DS(^W0R+H)(\R^&?G3D3DG-)
M]/FEC&?JXU2J<@FHS48R?)]ILE&I.G319]!YVW3+4P]6(?9=,R:<2X9=I)41
MZ?\ 8/5E]<>:9T[UQ*->S<9)U_[0!MQ#J=[:B6@^Q23(RZ?9(!P7*CMJV+=0
ME9=J34DCZ_8,P'!<^&W(3#<D-)EK+5MA3B2<47V$F>H#(4HD$:E&1)+J9F>A
M$0#@B0PZ9DTXAPRZF25$>A?M #+S4A!.LK2XV?M5H,E)/R=#+H Z46,%R2J&
MW)95+1[=A+B#<+3V4D>H#* 8S\^'&<;9DR&F77>C3;CB4*7_ *I*,C,!Y,\0
MW/7)G'O):\:Q6PC1JA,2&^33T1I]?>/F9+/>KKUT'E==,2U$-MXEL4YMR:WQ
M^7@+DV3CJ(B.]A5<M,-QNQ4HS[YU/>-FI)I,B2O4R1U[->MNB9(H] \?1<FA
M8511,RE)FY0S"81:RD*)9+D$GSC-1:$HR[%*+M/J-PDMV=C *3Z$<IGTS[G[
MQ'>_Q==14=LEXH[#CRC(B0DU:J,DEJ1>R8#SIP[XG9_*.;IQ.=CK%3']&DR3
MFIEJ=,CCF1$6U2$EUU]D>=MU9:F'HXG$FG>1D:--=VI::>SJ/1ET1K"#,4M$
M22S(4W[<FG$N&G]DDF>@#)
M           >+?'">F08<?L0YI__ ,QL>.(W:JSCO*LAX"SJCR&>A2\?OZ^-
M,FM-><B73S2W;T:Z?;8Z]>G^D1I[%#,325G=9G(LJ-/\2JY\)Y$B#,O:B3%D
M-*);;C+Q1EH4DR[2,C"=*1H33Q3\KY#=YR]QE13UP,>K%,1[ FGCCIESI!)6
M??N>;HRT2DEH9[==5'KH6FKYW:$0K7+./E\90X.3XQR-57%HA]#;S>/35(G1
MGE$:B=;VK,UMD:=%*Z=I=-!F8HJ_)/B4R!/AUC98G86?R9Z\:],V$3926D=X
MN83>FW7N32K;V;S[-.@WK;C--U3> \"\D<U4\_.4V[6BGW6V95R\^](G2&^K
MADHB5M3N/;O/R]A:$,Q;,M5HEWAFY2RO$^06>+,GD2'J6>^]7)A3%J=<K[)C
M=HEM2C,R0M25(4C734R47EUMLTFB3"$9->YUXD.5?4M>\I34F0^S1UCKJFX,
M*#&-6YUPBZ&K:G>XK0U*/S4^0AF9FZ30Z^6>*^1.'ZRNHKZX38XC9R%2H?H3
MKWHJ)[+9I41M.:&VO8KM3YJB^R03$P1-5J135]1Z8>Y6[OU>=N/=_P V3Y==
M1K_:;ZK>(>*,^Y?J[>FH;Q-5B]=(;D3FY3KQL/3W6S2C[6T>JC2@NU71)'TZ
MF,Q$R3N,SBG(,PX6YIBXI-D+0PJT:I,@K4N*<B/-OK)"'D),R+<G>EQM6A'Y
M#[3(6)I).ZUWB,PBPP/DNU78S&II9"N3?Q29)9&U'D274I:7O_A%MZ[>@ET4
ME87?A?$EUQKP?R/;VEHQ/9RBA:F0D1B=2ME"8KB]%]YY?MI>U]@;B*0S7=0S
MPA7;..R.0<@F&MR-54;<UQ!J,S4F.IQPTEJ9]3VZ"6+*OZ"DY'\3&>RU/6"7
M+!32ITN3,<6F# B;]&VFFT:]-5$E"4%J?52C[3&=VZ5T-?R[A>>\;SH&%9C9
MJL($2.[*Q]]EYQR-Z/(5HZ36_1:-%I\YL^P^I=#U"Z)@A>/*7+%YA/"''&)8
MQ*<@VV04K#LRR949/LPF66TFEI7:2W%*TWEU(B/3J8W,TAF(4PQQ4U)PP\U7
MG]$WD)QU6",=<G_\1-"2->PW>\U*0HBZ-Z=O3748IN-+P\.G+.095A.:8'DL
MIVQ?IZ23.J;%]1JD^B*:4TIEU9GJKNU&G8H_.T/0SZ$-VSN49F'GWA[$<USZ
M^=Q'#;1=8Y80%>N)BWG4-E7M+0I25[#-:B4O86U/:?;TU&(BK39Y7CV?^&_/
M8G<VA(M6&D64"?"<<]&EQMQI4AUI9]2,TJ0M"R^R7D,)K;)I?H_06:+NCK;I
M".Z191(\Q+9]324AM+A%K]C</>'F\/\ B6Y)RO-^2'N,,>=?32ULEFM9K(JS
M;5/LW=I*-TR,C425*)"$F>TM#4/*Z:S1N$=S[@;E'B/$'KZ7:M2*"P2W$OXE
M9(?)+275I-"7T+)*7$=X22WI[%"3;,%4_P##.:CX:Y?U4HS]%D:&:C,R_P"&
MN]AF8MNB2=+!\#QJ5F>2DI:E?\'C^V4:O_J"]DPLTDM+XSS47*L<DK6DO4D?
MHE2B+^>>]@Q+])&A(?$YRE=PZS&.-:28["KCIH<^^7'4I#L@W6R2TP:DZ*V$
M236HB/SC,M>P6Z=XB$4:\/'+^&84ODVKL6H<EN$N9,IHKSI3DP'6S[TG.G=.
M'W1F:VS\GV1-6:5*M]X)3_\ XC7Y)4I3941;2-2E%IZ6SIVF8MFDN1?@?_,I
M7_"-Q_NY ENE9=E\M2?%M[=>TLPA^;N5I_.M>370/]R;S7>)C";#">3K6PL)
M;4QO)W9-Y$;:)9*986Z:2;7OZ;NG\'H)=%)6%E8QX9KXN),GF2[*-82<AJZ^
MZQQB,3Y/L2HB52D(/4]#-Q#AM&2>G4:BW<2K&\%V=)K\BN\&GOFB/<,%9UY/
M+4>V3#+:^@MW0C-H]ZO]0+))A UHD^(3Q#NMMN.JI[6Q5JM*E([NCK2TUT(]
M"-;:/VU+$_%)HA^B;+#45AN/';)##*$MM-)Z)2A!:)27[!$/=A^9DNU<Y4Y)
MG+Y4RUS'8SS\IM4V2T[)CPU,K-+45#!*23:2TTU/]D^IC\^F=UZ+S\.V%\L8
M5FY+IK"!D?%LEQ<>SD0+6/)C&@T&IF4VQWBEM.$>FY&F[34C]D;MB8EF5=<F
M9CFO/?+1X/1RUM4I3W:RBKN\4U$)$<U$Y+D;.JC,D*6>I'HGS4C,S65C<9<G
M@KGWB'*(=A@1/VS[:2D-6-,HRC*-*O.CR6'E%J1Z=2,C)23]D-68*PL;Q)\W
MY948SC>+5K4C%\AR&N3:9)H9(E1&3U;.,VM)GM-3B5[EEYVPBT/SC&KKDB%1
MEX:N2%<>?.?Z3'U.'ZV*I-U[UEZ'M[SO.\]KOV?;-F[73R[N@SJS2JU6CX?>
M7[W*\%S7 <GF.6,RJHI<ZGL7U;I"H9LJ;6TXL^JS;4I)H4?G;3T,^A#5MVY0
MF'G3C2OY#OY\C%N.CE+M+N$4>P*.]W)^@MK2XLG'U*+NFS5M)1ZEN]KY=!YQ
M7>5<^=Y)G7!W#N+\2D_ZIRRU5/G7,J$]WKK, Y![$-/)[%.FKSE)ZD1:>4;F
M9B*)"M?FL:+"CS<\^HRR#T?UA^;A3O\ B/=Z;]G>]YKZ1IU[O3MZ:ZC--Q:O
M2OA$Y9O<N@6N$9/+<L)](TU*K)[YFM]<%Q1MJ;=6?51M+TVJ/J:5:'V#TLEF
M863XA.2)_&''$J\ITH.]F/-UM6XX1*2R_()1F\:3Z*[M*5*(CZ;M->@U=-(2
M'B7%./5\F0YV4Y1R-4T]HZ^XVRB_FJ7.DO)(C4XYN61MMF:M$JZ]AZ%H/&(J
MVF? '(.5';6G#%E:*E4N30;&JK''W526X-@;#B4+9<(S4;+FA^:D].Q1:=1;
M9WDE5D3CVS<Y)3Q84YE-PBS71G9:.=QW[1F@W-/;[3-/[(S3=HM4YY]XFNN-
M#Q65;6<>P1,KF*EM,<G2-+M4RDG5GWG\%9N%M\OLBW10B5A\+U-KPSQ7D7.T
MB5'L(=O4-E4U)$X3B)/I1LMDZ:C))IWF6NSR:C5NY%695%CM!9\T6MMD&=<@
MU]-):6G?*O9.CCSKI&HD1F-Z"2T@BT\W0D]"(AFE6M"5\'\A9)Q=RK%P5ZX1
M=8E8V2*>6B-(.37FY(63;,R(M6NTMQIW:::IU(RU(6V:2DPX\LYIFG-W+CF
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MMHS2TNMHED@B=V*1JDTFKJ6@]X8;D4
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M'DCE;'58&_KWQN&CH;FO7>:=#7KUW:C]$:&)3$5
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M
M         !%,LXTP/.C;5EV/P[9YHMK<A]HB?2DNQ).HVKTZ]F[028B5JZ<3
MXHXZP60J9B6.0JN:LC2<MMO>^23Z&1..&I1$?E(CZA$1!5,14        :S(
M,>I<JJ9%%D,)JQIY9)*3#?+<VLD*):=2(R[%$1B3%1@8G@F(8*S*CXC3QZAB
M:M+LI$5)I)Q:$[4FK4S["Z!$1 D0H         /BDDHC(^P^A_M@(11\.\8X
MU;,7M%B\"#<136J/-::^VH4ZDTK,C,SZF2CZC.K"U3@:0
M                          0:PX;XOM;E[(K+%H$N[D/IEO3GFS6XM]!D
M9+5J>AF6TOL#.K"U3D:0 0FUXAXTO+U>37&,PIE^XXT\NP=09NFXQH3:C/7M
M222T$U86J;"H
M
M
M
M
M                                         .#KJ&4*=<42&D$:EK49
M)2E*2U,S,^A$0#HK[.NMH_I=7+8FQ#,TE(BNH>;-2>TMR#,M2 90
M
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M_P!;0*P42R-(8EL-R8SB7HSR2<9>;42T+0HM4J2I.I&1EU(R%1V@
M
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MENJ=@4,QA=:2S-7=-3FUK4TG7L02VS41?]XQJR4N>HQZ,@
M
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MV+C\=MM;<<X\9?VU39N>>OSU><X?EZ%T()F9(6ISQJ? ?#>TC5]H1[4C5_\
M1)]@:NT0D/0GA9U^8S%]2,CTE]#(R/\ ]8][(W9H9EY4Y0P;).#^5',K9I6K
M;$Y$UZ=5KF1O3*YUJ5N-R))29*)*T[E$1F1>121YS%):A\/E+-^2,EB57&>!
M4-<\^DF6ZV/2PIR3<,_.>?D/L:-H3KU[$D7V0K70+]YC;YJX]X]QY>"O1)U?
M70UQ<PA0ZF(MDUK(EG):BDWH3.XUDI"$="/<9=HW=6(2'E7,,ZQK-*&O@Q\"
MBU/(#;K96%]4DIAN6A*32I)0&D$DE.&:3/V#+S>AZ#SF:M/1U?3<\\?>'/'R
MQ0E-9%7NOR;3'WHK4R2FIE*6I#1-NDKSVM26IM/711I_@Z#=)B&=]YWR+D?'
M\HQ1RJO<$AL\C;R[K+*U'JQ6WO"4?>06&TI6LTZMZ'T\O:,3.XTMO&,5RG&O
M"-GKF0QGX4:V=;G5-<^E2741U/1DF[W9]4$ZHMQ$9$>GG>4:B/X4WW'PQ8>C
M/N,^5,/><5%];G"8:D*2>B'2:<6VHR,NI$M*3/3R!;%8DE7>&YQR1X:<IMZV
M?3)2]+2AFQK)Y.)C/*84KNI##S?11=5;5$9D:3ZEKV9B9M-+)QW&\]\3'**\
MALXBF:V0^PN[LD-*;@PX,?3;':-?MUJ2G:A)&9F9FI734Q8B;I-#,\6;9-\U
M/MM-J)I%?6)024J,B(M2(NA>0+])#U?XB]?F"RS0C,_5['0B,S_GV?(0]+M#
M,:50^!DC]'SW5*D_;ZOVR33_ /"D>R0SAM7/70]6
M                                                        '3)B
MQYC1L2F6WV3]LVZ@EI/]I6I $:+&AM$Q$90PPGVK;2"0DOVDD1 /BX41Q?>K
M8;4Z9D9K-"35J78>IEJ ['66WT['4)<0?:E9$HO^PP'QEAF.DTLMI;29ZF2$
MDDC/V>@#IEUT">22G1691(ZH)]M+NA_8W$>@#(;;0TA+;9$EM)$E*4D1$1%V
M$1$ Z50HBW.]6PVIW77>:$FK4NP]=-0&0 ZG8[#Y$E]I#I%[4EI)6G_;J YH
M02"VIZ)+H1%T(B(!R  'Q2=Q:?M>SV@,:/6U\1#C<2*RPV]_.H:;0A*_]8DD
M6O;Y0'-N)&8,U,-(:49:&:$)29E^T1 /C<*(TLG&F&T++7SDH2E77MZD0#F]
M&CR-O?M(=V^UWI)6FO;IJ Y-MH:23;:20VGHE"2)*2_8(@'0BN@MRE3FXS*)
MJ^BY*6T$ZHOLK(M3_P"T!R3"B-K[UMAI#A:F2TH22B,_LD0#( =#<*(ROO&F
M&VU]?.0A*5=>WJ1 .QUIM]M3+R$N-++1:%D2DF7L&1] '3$@0H"%-P8S49M1
MZJ0PVEM)G[)DDB =CT=B01$^VAPD]4DM)*T_8U <FFFV4[&DDA!=B4D22+]H
M@'4W"BM+[QMAI#G7SD(2E77MZEUZ@/%/,&:<[\3\A2W9]D_;X%(EKEU+4Z.W
M)JI,-Q6[T1]1-D:5MZ[#ZI5T)1#QF9B6X5[R1S-EG.ATF*UV/LQH\)[?!IJ=
M+DEU^4XGNTF9Z$1)(C/:1)(BU,S,9FZIH>W^$L%D\<<:TN*SU)5;,-KD61MF
M2D%*DK4ZXDC+H9(W;-?+H/:V*0S*P1I !UNLM/IV/(2XCMVK22BU]G0P'UMM
M#2";;22$)+1*4D22+]@B 8Z:NN1*.<F(PF:H]522:03IG]E>FH#)6A+B30HB
M-)EHHC+4C(_(9& ZFXD9DS-AEMHSZ&:$$DS(OV- 'UV+&?,C?90Z9="-:25I
MK^R0#D3*"039)(FR+:22(MNGL:=F@#@W#BLF:F&6VE&6AJ0A*3T]C4B( =B1
MGSW/LH=41:$:T)4>GL=2 =J4D@B2GHDBT(BZ$1$ _/GQ=J(N:WR/\7UWD/V5
M#POTMP][1ZZ!+C09,J*R\^RTV;+KC:%K1YI'YJE$9E^T/9AL%H2LC2HB,C(R
M,C+4C(Q1U-Q(S)[F&4-*,M#-"$I,R]CH1 .\!AG55IRO3CAL'.(]2DFTCO=?
M9WZ:_P#M =LV.Y*BOQVGE1W76UMHD-Z&MM2TF1+3KTU2?4@'@FVY9YUXDS%V
MKY)4>10HJUH;B7,=!U\QK71N3&?0V6BM"Z&1].J5)'A68TMTA%<KRC//$SG5
M=&K:EM,I#)0($*"2UQ8D=2]SCS[RBT(BUU49Z="(B(29FZ30_0S',<A46-U&
M.)2A]BGB1X33BT$>[T=M+9KT/70U::CWB&&X::;922&DI0@NQ*2))%^T0H.M
M-OMJ:=2E;:RVK0LB4DR/R&1]# =42!"@(-N#&:C-J/52&&TMD9_9))$ R &(
MBKKFY1S6XC")BM35(2T@G3U[=5D6H#+ 8BJNN7)*:J(PJ:1ZE)-I!NEI["M-
M0&0XTVZ@VW$I6A7MDJ(E$?[)& XLQV(Y&3#2&]W56Q))U_9T <)<&%/;)J='
M:DM$>I(>;2XDC]G11& [&66H[266$):906B&T))*2+V"(M"(!P7"B.JWNL-N
M+Z%O4A*E:%V=3(P'8XTVZ@VW$I6V?0T*(E),OV# <68S$?=W#2&]VF[8DDZZ
M>SH [0
M                                                           !
MU2([$ME<>2VAZ.X6UQIQ)+0HO8-*M2,!B0**FJE+755T6"MPM'%16&V347L&
M:$EJ)0; 4                8;U56R7#>DPV'WNA=XXTA:M"["U41F RR+3
MH78 ^@     #&G5\&R8]&L(S4N,9[C9D-I=09EV'M61D X5]56U3:F:R&Q"9
M6>Y3<9I#*3/V3)!$1F S
M
M
M
M
M
M
M
M
M                                                      !K%9%0
M-K=;<M8:'&3VO)5(:(T&1Z&2B-73K[(#-C2H\QE$F(ZA^,X6K;S2B<0HNS4E
M),R,!W            Q)=G7P7XL69+8CRIRS:A,/.H;<?<2DUFAI*C(UJ))&
MK1/D 98   ,1-E!7-<K4265633:7W81.)-]+2S-*5J;UW$E1D9$HRT,!]]8P
M?3O5GI+7K+NO2?0N\3Z1W&[9WO=Z[MF[S=VFFO0!E  #BI:4)-2C(DD1FI1G
MH1$7:9@.B#/A6<5J=72&I<%])+8E1W$O,N)/^$A:#,C+[)& R0   :N=D=%6
M38-;9V<.#96BS:K(<F0TR_*<3VI8;6HE.&6I=$$8#*FV5?7(2NPE,Q4+/1"G
MW$-$9EY"-9EJ X1;6NG$DX4MB22MVTV74.:D@R)1EM,^PS(C]C4!VR)T2)IZ
M4^TSN+4N]<2C4B,DZEN,O*HB_;(!S>D,QS;)UQ"#=7W;1+42=RS(S)*=>T]"
M,]" <9LV)7179L]]N+"82;C\E]:6FFT)ZFI:U&1$1>R8 S,C28R)L=U#L)UM
M+S4E"TJ:6TI.Y*TK(S(TF74C(] '-B0S):2]'<2ZRLM4.-J):5%[)&6I& [
M   8L>RKY<J7!C2V7IT T)G16W$K>8-Y.]LG4$>J-R?.3N+J74@&4
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M/4@&?1W$3(*>OO8!.% M(K$Z*3[:V7>YDMDXC>VLB4A6BNJ5%J1]# ;
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MY--.8DL.:+B2X24H[IYC4D++8G7M[#U/,JL$0
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M41^P9'J.=,3$TETXF)BL.X10
M  :NY]M6_P!]:_DJ 9#EK6,N*:?FL-.HZ+;6ZA*B/[)&>I#<673O2Q-]L;\.
M/KJG_&$;^N;]T'N[N"4]Y;PP>NJ?\81OZYOW0>[NX)/>6\,.^-,BS$FN*\V^
MA)[5*:6EPB/V#-)F,S$QI;BZ)T(;FG)E;A&689CELTVU"RUZP87;R)+<5B&=
M?$.41K[PM%]Z9=V1;DZ'UZA$",'S?%L+N555)5J8<+*ZS%2LI$XW69R;.$F8
M:HAQFG"[].[8EI:MIZ'N4GL%H5;ZJYPXPOLB;Q.EOVY=])?E0X#*6)*6)<B
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M\;PQXCW=W%/B:3A7Z*,1^#6?W!^C:':<3G2_+LSLN'S8\2>#\#I
M   *\S[G3BGBZRBT^?9(Q2V<UGTJ-&<:D/+5'-:FR</N&G"2DU(47G:=@L1,
MI5,J*^I\GJ8E]C\YBRI9[9/0I\5Q+K+K9ZEJE2>G0R,C+R'T,16Q  $7QW/J
M#*,FRK$ZLWCM\.?BQK@G6]C1.3F/2&^[5J>XMO;V:& E    *T>\07#D;.?F
MV?RV&C,^_*$< R>[HIBCVE'.5W?HY/;O-[HW=^[S=->@M!/+N[JL<JY=Y>S&
M:^G@-*D39TE9-LM-(+4U*4?8((9@G.7%/)C=D[A63QK%-.COK-+B7H2V&-->
M^4B6VRKNM/\ XI%L^R+,#JP?GOB+DFZDX[A&4QK:[BI4XN&E#["G&VU;5+8-
M]MM+R4GVJ9-1!0=&.>(CA?+\L/",:S"'8Y,:EMLQ&TO);?6T1FM,>0MM++QD
M1&>C3BN@4DJLX0    :O(_\ DTG]EO\ WB0&IR+C7 \MGIM,DH8ME8);2PF0
M^DU+)I)F9)UU+H1F8_5A9O&PHI9=,0_'C9+ QKM:^R+I_;#4_,?Q)\D:_P#J
MS_?'MWCF?3EX]V97X=O@/F/XD^2-?_5G^^'>.9].3NS*_#M\#947%_'^,62+
MC'L?B5UHVE;;<IA!DM*7"T47:?:0\L7.8V+;JWW3,/;"R6!A7:UED6S^R&=G
M=)+R;"LDQJO=;8GW-5.KHKSQJ)I#TN.ME"EF@C4224HC/0M=.P?EA^Q5*N!(
M\6NXE320:2MN\&L*R=D=C&C)CNS&X-<[%>0RXVR2U[W'"61.&DCTU/J1"U2(
M0)>)WOA\AX5DJKJJ+)8T2]QZQ;EPK>?7/0+.V7<,K8571W'426C-*>[<027M
M5)29&DC%K5$A\/?%688]"XYRK(FT5RZK&+>LL:J4E35@F1<6R;%HU-)(T-Z-
MI^V(->Y"CV^0PNE8A8/&O%TW&N$XW%622V'I9PK&OG3*_>IDT63TA>K?>I0K
M4DO%VEVC,SND(5BO%^49)5\0GFD"-":P"ONL;RNGE[UG.9?KRJ&UQ]I*0MIY
M#9.J-2B\U73V!9DH[.-/#U=8S39IC>39(N3 N;""=)90.Z78(J:B,W$AM22F
M1G6N]0TTAI1DA6I)UUU"9(A,J3@^EI9CTI5_;6#<B))@O192:MMM34MLVUGN
MBP&'"41'YNCG[)&)55?\?\+9IBEO@)WZ:9O'.)HMLS43:-MX[2Z*P85'03["
MD(2P?=GWCR2=<[R01&73J+5$_P"%L<N:' Y]ADL,ZW),JL[7*+6K-1+]#=N)
M"WT1S,OX3;7=I7_WM1)(:SG/Z%V?A#&ORS""-)O+D$4     54Y_F4C?J/(_
M*[(N\BU1% 'Q7M3"$E">+/T=E_"EA[X4.#L/L\\Z[QOHMO\ :8YEGJPFX[SY
MY#N6?HQR_P"")G^Y4/W9#M&'SH\;F[4[)B\R[Q-C@GZ$8W\%PO>Z!^?'ZR[G
M3XW[,#J[>*/$D \7L  #RYS#9Y?4>*#!I>#8\QD]^>*6K:*R5/;JVNZ7(22G
M#><0X1[>GF$G4_9(:C0-CQ]3<F>'[ XE+!P=6=7F065E>WK&/2XE?6U3\Q;:
MDQ8Z9BT*-HD^UVEH1D?V-6D5UD'(?(M&O,_#ZF_L2Y)O\MJF,-N79"EV$3'\
MD(IKJD.%JI28"&'F'7$'H@UEM,B(A4:KF_/<CIIF:9QQMDF=V#^!VT2NG6BI
ML2-A4&2P]&CN0'82S)V:O[;M>42#7WBDJU-.IG;> EE\J9#=8KD7BNOL?LWZ
M>VB+XU)FRB.FP\TE[NFG-JRTT)2%J2K[!F+$;D)PK*Y7Y*R7$.8\K]0V3C\;
M'>)[7(FZ'O.\AIM8U@DFI#S!*(MQ(/J9Z'L[!C>:0GA\_$ 5SB>7+_.N3B5Y
M4NS<QM<AN*JXK72EP/28LNI@QEFMC1Y1&AA"#W-[4*T/<8LT2'/!N3^2;#,L
M;@6').6V$*590V)4*7QLQ71Y#3CR4J;=EI49L(41Z*>+VA>=Y!9IP)2>%%=E
M0]X&N1W[9+1WLC(+-VX,S)<@[P[II+?>&?G&[M[DNOG;=/()OM/1_+^#6W+G
M"UIQI#M(K&;R(-9(D-RG-R/2HSK,K9*0C<M*'5,J3NV_9T/309C<DE2LC\_L
M[\0L.DR^BJ<+M?S NJRZ*KL?62D5LS1EA<M1(:0AHI"R6PSU474U'V"B9X1<
M<I\(YCQGPIF=A2Y/BV0PGZBCDU49V%:0BHH:5I6\VI:TNM&A)$M>A'KJH]--
M%)W=T>G!D                  !K+GVU;_?6OY*P&S -2 -2  $?N<RI:+)
M,;Q2>ITK?*ES&JE*&S4V:J^.<I[O%ET1YB>FO:?06B,^=>TU9*A0K*PBPIMD
MLV:Z-)?;9=DNITU0RA9D;BBW%T21]HBN?K>MU27I;&JG_0R+O4:G*(C/N2Z_
MSFA&>SVWV '8FQAK9=DHD-*C,&M+[Q.)-MLV=2<)2B/0MFA[M>SR@*\B\\8*
M^]@K$DYE>OD94M.+',8[I+I1#225.&2E$V4C>@X^O\X2D]FHM$JEN+9E2YCZ
MZ]3*=5Z@M95#8=\V;>DV#L[TD:^V3YY:*\HBMA>WE5C5/.O[R4B#35K#DN?,
M>,R;:892:UJ/0C,]"+L(M3\@"!M\TU?YIWN9SL6R:KIJ!MJ3(38U:HLA^(Z?
MG2&&EN:J;:3]L>W;5(06IIUZ"T2JQX\AF4RB1'<0]'=2EQEYM1+0M"RW)4E1
M=#(R/4C(145O_P!%LT_N\[WF$#%X7^B# OU>JO>;0LZ4C0G(B@
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M"X XDXRM5WF%8XB#<J9]%3/?DR[!]J/_ $;*YCSQM)\ADWIJ7:$S,HLL10
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M:1_JE^X,JY@ ""\E>UQGX=A?NK'SVVOZ'SK/*^@V-_7^3?Y$Z'T+Y\
M&FR_]$[[X.E_[A8]\OUMO''C>&/U=W%/B1SA7Z*,1^#6?W!^C:':;^=+\FS.
MRX?-CQ)X/P.D            T"\*QI>8MY^J D\P:KE4C=H:W-Y5RGO2#9V;
M^[T[SSMVS=]G0!OP$5>XXPI_.F.2W:AE6=18:JQBYU<)Q,11J,T;"7W9GYRB
MWFC=M/373H A]QX9.#<@OIV36^(LR+>QD>FS%IE3665RS42U2"8:?0TEU1I\
M]Q*"4KKJ?4];61)++B/CJW;RMFSH6);6<''7E3;RW5)FJA()MA1D:_M:FR21
MI-K:9*+=[;J%1J\-X XAP"3*F8MC#$65/@NU-BZ^[)G'*@R'"<<:D>ENNDZ2
ME$6IKU/:1)]KT"9F1TX7X>.'^/,@;RC#\=]7W;"'FHKZILZ4B.W)+1U++4B0
MXVV2O^X@O8[ K(M 05>CP[<,HS4^0DXI&_.HY9V??]Y(.+Z>9Z^E>AFZ<;OM
M?.[SNMV[SO;=1:R-T?$7'*BRU+M!'>1G:T.9:V^;CR)RVDFE"E)6M1(-.IFG
MNB3HKSB\[J%1@8+P3Q/QO%M8F(8TQ$9O&2BVWI3C]BN1%)'=E'6N:X\KN=I[
M>[(]I^4@F9D=."^'[B'C6TDW>&8RS M)+*HJY+KTF:I$9:MRF62ENNDTA1F>
MY+9)(_V F:C"Q;PT\)87D4;*L;Q-F+=0EK=@.NR9DIF*MWJI4=B0^XTTHS/4
MC0@M/)H%9%L"    #5Y'_P FD_LM_P"\2 UE_C=[:STRJW)9-1')LD'%8::<
M0:B,S->JR,]3UT'+S.3Q<6_6MQ;K(X(=;*9W!P;-6_!MQ)KIF9\&XUGYDY9\
MN9_WO']R/R]VYC[B_P $/U]Z9;[:SPW<I^9.6?+F?][Q_<AW;F/N+_!!WIEO
MMK/#=RMA2XQ?UMBB9/RF7:14I4E4)YEE"%&HNAF:"(^@_3ELGBX5^M=BW7QP
M2_+FL]@XN'JV8%N'/I1-U?WN'*,.78\:9G75["Y4^90VC$6,T1J<=>=AN(0A
M"2ZFI2C(B(=:'(EYUN\HD9EPIBF"T]#DCWYOLXX]G]-ZJL(#\R@@&PU9Q(ZW
M&VN^</\ A,M+WK02B2-;Z-0Y0W,*GS'D+BO&[1G"L8R:CR3 <83%E17)SL9A
M42Y]$A+2EY$>0B1J2=A$HT*-*01O^&N.<RQ_E&HQV]BV*,7PZ#+RB';2.\./
M(N<IBQF),7>?F*]'<]-61:FHMY:^0Q)E5EVB5UGB=QNSLE;*V\PZPIJ52NJ?
M642P8FR&R]A2V-%%_I$V?L!O&^\V5G&>?8YQA@TNOQN>XG+IE37YG3E%<*57
MSZ7(3E0+-QHDFI*5Q2<C2%&1%M[I1ZC54HOG-.->5[C*K:SH[6>S4R7M\1IG
M,9]:VE&PBT3%:K'D-=2/S4N*&8F%1'/\.M<?RO!LGSR3DZL6C8Q/QVZGXM,L
M+*P:LER&I+'I4J*TU*6R]LT2XAI.KR&TN:)[4#(K/SYM87AXI,S[]/*#-O-O
MK)R7M3/:H($68R9S.[]JZZS(B-/:]KIF2NNHO"/3TK_TSW^HK^28PJH><_H7
M9^$,:_+,(6-*;RY!%     %5.?YE(WZCR/RNR+O(M410!\5[4PA)0GBS]'9?
MPI8>^%#@[#[//.N\;Z+;_:8YEGJPFX[SYY#N6?HQR_X(F?[E0_=D.T8?.CQN
M;M3LF+S+O$V."?H1C?P7"][H'Y\?K+N=/C?LP.KMXH\20#Q>P
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M;QQXWAC]7=Q3XD<X5^BC$?@UG]P?HVAVF_G2_)LSLN'S8\2>#\#I
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M+S+O$V."?H1C?P7"][H'Y\?K+N=/C?LP.KMXH\20#Q>P
M                                         T6:?H=D'P;-][K :/A?
MZ(,"_5ZJ]YM"SI2-"<B*            JWQ(?09G'P:O^6@:MTI.A9[7\TC_
M %2_<&5<P !!>2O:XS\.POW5CY[;7]#YUGE?0;&_K_)O\B=#Z%\^      #3
M9?\ HG??!TO_ '"Q[Y?K;>./&\,?J[N*?$CG"OT48C\&L_N#]&T.TW\Z7Y-F
M=EP^;'B3P?@=(
M       %4^(SZ+9'PQCWY;A"QI25K"*     *J<_S*1OU'D?E=D7>1:HB@#X
MKVIA"2A/%GZ.R_A2P]\*'!V'V>>==XWT6W^TQS+/5A-QWGSR(\J,NR.-LL88
M;4Z^Y53$MMMI-2E*-E6A$1:F9C]F1F(S%DSZ4>-S]I6S=E<2(BLS;=XG7Q5?
M5>0X!12JITW68L1F"_N0IM2),1M+3J#2LB/S5)$SF%=AXUUMVFM?#NMY+&MQ
M<&VZW12G@W)3(?D?M
M              &BS3]#L@^#9OO=8#1\+_1!@7ZO57O-H6=*1H3D10
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M<=Y\\ *PX(,SQ*T,^T[^XU^^UCJ;2ZV.;;ZL.3LKJ9Y]_K2L\<MU@
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M\^?PK</,7VVQ2(E^K9V+=BY:R^Z:S,)P/P.@
M            JGQ&?1;(^&,>_+<(6-*2Z[?DSE:KE2D%Q*^Y7-/N,QK!S(::
M.A]M*C)#A)==(T[TENVJZEY0H+ Q.XLK_'X5M<51TEG(2HY%4<IB<;"DK4DB
M[^,I32]2(E>8?373M(16Z   !53G^92-^H\C\KLB[R+5$4 ?%>U,(24)XL_1
MV7\*6'OA0X.P^SSSKO&^BV_VF.99ZL)N.\^> %7\$?HC:?#]Q[[6.IM/K8YM
MOJPY.RNIGGW^M*T!RW6
M                &BS3]#L@^#9OO=8#1\+_ $08%^KU5[S:%G2D:$Y$4
M  1NRY"P.EG.UEUE%16V3&TWH4RPC1WT;R)2=S;CB5%J1D9:EU(*#.H\HQK)
MVWG<;N8%PW&42)"ZZ4S+2VI1:D2S94K:9EV$8#;    JWQ(?09G'P:O^6@:M
MTI.A9[7\TC_5+]P95S  $%Y*]KC/P["_=6/GMM?T/G6>5]!L;^O\F_R)T/H7
MSX                         P[7_E<[^[N_R#&K/Q0Q?^&4#X#^B#%?[L
MO_?N#H[4[5?QN;LGLF'S860.8ZH
M  "J?$9]%LCX8Q[\MPA8TI*MO$%B&.97R%6>N9]!,N8=;73,;Q#(9JX7IRXE
MHXY.89-U*HY>FLFE@UZ+<)3:=4]V:C&K9HDQ5<'#&)66#\>5F-VL6-7/QW)3
MS%/"<5(CUT:7*=D,PDOK)*GNX0X39NJ+SC(S^R,RL)^(H  *J<_S*1OU'D?E
M=D7>1:HB@#XKVIA"2A/%GZ.R_A2P]\*'!V'V>>==XWT6W^TQS+/5A-QWGSP
MJ_@C]$;3X?N/?:QU-I];'-M]6')V5U,\^_UI6@.6ZP
M                                       T6:?H=D'P;-][K :/A?Z(
M,"_5ZJ]YM"SI2-"<B*     /._B/5 HEUZZ'",;M\QOV+68]>7U2U8[6<?K5
MS5-;4I)QUYU+9-LDIS1)$?;IH-6I+L\,&0,VB\PJV?S9D-P5U4IFSPRN:KJ]
M]FQB&\A#W=+62I+1DI+B3/S"-/\ I:$DAZ$&5  !5OB0^@S./@U?\M U;I2=
M"SVOYI'^J7[@RKF  (+R5[7&?AV%^ZL?/;:_H?.L\KZ#8W]?Y-_D3H?0OGP
M                       !AVO_ "N=_=W?Y!C5GXH8O_#*!\!_1!BO]V7_
M +]P=':G:K^-S=D]DP^;"R!S'5
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MM_;H:4)+:/R>[M]Q%^_K3'^E(?KC$NG'FS>U8G_6MW(E@_,_6
M                                             T6:?H=D'P;-][K
M:/A?Z(,"_5ZJ]YM"SI2-"<B*     *KYRR*)B]-4VCG(#F!V!3.[KUMUR;PK
M!Q:#(XZH"6UO.].NK*D*3_I"P2Z. ;'+9N.V3638-#PR.U,4NM=@1/5#=FET
MC-R2JL<-3T5>I$2B>4:E]O8$I"VQ%  !5OB0^@S./@U?\M U;I2="SVOYI'^
MJ7[@RKF  (+R5[7&?AV%^ZL?/;:_H?.L\KZ#8W]?Y-_D3H?0OGP
M               !AVO_ "N=_=W?Y!C5GXH8O_#*!\!_1!BO]V7_ +]P=':G
M:K^-S=D]DP^;"R!S'5                                    53XC/H
MMD?#&/?EN$+&E)1WF<KJ7EU7!P%C+7.1F()2FI&/3XT&D;B&ZXEKUJFQ-R*X
M7>)<-"/1U.*(E$1BP2M/ 6<UCXE6,\C28,S-D-J*WDU*5MPEN=XK8;:7"(]>
M[V;^A%NUT(BT(95)0   54Y_F4C?J/(_*[(N\BU1% 'Q7M3!)55B&3+Q:!,J
MK&BN'))3YCV^/"6XV:'7E*29*U+74A\?D,].5PYP[\+%F=:[196-+[3:.2C-
MXD8EF+A1&I9&[?2=RV$@^<J)\GKW[P5[H=#OJWX.-T/.YG<MWQL']3S'SE1/
MD_>_%ZO=!WU;\'&Z'G.Y;OC8/ZGF0GC+(WL.H9M9;T-NJ3(M+">CT>$MQ/<R
MWU.-ZF>WSM#ZD/W9S_(,/&Q(NMP<:E(CJ^".-S\C_CV)@X<VW8V#76NGK.&9
MG@9S>7FCD"1E!T-SZL=IF*U"?05]]Z0U*>>49IUTV[5IT/7M'GW[9[F+/<XU
M=:9_!O4C]KTC8.)[^;_?8.KJQ'6;M8F[]G[4F^<Z#\G[WXO5[H?F[YM^#C=#
MSOU]S3\;!_4\S'F\N4E;'.78U%Q$B$I#9OR(?=-DMU1(0G<I9%JI1D1%Y3&[
M-K:\TMP,:9_9A^=C$V5&'&M=CX,1\SS)9CU_"R6L;M8"'41W%+1L?1W;B5M*
M-"B4G4]#(R'0RF;LS.'&)96D\.G<<_.92_*XLX=]*Q31NQNQ5M!^Q^,
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MR_\ ?N#H[4[5?QN;LGLF'S860.8ZH
M    "J?$9]%LCX8Q[\MPA8TI*+<RUEI&SNMR?'F\Z9M_5!P'IN$PJJ9#7&*0
MMTFI7K!1&;B5*-2"(M$D?0^IBP2L;A^[_.'CVHM%2[6:^LI#4E[(F8\2X)]B
M2ZTXW+8BD33;B#3LVI\A%KUU$E4Y$   54Y_F4C?J/(_*[(N\BU1%
M   !6'/WT<O?"55[_9'9V/VF.*[Q2XFVXKE9X[?6AO.,/T6_^^G^^G!\/L'L
MD<=WK2^ZV]VN>;9ZEJ9CON
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MO?E<S@Q&+B7Q?,Q,775C0_=AX^'F\KCS.%AV39;;,3;;2?Q4X5GCZQ\B
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MI)J06AI=;=B..MK;61ZI42A!"'",O$G&/3H>#R"(_)J5NQ^^+O(M410
M     5AS]]'+WPE5>_V1V-C]ICBN\4N)MKLL\=OK0WG&'Z+?_?3_ 'TX/B-@
M]DCCN]:7W6WNUSS;/4A,QWW
M                :+-/T.R#X-F^]U@-'PO]$&!?J]5>\VA9TI&A.1%
M%4\YSL<@U%2O(\BRK'6%RE)8?PQ,M<EU?=GYCY1(\@^[TZEN(BU\HL)+3>'Q
MZZ>F9FOT[*;?!SDPOS7N,U[YJ<\?HZO2T,M2&V7"9;<V[7%-)WF9EUV:G9(7
M>,J  "K?$A]!F<?!J_Y:!JW2DZ%GM?S2/]4OW!E7,      07-OTLP;X0?\
M>ZAP-H]IR_.N\4/HMF=ES7,M]9.AWWSH                     P[7_E<[
M^[N_R#&K/Q0Q?^&4#X#^B#%?[LO_ '[@Z.U.U7\;F[)[)A\V%D#F.J
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M?_?3_?3@^(V#V2..[UI?=;>[7/-L]2$S'?<
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M_HK_ />S_?3@^)V#V2..[UI?=[?[7/-L]2$S'>?/@
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M)>370M1S,O?=.:QK9G<C4I^RL35T\>RV,M@W1&[.O6>&DQ1(QTW,
M                              !$N4_HQS7X!M/>;HL#CQ1]%N$? %5[
MR:"1+Q      >?/%7)JI./U>-R,9A9!<RF+BWKWK&;)K6XD>D@F_,-MZ":9"
MG76E]TAILR)>IFOS$F-6I+?\$N8S5R\NP;&*%51&H7:J5)F/279LN:_<5C,M
M2I;S^JU/MZ[%:JZ(V:$DN@DBY!%  !4?B>^@C,O[O&]^,"QI25N"*      "
M$9?^F>#_ -ZF>]C'!S_;,MQW^K#O[/['F>*SUTW'><
M    =,O_ -*]_LU_R3%C2S=H5SX??H@QG_9R/?;PZ6U>U8G'Y(<G8O8L+FK,
M',=@   ! ./R,LIY%U\MVS^3HH_?FI__ %X7-_-<Y62ZW'Y_Y+$_'X'5
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MF=GX-N7]]@XOO(BZ+9_AFW3%=^4P'<<,
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M28B%;U;>[==;:6HC3M,]R"ZZB*VX   *J<_S*1OU'D?E=D7>1:HB@
M   J[Q!?1K(^$*OW\R.MLKK_ /ZW>K+D;6ZC_P"UGKPM$<EUP
M !"I?TI5OP-)]\-CA7_W*WY4^L[^'_:[_FV^K*:CNN
M                    (ERG]&.:_ -I[S=%@<>*/HMPCX JO>302)>(
M "@.0>#L_P ER?)K3&,LJJNFR:;26LJ'85*IS[<O'DL]SM=*0V1H4IA)J(TZ
MZ:D-1,,S"T\%@<@P(DQ'(-U774UQXE0G:J"Y7MML[>J5I<>>-2MW774A)HTE
M@@  "H_$]]!&9?W>-[\8%C2DK<$4      %?\JQYD2M@Y972O1IU ^2V4FVE
MQ+GI:D,*(]W9H2C'S6W;;K,.W,674NPIW-S3K3%KZ;8%UE^)?E[[=:W%C=W:
M4U:W1^]/FS-2$J/M,B,Q]*^9<@
M                       !5?%GZ<<I_#;'O1 ZV=ZK!YOE<C(];C<_\L+4
M')==4_B'_0.O_63'?RM&%A)5[SS5T>8<HU&)3*[$&+2)0+MBR#-?2G$K95*<
M:*)#:CR8?5*D&M]9NGHE:=$C4"SN )]=/XJI?5-;"JX,1<R"ABH=<DU+JXDM
MUIR1 =>\]<9]:5.M*7UVJTZ]IYG20LP10  54Y_F4C?J/(_*[(N\BU1%
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M9%VA?EL&<*[$P[YNU*5K;33_ *IAYS'C&MP\6R+=>+J4NK^'_2.%: Y;L@
M                                B7*?T8YK\ VGO-T6!QXH^BW"/@"J
M]Y-!(EX@     *2\0'(MC@TS#*]&7QL#H;^5,9M,G?AHL7FUQF$N,,-LNDIM
M)/*-6]U:3V[2+IN&HA);_A7)XN3U-I(B\CM\D)CRDM*GM08U>40S;)7<FF,A
M!*UUW;C$DA9PB@  J/Q/?01F7]WC>_&!8TI*W!%      !">6OT$L?\ :1??
M+8^?_P @['=QV^M#Z'_'NVV\5WJRF;7\VG]@OW!] ^><P
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M]BT4>6A45]R.LG&R4LDGN;,R\[LT 1-PC^LG&/R?F/(Z_P#ZNR+O(M410
M                       0J9]*5;\#2??#8X5_]RM^5/K._A_VN_YMOJRF
MH[K@*QS3Z8N,/]G?^\VAT\OV7&X[/6EQLSVW XL3Q6K.',=D
M                      $2Y3^C'-?@&T]YNBP./%'T6X1\ 57O)H)$O$
M   !2OB!RFRQU6)QI.03,-P*SE2FLJS&LC%(EPR0R1Q6"=4V^F,F0LU$J0;2
MMIH).J=VHU$)+M\/V47.21LH3ZYE99@U?/:CXAF=A&*)+L8_HZ3?0O:TP3Y1
MW=6BDDTDG3U[=NH3!$U7*,J  "H_$]]!&9?W>-[\8%C2DK<$4      $)Y:_
M02Q_VD7WRV/G_P#(.QW<=OK0^A_Q[MMO%=ZLIFU_-I_8+]P?0/GG,
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M7[@^@?/.8
M       JOBS]..4_AMCWH@=;.]5@\WRN1D>MQN?^6%J#DNNJ?Q#_ *!U_P"L
MF._E:,+"2@O/N<3<)Y!Q2SM[1Z@Q*O3!E5]@S6E,:F37[1MFSBORTLONL(17
MZNDVT39N]?./8218C<296IPU.M+/ HEA9L+CMRI4]ZI2_%17R%U3DQY4)QZ,
MVAM+;BV#0HRVD9ZZJ\XS$EI/A   %5.?YE(WZCR/RNR+O(M410
M                0J9]*5;\#2??#8X5_P#<K?E3ZSOX?]KO^;;ZLIJ.ZX"L
M<T^F+C#_ &=_[S:'3R_9<;CL]:7&S/;<#BQ/%:LX<QV0
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M/=MMXKO5E,VOYM/[!?N#Z!\\Y@
M                       "J^+/TXY3^&V/>B!UL[U6#S?*Y&1ZW&Y_Y86H
M.2ZZI_$/^@=?^LF._E:,+"2A/-.0(Q'E*LN*O/)6+Y!+H%1I53&Q>7E")4"-
M*<=2^KT=:2:[I:UEV:^=U,^A"P2L+AKDS'\_QXFH&4(RC(*Y"%V\LZUZC<4B
M2I:H[I0I&JD-K06U*DJ4E1I/KKJ128H1*S!%  !53G^92-^H\C\KLB[R+5$4
M                          $*F?2E6_ TGWPV.%?_ '*WY4^L[^'_ &N_
MYMOJRFH[K@*QS3Z8N,/]G?\ O-H=/+]EQN.SUI<;,]MP.+$\5JSAS'9
M                             !$N4_HQS7X!M/>;HL#CQ1]%N$? %5[R
M:"1+Q      4'XILBRK'<9@OU=I9T.,+8M%6UU1L=],;LF(G>5+*UH;><98>
MD%M<=0WV[4&I*5F8U:DM[P9EF0YL[E&0ONNR<'D.UJ<9FOQE0_2'VJ]I%FXR
MEUMIU3)R2,DK6G12M^WH),"WQ%  !4?B>^@C,O[O&]^,"QI25N"*      "$
M\M?H)8_[2+[Y;'SW^0=CNX[?6A]#_CW;;>*[U93-K^;3^P7[@^A?/.8
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M7&X[/6EQLSVW XL3Q6K.',=D    U(
M1+E/Z,<U^ ;3WFZ+ X\4?1;A'P!5>\F@D2\0     %$>(JVA8Q8X-E7YZL85
M>0)4Z-6295/-OD3$S&$$]%[B&9;=20E>X^OF^;IU&H261PAS-39M)G8_.Y K
M,MR;<MZ&Q"IYV/J3'8T0\@FYRE&ZM"CU7L/5)=I!,$2N\94  %1^)[Z",R_N
M\;WXP+&E)6X(H      (SG]).R'%IE36$@YKQLJ:2ZK8@S:=0X9&>AZ:DD<G
M:V5OS.6NP[*:TS&G]DQ+K[)S5F6S-N)?75BM:?MB8:Q-ERFDB25!5Z$6G_K5
M^3_\L?G][M'X=G2E^KW.R_BXG0CE??6?*GXAJ_OUS^S#WNT?AV=*3W.R_BXG
M0CE/6?*GXAJ_OUS^S#WNT?AV=*3W.R_BXG0CE8_YUYK76]/!R&GA1XEK)]$2
MY&DK=<2K8I>NAH(OX(\_K<WAXMEN+9;$7S3<EZ?09/%P<2_!Q+YG#MUOXK8B
M--.%8 ^B?-
M   "J^+/TXY3^&V/>B!UL[U6#S?*Y&1ZW&Y_Y86H.2ZZI_$/^@=?^LF._E:,
M+"2A/-*H,+E"OLK-[*\:C+H$L-9AAD>5*6XHICJEP)J$19;.TDF3L=6PEI4:
M^NAD+!*V>)HF,Q,"J4X@4]5&\EU]$FY1(1:29#KRU2)$OTM*'C>==WN+4M):
MZ]").@DJFH@  "JG/\RD;]1Y'Y79%WD6J(H
M (5,^E*M^!I/OAL<*_\ N5ORI]9W\/\ M=_S;?5E-1W7 5CFGTQ<8?[._P#>
M;0Z>7[+C<=GK2XV9[;@<6)XK5G#F.R    C%QK^>6-EJ9$;-CJ1&9$>B&=-2
M\HY&8G_^S!YN)^5U<O'_ /)C<>'^9)QUW*
M  1+E/Z,<U^ ;3WFZ+ X\4?1;A'P!5>\F@D2\0     %)\_RTT$S#<NJ+URN
MSRME38N-TC=6]?\ K=,UA/I4?T**IM[S4-)<[]MQ/=D1D9Z+T&H26DX=QR%F
MELSR#894_:9G27L^?D52]4JI%0K";5-UR(GH4A2WHZ&XY)5OWJ-\]%*4>A$2
M1Z'&5  !4?B>^@C,O[O&]^,"QI25N"*            @^=_\^PGX6_\ D.#@
M[2Z_+\_R/HME=1F?E_FA.!WGSH
M                   JOBS]..4_AMCWH@=;.]5@\WRN1D>MQN?^6%J#DNNJ
M?Q#_ *!U_P"LF._E:,+"2I>PQ7EZCY-E9S2<?7MEE#652Y4O)&LAAHB66)*4
MZAFN3"?E)0ELF^X4A+C6Y*T;B41C44HFZ]48M:VMW0P[.\I7L>M9"5*DTTEU
MF0]'42U))*G(ZE-JU(B5YJO+[(PTW    *J<_P RD;]1Y'Y79%WD6J(H
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M  -W*W]'0?QIG[P?^G_T_P#,_P#,_P"[_@;N5OZ.@_C3/W@_]/\ Z?\ F?\
MF?\ =_P<859F\K(ZVUR#U6B' ;DHVP52#<,Y"4E_\4M.AH(7"R^<NQ[,3&G#
MI9%T?PZW^[CXC%Q\G;E[\/!C$UKYM_%JT_AKP<::#O."
M            B7*?T8YK\ VGO-T6!QXH^BW"/@"J]Y-!(EX@     *%\0]I7
M4N1\>6#^4%@=L<BSCU>:O$Q)AQEO,-=Y$E0Y&B7FY24]%[T=VMM)[NHU"2D'
M!T/&%M9'DE;G,?D3*[J6P>3Y'$3'8:WQ6":BQT1HIFVRAIKL+52E&9J4H]1)
M(6T(H  *C\3WT$9E_=XWOQ@6-*2MP10           $'SO\ Y]A/PM_\AP<'
M:77Y?G^1]%LKJ,S\O\T)P.\^=
M                  %5\6?IQRG\-L>]$#K9WJL'F^5R,CUN-S_RPM0<EUU3
M^(?] Z_]9,=_*T86$E; B@"!9%S)Q_BN2)Q:[LU,623BE8/(8>=AUYV*S:A^
MG24(-J-Z0LMK7>J3KV]",C%HC?9=F5+A->S8W7I*T27TPXD>#%D3Y+\EPE*2
MVVS&0XLS,DGU,M"\IB*^XAF6.YW3(O\ &)A3:Y3CD=PS0MEYF1'4:'67FG4I
M<:<0HM%(6DC+]@P$(<_S*1OU&D?E=D7>1:HB@
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M6WS3^&+HG1,[\SP+?''=Y$N4_HQS7X!M/>;HL#CQ1]%N$? %5[R:"1+Q
M  >0.;<SR:KSC+GT7N2Q[3'7*I.%XE7U#\_'[.(ZTR[..;MBO(?-SO'F^KB%
M-;2VZF-Q"5>C..LNPS+X$Z9A45Z+!CR.YDD_62*@U.["5J2)#+*EEH9><1:#
M,Q1:IF(   J/Q/?01F7]WC>_&!8TI*W!%            0?._P#GV$_"W_R'
M!P=I=?E^?Y'T6RNHS/R_S0G [SYT
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MSDGI&&2'DOWS[,EUG_BS);&C999(DGY2,C[!=X7R,J
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MGY?YH3@=Y\Z
M    *KXL_3CE/X;8]Z('6SO58/-\KD9'K<;G_EA:@Y+KJG\0_P"@=?\ K)CO
MY6C"PDK8$4     54Y_F4C?J/(_*[(N\BU1%
M                                        5?RI^EG&/ZP'[U='5R75
M8W-\L.1GNMP.?^6Y: Y3KHERG]&.:_ -I[S=%@<>*/HMPCX JO>302)>(
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M^7^:$X'>?.@
M   "J^+/TXY3^&V/>B!UL[U6#S?*Y&1ZW&Y_Y86H.2ZZI_$/^@=?^LF._E:,
M+"2M@10    !53G^92-^H\C\KLB[R+5$4
M                                    !5_*GZ6<8_K ?O5T=7)=5C<W
MRPY&>ZW Y_Y;EH#E.NB7*?T8YK\ VGO-T6!QXH^BW"/@"J]Y-!(EX@
M  U&1XKC685Y5.55$.ZJR<2^4.QCMRF2=;UVK)+A*(E$1F6OL&9>4!]=Q?''
MUQW'Z>"ZY$BN5\1:XK*E,PGDI0Y';,T^:TM*4I4V7FF1%J0# I>/,"QJ;ZRQ
MS%JBGL>[-CTNOKXT1[NCTU1O:0E6T]"\W70!"/$]]!&9?W>-[\8%C2DK<$4
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M[>NQU*5IUZ'HHM2'T5MT71$QOOGKK9MF8G>=@TR
M               JOBS]..4_AMCWH@=;.]5@\WRN1D>MQN?^6%J#DNNJ?Q#_
M *!U_P"LF._E:,+"2M@10    !53G^92-^H\C\KLB[R+5$4
M                                                  !5_*GZ6<8_
MK ?O5T=7)=5C<WRPY&>ZW Y_Y;EH#E.NB7*?T8YK\ VGO-T6!QXH^BW"/@"J
M]Y-!(EX@            J/Q/?01F7]WC>_&!8TI*W!%
M           1+D[] K[^ZJ_=(<?;/8\3B\L.YL+M^%SDBJO^60_]@W_)(=+!
MZNWBCQ.1C=9=QSXV6/9Y                                    *KXL
M_3CE/X;8]Z('6SO58/-\KD9'K<;G_EA:@Y+KJG\0_P"@=?\ K)COY6C"PDK8
M$4     54Y_F4C?J/(_*[(N\BU1%
M                                5?RI^EG&/ZP'[U='5R758W-\L.1G
MNMP.?^6Y: Y3KHERG]&.:_ -I[S=%@<>*/HMPCX JO>302)>(
M *C\3WT$9E_=XWOQ@6-*2MP10                           $2Y._0*^
M_NJOW2''VSV/$XO+#N;"[?A<Y(JK_ED/_8-_R2'2P>KMXH\3D8W67<<^-ECV
M>0                                   "J^+/TXY3^&V/>B!UL[U6#S
M?*Y&1ZW&Y_Y86H.2ZZI_$/\ H'7_ *R8[^5HPL)*V!%     %5.?YE(WZCR/
MRNR+O(M410
M             %7\J?I9QC^L!^]71U<EU6-S?+#D9[K<#G_EN6@.4ZZ)<I_1
MCFOP#:>\W18''BCZ+<(^ *KWDT$B7B            "H_$]]!&9?W>-[\8%C
M2DK<$4                           !$N3OT"OO[JK]TAQ]L]CQ.+RP[F
MPNWX7.2*J_Y9#_V#?\DATL'J[>*/$Y&-UEW'/C98]GD
M                   JOBS]..4_AMCWH@=;.]5@\WRN1D>MQN?^6%J#DNNJ
M?Q#_ *!U_P"LF._E:,+"2M@10!&K7D#"J._K\6N;Z# R*UT] K)$A#<AW>>U
M&B3/IO41I;W:;U=$ZF%!L[Z_I<8JI-YD,]BLIX:27)FRG":901F24D:E>52C
M)*4EU49D1=0'R@R&DRFJCWF/3V+.HE)-4>9$<2ZTO0S2HM4]BDF1I4D^J3Z'
MU 5ZY_F4C?J/(_*[(N\BU1%
M                           5?RI^EG&/ZP'[U='5R758W-\L.1GNMP.?
M^6Y: Y3KHERG]&.:_ -I[S=%@<>*/HMPCX JO>302)>(            *C\3
MWT$9E_=XWOQ@6-*2MP10                           $2Y._0*^_NJOW
M2''VSV/$XO+#N;"[?A<Y(JK_ )9#_P!@W_)(=+!ZNWBCQ.1C=9=QSXV6/9Y
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MO$.3&89.G*);F&2%QI**YFL[EKULSYFUE:R7^R?9^V$Z!?(RH
M                                                    "*9;A[F2
MW&*VB)A1DXY8G8K:-O>;Y&TIK81[BV^VUUZC]6#F/=VWVTKKQ3][\F/E_>WV
M75IJ37CW)CRI6/ROUHERG]&.:_ -I[S=%@<>*/HMPCX JO>302)>(
M     *C\3WT$9E_=XWOQ@6-*2MP10                           $2Y.
M_0*^_NJOW2''VSV/$XO+#N;"[?A<Y(JK_ED/_8-_R2'2P>KMXH\3D8W67<<^
M-ECV>0                                   "J^+/TXY3^&V/>B!UL[
MU6#S?*Y&1ZW&Y_Y86H.2ZZI_$/\ H'7_ *R8[^5HPL)*V!%     %5.?YE(Q
M^3\QY'Y79%WD6J(H
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M:_>B!UL[U6#S?*Y&1ZW&Y_Y86J.2ZZI_$/\ H'7_ *R8[^5HPL)*V!%
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M4+,I1E>)^'%/A#,9:F&U2DQHR4O&A)N$7IC'0E&6HD:25Q"*
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M:1E,+-,05E;RYC+"%PKAE^,E]$4X[;6R&XB2DD-+W&A2.BO.,2="O0(RH
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M4A2A5Z5P2_=RO"<;RI]E,=^]JH-H['1KM;7-CH?4A.O70C7H6HQ*I
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MOD7FW^&;#W 4#Y_:;Y%YM_AFP]P% ^?VF^1>;?X9L/<!0/G]IOD7FW^&;#W
M4&+8^)#$Z>(JPN,7S"OKT*;;7+E8[/::2M]Q+3:34:--5K4E"?949$%$99\^
M4Y&9'A6;D9=#+\V;#W 45\^?VF^1>;?X9L/<!0/G]IOD7FW^&;#W 4#Y_:;Y
M%YM_AFP]P% ^?VF^1>;?X9L/<!0/G]IOD7FW^&;#W 4#Y_:;Y%YM_AFP]P%
M^?VF^1>;?X9L/<!0/G]IOD7FW^&;#W 4#Y_:;Y%YM_AFP]P%!Q=\05"PTX^_
MAV:M,-)4XZXO&IZ4H0@M5*,S1T(B+4PH.J%XBL9LX<>RK,4S*;6S&T/PYD?'
M)[C+S+A;D.(42.J5$>I&%$J[_G]IOD7FW^&;#W 44^?VF^1>;?X9L/<!0/G]
MIOD7FW^&;#W 4#Y_:;Y%YM_AFP]P% ^?VF^1>;?X9L/<!0/G]IOD7FW^&;#W
M 4#Y_:;Y%YM_AFP]P% ^?VF^1>;?X9L/<!0/G]IOD7FW^&;#W 4 N?*<ST+"
MLW,S["_-FP]P%!BP/$?BELPJ54XOF$^*AUV.M^-CL]Q"7XZS;=;,R1[9"R-*
MB\AD%$JROG]IOD7FW^&;#W 44^?VF^1>;?X9L/<!0/G]IOD7FW^&;#W 4#Y_
M:;Y%YM_AFP]P% ^?VF^1>;?X9L/<!0/G]IOD7FW^&;#W 4$-Y,Y%^<.DJ\9H
M<-R]%D[?4<A*YF/S8T9#46R8>=6Z\XDDH0EM"E&H_8%B$>BQE0       $-S
M[C>GY *I?ESK"FNZ*0N537U*^F+815OMFR\E"UH<2:'6U&AQ"T&1E]DB,6)&
MRPG#:3 ,9@8GCR'$55>E1-J?<4\^ZZZM3KSSSBNJW'7%K<6KRJ483(D @
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MM%W-?8VMO9(KVJ*N?NI93#@5##G>(A1MJ&]K6XDF>_<L]J=5= F2BR1%
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M85,K9+4Q@G4$1J0:V5*3N(E$>FOE(0;4
M          5=X@,JR##^/DVF,S'X%F_;5%<<J%%:L)B6)\YJ.]Z/&>(T..FA
M9DA)^46(JDHM4<E9M5IJL1I:RUSG.K=%C<.,Y2F+BKT*HKW&8^KJ6F%$?>O.
M);C[6C-1J4I1DE(M!7V9<YY#D-=;93AEC,I:M[CY-S%KUDWWD2W:OS@2%&9I
M41K1L6SK[4R+4A:),K,NN?Y55:7E@QBRY7&>*W<?&,DRKTU#<AB>^MAIQQF"
M;9J=8CN2&D.J[PE'J9H2HD'K*+5BN^)VG@6E357%&Y#=>?R&)D;B92'45+^/
M+?0RE9DVDG?3?1U=UMTTU+M"@WKO/F/1L#D9)(9:3F,7'2RJ3A"9:%3FXZHR
M91(4O81$>Q2=5;>GL"4*L3/_ ! ,8(JS2YCKT\Z[%X>6Z(DH:-STZP37E%(C
M;5HI)JW[^P^S3RA0JD&$\D7=QF%M@&9XZC',K@P8]Y#:CS4V4:553'7&$K)U
M+;1H=:=;4TZVI/;HI)J2KHHJ#RH?*9<S1L"8Y.L&Z>712\FU]5U*G$+CV,>,
MB.2E1S,V]CQD>OG="/47<HC Q+F_)I%#C-3BF,RLJO;BOO+I;]W;QXBVHU1:
MKB+2\^B-L/<:DH9VM]"T)70E*"@VE/XE"=C1,@R?$Y%)AMSCEGEE!8)EM2YK
MT6C::>EM/Q4I03+FQU*FOMJB5V'M,*%6?Q!X@&N3LCD8Q)J6(%AZK;O8KM=.
M]:1TQU.I97'E.=PQW4ELUH/8G>E1&>U7FF$Q0B4<R?+\NI[?Q$9!!O):5X32
M1#QFM6;;E?$><IBG&^3*D'N<[TM=5F9:=- IH&;5W_(."VW&TB_RQS+,4SY2
M:Z?&L8D5B=!G/5SD]J0PY$0T2F=65(=0XD]B3)1'V@,2C\43US.OZ>%CD2TN
MZRFFW]9'I;54Z/+16.I1(B>D*AM([_:HEMJ8[UI>NA*Z=6J5;C)/$C!@P[BT
MQBA=O:*GJ**VDVANJ89:=R9PCC(?2AEY:&FHQ^E2'D$O8DTEM,S#5*L+*\XR
M&]Q/ <UK[=JM?7E]75O)QFT;M*>RA39J(SI..&P@U)4G=HVI*%MJ[>H4'H$9
M4                                       !UO]]W+GH^A/[5=T:O:[
M]/-U^QJ \5\2N8NX7A[@XQZ-\YT&?=GF339)]9L,IBRT6GK(B^V)W2#;V]_[
M9>W;Y!Z3OLQO/; \V@          >7.;YW&F7Y<?$<)R@I,B?FUMIG&93'(<
M&97-,.H?C-1WG#0Z[8/I;)MO:9]TT>JNU)#4)*"\AG2^IN<*RV]%^?&7FE<[
MAS2^[]>NQC76E2J@&?VU2$$3NG<^T^V;M"W#4)+[F[E(FFY<J)AQ"YWE\AP'
ML1:>)KU\MLY-<=2N&9_;NZ3'2YM-L]J4]X1Z:JU0/;@\V@        !YN\5%
MCD,RJ=QQS'K:=QZS2V5Q<SZIA,EF181V5IAPY1F\T;4=I?\ YM]1I5NV(21>
MV&K4E!<1ML,7?<9W?++$:!@;G$;<2I3E*&40U3F'V43^Z0\:D&X[%2TM))\]
M;)]FFI"RC3<>+QZK?PUWG;T=F@7Q,XU4GD>PV#(K-XWFFBD:D<CT%435"?MA
MHZ:=#%G]A#TMX=6;YC@[ 6<F)U-RBEB$ZF1KWR6MOV@ED?4E$UL(R/K[/48G
M2TLX0        4;XKBLE<8P4QG66*5614B<G?FMF] ;ISF()Y<QM)I-<9*^[
M4\G4M4:D?FZC5HI&RO&I31XQ9R:C(..L1Y%Q-5YFU5!BU]385\R(ZZIJP3$U
MBJ3"D'&0ZO=L)*D;R(R,:HS5W3G<77=V]K#]%/@OYVZ9U]]HD>I>\*E-N6\L
MR^U>C>LC8WK/[7WG77M#D%T^'DX#UORK,Q8VCX\DY6XO'5Q=/0UO)A1DV"XV
MWS3:.22O.1YAJW:>49EI>(R        (OR2ZPSQ[EKLJ+*G16Z6R6_"KU&W-
M?;3$<-3<=9$9I=67FMGH>BM!8'B3&3DE5P6*>?CMQ=/<76T>H5A[;:'JZ(VF
M,Z\F[V$I;CSJ-&F%F:$D^ES1HE*W%N64@Y:=QVW7RC*X>*-)P%.%8VC)58PE
M'H:G6[SO%I440B2I:*OON\(NI,Z)/IT""5P\9/8S,\0&;S>,EP'<#+&J1FW>
MI39.N7>)?DFSL4Q]K4M,0TDK9V)VD?D&9T*]!#*@
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MAMD@_M9)))%H6[4S5*+K$4
M   :V-C])"L9EQ"K8D:XL"2F?8,QVFY,@D=$DZZE)*7IY-Q@-D
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M)U*B2LM3T474@&Q =,B7&B=UZ2\VSWRR99[Q:4;W5>U0G7351Z="+J [@
M8=?;5EJRY(K9C$R.RM3+KL9U#R$N(]LA2D&9$I/E(^P!F  #JDQV9;+D:2VA
MZ,\A3;S+B26VMM9:*2I*M2,C+H9& TA0,.I8+&(HC5E?6ST/,1: FX\=A]"]
M3>0W&T)*R/?YZ22?;U 9K>.T;-1^;S59$1C_ '2H_JE,=I,+N%ZZM]P221M/
M7JG;H R:ZN@5,-FNJXK,*OC()N-$C-I99:078E"$$24E]@B 90
MU57C6/T3LM^DJH58_8+)Z>["C-1UR'",SWNFVE)K5JI756O:8#LJ:"DH(JH-
M#71:N$MQ3RXT%AN,TIUS3<LT-)21J5IU/3J ^T]%2X]#]7T-=%JX&]3OHL%A
MN*SWB_;*V-)2G4_*>@#8
M
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M.Q98:DPIEA6RGS3((S42UF^VA&PU*3N+8G4(C03*)6O(_*ME)S^= SJ)CK&
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M2N9J[9A]M^4W*C/,-))+*T*:2VZEOS5&@CZBH]2C#0
M
M
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MYA>OXOYI%BA0_4'K7<KT7T\S/O=-_>_S?7?O[SJ+N[H] C*@
+           /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>fc_screening-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_screening-4c.jpg
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M;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (  @ X0DE-!"4
M !#\X1^)R+?)>"\T8C0'6'?K_^X #D%D;V)E &3      ?_; (0 ! ,# P,#
M! ,#! 8$ P0&!P4$! 4'" 8&!P8&" H("0D)"0@*"@P,# P,"@P,#0T,#!$1
M$1$1%!04%!04%!04% $$!04(!P@/"@H/% X.#A04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@ OP/8 P$1
M  (1 0,1 ?_$ *\  0 " P$! 0             &!P0%" ," 0$!  ,! 0$
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M$;;FNJ/ "5L@@
M
M   &D0_BF+/5V/,E#JG;J1(*MKF4(9]3)VKE2#0V@B(U:$MQQ7\I]3 8=?Q]
MQ]3D:*S&JF$E4UJQ-+,..W_O[.IM/%H@M'$;CV*\4Z]- 'N_BF$M1%,R:6L1
M!8CRT+;<C,$TB+.<[\M)D:=";>66]TO!:NJM3 86,XYQP[2UUCBE-5)HY4A%
M[5NPXC+;2I3S9DB6V1(+1PVU&DED6[:>G@ S"PC"$VT[(BQ^M*[M&E1;&R]*
MSZB0RZ1(6VXYMU42R(DJ(S\W0C\" >$[CCCRRCIA6.*T\J,79V,/P(SB"](S
MZ=G1*D&7Z)H^VC_-1T+H P*3$N)L@CP+RBH:2=&K2775<UB''6EA,"4HC:85
ML\I-/H4:=G0E:F0#,L*SCF$]65UA7U3;UNY/A54=<=DS?78H7(G-MEM/4GTM
MJ6_]"]/-J ]VL"P1NS:N6,<JTV\8F&V9R(C!/M>D1L9)*R3N2;:/(G0^B>G@
M Q,3I^-*F[NXF%5M37WL,HS-\W5QF8[J"<:[L=#O:2GH:#WI+\NH#:9'AN(Y
M@VPSEE#7WC44U*C(LHK,LFE+T)1H)U*MIGH6N@#\9PS$(]?65+-#7MU=+(3-
MIX28C),0Y3:E*2\PC;M;<2I:C)2"(R,S ?LO$,1EL6S,ZCKWX]Z:'+Q#\5E:
M9JF2(D*D[DGW-A)+;OUVZ= 'W>8QC&4UY4N1U,*XK&EH=3!G,-R6DN-_85L<
M)1$9%X']0#)<J:61)@6;L*,[,JTN%63%--J<C(>02'"969:H):2)*MIEJ70P
M'A88YC=I)7)M:J%,F/MLL..R6&G7%M1'O4LH,UI,S2V[^E07@E?F+J ^/E/%
M/5*E_<L#UJW9$I3WIF>X;\QI+$APU;=34ZVE+;BO%22(CZ ->?'?'BJERG/&
MJHZ93;+#D3TC'9-J&XMQE!EMTT:6XM2"_--1Z::F ]%\=X"XS&CJQBJ.-#;E
M,1&/1,$VTS8:^I;0C9M)#VI]Q)%HK7J R"PO$"OVLK*A@%DS#11F;?TS7K$,
MDG82$N[=Q$2?*77[/3P >]=B^-4ZXCE33PH+D".N%!5&CM,FQ%=63BV6S0DM
MK:EI)1H3T,RU ;8              82Z^I=GLW;D:.NS8:7&CV)H0;Z&7E)-
M;:'=-Q)4I*3-)'H9D0#2*XZX\4Y6DK%ZC?3N.2:E'HH_^ZN.N=U:V4[-$&;A
M]PS3^?YO'J P+KBK +>LR6$U4Q:J1D\61"NK6M98CS5-RB_3'W=A^91^96XC
MW'U5J RXW'''D2@?QEK&ZHJ"P6EV9 ]'')B2^1%HZX@D$E2_*1DK34M.G@ S
MV\/PZ/&1#;HJYN(U =J$,%%92VFL=,C=BDG;H3"C(M[?V3^D@'G&PC"H-ZG(
MXE!71\BV=I%DU%91)V);)KHLDDK4D$2-?';Y?#H \X%%@G'E?;6M76UN.5NQ
M=C<R8K#41O8RE2U.NFVE.I)22CZ^'70!OH4R+8PX]A"=2_"EM(?CO(^RMIU)
M*2HOR&1Z@/<
M
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M3CCEC!963J'I'K%,I<=6XA@GMC>Y+*5$TG1.A)21%J1:@JF@
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M,^OB!5?O'53(HL$QZEEUC=-+@0&(S]8RZE]MEQI!)427$$1*(S+77\H(2<
M
M                         '(W/[]<OFXH=Y.I8]:G%X;T=G);>UIXG>.?
M,2I3!UJBW.FDBW;_ ,W30%H265RWDK6=,8S6S(/W4FXJ\<K\&*,Z]8V%'.BM
MN.7+4U+IJ[2$K<4E6W8E#9DXK>8(;;B# L8I.7.2/NZ/*0C&I5;$HT/3YTEN
M.Q.JF7GTDE]]:5;W%J5JLE&6O30M %_ @
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M&OF_BAH8,:L-W'IRK1UN<_>5:'HRGH#-78*K7]A[]LIPW4J-MMDS-2"-73P
MHW)<Z'(R!^D@8I-D1BMK'&XEF<F*VR_<5\)4]#)(4ON)0ZVDR[IIT0KHH"B4
M\19==9YQSC^7W\!%=9V\5,IR.THE-&E>IH6C12C)*TZ*2E1[B+H?4$)L
M
M                                                  /E;3;G5:$J
MT\-Q$?\ . _.TT3A.DA/=).PEZ%N)!GKMU^KIX /K0B,S(NI^(#]
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MX/0QL9QQER/2PMY1([K[TDVDK4:]B5OK6HDD9Z)3KH1=" ;L
M
M
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M<9CJ:[;JF6Y$M.]AAU]*#:;==3YFVUK)2BTT+J6H2<
M    1>5R+A<)!.2[9MI!W*,8U4AWI<.&24QC\G0SU+S'Y-#UUT 8MIRM@-/(
M?BS[<DOQ'9#,Q#3$AXV/1$T<AQWM-JV,M=YLG'E:-I-6AJUU ;P\FH"O(F-E
M8-*O)\1RRB0D'O6N&RI"%/>74B1N<21&9^;Z-=#T#;
M
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M\]\K97CI9+BF'E"@S:K%G<CFV\V4J/)2V\\Y%:*"V2%$MU"V]QFORF9I1XJ
MA]L\YW\;(V(3U5$?Q1J^C82ZXN2M%ZY:O0T2/6%'-!-%%-2M-=^[9J[]DM *
M-1!YMR3):Q46\BIH;MJWQDT5]<[(8E)A6]JB(LU.OLJ9DL?F]^,M2'=3+R>(
M%&;_ /(;(ZY#US<X]"7CC\'*I54B%*=5.6[A[ZFG>\2VB0E#Q$6W;N-'4SZ
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MK4F0\U$C)2Q 2M+*$,PF6&B_6+4M6S<M1ZF?AH3588(
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M)**1[$I,AZL2\LHBWTR9!$XIHCV&O0B+<9:] 3Y+U!
M      #G;\9_^$U?^\-9_M03#HD$            .>.5?XH.$?[&]_8U ET.
M"                        '.5I_&K2?N8Y^T/@GR=&@@
M
M                    <^Y!_&/B7[FROVJ0"?)T$"
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M.J=^AZ")BDT3;=S1$ZMPTRU':0PPVEIELB2VV@B2E*2Z$1$70B(0L^P
M                          <^Y!_&/B7[FROVJ0"?)T$"
M            '.WXS_\ ":O_ 'AK/]J"8=$@@           !SQRK_%!PC_8
MWO[&H$NAP0  "AOPI_\ 2F:_OK=_SLC;+QCT<G;<)]97R,76 *+R7^*[!_W7
ML_\ 7&-H]D^KDN^]'HO08NL 4)^+7_H''/WKI_\ U.#?#Q^#D[KVQZPOL8.L
M 5?^(W_ W.O^5N_^I(TQ>Z&'<?;E)N,O\-\._P"1UG[(T*W<97Q^R/1*A5H
M**X!_P"MN:?WN=_U1#;)PCT<F#W7^J]1BZP!SE:?QJTG[F.?M#X)\G1H(
M 4=^+W^'[*OZU?\ M[ VP^^'+W7VY7)3_P!TP/\ ^9G_ -!#*73'!FB$@
M "B\D_BOPG]UK+_7&-H]D^KDN^]'HO08NL         49^$?_!>#_P RM?VU
MT;9O<Y.U^W^Z\QBZP                            !77/?\ @KGO_))W
M^I4-,?NACG^W/HVG$O\ A5@W[OU/[$T(O]TIQ>R/2$Q%&H
M                 #GW(/XQ\2_<V5^U2 3Y.@@0
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M)9-[RGCM-G^/\:,[I^67IN.N1(^BBA0V65NG(D'UVDK9M0GQ49_4"$Y
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M
M
M
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M>][ VV70W>+J/F2C^-1[WL#;9=#=XNH^9*/XU'O>P-MET-WBZCYDH_C4>][
MVV70W>+J/F2C^-1[WL#;9=#=XNH^9*/XU'O>P-MET-WBZCYDH_C4>][ VV70
MW>+J/F2C^-1[WL#;9=#=XNH^9*/XU'O>P-MET-WBZCYDH_C4>][ VV70W>+J
M/F2C^-1[WL#;9=#=XNH^9*/XU'O>P-MET-WBZCYDH_C4>][ VV70W>+J/F2C
M^-1[WL#;9=#=XNH^9*/XU'O>P-MET-WBZCYDH_C4>][ VV70W>+J/F2C^-1[
MWL#;9=#=XNH^9*/XU'O>P-MET-WBZCYDH_C4>][ VV70W>+J/F2C^-1[WL#;
M9=#=XNH^9*/XU'O>P-MET-WBZCYDH_C4>][ VV70W>+J/F2C^-1[WL#;9=#=
MXNH^9*/XU'O>P-MET-WBZCYDH_C4>][ VV70W>+J/F2C^-1[WL#;9=#=XNH^
M9*/XU'O>P-MET-WBZCYDH_C4>][ VV70W>+J/F2C^-1[WL#;9=#=XNH^9*/X
MU'O>P-MET-WBZCYDH_C4>][ VV70W>+J/F2C^-1[WL#;9=#=XNH^9*/XU'O>
MP-MET-WBZCYDH_C4>][ VV70W>+J/F2C^-1[WL#;9=#=XNH^9*/XU'O>P-ME
MT-WBZCYDH_C4>][ VV70W>+J/F2C^-1[WL#;9=#=XNH^9*/XU'O>P-MET-WB
MZCYDH_C4>][ VV70W>+J/F2C^-1[WL#;9=#=XNH^9*/XU'O>P-MET-WBZCYD
MH_C4>][ VV70W>+J/F2C^-1[WL#;9=#=XNH^9*/XU'O>P-MET-WBZCYDH_C4
M>][ VV70W>+J/F2C^-1[WL#;9=#=XNH^9*/XU'O>P-MET-WBZCYDH_C4>][
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M>Z^U=Z*L'TCY8
M
M                           $PP+]=._JM_SJ'E?D.%KV/QO&[X)N/'>V
M                        U>1_W'-_L_Z2'3VWW+7+W7VKO15@^D?+
M
M
M           F&!?KIW]5O^=0\K\APM>Q^-XW?!-QX[VP       &&Y;5;,U%
M:[.CMV+I:MPU.H2^HOK)!GN/_P  &8       #X)UHW#9):3=21*4WJ6XB/P
M,R\0'V     U>1_W'-_L_P"DAT]M]RUR]U]J[T58/I'RP
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MY:*41&>I-ZF!*P00U>1_W'-_L_Z2'3VWW+7+W7VKO15@^D?+
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MK2LOR&")7."&KR/^XYO]G_20Z>V^Y:Y>Z^U=Z*L'TCY8
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M/*:N;#EBRVZ)_P!HHFXZ',
M          F&!?KIW]5O^=0\K\APM>Q^-XW?!-QX[VP
M  &ML<>H+=]B5;54.?*C?_C/RH[3[C?77R*6DS3U^H!L@ !J\C_N.;_9_P!)
M#I[;[EKE[K[5WHJP?2/E@
M
M                                   3# OUT[^JW_.H>5^0X6O8_&\;
MO@FX\=[8                       #5Y'_ ''-_L_Z2'3VWW+7+W7VKO15
M@^D?+
M
M                    F&!?KIW]5O\ G4/*_(<+7L?C>-WP3<>.]L
M                 !J\C_N2;_9_TD.GMON6N7NOM7>BK=!]&^7- #0 T -
M#0 T - #0 T - #0 T - #0 T - #0 T - #0 T - #0 T - #0 T - #0 T
M - #0 T - #0 T - #0 T - #0 T - #0 T - #0 T - #0 T - #0 T - #
M0 T - #0 T - #0 T - #0 T - #0 T - #0 T - #0 T - #0 T - #0 T
M- #0 T - #0 T - #0 T - #0 T - #0 T - #0 T - #0!+\"_73OZK?\ZA
2Y?Y#A:]?\;QN^";CQWM@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>bc_sfupbmc-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_sfupbmc-4c.jpg
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M%!04%/_  !$( 8H#Z ,!$0 "$0$#$0'_Q #1  $  @,  P$
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MI'F<)B#DJ8%U"C_^9;3]FU$7'?:$(KN?*2^2[:Y6#X&R!<,W%VN,L:56,!
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MVXC8H"(C09] H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H-2O\
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M?N>=.'U07^=I#W6F>X4S,.EK8:*F(YI'XLJD@X9KKJE-)OCW.FL0A1N*MPL
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M$.VJ-F-W[)V==)JX275;'Y3DB2A3F34^].!1$2C]@:@]4I%BNZ69(N4E'C<
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MB!3>Q@)1_E!0;4Z>MSY+/F^80$S+M,ED<+F#Q(95&D(BVE&IB<Q%?EI"*95
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M)^D.'C<0QJ$A,OF&,QA\P_R"(F&9&Y70J2&D540*:Q+CRR@4PCZ-PL-J5*+
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M//["%AMKHS6J*1Q*$Q;.S1\>ASC+P8NG[UY9R[=NC/2@9==50!,<XV_D+V%
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MN-2JJ[*=-6R[[%6>(_1-N,1%O%Y6);'<O2@B_<6$Y^:1<%=)Q*7637IL <.
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M#WCCK[YN)KC2)HKPSV)VG88HPPAKC2">,QD@E--6955P.,DW-J(Y56YG-54
M>%U3FN' >  %2HFI3;7!YR?>Y1,0J#Z;DH@^-/W#C6H1:'45YQFITA-RQ*)^
M\(Z-7V:"MX-T\[/[;R:\SB.-)M9-P@=D+ARX=/Q3:*#<R*0.U503(-["! "X
M<!X59F92CX8OTV[*X9DR67XWBB#2=;&448J&7=+H-#K7$YFS=94Z*(C?M3(%
MO):E2C5O71-R['!,4QY.55@<1R?(&T7EDV@!A%!@<HF$# 6PB2P&4,4![W+T
M]@C2!G;VX9MC*=.+7&7&X!F<-B#%%YCL^61;K*N7,8U.FU!44[ OKO8")V,)
MK"7B 4B<3<NO2IE64YIL/B60YBHHXG%D5T3O5QNLY1;.5445CB/$3&(0MS#Q
M-ZKRTDAN6HI0*!0*!0*#ESK_ /X?5_EB/_G4JQM'1.(?HE _)S/\@2H)J@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@YMRG8S<&#R>;G=HWT,O!9*\/*R
M.,9%XE!-K)KV!=PS<M2G-I7$-:B*A+ :XE'C8/MT.KNTHI2L.=U70V:\YJTE
M<]GMH9/"Y*6S;-I-O,;ASB*+)PK'I'1C6$<V,)TV;,J@BH)1.(J***#J.:W
M+7'PUM:[5NK+Z>GT+=&S+:V_7B^@H% H% H% H% H% H%!IO=CJ#8;699!84
M3$IS*\AR!JL]9,\?0(Z5%-N(@<.6)RF$0 HF'2'  JQ%4JD]L-^\%W.QB3R5
MN=;'0@79H[((_(.6P<,'11MI6U'$@7'@'>[0$! ! 0I14IF>\F 8*RQR0F95
M)5IE<DWAX19FHDNFLLY-IYHJ:P(5%/M55$UB_P H@%0?7$MS&&3KY<5U&NH%
MEB,DM&.)"4%)%JY(@%Q<HJ <0Y(AW@,:W 0HE5E3R*"69M)%*39J1[\P)L79
M'"1D'"AKV*D<#:3F'2/ HCV454\ZWGV]V^PIQGTQ+).\>;KD: I&*)O5%72A
MP)R4@(?28X7U&#4&DH"(U:)5>6KI!ZW3=M5"+-5B%4162,"B9R&"X"4Q1$!#
M[(#45H_.^JO!,!S%_BTC$3;QA JM$,KR5BR%6*B%9$ %L5PJ)BCWKAZDH^@7
M48!+5I*5;T(<JA0.0;D, "4P=@@/&]17+[,!#K.SL1"P#@[$0^R'C6H5+M@W
M-7D% H($?T^#_9__ .8#6MR;T]65*!0:\W!_2*'^3W7PA.NQVSZKN3A]X^BS
MG\E>KN/S90*"/7_SMA_=W/\ .2L3]4>UZQ_7/.$A6WD4"@H3O^)[8S_Q_P"!
M'KD]PW<OF_0=HV7\X=NUQWZ H% H-0YMU/['[<Y,YP_,LH"-R%D"0NFG@G[@
M$^>F54ESMVZA.)3 /JO+5B)E*MEX]D,+ED*RR/''J4E!R215V+YN;4FJF;RA
MV" @(6, \0&X#Q"HK!F<YQ3'Y9I S$HBVFW[=T^9QXB8ZZC5@GS'"H$( CI(
M4.T>WL"XT'G"<VQK<3&F688@\\X8[(@<6;L4E4!/RE#)']C6(0X6,00XEH+!
M00TYEF.8V[B&$Y)(,GT\Z"/AVRIO973HP";0F4 $1L <1[ \H\0H)F@UG$=0
M>SD]G*NV\1EK1UF22BB'F\A5@(=9&^M)-P9,$5#ETC<I%!'[0U:#9E0<B=+[
M-FY9;M&=-4'!B[B3 %%9)-40 2DO83E'T*S=NY(WKYLB?BUG[U1]96"AYLB?
MBUG[U1]90H>:XGXM9^]4?64JK4THU:CDF1@+=&P2:P '*)8 !-/@'"OTO0?T
MQSE^2[G_ -B>4/AX1I^;(^U$]*ON<P\(T_-D?:B>E0/"-/S9'VHGI4&!&MFH
MN)4!;I#9X(!=,@V#EDX!PK%NV>;UU-EO)G^$:?FR/M1/2K;R/"-/S9'VHGI4
M#PC3\V1]J)Z5!@,6S49&7 6Z0@"K>P<LG"[<O9PK%OU7>S]GK?\ 3;[?W9_A
M&GYLC[43TJV\CPC3\V1]J)Z5 \(T_-D?:B>E01O3 4I.H+?,I"@0H%@;%* %
M /[.KV %?GNM_ME^P[?_ ->UL[=C<S<;&LVA<*VZA(^5=/8MW-R*TAXDYTV[
M1=%O["@U'6J:ZP")2W-;L#A7QQL??,OA 9-U#93'%E<><[>/V!C"054EIJY%
M"VN10ADP,0X7XD. &#RA5P3%)Z^J/\5@/MLS[G3 Q4++-W]_,7:3KE!EA>0*
MXRT</YU&*/+"FT1:)G54*LX5*5(BHE3,!$M0G$?( <:8)68;DQS=+#IV99XD
M240)G#J);3JL".L%BM7*93@8IC% IK:NPIA, <1"U9;3+;-,9>94^PAM()J9
M7&-4I!]& !^8DU<#I34$PE H@(^0#7H)Z@C(+(H/)FBDAC\@WDV"2RK4[IFH
M59'GMSB14@'+<!$A@TC;RT$G0*!00659EC&$M&;_ "J13C6D@]0BV:JH',"C
MUV(@DD&@IAN80'B/ /*-!.T"@4"@@\8S'&LR1D5\9D$Y%&)?N(>1.D!R@B_9
MB +(CK*7B34'$.''@-!IKJYW/Q#;G;YFUSG#BYKCV2//-[B+.X\(4HI$%<J@
M* F<P& 2=T2:3 /$!JQM1P]AL;M%DCM*5Q;8;+,H;HG!4T>UGC/$1 H^I4(W
M8@KI]&Y@K<X)5^EVT\XZR+ (64>8DO@JADC()XH[)RU6*+90R*1-'+2TE$A"
MF(&@MBB'"O-872BE H% H% H.7.O_P#A]7^6(_\ G4JQM'1.(?HE _)S/\@2
MH)J@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4'+&^>V^5YYU(;9K0Z\]!0C>(E$G^80!13%BH)%C%(9R)#IIBJ-D])N)@-P
MK43@S*F;W[%DVUPS&H;#L<E,Z:R64'G<RR1\U4RB7([41!('!F*9VZ;G6!E.
M"X&( WOWCWI$C5#?:G)&^T&/FR3;>>E1Q?<XSY[!FBUBR)\5>H(*+IMVR8Z.
M4L9$"G!(V@JGW0!<:N_V$)[+MKMSI3"=S/,N*3#>+6W,)/N(<6!S.7V.@FKR
M^0T.9/Q14C&3$42&L(^4--PF]6$CL]F<QMHQB_HOD"V+2VY\7(A!N8DT49&*
M\,Z1>.TV+=14S-N?FD(.HVDNDMC>6E<4W8LS<'8V>0QK?>#QS W_ )A8Y) R
M>&Q[=HXY9FY"K)/58XO_ $OL9P*IR]7='['!O@=T;=N(,,(@?,D.OB\1X)$&
M6.R*0-'C%("]U%9$3&$AB^4!,-9:<J]40[C9W/?0MMMS.NY6)?LWVV\_#"5[
MCCTRBJ)ESS2:I!1+RBI"4A5;VU&O8@W-J$ENS..G'$=V7<5D6X#R3)D[6,;Q
M[L89^HS9F.G=10Q4P 0XJ'-8?O;>A4B:#3FUNWL!M?U3YMB6-*/%8Q'#&JX'
MD7!G:XJ+/FHF]D, #;T K-\X*Z1KR"@4$"/Z?!_L_P#_ # :UN3>GJRI0*#7
MFX/Z10_R>Z^$)UV.V?5=R</O'T6<_DKU=Q^;*!01Z_\ G;#^[N?YR5B?JCVO
M6/ZYYPD*V\B@4%"=_P 3VQG_ (_\"/7)[ANY?-^@[1LOYP[=KCOT!0*!0<0S
M6(Y_F_5-O'C^"9$PQSQ<+%(RZTE&DE 6:*M$4Q*F53NE$-5_L_Z.%W,J#OO!
M,-H6N*[(P\Y*LD\?QEY)-)A[(O8Z,?23ETJKJ:LXY%4ZSSF',"95%@3(724W
M8)C6,26&VF$I+.MDMP<QR*4+,3>%NB)RY7*X XF&!G+9NAJ(4WJS%(5<+V.8
MUS^J&]I@(J0S#.5=IMCVLWD+EAM]),YQ25EG;^18-UY5N^=@@F[=L$'*_L9"
MI"@3EB!A[> "8)OE%[Q/Z8;F9)L5B&89K.F9Y%CL^,J_BG;N,7?LVJ[DS851
M5(0XB8J)"F4,2ZA  ;CJU"5KQ.01F<7V*RS<G)9DD7%Y+,P#J=!TXYS5BT52
M50$%"%.<%0$XEU@&KEE O80+6@_40./&L-/S[=9;A^2;];9H;<PSMJ_@\G<-
MY7:EY$^;_-BBA@!Y-'7:FTF/;2I90QK<L+@!0L.MR.ELHVFWQE\DDI;'M\76
M/PCM<56,(3'V+LC1(;62!554#' /1$*F!BU?TC-WK3'MSVDD^&4DF^?2:+R3
M.F")G2Y$DP.N*91$""H8!-I#@%[5B_=R(=!UYJ4"@U#)_I)DGRHM^33K]-T'
M],<Y?D>Y_P#8GE#XU]SFE H(^,_UB6_OH_DB5BW;/-ZZFRWE\TA6WD4"@CF'
M^9S'_I6_P<M8M^J[V?L];_IMY3^Z1K;R*!01'3%_$)OI_1@?@ZM?GNM_ME^P
M[?\ ]>UM*8_BAQ7_ &-F/_B#.ODW/N_W?KP2FX++#X-ZGD:3]Q!9V]#E,3PA
M.=(21RE-I248E 2NR@-KBH7NV#OE"LK*L+S.;NCMV6\QU,3Q1V4B9',*82-W
M)C&*&B2>$,8[(3AW3))CRQN(<\>RB5G>L6[,5"PO3[GL?CS5!G#IXQ*"U2:%
M*5$2&9*"!@$OJA-VB;B(]HB-6W:7;)<MR6#9!EV];^8P1R=GN7A^"8W/8BN!
M]**CE!---9HL0>!R.43G1XB 7$+CIU -W-,4W4 NKD.ZN]^'-P2R)O@T(W<1
M;E,PFC98\D1@X25(H!=7ASF%0+A8Q0*(AQ$*1"5;;E4=P=J,NVVC%MRI?+8[
M<M=:#R%"0,V,HBZ7;"<LA$F32#PQ4C&N"??);3>_:$K42_1'"KQNSHOE9:0?
MIOI23(BT>J$.V;%:OG"8BW*4A1#FFN=6YAN?LM2=I#5.ZNYV;*OMPLAQ+*LT
MEW.(NW9(QWBK%JSPN*".L<S615=@)GJQ &Z^F_:&FY;!5C8BY1,KN/O#NDQQ
M<^>2F*8Z\V^@\JD$,?Y""QI-[P$455DE#))B934< ]4!0*--AM5./WCS7*=L
M]MV<]E>0FR*2<3;:5B\$C4W&43B$2Y%N@NDJ8.2T23TW<''O*6'3]T)4;5F5
M9DLXR[), - Y@O(O2XENO ,(TN0\@\R1H?6J"#Y1K9-14E[&,''R>0  -@Y7
MNYN/AYMQ]F"S"KG<Z0R:.C]MI1<""L$3E9Q43$O= 3 R(FL0RMNZ<2^0*E"K
M[;@PV<.-R6.U>U&Z&7OLX6Y#[)WCEXV5A\?B1* &4733;%,=PL'%!#F /'48
M0 0&K7!$7F&>;F9!NCF.#QSC/3P^ I1T=%*X.A'G<*OUV@*F>RYG1DQ5!0P7
M(D0"D,6_$H^J1L&?A&;;L[VY3B&W>4Y([P=9#$%LIR)QC*C0CV0?I2JL8CH<
M%*NF5+04BRA$PTZQ,00X!I;%VKWT=-GS+$=PF<H^\ZRC?/\ ($7TJ!"I [<)
M^'*HX A.Z4%# )M)> 7X5)(975ON[#;28+&NYC#F.:$F'HLD(^5Y8M$E"(F4
MYIRG25U6 +  :>WU04@E^<SF8P3<2;1F9%]CVTR*0B((XY&S+A?B':)"F.EJ
M#_F*$K>Q'ZA=-2T4MLOC)H3)GN8192N4T,@DT5&SI?ENUBB4R2IU#%*F("F0
M!./=*'&O.5AMBBE H% H% H.7.O_ /A]7^6(_P#G4JQM'1.(?HE _)S/\@2H
M)J@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4&H)[I<V%R>:D,BGL-0>S4JN=W(.S.GI3*KJC<YQ*1P4H7'R%
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MM_$#I+8QS!J-Y1L 652C*R#IQVSF8G'(N-;O,54Q-([6 D\:=JQD@W:KWYR
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MPHN4 3%1,0(F8UQ+;T!&E)*J3N!UE[?Q&V$CGF#%4G91E)HP@13U!RQ,BZ7
MRFMP4R>HI.4F<Q!^Z,&G@-[(C&A5T'C.0QN5P$=DD.<ZD7*-TW;0ZJ1VZ@I*
MA<!,FH!3%'[!@O45H7J0ZEG.TLQCV'X@Q;RV62+ELI,BY(HLVCHUPL")!5Y1
MB:55S#9+4;@!1$0XEO8A&U<RWHVKV\E4X/-LJ80DLJ@5TFS=J"504#F,0I[
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MD3&Y#E%)4IB<#6L(WX5%2S7J-DL;G,I4A,-4G, V]7;-<XR(CTB#A%9R!#J
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MWAX_+_JZT^=B_P"'K&!B>/R_ZNM/G8O^'I@8O'C\O^KK3YV+_AZ8&*(@'V5
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MG_4/^T5G_=[/F]/_ )_^WR2-A]"MO(L/H4"P^A01Y@'SZEP_ZBK^7)7G_O\
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ML<5-190#>?K\]4RHA9D?LU=E<OKXI3];W>[5=-T7;-L.Y*Y#NE H% H% H%
MH/11,JA1(< ,40$#%$+@(#P$! :"N_J\P$+"&*PX"'$/^[FO;>]_P=!9"@!0
ML'8'  "@\T'$?3_*S4(CNJ^44,TQ$=P)D'DJW9ED3LUR<NYW*.HIP0$IBV43
MU:1 =0  W!,;.2.G6>-STBU2?1^6M'3)<H*(.4(Y%5)0ANPQ#E6$# /H@-9R
MPK[_ $.RGZS(?-:7NU,HJ^2.9;'WC>%;3H3F5/"ZV>/Q\8AXDQ+VYBQSK:&Z
M("/%56P=ND##PIEA$7BL?FW*F?.$XQ;R7GAWXU)I&@LW!82(B/+,JJ4P@ "!
M>(<1 1#MJ2)[S?EGUC;_ #2E[O60\WY9]8V_S2E[O0/-^6?6-O\ -*7N]!!X
M^QR8TCE()3Z"9BRPE6,,6F?F'\,EW@#G!IX<--64A-^;LL^L;?YI2]WHIYNR
MSZQM_FE+W>@>;LL^L;?YI2]WH(:)8Y,,]E!23Z!52N&/..,6F8%!%B02B!>=
MW;!P^SVT$UYORSZQM_FE+W>H'F_+/K&W^:4O=Z!YORSZQM_FE+W>F UAL"FZ
M2ZG-_P!-ZX*Z=%& !5P1($"G'PJG$" 8P!]NO7="NI:!0*!0*!0*!0*!0*!0
M*!0*!0*#3?4EC&[&0X(+C9W)%X+*H<RCX63;NGDTB)C=L4_'2?RIW"QC<!MV
MA8'/^V.VG4]N5A<=ER6^$O"+.P.1Y$2<:LBZ:N43B11,P'4+J"X7*< #4 AP
M >%*PCK7;''<IQ3"HV!S3(3Y7DC0%?&3RA!2,XYBQSD 2B(CW"&*3B/DJ*M]
M H% H% H%!RYU_\ \/J_RQ'_ ,ZE6-HZ)Q#]$H'Y.9_D"5!-4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4'%DHW?[)Y#D\-ET5)*8O,S;_((#+(YBO)-%
MB2R@+';.O#%4.FY3/<H:RV.4+AP#CV.DZFRVS+=@X'7]#J:FIGLQPV-@[!XU
MD<SN#.;ORL.\QZ 7AF^-8XPE4_#R+U%-P+I9ZLW'O(DUV(@4_>,6YK%N%_DZ
MO6C4NPV0^_H>FG1LI=MF:MY2^=87CT@WB<@R.*B95V "T8/WS=JY5 PV#0DJ
M<IC7'@%@KXG03X#>@\T"@4"@4"@4"@4"@4'$'5U&QDOO]MI%36)R.<1:\-(\
M[&(A95!VY$@J'*8ADCD,'+$ 4-W@X%K<3@S,(["I/=K8/:A1 Z[?#QRW*U$<
M/QK)O%SLI'PYR_@VC1DF=1=8QA*708I"\-0@ J5-LJB,DWEWIW0P/;.0;O64
M'.H[F)8J_2Y+IH5Y(MQ059*.FP&$Q4"B<X.6XWN8"B <+ I^R)(F]DOM)&;M
M2F/P[!/*IK<U7&TWFE\Z;@Z,FH99XHAS%3G'N#RTD=/$UM(Z;"HJ:/U3;QHX
M.V.E%1RN9)9NPQ%O)/X]_'1DJQDD'1TERH..4LB?6B7F<.Z4P=T.RE(%7WBW
M<WKF-KMS,-GI2-:9!@^21$;*2\(5RS\:QDQ4,1%*QA,02JIEUB-M2=R]O$R(
MQA)=VXRE/HP,>EE2K1?)"-TRRBT<0Z;,[@"V.*)%!$P$$>P#5EI^=V]LG-91
MO)NS/9+#/IC']MU(E-F\CYH\,^@69U"%Y\>F)3D466,.L3'(8"\?*)1+J$HZ
MTS'<O>:+&"5VHVU'.\7DHAH_":=RK:.<<Q<HB!%$U+=[1H.8P<+F'T*S0JUE
MLE.YMD75MF$GN#BQ</R,V&-R'AB/$Y  2*[; 13G)=WO?>^2M;ATYF.+X]D<
M>52>$6IHT#NFDTBKX1W'F*6YED7 " IV +FOW1 .\ A65:E#<7-%V0-'#\$,
M$.L"'ZWBLA(51,;=T&0@!4A$P\OQY@\-?L+>C-6WL2QC'\9CQ3@4]8/!*Y=R
M2B@N73Y4X7YZ[@PB94QKWU"-OO;!PHTK$]_O,_\ I[_MP5F[8F]EUYJ4"@UY
MN#^D4/\ )SKX0G78[9]5W)P^[_19S^2O5W'YLH%!'K_YVP_N[G^<E8GZH]KU
MC^N><)"MO(H%!0G?\3VQG_C_ ,"/7)[ANY?-^@[1LOYP[=KCOT!0*!0<([U[
MR9M";V;@XT;>$VW<#C\<R=X_'C$I2A7KI5FFJ9 HZ!.43'$1$PZNWLX5J(P9
M7R'ZJLQQG:/#LKS?!9"5GI>+<2LO))"A$QA&C1PHD13G.-*8N%DR%6*V3"Y@
M, E"P@%2F*U?*9ZG<FF=R\&BL+BGA-O<HQIS.*NBHMCO#"HBH K#S#B4I6)T
MQYA"F[Q@'U11+=0J]L-ZI?H]M1MX>12D]P-PLP2DG+9 Y646X.TCG2Y%5ES:
MQ13 H)"1, $1/I]&E$B5F7ZOL?>HX8.%X?-Y2\SN.>/H5@R! C@KB/5.BLW6
M*<]BZ!24$ZA1, %#4&H!I15-R/JZR.<5VED=N<8?'A\NDG#>=9'(@H].LP4!
M)6.1$YM)3=X%14[MR"6PE'6 *)5V!]BHTX0VUZEL]SW=B,?/,T3A,=E,C5@V
M^(O(4WF<[ !+RT22J8"?SBH W(0P 2]KG !!.M3#+?&5]6. 8?D\IBLEC^4K
MOXIP9HNX9Q!EFRAR=IDC\P-1>/ ;<:E%53HCDF\UCNYTRS(JFSDL[EGK=-P3
ME+E2<)H'*50EQTG ![Q;\!I/R(;>D<.D<.6<9!MRLBR;B)G,KBKLW*B'=KF.
MHB?CX)80OWR!RS" :R?=5"B&C-SI'=!88/;\0A%4$P5FIB0*FHLW*)M(E8-[
MF*ZU#ZEU<6]NP3CPHE:K_BV'PN(M5D(I,YG+LP*R,DZ.9P^>+@%A5<+GN8YA
M_JE["@ <*-*;#?ZYDWRZ\_)H5YW;1*UD*!05_&_\SR[Y9'X*C6I2%@K*E H(
M.&_2'+/[S'_ "543E12@4&G-C/XI.H/^E ?!3U[1LA(=/T4H% H% H% H% H
M% H% H% H% H-,8_U5;(SV)2.7J9*C$MH<QDY:-DO89)NH!Q(4OABB<ZFL0[
MG)UW[.T! +24JNNUFXT5NSA+#/(-HY9P\FHY*R2>E*1P9-LX4;ZS%(8P!K%,
M3 &H>%15RH% H% H% H.7.O_ /A]7^6(_P#G4JQM'1.(?HE _)S/\@2H)J@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@YUS+?K.)')9?'-G8:)=M,<=&C
M9K)LD7<)L3R*0 *S1JBT**JAD;@514P@4#7"P\!'[-#I;M6*[(?!U/6V:$TG
M&>$)O"]ZYW+(7,(-_ %B=W<5C%)!.$15%ZRD"*(G%JZ9*Z2&4255)H,00U$-
MW3<:\=72NT[LMSZ-#7MUK,UNQH+;;#,-RS!HK)Y:+9Y9.92W!_D,Y)(IOW;J
M07OX@AE3 (I\HX"D5,FG1I]'C7?T-*R-.*16L/RG5]1J^M-9F*3@W;TGR+Y3
M%LKQPCI60Q'%LC=P^)OEU#+F"/2324%L54XB91-LH<Z29Q$>Z&D!L6N#KVVV
MZDQ;L?JNFONNTK9NVS#?]>#Z"@4"@4"@4"@4"@4%-EML<6FMP,?W-?$7'*L9
M;N6<4J14Q4"I/"'(IK2#@8;'-:@Q-SMG\.W:0B2Y.#QN_@7(O(:5BW2C%\U5
M.  ?EJI\0 P%+?\ D 0L(4%+/TF;/CAJV!HMI%#'CS)<D;$3D%A7:R1400$Z
M"QQ,< ,0+& PFX\>T &K42*W3-M0Z@\BQ]VQ=N&>2RA)]ZLH\6%RC*I%$I'+
M=8! R9PU&XW&]Q ;@-J5*/FSZ8MK&<&Q@N1(.",\@0R]5^Z?++OG<RU*<B:S
ME8XB)[%.("4+ /;VW&H,J>Z;]L,D;YPWEF;I4FX3EF^R 0<G*8',<)A04;C_
M -&)1,:X<0&]AX<*M17&[;J1PQ(,5P+&\7>X9#_V."=S,O(*22S)+@F=R;EF
M]D,'$UAL \ X4'WE^F["=U7<9F^[4$FWSU1! F2,X5\X)&/1;& 4DU@[HJE(
M!2V'NF\@B( %*I1O)!!)LD1NW(5)ND4I$DB% I"$*%BE* <   X %17*HY.P
MQ;K0S-X\37=+N,,8MV,>S)S73E<[EN()IEN =@"(F,8"E#B(@%7<C;[> 7S)
M9*5W,?-/ IF*LQPMJX(K'H& 0,!GRG#Q:Q1 . V1*(<"F]54-J_G>0ZB(MSN
MFQD#%%,R1CIB02"%A*)1&UK<+5%:_5A7N#JG?[;NVSR&.83.L(<NB)-@UCJ,
M>-6,:S8^H1'E&]A-?[CMJHC$,MA<HSHTBQ6%N9"#%L^8O=+9VU<E>E$R*R1Q
MN4P>3M*;M*(AQK-VPWK%XIG^=(>W)^NKS4\4S_.D/;D_74#Q3/\ .D/;D_74
M&O<_<-S9#$"5=(P!'N@$2J$, #XA/T!&NQVSZKN3A]W^BSG\E?YR/XU/^N7T
MZ[C\Y23G(_C4_P"N7TZ%).<C^-3_ *Y?3H4E@+JH^>F \TEO#N>.LOHD^S6)
M^J/:]8B?3GG#/YR/XU/^N7TZV\:2<U'\:G_7+Z="DG-1_&I_UR^G0I*B.3D/
MU/;&:#E-;S_?2(&_ZD?T*Y/<-W+YOT':-E_.';U<=^@*!0*#3\1LBV9[U9GN
MO+.&DJRRAFQ:-HAPS(H9JHQ33(*G-4$P#JT7X%#M^Q3<E%1WQZ99'=G/&>8L
M<F:L6_FA6!=1\M%IS*39-4QC"Y8IJG(1)P(&TZQ"Y?5 -ZL30F*H=CTKY3%F
MVW>16:MFTAAD,\QF6,,>*J3V.>J+&'E%,I=,XD6$@B(]O>#T!56B(>]%S@V&
M8!',<CC5LNP9O(,1<RT0G)1+YG(NEW(%5:+G,!3(F7-H-WN/&U[""J+O@_38
MYPO+-M,B)D23U' XR48O$2,$V9GSB7.LH=4A4# FD4HK6 NDPB!0N(CQI4HJ
M"/29E&/X?AC;'\W1:Y/@T_)9&SD1C!<I*IR/+$R?AS*"(G*"06X]ZXAPX#5J
M4; )U.QIC%+^K#<8!,8"7-C*P!Q&UQ]E[*E/&$S*;#=([R.RABB7,E!V?CLG
M+G<=AAF*97:<P4H FF=YJU<H@<+6]3PMJ[]*K1U/45R7TQYA$8G%;L.I=159
MX^W(G4H^/;$%P^>N-* \M!(O>.;B%Q&Q2WN8P!QJSNY)5NY'$\@SE0C[<:S*
M"(8#-<(;*\QN;2(&*>27(-G)P,%^27V$+!?7VU!/Y'@L-D2#6X'C96-#_N>8
MCK-WK(0+ILB< MRQ#NF2, IF#@):%$$US.8P]PE$[F$22;*F*A'YBV+RXUT>
MX%*5V2YO!K&N'JAY1AOI,'J:%6'#%,#W);@(#Y]>#Q#R"D@(5YW;52MA]"LA
M8?0H/%A]"@@,; ?.>7</_P"9'X*C6I2%@L/H5E2P^A0+#Z%!!0P#](<LX?\
M68_X 2JB=L/H5%+#Z%!XL/H4&G-C/XI>H/\ I0'P4]>T;(1T_12@4"@4"@4"
M@4"@4"@4"@4"@4'@>'&@X)>=#N=;F#D&X&XF0L(/<J6<"YC8A@S;FC$N4:Q
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M "V3O_SS$"HB(PO &L-'R4*2<FC$C91RU!1)^HW*;2FB81!,@"!0N:Q0OP*
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M07B@Y%DLI5Q?K,S([)L1U*OL,9-V2:YQ2:D-XA YU5SD YP33*43""9#'-V
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M'ISSA(<Q3[\WVQK=9>5(.8I]^;[8TK)2#F*??F^V-*R4A07AC&ZGMC-0B/\
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MOT!0*!0<#9[B66YGU/[O0N&XEC.5/G$/&(KFRLH&*Q(LS13!=KPN"@"(<2B
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M@4"@U#U/P.19)LAE$5C+=9\_,1LNYC6@B#AVP:NTEW;=+3WA,HB0X 4O$_J
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M)=5RB)K!<;  59FJ1"FM^A?9!OE1,@*$J:'2=^<4\2.[*:'!QJO^#%+F"2P
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M_7LU,)C+MCA,<UZB>H[*R;1QL>1Y'RF[[K*%L#;R*HIE2.*"BI?/"K-,^H2
MDEQ*'=%7_FCIKDQHUU,D3O=V[7BW2]28W5HBI.5WAP2.D,XB-RI+(Y6*;K2,
MC"Y W:&B)!%N0554B)-R)F:B)0$4Q2/P$+#P$:Z6IT%L6UMG&''T>Z7W:D1=
M$4F4M&]0>Z6-PT9N+F1X7(MN9!)F_ET8MDYCY.,92&C2L@"BRQ5R(\TO,(<
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MXOLWB9#;;QD,]B +$.(]A+H.GIE3'*M(2*:RP-5!.!U02[QQ$]QU&*-(E)A
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MC@Y\(SU:/&VY>G3:U^]?MJUP2F*;\PY%]<GWO)EZRI6%/,.1?7)][R9>LI6
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M-!_O1^T-=U^:-!_O1^T- T'^]'[0T& X(;SW']T?]7=>3[*=><_5'M>T3_\
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M4=N? LIMPU%**7<7 I2E6$VH ,(@ &.F4O$+C:K0="U!RU_]P#^'Y7Y9C_\
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M!0*!0*#G;%NK3'Y[;O<//)''W,2OMTN+62ACN$UEE5#FY:(%4 I0*)U0%/B
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$@4'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>fc_cd4cd8cells-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_cd4cd8cells-4c.jpg
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M%!04%/_  !$( :8#Z ,!$0 "$0$#$0'_Q #-  $  @(# 0$
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M2W*9,RVN(\TVM"B2I"TZ\4J(C ;$
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M["/0E)X&1B3&DJC$K6ZH%XJ^?LLS.%7CI?PH*UO!6?%'@/)\*Y&[=RMW*_\
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MI*9T5:'(\IC?KM-;+R4JVJT/:HBVGY(BI
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MGHI)%H1EMVF1;2()6%BQ%
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M4R= );1G)92EMLE+W)1J>G86I&KOC$E5KQ%
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M&1DCG+VD6]1\5*,S,S,^X4E(F$J?/!B?Y<4'WSB?T@+6#YX,3_+B@^^<3^D
MK#.T"Z[9NMEZ1;-9A5F/'43;[M/DM2DMK,M22HVE*(CT\D%9<
M                         !HN6<26?F>TGK0O&.I<4UD_"FL&2)422DC)
M+S*S)1$HB,R,C(TJ(]#(6)H(%D=)>5JM3SM"X,\5N=CQ22CNTDHNV4[$3H1,
MK?5(5J6A$1[DJ3_JA5*)/NWIXMNHX*F8+LQXK;HS[;"&9IM>%N<QJ0W(6Z\6
M]LW%NJ1WRMQ=O#0B(A(Q)A&:>E#+53I35K77GBL2K.0PW"72:=!3 -41I))2
MUO*0LC+:DD]\E7#MU&JP)B9P%C>+B27A6%3U1[,F,*9?)*M92WU*)SPI3IEW
MSQ.)2LE&6A;2+3:6@R40H?3%U!_!_P";3Y[5?-?L\#Y7B\O&?B[39X-S-V[;
ML[S3GZ:<--O>BUC4465Q]8M!QI9U(L>VFU-T6CL\B/S#W.K4I1K<<<5PU6XM
M2EJT(BU/@1$(KM1;/MF#<D^\8E+CLW3566XM1JR&R*2^PP1$VA:^Z2227\!>
M0 S8#2,P6 O*6-KAL!N>5+77(Z6$SS:\()HT.H=(S;W(W$>S3S1"P,M8EL?
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MLB\:ADS(=Y2K\R-.B>+&:G(9*,Q%@[B6IMIHE+T,U%VD9$1:Z)+4]52B=1%
M
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MQB4M"#/0C4EM2C(M?)!IG@
M          %"/I*/O>./5:G_ %8=,O'L8N^DI63][:]3;\X0]4\%.+Z
M  #"W?\ %>J^HEZX@<<_ER^CRW-MV_1FNX7UB_B(=Y?,"*      #AF?B<GU
M%WSAB3A+5N,;6.M7XL4;\C9\Z.>3R[=CKYCFW;99<=7       '5J?\ ==1_
M(Y7K*Q)PG8U;]T;8^;2OHU_B3?/NK%]CF/*W8O>KOC"@
M              TK,'ZIKZ]P*I[#=!)P5,^C_P#U2W1^D1>P6A,S%5K!R
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M"RXBM7R%D"V,7VG/O2\)2HE"IY)YSC;:GG%..*)#;:$)(S-2U&22["\DR+B
MH)975+D++G5/:J:?4YU#Q_.J"(<6V6WS)E<1#:^^DI3WJW'#+<KMV^9(^]U&
MYMI"/2,84 4(^DH(^5C@^YS:G_%%'3+Q[&+OI*5D_>VO4V_.$/5/!3B^@
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M42J8P4 0-U)]2]OX&H3*8R8]8ON<M!4^WU/&DTL&>JY#^PC4A!%P1KH:U=G
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MG954LF+4)D:FW/"..11GTRW>0\XEME!)3O:7W_86Y)+[=3$Z!Z>#+0
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M<DE14/5-RI<I3?*YQD2_,;B4CCW=/J#5DQ5F[!=]'WMKU-OSB1ZEX*<7T
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MY3\ISO@_8_0?E        ,'3OC5</J5.];<'*WF7?XOHOY5FV[YLX.KYP
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M.V(]4LG"% VG4&I*22B>31[U-N&I.UQYXS2DTMF9--\==?-28HJZ0B@
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M5$2B_@,!](M.  I"5I-"R)2%%HI)EJ1E]74 2DDD24EHDN!$7 B(@'T
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ML%H3,Q5:P<@       !#$GXV7C[L.>LMCTGX_E?%Y3\ISO@_8_0?E
M ,'3OC5</J5.];<'*WF7?XOHOY5FV[YLX.KYP       %=HG_7?:/\N+_AS@
M_"\[S)^#UGXSD1MGYO2D?G/U
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MU,_3.PA)_(94QTK;^+SHF)K#5_HU_B3?/NK%]CF/Q;L7J%WQE0
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M\=+Z/+<VW;]&:U/0OK%_$0[R^8$4      '!._$97J#OK:@G!;<8VI)Q\9_
M"U>/_P#51?.#QDXR]]&#8]3\D134_) -3\D U/R0#4_) -3\D!TJT9^(:UQ_
M_K9_L5P!6CZ-?XDWS[JQ?8YCZ+L47?&5
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M+SJI3<4R4YSMZE:.$DC6A;>W11%W B9$\=,&0JED["-KW57'BD5Y33L&J/\
MV3K\%Y;',5_KN)0E:_\ 648DQ22&N];/_35>7UZ=_B48(Q)5EQ;E_JZL_$5
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M<HSLTYR9<948DID<C9M-1GKKL5J.ED:6+OHM,G[VUZFWYPAZEX*<7T
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M;.1->K#>QE&O:M6AZ$$X%7YQ=3JA4^K+.-(II&55FTN[(D(BX&4AYY*&]/\
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M<%3/H_\ ]4MT?I$7L%H3,Q5:P<@       !J5E_WU?WZ1+]BM#4LQTMM&6@
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M
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M[H;B&YK*7DI5IPU(E:'H(0S *
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M#DW#=OVC5CI](N:J&S6V$M-.%)9\+AL[34XE1D6UY?F3(:B*Q*2M,,J
M                *$?24?>\<>JU/^K#IEX]C%WTE*R?O;7J;?G"'JG@IQ?0
M       86[_BO5?42]<0..?RY?1Y;FV[?HS7<+ZQ?Q$.\OF!%      !PS/Q
M.3ZB[YPQ)PEJW&-K'6K\6*-^1L^='/)Y=NQU\QS;MLLN.K@      #JU/^ZZ
MC^1RO65B3A.QJW[HVQ\VE?1K_$F^?=6+[',>4NQ>]7?&5
M               !I68/U37U[@53V&Z"3@H;T<_JZKWNU_5&A^_Y'[)VO,_E
MN;;L^JPX^]^,        PU!_&[@]TU^M-CEEXW?W/HSL+/[69'5\X
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MLJ:WZ<@M=N[7347<DTL=T<_JZKWNU_5&A^YY+[)VO-?EN;;L^JPP^]^,
M    PU!_&[@]TU^M-CEEXW?W/HSL+/[69'5\X       #!T[XU7#ZE3O6W!R
MMYEW^+Z+^59MN^;.#J^<       !7:)_UWVC_+B_X<X/PO.\R?@]9^,Y$;9^
M;TI'YS]0 5<ZL[GHMEWOA*Z[BD>"T6CUZ;,FO$E3BB;:C(,R2E)&9F9]Z7U3
M%A)85_,5AY>6EW).2J+:6.'=KC-B4RJMJJ<]H]="K$UA7I:5%Q5$C*[#T6LS
M+0,$I,I:H^?>FRWJ9&HU#OBW*=2(2":AP8C[+##39<=J$(T(BU/41IWOWEL
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M_P#\85DW8U-XA0XM.BL08+*(\*,VAB-&:22&VFFDDE"$)+@24D6A$0-.<
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M/^N^T?Y<7_#G!^%YWF3\'K/QG(C;/S>E(_.?J
M                                         *#_ $E)Z-8Y,^PG:G_%
M&'2S'L8N^C>DW=1R0V6R;P;;+\2D=Q!?ZH]+XMO7V2\5Z>_J_P!H??A?1_M)
MOYE(] 'BV]?9)Z>_J_V@^%]'^TF_F4CT >+;U]DGI[^K_:#X7T?[2;^92/0!
MXMO7V2>GOZO]H/A?1_M)OYE(] 'BV]?9)Z>_J_V@^%]'^TF_F4CT >+;U]DG
MI[^K_:#X7T?[2;^92/0!XMO7V2>GOZO]H8FY[HI4JWJC':1+)QQHB3OB/H3K
MO2?%2DD1=@Y9V9;-DX]DN_E\B^,RV=&.N&6^%]'X=Y-["_\ PI'D?R!V\6WK
M[)</3W]7^T'POH_VDW\RD>@$\6WK[)/3W]7^T'POH_VDW\RD>@#Q;>OLD]/?
MU?[0?"^C_:3?S*1Z /%MZ^R3T]_5_M!\+Z/]I-_,I'H \6WK[)/3W]7^T'PO
MH_VDW\RD>@#Q;>OLD]/?U?[0?"^C_:3?S*1Z /%MZ^R3T]_5_M#BDW;2%Q9"
M"1,U4TXDM84@BU-!E]J).;;3I[):M\O?6,,>*'1MRZ:3'MZE,.(EFXU$:0HT
M0WU)U)/<42=#+ZHYY6;;%EN.&J73/R+YS+IT8ZX9/X7T?[2;^92/0#KXMO7V
M2X^GOZO]H/A?1_M)OYE(] 'BV]?9)Z>_J_V@^%]'^TF_F4CT >+;U]DGI[^K
M_:#X7T?[2;^92/0!XMO7V2>GOZO]H/A?1_M)OYE(] 'BV]?9)Z>_J_V@^%]'
M^TF_F4CT >+;U]DGI[^K_:'6J-VT=5-GI)$W54221:PI!%Q967VHDYMM)Q[)
M:M\O?O1AC'3##?1K_$F^?=6+[',>9NQ>U7?&5
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MS2KKNM$TJ)1<R+Q29&7]W.>0/P?.\R?@]9^,Y$;9^;TJ'YS]0
M                                                    !0CZ2C[W
MCCU6I_U8=,O'L8N^DI82M?+:[X_O;?G$CU=7@9C2^[U>285*&]7DF%2AO5Y)
MA4H;U>285*&]7DF%2AO5Y)A4HPEWJ5\%ZKQ/[R7KB!QSY_\ .?XZ7T>6C_UM
MV_1F]ZM"XGV%_$.TR^>AO5Y)A4H;U>285*&]7DF%2AO5Y)A4H;U>285*&]7D
MF%2CAF+5X')XG]Y=\X8DSHEJV-,;88ZU5J^#%&XG^),^='+)G_SMV.OF(_\
M6[;++[U>28[5<*&]7DF%2AO5Y)A4H;U>285*&]7DF%2AO5Y)A4HZM36KQ74>
M)_B<KUE8EV$[&K(_FC;'S:1]&O\ $F^?=6+[',>3NQ>^7?&5
M                  !I68/U37U[@53V&Z"3@IAT,V;:=QXNN.97Z-&J,IFO
M\IIU\E&I+9PFE;2VJ+AJ%\S$E(E9OYK,;?):!]RYZ,<]Z=:;L:CYK,;?):!]
MRYZ,-Z=9NQJ/FLQM\EH'W+GHPWIUF[&H^:S&WR6@?<N>C#>G6;L:CYK,;?):
M!]RYZ,-Z=9NQJ/FLQM\EH'W+GHPWIUF[&H^:S&WR6@?<N>C#>G6;L:FLVGCJ
MPI=5O1F5;L-YJ#7%1H:5I7HTR4=M6Q.BRX:F9C4W3K2+8U-F^:S&WR6@?<N>
MC&=Z=:[L:CYK,;?):!]RYZ,-Z=9NQJ/FLQM\EH'W+GHPWIUF[&H^:S&WR6@?
M<N>C#>G6;L:CYK,;?):!]RYZ,-Z=9NQJ/FLQM\EH'W+GHPWIUF[&H^:S&WR6
M@?<N>C#>G6;L:FM4C'-@O7Q=\!ZW(;D*&Q1E1&#2O:TI]AU3AIT7]D9%KJ+-
MTTQ3=C4V7YK,;?):!]RYZ,3>G6N[&H^:S&WR6@?<N>C#>G6;L:CYK,;?):!]
MRYZ,-Z=9NQJ/FLQM\EH'W+GHPWIUF[&H^:S&WR6@?<N>C#>G6;L:CYK,;?):
M!]RYZ,-Z=9NQJ/FLQM\EH'W+GHPWIUF[&I4^HT>DT'Z0&UJ;18;<"GMJA*1&
M9(R01KIBS49:F9\3':V?Y2CT9&6@
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MZZC^1RO65B3A.QJW[HVQ\VE?1K_$F^?=6+[',>4NQ>]7?&5
M                 !I68/U37U[@53V&Z"3@J9]'_P#JENC](B]@M"9F*K6#
MD        -2LO^^K^_2)?L5H:EF.EMHRT        U.B?K$O?\FH7L9X:Z$C
M%M@RH       "E]S?]PZV?KP/\*4.]OVH]#!%
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M[_DU"]C/#70D8ML&5        4ON;_N'6S]>!_A2AWM^U'H8(H
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MW-_W#K9^O _PI0[V_:CT,$4
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M)>_Y-0O8SPUT)&+;!E0       %+[F_[AUL_7@?X4H=[?M1Z&"*
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MZ&"*
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M74M> ZQ%+2)>E0RT
M                    H1])1][QQZK4_P"K#IEX]C%WTE*R?O;7J;?G"'JG
M@IQ?0       86[_ (KU7U$O7$#CG\N7T>6YMNWZ,UW"^L7\1#O+Y@10
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M(+@DNW62M%;/HU_B3?/NK%]CF-78B[XRH
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M:]$(0DB(B(:Z)5Z&#"@
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MX*<7T       &%N_XKU7U$O7$#CG\N7T>6YMNWZ,UW"^L7\1#O+Y@10
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M9:]\*E*XIE$:>?\ ?/\ W&K=^O _PM0W&"/0 84
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M?8YC5V*+OC*@        #SX^DM_'\=^HU3S\8;L8G%KO45#Z.&<4FYCI=/\
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M22(H \_[Y_[C5N_7@?X6H;C!'H ,*
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M^W 82MMUN*XI*TJ).I&DRU(R"LI-L40/]'_^J6Z/TB+V"T,YF+:UHY
M  "&)/QLO'W8<]9;'I/Q_*^+RGY3G?!^Q^@_*        ;K@[XSWQ_(H_K,@
M?@^?YOPAZK\5R/C*:Q^>_6 $-5[(UQY!J\FR<*.-;83RHMS9#>;*13*6I/FV
M(:3[V9-(OL2/E-<-YZ]Z*S74[+W3I8)VRBCPU38MR,RCJS%\HD*5<95=1:*F
MKF*[Y:E]BVU%RC3WNS3314I#\VQDJNVM<$3'.8^3&N&<KDVS=\='(H]>T+O4
M<=4QIVGFXRCT4?%HS(R(")UI>$: 'G_?/_<:MWZ\#_"U#<8(] !A0
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ME)41ZD9'H8BJ#7S_ -QJW?KP/\+4-Q@CT &%
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M
M   %"/I*/O>./5:G_5ATR\>QB[Z2E9.G+:X%][;[A?:$/5/!3B^\/M2_@(4.
M'VI?P$ </M2_@( X?:E_ 0!P^U+^ @#A]J7\! ,+=^GP7JO B])+N%_.(''/
MY<OH\MS;=OT9KAH7 NPNX7D$.TOF.'VI?P$"G#[4OX" .'VI?P$ </M2_@(
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M-\^ZL7V.8\I=B]ZN^,J                              #2LP?JFOKW
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M9E=>-U*X;;*E/)-&O?:H)1:=T6L)+?\ Z/\ _5+='Z1%[!:'/,Q:6M'(
M    :E9?]]7]^D2_8K0U+,=+;1EH       !J=$_6)>_Y-0O8SPUT)&+;!E0
M       %+[F_[AUL_7@?X4H=[?M1Z&"*
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M?<W_ '#K9^O _P *4.]OVH]#!%
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MZ3](9:RW>]0X=/V'Y.^F*279Y)\!WM^U'H8(H
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M=I"O508:
M                 %%_I*_BS8'Y?4/661JW%%SK0^*5!]SHGK"!E6:
M  !5/Z0C]0;7N] ]:D#5J)6Z9_U XZ]PXGG!)Q5*P@      ").J'_I\R'[C
MO?QI%C%)1K]']_T_-^[50_B:"<1:410
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M>@W<0OUXCHOM;%_ -^A&:!XCHOM;%_ -^A"@>(Z+[6Q?P#?H0H'B.B^UL7\
MWZ$ \1T7VMB_@&_0A0/$=%]K8OX!OT(4#Q'1?:V+^ ;]"%!0C'\:,Y](==$5
M;#2HVM03R30GEZ% 1IWNF@U."+[^(Z+[6Q?P#?H1FBGB.B^UL7\ WZ$*!XCH
MOM;%_ -^A"@_3=(I3+B7F(,=IU'%+B&4)47UC(B,@'=
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M-N/'/-JKN174PE$N"E"32^:=AZJ+0M%#70B] RH
M
M
M
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MG:L[HB#'E22)4>.XI6AZN)/7?YE)FDC/B>TB9R/4%?0
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MC7JR_'>I;#-+HDQ!(=ERHA;>9&61$DG=A*6^6NYTSW$7>GMET45?H94
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M&&WC;6R;B$K-ITB)Q&XM=JB(S(E%V'Q&%<H
M                                             U"LY%M:F73#L#QG
M'^'U5AR9M(HBE&;CJ8J#7JHR+1&[0S3N,MQ)5IV& \YK$Q?;V0,.YHS+F*#6
M'+U@OR7:?5_3B;*8DC,R:21[7=)!DT]O(TMMZ:&GB9;F:2R[-A=1%(MS#EL8
M8S+CRH5'&U4:D)<N*0XXVXIA^6MYM^"A;)$HHY++::'M=2X>0:8U#;XW2?U"
MV2[.@8&OIB5C&\&"4N6N7X*:X<E'>J?:-M9;N6K0G8_?&7VO8)6)Q%P<!8>I
M^#\<PK)ARCJ$TG%S:M4-NPGYK^A+-"3UVH224H07D)U/B9C-6DG@   U>X,B
MV;:U>H%L5^KL0J_=#ZHM"@+,S=D.H3J>A)(]I:Z))2M"-1DDN)@*D?2*6I&J
M=,QS77W4PV$51^C3*@I!K)IJ>EMQ*U$7$R1R%JT[HU:DM'QCU'7CTJN5_#&:
M*7*JK% 9<<M%QE7?*XZLLH>7VPWB[YMS0S:XIVGYE%F*Z832_'5A'O3*-SX:
MR;CBF5*)/N^E'3Z-&)*H\^/-0ZM[:HR,MFJ'S4ES4D[$FO7;Q""96FZ:NG.A
M8'M;8OESK[JC:%5^LI+7_6*-',RU2R@_]*U=\K[$DXF:K"= 4  &M7S?UHXV
MH#ES7K5&J316W&V3D.ZF:G'E$A*4(21J4>IZF22X)(S/@1@*']9$&H)SS951
MRS/E3L!SU,'32IA[$1V"V%,09H(]SAJ,G%+3WZFC(D'JGAJU')4.J'J!53)5
MZX;L>/3\ VL[XO@I\7\UDX40]I+<,E(<2DDD6\V2)+78I6I&84A(=7'.!Z%U
M39%7FOPM,/'=5D*FW?;*73\.9K[6TWH1*2224P\2RD(D%HKEK-&A++<%::"B
MZ4+ N*J9D&-DVG6[&B73"A)IT13*$HC-(;+8EU#"2)!/);]*)PN.S@,M))
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M=%.N:?9*[>[]4S[1E6:
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MI+B5-J8@M(-#*E(5Q2;FY2B(^.S:$R0M.(H
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M=IL<G&WBF)0IK5LDK8T6:4]ZE:BTT/@3H'H:,M
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MF?1:A+BH5):9DH)U!H-U&]L]%=G R'-IL8
M             (VS;3KNNK$EUTW&=5.%=;L1U$"3$42W%K85Z?&0M/F''$I6
MR2BXI4?<T!)>:. LDYVQ51JK=]@$JN631)2&KJM9TU2&XY/D:DR'(Y>F,)7L
M6DGV^!*29+[A'TFB,I0,YV;CS/5.S+CE#T&TKF-17E:#I:.PO"EEX8TV:-$.
MM$K23&4G3B6PTITT.4T"\.4>E?$N?JW R#5Y]23)DQ8Y-2Z7+1X/*A$G>SHE
MUMTDI-*M2-O;KKJ,Q*I=L*P;5QG;,2T+,IZ*=0X1&;;*3-2UN+XK==<49J6M
M9^:4KZW81$(K90   :S>3%:K]HW#2[+JS=+NI<21$IU23L>\$GJ:U;WIX[3+
M<D^):D1ZZ /*7"UQ]0N/;@NNK8^<D3*O;CRI-[6G(4J4\^A#JFGWWHBCWN\M
MSO776CYB-Q'KM,S'2:,U9.Y,[6\QEJW.HC'L9=#NYU\COBT7#,V7)&W8^['=
M(B2MB6T:B62B):'2-1D>Y*A*3@KT4Q_CS$%<N5/4+9U-:77+M@-/-U(M#0E+
MZ?3'$-]C;ZR]+?47?<#+NJW8$L@H   #@*7'.0<3F(\*)!.FQO+F$T9FDEFG
MMVZD9:@/)VY(/4%:O4_<,&DW%(<RMX0])@3#>2QXVB)1SH[3;:_2EDXP1$B,
MKO=4\LN^(B&]%&7XS-F5G*D:EW1<5/<LKJ"L5UEB0XVTMAJHLL.[TF25]_'E
M1G?3$MN<#2:M%:DE 1 O!;)6)UI8'I2[J-]MQ+R"K+%.?..[%K4-LT+,BT-)
MI43G-0E:5%M67=(9PE<6Z8<Z=,:8.9DJLR&ZY5YR":FUJH.$_-<:(R/EDHDH
M2A&I;C2A):GIKKH0DZ52P
M                               -#RCAVP,Q4+Q#?5+1-;;W'"GM^E38
MBU%Q6P\1&:>PM4GJE6G?),$HH==^(<W=);M6J-K+.^,)U=M;%Q4QU"UQ78;Q
M&VXW/BH/<TK89I*2R>A=TRUV#5:I@="&:HMK9 J&+)CKC%IW<^IZWVWU\PXU
M31YALU$1%Z>T7+4K0M5I1P+46Z.E87UI6'L:T.^)F1Z/;D.#><Y@XTFI,-[-
M4J/5:TMD>Q+B^Q;B4DI1<#/M&"C> 4   !JN0,<69E"WW;9OBDLU6E.:J03A
M:.LN&6A.,.IT6VLOMDG]0^ "B-X]/N:^EFN2L@8/J#]RV*K<=5H[C?A#G@A%
MJIJ?#3HF0UIJ7-:(E)+4]$=HU6)Q9:'TEYVI>/\ -LN"A@Z+CR_'TQ7:8;IO
M-4^6XHU15(6>AFAM:U,[E<>6K56II%NC0KT<?P]C23?D7)SMMP_AS$0M+-72
M@TK-3A:&XM"3)"W2+4DN*2:R(^!C!1O *    QU<H5'N:E2J'<$%BIT::@VI
M<"6VEYAU!]Q2%$9'Y)>0?$!1G*G1I>..:X>3NF.JRHD^&I;YV\E[;,:3IJI,
M1U?!]L].+#VIF7#5?F1K>UHKK1\_5RT\^4_+<ZBG1;D)Q,:_:6RA4=N:I6C4
MQ?(<(C:<=21.*0? GD[RTUT+6[H1Z>5_&V)LS,6]=]>HD&X&F"C56@U1:#):
MV%I)YHE*3M-QE1&2C:<U0?=2.:XI#2DD%M3H22T(B(M"(B!7Z
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M;8QO2PAIDU*VZ)69J49F9J/MT(B"9J)Q$4
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MRF_ O!=O@_(VER^5L[W9MTV[>&G8(KM
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M74Y$QE5:.-$J$2E15()PF$L'/C1S6XM'?.J26I=Z1D1$1J78D+=#*@
D                                             /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>lc_neoagspearson-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_neoagspearson-4c.jpg
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M%!04%/_  !$( :0#Z ,!$0 "$0$#$0'_Q #0  $  @(# 0$
M!P@%!@,$"0(! 0$! 0 # 0$              0(#! 4&!Q    8! P," @0'
M"0D)"PP#  $" P0%!A$2!R$3"#$B011183(5<2.T=18X"8&10I(SPS87-Z%2
MTG,DU%6U=F*"HD-3-%97&+%RLF.3LU24)=4FP=&#TT1TI#65I<49X:,G$0$
M @(! P($ P8& @(" P   0(1 P0A,1)!!5%Q,A/P88&1H;$B% ;!T>'Q0A5R
M,V(C4H*2-!;_V@ , P$  A$#$0 _ +_  #0^8./9/)V#3L6K[V=C=NX92*NY
MK7W([C,MHC[?<[2DFMI6NUQ&O4CZ:&1& @_Q#YHRB[>O^$.4W%*Y)P9;C*9<
MA9K?FPX[ILKWJ5U<6RHTEW/^,0I*NIDI1V82%K!%
M                                                    5<\M\.Y"
MI8$?G7BW)+*OOL.2V]<434AU5?+KV%FI3RHV[MJ4T2C[Q*3HMK7XI]UA)3!P
MARE6<R<;T^>5Z$QWYJ#9M(*%;OE9[![7VM3ZZ:^Y&O4T*2?Q$5(8
M
M                ".N=N0D<6\391FI.$B= AK;J]3(C5/DZ,1R(C]='%I49
M?01@*&>'N49;QCS-CU1FKSZ:7E2G)^N5)=6ZEQ3KKAQ'CW']I;C+C1?'\9]8
MW*/3@851OG-@^+_-#B_D6O+M1LP./76FPB23BU+*N>4KZ=&7F3Z_WHU'6&9Z
M+R#+0
M              \X<;X9H><_*KF+'<IM;6!!JI4R=&.K?0TLW/G$-:*-UMTM
MI$H]"(B&\XAG#DYQXKO_  [7CO)?$^=6:X<JP*#,I+5Y*^\9-J>T6ELFT/,J
M)M27$J;U29I,C^)(G/<QAZ"5SK&2X]%DSHI%&MX3;DJ \6Y/;ELD:VED?J6B
MC28PTIQX2?-X'R9R_P */*-V'2SSF0G-WM(HSZHBE$GZ7&S9/_>C5NJ0NZ,J
M
M                        HKY^9K&N+K N%?O-FLB6,MJVOYTAPD,1F77#
MB1W'3+4R2@C?<5J7H1&-526J>764\03\8X]R3B'+JJ5D_'DB/ @1(3Y+DE7M
M)0IA22+3<3#C"/XYF%1>_CS,('(.$4&;5NA1+V"Q-)M)Z]MQQ'XQLS^EM>Y!
M_60RJI7G$93^3N"J6(>RU<MW%(66F])/3("$'I]2DGH-1VEF>Z[8RT
M
M   /-S',)Y*SCRKYD@<9YLK"+2-+EOS)J6U.=^/\XA/;]OIHHR4-SV9</,O%
MW*7$.0XMRISE:)YBP*NG(BOP9$N4U\NM[5:?Q*E$DMQIW%IN0I222X6TR(T2
M3#T7QZZK\DHZW(:A?<JK:*Q.@N:;35'DMDXV9I^![5%T&&E.> ".5YL<US(R
M](K+$IEU">I*<*9&1U^LE(4+/9%V!%
M                                                      4GQ'@3
M(>6O)#.^1^;\1<;PI"7(N-U]BI/;D)0I,>,HDM+UT0PV;BO]VLAK/1,)AR7Q
M$X'M,>M:NJPNOK+2;#D1X-DUW>Y&D.-FEIY/XP^J%&2OW!,F& \*Z#D_">.[
M3 >2J*34?<5@I=&])4A2'8LS<MQ#1H4KHAU*UZ_^,()$4L2?^T%YQQY]6?S6
M%<6-$3DKVJ:4_7J7H:#+H9JF.>WUW(;W$+Z"]@RH
M                                                 H(W3>1O%'D'
MR9R!@W&;F25V3RY+,5^0LDLJC.2$OI<1L=2?7:7J->B8=G.L9\N?*!%;A67X
MI!X]P-B6W+LI*UI-2UMDHDJ-)O..N&E*CV-H2E)JTW*]#)T@ZK;WEMC?!O%#
MMC)6I..854-LLDXHNXZF&TEAAO4BT-QU>Q!=/M*&3LKIX#8A:O8]F/,.0M_^
MU,ZLEG%D.$?<6PPZXM]PC/\ @N/N++\+8U8A<894
M
M      &G\H8]EN6839X[A5^C&+VR04=-VIDY"V&%GH]VTI4@R<4C5*5D>J==
M2ZD1@-4\?N!\>X&PU6/5;_WC=SW"DWUVIOM+E/I(R0E*-RMC;9'HA&X_BKU4
M8LSD2V(
M                   (%\@>!,@YWG8_4RLO52<=5SJ)5O11XQKD39!+/5?>
MWDE.C?M;W(423,U:'T%B43104%1BU- QZ@B-P:6L8;B0(;1:(:9:3M2DM=3/
MZS/J9]3ZB*R0
M                                                #"Y7E=!A&/S\
MHR><U74=:TI^7*>422)*2Z)27JI:C]J$%U4?0NH#1N"N=<=Y[QZRR/&ZZ;6Q
M:R<=>ZU8$T3BEDVATE%VEK+0TK+X^HLQA(1SG/G/PU@^82\16Q:W*JQY46UM
M*MAEV&P\@]BTDIQYM3FQ6J5&E.FOV34$1,F5A,:R2ER^A@9-CDQN?16C*9,"
M8UKL<:7Z'H9$9&7HI*BU(^A]1%94
M        !JV=<CX/QG4%>YW>1:.L4KMM.25&;CJR+4T,M()3CJB+J:6TF>G4
M(ZC$\><V<7<K?,HP#(X]O*AEOE0MKL66V@]"WG'DH:<V:F1;R3MU^(LQ,=TB
M8GLW\10
M
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MJ1 6:>KC3C1J-23]/AIJ.SSJQ.O,]W3]KO:-OC';'5> ?/OJ@
M         !TK>VKJ&LF75Q);AU->RY*G3'E;&F6&4FM:U&?H24D9@,/B7(&'
MYUCGZ78G;,V>-ZNI.Q02VVR./_*:DZE"BVZ==2 :1_VHO'S_ *PZ?_RRO\$,
M#;LQY0P#CZJB7>:9#"IJR>9%!>DN=9&J27^*0DC6O0C(SVIZ:]0&2Q/,L7SN
MF:R'#[:+=4KRE(1,AN$XCN(^TA6G5*BUZI41& U6)SWPW.RHL(B9K5/92;QQ
M40$2"/=((]O:2YIVU.:EMV$O7=T]0$C
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MV")"7E%T4X9F>FFA$9:C>S=?9]4Y8T\?7J^B,)M'"YP
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MZ5*49$1 $27&G1T2X;S<B*Z6K;S*TN-J+735*DF9& Y@
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M.X]'<5H8V*XS38Q"4:X=)!BUL=:NAJ;ALI929E])DD85T^0#,L"RDR/0RJ+
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M:*V3:%/OJ-;CBM.JE*,^IG^#T(!F
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M)U+7H>@#H8K@>&8+%<A8905]!%?,E/MUL5J-W%%KH;AMI(U&6O3< V(
M             ?*G$)4E)J(EKUVI,R(ST]= '3K+JHND/.T]A&L&X[AL/KB/
M-R$H=3ZH4;9GHHOB1]0'>          &N<@_T!RK\SV'Y*X J'XT_J.YS_\
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MTJG8FZ.]@V77C49JW$UM/<?JLDJV[B2GLGJO&(T
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M+$,:D3W5+PUN7R7#E(-#$6Y=4E]#*2-*>K).LMZ]?<;FAZ:Z)G*P]"1E0
M     !KG(/\ 0'*OS/8?DK@"H?C3T\'<Y/\ \1DGY&-3WAFW:77\=O$3A+D?
MAK%,UR>MFO7MHR^N:XS.>9;4IJ4\T6B$F1%[4%Z!-I5;GCOC#!N*:,\=P*G:
MJ*Q:^\^2#6ZZ\]M)/<===4I:U:$1>Y73X#*NERS0\CY'C+5?Q;E+.(9(F6T\
MY:2(K<U"HB4K)QHD.(<(C4HT*UV_P=/B A8^)_,W3ISI7_5_[$A_YJ-9CX"R
M..QK6'15D2^FIL;UB(PU9V#;9,HD2T-DEUU+9=$DM9&HDEZ#(JC@614?$/EG
MRU29U/CT</.F8-U065@XF-$?)HEJ4@GG-$$>KKJ2U46IMF7KH0OHCL\,3Z_D
MWRWY,Y3Q=SY_#:JHBX]$MVRUC2)2BC[R:7Z+(CCK/<G^#H?HHM4]AW/)^[QO
MG3QIRNTXRLV\BCXY.CR92H:7#T5!6A4A.BDI/V,NF[KIIM+4(Z2,'SSSYQSE
MWBVN#C]Y%L<IS"%7U\''HCB7K%,LW63?;<CI/N([>Q2=33H9Z;==R=40-R>Y
M/I^#H7%/"G(]&4?$;W'&*FSRF:ZDJYB7'BDP[$?0:#2:5'M2XI3A)(G",_:2
MC)W$5W4;CFO\M.+XOCD<-JP43WZ=L8TI*JDJM))_E2CF;)*[7=W_ .Z[9G[M
M!?3J+U#*@
M         #7,YP/%.2<=D8GFE<BUH)1I6[%6I;9[VSW(6E;2D+2I)^AI4 I;
MRIX50L*JK![C?E']$Z>W0J/)H,FG%$@RTF1*-HY*#02B,TEHEQE7UJ&HEG"2
M?$:TYIIF/ZK>0\?B-8=0U)/8QE-<:9$64E+Z4$T4N.ZY'=/12E>W:LM/<03A
M86L&5     &D<@\O\;\5%7JY OV:,K4W2K^\AYPW?E]G<T)EM>FW>GU^D$RJ
MIXMY!2Y7Y9\R9'CLQ%A26<5R3!F-DI*'6ERV-%$2R2?[Y#4]A>(94
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M>5L-K\6Y;=25I,LZ]A#"K-I@D(23ZD&LG%(;6E33B%[%)W'H2M34F"%L1%
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M7HI.A@,5A'%7'?&S<AO!<;@T1R]"E/1&B)YU)>B5NJW+-)? C5H W$
M                                                         'GK
ME-'@'+_E;GM!Y!9.[0U6.--1<0JGY:*Z,XQL2LS2^\6Q.J3[VTM%+->NNB=!
MKT1MWB*Y5XMSER3QEQOD3^2\0PHC=A D.+)UEJ>:V4*)MQ)$E1^]QLUH(B<)
M!'UVZB20NX(H     TW/.*..^3TP$Y]C\:]*K-TX'S.\NT;Y))S38I/VMB==
M?H PJCXO45/C'EMS+C^/PVZ^EKHKD>%"9U)MII$MC1*=3,]!J>R+P#*@
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MK>25.N+/J7V3U+0^;D\N-E?&L.OPO;YTV\[3F?R7$'F/9
M :ARCA$;DGC[(L#EN_+M7L)V(B3MW=EXR)33FWX['"2K3Z@%-L0Y9\J> <?B
M\77O$LC*X](7R-+<P6Y3K2V-3-I/>BMO-NI21Z)^PHDZ$HM2&L1+.<) \>./
MN6LLY:NO(WFFL3C]G+@_=6.X\:#9=994:4FI32S-;:4(0:4DZ>]9K4K0BVZI
M5;@94         :YR#_0'*OS/8?DK@"OO[/[]7YK\\V'\T+(M*(
M
M        "AGF+G/C[(S)RER#!9V7YO01VOORWJ):JM,)AS:;3,A]+;Q.'^,3
M]MO1&XDDK4S(:K$LRE[Q>ON&JRTS3BKCC'7L;OL;F*.T3,6J1(LH[2NTB7WU
M^XTDI6A-F1$DE$:?M&,RL+*@H      *7^/?ZYW.7^+>_+&!J>R+H#*@
M                                                    #1>9FLQ?
MXNRIKCXWTYJJ []R'$6EN1\P6AEVU*,B)6FNG4!YG.\F^3.-VAUO)V<YAA3?
M0DRID.2\CZS/JV9D1==4;AO$>C.5F_%7(,@R#/7),SGAKD.N37/J/&'$38TL
MEFIO1[LS&V^C?H9IU^T,RJZ B@        #7.0?Z Y5^9[#\E< 5]_9_?J_-
M?GFP_FA9%I1
M                             4#\BN#>9ZO)^0Y/&D:%>87RP4)^\A.O
MQFK&/(KWTR"[7S#K2C+N$9D;9J(TJT4G5*3&HF/5$G>-& \DN<C91S%RZ_60
M\NMJV/41,=JWF'CCPV2:(G'2CNND@M&4(22EJ5KNW:=!)F/06N$4      %+
M_'O]<[G+_%O?EC U/9%T!E0                                   &'
MR;*\:PRK<N\LMHE+4-&25S9[Z(S.]6NB24LRU4>AZ)+J8#H8AR)@_($1Z=A&
M00+^-'42)*J^0A]32E>A.(2>Y&NG3<1:@,ED638]B-6[=Y1:1*>G8Z.SI[Z(
MS*3/J2=SAD1J/3H1=3 8O#^2<#Y 8>DX1D5??MQCTDE D(>6T9^G<01[DZ_#
M<74!M(               -$YFR>_PSB[*LJQ9E,C(:JO=D5S2VE/I-XM"+5M
M/56FNN@#S"M^8^;.1WY$7E.YRY6-RDDA^JQ^&F(RZCT-"D))IO:9?WR5C?2&
M4_\ AHQQ5#Y-<B8I@N45F0_=4D_TAR.2AUHFB6WO;)IEAAM*E]-#ZGT&9E5^
M1%         &N<@_T!RK\SV'Y*X K[^S^_5^:_/-A_-"R+2B
M
M      \W.2<7XIS#RAY%@>0F>2*B#$1%7C"X+J#9)A3:3^76LVWR96TDT_BS
M06Y1J5K_ 'VXF8CHRGGQ?X_\<,0RVZF\+YK)R>^?K29GPWY#;R6H??0HW"2B
M.SUWDA.NIZ?NB3,RN%JAE0    !#7//+^<<4HH%X9QY.SP[54HIA0%/)*(4<
MFS1O[+#Y_C-ZM-2(O:8L=4F5<O#_ "&TRSR=Y8R2ZI7<=M;*"N1+I))K-Z(X
MJ8QJVLUH;5J6GQ07X!9(7R&5
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MO(?'[F.\1D[\2K*XK+=*N\HNK*M">4AMQ2%)=/4G4ZI4GIT/KF>V56^$4
M      :YR#_0'*OS/8?DK@"OO[/[]7YK\\V'\T+(M*(
M
M"(\H\8>"LTOYV4Y/A[%A?V2R=G3%29C1NN$DD[C2T^E)'H1>B0ZC+\?\$<4<
M5V<JXX_QQJDLYK'RDJ0V_)>-;&\G-FC[KA%[DD?0M>@"10       4O\?#U\
MSN<M?^2>_+&!?1%T!%                                    0YRMP2
M6<7D;-\0R%W#>08\<H+ULS';FQ)T%*MZ8\V(XI*7"2?V%[B4G7XZ)TY=6VVN
M<U<&[13;7%HRP^ >.UE793 S?E'+#S*\I#4YCM<Q";K*FO?<3M5()A"E]U_3
M[#BS]NO0M229;V\B^WZF-'%UZ?ICNSO+'!C.?W$',\8OGL/Y$KXZH+=Y'81,
M8E0%*W_*S(KAI2\V2M33[B-)GKUZ#&K;;7.:RWNT4VU\;1F&NX1XXVK&45F8
M\K9>>8V% [\UCU/%@MU=1$EZ:%*6RA:S>?3_ ,6M9EL^!&>AEO;R+[.[CT<7
M7ISXQW6 '7=L              $><ZXK=9QQ#F&(XXRF1>W%<Y%@L.+2TE;J
MC(R(UK,DI]/4S 4,+BORSN3PG%F$8_*E\6/HDX]7,6-.N3%=CK:5_E#:7C4O
M132-Q.%^$;S")QX-XN\BT>0,CESFNOA-&_2NU;DN&_#,E*(VB:3V8RS/T0>J
MM!)%Q1E6"S+,,?P'&;++LIF)@T54RJ1+?6?71)=$(3ZJ6L]$H0752C(B :_Q
MWS!AW)F"'R/1.NP\7;.24B1:)3%-E,+7O+<]ZTI2DBUW;O0!'F,>9W N69>Q
MAM;=2&ILM_Y2!/F15QX,AY1[4)0ZKJG>?1!N)3J>A>IBX&X\N\_\:\(L0EYU
M8.-S;'<<&LAM')F.-HZ*<V$:22@CZ;EJ(C/H6O42!D^,N8\ Y=QMW*,)M$R:
MZ*LV[!N01QY$1:2W:/MKZI(T^XE?9,M=#Z& C:#YK^/UAER,19OWDN.O_*-7
M+L9;=6IW=M+\>?4D&KH3BD$CX[MO47 L(1ZB#7>0?Z Y5^9[#\E< 5]_9_?J
M_-?GFP_FA9%I1
M                               5EPOE#DG/_*K*\1A2X\#C+C]A<6PJ
M%[$RIDA]&U$@O::UZ.D?Q)"$:?PE=;Z#H^/7(W*2.9,_X.Y0M8V0R*%L[:KM
MHIDX;;3SK:NPI:4I,RVR$:)<+<@TFG4RTT3"96H$4      %+_'O]<[G+_%O
M?EC U/9%T!E0
M        !&OD)>V>-<)9W>4TA42UB4\KY64V>UQI;B.WO0HNI*3NU2?P/J"/
M-V7@N)\;\8<8\U8=FY*Y3DVL=^XKD3HREQT/FZZ@R90?=1L)LD.]PS2O>>NA
M=#Y(ZSA)EZET^=87D,HX%!D=5;6!(-U42!.CR7B;3H1JV-+4>A&?KH.-IL("
MK'ECP6?(<&VY O<DF-XQA^-S9$#%8VJ6G;5AMYU,AQ:C-)%H:$JVHW&2=-Q$
M+$X9M\4)8M82Z_\ 9SY"N(:B6_/>C.&D]#[3]FRA?[AI,R/ZA?4EIW,&+T%/
MX;\,9#606(U\Y8.*=L6FTHDK^;3+?<WN)(E*T4VC3<?3:0L=S"1&4-9UYUXD
MWE;*+%B/CL&0B/*23K2G#I#E:FA9&D]'75K+I]KJ)V@RT.BF/X9E/EG1XS_D
M-2U6VS341CV-MH3:?*IVD6A)V-2'23IZ$?07X#IWV*8['\",:R)JOC_?TC)E
MO.V/;1\R9J=E1S3W--VW8VDMNNG0@]2.JWUERAR=A_ W&.1X/A4G/;^UJJI-
MG%9)Y:VD*KT.&^KLH6KW+(NI].HSCJ1/1%N2>2?DO88[;P+'@*PBP)4&4Q)E
M*3.2333K*DK<,S8(M$D>X7"Y;Q^S^_5^:_/-A_-!(M*,J
M                     $>H
M   -1Y)Y*Q/B?&'<PS22Y%HVGFHZG66ER%]U\]J")#9&?4!1_P AY?B[E?([
M^2)S^YPC.W(T8[>75ULJ2Q*;?C-.L.&2.V9+-E2"5M7H?34MQ&8U")-\,V?'
MVKLLAKN+\@L<ISJ5&*9>7-K$=AK5#0\2=K25IT26]Q*E^Y2E'H9GT(B3E5P1
MD      !2_Q[_7.YR_Q3WY8P-3V1= 94
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M6OU)20RK%\@_T"RG\T6'Y*X K[^S^_5^:_/-A_-"R+2B
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M8GN1)\)U$B.ZC4RW(<;,TJ+4M.A@.\
M   Q.1XQCN7UBZ7*:J)<U#BDK<@3V426%*0>J3-#A&1F1^@"D7*'(#EOS!DN
M#\3\!X]F\K%TL1;JTL*M,E\W&VTMI+5/;)#:"+M-DI1FK89ET&H9F(2?XRN<
M@+RRY_2_A:DXS@_=Q=BVJ*\H+TETGT:1UJ[B]R=IJ7I\#2$D1A:09:     $
M,\]<><OY\BA3Q3GAX2<!4H[70WD_-$\379ZM$?\ )[%]#_OA8173Q I\BH/)
MWE>FRVW^_LDA0%,V=Q[O\I?3+8U7[B(_WQ9["^(RH
M               *>\Z^0G.>*\YM<1\3U-19N2*UF?'9GLJ-]:S;===U<.2R
M@B)+?0AJ(C&929:[_7%YW_\ 0?'_ .*C_P!XA_+\?Q^Q/(_KB\[_ /H/C_\
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M.5?F>P_)7 %??V?WZOS7YYL/YH61:40
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MLH+VM?,M&:U(+UV$?H1#S.=KK6^8]7L>V;;WU?S>DXB5K1Y[U@
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M@_T!RK\SV'Y*X K[^S^_5^:_/-A_-"R+2B
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MD9DTVDB2DOI/4SX;6FTYGK+GI2M(Q6,0D(9;
M         'E?Y3'4M<J\NER@S/7F#S-9_5<\DU_=Z()/-F[J1&6NK.XD^J.Y
MW-2W:#=64Y^)=I69+S_R=E/'/WBKC&Q@1WIS]@2D-NW;RVW%*2DS/351R%()
M1FI*#^@R(9GM"Q"[HB@      I?X]_KG<Y?XM[\L8&I[(N@,J
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M,<.+O[GNTTW;-?X&W3IH/DKX\IQV??TSXQGOZIX&&P
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MR[\ON:;:FF,V%7,CNNQ9L5Q+S#J#F,:*0M)F2B^LA9[*NV,J
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MB*PA+3##22;;;;;+:E"4IT(DD1:$1>@PVY@
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M6\;;2)C&A;W#4H_]\9BSV1><94
M%%^2/U]Z7_9\_P AEBS]+,IK'&(ARF#=\?9[>\AU]+-R+$<N8A%D4>I1\Q8U
MMA6MFPW(3'U(W&'&S]^WJD]?JU]'A\F-68MVEY?.XD[HB:SUABI#MIS3+JJ.
MKH;.IX\A6$:TR/(+J.< Y28*^ZU#A,.?C'#<61;W.A((OW^;E\NMZ^-7!PN#
M;5?SOW](3LZXIUU;JOM+4:C_  J/4>0]M7GG+^WCQ_\ SRW_ *QB#DIVE'H
M(V              #3F.4L)?S^;Q>=FVQF\*.S,^ZW]6EOL/HWDJ.I6B7327
MVTI/<GZ-.H#IL<QX#-Y)_JFK;--AFC<9^9.BQ")UJ&B,:24B0Z1[4N&:OY,M
M5%_")/34-]          &N<@_P! <J_,]A^2N *^_L_OU?FOSS8?S0LBTH@
M
M                //#)X7%>9^6?($'R:MG*ZLJFF&,0@RY#D*N7%[:5)U?0
M:31JA1.I22DDI2UZGJ6AZCMT26V>'Z\;J.>N3L6XCLY=KPVU!8E1G9!K6RF?
MO:01H4HBW>KZ$+,B-:$%KNVD83V2%XQEH  $=Y/P/P[F=V>1Y3A=79WBC2;L
MUZ.1..FCT-W:9$X?P]Y'TZ -^B1(T&.U$AM(CQ&$)9CQV4DVTVTV6U*$)3H2
M4I(M"(@', I?X]_KG<Y?XM[\L8&I[(N@,J
M        "B_)'Z^]+_L^?Y#+%GZ6936.,?J5*29*29DHO0RZ& _5N..'N<4:
MU?2HS,_[H#Y 5\YR_MX\?_SRW_K&(.2G:4>@ C8              *&>4''N
M5\T<^0,0XTQ4H&24$:'(NN13D/QVVF7TJ6RAU2-$I[9=4;24\KT3[2,:B<([
M7B+B%IP[RS<\9\A80F/GDZ'*GU^>I><D-RX+:V][+2EZH-"C,E[D;5Z]'$ZZ
M:)G)"](RH         USD'^@.5?F>P_)7 %??V?WZOS7YYL/YH61:40
M
M            %"?([D?%.0^4[#CZLX1=Y-N<004:?<17IL:6@SVJ4VDZ]LU]
MI"E&G\:HRW;MI%ZGJ/FS*3?$RZOV9EQA[G"KO%>,LQBL&YKC<W=+F=Q+9-N/
M34)4XK89FG51Z$GZ!)^:PM2(H      *7^/?ZYW.7^+>_+&!J>R+H#*@
M                              HERE+B0?.^JF3Y+,2&QCIK?DR7$,LM
MI*#+ZK6LR2DOPF+/TLRFBOL*VWB%84\^-9UZE;"F07VY3!J+X;VE*3K]6HXT
M<K[\>)'=F3'VHL)@MS\J0XEEEM/TK6LR21?A,!PUUE5W,7Y^EL(MI )6PY4"
M0U*9)7]Z:VE*(C =AQ;;++DA]Q#,9E)K??=4EMMM!?PE+49$1?A,!7'F"XIK
MKG'@&526<.UBIO$-K?KY+,MM*RL8AFDU,J41'U]#')7M(]#!&P
M    ?B4DG73X]3_#Z /Q3:5FE1D6Y.NU6G4M?70_@ ^@         !KG(/\
M0'*OS/8?DK@"OO[/[]7YK\\V'\T+(M*(
M                    (YYQY(?XLX]FY+71$6&0OO1ZO'Z]TS)I^SL'298)
M9D9'L29FXLM2U2DR(R,Q:UFTXAFUHK$S/HKJ>.<K*D_?2^8,B3G&O<-2%,?H
MZ4K77M_=O:V&QK[=-==.NGP'N?\ 7TQC/7XOF_\ MK^6?&/']ZPW!7),OE'
M6;ZWB(@9/ E2:7)(;&IL-VE<YVGNT9F9[%^UQ):GM)6W4]-1XEJS69B?1])2
MT6K$QZI*&6@                       %(LXP;ROQOG;-\^X9K:N%2Y)\L
MR[NDP.U,1%:22'GF)3NY+Q&:]5$2?4_I/6Q,(EC@6;Y1RLCM$<[LUS6.)@D=
M:J J"ISY[O)Z'\HXM6WM[]=Q:>@=!8410    !"_/OD"G@M% L\3GY/]^JE)
M_P#9Z]A,?*$T?O/MN:FON^W_ +TQ8ZIE73P]RU.=^3?*^8)KGZDKF J7]W2S
MU?8-<MC5"^B>I?@%GL+YC*@                                  HSG
M6'XQR5Y.<@VV65K<]G#(U+55U;(U-EQ<J(<E3[[?3>1;C2A)^T_4RZ#U>#IK
M:)M/7#Q/<^3?7BM9QGU8[)*.GXJO\:SS!83=,N=<0<?R*E@_B8-G L5FV1''
M3[2?95^,;4@B^.NHY>=HIX>41B77]NY6RU_"TYC#OWM9"Y)YBRS'LM;^?Q3C
MI%;'JL?<4KY.1/LV%2'9TEM.G<41%VVR49I)/P]=>#@:*WS:>KL>Y<F^N(K7
MIGU8[,*&GXKE4_(^!06:.:U:0*N]JH"39A6M;8/=E;*XZ3)'=2:M[:TEJ77U
MT(=CFZ*>'E$8EU?;N3LML\+3F)C]F&:S:MC\@<OV."9&:I&$X76P['[B-2FV
M;&SL5J-,A_89&XTPA.PD>F_\)D.IP--;S,V]'=]QWWUTCQZ3:>[4^4\"PK"*
MZMY8Q>AAU6185:U=FPU";*/'F-IG,H-AUI&B=3W$:5)(E=-->H[_ "M%9I,Q
M&)AYW!Y>S[D5M,VB7H2A>]"5Z&G<1'H?0RU+70QX#ZE]             -9Y
M"QNPS##+G&*FY?QVSLXRV(EW$W=^*Z9D:5IVJ0?PT/11'IZ&0)*@?''$G/F7
MY[EO&F3\N9+C&48P:7FEFJ?,@SX2C)/?8?.4S_?-J))IU-*OI2HBWF/@QXK-
M\,>/_)7&F8JR/*^6K+,ZI4-Z*5--3()KNNFDTN_C93R=4[3T]NO7U&9F)]&H
MC"PXC0         USD'^@.5?F>P_)7 %??V?WZOS7YYL/YH61:40
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MTN7'G[*^MC3L^;LYSANR'23TT3J9(1_N4EKUU'D6M-IS+Z"M8K&([0D$9:
M                      4>YDX6\;LBY.R.[R_F5>.9--D(<LJ7YZ&W\L[V
MD%LVN)-1:D1*T/Z1J)EF8AT?#FGPK%.?N0\9P[)7\QK&*9E=7D*%_P"2JCF\
MRMYI:"29*<0M:4I=0O;T5TZ]$S."(Q*]XRT      "F'CX9GYG<Y&9ZGVGB_
M>EL$+Z(N>(H                                  *#<T.YFCS-52X%8
MPZNQN\?CG,38M+>@2OE&'G4E(0WHK71HDI<3[D_@U'8T[K:NL.IR./3=&+-O
MH>.<ML<AJ\JY3NH%C(H7#DT.-T;#C-5'G&1I*8\M\S<>=21_BR,M$'U+XD&_
ME6V])[./C<2FGZ>\^KO9GQ[;V60M9U@=RS0YHF,FOL6Y[*I57:PVSW--RVT&
M2DN-G]AY'NV^WT&-.^VJ<PY-_'INKBS'4_'&7W%[4Y%RO<5L]./OE.I,9H6'
M6JU%@C4FY<AR09N.K;(_Q:?1)]?I(^3?R[[8Q/2'%Q^'KT]:]Y]99C., G7]
MQ!S/$[=%!GM;'5 3-D,_-09]>XON'$FM%HHTDOW(6GJDS_ 9<6G=;5;-7-OT
M4W5\;0A//#Y/B<I<.XOR)84LJEO,CA2'J:B9?1%<^4G,((Y*I&JG->X>B/LE
M\2,QV=O*MMK,3TAP<?A:],YCO^;TA'2>B              #3&N5,'>Y$D<4
MHLR//(T5%@Y5=IW_ )NM._<3NSMZDDTJ-)J(]#(!N8           -<Y!_H#
ME7YGL/R5P!7W]G]^K\U^>;#^:%D6E$
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M1^OO2_[/G^0RQ9^EF4UCC    %?.<O[>/'_\\M_ZQB#DIVE'H (V
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MJ_,]A^2N *^_L_OU?FOSS8?S0LBTH@
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MJGT,M#(S29&?7F,=)=N)B>S;1%            ?AF1=3]/3]\!^@
M         #SQOLPS7%?*+E&7P9Q]^FA/?*LY5&GPE2TLSTI,UNL.-FE;*%KW
M>U2C)PR,]-"3MUCIU187@#D#F?+LEM8/)7%[&"U+,$GHEBQ&>C*?DD\E),FI
MQ2B5[5*5H7IH),0+$B*      "E_CW^N=SE_BWORQ@:GLBZ RH
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M!^9!3U+7[/O&)[<=HYSF4.25O[4]PGEO2V%'NTUU-M"4_@(@]2%M964\XUG
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M/03L5Q"DQRRM';NPJH;,.3;R",GI3C*"2IU9*4L]5'U/51_A&&FP
M -<Y!_H#E7YGL/R5P!7W]G]^K\U^>;#^:%D6E$
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M<.0;[,,HN8-KPBGC!IBO)Y%LF Y".4KO)3\N:EQ(^[H9K(B,_LB3\UA9H94
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M0)@RL:(H         USD'^@.5?F>P_)7 %??V?WZOS7YYL/YH61:40
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MQ-^<R.;/(T&<8TDI*6HR#->UI#"4^U)FM1Z$6;WF\YF<RU2E:1BL8A(BN/\
M(%<MIY&_32Q+&TUAUQX01?\ LXWM=?F#]^W=\?Y/=K_#V^T8;9*;QAA%AGU;
MRA,JD.YU41%UU=;&MTE-1G261I[9+)LST=<(E*3J1*,%;<9:GK\0'Z
M.G-MJNN__,)L>(1=3-]Y#73_ 'QD,S>([SAR4UWM],3/R:K:\O\ &%*2CL<K
MK4&GU2V^E]7\5K>?]P<,\C7'J[^KVOE[/IUV_9C^+XPGES!N0[&=68G/5-D5
M[:7Y"C:6TC8M6TC2:R+7J&O?6\XA>9[9R.+6+;8Q%OS;R.P\L
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MJ2I"C0HM%),R,OH,AT'I*]<Y?V\>/_YY;_UC$')3M*/0 1L
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M--O$MQ)+5_!)S;KZ%U,B'+?3>D9M&'%KWTV3,5F)PG,<3F
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M3H)*PM&(H      *7^/?ZYW.7^+>_+&!J>R+H#*@
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M!1?DC]?>E_V?/\AEBS]+,IK'&    *^<Y?V\>/\ ^>6_]8Q!R4[2CT $;
M          $7>1]1=WW!F>5..I6Y;R*A_LLLD:G'4-Z+=:21=3-QM*D$1>NH
ML#SPQ5>/<V3.%>#<'HWX5/4+.SY"4;>U,F:9ME.E+4E2MQ$PQM;6O33>39?
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M_P AEBS]+,IK'&    *^<Y?V\>/_ .>6_P#6,0<E.TH] !&P
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M#VW=T/;O(]-?J 4Y\<VFF_,7G%#+:66FFW6VVFTDA"4E,9(M"(B(O07T%TA
M   !6/,>"^1L9R6ZR/AF143J'))B[2VQ"^-V,4>Q>_EGX$E@CT)X]%+:<+:1
M]4GUT+N:.7;5&.\//Y7!IOG,])^+8N*N$LH@Y9&Y,Y7L($S+JV,]"QVEI$.E
M55;4LM'W2<?_ !KTAU/XM2ST22=2(CU+;C?R+;9Z]G+QN+31&*_M3T.L[8
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M^/X!C%9A^+1"A4%2R4>'&(S,R+4U*4I1]5+6I1K6H^JE&9CI/19T
M      ?F@#]         4O\ ';]<?G7\#WY:T-3V1= 94
M       &J<H?V:9G^8K/\C=%A)4]\1?[#X'YTL/_  FQFW=)[IP&0  '-$_Y
MTS_C$_\ =$D1'X%_TCYM_/D;_P ]/'+;T(73$: %%<U_7Y+_ &>__CG GZ69
M3:,    "OO.']O?C_P#GIO\ UE%')7M*+_B-@
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MA9&1E^$@''65572PT5]/"CU]>UKVHD1I##*=>IZ(;(DEK^ !W
M             4YR_P \X=7D5Y&PO 9V5X7C#Z6+W*&I"F&4;W.R2TDF.ZE*
M%+(R;4XXGN?00UXLY6DP3-J'D;$:G-L8=4]1W+!2(JG$['$]30MMQ.IZ+0M*
MD*(C/J7J8RTV(!2_QV_7'YU_ ]^6M"SV1= 10!!F2>6G$E#=6.,5YW&39142
M78=E34%5*ER&7&%&APS4M+39I2HMNJ7#&Z:[6[0X[;*UZS.'13YJ>/:&]DV_
MF0;1/M=IY-58)G-O>G94A+"BWZ].BC+ZQ)K,3C#46B8SZ/AGS-X:CF996B^P
M_=UB'?TTM@I*2]5,FPE\C(O]UM&K:[5[PS7;2W:8GY/Q?F=PZMSYFNCY#:8T
MC4I64PJ66NIC[?M=QQ:4.>WX[6C%C5>8S$="=M(G$S&7V[YH\#O)[6-V=EE%
MJKJU44E3.?F.)+U4E+K32-"^.JR&:TM:<1"VO6L9F<0V;C[R2XNY(R!K#Z65
M/@YFMIU]S'K:OE0IC*&2W+[AK0;1&23UZ.&):LUG$PM;Q:,Q.4N#+0 UO.<]
MQ/C;'G\IS2S:JJ2.I+9ON;EK<=7KL::;02EN.*T/1"$F?0S]",#*&B\T.*&W
M3B6-3E-99OIWT];,I)"9-F6NG^1I0:R5_P#2&@ARSJO&.G=Q1MI,3,3&(_-^
MGYF\5I2B']SY3^E:SU3B/W(_]\&R1&KO$V9]HV]"/J3NOU"_9OY>..I]ZGCY
M9C'Q]'P[YI\2:J1"K<FL'H;?>O68M+(-=2GKK\\3AHV:$1F9HWET]1(U7G/3
ML3MI&,S'7M^;F_[9O#JG?F6&,@D8H7\KE[5++.F;T^UN<-).^T^AZ,GU$^U?
M&<=#[M,XS&?@[5%Y?<17-E$B24W-%463A,U.2W58["IIBUJVH[<I1J)*5?!3
MJ4%])D%M=HC,QT6-E9G$3&83T1ZCC<C] :IRA_9IF?YBL_R-T6$E3[Q#2I?"
M->E)&:E6E@1$7J9FIL9MW2>[9K3G? *VRF5D)JYR(ZUPV+:PQZL=L8$-U'52
M77R4A)FDOM=O<0W75>T9B'';96LXF8AO&.Y!1Y?3Q,@Q><W:TT\C^5E,;M%*
M(]%(4A1$I"TGT4A9$HAQ3T;:5<\Y8'46DRGBLW&12:QPV;=_':URRB0G4_:0
M\^E2$ZI_A$WNTZEZCDKJO:,Q#%ME:]YB&\8ADV/YA7P<BQ>P;LZ64X1-26MR
M3):%%N;<0LDK;6G7W(61&..8PVC?P+_I'S;^?(W_ )Z>.2WHL+IB- "BN:_K
M\E_L]_\ QS@3]+,IM&    !7WG#^WOQ__/3?^LHHY*]I1?\ $;
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M42OFEG'7Z.I8;T;-9?26FI#S.=LK:_\ +Z/9]MU7UZOYNF9SA:L=!Z@
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M(.@RV++\]SR>E_2INB+%_GHWWT;7R'<^1[J>_MV*W;NWNV[>NH=!;<94
M               !#OE84D_'CD'Y37N_=9[MOKVNZWW/W-F[46$E2W+U0O\
M^O7"B8-&_P#211+(M->]W[ U?NZ#7K*0M/:0^?)/!G%J.$9T"#D"*:K^^E6I
M-&2H_P!W-$DD]]MPMQ+^UTU&?4CLBS+*CSZ1BMZJ_O<=71%73#LT(3$WG$)A
M?>).V,1Z[-=.HL87".?&JN\O)/%D1WAJVI8F$G,EDRS/3&.04@EEW35W&'#T
M,_3W"S@2VFB_:&H-1HO,90:SW+-+<%)J5])Z1.IC/0P^ON;]HC_I_&_XD/\
MS4.AAB<EX^\[<SII..Y;)Q*[HI9$4BOFLPG6E:'JE7_-2-*DGU2I)DI)]2,C
M#H8:/AOB_P"5N!7+>18Y&Q=-['+;!GSW_O-V(D^A_+?.H>)HS(]-R")6G370
M;M;R[LQ2([).^YOVB/\ I_&_XD/_ #48Z-8/N;]HC_I_&_XD/_-0Z&&@<I<E
M>;W#\>EDYCD=(AN^FE6P"B1X3Q]\RUU61QTZ)Z^HL1 W6PQ+S_MH<BMM[3%;
M*LE%MD0IC$"1'<26A[5-N0S29:EKU(3H81[3^-GF=C;<V+C5Q44U9-?=E'6P
MY328C#DA1K649I<=1,)U/HEK:1? =FG)O2,1/1U=G$U;)S:N99W ^%?-;C6+
M(8P]_%X4J<XMZRM'/EI5C,=<6:S5(E/QUNN=3Z$I6A? AP6MY3F78K6*QB'Y
MGG"WFYR2BM/*I^.O3Z9XY-/:Q7&84^&XLB2YV9$=AM:4N$1$M&NU6A:EJ1:*
MV\9S'<M2+1B>L,53>.OF=3Y1$S-5G36N1UK:VJJ7;3$STP^YT6N.T\RIM#BB
MZ&LD;OK')?;:_P!4Y<>O137],1'R2+]S?M$?]/XW_$A_YJ.'HYL'W-^T1_T_
MC?\ $A_YJ'0PBD[GRRY Y9M.*[1>(W.<XC%38./6E75R6F6E=A1=A]V(M1*U
MD(Z$1:=?H&NF,IZMIXY18X%D>58GRP<&JY:LK)R]D3U&RPS9Q+!"#)<)\TMI
M4VVI*T&TC3:>O3H>GL\'93QQVE\Y[IJV3>+=9KC]_P G[D1YWG?)&-L>/TJ'
M*SS!V9TZSO%N-N5L&/8ME&**ZX:7&EN/>]1-=3+;NZ:&9<7/V5G%>\PYO:M5
MZ^5IZ1+;/N;]HC_I_&_XD/\ S4>3T>]@^YOVB/\ I_&_XD/_ #4.A@^YOVB/
M^G\;_B0_\U#H8:QE7$WG-FECC]KD-CCDBQQF6N=42$*CL.-K=;[3K9FU'2:F
MW4>UQ!]#')KV>$YCNX]FJNRLUMUB76SV#R^5C0\<<HQZG#*#-4R(C]U4/.35
M3#CDA3E>VX[HB,N0E6B3<UW%J23,_:/5U\J=T^$XKG\8>'LX5>-6=D9O->WY
M?G^>&5YHC5-=Q/84;D<V7%MQ:_#ZYK4I/WLA:$040TE[S<09?P.NW77H.YR?
M&-4Q/9YO!\K;XFO?/7Y>K,HI?VB)(27W_CFI)21[DPC5Z?'_ "7U^D?-='V6
M'U]R_M$?^D&.?Q(?^:AT,'W+^T1_Z08Y_$A_YJ'0PQU_A?[0'):*SQRVO<><
MJKB(_7SD-G%:6J/*;-IPDK1&)23-*C+4CU(.AAC,1Y(Q#'\<AXOFDZ/AN58O
M%9JKK'KA7RC[#L-LF]62/4GFEI22VU-&K5)D/H]/(I:D=<8A\CR>'MC9.(FT
M3/>&M819P;CG2QS>=4R*J+E-23/'5I9,*B'9M0#;:E/1NX1'O6G12"^WVC^L
M<.G;6^^TQ\.CL<G1?7Q:UGXYLR?D^54YQ7(K+5"'+R;,BMXU%7H<E4TWDDLV
M2/J1=LU)6?IU(O4<O,Q&N<_HZ_MOE.Z)KV]?DV>CP_S_ *"G@4M/:8Q K(##
M;$:&TU 0EI"$EHG1$7;K].GJ8^=Z/KL,!R)POYK\L4\3'^0)6-V]+#F-V+<;
M>Q'/O-(6W_*,1T+(C0XM)Z'\?I&JVBLY2:YC&6*H:'S*A.(P.LQ!!JAM$Q'R
M2^^77\LTV1)2?SC3W9D["(B2OLFL_P"$D>C'.M6N(>3;VS7>V9_=V_T8?(.+
M?)KC/C&759\]72.'BMX]OG#%8I$BQEMR)[3DE]]Q+)/.IUVFY[OL)+^"1CHU
MM$WB;?%Z5ZS%)BGPZ+ N2ZTH"K)Y^,6*_+FZN6I2/N[[MV:F9JU[?:[?P]-!
M]5^?I_@^$Q.<?\OWY5VXIX<\EI;E9RGQ4NM9Q]*;!K RR!PG7J^JE2G/?'CR
M6W$M&\CT7IN-L_7:8^6V7ST]([/N]>O$9_Y3W^:2\IX[\[,VHI>,Y?+Q2YH)
MR-DJ!+:AJ;5IU2HC*,2DK2?N0M"B4D^I&1CAZ.7"OV%\8>0-AR_8<<PIM=<Y
M?Q^TBP1$O):K&JC&9-;%LHD$XVM:.^C;O0>T_K(<UMDVCK,N*NJM9S$8E.64
M<.^9F</,2LT@X)D,J,DD1I%G K9+K:",U;$K7#W$G4]=NNGU#BZ.7#/5V*?M
M *>"Q65%GBE?614$W%A1&(###2"]$H;;B$E)?41"=##L_<W[1'_3^-_Q(?\
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MAF>A%C]J9F?_ -S=!)[(?\#OU<Z;ZI]EK_ZRH6>ZK+"
M          .A=TM9D=1/H;F.F746<=V%/BN:[78\A!MN(/30^J3,!4.'^S^H
M6K>-"L,^MY_&,.<NRC8:M&U).+Z&DW2=-O524I0MU#"5J3T]OJ->287'99:C
MM(880EMEM)(;;01)2E"2T2DB+H1$0RK6>3M3XWS$B(S,Z.ST(NIZ_*.="(O4
M6!!?@,E2?'J$2DFD_O6Q,M2,M2WI%E(E9X94      $>\J\,87S&Q2Q\Q3*-
MNAF?>$#Y-_Y<^]H1>_VJU+I__D42$(        *><8I67GORLLT*))T#>BC2
M9)/VUGQTT^!_W1J?IC\?%B._X_)9W,./<)Y!A-5^;T$"_B,*-R.B?'0\;*U:
M;C:6KW(,].NTRU&6W;Q;#\6PBK328A3PZ2I2HUE#KV$1VS6?JM1((MRCTZJ5
MU,!FP    &N9S@N+<D8U,Q+,:]NRI)R3)QEPO>VO0R2ZTOU;<1KJE:>I -"P
M#QFXHX\MH^15T"5;Y+#(TP+>]ENV3\9)]-&$N'VVS(NA*0V2OK&IM,]Y9BL1
MVA, RT    PUMB6+WTF/-O*2OM)D3_FDB=$9DNL]=WXM;B5&GKUZ ,=GG&^%
M<FTOZ/YS4,V]8E9/,)<W-O,/)Z$XP\TI#C2R+IN;41Z=/0PCH84<\L>#\"XJ
M+CB;B$&6NVL[]+,ZRG3)5A)6RSVS;:(WEJ)*4FH]"2DC/ZQORFW=B(BO;H]#
M1AL  '#*BL36'8DII#\5]"FGV'4DXVXVX6U25I5J1I,CT,C]0$*)\1.!4VI6
M/Z..'!)WYDJ!4Z8JF)_=NW_)F[V]-?\ B].W\-N@UYVQC/1GQC.<=4V1X[,5
MI$>.VEJ.TE+;33:20A"$%HE*4ET(B+H1$,M.4!'N/\,X;C/)F0\LU92BRW)X
MY1+,W7]\;MD;1^QK:6T_Q*/B?]T!(0       -%YJU/A[/TI(U*/';;1*2,S
M/_(W?0BZF"3V1=X-I6CQOQDEI-)_,61Z*(RZ'.>,CZ_2+;N0L49:B*B6?XP<
M!V>0*R>;@E:Y;+<[SJ2)YN$X[KJ:G(2'"C+,SZJW-'K\1<SC"8C.4KL,-1FD
M,,(2VPVE+;32$DA"$(+1*4I+H1$7H1"*Y    1YR?POA?+DC').7)EF[B\L[
M"L^4?[!=Y1MF?<]JMQ:MI^@!(8                      ^5K)!;E=$EU,
MSZ$1%\3 <+$Z+*;4]&>;>929D;C:TK21EU,C-)F1 .A.A8WEM>[7V<:#=U*C
M+OQ)"&9L<U)T4G<A9*3J7J6I .U6+K/EDQZE3'R<5*6&V8IH[32&RT2A*6^B
M2(NA%] #G8EQI7<*,\V\;*S;=[:TKV+3ZI5H9Z&7T& Y@   <,F5'AM=Z4ZA
MAHCT-QU9-IU/ZU&1 /QZ9&CL_,2'FV6.GXUQ:4H]WI[C,BZ@/QR;%9C_ #3S
MS;<4R(R?6M)-Z*]#W&>G4!C(%1BM!\];UE?759V"BD64^,RQ&^85J9DX\Z@D
M[S]QZ*4?Q 9A#B7$DM!DI"B(TJ(]2,C+74C(!\1Y<:42SC/-O$VK8LVUI7M4
M7P/:9Z& Y@   <$>9%E&LHSS;QM'M=)M:5[5?0K:9Z& _&)T24MQ$=]MU;1Z
M.);6E9I/TT423/3T^(#&3:C%<CF1G[&!76MA4.]R(Y(98E/1'M2/<V:R4IM6
MJ2ZEH?0!E6I<9]QUIEY#CK!DE]"%I4I"C+4B41&9D?X0'XY,C-/-QW'FT2'?
MY)I2TI6O3^]29ZF YP   =9R=$9>;CO/MMR'?Y)E:TI6OX>U)GJ?[@ [/B1W
M6V'WVFGW?Y-I;B4K5J>GM(S(SZ@.*P=K'6SK[)4=34Q*F3B230:7T++:I!H7
M]HCUT,M '!45V/XZPU14<.%4Q2)3C%9";:BH(C/52DLMDDNI]3,B 9)QU#+:
MG7%$AM!&I2U&24D1?$S/H0 R\V^VEYE:7&EEJA:#)23(_B1ET,!]@
M                    &>A:@/E2261D9:D?0R/J1Z@/EEEIA';90EM!>B4)
M))?O$ Y                  !Q%'9)Q3R6TI>66BG"21*,B^D_4P'(9D6A'
M\>A /T               'YJ ^'6&7]O>;2YL/<G>DE:']):^@#D,]
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MI-6@D]U9_P#9SI>1BW(*9#QR)";MDG7U&I1N+)@]RC-74S,^NI]0MW(76&5
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M.QE3,)JFW+"EC3'.ZIA;+S"2VZ$1$:VI!$O:1$HT$>@3UZJNV,J
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MUXO#M;2&[C>+I6MHXT IB4*4ZTHR62W5%[E.D2E$7V23M(:Z8EF7I@,M
M         #'7UJW14EE=OIW,5L1^:Z@NAFF.VIPR_>2 \MH--G_*7%W('E):
MYM:1,OQRV9^[(T9Y3;!();!K2V:5$;1-D^DFDHT(MG7774M_DR]#O'S.K'DO
MAO$<UN#)5Q90S38N)(DDY)B.KC..;2Z%O4T:]"Z=1F5A!7*_ G)W+W+-U=\D
MY6O%N#Z6$ZY2'6SDI-HF4(U<=;<(D(-1]QYUQ9'HDB01Z:&3.!P^ &7Y=>XW
MFM!<6<B[Q3';".QC=G+-:E&EXGC=;2IPS42"2AIPD:^S?]8MB%QQE0
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MF;A"LPJOFFWB,.O=RE]YHDM1U17FWY1[B4HNV1,DE"U&6Y2B(BU%[0/2P84
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M_C%="UZ&=GMU1Z3C+0
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MOBHFTEJ8#O@
M
M
M
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M,K$"*
M
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M<BVJ<85%G6USF5J11JB1&63BVF"5%,EL&;9$3>]M;GT)(C"?T(R](!EL
M
M
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MCGZ)47Z']O\ 13[OB_<?8U[7R'93\OMW==.WM]>OTB+#. H
-              #_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>bc_patient-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_patient-4c.jpg
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M%!04%/_  !$( 90#Z ,!$0 "$0$#$0'_Q #:  $  @(# 0$
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MQ#J"<;42D*+5*DF2B,C\I&0#[
M                       %:\M\V8[PZ5"B[J+F[FY+)<@U-?C\1$Z4X^TE
M*MI-K=:,S5N(DDG4S]@3$#18/ZS.#9GET? YM1D&&Y=.;4]6566UIU;LQ*"-
M2NY/O'$F>B3,B49:Z=-0F!!&6W^ /6)J:&O?>_91S"J2;-8ZZIYJMREC:I:V
M>\-1H;D$I"=A*ZJ7_JMI(F\>HA
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M=6;CKD1A:W%'JI2E-I,S,_*9F(2V
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M]V73XY<5!V=C7UANJ.+&?D^,2:UM-*0DRT\SHCZT5^2;9NFBTQQ=%L5WI/\
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MDBE-)&6XODV?5.O4OP[RD/6L(VK906B2+77H(9/H
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M8I;$
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M_5VT_DK@RMWHG<F6/?D"J^)Q_@DC%+9
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M3^KMI_)7!E;O1.Y,L=_(%5\3C_!)&*6R
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MA5-'9&X&I8TEB4G,,S<5'=0\EMW))ZVUFVHE$E:37HI)Z:*2?:05*+6$)
M                               !7?/GS(\B?U=M/Y*X,K=Z)W)ECOY
MJOB<?X)(Q2V0
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MK/@HYM.[U_7=XHR7T_R@)IH7: YT(@
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MT/J,4MB
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MMD
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MX>/54.IB.K-YR/7QFHC2G#(B-9I:2DC5H1%J V8
M               "N^?/F1Y$_J[:?R5P96[T3N3+'?R!5?$X_P $D8I;(
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MOGSYD>1/ZNVG\E<$V[T3N3+'OR!5?$X_P21"6R
M                                       1'D;%IV8XZ=+ ?:C/G(9?
M[U\E&C:T>IEYNIZGY!I:O!=FLY8V;A5/[ <H_G6!_P!E[_H%/]IR?FC\0_8%
ME!__ -V@?]E[_H#[3D_-'XB3\?<4W>(9*BZGSXLB.EAU@VV"=)S5S;H?G%IH
M6@V])H+\.3FF8G8)OR#A-9R-AUOA=PXZQ!MF2;.3'5M>9>;6EYEYL^S<VZA#
MB=>AF77H+N)H(#+X^YBR:OL*7,<[KSJ5U%C4,M4U4<15A)GQ'(J)M@;SSQI[
MHE]X4>,:$FYU-6A)2)K"';Q'PE#X@M)Z\?D12H;BMK6[*"B(EETKBN:*.Y*9
M=2>XF9"")2HZ]VQPC4DRWJ(1,U2M\0        .%'II]$] %(0.<[I>1VU,>
M+.3HR;61143T)Q;)/6$5YU!QWGIJ&8YK4RPY)W,N+2E);#\\R(31%6 GUF*E
MR++O7*E^)B<0VO#2WE(=ES#?@(E$@FFE&3"D..(;4:]R33YQ&%$U;/\ Q$5S
MT%<N%C=BX<5@CL5NKCLL1IKQ2DQV#6I>YQ#KD1:>^;0:$I-*C[3(E"KMR[G>
M!BF+8C=6,1B%=96W!F>BILQM+<.%)=83(=-]!&ETVR?23:$=7%'TT+4R415+
MX&59$>/W=IEF,2JIV'-DPXD""HK63+A(63;,I"&.I$LCW&CM21:F(%<\?<VU
MM7@V.UY83FTOPU?':.3&QJ<ZPX:&R(U-K21DI)G[51=I=1E0JDG[?*[]0<\_
MLQ/^U$4*OE7/5>9_H%GFFG0ODO/[?^R'*54_F7/_ "%>Y/.K,(=?PVLI>YCO
M,7-21V\F7(:2^:WXTO0V8Y)6E+24EN<\Y6XBT(5>LULX)B(BM79] Z!9KL5U
M]]TQZ(IZ/;*8XUZSB)6#EDMUA>22+*(Q)*R?I*>7,I'9%>IQMYR-,(C3W*E-
MF9*49[.I&9[3,6-MW-;5RFHP_)S78ZUY9Y:^A6]3ZQ?*%5-K<IR*5%M\<G/Q
MBL,9JX"=[;%BXA#95SK:C=>>;-Q.U+AJ)[J1;3,A5XM?-^;DIL=KKOVS9I]%
M\Z+_ .J(K[)KZESWWK#UU536-J>!9L::^,_)44G'9T:.HF6U+^Z/*29-HZ><
MX9&22ZBWI1P=O]4Q'K5!1^L)RA57%7<93*C9!0V<AB/,QVIKR[YHIYDEKT6I
MHU/2'&U*226W-YNHU,MIZ"HT^OG)EFSEIM=UU+]MV:;1QGB[^J*5]M?4NY//
M-<DS+Y!YX?:9E\F)_P!J+?EHX2KZ5SU7'IK@.>=/_P KS_M1-$55#FG/W(%Y
MDTRMP=<C#*NG)EEYBYJ2.WD2Y#:7MS\:9H;+!)4DFB26YSSE;B+056LUGR)B
MV(K5VG0N@V:_'=?==2FZ$ZP7UDO3F,P;&YPC)I-QJ]'GR,=I)ME4.R(KRV''
M(DE)&2VU*1J1:F:?:F9F6HLK/ZHBYRNJP_)RW8ZUY9HDO[?*[]0<\_LQ/^U&
M5&M5T3?6#JXD.1+=P+.TM1VUO+,\9G(+:VDU'YRB(B[.T^@4*J)@^LARG6NP
M<WO)<2PQJ4['=G8M!A(42(,U:4I1"DI5WKLA!+3LWF:75^;HG4M*C%KYOS_*
MIZ7=ZW]MV8-!.HBZMUMO-/JFOH_%?A<]UZ=2/ L\5H9]?DQ/^U%O1PE0^>ZX
MR/\ ] YY_9B?]J)H1*&<B^L380J>-#Q/&+ZDO[>4F#$MLKI)4&NC;T+=<6DW
MMB77B0V?<L[BW*[=2(R&OGR?*LF_>L^EZ.-9J+<4SRQ<T/'GK!Y=!O7\;SB)
M89D;\,[*NG8[4JD63*6G4LNMRHL,MO=&:DFT\1)\[<D]W0QK:+4SGMF9BE)6
MW7^CV=/R6\DUB[U[UI?M\KOU!SS^S$_[46%'+5/V^5_Z@YY_9>?]J%"JH<WY
M^SJXR212X,<K#8%0S'.=Z;J-EM(E2R4M.L:8?W..E!$25;=SBMVAD216:[63
M@F(B*U=C^W^AV:^V^^^Z8BW9L]?K3/C[UCG+?'&GK_#\EL+Z(\_ M)F-T<R?
M4NR8;JFE.1WD;BVJ(B-2#/5"MR.NW46&._GMB[UN:UNG_P ?/?BK7DFB5ESW
M7?J#GG]F)_VHSHTZN#Y[KS__  %GA?\ ^KS_ +4*%5 +]97E&0;G($27!9Q@
ME+E,XB_$22/1R%FCNG9FO?%+-!:FHO-2]YFS345-VNF,_P KE=YB_;5F30QG
MY_ZYMY_93U<5^M\^5QMH46!9X9*(E%_Z7GZ]2U_U1;4<%S-UC/+D/*+N-1LX
MCEE6Y))Q13KBBEP(*.Z0:S)Q]U))29Z:)U[3Z!1-5AD>O40D
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MF%N]$[DRQW]'ZKXG'^"2(2V0
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M^HU456H]-51(YGH6A=6D^0ABEL0
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M02#>D*2E"G%Z>V4:4)+4_(1 ,L
M>>J?E_D'*[R2NIM\$Q^BCW$BG/'[Z9(<R5M,&6J(Z4AMIYMMI][8;C36U6B5
MHU-0RH/0HQ     !7?/GS(\B?U=M/Y*X,K=Z)W)ECOY JOB<?X)(Q2V0
M
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MS_.IZ%]%D/K$IT(L&QHM"TT^4$@__P#'D*>D+RLAY'ZQ)]#P;&NO9_Z@D?B
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M>XAYI     %=\^?,CR)_5VT_DK@RMWHG<F6._D"J^)Q_@DC%+9
M
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M)UT TE7/I9BFZGQB30HEDHRV)WJZ?6Z*Z@+7+L <@
M            U61T:,DII=*Y/FUB):"0<ZJD+AS6M%$K5IY'G(/IH9EY-2 >
M-+'D>1)R:5=PI66&47(=EOCZ<IF,N14R+<JR%7HAICF@ITAQ+TOP.[8B&W[8
MS7N3G1#W ,$@    "N^?/F1Y$_J[:?R5P96[T3N3+'?R!5?$X_P21BEL@$8R
M3D/"L/DL1,INXM3)E(4[':E+V*6VD]IJ+IV$8B9B$T:;]N7$7ZX5O[[_ .P1
MS1ZRDA<X<2*4E*<OK34LR2DN^[5*/0B[/*9AS046 ,D
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MH[LBUW&>AZ)(S\@6[T3N6QCY;:&K3J2M(D<MR3U2?W)/4C]@8I;$!X_]</\
M2S&/Z/D?#I&MEWP]+'G/0AXLWVR7^\QO?V?A4@/U)&^\
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MSK'L$MZ.P=1C4I;S;M<ZE$6RE-]VPTB2XZ2-(ZR>6VLVRV[B2KSS-74)(:/
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M&^\
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MW%IKH J[AOC-CCU_.'4U4>L5>Y%,GPSC.=YWU<I+?AU+ZGHK<;G0^O4!:8
M@O,&&(SSC?),63 :LYEA"=3 AR5FVR<Q*3-A2E:I(MJ]%%KTU+J DF,4L+':
M"MHZZ,B%!KXS49B$T9FTREM)%L0:C,]I'T+J VP!T 57FW&4?(^6./LX54L2
MV\=*Q](6#BS2^QN92</ND[B,]'349[?\H"U
M                   <&1*(TJ+5)]#(^PR >*X5OS939[(IZ>'D$7*7I)N(
MH6:TT8<SI?\ _<.)C)81">K5N./2.^[Y;_4S)SS!GL'M4A@     "N^?/F1Y
M#_J[:?R5P96[T3N3+'OR!5?$X_P21BEL@'D#UPOTLQC^CY'PZ1K9=\/2QYR'
MBS?;/X3&]_9^%2 _4D;[P
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MWUVWJ/:,%_+S/#_(LYN6NU;!&9]I:#Q>[D
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MRX[ZUM-.H6ZT23<0A:5*23A:I,R(^FI=2]D!W
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MJ6 ]6<8OY@\U+F0\NNHG?FY<> >L55;+1-[%/EW2F-26K37;MZGF5>T2&
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MZ"CS^3<KM)>0RKQR75,.IE*(IAT<<CCO2RBEL;?Z+4[H\HTJZ%G5#UR,$@
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MEI2VG4/+-25&HC09H+4AJS%&ZNP0
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MFD^DGA<EY]9^\M_8I^H.:A$/L2E>?J]_@60?&(_P2AT'2/#?Q0N@7P
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M:<3R95A'[TE*3*63CI$@UFA)*41'YJ?I#Q;"?]@
M             U>18_79332J&W)XZV:DD2$QGWHCII)1*+:\PM#B>J2ZI47L
M *)?G>KE,SZ=$>RBV3E4>U:1+2B[R%JN*S?D[$L)-,@H9D3Q=TMM'W-"C)M6
MAGM&6VB'HH8I     %=\^?,CR)_5VT_DK@RMWHG<F6._D"J^)Q_@DC%+9
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MC&$PE)A     KOGSYD>1/ZNVG\E<&5N]$[DRQW\@57Q./\$D8I;(
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M*C?\]*4CA+D0T&:3^3MJ1F73H<1PC_SD%N]$[DQQW]'ZKXG'^"2(2V0
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MH0#D  =#L.,\^U+6RVJ4PE:&7U(2;B$N:;TI49:D2MI;B+MT(!W@
M                                   P[6UKZ2NE6UM(;B5D)I<B9+>5
ML;:9:+<M:C\A$1:F \7X[<\?9[R&KDB1G>&8KE97KD6+2-4D6=+4F++[N.Z<
MU]Y)/29+6Q12VF]2)9)0?FF0SH5>W!@     "N^?/F1Y$_J[:?R5P96[T3N3
M+'?R!5?$X_P21BEL@                 !JEXY2.+6XN PI:U&M:C;(S-2C
MU,S/Z(]XU&6(I%TM6=+BF:S;%>#CY,T7\WQ_WLA/^3F_-*/\3#^2/@[XM+5P
M7>_B1&F'M#3WC:"2>T^TN@POS7WQ2ZZ9>F/3X[)K;;$2@^4\*8CEU[)R*T>G
M(GRDMH=3'D=VWHRC8G1.T_(*K-H<>6Z;IF:S_'J=;H?W)J]'AC#CY>6VN^VL
M[=OK:?\ PX8%_P 3:?QO_P#<'E]LQ>N[XQ_X;W_<-=ZK/[?YLZEX%PNAN8%Y
M!D6"IM<\F3')Z02V]Z2,BW)VEJ74>F/08\=T71,UC^/4UM5^Z-9J<-V*_DY;
MXI-+=O:R^0RTL():Z_<%]?\ [Y#K>F^&[C#YCU;QV\)0\6ZF?2/OK?OB/=$(
MG=*8WQQ3_D/\!A_&#^#4*'I?BNX=[H>K>"WCW*_%^YUP?M3^D)A$[EC67S>%
M\58]T@<[@^J]\][I]1]'_ICN5T.A<RX 6+B?Z'2?^:_TCGM9]1\'3:+Z7^Y7
M*/:(^D7U!T4[W+V[H?0ADGG'7WBP]^;]P*/JF^WA*_Z3X;N,(3-_#I?O[WNS
M%QC\$<([%'D\=W&>UT#T8)5@'Y<=^+*]VD5?4O+CBM>E^;/Z>]@YA^DL[_9?
M!I&QHO)M]_:\-?Y]WN[&C&XT6UQK](:WW[]PH:FK\FYN:+S[?X]#=<B?E2%\
M75[L:O3?!=Q[FWU7S+>'>B(M50Y;^^-_9H]T0B=TD;XXQVK!Y$_)\3W_ /<&
M*#IGF3P[W1]5\NW]2O!T#G ^PP0D_(GS0+]YA?"MC@NM>#)Q[W::3R;>$/.8
MXMM "_\ C3YH;'[&T^HL=)I/I)X7#SZU]Y;^Q3]0<U"'V)%Y^KW^!Y#\8C_!
M*'0](\-_$70+T          !1F7JYDAYAE5_C"GUX]4-1$U]8M!RDS&WXJ4O
M^&B;$$M;#BCD;B>WK4CN2+10E#2Q,HYKGR_$JB3YD3:;=+".L75,SUQ+%ONY
M,EW?WD<W6%><VO1M2-5;?-,@'./YES_:U[DJ56G"5":E3C0_4N*>ER(B8RCK
MC3N:)"%../--O((U*)&I:Z'J&WE2^696 U3L5ZR=SV)D4IB22HB(1>'+Q1,(
M>2DB:=C%JQ]V]JKH9GV@-IQD_G[N*71R4RW"2XP5.K+2?9FF9QFCL">T23G=
MD_WI,]/I>;H(3"-8$?K+_(K'_03>!>A_1\;P7B7+HG^Y[LMO>[4:;]/;;>FN
MNG09;$;4BW>M;_\ #X]_?+O[0-AM-?6M_P#A\>_OEW]H&PVO(7-[F9'R/9GS
M*:&[QDF%4Y5:IY52*XVD;%U.NCAN&[O[XR^Z=]T]KM&ODYJ[&<1%-KTU@2O6
MU/#*%4QK$"E*A,Z_*%=JFY-)(+8<XF$FCQ&S;WVWZ_4>\48;4BW>M9U\SCSI
MV_=+O[0-AM:[(#];4J2R5":P0YZ8CZHI0UVZI7>]VK;W)/)[LW-?:=YYN[37
MH$THFWQ17=5Y?P!VT+-:%?&#LESE)V6@IZ;)<Q2UH,_]_P#3Y:FHFB\XW-Q;
MB<V]WY!2Z:=3\Z>?P]WL?1>KV],_P(^5R\__ .--]?3S>RB\_5\/UJCY1R0^
M;B=+!?!3/1!%X/POC?&L]SW!L_=]O<][M[[KMTW><+N:4?.GJ,8@
M                                             X4E*B-*B(TGT,CZ
MD9 /+3UMRZW%7BK4#*3Y=^5Q3V[5$1!8@53WY()@I>WNO1A5_4V#/O\ Q/73
MO!GL'J88      KOGSYD>1/ZNVG\E<&5N]$[DRQW\@57Q./\$D8I;(
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MZE))6O86A;C(M3T\FH@=J4DDNG^<^I@/H
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M4LDZ[2(S,!%>?/F1Y$_J[:?R5P96[T3N3+'OR!5?$X_P21BEL@
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M$I"TGT4A9$HO*03$Q-)(F)BK=:D7:(9
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MOGSYD>1/ZNVG\E<&5N]$[DRQW\@57Q./\$D8I;(
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MMI*;%I#J2AQ7-TA+>]"_/6GIITW>4Q,2A824DGL[/8^D(2Y
M                          !U/L-26ELO(2XRXE2'&UD2D*0HM#2HCZ&1
MEVD8#1LX%A$9UE^+C54P_'5WC#C<",E3:]==R3)LC2>I=I!42$      5WSY
M\R/(G]7;3^2N#*W>B=R98[^0*KXG'^"2,4MD
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M?V_M@';'LJ^6LVXDMF0XDMRDM.(69%V:F23,!E
M                            "N^?/F1Y$_J[:?R5P96[T3N3+'OR!5?$
MX_P21BEL@                                 !A6U:W;US]<ZXII#Y$
M1K1IN+11*Z:]/(/;#EG'?%T>AX9\,9;)LF:51C]G,'_CG_\ ,C[46'W*_P#+
M'XJO[39^:?P/V<P/^.?_ ,S?VH?<K_RQ^)]IL_-/X-U#I$U%(_5QG%/;TO&E
M3FA'N=(^AZ%IIJ8T<F:<F3GG9N6&/3QBQ39$UWH"C"<D)"2..UJ1$1_=D_\
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MXHXXP*<_987C-?13Y37AI,B"PEI;C)*)>Q1EY-Q$853$1"9"$@
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MA*E)UB.=AF1Z!;O1.Y-L>_1^J^)Q_@DC%+9
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M/J*IDGUHN#%K0VG*%&M:DH27HVTZJ69)(OP7V3&_22L+?$)
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MU%CI-)])/"X>?6?O+?V*?J#FH1#[$I7GZO7X%D/QB/\ !*'0=(\-_%"Z!?
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MPBE"G+9;7*B$X3Y,NJ21K;)Q)$2]I]-Q%U 98
M                   KOGSYD>1/ZNVG\E<&5N]$[DRQW\@57Q./\$D8I;(
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M*VU>U6DR4D_I&7T@%?\ /GS(\B?U=M/Y*X,K=Z)W)ECOY JOB<?X)(Q2V0
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MUI02MFNWO",M^FOFZB+=Y.Y;=!L]!5G=ZDCPD?:2M-VG=)TUTZ:C%+8@
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M;K*^_F:]_91HK33ZM^N_124EMWZ^?MTW'[;411E-\S%)F:)6)8@  $1%V%H
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M22KS%F6NU70]#$T$I$  B+/*/'LB6S 8R:M7,?LG:)E@I*"<5:QR(W(A$?\
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M)9-XUEHWW2WE+6[YZ5=-PL]1?BG'%%/I<>:,D\VY<)X]ZRB>OR[Q73^KLO\
M\R%76%SM<_)[UE3T_P#7>+=>OZ.R_P#S(*P;4'Y'Q[EIE-'.Y2M*W+..(4U3
M]Y6T=/(CFTLF5E&E3&3D2E2(K+OG.MI3H71:DJ)/3WP761?%=S5U47SCF+=[
M$P6IS&UR&TM^#I=?C&)R(K"+698U#[M5962%KVN0(R7(>U337W-]Y);5GM3H
MHT[B]M7=9-VQXZ&W);9_7O6'\GO64UT^7>*Z_P!79?\ YD-*L+#:?)WUE#+]
M.\5T^CCLO_S(/Z?4;55WL'T%EER_SXU#OKFP\,W0W7HA^34OU:622J%"CZ3#
M8?2]WJGF]Q+<WI46I=EGI;\<6[5/K<>:ZZ.5,,"Q?UA8V)US51D=5CU*DG#J
M*+(JF396\*N4ZHXD>5(3/1N<;9-"3+;JCVI]2,5^2;9NFD+3'%T6Q7>A%E@_
MKA*YTQZZ?R1-AQM'F5KESZ)D(JJ]<1I:?%(. ](><4>TE;NW?Y-/)AL>B?\
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MT)UZ$6IJ4I1GU 2P
M                        !7V,\W\5YED3N)XUDL:=D+)OI*%M>94ZJ(HT
MO$PMYM"'C09'N)I2M"(S[!-!,K:YJZ.JFWEM*:B5%:R[)GS'5$EIEEA)J<6L
M_(22(]1 Q(&4U5G:O4\$WG9#,2/8'()ATH:X\LUDV;<@TDTM1[#,TI4:DEH9
MD6I -L3S2FN_):38-.\G"41HV&6N[7LTT\H# F9!35]O74$R:RS=6R)#M;!6
MHDNOHAD@WC07EV$XC=],!LP
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MQUU,<T:*2AY9N),U$?D$)3\
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M$)
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M_+[>92[E#JYRTUUA'4],5X]"D:O35OJ-Q9;C-2S;(U"XF:N!I/N>GNSH0Q2
M                       H7F6!ZN$;)8<KEBR8I,CM(Z6STF2Z]RQA-*-!
M-R"BJ23K9*4:2W^<1="/:/*[';=.V*T)HO"N@0ZN%'KJYAN+7Q&D1XL5A!-M
M-,M))*&T)3H24I(M"(AZ0(1EF6\;0+DXV4,MS+C'XOI=;WHM^R571U[C)XW6
MF'2:-7=*,DDK<9)UT$B28M*QRYJHF1XW';176$='@Y*8JH:W(J5*4V6QQ#:R
M1JI2D$I/UVI=H#>@
M
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M5?&8B(=<TWK3';2T2E:=-3).IB!L
M
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M08^SDK$9:,FE0YDTW#-MVO8<C-$SH6A*2XXX9JUUZZ@-R
M
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M[TDD[M+O"1KMW:==->NFO8(2[
M
M                                         -2,  -0#H0   *NY?S+
M+\.*K3B<6)-EWR9-15,S$KV>GWDH<@$M25%HRI*)'>%T["T,3")5\SZR5QZ1
MK5LXTNSI+DGY]:J&2R?>KB=<BM):)6A&\ER.ZXZE9$>TTD1>4*%7.,>L3?9%
M=XW$>Q\H$6ZD/05O/+-$1#CGA7F5+>-*EH6VAU3!MF7W5\R))I(*%7I!)ZD(
M2Y    (R/L -2
M
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MI=2^F(':
M
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MS=O<Z]U_U-=.FH#LF_)'9+]*>B^ZVR?'>)\/MV]T7B^]W]-.ZT[[=]9INZ:
M(SE7[*?D-8>EO1WR&TB^E/1?==SX7Q:-F_PW7N>\^^>3;N^B E.1?(WOZ[Y6
M>BO%=XOT3Z5\/WG?>;N\/W_7=IMUV=>P!B6/R"]&K]+>A?0FC6_Q?A/";>^7
MW.[?YOW[=L_Z^NG74!JG_P!GORKQ[\']+=S9>@O#]UX'O/#L^)U[OS._\-II
MK_W6[R ,G_\ Y1Z,B[/DWZ$WM>#_  #PF_OE]WW?UNO>[]FWZ_73KJ FY=A
M.0
M                                                           !
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>bc_preexisting-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_preexisting-4c.jpg
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M%!04%/_  !$( :@#Z ,!$0 "$0$#$0'_Q #+  $  @,! 0$!
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M:4KL\8DI(DI(6=1T&,@
M                                                     *$L?>@B
ML9=DF(T/'&7Y1(Q6;]GVLVC@L2XZ7=-Q:'WZ3ZD1Z$HB&J"0U-]QC[T7'-S4
M+C2%U3CCM7>TUBSY';5D]GP.-JW]T^V>BT*2:BUZ==%$)N&I]V;,<AM<=O\
MCS-IAV&;\:6CN-V-BO7?.AL]84Q6[4S-ULC+51FI6W<H]RC%D7@,@
M                                                      XUY/RW
MC#-_>7F8WR9D=?4X1Q_C<NM2Q/DMM%)NLF8-F0;>_HHFXKA$?]VXDO"-QL@6
M'[FF:MY%Q,>)O6+%I:8!/D8R[.C.$ZS)AQ5F<-]I1:ZLJ:,FVS\)-B7#\9V?
MSO2C@Z:>S-/VGM[.^^VB[O=_VMFS3_LA_P 1T0,@
M
M              .,N/'.;F^8N=/9*SBKL7TC:^TCRERP;=[WN5]V3)0DJ(TZ
M:[M^G4;V"?>ZJ@H]CR?#RE#S',_VZF7R#'4390DKEH6Y 5 [HS(XRF=QH-P^
M\UUW=-HDCWXJ_P!4W/IPM/(.YQ3RO;\CRO[.5IV>'3=K\?;U"=T#H@9
M                                                        !4G'
M/ .*X=#O%Y.W"S/(\BN9E]9W=G6QB=-V<:?U2$K[W:V@D^*DE::F9D1:Z"U'
ME XTQGB/.LSYABVR*/#K>H8](,>8AI;AM/52?$FMFSUU2T2T]TAKQE+4>IF>
M@5J(Y[N]+=95D>;^\#DT!VL?SUZ/&Q2ME(-N1'QNN3LC.+29GM5*T2XI/9XI
M*2>B@D=!B
M                                            .>W/=[Y(J,TS#+>/
M>7'L49S*?]IV-<6/P+,B<2DTH(G93BC\4C/Y*4_&-5@;K'<5Q+W9\,RO.\GN
MI^07-FZFSRO)9:>]GV$E.K<=AEAOHDB4YL9;(]$[NJB3V3>/'W9L,R*GQN^Y
M SB*<'.N2;1W)+2O5KOA17O_ %.&K=U(VFS,]JM%)W[5=4BR+P&0
M
M       !4<SERPB^\/6\)E6,JK9V.JR%=L;BN_2ZE]UHFR;TV[?U7;KKU"@M
MP
M                          T+\'8
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MCH<FQK$9RG3N\K7,14,M-FM)E7,>4/J<471"4ITZGVF9$ D0
M                                            #4IR2E5D+F)E+1Z1
MM0D6CE?XW>%"==6PA[73;H;B%)[=>@#;
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ML(DD1MFIO3M^#47TA$?L<>Q.JPCF;!IF+6>$9"QASM\_Q\Y9_:^/ZQ27W%M
MD-+W)<[Q))<;7MW:%N2KJ(M$J3CE)AE;[L<+%&55T&YN(MG9-,OO+0_*D4R5
M.+5O6K4C,B\4O%^ @U&IPSA_#<\P#EG-LH\NF9169%EGH_8E/E-KJ?(7%N,G
M#2ATD(-+A;^J3U/H?3H+,I2&RQM,;FW+N-<2Y;L7K2@=XXK<EB4KC[D1BWO7
MW%,RI#RF5-F\XTVDE=UKXNXUZ::A.SY(VI7P54TN-^\!RQBN,6LBQQREKJ*-
M"B/RW9R*U2BD+<AM+<6L]K:C/Q3,S3\D^I"3N@C>Z9&6@
M             !5#'^I:Q_R+!_QB8->@M<9
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MJ9:$9GT"A5:(B@
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ML%)>A&2B)23U29:D9=2,C%1^@
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M                                  50Q_J6L?\ (L'_ !B8->@M<9
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MA6+\?T+&,X?6M55)&-2FXS6Y1J<</5;CCBS4MQ:C^4M:C4?PB#?@
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MXDF=-W>&9$G:?AU[- 'V JAC_4M8_P"18/\ C$P:]!:XR
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MK=[]F-MU227%J<0WNV)69F1> 6J47&(H
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M6,=LDX7!0Q"C3RM$.,?:LL^\-TF6-I[C-.W:?PZB^BKV&0
M                           ?BE$DM5'H7PGT ?H
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M%J4J[YI*6MQVIA4=.SY-55[*(T./N6YW;+1;4IW.*4H]"\*C,QAIG@
M           "J&/]2UC_ )%@_P",3!KT%KC(
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M          AW*&<IXYPZ3E2H?EZF9,*&W'-PF&]]A+:B)4XZHC)"$&[N4H_
M0L)*NT\]6#G(::IFA:>XT<R+T#:R1N5NFJR-+)O+TC;=#C(42F%+W;MY;NSH
M%"J]1%     %4,?ZEK'_ "+!_P 8F#7H+7&0
M   !#<\Y'J<$37QGX<RWOKA;C=325C:793_<IW.+\=2$(;;(RWK6HB+7PC=E
MDW32&+\EMD5EZX)R%49[&FG#C2JVVJGDQKBELFR9F1'5IWHWI2I25(6GQFUH
M4:5%_6)?9-LTDLOB^*QN2T9;     %$<V6;CV88WB60VK]%@-A"ERG)#$I5<
MFPM&%H)N&]*2:30A+1J=)!+3O/PGH.UTUEMUW[G3ZN^^VW]K8<!W,Z<K+Z:-
M9OWV%TD]B-CES*=.6LS6P2Y45,D_[9$=S1*%GKT5MU/08SVVVWTMW-]/===9
M6[>N<<#L@                        #E3*JJKNO?IH:^Y@1[&"K EK5&F
M,HD-;BFRM#V.$HM2^$:KL'0?LUXY]4*3S;$^C&0]FO'/JA2>;8GT8![->.?!
MB%)YMB?1@'LVX[]4:7S;$^C%XI#V;<=^J-+YMB?1B\4ZC]]FW'7JC2^;8GT8
M<4ZA[-N.O5&E\VQ/HPXIU#V;<=>J-+YMB?1AQ3J'LVXZ]4:7S;$^C#BG4/9M
MQUZHTOFV)]&'%.H>S;CKU1I?-L3Z,.*=0]FW'7JC2^;8GT8<4ZA[-N.O5&E\
MVQ/HPXIU#V;<=>J-+YMB?1AQ3J'LVXZ]4:7S;$^C#BG4/9MQUZHTOFV)]&'%
M.H>S;CKU1I?-L3Z,.*=0]FW'7JC2^;8GT8<4ZA[-N.O5&E\VQ/HPXIU#V;<=
M>J-+YMB?1AQ3J'LVXZ]4:7S;$^C#BG4/9MQUZHTOFV)]&'%.H>S;CKU1I?-L
M3Z,.*=0]FW'7JC2^;8GT8<4ZA[-N.O5&E\VQ/HPXIU#V;<=>J-+YMB?1AQ3J
M,VKP_%**2<RBHJZLF*0;:I$*&Q'=-LS(S2:FT)/34NP29F1NA       '.IW
M='7YUR$Q96T"#(.ZCJ)F7+8CN;3K8VBMCBTJT/X=-!66<658GJ6N15/:7_\
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M&Y<,N$,>BHB,7:TF2[2V6A$A]UMUS;W<>*VHFEZI+5S=U,BZ06/79EB%Q+1
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M$EQY1*/53AF9ZF>NO46:$.D1E0    !5#'^I:Q_R+!_QB8->@M<9
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M6/\ D6#_ (Q,&O06N,@
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MO[S0N\,MIKT+=M(]=->W0!]@
M                           U=X]0'#5 R)V&5?8ZPEQ; VNXD]\G:;)H
M=/:O<1Z&C0]2 1'"N#>)^.K1Z\PO%HE5</(-GRY/>OO-M*,S-#*GUN&T@]>J
M6]I&+,S*46$(H     JAC_4M8_Y%@_XQ,&O06N,@
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MRB:ZD^PT,J42SUTZ:$(K=
M      .1.6N/BP:8NPO\IQ:-@%@BSKH"<L9F3;*,=]+5-EK@LM*-+DEI:U=T
MXE&[9M2KQ4$-1M25U\7<M<591'A8=AN8-7UQ5P66NZE&ZS8OLQ6TM&^I$AMM
M;AGMW.*2D^I]1)B8*K0$4     50Q_J6L?\ (L'_ !B8->@M<9
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MR6C33:\IM)K+3P:*,QAIL
M     5!R5@>:+SJCY4P%BIN;^EKI-2JAR!3C3'<R74/'(A/MI7W$K5/=J4I)
MDML]#,M.MA)JT/HQRGR+F.'Y'R744.%UN)67VE7%7S%6-W+E=RMHHR9/=M-M
MQG"69O(3N4YM(M/"&Q-M5^B-     "J&/]2UC_D6#_C$P:]!:XR
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MLC3(:.J;6VLW$DE*"(]WB[/P$,M(!;>[]F$G&,AC5UO6MY,?)+W)F-')0\N
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MP$2I#=5,G1M.YDRH*5DPZZC0O&6CQORM1:BSQ
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M[6?C-O"NH+.$P67I-;):F-(=^UI:MBELJ41*T/70^N@OHJZQD
M                           !Y2([,MER-(;0]'>0IIYEU)+0MM9:*2I)
M]#(RZ&1@-3CN'8IB+<AG%J2#2M2UDY)37QFHQ.*+70U]VDM=-3TU[/  W8
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MZA1+0M"BU)23+H9&789 /4
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MJV*YA$%UQF$PW&;4Y]K2T[E);2DC/0M-1KT5<PR
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MN^))>:2MQE1*T,C0HS3XW7X>HBMZ
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M
M         ")<F9RUQOAL[,Y,0ID&N<C>6(4^B*3<=^0VPX\:W",OU:5[]I%J
MK30NI@/VMY/XVN94:#3YA1V$Z89)B1(UG$>?>4HM2)MM#AJ49EX"(6DB6"
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MOT+=MUUTU[=-1EIZ
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MK,B-742A5;Y&(K]
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M4GH9:&7:$PD(>Q_J6L?\BP?\8F"^BK7&0
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MN][\SVD2>IZZ$=C?5)W4=NPFG&(C$=U?>.M-H;6O\Y24D1G_ %F0PVR
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M;U&-,R&8,C#(,EU,J9+L%F[]JRT:DY,=>6DM"^2E1)\.FHLSL5>XR
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MI0;2))H2;J6S/4TDO34B,_!J R
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M>(W[6K,S,S,SU4?:9]3,<;M    /MG^V:_[Z?^DA89NW2F8[;QP
M      ''_)>5-X9[ZU'>NP)%D2<$4TF+#V=Z9G,EGN/O%)+0M/A&,F6S'9Q7
M3ZHL[^9*-ZEW/Z47Z4=/R'3\T_$E7ZGWD8RC)*<+N=QGH1:Q>T__ )T2?R/3
MQ_RG_P#,M4E[U7O"?;L%-G4X1<O05N.L)<6N*THW(ZS:<+:;NNA*29:^$>SB
MZ;)EMBZW=/NZ.3K<-DTNF:_P9OMMLO4.W_;1/I1S=AFTCYAQ^1P:S\2>VVR]
M0[?]M$^E#L,VD?,'D<&L_$GMMLO4.W_;1/I0[#-I'S!Y'!K/Q)[;;+U#M_VT
M3Z4.PS:1\P>1P:S\2>VVR]0[?]M$^E#L,VD?,'D<&L_$GMMLO4.W_;1/I0[#
M-I'S!Y'!K/Q)[;;+U#M_VT3Z4.PS:1\P>1P:S\2>VVR]0[?]M$^E#L,VD?,'
MD<&L_$GMMLO4.W_;1/I0[#-I'S!Y'!K/Q)[;;+U#M_VT3Z4.PS:1\P>1P:S\
M2>VVR]0[?]M$^E#L,VD?,'D<&L_$GMMLO4.W_;1/I0[#-I'S!Y'!K/Q)[;;+
MU#M_VT3Z4.PS:1\P>1P:S\2>VVR]0[?]M$^E#L,VD?,'D<&L_$GMMLO4.W_;
M1/I0[#-I'S!Y'!K/Q)[;;+U#M_VT3Z4.PS:1\P>1P:S\2>VVR]0[?]M$^E#L
M,VD?,'D<&L_$GMMLO4.W_;1/I0[#-I'S!Y'!K/Q)[;;+U#M_VT3Z4.PS:1\P
M>1P:S\2>VVR]0[?]M$^E#L,VD?,'D<&L_$GMMLO4.W_;1/I0[#-I'S!Y'!K/
MQ)[;;+U#M_VT3Z4.PS:1\P>1P:S\2>VVR]0[?]M#^E#L,VD?,'D<&L_$MKBO
M+2,BR2/C$['+"EF3(S\N&]*-AQIQ,4T$XG5I:C(R[Q.FI=1P9>GOQ?U.QAZG
M'E_HE9 Z[L@#1TV7T&07%[0U,ORBSQIYF+<MI2LDLOR&B?0C>9$E1[#(SVF>
MGA ;P                                              4!RMR+08U
MR3,HLKCXZ=9$PB9D%2]?H8)UZU9EFVW&;<?,M4*2G4VT>,?:-1"2DW%/)7%M
MOCF..5EOBU=E>10(,F;1U$J$R\<Y^.EQ;*6$+[PU(4I222K51"3$D2MD10
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M2BSN:R/)G;")*3D;=KJDD70B4M)J(O!J)+2=B
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M<HF8Z"0G<?351Z:J/PF(K;@
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M:6T?^NRNFJC(NT7T'2'I-C?WQ!^LL_.$#TFQO[X@_66?G 'I-C?WQ!^LL_.
M/2;&_OB#]99^< >DV-_?$'ZRS\X ])L;^^(/UEGYP!Z38W]\0?K+/S@#TFQO
M[X@_66?G 'I-C?WQ!^LL_. /2;&_OB#]99^< >DV-_?$'ZRS\X ])L;^^(/U
MEGYP!Z38W]\0?K+/S@#TFQO[X@_66?G 'I-C?WQ!^LL_. /2;&_OB#]99^<
M>DV-_?$'ZRS\X ])L;^^(/UEGYP!Z38W]\0?K+/S@#TFQO[X@_66?G 'I-C?
MWQ!^LL_. /2;&_OB#]99^< >DV-_?$'ZRS\X!](R.@=<0TS:PW'7#)*$)DM&
MI1GV$1$K4P&S
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M[M7Z)@'<N_W:OT3 .Y=_NU?HF =R[_=J_1,!&^0&G2PZQ,T*(B7"U,TG^_,
M,#F:K<I^2'\BCTF9PDW-6S$D7?'ZTR#MU1E+)-?/CJ0?</()7_AY23+Q%J3N
M+:+!+2T.*6=,KW=N$[=#4>PI%S<ROX+*N_\ )?LI#BHR%+U,C(GY?=FOPJ1T
M"N\HD_*7'N0YQRIF$*#"=;KKSBR31PK=:33"^U';)U;;"G/ K0TJ47YO4()B
MK3T<C+.3;SB.A>PVZQIOCAU%GF%A<Q4Q8R9D* <-J-#62U%([UQ9JWHZ$V1*
M\.A#>ZB&6@
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M?V85EM_7%"-WONY(_ G?XW](#:@
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M1'X1Y_VX>C/47-@U70F?D,)_I,MW_3J-1;#BG+=/JR"222T21$7P%T&G&_0
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M*K,IK>NR"I@WM0^4JILX[4V!*22DI=CR$$XVLB41&1*2HCZD(K.
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MM^-&CPX[42(TAB*PA+3##:20A#;9;4I2DNA$1%H1"*]0
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M8K:X1D2BUZ'VD ]:FGJJ& S54D)BNK(Y;8\*(TAAALC,S/:A!$1:F>I@,T
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M%SS'H'R_]U8]YPF?PP>3MTGZ'BYYCT#Y?^ZL>\X3/X8/)VZ3]#Q<\QZ!\O\
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M-).2B.XHEJ:2X9;B2I1$9D1]1%;
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M*1WJ?M4[8W>G<&GO=V_Q?D[1Z.3[7V]F]Y6+[WW=NYVN9:CSGJA
M                     #D/D3+*G"_?;HKV[*0<%."*9(HC#DITUJF2C^0T
M1JTT\(7W6VVUNF(1;G\RG&_]U<^:9?S!UNZP\\?*G\RG&_\ =7/FF7\P.ZP\
M\?(?S*<;_P!U<^:9?S [K#SV_(](7O'<>V*'G($>ZDHC/*C2#;J99]V^V1&I
M"O$Z&6I#N8K)RQ6S;#AOS8[9I,Q$LCV_87]WWOFB7\P<O;Y.66.ZP\\?)[?\
M+^[[WS1+^8)V^3ED[K#SQ\GM_P +^[[WS1+^8';Y.63NL//'R>W_  O[OO?-
M$OY@=ODY9.ZP\\?)[?\ "_N^]\T2_F!V^3ED[K#SQ\GM_P +^[[WS1+^8';Y
M.63NL//'R>W_  O[OO?-$OY@=ODY9.ZP\\?)[?\ "_N^]\T2_F!V^3ED[K#S
MQ\GM_P +^[[WS1+^8';Y.63NL//'R>W_  O[OO?-$OY@=ODY9.ZP\\?)[?\
M"_N^]\T2_F!V^3ED[K#SQ\GM_P +^[[WS1+^8';Y.63NL//'R>W_  O[OO?-
M$OY@=ODY9.ZP\\?)[?\ "_N^]\T2_F!V^3ED[K#SQ\GM_P +^[[WS1+^8';Y
M.63NL//'R>W_  O[OO?-$OY@=ODY9.ZP\\?)[?\ "_N^]\T2_F!V^3ED[K#S
MQ\GM_P +^[[WS1+^8';Y.63NL//'R>W_  O[OO?-$OY@=ODY9.ZP\\?)[?\
M"_N^]\T2_F!V^3ED[K#SQ\GM_P +^[[WS1+^8';Y.63NL//'R>W_  O[OO?-
M$OY@=ODY9.ZP\\?+;8OR_B667K>.5[5C&M7F'93#=A!?B)<;8-).;5N)(C-.
M]/08OQ76[XHY+,UE_P#3,2GPXW*T:<NH596K!TRR5E**]-RY7DE9FF MXXZ7
M37MV%JX1I).[=TUTT ;P
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MT9H223BM&TTHNOC+/X G<L.@QE0
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M (XUPZ/CBYZK>U<?DV-U=.H)MV?93WE/R)"TD:M#4I6A%KT21$$S4A-!%
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M6G'_ #A"^D"A5EU>:8%83$5]'D-/,L7]>[BPYL5UYS:1F>U#:S4K0NO8 DH
M                                                       "O^9,
MOML+PLY^/]TF_LI]?25;\E!N,,2;:4W$0^M!&6XF^\W[?"9"Q%4F6KX[R?)8
M%[G.%YS<)OG\/*!.:R!,1$-YZ#91UO;7F(Q;-[2FG$D;:?&3MZ;M0%:,\\\6
M%SA-S [B06..XG$JFYWV5:;536K*2^MHD^2[M4MK2H^FG4:I-%3[^:7@KO\
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M-KCON;\!PZ"JA7N&0I]W&AQV+.>A^:A$B6VTE+SI)[\M"6LC5V>$*C9_R?\
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M.QQE0
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MIT-)^%*DGT4E1$9'T,A!M@
M
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MJR>7FO&F(Y=8)2FQNZB#.FDV6U'E#["%N[2\"=YGI\0DQ22$O$4
M                                              !\]VC>;FTMYD23
M5H6II+4R+7X.H!L0:B6:2WI(TI5IU(CTU(C^/0@#NT;^]VEWIEMWZ%NVD>NF
MOP /H   'P331*4LD)WKTWJT+56WLU/PZ /WNV^\[W:7>Z;=^A;MNNNFOP !
M-H):G"21.*(B4HB+4R3V:G\6H#Z   !\FVV:^\-"3<V[-^A:[3ZF6OP /H!\
MMMMM()MI)(;3\E*2(B+^@B ?0   /GNT;S<VEWAD235H6II+4R+7X.H#],B,
MM#+4CZ&1]@ A*4)2A"22A)$E*4EH1$70B(B 8LVSKZWR?R^6S%\K>1%B]^XE
MKO9#FNQIO<9;EJT/:DNI@%=9U]LPJ562V)L5*UM&_%=0\WWC2C0M&Y!F6Y*B
M-*B\!@,L!\$TTE.Q*$DCJ>TB(BU4>I]/C,P'RB-':<4\VRA#J_EN)21*/^DR
M+4P'VAMMI)(:22$%V)21$1:]>P@'T   #X0TTV@FT(2EM/1*$D1$1?$1 /EN
M-&94I;+*&UK^6I"229_TF1=0'VA"&D$VVDD-I+1*4EH1%\1$ ^@ !^&1*(R,
MM2/H9'V: /Q+:$)2E"22E!$E)$1$1$70B(!^)9:0WW*&TI9T,N[(B).A]O3L
MZ@/I*4H22$$24)(B2DBT(B+L(B ?H               /PR(RT,M2/H9& Y<
M=X1YH@XK9<%T%O2-<,6C\E+60/')/(85/.DJD/PD,[39<<\=;:'5*TV*\!Z:
M6OJE/1TU6U\6IKXE7!1W<*"RW%C-]NUIE!(06OQ$1"*R@            &-8
M1%3H4B&B0Y$6^TXTF4P9)>:-Q)I);9F1D2DZ[DZEV@.=+7C;W@LXI&.)\^MJ
M&5@*)$9=QF3'?_;=I7P9")#3/DAI)IE]:FTI==WFG34RU/MU6B3M;K(<"YBQ
M+D#*<PX9<H),'.DQ'+FOR(Y+/D%E"8\F3+8.,1]XA;>TW6U:&:BZ'VB"P>(.
M/6>+./JC"D2_M"3!2X[86)H[LY,Z6ZN1(=VZGH2G%JVEKT3H02J<B
M     "A['@B5E%OS@QD<IEO'>4&:AFI=C[G)$9=9"-GO74'M+5#Q(<21*\8B
MZZ"U2C#I^.>:LPRC#I/,DNA+'./I/VG!^PSDN2;BU985'CRI!/)0EA+9+-S8
MC759F6FW30-99\2<V4C698#QU9T+?&V=3[">NSLRD_:M*FY+_P <RPRT7=O)
MU-9L&:B-)J\;P"U%_P"*8Y P_&*;%*K=]F4<&-6Q#</59LQ&DM)-1EIJHR3J
M9_",JW
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M2=%'T/M/M&9:2P0
M
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MCN-W,PV+C*GWXM'')M:^_>C-=\X1J2DR3HGPJ,@5(@
M
M                                                      &)9UT6
MWKI=7-2:X4YAV+)01FDU-/(-"R)1:&6I&?4@'%F?8/1X7=1\#MLIF6]9'Q^!
M!RRS..W&74\?5DPO)*A"8A)-^992U-QDK/5Q2"5XNAF8W5BE'67'N9XUFM"<
MS&&W(<6M>752JB3'.%)KY,,B0J*]',B[M39;?%+IIIIT&&JN6LOS3D%[%LM8
MK,NLJVT/F=&-5EFV[WBX5<^;2"80A713*-YJ[I7BGX1NG^3,2D6287EF(\M8
M9Q70\EY2>*<C1[21?NSYI3+-A=&VB3N@RUHW1SD=YW;FQ/1)=/!I*K1H\KR/
M,N-*+GGCVORNWLX>)TM5=XM<V,DWK:"JR,TNLG*T):T$I!&C7JDM2^,6(K,%
M*-CFN+<AX##X]O*+E'('\AY!MJW%\H>L742X1)NF5&N7!B*23<9UE2/U)(Z$
M1]>SK(VFYGW'I-PYR#/P6HRZ\OL?R?"[VX:^WIBK"=!MJELU)D1I"DI4DEDK
MJC33=XWP$3>M*/?+\SR>/[EU-F,._ELY4_5X^XY>M2#*8MZ3+BMNF;O::E[E
M)5\.N@L1'%1G;PLYS%\@Y1YWY3QFQSK(Z/#\<9Q]<.HHIQP?_%SX)K-TG22I
M24I[LS-M/BK6>Y7R2$W0N^4+HN2N1\LQG">*Y.3R*^TN<OO<0M\[CDANS<K<
M:0ITN[69&EN5)3M;)W0SZ&K0U&%/59;[)K_*?=RRR92U&1V>9XY9XAD.1Q:O
M(Y)V,JML<=CD^AWRC1+GDTC78I"ORB,TGX WD11'>0,6SO%O=UF<SUW+62.9
MM.J(5K:/*F)54OHLU,J4U$C$@DQ].])+#C.BB[/RNEC?1*,C-LUR;+.4+S#+
M!.>OXOAM92)CQN/"2V])FV\,I;DJ?)WH6>W38TV6J3-*CZ'KK(W$[6#997S'
M-P+ :&SO+O&+J5R6QBL&[E$S'NIF.O1GE-N3V6U.-^4)(]JTJ[5))1EKU#8)
MFM&1\1<I3<!K,MN[[&LBPVWO&T7\P["9!M*T]J7H\A1$I*5I7U;[-WC? 1-Z
MQ%$?P*ZS/EQ/&'&UQF%K55;^")S+(+.LE''N;:6Y,\B;85*T-:&V_P"T7LZJ
MU(C\!E9BB;]B_.+,=O</>R'%[3-5YC6PI#+M,BQ<2_=UT:0V:_)YKR3U=(S\
M9E:TDHT_$1:9E850]2Y)R7[P?)>%SL[O:/#*.'0RVJ2EF>1/N/RHJM5MO$DU
MMLD9&;B$=%K-)J["%C9";Y0?(^4N2<(QW*>+8M_8Y!85>:4^'UN8L--R[_[+
MO8JI:VT$9H;>GLD@V$K5MU-6OBJ(@H52#CFRSNEY#KZFCB9^C KF#9HR17(I
MM.+AR8L93T677O*<4Z:UK(VW6DEM\8E?!I)W+$--QMBF=9M[O4+F"SY<R2/F
M,.LG3ZA]N:A%7$16N/&EN8P:#3*U[HR?<>ZFGQ>Q/74[)HD0\\5C2.6^?..\
MUM+2[I;&_P"-V<@F1JN<Y%90ZU.80IE"=JC*(\>KBFM?&,R/4)V0M&PF\AY^
M]7WF*0LDF0)F5\OV.$Q\B<43KM34;$N=S#-9&2'#))ML?FFHS+0]#$F/\DAE
M97QW*P'GC@VO;R^YR&BFV=P^S R*25C+CRH]<HUNLR5)2YW;A*22VC\4E%N+
MY7256(HKZLSCDC/L:F\F,*Y+3G<QV=*QUS'V&2PR(4-]QJ-&4PXZ2'F/U))D
MN/)U^5KV:GJ8IL9C;M3;D27RC<SZS)LS<RZMQ)S&X$E4;CB4VI^AR!UDWI3M
MC$:5WTAHC+5I:5&V2",M-3U$AJ8=+\9VAW6 X]:*R!G*SDP65GDD9GR5J>9%
MH;_<ZGW:E:>.C\E6I=.P95*P
M
M                                 !7$SA'![")F3$Y$N1+SF:Q97-FJ
M0HIJ'X.PX7D[J2(VTQ%-I5'3U))_#J+5*-[@6 4W'E7+KJEZ5-DV4QZSMK6Q
M=\HFS)TC3>\\LDH3KHE*2)"4I(BZ$!$(U*X%P.9'F17BF]U.RM&>OZ2-#^V6
MS29:>+T:\0OU?^T*E$FN, Q^\S;&L^G$_P#;^*-3V:DVW-K.RT;2T_WB-/&\
M5);>O014>R?@W!\MF9C.MO+._P YKH=1>=R_W:?)J]1J:[HMI[%:GXQ]=1:C
M>9)QQCF4QL7BVG?]UB%G"NJCNG=A^5UJ5(9[T]#WIT4>XO"(DP^K/CK'+C.*
MGD&>AUR^I8,NKB(WEY,J-/,N])QHR/<?30NH*K.1[I'&$F(_2KL,A3B1OE,K
ML53;O?8]=)[WON\B1S(]A[MW1:E)+<K0BU%JE%I4N"T=#E^3YO![[[;RXH";
M?O'-S.E4RIACNT:>+XJCW=3U,2I1$7?=[XX?Q.PPY]B6NOFW;^4LS$R5M3X5
MS(7WGE,20WM4TML_D:>#H>I&8M2CZQGA;&\%^W;Z$Y.R[-K> N ]<9;-58R9
M$9*3-N$IQ220W'4K3>E#?7\K70@J4<GWN!Q,IQ&7QC0X3G]?G,Q:8L'";>3)
MD85CKSKZ#>G,2C,F5,-H-Q3"M[FIJT2@C/4:C8CK'*.#,;RF?7WR+>YQO+8,
M!NI=R'&9RJR9*A-Z&3+YDE:'$$HMR=R-4GV&,1*S#[C<!<<PJ;%**!$D18.'
MW+635RD2%J>?MFB5J_+=<W*>4LUF:]3Z]G0BT%JK=W_&&,Y)ED?,[/R@[F-4
MS:!ONG=C/D5EIWVJ=#\?IXJM>@@C4[W>L$DXWBN/P)-K33,*9.+C61U4U42Y
MBL.%M<;\H2DR6APNBT+0:3^ 6J42?COC+&.,ZZ9#H?*94^TD'-NKNS?5,L["
M4KIWLF0O0UJ(NA$1$DO 74Q%4NKAX\WY^Y0O+==[C:FX^/HQO+J.2[62%-G"
M6B8PR^1*;<;-24=XA2%:*(NPQJNQFFU9L+@/C*%Q_,XU^RUR<?LGU3[*1)?=
M=L9%DM1+.<Y+-7>^4[DI43A&6FFA>+T$JTPJ'@_',/FV&5KM+S+<P.N?KZ^W
MR6>NSEQ8JT*,V(WBH2@EJ^4>W<?YW4]9,D*EX1]V>CN^(,61FB\DI'9D<W,K
MPMNPDP*RPD-2G-JIL,^NY:$HW[%(W$1&?7J-3*1"\LHX;Q+)KO',D;=GT%[B
MS91:R;0255RCKR4E1PG4H(TKCF:2_5[?Z-!*E&/*X+X]L,=RC%[&(]+JLLN9
M&2V'>/*)YFUE&A7?Q7$;5,FA2$FC:?3L/4C,@J4:>D]V_":G)J3-+"WR#(\P
MQ^0M^NO+ZT<GRDM+94SY.>Y*4=R1+4K:E)&:CU49A4H\K?W9./;>PL%^77M?
MC%S*.PO,+KK1Z+C\Z4M1+<6]%06I=XI)&M+2T)5IV!4;#+_=^PS*[=-]#L+G
M$[94%%/-D8O/56>5UK);6XSZ"2M)H071!I2E1%TW=FBI1/\ &,9I,-H*_%\;
MB(@454RF- AMZFEMM'QJ,S49GU4I1ZF?4^HBMN
M
;                                /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>fc_evx02-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_evx02-4clr.jpg
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M;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (  @ X0DE-!"4
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M P$  A$#$0 _ -_D 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ U" ( @"
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M-F\-Z4CUNRMU@UZAYP)9_GMTT6'M-O+\J,_JKTN+)?M[O#;BD9#N2!LU<_\
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MR+-=6%A?TD\/W7<0NKW=2NI>/BCF-M8Z;EEXY,V/#M?_ -?!<8=@<H @" (
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M;.D'>O%N<!9Q5F)OBZ-\<G[."]/M$^4D>5W:/]K^XDN([C;2S#VQ0WQ6L.T
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M< / *F[ENU/_ !QU2XEQVW:N'K>C? L]H(''FJ(NSL@" ( @" ( @" ( @"
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M)E][)GDFVEABYP=+\K&#QUY#0?L7+;A8L?Q.FH>:T2('D"=2M&=3<<K(" (
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M0[BWW+&^1>40Z()$@(XZ^"CX-YSH-=?% <K(" ( @" ( @" ( @" ( @" (
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MRCPT\&_>H&\WV5T0^O\ H3=KLM5.7+A_4N *D2+DY60$ 0! $ 0! $ 0! $
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M/7Q:?6KWN='77U+C'\"D[;?T3QRE^)?:Y0ZD(!_*@&FJ ( @" ( @" ( @"
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MQT)O:[,Q<? M541=A $ 0! "L,&LL)^?WS'\UQ%G+#S0[US^/W+K>%&5_;_
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M]PFE0R"=EP\YS)O&O0*K0X^'49."M^[O_''XE7VI/KE\"ZP2>:YHZ,Y0! $
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M-:L3XS/T+B/Z+>'VK3W:[$56N+U?P-W:ZLR<WP6GUESMT+B1X<-%S2.C.ZR
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M  7.;W<>]:VN'(O]E1[5>'Q?$E:@DX( @" ( @" ( @" ( @" ( @" ( @"
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MX[6>VX<C-)Q('J:/=^Q<SN[_ 'K7+ER.EVE/M5J+XDB40EA $ 0! $ 0! $
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M'&1/M?YX 9_GJ)+>5QYF34[??<#;N8SUO([/P\N,H6"9'U[;F=/FD\7QQQ_
MT\^CJX'EP7+[JFJV?5'TGI$;HX[=O<7,0XO&57Y;)2C2.")K8XPU@T+W'@T
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M:VKG8VESH6G\N9C>;H]>/#Q;S"Y[<[1TZK6)>[?=JST\&3EOPA0L$TY0! $
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M]'0-/V*@M^>7Q9?5?(O@9E:C:$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MZR?42"C"3KZ'#J;^PA==M,JF.? \$L4TP$ 0! $ 0! $ 0! $ 0! $ 0! $
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MN$+;%@CETL# ?M<0MT=C;Y&F6]K17G<+=-+=-:I)7HOKS4WD><]P<3'(.+=
M/2 >:M-CMW5)K**[>W*R*>&2WLK<=+ALC1<=6UK(>P>@3,!(^]J@=QCB:?BB
M9VZ3<&O LY59:! $ 0! $ 0! $ 0! $ 0! 8G<NVL%O#!7MM;EI1Y'"9&(PV
MZDPU:YIY$$<6N:?>:YO%IXCBLIX,-)K#/S0[Y]C=R]B=S07:,]B?:<]@2[<W
M'&2R>"=AZV0S/9IT3LT]QXT$@&HX]31+A/J17V5N#\C:_P"F;ZF*W<JM#LG>
MTT=;N%6CTKV.$<65AC'&2,< )F@:R1CG\3>&H;ILKQJN!)JMZM'Q-EEI) 0!
M $ 0! $ 0! $!6G?O<<^V.U>?N57F.Y;C;CZS@="'6W"-Q'K#"XJ)NIN-;8-
M3>PUC:V(WU#N'=CWLHX>(R46-B=,TW'^XQSNGB/+;U.!TYJAVME<)=4SU@W%
MI=W>V]TM9%GX&O<= V<21'4_TV@*]CNZI?F,$CI[EV[? ?3RU.<.^'RYXW$_
M8'+:KZW^9#!D@[K;U,<"T\B.(*W<C!&]W1[.QV'M9G=-&HZA687R230L<]Q\
M&,U&I<X\  5"W"IC#JL2Q]-#UJ:D8[&V-\[PBQ^/JMK?JUHN;5A!+*U8GJ=[
M Q@Y^E<356K[\16$V>WP-V*E>&I6AIP#I@KQMBB;Z&1@- ^X+Z!&*22\#6?9
M>S 60$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! =0WI/
M$\2@,=GL8W,X>]BCP%J%\8/@'$>Z?O6RFQUV*?@S5=7UUN/BC7W;-YNU]SL_
M6ZS9(8)'5<A#(T.Z#KIU@']T^]ZPNQW,'=5Z'YHY+;R55JZESUR;&5Q5$,;Z
M;6"&1H<QT0 :YI&H(T\%Q4W+.IV,4EP.SK$,(UFE9&WGJYP _:B3;#DD8ZUN
M7;U,_P!YR5=FG'3K!/W-U6Y4V/A$U.ZM<68JUW$VI#\-MT^G'\F)[AJ/60%M
MCLK7RP:I;NI<RD][6\=D-Q6LEB ]E:T&S$/;T.$P&CCH">9&JZ':PG&&)<5^
M!1;J<)3S$V!VMD),KMW&9"0]4D]>-TCO2\#1Q^\+F+H],VO!G14SZH)^*(7W
MID>W!8Z,? ^X"[^K&XA6W:%ZY? J^ZOT17BS!=M]I8O<.$LV[<DK+++)CT8X
M:!H:--01ZU*W^[G58HKP(NPVL+8-R\24GME TZULE)&?7&-?V$*"NY-\8Y)K
M[:E\LFCX.V%NBO(Y^/W$Z,?@:72L'['$?L7F6[JEQ@>UM;8\)F(S5[>&T6>9
M?W+6<_3W*[G>;,_^C&YFOVE>ZX57<(-'FR=M2UDB%9S>FYMV1Q8JQ(987/ C
MJUX^ETTFONAP;\7J')6->UJJ]7!^;*^>YLM]/X%G]NMA2;=C.7RK0<U89TLC
M^(5XCQ+?Z9_$?L51O-W[KZ5\J+7:;7VEE_,RPQR5:6)R@" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( >2 C.[=ITMVXT5)B8;L)+
MZ=L-XQN/,$>+7?B"E;7=2IEF/#F1-SM8W1Z9<>3*&OX_.[1R$E.XQU:8G0$$
M^1.T>+3P#A^T+KJ[*[X]2U_%'*V5V4RZ7I^#)?MBYL'*%D&9=8H9!WN_G2_W
M9[C^Z\#A['*OW*W->L,-?>3J/TUFD\I_<65#L;:9C:X4VSQGBTND<]I]? Z*
MCGO+GQ>"ZAM*5JED]\&V=O5?[#&5FD>/E-<?O(*CRNL:^9DA4P7Y41#NZVK4
MVBV"&*.-TUN!C&L:&\&]3CIH/ !3NWY=V61-]A5:&,[(Q.%?,V#\+I86#VAI
M)_E6[N;Q**\C1VU9BWYELJG+<( @" ( @" ( @" ( @" ( @,1NC:^!WG@;N
MV=S48\CA,A&8K568:@@\B#S:YIXM<WBT\0LIX,-)K#/S0[Y=CMS=B=S07:4]
MB?:D]@2[;W'$2R>"=AZV0S/9IT3LTU8\:"0#4<>IHEPGU(K[*W!^1MC],_U,
MUNY=>'9.]98ZO<*M'_=['".'*Q1CC)&. ;,T#62,<_B;PU#=,X8U7 DU6]6C
MXFRJTD@( @" ( @" ( @*(^K,2?]6-9S?A;EJI?IZ.B737[56[__ (S**[^E
MO:6U-V8_=$.X<?%?LUK%0P^87-<R)\;^1:6G34*'L:83B^I9,LO"WV'[<6B>
MBA-5]4%B0#[G%RF/MU#? QDQLOT^[49&&4;]RL&CW2\QR@#GQU:W^50K.RU3
MSJT9ZBLMW5=M[+<^OAMXVLEF(SH*5)IZ&'_E)F2]+?8-3ZE3;FB&WSTVO/A]
M/I]AZ3R0U]_>>_KM3"?,7,U8:[6I2=(Z1D9/ O/5P: /Q.4!3NW#46W(R;+=
MJ^UU;85)]R\]EK<EQH;9L,'Y<4?/RHM>.FOQ.\2NQV&PCMXY>LF:V6+IZ%:F
M#E9 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! <<!
MS7E<05CW([?S9:5^X,(P/R'2!<J#G,U@T#F?Q >'BKSM^^5:Z)\/'P*;?[)V
M>N/'F5GCMQY.@&XZS8LBA$XL?7:]S9(AKQ#6DCB/05?3HA/U)++YE'&Z4&DV
M\+3!8^W]O[5W+$9:N:FMR#XZSNF.9O\ 28[4_P RI+]Q=2\."7WHN*-O3;PF
MVR0Q]MML^ZZ9L\CN7O2$</6&@*#+?VRYDZ&QJBC(1;$VI!\.,C>1XR%SC^TK
M1+<V/F;UMJUR*I[N5<?2S>/JX^"*NUE0ND9$T-UZI#IKIXZ!77;9-Q;;;U*C
MN"2DDDEH6AVY8Z/96'#M=3"3Q];W$*FW6MK+;;:5H\/=7%.R.TYYHQK+CWMM
M@#Q:WW7?L.JE=MLZ+DO[M"-W&OJJ;YQU*_[7[LI[?LW:.2>YM2Z&2PN:WJTE
M9P(T'I!5MW+:2N2<>**GM^Z53:EP98\_<S9U>)\LMQP<T'2(1/,CB/!HTYJC
M_16YQ@N_UE6,E<[C[N9G(]4&$9^E4C[OG'1]EVOK^%FOJU*LZ>W1BO7Q^XKK
MM_)_*M/O,7@.W^Z-U3&],UU6M,0Z3(W>HR2:^+6GWG_;H%NLWE=.D=7Y<#57
MM++=7HO/B7'M?8N#VJT/J1&?(N;TR7YN,I!YAO@T>IJHKMS.UZ\/ NJ=O"I:
M<?$DZC$D( @" ( @" ( @([W S%[;VP]T9_&.:W)8K$7[U-TC>M@GK5I)8RY
MO#4=31J$!^953Z[?J3O2>11FQUJ<-+C'#BVR/Z1S/2PDZ(9/;_VU_JH_^RU_
M]RN0%U?2Q]2/?'NEW4;M7?\ ##'@'8ZW:ZH\::CO.A+.C\P_TCP0%?Y7ZRN^
MO;OO#-LK?UG'6<'@LV*&;\FBR"2;'LG#72QNUU;U1'S&'V(#]'HY(YHV2Q/$
MD4@#F/:0YKFN&H((X$$(8-8_K*^H7<G8[!;:J;(EJLW1G+4TCW6HVV RA48
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M)ZB2X7GFV7J =&?X-![%W&THI@O\?]3RV6(I[9Y'BL<P%Z 0! $ 0! $ 0!
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MKBV(MU''I)'(E 8?_O$MOT,7WFQ69IQ".QG<'!/D"-/S+%:::N'GU^4R-O\
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M 7)]/_TQ[;^GVYG;F!S=[+/ST5:&=MYL+1&*KI'-+?*:.?F'75 =/J_[<_\
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M_NC',=I-L_J-"M=+GV,W;Z_,\Z4R:N,'7[SG._MCPXMU*&3]+D,! $ 0! $
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M@:#^)O2>0R?J;MG.0;GVWA]RUHW0ULS1K9&&)YU<QEN%LS6DCQ =H4,&50!
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MM8/M]F=O8C'XW*,N.FM5#9\]IJTYK+>CS)'-XF, ZCDA@W:DCCFC?%*P212
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MOH'B?6[BNDIIKI6G^ISUMUEKU)'M?![#C+)]RY)UFP=#\JV.2.NWU.<!J_\
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M+<6+A)AT5OD8YW;G:Y>Y\4,L)(T]R4Z >QVJWQWUL>9'EL:9+&#QS=L<<?\
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M1<IN8]-LEYG5;>757%^1FE'-X0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M$6L8_8U=!MW_ (T>2=J0 L@( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MQ7D9A1S>$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MTM'X6^H+E]SNY[AZZ)<CH]MM84+35^))FC@#XJ&33L@" ( @" ( @" ( @"
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M ^$O0"\?Y1*Z.J/3!+R/))5M 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MT.','U%<39"4'B2PSL:[(S68O*/<"#R\5X-AR@" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @."YH.A* P^X-RXG;-(W<G-T!VHA@;QEE
M>/!C?'^0*111.Z6(HCW[B%,<R90>[-S3;PRL=SY%E9T;?)KQQZOG>PG4!Y'
MGCPT"ZO:;1;>#6<G+[K=2NEG&AB,?49?OUZ4MJ*F9W^4+%CJ\ICN0#M.(U/!
M2++5"+>,_ T5UN34<X+8QW9?'QZ/R^3FLGQBKM;"T_:>HJAGW>6?3%+XZEW#
MM4<>MOZM"88S8>U<1TOJ8R%T[>4TP\V34>.K]566;RZ?S2>/(L8;2J#RHK/F
M2  ]6FGN@<"%%)9WYH#D#0:( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M<N-=1R#^K-40!,X_Z6'DV3V^#O7[55;S;^U+,?E9:;3<>Y'$OF7$G7BH!."
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M:IC6C3B9)I'3GCZ@P?>K#NDLX1YB;TJDYGHY60$ 0! $ 0! $ 0! $ 0! $
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MV.R%V/YJU/"RQT2G\MCI!U<&\B1KXJIWF\G*;BGA)EKM=G",5+BVB> ,B:
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MI<UN[?<L;SHCVBZE%,A $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M9L?#79!''# T1PQ-#&1M'NAK1H %R>O%G3<%A'V7H! $ 0! $ 0! $ 0! $
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MA;ZM5Y[AN.KT+ZSUL-OCUOZBW  "3Z53%P<H @" ( @" ( @" ( @" ( @"
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M1R5#)1>?C[45J+]^%XD ]NFJT2A*/%&Z,XRX,]:P>@@" ( @" ( @" ( @"
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M3[!H%0[ZU67-KAP^PO=E4ZZDGQ)0H)-" ( @" ( @" ( @" ( @" ( @" (
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M_0O1@T"Y5'3G99 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M/\KP9AO)>C4<H#C4?>@&HUTU0 N XDH!U#377@L)Y!RL@XU" YU!0'!('-
MX'D@.4 /) ?,-ZW=?V(#\_>]F[[?<;NC<BIO\VC4L-P^'A<X-8!')Y;G:G@.
MN35VOHT7-;B;NMPO@C[CV':0[?V_W)K67JES?TQ@VOPG8W;6([96>WW2UUG(
M1!^0RH;I*_(-'4R=IY@1O'N-\![2KJ.VBH='WGR_<=\NMWBW+_*_3'DEX?3F
M83L?O_)V;-_MGO%W1NG ND9!*[@9H8B&N;IXN9P?PYM=KX%>:=S*R71/YU]Y
M+[WVFNBN.YV__#;]S_D3_N1AX,GM2[-(SIM8^-UB"0<QT<7-]C@KG96N%R\'
MQ.'WE:E4_+@5_P!F+)9N*]7UX3T^H#^)D@_F*L^YQQ!?$K^W-N3^!;>9VO@M
MP,Z,K1BG=IPFTZ96^Q[="J>K<65_*VBUMV]=GS),KS+=E@YYDP62,3/""XWS
M-#ZGLT/[%<U=W?YXY^!46]J_L>%YZD6L=J]Z0./13BG _%%.P:_8[I*GQ[E0
MUQ:^H@OMUZ?!/ZSK7[6;SG?J:$< )T+Y)HQIZR&DE9EW*A+CGZF%VZYOA]K1
M-]N=GZ=*1MK<,[;\S="RI$"RN"/WM?>?^Q56X[K.6E:Z?/F65/;(K6Q]7ER+
M+CC$;0QH#6-'2UK1H !R 'J5'Q+I:'<:Z<>:R#E $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0&O?>[Z3]G=U)[&X\'
M(W;F]Y27SWHV==2X[3_ZS""/>) _-9[WIZE/V^]G5IQ1AK)I9N?Z<>^.P+SY
MI-MW+44&LD>5P)=<CZ6G@X.@TE9['-!5S'=TV<3SAD3I[([KNMN^0V[GG7Y2
MZ.1T-2XV7W_B!<UH/O:\?VK?^HK:XHQ@GNT/I+[Y;NF$LV & JN>&OMYN05W
M#TN,0ZYG#V,4:6^JBM#.#9KMS]#>P\!Y-[N!?FW7DP>MU-FM/'!Q!X%K#YL@
M&O N>!_"JNWN%DN&AZP6KWAQN'V?V,W9C\!CZ^,Q<&.?%#3IQ,@A;YSFQ\&,
M &IZN)\5'VN9W1SXA\#6_P"D#$T[_<S(6[<7F/Q6*=8J$_"R:29D75IZ>DNT
M5[W9XK27!LU0XFS_ 'P[H5.T_;W([D<YGZU*TT\'6<6ZRWIFD,.CN;8QK(_^
M%JY_:T.Z?2C<W@J_Z:.RU$=MLIG^X-,9/-=QHG2Y.*X YQQLI+X@3H"'REQL
M.<#KJ6\BU3M]NF[>F+TAP/,5H:9]P=NYCZ>>]%BM@[+_ )C;ER')X2R2"^6F
M_22(/T !)83%*--'<59UR6XIU,<&?J9M7<-+=NVL1N?'$&CEZD%Z'0ZZ-G8'
M])/I;KH5S$HN+P;#,+R8"R#J'@G37V%8!V/ :K(.C7]7@=#Q!\%A [K(.I?Q
MX<0@.P.O$(#JYVG+T_8@.P.J X<=$!R.2 X) 0&+SV8K;?PN1SUTGY3'5I;4
MC>6HB87:#UG30+Q9)1BV^1MIK=LXP7&3Q]I^?6T<38[Q=U(*F;O.KOS]R6U?
MG>[ID\INLCHXSIP=TCRV>A<U7%W6?%GW;?7+M?;_ $I^B*BOCX^6OTR;E]P^
MU^.RO;Z+;^U*S,=D-NL%C;7D>X8IH1Q8#XB0:AVOQ$ZE7\X:+IRI1^7'TYGR
M'MW<7"]NW$Z[?38I<'%_ACBFM4?/LCW*._-MNIY8MCW5A]*^3KG@Y[1JUDP:
M>/'3I=Z'!>=ON'=%MK#YFWOO:%L+DH2ZJYZQ?EX/Q^/,=Y<56=BZ>::T,MQS
M-KO</Q1O#B ?6"."Z#MMOJ<>31Q'<89BGS3/MV8LF3 7JI)_N]LNT]4K&G^4
M+'<O^1/R,]N?^-KS)=F=G;<W WJR-%CIO"Q&/*F!]/4W0G[5%IW5M7RRT^XE
M6[6NWYEJ5_ENR[V]4F%R8TYB&XWEZNMG_ K:ON_]\?L*NSM7.,OM(U-VJWE$
M[1E6"5IU]Z.=NA^QVA4Y=TH?%O["$^VW+@CTX_M%NBP_^]NK4(?%SG^:[[ P
M?SK7/NM*^7,CW#MEKXX196UNWF&VU(RV0;V4;_\ 6Y@/</\ R;>3?;S5+N=_
M9=I\L? M]OL*Z=?FEXDQ T5>6(0! $ 0! $ 0! $ 0! $ 0'70Z^I!D^5BG4
MMLZ+<$=A@_#*QL@^YP*)XX,PTGQ/"S;NW8W=;,53:_GJ((]=?\E;/>GXLU^S
M#P1D(H886]$+&QL'X6-#1]P6K.3:DEP/H?4CR# ;YD,6T<S(TZ.%5XU]O!2]
MG'-T?B1=U+%4O@53V=8/\43G3X:;M/\ +:%?=V_XE\2C[7_R/X$RWQ9GSV2J
M;1Q\A!=('VWCBT'F ?4T>\?L59M(*N#ME]18[JQSFJH_63FC1@Q]*OCZHZ:]
M=@C:!ST:.9]9YJKDW)Y?$LXI)81^?WU$;HM]P-[97/T&>;MO;4D6$JSL&K '
M/>.LN\?-E:_I_A"I-Q/W)/'!'T[L]*V]*B_GL]7T^!L9](6XAE>U+<*Y_7-M
MZ[-3#2.+()CY\8U\?C*G[66:SE._4]&Z>%HTOP-@ I9SQU?KTG3GIP0$;WCO
MG:^P\9^J[IR#*-8DMA8=733/ ^&.-NKG']GI6JRR-:RW@F;397;J:A5%R;^F
MKY&MFZ?K"R+[/E;,P$,50%P=8RQ>^5^AT:X1PN ;["XJKGW'^U'T+9?LK.'=
M/ZE_/4B$7U7=TV3!\HQDL6NKH#6<UI!\.ILG5^U1?UUN<Z?874OV9L>G&9Y^
M/]"RME?5WB;DD=3?N*.,>\D.R>/+IJS1X%\3M9!Z^GJ]BG5]PC+YE@YG??LR
M^M.5,E->#T9L;B\IC\Y1K97#6H[N+MQMEKVH7![7M=Q&A'+V%6D6FLIG V53
MKDXR3BT5#W7^I79O;:Q-@Z,;MP;KC]V:A6>UL%9^G*Q,=0UW\#=7>G1:+=Q&
M!;['M%NYU^6/BS77(?6#W;MS]55F)Q<?'2""N^<GCS+IWZ_<J^6[ER.IJ_;N
MV2]74_I\#V8'ZR.Y-&PTYNAC,U2ZM9@QCZE@,\0QT;G,!_I-7J&[:?J/%W[<
MIEI6W%^9LOVP[^;"[HN90QUB3&;E+.M^$O:,G(;IJ8GCW)1Q_"=?4K"NZ,^!
MR6][;=MOF6GBOIH6J.2W%6<H"/[US8VWL_.Y[KZ'8^C8G8\\=)&1NZ.']+1>
M+)]$7+P)>SH_47PK7YVD?GKL/:>2WK?R\E/5]S%XVSF9(P/[5T1;JP'P<2XE
MOK"Y6%;L;2\#[YO=[7LJZE+A)Q@_)/G]QO%V8WR-];'H7I9/,RM!OR.5!X/^
M8B:"'\>.CVD.]NJZ/;6^Y!/F?%N^=O>RW4HKY)>J/FBN?J'P5[:64Q7>7;FL
M=['2Q0Y/H' N^&&5_ATD$POUX:."C;NMQ:MCRXESV#>PLIGLK=5/Y?Y+P\2V
M<=NC%;_[<R;DQ3^JED<=*Y\9(+H91&?,B?\ Q,<"TJSHFI.,D<9O=O*F4JY<
M8E7]I9"S>=1O^LKSM(]08'?S+I.X_P#$WYG,[#"M\FM#81OPC1<V=$<H @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MHXA4Q<'! (T* XZ0-!X!8'$: \ON]"R#L$ 0! $ 0! $ 0! $ 0! $ 0! $
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MW6SC"#E$D_M_]S;B[<0V]JZU/1/G]?B47M;N3OWM_0R^'VWD),=%E8G1RQR
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MAVJH29"(PY+/2/RUF)[>E[(YP&PL(](C:T_:K';PZ8+S.,[UN?>W+QPCH70
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MC;/8:CB&Y 8<[GCLT8\XR*.^V.>62=AD;$2P<7]3-#\.B\*<I3W#EC/1KT\
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MPZL]QW$0:^\2[XUOVVWZO7+["E[OW>-<732_5S:Y>2\S>YK0T!K0 T#0 <
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MK&]OC:X=/Y817UH,L)0# 0! $ 0! $ 0! $ 0! $ 0! -$!QI_\ "@.4 0!
M$ 0! $!U(_8L@  C7TH#LL ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @(EOGN1M?MTW%R;HFEKU\M8^4@G9&9(XW
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MWV,A5QYADD,0#;+BTNU#7<1IR6V^WVXY\R%VW9+=VN#?3B+?V$V6\JP@" (
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MG,U9J>9ZSIQY<BLJJ4;')8P^)XEO:+-E&F:EUU]72UC'J>?468I11! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0&%W;M3"[VV_<VUN"
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MNNK&@Z]17C;7^Y'7B;^\]M>SMQ%/HTPWS>%G[RSU+*$( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (#6O9>P;.\-\
M=S;,&Z\[MT5MPRQF'"VQ5BEU!/5("QVKAR'J5775USGZFM>1W&\WRV^WVZ=<
M+,UKYEDMW9G;NUM#)3Y"?>&?W"R: P"GFK@M0,)>U_F-;T-T>.GIU]!*FUU=
M#SU-_$YS=[];B"BJH5X><QCA_ J#8FR<QNK=G<VQC-X97;;(-SW8W5L:8Q%(
MXN)#W=8)U\%"JK<I3Q)KU'1[W>0HIVZE5&S-<=9'J[;8F+#]W+. [H6[N:[B
M489+&TLU?L.DIV,?("'&K"[01RAH=UC5W)^GPZG-,<6XGK+D_(U]PM=FR5FV
M2A2WB<4M5+_<^:\.'+Q);W B.T.ZNRNX< Z:.7>=HYXC@"RX3)3>[P ;*/><
M?  +=;Z+(S\?2_X%?L'^HV=NW?&/^2/U?-]QW[8Q.W7O[>W<VP.JM\Q_AC;K
MCR%'&N_/D8?%DTWO#U@K-/JG*?U+ZC'<G[&VJVRXX]R?_E+A]B+5N\:=C3B?
M*?\ \4J6^!S\/F13WT_O9']/F*DD<&1LKY5SWN.@:!<M$DGPT4+:_P# OK.D
M[ZL]RE\8?^V)68I5\C]-?;/&W&==2[N*K7L,Y=44M^VUPU'I!47&:(+S_BR\
MZW#NNXDN*K;_ /MB69WPPV)QU;MW:QU*"G8H[MQ%:G)6C9"8H)'2=4;.@#1A
MZ6^Z.' *5N8I=./[D4?9KIS=ZDVTZIMYYO34]>WFM?WZW^U[0YIP^*U:X @^
MZ[F"O4/^:7P1KO\ _P#G4_\ G,^?TP,:.S.!?T .=)>U<  2!=FYGQ6-E_Q+
MZ<S/[D?_ /=/_P!/_M1<*FG-A $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! 5%D>P6+MYS+YVCNK<&'FS5I]ZY7QM
MTUH3+(2=>EK>.FO#50GM4VVI-9.CK[Y.-<82KKGT+"ZHY9E-J=HF[5SU;.C=
M^XLK\L)!\ADK[[%5_FQNCU?&1H>GJU'KT*]U[?IEGJ;^LC[KNOOUN'M5QSSC
M'#)%M/8^,VA>W#>Q\TTLNY,C)EKC9B"&33<VLT ]WVK;"M0;:YO)#W6\GN(P
MC)+_ !QZ5\#S;X[=8C?$^&R%F>?'YK V1;Q>4I.:V>,\"YGO @L<0WJ!'A[5
MBRE3P^:/>SW\]LI124HS6&GP,CO/:.,WSMJ]M?,%[:=UK-9H2&RQR1/;(R1A
M(.CFN:"O5E:G'I9HV>ZGMK59#BC[;3VSC=F[<QVV,0UPQ^.B\J(O(+W$DO>]
MQ&GO/<YSG>LK-<%"*BN1YW6YGN+963XR9F5[(Q4T78+;M>]9BJ9G+UMFW)G6
M;FSH+;X\7*^37J:6MT=Y;C\3 [0\N2A_I8YXO'AR.A??+7%-P@[$L*S'J_U\
MS+1=G]O0[,V]LAMJU^F;<R$64IS%[?.?-#/).&O/3H6ZRD<!RT7O]/'H4?!Y
M([[M:[YW8759%Q?UI+^!(-X;-QN\X<1!DI98FX?*5<S6,!#2Z>GU=#7:@ZM/
M4=5LLK4\9Y/)#VF[EMW)Q2]<7%_!BALW'8_>68WK%-*[(YFM6J6(7$>2UE0$
M-+1IKJ=>/%%6E-R\1/=RG1&EI8@V_M,1L'MAC>W=O)NPF4R$N'ON+Z^$LS>;
M3IN<\O<8&D:M+B[B?'Q7BJE5MX;QX$G?=RENXQZXQZH_F2UE\2=*05(0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
/0! $ 0! $ 0! $ 0'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>lc_empty-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_empty-4c.jpg
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M ,$  0 " P$! 0$            &!P0%" ," 0D! 0$  P$! 0
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MU^#=-RER1Y;<5,L?,9/R3OCICJ"Y/[W<8A=W0E;"((" @(" @(" @(" @("
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M! 0$! 0$! 0$! 0$! 0$! 0$!!S5_.IIVU;KX[P>.U+#6\U>@S06)J]&$IY
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M%Y&[F*38ZY4RN0QS4NG?''3G*(&-Q,Q(G%N>X"[2]K(B6(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @("#0[3M=#4Z^/EN06+=C*WZ^)QU.G&TDTMJ
MT[\,S$0BP@ G+(1$S" $_P!Y!&]&\MXC>\U8Q=#&W:M,X[5G!9:PT3U,K4Q]
MKY*Q-7>.0B%@F<6891$B$A)FX?H582(Y2VBG4D\;>9L_8A MWJ;H;X^^8-\_
M%9JV:(8D8I';O'B-XFA87]A/Q])^2K@\UXJ/9,!@M=?-XS$%?V'%AVY>-[->
MW)6D>V%1H6(&D.0H1=HS)F-AX]Z$,7Q7DLG0O[OH]FEC;64U.>JXY3#U(\37
MR#WZC6(PEA!S&.>/A@D=B=NUP+AN>$&7EO(N\Z]2;*Y_1/EL2$U:&U/#EZT\
MD;6K$==B:-HQ[NUY&=VY068B" @(" @(" @(" @(" @(" @(" @(" @K_9/,
M.JZY-DZ;U\CE<EC+U+$/1QE.2Q+9R>0A*R%2L1=D<DH0#ZTS,?Y,';N=G?A%
M2S7-AQ6V8+'[)@YOF,3DX1LU97%P)P-O80DS.),_PD+]6=N'1$,\]3M#XDV>
M)K=JE/>@BQ]66CQZY6;]B.M#$SD0,PRR2#%(7<W $[\HL(AXAI2:QY.V76\G
MA*.I9&_A<9DJFMX&1Y\1)7K22UI;C&X1=MAS(8C'T0^ 0?DWY=@FV5\F9'"T
M+N5R.B;!'C<=%+9MV!^JS[8(!<S-A&_W.S"SOPS<H)Y!,%B".Q'_ %<H#('/
M1^TFY9$>B @(" @(" @(" @(" @(" @P\KE<;@\=8RV7M1TL;4#U+%F8F$ '
MGCJ_W7=^&9NKOT;J@TA^1=&CKXBW)GZ85\Z3AB9"E9FG(2:,F;GZ/:;M&7=Q
MVF_:_P 71!G8_;-:RN:OZ[CLI7LYO&-S>HQFSR1]69^6]_:[LQ\<]KNS%P[L
M@U^^?J_$_MS$?IT2"4H""+[3XWT/=[N/R.VZ_2S%[%%W4)K<32%'\3%V_P#*
M'EN>PN1^\@E"#0[1J.(V^"C#E7LQ28VRUZA:HVIZ-B&PT4D'<,M<P+K'*8NW
M/#LZ# B\;ZPT,D=H;>0EFAAK36K]VS:LG#5M/<B$I99')V"5W)NOLZ>SH@TM
MWPWKE_:YL_8.9L99@D"UB8Y9XX[%BQ=^=F.=QDXDC,F'\B0]O3[CNR*]A\5X
MN+;,%FH#$,-KUC)92ACB]660<GF.YIB$Y)'$(!8S((1#AI'[F=NUF0>DGBS$
MWMVR^WY>>6W'D2Q\D.+8Y8JHR8R,PC.:,3[)B$C[P<P^%V;V\-P'Y#X9T&N0
M^E2L!6CE&U'4"[:"$;;5/D7L=H2CS*\'Y-S=^?>W!=41ETO%NG4QR#O6FM7,
MM6LTLK>LV9I;5J&X,,<GJR.7)%V5X@$OI,P]']O(>^3\;:AE[US)W*9_6=TO
M4.Y'/-'+',PU6&:)Q-O3D#Y*!P,.'9Q^^7(;77-:Q6JX\\;B D:"6>:Y/)/-
M)8FELVC>2:4Y)2(G(S=R?KQ]SAD&W0$! 0$! 0$! 0$! 0$! 0$%>^2==Q&4
MOZS9NPR'-/E:]"8H[$\+'6..<WC)HI 9V<FYZHJ?5X(JL$5: >V"$!CC'EWX
M &X9N7Y=^C>]$>B @(" @(" @(" @(""A?.>XT&OCI^3L:]5BK_+Y*E<N;<6
MLYJK:9C$9H&"G.0?"Y"Q]WQ"1,[<(L//P9;UB_L\OU1'KX28K"0XO&P8+:'V
M!ZF.@E!O3"N]6OZ8R$PG-,1$1FP\H2OY$1B[XZT;);17W2]@:<^T5GC*')'&
MSR=\#.T1DWT2.-GXC,F<@_%=D'I?T+3<K5R]+(X2K:JYZ<+>7CE#N:Q9A  C
ME+GJQ@T8=I#PX\,[=4&7K6K:[IV,;#:SCH<9C6D.8H8!X[YI'Y.20G=R,R]Y
MF[D_W4$:\S_9WD/SK%_O.J@GJ @(" @(" @(" @(" @(" @(" @(" @PLO>+
M%XF_D@C&8Z=>:P,,DH5P-X0<V$I9'8 9^.',W[1]K]$')US:J=O:K.XPXOY'
M)3E9M5ZM;>-9>E4R=RDV//)0Q2$7-EH![1]1RB]I=G<[NC)TEXQHX[&^/M<I
M8FLU3'Q48FA@^;BR+MW-W$16H'>.8B)W(I Z$[N[(Q;O.X+#[/A[F S].+(8
M;(1/!<ISMW1R1E[G][.S]1)NK/U;AV0:G5= UK3I[=S$16)LG?&**WDLC;LY
M&Y)#79VBB>>W)*;1AR_:#/V\N[\<N@\O*'V:[C^Q<C^BR()!B?U71_-XOZ#(
M,Q 0$! 0$! 0$! 0$! 0$! 00WRC@\QL6HRXS"1O+:>W0LRQQ2#!:>"I;BL&
M]28W88K(M'W0R%T$V;V>U@JF/QOO-;'9& ,,-Q]DH9'#Q_-V8'LT N922W'9
MO2<NTLA!/)-*4/<7> CU^DBI7JFE;/0VC 17ZCPXO5)MAF^N3FBD?(CG+/JP
ML( [F)<$YS^H+?&+=O=SRP;O<\#/7FQF4+-Y*:(\]BC;&R20_)MWWHN!86A8
M^T>?A;O^Y[4%A(@@U&7VG7<!/5JYK)UZ-BX_;6CGD8'/JS<]?8W+^U^BU7W4
MI,1:8C+MX_!W[ZS;72;17KQ#;K:XFOR^>PFOUVMYW(UL;5)W$);<P0"1,SD[
M"YNW+\,[\-[D$<S/DW7,<%)L1W[-<OY <3!2P<E:Q*-DZLUQO4>2:( 'TH#+
MDC_!R@]J/D#&S7K&,S-&YK^0K8TLW+#DVA9FHQRG#(??7EF!WC<6<V[N@F#^
M_H&IH^8];O%5J#1R4.;R#T"Q>%FKL-RW6R@>K%:B9C<'A !D*<W-O2],F-F?
MM8BX;39_(V#U3*1XO(06YG&&*YDK=:)CKT*EB?Y:*>R9$+L!2,3? Q.S"1.S
M"+NB/O!;_CLYG3U_ZNR..ME#8MT),A7^7CN5:<XUII86[G-F$S#I* .0F)"S
MLZ"6(" @(" @(" @(" @(" @(" @(""([S_7ZG^WJO\ [BP@ER @(" @(" @
M(" @(" @KCS+?O8C7*=ZE-+C*,V2JU=BV"G7"S=QV(D[_6L1,02,+L3!&\G8
M7I";R<?"BH'X W7)[5D<>U3,S;!A1UYOKVR<(%#5R\-MHH!&T(!WS6(.\YX^
MO#@)?#W<.)=!H@@(""!>9_L[R'YUB_WG503U 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0>=BO!;@EJVH@GK3@44T,HL<9QFW:0D)<L[.S\.SH.4]NM:GB_)5W!9
M6YK>D8F*Y-BHL58PV'%_D3P4]V',E-<B<I6^<88HPCXCY#L/DRX15_>)\C?R
MWC75\EE,=%BKUG'PG+1KP_*PCRWPE'#PWIB8\2-'^*Q<>Y$3) 01/RA]FNX_
ML7(_HLB"08G]5T?S>+^@R#,0$! 0$! 0$! 0$! 0$! 0$! 0$$6WS]7XG]N8
MC].B02E!B9/&4LQ1FQN0C>6G89AEC$SC=V9V)OBC<2;JWN=87I%HQ/4W:=U]
M-XO2<3'Y_P!59[+X"U'/7*EJK/9QH0_!9B"0['K1L7/#%.9N#]7ZMRWWEYVW
MN[7>8F,Q^/*^KX?W5RM%+5M$7SU=$1B?^L1G\=*;X/2=:URT]W#U#@LO&\+D
M5BQ,WIN[/QVRR&WXK=>.5VZ^/2DYK'ZR\#D]Y<CD5[.RV8SG^VL?TB'QL>K-
MG\QK>3.2,8\!:LVWAEC:3U'L4;%-NUW?@7'U^[GA^G+>];WFJUS/@F>U7U^.
MC-B; 8*GAJ18W)43DH67P];(5W(PBD!^KW6,&Z]KA[^47+<9+Q1?S.N8+$23
MX[!SXZ2Q3OPX6M)#2FP61)GNTXXSD=P*=A#X^7X)N>$&9E?&^=R.S_QM'G6K
M[%C[$<.O0QQ$U&OA.!&U2EC8F<RM=3.;EG QB[.D?!A@YSQ!=M2V:F(SDWU-
MFZ<&+V$LM+8R.0>K6LG9%Z]B:0B8G:66+M/D1[F)NK<$,MKI&F[9A=FS.Q[5
M=QV6O982!\A!%8CMQP!,YUZL;22G''7B B;L!N3/F0G<G=!82((" @(" @("
M @(" @(" @(" @((EO D4^J=K._&>K._'7AF@GZH):@(" @(" @(" @(" @(
M*^\PP[#+K5&7!PY&W2JY2I9V+'X24H,G9Q$3D\T5<@("=^_TR, ,2DC8@9_B
MX16FT/(9'8/(V3V/#8?/8+3)\8T.2K9^&:A#8RX2Q#!+3I6/CC[(!D&:01 9
M'<.A$/*"VD00$!! O,_V=Y#\ZQ?[SJH)Z@(" @(" @(" @(" @(" @(" @("
M @("#G_;+^*K[7N=+REC\]=&\\$6D28O%SY&O%1:K&_..FJ02E#>^9>5Y2E(
M7Z1]OPLR*MCQN^UOHFOOO'/\5O2B?*=S"TGJ\=/4:/X?4[>/4[/A[^>.B(E"
M @B?E#[-=Q_8N1_19$$@Q/ZKH_F\7]!D&8@(" @(" @(" @(" @(" @(-;GK
MN3QV+GN8BC'D;T7:X5)K TXR'N;O<IB V'M'DOH^Y!6=7S?<L8NGDRU.<0*@
M>>R8#;C+Y?"?,E7AMQ.X#ZSS"!SA'\+^F///<["Y<)#@?)L.;V"MBRQIUL3E
MCR,6O9;U@D:X>'E]*SW1"W,3.[$4+N1=X"[OVOPSA][MGL%8;%XN#*4Y,F&=
MQ('2"Q$5AB"]%W#Z;%W<MQU;A!.D00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$'(W\U-/RGM?D?3M6\89>Q'-3B"]:JU9RJ1TKDTYQUK-B9G8>9!&08
MAZEP!\#P_4RAU?C8[L..J0Y*8;&1CAC"W8 >P))Q!F,Q'W,1<NS(Q92 @("
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M.(,S<O[W01WRA]FNX_L7(_HLB"08G]5T?S>+^@R#,0$! 0$! 0$! 00C2/\
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M].'T_3C&-V^-B<G?HR*^,1D\WA_,>0TRQERR^$RV'DV.I7L#&UG%R17(ZSP
M40!W5Y6D=XFDY(7C)N7064B.<]CW+=!Q.^>6*F>M5:^BY^7%4-6C&!\9:Q^-
MF@@M?,L43RE+/WRD)C(WI_!PW1^2KJW3'[#E<*U+7,N^#EDFB?(9&*%K%L<>
M+]TXU6)B$9S%NV,R V'GGM=^$1"O#6V7,GCMKARV4M7,;KV3*O1FST8U<[#3
M:M%,7UA"P1N'QE(\)F D<7!.R++7^4?)6@YW2[.+P^Q4;N1M7,6->K!,)R2%
M]95GX%F]OL07.B" @(" @(" @(""$:1_O1Y!_;4'[JI(J;H@@(" @(" @("
M@T&]9Z;5M*V/9JU9KEC#8RYD(JA\]LIU8#E8"XZ\.X\/Q[D$9QNO[#E?&%4/
MXN -LNU O1[A5I4GA I7:P+! \;Q%687:/A_B*+VGW/W(K;>+-HM[KXZUK:K
M]8*EW*48I[$$+.T/J<=I%$S]6C-V[PY_%=D1+T!!$_*'V:[C^Q<C^BR()!B?
MU71_-XOZ#(,Q 0$! 0$! 0$&LV/&3YG7\IB*T_RUB_4GK16.OP'+&X,73KPS
MO[EKVTF])K'AAU\/=&G?39:,Q6T3CS2YU\0^,=JQ_D$[U]@IU]:L%!?,)1-S
MFEK#(,8,+ORQ1S@;N_3M?[O1>#Q.%MIMBUNB(?H_?GW!P]_#MKUSV[7QT8F,
M=,3TY_T\+IU?1/RT0$!!J]ELM3US,6R"O(->E9E>.\[M4)@B(N)G9B_)OQ\?
M1_AY05'X&P84)K.4]"[&=^E%*P7\+:Q@P-(?>\5>:S8G?T^>OI#]XG=^&X+*
MP/*&)#.:5>QD]6_<J2RU#M08AH"NO#!:BF-XPL"0'PP?$':Y$/+"SEPR(I>Y
MJ^VVZMF3*ZU<RQYC&W<+J<I5H(;%'G(O/5L7@C:,*TI"03',(C_5-W<2='*E
MFEZSG:F[8<)L58J6L%-L4NQ9^6(8H,F&7M-+5].47=YN]NV4A_Z+L[7X?MY"
M4[GB\]%/C;L^?.;%EGL608IZE<182O1=H^JS=_P_=]K\(+#1! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$!!J-HV;"Z;K^0VC8;+5,-C(7GM3/U?AN&$1%NI&9
M.P +=2)V9NKH.9_'/@B&]YN;RUM36,3L%T)=KBU8..RI)>GFBBCL3$[D4@@W
MJ2B(BS2/VM\(]3++J]&(@(" @(" @(" @(" @(" @JS=\=XCW/9&Q^=RCX[=
M\+)6QL=['7;&)R<)92,K$%=K$!1N8RC&1C&[D/+._#.BI+I&A:;I/SKZW$4F
M2R+@>4RENU+D,C:>)G$/6L6#DD)A9W81[NT>O#=41+D%29GPK8REW-XV#8BJ
M^/MHRD6<V#7?E!DGEM 4131PV_49XX;)0@4HO&3_ $NTF[^A<I1L6I;3G*]P
M:VW3XRW'D:^3P$U2L(!5"O&P%5M TC?-PR%WD8DX?2;CZ+.B/G1M$LZSDM@V
M7.91LSMNT2UCREV*!J=88:,3Q5H(8.^1Q&,2+DB,B)R=W]S,&+YF 1\>9!V%
MF?YK%^QO_$ZJ+"?H@@(" @(" @(" @A&D?[T>0?VU!^ZJ2*FZ((" @(" @("
M @(,'-9/%X7#W\OFY@KX>A7ELY">5G*,*\0.4A$S,[NS"S\]$%55/"7BO+E<
MI8O)Y636:\WI7]1J9RZ.#"2:(+/HE4";M$"CF _29V#M)OAXZ(N5NU:U6E5A
MITH8Z].O&,->"$6"*.*-F$0 19F819N&9O8B/9 01/RA]FNX_L7(_HLB"08G
M]5T?S>+^@R#,0$! 0$! 0$!!\2RQPQG-,8QPQBYR2&["(B+<N[N_1F9E)G"U
MK-IQ'7*K_'&Y:KEMPW.KC<F$]K*9..[1C<#C]6"''5*YD#FS,7!PGT;\5N[V
M+FU<K5LMV:STO9YG<O+XNN-FVF*SY8G'GQU?FM-=3Q1 0$&)E(XY<9=BFX](
MX)1D[@*5NT@=GY '8BZ?BCU=!3GANE%C-DM4L.QW-?'%BWS[8[,XN*"<)A8*
M[#E;4PEW [D/I!\+"_<_46197<B" @BV^?J_$_MS$?IT2"4H" @(" @(" @(
M" @(" @(" @(" @(" @(""G<3_\ 6C<(=HEXD\5:E:+^&XOI1YG-UB<#R#\]
M"KU29XZW'+')W2<\"**FL?VGV?V#7_3)D1+4! 0$! 0$! 0$! 0$! 0$!!2O
MGO3],R8:]E,AJV'RVW9'+TL+BLEF0(:L)S-,0O;>(HSFA'@NR#O9CD(1Z<HL
M/'QAK-;Q[Y(M:C:PVLAE;^%+)U\UK..?#S_+0VHX9(+=9YK'0C,"AD&1F+L-
MG;D>4%X(@@(""!>9_L[R'YUB_P!YU4$]0$! 0$! 0$! 0$$(TC_>CR#^VH/W
M5214W1! 0$! 0$! 0$!!Y6JM:]6FI780L4[,90V*\HL<<D<C.) 8ERSB3/P[
M.@Y;_P &=<S6S[M3T+6=1Q&-UR[%6LP[#4M9&>>V5&"P1",5F!J=1QD!H^UC
M<B8S;AN!1<KV\2Y;'9SQKK&5Q.,'#8^S0B*#%Q/W10,+=KA$3\=T?+/Z9?C#
MP_O1$S=V9N7Z,WM=!"_'_DK"^1RSTN BE^KL+?\ J^*[*S,%QO1CE]>%O?$7
M?^3/\=OB;HZ#(\H?9KN/[%R/Z+(@D&)_5='\WB_H,@S$! 0$! 0$! 0:[/8F
M//83(X260H8\C6EJE*'4@:8'#N9O?QS[%KV4[=9KXX=/%WSHW4VQ&>Q:)]$J
M"\4>(\EC-]O9#(WZY0ZK;^5(*Q&1S3RU(YP^D(]H^G8!W]O7D?OKQN+W??7L
MBUIC$/O>^/N?1R>+.K76W:OU]K&(\/CG/Z>-T<O=?G(@(""+>0X,%8U:W#G8
M\=.)?JVOF9!AIRY%F=ZH&1D/TI.&Z/S]Q!7?AG7[6'S]J>#$9.I4FQH#F+.<
MHP49 ROJ"[PTGB=NZOQZCD+,48NP=AEW$BRN2_?IXNE8R.0F&O1J@4L\YOP(
M@+<N[HBNH_-^OSXO&9>KBLE-5NT7S-\/2C&7'8QK#UO7L 4C/SWB_,<?<;")
M/Q\*+AO,+Y'Q>:SXX2.I8@@N%>CPV3E])ZU^3$RM#;:+L,C;L)_A<Q'O%B(>
M69$>F]6("IXF(90>5LYB&<&)N[EKT73CGE!+D! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$%3^0<E?WS87\.:O9.M \4=GR!F:[NQT<5.SN%*(FZ#:NLSLW/6.
M'N/CEQ15G8W&T,-CJF)Q5>.GC*,,=:G5A%@CBAB%@ !9O8PLS,R(CT>H9 -I
M+:'V*V4A@U8J+P5/0>H$A2C#RT/?T<W^/N[OOH)6@(" @(" @(" @(" @("
M@(-%N5?4K>M9"OO0TBU20!')-DW :C YBPN92.PCP?;VERW!<.W5!&M!Q'B3
M4LC)@?'\-&ODLK4;*RG3,[4EFG#(T+&5HBD[A S[1%Y.G/1O:BK"1! 0$$"\
MS_9WD/SK%_O.J@GJ @(" @(" @(*OQ/D3?\ -:Y!M5/2*K8>S6>]%W9GNL/
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M]6<F]W \LY,BL[Q]I%30\ V,"P>0R]N4[^>S,S,T^0R5CAY[$G'L[G;@!]@
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M,+,^-Q#8O)QE'GL6'SLE,QIOZ=Z+KZSOQVOQ\+^_H@L-$$! 0$! 0$! 0$!
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M!FK_ '_,VA<W_KB$Y7 ")PC>0A$I'C$>\F9RY=!B;Y^K\3^W,1^G1()2@("
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M%D02#$_JNC^;Q?T&09B @(" @(" @K[P?]EFN_Z.?]*E196"B(1I'^]'D/\
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M,_NSD/T^BBIRB" @(" @((MOGZOQ/[<Q'Z=$@E* @(" @(" @(" @(" @("
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M,,C_ .X#QU_XY_\ \[F_]B0P_'_F!\<"SD3YMA9N7=]=S;,S-_\ LD,/R/\
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M3+3,M>CIEBZE>22S5@L2, G%('=)+('+.3=K]_5A$7=N"X=AOY>T1GX^9O\
M]CY7_9$3!_B_HG^LW_['RW^R(8/\7M$_UF__ &/E6_\ XB&$-\4^1-8UWQ_A
M<-FOK*GDZH3-8K28C*.0.=B0VY[:KMU8F?VH)/E/,NHUL9=LXU[UO(002RU:
MI8O)0C+* .X \DE81%G?HY$[,RU[+=FDV\4.KB:(W;Z:YGLQ>T1GQ9G&54:'
MY\V>QM$%;:#&WA+SFQC5JD<E=AC(V.,:XE(0MV]6=B?CJO#XG.V7VQ6W3$OT
M7OO[<XO'X=MNO-;:\>'.<S$=/I\&%Q?XOZ)_K-_^Q\M_LB^@?F&$3G\D:L?D
MRAGA?(OB(<%=I2VOJC*=@V9KE64(W_[+SR0QF7L]R"6?XOZ)_K-_^Q\M_LB&
M#_%[1/\ 6;_]CY;_ &1#"<H@@("",8K0=<PV?GV.G%,]Z5[#P12SRRUJI7I&
MFM/6A(G")[$@L<O8WQ/^%^0^-Y\?:SY!J8^GLF.J7X\==KWH/G*X6>/1D$Y(
MQ8_8THCV'[G9^K.@E  $8#'&+!&#,(B+<,S-T9F9D'T@\YXWF@DA$G!Y (&-
MO:+DW'+?@08F#QGU+A,;A_6>Q]7U8*GKNW:\GH1C'W.W+\<]O/'*#"S.FZEL
M61Q^7SV#HY+*8HO4QMRW7CFFKESSS&1B[CUZ_AZ^U!O$&LQ.(?%V<M8>P\[Y
M6[\]VD/;Z7_9X8.QGY?EOR///WT'IF<'A]BQ\F*SU"#)8V;AY*MJ,98B<7Y9
MW$F=N64F(EG6\UG,,BE2IXZI#0Q\$=6E7!HX*\(M'& #T81$69F9DB,):TVG
M,L2?$O-GJ6;^8(6IU;53Y9F^$_FI(#[G?GIV^A[..O/WE6+8D(F) 8L0$SL0
MNW+.S]'9V=%B<=,,#$X/#8*&2OA:%?'P2F\DD=:,8A(W][L+-RM=-=:1BL8=
M&_D[=\Q.RTWF/'.7SG,2^9I1TQL%6>.U4M^H+=SO\G9CL=O'+?2]/MY]WM6Q
MS-D@(/.>""S#)6LQC-7E%PEBD%C P)N'$A?EG9V]K.I,9ZV5;368FLXF&MUG
M!0:S@:.#@(3"G$T92A&,+2$WTC<!Z,Y/U=2M8K&(C$,]NV^VW:O,VGQS.9;9
M9-0@T&$U+$X'+YG,4:\$5C,3!-(\4 1&+#& D+D/TF(Q*1_9U)UKKJK69F(B
M)EU[N9NVTK2][6K7JB9F8CS-^MCD$&@OZEBLCLV,VB>O =[&Q31 1P <A/*X
M.!-(_5GC[2[?;])_8M<ZZS;M3$9AUTY>ZFN=5;VBENNN9Q/Y-^MCD$&JV/#/
ML&(EQ362J/))!*TX#WD/R\X3<<<M[>SM]OO0;5!K1U[!!ERSX8ZL.;,>PL@T
M0^NX\=OT^.?9T_!T6O\ BIVNUB,^-U3R]TZOXNW/8_QST>ALEL<K5:UAGU[!
M4<*]DK;TH_3^9,>PCZN_/'+\>WCVH/O*Z_@\X5<LSCJ]\JA>I6>S$,OID_'/
M;W,_MX;E:[ZZW_NB)PZM'+W:,_QWFO:Z\3C+9+8Y6IQV#;'YG-9?YAY7S!US
M>%Q9FB^6A:'AGY?GNX[D&V0$! 0$! 0$! 0$!!2GDS >5<WL=VMB()KVO6(:
ML>'@&;&_4@.Y<6VS%2[&<U@7]K-!W?!PP]A_$BI[K6B#J.2<L%F+P:N4+QCK
M-N3YRK!(W;V%5EF[IH1%F)O2]1X^OPB/"(ER"J,SX4^M<AF*D6PS5-"V3)PY
MO8=7&M$;V+D3Q%(,=MW:2*&P4$93Q]I._P 7:0=[HN6]VSQ_D-NKVXKNPRPS
MU\G3S6IV(:L+'B+5 18?;RU@3+U.]I?:!N+<='09>CZ1+JT^;S&6RA9S:MCL
MQVLOE'@"I&0UHA@KPPP Y-'%%&/#,Y$3DY$1.[HB7H" @('#<\^_[J"'X/'9
M&#R+M^3GK''C;M+#14[1<=DIU_G/5$>O/(=X\]/>@F" @(" @((EI>/R%'*;
MI+>KG!%>SKVJ1GQQ+7^KJ432#P[_  ]\9CU]XH):@(" @(" @(" @(-9L=7,
M7=?RE/7K88_/6*D\6,O2CWQP6CC)HI"'A^6$G9WZ(*CTWQ7GLI8NR>0H+4..
MABA'"A;SD^;S%;("Y/-<JY)HZ\M8#'TQ]('X=Q[G$?8Y5P8;'S8G%UL=8OV,
MI+6'L^?NO&]F5F=^UY'B",7)FX9R86Y]K]41B;;JV)W;7,AJV< RQF2C:.5X
M3>.:,@)I(Y8S;Z,D9B,@%[B9D&FT_0/X;RV1V3+YJWLNTY.&"C+EKX01%'1I
MN90UXHJT<8 /=(<ANS<F9.[^YF"9H" @(*RSG\OGB#8]R'?,SK,%G8FD&>:1
MSE&O-,'';)-7$VBD+IU[@^+\;E%RW?U/E?\ %A]@^7?ZD_AUJ'S7</;\U\\\
MO9V\]W/9UYXX1&'B?"?BG!;9)O&(U6E5VB0SF^> 3X"67GN..)R>.,GY?X@!
MGZO]U%RGR((" @_'9B9Q)N6?H[/['9!!-)TJC@-DVO)!A*U 9[X?4UF( 8GI
M%1J^HP=KOV"\[3<MT_\ P]JT4T:Z3FL1$O1Y'>7)Y%(ILV6M6/!,IXM[SA 0
M$! 0$! 05!YGR7R=VG#DLM9PV&'"YJ]1GJV9*92YRH-<J8=\3BYF(E*<4+N[
M2$WT2[>$59>M3Y.UKF'M9H'CS,U*M)D8W'TW&R<0O*SBWT>#=^GN1&T01;R1
MD\-A](S.3V'+6L)A:T(G<R6/)X[@!Z@MV0D(D3'*[M$/:W=\7PNS\.@TWAN6
MQ8U2Q;ER 7*UG(69J%$+S98\;4)@].E+:8Y.^2-OC-N\NQS[&(A%G<LK"1'X
M1=HD7#EPSOVM[7X]S(*=\4[1L^>W_;VV6EFL>=BEC+M;%9. 8:6.C]2U$U>!
MPD-C,V$3DE_')B]@@+(JXT004%L.?SD/F@X;ELVIT\GA:6(Q,5^S6MS5+\(O
M-/!5C'T)X1E>5[+RL3]D3]I1N ]Q5^H@@IKSYD<E6#7Z%'*_4\5ELG//9LW9
M<50(ZM-RA&2U7_*-,,A#+!$WPGV'W<]K(L++U"Y-D-3P-^R5@K%K'5)IBN@,
M5ISD@ B>8 X$9'=_C$>C.B-T@KSRA+EZES2K>/RMFE4+8\?5NT:W A:CL$0N
M,Q,SFX"W+]C.PN_'=SPBHAH68REC=\6)Y&>SG[\FQMNF+.Q)-%4CHW1CH<P$
M3C7[1< A[1'U0)R^/Z3!>2(C?D&/(2:3G_JO(SXFZ%"Q)'?J,#V(_3B(G]-S
M$F$G9N&+CEO:W5!3F2V&G=M:)BXMIL4MZN8O!7Y9K>2>G1QU/N$YI2A(A:W9
MO?%7&&3U'=OB^ 1=R*Z'1!_9T]J#G;)['O&%TK>,?5LYS-77SV7J3['3BBGM
MXVG%0BG8H8NZ)@;O+TH?3;B/GOZN/Q%75HU^7*:7K^0L1V(9[..JR2QW&<;#
M&4(\^HSN3]SOUZNB-^@ICR#DMNPNW[-9PF2NVI/X)R%[$X<.UJ]>W6GA$9(@
M$'[YG[B?N/N?V"S<='*V/A3)2V8]@Q_SCY2K3GJR096O?LY3'2_-5VE<8)K?
M=(T@]"G'O<>XF)F'N<6$K61%?>4CRU<]/MX[*VJ%<=CQ<%VI5[1&W%9L#&X3
M'PY>FS.[N(NS%T[NC<(J":1G\O8\NS#8R4\]?(6\_6/&-:DFLPQ49HVK_/TB
M_)58@83:M)#\4@R Y\N;H+\1$2\FY7!X32<ID]DREO$86!HGM6L<;Q7#9Y@8
M8(B%NYBG)VA^'@OBZ$+_ !,%$6<Y?KX4CR&RS5X8L/ELMI\6/RIW1BS/S@-4
MQSVHC+YR:N!11/";R"_JF+,0BQ(KI^J4YUH3M"P62C%Y@'V,;LW<S?@=$>J
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MIVYWZ^1R6H6JD8Y^*$:(6JN1JA:B>6%C(0D!R*,NUV$NCLS(JQD00$! 0$!
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M]HDS.W_ Z#R:E288P:M$P1'ZL0L \!)P[=PMQT?AWZL@]T! 0$! 0$! 0$!
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MXL+L]?37%VDDR,6.@CC;(2=K>I%7]-CC@;X"D?O-OA9G"]$00$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M9(-<U;#?Q3N+5PR4^OQW(,?..+.0X7LA):[8S9I![.SO9^K<\=.0IG3O*O\
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M:(QO"!0EQ(_]8+B[,R"-VO-VSUL-5V?ZIQQX;8[QXC5J(3S290+07OD6.S
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MG*<XL-\0=C$9>8WYEBX&P'89#W(+81! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M" @(" @(" @(" @(""/Y?<L)AL]A]8G.2?/YPC^3H58WFE"")N9+,S#_ %<
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M [1V[5,X^X0A/_N<SDTIQN_/$;B*"V&9F9F9N&;V,B" @(" @(" @(" @("
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>lc_tumar-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_tumar-4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    1@  _^$$ &AT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@-RXR+6,P,# @-SDN9&5E,V$W-S S+" R,#(R+S X+S$X+3$V.C4P
M.C,P(" @(" @(" B/B \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N
M=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B \<F1F.D1E<V-R
M:7!T:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+VUM+R(@>&UL;G,Z<W12968](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B('AM;&YS.GAM
M<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(@>&UL;G,Z9&,](FAT
M=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(B!X;7!-33I/<FEG:6YA
M;$1O8W5M96YT240](G5U:60Z-40R,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q
M-3 X0S@B('AM<$U-.D1O8W5M96YT240](GAM<"YD:60Z-34W0D(T-$$Y038U
M,3%%1D%#-#5",#5",#4R1D)%,40B('AM<$U-.DEN<W1A;F-E240](GAM<"YI
M:60Z-34W0D(T-#DY038U,3%%1D%#-#5",#5",#4R1D)%,40B('AM<#I#<F5A
M=&]R5&]O;#TB061O8F4@26QL=7-T<F%T;W(@,C8N-2 H36%C:6YT;W-H*2(^
M(#QX;7!-33I$97)I=F5D1G)O;2!S=%)E9CII;G-T86YC94E$/2)X;7 N:6ED
M.C-A96-A.#$T+3DV-F0M-#1B92UA-#,X+6-F-S(Y9#0W-S@W-2(@<W12968Z
M9&]C=6UE;G1)1#TB>&UP+F1I9#ID,&$Q-V8W82TS,31C+30S-V$M86,V-2TR
M8S!D83<R,&(P96(B+SX@/&1C.G1I=&QE/B \<F1F.D%L=#X@/')D9CIL:2!X
M;6PZ;&%N9STB>"UD969A=6QT(CY0<FEN=#PO<F1F.FQI/B \+W)D9CI!;'0^
M(#PO9&,Z=&ET;&4^(#PO<F1F.D1E<V-R:7!T:6]N/B \+W)D9CI21$8^(#PO
M>#IX;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^T 2%!H;W1O<VAO<" S
M+C  .$))300$       /' %:  ,;)4<< @   @ " #A"24T$)0      $/SA
M'XG(M\EX+S1B- =8=^O_[@ .061O8F4 9,     !_]L A  $ P,# P,$ P,$
M!@0#! 8'!00$!0<(!@8'!@8("@@)"0D)" H*# P,# P*# P-#0P,$1$1$1$4
M%!04%!04%!04 00%!0@'" \*"@\4#@X.%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!3_P  1" *7!#4# 1$  A$!
M Q$!_\0 W  !  (" P$!              8'!0@! @0#"0$! 0 # 0$! 0
M          $"!08#! <($  ! P," @,&"Q,(" ,' @<  0(#! 4&$0<A$C$3
M"$$BDQ16&%'1,M)4E-05E18787&!D<%"4G*2LG/3-'0U578W.+'"(S-3L[0V
MH6+B).1UI69#A,3A@H,E9;4)1%=CPV2%)B=W$0$  0$#!@D*!04! 0 #
M 0(1 P1!D5(4!14Q47&!$C(S4Q;P(6&AL='ADM(T8G*B8P;!(K(3-8)"(R4'
M_]H # ,!  (1 Q$ /P#?X        !7.?[V81MSD>.8E>I9ZK(LGJX:.BM]
MV.66%*B5(63U"/DCY(E>[37BY>/*U=%T+8L8(I&_]J+!+5DURQ.Q67(<RN=G
MYFW5^,6]MP@IGL54<U[W31<6JBHJM16ZHJ:ZH%L3':W>#"]W[757'$YYFU%!
M(D-SM5=&D%=22.UY4EC1STT=RKHYKG-714UU140/)NCO?A.TS[=17[QRXW^[
M+I;K!9X$J[C,SFY>=(U?&U&Z\$YGIS+JC==%T%C#89VD<&R[+F8)6VV]XEE5
M0SGHK=D]$VW25.J*ND?+++Q5$7E1W+S?6ZJ"Q<(0
M
M
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M3G+)<?'?#OU]0>V(_7#7+C3ISEDL\US7M1[516N35%3H5%/K1R
M
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M,,HFUMY1?D5-^"9]ZA^BT=6'SON9@
M
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M!;1^XK\LCWIX&SU%^14_X)GWJ'=4=6'@^YF
M
M                          43B/\ %5N+^SUG^H%R+V"
M              1?./R"F_#?S5-C@>M/(U>T>I'*8/\ D%3^&_FH,=UHY#9W
M4GE9>_\ Z"NGYI4?W3C57G5GD;W"]M1^:/:U&V-_>A8__-?X28Y; =O3S^Q^
MT?R;_G7G_G_*EN4=:_#@       #5K<__/EZ_"L_NF'!;1^XK\LCWIX&SU%^
M14_X)GWJ'=4=6'@^YF
M
M         43B/\56XO[/6?Z@7(O8(                          !%\X_
M(*;\-_-4V.!ZT\C5[1ZD<I@_Y!4_AOYJ#'=:.0V=U)Y67O\ ^@KI^:5']TXU
M5YU9Y&]PO;4?FCVM1MC?WH6/_P U_A)CEL!V]//['[1_)O\ G7G_ )_RI;E'
M6OPX        U:W/_P ^7K\*S^Z8<%M'[BORR/>G@;/47Y%3_@F?>H=U1U8>
M#[F8
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MDLKFQIJY4:U>XG$\[S"7UW3TJJ9B$L2H^4
M
M                    *)Q'^*K<7]GK/]0+D7L$
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MS%,?V99\Q9*>=DOCO-;5_P#Z.M_N5-WMK[:>6&,\#]"#@&
M
M                                !1.(_P 56XO[/6?Z@7(O8(
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M$NJ/]]'FCK4Y/2-*NR7^^:W?F=;_ '*G=;:^VGEAE+]"#@&
M
M                                 !1.(_Q5;B_L]9_J!<B]@@
M                    $7SC\@IOPW\U38X'K3R-7M'J1RF#_D%3^&_FH,=U
MHY#9W4GE2@US:  #37?+]Z%\_P#*_P"$A.2Q_;U<WL?N/\9_YUW_ .O\JFW-
M@_05K_-*?^Z:=3=]6.1^+XKMJ_S3[61/1\P         C&Y/[NLN_P"2W+_"
M2'TX7MJ/S1[2&CW9+_?/;OS.M_N5.VVU]M/+#.7Z$' ,
M
M                              "B<1_BJW%_9ZS_ % N1>P0
M                  "+YQ^04WX;^:IL<#UIY&KVCU(Y3!_R"I_#?S4&.ZT<
MAL[J3RI0:YM  !IKOE^]"^?^5_PD)R6/[>KF]C]Q_C/_ #KO_P!?Y5-N;!^@
MK7^:4_\ =-.IN^K'(_%\5VU?YI]K(GH^8         1C<G]W67?\EN7^$D/I
MPO;4?FCVD-'NR7^^>W?F=;_<J=MMK[:>6&<OT(. 8
M
M                           %$XC_ !5;B_L]9_J!<B]@@
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MUKE8J^BB.:OT3Y;VYKNILKBR49@\0
M
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MNU1,BP1L>WE=# U-5<]O'5JG*_R;:-W<8N**HFWH1/KGTI9,KJ^7'#O["O\
M Q_C3EM\W'%5F^)T)/EQP[^PK_ Q_C1OFXXJLWQ.A)\N.'?V%?X&/\:-\W'%
M5F^)T)/EQP[^PK_ Q_C1OFXXJLWQ.A*R6.1[&O3H<B*FOH*;N)M8.Q0
M
M                     :[UW:@K[W?[I9-H-OKEN!36218+E>*>=M'1)(BJ
MBI$]8I>?71>77EYM-6HK>(6Q.-H=\,=W:2YVZ"AJK#E]C?U=ZQRY-Y*J!>96
M<S5X<S4<G*[O4<U>#FIJW46/-NSOO9]L[I:\3M]HK,KS^])SV[&K9_7+%JY$
MDE?H[D:JM=IHQR]ZJZ:(J@L8'#^TB^MS*@P#<W#:_;[);QPLGCTB5-'5O5=$
MC;.D<6CW+WK>]5%=WNJ.5$46+W"  "B<1_BJW%_9ZS_4"Y%[!
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M3:VWI_ZB+[1O\A^AT\#YWT,@
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MDB(B=/-IP>%R,CL@B8WVH-Z<8K%2*LN[H;S2,=PZR%TBSJK=>G1*QO1]0)/
MR7;=N,<6ST%BC7K+G?;Q14E%2MXR2.CYY5Y6]/#E:FOHJB=T$-@,<MKK-C]I
MM#U17V^CIZ1RIQ36")L:Z?2"*YS'L]X?F^1UN3W2[W^FKJ[J^M@H+I+34S>I
MB9$G)$U%1NJ,15TZ5U4+:P7FH[?_ *^RGX:G]:"U'=FL+M> ]HK/\;L]1655
M%#8;7*DURJ'5=0KI7<RZR.T54]! -F @
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MRL]3P[U>AKM%T*\G8N>^78FW2R/5\C[A<7/>Y55SG+4*JJJKW5!+8,(
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M*KVKS,X= 65O!                      "B<1_BJW%_9ZS_4"Y%[!
M                                !YZ[\BJ?P3_O5,[OK1RO.\ZL\BO\
M3_3M/\Z3[QQO,7V4M!@NUCG]BR#0.C             CN?\ ^1,H_P"45_\
MAI#Z,-VM'YH]I#13LH_OKL_YM7?X60[C;/VU7+'M9R_0T_/V#7'/L/RFX9A=
MJRBM%5/2RS(Z*:.)SF.3D:FJ*G2<7CL)?5W]4Q3,Q:]J9BQ@_BAG_P"JKC]Q
M(?)JN)T:EM@^*&X'ZKN7W$@U7$Z-1;!\4-P/U7<ON)!JN)T:BV#XH;@?JNY?
M<2#5<3HU%L'Q0W _5=R^XD&JXG1J+8/BAN!^J[E]Q(-5Q.C46PPM2MVH*M]%
M6OG@JH7<LL,CG->U?05-3YJNG359-L2K<-OJ6_.0_2(?.Y
M
M             *)Q'^*K<7]GK/\ 4"Y%[!
M           !YZ[\BJ?P3_O5,[OK1RO.\ZL\BO\ $_T[3_.D^\<;S%]E+08+
MM8Y_8L@T#HP            ([G_^1,H_Y17_ .&D/HPW:T?FCVD-%.RC^^NS
M_FU=_A9#N-L_;5<L>UG+]#3\_8        &JNX?^>KU^=+_(AP&/^XKY7O3P
M-J6>I;\Y#OH>#DH
M                                         *)Q'^*K<7]GK/\ 4"Y%
M[!                                     !YZ[\BJ?P3_O5,[OK1RO.
M\ZL\BO\ $_T[3_.D^\<;S%]E+08+M8Y_8L@T#HP            ([G_^1,H_
MY17_ .&D/HPW:T?FCVD-%.RC^^NS_FU=_A9#N-L_;5<L>UG+]#3\_8
M  &JNX?^>KU^=+_(AP&/^XKY7O3P-J6>I;\Y#OH>#DH
M
M         *)Q'^*K<7]GK/\ 4"Y%[!
M       !YZ[\BJ?P3_O5,[OK1RO.\ZL\BO\ $_T[3_.D^\<;S%]E+08+M8Y_
M8L@T#HP            ([G_^1,H_Y17_ .&D/HPW:T?FCVD/S_[.>2V+$MU;
M9?,DKH[=:8(*MDM5+S*QKI*=[&IWJ*O%5T.]VI=5WN'FFB+9\WM9RW6\X39C
MROH_N9OQ9QF[,3H2QL/.$V8\KZ/[F;\6-V8G0DL64Q[9&-D8O,QZ(YJIW47B
MAK4=@     U5W#_SU>OSI?Y$. Q_W%?*]Z>!M2SU+?G(=]#P<E
M
M                !1.(_P 56XO[/6?Z@7(O8(
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MB' 8_P"XKY7O3P-J6>I;\Y#OH>#DH
M                                                       *)Q'^
M*K<7]GK/]0+D7L$                                     'GKOR*I_
M!/\ O5,[OK1RO.\ZL\BO\3_3M/\ .D^\<;S%]E+08+M8Y_8L@T#HP
M        !^:?:$_?/E_YXW^YC/T?9GVU'(](?I)0_D5-^"9]ZA^=5<,O-Z#$
M    !JKN'_GJ]?G2_P B' 8_[BOE>]/ VI9ZEOSD.^AX.2@
M
M             HG$?XJMQ?V>L_U N1>P0
M          >>N_(JG\$_[U3.[ZT<KSO.K/(K_$_T[3_.D^\<;S%]E+08+M8Y
M_8L@T#HP               !^:?:$_?/E_YXW^YC/T?9GVU'(](?I)0_D5-^
M"9]ZA^=5<,O-Z#$    !JKN'_GJ]?G2_R(<!C_N*^5[T\#:EGJ6_.0[Z'@Y*
M
M      !7N[FY-WVSLU!=+/B%QS&:LJO%9**U->Z6%O5N?UCNKBE7EU;R]'=Z
M0JH/.QS?_P#8W*?!U/N(%AYV.;__ +&Y3X.I]Q L6-M%O+D&YMSN-OO&WUWP
MZ*A@9/'575LC8YW/?RK&SK((>*)QX*H+%MA              %$XC_%5N+^S
MUG^H%R+V"                                     #SUWY%4_@G_>J9
MW?6CE>=YU9Y%?XG^G:?YTGWCC>8OLI:#!=K'/[%D&@=&
M/S3[0G[Y\O\ SQO]S&?H^S/MJ.1Z0_22A_(J;\$S[U#\ZJX9>;T&(    #57
M</\ SU>OSI?Y$. Q_P!Q7RO>G@;4L]2WYR'?0\')0
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M5SFMU1ZJBN;S-1%Y@6-A @  HG$?XJMQ?V>L_P!0+D7L$
M                      'GKOR*I_!/^]4SN^M'*\[SJSR*XQ^LIZ"ZPU52
MY6PL1Z.5$5?5-5$X)\\W^(HFNB8CA<YAKR*+R)G@3/XW6/\ MG>#=Z1J=3O.
M)N==NN,^-UC_ +9W@W>D-3O.(UVZXV;:Y'-1R="IJGT3XWW0Y
M  !^:?:$_?/E_P">-_N8S]'V9]M1R/2'Z24/Y%3?@F?>H?G57#+S>@Q
M:J[A_P">KU^=+_(AP&/^XKY7O3P-J6>I;\Y#OH>#DH
M                                                 #6'=N^V[:KM
M*X=NAE398<,NUBGQZ>Z-8^6.DJXY9)45Z,1RHBMD;P1-=.94UY5"OA>\TL&V
MO:F@RZ_UT=#A6X&*PQTUYDU;2+54\C%8KWZ<-(XVIJO1UC== 9'NVERNRYIV
MG=Q;[A%0VNQ-]CM\%RN%.B^+U%R@>QD;T5=.;2-)6-=W>5=-4X@R-EP@
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M[T\#:EGJ6_.0[Z'@Y*
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M^'TX.C+.VVZ6^\4C:^V5#*JC>JM;-'Q:JM714X^@I]5W>4WE/2IFV&+UGH
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M&D5.A\<6KN_;JO+J[1J]\C>;B"U=P0  43B/\56XO[/6?Z@7(O8(
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M:C^]<=5LG[>.?VO.KA3PVS
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M+)?TY6?;-^]0Z'#=G#F<7VM2RH?ZF/[5O\AH*N%TE/!#N8L@
M/S3[0G[Y\O\ SQO]S&?H^S/MJ.1Z0_22A_(J;\$S[U#\ZJX9>;T&(
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MZW=!8ONQY#8<GH([KCESI;M;9>+*JBF941+JFNG-&JIK\P(R0
M   %$XC_ !5;B_L]9_J!<B]@@
M     %99+^G*S[9OWJ'0X;LX<SB^UJ2V/+;*V-C5D?JC41>\=W$-7.#O+>!M
MXQMU$<+O\;[)_:/^X<34[SB77KKC/C?9/[1_W#AJ=YQ&O77&?&^R?VC_ +AP
MU.\XC7KKC>BAR&V7&H;2TKW.E<BJB*Q431J:KQ4PO,/71%LO2[Q5%Y59'"RI
M\SZ@       #\T^T)^^?+_SQO]S&?H^S/MJ.1Z0VWI^UALS#3Q1+<:S5C&M7
M_<INXB)Z"G*3L;$S/!&=A8^OG:;,?K&L]I3>D3<N)XHSEAYVFS'ZQK/:4WI#
M<N)XHSEAYVFS'ZQK/:4WI#<N)XHSEAYVFS'ZQK/:4WI#<N)XHSEAYVFS'ZQK
M/:4WI#<N)XHSEAYV>S*\/?&L]I3>D-RXGBC.6+O14<B.3H7BAI$<@
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MC3_6E0$,AVK;_5W;$L;VLQB=K[WN9<J>@@D8O,B6^-[)9I=6_6<SHN;N*Q7
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MNR51=;S67WWUO5ZB9#504T"4U#"UDBR:1M5SG.T5=$<O+P^M"3*^ @
M       "B<1_BJW%_9ZS_4"Y%[!
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MK9\KQ?(998+!>Z"ZS0M1\T=#50U+F-5=$5R1/<J(J]U0,N
M!1.(_P 56XO[/6?Z@7(O8(
M       'EN?Z-K/P$OWBGI==>.6'E?=2KDE!,0_3<?VC_O3<XSLY:+ ]K"Q3
M1.B                'YH;[_OGR[_F+OO6GZ1L[[:CD>D/TMC_JV?:I_(?F
M\O-V                4?OY^6V/\%4??1G*[<ZU'/\ T>M":;/?Y#H?PM1_
M>N-ILG[>.?VL:N%,+M-+3VJNJ(7<DT5/+)&_@NCFL547CZ"FV8-6.QENWN)N
M?69C%G5[?>([9%;W4*/AIX>K6=U2DFG41QZZ\C>G7H#*6V88@
M                  #7W=+;+>C=;)9\.NEXM=OV/GJZ6KJO%6R)=ZFF@ZN1
MU*_5%;KUK55KM41-&N7F5.4*OVFIH*.GAI*6-L-+3L;%!"Q.5C(V(C6M:B="
M(B:($5/L/M;D&U\&8Q7^II*AV0W^IO-&M$^1Z,IYT:C6R=9''H_AQ1-4^:%E
M;H0           &NO:"MO9DK<HMDF]M<ZER)*!&T#&/N#=:))I%15\38YO\
M6*_U7$+"I/>'_P#']^N)/"WO\6%\ZXNSU;^S917V\NV0KG55X=21I=&O?7NT
MINM[U4\<8U/5=/*$EL&$              43B/\ %5N+^SUG^H%R+V"
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MQ3TNNO'+#RONI5R2@F(?IN/[1_WIN<9V<M%@>UA8IHG1
M#\T-]_WSY=_S%WWK3](V=]M1R/2'Z6Q_U;/M4_D/S>7F[
M .KXXWZ<[&NTZ.9$7^4DQ$CKXO!_9,^Y0G1@?.H2CI8):F:-C886.DD=RHNC
M6)JJZ(GH(.C @^VN\VW.ZS[C!@5R=7NM*1/KFNI:BE1B5"O1BIUT;-=>K=ZD
ML*L J                                               I_=S:S<K
M.[W0W+"MRZW"K?34OB]1;Z2*21DTW6/?URJR>+CRN1O%%Z JL+CL3O';UC@N
MG:-K:)U0ND39TE@>_CIWFM<U5Z>X%M6ILEL/9]G([M7+=:G(LLOSV/N]]K4Y
M9)$8KG(UC5=(K45SE<Y7/<YR]*\$T),K;"              *)Q'^*K<7]GK
M/]0+D7L$                                             #RW/]&U
MGX"7[Q3TNNO'+#RONI5R2@F(?IN/[1_WIN<9V<M%@>UA8IHG1
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M13MN^>4KI6-JI::VR10*O?NCB?4H]R)W4:KV(OVR&ELFRW(LM[",0
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M^*K<7]GK/]0+D7L$
M #RW/]&UGX"7[Q3TNNO'+#RONI5R2@F(?IN/[1_WIN<9V<M%@>UA8IHG1
M             #6;/NR/\=\QO&6?&[Q'WVJ%J?%/>_KNKU1$Y>?QEG-T=/*A
MTF&VU_INZ:.A;9''\&5J.>8[_P!\?]+_ .+/I\0?M_J^!TCS'?\ OC_I?_%C
MQ!^W^KX'2/,=_P"^/^E_\6/$'[?ZO@=(\QW_ +X_Z7_Q8\0?M_J^!TCS'?\
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MW-WNIJ>6'%JUD-BLDLS59UT</5<43N*C*>)[T[BR:>B"6U(0
M !1.(_Q5;B_L]9_J!<B]@@
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MXC_%5N+^SUG^H%R+V"
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MF>^>\]!O7EUAJ<8P7%:=U/B-HN+595U,[T=_3O8Y$5$17K(KM$35(VMYM'.
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MFKHJ(^-7)JB]/$+D; A
M     \MS_1M9^ E^\4]+KKQRP\K[J5<DH)B'Z;C^T?\ >FYQG9RT6![6%BFB
M=$                                         T377N^B  =/2   =7
MQQR:<[4=RKJWF1%T7T4U [
M$!W/W&N.VM/;;PW%[AD6.222,OE5:42:IM\;4:K)E@TUD8O?<W?-Y=-=>X%9
M3!=R<(W)MB77"[U3W2G1$6:*-W+40JY->6:%VCXU^V;\X(U7M%TV4Q?<K<:+
MM'VZ-V<5M]J:FU7"^4,UPHYK$[E2B2FY8Y6M1K45/4IPT;KWJHTR2;9.?";U
MOY=[YL70246V4=B\5R6HAAEI+747;QA'P)!#*C51[6*OUC4TYM$3FU<1M8$
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M5$1?JGS7EU-W-DOJNKVF\BV'L/)[
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M>%?HA_X=_P!ZT^#'=IS-EL_L^=(SX&Q
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M/\56XO[/6?Z@7(O8(
M        (GG7Y/1_;O\ Y$-G@.&6IVCU:7IPK]$/_#O^]:>>.[3F>NS^SYTC
M/@;$
M                         '5K&-5SFM1'.75RHFBJOS0.P
M     !1.(_Q5;B_L]9_J!<B]@@
M                 B>=?D]']N_^1#9X#AEJ=H]6EZ<*_1#_ ,._[UIYX[M.
M9Z[/[/G2,^!L0
M                                                    !1.(_P 5
M6XO[/6?Z@7(O8(
M     (GG7Y/1_;O_ )$-G@.&6IVCU:7IPK]$/_#O^]:>>.[3F>NS^SYTC/@;
M$
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MFY
M                                     %$XC_%5N+^SUG^H%R+V"
M                                                #&7BRPWED3)I
M71I$JN3DT775-.Z?1<W\W4S9'"^:_P /%[$1,\#$?$:B]E2_2;Z1]6O5<4/D
MW=3QR?$:B]E2_2;Z0UZKB@W=3QR?$:B]E2_2;Z0UZKB@W=3QR?$:B]E2_2;Z
M0UZKB@W=3QRB5TI&4%PGHXW*]D3N5'.Z5X(O<-G=5].F)XVHOJ(HKFF,BU8_
M4-^<G\AS<\+JHX'8B@
M                                                   !1.(_Q5;B
M_L]9_J!<B]@@
M        !6.1?INL^W_FH=#ANSAS&*[6I9D?J&_.3^0Y^>%TT<#L10
M
M                            HG$?XJMQ?V>L_P!0+D7L$
M                                              *QR+]-UGV_\U#H
M<-V<.8Q7:U+,C]0WYR?R'/SPNFC@=B*
M
M     %$XC_%5N+^SUG^H%R+V"
M                      %8Y%^FZS[?^:AT.&[.',8KM:EF1^H;\Y/Y#GYX
M731P.Q%
M                                         "B<1_BJW%_9ZS_4"Y%[
M!                                                         "L
M<B_3=9]O_-0Z'#=G#F,5VM2S(_4-^<G\AS\\+IHX'8B@
M
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M5S0-FP@  HG$?XJMQ?V>L_U N1>P0
M                          K'(OTW6?;_ ,U#H<-V<.8Q7:U+,C]0WYR?
MR'/SPNFC@=B*
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MHH&Q@0
M   K'(OTW6?;_P U#H<-V<.8Q7:U+,C]0WYR?R'/SPNFC@=B*
M
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M_:',I:.%E/$CG+JJHR-&IJJ]/ +D; A
M                            "L<B_3=9]O\ S4.APW9PYC%=K4LR/U#?
MG)_(<_/"Z:.!V(H
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MIF&DOL+57557$Q9#9>/^K;\Y/Y#43PMU' [$4
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M[>?JWHU4XM5.^;KJ@,C:@(
M     43B/\56XO[/6?Z@7(O8(
M                      ?GSVD*6IE[56,S102/A9-9>:1K'*U-*YRKJJ)I
MP0^K_P"J.;VOFM_LKY_8_02/^K9\Y/Y#YIX7T1P.Q%
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M6[MJV6W6^".EM]'AO44E+ U(X888UF1K(V-1$:UJ="(F@,C:$(
M                                 43B/\56XO[/6?Z@7(O8(
M                                                  8>MQJV5]:E
M=.U_6+HLC&NT8_EX)JFG\A]5&*KHIZ,/CO,)=UU=*68Z#Y7V
M                  "%[NV"ZY5MAEN-V.%*F\72UU-)10*]L2/FEC5K6\[U
M1J:KW570"J(=HMSG]G/%,-L=XFQ/<?&T95LC@JU9!/)%+*[Q6HDIW.:Z-[7H
M[ZYO,B:\-0K&97?.TSN)B5RVYK-J;?:*J\4S[?<LBJKM33VYD<R*U\L5.WG>
MBZ<6:/>YBZ+HJH#S/9E?9SO]!@^W3MN[K"W<?;%J/MM55HK*6OZU4DJ87Z:J
MUKWHO)JJIRJK57ON9!:\N57'M/[JX]4[>K@5%@M/=8_$K]DU1=8:V/Q631LS
M:>&'5Z=8W5OU_>JJ:HO? >_>#8B]R['XK@.V;(ZVY857T5QI:>J>R%:UU,R9
MLJJYSFL:]\DRRJBN1.E->@%JSL<BR?<7;FNM>ZV.1X[<KS#56^OM,-1'5M2E
MF8L:/:]CGHCE:[7375% U][&V)WBNO609KD=:VZ1XM"F"XQ6,T6'Q2CE=-,L
M2_8=]'R.]!SD"RYW7BSI>UW9:S;I]*[)[?BK:N*@KW.93UT+)ZILM*YZ<&K(
MUR\CG:(CD1=4!D2+(L6WJ[0U;9\>W"Q6#;[;2V5D=PO5*MPBN5=<I*?5&PQN
M@1J-8O,J=\B(FO-JY41 B1;L;79Y1[AV?>K9U*6?*K?2>]=YQRL>D$%QH$55
M:UKU5K6O373OG(G>L5%[W1P8&^IVE]Y9[;CLUA?M'B\-5'/?+W37=E3<YF1*
MJ]73.I>1S47IXMT5=-7:(K5#9:")((8X&N<]L36L1\CE>]4:FFKG+Q55[JJ$
M45NYMIGU-N+9=[=HV4U9EENI76N]8]6R)!%<J!5<J(V15:ULB<VG?.1.#%U[
MWE<5'KQC^^._=WL-KS;&F;;[>6:NCN=TCCN;:VY7"6G1S6Q1OIN16,5'.354
M1$UYM7*UJ ?;),3WCPSM#77<W!<:I<IQW*J&BMU<U]7%224;:=(&/<O6O8JJ
MB0\R<J.1>;3I0"4[/[?Y9BFZ>[N2WZB;36;*;C25-CJ&S12K/%#XRKW*QCE<
MS3K&\'H@'PJMN\ND[4U%N4RA:N&PX\ZVR7#KHD<E5K(O)U7-UGUR<>73YH,B
M98[<-VIMS,CH<CM5#3[80P-=C=RA>U:R:=>JYFRM29ZHG&7IB;T(!8 0
M                                     !1.(_Q5;B_L]9_J!<B]@@
M
M                                  %:[O;>YON!26^CP[.JG"XH^OAN
MZ4L"3^-T]2C$X*DD;F/CY7<JM=]<H5(MN\#L>V>'6O"\>:[WNMD:MZZ7199I
M9'*^66141$YGO<KO03H3@B!$?JMIHZG>NBWC]]G-DH[.ZR^\_4(K7(Y\C^MZ
M[K-4_K/4]7W.D*L@(
M          "B<1_BJW%_9ZS_ % N1>P0
M
M
M       HG$?XJMQ?V>L_U N1>P0
M
M
M  HG$?XJMQ?V>L_U N1>P0
M
M                                                         HG$
M?XJMQ?V>L_U N1>P0
M
M                                                    HG$?XJMQ
M?V>L_P!0+D7L$
M
M                                                *)Q'^*K<7]GK
M/]0+D7L$
M
M                                     &NNY>Y&XV7;JMV+V<K:>RW&
M@I$N.69341-J%HXGHQS8HF.1S>;22/7@JJYZ(BL1KG!6 K\PWD[.V58\W<W)
MHLZVNR.K;;9KU)2LHJRW54O%'.Y->]1$5^BO?S-:[3E5$U'"VI"  "B<1_BJ
MW%_9ZS_4"Y%[!
M
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MBJ8(JF!W-#,QLD;M%35KTU1=%X]"A'T
M                         #4ZR7>V[*]JS,*;+IVVO&MQZ:&OLUVJ%ZNE
M6K8Y'.CDD=HUG?NF;Q7AWFOJD"Y'?M89;:=P:'&=D<'KX+SEN2W>FDGBHI&U
M+*6DB1Z\\SHU5&\7))QZ&,<Y=$T!#:6WT4-MH*6W4^OB]'#'3Q:]/)$U&-_T
M($=I**CE>LDM/$^1>ESF-55T^:J =?>ZW^Q8?!M]("C<2I:5W:FW$A6"-8DQ
MZSZ,Y&Z)Q3N:!<B\O>ZW^Q8?!M]((>]UO]BP^#;Z0#WNM_L6'P;?2 >]UO\
M8L/@V^D ][K?[%A\&WT@'O=;_8L/@V^D ][K?[%A\&WT@'O=;_8L/@V^D ][
MK?[%A\&WT@'O=;_8L/@V^D!'L]H:%F"Y.YM-$CDM->J*D;?8TGS (?V<*.CE
MV,P9\M/$]ZVQFKG,:J^K?\P+*T?>ZW^Q8?!M]((>]UO]BP^#;Z0#WNM_L6'P
M;?2 >]UO]BP^#;Z0#WNM_L6'P;?2 >]UO]BP^#;Z0#WNM_L6'P;?2 >]UO\
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MO#CIW J]_>ZW^Q8?!M]((>]UO]BP^#;Z0#WNM_L6'P;?2 >]UO\ 8L/@V^D
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MOYK!_=M"/>
M    $=S' \.W!MK;1F=FIKS01NZR*.I;JZ-^FG-&]JH]BJG#5CD Q.#[.[9;
M;3S5>%8W2VJMG;U<E8WK)ZA6*NJL26=TCT:J]+4=HH$X   *(Q%[5[5FXS4<
MG,F/6?5->/<]- N1>X0          (YN J-P+*7.71J6BX*JKP1$2FD AW9K
M5%V)P5475/>UJ</121Z!96H$          "B-^WM;N#LDCG(BKE/#5=/_!1/
MY5"PO<(           "A]DWM7>+?1J.17)>+7JB+Q3_=)$^HH65\!
M    KC?]439//=?U)6_W2A89;:1S7;4X*YJHK5QZTJBIQ146BB")B
M    *$W0_B7V,_!Y-_\ ;D"Y%]A            4)V9?RO>#_P#Z%?/OHPLK
M["          !2W:T<UO9ZS17*B)U="FJ\.*W&F1/](6%LV)46R6U4XHM+!H
MO_PVA&0
M       'P90T4=7)7QTT3*Z9K635+6-25[&^I:YZ)JJ)W$50/N
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M145-6N14714U ^S6M:U&M1&M:FB(G!$1.X@'(
M
M
M
M             *8WSWBO>"5F/X+@%MBO.YN7RK%::6H5?%Z>%J\KJB9$<U53
M77EXHW1KG.71NBEB$ R;.^TKL?3TF9[D26;,\#6:*&^QVB%::JH$G>C$>QRQ
MPHJ<RHUJO1R*Y>5>75' ;-VRY4-YMM'>+9,VHMMP@BJZ.H9ZF2"=B2,>GS%:
MJ*$>L          U9R#=+?\ RS>+,\#V?;95L^)I2MFDND:H[GEB9SISHY=5
MZWK$1-.AH5+\"\Z[XW6WY0OBY\3N:3WT][]?&N7JG\G5Z]WK.37YFH/,O<(
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MY%7FUZM7*NB=*!DLS;'SF?C2WY5?>#XI^+R\_O7KXQXQWO5]/<Z=0BZ0@
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MHG2@59FV/G,_&EORJ^\'Q3\7EY_>O7QCQCO>KZ>YTZA%TA
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M>5S5:UZ:*2QL0$
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MW:?;[$9FU]ZQJXONE_J:94D;14[9J:9S7O;JC7M93N<K57I5B=+@L-MPQ
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MX\JN8V-/1<[1.Z"%Z8785Q;#L?QE5176:VT=O<YO0JTL#(E5/GJT(S@
M *FW^W9OFS>,V[*[;8F7FU/KXZ.\2.D>Q:6&5%5LB(UJZ\RHK$5RHB.5J=T+
M"<LSK#GXLF;MO='\4U@\:]]UE:E/U7+S:JY>A>YR^JUX::\ C5[LI2WBAQW>
M+/L2M#ZG'JZXU%7AUD=K3MJ'TB5,J0QZ([EYFR0PZHU4YDT[@92NW8C>JU;T
M8@EZ:V"W9%2RRPW>QLFZV2F5KUZM_?(URL>SE=S<NG-S-^M4),*=R:OH=T>V
M%AL.'2MKZ3!:&27(KI3JCX8GL=,[J>L;JCM'21Q\%]4]R?6N"Y&VP8@
M                                                   & S+"<6W
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M0MJ;X!ME@^U]J?9\(M$5LI9G(^JD172U$[VIHCI99%<]^FJZ(KM&ZKHB!$M
M
M
M
M
M
M
M
M
M
M         %<[U;NV_9;$J?+;G;)[K35%=%;O%Z5[(WM=-%+*CU63AHG5:<./
M$+"J&]KVXNB;.W:++%A<U'MD2F>K58J:HY%ZK314[H+$YVK[2NWVZ5V?C-.V
MKL&81H[_ .17B-L$\G5HKGI$YKG-<K4356KROTU7ET15!8N0(          &
MOF7=I^:W9W=<!V_P*ZYW<[!WMZFM[ECCAD;HCFM1L,RNY57D57(WOM437I"V
M+/QS<[&\ERNOP>B=(F4V>B@KKY2<O-%1OJ-/]W?+P1TK>;BC45/FZ\ B:
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MN<TBW#PNTYG!;Y[7%=622-H*O3KHTCE?%WVG#CR<R?,4"4@
M
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MU1JMT4DPV "
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MWK 9&T(0
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M.I=UB.T:G/UO/IIPZ.4%JUP@
M
M       $&W=Q6Q9I@U;CV07UV-T53+ Z.\1SLIGPSQ2M>SE?(K6]\J<NFO%%
M C.P6$[38)9[G9]MK_1Y+<W2LER2ZP5M/75;YEYTB2?J'.ZMJ:2<C%TX\R\5
MU"RM\(
L                                                       #_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>lc_tumarvalume-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_tumarvalume-4c.jpg
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M Q$!_\0 V@ !  (# 0$! 0            8'! 4( P$""0$!  (# 0$
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M09+@F8UC%%GF./.)7"C+6IEYEASL/;>X9JW-.%HKKU)23+V@S,+X!@
M
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MK^:\(1D+;*(5Y#=.)=UB%&HF7R+<E2#5U-MQ!DI)G[=R=3-)@S,+2!@
M                          !\6M#:%..*)*$D:E*4>A$1=3,S,!_,#)*N
MV]1V><L<A0%.JJ\;KWK*OV(-1+CPEH9BLF7Y)N1VW7="\5),&^YUMZ,.0/VQ
MX@CT<MW?;8B\=6Z2CU6<11=R*K\!$@S:3_T8-943G$D^//7+7V5:9M,6UG6^
M\(3T(T7##<61J7MU4M:_Q@SV/Z  U
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MB'J!S# F%J^%26K"*;6IZ=VIE?F5G^%*#=3_ ,(&9=_@U
M                 5IS[(R]'%-_ P2JDVV36[/PN*S#(C6TW+U0\\9F9:;6
MM^TR_*-(,PY1XF]&.:7.+.6F1Y188+9S7G&7J1J.;BEQVO*A;IHDM:[C->B3
M2?3\8,ZMYZ9>-^6>&>9+:HM<?FO8/:%)K'[M"$E$6<1:G(DS0EF9)625)+Y.
M[U EHLGA*Y-]<T:%7([T*AGP7);A=4I;I&&WWMQEX?G4&U^,R+V@=COH&H
M
M         #A/U3\5<IY-S6QEF&XK,N*Z)#@&W)90E3*GHRUK-)^8CZ'IJ#:&
MEY4QWU2>H2730,@X\8IF:Q:^P^VA,5)'(VDM3KTF0XHTD2==J/[1GH!L75Z@
M8I<7^DI&%S)92Y[<.IQYN3U)+KS2VE.&@CZ[=C+AI+V$0,1O;GT8XK*QK@^O
MDS6C9?R"9)N$H46BNR[L8:4?X%H92M/X%$!+H,&
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M:<7WEH0@G'3+N.F:W#W>;1/0MO4S,KE!@
M                                               %.\W<&.<VS,:B
MVF0JK<2I)"I<^H9C=QV:XLTI/\_W4]LR;)2$GL5IO,^O@#,2MN'#BUT./7P6
M41X45M#$:.TDDMMM-))*$)270B21$1$##W
M                     !&.0\:M,RPF[Q2HM2I)ES&5".S-GWDVF7]$O;6R
M6WJI39J21[RT,]?8 TG#'$M-PUA,?$:M[WV2;BY5G:*;)I<J4YH1K-!*5M)*
M22A*=QZ)3[3U,S,K"!@
M
M
M
M
M
M
M                                                  !\W%J2=2W'
MU(O;T ?0'S<G=MU+=IKI[= 'T
M
M
M        '&4;#ZG.N"<V]0]HJ07+"%Y'D%#DB'W$2ZM./2I:(42*>[:AA*(V
MQ3>FBMZMVIF Z4?S6:UPXYR,3*#L48RK("CGJ31OE ][V?+MW= ')^"EB+=5
MQ_R'D6+Y326UM.K),KF\WV>[-N)RD$ZU+84ZIY-9(69QFU.,):V&C0B(]P#L
MO+LUQ7 ZM%UF%JS453CR(J)4DS)!O.$I24>4CZF25?V@$2K?4'PM;V,.HKLU
MKG[*P?;B0HY+4E3LA]1(;;3N21;E*,B27M,!98
M                        YY]2F8Y!98[E7'6 RUPIU7CT[(<VOF$J4JNJ
MV(SSK$-M1&24RIZFC0DC5N0P3CFGS# 6IQ0^:^*,(E2%GN5CU4XZXXHU'J<)
MI2C4I1F9_A,S :G_ ,P7!O\ M%Q[_6<;_E@)S27E-DE7&O,?GQ[2GF)-<2?#
M<2^PZE*C29H6@S(]#(RZ'X@,\                               &NOS
MM4T-HJB4TB\*)(.L5(Z,E+)I79-S7\G?IN_  X7P7*L;DS>,58-?7R_4'97D
M6-GC]K/F+K9K+*G"MVG7)#AU[S.B%^ZHA&ISHC;Y@%T5V'P^?.0>2Y>:V-H5
M)A]JWC.)0*RQE5J(#\:(T])FI]U<;)Q];KQ&E3I*)))).AD AE/F67\G8]PU
MQ5DMS+;=R*UR2!FUO7/+AS)T/"C<031NMJ)Q!2S[/?4VHE'YM#(C,!8_'4+^
MC#GBYX>I)<U_!+3&&,MIH%A+>G?#93$XZ^2Q'=DK<=[3I*;=-*UJT5KMTU,!
M<]GE.,4L@HEQ=0*^6I).$Q+E,L.&@S,B5M<4D]#,CZ@/E;E6+W,CW6HNX%A*
M(C4;$24R^YM+Q/:VLST ;<        !@Q[JHEVDVDBSF'KBM0R[80&W$JD1V
MY1*-E3J"/<DG"0K89EUT/0 @W51:29\.MG,2Y=4\46R88<2XN,^I"72;=2DS
M-"C0I*M%>PR,!D2I<6"R<F:^W&CI-*5.O+2V@E+424D:E&1:FHR(OP@/8  ?
ME:T-(4XXHD-H(U+6H]$DDNIF9GX$0#\L/L2F&Y,5U#T9Y*7&7FU$M"T++5*D
MJ+4C(RZD9 /0!A5-Q4WL(K&EFL6%>IQUE,J*XEYHW([BF74DI!F6J%H4A1>Q
M1&0#-   !XQ9<6<PF3"?;DQEFHD/,K2X@S0HTJ(E),R/0R,C_" ]@&#67-1=
M(E.5$YB<B%)>@3%1G$NDS+BJV/,KVF>UQM7E6D^I'X@,X
M                       <Y3^%N5XM%DO$F,6]+'XBRF9.>592"D_'*RON
M7EOSH4>.ELV'2,W'$LNN.I-*5GN(S(@%MO8S</R7,06U6EQ"[CJJA4,O>"N/
M?%'V#22]>S[M[KY?#N;_ &Z *C:X8Y:L\5H^&,HMJ)_B.B>KT+N(R9)7MA54
MKS;\.&Y'4@F&5ZL-(=>0\KRIU).IF Z. 5=SU^Z5$7RY=BGU[# 6B
M                                       **Y/],F&9C S>WIRGQ<WR
MB'+4EPKBQC5[MDJ(IB.J0PT[VU-D9(2I)MJ+;J6AET 3[B+ V^-N.L?P_<M<
MN##838*7)>F(.8;22?[2WS-1-;R5L21$E*>A$7@ EWPZO_\ NC/_ %:/_4 K
M+TWI2GB"H2DB2DIUYH1%H1?]]3? B 6L
M   "+\D8O+S?C[*,.@S/<)M]53*V/,/7:TY*86TE2MO7;JKS:==-0'.]U2\E
M\@\;8UP4CC25B=E4/TS=GEKKT$J:M9IGFG#EU;C3RWG77$LFEMLFT*23ADI7
MB8"8*3GO#F?9W.H<'GYMC.=RV;NG.F>BMN1+CW5$:0Q-]Z=;[;+JFDN)?02B
M21Z&1F CD+AO/N/<3XIR^N@HR;/L#L+BSR6DBO(CG+8RPG3L415NJ)"G8YN(
M[25J23FSQU,B,)QQW2Y5EO+=US5D^/R<3@? H^*8Q2V3C*K)R(4I4Z3*E-,.
M.H94ITT(;1W%'M3J>G34+$R#CCCS+9R;/*L2I;RR0VEA$RSKHLU\FDF:DH)Q
M]M:B21J49)UTZF J>ZP?"L-]0/$BL0QNKQ]4R'E)2SJH,>";Q-18>SN=A"-V
MW<K;N\-3^4!?X#491<3,?Q^PN:^JD7DV$R;K%3"T]XD*(R(D(U]O77Y?D(SZ
M#,1JQ,Z0I4O4)R-_L/R?_P"E_P"[B3@CRH?B3_#+B'+.;.4<ERR1DTK(K&OG
M$^I<2'%DO1V8:269I:;;0I)$2/FGJ6JORM3U%B*Q$*DWM,ZNN\ ]2?)MGAM/
M-E\57F1R5L;';VO2:(TQ32C;-U"28,BW;?-MZ;M=.@@FD:[UJN6=-R[N-<XO
M<YKIDV^P^RP^1%>)EN+:Z;GT&G=O1Y4'H7@>J?Q&8CM&B6MIGLT38:MU,8,1
M-^I#EU*_(MZHQ)QI*NBEH0W8(4I)>TB/RF?R@*GG9'EE)E>:(P>W33S<DY<J
M<<D6A,,S$)CR*-HI"20\E236@TD>G319%KTU 87)[F:R(.<<7W&9V-G%Q/(L
M!G5-TXQ!39.-W]@3:H\@VV$-.$PZT4AE26DJW$E*MR"T,-QE'(?*V/UO*F>Q
M<J>F1,%OVL4Q_&E0X11WGK!JNC^]2W";0MPVW)Q/-MI6VG>G:H]JM"#8P,^Y
M-PU5\]?V=W PQ-!,F.9-R% JFG:VYCK;2AUAFG=)R3&<)W0XY,FI"R025>?0
M!$[;+\_<;N</L+C+SHLFPO)9DB3F-75U<DIE3'96IV U';)QMIQ+RFW&I#9;
M246P]VN@?<:ROD%FJP7C:EGY6Y2T^#4EY(FXK!IY%H[)MDK*,TXJ>2&D1(K;
M';0EMHUN?\XOIY@FF'Y?R_R3D=!@.17+N"W%7CB\@O9-6U7O3+&45K(KHVJ7
M"F,-M$B,3TAILS,G'.WJ1$ D' -G*Q7T[2;B9MM)]')RR7).,DFD2WH=Q8.+
M-I*=223BD>4BUTU 1S]K.3,,XIJ^>;?/6KIRUH7;R?AUC%B1JUUZ56+GQ(U6
MIA*'T*8,B)>]UTW6DK6>U1:D&PE67)G'S^%V-CGKV5LYTU,AVD-^)"0U%FE4
M2;)F96>[--*0RTJ-L6AXW2-"B5KNZF&HQ.]Y48K>'<IN\_F6JN4VD0+BL.%7
ML1H9SJ9^?'D0S0QN0\PII._N*<0Z9GY4EH1!".%T\@?L7PKQ_C&<3:*IRJ#E
M5C92FXD!^2RS62H_99BFZPI*2-;BU&I9+5HM77YNT)27(G)O]$"O4L>6/[&)
MZE%Q_P"[0TU2JEFU.L.&ISLG)]\42>YWB=_RQ["1LZ +.].J=M;R-^'D/+#/
M3\-@H!<@                                           *NYZ_=.A^
MUV*?7L,!:(
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MDE$6I=0&R                             5=SU^Z=#]KL4^O88"T0
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MP=3Z<Y<O7CEE/D2G&,:[\=Z2:XRUS:EI\UJ:TTW(-.QH_P E!FD@'18
M                       "KN>OW3H?M=BGU[# 6B
M.=/4K=7L>?44[+SK%$_'4^HFS-"7I!.&E1*,OG;$[#(O9N' ZIDM$Q7LT?3O
MR;RV&U+Y)B)O$Z=T:?7M^AE^FFYO9B+FKE.NR*6*EER.;IFI++RS41H09^!*
M(M33^#\)Z[=+O:>*)W0@_.7+X:3CO6(B]M==.V/++H =U\X
M               55Z</NAJ/IUY]=30%J@
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M3X].I@,V]XDXUR:Q5:WN,P9L]RO^"N.K;VDNM):72CK2DR2I"5))22,O+[-
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M=1K,:-XG5M1AD                  %7<]?NG0_:[%/KV& M$
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M<>0RLRZ&;;S2T:ET/34!*0     !5W/7[IT/VNQ3Z]A@+1
M                            %8YASCB^&6V45LZ),D1\,HRR#([%A+?N
MT<WU&4.%JM:35)D[5&VG3;IIJKJ ]^+N4IN>OV]+D>+R\-S&D1#E3:.:\U*U
MA6:7%Q7VWV=$JW]IQ*T:$IM:32H!8X    "JO3A]T-1].O/KJ: M4
M                                %/Y]_6 X<^AY9^BP@%P -1DUK8TM
M0]8552[=36S02*]A9-K42E$1GJ9*\"Z]",19;S2NL1Q3Y%WDL&/-EBF2\8ZS
M^].U7DSE+/VHDAU''$YI2&UJ2ZM_>A!I29[E))DC,B\3(C%"W-Y8CY<_IZ'I
M<?1.2FT1^+K.WR?_ &<T+S/*W+;XZNYE_%=_<]Y)U1&1ZZZ$1'H2?\'3;ITT
MT'G?CY.+BUG5]5CIW+1B^%\.O!Y-/T^G>Z3J^5,_D5L.0OCN;*4ZPTM4II_M
MMNFI!'O2DV3VDKQ(M>@]#3F\LUB?AS/Z=SY;GZ'R5<EH_%5KI,[)C=YO%V+#
MQ6YM+VJ*?;TSU%+-Q:/<9"R<7M3IHO4B3T/\)$+^&]KUUM'#+S//<OCP9.#'
MDC+&GBC9Z&[$R@Y"L,DY7_9G(N1(_(,^/-K.0I>*4M1[K"<K&ZM^]*K(I#1L
MDM]QLG36VLW2TVI3\IF&+RT]E=9BG+W'LO(I>41*%_ K*ADWQ,KDHD7%VDG6
MG78K3.]G?&0I)=O5)&9%KT 7YC<+F29:*B\A5^'*Q.0R\U+13KL'9B^X@TDG
M;):2V:5:Z+U/P 4:TY9/8 QZ4W)+AWB,K5A4ATWTIF'A,=!7/O?E(]$KK#1"
M+7\M6GB V7J/1+BY;"3Q&BP:Y B4,E.=HQXF$.MX*DC)1))S0BGDX7_=I-_G
M->Y[-H"SJ//L4Q+&\)I>-,,O,@P2QKXQTMECD5B17Q8JU$VGWI<B2RXE9:[W
M=4*7KN-7FU 4F<=U/I%EVW:0>>?MF[8G*:0E4S]HBS7LH=29EN[^TDMD?SMG
M3YH"4<ZU5-7\=W=UA#5,OC6!D2LBY)9@.J1>R+>#:,NR_=9*E&TU()QK:LG"
MW&1=M!IU(!T^VLG6T.)U)*R)1$9&1Z&6O4CZD _0
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M:<0ZM#S,EQU2U&XTZE;2O,9$:="Z: )V      *NYZ_=.A^UV*?7L,!:(
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M:&1[5$1Z'KX )$ I_/OZP'#GT/+/T6$ N
M                        5IEA'_35QL?R5V2_XE>-XW2CGQ1Z5EC1(
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M%\3B?RH")>FU:'>':5UI:7&G)MVMMQ!DI"D*N9II4DRZ&1D>I&7B M<
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M/%9-8Y?X_P"X0LH4?[1UKM7W^]&B%HQW#/N&G;Y]/ C(!T>
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M\K%[]/M0R\?_ )AJ_HD?^*2-L?ACN0<W\Z_O3ZVQ$BL
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M*KODGD:XB7>?7<6-5H35QEQ*RMJXBENIBQ4O..NJ);JU.N+=7J:M-"(BZA:
M"G\^_K <.?0\L_180"X
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MB>OFZ_)U =0@         "G\^_K <.?0\L_180"X
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MZ?4Z'3?\K%[]/M0R\?\ YAJ_HD?^*2-L?ACN0<W\Z_O3ZVQ$BL
M          YMYJY@Y%I[C+8F!2(%73\<QJ.;D;TV,<N98/7\KMM1HQ&I+;32
M&DJ4X\HE*-9DE)%HHP%E8'F.3SN0,^P#*O<Y#N.NP[.EL(!*1NJ+HY"H[$E"
MC5MD,''6A2B,B<3M5M+J L@    !57IP^Z&H^G7GUU- 6J
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M$M]'<:[T=TB,DN)(U(6DS2K0]#Z& FH"G\^_K <.?0\L_180"X
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M.*0E3C>O;69$9IW%H>A^S4!^@%7<]?NG0_:[%/KV& M$
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MC7&B$LB]S6K9L(B/S^.O0!T<
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MSSCAIVGN6\>I[NAGUT"UP    %5>G#[H:CZ=>?74T!:H
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M\FS7#92^-:5^OQ3&L5MT6\Z7+<AIAR)TI9&1$E+"5[&FTGH:C,SZ$ Z]
M      %/Y]_6 X<^AY9^BP@%P
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M:'B-:]5GYU:JTT+P(AG#OO[WU0TZA&E,']J/MW2%7%%(1&?QO)/#_P#7[/\
MEQ9<AD\13IMEQGB\ZRDNS)S\!I3\I]1N.N*TTW+4?4S/VF8":    YW]0+SE
M!G6(9C3\B8UQ[D,.#80E.Y$DUKL8,AQA:F#1W4)4RAQM+G\)*]-%%J9&#B;D
MO)\ES:)467+>#9;#=9?6NEQZ.MNQ<-MLS)2%')<(B0?F5Y3Z?VP'1    *UM
M^:L7K.8<=X590Y.RF[C29LM;"D=JO98CN2&^_J>N]XFE;4)\Q%HH_*9&88&6
M\U2ZO*;3$<'PNTSJTQMEB5E9U;L6.B B6@W&FDG*<0;\A;9=PF6BUVZ==3T
M>MMSWB+&"XQFV-QY>3.9L\U"Q.DKDH*=,F.DHUM*)Q:4-$QVU^\+<5M;VGJ>
MNFH;'CGE0LVM+K%;R@F8EG6.DP[:4%@ME_6-,(S9DQI$=2FWV5&E2#4@_*HM
MJB+IJ%A@*?S[^L!PY]#RS]%A +@
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M@>(\V>Y$XYH,PDP"K)5@RM,B&V>YE+T5Y<9Q3*ORF5J:-;*ORFS28":@
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M <88IQNW8JH&Y,BUN76Y%W=VDIZPLYSK*.VV;\F0I2U$A/E0GHE/70NI@)D
MI_/OZP'#GT/+/T6$ N                                     !S!ZG
MN?</QQ']'"&9%ED+,RJL;#W<T(9BHAS8\\FUJ5U-QQMOH1%H6XC,_8)L=)G:
MKY<D1L8/&J'O4_GKG*64I0CCS$))Q,7Q1:TN&J:24.&_+21F1GU2K3P4>B>J
M4*W+>Q&G:Q7VYUG=#JT0K(       #'GI<7!E(9>*,ZIEPFY!^#:C2>BS_\
M9/J-J[X9A_*$ZFSE62H$1IRRFNO+995$)4GWAQ"M#-HTD9KU/KJ7RCZ;QUBN
ML[(=;5_3#B&CNL:XSQBBR'4KB%"0W);4>Y36IFI+1F1F6K:32WTZ=!\\YS)7
M)FM:NZ9<S),3:9A-A31@        #A;&<KIK'*J:VY)Y EU>29)6YG Y*@R+
M@X!8^[$=C-18L2.:R**;*35V%DDU.GJO56N@#J'@*ZR;(N'\4N<O6Z]>2HJU
M*E24=I^3%0^XB))=1[%OQTM/*_"H!9       J[GK]TZ'[78I]>PP%H@
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M?E2=C;?;0SN2VVVGYRC-1]" 7@          *?S[^L!PY]#RS]%A +@
M                                ?S:]3&"S)/.>3(Q4UW3CY09UFTPD
MS.#(L%-14,.K/RZK<<:-'X'$E[#%ND^RH9:^U.CJWTK\09!Q/AD\LJVM7U[)
M1*>KVUI<*,TTC8VA2DF:36>JC5M,R\"U$&2VLK.*DUC:O@1I@       %"\S
MY5<9ID$;@? ']EO:([F6V:.J:^K,B-:%&1EYEI46XM2U(TH_YSIV^1PUQ4GF
M,FZ/#'EG]/TV+&.L1'%+>MXM385GO%N,4+'8JZZKR%IE)Z&M2C3!4MQ9Z%JM
M:C-2C^4Q%\6V7#EO;?,T^\AM:9VRMT<EJ         (KGE9GUI61V>/;^%CU
MJA\ER95C .S;7'V*(VTMD\SM5N-)[M3\-- '(F7W]0>36+V8\@X1<Y/2O%&L
MKT^-I-PW!?C]-CUBTXZVVIL^AD:_)[= '8N#O6,G$:B5:W4/(ILB.E]5Y6-%
M'A2T.ZK;=9;)QTB0:#3IHLR/Q 2       5=SU^Z=#]KL4^O88"T0
M         $ X5^[FN^EVOUI* 2/-/W.R']63?T=8AS_+MW3ZG0Z;_E8O?I]J
M&7C_ /,-7]$C_P 4D;8_#'<@YOYU_>GUHIRU^[U3]HL?^M8PD5D\
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M[1,IC+)QYM1D1FY*80HR/77V .C@         !3^??U@.'/H>6?HL(!<
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M=T^IT.F_Y6+WZ?:AEX__ ##5_1(_\4D;8_#'<@YOYU_>GUHIRU^[U3]HL?\
MK6,)%9/                  !AV\R37U4Z?"@N6<R+'>?CUK"D(>DNM(-26
M4*=4E!*<,MJ36HDZGU/0!S-3Y)RO5\N9#R&OA2]E0<CJZZ"LGI].J; >K%/E
MVXQ^\[?=WB=2M:=Z3[A:^;4M G'"T#*YN?\ (^=9+A<G!6\@.H9A5K[L1\I2
M8#<A*Y;BHKKA>\*-PDK\I$2$H+<L]3(+M     55Z</NAJ/IUY]=30%J@
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M^6?)^G[4^28K'#'I= #AJZN\H^]_CWZ!D/\ BP1T,/\ CY.^GWF5B#GL
M       XPN*ST3S';)$K ;5V8XX^B2[&H\A)PWU*42C;<0@B)1J^:9&0#H#T
MZUMW3\*8;69#6G46<:$IOX>XV3#S<<GG/=C?;+YKZV>VM\O_ *PU> "SP
M  !5W/7[IT/VNQ3Z]A@+1          %;<\9M<\?\8V^14"2*V2;,:/(4DEI
M8.2ZELW32>I&:2/RZ]-VFNI=!T>G<O7/GBMMS,.2N%N<^34<ET=?:7<R\K+R
M<S FP9KBGTDF4X3?<;W:]LVS5O\ )H6A:'T'J^?Z?@^!:8K%9K&NL>9M,._A
MX-H  " <*_=S7?2[7ZTE )'FG[G9#^K)OZ.L0Y_EV[I]3H=-_P K%[]/M0R\
M?_F&K^B1_P"*2-L?ACN0<W\Z_O3ZT4Y:_=ZI^T6/_6L82*R>
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M_D-1E%6S=44CWJL?-:6G^VXUJ;:C0KRNI0HM#+VD./DQ6QVX;1I+#9B(
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M ##5_1(_\4D;8_#'<@YOYU_>GUHIRU^[U3]HL?\ K6,)%9/
M       4+DC>1\H<Q9#QN[F=MA&.XM5UEA%AX\\S!M+=VS-\W)/O+C;BR8CF
MR3)H:3U6H]Q_-(!MN'+7(*_,L[XNM<E>S*MQ JM^NOYW;79-?%&WU.09CK*4
M(<=9["7"7MW;72W>P!<@    "JO3A]T-1].O/KJ: M4          0+(?O8P
M?]77W]V +N/Y%^^OWDD>&?0GHI(P  5XG[]7?LDW]9+ 2.VRA55-5#*CM9Q)
M2E7O$*.EUD]WL)1N)ZE[>@@OEX9TX9GNATL'(_%IQ?$QU\UK:3ZD6Q[(IU5)
MOGI.,79HL[)<Z-LBH4?:4PRT6[\[T/<VKH*V/+-9MK6VV==WFAU^;Y2F6N.*
MYL7L4X9]J=_%:?)YT[K; [2 F:<21!-S<7NTQ!-/IVF9>9)&K3734NHNTMQ1
MKI,=[SN?%\*\UXHMYZ[81+A;[J<2_5S7]\;H$[   !1O++%MBO*F'\N+QFPS
M+&*BLL:63 IXY3K"JESWH[J+%B-\YPE(:4PZ;?F2@]>O@ UU18V7+7->(9Q0
MXG<XSCN&0[5NWO<A@+J'[/XFPEEF"PR[HZZVVLO>%+4G:E2-"ZGU#H,   $%
MI>%^)\=R9S,:/#JJ!DSBE.?$6(K:'$+<UWK;+3:VI6I[E-D1G[0&3F?%'&W(
M<N%/S?%Z^]FU_EB2)K"7'$(UW=LU>*F]3UV*U3K[ &XN\2QC):!S%K^GAV.-
MN-H9552&$.1MC6FPB;,M$[-"V;?FZ= &/AV"8=Q]5'2X52Q*2L4LWG6(;9-]
MQTR(C6XKJI:M"(MRS,] $A 4_GW]8#ASZ'EGZ+" 7
M                .9V?_P"//J$5)/\ /\;<4+V,^UF9?*5U/Y%$VI&OM+\V
M7L<$WAKYY5_'?S0Z8$*PJ#DZOSC'*R5DE5GMDPA^R@QV:[W.M<89:LK!F*:4
MJ5&WGVT.F:-RC/4BUU'7Y2V+):*6QQNG;K;LB9\K,)[B^/WE&<D[G*)N1]_8
M3)368;!,[===ONK+6N[4M=VOAT%#-EK?3AI%>[7ZY82(5P  &+86-?4PW;&U
ME,PH#"=[TJ2XEII"2]JE+,B(;5K-ITB-99B-7\TN2>4LLS;,9]U(MY!1F9+Q
M5#$=Y:&(T<C4V@FB09$1F@]%+\5:GKXCZ'RO*8\6.*Q'9M\[ITI$0[/]*SR'
MN&:A2(+</:_+0IQI.WWDT/*+O*U\5'IL,_\ !^3H/(]6C3F)VZ[O0I9_&N@<
MA              (ER GDY55&+BMRB;N_>"][/)D3%Q?==B]>V4)25]S?L^=
MTVZ^W0!RI18'R5S?6IY;<P3B>P?L''W*Z785UJ3UHW&<4RB0Z1/;22]V_(3Z
M5+).FXB\ '3?"N82<]XNQS*9S,6-/F,.-38D!M;,6/)AON176&D+4L]K2VE-
MZ[C(]NJ?*9 )Z Y+QNEJ;_TH<LW%]%:>M;M[-+>X?>02UE809,LH[AZ]=S'N
M[1M_P=I: .A./WY>2\68M)N7G53K?'Z]RP?2M3;YNRH39NJ):3)25:J,]2ZD
M8"D\NQ_&,BCX]Z:^(:QOW/$["MG9%D31$IC'6:V0B5HF3XJLI)HV$A)FO1:U
M.:%U 7]EV2O8K5HLF:*TR%:WDL>XTC+4B4DE)4KN&EYUE.PMNAGN\3+H I#E
M'DF9DU7CM2[@F4T3;N68NH[.WAQ683>R[B*T<6U+=46[3:G1!^8R =&@
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M?_F&K^B1_P"*2-L?ACN0<W\Z_O3ZT4Y:_=ZI^T6/_6L82*R>
M        J_-N'7L@R=><8=E]K@V7R8K5?9S*LH\B+.C1U*4S[S%E-N-K<:WK
M)MPM%)2HRZD V_'7&4' #MK%ZUG9'EN0.-.WV26RD*ER?=DFAALDM)0VVRTE
M2B;;0DB+<?CJ G(    "JO3A]T-1].O/KJ: M4          0+(?O8P?]77W
M]V +N/Y%^^OWDD>&?0GHI(P  5XG[]7?LDW]9+ 6&  /BOFG^(P$%X6^ZG$O
MU<U_? 3L   %"<R5685?*6'\A8CQ^[R#[G5V5/:0%R(4=B*S*=8>;?85+61I
MD;FS09D@R4V:DZI ;W ,QSFXR9B!><,R,,KEMNJ7?.3ZR2EM2$ZI0:(I]P]Y
M^7H MX          4_GW]8#ASZ'EGZ+" 7
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MQ,<>][7G6TZR@F9G>SAHPKSD3][.,_U^]]4SAT.5^7E]W[U65ACGL
M        Q+63+A5DV9 A*L9T=AUZ+7MK0TN0\V@U(92MPR0DUF1))2CT+7J
MYJQ+EOF25S'F$&5QG<NQ/<\>)RC<NJQ3-.A]4PER2+O;%>\$6IDUJK\UYOR0
M'4        *NYZ_=.A^UV*?7L,!:(           (%QO_.G('VG>^KX(O<UX
M<?N?79F4]%%@  $ X5^[FN^EVOUI* 2/-/W.R']63?T=8AS_ "[=T^IT.F_Y
M6+WZ?:AEX_\ S#5_1(_\4D;8_#'<@YOYU_>GUHIRU^[U3]HL?^M8PD5D\
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M,DO2GF6U+0P@U="4XHB01G\H#GR[S+GSC>AH>3LZMZB=66TZLB7?'K%:<:1
M1;/(9)J%,)]Q;\E@W"WI<1M5M5IIIJ WT_)^6N2,YS"@XOO:W%:+ GH]>Y,L
M*_XHJVMW6"DNL+_.M]B.TE:&U*02G-QF9=.@#3IY[RS,\-XT@8;%B4O)7(TZ
M?5R#GH5*B51X^3OQ9\FDK2;IH-K\PVI9$K>G<?L,);QQF.<5W(]WPYR381+R
M[A54;)*#(H,7W!4VK??7$>3)C)6XAMUE].W\VK:I*B/0O:%P@*?S[^L!PY]#
MRS]%A +@                               !_/3UO0)R.6H4MR2F3'DT
M["HT9"MSD=MEQTEDI'BE*E;EDKP/4_D%K%N4<_B6!Z%\0RNL5DN4V$9^%C5B
MQ'C0TOI4VF4^TM2S=;)6FJ6TF:=_AJO0O ]-<LPDP1.V798KK0 _G;ZG<BR"
MVY;NZNVD+]PJ5M1ZR%OU9:9-E"R4E)'IN<W;U'X]=/ B(O>=*QTKR]9C?.]T
ML,1%5@>G7C5'+].[8\AV-I:8UCLA,.FIG)+B8*E;>ZYKUW>7<DM$&GQ\=.@H
M]2YK\-;3'$1:VV9TVH\M^"=CL.GI:C'J]JJHH+%=6L%HU%BMI:;+V:Z)(NI^
MT_$QY2][7G6TZRI3,SO9XT8  !7O(:5*ROC0R(S(K][4R+__ %,X_P"\.ARO
MR\ON_>JRL(<]@              $"Y=Y.+B7%%9>_CEID=>PZ2)[5,AMUV*R
M:5*.0Z3BT:-),B2I1>&NI].H"C[_ -0%W06M#E^.<.6K,W.[2JJ)MO)<@/?$
MX),278[41R+-6A3VBE*94O\ -[=VI^ #I?&+B9?T,*XL*B50S):#6[46':]Z
MCF2C3M<[*W$:F1;O*H^A@-L      *NYZ_=.A^UV*?7L,!:(           (
M%QO_ #IR!]IWOJ^"+W->''[GUV9E/118  ! .%?NYKOI=K]:2@$CS3]SLA_5
MDW]'6(<_R[=T^IT.F_Y6+WZ?:AEX_P#S#5_1(_\ %)&V/PQW(.;^=?WI]:*<
MM?N]4_:+'_K6,)%9/                  !K,COJ[%<>MLGN%J;J:6'(LI[
MB$FM28\1I3SADDNIF24GH0#G.XY5SG)K/#8%MQ$F+F=U(7<\5O3K=+D%HV8K
MGO+]F<9*5QULQ7M_9V.[S<V)\Z3,!:_&.?Y/D%I?X5R!3QJ;/<83#?FE6/KE
M5DR%9)<-B3%6ZE#A$:F76UMN)U2:?$]0%D (_FEQD-'0/S<4H5Y)D!J;9A5:
M9#<-M2W5$G>Z\[T0T@CW+,B4K0O*DS 0#TZ9'FF2XED+_($YJ?E%=E-W52W(
MA:0V_<)/9)J*1I2KL(T,F]_GT^<>H"WP%5>G#IQ#4D?B4^\U_P!=30%J@
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MAQ($=$2"PW%B-%HTPPA+;:2,]=$I21$74![ *?S[^L!PY]#RS]%A +@
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MP%>)^_5W[)-_62P%A@ #XKYI_B,!!>%ONIQ+]7-?WP$[
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M67BV?8EFJI2,8L2GJA;#E$33S6PG==O^50C77:?@.=FY;)BTXXTU8205@
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M8""\+?=3B7ZN:_O@)V                 I_/OZP'#GT/+/T6$ N
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M_2G@%A@(!PK]W-=]+M?K24 GX  @?+7[O5/VBQ_ZUC )X
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M[S%Z7O,TKP5\FLS^N6<-U<                  %7<]?NG0_:[%/KV& M$
M       ! HGWTVOV8KOT^: GH"!<;_SIR!]IWOJ^"+W->''[GUV9E/1185YP
M7]U..?\ 1R/TIX!88" <*_=S7?2[7ZTE )^  ('RU^[U3]HL?^M8P">
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M"^./4#Q6>(07X9V<'*$3>_.FS]R6(T12-OOC[VS0U'KLTU]H#HX
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M)SF2V+PS;9]<^F4G%ER0                  5=SU^Z=#]KL4^O88"T0
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M["\"]@SAP4Q1I6&G/=1S\[?CRVUF-WDCNAH>6OW>J?M%C_UK&$[G)X
M                     "JO3A]T-1].O/KJ: M4       $"Y7_ )KQW[3T
M/U@T GH"!9#][&#_ *NOO[L 7<?R+]]?O)(\,^A$.:_455<2V$:@BUBKK('V
M4RG6.][NRPRM1I2:U[%F:E;5:)(O#J?B6MOD>FVYF)M,\-6^/%-]KPX#Y"C<
MH9#FF7QX:J\WV::,_"6X3IH=CMRB4:5$2=4'N\IF1'XBMSO)6Y:^DSK$[I:9
M*325YB@C5XG[]7?LDW]9+ 6&  /BOFG^(P$%X6^ZG$OU<U_? 3L
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M@XII!N'$MO.:2-7D**:>NFO34]!3R1'QJ=UOJ=WE;3^ SQK^]C^^F@N.$
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M*^:?XC 07A;[J<2_5S7]\!.P                %/Y]_6 X<^AY9^BP@%P
M         ##EVM77D:I\Z/%27B;[J&R+_C&0WBEIW0SI*.3^5>-*SI.R^H:5
M_ ]^84K_ (J5F8GKRF:VZEOH;12T]BMN2_4[@E!BTY[";B-=96K:U7Q4H=4R
ME:ST4ZM6U*32A.JM-W4]"'1Y7I66]X^)6:U[4M,,S.W<YQQWU4\QUUDXJ1.:
MOSFZM,5\F*@R)]SHV;11DMKU)1EY==#\/PCL\QT[E8K_  ]VV?K2Y*8XA)YW
M"_J7YHF-V.=3FJ2O,][35D\1]I)GI^9A1=R4GI_]8:5'[1R9ZACQ1PX*\/G[
M52V:VZD<,>7M6ACGH]Q%B/&;SO(+3+$QMJD5ZG3@5J5)(RU2PR9J+QTU)PAR
M+YK6G6=ZO\+7;:=5F2."^))&,R<13B5?'II9)[I1VB:D;T?,<*0G\[O3[%;_
M /<,Q%QSKJW^'7331K>,/3_Q?Q=8/7F*PW)%PXE3*;&:][TZRVKYR&M"2E&I
M=#,D[C+IKH,SDFQ&&*3N6J-&X   "+9OR!CV PFI=XXM3LDU)BQ&$DMYTT$1
MJ,B,TD1%J6IF9>(K9^9IAC6SK]-Z3GY^\UQ1&D;YG=##PSE/$\V8D.0)"H<B
M(1+DQ9NUEQ*#Z$LCW&DTZ]-25T]NFI#3!S>/+&S9IY4_4>A\SR5HB\<46W37
M;Z/*S;#DC JLS*9D,%*R\4-O)>7_ ,5K<8WMS6*N^T(,/1^=R^'%;Z-/7HC$
MGGO DK-FM.;;/%J240HJS,S_  =WM^(K3U#%V:SW0ZM/RMSLQK?AI'\UH^K5
M2/,F>W>5V<5EV%.IJ-#)+C5TU*F5.K-2MSRD^"O#:GQTTZ>)CC\[S%LEHV36
M/)+WWY>Z7AY7',Q:N2^NVU=NG\OUMIPU<<IS(UA28=(BK@1^VXXNTWK;C&YN
M(B:TUTW:&9IT,NFO3KK)R-\\Q-:::>?L5/S%R_3J6KEYB+<4Z^#36W?W>5:9
MX5S!9J+XMGC<)L_G-UL1/0OP*T:4.G\#F+;\FG=#R'^Y=+Q?+Y:;>_;_ *OI
M<(QYJM^199=VIGU4A4GMMF?_ +)DO3^V'X")\5[3Z3_DMJ?)P8J?T_\ 17')
MG!)TAIN,6?1\(6N-&=B2G#[K;\EU$=*DK,C)25*6DSUZEU]@Y_-=/X/:INV?
ML>HZ+^:/C_\ ;SQ[>EIUB-DQ$3;=Y=(]*V>+>,(V!TZV[#L3;R4YWI,E*"-+
M9$6B6VU*(E:%XZ]-3,=3E.4C#7;MEXWKG6K<]EUIK6E8TB/+YY6&+[S(  !F
M1%J?0B 5]EF0T#U[ASC5M"6ABU<6\I,EHR0GW&2G57FZ%J9%^/H*&;)2;4VQ
MO\OFEZ7D.4SUPYXFEMM(T]F?XZ)S#GP+%HWZ^4S+92HT*<8<2ZDE%U,C-!F6
MO47:VBVZ=7G\F*^.=+Q-9\\:,@;(GE)]Y]V>]SV%+V*]W-W4V^YH>W?MZ[=?
M'08G739O;TX>*.+737;IOT\ROY='R?,NJV]<>H4RJMN2RPTE,SMJ3,)LEFK4
M]=2[9::?A%&<>>;1;V=FOE[7I,?-=/IBOBB,NEYK,^#]W73UIO4?&/<&_CQQ
MCL]5=WW$G"8TU/;M[IFKP\=1<IQ:>UIKYG YCX7'/PN+A_FTU_5L9PW5P
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M/HE#_%2Q7:I^ KQ/WZN_9)OZR6 L,  ?%?-/\1@(+PM]U.)?JYK^^ G8
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MA=$KOOEMZ(_9 G+.0Y/5SD'#(?X&Y3+AE_QDJ#@YN>VL'QNB5_\ SRV],?\
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MZG_M\;^4 9=;E&,W#YQ:BZ@V$HDFLV8DIE]PDEXGM;49Z -L
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MT=/V?LFV1'_^Y+ 6&  /BOFG^(!!>%R-/%6)$HC(_AS/0_[("=@
M   *@YGQ?)U9%@'*>'52K^XP&=-.70-.H8?EU5S%]TE]A3II0IYK:VZVVM22
M7MTUUTU#"XZILJR[ER[YIR;'Y6)UY44?$\9IK);*K%V*4I4Z5*DM,..H9-3I
MH;;1W#,TIU/3IJ%CW_'?'^53DV>48I3W=DAM+")EE7Q9CZ6D&:DH)QYM2B21
MJ,R+73J XPS?TQVE1R?2891VL8Z_+#L9-,])[A+CL5J6W74/$E*MRDI>22#2
M?GTZ[1Z_'UO'P>W$\7FW+T<Q&FUU5BO!'&F-45?4NT$&TEPV4MOV<N,VM^0[
MXK<5N)6FIF>A:^4NGL'F>9YB^>\VF9V]FLZ,5YW-396TPD37&W'[)&36,UJ2
M/Y(K7_)'.MR^.V^L3WK$=7YR-V6\?U2R$X)A*4DA..UNTO O=&3_ +J1B.5P
MQNI7Z(8GJW.3OS7_ -5OVJM?Q^@/U*0J0ZF&=,K!I<M5?[NU[L<@K>,V3IM;
M=IK))FDE::Z=!O\  Q_PQ]"*>H<U._+?_5;]JTE8'@ZRT7C-2HBZD1P(Q_\
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MZJ6XXT:E&?RF8"T2X5X;(]2X\QDC+P/X+ _D0 ^%N'%&9GQYC)F?B9TL#^1
M13D_A[B2#QKF4V%@6.1ID:CLWH\AFH@MNMNMPW5)6A262-*DF6I&74@#C#A[
MB2=QKALV;@6.29DFCK'I$AZH@N.N.N0VE*6M2F3-2E&>IF?4P$K_ *%>'/\
M9YC/^I8'\B ?T*\-_P"SS&?]2P/Y$!5/J4XHXMI>#LRM*?"*"OLHT5I4>9$J
MH3#[:CDM%JAQMI*DGH>G0P%K?T*\-_[.\9_U+7_R(#Y_0IPW_L[QG_4M?_(@
M']"G#?\ L[QG_4M?_(@*PYTXHXLJL=QI^LP?'X;SV88O%><CU,)I2X\BWCMN
MM*-#1&:'$&:%I/HI)F1] %H?T*\-_P"SO&?]2U_\B ?T*\-_[.\9_P!2U_\
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M.)4OV[M2(R"S/V*H?_QG\T_L_P#SA-_T#_KO\M_^(_RW^& D(
M   T=EB-';9+19=.84N\QQ$UJI?)Q:4MHLT-MR"4@C)*MR6DZ;B/3V -X
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M   :2PQ2DL\EI<NF,J7>8^S-C5;Y.+2EMNS)DI!&@C)*MQ,-Z&HNFG3Q ;L
M                                 ?$J2M)+09*0HB-*B/4C(_ R,!]
M    :++LSQ; J1[(\QM6*>E84E"Y<E6A&XOYJ$)(C4M:O8A!&H_D ?<1S'%\
M\HH^2X?:L7%%*W$S-BJW(W(/125$>BDJ2?BE1$9>T@&\
M                       !CPI\&RC)F5TEJ9$6:DHD1UI=;-3:C0LB4@S(
MS2I)I/Y#+0!D     -%EV9XM@5(]D>8VK%/2L*2A<N2K0C<7\U"$D1J6M7L0
M@C4?R /N(YCB^>44?)</M6+BBE;B9FQ5;D;D'HI*B/125)/Q2HB,O:0#>
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MDI75IQ[&KV"K+!%C(8@$PT\I)R2F.,DRO>E6BG2/R:*-0#JH
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MOLGZUU,E$.L@0GD$N0;9GVNZX^AM"5Z&:NF@#HP
M 8Q6->JP74IELG:MLIE+@DXGWA,=Q2D)=-O7<2#4E225IH9D9>P!S;FG/'(2
MIM[8X#\%;JJ+('<.I\=L8\J;=Y)>0C3[VU'*.ZVF,T@U;4.*2OHDW%[4::AX
M<>U?*]+2W6.<.R<;LL)5.FP#J+IZ43V(7"EFJPKDK:CFBPC1GG%]KH@SUTW&
MGJ NWBCC*@XBP>LP?'=ZHD)!*DR'%+,Y$M:2[[^Q:UDWW%D:^VC1"=>A )J
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M@B!R/8M1KFS8?D2GF8MP_'1W5IBN.J82^V9F@G2;WEIT/4!;
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MUB"('(]BU&N;-A^1*>9BW#\='=6F*XZIA+[9F:"=)O>6G0]0%L
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M%"9DOS68S3<R42"E2$(2EUTFB,D$M1%JK:1F2=? !ICP3"#ZGC54?XX,;^3
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MS&X)3;-Y*%.K*/!B[VT/S):TJ-J-'2ZM!+>=VF3:-W4P'*//7.$:=C5),R#
M<OQ2RQ+)Z/(V9-Q4&JN,H$U!/$F9%=>:_P BXY[>OS?R@$URODO@[GZ#6X;!
MY7C5E'*FH3?4*5G5S;B.?0J\URR8>;2XO:3A-)WK3JCIKJ N]6$8:N353G<?
MKG9]$VAFEF.Q&7)$-MHB2A+#JT&MLDD73:9 -\
M
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MY,QY&2XC,.5 [KD64TZVIB3%ELZ$['D,N$2VW4:EN2HO:1EJ1D9A*
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M                             BG(.?U/&U(SDE_&E.47OD>)8S8C7>1
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MC)#R.W7=(4U :K2;?>:0A]U3;2E([CZT=QW824;]5)26XR 6@
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MHSG*(?,7*++M;+B$X>"84:S2FFBR4&VJ3,))Z.3WVU:+(]4LI/87FUVA<P
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MIR!;1D.IPG#26?:HX<I!MK=D[3T<G/MGHZ9^5M)["_ %Q@
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M?.8:E$ZIMIY6BV77(R^W(;(T]QKN;MF[V*U 6$
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MT5BV*0KZPHN6,HQ;]FN4?A:J^QCMRB>4VVZHC4P\Y'5VI"4J3N:-9'MUZ:&
MGX
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MDDXCQ-*7"423,S3H9F8#?@
M
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M)*+KH>FN@"2@
M
M   K+D[FNCXEN*6)EE;-^"7R7(]?<0T%(0JU)2>U!-I.BDK>2:E(6HR1TT,R
M\2#+Y,X@QSDMN/8279%3F=2@_P!F<I@N+3,JY&]+A.-)W$@R4I)$ZDR\Z/*9
M^!D%5PN,LXY2RHG.6Z:?BEO159T5GFF*WB8D7*(2Y!N>ZG$0TIU$9:34ZL][
M2T+6:$_*D.C*RLKZ6MAT]3&;AU=>PU$@Q&4DAIF.P@FVVT)+P2E)$DB 90
M                                         *KYLYD_H3A4V3V]*Y98
M3)>D1+N;$=1[[$?[)NQ.U'7M)Y+JD+2X>]/;+174M0&]R?!<'YAQ6(C+*F/8
M1)L,G8,E*VGGXGO:&W.[$E-&HDK(TH-+K*M#T(R,R 5.QPMG.87-=C/,#46^
MQ?$VI3='R##L9E;DLZ/+[:$QI"(AMD6K:5-RU&O1WRJ3YMQF'0=34UE#5PZ6
MFB-0:FO91&A0XZ20TTRTDDH0A)="(B(!F
M
M                         T.:9A1X!C%CF&2N/-454A+LYZ.P[+<;:4M*
M#7VV$K6:4[MRS)/E3JH^A& I+F-PX6O)ENU&Y%X N8#;.1TQM,RGJB&^WL^*
MU;K9;EM+0K60E*MY%HXA6A>4-]Q#5\F5$BLKZO)ZC+>"$QW)5!D$A3\C(78;
MR"*+#4M!I94E@]=7U:J4@B3M2>NT+M
M               :S(KE..T5E?+A2[)%;'=E*KZUGWF:^3*34;;#6J=[BM-$
MIUZF I'+KZ?D=)7^H3B2V/*<78K5MY'@TMW6!85+>]<CM-.:ICV+!*<2>XO.
M1=M7R&'EPMCUD\BGR7AS,T-^GVU<<M6L6GP5/3X;JMZ'H$5YU1=F-WCWJ3HK
M8I)D@S2HS,.A@
M
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M6&&R)*$-MD24I21="(B+0B >H
M
M               _+CC;+:W75DVTV1J6M1DE*4I+4S,SZ$1$ I;F7D*D)V+Q
MP>1V^%7V2QHDW#,SK(RI<.38G+2VW#;[1.&^K<;2WF-I$MESYWB J[&,<L>7
MLSRRGY?NK#$O4%CIL.8HU3S9$>O@UC3#:$656P:TMRV9,DG52>]O41&EI7;T
M(!),0X3F9A+R!S/$7^#Y,J3[OF3>*62J_&<M-Q!?]X);2E2DF^WY7R:-I9*,
MR49GJ Z,JJJNHZR%2T\9N%4US#<2##93M:98822&T((O DI(B(!F
M                                  #XI24I-2C(DD6IF?0B(@%$<S<O
M\?M8Y7U5XY-F<=Y[&=A5.98I-0XL[5#J>S&8<87Y5K-*E)=-7;W(-*^FX!7$
M+!(E[R=/X^]4+OQW(I=>Q XMR<E.0XLF'$)2GW8IH7M9M36;;DC\H]J=GD(M
MP3"@X">R*\LX7+U>_93ZAEF#6<BU5F_53,CIG"411+9J$\TM;S"4);=<7_E"
MV[3^=J'05145=!5PZ2EB-0*BO:1&A0HZ";::9;+:E"$ET(B(@&:
M
M                                          ##M(T.?7RJR=':F1YK
M#K#L![;LD-N(-*VU$K4C2HCT5T\# <<SK?&\@H:^?R)CK;/"&IXW&]V::8N.
M,[^ IN&ZPX^P6[LF\PVM$LRW),TDM.Q1$H+)I.-N0LPNZ&#R8B%8UV#K*?B?
M+5-/.+>V&Y;9M(-EM"B0AQ@E-SDK6;;VI&C^$ Z)
M                         8TJPKXCL:--E,L/35FS$9><0A3SA)-1H;2H
MR-:M",]$^P!R4]:6+\"YN;;$8ME@V-R)F+<F<41XS3ITC25*6FVI-&F5J:D1
MWD2'4DE)K(S4@]4:I"58KQ;=YI3UN*V%_49QZ<-I6F+W#RY9Y4ULT5"99F,K
M:)LXJR47O&O=-'YI24]= Z3(B21)+P(M"]O@ ^@
M
M                              ^'J1'H6I^PO#J XH]0^3G/;HKKE6@M
M< SO")K\RHLZJ>OX=:UDA.V6S6VS/:2U.)IM+[+4IM!J6V3>BB<,@%G\.\?9
MLQE>37ES>TV;\.\@T\:3[^AA3$BPD]M+*'I,/14?<_%5LDK;VD[L09H2K< O
M^LK*^EK8E/4QFX57 9;BPH;"2;:98922&VT)+H24I(B(B 90
M                               /&+,B3F?>(3[<E@S-).LK2XC<D]#+
M5)F6I'X@.0_4F_>VE [#YCPUIEG';#XUAN9TSLJ32/$TLS]PLE,DF7 5(9T9
M-\OS:7C0X2R) "8<%85?.Y77<QXOG"LCXRRK'VHCT6X:([TU1G%*BHE26=$R
M7HBEO,&^[^<).K9[]$J(.BH,"#61&H%;&:AP6"VLQH[:6FD$9ZZ)0@B(NI^P
M@&0
M                                                     !F1$9F>
MA%U,S 4]R<])Y*A8Q18-9G<8;.R!J%G[V-V+2)2*HF'EJ:5(9<)3;2G4M)D=
MI:73;U2GYQ@*VJK+D+T_RL^G4.$6%GP)3SFY$9B=:F=C7PXT9/Q*37L2>\MZ
M*:]SR4K?1T2HRTW'H'2SC-#F./DW*CQ[?'+F,APV)+:7H\B,^DEIW-N$9&E1
M&1Z&0#)JZNMI*Z+3T\1F!506D1X<*,A+3+++9;4H0A)$24D1:$1 ,L
M                                    ?%*2E)J49)2DM3,^A$1>TP%&
M<AY-0\V4*<)XLRJJR%Q%S6EFE17V;;;\G'424_$&4NM+)9(<1Y5+;/S)W((_
M, BLK".3^'\PS?*N$L1H*_CI$&"[)QJ9+?9^*28#3CLB17,QMS45Q;:TQS[Q
M$2UM;C+0]0'0&'Y-79WAU)EL!E:*S(:^/8LQY!%O2U,:2X2'"+4M2)6U6G0!
MMH4&%61&H%=&:AP6$[&(T="6FFT_(E""(B+\1 ,@
M
M                               %9>H.@R3)N(,EJ,59<F6KC3#JZQEQ
M;#D^''DM/2X27&_,1R6$.,EM\=VWV@*Y+",-R?%*_FKTP(A8SF%?'WL0J]EN
M#!LFXY:O5%M#9V(W].WN5HMI>U1*T(C ;9G&LHY^H(>4HY!F5O$&<5T2188,
MS6Q43$,.L)3)AIM$FETFW5$I+WYM1F6XD*2DP%\1HT>'&9AQ&DLQ8Z$M,,MD
M24(;;(DI2DBZ$1$6A$ ]0
M    0OES$[7.^,,LP^CF>XV]U628<*3N-">ZXV>U"U%J9(<_R:S+\E1@*CK,
M=P7GC"(2\>B-\><S8(E$9A$%I$6SQJWCHVDPIM!%W8+FAD2%$;3S1]-%?-#(
MQ3'[CU#X339M=9C>4%;=PG:C+,2IGXZ:N6[62GX<HX[IM./--R%MKW*:=W*:
M,D[B\0%_5E; IJV'3U4=N'5U[#<2%$93M:98803;;:$EX)2DB(B 90
M
M                                            ^*4E*34HR))%J9GT
M(B(!SMSMS9A<WB.^MN.,[JYU]2/UU@J+4VD<Y3D:)8QUR6S0VYO-*V4N$9%\
MXNG4C 6WR'*SP\6-'%T>'*R6P=:C1I\YU*8D)B1T7.4G0^\31>9+2?G?A+H8
M01[TTXM-VS)F07T2]L(S<?,9]'.53-9"M"-CCD^-&(FS4YJK>MHD.&1GJL]3
M,!;U355M%5PJ2GBMPJFN8;B08;);6V6&$DA"$E["2DB(@&8
M                              #F;G'GOA[*>,.1,,I<[BPLNC5LYIB,
MXM^MD+FPDFXEEE;R&NX;BF^VGMJ,EZZ%J1@+.++[WD#BZ-:\36].K,;6#"=8
MD3'>_&AJEI;4\M;;&\S<90I2D-J+0UD25=-0&J<]-O'=M5U#68?$,BR>MBJA
M2LN?L)<.YGLNK4MQN5)ANLK<:,U&E+2U*)"-$I\ %IT]/5X_50Z2DAM0*BO:
M1&A0HZ2;::9;+:E*4ET(B(!F@
M
M              #XI24)-:S)*$D9J49Z$1%XF9@(+R]2Y-D_&EY#P2S=K\J*
M.B=1R8JR3WI,-:9+3"CU(C:D&WV5Z]#2L]>@"LKG"N)^=.!)F<5F&TR;J\QR
M8_73$0(Y385F49Q!MI>2VE>^/)2:#T/YR &FX9]/W%^0<:X1FV-/WF+V-G55
M\ZQ_9Z\L8;+LLV4')0IOO+223<):5$@D_P!@!U 1$DB27@1:%[? !]
M                                    'Y6M#2%.NJ)#:"-2UJ,B222+
M4S,S\"(!#\IK:3EOCFYI:*\;<K<@A/Q8=[4R2>0VZHC)#K;L=>BMBR(S(E==
M-I]# 1+C2? YIXF9BYY71I64P"EXSET24TS(7&NJ_6+*Z&1I2:S(GT[?!*T@
M*HX X!X6Y'X4PZ_R7#8K>3,,O09UA!<D5LM4JLE/0UN*=A.LJ4M1LZJ49^;4
M!UA$B1X$1B#$1VXL9M#+#9&9DEMM))26IF9]"+V@/8
M
M                                ?E:T-H4XXHD-H(U*4H]"(BZF9F?@
M1 *.+,+;FK(9,#&%1XW M.<F+E>1364/,Y(HD+9?@P>[Y2AMZJ[\LOG*+:V>
MA*48:7$N.7HM(QF7I:Y 5%Q24M[W7%;TI%MB\@X[JV5I8-TTRXB>XA7G96I)
MZ>5)I,!M^!*;D6ENN0J?,\23CF+V5@BYJV6Y[5C$.=9(5\21%6G:LHZW$%(0
MA;:#0;BDZ'X@+KJZJMHZV+3TT1F!506DL0X49"6F6FFRT2A"$D1$1%\@#+
M                                        'Q2B21J49$DBU,SZ$1$
MH>-FE_S3E")6%VGP/@O%)1O766)[>N22H9GW(<0W24@JYLR,I4A1?G?F-^7<
ML!K\>XJX_P RBO<C^GN\L>.9DJ0^TW84[!HH[%499M=URJDD4>0P9D>Q;1-[
MO$E -MQ)AW+^-<GYA;YK'IBQ[(H<1^7.I7WR:EW<,_=TRD0GRUC*=B[4R4DM
M236VE25'J>@7;%B18+"(L)AN-&;UV,LH2VVG<9F>B4D1%J9Z@/8
M
M                                          $3Y%SC$<"QMRTS)9KK
M9KB:UBN:CKFR)\B42B3%8C-I4IY;A$KR$GYI&9Z)(S <C6,2CJJ&M?HLAL;/
MT:VEJH\II(1.)L<>E;OSE=,WZ26JQ3ZDJD-)(G$$?R+)2PO3&<RON4LJK8W$
MKS5'PAB+Z6IV0L1VC;O7HA=HJVL;6G8B$UIM>DH3YE))#.A$:C"\0
M                                     $7S[.Z7CS'SO;IJ3+[S[4"N
MJZ]KWF?/G2E;&8L9K5.]UP_ C,B(M3,R(C,!R#D%72VS5OE?'<2[;XU9LVW^
M;N"]"KK1A3:5+]X:CD:C2VYY77V6'"1(0C0E]#V!<V/Y5=\XW=6GBV6_C' V
M,O,+=R*&T<*1?R8>FVOKVW$)-J R:=DETT$;BB-I&B24H!T
M
M                                         QY\AZ' E2X\9R:^PRXZ
MU#9-!.O+0DU$V@W%)22E&6TMRB+7Q,!R52O\G\I-%SOBMZY/S3#;ZR)'#MDV
MW#BPH;27X)P'#V]UJR<BN*<]Y<4:#6O9M) "R<+QK%^2+J)S1@<J10U^1M2*
MWD;$+"#^9M5,H6PIB;&>,DM2H[NJ%/))6]&Y/F2K4PNFKJZVCK8E/3Q&8%5!
M:1'APHR$M,LLMEM2A"$D1)21%H1$ RP
M              ?EU2TMK4TCN.$DS0@SV[E$70M>NFH#D&JILWYFNLER*3D<
M[$.>L&NRF4?']A)-ZB@0X[6V*EZ,@B3):EH6[OGM>;S^3RI)*@M'%*.-RO:4
M/+4BKM>.^4,8EN4V31-A(]]9CZ'(@.K6DVYD-:C2MB0C73Q0:5$>@73%B18,
M=N'"8;C1&2VM,,H2VVA)>Q*4D1$7X@'L
M
M                          *^M.*8+O)%=RACEB]CV0I247)FXJ$+C7E>
MA)DVS+;5H7<:/3M2"\Z4ZIZEIM"P0
M                0G+>,*'+,FQS-._)J,MQI]*XMQ6+2S(D035N>KY)J2HG
M8SOY2%%JD^J#29GJ$V
M
M
G                                                '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>lc_emptyplasmid-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_emptyplasmid-4c.jpg
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M%!04%!04%/_  !$( <$#[0,!$0 "$0$#$0'_Q #-  $  @,! 0$!
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MX(
M                          \WWV8S#DF0LFV&4*<=<5T2E""U,S^HB(!6
MW^\3P=_V[J/^<%_D!<)7BF>X7G+#TC#[Z#=MQS),CX)]#RFC5X;TI/<G73IN
M+J"*EP#U!65KS-D7"^>5L6IO(#CI44J(ISMS$-%W2)1.F9DIQ@TO(TZ:$HO'
M34N%^ @
M                 /EUUMEM;SRR;:;2:W'%&24I2DM3,S/P(B ?RZR"IN?4
M1EW+7)T(WCK<=AKLX9)0:B5'8<2S&95_%,XK3KIZ>*D'])@SY.P_1MG_ -\^
M'853*=WVV)NG4/D9^8XJ2WQ5:>Q)-GVB_-F#&5!Y+(5QYZZXLFM4;4>XM8"'
MT)Z$I-Y';9?)1%XZN.J7^'0_$%\']  8@
M                                                        -7DO
MZ.7'^I2?Z)0#^4'#5SQ936UF]RIBTW*JQR*2($6O4I*VI&\C-:C2^P>AIU+Q
M/\ ,Y71Z*JROG<RW614]DQ45#,>8U!QR1)[EC(C2'"4T@DZ%W$,I2DW'/XQ)
MZ=3,B2S?5^ZY@OJ'Q'.ZI1M3CB0+!PT]#4] EN(ZF7B2FTH09?1T AWXVM+B
M$N(ZH61*2?U&6I Q?0
M                            J[U"NYBKB>]JL#JI-MDETV54RU#(C6TS
M*(TONJU4G0B:):2,NNY206'+/%7HNS*XQ-5GD>53\(LI[CK4FB:CFXI3#1FA
M"GC1);(]VJM$FD_*?U@N6]]+O'/+/#G+MS2W./35X3;)D5[UTE"2B*<@K6N+
M*]\S)"R):$_G )1^UAKY,]=26ZY'=@X_8Q7I;I=4MHH8[:G#6?L_+M]O\)D0
M'@[Z!B
M                              UU^R])HK2/'0;C[L20VTVGQ4M32B(B
MU]IF8#^>'#6+>ICA.WLKK'.-W9TFSBE#=18-*4A*$N$X1I[3[9ZZE[3!E*><
M%\&\PV?.2.8.0JAO&(S,F59R&D]IHWY$IIQOLLL-K6I"?RFJE.>)%XF9@3+5
M^JZ*[R/ZE<0X]JD=Z4W&@0)))ZFA4N0Y(<4HO82&%)</Z@(=[I2E"4H06B4D
M1)(O81 Q?H
M                      #SD)?5'=3%6EN2:%$RXM)K0E9EY34DC3J1'XEJ
M0"H.#^ H/#\B^O)UPK)<QR)\W9]V['**HFE*[BFTH[CNF]PS<<5N\Q[>GE!9
ME<8(
M                                I? . &,5Y2R3EW)+O[Q95=K=.!K%
M**U :>/12$:NNFHR:)#*5>71!&77<"Y70"
M
M
M
M
M
M
M
M
M
M
M
M
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MI4734PL0
M
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M*)+IV#A),B=W$>P_ %7F"
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M;J<KH7C?IKJ(S/@NF6U1LR$$M.Y)]4J(CT4D_ ^@#;
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M@%(8SZG*#,'ZT\>P+.9M-;2$1X60-T#BJI2''>UWSD$Z9$RD]34O3H1& O
M                                           !57J/_8Y??GZK[5B
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M4$C?:;,C,B0T\;B$I+RI(MI=" =(
M         (QG''F&\D5;5/FE4W9PX[R9411K<8?CR&_==8?84AUI9?QFUD8#
MSP_C3!<"HY6.8M2L0ZB>MQZR:<-<I<MU\MKBY+LA3CCREET4;JE=.G@ TN&<
M$\4<?79Y'B>.-PK@FW&8[[DB5+3%:>,U.(B-R7741TJU/4F$HU+IX= 'SEO
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M /[D3_VH!T+B4W(K+&:N=EU8W2Y-(CH<M*IE],IN/(,O,A+J>BB+Z2U_"?B
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MI^5*D+4Z\ZZY$;4I:UK,U*4HSU,S/4P$_
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M+$:,T-]Q2$(U<<)"24M1Z%[3"W0
M               %8<F_IYQ)^L,S[$G@JSP0  &#$I::!,DV,&NC1K":>LR6
MRRVV\\>NNKBTI)2O_",!G    HI/I>IX=A;S<?Y%SK'6+JQE7$RNI[AF+#*9
M.<-QU2&_A%::GTZF?0B ;YC@:E74T=5?95DV3'CN2Q,QK9]W8-RY:9T!!H:8
M4X3"-8W4U&V1$>XS\P"7)P&D3R.OE G)'WC72)QLVNXGX3X)$M4PE=O;KW.X
MK3=OTV]- %&<J<#1SDX/18TS<R*FRY F97D%C"?-$JN>L8[[BI#3[*$&RAIX
MT&V9ZZ'XF>H"T,4X1QW'I=W<75K:YADV00/DUA>Y!(0_*35'J?P;!,-LMLLF
MI1K4EM!;E^91F8"L.2./7L)X9?X#Q*JR?/UY:ER#CTNP-N5 H^T<<F/B9C:&
MOAX\8TD^P2D*,U(-.OT!?F$8G78)A]%AM27_ $?106(#"M"2:R8;)!N*(OQE
MF1K5]9@**?XAOLL]0O(N2KM<CPZ*JMH8]+D5&\B*W+03#J9;!D^R\TZ25$V?
M5.YM1:D9:]0LJNX,P>H@8=75GQD=K"[1V]A.]_NOS+&2T\V\]-==2I3JG.^M
M:SU2>NA%HDMH"*'Z5\/^4S<03DV2M<:2UR'48*Q8(8JF%2E*<4EM3;*9':2X
MHW4LJ?-&_JHE%T ;27Z>*-+M18XUE60XOD-73Q,<?NJB5'0_85U>C8P4QMZ.
MZRXX@M='4M)46OT:$ V%)P'@V/S<-L8#M@J?A4JULHLJ1*[[T^?>M&U,DSW'
M$&IYUS7=N(TZ'_)\H"44> TE!FF5YY!<D*NLQ16HM6W7$JCI*G9<88[*"21I
MU2XK?JI6I^&@"*8GP!@^'*P<ZM^P>3@$:WATJ)3[;J7&KY?<D_$Z-)WF1^YI
MM(B\=0$7M/2;A%M3R\2>R7)V./GG%2(.'1[)"*N"^ISNDJ.DV#<V(7JI#3KB
MVTJ/7;KMT"\+:JKKVKFTMQ&;FU-BPY$G0WBW-O,/H-#B%%[24DS(P%1TGILQ
MBJE4C-ADV17^)8R^W*QO$+><V_4PW8YZQSVI90ZZF/T)A+SJTH+IH8"TLHQJ
MFS+';3%<AC_%4EQ&=A3X^XT&IEY)I5HI)D:5%KJE1=2/J0"JJCTTX[!ML;NK
MC+LIR.7A\IJ5C*+:Q;=9AML(4V3)-ML-I62R-)+6LC</8DB41:D84CGV(RI4
MG.<=:P/D&OR#(I,\T8YC4I;F"7$R42DQ[*3*+8F.3FJ'931NM]4Z+2KP =7\
M9XS+POCG$L0L'$/3Z*G@5LMUK4VU/Q(R&G#1J1'M-23VZEX )4
M                             "JO4?\ L<OOS]5]JQ 6%J@@
M                                               #$LX\V572HU;,
M^7V#K2D1IW;2_P!EPRT2OMKT2K:?7:?B J3'6N5;#-\@QN5GR5Q,:.L=6LJ:
M(E4I$]M;JT*T5Y--FTC3]("Y@   55S _G^.U,[+L:RM-?!C?!LHIW*V/*2:
MY,EN,I9O+42_\[NV_4 G.+U>1U,-YC);_P"\,M;IK9E?!LP.VUM(B;V,F9'U
M(SW?6 W@                    "L.3?T\XD_6&9]B3P59X(
M
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MGL@P;**.GS"?"K,4M9D6-\/,<L'4MM*<V25*CZDKNDAXB4ILC-)'H9 +U
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MXZQ&37SXTI3KK""==0@FG%&I2$&2U$74D]3Z )*
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M$,L^]T%^=\CMJ+L/&Q\->1/@GUZ)2K>A&]>J/-INU\2,!(0
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M,CT 69>,\8(]5O$1X&BH3>_+<A.]*G)C_0_@$_!&[V/+KJ;W;/QVZ^S: ZA
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M]GD6294SC;A/XS4Y%9?&U]:^A)MMNLM):;-2VT&:6UOJ<-'XNA]0%O
M                "NN(_P":S;];KG^E0 L4   %><G?WOQU^M+'V?. 6&
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M7='.IYF,YKC+C#608Y9&TX\P4M!N,.MO1UN-/,NI2K8M"O8>I%TU"?
M                        "NN(_P":S;];KG^E0 L4   %><G?WOQU^M+'
MV?. 6&      /PR)1&E1:D?0R/P 5QB#+7^+/)'Y-.B6J';Y2Z?U5_P 60
M "NN=",^,+<BZG\16?:48!8H        #"MK>JH*V3<WDUBMJ839O3)TMQ+#
M#3:?%2W%F24E^$P%/N>H^/:KW\?\>Y?F=69;FKR#6E"K'D]>K#\]R.;I=/%*
M-I^PP&PH/41B,RSC4.9U-UQY>3G"8@1\N@JKXTMXRZ(CS$J<C+4?@E/=)2CZ
M$6H"W0        %8<F_IYQ)^L,S[$G@JSP0
M              !7E9^V[)/U;I_[98 +#   !7G(7Z8\9?[=D_9,T!88
M  UV0?W#:?ZG(_HE (]Q'^RO"/\ 8-9_9&P$R   !7?%G]X<B_K;+_L,$!8@
M#29?BE-G&.3\7OVUKK)Z4DX;+BF7VW&EI=:=:<09*0XTXA+C:B\%)(P%0<TW
M>+4=+5\4RXN69/D.01$*FQ,20TY=V%76I0R^NQDF31)9>)7:=6DTJ4:C)&W4
M!(>/>59V06T'$T\695B-6W'4AB?;0HT:NCMQF_(WJU(69:D1(01) 6R
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MQG'(?"=+DF?[W;I;LB.Q8.-DTN;$87L;?41$1&9]4&HB\VW=XF NX
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MB1;5GX6:XPEN7L>>9U-39N=30A>B]FFXDGT(.D
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MS&-.XQ(8?2AQIQ&I:I6DO89=#(P$F 55ZC_V.7WY^J^U8@+"U00
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M5K8?DS664C=LVR<=>];+[)GN)+C9Z'H>A:D9:&0V]GW,=QJB^,),8EOAVH
M      Y(R&MJ;GGCD)S+.5Y/%MG':JX]57T\^#3_ #*J3&WHER7)!+*0ZEY;
MS74M[24D7N&D!<O#=335:+GY/RE/Y+2Z<?NJL+.%:? FDG-"0<1"=G=UZ[_'
M86G@8"T@        %8<F_IYQ)^L,S[$G@JSP0           ! N0>*Z[.[&G
MR%BYM,9RZ@2^W5WU(\AI]+$PD=YAUMYMUEUI9MH/:XV>AD1D9=0'KQWQ?2\=
M?-YD:=/O,ER%YN3?Y)=/)D6,U<=';82M2$-H2VR@]C3:$)2E("<
M                .:,=]27"=ES_ '=9%RMC?-JX-/#FNH6U >FP9$MQUM$E
M9$V?1U)(49DE9]$F?34+'OO49PAC9K399O6+<;Z*;@N*L%Z_1I$2[U!<(&_Z
MQ\#GK./@^-9)E\K7:@JRN5VC/Z#-2MY:_FP,/G_%_P!2F3*VX?PT52PHO)*R
M2<EK0C\#4R9QEE_WI:F!AQ;ZE.+?4G?<J1K?.*-VWN,B2RQ2_($NRJ]KM-_Z
M*S[W:4C8IQ:5'_&<U/JH$=>XSZ9^4+7&:=KD;F/)2GE#83/JJV0IIIEPFTDI
MHWNZLGC0?E-PT>;37V@N6]C>C'AXW$OWSMWD3Y>\Y9V2U*5^$V$LG_"!E,ZG
MTW<%TNSX/!JQPT>!S4+G'T^GXI3NH&4\J\5Q>CT^24D"MVEHGX.*S'T+ZNVA
M((VX#6Y"1'06I*(C(X<@C(RU(R[2O$C 1[B(B+BK"-"(B^15G0B(B_T1OV$
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M]3W::$ PJC+,6R%IA^@O*^U9E&X49R#+9DI=-C3N;#:6HE;-Q;M/#7J W
M                      #DCDI1^HOU%TW#L;^L<9\:*1?9THO,Q*L_!B&K
M34CT(^V9:D>BGB\4$ O/B0S4UFIG_P!KKDOWG$$ L0   %><G?WOQU^M+'V?
M. 6&      /E:T-H4XXHDH01J4HST(B+J9F8DS@4Q@F=8W.Y@SIEB2?_ $HF
MF:@N*0:4.K8C/$9$9^&NOEUTU'%3OM5YK$3]V<?HRZ960O+X#U<FRIF)%PS\
M84!U,-M1K;7KHI2B623VIZ=?K(93W59KU4B;\<<$P]WE9+)E6T-I#$*'V"*H
MLB/NN=]2.IK:/IHE7_<8RGS9FT1B(Q],^_X'!\LT,EQ^GL+*R?=L:QI:'B8,
MF8TAQU!)4IQHBT/3Q+30(T3,UM:TYK'PB?T,JQYVP/%T\=64Z-"3%E-2H:^X
MP9I-1RK",AS=KKKT/I]'L&O\'3U1:(Q,9Y>_@O5*VZ:FKZ"O:JZQKM1&M3(M
M=RC4H]5*49^)F9C?HTUTTBE>4),Y9XWH        Y9S&BR+D[D[,HF#<;<:3
M#QB3$K[J[SRO7-LITMZ$S(2I!1F5*2TAI:$)4Z9[M/+T+0@LWA+!<NPIN[+*
M\:P3'5S51CBEQ]!?@)>2T3F[XSOH1N-)K+M:>&JOI 6R \I,F-"C/3)CR(\2
M.A3TB0ZHFVVVVR-2EK4HR(DI(M3,_ ! ,'YKP7/<$M.2JR2[#PVI>G-2;*>@
MF4FS6]7)"4I4M7;4GS)W$2]/%)'T :G$?4!CN47U113<=R#&$Y*AQS%;*_A(
MB0[4FD=TTL+0\Z:5J;+NH0\E"E)\.O0!\Y=Z@\;Q:[N*>)CV09,QC!(5EEM0
MP42H-5W$$Z:7UK>;4M2&S[KB6$N&A/CUZ +/I[>LR"I@WM+)1-J+)AJ9!EM'
MJV['?02VUIU]BDF1@,T!6')OZ><2?K#,^Q)X*L\$        5=G_ #I08#E3
M&%'CN1Y/D;U>FX<A8Q6*M%LPEO+CI<=)*TFDC6A1%T 3'"\K3FF/Q\@336M
M4A3B/EE_$57V".TLT:K84:C22M-R3UZEU 2
M   &MR*55P:"UFWC_P +2QXDAVQDFHT]N,AM1NKU+J6B2,^@#^7/I^]*$SD[
M.8]C8R2A\<0W&[4FY6Y%E/K/BGF6DI0WY4=Q4=;:W-Y;>IIUZ /Z,T/!_$&,
MFE=-A50R\GW7W8C<EXM/H<?)Q9?_ '@7*=L,,1FDL1FT,LH+1#;:20DB^@B+
M0B!'H KWD)1EF/&1$9D1WLG73_9$T!80      UV0?W#:?ZG(_HE (]Q'^RO
M"/\ 8-9_9&P$R   !7?%G]X<B_K;+_L,$!8@#S?-XF7#C$E4C:KLDX9I0:]/
M+N,B,R+7QT(!RSR?DO#&5O5L7U38?<8E;TQJ3!E.N6CU"MQU2=7(EA3K)I>N
MB=#?0VXC70TIUZAJL&N_2KB>3-7/!=%>YIG+"%L1XM"J[L&T)DIV*[SMB\F&
MVC0_,MQ?E\?H =58W*OIU'"F9/7,U%Z^WW)E9'D?&MQU*49DWW]C9.&E.A*4
M22+=KITZ@,^3$BS6C8F,-R&#,C-MY"7$:EX'HHC+H @Z^)Z ^4*_DYK8S*KZ
M=ZD:JT1F"CGWI*)/Q&[;N)Q)H)):>S]T!$<B]/\ 83;3)/N=G=CB&)YN^Y+S
M''H,6*^4F3);)J2]$D/)-<1R0A/Y5227J?F+0]- W.5\)5ME!Q \&MG\*R/
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M+F-6ZKZ#5H:9;0@B9*(XMIDB0EQ23<+=IN4@DZ]"2 Z?
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MI(MQ,<G.06I92W%L[W#,ST/W5*\^S82E*VZ@.@P
M  <W^IJ[L\PM,8].^*/FW=9F^B3D,AOJ<6DC*-:U*\/?-M2M->I-FG\<@6$_
MQ"GK\=Y4L\?J6NQ556)44*"P74D,,2IZ$)U]O0O$$6B   "O.0OTQXR_V[)^
MR9H"PP     !KL@_N&T_U.1_1* 1[B/]E>$?[!K/[(V F0   *[XL_O#D7];
M9?\ 88("Q  !I\FRG&<.J7+O+;:'2TS:B;7-L'VX[.]?NHW.&1&I6G1)=3 >
M6/Y;B.0FF/C=M"G.'#BV11HKJ%.%!GH[D9\VR/<3;J>J%&6BO8 WH
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MP]\VTI\.I-DK\<P65F5G[;LD_5NG_ME@"+#   !7G(7Z8\9?[=D_9,T!88
M    UV0?W#:?ZG(_HE (]Q'^RO"/]@UG]D; 3(   %=\6?WAR+^MLO\ L,$!
M8@  YS]0++%+GF-YUF=)(R#C:#26]<CL0E6C-1?2E,J8GR(R$K,T+:0MA+G;
M42%'UTW$8" \ O1\VR/AFUPZJFL/8'BKU3R#DLB&]!8D)7!;8CU27'DH.2IF
M0GO]-4-DCRGY@'90        "JO4?^QR^_/U7VK$!86J"
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MV%&DTK;<))[5$6YM9>59>!^("2@        *PY-_3SB3]89GV)/!5G@@
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M@(!Q]CO*F,V,YNY9Q]REN+6;<6#L.3-5*:5-\W;:0Y'2A6U1$6JE)Z +3
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M3.<8-39O.G(/:@CU;0DDF9F N$        !6')OZ><2?K#,^Q)X*L\$
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MQ?@6[P*W-E]3>26.)1*6.TDD>9LY32C4DW"\I)_&\ '08        "JO4?\
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MB]P]'OA]#LB+=I^4U[?AKYO$@%X@        *PY-_3SB3]89GV)/!5G@@
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M1<A5610+CX^GLL@.W16.0V$.M3'4M%M4TYHMA*7B(R<,E)4>AD ZF
M  55ZC_V.7WY^J^U8@+"U00                                   !7
MG,>TL<IUN+2TRWD="XZZL]J$(19,*4I1^Q)$6IG[ %'<,,N<_<]9)Z@+%)NX
M-B"G,9XX;41]IU;>I/S4D>FNI+4HCT_SI%XM .M         % <LYA8*R^'
M:;;2UC$QJQ@*4G<9S?AUH[BNO4B0^M!)_=\=-/EN_P#4=NO=-*<(C]VVM8PM
MG"FRDUGWC4N04B^2W,?C/.&XTTLTZ&3)'[J#\2^K3Z![?9QFGF<<WX_#X,)2
M8=S$   !AVL.185LN#%FO5LF0TMIJPC$VI]A:BT)Q!/(<0:D^);D&7U *PJ.
M%;BGR&9DS').1.6=HN(=N;C54:)2(!&EI"B*"6TB2I23V;3/7Z07*VP0
M          '.=@QS-@'*><V^ 8M1W.+92]"GN%9W3<&64]B&W'<<3HR:DM*)
M"2)I>[11&M*B)>T@L[C3(^2<@*S_ ,0\<J\?..;'RXJJU*V[V_N=WN:--]O;
MM1M\=VI^&G4)\         K#DW]/.)/UAF?8D\%6>"
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MI(NIF9Z (JSR[Q/)=89CYWCKSTI9-1FV[>"M3KBC)))01/&:E&9D6A>T!,@
M  4GSU:<L891V.=X?EL"#30OE\=-!+IBF+4[,F-1%N'*^*;/0N\2R3VOQ=->
MNH"R,,JLSJ*]]C-LCCY-8K>-;$R+6E4H;8-*2)LVB?D;C(R,]VXO'33H D@
M       #F'EF?Z+8^?6S7+#%8K/OR!VRI,2Q=>/5AOLFI<=M2#_);--#\ 'K
MZ68.!QLJY)F</52X_$L]VK<JK9V/(8*18H:>3,9CKEZ/.1VM4*22BT0M:]OE
M,@'3(        "L.3?T\XD_6&9]B3P59X(
M       /Q2DH2I:U$E"2,U*,]"(B\3,P'$5E+1S/E[?!6,3REX[(RV\R?.YD
M->]E-6U/,X[9/-F9'W?9XZ+4V?L!8=LQHT>''9B1&DL18Z$M,,MI)*$-H(DI
M2E)="(B+0B!'J                          .>.<WJ'&^4L*SSE"K<MN(
MZVMLHAO?!KL8=3?/NL+9G2V&TK,T+80XRVYVU]M?7RF9& T^)76 \C<\8KEO
M!4%/R.E@6K&>Y+!@.UM?*CRF4)A034XRT4AY,A*7NA'L2@^OL(.GP
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M$AE*C=9?CLI2LU+)23U66GE\IGU 7*         K#DW]/.)/UAF?8D\%6>"
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M*K>R9[=>W(90?4BZF8"[0        %5>H_\ 8Y??GZK[5B L+5!
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M_+\*<92=L,O%BVO"T5N,O=6VC0C]I=LD]-'C!>2X^'_]!R_];L@_MJ@18P
M                        ^'>[VE]C;WMI]O?KMW:=-=.NFH"B&^!LVSC\
MOSER+87D1SJYB6-&J@HR29:&TZI@RDR4^W5QQ)_O +7P_ ,)X_K_ )5A-!!H
MH)Z=Q$%A#2G#3T)3JR+>XK^4M1F D8        "JO4?^QR^_/U7VK$!86J"
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M_P#\39$ MD       %18!^WCF+\SBW]BD@+=   !4?J;_8M??ZU3?;$(!;@
M       #5Y'C=#E]),QS)ZYBUHIZ21,@2D$XRXE*B6G5)^U*DI4D_$C(C+J0
M#GK+L$H^!(16^#<O.<<52"W1\4R:0F[HG4HZ]J-%E+^+;U]OPSIJZ=$@)WP)
MRIF'*-3:2\JQHJIFO<9;K,ABMS(]9=-.DO<_#8L66)+:$&DM2<2?O%HH^H"W
M@        %8<F_IYQ)^L,S[$G@JSP0
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M/U*DK22T&2DJ+5*BZD9'[2 ?H"JO4?\ L<OOS]5]JQ 6%J@@
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MY)J[:M/_ #24 +1          %8<F_IYQ)^L,S[$G@JSP0
M                $8Y"SJDXUPZUS._7I K&363*3(G'WE>5IEO7\=Q9DDOH
M\3Z$8"H_3=@MW*5:\Z\AHWY_G7Y:(TLC_P"CZ<]#8901^[O2E!Z>)(2@C\V[
M4LKMR)K)'JXT8I*A1+;>DR>LF'94?M_C%L9=95K]![@1"<!PWD7$I\E%E=T\
MVCLK&=;V++$"2S*^(L%J=4EIQ4I:4H2LRTW(4>WIKKU 68
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MC2)#JDV<59DAMMQ2E&24F?0O %AT$"
M ^7'&V6UNNK)MILC4M:C)*4I26IF9GT(B(!R!C;;GJTYO5F\U!N\#<8RE1\:
MCK(^Q<W:#2I4A23]YM.B5Z*_$[:=OG<(!V"     > ".6L=>22)&.SJ]:L:D
M1D/E;,R"3O>2X1DV24]?9KKKH.+;7SIG7:OT3'W9_98X)"VA+:$MH]Q!$E.I
MF9Z$6A=3ZCLB,(J_A+^9S_\ 7:^_ID"K*T@0  %3<T?W]Q'^N\;[*L@%L@
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MOP-)E^\9>)'T/J V "L.3?T\XD_6&9]B3P59X(
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M([DZ9MVKE3'"(WGU>/O'T21F>U))3X$")F
M-7D3F1,T\AS%(T.7?%L^%CV3SL:(K59$O>XRT\LM$[C+1!ZGT^L!6N!YWRWE
MMY90YV/8_"J<?MUTEY(9LYCTCN,LLOK7&;.$E*RVOH(MZT==05;P( .8?4>O
M'I?*G'M5R'FC^#8/\%:2Z^XJIC5;8_/$&RTE"Y9I4XPPJ.MSS)-*%++:H]=@
M#;<2UW$$7-HCN(\W7>;WG:?)G'K#+$W,=U)MGO6<4O>-"=5$?XOB Z(
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MYDV6ZI^1(>46FJW'%F?U%H1=" 2L!6')OZ><2?K#,^Q)X*L\$
M                 :'-,OI,!Q:TR_(GNQ45+"GWS+3>L^B4-H(S+5;BS2A!
M>U1D I'TY8?=Y/:6OJ(Y!9VY7EY;<=@KU4FNI.A-$V2B+0W$DG0]-306[75Q
M8++HP$                            5?P[_>G*/ZZS?LZO!5H @ J_EC
M$<^R:56.897X7-:CMO(F'FE;)L74FM2#24<V%H)*3T/>2O$] %=86G/\&YCQ
MK&,]HN/ZV#DL2R526N)U$J-->E0&4NNQNZZX?9/MF;O5*DK0E1:DH!TJ
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M1=S9^4UV^[NZ^\0"Z0        %8<F_IYQ)^L,S[$G@JSP0
M              !RQE[CGJ5YE:X[@K4YQ#QX^F9ELELS)JQM4F:41",O%*3)
M3?33IW3U_FS!>3J5MMMEM#32";:;(DH0DB2E*4EH1$1="(B!'T
M                   J_AXC*TY1U+3_ *ZS#Z_775X*M $>4EXHT=Z09;B:
M0IPTET,]I&>G\ "G(,!SU$81B?(5;E64X!&GQ''TUM!/CL;R=<VD;ZEQG=YI
MV>4RV]# ;+#>!Z;%LMCYQ;Y3DF:9'7QWHE1(R>>W,1 1*(DOJC-M,LI0MQ);
M5KT,S3T 6L         JKU'_ +'+[\_5?:L0%A:H(
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M>$\%T^#9"QD43+<MMWV$.-IA7=Y(L(2B=2:#-3+GE49:ZIU\#Z@+2
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M $ZXRQCBO$:J33\51JJ+6]TGIK=2ZV^9NK+1*GEI6M1F9)T3O5X%T 3@
M    !6')OZ><2?K#,^Q)X*L\$                         '-GJQY,XFP
M&A8K,L99?R^X=@R8<=B(W(FG"A3V7'E*6HM$(4AM;:=ZO,>I$1D2M UWIAQJ
M'R#>6_J1LHD6.5R[(@855QD-(175;"U,*-26B(B>5M-LST(]-ZO!SH5U("
M                      -1E3S+.-6RGW4,H5#?02W%$A.Y;:DI+4_I,]!A
M>]:1FTX@1;B"5$K>'\';GR6HZHE)5PY7<<2@FI2(K2%,K,S+1:5>4T^.HPC=
M2:]46C'MRN$ED7K[TFVJ*B*XNYKV$NM')0IN(ZMU.Y"2<+Q^OP_X1KMNF9M6
MD?56/'E\S#]8K[:3,K;:=-7&6U&[<ZI8,E15ON)ZJU/J>TSZ?@+Z];77>;5M
M:<<.-?#(S:NIKJ6(F!51TQ8:5*6EI&NFY9ZF?4S,;->JNNO36,03*O.(#WVO
M)BE$6K&7RHS/0BV,(KX"DMI^A)&I2M"]IF?B9C*M*UY1$$K0&:
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MG>0P>5LUR>9QCFC%3F)T4:O<771B-@ZYEUAY<DBE^1!&Z1D9;O*1GH"ND@0
M '//JGXPP*WP2YSBSI&I.4M.5$9%BMQXEDRJSC,FC:EPDZ;'%)]WV@L+BPO
M,0X\KWZK#*MNJKY+QRGV&EN.$IXTI0:C-U:SUT21>((D@       *M]1N%Y%
MR'PUDN'8I'1+O;/X%,>,ZZF.VM#-A'>=)3B^A%VFU_A\ '[_ +MW G_Z<T'_
M #!G_P D!*,.XVP'CWXW[CXY7X_\Q[7QWRZ.B/WNQO[>_81:[=Z]OT:F E(
M       "L.3?T\XD_6&9]B3P59X(                        Q;*RKZ>O
ME6MK);A5L)I;\N6^HFVFFFRW*6I2M"(B(@'\X^=L0R#U37EGS%B,1NFP;'FX
M.-UME:&ZVNU4[/-DG6D$E6TD+E'N^A.A>_JE)9=L\!\0Q^$.-:_!6YYV<QIQ
MV98SMIMH<E25:K[:#,S2A)$E"=3ZZ:GU/0$6:
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MT:3RYG=#)RK+7ZK%/D$BHC.Y):K02YK#KSQ.$;_Y1*U-IU2O4M.G@*KH\1
M 5ISQ52LCXXLL:JS0JWG/U[L9EQ9-DI$2QC273W*,B+1#:M-3ZGT&[7JM?[8
M:=F^FO[I6+%E,3&$28RR<97U2HO_ +1KM2:SB>;.EXO&8Y/88LP
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M6A>)]3&VNJL3%N=L8SXF7EDO3'+@R\?@I/\ 1*&Y$8X3,SX<X^U_[.5/]B:
ME.P !J<EGW=732)N.T_SZW;V?#U?Q+<+N[EI2K\LZ1I3M29JZ^.F@"I^,SY8
MH<@OTW?'Z8M5E>0.W3\]%U#>."R_&CQ]JFDIW.*3\/N\G\;3V J[@0
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M),]MV>S9VCZU$RELU)7VF6S/HDC26AJ^CRDDN@G>=[YT12M8K2O*"96@/,0
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MZEK#J8"(BE]Q>IK6HNA:J^@<6_;YELN_M]7E4Z6P&AT
M   *PY-_3SB3]89GV)/!5G@@                     \WWV8S+DF2XEF.R
ME3CSSBB0A"$%JI2E'H1$1%J9F Y5O+F^]6&4OX7B4A^KX&HY!(R;(F=6W;F0
MUHLHT<S+JC70RZ:$6CB]3[:#+R=.T-#3XQ30L?H(;<"FKFDQX<1DM$-MI_A,
MS/JI1]3/J>IF"-B                   "F^3LLIV,VPW\L\I>*6CMC9H92
M1D:)%=)AD@C-1:J+XDE'[-NI>(\GN/4]6F_1.9GQPSBLRL1G)DVKCL2DCNNO
M+KRGP)[S:DP7#<+1M!K(]==3+<G37Q^@=4=QUS,4C^.8G^+'#ZCU5K-=IK6W
MFKC6,%MSXR#"690GENIT\R5=3V^)?6+75>TUM><3'.(Y29;2!6U]6TMBNC-Q
M67'%/+0TDD)-Q?O*,B]IC?376D8K&$90V  B><8G?97'9B5&6S<8C$AYJ:B!
M'A2#DH>(DZ*.6P\:=I$K39I[W7V ,#CGC^WX_A,4[N7S[^@@PV*^JK9\>"TF
M*S&22&]KD9AIQ9DA)(_**/\ ?!4[! !\.NM,-J=?6EMI/O+69)27X3/H \&[
M*N>6EIJ6RXXOW$)<0I1_@(CZ@,H              55ZC_V.7WY^J^U8@+"U
M00                     ?S"Y_Y]M<.YDR3':JJA2H]18R2DO)G7:$2UR&
MMQ(>;*>1)-A:_P#,[$FM/0MGE =*>FCC"KQ'$4<QV#ZL[Y<R>OA6$B0IS=)A
MP9[3:F8S1.[EH,FC+N+,M5;=I>4NO-LW=,3TQU6KX1S7#H]-,]+FSI-I)5+J
M;!EI!4DAMM;+*DD6[KUW&9]?P_N:/*FUIFTYK:/MGE!EN&VT-(2TTDD-H(DH
M0DB)*4D6A$1%X$0Z(C'"$1S,[+.*R%&=P:@A9!/6[MDQ["R55-ML[3/>E:8T
MK<>[0MNTOIU%$*X<Y.Y Y/KX.2VF&0*'$+%F0N--:NCGR^]'?4QL5'^"921&
MI"SW=WPTZ=0%M  " 9/S=Q7B#CT>[R>&F:P9I=AQE*F/I6GH:5(CDX:5:^Q6
M@[]/I^_;QK6<?+_5<,"?RY)L<%@9IQQB\_+"LI*HK$(B.&MLD&LC=<WI6>S5
M.FJ2,NOB0V5[**[9U[;Q3$?$PUF)V'J+O,A@3LGJZ/&L30HU3JXG%2I[C9D?
M0EMK<22M=-.J=/:1^ V;J]G2DQ2;7M[>4'!2_J0X+R%RW:SI.2_-?G5M#IVX
MEB1M*B':S$1HC32D$I)M-K>T5Y4F1>;S'J/2[#U?5JIT6KC'L\?BL2Z3XEP$
M^-,"J\1<E%-E1"<=E24D:6U/R'%.K)!'UVI-6U.O4]->G@/#[WN?R-LWQC*2
MFPXD &CRW)F\1I7;MVJL[E#2T(.#21%V$U7<5MU2RWYC(O%1^P@%*<%9I.AV
MV1T%KA&6U3F495<7<"?84K\>"W#G*)UHWWS,TMF9(TVJZ[M"!70X(  #G_EK
M#KZ!E&*2JKD/+:]C,<F;JIT"+.CIBQHKT*7*4F*A451H,E1TZ&I2M$[OPE57
M3C-&O&Z2+2N6L^[7&)9'9V[J)$YW>M2_RCC:&TGINVEH@NA$(C:K<;;3N<42
M$_2HR(OX18B9Y),Q'-KI&0TT;7?+0HR]C>KA_P#)U&^O;[+>#GMW6JO.6']Z
M$OGI70),H_8HD[4_O]1M_%Q]UHAI_,S]M9E^?$Y7*_F8C$-!_C.JWJ+][7_Q
M1>G17G,RG7W%N417XATEQ+(RL+9>Q1:*;83L(R/V:EI_P!Y^NOVT^9^/LM]U
M_DAV/-UUIFV08GN<5)Q4H+EB:T$EIY-DTMYDFS)1GT)L]^I%]6HWW[Z)KPCB
MYM?I\Q;-IC"R8\&%%+2-';:T]J$D1_OCS;;+6YR]6NNM>41#(&#8 *F]2W[&
M;W_6J?[8ABPL+9$0                     5AR;^GG$GZPS/L2>"K/!
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M5"24XM1$GIJHQE,CH08@             JKU'_L<OOS]5]JQ 6%J@@
M            ()R?S'QWP_4?-\[N6H.\C.)7H_*SI)ETT983YE=>AJZ(3^,H
M@'.]CEG/OJ'..Q6K=X4XDLGD18]G.2O[QVI/="2R@MJFTJ+J2DFA/7^<<+H-
M.S=37B+3CJG$?%<*CS+TFP*?+(];#QB2]#:DO(8>DVCSDBX;(U;''#;8T2M6
MF]1-:=/+]8\K?W=M=[5F;<?M^C./AQXY91#OK!Z9RLH*]RRJXE7D#D2.S9,P
MCWMD<=&Q"27M3J24EX:=/K\1ZFK5%8S_ "F(S/C/Q8S*2C>C$L+2LJ8YR[6:
MQ!BET-^4ZAELC\?>69$,ZTM:<1&12W*GJ8PK$L>E*PRU@Y!E9J2S$BLJ4_'0
M:M=SKBVO*:4D7NI7J9Z#V>S])V[;QYD36JQ"G. N<<[@8LCCC%<*+)IU63CL
M!V.^<9+3,A]3CAR362DGHX[Y3)2.AZ>S4>AW7I&C5BTWZ*^_C\EPZ(N:WF?+
ML-IDPK2%@N4NK<._;9;38DEHS,D)9</<1*VZ*5H?B>A+Z=?&UW[;5LMF)V5\
M/!&)A?"4K'LDBY?D><7F3WL0EDTF4^;4+\JA2%$;&YP]-%=$[]/J&>_U"+TF
ME-=:1/S^9E*Z[BOCBJL)%K!Q>M19275/NREQT.N]QPS4HTJ<)1IU,_!.A#DM
MWFZT=,WG'Q,I<1$DB2DM$ET(B\"(<B/T!1?J,S#$8M+1TLO(*R/<1,LQ:3*K
MWIK#<EIA%M&=4XMI2R4E"4><U&6A)Z^ *N.FOZ+(X9V&/6D2V@$M31RH#[4I
MDG$:&I&]I2D[BU+4M01L0 !I,L5F":5T\%;K7<BWH[*+IQ]J%LW>?<J,AQ>N
MWW=$^("L^-,RYPR^XEJR"JQB!C=/:S*:U7%D6*ISBX/E-Z*EUDFS;6LRVFM1
M>7468P9B>2Y5N-M)W.+2A/TJ,B+^$(B9Y),Q'-KG\@IH^N^8VHR]C>KA_P#)
MU&^O;[+>#GMW6JO.S#/*F'3T@0I,L_8:$:)_?ZG_  #;^),?=,0T_F1/VUFR
M*Y&NPL)\=Z?"[:HRTOU[;B"<-ETDJ23C:C+HYH:BW)T5H>@[]&K5%>&+/-[C
M=MZN.:^Y)8];D4YAIR;9JCI4DC-II!)66I>TRV]?I'%;9JK,]-<N^NK=>(FU
M\/9&)UQF2Y;CTM?M-UP_^+0_X1C/=W\,0SCLJ?RS9LH]361?YB(TD_XVTC5^
M^>ICGMNO;G,NFNC77E$,P:FX  %38&1ESGR\9ET-G%]/^9211;(@  "G.;L8
MY<SNHGX=B,''BQV;\"]\QM)\QB8EZ'+:EJ3V&8;J#29LDDC[NO7455@X=(SF
M3 ?7GL"KK[,GC*,U2RY$Y@X^U.BEKD1XRB7NW%H23+33J(B1
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M^R;>-82Q&)U>I*DJ>E+]INN'_P#RZ#@GN[^&(>C'9:_',M@Q45<;^9B-)/\
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MI634=,.*\;IDE"=75?$K;W>&WV:F8Z.[]4V[Z=$XB/''B3+I4>.@
M I[E/)\QGY_B'$."VQ8[.OXT^YOLC1':ERHE77=M"6XS4A*FC<?=<)LUK(^V
MDC,B,] '[Q-E.8,9KFG$N=VJ<@M<63 L:?(_AVH;\VJM4+-*9#+!$V3K#C2F
MU+02266A[2/4!< "J_4>1GP[?$74^_5?:L0%A:@(CV;9QBG'6.RLKS2S:J:&
M'M)Z4]N5JM9Z)0A""4M:U'X)0DS,!JN-.7./>7JF1<\?73=M$AN$S-;V.,2&
M'%$9I)QEY*%I)1$>U6W16AZ&>A@)L _#,B\3(@'X;C9>*B_?($RIR1ZJ.#HO
M(!\:O9.VG(TR?@''.TY\"B82MALJDZ=LEDKR'UT)70SU&OK]TX]O^<56#:<A
MX!1ENNLJIZY/AK+L(S'AK_YQPOH,9Q,2(+:^J;T]4QK*9R%4N&CHKX-Q<[P^
MCX5#NO[@H@]AZ[?3]%-::Z?:W1I_]WUDCKI]'Q),"Q$SR$3E_P#U ,8?D)C8
MUQYD=BZYT9^,*/!2HS\.I+?(B,;H[?;,9BLS'PD>.1^K3FRKMRI9'%M9B<Q;
M)26DY)>-;NRM1I2HT-I95U,CZ?48RU=KNVQFE9F/@DS$*]Y%Y2]37*'%^0JB
MV>'Q* V6FKFNQZ3(*X0S)D$TAHUO+6G\LHNV>Q?F2>W\;KCM[;?KB)MKM&<^
M'+$9G_(R1,3XN?N#\'KTY*X?*N+W-CC*&UG"HXQ+C2'[1*D=M?9<V[VT(WDX
MHRVEJ1'KX'CVW;3WN::[],1'&T8X?KB8S/A!,Q7F_I-D:^1H$:BA<0T6/T-<
M]7,)E2K=:&GJ\]"-,8V6#,M$)T]TG"UUZ=",^WMNT[:MIMMZIM'#Z8^Z/C_Y
M,)W4CG,?-]X519E!?M)W)G(C=\Q9Q%P3J:]I,:*PITRU<;=:)"B62=4I-*$G
MUUZGIIT[^BT1&G5-<3G,\VJ>ZU1_*&'0\,<"8VZ;B*=%M.UWJ>M.].4?MU-#
MA=O_ ) V;.Y[W9X],>[$?\L)[[5'\D0RW@WB[)\@E7<Y%O,=F.&I2UV;S:";
M,_(PPVDB)EEHO(TAO3:DB&?;QOUTF.N8RXMGJ/U?3'!=6-2VZ"BA4<%BVLV8
M#1-(EV#ARI3B=3,M[I]5F6NFNGAH/*GM<3QM#ICO,QPI;Y-L=W;*T[5*]YNI
M&M>W]_R] \BGC>%_)V>&N7X5ADSA&:*IM'YQTO\ *0>7IC^7['F[YY4_=',S
MQ=S,*U,;*L>JK>'%64AAF5';F*;<TVFILGB61*T,R,T]=!MU1HBW.?UY-.Z>
MYFL\,?#FTV#\<4M+,=ML7Q^JQ^:;9L'8Q:^.Q([:C(U-I4A!*T/0C,O#P&W?
M.FLQPS/N:>VC?:)^J8CWIW\AM'/](NGSU\2:+M_\"AR_D4CE2'9^-LGG>0L3
MA+_TF3)?/V[W.G_ 'Y=O"(@_"K/.9G]7LUBU&W_ZMO/Z5K6?\&N@PGN]D^+.
M.SU1X,MNGJF?YN$R1_2:$F?[YD8USNO/C+;&C7'*L,M#+371MM*"_DD1?\ U
M3,SS;HK$<E7<BXCS%D]D3>*Y+0TV/L2(DN*F36S7[ SBK0ZXPZ\U.:0IE]23
M0XE+9'VST(R/S#*M[5Y2QOKI?[HRFN(1LPBU'9S:763+DG5;7*6*]!B)8T+8
MDFI#\A6XNNI[]/J&,SEE$1'"&_$4 :7*:*7D=.[50KR?CTAQ2%IM*DV$RT$A
M6II2<EE]&BO!6J $$P;A-S [==G S[)I\63.D6ME53W:Y<27,F$?=<=)J"VX
M6Y6BM$+26I"BU1                                      :Z\OJ/&:
MQZZR.RBU%1&T.1/GOMQH[>X]"W..J2DM3Z%U ?E#D5!E-:U<XS:1+FH>,R9G
MU[[<J.HTGHHB<:4I)F1]#+7H V0"L.3?T\XD_6&9]B3P59X(
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M,N/+D,+)1O$KS$DB+4C^KKH0ZNZTTK3.,2X^SW;+;,9S"=#QGN@
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MDE"26MM,IM39K))F1&9;M= &VA1BA0HT,E&LH[2&26?0U$VDDZF1?3H ]P
M 1JHP]FIS+)<Q1+6Z]DC%;'<B*2DD,E5H?2DTJ+J>_O'KKX: )*   ",\@X<
MSGV)S<5?F.0&ICD5TY32$N+3\'*:E$1)7T\QM;3^HP$F
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MMNJ(;70M=?;](YG6K'(CTYWP%'XJ:#)-J?81F]5^!>SH0*LW:74M"T/Q^OV
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MVDKFC?FSI*B0TVVGVF9^TSZ$1=3/H74P$+PKG3C;/KI..T-C(:NW6#F0H-I
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M]2G#<6Z=I7L@42(\SY9)N2A354S4[<2>RNQ)GX4E:GH9]W:1]#/4!;
M               #P?A0Y3L>1)CM//Q%F[$=<0E:V7%)-!J;,R,TF:5*3J7L
M,R >X   /"9"AV,5V#81VI<)])H?C/H2ZTM)^)*0HC(R^HR >Y$1%H70B\"
M    >$.%"KHZ8E?&:B14FM26&$):;)3BC6LR2DB+52E&H_I,]0'N   #P:@P
MF)4B<S&:;FRR04J2A"4NNDT1D@EK(M5;2,R3J?0![@   QW8,*1)CS7XS3LR
M'O\ A)"T)4ZSW4[5]M1EJG<716WQ(!D    QYL&%91EP[&,U+B.&DUQY"$NM
MJ-"B6DS2LC(]%$1E]9 ,@    !X0H,*MBM0:Z,U#A,%M9C1T)::0GQT2A!$1
M%^ @'N   #P9A0HS\F5'C-,R9BDN2WFT)0MY:$$A*G%$1&HR2DDD:O86@#W
M  !X+A0W);4]R.TN='0MIB4I"3=;;=-)K2E9EJ1*-"=Q$?70OH >X   /"7"
MA3VTLSH[4IE#B'D-OH2XDG65$M"R)1&1*2HB4D_$CZ@/<   'RM"'4*;<22V
MUD:5H41&DTF6AD9'XD8#XBQ8T&,S"A,MQH<="6H\=E)-M-MH+:E*$I(B2DB+
M0B(!Z@   \(T*%#4^J'&:CJE.G(E*:0E!NO*223<7M(MRC)*2W'UT(@'N
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M?BN.<O1*"]NLCK;4\-RZEANP9<5<)+3TZ"\V\Z\9LFVI*VW"7XEH9:GT#H$
M  '%$>%R?>8-S"OA^M@3N'LON+R4[)N%J3D$DY>L:X56-LD;#C9J;=3$^*6A
M>I>;7H0#J;B:=C5AQAA\G#7GW\5^3P6JAR9H<KX5AA#2"?TZ=U))VN:=-Q&
MF(#'G1?CH4F%WG8WQ+2V?B(R^V^WW$FG>VOKM6G75)^PP'.O%^"8SQSZE,DQ
MO%8BHT+[E5LJ6\ZXY(E3)CUI*-V5)>=4I3CSA^\L_P !:$ W'ITC1;:#R^]:
MH3*D67(.21+4GR)1J88-J,VPLS\6T,D24I/H1']8#+]($N9-]..".SG%.NMQ
MY<=I:^I_#QI\AE@NOL)I""3]0"[P'/GJRXZQF^XQR[.+MMZPLZ''Y3=-#D/+
M57Q9!ZF<MN,1DCXG16WNGJ9)(B+0!9-I281,Q?&LFSE$=,'#T1[Z'/FO*8CP
MI,>,:2D*/>E![$K5IW-2(^I== %=\>N6/+_+;?.$: [4\=TU0_18>]*;-B;=
ME->0Z]/4A1$M$0B;(HZ'"U7KW/+KM 7\ UU]4(OZ2PHW9<J"U8QW(JYE>\<:
M8TEY)I-;+J=30LB/RJ+J1]0% <(8WC''',O-F/8_&158Q3PL4=2WN4O:1P);
MKSSBUFI:UJ/5:UJ,U*/J8"CN1.5...4&F>4+W**KYC'R2EB8+C3LK=+J*"+;
MLJFSWV2,B1)F$SW7=4F;4=*$;M34 [UJ;:LOJR)=4TMJ=4SVD284R.HG&GF7
M"W)6A1=#(R/4C 9@#F3U:<=8RO$YW)<UI^=E4>;C\&I=E/N.1ZUI=O$2\<-C
M4D-+>+HZO0U*+IJ1 /?U!R\K=YLX3H\4C0Y=G(5D4NM:MC7\M:GQX;*4S'T(
M\SAQ6G'G&T)-*C69:*3X@-WQY<9'6\X6V%<FP*:?GSV.-6E-FM)%<AJF4C<S
MLN1)33KCIH<:?42D[5FDTG[# 7R TF78Q"S/'9V,6,J9$K[%*&Y3U;(7#E&T
MEQ*U(2\WHI*7"3L7M/J@S+V@*:]/%7CV%3^9*NHBL5&-4N5N)8C,I-++$=BJ
MA&9Z=3\"-2C\3/J HGY1R"[Z;;"OKJM@_3._+>M2==41YT6*JL/F#[R65ZPE
M+(][B%K=W]K\7=H8#NFFGP+6HK[.J=[]7-C,R83_ %_*1WFR6VKS=>J3(^H#
M- 4_G65X5PJ_8NXQ2*M^5.0)?Q$#&8"UNS[:P0TEE+CAK4HF(S2$:NNGM;;2
M2C(MQZ&%357']EQWD_IKX_R-]J4Z=GE5[<-1T:04W*X+LUI#*=-"2PN0XEH]
M"]W=H6O0+$>TB>L.*B&>P[+CUY=HVCH2_A;A"8[JR+Q4GN+0E1^SH O4!H,P
MQ?%LMI_E^8Q6IE)$?8LEMR'%-,I=@.$^VXX:5((TH4DE&2_*?XQ&0"EZRT>Y
M[Y>QG,L7CJ:XJXW=L51<I<1L.\MIL<X3C4#<1*.(RDU=Q_W7%EM3J1;@&!R.
MWC\C%W?29PC5L.V,J*4&YV;I%;C53+<-UV1,<6I1JD.;EJ89W]Q2SWGIH6X.
MBJFN;J*J#4LK6ZS CM16W73W.*2P@D$I1^TS(NH#,
M!1-AR9R_E^09<WPY54$C',%FKI[!=\N7\5:VT5I#TF-#..I*&.V2TM=QXE$:
MS\-NH"S>-LZJ^3,$H<\ID*:@7D5,E+"S)2V7-30ZTHRT(S;<2I!F7CH E(
MJ_D#+N34Y=6X#Q?20U6,F"Y;V>4Y"U+51Q(S;I,(83\+L-V2XHS,F^ZG:@MQ
MZD?0/SB7D?(\IM\PP3.H,.'GN"R(;%N]4*=75RF+2/\ %17X_?\ RB-R"/>T
MLU&DR]X]>@6B  /AYYJ.TY(D.):8:2;CKKADE"4)+4U*,^A$1=3,P%,</<XS
MN6,]S:H8J?@,-I8];+Q>P?;<:EV42<J2CXPTK5H3#IL;X_D29MF2C][H%U
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M9GIT\" =#PF9$>''CRY!RY332$/RU)2VIUQ*2)3AI1HE)J/KHGH0#W
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M ^_I7;&22N3TV<'OEE9LO$PXM!/=KL]GO-(AF>WL[R+KJH!U$
M
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M
M
M
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MT1YO !O,&SW&^1*ARYQMYQ;4:0Y!GQ93*XTN+,8T[C#[+I$I"TZEJ1_2 DP
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M?*W?8V5TKXDE>2.]N/>MO;^43M+;J7T@-T
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M<::=R@G&36A2$K2<&.DU)U(B,M2\2 6\
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M/.^3(T.SEQXT3BYR=%89?<;;:EE-D)[Z$I41)<T(BWEYM/: QK:AEX'#XBY
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M22 =+\>6TZ_P#%;VS63EE:4]?-F.)(DDI^3%;=<,B+PU4HP$D
M                            ! W>-WK#D:/GE]D$NSA5!.*QK'%MLLPJ
M^1)82P\]N;22WEFG?L-TSV;U:>S0)X  (IA^"Q,.L<IL8LQZ4O*;5=U(;=))
M)9=<:;:-"-I%JG1LNI]0$K
M                                       :C*<<K\OQNUQ:V-PJRYBO
M099L*)#I-2$&A6Q1DHB/0^G0!5K7IIQ=<9JKM\MS&[QUM"6E8_8WSZZYQELB
M)+2VFDMF:"(M-N[P 2O+.(\<R8Z&3 ESL6M<8:7%H[+'G40WH\1U"4+CDA;;
MC2FC2A);%-GIITT :JOX\QSB-V]Y&J6,@R7(9<%IBX92]\TL;)3+NJ720Z:"
M-Y)*V$E"D()M.B4%H U?!G%\:AQC*["^HD5C_(-G.LYV/OI2M46LE*6F/!>(
MC-)[6UK4I/@DW%)]@#,J/3WBU5(JVGK[(+7&*-]N538G96'Q%1&=CGN8T1VT
MNK2R>AM(==6E.G@9 /7U)T-WDW"F44>.5[UI<3"A)CP(R=[KI(GQUN$DM2\$
M)4H_J(!FXSPKCN.W\+(I-Q=Y#*IT.-8['O9QS8]6V\G8LHR=B#W&C\GO=-:]
MO3< U4KTZ8=(>EQ&;>^A8;82%RY^$0[ V*)YQU?<=3VDM]U#;BCW+:;>2CZB
M ;3(N%,?M[Q6245S<X;<OQ6:^>_C,IN$F5%BIVL(>:<9>;,VD^5M:4DI*>FN
MG0!XS^!<+D4>-TM9*M*)[%9+TZJN*N8;=E\1+U^*6Z^ZES><C<?=-1==="T+
MH FF8XE39WC%GB.0-K<I[9DX\I+2NVX1:DI*D*ZZ*2HB473Q(!!9W U-,122
MV\JR:'E-)#<JRRR-8(3;S(#KJGCCRW5,*0ZA*U:H_)D:3T/74!]P/3]@-93?
M(8:K%, \ACY>9N2U/O*M(I-D1J==):U(6;9*62C-1J,SW )BYA=.[G3'(2E/
M?/X]6Y1MI)9?#_"/2$R5&:-NN_>@O-N\/8 C$W@[!["HO*B1\:17=^[EWQ[4
ME3,V%=.I0DI$-YLDJ:-!(\GCIJ9=2,!^4G"F.UCMM86UM<9-D%Q7NTKUY=RT
MR)C-<^1DMB-VVVFVDF9[CV-ZFKJ>H"9XKC=?A^-U.*U)N*K*:*U!B*?42W3:
M802$[U$22,]"Z]" 13+^(J;*;[[TP;JYQ7)'&$PIUECLM,-V9%09FAN0EQMU
M"]FI[%[26G^-IT 8DS@G"'*&AI:=RPQ^7C"WW:2^JI:F;1EV8>LI2GW"<)SX
M@^KQ.I42OH >". ,*7C=_C]C+M+27E,B'*R'(9TLGK:6NM>;>C)4]L)*4-FV
M24H0VE))Z$ F5+A=/0Y/DV6P5/':Y8N&Y:$XLE,DJNCE&:[22(MOD+S=3U,!
MI\FXFQ;*[>\N[1<M,S(:!6*3R9=2A!5ZG5O&:$F@]'-RS\QZEI[ &5=\;8[?
MU.*TTY4DHF'6%=;U!MNDE9R:A)I8[IFD]Z=#\Y=-?J 1J[X%QJUMK>QKKR^Q
MV%D3JI.24U)/^$K[!]PB2ZXZV;:U(6ZDMKJF5H-?XW7J V>0<-8C<0:&+4N3
M<5FXNR<6@M<??*),BQ5))*V-RTNI<;622W)=0K4^OB9F USO 6$O8LO'%RK4
M[%RS;R!>5G-4=Z=PRDT-S/B=NWN(09H2GM]LD^"0'S6< XE E7=E,M;NXN\C
MI96-W5K9SSD2'X4PR,S+R)0VM!%M;[:$I27XIF9F _97 ^.D]53,?OK[&+&L
MJ8F/.3:::AEV975Z=C")).LNH4M)>#J4I7]8#Y;]//'[&*Y'A\9=DS49-,8M
M)BRFN.2FK"-VU%)9?=);A.J6TEQ:EJ7JK7V= &Q:X6PUQ%TB[5,OSR.I@T5X
MNU?)Y<IBL2I+3RU(0V??,U;E.)T/<1*3M,!C8YPA0TEW77MI?7V52*3<>/Q\
MAG%,CUZU)-'<9;0VUN<))[2<>WJ(O ]>H#<5W%N,UF&Y#@T=<HZ7)EV;EDI;
MI&^2KK?\1VU[").F\]G0]/K 23'J2%C-!58Y7&X=?3PX]?$-Y6]TV8C264;U
M:%JK:DM3T ;(
M
M
*          ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>lc_tumorvolume-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_tumorvolume-4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    1@  _^$#@&AT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@-RXR+6,P,# @-SDN9&5E,V$W-S S+" R,#(R+S X+S$X+3$V.C4P
M.C,P(" @(" @(" B/B \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N
M=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B \<F1F.D1E<V-R
M:7!T:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+VUM+R(@>&UL;G,Z<W12968](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B('AM;&YS.GAM
M<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(@>&UP34TZ3W)I9VEN
M86Q$;V-U;65N=$E$/2)U=6ED.F8X,S%A.&(T+3<U8C4M,S4T,BTX8S-F+6,U
M,S@R-31A,&5D92(@>&UP34TZ1&]C=6UE;G1)1#TB>&UP+F1I9#HS13E#1#$Q
M-#E!-$$Q,45&.30Q1D$X-T)&,T)#,4-#-2(@>&UP34TZ26YS=&%N8V5)1#TB
M>&UP+FEI9#HS13E#1#$Q,SE!-$$Q,45&.30Q1D$X-T)&,T)#,4-#-2(@>&UP
M.D-R96%T;W)4;V]L/2)!9&]B92!);&QU<W1R871O<B R-BXU("A-86-I;G1O
M<V@I(CX@/'AM<$U-.D1E<FEV961&<F]M('-T4F5F.FEN<W1A;F-E240](GAM
M<"YI:60Z-C$R9C-A.#(M-#8S."TT,3(Y+6$R-#0M9#)C,F-D9F0P,S4Q(B!S
M=%)E9CID;V-U;65N=$E$/2)X;7 N9&ED.C,X-#)A93<R+3-D8S<M-#DW82UA
M-C%D+3EA-C%B-F0X9F-E,R(O/B \+W)D9CI$97-C<FEP=&EO;CX@/"]R9&8Z
M4D1&/B \+W@Z>&UP;65T83X@/#]X<&%C:V5T(&5N9#TB<B(_/O_N  Y!9&]B
M90!DP     '_VP"$  0# P,# P0# P0&! ,$!@<%! 0%!P@&!@<&!@@*" D)
M"0D("@H,# P,# H,# T-# P1$1$1$104%!04%!04%!0!! 4%" <(#PH*#Q0.
M#@X4%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%/_  !$( P$'T@,!$0 "$0$#$0'_Q #<  $!  (# 0$!
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MGR&W(;8MZ[U:?Y-2MIUJN_1=%C[K?OWI_DZ:@>X
M
M      =#Y<LO])4O3I^_Q_= <D%UME3(D--6P33+U2..5CW+I[2*J@=L
M
M         \7*LMQK"++/D.67."TV:GT22JJ':)N=V-:U-7/<NG1K$5R^1 ->
MJWQX<,4M2^""WY!71,71M53T=*V)Z>RU)JN)^GV6(%PJG%W/7&O+R20XE<W)
M=H6=[/9ZUGH]:V---7HQ5<U[4UZNC<Y$\H,*6$
M                                        XY:B"!$6>5D2.Z-5[D;K
M]C4#B^4*#L]*AU7L^^-_Q@=E%14U3JB]B@
M                               ,8Y%S&CX^P:_YG7:.ALU'+4LC<NB2
M3Z;88M?_ )DBL8GV0/Y.,H\WIZ*'FY'KW?SA6*.[*Y%D6]1HEPW*W]G?K[.H
M;?UFX_S"AS_"K%F5NT2FO-'%5+&B[NZE<FDL2K[,<B.8OMH&&2
M
M                /Y2<%<-TG-O(%YQ2JNTEFBHJ*HN3:F&!*A7+%4PPHQ6N
M>S1%2;777R!NU4^7?!PG%>"7'D"R9C)65%C6*>6GGIDI'*Q\K(M8I63.T>US
MT5$TZ^SJ$RV,\(&?Y+R!Q$RKRJ>2MN-GN$]ICN,RJZ:I@ABAE8Z1R^Z<U)>[
M5W:NW5=7:J$J^!
M                         #^;_B8RC(.9>?Z?C"U3JVUVNOAQ^U4ZJO<I
M6S/8RIJ)$3RH]58J^1C$]L-1MAC?A*X.L5BAL];C<=ZJDCVU=TKI)5J9I%31
MST5CVI'KY$CTT^SU"902?P@<G8;S!#D7$=;24>.VVIAN%GN-UJG-='KUDII6
M0M?(]J>=&OFZ/C=HJ^Z"Y;U)KHF[W7ET[-0R_0
M                                       TV_\ <%_-K"?AU;[S&&HP
M7 _ ^_.,'L68Q9PE%)>Z"&O91+;%E2)T[$>C%D]*;KIKINV?L R\?&<OY-\(
M_+%-A68W%]PPJH6%]53)))-1R6ZH>K$K*5LG6.2-6NW-1$U5JM75-' [OZ-,
M>V1K7L<CF.1'-<U=45%ZHJ*@9?H
M                      --?'OR%Z%8[#QI12Z5%TD^5[JQJ]?1:=5CIVN3
MRM?+O=]F- U& U/(? #_  P,XBCO4RY3%2-N;)?D^IT^7MWI+F[U9MT5RNIM
M^NFSJ#U9]X">1/3K'?>,JZ;6HM;_ )7M#'+JOHE0Y&5#&IY&LEV/^S*H*W*#
M(
M                         !_)_A/%^4LLSZ\6[B6]?(>11TE1/557I4E%
MOHFU,371[XVO5=7NC7;IY-?(&ZI'*_"/BI9B57=<XO\ +D^.VICJVLH8KI-5
M)''"FYTRP2MC1VQNKE5$5434)F-E/")R3B&9\=KCF-V5F.U>+N9#76N*1T['
MI5;WLJ6R/\YW>N:_=NZHY/8VA*V$"
M                                        '\QK"JV/QF:79^UWSUJF
M+(_IJM762-B7K_E+(U0WZ/Z<AAC%QY%P2SY&W$;OD5!;\DDA94QVZKG9!*^*
M17-:K>\5J.55:OFHNOM 9,BHJ(J+JB]45 /T
M                                     --O_<%_-G"?AU;[S&&HV"X
M]2>!?U)1>]($K4S_ -P/N/G?ANW3TKY-J>\]GN^_39_P[PL;N8.LRX5C:U&O
MI"VNA[W=V[_1V;M?;U#+W@
M                 ?SX3"<F\0/BDENN48]<J? 6U;W+)74M32P.M%K;LACW
M/:S3TAS6[D:[761RH&O1M/\ JL\ ZZ_,FE_CZO\ #!,M4Y\)RCP]^)^*\8KC
MUSJL#2K9*U]#2U-7"EGN3=L\6YC7[EIU<_:CG:ZQM50OH_H8BZIJG8H9
M
M                     /Y2</<D9/PKG%URNW8S+=Y:VEJ+<M/4-G@:ULM1
M%-O16L5=4[K314\H;5S+O%]ROF^,W3%+-@?R?47BGDH9:N!E55S,AJ6K&](V
M=VU-ZM54:JZZ>P$PKW@RX9R3C?';UDN84C[=>LD=3LIK9,FV>"CI=ZHZ5O:U
M\CI%\Q>K4:FNBJJ(2UM"$
M                                -*/%[X><DN-_7E_CREEK*IS(W9!0
M4:.6KCFI6HV.L@:SSG>:UJ/1GG-5J.ZZN5IJ5BEB\>N<V>QLM.0XO27;(:5G
M<K='3R4>][/-W34[8W(K_P#*V.8FOD0&&*<7<:<A^)OE/Y_9O3R_-:6J957R
MZOC6&EEA@T1E%2(ONM6M;%YJKL;YSE5VFXO9_2QK6L:C6HC6M31K4Z(B)Y$#
M#]
M   #3;_W!?S:PGX=6^\QAJ,%P+QP.P?"+#AT>#I7/LE##0-K%N:Q)*L#$8CU
MC]$?MUTUTW*##S<?P_DWQ;\L4>;9A:9+5@M,L,51/W<D5(RW4SED]%IG2:++
M)(KG;GIKM5ZN71-&@[/Z*,8V-K6,:C6-1&M:U-$1$Z(B(@9?H
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M@2MH@@
M
M                                    >55XSC=PJ5K*^ST-55KU6HGI
MH9).G^<YJJ!ZC&,C:UD;4:QJ(C6M31$1.Q$1 /T
M                                         ''+3P3HB3Q,E1O5J/:C
MM/L:@<:6^@145*6%%3JBI&WM_P  '8
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M3M V<"
M
M
M
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M!:L@1%/$S^:V(?7/'_C*A8M80
M
M
M
M
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MV6Z6>7&\YQR3NKS8YWJ_:F]T:O8KFL=YKVJU[7-U8NG;J"Q8@@
M
M
M
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M"*C(,HI*.BN]-<ZRVRPV[O$I]*16MU3O7R+KJJ]=P*J(0
M^)IH:>)TU1(V*%B:ODD<C6HGMJO1 /FGJJ:KC[VDFCGBU5N^)R/;JG:FK55
M.4#K/N%!'4I1OJH6U;E1&T[I&I(JNZIHU5UZ@=D
M
M
M                                       (IXF?S6Q#ZYX_\94+%K"
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MU4]"MZ)K)-*L>Y6*B>?YR>X:Y=.P&%+RC\V;S\!JO>7!$6\&/J!L7PJX_&Y
MM>CR[RYD-#D=+Q'Q/3P5W)UT@6IJ:VK>UM#9J'3K4U"NU17Z><R-47R*K7;F
MM>'N\0<5XYQE254ZW/Y?SJ^/[_(LFJWH^KK)U7<K6ZN<K8T7W+-5]E5505*O
M#-8['BW+/,5AN4<,6<1WAT])WJ(E0^S5$DD\3H=W78[>Q\FWV6;OVH*].GBH
M)/&A)+B",3NL5=\]W4VG=K4NF7NDF5.G>Z>CKUZZ(GL*#T;)A
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MHG1-JMW.54#-C9 (
M
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MZDD3MVZ:^V"J@$
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M6R=]7U<CWU%74RIKHZ::57/=IJNB:Z)JNB)JH1F
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M=3*D2K<(Y//[Y7*C=VY=5Z;6H@2MQ R
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MTQLG]ITGX4#(*"X6^ZT<5PM=5#74$Z*Z"JII&S0O1%5%5KV*K5ZIIT4#L@
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MBO77RK[ $@YLP?DSBSC.]YW0<P9+<*NU^BI'23K$R-_I-7#3KJYO5-$D5W[
M(VHL\DDUIH)IG*^62FA?(]W:YSF(JJOV5".Z
M                                     $4\3/YK8A]<\?\ C*A8M80
M
M                          ('X1?5I=_K+=_?6A:O@0
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M1-/]FJ/^&LG!5A"
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MQ6/^9;;\%@][:$=\
M                 (IXF?S6Q#ZYX_\ &5"Q:P@
M
M      0/PB^K2[_66[^^M"U? @
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M>%?U 83\%J/CDX6K"$
M         'XJHB*JKHB=550(CS_A-9R+:+#=L#R6@M6>8C<$NECJ*B>/N7NV
MZ/C<JH]$55:QR;FN:NW:Y-':H6(W;N!,^LW$=]L%%E=K3D+/[U!+F5>RJB6%
MMF5LR21ND<B.<O>2NDD[MJ*[<K$U355+EMOAF/6_$L2L>,6J7O[=:*&GH::H
M715E9!$UB2+IJFK]-RZ>R&7N         (=XP/[O&7_9MOY3I0L6*Q_S+;?@
ML'O;0CO@
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M&JAI$>O9YJS.;K^P!Z%'64=PIHJV@J(ZJCF3=#40/;+$]OLM<U514^P!S@
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M9;L!D        \G*/S9O/P&J]Y<!-/"OZ@,)^"U'QR<+5A"
M                                      #JW*.&:W5<-3)W-/)!(R:7
MIYC',5'.Z^PG4#^?Z<$>%/3UT?\ W=+]P&LT_0/X4_\ ?1__ %*7[@&:WGX_
MM]HM."8S:[!7?*=BHK514ULN.J+Z32Q4[&12ZM1$\]B([I[(99&
MAWC _N\9?]FV_E.E"Q8K'_,MM^"P>]M".^
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M6;M7NT35VSIJW4*SSCO%;!S7R_R?EO(M&R_P8I=G8SCEHKT[ZAI:>D5[9'I
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M5XH?E2WT&04$])#17:)\;)60*]9&-;*U[G;4?KYJ)IHT)6U00
M  !^*J-17*NB)U5?:0#$;9RGQU>KC#:+3DU!672H<C(:.&9KY7.5%5$VIU35
M$734#+P                          @?A%]6EW^LMW]]:%J^!
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MA7]0&$_!:CXY.%JPA
M        !Q5$$553RTLR:PSL='(B+IJUZ;5ZI[2@:PYWX;O"SQKC=3E67T%3
M16FF5K$=Z?6/EEF?KLBB8V35[W:+HB>355T1%5"YJ1X[;O!K?<>N>5U6,7RT
MX_;;E16A]55UDSGNDN#97,D[N&I>NUC87.?IJ[3L10O5O5C%LL]EQNSVC'E1
M;!045/2VM6R+,U:2&)K(521557IL1/.UZ]H9>J         AWC _N\9?]FV_
ME.E"Q8K'_,MM^"P>]M".^
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MO=KJUT[MJ:N9[+NJ[D:P*V$               ,"QGUI9]\%L7O54%9Z$
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M7 33PK^H#"?@M1\<G"U80@
M              :Q^,BG?26W ,NNEK?>\'QR_P =3D]L8FYLD$FQ&*]J^;M5
M&OC\[S=7HU?=!8@62<S\57*DYHH**W271N<2VSYG4*4:0MAGIZ/N._T_YMT+
MW:MV^<_33L<H7#>7B&S77'N+<-L=[8Z.[6^ST-/60O\ =121P-18UU\K/<+]
M@,LT         0[Q@?W>,O\ LVW\ITH6+%8_YEMOP6#WMH1WP
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MEYFQ3.K?B%CL]%>:>L^=MBG22XVJJHH-L=3U3O9F-;KUZ)VJ"-K0@
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M-6]5"MM R        >3E'YLWGX#5>\N FGA7]0&$_!:CXY.%JPA
M                                            CWB*Y7=QAB%+!;K+
M'D62Y14_)%FLT\:S0322-\Y98F]9&]6M[MO5SG(GLA8G/)]-;^#\>Q?E/"^)
M;,ZO1\55ENE$QLEN9)$Q5;$]CG>CN[U^U)&-<UNFB].T-DL8R&WY9CEIRBTN
M<ZV7BD@KZ17IM>D53&DC4<G71R(NBI[(1ZH        "'>,#^[QE_P!FV_E.
ME"Q8K'_,MM^"P>]M".^
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MVN5.FKO:4%;F!E%?$PJIBV(:>7,\?U_&5"Q:@@
M                                     8%C/K2S[X-8O>JH*ST(
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MZBLZ_JQ_[M@6,LXT]7&'_P!26WXI&$90
M                 :B\VY%'PWXDL?Y<RJS3W;"Z^RK:(:N"-DDE'6,?(KN[
M1ZM;O1JHJ(KF[FO?M]RH:C$>5N9,>\2>28)@/&-CK:F[TUZI[C/>:R!D+Z>G
MB14D1NQ[W)&B.[V5R[4\QNFJ]@QAO0&0       #R<H_-F\_ :KWEP$T\*_J
M PGX+4?')PM6$(
M      $'\3V!9IDMFQG,^.XDJ\QP2Z-N]%;U1'+/'YJO1C55$>YKHXW;-?.;
MN1/.T12Q#LHYH\0_--CJ^+;5QE-9ZN\M2BNM?)!5L9'"YR=YJZI8QD+5TT<Y
M[G=-=.N@7#<7C_%OF1@^.XAWWI+[);Z:ADJ$31))((VM>]$7L1SD543V RR0
M        !#O&!_=XR_[-M_*=*%BQ6/\ F6V_!8/>VA'?
M                                !"O%+RSE/%V'6N+!XD=EF25[;;03
MK$DZPIM5SG1QN16ND<NQC$<BIU5=.@6(;'8?_<!EC;+Z=,S>F[8ZJLC7)KUT
M5->GV O1LAX?Z+F*AP^NBYLF=/E#KE*ZC<Z2EE5*!8(48FM)YG[XDO1>O_ $
MJKA #H4MCLE%7U%THK;2TUSJM4JJV&"..>7<J.7?(UJ.=JJ(JZJ!Q7W&L=RB
ME2AR6T45XHFNWMI[A3Q54:.]E&RM<B*!V+9:;79**.VV:AI[=;X?WJDHXF4\
M+-?\ED:-:G[" =*_8CBF5,BCR>QV^],@76!MQI8:M&*OE;WK7:?L >E1T5';
MJ6*AM]/%244#=D-- QL43&IY&L:B(B?80#G BGB9_-;$/KGC_P 94+%K"
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MP        'DY1^;-Y^ U7O+@)IX5_4!A/P6H^.3A:L(0
M                                   ?CG-8U7O5&L:BJYRKHB(G:JJ!
MU+;=K5>:?TRSUU/<*1'*Q9Z25D\>]NFK=T:JFJ:]@'<           $.\8']
MWC+_ +-M_*=*%BQ6/^9;;\%@][:$=\
M                  &MGC6O>/V?BVA2XP329))=8)<6J*9Z124M=3-=(M0K
MM%\QK-6JWRJYO9IN0L2:T^*+Q4QT$+9^-ENCD8U$KELEU8Z7I[I>Y>UFJ_YC
M43V@N(V8X#S_ #[D7$*Z]<B8[\VKS3W&2DIZ'T:IH]]*R"&1LNRJ<YZZN>]N
MJ+IYH2JH$        (IXF?S6Q#ZYX_\ &5"Q:P@
M                                      8%C/K2S[X-8O>JH*ST(
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M_OK0M7P(        2OQ)^HK.OZL?^[8%C+.-/5QA_P#4EM^*1A&4
M       :N9)X&>-K]ET^0TMUK[5:*R=:FJL=*V)8D<]VY[8)'(JQL5>QNUVW
MR=-$0N6REELULQVT4-ALM,VDM-M@CI**F9KMCAA:C6MU755Z)VKU7RA'?
M                       "8>(C*+]A?#64Y-C%8MOOM!'3.I*QK&2+&LE9
M!$[1LC7-75KW)U0+'[Q?R=8+KQQB=SR;*K8_(:VTT51='35E+#*M5+ UTBO8
MUS4:[<JZMVIHO30#+HLZPB:1D,.2VJ2:1R,CC974SG.<Y=$1$1^JJJ]@1D
M       #R<H_-F\_ :KWEP$T\*_J PGX+4?')PM6$(
M                                 .A?4ULER1>ST6?WMP&@7AR\4N#\
M-\?28E?[1=*VX27&HKEFH&4SH=DT<3&HJRS1NW)W?7S0U8KGZ_G%WT=O_P#%
MT7\J!ALSBN0TF6XS9LJH(Y(J&]T--<J:*9$25D57$V5K7HU7)N1'==%4,O7
M        0[Q@?W>,O^S;?RG2A8L5C_F6V_!8/>VA'?
M                              !K)XV;A9K1@..W>KCE7(;?>X*K'9HV
MLD@;50-=(]E2U[D58GL:ON>NY&^34+&%TG_N#61:6%:["*IM;M3OT@KHW1;_
M "[5=$BZ?90+AL'P?S'0\VXK6Y3;[7+:8:.X26UU-/*R9SG1PPS;T5B-T14F
M1--/($L4P(        13Q,_FMB'USQ_XRH6+6$
M                                     # L9]:6??!K%[U5!6>A
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MRC\V;S\!JO>7 33PK^H#"?@M1\<G"U80@
M                        Z=VADJ+5700MWS2T\K(V)VJYS%1$Z^RH&O/A
M=X69CG&DENY-PVA9D?RG4RL2Y4M)5SK3.CB1B[])/-U1VB;@MJT_HTXX^A]D
M_LVD_!A&24U-345-#1T<+*>DIV-B@IX6I'''&Q-K6M:U$1&HB:(B <H
M   "'>,#^[QE_P!FV_E.E"Q8K'_,MM^"P>]M".^
M                           "8<[<EX7Q9AT>0YC:V7M):EM-:[4Z.*1T
MU4YCG=%E1S6-:QKE<_3IV=55$"QJHOC7P[5=.'+;IY/]KI__  \+ALWX<^4K
M;RUA=?D5KQF#%:>EN<M Z@II&2LD?'!!*LNK(8$U5)4;[G]KVA*KX0
M  BGB9_-;$/KGC_QE0L6L(
M                  PC,N3[5A%PI;?<[/>JM:UT4-+56VW2U=/)45#G-C@2
M1G3O%VKYH&5VJX)=;;2W)M-44:54;94I:V)8*F/<FNV2->K7)Y4 [@&!8SZT
ML^^#6+WJJ"L]"          !_.JBOO/V8<I9]F?A\M4]JM51<G07*&D6E;2S
M2P*YK99F5[NZ=/(FLDFQNJ*]?9U4TIV!U?CC=FN/-S.*5,26XTJ7Q71V-$]!
M[UO?ZK G>>XU]QYWL Z-QPR           "!^$7U:7?ZRW?WUH6KX$
M  )7XD_45G7]6/\ W; L99QIZN,/_J2V_%(PC*              %1%145-4
M7HJ*!IKDW@'M-SR^:Y6#*%M6)U<[IY+6ZE[ZHIVO=N6*"3O&M5O71BO;JU--
M=WE-9;9XOC5IP[';9BUBA6"T6FGCI*2-5W.V1IIJYWE<Y?.<OE5=0R]<
M                      .K<+;;KO1RVZZTD-=;YT1)Z2JC9-"]&JCD1S'H
MK5T5$7J@')24E+04T-%0P1TU'3L;%!3PL;'%'&Q-&M8UJ(C41.Q$ Y@
M    #R<H_-F\_ :KWEP$T\*_J PGX+4?')PM6$(
M                               '3NMTM]CM=;>KM.VEM=N@DJZVI?KL
MB@@8KY'NT15T:U%4#J8QE%@S.R4V28O71W*QUG>>C5L.Y&/[J1T3]-R(O1['
M-[/(!ZX         !#O&!_=XR_[-M_*=*%BQ6/\ F6V_!8/>VA'?
M                                        !KAXS;';*GCFU9975-*R
M?%;O3UU/;J]RI#<FOU;)1HB(JJ][4W=GN6N\G5"QY-L\:W \M# M5:[C;YT8
MU'TGH$$C8U1.K6NCDT5J>1=$^P@,+5Q3R?AW+&/U60X2R9EKI:Q]#,E3 E,_
MOV11RKHU%75-LC>H1G8        "*>)G\UL0^N>/_&5"Q:P@
M                                           "?<K>YPKZV6G]U(%B
M@A # L9]:6??!K%[U5!6>A           _GM1<O<L\4<C9XN"8!,N+7F\5%1
M):JBCKJF!*J-[HWU-/+&D:M2;3>K?.:B:(WHB!K"DX/XI^9LDS/'\>NW&WR?
M:[K<:6BK*[T:X,[B"HF;&^3<]-J;6JKO.Z>R##< ,@           @?A%]6E
MW^LMW]]:%J^!        "5^)/U%9U_5C_P!VP+&6<:>KC#_ZDMOQ2,(R@
M                                          UD\3G/MKQ_!:NEXVS:
MC@SJBN<--4TM%+#-5L9&LC)V.C>C]-KD1'=.@618^/\ D_",WIJ6W6')J"]W
M^&ABJKA3TD[)9FZ-8V1[FM[$WN1%Z=%4(S@        !Y.4?FS>?@-5[RX":
M>%?U 83\%J/CDX6K"$
M          #6+Q)\B<Q6B#+,4Q[ _E7 :FQSQUN2[9E[F*II7MJ7ZM<C?O35
M5>J>3J%C!_"MR)S%2X[A6&T.!^D<;OJ*B)^6;9ND,M5/)+)KNV>9(KF=GD]D
M+6ZH9         $.\8']WC+_ +-M_*=*%BQ6/^9;;\%@][:$=\
M                )G/X@N'J6>6FGR>)D\+W1RL6GJU5KV+HJ=(?(J!<./\
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MU'OW:?M]G=_L: 9V$        (IXF?S6Q#ZYX_\ &5"Q:P@
M                                          "?<K>YPKZV6G]U(%B@
MA # L9]:6??!K%[U5!6>A           TTR3G#Q>4&17BALO''I5GI:VIAM]
M3\B7&3O::*5S8G[VSHUVYB(NJ)HH:Q'6X_\ $?XD+_R?C^"9)B-);TKJFGDN
ME-+;:NBK&6QTS63U#$J:A.C&JKM4:[L[.@,-U R           "!^$7U:7?Z
MRW?WUH6KX$        )7XD_45G7]6/\ W; L99QIZN,/_J2V_%(PC*
M                                       #4+Q0>&_%&X=7Y1QSA]76
MY]<;LRHJY*!];6S/;5/DDJ']QWDC417+UVLZ>31 U*MG%'"''/&J09!BUA6T
MY%76Z.EN,SZBJF>K9.[ED8K)Y7M:O>,15VM3L"95$(        >3E'YLWGX#
M5>\N FGA7]0&$_!:CXY.%JPA
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M        BGB9_-;$/KGC_P 94+%K"
M                         )]RM[G"OK9:?W4@6*"$ ,"QGUI9]\&L7O54
M%9Z$          #5^^^.7C6P7RY6*JL%\DJ;75ST4TD4=(L;GTTCHG.;NJ47
M15;TU0+A*\EY]3GOE_BFBXZL-9;[A8KRVI?752L6=:>62+TAJMA5R-A2&-[I
M=7=4\GLEPWT#(           ('X1?5I=_K+=_?6A:O@0        E?B3]16=
M?U8_]VP+&6<:>KC#_P"I+;\4C",H
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MFYW35=K4U4,O3         0[Q@?W>,O^S;?RG2A8L5C_ )EMOP6#WMH1WP
M                          ,1S^OJZ2WT\-,]T;*A[DF>WHNC4U1NJ>SK
M_P !Z?R_CUVWMOH\GYER;:Z23U>!@%94PW1+?&Y5HI6/5T7:UJM\Y'(GDZ]/
MV3N^?QZ_E^[UCH?+>7;\SVYZ533Y]]*               ?+V,E8Z.1J/C>B
MM>QR(K5:J:*BHO:B@:V<C^"WCG+ZZ2]XE53X7>Y'+(Y*%B2T"R+UW)3JYBQK
MKY(I&M_S0N4[3P9<O*[T5_*\B6WW*Z/KU7;K_JEF1O[&X+E3.-O!IQEA59%>
M<CDFS*^QN21LER:UE$V1.NY*5%<CEU_UKWI[6H3+8QK6L:UC&HUC41&M1-$1
M$[$1 C]        BGB9_-;$/KGC_ ,94+%K"
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M!D        \G*/S9O/P&J]Y<!-/"OZ@,)^"U'QR<+5A"
M                                    !J_RIXS,=PS):K#L+L,V7WJA
MD=3ULT<W<4C)V*J/C8K8Y7RN8J:.T:C=>Q5"X2;BOG'A>S\K1Y+DG'<O'V2W
M#O('W:FJYGVYBU7FN?+1R,A;"U?VSXVJB+YRHG50N&_"*CD1S5U1>J*G9H&7
MZ         AWC _N\9?]FV_E.E"Q8K'_ #+;?@L'O;0CO@
M              =6OM])<Z9U)6QI+"[KIV*BIV*BIU13DX^3;2YU[N+DXM>3
M7V[3,3S@>J6^<<6C**R-ORO<O2DJIFHO5(*N:%J(BZZ)M8WL\IR<OD;\O]5<
M?#XW'P_TQ33KNR                "JB)JO8!C5%R'@5RKZZUV_)[55W"V0
M25EQIH*V"5]-30JB22RHUZ[&,5R;G.T1->H&1QR1S1LEB>DD4B(YCVJCFN:Y
M-45%3HJ*@'T         BGB9_-;$/KGC_P 94+%K"
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M\V;S\!JO>7 33PK^H#"?@M1\<G"U80@
M                      ZMSG?2VVLJ8_WR&"61G^DQBJG_ ! :I^!YF)6O
MC>Z9%7U%%3Y/<[M41U=;4RQ,JGT\4<2L9J]4=LW.>[VU50U66>+I,,R/@^_U
M#ZJ@K+Q:G4M5:I&2PR5$4JU<,;^[T<KO.C>]KD3R?8"16.(ZJ>MXJP>LJGK)
M4SV"UR2R+VN>ZCB557[*A&9         (=XP/[O&7_9MOY3I0L6*Q_S+;?@L
M'O;0CO@                             )7X;_4OC/_;_ ,H5(6JH$
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M>30QRNIYF2*U&HYT4C41'Z:N1W7JFJDK9D(BGB9_-;$/KGC_ ,94+%K"
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M,E.NZ*)M4LZIV;6VV.-=?L/5 >AX'VN@Y$Y2I:I?]M:Z%'HONM8ZNI:__A5
M4\,Z23^*_ENK@=K1HZ]H]R>Y57WF)6?N7 O9LSFV#Y_D5X97XQR-68G;FP,B
M=;*:W458QTK7.5TO>5#5=JY%1-.SH$1/F3!N0<>MV(U^3<DUN4VWYVV*/Y+J
M+;0T<?>.JO-?WE.U'ZMT7IV C:X(
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M^HK.OZL?^[8%C+.-/5QA_P#4EM^*1A&4
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M1JN54Z>:$M6T(BGB9_-;$/KGC_QE0L6L(
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M -VP+&6<:>KC#_ZDMOQ2,(R@
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M^65^B;GNT1/81$1$1$1$",I AWC _N\9?]FV_E.E"Q8K'_,MM^"P>]M".^
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MC_QE0L6L(
M     GW*WN<*^MEI_=2!8H(1"'__ (:>9TC3[]QKQ15:O[5AK\NV]$]AS:!K
MO:5)%\K7!6=8SZTL^^#6+WJJ ST(          &M-@\&. ?.B[9?GM5/DM?<
M[A4W!EN174M!$E1.^5K7HQRR2JFY-55[6KY6A<MA[-9+-CMOAM-@M]/;+7 F
MD-'1Q,@A8GM,8B($=\            ('X1?5I=_K+=_?6A:O@0        E?
MB3]16=?U8_\ =L"QEG&GJXP_^I+;\4C",H
M                  ?CFHY%:Y$5JIHJ+U144#6_-/!-Q#E5TFNUL?7XU+4/
M62:DMDD7H>YW559%-&_9JO[5CD:GD:%RS7B7PX<:\.U#[ICU-/7Y#(Q8EO-S
M>V:H9&[W38D8QC(T7L56LW*G155 95P(  /#O6&8ED=PMUVO]DHKG<[0]);7
M5U=/'--32(YKT=$YZ*K%W-:[5OE1 /K),/Q7,:6&BRRS4=ZI*>3OX(+A!'4L
M9+HK=[6R(J(NBJFH')D6+XYEUK?9,GM=+=[3(K7.HZR)LT6]GN7(CD71R:]'
M)U0#@Q7"L2P>A?;<0LM'9:*5_>3144+8>\?V;GJU-7+ITU<J@>Z!Y.4?FS>?
M@-5[RX":>%?U 83\%J/CDX6K"$                      )Q:O7OE'U7L?
MQZZ 4< !B&2UW)]/<DCQ&RV2OM/=M59[G<ZFBG[U57<G=PT50W:B::+O_8 \
M?Y5YW^B^+_VY7?\ A8'!5S\W7*EEH:O&L993U#58^2.^5RO:B_MD1;7HNG;H
M<G'O[-IM\''R\<Y-+K?5TY\'RQ(I4I*:EDJF-58DGJ%A@D>G8BO9'*]J+[/=
MK]@]W?S^.:YG?X/G=/EO)=L;=OB]/Y4YV3HW%\71J=B?+E=V?V6?//ICY5YW
M^B^+_P!N5W_A8&28I59U4MJOGK;+7;7-5GH26FNGKT>B[M_>=]2TVW3S=NF[
M7KV:=0R, !.+5Z]\H^J]C^/70"C@             X*ZL@MU%4W"J=LI:2)\
M\[^W2.)JN<O["(!@5HYPXWN^.XSDZ71U';<PJW6['TJX)62U%6R9:=8T:UKM
M%[QJMU<NGMA<*($          "'>,#^[QE_V;;^4Z4+%BL?\RVWX+![VT([X
M                      "<<*?FQ>OK1DWY9J@*.     $K\-_J7QG_ +?^
M4*D+54"     E_AV]3.*_P %4_')@M5 (         -?O%W9LTR+CRWV;"<<
M=D%QEN<4SI((WR55 M.Q[XZF!S'MV/1WF;EU3:Y4TZA8BM)R7XZ*6EBIGXM4
M5+HFHQ:B>TQK*_3IN<K%:FJ^TU O1LIX?[_ROD>'UU;S!;76O)([E)#20.ID
MI%=1)!"YC]B*NNKW2)K[02JN$        (IXF?S6Q#ZYX_\ &5"Q:P@
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MX$        )7XD_45G7]6/\ W; L99QIZN,/_J2V_%(PC*
M                              $[YSY#N/%7&-YSFTT<5?<+<ZD;#3U.
M_N%])JHH'*_8K7:(UZZ:+VZ!8G]!XM>/ZC-K1B\]=;66*OLT=TK,H]/1E-35
MKMVZC=%)$BH]-J>ZD1>ON084*FYVX;K:F&CI,YLTU542,A@A961.>^21R-:U
M$1>JJJZ PH00        \G*/S9O/P&J]Y<!-/"OZ@,)^"U'QR<+5A"
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MC@    !*_#?ZE\9_[?\ E"I"U5 @    )?X=O4SBO\%4_')@M5 (
M )#X@Z[FJAQRU2<(P.GOSJ[;<6MBI)52D[EZZZ5?FIY^WW/4+&MUQS'Q\6NB
MFN%9;JCT:G8Z258;?::AZ,8FJJC(6/>O1/(T+T;#>%[+^0\[XT7*>1*R"OK*
M^NE=::JF2E:UU V*)J(YM*B(U[9DF:YKT1Z:=>F@2K2$        (IXF?S6Q
M#ZYX_P#&5"Q:P@
M         "=\MS0P0X;+/*R&)F56M[WRO;&U&L65SEU<J)T1%4+&'<3PS<J9
MU=.=[HQWR! DMAXWI945-ENB>K:JX;53H^JD16M71')&BM75- +J$8%C/K2S
M[X-8O>JH*ST(          &AMYX6\6%%R3D^:X2D=HDO%9.Y9[?6T-&RHIN^
M<L+IH6N:QSMJHJJ]F[755ZJH:S&8X+C?C9I<QQZ7+[LLN)PW"E=>XW55L>KJ
M%LK5G1=C=ZZLW>YZ@Z-P0R           "!^$7U:7?ZRW?WUH6KX$
M )7XD_45G7]6/_=L"QEG&GJXP_\ J2V_%(PC*               .I-=+93U
MD-NJ*V"*X5":T]))*QLTB=>K&*NYW8O8@';
M  !YN08_9LJLM;CN0T<=PLMQB6"LHY==DD;O)JBHJ*BIJCFJBHO5%U U"Y&\
M,? '&U^@S'+KPMFXY6E=3?-YTM3-75%RU<Y'P2-<Z1R(U6ZL1JZ::JJ(H:R^
MN)>/_!UR!D--%A$U>W)[?(RNI;?75-533/6F<DB.C;)YLB)MU<UCE5$ZJF@+
MEN:&0       #R<H_-F\_ :KWEP$T\*_J PGX+4?')PM6$(
M         3BU>O?*/JO8_CUT HX            3BU>O?*/JO8_CUT HX
M           &N?BXR')66;#^.,7KUM-5R#>8[/57)'.9LIU=&Q6*]NBM:]TS
M%?HNJM:K>Q5"Q)^1O"10\/X35<F8'F-RI\LQ6-MP6:H[F*.3NW(C^Z6)K71N
MT7S6N<]'>Y7MU"Y;=<9Y/4YIQ[C&65L;8JV\6REK*J-G1B32Q-63:G^3NUT]
MH,LJ         0[Q@?W>,O\ LVW\ITH6+%8_YEMOP6#WMH1WP
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M$S^:V(?7/'_C*A8M80
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MM1#%/(]D2/B6=$?"Z-\D?>L]PYCM>KM%0=V[X9           ! _"+ZM+O\
M66[^^M"U? @       !*_$GZBLZ_JQ_[M@6,LXT]7&'_ -26WXI&$90
M        #BJ7S1TTTE/'WL[&.=%%KIO>B*J-U\FJ] /XPY+DF29#DU=DF0UD
M\N25-2Z>IJ)'.;+'.C]=K=5U8C%31K4TVHB(FF@<C^L'!%]OV3</X??<G<^2
M]UENC?4SR_ODR-5S(YG:]JR,:V15\NNH8JAA
M   -0.7[=BV5>+3%<<Y4F8S"X;$DUGHZJ58:.HK9))O-D=JU$WO9HJ:IO5C&
MKKKHIKT>7XC,.XPX_P DXYNO%]-267DA<@HV06ZSJC5FI%=[N2&-=$^^=VQJ
MZ)O1[D7=Y!&Z89        /)RC\V;S\!JO>7 33PK^H#"?@M1\<G"U80@
M                  !.+5Z]\H^J]C^/70"C@           !.+5Z]\H^J]C
M^/70"C@              2_G;ARCYGPYMB6L6UWVWSMK[)<T17)#4L:K=KT:
MJ+L>BZ+M75%T=UVZ*65KS)X>/%%R!Z/B7*.>Q+@D$C'5;HJEU3+.R)R*FC$A
MC=*[RM6H=T7SNJH%S&Y%EL]OQZSV^PVJ)(+7:Z:&BHH4Z[(*=B1L;K[36H&7
M>         0[Q@?W>,O^S;?RG2A8L5C_ )EMOP6#WMH1WP
M        $XX4_-B]?6C)ORS5 4<    8KG5JK+C002T;%E=3/<Y\+$U<K7(B
M:HB=NFG8>EX'+KIM9MZO*^8\.W)I+KUPQSCNBEK:ME\IU1UL:Q[8ZAJZLE<N
MK%1JIT714754\J:'<\[GTNGMES:Z7R_Q]YR>ZRR3XJ:>"^B    !+_#MZF<5
M_@JGXY,%JH!        #S<@NOR%8+K?.Z](^3*.HK>X1VSO/1XG2;=VBZ:[=
M-= -+*GQ_P!)6-:RLXUCJ&-7<ULMT:]$7LU1'4*AK#KIX\+*BHJ<5TJ*G5%2
MXQ]%3_L ,-F> ^9?TX8C795\C?(?H=QDMGHOI/I>_NH(9N\W]U%IKWVFFWR=
MH2Q5 @       !%/$S^:V(?7/'_C*A8M80
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MU#F1I)+,Z&-B,8WS6ZK[*@[-[0R           "!^$7U:7?ZRW?WUH6KX$
M      )7XD_45G7]6/\ W; L99QIZN,/_J2V_%(PC*               )%D
M/ACX5RC*GYC>,:9)=II5J*R.*::&EJ9E7<LDL,;VL<Y5ZNZ)N7W6H7*M0PPT
MT,=/3QMAIX6MCBBC:C&,8Q-&M:U-$1$1-$1 C[
M     !-.8N#<*YJM5-19,R6FN5 KUMMWHU:VI@[S3<WSD<U[':)JUR?85%ZA
M<L$XH\(''O&&1P99+6U>0WNA=OMKJU(XZ>GDTT21L3$\Z1-?-<YRHWM1-R(H
M,MA@@       !Y.4?FS>?@-5[RX":>%?U 83\%J/CDX6K"$
M         )Q:O7OE'U7L?QZZ 4<            )Q:O7OE'U7L?QZZ 4<
M                        $.\8']WC+_LVW\ITH6+%8_YEMOP6#WMH1WP
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MZJD<>NC4]ERN52.ORM[G"OK9:?W4@6*"$ ,"QGUI9]\&L7O54%9Z$
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M?^[8%C*^,UUXXP]4[%LEM^*1!&4@
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M$]S57M3<WN]?98H*VD"        $4\3/YK8A]<\?^,J%BUA
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MHUC41K6M31$1.B(B(!^@
M    &@WBHLWB*I<=O-?G-_M]9QB^]:VNVT[8$J61OEE6D1RLIHW^8SH[65?;
MU#47[@*S>(FWUR5'*]^M]TPV2TL2T4M&V!)HZA70K$KEBIH55$B1[5U>[K_A
M"5>P@       !Y.4?FS>?@-5[RX":>%?U 83\%J/CDX6K"$
M         )Q:O7OE'U7L?QZZ 4<            )Q:O7OE'U7L?QZZ 4<
M           #6#Q*XYXA:R+*KOB&3T-#Q9%8YW7.SS=VE3)!%32+6-;K2R+J
M]FJ-^_)^P%C!_"MCGB%EL.%7JW9/0Q<.)45#I+$[NUJ_1VU,[9F_]%5VKID>
MY/O_ )?)V!:W7#(         AWC _N\9?]FV_E.E"Q8K'_,MM^"P>]M".^
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MBCZ;G(OGNZJJ]JE54( 3[E;W.%?6RT_NI L4$( 8%C/K2S[X-8O>JH*ST(
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M?G2E3&_=2I,Z9K-J2]ZYC7N5[6]PC^C6ZHB!>BO\X^'.IR[C#$\<P*H9!D6
M,B98G5+N[2>*.)D<C'/3HR1ZQ,D1R]-S=%TUW(25B-BXLYSY:Y8Q7/.;[708
M_9L+;%)2T%'+%*ZKJJ=_?-<C8IIT3?*C72*YR)M:C6M\H5[/+/$G*=AYFI>=
MN&:2DO%TGIVTUZL-9(R#O'-A2F5R*^2)KF.C1G3O$<U[$7SD71"/4\.W#N<X
M[EN6<N<J)3P9QE2NC9;J5[96TM/+*DTJ.<QSV]7,C:QK7NVM9U<JKT%K8P(
M0/PB^K2[_66[^^M"U? @       !Q3U-/2QK-52LAA3MDD<C&I^RNB&M=;M<
M298WWUTF=KB/J*6*>-LL+VR1/35KV*CFJGM*G0EEEQ5UVFTS+F/LC0
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M<L;T:]CT147:Y$Z*B]BH$9&!%/$S^:V(?7/'_C*A8M80
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M='HJ*W4"W!        #R<H_-F\_ :KWEP$T\*_J PGX+4?')PM6$(
M               3BU>O?*/JO8_CUT HX            3BU>O?*/JO8_CUT
M HX              &$\L7QV/X747!]=-:K>ZJH:6ZW>F5$GHJ"KJHH*BH8J
MM=M5C'KY^U=GN_VH&.7OC;@5<9^5:RAM%MMM*CJVGRNFFCIJZ"9/OGI4=R8[
MON]1R(_>LJJJHFNH5F7'-VK[[@>.WFY.=)65U!!.Z>1O=OF:]B*R9S-$VNE9
MMD<W1-%=H$9.         AWC _N\9?\ 9MOY3I0L6*Q_S+;?@L'O;0CO@
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MV^H@C;TU3INU"X;8!D
M    $T\0'JCR+_L7QZG"Q2PCPLQS#'L"QRNRK**QM%9K>SO)I7=7.<O1L<;>
MUSWKYK6IVJ!+N/,2R#D+)*?F?E&C=23Q-=\PL0FZML]'+U]*J&KT6MF1$5=4
M^]IHG:B)&5;@@   3[E;W.%?6RT_NI L4$( 8%C/K2S[X-8O>JH*ST(
M     $9N6'^%R>XUDMVH\.==9)Y75RU$M"DZU#GJLG>;GZ[]VN[7KJ%ZH7GD
MG"/'O-7%UVXFALU?<:^Y-MU]M-M=#<*5M//-#'#.U&K(V&IC>Y7Q.8K7*K4\
MB=2MV@R           "!^$7U:7?ZRW?WUH6KX$        .A=++:[U$V&YTS
M:AC%U8JZM<U5[='-5%37[)R\?-OQW.MPZW/XW'SS&\RY+=;*"TTR4EN@;3TZ
M+KM;KU5?*JKJJK[:DY.3;>YVN:UP\&G#K[=)B.V<;G
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M@6$^&+PW9*ZAY%QBBGN^.USG55OH9YYUMJJR1S%^\3-;(K6N:J;)7*G3145
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M,_FMB'USQ_XRH6+6$
M   !-/$!ZH\B_P"Q?'J<+&>7N]VG&[16WZ^U<=!9[?$ZHK*R9=K(XV)JJKY5
M]A$3JJ]$ZA$3Q*PW7G+)*'E3.:22CX^M4GI''F)52:+,[]K=JZ/L5[TZT[%Z
M,;U3MW/*O80    $^Y6]SA7ULM/[J0+%!" &!8SZTL^^#6+WJJ"L]"
M    !I/8_#-PMS'E&9W"R9-D#*^V7BIBO4,D%/!''6332N>R)7PKN:US7)_@
M#67M6[A3@?PZ<AX779!67F[Y#?J[T7&'5387T,%8U\422RI$R/16.G8K5<JH
MGND35NJ#.6WP9           ! _"+ZM+O]9;O[ZT+5\"
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M7>         0[Q@?W>,O^S;?RG2A8L5C_F6V_!8/>VA'?
M        3CA3\V+U]:,F_+-4!1P            E_AV]3.*_P53\<F"U4 @
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MS:R91F>;?+5#9*F&NCHV0RK)+)3R)*R-9)I7;6*YJ*[1%54Z=-=4&6X89
M        ! _"+ZM+O]9;O[ZT+5\"
M                       87RS\P/T>WK]*.GS$VP?*^OI'N?2(NZ_Z+]]_
M?=GN/^(#53_^'K_^7SC#75Z-@_4(^7;7\B?SUZ73_)WYP_\ 2N];W7[YYON]
M/==/9!U;G!D        \G*/S9O/P&J]Y<!-/"OZ@,)^"U'QR<+5A"
M               $XM7KWRCZKV/X]= *.            $XM7KWRCZKV/X]=
M *.             #KUZTR4-4M:FM&D,BU"=>L6U=W9U[/8 TB2_?^W]I_,\
MG\5>_P (&NHM^_\ ;^_H>3^*O?X0'5N/A,F/38;CTN(L[O%7VVD=8XU1[=M
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M[)&/:]$77;JK=5VZA*J80        BGB9_-;$/KGC_QE0L6L(
M                                   #1[QHX?'F^?6UN.3))D-AL"U>
M0LF>C*:GM[JYL5)Y^B_?I):A_P![[=NCNP-1LCP#Q-)PSQW3XC55K+A=):B:
MX7*IA1R0+43HUNV)'Z.V-8QC=51-RHKM$UT0E5 (     !/N5O<X5];+3^ZD
M"Q00AV=5 FV*W:U2\IYPD-?32.J*>R-@:R:-RO<V*JU1J(Y554"J2$
M   &'7#D[%;9R+:>+:J2?YV7JC?<:*)D+GP=Q$DRJKY$Z-72!^FO_P!J >AC
M.=8EF4]UI<8NL-RJ+)4+1W6.%'HL%0BN38[<U.NK'=GL 9"
M"!^$7U:7?ZRW?WUH6KX$
M               \O(\;L676:JQ[):&*YV2MV)5450FZ.3NI&RLU1-.Q[&N3
MVT TVYBOOAHP:L=B/'W'EKS+D21_<145+'+/1P3JNB-E6%ZNED1?^9BZ^1SF
MJ&H[/"7@\KIKU3\B<L,CM=0VI9<+?B-L1L+(GM<DC._<Q51C6JB:0QKK_E.[
M6@M;J!D        \G*/S9O/P&J]Y<!-/"OZ@,)^"U'QR<+5A"
M           $XM7KWRCZKV/X]= *.            $XM7KWRCZKV/X]= *.
M            #XEBCFC?#*U'Q2-5CV.ZHYKDT5%3VT U4YHNOA9X?A?;7X+9
M+YFKV?[+C]'2PJ]KE]RM3(C7)"U=>Q45Z^1JIU#4RF_'GA8R3E^^)G?)-II<
M"Q&;8ZAQBSTK*&HEA;V-[O15A:J>Z?+NE=[")HX&6]%FM%NQ^T4%BM$"4UJM
ME/%14-.BN<D=/3L2.-FKE55T:U$U5=0R[P        "'>,#^[QE_V;;^4Z4+
M%BL?\RVWX+![VT([X                      "<<*?FQ>OK1DWY9J@*.
M          $O\.WJ9Q7^"J?CDP6J@$         &MGC0Q"_WSCRTY3CE.ZKK
M,/N;+G44S&+(OHJL5KY-B:JY(W(Q7)Y&;E7H@6,0?X_<.^:_?QXS<?GDL.GH
M+EA^3DJ=O;WZ2=XL>O\ \K=_QA<,T\&&&WO&^+ZR_9! ZEK<LN,EV@IWM6-4
MI%C9'&]6+IM[Q4>]OLL5JA*V."        $4\3/YK8A]<\?^,J%BUA
M                                        \?*\FM.&8U=<KODO<VFT
M4TE75.33<K8VZHUB*J:O>NC6-\KE1 -<'XQ=J?@7,^1\NBV9UR'44%[ND:ZJ
MM+1K60-H*)%71=L$"IT<FY%<K5[ K:<(       GW*WN<*^MEI_=2!8H(1^*
MB.16N1%:J:*B]45% CF%<;\>6OEC+JBV8I:*.>TPV::V2T]#3Q.II9XJGO'P
MJUB;'.T3<K=-0JR!         !K3XB^#N2<QS7'^3N)KNRW97:*1;;*UT[J2
M5(M\KVOBD1KFKJD\C)&NTU;IV]0LK6GBW O$]<KAF$> WJ:V5E+='QY)(ZM]
M&])N&Z3=(CG-7O-51R[T[=0UT6;!N./&/;\TQZNRO*9*G&*:XTDUYIUNC9$D
MHF3-69NS8N[5B.3;Y?:[0G1N,&0           0/PB^K2[_66[^^M"U? @
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MW]U!#-WF_NHM->^TTV^3M"6*H$        (IXF?S6Q#ZYX_\94+%K"
M                                       !"^2__P *O*%BX<I_ON*V
M#N<GY TZQR-C=K;[>_M1>^>G>R,=VQHCD7H%93X@/5'D7_8OCU."*6$
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MZRW?WUH6KX$
M      C'BR:CO#YFB.1%3NJ)=%Z]4N%,J!8B''/C7XXPW <8Q.NL-[FKK);*
M2WU,L$=(L3Y::%L;G,5U0U=JJFJ:M10N&9V?QU<9WF[4%GI[!?8Y[A4PTD4D
MD=&C&OGD2-%=I4JNB*[KH@3#:,(        >3E'YLWGX#5>\N FGA7]0&$_!
M:CXY.%JPA                      "<6KU[Y1]5['\>N@%'
M "<6KU[Y1]5['\>N@%'             !T+[ULER1>ST6?WMP'\_O#KXIL/X
M;X_DQ&]62Y5]=)<)ZY9Z+N.ZV3,B8B??)&+JG=^P&K%:_7^XY^C%[_[I^&!A
ML]B>0TV78O9<JHHGP4=[H::Y4\,VWO&1U<39FM?M54W(CM%T4,O8
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M4NO^3/5-'1S5/6&E1%U5K*>-6QHS54:[=IT"US^(#U1Y%_V+X]3@BEA
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MZ(H',!Y.4?FS>?@-5[RX":>%?U 83\%J/CDX6K"$
M  )Q:O7OE'U7L?QZZ 4<            )Q:O7OE'U7L?QZZ 4<
M   '3NT,M1:JZGA;OFEIY8XV=$U<YBHB=?94" >%WAN;$^-)+5R7B=%%D2W.
MIF8VMAI*R7T9\<2,7O&]ZFFJ.T3<%JT_,#!/HO:/Q"F_!A'O4]/!2014M+$R
M"F@8V.&&)J,C8QB:-:UK=$1$1-$1 ."Z7"GM%LK;K5JJ4M#!+53JG5>[A8KW
M:?L(!H?:[MSGRK@&;>(*EY!K\?;CU3.^TXQ0O>RA6GHHV3RM5K7M8J-CDVM5
M\;U>YJ[^W4--M>".0ZGE'BRP9C7M:R[5,<D%S;&FUGI5+(Z&1R-3L1ZL[Q$\
MF[0)4R\4W)&96>Y83Q7Q_<'6?(<XK6T\]WBZ34\#YHJ>-&.3JW<^17.>W1R(
MSHO4$8UA.1<A<,>(6V\-Y=EU9F>+930MJ;?7717/J8)WMFV*CI'R.362!\:L
MWJU4<CNU K'.8LXR[(/$#?\ #+3RE^CK&<>ME,LM7453Z>D?5*R*1S&L:]FZ
M5RU'^!B^P!?N L:RVQV*X5^2<AMY%HKM)#-:+G%*Z>&**-KFO1CW/D1=RJFN
MU?($JMK(QJZ.<B+["J@1#O%\]CO#SEZ->U5UMO35-?YSI0L62Q_S+;?@L'O;
M0CO@                      )QPI^;%Z^M&3?EFJ HX            2_P
M[>IG%?X*I^.3!:J 0         :Q^-FR4=?@V-7BYU4:6FRWJ&>Y6Q9V4]15
MT<K59*E,CW)OE8WJC6]=JN=Y L<%OE\#,U%!- W%V0O8CF-JFO9.B*G8]LWG
MHOL[NH.JT<4?HI^;]5^B#Y.^;GIC_2_DC3N/3>ZCW[M/V^SN_P!C0#.P@
M    !%/$S^:V(?7/'_C*A8M80
M         0K,4_2US-:N.X_ON%\>K3Y)F'ECJ+M*BK;*)WLHU-U1(U=6N3S5
MZH%74(FGB ]4>1?]B^/4X6*6$          # L9]:6??!K%[U5!6>A
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M<U[D371W54"5L1EW)6!8%-2P9ED%'99JUKWTC*R3NUD;&J(Y6_854",+R#Q
M\*55ANE+!G5I?/-1U$<;$G155SXG(B)HGE50N'QX6/4!A/P6H^.3@JPA
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M6^Y95KIN?<ZY=\C.FJ;8DVQ(C?-\W5.T+5'")IX@/5'D7_8OCU.%BEA
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MB=B(@1D8$.\8']WC+_LVW\ITH6+%8_YEMOP6#WMH1WP
M     $XX4_-B]?6C)ORS5 4<            )?X=O4SBO\%4_')@M5 (
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M                         "7Y?Z\>,?ZMR?\ <6\*J 0
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MSP-Z>,\8J<+X]Q?$ZQ[9*VSVREHZI[.K%GBB:DFU?\G=KI[0994
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MNY?9UU50E4<(        13Q,_FMB'USQ_P",J%BUA
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M97(JMWN:W1%7HNNH2ULH$           ! _"+ZM+O]9;O[ZT+5\"
M                  E^7^O'C'^K<G_<6\*J 0
M       :(FJHG5>T          \G*/S9O/P&J]Y<!-/"OZ@,)^"U'QR<+5A"
M                      $XM7KWRCZKV/X]= *.            $XM7KWRC
MZKV/X]= *.                           "'>,#^[QE_V;;^4Z4+%BL?\
MRVWX+![VT([X                      "<<*?FQ>OK1DWY9J@*.
M     $O\.WJ9Q7^"J?CDP6J@$        ,=S_P#,3*/ZHK_BT@'\Y^&.8.?<
M&PYUEXUQ9]XQQ:R:H=6-M-97IZ3(UB/9WL#D;T1K?-[4#=BA_K)>+WZ!2?\
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MJHYNB=H2QL.$13Q,_FMB'USQ_P",J%BUA
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M?K+56&X8[>\==2MN%!<UIG/VUT2S1.8ZEFF8J*UO7SN@&;
M         -6?$[X@K':\(J[9QMFT=-GE!=(J>JIJ%Z^DL9"Z2.=B[F*FC7(F
M[[ 619>..6<"SR&EL^.Y-2WO(:>@CJKA! Y5F1&)'')(Y%:W]N]$7VU H(0
M       \G*/S9O/P&J]Y<!-/"OZ@,)^"U'QR<+5A"
M   $XM7KWRCZKV/X]= *.            $XM7KWRCZKV/X]= *.
M     !'N:^:<(PO',JQR3*8;3GS;-5R6JE;WB5+:J6F>M,K%:Q6HY7[=O4+(
MQ'PV<]8M?L"Q7',MS!E?R97R54,]+5K(^KDD=5S+"USMFU?O6S;YW9H"QL>$
M         $.\8']WC+_LVW\ITH6+%8_YEMOP6#WMH1WP
M      $XX4_-B]?6C)ORS5 4<            )?X=O4SBO\ !5/QR8+50"
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MV81;JIEAQRLCJI:FJ8UDSHF3Q5-7*YK'/1C&L@:UFYVJN7V51 O9OX&0
M       0/PB^K2[_ %EN_OK0M7P(                   !,.>?S+MOUEQK
M\M4@%/    $OR_UX\8_U;D_[BWA50"   !*\#]='+G_ES\GR!54"
M              &J'B=\.N.5>%UM[XVPMU7GUPNL=35ST*S35#V3NDDJ'JQT
MBMT5RIKHWRA95GXQX;X]X\CIKYC6.16;(JNWQ4MQG:^9TBM>D<DC'))(]J>>
MQ%71.U *0$        /)RC\V;S\!JO>7 33PK^H#"?@M1\<G"U80@
M              !.+5Z]\H^J]C^/70"C@           !.+5Z]\H^J]C^/70
M"C@              1_FKA7",VQW*<B?BT-VSY]GJHK35(K_ $AU5%3/2F1B
M(]K=R/V[=4^R%E8EX;^ L7Q[!,6R#+\/CH.3;?)4S3U53O2JCD;5S)"Y4:]6
M?O6S3IV>V"UL:$         $.\8']WC+_LVW\ITH6+%8_P"9;;\%@][:$=\
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M5_"(IXF?S6Q#ZYX_\94+%K"
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MR6M;*]-=$[&=TBI[*K[77GY?F&V^GMQC+J^/\EX^+DF_NMQVBJGEOH
M   !@^;\/<:\D5U-<LVQ^&[UU'$M/332R3QJR)7*_;]ZD8B]55>H,L(O'AW\
M-&-4$EXO^,VRV6RG\Z6LK:RHA@;TUZNDG1OD[ N4ZQCGW@+#\VLV <*XO#-4
MY%=*2UUU[IXO0J9K*B=L6Y)96NGGV[E5K51K=>QW4+AMH&0           0/
MPB^K2[_66[^^M"U? @                   $PYY_,NV_67&ORU2 4\
M2_+_ %X\8_U;D_[BWA50"   !*\#]='+G_ES\GR!54"
M     $NYOLF*7"PT-WRK-KC@D5GJ%FHKM:Z[T%[YY&Z=VK%:_OE5$\UC6J[M
MT[5"QCF*Y?S%14BLM]DJ^0[%&QRTUWND$.(W-^B:QIW54[;.CD[)%A@]O7M
MS+CO.LXRRON5'EO'U9AD5"UJP5556T]9'4/<NBL9W2-ZHG75-S?; H00
M  !Y.4?FS>?@-5[RX":>%?U 83\%J/CDX6K"$                      )
MQ:O7OE'U7L?QZZ 4<            )Q:O7OE'U7L?QZZ 4<
M #%N1[-C^085=[5E-UFL=@EB:^NNU-5I;Y:=D,C94>DZ]&:*U-=W14Z+V@1S
M!+SGEL2&+C.Z7CD[#$V=U/E5.EO:L.JHY]+>)4B?/IIT1:65CO(]J!6<8[R%
MRQ<<RI\>R'BF>QV"7O%FR)+S1UT,2,:Y6N6.)C57>J(W;NW)KV=H%4"
M   $.\8']WC+_LVW\ITH6+%8_P"9;;\%@][:$=\
M !..%/S8O7UHR;\LU0%'            "7^';U,XK_!5/QR8+50"
M              $4\3/YK8A]<\?^,J%BUA
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M1/I_T>U:[516>D;1T,>R)O5SEZO>]>USW>5RG6Y.3;DN=GH<'!IPZ^W6=/\
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M@M1\<G"U80@                     !.+5Z]\H^J]C^/70"C@
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M)ORS5 4<            )?X=O4SBO\%4_')@M5 (
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ME<B+IY41413P_*Y)ORVSL^M^7\.W%P:Z[3%>V=5Z# L9]:6??!K%[U5!6>A
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MY$>[1%?N26*1F[SD17(JKHFA*V;" $$\(R*G&MW1>BIDMXU3_P#FM"U>P@
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M]0&$_!:CXY.%JPA                      "<6KU[Y1]5['\>N@%'
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M-H^*KA2,>^1E/D-UB;)*NZ1R,>QJ*Y?*JZ=5!6P00
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M9AD        \G*/S9O/P&J]Y<!-/"OZ@,)^"U'QR<+5A"
M       $XM7KWRCZKV/X]= *.            $XM7KWRCZKV/X]= *.
M        #JW..&6VUD53)W-.^"5LTW^0QS%1SNOL)U THQ3P<<29A:9<BQ+D
MNKN-HAD?3S5]/% D;)&-:Y[7.7;IHUZ:^TH:R]V'P$8;4Q-GI\XN4L+^K)(X
M:=S53VE15109;5XECT6)8K9,6@G?5062@I;;%4RHB22-I(6Q(]R)TU<C=5#+
MV0        $.\8']WC+_ +-M_*=*%BQ6/^9;;\%@][:$=\
M        !..%/S8O7UHR;\LU0%'            "7^';U,XK_!5/QR8+50"
M                     $4\3/YK8A]<\?\ C*A8M80
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M^"8UG[;ZW]M>B<+M)]RM[G"OK9:?W4@6*"$ ,"QGUI9]\&L7O54%9Z$
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M$Q[56KF7JCG(J=H2K=%+%/$R:%[9(9&H^.1BHYKFN35%14Z*BH$?8
M "'>,#^[QE_V;;^4Z4+%BL?\RVWX+![VT([X                      "<
M<*?FQ>OK1DWY9J@*.            $O\.WJ9Q7^"J?CDP6J@$
M           (IXF?S6Q#ZYX_\94+%K"
M    F66\^\8XE6_(SKJZ^Y,JJR+'L?B==;B^1$UV=W3[D8[VI'-"X89?ZCGO
MF.QW3'K9C=%QWB%XI9Z&IK\AE6LO,U-4Q+&[NZ2F7; YR.5J]Z]53M3KH!KM
MX=_#=R/9N;8Z[((XK90X-5LDN=3%4,E6:66G[V&*%&*JN;*R1KG*Y&Z,547S
MO-"VOZ$AD         3GF3(<VP_%JC*\2J[;'%;DC]*HKG1S52S.J*B*%JLD
MAJ8-FW>JKJUVOM!6:V.&^4]MBBR.LIJ^[(KN^J:&G?1P.17+M1L4DT[DT;HB
M_?%U7V CT0/'N^14EKD;1Q,=6W:73N+?!YTJZ^5WD:WVU.SQ<%WZ]M?C71\C
MS->*^V?>WO;6=_\ A'1I\>K+M,RX97(V9S%W4]JB_P"BQ>QN_P!8[VUZ'+MS
MZZ3V\73_ )O6_8Z^GB;\MF_D7/PUG],^VLE1$:B-:FC4Z(B=$1$.B]9^@ )]
MRM[G"OK9:?W4@6*"$ ,"QGUI9]\&L7O54%9Z$
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M5T=93U$%*V6WJLLD4K7M8B)4*NKE33H@,MX R        >3E'YLWGX#5>\N
MFGA7]0&$_!:CXY.%JPA                      "<6KU[Y1]5['\>N@%'
M           "<6KU[Y1]5['\>N@%'             !UKA#'4T%53S2=S%+#
M)')+T38US517=>G1%UZ@:+?JI^'U?_WT47X[:_PP:R?JI^'W_?11?CMK_# R
MW3P:T6ZP87CMBM%:ERM5LME'1T-Q:K'-J*>G@9''*BQJK51[6H[5O3V R]\
M       !#O&!_=XR_P"S;?RG2A8L5C_F6V_!8/>VA'?
M      3CA3\V+U]:,F_+-4!1P            E_AV]3.*_P53\<F"U4 @
M                  !%/$S^:V(?7/'_ (RH6+6$
M         ,6S+DG ^/:7TO,\@H[.Q6JZ.*HD1:B1$_U<#-TK_P#X&*!.?TR<
MA9QK%P_Q]53T+^D>4Y8KK/:]%3I)'!UJ)V+_ )B-4*?H0R[-=9N9L^K[S22=
M7XOC^MELR-5-%CD6)>_G;[;WM4&5-Q+ <+P.C] PZQ45FIU1$D]$A:R233L6
M23J^1?;>Y5"/?F=*R&1T#$DF:URQQN=L1SD3HBNT735?+H!-<*M_(-#FN1WF
M^V&@I+5DT]-4/DIKHZIEI?0Z&.E1JL6EB23>Z/75'-T1?+H%4T(
M)IX@/5'D7_8OCU.%BD3314\3YYWMBAC17/D>J-:U$\JJO862VXC&VTUF;<1C
M#KQ=<C>ZGQM/1;8B[9KS,WW2>5(&+IN7_.7H=[\K3BZ\G6_A^UY-\CE\FXX?
MNZ^N]_\ C/YO7L]BM]EC<E*U7U,O6HJY5WSRN]E[UZ_L=AU^7FVY+U[?#T=W
MQ_%TX)]WO>]O>_MKTS@=L   )]RM[G"OK9:?W4@6*"$ ,"QGUI9]\&L7O54%
M9Z$                         ! _"+ZM+O]9;O[ZT+5\"
M        3#GG\R[;]9<:_+5(!3P,1Y'Y+Q+BK''Y1F-6M-;TD;!!%$WO:BHG
M>BJV*)B:;G*C57M1$1-55$ Q+B/Q&\<<RUE5:L:DJJ*]TL:SNMESB9#/) BH
MBR1K')*QR-54W(CM4U[- N%:54:BN<NC4ZJJ]B($:6Y+X^J6@RV:BQS%FW+$
M:6=85KYJET-34QL<K72Q-1CFL:O:Q'ZJJ=NW71#6&W>*9/:,TQNUY78I5EM%
MWIXZNE<]-KT9(FNUZ:KHYJZM<FO144,O8   )7@?KHY<_P#+GY/D"JH$
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MBL?\RVWX+![VT([X                      "<<*?FQ>OK1DWY9J@*.
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M;E]')),1^A0    3[E;W.%?6RT_NI L4$( 8%C/K2S[X-8O>JH*ST(
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M+4?')PM6$(                      3BU>O?*/JO8_CUT HX
M  3BU>O?*/JO8_CUT HX               "%Y=XN.&<,R>JQ2Y7"KJ:^@F=
M37">AI5GIH)F+H]CG[FJY6+T=W;7:+T[4"X6:SWBV9!:J*^66I96VFXPLJJ*
MJB75DD,K4<UR:Z+U1>Q>J!'>         0[Q@?W>,O\ LVW\ITH6+%8_YEMO
MP6#WMH1WP                      $XX4_-B]?6C)ORS5 4<
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M4\G2CJZAR7Z.TT]I>^@KH8YY:6*I[UJ/D@:U-FY-=RIVA5G"
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M_13W*%;,\6X3^CGCW'L)=4^F2V>D;!/5(BM;),YRR2*U%ZHW>YVW7R:!EEX
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MH(YIZB.G8D;9JJ5]1.]&^5\LBJYSO;<H':
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M,Y0Y#ME[L%OS+CV.RVN_W&.T0W&GOD%P='4312RLUA93QJK52)VJ[N@%9"
M !,.>?S+MOUEQK\M4@%/    $HR#PU\+91E3LRO.+PSWF:3OZM&RS14U1-KJ
MKYH(WMC>Y5ZNU;YR^ZU"Y4JIK;18Z2+TRHIK;0LVPP]Z^.GB31-&L;N5J)HB
M=$0([C7->U'-5'-<FK7)U147RH!^@ )7@?KHY<_\N?D^0*J@0
M         !/><,_K^,>,+[F5JIXZFZ438(:-E1KW#9JNHCIF22Z*GF,63<J:
MIKIIJFNH6->VY1RQ37[%L?YCON'<BX/F]T@L<]CMJT]344[ZUKN[J&)'!$NV
M)=-9-7Z>RBJC@K.)^$>1>)*F6[^'N_\ >61SUFJ>/+_(L]O?JJ*Y*6=ZHZ)R
M_P"<Y%7RR*G0)EL:Q5<UKG)M<J(JM]A?8"/T       #R<H_-F\_ :KWEP$T
M\*_J PGX+4?')PM6$(                      3BU>O?*/JO8_CUT HX
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M6VO@NMNH[I3;DIJV".IAWIH[9,Q'MU3KUT4([0 "<<*?FQ>OK1DWY9J@*.
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M/;W\KA_+SF7IV_D^3XOE_D_GS7VV67^KT_;GU9_^F?B9W[[R_2+_ *$D+/\
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M].[3_'_\@,'ZQ7!WT[M/\?\ \@,'ZQ7!WT[M/\?_ ,@,'ZQ7!WT[M/\ '_\
M(#!^L5P=].[3_'_\@,'ZQ7!WT[M/\?\ \@,'ZQ7!WT[M/\?_ ,@,'ZQ7!WT[
MM/\ '_\ (#!^L5P=].[3_'_\@,,EQ#DC!,^?5QX9?Z.]/H$C=6-HY.\6))=R
M,5WL;MKM/L!&4@                         ! _"+ZM+O]9;O[ZT+5\"
M  !,. /5RG]=Y'^7*T+5/"  #'\RM5ON-CK)ZR!))J2":6FDZHYCVL5>BIY-
M435.P[GB<NVG))+WL>9\QX./DX=KM,W66QZ%EM5OM%#'3VZ!((G(CWZ:JYSE
M1.KE7JJG#S<FV^V=KEV?&X./ATDTF(] X7:  $TY=_Z=QM]<J#XG6A8I80
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M7/3]CR]/F7'MMC%D^+*CS7J@      )Q:O7OE'U7L?QZZ 4<
M)Q:O7OE'U7L?QZZ 4<             #MZ+V 1Q?"OP0N1_.;YI0^F=[Z1Z)
MWU1Z#WNN[7T;O.ZTU_:;=G^:%RL?9T3L"          !#O&!_=XR_P"S;?RG
M2A8L5C_F6V_!8/>VA'?    '2N_\TU_P>;]PH&(\*>I[ OJ_:_BD8&=@<-9
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M_5;F_P#4%U^)2@CT\+_,['OZLHOB[ /<  3CA3\V+U]:,F_+-4!1P
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MR]7.<JJOE4(]D !*\#]='+G_ )<_)\@55 @
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M%H_'Z;\( ^?^"?2BT?C]-^$ ?/\ P3Z46C\?IOP@#Y_X)]*+1^/TWX0!\_\
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M?M9_P0,'ZSG OTXH?M9_P0,'ZSG OTXH?M9_P0,'ZSG OTXH?M9_P0,'ZSG
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MG;[?:#*KA
M                                                 !J]R_Q3RA8>
M9K?SSP]0TU[N2T[:6]V&ID9"Z3;"M,KD5[XT<UT6U-$=N:YB+YR+HA7H^'OB
M+/+7G65\S\K004.89,CX::T4[VRI2P2R,D?N<QTC4Z1QL8B/<J-1=RZJ"MD
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MRVVC9!+(FCI$U<[3MT17*JHGM(.3GWY/ZKE>#P^'AN=-9*],X';
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ME5$U"Y958K#9<8M-+8<>H8;;9Z)G=TM%3,2.)C==5T1/*JJJN5>JKU7J$>B
M             !.^>+)=LCX?R^Q6*CDK[O74#H:2CAT621ZO;T;JJ)V!8R+
M:.KMV"8O;[A"ZFKZ2T4$%53R:;XYHJ:-CV.T54U:Y%1>H1D0
M  'FY#!-4V"ZTU.Q9:B:CJ(XHF^Z<]\3D:U-?*JJ!//#;CU\Q3A3%<?R2@EM
MEZHHZMM50U"(DD:OKIWMUVJJ><US7)U[%"U50@
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MYIQ[G-Q^7ZG#JEL-+?\ 7O'2-6::%['RZ(LB*Z+?$]WG*FNJ]$T)6SP0
M  !BW(G(&/\ &&)5V99,LWR50[&O931][,^29Z1L8QNJ)JYRHFKE1/94#2[&
M^;>1^1_$WA55<OE'&\5N+VK:<<[V:&GFMKHYUCFE9JULRRN17=XK=%T1&]$0
M-8;#^)[+>6,=Q.WVWB.SU];>[Q/)'6W2VTKJQ]%2Q-;KHC6NV/E<]$:]4Z-:
M[L714)&O_)-K\0'AHHK!R%4<FU63I7UC*2YVBNDJ)Z7TAT3YECV5$LB21JV-
M[>\:D;TZ::>0O=O#C]W9?[!:K]'$Z".Z4=/7,A?U<QM3$V5&K[:;M R](
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M]LE#/;*6G8]B4CH:E7*Y7M5BN5R;NFCT3V@,O
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M-&R;V:)M37LZA51"
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M28WR=!@V76Q+78;\R)N(9+WF^FK*Y&_?J.?5$2&;5?O+554D3R[E1H52 @
M            !,:GFJWNS&3$\?QF^Y)3T5=':+U?[32-GME#72*B.BEE=(U5
M6'<BU"M14B3MZ] N%."
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M9K?,RQFOARJ&*++\8NE7CF0.I45*::MH-BK-#KHNR6.1C^SHJJ@*H@0
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M\E\=6W([M3)1Y!&^:WWRE:FUK*^BD6&7:G71'*B/1NJ[=VFJZ JAA
M      -;N2?D'D/F2X81R/</0^+L'QZ/)*^U.G?2PU]5++M[^H=&K7.A@9HB
M-1?=K[>@5@W'5PM_$E/?^;[1076P<)WBIIK=CN']XZH6K])E;'\JRI4N5::)
M>JQHBJYR+IKMV[BMR@R
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MK6UMJJ[=+&R5J2N\[T>9LR;4=^W3I^VW$7((
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MB;GO=_@31$Z($9,
M
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M*"J96U%VFHE1T$*=VY[8J;<FYR*N[HFGLH1L8$
M                             &(7WE#!L7R*3&,DN\-HN$=L^6^]KE]'
MIG4:3.@=LF?HQSVN;UC1=VBHN@$8IG7'F[.>5>.L[K*O':>&UP6NT8?(Z.2-
M(7R)*V\L5$:DSDF9&K%:[1K7;'=J:%=NY7#GG(L0N'#E_P +9+?[E1RV2LS]
M*J);')05$:P25ZQZI-WRQN5>X1NN_P [HWS4"]V&T4^/V.V6&C<Y]):J2"A@
M?(NKUCIHVQ-5R^551O4(]             )]D_)<EOS>R<>8I;?E_)JR6.IO
MT;9.Z@M-GU\^IJ)-KD21W9#%VO\ 93IN*\K"<'N&&8?G]MRIM'5T5WN]]N\<
MT*N=)54%R19-:O>U$[W15C=IJFUK0)KCL'&]VX$XCQ+DN.:MNM^CI*?&(Z!)
M%NL-3[IM13NA7O(V0,VK+)[EK=-VNJ(!9<"XHQW *JKNU/6W._9)71-IJG(<
MAK'W*Y.I8W*]E.V5Z(C(FN7=M8U-5ZNUT30C.P
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MDNF1W.5:[),AJNM7<:^3J^5Z]=&)KMCC1=&-]E5<JD9J
M
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M#9J6J:N^FMMII$V0T=)JUFB*U-TK]J*YR]?9<6U:0@
M                          Z%ZO5HQVUU5[OU;#;K11,[VKK:I[8H8V:H
MFKG.T3JJHB>RO1.H&M^>Y];,IO\ C/+V$7Z'-^.,%JDJ<IQ&DC:M51.=%/"V
M[1Q/:V5ZPMF<[:Y-J;-S?VSFE9S=\+FO>1V3FSA2Z44=TN:4\=^CD>Y+7?+.
M]4173=VBJE1"WK%)MW)IL=V: 4^Q8KC6,>F_-RT4EJ^49W5=?Z%!'!W]0_MD
M?L1-SE]L(]<            )?S/DN044.,X/B59\F9'G5S2TQ7?1'/H:*.)]
M165$2+T65L;-L:+IYSM=4T"QV<"X6Q;CJ\S7ZS7"\U=?4TRTU8MTN4];'.YS
MVO=.]CUVK,NW3<B(B(JZ(FH,N6HAXZ\0G'=13KK=,5N3YZ=DRL?3U,%51ROB
M[V-)6H^.6-[=S%5O9VHK55%#(L'L5YQG%+78<@ODN27:@B[F>]3Q)#+4(UR[
M%>U'/ZM9M:KE<KG:;E755",@                                 #!.
M7N3J'B+"JC-;C037*EIYX*=U+3O9'(JU#]B+J_IHBA6OS/'QBJL2:3";NVE7
MJLS98')I[*:Z(O\ A"X7KB;FC!^9;3/<\0J9$J*)S&7&V5;$BK*9TB*K%>UK
MG-5KM%VO8Y6KHJ:ZHJ!,*$$             Q+D3DK#N++ [(\SN"45%N[JF
MB:U9*BHFVJY(H8V]7.5$]I$[55$Z@9);ZV.Y4%+<86N9#5PQU$;7HB/1LK4>
MB.1%5-=%Z]0,8Y&Y.PWBJPKD.9U_H=(YW=4L$;5EJ:B;37NX8V]7+[*]&IVN
M5$ RJCJ65M)3UD;5:RHC9*UKM-R)(U'(BZ:IKU Y@             3GFKEV
MW\+8E3Y;<[9/=::HKHK=Z/2O9&]KIHI94>JR=-$[K3IUZA8Q?DOQ)67C3"L.
MS2OL-76TV8T\=53TL,L3)*=)*>*H1LBKJBJB2:>;TZ PM5/*D\$4Z)M25C7H
MU>U-R:Z!$GRWGFUXER[C_$<]EJJJX9 RF?%<XGQI!$E7+)$FYJ^<NWNU5= N
M%<"        $C_3S:OTZ?H,^1JKY5[OO?E?O(O1MOH'I_N-=_9YG^E[07"N!
M #"</Y8PK/<CO^-8G7+<JK&DA2Z5435]%;).Z1J1QR+IO5%B=N5J;?;4#&N/
M>>;7R%R1E7&])9:NAK,5=5LJ+A.^-T,RT=6E(NQK?.3<J[FZ^0+A6P@
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MH5<Z16Q1-1K45SU5RKHG:JA'I@
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M-<9XWB.79#E]@[^CGR?NI+I;(Y-+<M5&KE=4M@1-&S2:^>[7KV]JKJ&9
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M^[;DUXKJR^WJ"G=N@@J[G,LSH8UU5%2-%:Q51515153H"J*$
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M>BYHO_!_*5TCR">@BGDIKDUC$D9+3HR1-KV,C5T<D;]VDC=S5T[.J K;4,@
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MQ_C?&N/1XWC,,C*7O7U-555#UFJZNKF5%DJ*B5=%?(_1-5]A$1$1$1 C*
M                                                 #7[.,]9S9BF
M4\<\?6B^31W>@KJ:U9DE&L6/U511+K)"RL<]-62JU8$D5NQRJJ(JH%>'G'+'
M%O('"-VQ.XPLH\XDHEM=)Q^Z%S+Q29%&SNJ6&"E1J2:1SHW9(QNW9[K3JT"Y
MXGBK*.DL=_R.DIZCD6GLE):+M?$8UU1)L:R2>/O>U6+,CGZ>SU",J
M      !PUE)37"DGH*V)L]'51O@J('IJQ\4C5:YKD\J*BZ*!KW8*CDWP^,DP
MZ3&+ER#Q?"][L6N=D1E1>*&"1RN;155.YS5D:Q5T9*U=$3VM&,*RKC?'LNR3
M.[ES+GEK^;U;/;FV#&,:=(DU126M)_2))JMS?-[^>1&KM;^]L3:NJ@6 (
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MCS%;5<JW*J2R4$.0.;!MI:"FMCH._J))M=JL?W6UB)U\]-=%30&.KQ<L7_\
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MED%HL&0YKEM&MLR/D"\U.13VEVJ/HZ>H76"%Z+UWHBJY=>J;D1R(Y%!5H"
M        !U+JES=:ZUMD= R\K!*EO?5H]U,E3L7NEE1BHY6;M-VWKIV 1?CG
MF>[9!:\DP?.H&V#F7%J2H=<*%$1L=4R.)5CK:375',=YKE1NJ=45/-<@7#J\
M18UB_*_ANL.*Y;,V]LKZ)\ERD6=)JR&KFGEE2;O%5[F3-<[<BN^PJ:*J 8?9
M,@\26'7U_ =/36^\5;:.23%\_N:U$;/DN/2-LDR1,E1\T*.1NU^B[D37>BHY
MP7[B[ :'C# [+@]!,ZJCM<+DFJWIM=/432.FFDTU71'2/<J-U71-$UZ!&7@
M                                                 ,9S'/L:P)EI
MFRBH=145WKH[9!6K&Y::*>9KE8L\J>;$Q5;MWO735?8U5 ]B\VUMYL]PM#Y7
MT[;A334CIXETDC2>-T>YJ^RFNJ :\X3S'8>,<+9Q1RG%5V'-<7I$L]#2T--4
M2+>:>)O<TM1;)(F*CWS)L3JK52155=.NA5,X=Q*X6S!<5K\YHH9^1Z>VQPW&
M[5$;);DU'(NV*2H5%D<YD:M8_P ]=51>T%4@(           #QLMR6@PW%[Q
MEET1[K?9:.>OJ&1(BR/93QJ]6,151-SM-K=5[0(O%RIREB%PQ+(^5FX[;N/\
MSF]%='32R05-EEGII*JF](J*AZ1S(K(U;,Y$:U'>YZ:(XJZ6F[VJ_6ZGN]DK
MH+E:JIN^FK:25D\$C==-6O8JM7JFG10CPL\SJW8):8ZR>"6XWBOE;16*QTFB
MU=PKI/<0Q(O1$_;/>OFL:BN7L R6F?/+30R5,7<5+V-=- CDD[MZHBN;N31'
M:+TU\H'*                                             :W<CT&8
M<G<B5,_$E';[3E/&<T4$N97">6-]54U,/?R6ML,#'I)!L>SO73^Y<Y48B><J
ME53B[DNFY!MU935U(ZS9O89?0<IQR946:BK&^5J_MX9--T,K=6N;Y=44#V+9
MQ[@EEOU1E%HQJV4.1U2.2>Z4U)#%4NW^[^^-:B^=^VT]UY=0C)0
M   QKD'+X\!PN]9E+1OKX;+3.JY:.-[8GR,8J;D1SD5$T1=0/!M<&#<P.PGE
M>QU\U0EC6JJ+//3/2/\ Z=#Z/4T]2Q4<O31$>S5%1S?8"IGRMQ!Q&VW<@9]D
MM[D=G<+9+I%?WUZPUMHE9!K004\4#XT:U-C6Q-<Q7R:]JKIH%%HLJSJW\18S
M>'V*>]\B7.WVV&2WHWNF-N57 S?+6+HG<PL=JZ9=/-[$ZZ >MQ[@+,.IJVXW
M2K6\9O?I&U639!(W:^IG:FC(XV_\W3PM79!$G1C?\Y7*I&:
M                       ?$L44S.[F8V1B]5:]$<G3VE XFT-"QR/931-<
MWJCDC:BHO^ #L =.6TVJ>MCN4U#3R7&'I%5OB8Z9G^B]4W)^PH'4R&"YQV2[
M56+P4SLJ]#J%M+JAJ)$^M2)>Y;*Y-J[%>C4=U[ -5\;X3YOY-YBLO)?/$5#;
MK7CBQRT5HHY8Y6O?3/66&.-D4DR(SO5[R1TDBN<B;>S3::RV_#+SW6&QNKOE
M-ULI'7+7=Z8L$:SZIY>\V[M?V0/0 @/BOXES#E[#[)9<-BIY:VAN7IE0E5,D
M#4B[B2/HJHNJZN0+%@L&/4M':;'\I4-,^]VRAIJ9:E6,DDC?%$UCD9*K=VFJ
M+V!'O =)EGM$=<ZZ,M],VYNUW5K88TG77MUD1-W_  @=T#SZ:PV.BJG5U';*
M2GK7Z[ZF&"..5=W;J]K45=?L@=RHIX*N&2FJHF3T\J*V6&5J/8YJ]J.:[5%0
M#CHJ"AML"4MNIHJ2F:JJV&GC;%&BKVZ-8B(!]U%-3U<$E-5Q,GII4VRPRM1[
M'-7R.:Y%14 ^*.@H;?3I24%-%2TK==L$$;8HTU[=&M1$ XJ2T6F@BE@H:"GI
MH9W;YXX861M>[V7(U$15^R!SK2TJQ) L$:P-75(E:FQ%^QIH!].@@?$D+XV.
MA31$C5J*W1.SIV= '<0+%W'=,[C33NMJ;-/8T[ /J...)B1Q,:R-.QK41J)^
MP@'3^1K/Z?\ *GR?3?*?_7>YC[_^,V[O^$#MRQ13,[N9C9&+U5KT1R=/:4#]
M8QD;49&U&,:FC6M31$3VD0#Z Z-99K/<)XZFOM]-55,/[S-/#'*]G77S7.:J
MI^P!W@.C\BV?T[Y4^3J;Y3_Z[W,??_QFW=_P@=N6&&=NR>-LK-==KVHY-?9T
M4#YDI::5K62PL>QGN&N:BHWR=$5.@'*!QNIZ=\K9GQ,=,WW,BM17)I["]H#T
M>G[[TCNF=_V=[M3?V:=O: ?3T\DC99(F/E9[A[FHKDTZ]%7L _9H8:B)\%1&
MV6"1-LD<C4<QR+Y%1=45 ."@MEMM<2T]LHX**!5W+%31,A8KO9T8B)J!S3P0
M54+Z>IB9-!(FV2*1J/8Y%\BHNJ*!PT%LMMKB6"V4<%% J[EBIHF0L5?9T8B(
M!^5UKMMT8R.YT<%;'&[?&RIB9,UKO91'HNB^V!S+34SGLD6%BR1HB1O5J;FH
MG8B+IT _?1Z?OO2.Z9W_ &=[M3?V:=O;V <%1:K75U4-=545//74W_1ZF6)C
MY8^NOF/<BJW]A0.?T>G[[TCNF=__ *W:F_LT[>WL Z[[1:I*YMT?0T[KFU$:
MVM=$Q9T:G8B2*F[3]D#L,IZ>.1TL<3&2O]V]K41RZ]>JIV@<%?:[9=8VQ72B
M@K8F+N8RIB9,U'>RB/1410.S'''#&V*)C8XF(C6,:B-:U$[$1$[$ ^8J>GA<
MYT,3(W/]VK&HU5^SIV@$IZ=LJSI$Q)U[94:F]?V>T#D
M            X:NKI:"EFK:Z>.FHJ9CI:BIF>V.*.-B;G/>]RHC6HB:JJJ!A
MV(<P\8Y]=*BRX?D]%=;K2M<^6DA<YLBL:J(Y[$>UO>-35-7,U0&&;@%1%145
M-47HJ*!B%'Q5QI;[XF34.(6BFOZ/[UMPBH8&3-D[=[7(Q-K_ /.3J!EX
M        37E/DZXX=5V7$\/LZ9'R)DSY4L]I=*D%/%!3(CIJJJE_:11HOV7K
MT3L4*F^5<6<F<KXPN3Y/16_".;,:FFCQ>\V6J=)%4TBQ^=%.[5ZMBE5[V(CG
M*K>JZ;7.:X)MPGPEP]R!8%L-9'=\-YFQ5KJ+)X:*NDI*_O6/5$J6,D65CHW(
MJ)N8Q$1>B]K7.+:VSX^PV3!,9I\>FOMSR.:)[Y)+K>JAU55/5Z]&[G:[6-1$
M1K4[/LJ&64
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MKG(Q&;5DCW-T3LT H@0
M
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M4D-%<+Q'"UE1-%#U1JOTUV[NNGM)_DIH1[
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MCBBC:C&,8U-$:UJ:(B(G1$0(Y
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MUME:Z"NHX+A-K02U-/+M=$D-8G=OE<FBH_1JZ ;+A
M
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MM.19/<5KL5L#&U%HQ58D;3)=T<[_ &VH=N7OE8S1(6.;HQ=5\O4,_"
M      UB?=I..K_RUR]GM@J*S)UND5@P-9V;DK:.2)&4=)0-75R)(]=T[F-Z
M]5ZN1R!6!4ECY%\-V2XQ54M+)E\7)$%;59S@5O@8]L=7"K9JE]!#$FQ&Q1U#
M8]$3:Y&JB^:YFPO=M-B7%_'&*UJY%C.(T%BO-7'K+-#311U$22HBNC16;D9[
M#FQKM7VPRS0
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MV-S'-;<:-5AJ--BN;M<]JR,T7W#FJ"L]"
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MF29%@O,#)J.:5:=R:Q2O:D4DD:*FU8Y-6I[2A%9"
M
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MN]ZIJB)M15;V$5P(
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M[L=@L>,6V*S8[;J:U6F!7+#1443((&+(Y7.5&,1$35555"/1
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M%-&FD<,348QJ>PC6HB($<H
M
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M.Y9E?43Q>8^25ZH[1ON4Z?8(L80
M                  >1>,HQ['ZNU4%ZN,-#5WRI]!M,4[MJU%4K5>D;%[-R
MHG37M71$ZJB 07DZ"3'+Q<\;Y>J);]P=G57K07^94;58Q=Y/WJ-9&IYE/JB+
M!-I][7H_5-RN*Y[/Q)=LZK'6+EIMR?><-8E%8^0[-6.H'7ZR5J*[N*E8W*]7
MHC=L[?975'><KG!?;1:+98+71V2S4L=%:K?"RFHZ2%-L<<,34:UJ)[2($=T
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M2+FUJ-33M]E5[5]M0C]
M
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MLD;MJHY-6N14714U".8
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MK:AV^>=ZN<[3>]57:BZ)[?:I&4
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MR)T71$"L["
M
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M\TD"*O=PLB31NJ]7=45>NT+\$
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M3)J>*)M.RIC=]XM\D^J/DF:Q[I%8B*D;>CE17(@&:@
M                          &,<B6>KO\ A-[M%OKZRV7*IIG^@5EM>D=8
MRIB^^Q)$KG,3<KV(W17-U3IJG:!KS8(,MY9958QR/<EQ3Q(X?,V]8K/'!#3L
MI:66")B.@="Z1M533N:K:M-7:.<K=-K4:%>[@U'>,PSU,SLS685RO8*FFL_+
M^-31R/MUSHG,5T51#MZ.>]C=]+-NU1O1RN;IO#9!$1-51.WJH0
M  "29)SM36:]7:WV/$;YE5IQN1*?*+U9H8Y::BGV)(^%B/D:Z>2)KFNF;&GW
MM%37KT"X>=C>#X3F/#UTL^(9;4R8%EMPJ[K-71K%O@HJZI2>KH(U>U%B:J=Y
M&[O$5[%<[7V /(QS%:#BKG:R8A@-?628[D5EKZW)<<J:N:NCH74+H6TU<U9W
MR/8L[WNA]UHNB^UH&6YA;LCY0R2IP!]/5V;C*V]VN5W%R/IY[XZ1B2-MU&]-
M%2EVN3TN9JZO_>6Z>>H%0I*2EH*6"AH8(Z:BIHV0TU-"U(XHXHVHUC&,:B(U
MK41$1$Z(@1S
M
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M:L:2=VC59YNB)MZ("K^$
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MB[I)II%ZODD<JN>]W55 ]L
M     !PU5724,*U%;/'30(J-669[8V(KET1-7*B=5Z(!JIR94I=^4+[;LTPF
M_9O?J&:C_1GCE$L]+964R1,E?725<3XXVO=/N9,^1';$:C.S70T]^FM&4<P7
M^YXMR1#38ERI@Z45WQ_+,1F?(ZEIKLDJ>CO6557=MC<V1CEVO1=S41.KB+SB
MF.Q8ICUNQ^*MJ[EZ!"V!UQN4SJFLJ'-[7S2NZN<J_L(G1-$0(]D
M   /Q'([JU45-53I[*=% @]BO3.%>3[YB64_[/A/(=VGOV+9#)T@CO%?HM7;
MZEZ]&.<]O>0:]%1=-57HTKJ7/"[!C?,B8-#2-J\ Y>MURJLBQANYM/3W*U)%
M(M:WNU:L3:AK^[?MTUD1%U[$0*E@/%>!\9054.&6AM!)7*Q:VJ?++55,R1)H
MQKYJA\CU:Q.C6[MJ>1 C,@
M
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M8VQ0QL3KHUK41$ZKK]D#N@
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M"@JH*">IN5VN<ZUEZOMRD](N%=4JB-1\TFB)HUJ(UC&HC6-[$[54C+
M       \9^7XG'>)<>DOMN9?H$8LUK=5P)5L25-6;H5?O3<G5-4Z@3?PTRRP
M\;U&/5,KYJO&K]?;-4RRO6217PW&:7SG.555=)4ZJH6OVR8#D^?UF27;FF%C
MK!=FNMEIX^25M3;Z6BIYMS*N9[.CJR14WMEC5%8U=-==&L#)L"X@P7CBIJJ_
M&Z.9;G51-I7W"OJ9ZZI921NW,IXY*A[U9$U>NQNFJZ:ZZ(#+.@@
M
M                                                        #P,Q
MS?%./[)+D68W2&TVB)48L\RJJOD=JJ,C8Q'/D>J(JHUC571%]@#S./>5<!Y3
MH:BX8->8[G'2.1E9#LD@J(5?KMWQ3-8]$=HNUVW1=%T7HH&9 =:X6^ANM#4V
MRYT\=7;JR)\%52SM22*6*1%:YCVNU145%T5% FW$? N!\-U%ZJL7B?+<+O.]
MZU54J234]$YVZ.DC=VI$U4UU7SGKU<JZ-T+E4@@          3CG#D&[\88)
M)F%KMB7.GI*VCCNZ*YS706Z>9(YIF(W17/35&-ZIHKMR]&JBEB>5'A'XIN__
M .T>'WF_6"JN2)617*U7223O>_3O$D5]0DKW[M=VN_5?9!E*,2XYYFQOF;/\
M*X]Y+?3W2DAMUWGK+Y3MJ_E1E3"B*^97MGVNB<[NU<B*KDZ] JWX34^*RDR6
MBM6=4>+5^+N?K7WVC?-'.V)O54CC1S-7N[&ZPHGLJ$Z+D$
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M_@TN2,S&3&[:[*H^K+RM)"M8CM--W>[=V[3INUUTZ!&1@
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M5.JN>YRJOM!EEH
M
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M< <><=W^._8BRY4*1,D9%:UN57-;VK*FBO[F61VYR)JB;E5$UUTUT5!E4 @
M                                             (/5<:\D\7Y!<+OP
M4MLJ<5OTJU-SPB\OD@I*2N>FCJFADB_>VNZ=Y%V?Y/[5&%9EQ;QW=\4EO>59
MG<HKSR)E4L4U\KJ9CHZ.&*F:K*>CI&.ZI#"U51'.\YZKJ[J!1@@
M  ,,S7D:SXA<[%C;HZBX91DU2E+;+5;XVSU+8O\ GJN1BN:C8(&ZOD<J^3IY
M= GOSCYXXKDD7,[:WD_#4>YZWZP0,I+[31JY5^^V]%2.9K4Z(D*ZHG:JA7BX
M'R'ADO-TUUP^[15F+<GTB,JJ;SHIZ+)[+'UCFIY$8Z!9Z77W3?ODD?34"QV7
M Z&RYWE.>0U4KZ[*8;=!54JHC88TM<;XV.33JYSD?U5>SL0(RP
M
M                                                         !KE
M6V2Y\\\GYQCUYRBZV##\$EH[=0V:P5244]35U4"S/JZF3:Y51%\V)NFG3R:.
MW%=6TYAGGA\RZWX;RK=I<EXLOTR4F-YS5_\ 2J&I=[BFN#^NJ*B?OCU[/.UV
MHYK SWD'GVQ\;94S&K[C=_J89J5M1276W4*U5+/.]53T:-=S=ST1$]I%71=
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M/:YWF-5$17.4*VQ#(
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MK9I*=W<2/:FB^:V;=M7INTU[ RRX
M                              '#5K5I23K0-C?7)&]:9D[G,B67:NQ'
MN:CE1JKIJJ(JZ :J\><BX[A"9EEG)4=56>(E]<EJN./O8BUDW?O7Y/H;-&U7
MZT<B;7;FZJJZN?JFQ5-+)CM^ON 8%7YGSE?Z:EJ9ZAUQJX8V(E+:H:A6,AH(
M5B:KYE9T3=YSG/5=%<FBJ1D$_'7'UWR:W9_/8**;*:-.]HKQW2,G^^,T1SE3
M3>J(OFK(BJW]KHH1E@
M
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M5?6R2MI:&/OTHZ>-BN2:JT76.-RIM:NB^RNB=0C-P
M                                                   -<N3ZR3!.
M:+)R-RA$MVXIBA2DQZNC8]T&.79Z(CIZFG8C^]694TCGT\SLT16M52LGP&;+
M,^R+],>3U55CF#TE//'AV,22>CI)0S-\^Y7--=%=(U$=%&[S8FZ+V^<H9OA^
M8XSRMCU;<K91356,NJJBWQR7&F1M-<(Z=4:L\#7JY):=ZZHURHFJM7HF@1ES
M&-C:UC&HUC41K6M31$1.B(B(!^@
M                              2CE_BFJRV>V9YA,T5JY9Q5738_='M1
M8JB/1R/HJK7W44B.<U%[6*Y53HKM2L?P[&<QY>OMMY$Y?L[K#:+"]KL6P*5R
MO;'<(DV2W&L1S6[W[T<E,US?,9YW:NYP7<(
M
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MP1]C41$W::Z(B-:TBIA
M                             '1O-FM60VJLL=[I(ZZTU\3J>LI)V[HY
M(GIHJ*G_ -O:GD U\IN$.29*C]$MUR!:GP_4TJ5\50LKDO=31Z^98Y94<CDI
MV.3<Z1$U='HUKD]RPN6Q5%14ENHZ>WV^".EH:6-D%-30M2.***-J-8QC6HB-
M:U$T1$".<
M
M
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M9L2M<L"*K(=SGZN=)W>B/>O5?+N]TXC-
M
M
M
M
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M9&O1_?/A31JRKM:BO7R)[*N52,Q
M
M
M
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MC)HG;F/:CD71S535KDZHH'.
M
M
M
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MY=SE1--5T1-5_80#]
M
M
M
M
M   !).4>4,QL61V_C_B[&H\GSRLHW7>JBJYDIJ*CMK)%A;)+(YS$5TDB*QC=
MZ=GV J6WFBL_BBQ]U=;Z;YF>(CC^9KDH:M$[ZFJ:>3O&QR;F_?*9[TU8]6KW
M;_(J*J/'9UH.:^5N7+=!PYCMFJ,8Y51TE%R!?96*REM%)$J,?/3JCM>\G1?O
M::^:ON%7I(TN&QG'?'N-\88K1XCB]/W-!3(KYIWZ+/4U#T3O)YG(B;I'Z=?(
MB:-31J(B&65
M
M
M
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M
M
M
M
M                                               $RYIX;L_+N/QP
M.E^3,NM+O2L:R"+5L])5,5'-17-T<L;E:FYJ>TY/.1 LK'>+.2/T@TUXX?Y>
MML-+R3:8'4F06BH:U::Z4;FHWTN!/<N9(U4<Y&]$U1S?-5- S_C3CFT<68RF
M)V&KK:JTQU,]32MN$WI#H&3OW)#$NB;8V>1/9U<O55",P
M
M
M
M
M                                   /,=CMC=?VY4ZWP+D;*1;<RYJQ
M/2$HUD[U8D?V[=_G: >F
M
M
M
M
M
M
M
<                                  /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>fc_vehiclecontrol-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_vehiclecontrol-4c.jpg
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M%!04%!04%/_  !$( WX(K ,!$0 "$0$#$0'_Q #&  $  P$! 0$! 0
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MZ63Z0SJVO$'UU#3F47]4C]Z_=K?+[#W:>I^+)L_U7B?#_C=ITO\ N?\ X?\
MU_S_ +UZ?^>CE_\ $9'_ ,?]_P"-.LZ=?_ZE6+]]Z^]*G]DYONOP]$.K[/\
MIZ_,[YX70
M
M
M
M
M                              KW^9'Z_P##G=^'VU?._.[?JD>+]]Z^
M]*G]D\'NOP]$.E[/^GK\SOGA=
M
M
M
M
M                                              "O?YD?K_PYW?A]
MM7SOSNWZI'B_?>OO2I_9/![K\/1#I>S_ *>OS.^>%T
M
M
M
M
M
M   *]_F1^O\ PYW?A]M7SOSNWZI'B_?>OO2I_9/![K\/1#I>S_IZ_,[YX70
M
M
M
M
M
M                    KW^9'Z_\.=WX?;5\[\[M^J1XOWWK[TJ?V3P>Z_#T
M0Z7L_P"GK\SOGA=
M
M
M
M
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M31=L+$D8BZ)N<OE5-= O1IX(
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M[X3RAF%ZQ7"WRW"GL=,RHJ;SM\.ED>^7P]D*.T>]$TUWZ(U?)JG:%Z+/"
M  S%;.JB\U_/K^&GXW3,HF7BIM*75*F19?#IDD5)/#V::KL[M0O1IT(
M
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MQR*UR?THJIHH92(
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MI<Q%DB21FK7HUVJ(Y.\,N@
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M]^6;_P 57'_1G#7@_P!'0P
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MFDCRFGEH:N]7&:Z4UMJ&JR:"G?##"WQ&.[6N?X2OVKY%37M"2T*$
M
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MK=(607.Y0/2L9$BI&L]--)3O>Q%UT:]T:O1/)KH&93\(
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MC_HSA?!_HZ&
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M+7(9
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M(OB]WY D2NWD'#:G,^-KU@U-51TM5=;<ZWLJY&JZ-CG,1NY6HNNG8$5OTU\
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M5VQQIHFJKVN<O>YR]JKVJ&74
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MXGQBNCQ-<CKJM+LYC? 6FD29&2:[ODNU30+X-U!D
M                                                 !Q\MIJBLQ6^
MTE)$Z:JJ+?5Q00LTW/D? ]K6IKIVJJZ ?YL\?<>=5'%MUJ;U@V+7.V7*KIUH
MZB9:2FJ=T"O;(K=L[9&IYS&KJB:AO_%B^^/7S]1N7_WIMG_P G^- =-5YYYN
MT&2_\<*>I@EA?1>Q%JJ2EH]S7I/X^WU9C-VBI'KN3L\GE"2DW45QW-R;Q)?\
M=H8/6+W#&VXV:---[JRC7>UC==$W2-WQ)K_C@AC'@'IJY'_XL8[<,XQ>LM>-
M6F?VG55%6QK8WR4B>)#'IJNNZ5&:I_BZA9E_HQ<:SV=;ZJO2GFJUI8GS)2TK
M/$J)?#:KMD3%5-SW::-35.T,O\]KCPOS?SYS0E]Y"Q^NQW'[A4)ZQ4U&U(Z&
MU4^JLIX=575ZM\UNC>V1RO<GR@UU;3SWB+%,XXSFXQ=2QT-GBIHX+*L3=?49
MJ5FVFDC[=?,TT=V^<U7-5?.4(R/TYXGSSP=R+/173#[E587=)?9]\=2M;- B
MQO5D5;"J.3<D:JJZ_I1N=V:[="RWN&7'RO&[;F.-7;%;NU76R\4DU%4[=$>C
M)V*S<U5UT<W7<U?A0#_/ZTX5U-],62W>+";+/?+5=&I"M90T4ESHZED3G+#,
MZ*'5\4K-SNQ^FFJIYR:*&O\ )6%TR=/O($G(DW,O+=--15\<M164-)6[6UE3
M<*Q'(^HEC3_5M8CWJUKD1=VBHB(WM$RF'5KTY7OD]]%G6"QLGRJW4_J=?;'.
M;$ZLI6.=)&Z)SE1OBQJYR:.7SFKWZM1'$B5(WW(^LG/,8_X6W/&;JZDD8REK
MJUUM?2SU4+-$1D]9+MB5JZ)O<BMW?I*J*NI?\:DZ9."7\*8E5>V98ZC,+\^.
M>[O@7=%!'"CDAIV.73=LWO<YWE<[LU1$4),KQ"
M                                                        %>_S
M(_7_ (<[OP^VKYWYW;]4CQ?OO7WI4_LG@]U^'HATO9_T]?F=\\+H
M                     'RJJ6FKJ6:BK(F3TE3&Z&H@D1',DCD16N:Y%[%1
M4714 Q[E/03:Y+O)<\ R^>Q4[GN?#0U<#JI8=WZ,=0R6)^U-51-S5=IWN7O#
M75Z<*Z$K)07N"]\@Y1-DK(I&ROML,"TT4ZL[FS2OEE>YBZ=J-VKIV:@ZM>,8
MR-C8XVHR-B(UC&IHB(G8B(B=R(&7Z        SQRUTJT7*O(D/(,^436N:&.
MDB2ACHV3M_Z&Y7:^(LK/E:_XO8%ZM#A
M
M
M
M
M        KW^9'Z_\.=WX?;5\[\[M^J1XOWWK[TJ?V3P>Z_#T0Z7L_P"GK\SO
MGA=
M
M
M
M
M                        "O?YD?K_ ,.=WX?;5\[\[M^J1XOWWK[TJ?V3
MP>Z_#T0Z7L_Z>OS.^>%T
M
M
M
M
M                                         *]_F1^O_#G=^'VU?._.
M[?JD>+]]Z^]*G]D\'NOP]$.E[/\ IZ_,[YX70
M
M
M
M
M                                                          KW
M^9'Z_P##G=^'VU?._.[?JD>+]]Z^]*G]D\'NOP]$.E[/^GK\SOGA=
M
M
M
M
M
M              "O?YD?K_PYW?A]M7SOSNWZI'B_?>OO2I_9/![K\/1#I>S_
M *>OS.^>%T
M
M
M
M
M                               *]_F1^O\ PYW?A]M7SOSNWZI'B_?>
MOO2I_9/![K\/1#I>S_IZ_,[YX70
M
M
M
M
M                                                KW^9'Z_\.=WX
M?;5\[\[M^J1XOWWK[TJ?V3P>Z_#T0Z7L_P"GK\SOGA=
M
M
M
M
M
M    "O?YD?K_ ,.=WX?;5\[\[M^J1XOWWK[TJ?V3P>Z_#T0Z7L_Z>OS.^>%T
M
M
M
M
M
M                     *]_F1^O_#G=^'VU?._.[?JD>+]]Z^]*G]D\'NOP
M]$.E[/\ IZ_,[YX70
M
M
M
M
M                                      KW^9'Z_P##G=^'VU?._.[?
MJD>+]]Z^]*G]D\'NOP]$.E[/^GK\SOGA=
M
M
M
M
M                                                      "O?YD?
MK_PYW?A]M7SOSNWZI'B_?>OO2I_9/![K\/1#I>S_ *>OS.^>%T  JHB:KV(G
M>H'.]X+#]J4G_P Q%](#T4URMU:JMHZN&H<WM5(9&2*GS54#T@
M
M
M
M
M
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M+;5=+E^C24U9"^9W^8Q':N_510)@
M
M     #Y5%33TD3IZJ9D$#?E22N1C4U^%7*B ?J*6*>-LT+VR1/35DC%1S53X
M45.Q0.1E^14N(XK>\IK-/5K-0U%?(U?TDIXG2;?SN5-$ J3I)L]SI.(:7(KY
M/+4WK+*RJO=5+.]SW;9I/#BTW*NB*R-)$1/\8+*[*JXV^B5K:RKAIW/^0DTC
M8U7\VY4U"/0US7M1S51S7)JUR=J*B^5 /Z
M
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M+%P/R;?),FL5\@]9Q#(JM7+4]SU9&][W.=H[PWQJQ[G*UZ-VKM<$:J"
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MJ:A'RT[=9G.VN5&21.1.]SFZA9;E#(
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M3HWQJ_X7:J$E<00
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M56-D:CG12;-$=WJB:(B%EM$,@
M
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MT6OPQR->Q?S!$G
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M==-%0$K8"
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M[Q[G*Y4EWH[R(J+IV!?!NT,@
M
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MR:KH8G+^BR7U>K8W7]%LB,D;\/B.4++7X9
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M7RA>K0U+2TU%30T5%"RGHZ=C8:>GA:D<4<4:(UK&-:B(UK431$3N"/J
M
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M\=EH_49[3L2H96;V2QR2RRR.W(]Z2)JK4TU:FB)W ZKV"
M
M                            K;FWB&BYJQ*GQ.ONDUH@IZZ*X^L4\;)G
M.=#%+&C%:]4[%\775%\@6$\M%O;:+306IDBS,H:>&E;*Y$1STA8C$<J)V(JZ
M:A%:<R<!8OS"MONE35U-BS"T:):LBMR[:B)J/WHQZ:IO:UVKF:.:YKM5:Y-5
MU+$H!0])=7>[Y;[MR_R'=<^H;4]'T5HJFN@IEVZ:)+OGF547]/;M5WE70'5I
M5L<;(TB8Q&Q-1&M8B(C4:B:(B)W::!&;;KTFRVG(+A?N'L]N?'L=U<KJ^UT;
M'34>KE552-K)H5:U-5V-=NV_HJB=@7JF_#G3]C7$=3<+[Z_59'FMV16W'([D
MNL[F.<CW,8FKE:CG(CGJY[G.5.U>Q$!,K=".9D>/6C++%<<:OU.E79[I ^EK
M:=55NZ*1-%T5-%:J=[7)VHO:@&:J+HZO&/RU%MP_EG(+%AE6]SY[+3[VO5KN
MQ462*>*-55.Q7>#_ $!>J;X1TP8;QYR%:LZQ:MGIH[7;GVY;;(QLBU,DK'MD
MJ9YU5'.D>K]RZ-1.Q$31.P'5RN8*/A+F#/*;AC-%K+=R!1Q>LV2Z0,2!RMFA
M\=60SN1[)$5&]K'M^4U=OG A#,QZ<L.X_P /O6:<DYK=\OH[#;ZIUDMM\J5]
M196/A?'3M2-7N5[UD5J,:US4U[T5 O5,>BBTU-LX*H:BHC=&ETN%;6P;D5%=
M%O; CM%\BK"N@26B C/?*_2O0<HYZ[/_ 'MK[%<E@AIHXZ*%BK&D#%9N;)O8
MY%<BKJ%ZHH_HE94)X-?R?D%32N_UD+NYR?!YTKD_Y O5;O$W3]QSPVDM3C%'
M+47RHC\&HO=P>DU8Z-=%5C5:UC(V*J:JC&)KY==$"=73YCXMH^8<*EPRNN,M
MKIY:F"J6J@C;*_6G551NURHFBZ_"!*,5L3,7QBR8S%.ZJCLM!2VYE3(B-?*V
MDA;"CW-;V(KMNJH@1'^5^+\?Y=PVJP_(=T4<KFST5?&UKIJ6JCUV2Q[NS715
M:Y/*URIY0(38>G>'&^%[OPY;,HJHJ6\S2OJ+SZO%X[8*E8_&A;'NVZ/8Q6*J
MKKHY0O5-^)^-;3Q+@]!A-HG?5PT;II9JZ5K62SS5$CI'/>C>Q-$5&)_DM0(F
MP%,U73Y;?^-T7-MGOM1:[JJL6OM<4,;Z>I1(/5Y4<Y514\2-$U[%T=YW>%ZK
MF"
M          KW^9'Z_P##G=^'VU?._.[?JD>+]]Z^]*G]D\'NOP]$.E[/^GK\
MSOGA=
M
M
M
M %6\M\!8'S$M)6Y RHH,AM[490WVVR)#61QM<KT8JN:YKVHY5<U'-U:JKM5-
M5U+U5W1]&F+55=35&<YCD67T%&])(+9<*M4IUT[-'*BN?HJ=GF.8H.K1MNMU
M#:*"EM5KIHZ.VT43*>DI8&HR**&)J-8QC4[$1J)HB!'I
M
M     %>_S(_7_ASN_#[:OG?G=OU2/%^^]?>E3^R>#W7X>B'2]G_3U^9WSPN@
M
M
M
M
M
M                    !7O\R/U_X<[OP^VKYWYW;]4CQ?OO7WI4_LG@]U^'
MHATO9_T]?F=\\+H
M
M
M
M
M                                    5[_,C]?^'.[\/MJ^=^=V_5(\
M7[[U]Z5/[)X/=?AZ(=+V?]/7YG?/"Z
M
M
M
M
M                                                   %>_S(_7_A
MSN_#[:OG?G=OU2/%^^]?>E3^R>#W7X>B'2]G_3U^9WSPN@
M
M
M
M
M
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M/_\ 3S97_7_/^_K_ .DQQ?OO7WI4_LG*]U^'HAV?9_T]?F=\\+H
M
M
M
M
M
M            5[_,C]?^'.[\/MJ^=^=V_5(\7[[U]Z5/[)X/=?AZ(=+V?]/7
MYG?/"Z
M
M
M
M
M                           %>_S(_7_ASN_#[:OG?G=OU2/%^^]?>E3^
MR>#W7X>B'2]G_3U^9WSPN@
M
M
M
M
M                                          !7O\R/U_X<[OP^VKYW
MYW;]4CQ?OO7WI4_LG@]U^'HATO9_T]?F=\\+H
M
M
M
M
M                                                          5[
M_,C]?^'.[\/MJ^=^=V_5(\7[[U]Z5/[)X/=?AZ(=+V?]/7YG?/"Z
M
M
M
M
M
M             %>_S(_7_ASN_#[:OG?G=OU2/%^^]?>E3^R>#W7X>B'2]G_3
MU^9WSPN@
M
M
M
M
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MNU&:IN0+#5B=R:]X0
M
M
M
M
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ML<NCX9HTVN5S>QS7[.U-=RZIVDE?H0
M
M
M
M
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MLZD\1XGSG%Z6S<C9118K<J1RU=EN51/"RHC<]-C](9'M66-^B(YK=.U$[45
MD,J3])O.N'LBR/C"_07J@GB95T5=8J^2@J987HDC'HUZQM7<W1R;97:A>JS>
MD7J#S_+\MJN-,^J779S*2:IH+E.U&UD4E*YJ/BF<U$WM5'*NYWG(J::KKV"8
M;.#(
M
M
M
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MIB8K*:FIU<CW1P[_ #G*]S6J][D3N1$1.W<297^$
M
M
M
M
M                                   *]_F1^O\ PYW?A]M7SOSNWZI'
MB_?>OO2I_9/![K\/1#I>S_IZ_,[YX70             _$T3)X9()-?#E:K'
MZ+HNCDT7M PX[H6SV]76%<LY!BJ[3 [:R96U575)#KJK6-G<C6*J)_CJB?E#
M75LG#,0L>!8O;,0QR!8+-:84@IV.5'/=VJY\CU1$U>]ZN>]=.URJ&7=
M
M
M
M
M                                                           *
M]_F1^O\ PYW?A]M7SOSNWZI'B_?>OO2I_9/![K\/1#I>S_IZ_,[YX70
M
M
M
M
M
M                KW^9'Z_\.=WX?;5\[\[M^J1XOWWK[TJ?V3P>Z_#T0Z7L
M_P"GK\SOGA=
M
M
M
M
M                                "O?YD?K_ ,.=WX?;5\[\[M^J1XOW
MWK[TJ?V3P>Z_#T0Z7L_Z>OS.^>%T
M
M
M
M
M                                                 *]_F1^O_#G=
M^'VU?._.[?JD>+]]Z^]*G]D\'NOP]$.E[/\ IZ_,[YX70
M
M
M
M
M
M      KW^9'Z_P##G=^'VU?._.[?JD>+]]Z^]*G]D\'NOP]$.E[/^GK\SOGA
M=
M
M
M
M
M                      "O?YD?K_PYW?A]M7SOSNWZI'B_?>OO2I_9/![K
M\/1#I>S_ *>OS.^>%T
M
M
M
M
M                                       *]_F1^O\ PYW?A]M7SOSN
MWZI'B_?>OO2I_9/![K\/1#I>S_IZ_,[YX70
M
M
M
M
M                                                        KW^9
M'Z_\.=WX?;5\[\[M^J1XOWWK[TJ?V3P>Z_#T0Z7L_P"GK\SOGA=
M
M
M
M
M
M            "O?YD?K_ ,.=WX?;5\[\[M^J1XOWWK[TJ?V3P>Z_#T0Z7L_Z
M>OS.^>%T
M
M
M
M
M                             *]_F1^O_#G=^'VU?._.[?JD>+]]Z^]*
MG]D\'NOP]$.E[/\ IZ_,[YX70
M
M
M
M
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M/KWIW Z+D"
M            <?*\CHL0QF[Y5<8Y):"RT<]?4QP(CI714T:R.1B.5J*Y43LU
M5 (;P_SAA?-=MKZ[%5J*>IMDK8JVW5S61U+&R)K')MC?(BL?HY$7=WM5 LPL
MH(K?C3FK&>4KWE-AL-)6TU7B50VDN#ZQD;(Y'NDFB18E9(]536%WRD3R!>BR
M @     $.Y0Y(LO%&(5.:7^GJ:FV4LL,,D-$UCYE=42)&U421[&Z(J]OG =K
M%<BHLNQFT93;HY(J"]4<%PIHYT1LK8JF-)&H]&JY$<B.[=%4#K@
M    ^-554M#335M;/'34=.QTM143/;'%'&Q-7.>YRHC6HB:JJ@<C$LPQW.K.
MF08K6MN-F?--3Q5C&N;'(^FD6)ZLW(FYNYJHCD[%\G8!%N->9\8Y1O656*PT
MM93U>(U3:.XNK&1L9(]\DT2.B6.1ZJW6!WRD3R!>BQ@@
M
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M2-[VZ+Y/. F@
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M_P!XS@[[PI_^T8 L/QUC?VC\*?>TO];H 0U\&0
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MPNVM_2V;E3X =&EF/9(QLD;D?&]$<Q[5U147M145.]%"/T
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MNVFM=V14CG?HJ[&2.9&J/73S4>Q$=^BJKV Z)1S!S3:N'I,8]L4#JFCR.O\
M4)*SQFP14;&[-TTFYKM6M1^Y=/(@(A6-WZN;G)ZW=\%XPOF3X/0O>V;)VMEI
MZ:2.)5:Z2-&T\OF=FNKW(NGRD:#HMOA_F+%>:,;DR#&?%@EI94I[E;:I$;44
MTRMW(B[55'-<G:Q[5T7M[E140*^S#JBBH\NN.#<989<^0+]9W.CNTENUCI()
M6*K7LWMCF<JM<BM<JM:W=V(J@Z/O@'5!:\CS.GXZSC%KE@F:5FB4-'<D5\,[
MW(JM:CW,B<U7Z+LU9M=W([71%'1?@0
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M_'6-_:/PI][2_P!;H 0U\&0
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MH.C7EE2U)9K<EB=$^R)30I;74[M\*TJ1M\)8W(JZMV:;5U[@R]P
M
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M$,@
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M<O;\"@AJ$(
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M2Q#4_$V*5^#<:XOB5TE2:Y6FWPT]6]B[F),C=SVM7RM:J[6K\"!E,@
M
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M/'JE\MOJEFO>9STOJK8*5RM14<].U6,1%>B2*CE=HUB:JH.YNX,@
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M4\<;%5&QP1KM;V]O:OP(A4Y"
M                                       _CFM>U6/1',<BHYJIJBHO
M>BH!\::BHZ-'-HZ>*G:_M<D3&L153X=J(!]P 'XEBBGC=%,QLD3TT<QZ(YJI
M^5%[ /S3TM-2,\*DAC@C5=59$U&-U7RZ-1 /KW]X'PJ*.DJT:VKIXYVL75B2
ML:]$7X4W(N@'W1$1-$[$3N0#\O8R5CHY&H^-R:.8Y$5%1?(J*!\J:BHZ-')1
MT\5.C]%>D3&QZZ=VNU$U ^X'GJ+?053VRU5+#/(SL:^6-KW(G?V*Y% ]
M  ?&II*2L:C*N".H8U=6ME8UZ(OPHCD4#Z,CCB8V.-B,C:FC6-1$:B? B(!^
MD1$[DT ^:4\#95G;$Q)W)HZ5&IO5/@5>\#Z ?F2..9CHI6-DC>FCF.1'-5/@
M5% ^=/24M(Q8Z2"."-5U5D3&L15^'1J(!]@ #3R^4#\O8R1CHY&HYCD5'-<F
MJ*B]Z*B@?*FH:*CW>ITT5/O^5X3&LUT^':B ?<
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M $%/3TL:0TT3(8D75&1M1C=5_(B(@'U
M                              *]_F1^O_#G=^'VU?._.[?JD>+]]Z^]
M*G]D\'NOP]$.E[/^GK\SOGA=
M
M
M
M
M                                             "O?YD?K_P .=WX?
M;5\[\[M^J1XOWWK[TJ?V3P>Z_#T0Z7L_Z>OS.^>%T
M
M
M
M
M
M  *]_F1^O_#G=^'VU?._.[?JD>+]]Z^]*G]D\'NOP]$.E[/^GK\SOGA=
M
M
M
M
M
M                 "O?YD?K_P .=WX?;5\[\[M^J1XOWWK[TJ?V3P>Z_#T0
MZ7L_Z>OS.^>%T
M
M
M
M
M                                  *]_F1^O_#G=^'VU?._.[?JD>+]
M]Z^]*G]D\'NOP]$.E[/^GK\SOGA=
M
M
M
M
M                                                 "O?YD?K_P .
M=WX?;5\[\[M^J1XOWWK[TJ?V3P>Z_#T0Z7L_Z>OS.^>%T
M
M
M
M
M
M      *]_F1^O_#G=^'VU?._.[?JD>+]]Z^]*G]D\'NOP]$.E[/^GK\SOGA=
M
M
M
M
M
M                     "O?YD?K_P .=WX?;5\[\[M^J1XOWWK[TJ?V3P>Z
M_#T0Z7L_Z>OS.^>%T
M
M
M
M
M                                      *]_F1^O_#G=^'VU?._.[?J
MD>+]]Z^]*G]D\'NOP]$.E[/^GK\SOGA=
M
M
M
M
M                                                     "O?YD?K
M_P .=WX?;5\[\[M^J1XOWWK[TJ?V3P>Z_#T0Z7L_Z>OS.^>%T
M
M
M
M
M
M          *]_F1^O_#G=^'VU?._.[?JD>+]]Z^]*G]D\'NOP]$.E[/^GK\S
MOGA=
M
M
M
M
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M8NSS&(BKY5=Y$+T7.$
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M#_K>W_E M8(
M                             4CU4Y_EG&W%GO)AM<EOO'M*EIO6%BBG
M_<RMD5S=LS7M[=J=N@6'DZ7N=_\ C'B4E'?I6)GECT9=FM1L:5,+U7PJIC&H
MB(B_(D1O8UZ>1'-0$PM7D*Z5]CP+*;U:Y4@N=MM%?644RM1Z,GIZ:22-VUR*
MBZ.:BZ*$5YTN9WE/(W%%-DV85J7"]25U7 ZH2**#6.)Z(U-L36-[/S!97.$
M     SKU/\H9OQU>>.*3#[DE!3W^Y34UU:L$,_BQ,DI6M365CE;V2/\ DZ+V
MA8:*"              *PY[Y8EX9X_FR^FMJ72N?4Q4%'3R/\.)LT[7N;)(J
M><K&[.UK>U>[5.]"PD3+EDM[XP;=[+X3<QN-A2KM^U&MA2YU%'XD6B2JK4;X
MKD^6JIIWA'-X:9R?'@].WEYS'YIX\_CNC6F5O@;_ -U_U72/Y/P?TA93\(
M
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MU$_9XC>RH6&5415VK&V)B?EF!X-+A
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M26%TC4<L;T35-S==J_E#+T@
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MNT3<G81J4(
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M
M        ! ><?[&\]^X+E_5GA85YT7_V!67_ 'NX?UIX)5-E%!5])7.M+FEG
MC<SAW.9?5[M21HJQ4CW.W2,1K45$6%7+/!V=L>^-.Y5"][L=&-52UN?\S5M!
M.RJH:BYPS4U3'VLEBDJJ]S'M_(Y%14!+Z=&DD5%G/,5EK_,R%EUC?.Q_9(YD
M-161O7M[?->[M_SD!+1/,-;;[?Q1FU5=%:E"VQW%DB/[G+)3/8UOYW.<C4_*
MH9A571+354'!-%)4(J15-RKY:75-$\))$C73\F]CPLK^NT4\]JKH*75*F2GE
M9"J=B^(YBHW_ )0C*_0-/3-X_P JMBHC+M2WOQ*R)>R1L<M-$R/<G>GG12)_
M0H:E:O5'64%%P+FCK@K4CFI(X(6N7Y4\M1&V)$^%4<J+_0$AG[+*>JI>@:QQ
MU:*DCEI96(Y-%\*6Z/DC_H5CFJ@7Q:KX>J:*KXHPB>WJU:1UBMK8]G8B;*6-
MJIIY%145%#+._+KF7/K/XMH;8J2U]#10R5S8_E,8R2LG5'*G_P!$BNT^!?RA
MKP2GE?A#C#FS.:NLQC,&6/EFT0M2XK;)8ZB1J0:1L=4P,>Q[7LU:S>U[5TT1
M==$"=5;Y+_YKNFZV>\]7D]/G&!T,D+*QM:Y]2]D<CTB9XGCHV=B*JM:BQS.1
M%5-0O^2^/5]D;<\XUXESJC\2W62[SOJ9E>GB.II:J"%[4731'*Q&2_GT!"Q8
MNG_G.HB944_/]SD@E:CXI&4TBM<QR:HJ*E7HJ*@3JY6"\,.Q[GRTY!E',4&4
M<@6J&1);%4QM9<YJ:6DE:UOG5+W(UK)/$^0O8%>:SM:[KWORN1%5MG:K57R+
M[-IDU3^A0>#6E;14MRHJFW5T39Z*KB?3U,+^UKXI6JQ[5_(J*J!EBSAC.9.G
M^GYGXUOCU>_#/'ON/LE[YVO1L$?8NG9+OI'=G^.JAJ5H]&^%5./<6ORZ[;GY
M!F]6^[U<TG^L=3HKF0;E\N[SYD7_ .D"2A\?*W.?/6<Y'CO"U=08IA>-3)2U
M-^K8FS5$SM[V-<F^.;MD\-SF,:QNUORG:J@5#^H;B/D/&^*+IE/(O*UPR:HB
MGI(J2Q-8M+;Y)9IV-7<SQ%1ZM;N>W2---H(7"W^Y7_\ X*O]14)XO9T9_P!W
M_'_]YN/]=E!* =)3)9,WYTC@7;.^\;8W=VCUJ*]$7_""7ZZ"988<3S6TS^;>
MZ2\L?71N[)$8^!&,W>7Y<4H65Q]2U904/!.<2W!6I#);G01[ETUGGD9'"B?E
M\1S0D,]5=-5TO_I^Q,K%7?(R.6)%314AEOF]G^%JZH%\6E> 6M;PG@2-1$3V
M)1+HGPK$U57^E0DJ1J_[^E!]QN_J$H7P23EOA3B[FW.)WV'+V63ENST[?7?9
MLT=1,V*!48QU33M>Q[7,5[6H]KVNT5$77S="=5:9)3=5_3C:WY1)E5/F^"V]
MT25L=:Y]2]D3WI&WQ$G1L[455:W6*9VFO:%_R6MN/LPIL_PFQ9G20.IH;U1Q
MU?JSUW+$]R:/9NT37:Y%3=IV]X924
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M]=39C@-SJO5?:#7)+.UJ:*_9,K(I4D1OGM;,CFNT5$7RH.]MCO[0R
M                                                   *]_F1^O\
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MED;V))4:;YY/UY'/?_2&4I
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M='$J[G)%"U&IN7RN735R^5>T,NH
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MKW*WS4VZZ@ZM2!
M            !7O\R/U_X<[OP^VKYWYW;]4CQ?OO7WI4_LG@]U^'HATO9_T]
M?F=\\+H                                     #FY#0U]SL%UMMJK7
M6VZ5E)44]#<6=KJ:HEB<V.9$^%CE1W] &?>/NG/.EY"H.2.;<Q;EUUL*?_@_
M10(]:>*7]&5V]D2-5B^<C61]K]'*[S=%+U:4"
M
M
M
M
M                 *]_F1^O_#G=^'VU?._.[?JD>+]]Z^]*G]D\'NOP]$.E
M[/\ IZ_,[YX70
M
M
M
M
M                                  KW^9'Z_P##G=^'VU?._.[?JD>+
M]]Z^]*G]D\'NOP]$.E[/^GK\SOGA=
M
M
M
M
M                                                  "O?YD?K_PY
MW?A]M7SOSNWZI'B_?>OO2I_9/![K\/1#I>S_ *>OS.^>%T
M
M
M
M
M
M       *]_F1^O\ PYW?A]M7SOSNWZI'B_?>OO2I_9/![K\/1#I>S_IZ_,[Y
MX70
M
M
M
M
M                        KW^9'Z_\.=WX?;5\[\[M^J1XOWWK[TJ?V3P>
MZ_#T0Z7L_P"GK\SOGA=
M
M
M
M
M                                        "O?YD?K_ ,.=WX?;5\[\
M[M^J1XOWWK[TJ?V3P>Z_#T0Z7L_Z>OS.^>%T
M
M
M
M
M                                                         *]_
MF1^O_#G=^'VU?._.[?JD>+]]Z^]*G]D\'NOP]$.E[/\ IZ_,[YX70
M
M
M
M
M
M              KW^9'Z_P##G=^'VU?._.[?JD>+]]Z^]*G]D\'NOP]$.E[/
M^GK\SOGA=
M
M
M                                                   $.S#E?CK
M*VGMV99%26:NJHO6*>"I<Y'/B1RLW)M:O9JBH!'/_,GP5^.K;\]_T O07J3X
M*3M]^K;\]_T =%FT592W&CI[A12MGHJN)D]-,SM:^*5J.8Y/R*BHH1]P
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MI? M%+.JH^IEWLCVLT1>W=(U.WX0)&          ?QSFM:KG*B-1-55>Q$1
M/G3U-/60155)*R>EF:DD,T3D?&]CDU1S7-U145.Y4 ^H
M!7O\R/U_X<[OP^VKYWYW;]4CQ?OO7WI4_LG@]U^'HATO9_T]?F=\\+H
M
M
M
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M[OP^VKYWYW;]4CQ?OO7WI4_LG@]U^'HATO9_T]?F=\\+H
M
M
M
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M0CA'E&HY>PGWNJK(^P2^N34?J+Y5G54A1B[T>Z.+L7=_B^0+*QP@
M         <7,+_[J8E?LH]7];]B6ZKN7JJ/\/Q?4X'S;-^CMN[;IKHN@$4X2
MY17F' Z?-5M?L=9ZBHIO4O']9T]7?MW;]D??\&T+*Q0@
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M$K)'[DU@?WHGD"]%A!
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M=,8NLU-+IHY/^AS-<QZ?HO8Y%8]OD<BH!!>B?^P>W_>%?_M02T0$
M
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ME+<;BQTE-WZ*YZOB@<C4_25C7:>7L!T:3:YKVM>QR.8Y$5KD75%1>Y44(_H
M
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M1I)%"KE755\&-[8NW_,"]4FNG%W'5ZI+107/&+=/16!7+9*?U=C(Z-7JUSO
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M--% C^&\3\<\>UE7<,+QZEL];6L\*JFI]^Y\:.1VWSW.T;JFNB 3(
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MT0$
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MLTT75=4#+V@
M                                            '+N6-8[>:VBN-WM%
M%<+A;7>);JNKIHIYJ9^Y';H7R-5S%U:U=6JG:B =0
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M8^35KE9(B+HJ=W8"5ZA
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MB5,MHIK=%43QHNV2IDN$,LSVIIKM61[E37R!([UN<!HJ<*X$BIHJ6.AU1?\
MF6@E2%6CO_/E0.VKM]AN371=/^H2^4+X.AR#R_R3PCS3/<<[;67CA"\P(RV2
MT5+#MH)7[%7<YC&JZ2-S7IMDDU=&[<W54VA.B$\]\X\8<W8C[B<>6&KRW/+G
M+3MM50VWNCEHE;*U[WM>]$DU5J*Q4;YNCE5RZ)VEB&I^),5N.$<9XMB=XE26
MZ6JW04]8YKM[6S(W5S&N\K6*NQJ_ @93,
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MAD;V35U.QU1=:J-/-FKJA=\KDU1%5K5TC8JIKL:FH)6 $
M,U]0V 9EE?+?#]]QVSSW"T8_<V5%XJXE9LIXDKJ217/W.1=$;&YW8GD"PTH$
M
M                        ?Q41R*UR:M7L5%[4 _C&,C;M8U&M^!J:)_R
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M?A1'HN@'UBIZ>"%M-!$R.G:FUL+&HUB-^!&IV: ?IC&1MVQM1C>_1J:)V_F
M^+:&B94NK&4T3:M_8^H1C4D5/RN1-5 ^S8XV*JL8C5=VN5$1-5_*!^9X(*J%
M]/4Q,F@D322*1J/8Y/@5%U10/E16ZWVYCHK?20TD;EW.93QMB:J_"J,1 /0Y
MC7M5KVHYJ]Z*FJ &M1J(UJ(C4[$1.Q$ _GAQ[_$V)XG=OT3=I^<#^2PQ3QNA
MGC;+"]-KXWHCFN1?(J+V*!YJ*TVNVJY;=0T]&K_EK3Q,BW:?#L1-0/8
M
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M9L*LE)E-KME-QY#9XEQROI)%=73/\1$:D[?%<B:L5RKYC>W0$M%A
M                                   "O?YD?K_PYW?A]M7SOSNWZI'B
M_?>OO2I_9/![K\/1#I>S_IZ_,[YX70
M
M
M
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MK_PYW?A]M7SOSNWZI'B_?>OO2I_9/![K\/1#I>S_ *>OS.^>%T
M
M
M
M                                4_U.<?W[DGB&ZX]C$*55]CFIJZDI
M%<D:S+32(KV-<Y43<K%=MU7M7L"PB7#F2\JY!QW><%S7 JK'7V''6VRTUDC)
M(_7Y8J9U,C49*B(CE1K%\URIVKW ET>D'#\HPCB>6RY;:I[/=5NU5.VEJFHU
MZQ21PHUZ(BKV*K53^@$N+U.8+F&6Y[Q'<<:LU3<Z"R75]1=JBG:CF4\7K-$]
M'/U5-$5L;U_H!"0=2?"=YY/MUER;!ZIM#R+B4_K5FE>Y(FS-W-D6/>O8U[7Q
MM?$YWFHNJ+HCMR")1"'J ZA:2T)9Z_A&YU.:,:D*W&+QO93YM-/%5&1.1&Z]
MJM2?3_*0'1*.F_BK/L3??L]Y2N4L^:Y5(Z62U>.LL%'%)(LK]6L<L7B/<J=C
M-48UJ-:O:J()7Z$9JZML&S#-%X^]T[-4W?V9=GU-?ZJU'>#%^YT<[54T1=J_
MX L+3YJXNH^8./KCAM1.E)5R*RJM=:J;D@K8-5C<Y/*UR*YC].W:Y=.T$*,P
M_D_J)XHL4&"9AQ3<<OFL\*4=JOEG>^6.:GA3;$DKXH9VKHW1-Z[7:)YS=VJA
M7OXOXJY-SWEQG/'-5)'9Y+=%X6,8PQR/? U$>V-9$17;6Q[WO1'+O=([<J-1
M$12/3E^!9E7=86'YS266IFQ&AMR0U=W:U/5XY/5ZUNURZ]^LC$[O*#P?KDG!
M,QNO5AQ[F=NLM34XK:Z&**ONT;46GA>CZU5:Y==45$>SR>4'@]_4+PUFEZRB
MP<R\2R1MY$QEJ1R4$KFL;6TT:N<U&JY6M5R))(Q[7JF]CM-R*U$41+C5W/74
M3=[4MBQ_A:Y6S,IVK MUJU>MMAD5-OBL6:*.->WM:CYMJ>57(#HG73=PG5</
M8Q7S9!5-KLWR29M9?:F-5>QBLW>'"UZ]K]JO>YS_ "N<OD1%!,J2ZI^%N2+[
MR>F0\;VRIJZ#+;7!;,CEI4;L1T$[$TF5531BMC@=^H%A??,W%[<CX%NO'EAI
MEJ*JVVRG;8J=J(CW36I&.A8S5=-STB\/]8)"!=('&>98G093EW(U'4TF77VI
M@I&-K]%J/4J&)-K^Q5T1[G[>W_W: E]>9,&S"^]1G%64V>S5-;CUF6/VI<8F
MHL-/I4O<N]55--&KJ"'\ZA\%S#)^7^'KYC]FJ;C:+%<F37>K@:BQTT?KM*]7
M/5531$:QSOZ 0TL$9JZ1,%R["[=G,.7V6HM#KE=DJ*-E6UJ>+"K'HJIHJZIV
MA91>EP#FKIMS"^5G$EABS3C#()O6EL7BI'4T<FJJC6HKMR*U%V(]K7HYFW<F
MY$"]ZL^J"IYLS+":',^2[738;B]%<(Z.RXJR7UBJGJJF.5SJB=R*J:L9&K6[
MD;WKHU-551#=^'1/AQ&P0R)I)';J-CD_*V!B*&7: Q5QE;>:^!>3<FL-+@%1
MD6*95>895O=+O=%%1I/)I,U[$<U%\.;5S)-JHK0TL&GP?+V]9%7G3K-4IA[[
M0E,R\JU/5EE]3C9M1====R*WN[PG@7G!LPGZR,=SJ&S5,F'TUIDIJB\M:GJT
M<JT56Q&N7777<]K>[O4'@L'J.L%[RGA7*[!CM#+<KS6PTS*6BIT199%;60/=
MM153N:U7+^8$/;P)9+MCG#V(6.^T<EON]#0I%5T<Z(DD;TD>NCD15\BZ@E5^
M!8+F%MZM\]S:OLU3!B=RMBP4-V>U$IY9-*!-K5UU5?W;_)Y >#E\B<8<H<8\
MNU7.'"]O9?Z2]L5F48LKD;)(LFWQ71IJBN1[F-E16:O;)KV.8JH!S\WY*ZBN
M7;'+@6&\67/#77=B4]UOEVD?"V.GD[)6QR2Q0(U%3L<Y-SMNJ-;KHH5/,NP1
M_&_2IDV)5%PENU?1V.K?7W&=[Y'35,J*^16[U548BKM8WR-1/+J$\5,=/F;\
MT\7\9V>>DPBHS_CR]>L5=F=9WO6NH)DGDBGADC;'([8Z1BO3S-/.5=R_)0LI
MSA?'W*',O+ELYBY?LR8MCN,(UV+XM([?4+,Q5DC?(BZ.;M>OB/>]K7.<UK4;
MM0"0]0_#697W)<?YBXFDC;R+BZ-C=0RN:QM;31N<]K6JY6MW)OD8YKU1'L=I
MN3:B*2)<6MYZZB;M:EL5AX5N5MS.=JP+=:M7K;(9%3;XK/%BC8O;VM1\VU/*
MKD!T3GIMX2J^(,:N%3D=4VNSG)9FUE]J(W*]C-FY8X4>O:]6K(]SW^5SE[T1
M%43*+=)>#YAAD_(KLKLU3:&W2[QU-O6J:C?&B19]7-T5=43<G^$$OSTSX)F&
M)<B<O73)+-4VRWWRZMJ+345#4:RIB];K7[F:*NJ;9&+_ $@EW>KW$,GS?B5M
MDQ*USW>Z^U:2=:6E:CI$BC9+N?HJIV(JI_A!#M\DX%?<UZ=ZK!;= C,CGLM
MR&DF<D:^M47@3>$KE7:CE6)6:JNFO>N@$/Z7LCY5I;?1\9YU@55C]HQVV.CI
M+_,R2-E1+%,UK(E1R;556/<NYCE1=OY02T>$
M                   *]_F1^O\ PYW?A]M7SOSNWZI'B_?>OO2I_9/![K\/
M1#I>S_IZ_,[YX70
M
M
M
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M #(_7_ASN_#[:OG?G=OU2/%^^]?>E3^R>#W7X>B'2]G_ $]?F=\\+H
M
M
M
M
M
M               5[_,C]?\ ASN_#[:OG?G=OU2/%^^]?>E3^R>#W7X>B'2]
MG_3U^9WSPN@
M
M
M
M
M                               !7O\ ,C]?^'.[\/MJ^=^=V_5(\7[[
MU]Z5/[)X/=?AZ(=+V?\ 3U^9WSPN@
M
M
M
M
M                                                 !7O\R/U_P"'
M.[\/MJ^=^=V_5(\7[[U]Z5/[)X/=?AZ(=+V?]/7YG?/"Z
M
M
M
M
M
M      %>_P R/U_X<[OP^VKYWYW;]4CQ?OO7WI4_LG@]U^'HATO9_P!/7YG?
M/"Z
M
M
M
M
M                        %>_S(_7_ (<[OP^VKYWYW;]4CQ?OO7WI4_LG
M@]U^'HATO9_T]?F=\\+H
M
M
M
M
M                                         5[_ #(_7_ASN_#[:OG?
MG=OU2/%^^]?>E3^R>#W7X>B'2]G_ $]?F=\\+H
M
M
M
M
M                                                           5
M[_,C]?\ ASN_#[:OG?G=OU2/%^^]?>E3^R>#W7X>B'2]G_3U^9WSPN@
M
M
M
M
M
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M(WPU5FGB;M-O9\ 1V0
M                    0WEJ_P!TQ7C++<DLDJ07>U6NJK**9S&R-9-#&KFJ
MK7HK5T5.Y4 BG31G>2\C\2VS*\MJF5E[J:BLBEGCBC@:K()W,8FR)&M[$3X
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M0(XF\?MG?[F.C]3WK!X[]F[P%67_ %6W7Q0+4"
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MD2O7X&HY4U_H ]2*BHBHNJ+VHJ ?T
MKW^9'Z_\.=WX?;5\[\[M^J1XOWWK[TJ?V3P>Z_#T0Z7L_P"GK\SOGA=   8\
MZ*/^^7,GWE2?UBX!J7GR3E'FR?J0S'BK +@DLM>RFIK.M>K%H;1'ZK3U-15[
M/#=N<B;D:CM4U=\ERZ(!^.2<5ZEN$\?DY-H^5)LII;:^)]YME9"J0MCED;'J
MR&1\K'LW/1';?#<B+JG=V!<V1\EW*_\ 3/7\H6*1UHO-5C[KA"Z!4<M-5M;I
M(C%<BZHUZ.1JJG<$>;@[DFK7IPM_)?(%REKYJ.FN=;=*^1&K-)'25E0UK41$
M:BNVL:QJ>5= 2J["TZA^I6&HSF/,Y.-L EFDAL5#;(EEGF;"Y6.<KFOA>]$<
MFQTCI-%<CMK&H%[G2LW(/+' W)MBX\Y@O3<MP;+)/5[%E3V>%4PSJYL>DGET
M1[V)*U[G;6O1[7]BM G/4ES5?>-:.Q8I@5*RNY'R^H]5M$;VI(V!FYL?B;%7
M1SWO>UD2.\W755UVZ*2(0N;A+JAI[,[(X.9*B?-61K4>P4B_^USID3=X+9'O
M2+M7S45U,C?AT0+UA\(,TY'YWZ?KI6MN,^#Y9C?K:9,Y*-Z172C@HI5<R-K]
MNQ)=='Z*NU[%[-%0#A=%&(YW/8;=EU/F3X<$IJZX0U6')3HK)IE@V)(LRNU3
M1[V/T1OZ/Y02GO!F>9CD?.O+N-WV\SU]BL59+':*&79X=.Q*R5B-9M:B]C6H
MWM4)+@Y3R=RKS3RG=^*.%;G'C6.8RKX\BRQS$DE=+$_PWI&JHNU/$161MCT<
M_:YV]&]P<_-[-U']/EL_X@6[D"7D+%Z![%OUJN\#D>V"1Z-WM1\DSMB*J(KH
MY&N;KKM5N[0JSN1>59+]TS73E3 ZV6V5-5;X:JBG8K5GIIO6HX9HE545-S'(
M^-RZ?F"*NP"FZC>H'#[5D#,X=@6*T],RBHIZ2-T]QNE32IX4]9,]CH5:CY6N
MT1'HB:*B-_2<5TN(.0^6,&YPEX%Y6N[<EBKJ>2ILEZ<B>-YD+JACMZHUSF/9
M'(US9-7->G8[;WAK$,J6ZG>7[MP]QXR[8]$Q^17:L9;+=/.U'PT[GQOE?,YJ
M]CE:UBHUJ]FY45=4144L("S@_J0FL[<BI^;ZF7*I84J8[:V)5M3I7)O1C9$D
M5FQ>Y'>K:?Y.@.JS>GO-.1\QPN5_*=AJ;+E5NJ74KYJFE=1-K8=J.;.V-R-1
M%UW-?L3;V:IWZ()5?TX95R/RAA_)UNN&5U+;[#6NH+%=YV,E=0N?'(C7M8U&
M:Z*B+H"5.\.X#RC=^;>1K)8N1);/D-IJ9$OM[;2I*ZY+'6*QRJQ7(C-7(KN]
M?@"RT!SWS'G%#F=DX3X>BB=R%?V)-57.9&O90TS]RHJ(Y'-1R,8^5[G-=L8B
M:-<YR:$B$?N_#_4[B%HDRO&^7*K)<DHF+538[5TZK2U'AIN?%#XLDK7*J(J-
M18F;OA:#_%M\!\P4W-&!0Y*L#**]TLSJ&]T,:JL<=7&UKMT>Y5=X;VN:]NO=
MVMU56Z@F%HA&-.5>5>8K9U'73C7CZN=437NW4U!8Z"H<U*2AJJJGCEDK=-BZ
MK$QLC_.U1._1VFU32Q<"L_*O"5KR_,N:,[7*<5M]N2KI::-[YY4J&JYTB(M1
M&QS571L<36OVN5_:C=$"('A-'U%]1U'+GL^<R<<85522,L%MM,3I)I(XGJQ7
M*K7P/<U%16[WR><Y%T8UN@7N=?&.1>5.%.4[-Q9S)=X\HQ;*G)%C>6*SPIV3
MN<D;62>54\1S62->KE;O:Y'[>P"8=0O)/)5BN6-\=\36YZY5E,B,??Y:=TM)
M0PO?X;5WJQ\:/5=SGJ]%V,;KM57)H2$4N? O4?2VV2[VGFZNKLFB8LK+9+%)
M!122-15\-KUF>U-5[$5T&GPZ ZIETL<P7[EW ZRJRQK%R2QUJT%;51,2)E0Q
M8VR1RJQNC6O[7-<C4T[-4TUT03"MJ;.N8>I7.;]:.+\C3".+L;F2EEOL$?B5
M=9(KG-:YBHK7JKT:Y[6,>QK6:;U5RIJ7N?R\W?GCIMRG'Y\AR2JY,XUO=0E'
M7.EIGON%._35RL1%FD1R-W/8B2.:_:K51JZ*#O07JEQ;.:?F7!):C,WU$60W
M=S\3:L&WV'OJJ1C5;HO[S1SF/\B^8"%P\P5')_$/3I<*FKS:HN^:TUPIU;D<
M<3:>7P*BI:WPT8N]-$:N@2$RNG+S>.NGFQ\E9&YUUO$MDMCXXWN1DE;<ZVFC
M5$<K4T3<Y72/5$[&H[1/(!5>'X)U,\P62#/LCY/GPF*[1I5V:QVNG<C&TTB;
MHG2-CEAVM<B[D1SI';53<NO8%=7BWEGDS!^5V\$<WU$5TK*^/Q<8R>-J,6H:
MJ.6-KU1K$<V1&/8URMWMD;M7=KJA'.YWY9Y1PWJ#QW%,#F?7I>+-%#08_*YK
M**2Y5TU53QSS:MU5L>C7KY[4\SM5$U"Q#XYIQ?U1XOCM?R!3<NRW._6R"2XU
MMCBA6&B6.!JRR-@:[6)^C47:UU.U'=W8#_%T]/7)]9RYQA;<KNL,<-Z;)-0W
M1L*;8G5%,Y$WL1==$>Q6O5/(JJG<$E:00
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MM^J1XOWWK[TJ?V3P>Z_#T0Z7L_Z>OS.^>%T  !CSHH_[Y<R?>5)_6+@&I>C
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MXBXBYIR3C/&;WBG-$]KL%71,6CMD5(Y[*5&*K'P([QDU\-[7,7L[T"F;=/\
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MZN\,J'Z&?[$7_?5;_LX LM+!
M                    %=<^?V*9]]QUW^Q<%A ^B_\ L"LO^]W#^M/!+0(1
MD*9[*'KWC==%1C:ZTHVTND[$5RVU6^:J_"L<J?G[ UX->AEB'I_9+>,OZCJ[
M&D5;;6-KF6]T?G-?+/-7.@5CD[^S54_.&I6!T(U%')PU6P0.;ZU#?*KUMJ?*
MW/@IU:J_G;II^8)*]<YY'PKC:AI+EF]VCM%#73^J4LTC)9$=-L=)MTB8]43:
MU?.5-/RA%(\K\V<D5_*D'!_"5+2)E#(&5-WO=R;NBIFR1).B-:Y%:C6QN8YS
MG->JJY&M;KWEZ.1DG#O/E7B][NO)',\T=JH[?555;0V6G2FCDCAA>]S'2L]6
M1&*B:.UC75 O5^NC3^[M?OO&Z?U. ))T#?V4W[[_ )OZG2A9:L#+(U=_?WMO
MW,[_ +-F#7@[O6EB=;)AUBY2L.L>0X'<8:IL[4\YM-/*Q-W9VKLF9"Y/@3<$
MA#^9\D9S_F/#7&=HU]B9!3TV6WZ-BZ[*::-RJQRIW/BBCJ&]OZ3FA863UF1Q
MP]/UXBB:C(HZJW-8QJ:-:UM3&B(B)W(B!(6;PY&R+B7!8XVHUB6"V:-3N_ZI
M&$EGKIX_O1<V?\_5?]H*&I[GJZ^O[-<9^_F?U2H"0_77&L:</8LLJ:Q)>Z-7
MI\+?4JC4+#4MMFIJBW4=11.:^CE@CDIW,^0L3F(K5;IY-.X,LGTJMN/7K5/M
M?GLMUG5+LYG:B+[/:SSE3X'2Q-_.&O!_..VM7KFY%5415;:%5J_ OA6U >"W
M^I_^P3./]RC_ *Q$$AGCD&"JEZ$<2?3HO@P/H9*O3N\):J9B:_DWN8%\6L>(
MZJAK.*\*J+:YKJ)UCMR1;.Y-E+&U6_D5JHJ+^4,LY=9<D-7GG#EHH-'9$ZZR
M/A1O;(UDU31LC[NWSGM73\RAJ'[RA6477ABLUV[*>JM.VVN?\G<ZCJXVZ*OP
MR(]/SJ#P:[>YK&N>]4:QJ*KG+V(B)VJJAE"+#EW'G->*WBGQRXLOF.U3)K3=
M%9'+$B>L1;7QJDS&+KL?KW 97X:Y)K^$>/.8<!OLFMYX^GFJ+*K_ ),CZV3U
M2+:G^(L_A2_FE#4KCZ/\%DQ#A^BN]P8OMO+I7WNLD?JLBPS(C:9%5>U46-$D
M_.]0DH'PG_?#Y>_W2?\ K5(%GN1#F2Q9)>NL>UVNRY([$;O<;9"EDOB1K*L:
M>J3L5C4W,_UCFRQ]_>H([EF_\!NHO_\ 7O5__(N_^.$ZO=TR<94&"WO-;K2<
MAV_.:Z\R0^UTM^SQ(*N*6=SG3HR:71SW/?WHG<H):-",DY9_?NPW[D=_5:\-
M>#^<GM:_K:XQ1R(Y/9:+HOPHEP5%_H5 >#3>:?\ <[(?NRM_J[PRH/H6_L3G
M^^ZW_94X67$Z-?\ O7S/]^Q?[>N!+^?_ .^:?<7\ %\'RN?]_>S?<S_^S:@'
M@=1W]Y?A#_?*;_M",$)#UT_V)P_?=%_LJ@)"]./&-9@&*L8U&L;9[>UK4[$1
M$I8T1$",ZWCF/F?EKDW(..>"5M]DL^+O?3W7)KDQ)7.EC>L+E1'LE:B*]KVQ
M-;$Y7(W<JHG8A>B*\W<3<NVKBG)<HY,Y;JKQ3444*ML-'#ZI15$LE1%&QLJM
M=&UR(KM4;X7?HH6%J\5_W/Z;_P +77_0J0GB\'0Y_8>GWO7?Z,0)1[IR_O(<
MZ?[_ "?UZ8$O+T2/CI;URO::U=N00W:%U6Q_9(K6253%UU[?-?NU_.%EH#F^
MJM]%P]G4]TV^I^PZ^-R.71'/E@?'&U/RJ]S43\H2&8<(@JH>@O(7U"*D<[*Z
M2EU33]UZ^UO9^3>UP7Q7]TO-:S@/"$8B-3U.1=$^%U3*JK_2JA)5%R'_ 'YN
M.ONA/]E<@O@UT&0                                         &9NN
MG^Q2#[[HO]C4!87EQMV<=XBB]_L6V_U2,(DX&.^E^K@PWG?EWCR]O;37NXUS
MJRW,E7:ZHBIIZB3S-=-RNBJ&2HB=NW5>Y%#4M%<RY3:L.XNRN]W:9D4++;50
M0,>J?O:FHB=%#$U%[U>]R)I_3W!(9#QO";S-T)9 ]D,GBU5>_((8E1=745)4
MP,D?IY&HR"23\R:A?%J#ILR"VY%PAAE1;9F2^HVZ&V5;&JBNBJ:%J0R,>G>U
M?-1R(OZ+D7N5 DOU?><;-9^8K+PS36RHN=\NL#:BHJJ5\:QT:.22329JJBII
M%'XJ_P"2YOP@Z,Z8G3YAU9\AYG[>S*X8W@V,5#::BQVTR^!(^.625D:N37:K
MML*K))(UR[G:-1&]B%[GDZC. >&N'>*JVZT"UE5FMRJ*:DL]7<ZQTU0YR3,D
MJ'-CC2-BIX37(YRL735.Y50$2GN8*B]"-,J+JGN]9T[/R55,$\5M=-O]A6"_
M=C/]-X)6F$9 Z3_[;><OO67_ +1K0U+W=5E!48!R!QSS[:HU1;371VF^JSL5
M]*Y7/8BZ?X\3JF)7+\+4!#Y\2*SF/J?S/E?>VJQG#86V7&YV^=$Z1[70MDC<
MO>U6)42__6M!X/WUE?\ >KAC[^E_V]""&G<G_P"[=Y_W&I_V+@RS9T$_V1WG
M_P 05']4I LO)S;_ 'N>'?\ F&?UBH"QW/-U$9#;<5ZG>(;[>)6P6RFBVU50
M]4:R)D]1)"LCE7N:S?N<OP("&M*NNHZ"BGN5;41T]OIHGU%152N1L4<,;5>Y
M[G+V(U&IJJAED[HPIYK[DO+'),4;F66_WC9;W*FU'.6:HJY$T^%K9XO\(:E]
MNAK_ .YG(OWZG^@\$O[U\?V>8K]_-_JLX(>'K0@GM%7Q-R!)$^6T6"Z.;7;4
MU1'/=35+$_.YM-)I^8$-;6VY4%YM]+=K54QUEMK8F5%)50N1\<L4C4<U[7)W
MHJ*&61&UE/G_ %TTE78'I56_#[;)#<JN!=T:/@IIHWHKD[]LU4V%WY45 UX/
MIP!-#AO5%R[AMY>E/<[Y437"UMF5&K/&M2^K:C->]SH:E)-$_1:J^0$]S1_*
M?(UHXIPFXYK>6+/3T/ALAHV/;'+433/1C8XU=WN[5=_FHJ^0,N%<Z6CY_P"#
MJB.2WRVR#,+4L]!35NU9(97?O:25VQ514WMCE33]$*Q<O)-\R7I[QW@*F<K<
MXJ<E3&JBBD7]_P"H02MFA1[4[4:D\C(OR)$H5_H%C^-T&(8=;\5M3=*"SV^.
MAI^S1SFP1(S<NGZ3M-SORJ&69>@%-./<I1>QR7I-4\J?]%B\@:E5^&<08!EG
M4=R1Q[RBM5#=):ZJN..^#4>JK.R6=]2J=K5WN?!+'*U/\5K@+:S3I1Z;\ QB
MXY=DK[K36>V1++,Y*Y%D>[N9'&U6)N>]RHUC=>U5"=5K=.E!Q]1\9TL_&$5Q
MBQ&OJJBJI_:^J5#I=R12*FO9LW1Z)IV:HH)6P$9,Z=/[R7.?^_2_UZ4-2_G!
M?][+F7_,D_K4()[D_P"L7^[UE7_.6W_M&G"0_-D_N?1?^ I?^S' \7EZ+O[
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M\T+*X @
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MR1EW)-+=:FKKLN5[JFAF9&V&'?*DOF.:FY=--$U"]5GA
M              !7O\R/U_X<[OP^VKYWYW;]4CQ?OO7WI4_LG@]U^'HATO9_
MT]?F=\\+H      4%SQQASCR;736'$LLMMEXVN-'#2W2W5#'^M22-D<^1^YE
M.]RHY%:W:V9J*C=%[UU+"U>.<)H..,(LF$6V9U12V:G2#UF1$8Z61SEDED5J
M*NW>]SG;=5TUT")0
M
M              #/O-?$W.'(=^J*'$<]@L?'-VIHZ:[6J5'I.U4:K)?#\.%7
M.9(U?.9X[$7M1>P+"VN.L$LW&F&6G"K$BK06N+8L[T1))IGN5\LS]/TGO<YW
MY.Y.Q B4    "G>H_AV[\UX;;L9LURIK944=RCN$DU6V1[',9!-%M3PT5==9
M$4+"VZ&!U+14U*]4<^")D;G)W*K&HU53_ $?<        !$.3;+FM_PZMM_'
ME[9C^7*^&2WW*9NZ%JQRM<]DB>'+YKV(YOR%_,!6?"? F0X;E5TY-Y0R%N5<
MCW*'U2.JCWNIZ6G7;N1CI&L57.1K6II&Q&-U1/E*%F5]A
M
M              9]DZ0.-:WD*JSV\U=QND517RW5E@J)(_9[*FHF6=Z*B,1S
MHMZZ^'NT\CMR=@7JT$$    !7F6\-XOF6?XSR/=*FNBOF*;?9T%/)&RE?LD6
M5/%:Z)SE[5_1>WL"]5AA         !5W-'!]AYKH+71WFYUUJDM,DSX)[>YB
M*^.I:ULL;VR-<BHJ,:%B4@XSXQQ3B;&(L5Q&G?'1)(Z>IJ9W))4U-0]$1TLK
MT1J*[1J-[&HB(B(B!$Q
M                    "O?YD?K_ ,.=WX?;5\[\[M^J1XOWWK[TJ?V3P>Z_
M#T0Z7L_Z>OS.^>%T
M
M
M
M
M                                     *]_F1^O_#G=^'VU?._.[?JD
M>+]]Z^]*G]D\'NOP]$.E[/\ IZ_,[YX70
M
M
M
M
M                                                      KW^9'Z
M_P##G=^'VU?._.[?JD>+]]Z^]*G]D\'NOP]$.E[/^GK\SOGA=
M
M
M
M
M
M          "O?YD?K_PYW?A]M7SOSNWZI'B_?>OO2I_9/![K\/1#I>S_ *>O
MS.^>%T
M
M
M
M
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MY[I@
M
M
M
M
M
M
M
M
M
I                                                  !__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>lc_clinical-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_clinical-4c.jpg
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M%!04%!04%/_  !$(!2D%* ,!$0 "$0$#$0'_Q "S  $  @,! 0$!
M    !P@$!08) P(! 0$! 0$                  0(#$  !! $" P,%!PX)
M" 8' @\  0(#! 41!A('""$Q$T%1(A0U87$RLG,6"8%"4G(C4Y.STW05E5<8
MD:'18M*T=3<XL8+",Y34-E;!DB3$%QFB0V,T5%6%I7:U@^0E1V?PX<-$A*0F
MEB<1 0$! 0$! 0$            !$3$A00(2_]H # ,!  (1 Q$ /P"_P
M                      P,Y[$R7YK/^+<!3GZ/=SG4.8"N<J_=L5WJJ_6V
MPU5U0R
M
M
M               P,Y[%R7YK/^+<!3CZ/7V?S ^6Q7Q;8:JZP9
M
M
M                                                           8
M&<]BY+\UG_%N IQ]'K[/Y@?+8KXML-5=8,@
M
M
M                                           ,#.>Q<E^:S_BW 4X^
MCU]G\P/EL5\6V&JNL&0
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M08?,S-_?H?PC_P"B##YF9O[]#^$?_1!A\S,W]^A_"/\ Z(,/F9F_OT/X1_\
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MZ_\ 6&&I+Q>6Q^:J,O8V=L]=_9JWO:OV+D7M1?<4RK-
M      :C/;FP^VX$FR<_"]Z*L5=B<4LFGV+?^E>P".KW.2VLBIC<;&R).YUA
M[GN7WT9PZ?PJ:Q-?RESDN)(B9'&QOB7X3J[W,<GO(_BU_A&&I%P&Y\/N2!9<
M9/Q2,1%EKO3AE9K]DWS>ZFJ&5;@                     #5;E56X.ZJ+H
MO B?45R(H&IV*QJ4K4B)Z;I4:J^XUNJ?Y5"1U84
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MGN&%;,                    &IW-["N?:M^.@2M9L7V?9^6_T4!'4A0
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M5&JNFOD ^V+RV*SE&+*86]7R6,GXO N4Y66('\#E:[ADC5S5T<BHNB]X&8
M                                        !P&\_;</R,?QW!*[\*
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MKI&]$>UOU$70VB2^3=I[\;DZ:KJR&:.5J>996JB_$,TB2R*
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M8VG(+EOF.4_+/';*SMFM<R5.:U+)/261T"I8G=*W19&,=JB.[?1!4FA
M  %6.O=$7E#A?<W%6T_V*X%CM^D)$3IZVAIV>T?_ ,)605. 0          *
M.<HN:V^>8O5>ZEN;*/EQ.(=FJ^,Q4.L5.!D+9(D5(VKHYZHG:]_$[W=- U\7
MC#(                            !P&\_;</R,?QW!*[\*
M    ><')G_&O8_M_<WXJ\&[QZ/A@  >='6C4GVWS[Q6YN!5AMT,??B>GEDI3
M/B<WWT2)O\*!J/1&G;@OU(+U5Z25;,;)H)$[G1R-1S53WT4,N'YWYF+ <H-\
M9254;X>%NQ1JO8GC68701I]5[VH%BKGT?.%E\7?&XGMT@X:&/A=YWZS2R)]1
M/#_A"U>$,@',R<N.7DTCYIMI8:2:1RODD?CJKG.<Y=5556/555>]0-?F.7'+
MN+$9"2/:.%:]E:9S7)C:B*BI&[_V8%7_ */7V?S ^6Q7Q;8:JZP9
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M#KV:A*E (  ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
M       &JW'@:FY,5-C+?H\7IPS(FJQRM^"Y/X=%\Z 5[SF R>WKCJ>2A5CN
MWPY4[8Y&_9,=Y?\ *GE-HU\4LT&O@2R0\7PO">Z/7W^%4"/QWJKE[7.[7.7M
M55]U5 DCE[L*Q<M0YS,PK%0A5)*U>1-'3/3M:Y47ZQ._M^%[Q+53(94
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M?EGGF9/-93UWPHF/3BG])%1C8_1!4G!        #@-Y^VX?D8_CN"5WX4
M                        !@9SV+DOS6?\6X"G'T>OL_F!\MBOBVPU5U@R
M
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MBR,:_1?<U1= /JB(B(B)HB=B(@']          . WG[;A^1C^.X)7?A0
M                       &!G/8N2_-9_Q;@*<?1Z^S^8'RV*^+;#576#(
M                                      .,WOOVOMEOJ--K;&9D;Q(Q
MWP(6KW.?IWJOD;]7W[((9RFXLWFI'29*[+,B_P#J^)6QI[S&Z-3^ TC7Q32P
M/22&1T<B=SV*K53ZJ =QM?F;EL5-'7S$CLAC55$<Y_I3QIYVN7X6GF=_"A,$
MUU+=:_6BN4Y6S59VH^*1O<K5,J^P                              !J
M=S>PKGVK?CH$K6;%]GV?EO\ 10$=2%
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M=S>PKGVK?CH$K6;%]GV?EO\ 10$=2%
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M#&OTUX56-SD1=%UT S@      <!O/VW#\C'\=P2N_"@
M          ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
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MF37YL<NL/O6*)M>W;8Z')5&*JMANUW+'*UNJJO"JIQLU77A<FO:&:[T(
M                   (>ZJ$1W(#>R*FJ>JUU[?.ER!4"Q%70"G_ /SG<Z^7
M]-_]TA"U;8,@     <!O/VW#\C'\=P2N_"@
M  ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
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MJ^Y@$D8DKK]:E;IZO71&OL8_1T:N[DUD3M!XM9R+YZ[<YW[>DOX^/]';BQ_
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M'T>OL_F!\MBOBVPU5U@R
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MPU5U@R
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M.W/-9AFC[6OKXQ'N61%3ZU6P<2>X&_B7OI!?^&=D_GUW\3&$B=>FS^XK8O\
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M56NH/_&+C/[1VY_W8+./18,N WG[;A^1C^.X)7?A0
M        &!G/8N2_-9_Q;@*<?1Z^S^8'RV*^+;#576#(
M               ?)MJJ]_ALFC=)]@CD5?X-0/J
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MT]&.&&+@C8U/,UJ(B!E0WH,Q]^GS0W"ZW4F@8[ 2HU\L3V-5?7*O9JY$37W
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M%G*&X<='DL>_BB?Z+V.['QO3O8Y/(J?_ +S"MD
M                   #4[F]A7/M6_'0)6LV+[/L_+?Z* CJ0H      #3W]
MI[5REA;>3P>/NVE[5GLU(9I/^L]BJ!LJM2K1@96I01UJT::,AA8V-C4]QK41
M$ ^P                  PGX;$26?79,?6?<1=4L.AC677[94U S0
M         &)<Q>-R/"F0IP6T;\'QXF2Z>]QHH'WA@@K1-AKQLAA;V-CC:C&I
M[R)H@'T  8"X/"K8];7&U5MZZ^.L$?B:^?BX=0,\"!^LC_#YN;Y;&_U^ +'(
M=!/]T.:_^\-G^I4P59RMBL72F?8ITH*\\O;)+%$R-[M?LE:B*H1E@ /G/7@M
M1.@LQ,FA=\*.1J/:OOHNJ ?*GCL?CFJS'U(:C'=KFP1LB15]U&H@&2
M#%N8S'9%&ID*<%M&+JQ)XF2HU?<XD70#(8QD;&QQM1C&IHUK4T1$3R(B ?H
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M<OJF218W-\B2L17,=_E;]4E$YF5
M        U.YO85S[5OQT"5K-B^S[/RW^B@(ZD*
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M@;&O'_E:6)4<;0:]VZ,.D?PO6X5^HCT5?XC5%DC"@
M                     :G<WL*Y]JWXZ!*UFQ?9]GY;_10$=2%
M
M         . WG[;A^1C^.X)7?A0                           &!G/8N
M2_-9_P 6X"G'T>OL_F!\MBOBVPU5U@R
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M                        &IW-["N?:M^.@2M9L7V?9^6_T4!'4A0
M               %<LKUL<F\/E+N)MPYGUNA8EJS\%.)6^) ]8W:*LZ=FJ=G
M8%QB?OT\D_O.;_V*+_> 8^D/7+R1D?PO3,PM^S?28K?_ $)G+_$#$L\O.<G+
M?FG'(NR<[#?M0-X[%!Z/KW(VZZ<2PS-8]6HO9Q-16^Z$=V
M           (WYM<[MF<EZ^*L[P9=?'F'S1U/4(6SJCJZ,<_CXGLT^&F@7'6
M[/W3C-[[8Q>[<,DK<7EZ[+51MAJ1RI&_NXFHKD1?JJ$;L
M         X#>?MN'Y&/X[@E=^%                            8&<]BY
M+\UG_%N IQ]'K[/Y@?+8KXML-5=8,@                            &H
MW%MO';FH+2OMT<W5T%ANGB1/7RM7S+Y4\H$-9GEKN;%2.6O7_2%5/@S5O2=I
M[L?PD7WM??-:C1,V[N"23PF8JVLFNG#X$FOQ2CKMO<JLO?D9-FU_1])%U=$B
MHZ=Z>9$35&^^[^ FB8L?CZ>+IQ4*$20U8&\,<;?XU5?*JKVJIE62
M  868R<.&Q=K*6.V*K&LBM[E<J=C6I[JKH@%:\GDK>7OSY&\_P 2S.[B>OD3
MS-3S(B=B(;1TVUN767W+7;?DD;C\8_\ U4TC5?)*GV3&:IZ/NJO;Y":-MF.4
M&3J5W6,1=;?>Q-5K2,\&1VGD8J*K57W%T&F(Y5'QO5KVJR1CE:YKD5KFN:NB
MHJ>144J)[Y=;DEW!@^"V_CR%%R0SO7M5[535CU]U4147W4U,UIV!
M                :G<WL*Y]JWXZ!*UFQ?9]GY;_ $4!'4A0     /G-/#6A
M?8L2-A@B:KY99'(QC6M355<JZ(B(!&V2ZB.2.)MNI7-\XKUAB\+T@F]9:CO,
MKX$>W^,+CK=K[ZV9O:!UG:.>H9J)B:RI1L1S/C^W8U5<WO\ KD0(Z
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MV?S ^6Q7Q;8:JZP9
M #B.:TKX]IN8U?1EL1,?]JFKO\K4+!"-*!EJ[5JRKPQ3SQ12+_->]&K_ !*:
M96CBCCAC9#$U&11M1C&-[$1K4T1$]Y##3] 0)S0J05-WSN@1&^LPQ3RM;V:2
M+JU57W51J*:B-OR<E>F8R$*:^&^LCW>;B9(U$^,HI$R&5
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M>X@9JI?21BZV1ZDFSV&HY<;'E;D"+VIXFCH47ZB2JJ!JO2H,
M     !P&\_;</R,?QW!*[\*                            P,Y[%R7YK
M/^+<!3CZ/7V?S ^6Q7Q;8:JZP9
M            !$V^^7%EUF7,[>B\5DJJ^S08GIM>O:KHT\J+Y6]_F]S4J(ND
MC?&YT4S%:]JZ/8]-%14\BHI4?A&M;\%$3WDT Z_:>P<KN*:.>PQU/$:HK[+T
MT<]OFC1>_7[+N3^(EJIWITZV/JPTJ<:15H&)'%&WN1K?\ONJ95]P
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ML;'MC61S6R:1>CI(B>(U?*U44(HGT<_XB[_YEE?QK W7HZ&
M     X#>?MN'Y&/X[@E=^%                            8&<]BY+\UG
M_%N IQ]'K[/Y@?+8KXML-5=8,@
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M%/>RSX[F^LPQB9.U%Z45>%J\3:T+E1%5J+Z4CNSC=IY&M#-J=0@
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M\Z<^GCFARXYPV=Y;JHU8,)-6O1))#;CG?QV7M<ST6]O;H&K5R0R
M        ' ;S]MP_(Q_'<$KOPH                           # SGL7)
M?FL_XMP%./H]?9_,#Y;%?%MAJKK!D
M                                             !J=S>PKGVK?CH$K
M6;%]GV?EO]% 1U(4      !R>1Y6\L\O9=<RNS<'=MO[7V+&-J2R.5>WM<Z-
M54#?8K"X; U4I8/'5<931=4KTH8Z\6O=KPQM:@&<
M     *0?2%JFO+Q/+_\ GCL_V(-1:?DPJ+R@V"J=J+MW$Z+_ /T409KN
M                                     X#>?MN'Y&/X[@E=^%
M                      8&<]BY+\UG_%N IQ]'K[/Y@?+8KXML-5=8,@
M
M              -3N;V%<^U;\= E:S8OL^S\M_HH".I"@
M                   -/G-I[6W/X'SEP>/S/JO'ZM^D:D-OPO$TX^#QF.X>
M+A373OT V52I5H58:-&".M2K,;#7K0L;'%'%&B-:QC&HB-:U$T1$3L ^P
M                                     <!O/VW#\C'\=P2N_"@
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M>OL_F!\MBOBVPU5U@R
M                                   UV>@?9P]R*--7K&KD1.]>#TM/
MX@.;V3D:T*3T9GI')(Y)(N)=$=V:*FJ^7L0)':A0
M                                                        '\<]
MK&J][D:U.U7*NB(!'>;L1YG<,<=-?$9K' Q[>U%T7M5/<154(D4*
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M8P(  ,#.>Q<E^:S_ (MP%./H]?9_,#Y;%?%MAJKK!D
M
MY/*[+CLS.L8Z5L"O75T+T7@U7[%4[O>T"8U7S-SB=B21:)YI'?T08?,[.??(
MOPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCO
MY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?
M,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.?
M?(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OP
MCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY
M8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[
M.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(
MOPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCO
MY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?
M,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.?
M?(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OP
MCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY 8?,[.??(OPCOY
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M\2Y[ZTS6M2_6U55C=_[0"K'T>OL_F!\MBOBVPU5U@R
M
M
M                           "A.YL=7H]>V/DW0UJX^]?I6L>^?X#WKC6
MQU%;KY6V6-8W^<T-?%]@R     !0'Z0&LYF]]HW.'1LV*FA1WG6&RKE3ZGB!
MJ+N["G9:V-MBU'VQS8FA(S3M31]:-4_RAET('G#TEJ[)=35R_$O%&D>8M.<B
M=BLD<K47W.UZ!J\>CP9 *(];?-'<F1W=1Y-[=FEBQK8:\V5KP.5C[MRX[[C
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MEL5\6V"KK!D
M
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M_P 6X"G'T>OL_F!\MBOBVPU5U@R
M
M
M            ##LXW%3O=9N5*\CT3TYIHV.7A;YW.3N0"&]S]1'3CM.V^A?S
M6.MW8G*R2+&4W7T:YO>BR01/CU1>S3C"XP<+U.=-.;L-JMR]2C,_3A_2&.EK
M1ZKYY70^&G^<Y 8FK'5=MW8*^4Q$-&Q6E1):EVJV&2-R+W/CDC145/=10C:
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MJO<"UV7-+E7M3F[M>7;&ZH'+'Q>+1O0Z-LU+")HDD3E14[NQS531R=X14/\
M=*ZA.7.1L/Y4[TC_ $;.J^G6NV,5-(G<GC0Z.C5=/_:.#6OMC>C7F_OW-Q97
MG)O-'5V=CW-LS96^L?>K(UF1L<:+Y^)VGV*@U<W96R]N<OMMT=J;5IMI8>@S
MACC3TGO>O:^21W>Y[U[7.7_(&6_   ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V
M&JNL&0
M
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M\UG_ !;@*<?1Z^S^8'RV*^+;#576#(
M
M
M               *'9>[2VKU\1Y'<ZI'1MV8&U+,OHL1UW$-JUW:KV:)*Y&:
M^1>WR!KXOB&0"B/4_>I;@ZH^7N#P*I-G<>_$5;SXNUS)Y<@L\<;M.Y6,>DGN
M(X-3B]P9                 # SGL7)?FL_XMP%./H]?9_,#Y;%?%MAJKK!
MD
M
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MS6?\6X"G'T>OL_F!\MBOBVPU5U@R
M
M
M            $3\N>HWE?S3W NV-H7;4^62O)<6.>K+ SPHE:UR\3DTUU>@7
M'QW_ -2_*GEIN6?:6Z[UN#,UXXII60U)9F<$[>-NCVIHO8H,<G/UF=/MJ-8K
M-^W-$O>R3&S/:OU%:J Q^:W61T]4T5M2Y:KM=VJD6,E8BK[O"U 8W>VNK3DQ
MNS<&,VSALA=ERV6LQTZ;'T9F,6:9W"U'.5-$35>\&)Q"
M !@9SV+DOS6?\6X"G'T>OL_F!\MBOBVPU5U@R
M
M
M                     $1\M^F[EERIW$NZ-HP7(LJZO)35UFTZ:/PIE:YR
M<*HG;JQ NM#S'Y'\A.8_,*2QO#)M^?=Z*&+]%196.O9>R*+2/@K<7'VL;KV-
M[>\&M=^Y)R*_^$R?^WO_ *(-/W).17_PF3_V]_\ 1!K7X[D3TQ<M=_;?1,SZ
MCOF"]5EP^+LY5'6'VG2)X"+!\)4>[1$U31W<#:LV$                 #
MSGL7)?FL_P"+<!3CZ/7V?S ^6Q7Q;8:JZP9
M
M
M                   "IW,WK(SG*S>N3V7GN7G'9H2:U[;<JK([563TH9V)
MZFO8]O>FJ\+M6KVHH:Q67+]1*93GYCN>'S;2+U!L;5P?KG%QK%5?6U]8\!-/
MA<7^K\F@7$V?^87_ /J\_P#M?_\ (@F"_2%KIV<O>W^U_P#\B!B)</NW<O45
MU,[7W-7Q+:4S,AC9WU:JNF;5Q^*E9+)))*J-U5$:[TE1O:J-3R!>/3D,
M             !@9SV+DOS6?\6X"G'T>OL_F!\MBOBVPU5U@R
M
M
M                                 &CS>RMG;ELQW-Q[>QF7MPL\&*QD
M*5>U(R/57<#72L<J-U55T0"!-Q=,>W(><E;FS9GP6+Y?8R-C[VW)Z44-/@CK
M.B<Z37A@1.)R/U<T+J1]H8/I_P!_4;62V;M[;.8Q]*RZC8LUL546-MAC&2*U
M%="B.]%[5XFZIV]X&%S K=//*^C0R6]]LX#&T,C:2C7G_0M>9OC*QTGI)# ]
MR-T:NKM- .WV3%L";$QY?EY!B4PMUJ*RUA8J\<,B-\BK B)JWRM7M10CI@
M               !@9SV+DOS6?\ %N IQ]'K[/Y@?+8KXML-5=8,@
M
M
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M2_-9_P 6X"G'T>OL_F!\MBOBVPU5U@R
M
M
M                "@_,;-P\F^M:#>^X6N9MW)>!9?85KG<-.[1_1\LJ(FJJ
MD4C7N5&]NC=$0-?%\*%^CE*4&1QEF*YC[3&RUK5=[98I(W)JCF/:JHJ+YT#+
M[JJ-17.71$[55>[0"@G.G<V.YR=5&Q]M[,E9D*N$LTJ$]^NJ21OD@M.MVWL<
MWX3(8T7M3LU:[3L[0U.+^!D                 ,#.>Q<E^:S_BW 4X^CU]
MG\P/EL5\6V&JNL&0
M
M
M 1/SUY$;<YW[?AI7Y5QNXL=QOPV9C:CW1+)IQQRLU3CB?HFK=45%35%[T4LJ
MGR]/G5ERMFEJ[&NW)\6KG:2;?RO@P/37X3J\LD+M5U^]K[X78_#^4/67S!C_
M $3N*QF&XF3T9DR^7;'5X7=GIQ-F<Y_X-P/%GNGCICP_)9LN?RUIF9WU;B6!
M]V-JMK5(7:*Z.LC_ $E5RIZ4CD153L1&IQ<1+4_!                  P,
MY[%R7YK/^+<!3CZ/7V?S ^6Q7Q;8:JZP9
M
M
M                 "N/(_JPK<Z-Z.V=%M63#/;2FO+<=>;:3[@Z-O!P)!%W
M\??Q!;&-SEZNZO*#?EO9$VTI,NZK!7G]=9?;61WK$:2:>&M>33373X0)' ?^
M85C_ -G\WZU;_N@7#_S"L?\ L_F_6K?]T!CH=B=<-+>^],#L^/9,M)V<O04$
MN.R394B6=Z,X^#U9G%IKW<2 Q;4,@                !@9SV+DOS6?\6X"
MG'T>OL_F!\MBOBVPU5U@R
M
M
M     '-8+EYL':]Y<GMK:V)P^15CH5MX^C7JS>&]45S>.)C7<*JB:IJ!^<WR
MWY>[EOORNXMJ8C+9-[6L?=O4*UF=S6)HU%?(QSE1$[NT#7?^#/*'_D+;WZII
M?D@:?^#/*'_D+;WZII?D@:R<?RIY88F[7R>+V7@Z61J/;-5MUL;4BFBD8NK7
M,>R-'-<B]RHH'7@                 # SGL7)?FL_XMP%./H]?9_,#Y;%?
M%MAJKK!D
M
M                                                    /.].E'JA
MT]NQI[GZ:L?R!K8CSFGR\YP\GJU*;>6[$9:R#U;4Q]3+V9[3V-1>*7@[-(T7
MT>)5[UT3RA76;)Z<>IK>F/AROZ1LX"A8:CX'9K)V:\KV*FJ.\&+Q9&Z_SV-!
MK<Y[I0ZF\/3DMT=QQYMT;5=ZK0R]ML[M$UT:EEL#57W.()KG>G+"[[W#SDQ>
M+RVZI<9EMMY&*WD-N9FW=AM6HJ<G%8BBCX7-?(Q&KQ1/5OHZKVHC@M>F 8
M               # SGL7)?FL_XMP%./H]?9_,#Y;%?%MAJKK!D
M
M
M                                    %$MQ.I;IZ\Z>,WEPOQ6.FKP8
MVM/VQ<5?&>MU6=O9H^P[C1/*YVGE#7Q>T,@%%>I>2G@^JOE[E=L*D>YYG8E^
M3;!\*25;SH(TDX>U7/A1(W(O>SA\BAJ<7J#(                 8&<]BY+
M\UG_ !;@*<?1Z^S^8'RV*^+;#576#(
M
M
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M,@
M
M                                               ^-NW4H59KMZ>.
MK2KL=+8LSO;'%'&U-7.>]RHC41.]5 K)S#ZENEF>[)5SV-AWK8B]!T\&)@O,
M16^1LUOPT<B>=CE3W0N5UVWMV<B-L\J:W/'#[2J[?VT_A5DD&+J19)BK<]23
ML@U55\3M[)%]'M E39^]MJ[^PL6X-GY6#+8F5>'QH'+Q,>G>R1CD1\;T^Q>U
M%"-^                  ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
M
M
M                                           4=ZL]W[MYD<TL-T\;
M,D5D"NK+DH4<K&6+UIJ3L\=6ZKX->%6RJGG555%5K=#4:_G'TI;#Y1\CLONA
MENYF-YTUHL_2,LB0UFOGMPQ2>'78G8U6N<B(][E\NH)4N<G>7&#YK=)NUMF;
MAELP8ZW'8E\:F](Y62PY&PYCDXFN:J([MX7(J*$^H#V'3W1TL=2F/V1>ONM;
M8W'+6IR3(BQPW*-^18JUA8U54;)#-JCN_3A>B+PNU4O7HD&0
M     P,Y[%R7YK/^+<!3CZ/7V?S ^6Q7Q;8:JZP9
M
M
M                         !0K>6:I\J^N2/=6Z'>!@<@Z&5+LO8V.OD,;
MZCXRJO<R.5'(Y?(UJAKXGOK$DCEZ>=QRQ.1\3Y<8YCVJCFN:Z_ J*BIWHH2-
MITG_ .'S97R-S^OV056WGYN"CS/ZJ=C[6VK(VZ[!VL?C;EJ'1[?6&7%LV41S
M==6P,^%YG(Y/(%G%^ R                 &!G/8N2_-9_Q;@*<?1Z^S^8'
MRV*^+;#576#(
M
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MS80                 ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
M
M
M                                         4#YM;^WY#U?U\%7W)>V
MWB5O8;#,=!,L<*8ZRD#WN<Q=8WHY\TCM7M5$7O[@U\7\#(
M      # SGL7)?FL_P"+<!3CZ/7V?S ^6Q7Q;8:JZP9
M
M
M                            !Y_]:>?9EM^S[779L=C)XNM4=C]UUO6&
MW$CF;XKH9$8BQR,1SEX45-6KKHJ:N134<9M;JIZC-KT8<<YZYNM7:C(G9>@^
M>9&M31$=-'X4C_?>Y5]T+CH_WT^H+_E[%?JR[_O(3'5<L^K/G;NSF%MG;.<P
MF.@Q&6R-:G=FAQ]R.1L,ST:Y6N=.Y$5$7O5- 8O,&0                 P
M,Y[%R7YK/^+<!3CZ/7V?S ^6Q7Q;8:JZP9
M                         '\54:BN<NB)VJJ]R(!'6X^:]#'ROJ8.%+\S
M.QUERJD"+_-T[7_Q)[I<1Q\G-7=KWJYLD$;?L&PHJ?\ I*J_QEP;K#<X+39&
MQYVFR2%>Q9ZNK7I[JL<JHOU%08:E'&Y.CEZ<=_'3-GJR?!>WR+Y45%[45/*B
MF598
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M3W%:O?[FI*+ F5
M
M/,*MAMW]7?//++'?]6Q:.EF2W*BR0X_#5Y$CA9''JU'/7B;Z**G$]SG+IZ2A
MOBP.3Z =B/P[XL-N?+0YY&+X=JVE>:HLFBZ<4,<4;T:J^:75/=":BGI:W+NK
ME!SVM<H=QR.CHY6Q/C,A2XE? S(P,<^"Q%KI_K.#@1R(G$QZ*OP6Z"O1(,@
M   X[FES%P_*K8^4WKFD66&BQ&U:C5X7V;4J\,,+5T73B<OI+HO"W5VG8!17
M;>"Z@NKK*7\]:SRXK:%:9T*N=+-!C(9%1'>!6K1*OBO:U6\3G=NFG$_734UQ
M^MY\JN?_ $P,BWMMO=$M_;<$C&V[5"258(W/<B-;<IS<3%C>[1J.])NJHBJU
M5;J.KD<A.<-/G1L.#<B1,J9RI(M+.T(U7@BML:CN*/BU7PY&JCV:ZZ=K=55J
MJ$L2B$ (VYX<WL7R8V-8W1<C2WDYGI4PN-5W#ZQ<>U7(CE3M2-B(KWKYDT[U
M0+%,]I;&ZA^JM]K=F;W-)BMIK(^.O+/)-#1<YJZ.CITX51'(Q?1<]VG:FBN<
MY%"\8^^>4W/OIAB@WOMS=4MS;T,D;+-W'R2I%$^1VC6VZDW$Q8WNT:BKQ-XM
M$715;J.KC=/?..'G1L&+<$\3*NX:$JT<[4BU\-MEC4<DD:*JKX<C7(YNO<NK
M=5X=5)8E<(  ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
M                                      !7;?D[[&[LJ^1=5;-X:?:Q
MM1B?Q(;B.RY-8^N[]*95[4=:8YE:)R][6*WC=I]LNG\!*1*YE7-[\QT&2VGD
MXYT3B@B=9A>OULD*<:*G\&GU2P5W1=4133*SF"G?:PF-LR:K)-5@D>J]_$Z-
MJJ8:;
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MN IQ]'K[/Y@?+8KXML-5=8,@
M              "!^9^*DQ^Z)K7"OJ^0:V>-WDXD1&/37SZIK]4U$?+E]NV+
M:^2ECO:_HF\C6V'M3B6*1FO#)HG:J:*J.T]_R"P3E6RF-N5TM5;<,U94XO%9
M(U6Z+YU1>PRJ..9&^<?+CYMNX>9MF>QHR[8C7BCCC1=58CD[%<[N[.Y#4B5%
ME*G/D+D%&LWBL6)&Q1M_G/71"BS]2LRG4@J1_P"KKQLB;[S&HU/\AA7V
M
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M/]SV_P#ZOA7B^"FO=YNT'C<?1Z^S^8'RV*^+;!5U@R
M                                 -#NS;%7=.,6G,J1VHU62I8TU5DF
MFG;YVKW.3^0L$!9C!93 VEJ9.NZ%^J\#^^-Z)Y6.[E0TC6\+>WLTU[]/+[Y4
M?2""6>1E>M&Z25Z\,<4;5<Y5\R(G:I!,W+W83\(J9K,-3]*.:J5Z_8O@-<FB
MJJ_9JG9[B?Q9M5(9%
M
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MS6?\6X"G'T>OL_F!\MBOBVPU5U@R
M                    'QM4ZEZ%:]V".Q [X44K4>U?J.14 Y^3E]LZ1_&[
M%,1?,U\K4_@:]$+HVV-P6'Q"*F,HPUE7L5\;$1ZI[KE[5_A(-@
M
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MS ^6Q7Q;8:JZP9
M
M
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M?1Z^S^8'RV*^+;#576#(
M
M
M     (3ZB.H3%\C\+6BK5V93>>61RXO&2.5L3(F+HZQ85OI)&B]C6IHKUU1%
M31RH613'=F_^K'<>V;/,C+Y#.8G9;?#?ZY2<N'II'8D;%%X3(EB?(Q7.:U'>
MGKY5#7BQ.,SG,^_T88G+;-L97*;]G:KTOUI)+&22*'+2.D<CE5TC](H_#T35
M>%=- S]?/I?ZI,MOS,)RVYE(Q-V*Q_Z*RS6) MMT"*Z2">-J(ULR-:YS7-1$
M<B*BHCD3B+8MJ&0                 P,Y[%R7YK/\ BW 4X^CU]G\P/EL5
M\6V&JNL&0
M
M                                                      4-W3B:
M?,KKJBVYNIJ3X3'/A9%1F])DD6/QGKS(E:O8K'RZN<WN5KE#7Q//6,B-Z>]R
MM:FC4EQJ(B=B(B7X D;/I/\ \/FROD;G]?L@JN74IB*&S.J386Y=NM;5R>7G
MQ>0OQ1)P\=EE]8%D5$^^L:C7?9*BJO:JA9Q?,,@                !@9SV
M+DOS6?\ %N IQ]'K[/Y@?+8KXML-5=8,@
M
M
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MX^CU]G\P/EL5\6V&JNL&0
M
M
M      ?&U4JWJTU*]!'9IV&.BGKS,;)%)&]-'->UR*BHJ=Z*! .Z.B_D=N.U
M)<K4+N EE7B>S$6?#AXO.V*=DS&^\Q$3W NN0EZ5>EW8-Z!=Z;DD21^DD5'/
M9FK2;(W7[&)M9ZIV>1P7:LSM/&;5Q&WZ5+94%*OMIC-:+,9X?JJM[E<UT>K7
M*JIVNU557O74,MT                  ,#.>Q<E^:S_ (MP%./H]?9_,#Y;
M%?%MAJKK!D
M
M                                                       %+NK?
MG!ON?>^,Y(\L[%FOD+4<'Z37'/6*Y9M7E^XU6R-5%8Q&*U[U1R<7'Z78WM-2
M)>Y?5]R<@>G>U-O^:"WE]M5LAD."*9\[7+-(^>&!TCD:JO=))P+IV=O8JA%+
M>47)K>75!NC<>XLUGUIQP/;/ELW9B6U)):M*Y8XHHN.--$1B]B/1&-X41.U$
M#6XD'E+;WQTQ<_:7*G<][UG:NY)8:Z(QSO5)4O.6*K<A:_\ U;TE3PI?\Y%U
MT:X)UZ"!D                 ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL
M&0
M
M                                               46EFKX7Z0#Q\\
MK616YF1T99=$:LEK")#7TU\JO5(V_P X-?$A]=>\H\+RNH[1AF1M[<U^/Q84
M71RTJ'W=ZZ=^B2^ $CH^C+:*[8Y(XZ_/%X=S<EJQEI=4]+PG*D$.ON+'$UZ?
M; J$^I_*4]S]3_+W;>$>VQE,9+BJ=UT2ZK'8L9#QFQN5.Y6,<UZ^;B"SB]X9
M                 # SGL7)?FL_XMP%./H]?9_,#Y;%?%MAJKK!D
M
M
M                                      %<^ICIIEYPR4MU[4N0XW?&
M,A]7_P"T*YD%RNQRR1M<]B*K)&.<[@?PKKKH[L1%0LJ!,)T=<[]\[FK6>:^8
M\#%5^"*SD+607*7GU8E[(J_I2::HJ\/B.1&]^B]REU:WG9@-Y4.3-G!<FULT
M,]C&4:N'JXQZ1S^J121P.BC>Y4X4;$JNUXD7T>\)$/=-72MG]G;F;S-YIRLD
MW-$LDN,Q:2^M/BL6$5)+%F9%<U\NCG<+6N<FJ\2NXM-"VK=AD
M      ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
M
M
M                           1=SFY\[*Y)XZM/N%9;N9O\2X["T^%;$K6
M=CI'*Y4;'&BKIQ.[U^"CM%T+(K;8^D*G\5?5>7[/!^M\7*KQ=_EX:F@7'R_\
MPK(?L_A_6KO]T!CI.7W7#<WOOC;^SY-E1469R_!0=<3).E6+UAZ,XD8M9G%I
MKW<2 Q<0,@                !@9SV+DOS6?\6X"G'T>OL_F!\MBOBVPU5U
M@R
M
M                                               #SSYK;?7FYUH)
ML7/S218A)JE'A8NCVT*M!+TC&+V\*R*LFB^17ZAKXNKBN3G*?"U(Z6-V3A(H
M(F\+5?0KS2*G\Z25CGN7W7.50SK/_P##3EQ_R?A/U;4_)@?:IL#8>/M0WJ&U
M\15NUWI)7LP4*T<L;V]SF/;&BM5/.B@=$                  ,#.>Q<E^:
MS_BW 4X^CU]G\P/EL5\6V&JNL&0
M              ,>2]1A?X<UF*-Z=[7R-:O\"J!]F/9(U'QN1S%[G-75%^J@
M'Z
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M:5QK8,S$WB<QO8R9J=[F:]RIY6_5][-BNS(
M
M                            $'\R^E;EOS5W98WEN6WEHLK9BA@DCI6(
M8H$;79P-5&O@D7543M](+KD?W$.3'_Q^?_VRM_N@-/W$.3'_ ,?G_P#;*W^Z
M UN-I]&O*C9NYL3NO$W<V_)8:U%>JLGM5WPNE@=Q-1Z-K-56ZIVHCD!JPP0
M                ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
M                                     AOF[FI+&4KX.-VE:HQ)I6^>
M:1.S7[5O=]LIJ(Y#:^W+6Z<LS&UG>%$UOBVK"IKX<2+IJB>5RKV-0HF>IRVV
M;5@;"_'-M/3X4UASGR.7SJNJ(GU$0SICB-^<N:^'IR9O \24X>VW3<JOX&*N
MG'&J]NB>5JZ]G:64<!C;]C%WZ^1J.X;%9[9&+Y%T\B^XJ=B^X46;HVX[]*O>
MA_U5F)DS/M9&HY/\IA7W
M
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M;P@
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MW>[V%%E888Z\,<$+>&*)K61M3R-:FB)_ 85^P
M
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M43W&?"5?J$T3!M?:>-VM46&FBRV9=/6+;T3C>J=R>XU/(A-5OB
M
M                                           !\+E.ID*LU&_7CM4K
M#%CL5IV-EBDC<FBM>QR*CD5.]%0"KW,;IKZ5JMV6QG<Q#LBS*O$ZM!EJ]1NJ
M]NK8+GB\*+YF-1/,@7:UFQ^F;I/R=^-N*W5\[K'&G#CW9JK)QJGUJQTFPR*B
MZ><+M6HP&WL%M7%5\'MS'5\7B*J<,%.I&V*)OG71J=JKWJY>U5[PRV8
M             P,Y[%R7YK/^+<!3CZ/7V?S ^6Q7Q;8:JZP9
M
M
M                                 !4+JVY];KP6;I\G>6CYX=RY%D+L
MG=I(KKJ+<7A@J5N'TFR/31SG-]+1S4:O:H:D1_M7H-WOGJS,KOK=-?"W[7W:
M:I%"[)V6N?VJDLBRQ,X_/PN>GNJ#69N'Z/\ W%2KOL[2WG6R%V-%?%6O5'T>
M)S>U$26.6?15\FK4!K:=-G.[F!M'F'_X%<X7V'3OD]2QD^1=XENI<1O%% Z5
M559(9FZ)$[5W:K>%>!W8+%W0R                 &!G/8N2_-9_P 6X"G'
MT>OL_F!\MBOBVPU5U@R
M
M
M    "C.6DQ^T^O2/);Q5L6/R:Q/Q5NQV1(^SBTJUW:N[-$F:L*+Y'=OD#7Q>
M8,@%%>I5*>>ZJ^7N)VNB2[GK.Q,>2?!\*.5+SIX_$X>U'1PJDCE7N8K?,&IQ
M>H,@                !@9SV+DOS6?\6X"G'T>OL_F!\MBOBVPU5U@R
M
M
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MG_%N IQ]'K[/Y@?+8KXML-5=8,@
M
M
M            UN=W!@]L8R;,[CR-;%8JNFLURY*R")NO<G$]435?(G>OD ^.
MUMU;?WK@ZVY-K7F9+!W%D;6N1(YK'K#(Z)^B/1J]CV.3N A[?_5YR?Y?YVQM
MRS/=S64I2+!?;B((YHH)6KHYCI)98FJYJIHY&*[1>Q>U%0+CO^6G.#8/-O'R
MW]E91+4E;A]=Q\S5AN5^/5&^)$[MT73L<W5J^<&.Z"                 !
M@9SV+DOS6?\ %N IQ]'K[/Y@?+8KXML-5=8,@
M
M
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MH]?9_,#Y;%?%MAJKK!D
M
M
M    %"]^YFMR?ZVH-Y[FXH-MY-(;*VU:YR-JW<>M!\O9JJMCF:Y7::KPM[$#
M7QL.M7G7M#<^UL)L79><JYI;%M,GE9\=*VQ#'%!&YL,;I&*K5<]TBOX475.!
M-=-4U$B=^FO;M+EER'V\[/SPXQ]Z)V:R4]M[:\;'9!?$CXW2*U&JV'PVKJO>
M@2JR\T-Z8WGSU2[(Q.RI%O83#VZ5%MZ-%5DZ5K+KER>/NUC8Q%1%\O!Q)V*@
M7X]!PR                 &!G/8N2_-9_Q;@*<?1Z^S^8'RV*^+;#576#(
M
M
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MCU]G\P/EL5\6V&JNL&0
M
M
M    0)U+=15;DIB:V*PL,5_?>7C=)1K3:K!5K(JL6S,UJHKD5R*V-FJ<2HO;
MHW12R*=;VCZI\YM*US2WM?S-/:D?@R(^:Y^CHU;;E;'&L-&-\:HU5D;HJ1::
M=NN@:\6)PL7,?</15AX]B27[V\[*+*VS6M/9D$C@S$LLCHY72->KD;'P\+7:
MJWT43R!/K Z7.IK<FX=QIRGYJ/=)N%RRQ8G*V&>!9=/71RR5+3=&_=$1KN%R
MHCM4X7:N5 6+C!D  5MZU.8]W97*Z/;^)F=7RF[IW8]\K%X7MQ\3..UPJGV?
M$R)?YKW!8T?2!R(VKB]@X_F+N3%P9+=&?1]FDZY&V9M.DCE9$D37HJ(^1$\1
M7]_"Y&]G;J+79=1O3_M#F#L?+Y?%8FO1WQBJLEW&Y"I$V&2=:[5D6O,C$3Q&
MR(BM;Q=K7*BHNFJ*)4:]!O,BWE<%F^6F3G=*N$5N2PO&NJMIV'JV>)/,UDJM
M>GNR*%JXP9  %<NK3GLO+#:J;4VW9X=^;CB<R!\:_=*5%RJR2SV=J/<J+'#_
M #N)R+Z&BED4<VUL_.;$YW;,VWN2%*V;AS&!L6JFJJ^'UR6M99&_L31[62-X
MT\B]@:>N 8   # SGL7)?FL_XMP%./H]?9_,#Y;%?%MAJKK!D
M
M
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M<&-=]'K[/Y@?+8KXML%76#(
M
M
M        *3=7_+C=NU][8OJ#V(DB24?5OTO- WC?5M4E1L%E[>W6)[$;$_5.
M%.'1W8\-1R'-+JWP/-KDIE=EY7"V<5O2XM)R.K\$V-D=6M13/<U[GI(S5K%5
M&JQVG=Q+W@QON575UL+E9R5V]M-,=?S&[<;#99)4C8RO4226U-,WCG>Y5TX7
MI\"-P,:7D7M_>_49SS3G-O&#@V[@K,=M9&L<RKX]1-:=*MQ:ZI&Y&R2=_8B\
M2\3TU%\>@@9  % ?I JKF;VVC=5NC)L5-"C_ #K#85RI]3Q$#47=V#89;V+M
MBU'VQSXFA*Q4[M'UHW)_E#+H0/.#I)XLGU,6\A$O%&D68M.<B=BLE<K47^&1
M U7H^&0#SAY[<T://7G%2V7?SL>VN5^W[<M5V0M<2,<Z'5+-I6-:Y72/X%CK
MM5/-KP\;PU%L-M\^^F[:6!Q^VL!N_'4\-BX&5J==C9]&QL3355\+57*OI.<O
M:YRJJ]JA,4OYH[VVGF^JV#>^+RT-G:3<S@+3LLQ'^"D-2.FDS]%;Q:,6-^OH
M^3L#7QZ%;,YM\N.8=ZSC=E[AK9B]4B]8LPUTD1S(E<C.)>-C4TU5$[ P[0 !
MS,G+CEY-(^:;:6&DFD<KY)'XZJYSG.75555CU557O4#7YCEQR[BQ&0DCVCA6
MO96F<UR8VHBHJ1N_]F!5_P"CU]G\P/EL5\6V&JNL&0
M
M
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MH]?9_,#Y;%?%MAJKK!D
M
M
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MTP0   ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
M
M
M                          H1]'_AZ5S=F\MPV6))D<?2J5JTKTXG-;>E
ME=*J*O<J^ U-?-J&JOG/!#9ADK68VS5YFNCFAD:CV/8]-'-<U=45%1=%10R\
MCW1;LPF]]Y<J=@I+)\X,E-MQU*O_ *VQ#5O+X<2/54X6JK$XU5=.'7B7AU#:
M[G(KI"VIR[CJ[BWNR'<6]D1LK(WMX\=1D[](F.3[H]J_^MD3[5K>]3-JS 0
M                 &!G/8N2_-9_Q;@*<?1Z^S^8'RV*^+;#576#(
M
M
M                                     47^CU]H<P/D<5\:V&JO0&7G
MOT_UX)NLG<TDL;7OKW]R2P.<FJL>L\K.)/=X7.3ZH:O'H0&0
M       ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
M
M
M                           \E>6>_.<7*-^3DV-4LTG9=(6WEEQOK/$E
M97K'IXL;M-/$=W!M(/[TW5)]G)^I8OR ,B-ML[PYM[1WS>YC82C:AW7D)+<M
MJT_'+)&Y]]ZR3*D;HU8FKE[-$[ ))_>FZI/ODGZEA_( R.MY6]1O45N+F/M7
M [BDD_061R=6KD47$1Q(M>61&O\ 3;"BM[%^%KV=X3%_ R
M   &!G/8N2_-9_Q;@*<?1Z^S^8'RV*^+;#576#(
M
M
M                                               # SGL7)?FL_XM
MP%./H]?9_,#Y;%?%MAJKK!D
M
M
M                               !@9SV+DOS6?\ %N IQ]'K[/Y@?+8K
MXML-5=8,@
M
M                                                      XC<G.'
ME?L_+28+=&ZL?BLQ"UDDM.U*C)6ME3B:JIIY4[0N-3^\3R._Y\Q'^T)_(##]
MXGD=_P ^8C_:$_D!C^MZA^1[G(U-^8C55T36RU$^JJ]B QVV W3MK=55;VV,
MQ2S--NB.GQ]B*TQJKW(JQ.=HO9Y0C;                 &!G/8N2_-9_Q;
M@*<?1Z^S^8'RV*^+;#576#(
M
M
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M3=7]Y<[TJ<Q-C8'>M*/P8<S498?!KQ>%-VLFCU[->"1KF:^70,NH
M        8&<]BY+\UG_%N IQ]'K[/Y@?+8KXML-5=8,@
M
M
M                             H5N++4=I=>3,QO%S8L7+9KLK6IUX8HT
MMXEM:O)JO8C62N1JN7L;HJ^0-?%]0R 4+WQEZ.YNN;;B;7>D\N.NT*>1FKZ*
MCIJ4;GVDU;W^''K&_P W"J>0-?$_=8=S&U>G_<L60<U);<E""@Q5T<ZREV&1
M$;[J,8]R^XBA(_O1Y#:AZ?=L>LZHV23(25VKWI$Z_/I_"NJ@J=0@
M      !@9SV+DOS6?\6X"G'T>OL_F!\MBOBVPU5U@R
M
M
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M
M
M                                             "#^9?53RWY5;LL;
M-W+4RTN5K10SR24J\,L"ML,XVHCGSQKJB+V^B%QR/[]_)C_X#/\ ^QUO][!A
M^_?R8_\ @,__ +'6_P![!C<;3ZRN5&\MS8G:F)I9MF2S-J*C5?/5KLA;+.[A
M:KU;9<J-U7M5&J#%A@@                 8&<]BY+\UG_%N IQ]'K[/Y@?
M+8KXML-5=8,@
M
M                                                         C'>
MO3URAYAY^7<^[]O?I'.3LCBEM>MW(-60MX&)P0S,;V(GV(77/?NA=/7_ "A_
M]HY+_>0:UV7Z,.0F2K20T\+:Q,[FJUEJG?M/>Q53L5&V7S,73W6@U7[EKMK
M\A^HFKRNW]AJ&;K7[=:UM3=<D2LN06)E_P"QR-7BTX72-\)[%1>&1.)JZ(O$
M5Z AD                 ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
M
M
M                                           :+)[UV;A+;L?F=Q8S
M'7V(USZMR[7KS(UZ:M562/:Y$5.[L Q/_$OEQ_SAA/UE4_* 8]KFSRMHQOEM
M[VP43&-XG<63J:Z>XGB:K]0"B_-'?=#GKU0[-CV+Q6L;CK6-Q=.\UKF^.VM<
M=:GL(BHCDC8CWJFOUK.+RAKX]& R                 &!G/8N2_-9_Q;@*
M<?1Z^S^8'RV*^+;#576#(
M
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M+$FJ*GG6/33[%1BZL?7L06X(K565D]:=C9(9HW(]CV/35KFN3L5%3N4BOH
M                   !4?GETTX?FSS<LY!.86/PFX+U*J^/;DM=D]U886K"
MDJ-]9B<YKE8O:C/(&I7'_P#EZY#]H$/ZJ=_O8-?J/Z/6YQIXO,")(_KE;B7*
MOU-;B U._)3IAV/R8N/SM6>;.;KDC6%N6N-9&V"-Z:/2O"W5&<2=CG*YSM.Q
M%1%5%):F\(                 &!G/8N2_-9_Q;@*<?1Z^S^8'RV*^+;#57
M6#(
M
M #2[NW'5VCMO);CN)Q0T(5D;'KIXDBJC8V:^3B>K6_5 H7GL[D]RY>WG,Q,L
M^0N/625Z]R>1&M3R-:GHM3R(:9?7';?N9"-+"N;7K.^ ]Z*KG)YT:GD]T#[V
M]K78(UDK2-M<*:NC:BM?I[B+V*!I8I98)63P/=%-&Y'QR,56O:]JZHJ*FBHJ
M*!=SD[OI^_-G07;KD7,T'>IY)4[..1C45LNB?9M5%7R<6NAEI(
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MK/\ BW 4X^CU]G\P/EL5\6V&JNL&0
M
M                           $,]3-J6#E[6AC71EG)P1R^ZUL4TB)_P!9
MB%B54NK$V>U! _L9)(QCO>54U*B2%1$]%J:-;Z+43N1$[$0#^ </N&&.#+SI
M&FC9$9*J)W(YZ:K_ !@3ATKVIFY3<=)'+X$E>O,K?)QQO>U%_@>I*L6;(H
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M[%R7YK/^+<!3CZ/7V?S ^6Q7Q;8:JZP9
M
M                               1SSRVY/N3ESDHJK%DN8]69&&-$U5W
MJ^OB(GN^&Y^GNA*I.BN:J.:NCFJBM7S*G:AI'<XW-U,A$WCD;#<1/NL3U1NJ
M^56JO8J*!][>3H48UDGF:J_6Q,5'/<OF1$_Z0.%NVY+UJ6W*FCY5UX4[FHG8
MB)[R 6=Z8-MS4L%E=SV&*U,I*RM35?+#5XN-R>XKW*WWV$JQ/9%
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MK+DOOVS%CX<P_!9694;%3S<:5.-[NQ&MF1SX=57L1/$U7R($Q-X0
M          &!G/8N2_-9_P 6X"G'T>OL_F!\MBOBVPU5U@R
M
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M_);>DTLTE>*5^WI+?%ZS ^IKX])_%Z2HUJ.>Q'=K.!S>[A1HL78#(
M          8&<]BY+\UG_%N IQ]'K[/Y@?+8KXML-5=8,@
M
M                                              #G,UL#96XI5L9G
M!4[5EW:ZPZ)K9G>_(SA<OU5 Q<=ROY>XF=+-';E)L[>UKY(DF5J^=/%XM%]X
M#K$1&HC6IHU.Q$3L1$0#^@             ^%JG4O1+!=KQV8%[XIF-D8OU'
M(J :V#:&TZLJ3U<#CH9D[I(ZD#')]5&(H&Y[NQ
M 'G]T"8Z&YO_ '7F[#4DN5,6R&*1_:Y%MV$<]R:^5?"TU#5>@(9  'GKGZ:;
M5Z[ZR8]J0LMYVC.J-[-5RU2-9U[/LG32*OOAKX]"@R                 &
M!G/8N2_-9_Q;@*<?1Z^S^8'RV*^+;#576#(
M
M
M                   >?_05EL5B=Q;SERM^M1CDI4VQNM31P(Y4ED54;QN3
M73RZ!JKR?/39W_,.,_VVO_3#)\]-G?\ ,.,_VVO_ $P'STV=_P PXS_;:_\
M3 HKOV]2R/7-A;>/LQ6ZDF5P/!/7D;+&[AK5T71S%5.Q4T#7QZ#!D
M          ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
M
M
M                              \\4Z ^:6G;N+ :_*W?]U#6O[^X'S1_
MYBP'X2[_ +J#3]P/FC_S%@/PEW_=0:?N!\T?^8L!^$N_[J#75<L^BOF-LGF#
MMG=V0SN$GH87(U[UF&"2VLSHX'HYR,1]=J<2HG9JY :O&&0
M    P,Y[%R7YK/\ BW 4X^CU]G\P/EL5\6V&JNL&0
M
M
M                                                 &!G/8N2_-9_
MQ;@*<?1Z^S^8'RV*^+;#576#(
M
M
M                    JHB:JNB)Y0/XBHY-6KJGG0#^@   #^*J-35RHB>=
M>P#^HJ*FJ+JB^5      P,Y[%R7YK/\ BW 4X^CU]G\P/EL5\6V&JNL&0
M
M
M -7N+<6(VKB+&;S=A*U"LFKG+VN<Y?@L8WO<YR]B(@%5MZ]0^[\]8D@VX_\
M06(152/PN%UM[?.^1=>%5\T>FGG4J:CA^\=W23>L29_(NGUU\1;<ZNU]_CU*
MCM=I<^M^[;G8V]<7.8U%3Q*M]>.3A_FS]KT7[;B3W"&K5;(WQ@]^X9N8PDB^
MBJ,MU)-$F@ETUX7HG\3D[%(TZ4
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MI'*WM:B]RHYNJ\.JDL2V$  &!G/8N2_-9_Q;@*<?1Z^S^8'RV*^+;#576#(
M
M
M   %1.HK>EC.[O=MJ"14Q."T8L:+Z,EQ[4=(]?/PHJ1IKW:.T[RI448S&SY2
MPL,*HQC$XI97?!:W_I5?(A4=(W:N,1G"Z29S_OG$B?\ HZ: :#+X:;%/:[B\
M6K(ND<NFBH[[%R>10.KY0;TL;+WK0LK*K<5?>REDXU7T%AE<B(]4\\;E1Z+W
MZ:IY5(+Q$:                                          4F^D%W%,
MRMLK:<;E2O*^YE++->Q7Q)'!"NGN))+_  AJ+(\@-M0;3Y,[+Q$,:1O=BZ]V
MRB)VK8OM]:E55\J\<BH$KLMT8&ING;>7VW?:CZ>7IV*,R.35."Q&Z-5^IKJ@
M10OH1S]O#<T=P;/G56U\KC7R21:]GK>-F;P+]1DLH:KT*#(!6[GCTJ2<Y-\U
M]Z2;K]09!7K4DQ4M+QV>! ]SW(V5L[%3B5[E^ O:H658^**.&-D,+$CBC:C(
MXVHC6M:U-$1$3N1$"(TZA\IB,3R2WQ8S2L]5FQ-FI"U^GI6K;/!KHB>?Q7L5
M/-WA8K9]'O3OH[?N0])N+>F-@15^"^PSUERZ>ZUKNW[9 M7@#(!S\F^]CQ2/
MBEW-BF2QN5CV.O5D<US5T5%19.Q44# S&^]CRXC(1Q[GQ+GOK3-:U+];556-
MW_M *L?1Z^S^8'RV*^+;#576#(
M
M                              'G_OA\TF]-QOL*JSKD[OB:]_%X[]2L
MMAM1&)CI7-_UBS+XGU&IPE&] UNX&L=AK7'Y$:K/M^)- .%151=4[%0#T6QS
MI7X^H^?_ %[H8UEU^S5J:_QF6F2
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MOH]?9_,#Y;%?%M@JZP9
M
M                        IMU ;2GV[ONSE61K^B\]_P!LKR:>CX^B).Q5
M\Z.]/WG(5FHZP^6DQ4[G*WQ*TNB31HNB]G<YONH4=0W<.&<SC]85O\QS'<?\
M&@'/9O-_I/AKUVK'38O%Z7PGN3N54\B)Y$ V_++:4^]-Z8S#LC5]-LC;.1=I
MJUE2%R.DU\W%V,3W7(07P(T
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M?1Z^S^8'RV*^+;#576#(
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M6IV\+&ZKPMU]U2-.V
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M3CZ/7V?S ^6Q7Q;8:JZP9
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MOL_F!\MBOBVPU5U@R
M                                                    #%R=^'%8
MVYD['_N]*"6S+I]A"Q7N_B0#SZSF8N[@S%[-Y%ZR7;\SYYG=Z(KUUX4U[D:G
MHM3R(:9;7 X&">!M^^WQ&R=L$"]C>%.SB=IWZ^1 -Y+B\9,SPY*D7#_-;PJG
MO*FB@<?F<6N+M)&UROK2IQPO=WZ)V*U?=0"5.F[<\V)WL[;[Y%]0SD+V>&OP
M4LUVK*QW_51[?JDJQ;HB@
M                                             &!G/8N2_-9_Q;@*
M<?1Z^S^8'RV*^+;#576#(
M                                                        .<Y@
M5YK>Q=RUJ_\ KI,9<:Q$\J^ _L^KW 4#7N-,I!Q4K)L94?'\'PFMT\SF]BI_
M"@&6!S6[Y&<-.#_UJ*^14\J-5$:G\*@;;DM7FL\S]N,A1>)D[Y7:>1D<+WN_
MB0@O$1H
M                                P,Y[%R7YK/\ BW 4X^CU]G\P/EL5
M\6V&JNL&0
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M>5RKW(U556.7W&N52*[T
M                                      !@9SV+DOS6?\6X"G'T>OL_
MF!\MBOBVPU5U@R
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MK9").]]69DR)[ZL5= ,\
M       ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
M
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M,B@                                            !@9SV+DOS6?\
M%N IQ]'K[/Y@?+8KXML-5=8,@
M
M <'SFQ,V9Y9[@JUT5TT4#;;6IWJE21L[NS[5B@4<[>].].U/?0TRD/'W8LC4
M99B7MT1)6>5CT3M1?^@#)1%7_I XC<-Z.]D/N"HZ"!OA,>G<Y==7*GN:@:H#
MJ-J48^"3(O1'2HY8H%7ZU$3TE3W5UT Z0#2;GI1STEO(FEFNJ:O\KHW+HJ+[
MW>@'(1R.AECF8NCXW->U?=:NH'9[DNQPXQ\.J>-<1$8SR\"Z.<[WO(!R%2K/
M=M04JS%DLV)&0PL3O<^1R-:B>^J@>B-"JE&A5I(NJ5H8X47SI&U&_P#09:9
M                       !5WJ?W/-9S>,VE"]4IT84O66)W.L3JYK-?M&)
MV?;J6)4'XO'OR=MM9KN"-$XYI._A8GF]U>Y"H[2#%8RLSPXJL:IW*YZ(]R^^
MJ@:G-X"NM>2Y0C2*:)%?)"WX#VIWZ)Y%0#F:EJQ2LP7:<CH;5>1DT$S%T<R2
M-4<UR+YT5-0/0#:.=;N;;&)SZ(C79"K%/(Q.YLCFIQM3WG:H9:;H
M                                     P,Y[%R7YK/^+<!3CZ/7V?S
M^6Q7Q;8:JZP9
M                                                 _CFM>US'M1S
M'(J.:J:HJ+V*BHH%+>;_ "LO;"S,MVE"Z7:EV174;#45R0N=V^!(OD5OUBK\
M)ONZZ5E'$%FQ5D\6M*Z&3N5S%TU3W?.4?>QE<E;8L5BT]\2][$5&HOOZ::@,
M5B<EG,A7Q6(K/MY"RY&05XDU<JK_ !(B=ZJO8B=J@9NZ]LY#9^?N;=RBM6[3
M5B2/CU6-R2,;(BM5R(JIH[S 9VU;\:-DQLCD;(YWB0:]B.U31S??[-0.E]SR
M@:/<]Z.&FM!JHMF=4XV^5L:+KJOFU7N X\#]RRRSR++.]TDBZ(KW+JNB=R 3
MMT^<L+>1RD&^LU L>)HJK\3'(FBV+*=B2HB_61]Z+Y7Z:=RD6+3$4
M                 *;=14$L/,ZY)(FC+%6K)$OG8D?A_&8I6:XG:4C&V[,*
M_P"LDB16>[P.U5/X]2CK /G8E9!6GFE72..-ZN5?-HJ?Q@1LG<GD]P"\O)F"
M6ORPVW',BH]:SI$U^PEE>]O_ *+D,M.[
M                 ,#.>Q<E^:S_ (MP%./H]?9_,#Y;%?%MAJKK!D
M
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M5(F5Z\:=S8XFHQJ?41"-,@
M       P,Y[%R7YK/^+<!3CZ/7V?S ^6Q7Q;8:JZP9
M                                /XYR-17.5$:B:JJ]B(B <!G^:V(Q
MLCZV)B7)3M['2H[@@1?<=HJN^HFGNEQ'++SAW!QZMITTC^Q5LJKI[_B)_D+@
MZ'!\W,=;D;!FJRT7.71+$:K)%JOV2:(YO\9,$BQ2Q3QLF@>V2&1$<R1BHYKF
MKW*BIV*A%?L                                               .#
MWCR?V/O:9]S)4EK91_PLA2<D,SE\[TT5CU]US54"/'=+&#635FX;:0_8+!&K
MM/MM43_T2ZF.VVCR-V%M*>.ZRJ_*9*)4=':R"ME1CD\K(T:UB+YE5JJGG(8D
MD*   $3\ZN;"[!H1XG#*U^Z,@Q7Q.<B.;5@U5OC.:O>Y5148B]G8JKW:+4JH
M-_(7LI;FR&2LR6[L[E?-8G<KY'.7RJYW:5&/POX>/@=P?9<*\/\ #IH!]J5V
MWCK4-_'SR5KD#DD@L0N5DC')W*US=%0"W/)'FT_?-.3!9YS4W/0C1_BHB-2W
M BHU9$1.Q'M54XT3L[=4\J)%B7R*                 '\5$<BM<FK5[%1>
MY4 @3F#TWT\M8FRVR9X\=9E57RXN?5*JN7M7PG-15CU^QT5OFX4+J8AZYR/Y
MH4YEA=@))D3ND@EAE8J>=%1_^4)C?;;Z<M^Y>9BYEL.#I:^F^9[9YN'^;'"Y
MR:_;.:%Q938O+W;O+[&K1PD2NL3:+<ORZ.GG<WNXE1$T:FOHM3L3W]5(KJP
M                                            !@9SV+DOS6?\6X"G
M'T>OL_F!\MBOBVPU5U@R
M          13S5W7,R3YLT)%8WA1^1>U=%7C35L7O:>D[SZI[IJ1$7U*EJ_9
MCIT87V+<JZ1PQIQ.73O]Y$\JJ5'9,Y3[M=7\9WJK)=-?5UE57^]Q(U6_QDU<
M<EDL9D,/<?0R==U:VSM5C^Y6^1S535'-7SH5'=<K]URT;[-O7)%=0N.5*O$O
M^JG7M1$]Q_=I]E[ZDL5,YE0
M                 *%<R<_-N7?.<RLKE<Q]J2&NB_6P0+X42)YO1:FONE98
M^VL5#8:[(6FI(QCN""-W:WB;WN5/+IY"CJ^)=.'ZW['R?P <MN7$PPQID:K$
MC17(RQ&WL;J[N<B>3M[P/SL//3[9WCA<U Y6^K6HTFT^N@D7PY6_58YR$%_2
M-
M           ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
M                                    "L^Y+,ES/Y.S(NKGVIOJ(CU1
M$^HB:&T2=R>Q5>/%V\TJ(ZY9F=7:Y>]L46GHI[[EU7ZAFD2417#<U<37N[8D
MR+FHEO&N9+%)]=P/<C'M]Y477ZA8E0C7GDJV(K,2Z2PO;(Q?,YBZI_&AH6EC
M>DD;9$[$<B.3ZJ:F%?H
M             //;=-&;&;ES&.G16S5;MB%Z+YV2N37ZIIENMJV628]]77[M
M ]SE;Y58_M1?X>P#> :7=%ED6-2LJ_=;#V\+?+PL755_Z .<P=&;)YK'8ZNB
MNGMVH8(T3M572R-:G^4#T0,M
M                                  ,#.>Q<E^:S_BW 4X^CU]G\P/EL
M5\6V&JNL&0                                                 "
MN6],9)BMSY*N]JHQ\SIX5\BQS+QII[VNGU#<1T_*_=]/#OFP64D2"K:D\:I8
M>NC&RN1&N8Y?(CM$5%[M26"96N:YJ/:J*U4U1R=J*B^4RJ*N:6\*5BHNVL9,
MV>1[VOR$L:HYC&L7B2/5.Q7*J(J^;0U(E1OAL=)ELM3QL2*KK,K(UT\C57TE
M]Y$U4HLZB(B(B=B)V(AA7]
M                "L?49RWM09!=_8B%9*-EK&9EC$U6*9B(QDRHGUKT1&N7
MR.3M^$5*@"">>K*V>O(L4S?@O;[OD]U"HV_SJR?!P\$/']\X%U_@UT U-BS/
M;F=/9D669W>YWF\R>9 )VZ=>6]J_E6;[RL*QXNCQ)BFO33Q[*HK5D37O9&FO
M;]GW?!4BQ:0B@
M                      ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
M                                               #CM_;,3<]-EFE
MPMS%5%2%7=B2Q]ZQJOD[>UJ^?WRRB"K=2S2GDJ7(70V(UX9(I&JUR+[J*:1^
M6V++8O ;8E;!]Z21Z,_ZJ+H$?F*&25[(8(U?(]>%D;$5SE5?(B)W@37R[V._
M!,7,95J)E9F\,4/?X$;N_7^>[R^9.SSF;5=^10
M                                /Q+%%/$^"=C9(9&JR2-Z(YKFN314
M5%[%14[T @[>/33@<M/)>VK=7#32+Q.I2-6:IJO?P=J.8GN>DGF1"ZF(_7IA
MWYX_AI?Q?@Z_ZWQ9^[[7P-1ICO=G],^#QD\=W=EY<O+&J.;1A:L-;5%^O555
M[T]ST?=U&F)S@@@K0QUJT;8:\349%%&U&,8QJ:(UK4T1$1.Y$(KZ
M
M   8&<]BY+\UG_%N IQ]'K[/Y@?+8KXML-5=8,@
M                             #797 8;-L1F5IQV=$T:]R:/:GN/;HY/
MJ*!S:\J]HJ_C2*=&_8),[A_C[?XRZ-_B-LX+!=N+HQP2::+-VOE5/MWJKOXR
M#;
M
M                8&<]BY+\UG_%N IQ]'K[/Y@?+8KXML-5=8,@
M
M
M
M,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
M
M
M                                            &!G/8N2_-9_Q;@*<
M?1Z^S^8'RV*^+;#576#(
M
M
M                            # SGL7)?FL_XMP%./H]?9_,#Y;%?%MAJ
MKK!D                                                  ^%RY5H
M5I+EV5L%6%.*25ZZ-1 (OS?-]Z2.AP%1JQIV):M:]ONI&U4T^JOU#6(Y].:F
M[D?Q++ Y/L%A;I_%HO\ &,'5;?YN5K,C*V?KI5<Y41+<&KHD5?LFKJY$]U%4
MF"2XY(YHVRQ/;)$]$<Q[51S7-7M145.Q44BOT
M
M                                                 # SGL7)?FL_
MXMP%./H]?9_,#Y;%?%MAJKK!D
M               @WF7NB7+Y=^)KR*F,Q[U9PHO9).WL>Y?/PKZ*?5\YJ(Y;
M"X+*;AN>HXJ#Q943BE>Y>&.-J^5[O)[B=ZE':2<G,ZV%7QY&J^=$U\+AD:U5
M\R.[?\A-,<)D<;?Q%R3'Y*!U>W%\)CNU%1>YS53L5J^14*)%Y4;HE997;5QZ
MN@E1TE!7+\![?2<Q/<5-7>^GNDHETRH
M
M                                          &!G/8N2_-9_P 6X"G'
MT>OL_F!\MBOBVPU5U@R
M        ^<[UBADD3M5C7.1/>34"K,DCY9'2R+Q/>JN<J^55755-HG?E?CZ]
M/:-6S$U/'ON?8G?IVJO$K&IKYD1J(9I'9D5&_.+'UY,-2RG"B6Z]A($>B=JQ
MS-75JK[BM14+$J+]M3R5MPXN>-='MM0_P*]$5/JHIH68,*
M
M                                                         !@9
MSV+DOS6?\6X"G'T>OL_F!\MBOBVPU5U@R
M                      _BHCD5KDU1>Q4]Q0*R9S&2X;+W,9*BHM:5S&JO
ME9WL=]5JHIM'>\M-\4L97^;V9E2"#C5U&T]=(T\1=5C>OUO:NK57L[26"5GY
M''QP^LR6X65]-?%=(U&:?;*NAE4+<Q]YUMQSPXW%N5^*IN61T_:B33:<**U%
M^M:BKHOE534B-5L'%297=-"-K=8JSTMSKY$9"J.37WW<+?JEHL.84
M
M
M    # SGL7)?FL_XMP%./H]?9_,#Y;%?%MAJKK!D
M                              XC?^QUW)$W(8[A9F*[>'A<O"V:-.WA
M5?(Y/K5^HON640A;IVJ,[ZMV%\%B-='Q2-5KD^HII'PX&Z::)HG<GD_@",W&
M8K(9BTREC:[[%A_UK$[$3SN7N1/=4*GG96T8=JX]S9')+D[.CK<S>[L[F-U^
MM37ZJ_P)FU73D
M
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M16JFJ*G:BHH1_0  # SGL7)?FL_XMP%./H]?9_,#Y;%?%MAJKK!D
M                                           861Q&+RS$CR5.*TU/
M@^*Q'*GO+WI]0#3)R^V<U_&F*9KKKHKY53^!7Z%T;VECZ.-A\#'UHZT/V$3$
M8B^ZNB=I!D@
M
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M7)?FL_XMP%./H]?9_,#Y;%?%MAJKK!D
M
M
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M"FO=YNT'C<?1Z^S^8'RV*^+;!5U@R
M
M
M                      !0+Z0*JYF]=H75;HR;%SPH_P ZPV%<J?4\1 U%
MV]@V&6]B;7MQJBQSXFA*Q4[4X7UHW)_E#+H@/.#I(URG4O<R,*\<219BVYZ=
MRLE=P(O9[LB!JO1\,@'G#U2<6+ZIZF1E7AC<_!VVN5.Q&1>&Q5_AC4-3CT>#
M+EN9=F.ERYW?<E5$C@PF2E<J]B:,J2+_ - %,?H^ZSG[JWI<1OH0X^I"KM.Y
M9IWN1-?=\-0U5]PR  ,#.>Q<E^:S_BW 4X^CU]G\P/EL5\6V&JNL&0
M
M
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MEM;MBWFLDRJ_U"TRI)X;H^-RZO>BMU8G9Y@J5OW7^K#]J#?U]F?R 38?NO\
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MW@U=&E2IXVE7QV/@95H5(F5ZM:%J,CBAB:C&,8U.Q&M1$1$0,ON
M                                    4:YZ?XT^77RF _KT@:G%Y0R
M
M                   %%^E__%AS0^USW_X9@#5XO0&0
M
M                              ! F_\ IWO[TYX[:YO0Y^&G5P#\<Y^*
M?6=))*F/L.G5$D21J)QH[3X/8%U/80
M                                                  ("Y4].U_EQ
MS?W7S.GS\.0K;C;D$9C65G1/A7(7H[::R+(Y'<",X?@]NNH74^A
M
M
M
M
M                                "F_4+U2<S.5W-*WLG:U+%6,=%7J2
MP>MUIYK#I+,:.5-8YXT7M71$1H:D<A^])U7?\@1_J'*?E@9'XEZL>J''M6UD
M-B5HZC$59'387*1,1$\[EG330&1W?*3KCQNZ,[5VYS&Q$&!?>>V&MFJ<KG4F
MS/71K9XY=71M5>SQ.-R)]=HFK@8M^&0                      !%/45S'
MS_*GEC=WCMJ.M+E:]FK QEUCY8>">5&.U:Q\:ZZ=WI!8^?3CS+W#S8Y:0;OW
M/%5BRDMRU6<RC&^*'@@<B-]%[Y%U[>WT@5+00
M                 ",>H'F#G.5_*O,;UVY'7ER]"2HR%EUCI8%2Q:BA=Q-8
M]BKZ+UT]+O"Q#?39U9Y/F=NF?97,&"C1R]QGBX"S19)!%,^-%62N]))9?35J
M<<:HJ:Z.3OX=2V+9!EK=Q7Y\5M_*Y2LC5LTJ=BS"CT56*^&)SV\2(J+IJG:!
M6_I8ZAM]\Z-P9_%[MKXZ&MBZ<5FNN/@EA>LDDO O$LDTJ*FGFT"V+1!
M      JCU1=2._\ DUO7$[>VG6QDU"]BV7YG9""::1)G6)HE1%CFB1&\,;?(
M&I$:,ZJ.JN5C98]AQ/C>B.8]N"RBM<UR:HJ*DW:BH#(_K^JOJGK-\>SL.!L#
M.UZR8/*,;I[J^.F@,CI>7/7BR]F:^(YG8"'%5)WI#)F<:Z58Z[U7366O+QOX
M$7X2MD56_8J#%T(9HK$4<\$C98)6H^*5BHYCF.35'-5.Q45.Y0R_8
M               #A><N\,KL#EAN3>.#9#)EL362>JRTUSX5<LK&>FUKF*J:
M.7N<@'!]+?.+=?.;:69SF[(:4-S'Y'U*!N/BDAC6+P(Y-7)))(JKJ]?*%J=@
M@
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MRYZK.4/,K*P8''7[&(SEIR,IT<Q$VLL\BKHC(Y&/DB5Z_6LX^)W<B*H,3:$
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M$55\L7O@Q8\(
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M,:W^#L#.IQ"
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MM!TKH6PS10L1JK*R->+BC<J^CIVA*J;TQHB]6.<54U5)<\J>Y]V<%O'HB&0
M
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M:>UTDJ^))Z3FM<Y6LXNW@1 RI3T _P!X^Y_[$_[W"&J]!PR
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MWQ2SKQ) V1[GJK8F\+.QRHKD54[%"53'IC_Q89WY3/?CG!;QZ(!D
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M,KLG;T.(R%J'U6Q/%)/(YT*O:_A^ZR/1$XFHO9Y@:[H
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MY9EG67(,DG<]5M*JR^B^1S?25?L?>"Z[P(
M                                                   K+D>F'<%W
MJ&9SH9GZ;,:W)ULBN,6&59_#KQ,C5G$B\.J\'8H75F@@
M
M            *R\V.F#<',3G'0YFTL_3I4:;L<[U&:&5\J^H/1[O2:NGI:=@
M75F@@
M
M
M
M
M
M
M
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MS-0+8M&$
M
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MJ)XBUK+GI*WS\#F^YKW*,7)PN:Q6XL33SN#MQWL1D(FV*=N%>*.2)Z:HJ?\
M2B]J=R]H99X
M
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M*@CG>@7>5S);3W-LFW*Z2'!68+N.:Y=>"'())XC&^9J21*_3SO4+5P0R
M
M
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MDYN)V=?;CK1Y5KKD=I86M=(Z+5C8XW,XEX_A)VZ>X"IX"
M
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M7<]<B3[FLW#PLAC5415CB;V-5>]RN=HG%HA+4N!
M
M                                                      !A6\1B
M<@Y'WZ%>T].YT\+)5_A<B@?>K3J48O I5XZT*=J1PL;&W7WFHB ?8
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M,?@TJ\5:'O\ #A8V-O\  U$0#[@
M
M
M
M
M
M
F                                               __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>lc_liuhugoanti-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_liuhugoanti-4c.jpg
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M%!04%!04%/_  !$( L\(_@,!$0 "$0$#$0'_Q #C  $  P # 0$!
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M0Q7R-Z,21J>=TCX^9=?[._S(#<U&$
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MZSWMTGWQ]12M;R2NUX\TD;F.<OU?,"5QA
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M-%(Y$]T]L;'.3TQ1H%AJ!CV2,;)&Y'QO1'-<U=45%XHJ*@1]
M
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M[(
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M")/<L5E74-X:=GJR(GT REK$,0
M                                           #)&TR)LYU1YGM9(G<
M8WFT?RWCT?N6)*G/4-9&G8C6M6HB]/=M#+<[/5K75>=97M]L#9I5;4Y%7QW*
M\K'[J*CC<Z)CE3RM:U*B54_ZM%"0NC<_%=JI=OZ:U[CK#0[?V&2EE;#+.^EI
MV^$:L4$2K&J.<FB\J,:NKN" 9KR+/NANZ6JIL$6/-9"]CHH[G:K1+35,;E31
M)&3*UDBJB\4YT5%\J*G +FGW0_E5??-LKI8:NIDK*3&[I)1VFHE14>E#+&V5
MC%1554Y7*]437@BHWL0)*N-OMK[/N;U,[KTV4.EJ,4M-R?6U=D9*^*GK:M:A
M[:?Q",5.=D?W1W+]5IY-44KU^K7:G#-M\5L.YNW5L@Q?)[+=Z:*.6V-\/&]K
MVOD8Y6-]7G8^-JH[3BBN1=>&@AK"7)J&@P]V8W=R4UNI[;\JUKO)'$R#OWZ:
M^9-0Q9OZ/K359-/G.^.2,;\J9G<9J:B:]47DHXY%DE:S7Z17JV)$_P"I"RZ?
M3M([:;?3<'8NI=W=GN$JWS%VJOJ\G*CT8SSN=3O9S?@5"R[76_\ DO;K](6_
M8($A+.M+_D)>/\MM_P",M!!N!G]QVVZ5+9D=E>L5[?8+/06V=.V*:LIX8N]3
M]]&Q7/;^^1 ;U/;.S=(>.X;0U&?76V7_ #JZ0I67^JN]-4UKHZFI3G?"Q'PO
M8G=JO*KV^LYVKN;BFA9Q?FUV48!A?4]0V39F])7;;9Q2/9<;9'WZ04E>R.:1
MC6).UJKRNB:K5\C9'-[$ ]+?;#OS_P"KO#,/EJYJ*@NF/LCN<E,]8I7T,3[A
M+40HY.*)+&QT2^AWE!&Q8&^?3IM)3[/9+5V#&:.S76P6Z>YV^X4;%94<U%&L
MRLD?JKI$>UJL7O%=VZ]J(H2)3CIDR2X95L9A]UNLSZBO;32T4T\BJY[TH:B6
MF8KG+Q<JLC;JJ]J@E;01DNS2_+W7A?%JM7)CEC1E"CN/+S4=,CN7S:^+D]L,
MMS6@8H;N=N=B^T^*U.5934<D$>L=%1L5/$5=2J*K(86KVN73BO8U-7+P0"CN
MF;!LKR3+\@ZC=PJ=:*\98Q8K!;'(J+%;Y.3271W%&]W''%#KQ5B*Y>#FJ%EX
MN[3G5/6OM=2S^M30VV"6)B]B/[VX.U]G5K0L;&NWL9(QT<B(YCT5KFKV*BIH
MJ!BR1T&JL6-9U11+K107EBP>5-5A5J_L,:&4K^WM_P"3F?\ Z/77\3E#&%;]
M%O\ R$L_^6W#\9<%E/M\]OKGNEME=\&L]3!1UUTDH^6JJN?NHV4]7#.]51C7
M*J\L:HU//Y@0I1W35OOCMBI?S0WJN$ESM=,R"@L\K)J:VI'3L1L<+=*B5K6H
MB<J<T*IYPN*9],N]>1;ET=_Q//J9M+N#B,Z4UT5C&Q).Q7OC5SHV^JV1DD;F
M2(WU?<JG;HA)AVNK^UPW+8#)Y)$3O*!U#60.73@]E9"Q>WSL>Y/H@A,]C;M4
M7O9W![E5N5U3+9J)DKU[7/AB;$KEU\J\NH)6 $
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M,44<$3(8DY8HVHQC4\C6IHB!'V
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M>%R:]OAM[G)IK&R26I>J>C2>-/H*%EJP(
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MV XSBLGWZSVRDHYUUUUFAA:V1?HOU4(DP
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M%I?"VZF2TX+;J>59W04R\[7U$JJQB->Y'/5&IS??7)]*W4JZP@
M
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MD<YVGD[/($2P
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M*J[2*Q_>RQ\B(QC'-8J>LOWI.&CUT*NL(
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M;3>[;S=RHN--@]?-6RVID4E8DM--3(ULZN:Q465K==58O8%P6($
M
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MJ:F1L5/"QTDTKU1K6,8FKG*J]B(B:J!2]YZMM@[+,E._*VULOE\!2U54Q/\
MZC(N1?H."X+CM]=372@I;E1N5])60QU%.]45JK',U'M547BFJ+V*$=D
M
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MJL<K4<U=%XIP4(YP
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M,M]OM&\V]=IM-,RCM=OKVTE%2Q^YBIZ>LJXXV)KJJZ-:B:A9:_#$
M
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M<VK5GDYI%1=$U3FXA8:KPG_<S'?]%T7XNP,7N@
M
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MZ<\,X?T(Q'_=.P_Z.I/[@P,'L@
M                                     .G=KG1V2U5UYN+^[M]NIY:R
MKD1->6&G8LCUT\NC6J!F#$]P^IC?6"HRG;I+'A>!]_+3VV>Z,=55E0D+N57>
MXE:JHOJJJ,8W75$YM-0R06Y46Z%CZK=K6;FWZW7O()(7)35%J@\,C*&3Q4?)
M(G=Q:ZN633AY5!N3+K.I*:OR+9RAK(TFI*F^RPU$+N+7QR2T37-7T*BZ AK/
M1---.'F#%E+H;TAQ_/J.)$92P9"_N8T[&HL2-T3Z#4#*7YTR_P#/C?W_ $RO
MX_7!)3KK"_5\RKZ^W?[0IP0[EA_5/H_T!3_9 -[./3?M1NOF.V45XP_=6LQ&
MSK754*6>GIG2L;(Q6\TG.D\?%VOU(65_[3=,=DV[RJ;<'(K]69GGLJ/Y;Q<4
MY$B=*WD?(QKGRO616+R<[Y%T;P1$"8JXW2_7>VT_T9#^W< L;&O@Q8TZD9X\
MJZFMH\.M3DFN5LJ*2JKD9ZRQ,EK&3N1VG8K8J=9-/J51?*&4;&RPQ9%7]?AO
M^A__ /&*&6YKH,6>LNPOJTKLGNU9B.XEDMN+S5,C[105%+&^:&E5=6,>JV^5
M5<B<%7G<%R4):L6ZC7]2%\L]'FUKBW0CL+)KA?G4[%HY;<KJ;2%L?@U3F15C
MX]RGN5X^<K16WF(=4-KR^WUVXF>V>]8?%WWRC;:.FCCGEYH7MBY7-H853ED5
MCE]=."!,G8WWWIR# ;IC6!;?VB&];BY=(YENBJW*VEIXD<C$DD1',5=7*NGK
M(U$:YSEX:*(A#,EQKJXDQ2\5>0YKB\%M^3ZI]RH(J)9&^'2%ZR,YWTWE;JG;
MH#)Z?1#)(_8RG:]RN;'=*YD:+]*U7,=HGT7*H)1[HKHJ5M1NE<DC3QLN0+3O
MFT];NHEE>UNOFU>Y02_>M=K6+M=4M1$J8L@TBE3W;47N55$7TJUJ_0"P]OKD
M_P"2"_Z8HOL90D+_ ,:_W<L_^14W]R:$9LL/Z]64?HU%_<:(+N1^YSLQ7KUI
M*R[Z04N26^**@F?P:KI;=X6/BO;S34ZQIZ5"[FQPQ /"S7_<W(O]&5OXN\#/
M_0C_ ,EJW_3U9^+TH65A=3W_ "%SC_(6?C$0(<?2W_R"PC_))OQN8$K?", Y
MUN_::SJLFS"YVBXY%C.WZ.M=KH[3$DZ^-IT>U97\RHU$2=\KFN1=5Y&>1 RW
M.MU&[Z6;=K&;4^T8ED5DR7&ZYMQM]VJZ=C(8HE325'/8YRMU5L;T73M8@(AI
MVZ[XNCZ;7[U6F!E3<5M<,C:?^QQW*65E$]')Y615#E54^F:WR:A,&>MA>HS9
MG:S&JN6_R7FY[@9)4.N65WA*2-ZRU,CG.;&U[IFN5L?.[BJ<7N<[RZ(68>)L
M;U!8!A.ZNY637AEP=;LTN2365*>G9)*C)*RHD3OF]XG*NDS>#5=Y03#^A08@
M
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M!'N@
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M*\@@!D'JI_Y[[&_Z3A_VC2!E#7P8LB5OZ_%M_P!#N_V9,&6YKL,5-=4>X/\
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M<:IJ"EN"UD+86K)+"Y&]VK7OYD^Y.U[/)YPDPMD(
M                                                   >=D%FILCL
M-UQZM<YM'=J.HH*AS/=)%51.B<J:^71W #*.WEHZI=B;=/MY9,.MV;8O#42R
MV6ZI6PTB1MG>KG<R23,<C5<O.K',U1571RIH&63YMVQN^-=OIAV[F;RT=QJ>
M]\1?F4<L<5+:X8VOCAI8&/?SR(UJHYRM1?6<O%RZN48K$ZC=K\SW#R';.OQ2
MCCJJ7&[NZNN[Y)XX%CA66E<BM214YN$3^#>(2%^A% ]+NV&9[96_,*?,:*.C
MEN]W6NH4BGCJ$?"K%355C5=./D7B%E%J_;#?;:_=C+\[V>I+/D%CS25*JNMU
MTE6&2*=SW2N_LD/N9'R*U6R+JUW%NJ 2S<K%MW-T^G>YXW?K+0T>Y-QE@5]K
MHJAC:1(Z>X1RM5)9)9&HJQ,YEUD[0)?:\/O])L!3X%+ Q,GCQ+Y%=3=XWN_'
M?)WA^3O$56Z<_#F[/*!XG2]M]E6V6UL>,9A2LH[PVOJJE88YHZAO=3<G*O-$
MKF\=%X:@E<X1E??';#>6X[ZXYNKME9Z&YML-MB@B^4*F**):ELE5S-?&Z6)Z
MHC)D5%:[M"P[-37]<5\8M%%:L6QKO$Y?E"-Z2N9K],B/FJTX?@U!DDVR?3BW
M;S(*W<3-[V_*]S+FCTFN<B.[FG[[A)W7>>LY[D]59'(W1OJM:U-=1,I]NS6;
MJ4.-T\VT%OH+EDZUL;:F"Z.1D"4*QRJ]S=98=7(](T3UNQ5 RQ_P]ZNEW83>
M3\V;%^=:4W@^X\5#X+N^X[C7N_%<^O+_ -9VA<FIMIJS=:NQRIEW?MUOMN2I
M6/;2P6IR/A=1)'&K'.TEFT<KUD3W78B!$\"*0M&W&6TG5%?]SIZ2-N'5V/1V
MREK$FC61U2U:55:L2+SI]Z?Q5- NY=X1GKJ(VESW),CQ+=/:N2"3-L0<YK;;
M5N;&RI@Y^\:C7/5K-457M>USF\S7\'(J<2P\"_Q=4V\=@J\,O6-6_;VP5L$D
M=YN+*N.LK*N-&*JTT#&3.1C9ET8]7K[E?=::M<,D\Z7=O<JVRVM9C&8TK*.\
M-N%54]S'-'4)W4W)RKS1*YO'1>&H)>=TS[99CMO'G#<NHXZ1;W>GU]N[J>.H
MYX'([UE[M5Y>WL=Q!+BZG=K\SW+CPAN'T4=8MDN_CKAWL\=/R0Z,XIWBIS=B
M\&\00E^_^UM3N_MK7XA;JJ.CN_>PUMMFJ.;N/$4[E5&R<J*J->U7-U1%TUUT
M730$(9MS<.JJVW''\<S+&; _%:/NJ2YWNGJ=:M::)G*DJ,2IT5_!-=(N/F0&
M3LVG;+,:7JIONZ,]'&W#*ZRLH*:L2>-9'3MBI6JU8D7G3C$_CIH#<]??W8:@
MWFM5#4T5<MDS>QN66QWIG-ZJJJ.6*7DT=R*YJ.:YOK,=Q;],UPB5>6[*NM+$
MZ9EDN>$6C,'TZ)'%?(ZN&%TR-X<TG]\0ZKZ5B8OG!DEFV>-]0=[SFGSS>"Y4
M5IL]#3SQ6[#;4]71)+4M1O>3*Q[VN5J=BOED7S<OE"Y,GHJFY8U>;=1M1]96
M4-33T['*C4626%S&HJKP355[0BH^E3;?+MK=M*K&\TI(Z*[27:IK(XHIHZA%
M@EA@8U5=$KFHO,QW#4+*7[Y8K>\VVGRC%<<@;4WNYTK8:."21L+7/2:-ZHKW
MJC4X-7M4$,_X+;NL_;W$K7AMBQ;')+3:8W0TSZJ>.2=6OD=(O.YE:Q%75R]C
M4"Y)_C%ZZN)_EE,OQNQ01-M-8ZS_ "?-&DK[MRHE*USG5<C49S*KG*J=B=H3
M)Z'2UM#>MIL%K8LLC8S,+Y725MTY96SJV./[G"Q9&*J.X<TG;VO4$KGN]KHK
MY:JZRW*-)K=<J>6CJXE['PU#%C>WZ+7*@1172_MSN)M?9<DP7.**)^.1UZU>
M.US9X9TF9+JR5JQM<KF(O=QRHCD[7.\H65\?)]!_BL/\FW]P(H'8W:3+<,W3
MW4R;*+93P6/)[@ZIL<C)()E?%XNIE1>1BJL?JR,7143]@++0X0
M
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M6([U.Q5[ F30(0
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MCIH:EL:-T[R*)K')JW@NBH$>J
M     &8[[UJ8I;5[^VX9D5=9TJ/"+=IJ>.CI73JJHC6/>YR*J\KM$=RKP[ N
M#3@0 J3<[?:WX'D=OP3'[#6YEN%<HUJ(<?MBHQ8J=$5>\GE5'(Q%Y55/57U4
MYG<J:*I<''MMOU19GE55M]E..UV%;@TT*U3+)<E;(VHIT357T\S6L1^B<=.5
M.&JMU1':#!;X0
M                                                           S
MYN!U9XUA%VO-GIL3O]ZDQ^=U-=[A!3-BM\+VN1JZSN<O#5R(BJU$77M"X+HP
M_(X<PQ2R973P/I:>]T-/<(J:54<^-M5&V1&N5O!51':< CVP*VW:WGL.U$-K
MI:BBJK[E5^E\/8L<MK>>KJI$5$5?+RM17-;KHJJJZ(B\="X(OBG46^KS.W8#
MN1AEQP#(+VB_(3J^5E31U;]=$C;.QD:(]5T1$T7UM&ZHJM11@O$(
M
M                                      4QNAU&V+;6_P V+,QJ^9%?
M:>F975#+73(^FB@D1SD=)*KM4T1JJNC%1 N"9;4;C46Z^#6_.;?0RVZDN#ZA
MC*2H<U\C?#3/A555G#BK-0B:@0K=+='&-I,6DRC)WR.C61M-0T-.B/J:NJ>B
MJV*)JJB:Z(KE551$1/H 5=3=4-79[I:8=T=O+O@E@OLK8+;?ZV1L],V1Z:M2
MI1(XUAX<51=53M5-$54+@T,BHJ:IQ1>Q0@
M
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MJ(F&DSBNJ
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MEXG+=
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MZU51L<JM?$Y=&RQ\W'EU]5R?2KIYT.=J=--J>,2WK%^+D=JQC3;0
M
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MBR
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MRU_YE3_U@^=7^:?*?*HX1Y#\R,+_ )N6O_,J?^L'SJ_S3Y3Y5'"/(?F1A?\
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M?=GS-O37^>,)VK<.>W0
M                                   %1[U;Q;;879KWA^3WZ.WY)<[+
M5/HJ%T-1(Z1M3%-#&O-%$YB<SVJWUG(%B%5](V\.VUNVUQ/;:LOS(LVGJ:R&
M.U+#4*Y9*BKFEC3O$C6/UFJB^[]':"87EFN[>-X)EV(89>*>LEN>:5#J2US4
MS(G01R-DBC^[*^1CD15E;IRM<!4W5!;[GBV5[<[Y4%'+76S#*YT.1Q4[>>5E
MOJG,^Z(G8B(G>,U7AS.:"'C]0.^N%[@[=?\ #G:RX)E.89O)345'0T#'J^*%
M962R.FYVMY%5&\G*[14U5R\&J"(:/P3&FX;A6/8FUZ2?(MNI:!TK=='OIXFL
M<Y-?JG(JA$@ SWU:JOYO[>IKP7-[.JIY.#9PL-"!      /#=A>'/<Y[\>MC
MGN57.<M%3JJJJZJJJK/*8\E/!N1K=1'_ ,E7\TOS\R<,_F[:_P#,J?\ K"<E
M/ ^MU'^2K^:?:?F3AG\W;7_F5/\ U@Y*>!];J/\ )5_-/M/S)PS^;MK_ ,RI
M_P"L')3P/K=1_DJ_FGVGYDX9_-VU_P"94_\ 6#DIX'UNH_R5?S3[3\R<,_F[
M:_\ ,J?^L')3P/K=1_DJ_FGVGYDX9_-VU_YE3_U@Y*>!];J/\E7\T^T_,G#/
MYNVO_,J?^L')3P/K=1_DJ_FGVGYDX9_-VU_YE3_U@Y*>!];J/\E7\T^T_,G#
M/YNVO_,J?^L')3P/K=1_DJ_FGVGYDX9_-VU_YE3_ -8.2G@?6ZC_ "5?S3[7
M#58#A552STKL?MS&SQNB<^.C@8]J/16ZM<C-45->"B:*>#*G7ZBF8GYE67ZI
M92VZ@HL:W5AL&2T=/64RU4UHJHJN)DL:2N<L<;T;(BHGW1&Z+YE-.Q75;N93
MAN?H/5[-&MT'-ACA$5Q]O!BUE^9&%_S<M?\ F5/_ %AU/G5_FGRORSY5'"/(
M?F1A?\W+7_F5/_6#YU?YI\I\JCA'D/S(PO\ FY:_\RI_ZP?.K_-/E/E4<(\A
M^9&%_P W+7_F5/\ U@^=7^:?*?*HX1Y''48#A%3!+32XY;>ZF8Z-_)20QNY7
M)HNCF-1R+YE1=4+%^Y'XI\J3:HG=#)^36+(MD,^@K+9*Y8&/6HM56]/4J*95
MT?%)IHBJB+R2)P\CDTU0[]NNG46\)\;C5TU6*\8:SPS+K7F^/TN06IVD4R<L
M\"KJ^"=NG/$_TIK]%-%[%/G[MJ;=7++M6[D5TXP]\\GH
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MGZJG"[5X6[IYQMPFYJM@
M#P:JYW.JN$MOL[&)X?3OIY.S5?(A4?G=9;\/3>U]J [K+?AZ;VOM0'=9;\/3
M>U]J [K+?AZ;VOM0'=9;\/3>U]J [K+?AZ;VOM0'=9;\/3>U]J [K+?AZ;VO
MM0'=9;\/3>U]J [K+?AZ;VOM0'=9;\/3>U]J [K+?AZ;VOM0'=9;\/3>U]J
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MZ6&D1ZI]4D36Z_1 ]8 !G[=[]8O8K\)?_P 38%:!"
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MM0'=9;\/3>U]J [K+?AZ;VOM0'=9;\/3>U]J [K+?AZ;VOM0'=9;\/3>U]J
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MV/)L:M5^BTTKZ:.9Z)V-E5NDC?X+T5IO4U8QB_/M78FQ>JMS^&?^'LF35
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M7&,/9,&8                         (_#_O=4?Y.G[3"HD!%
M  !5.?\ 4)@&V^;V? \A\8MTNZ0/=54T<;Z2CCJYE@C=4O=*US$5S55>5KM&
M\?,%P6L$06Q;K8]D&Y61;6T=-6,O^,T\557U$L<:4CV3MB<U(GI(KU725NO,
MQ/*%3H(J3=#J$Q;:O)[=B-TLMZO%ZN=)X^EALM+%5*L2/D8J:/FC<KD[MRKH
MU> 7!$EZQMOJ.1OYP8SE=@HW.:U]=<K4V.!G,NB<W),]WM-508+VL&067*;/
M1Y!CM=%<K-7QI+25E.[FC>Q>'LHJ*BHYJ\6KJBZ*@1Z0             (_E
M7WJA_P H;^TI4E("*                  #/75K^0-O?TWL_P!C.%AH4(
M.*6JIH%1L\S(G+Q1'N1JJGT5 X_E&W_XU#_*-_= YHIH9V\\,C9&:Z<S%1R:
M^;5 .)U=1,<K'U,37M71S5>U%1?2FH'Y\HV__&X?Y1O[H'.KV(Q9%<B1HG,K
MU7AIVZZ@<'RC;_\ &X?Y1O[H'TRMHY'I''41/>[W+6O:JK["(H'W+/! B.GD
M;$U5T17N1J*OT0.+Y1M_^-0_RC?W0.2*HIZC7N)62\ONN1R.TU\^B@?DE920
MO6.:HCC>G%6O>UJ\?0J@?'RC;_\ &H?Y1O[H'/')'*Q)(G(^-WN7-5%1?85
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M5$BZ=U,]=5@77Z5ZKJSS.X?3)IM:W3XQST^-KZ2_A\$^)IPXCK
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MP<0W*L3,CPRYQW*V.=W<JM162PS(B*L<L;T1S'HBIP<G9Q35%10B3@
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MO=QM1]735=/ V7FT5Z>J]Z<O/IQ)5C$\O!E&$QS<6^#
M                         C]C_+%Y_"M^R>5'M355+3JC9YXXG.35J/>U
MJJGHU41$R3,0X_E*W?XW#_*,_=+RSP.:#Y2MW^-P_P HS]T<L\#F@^4K=_C<
M/\HS]T<L\#F@^4K=_C</\HS]T<L\#F@^4K=_C</\HS]T<L\#F@^4K=_C</\
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M[9K>&&AEOE=2/N6,9%:FNBIJ^"+F5\;XGJO+(U&/7AI[E>"ZM<X+U"
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M1!5T\572R-FI9V-EAFC5',?&].9KFJG!45%U137F)B<)>D3C&,.4B@
M                 !'X?][JC_)T_:85'N35%/3HBU$K(D<NC5>Y&HJ^C41$
MR8N'Y2MW^-P_RC/W2\L\#F@^4K=_C</\HS]T<L\#F@^4K=_C</\ *,_='+/
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MI%:B31M?JK7)SLYD]/N6JUR!%TA      (_E7WJA_P H;^TI4E("*
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MI_UC43UV^7W2>7E\-7I?ESS4_=]#TTVHYXY9VKA.<W@
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MBCK::=7N5?6=(RJ>B(JZ)QA.MJ]+131-<8XN=I]3555%,X-KG'=,
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M(H                  ,_;O?K%[%?A+_P#B; K0(0
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M&_M*5)2 B@                  SUU:_D#;W]-[/]C.%AH4(
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M/Z*O_JK_ +!_X@?N7Z?/[CZ']7F/Z*O_ *J_[!_X@?N7Z?/[CZ']7F/Z*O\
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M B@                  S]N]^L7L5^$O_XFP*T"$
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MH93+4N&8+B.WMF98,,M,-HM37+(Z&%%5TDBHB*^21ZN?([1$3F>Y5T#%(0
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MQ5,2ZQ3,;(Q?.UZ(J?L*<^8PEMQ.+E(H
M           (_8_RQ>?PK?LGE1("*
M  !'[K_O#:OX7]4J) 10                  9^W>_6+V*_"7_\38%:!"
M                        PQU>N:G4/MBBN35L5N5R:]B+=9.*^T&4-R2Q
M13Q/@G8V2&1JLDC>B.:YKDT5%1>"HJ=J")P8L@;K[>7+:[)(,CQM\D-CGG2:
MVU,:KS4E0U>;N7.X]FFK%7M;P7713Z+37XO4\M6WTN)?LS:JQIV+VVKW?M.?
MTL=OK%;195"Q/$4:KHR?E3UI(->U/*K.UOI3B<K4Z6;4XQ]UT+&HBY&&]9AI
M-L                      C\/^]U1_DZ?M,*B0$4
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MK%5$70#M@1^Z_P"\-J_A?U2HD!%                  !G[=[]8O8K\)?\
M\38%:!"                          A^3Y%MA:KY;J#,+A9:7(JE(UM<%
MS?3-JWHZ16L[E)?6XR:HWE^F F '4N=KM]YH)[9=::.KM]2U63T\K>9CFK^T
MJ=J*G%%XH94U33.,;6-5,51A+*6YVS-YP&I=D^*2S5%@A?WS9(U5*NA<BZHK
ME;HJM3R2)V?3>=>]I]73=CEJV^EQ[^FFW\5.ST+ VGWZI[SX?',VE;3W==(Z
M6ZNT9#4+V(V7L1DB^?W+O0O;J:G133\5&S@V=/JN;*K:O@Y3H@
M          (_#_O=4?Y.G[3"HD!%          #SJ_(+#:I6T]TNE)0SN;SM
MBJ:B*%ZM5535$>Y%TU3M ZGYZ8=_.&V?Y[3_ ->!V(,DQVJ@GJJ:[T4U-2HC
MJJ:.IB?'$UW!%>Y'*C473AJ!VZ&XV^Z0>*ME7#6TW,K.^II&3,YD[4YF*J:I
MJ!\7"ZVNTQLFNM=3T,4CN1DE5*R%KG::Z(KU1%70#[FN-OIJ+Y2J*N&&W<K7
M^+DD8R'D?IRNYU5&Z+JFBZ@>?%EV)SR-B@OMNDE>NC&,JX'.5?,B(_50/9
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MJVFZ&NI+G1P7"@F;4454QLM//&NK'L>FJ*B^E#B3$Q.$NM$Q,8P[!%
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M=32Z>5$<Y)T3^VF&NIPN^&%T<XV_ M<T&X
M             "/V/\L7G\*W[)Y4>Z^:&)4221K%7BB.5$_;(RB)G8^/%4OP
MT?OD_=)BO)5P/%4OPT?OD_=&)R5<#Q5+\-'[Y/W1B<E7 \52_#1^^3]T8G)5
MP/%4OPT?OD_=&)R5<#Q5+\-'[Y/W1B<E7!^MJ*=[D:V5CG+V(CD55*<L\'*&
M(!6.5=/.SF;7^KRC*,7BN%]K^[6KK'5-7$LBQ1MB9JV*9C4T8QJ<&^0+BS=L
M#L;M5F.=;O6G(\=CKK=C=^\#9('5%5&E/3=_5MY$6.5BNX1L35ZJO +,I1U4
M;>X7MOT]2V+#;4VU6>7(*2MFIXY)95=/)&Z-[^:=\CM58QK>W3@"$QZ7*BLQ
M./+]C;S/WMRP.XK);7JOWVT71/$P/3S^LYSW:=G.U DLV]0<TVXV:7[<Q9%?
MC..9';,$L*)HL<TD+9ZBL=V:*B/:KD5.U)&A87YUP005&V^,0U#4=#)E%$R1
M%71.5U/4M=Q\G!0D.+<SI\Z9+/@]ZNT4%+CM90TLU1172FN<ZRQU,;%=$C62
MSR-D57(B(SE57=B<08I[TL7G*;]LAC=QRZ2:HN+DJ(Z:KJM5GFHXIWL@>]7<
M7>JG*UR^Z:B+QUU42LS+;A56G%;[=:%S65M#;ZNJIGO;SM26&![V*K5[4143
M@$1/8G+;YG>TV,Y;DDK)[W<X)9*N6*-(6.5E1+&W1C>">JU.P++K=1"(NQ^>
M:IK_ .45"^TB A4&T_3%LOG&S>+W:\X\YM]N]KBFJKK3U=5'4),]%UD:WO%C
M1?0L:M] ,4=V8R.]W/IUWDQ6[7)]ZMV*P7BWV>Y2N63GI%HI=&-<Y5U8BMYV
M(JKHC].Q$0++UNGSITV:SG9?&<BR?&&5M\N,52M97>*K(7O6.KFC:ND4[&IH
MUK4X("9='*+-=.DC.L5O>'W>MJMH<FKFVN]8Y7S+41TDCU1>\A5W8O(KI&*F
MCM6*USE:X&U+NIB.-^ZVP*O:CE3)7Z*J(JI]WH%_;1%"0TP$5ENAL5AF[UQM
M=;F,]P?36J.2**VTE3X>EE65S7*^5$:KE<G+HBM<@7%4O0_24]#C&>4=*WDI
MZ;)9X86JJN5(XX8VM157BNB("6IPB/W7_>&U?POZI42 B@
M    S]N]^L7L5^$O_P")L"M A                          89ZO43^D/
MMA^"MW^U7AE#<P8@'XYK7M5CT1S'(J.:J:HJ+VHJ 9UW9V!23OLCP&G1'\9*
MRQL[%\JNID\__5^]\C3L:;6_AK\OM<O4:3?1Y'A;5;Z5V-218UFSY*BS1KW,
M%<]'.J:3E]7E>GNGQIYO=-\FJ<#UU.CBOXJ-OI>=C533\-6QJ*DK*6X4L5;0
MS,J:.=J203Q.1\;V.XHK7)JBHIPYB8G"77B8F,8<Q%
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M]I2I*0$4                  &>NK7\@;>_IO9_L9PL-"A
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MK:R,;4KSZ6;BC[?D5I5>,,U/5,;^&:]CE_M;3;ZC3G3+5T,Y3#0IR'3
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M@(H                  ,_;O?K%[%?A+_\ B; K0(0
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M\D4GB'1]ZB=T]'Z<J.;VZ><\KE'-&#I=.UGTMZ+F'-ACELVJ8_HLU7\Z(_\
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M_%8PQE8 &7YOUY:?]%E^Q>%W-0!'CY1^19_9C^S0)+T*#_ :;\%']B@5V
M            ,[Q?KJ3?H*GX\T+N:("          !0-DWZQ_=_(,XVAH++6
M4MRMEONK):N=T3H9%I)4I%Y$8Y7(JOD1S=3TM5<M<3VL+E.-,QV(7TRW'PV<
M5MO<OJ5UODY4_P"LAD8]/XO,=OJ%.-N)X2Y.BG"N8[&LC@.R
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MJ:2GAIYJ^?3OJA\3$8Z5^G#F>J<SM/*H1Y>5?>J'_*&_M*5)2 B@
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M[R5\B<^BK[E'(Q./8U CGRC\BS^S']F@27H4'^ TWX*/[% KL
M    9WB_74F_05/QYH7<T0$          #!_2Q^M7N/^"OO^UX RG8D^WW-B
MV^5/0+]S9#=*NVJWR*V3O8&I[:M5#Z._\=C'LB7!L_#>P[6R3YQW
M                                1^Q_EB\_A6_9/*B0$4
M                       "/W7_ 'AM7\+^J5$@(H
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M("*                                 !'\J^]4/^4-_:4J2D!%
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M?^&]CVXMD(J.1'-75JIJBIV*BGSCN/T
M          >#5VNY4U?+<;/(Q%J-.^@D[%7SH5'SWF7?!4_M_; .\R[X*G]O
M[8!WF7?!4_M_; .\R[X*G]O[8!WF7?!4_M_; .\R[X*G]O[8!WF7?!4_M_;
M.\R[X*G]O[8!WF7?!4_M_; .\R[X*G]O[8!WF7?!4_M_; .\R[X*G]O[8!WF
M7?!4_M_; .\R[X*G]O[8!WF7?!4_M_; .\R[X*G]O[8!WF7?!4_M_; .\R[X
M*G]O[8!WF7?!4_M_; .\R[X*G]O[8!WF7?!4_M_; .\R[X*G]O[8!WF7?!4_
MM_; .\R[X*G]O[8!WF7?!4_M_; .\R[X*G]O[8!WF7?!4_M_; .\R[X*G]O[
M8!WF7?!4_M_; .\R[X*G]O[8#[H;5<);@VYW>5KI8D5L$,?N6ZZIJOM@>Z10
M          HK,>H"]LSNMVTVDPR;.<HM#$DODWBHZ"@HU5$7NUFD16N>FJ(J
M*YO'U4U<CD0N#W-I-[J?<:Z7C#[_ &2HQ/<7'T1]UQVK>DJ]RO*G?0R(UO.S
M5S=?5^F:J*Y%108+9"*BW;WTAV[OEHPC'+!4Y?N+?F+-;[#2/2%&P)S)WLTJ
MM?RM56/T]7L:Y7*U$U"X(K1=1F6XUE-FQG>K;Z;"X<AG;2VJ]05L5QHEG>J-
M1DKHDY6\7)JO.JIKJK>7508-#A #/V[WZQ>Q7X2__B; K0(0
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M9/3S,75KXI&HYKD7S*BZH$<P&>NK7\@;>_IO9_L9PL-"A
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MM@'>9=\%3^W]L [S+O@J?V_M@'>9=\%3^W]L [S+O@J?V_M@'>9=\%3^W]L
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MCWCR>@
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M8YWK_"?3JJ_1=']%/J4/?7:?\<>-Y:.]^"?$T:<9U
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M*2]1-UK+5*Y%D9YW,7ASLU^F3L\J(<2_IZK4Y[.+K6;]-R.U.35;
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M91*:;"7+Y0VPM+7+K)1/J*1Z_63.<W^*YIK:VG"[+WTLXVX66:3;
M
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M\L-U@;HGKZ>K*U$^ED1-?0NJ>0Y6IL?*J[)V.CI[WS*>U/C4;(
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MR:&IT4T?%3G#=L:J*LJMJ[3F-\
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MC5[M:NU\)6LJ$3S)4Q(W]N)3WZC3\43V/+0S\,QVKX.4Z(
M
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MIY6N\BIY%1>#D\B\#YNNF:9F)VP[E-451C#O&+(
M                                       '#54M+6P/I:R&.HI94TDA
MF:DD;D\RM<BHH'Y1T-%;H&TMOIHJ2E;JK88&-BC37MT:U$0#D?##(]DDD;7O
MCXQN<U%5J^A5[ /IS6O:K'HCFN31S5XHJ+Y% Z-%8K);)7SVVVTM'/)PDEIX
M(XGNU\ZL:BJ!WP &>NK7\@;>_IO9_L9PL-"A
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MKVKHK7)Y6N34X5=NJB<*HS=>BN*HQAZ9@S
M                          #.\7ZZDWZ"I^/-"[FB @          81Z6
M7.7JJW'17*J)#?=$555/RO &4[&RMP;;\KX-D-O1-7S6^H[M.W[HR-7L_C(A
M[6*N6Y3/:\+U.-$QV,_=+MQ2')[U:U=HE70MG1/.ZFE1O[4JG7ZC3\$3VN;H
M9^*8[&I3A.N
M                                              #/V[WZQ>Q7X2__
M (FP*T"$                      *;W"W_ +#C2RVS&49>;TW5KID7^\H7
MIP]9S>,BI]2Q=/WQK5WXC*'U/3^@7;^%5WX*?ZI]GC\BE+;8-R=Z[PM?4225
M$#%5K[C5:QT5.U5XLC1$T_@1IKY5\YK135<E]9=U&DZ9;Y8RGA'WI\/MEHS
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M=Q1'MX.:J_OD/>FJ)V/G+^FNV)PN4S3/:]8R:P
M                                            9ZZM?R!M[^F]G^QG
M"PT*$                         !C3*(I-L=Y)*V!BLI:.O9<(&MX(ZDJ
M%21S&^CE<Z/Z!S:O@K?JFEF-=H.6=LT\OCC[8MD12QSQ,GA<CXI&H^-Z<45K
MDU14]E#I/RR8F)PDE^]/^M7]H(P]T N<M]W#1SE<B1V[3557^R57G#*6Y Q
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MVR5=$[ZLMLNOG1DB-_CL:?1ZOX[./@EP]-\-W#Q-CGSCN
M
M                     S]N]^L7L5^$O_XFP*T"$
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M/<BRPO7RIV<S%^E?^TNJ&]1<BJ'Y[U#IUS1UX59TSLGC[^Q,#T<L
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MO>-LD^<=P
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M!]2Z9<T=>>=$[)]4]J=GJXX
M                          !GKJU_(&WOZ;V?[&<+#0H0
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MZ[;FW5RR[=NY%=.,/</)Z
M SO%^NI-^@J?CS0NYH@(          &#^EC]:O<?\%??]KP!E.QO ,61^I2W
MNH]P(*]J:-KZ"&7F3ZN)SXE]I&M/H-!5C;PX2XNMC"O'L:EQVY-O%@M=V8[G
M;74D%1S)YY8VN7]LX5RGEJF.$NO15C3$O3,&8
M
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MIHT71DK4[98=5U5OU3>UOI3B;=N[%7A?%]5Z37I*N:,[<[)X=D_;-9)[."
M
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MO7258V_ M0T&X
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M8
M  &>NK7\@;>_IO9_L9PL-"A                            'R]%<QS4[
M5143Z(&;>EK83-MF+EEE9EM1;YH[VRD;2);YI9E1:=\[G<Z211Z??$TTU"S+
M2@0               R_OEM=<++=I\\QN-WR7.]*FO93ZI)25.NKI4TXHQSO
M6YD]R[7L30T;UN8GFA^A=#ZI1=HBQ<^]&48_BCAX?3"9;/;VPY$V#&<LF;#?
MT1(Z.N=HV.K\B-=Y&R_L.]G@OI:O8Y3M<KK'1)LXW;48T;X_+[O0NXVGR0
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M:;'XZ?&U])?P^"?$TV<1U@
MSO%^NI-^@J?CS0NYH@(          &>-H>HN][D[P91MI762EH:&P,N#XJZ"
M61\LBT%;'2M1S7)HG,C^9= N#0X1#]T[%^<6W]^MK&<\_AG5%.WRK+2JDS43
MTJK.7Z)L::ODN1+POT\UN84CTNWSN+S>\=D?ZM93QUD+5^KIW<CM/2J2(O\
M!.IU&CX8J:&AKSF&GCANL
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M71D=8B)[39?.WL=Y/,>]J]S93M<'K'19L8W+6=&^/R^Y=!LOE
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MK] ^RBY]3I>;?AGX8^WG?B^OT<:#7UV8RIB?A_@J^[Y-GB;G."W
M      ""95N_@F'W%EJNM>LE?S:3PTC%G6!//+R^Y^MXN]!M6]+<N1C$9->Y
MJ**)PF4HL>0V/):-+A8:^&OI%[9('HY6JOD>WM:OH<B*>%=%5$X51@]::XJC
M&)>F8,P
M                      ,_;O?K%[%?A+_^)L"M A               "E]
M[-WW8G')BV.2?_M),Q%JJI.RDBD35.7_ *UR+JGU*<?,:UZ[RY1M?5]$Z1]1
M/S;GW(V1^;W(#LUL[+E$\>7Y=$Y;'S=[24LNO-6R:Z\[]>/=:^_]CM\;5KFS
MEV>L]8BQ'R;,_%OG\OO]#4K&-C:UC&HUC41K6M31$1."(B(;[\\F<7Z$
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MV>Y;)L/FP
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M$Q.QR;EBY;^_3-/AC!WRO$                  &=XOUU)OT%3\>:%W-$!
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M'%KRS(<;M-\8J+X^DAJ'(GD>]B*]OT':H:]RCEJF.$OEZ*N:F)>N>;,
M      '0O-[M./6^6ZWNLBH;?#[N>9W*W5>Q$\JN7R-3BIG11-4X1&,L:JHI
MC&69MQ.H.[W]\EEPALMNMLBK$ZNTTK9]5T3N]/O:+Y-/7]*=AVK&AIISKSGS
M.3>U<U94Y0X<*Z=<@R*CDNF4U3[(V=BNI8',[VJ<]W%'RM54Y4_>JO,OH+>U
MU-$X4YI;T=548U9/$OFV.YVUU8MYM+YI*6'BEUM+GKHSS2QIHYJ>?F:K?2IZ
MT:BU>C"?)+"JQ<M3C'F2[#.IFX4RQT>;425L/!JW*B1L<Z>E\7!COX*M]A37
MN]/B<Z)P>UO6S&52_P#&LQQG+Z7Q>.W**M8B(LD35Y9H]?JXW:.;]%#DW+55
MN<*HP=*BY37&4O</)Z
M                               !G[=[]8O8K\)?_P 38%:!"
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M8,FJ
M  ,]=6OY V]_3>S_ &,X6&A0@                           #\<B.:K5
M[%31?H@5CM/L-@^S53=ZK$)*]\MZ;"RL\?.V=-*=7N;R\L;-/OBZZZA<5GA
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M\R-<NC_X"N.5=TURWMC)TK=^BO9*9FL]P
M                                           #/V[WZQ>Q7X2__B;
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MQ[VN3H/S,
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M0TJ[=5&V,&W3735LEZQYLP
M                             9^W>_6+V*_"7_\ $V!6@0@
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MB/@K\T^]<ILOE0
M          #/75K^0-O?TWL_V,X6&A0@                           #
MXE^]/^M7]H##G_Z/]S77W<-6JBHL5N5%3RIWE4&4MS!B
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M5:\BY [5-?4I)F\/1RQ(/EZ>/R^4Y[\\7UWO4/4(JZ9(B.1%]S41_P!1I/\
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M5=$KD1>9OTS?-Q35-=-34Z2;6<9PVK&IBYE.4K1-%M@
M                        *$R??3,[KN#<MMMEL4@R>Z8\U%R2[W"I\+;Z
M65VJ)"BHJ<S]45J^MKS(Y$:J-54+@]S:7>JLS7(;UMYF]B7%=S,>:DU;:>]2
M>GJ*5RMTGIY$[6^NS5./!S51SM5T$PM\(K3>'>2U;44%NA;03W[,;]-X3',;
MH_\ "*N?5K5551KN5B*YJ*O*JJJHB(O'0N")6'<'J4^6+1^=>UU#!C=QJH*>
MMFH+E'+5T,,[T:LTC$D?S)&B\SD:WR>0"^ @!G[=[]8O8K\)?_Q-@5H$(
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MC>]K7.C=VM54U5%]@(Y ,]=6OY V]_3>S_8SA8:%"
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M721.J%1=?N[6\DJ:^AZ.0Z=VF*:YB-F[P;GY3;FKECFV[)\,93YT@/)Z
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M.Q-$[Z)/-]4WZ5?0J'+U6FFU.,?==#3WXN1A.U9II-L
M                 !'\YRVBP3#[WF-PB=/266DEK'P1JB/E6-NK8VJO!%>[
M1NJ]FH&>[!=NLC<6TTN7V>?%\4LMUC;56RVUL<LE1X65.:)[E[JH7UFJCN+F
MKQ]RG8%R3C +-U0TF5T-1N-D>-UV'L2;Y0I+;#(VK>JQ/2+D5U-$B:2<BKZW
M9J#)=@0 S#T5IXS',^R&H36ZW/*:M:R1WWQ>2..1$<O'L=,]?HA9?N=Z6OK1
MVWK*-.66[V*JI:]&_3LC96JU7<?)HWWJ W-.A&*=V<DRV#K M]/B5HAOF5TU
MEBM^+T]:]S*.DGJHY)):N5&Z*K8HY)G.1%1=/+PT#+<FV0;H[[;&W6RW3>%;
M-D>W=WJF4%;=++%+3U%OFE17(JM>C.9J(CG:*U>9&Z<S5TU(T^US7M1[%1S7
M)JUR<45%\H16FY>XN=X9<J*CQ/;BNS2DJ8%FJ*VCJXZ9D$B/5J1JUT<BJNB<
MVO *HRXYSF>:]0VS<F78%681X.:]-I/&U#:GQ?>42*_D5L<>G=\K=?K@K7X8
M@           Z=UN='9;95W:X/[NBH87U$[_ "HR-JN73SKPX(29PC%ZVK55
MRN**=M4X,?8M;JW>'=-U5<FJM+53NK[DB*JI'10JB-B1?-IR0M7TG.ICYE;]
M/U5RGIVBPIVQ'+'\4[_3+9C6M8U&,1&L:B(UJ)HB(G8B(=)^5S.+]
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M'1#2M5\E6$OO.K:&G76(N6\ZHC&GMCA[.UKY%1R(YJZM7BBIQ144Z+\P?H
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M%D:D*-;%'HKD<YVNOTH90VJ&(                           #XE^]/\
MK5_: P[T (B7W<1$31$CMR(G_P!2J#*6Y0Q
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M@7;U5RK&79MVXMQA"1'B]0                   /SE;S<VB<VFG-Y= /T
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MIF45)3T<2JL=/&R%BNXJK8VHU-?:#%S 9^W>_6+V*_"7_P#$V!6@0@
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M-^57\ZB/AJV]D^_TKO-I\B
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MSVZGI*J5G%CIV1IWG+^]YM>7T!BE8&>NK7\@;>_IO9_L9PL-"A
M                  'S(BK&Y$[5143V@,F]&VU>X.W-VS6IS>Q36>&YLHDH
M7320R=XL3ZA7HG=/?V(]O:&4M:!B
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MFGETT621WE<OM)V)HA\_=NU7*L9=JW;BB,(>^>3T
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MB(BJOI7R@?0 #/75K^0-O?TWL_V,X6&A0@
M #\<[E:KE[$37V@*BV5Z@\;WNJ[W1V&U5UMDL38'5"UW<Z/2I=(UO+W3W]G=
MKKJ%F%O!
M          *=ZG<0OV8;3UL&,TORA>+35TEXAMB-YUJFT,G-)$C$]TJL5SD8
MG%RIHG%4"PCMDZSMD:^ULJ;Y<JK'[PUNE99ZNBJIIHIFIZ[$?!$]CD1VJ(JJ
MU?.C>P&#S-H;Y4[Q[ZWG>FT6JHMN!6ZP)B]IK*R/NI+C,M7XETJ-U5-&^LU>
M*Z)R:\=402TN$         &=XOUU)OT%3\>:%W-$!       &-'?_G)WLT^^
MTE?==//K0T:_$Q'-^_<?J?\ _%T[MIH_JGWRV6=)^6 &#^EC]:O<?\%??]KP
M!E.QO ,0   Q'FD-3@.ZMPFH4Y)+?<6W"C;V)R2.2H8WTIHY&J:-^GDN8QOS
M]OG?J'2+M.LT')5MIB;<^K^F8;1MEPIKO;:.ZT;N>DK88ZF!WGCE:CV_L*;L
M3C&+\SNVYMUS15MIG#R.:IJ::C@?55DS*>FB3FEFE<C(VIYW.<J(B&41,Y0\
MIG!467]16'6))::PH^_7%NJ(Z'[G2-=Z97)J[^ U47SG0M:&NK[V4-*YK**=
MF:C['8<SWSR^:OK9E[KF;X^X.:OAZ2#55;%$W7MTUY&(NJKQ<ONG'4KKHTU&
M$?\ +GTT5WZ\9:XQ7%;+AMGALEBITAI(O6>]>,LLBIZTDCN',Y=/ZB:(B(?/
MW+E5RK&IVK=N*(PA[1Y/0                                    B.X
M4V"SV"IM.<UM-3VZI;JC9I&MG1Z>Y?"WB[G:O%.5J^UJ94WOE3S1.#VMZ*YJ
M?AHIFK[<6,G5\F(9*^LPJ]R31TSO[SND<<E*][%[4=$]%X>16NU13J_NFFKI
MPKQ\F++_ %/J=$XT13_/$3Y,_2T7@/438[I2)29NK;3=8F_X9&U[Z6?3RZ-1
MSF.]"^KZ?(<J[<L8XT58QX)Q;M'1.HQ'QVO'%5,QZ4^AW9VWG]QDM$GX1ZQ_
M9HAX_-IXD])U<?\ QU/:M>68O>YDI[/>J&OJ%17)#35,4LFB=J\K7*O#V#**
MHG9+4NZ2]:C&NBJF.V)>P9-4                             A6[N+7#
M-ML<KQ6TJGRI=+=/!1-<J-:Z?EYHV*Y>"(YR(U5\FH%)[9=5VV>/XE:\/W&6
MJP[+<;I8+1<;94T-3(WO**-L/,SN(GJU%1J+R/:U6]G%.*EP<%KSBFZA]]\+
MO>!V^I7!]N6W"IN62U,+H&5%17P-B9!$CN/:UJZ.T<J<R\J(B:AJ@(
M   ,_;O?K%[%?A+_ /B; K0(0          **ZDLS^3;+2X=1R:5=UTJ*_1>
M+:2)WJM7\(]/::J>4U=17A&#[#NWHN>Y-ZK93E'A]T>EW^G;"_D/%Y,FK(^6
MXWQ4=#S)ZS**-?N>GFYUU?Z4Y2V*,(QXO'O%K?FWOE4_=H_]6_R;/*N8V7RH
M           ,,]7OZPVV'X*W?[5>&4-S!B                         "
M,Y]AE!G>-55BK-&3.3O:&J5-5@J6(O(]/1QY7)Y6JIA71S1@Z&@UM6EO1<CQ
MQQAE7!LON.TV45]JR"A=46Y7K3W>UN1KE[R+5&2Q\_JJY->"]CFK["IHV[DV
MZGZ'U#0V^I6*:J9C';3/J^VR6D,=K]IMPH%?;**UUL^FLM'44D+:IGUT;V<W
M\)NJ>DZ5&HF=E4^5^<:SI=S33A<HRX[8\KMU.T6VM5KWN-4;=?@FNA_N;FFQ
M&JNQ^*7+G3VYW/%JNG[:^I55CMDU,J_ U4_[3WO/6-==C>PG26YW/%J^F3!)
MN-+6W*F=YDEAD;[3HM?V3TCJ%S?$/.=%1VO%JNEBV.1?!9)/$OD[ZF9+]C(P
M]8ZC.^EYSH8W2\.JZ6KZS7P604DWF[Z&6'[%9#UCJ-.^)83H:MTO"JNFW<:F
M55IW4%5IV+#4.:O]LC8>L:^U/%Y3H[D<'3=M?O?9?\%I:]C6]CJ*N8OM)'-K
M^P9?46*MN'D3Y%ZGCY7ZMQZ@;&GW1V0M8WZ:6.>I9[;FO0<NGJ_*8WZ>+]9O
M=O!:-&U]6YR)]+64,3%]M(V+^R/I+-6R/.?4W8V^AZE'U-YU!HE70VVJ;Y5[
MN:-WMMET_BGG/3[>Z99QK:^$)A:.J2U2<K;]8)Z=>QTM%*R=/9Y)$B5/?*:]
M73I_#+WIUT;X3VT;Y;9W?1J7E**5?['71O@T]EZHK/XQJ5:.[3NQ;%.JMSO3
MFWW>U7:/OK574]=%IKSTTK)FZ+Z6*IJU4S3MC!L15$[)=PQ9
M           #JW*C^4+=5T'>+%XJ&2#O6^Z;WK%;S)Z4U R9LQOGBVQV.-V8
MWA@J,6R'%YJF**L\+-44E;3SU$D[)F+ Q[O6YUT=R<KDT7FU540RF'-GFZ=D
MZC<FP_;C:>FJ;O26R^T607_))*>2GI:*DH'.UY>^:U_,Y'.T5R-U71K=>;@-
MC6X8@        #/75K^0-O?TWL_V,X6&A0@
M  #XE^]/^M7]H##O0!^7=Q/P=N_NM4&4MRAB
M                                     !4,&^_?X)><X_,;(V?)%P;;
M/D1U'I<*CF6-.^ACU]:-.?BOH4+@K.OW_P -NM6MPNFP^1UU>JZK55-@IYIM
M4\O.]%=^R#!:&U6],6XEXGQV#!K_ (M#0T:U4=3>*)*2E5L<D<20QJBZ<WKZ
MHWS-7S P6T$         &=XOUU)OT%3\>:%W-$!      (SN'??S:PF^7E'<
MDT%*]M.[732>;[E%_'<TPN584S+H=.L?.U%%'&<_!&<^90'3+8O%Y/<[_(W6
M*V4J01*ODFJW=J>PQCT^B:FGISQ?:=YK_+9IM_FG'Q1[Y:E-Y^=@%#[5]-__
M  TW6R/<W\Y/E/\ .!E>SY,\%X?N?'UD=5KWO?R<W)R<ON$UUUX=@7%? 0
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M%T<QWH<B&Y35%48P^%U&FN6*N6Y'++UC)K
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MO\S9E/3PTL$5+3,2*G@8V*&-J:-:QB<K6HGF1$.D_+*JIJF9G;+D#$
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M)V!9E>80
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M:V%KFI#4TC=/[WGC1$?%P\B<%;YVJBFY17SQB_/-=HZM)=FW.[9VQN24S:(
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M7>H7>W<';S=_",/QBLIX+'?8Z-U?%-31S2.=/7O@>J/=Q35B(G +$-1!
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M>16/):-*^PU\-?2KVO@>CE:J^1[?=-7T.1%.57;JHG"J,'1IKIJC&)>F8,P
M              !Q5%1%2T\M5.[EA@8Z61WF:Q%<J^T@%585O9'?]FJS>;(K
M5\C6>".NJZ>BCF\1+)2T3W1,]961HDDCV.:UO9V<0N"N,1ZC-U/'8E?-R<(I
M;-MIG57%06*[T<SGU$$M9KX5:AKI':LDTU15CCU;J].S11@U"$         &
M>NK7\@;>_IO9_L9PL-"A                            'R]5:QSD[415
M3V@,P=)>]NX&[=TR^DS:KIZJ*S,HW424]-'3:.G?.U^O)VZI&WM"S#4(0
M                                                          "K
M>H/;^^;C[:U=FQA8_P YJ&JI;K:(YG(R.6IHI$>D;G.X)S-5R-5W#FTU5$U4
M+"L\7M.[F[N\6*9SN/AZX;C>!4M2ZFHY:AM0M7=*MG=N?&B:*C45&/3@J-Y$
M3F<J@3&V6'([KU27C,JJTU-%B]EQ6*P4-RG9R0UE3+5-JW+$JKJYK.=[573M
M;[8W+M"         #.\7ZZDWZ"I^/-"[FB @     &1-_;K-D.Y7R-2?=?DZ
M*"WPQM['3R_=':>G61&K[!S[\XU8/TWH%J+.DYY_%,U>*,O4U78;5#8K);K+
M!IW-OIHJ9JIY>Z8C=?HZ:F_3&$8/SF_=F[<JKG\4S+T"O  P?TL?K5[C_@K[
M_M> ,IV-X!B    "+[@870YYC-58JK1E0OW6@J5358:EB+R/]A=>5W[U5/.N
MCFC!T.GZVK27HN1LWQQAF3:[,;AM7FM19<@:ZGME1+X.\0/[(9&.T9.GGY=>
M*IVL75->!I6ZYHJPE^@=4T=.OT\5V\ZHC&GM[/MO;":YKVH]BHYCD16N1=45
M%[%13HOS"8P?H0                             \>_Y7CF+4_B<@N<%!
M&J:L;*_[H_3ZB--7N_@M4QJJBG:VM/I+M^<+=,U?;BI3*^IJCA[RFPZV.J).
MQM?7ZLC]EL+%YE_A.;[!K5:C@^LTG=FJ<[U6'93[?^59NEW<W@GT3QEQHE=I
MRMTIK=&NOE]Q'JFGEU<>'QW'?PT/3HW4SY:O;ZEBXOTQM3DJ,PNVO8KJ&W)P
M\^CII$]OE9]$]J=/QEP]5WGW6:?'5[(]JY\;P+$,18B6&TP4TR)HM4K>\J'>
MS*_F?]#70V::*:=D/E-3K[^H_P"RJ9CAN\B1F;1        .M66^@N,?<W"E
MAJX?@YXVRMX^AZ*AE%4QL28B=J&W;9G;2\<RSX_!3R+Q22C5](J+YT2%S6_L
M&Q3J[M._RYM>K36ZL\,)[,L/!@@60=,=@G@?)C-TJ**L[615G+/ OHU8UCV^
MSZWL'.NVJ:YQB.7P;'V73^\-ZS$47L;E,;Y^]Y=_CS[5)7[#<^VTK4J:J*IM
MW*ND-TH9']PY=>&DT:IHJ^9VCO0:]-5RS.7MCR;'U<U:#JM&%415/\M<>"=O
MJ2?'.H?/;+R17-T-\HV\%;5-[N?3T31(G'TO:[V3HV]58N97(Y)XQG'DW>)\
MEKNZ^IM8U::KYM/Y*LJ_%5LJ\>$K?QKJ,P6\JR"[I/8JMW:E2WO:?7T2QZ\/
M2YK4-V='5,<U$Q7'8^.JO_+K^7=IFW7&ZJ,/MX=BT;9>K/>X?$6>OIZ^#1%[
MREE9,B:^?D5=#2JHJIVQ@V*:HJV2[QBR                     13<W$9<
M]V^R3#H)FT]3>:">EIYWZ\C)G-UC5VFJ\O.B<VGD S/38QOKNC-MUMKG6&-Q
MW$\%K*2LR"^/J630W%+2SNH4B8U>V1G,U>57IS.YO51- R6ON#8\DR;?[:]]
M)::G\V,4BN=TN=\6/2E2:L@6&*!KU7B]'1-5R:=CD^@1=@0         9^W>
M_6+V*_"7_P#$V!6@0@       !QU%1#2P2U53(V*G@8Z6:5ZZ-:QB<SG*OF1
M$#*FF:IB(VRQI4R5^]&ZO+$KVTM?4=W$J_\ X>VT_ET[$5&(KO2]?2<W.Y6_
M4Z8IZ;HL]M,>6J??YFR:2DIJ"D@H:.-(:2FC9#!$W@UD<;4:UJ>A$0Z,1@_+
M:ZYKJFJ<YES%8             89ZO?UAML/P5N_VJ\,H;F#$
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M<NYTG5V]MN?%GZ,4KI:VBKH^]HJF*IB^KA>V1OMM53.)Q<ZJBJF<*HF'.5@
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ME54>BM\Z-=Z D+X"         #/75K^0-O?TWL_V,X6&A0@
M              #XE^]/^M7]H##O0!^7=Q/P=N_NM4&4MRAB
M                                                 !3M/1=228#>
M8:FY8\[<5UQ:ZQU+&2);VVW6/F;*BQ:]XOW33U5\G$*AOR7UN?/6&^\F_P"[
M R3G:RCZAZ>^U;]W;C8*O'EI')1Q69DB5"5O>Q\KG*Z*-.1&))KZ= +;"
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MZ]J;V5,\D=FWR[?)@LZ***"-L,#&Q0L3E9&Q$:UJ)Y$1."'N^?F9F<9?80
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MDDF8^)L,JS,1$C>UJZ/57>LB@3,
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MD[]CMO6,R]VU^07C$I+"VJ@6Z,IV3=^ZD21O?)'K3M]96<W+Q3B#)H4(
M     ,]=6OY V]_3>S_8SA8:%"                            /Q4145
M%[%X*!#L'VHV]VVEKI\'L4-GEN21MK70OF?WC85<K$5)7O1-%>[LT F0
M                                                          *8
MZHLION*;52U..W*6S5]?<K?;GW>!RQRTL,\Z+)(UZ:<O!O*J^90L+AI:=*2E
M@I4DDF2"-D22S.625_(U&\SW+Q<Y=-57RJ$4Q0Y#?:'JIN>'MNU168U<\1BO
M3K5+(LD%%6PU;:;6)J\&<[&\SD\JOU\P7<NT(         ,[Q?KJ3?H*GX\T
M+N:("     \W(JGP>/W:LUT\/1U$NOX.)SOZAC5LE[Z>GFNTQQF/2R_TTTBS
MY[5U.GJTMMF=K^^?+$Q/V%4T=/'Q/T+O+7AIHCC5'HEK(Z#\V  &%.ENHJ).
MJC<:*25[XVQ7SE8YRJU-+O B<%4,IV-UAB     !\R1LE8Z*5J/C>BM>QR(K
M7-5-%147M10L3,3C#'FY6(W+:7.*:\6!SH;;++XVRU"<4C<QVKX':]O)KIHO
MNF*FNO$YURF:*L8?J'3=71U#331<SJPPJCU_;>M"Y]3%@I['23VR@EJ\@J(4
M=44C]8J>GF['-=(J:O37BWE3BG:J*>\ZB,,MKYZUW:NS<F*JHBB)RG?,>#<J
M>KONZF\M<M# D]92\R*M%2)W%!#JO!9%54;P\BR.5?,:\U5W'TM%C1=-IYIP
MB>,YU3X/<M'"NFRW4?=UV;57CZA-'?)M(KF4Z+VZ/DX/?_!Y?94]Z-/&]\[K
M>\E=7PV(Y8XSM\FSTK>GPC#ZJVQVB>Q4+[;"G+#3K3Q\K/2U435%]*+J;')3
MAA@^8IUM^FOGBNKFG?BK?(>FW#+ESRV.HJ++4+JK6-7Q-.BK^\D7G_MAXU:>
MF=CO:?O)J*,JXBN/)/FR\RK+SL#N-CDOC;(Z.YMB]:.:@E6&I:GGY'\BZ_6.
M<>$V*HV/HK/7])>CEK^'^*,8^WA=6W[O;L8/4MH+Q)-.D?!:*]0O5^B<%]=W
M)+_'T)%VNG:]+G2-#JHYJ,([:)^T+/QSJ9QVLY(<FMT]LF7@ZHIU\5!KYU31
MKT]A&N/>G41O?/ZGNS=ISM515V3E/L]"V;#F&+Y.SGL%VIJY=-5BBD3O6I^^
MC=H]/HM-BFJ)V2^:OZ.]8G^Y3-/H\NQ[9DU     ?+GL8FKW(U$XJJKH%B,7
M!)<K?%KWM7"S3MYI&)V^RI,89Q;KG9$JTS??C$,5[VCMK_ER\,U;W%*Y/#L<
MG#[I-Q3@O:C.9?/H>-=ZFGM=[0]!OW\*JO@I[=OBCVJ'NN7[G;PW!;51LFGI
M7*BI:Z!JQTL;57@LKE714_?2NT\QJ357<G!]E:T>CZ=1SSA$_FJV^+W+-PCI
MLH:7NZ_.*GQD_!WR72N<R!/+I)+P<[THWE]E3WHT_%\_KN\E57PV(PC\T[?%
M"];=;+=:*..@M5+%1T42:1P0,2-B?0:B<?2;41$;'Q]R[7<JYJYF9[7:*\P
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MKV,?%;D<UKG-1?\ S5_D10RAN(,0
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M'P\W'3B"%V!         !GKJU_(&WOZ;V?[&<+#0H0
M         !\2_>G_ %J_M 8AZ!)YYKYN$V:5\B,CMW+WCW/T^Z57G50REN$,
M0
M  (SN#@UDW)P^ZX7D+7+;+I$D;Y(E1)8I&.22.6-514YF/:UR:IHNFBZIJ@%
M!46 =8>&TL6,8QFUAO6/TS4@MUQNT3DK88&IRL1Z+!(J\J=FKY/9T"Y+%V9V
M9N& 5UYS/-KZ_*MS,D1C+K>7-Y(HZ>+3E@@:J(J,U1NO!J>JU$:U&\1,K>"
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MG9# Q&(J^=R]KE7RJO$VXB(V/C;U^Y>JYJYFJ>UZ!7B
M                          ?BHCD5')JB]J+V >=48[C]8O-5VFCG=KKK
M+3Q/75..OK-4QY8X-BG47:=E54>.7I&37       =*\6BW7^TUUCN\#:FUW*
MGEHZVG?[F2"=BL>U=./%JJ!F:W[1]3.U<3L=VGS.UW?!HWN^3*+(8U\51QO<
MKN1')"]%1-?I7HWRHQNH5,MK=D\OMV9NW5WBR5F49^RG?16N&E9W=OMT$NO.
MD*<D>KE1SF\(VHB.=KS*[5!BO0(         ,_;O?K%[%?A+_P#B; K0(0
M      R#O]5ON^Z$MOA7G=2P4M$Q$X^M(G>Z>W*<Z_.-;].Z!1\O1Q5.^9GU
M>IK:@I&4%!2T,?WNEAC@9];&U&I^T="(P?FEROGJFJ=\XNP5@
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MK+?!5<%;-(JQQ:N8J(Y/5555$U?RIRJ,6B@@         SUU:_D#;W]-[/\
M8SA8:%"                            /B7[V_P"M7]H#%?0?9KQ:KWG[
M[I;JJA9/';^Y6J@D@1_+)5*NG>-;KIJ@92VN&(
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MG&77/!<:NCZO)K.VH=7TCJ:HA:Q*.9M/+I))&UCM'O1/5=Q\@7!8(0
M            ''+!!.B-GC9*C5U:CVHY$7SIJ&453&Q]HB-31J(B)V(G ,7Z
M
M  "([IY;48)MUDV7T<39JVT6^>II8G\6+.C=(^9$TU:CU17>@#)-ZVQN=DMV
MT6[&691<\AW RG+<=6NDGJ/[Q@I;@JU/<PQ(G#E1K&ZH[E[>5J(&2[=QZJMQ
MWJ,VGN-!6S,I\F@NUFNUN2:3N)8J6!)H9%AYN3F:^757\NO! B]P@
M  S]N]^L7L5^$O\ ^)L"M A        #'+=,KWZU]W%+?=?9AI)?ZR,YWWKG
MC?J/_P#/TS__ #\\Q[9;&.B_+@              " 9GO1MWM_DMJQ'*KH^C
MOUZ;$ZW4S::HG21)YE@9J^*-S6ZO14]94"X)^$
M                                               ZUPK([=055PE:
MKHJ2&2=[6\7*V)JN5$]/ #!.8XI?=Q]@[_U&9WDEPJK[6/[['+#2SK%:[=2?
M*3:/N^[T7F73GTT5/(KN9VJADOO?NIKK#9]I\SM==/2W"VY':**2&*61D=52
M7!FD\,C&N1'\R1-]TBZ)S:=H2&A @         SUU:_D#;W]-[/]C.%AH4(
M                           _%5&HKE[$XJ! MN=Y]N]UY[E38-='W":T
MI$ZN:^FJ*;D2=7HS19HV([56.]R%P3X(
M                                 !7&^N/X;E6VMUQ_-[S3X_:ZY8F4
MEXJI&1-IZ]CT?3N17N:CEYV\6(J*YNJ:IVA89YN^+=7=-FF%7^JQZSY;<L#C
MN%/:[VRKBACKF7*G\,LE4V6H@>KFM3FU:QFJ]NH7)<6RVUF9V7(;[NGNO<(+
MAN1D<3*+P]%_@EOM\2HYM/$NB(NJM8KM.'J]KE5SE)*ZP@         SO%^N
MI-^@J?CS0NYH@(    "H.I&I2#;QD.NBU-PIXM//RLDD_P"@:^HGX7T_=NG'
M58\*9]4.'III4AP*KJ/IJFY3.U_>LBB8G[**33Q\+/O+7CJ8CA3'IE<ILOE0
M !@_I8_6KW'_  5]_P!KP!E.QO ,0
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M$
M         #CJ'0,@E?5*UM,UCEF=)HC$C1/65VO#33M Q'?MKMV?^'M_P+9*
MMM.?;(Y)4.FM+F5<*5MM<RK9.^&*:26.-[6R1\J^L_7BNC7*H9+'QK;7>C<W
M+<:R'>^*@Q_$L-FCKK+B5MD;.Z>O@1$BEJ'MDE:J,5O-QD7ZE&IS.4(TR$
M       &>NK7\@;>_IO9_L9PL-"A                            'Q+]
MZ?\ 6K^T!AWH _+NXGX.W?W6J#*6Y0Q
M                                 I3JMHK76;,79]R=4QS4=1255LEH
MX/%/97QS)W/-'JW5CE56/7R(NNBZ:*6$%QOK;Q6HM-.[*\1R"AOB,:E7'04C
M*FE61$]9T;Y)8WHU5[$<W5/.O:#!9NUW4%B&[-]JL?Q^UWJAK*2D=7R2W6C9
M30+&R2.)6M>V63U]9$5$5.S7S P6P$         &=XOUU)OT%3\>:%W-$!
M   4-U0U/+C]AH]?OM9)+I^"BY?_ +AJ:G9#[+NO3_=KG]/K]R6[!4JTVV%J
M>J:+4R54WMU#V)^PT]+$? YG7Z^;65=F'H68>[@  #,FR?3]G&WF]^7;BWVH
MMTEAOL=S91QTLTLE2BUU?%4Q\['Q,:FC&+S:/7B%F6FP@
M
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M<S=?#,VQZHM\5GQ]E(VM9632QSJM/7.J'<C61/1?57AJY.(6):5"
M
M <%=#!4T533U3.\I9HGQSQ_51O:J.3Z**!B79+J8QW:O'I-O+I8+]<,:M-55
M+CUYIZ)K:F2CJ9G3HRJIWR,1LC7/=JYCW(OF3353*87#9.KW;J_7JVV*DL62
MQ55SJH:*"2>W1LB;)42)&U7N2H54:BNXKHO )@T $         &>NK7\@;>_
MIO9_L9PL-"A                            'R]%<QS4[5143Z(&;>EK8
M3-MF+EEE9EM1;YH[VRD;2);YI9E1:=\[G<Z211Z??$TTU"S+2@0
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MT%;'2HCF.:B)S(_F7B%P:$"
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M)633OBDB6IK'4RHUK6JBZ(WF[0L0O\(
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M5R*O'71R!<&FP@!GKJU_(&WOZ;V?[&<+#0H0
M   !^/=RL<[S(J^T!0/3EU#77?"OR6BN5CI[.EA93.8ZGG?/WBU+IFJB\[6Z
M:=V%F%_A
M          ,/[:;W3;-7'/[%<\&O]WDN>672Z05=#3+W2PRO;&U/7:BJOW-7
M:]FBAE@ZEMZ@YJ'?&];J.V_R-UKNEBALS*!M,O?MFAFCD61RZ<O+HS1..H,&
MB-I=_P"#=;(:NP1X?>L?6EHGUWC+K"D<#T9+'%W:.3Z=>\YD3S(H3!<81%MR
MZF:BVXS"LIG*VHI[)<I87)VH^.DD<U4T]* 5GT>4L%/T^XO)"U$?4R7":=R?
M32>/G9JO\%K4^@%E%\$3P'6IN50TC>6DK<?I*NI:GN>_:RWZ.T3RKSN7Z*@W
M-.A&<LK>O4%NS'MW2+WVT^ 3QUN9SM^\W*\L5>YMVJ>Z9$J*LJ=FO,BZ*C%"
MNGM+S+U8[S*[5=*6W)Q\W=0:?L W-,A%29[FV^5DR2:WX-MG!D^.LCB=#=GW
MBEH7/D<W61JQ2N1R<J\/2%5/MQ>LWOW5I/79_C#,3OJ88^-MLCK(K@CH&UL:
MLE[V)5;ZRJY.7R: W-9A     94ZFZM)<UMU(B\*>VL<OUTDTJ_M(AH:B?B?
MHW=FC#3U3QJ]4-)XG3>"Q6QT>G+X>WTL6GFY(6I_4-VF,H?!ZNKFO5SQJGTO
M8,FJ  ,']+'ZU>X_X*^_[7@#*=C> 8@
M                                                      ,;5VZ%
M1L[U$[I7>LQ&\WVCOR6J*EFME.YT:+2T;.=5<YNBZJ[3U5\BADCN2]04M\WC
MPK<N';_(X[?C%'<*2IHWTR]]*ZNB?&Q6*B<NC5=QU4&"\]NNIFGW"S"W8BS!
M;_9W7#OM+E7P(RFB[B%\WKN3LYN3E3TJ@3!? 0 S#T4HE3BV=WB=-;E7935K
M5O717KRQ1/1%5/,Z1Z_1"R_<^TM_6AMG54::3W&QU=/6HW1.:)C*Y6J[S_\
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M_!6[_:KPRAN8,0
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M\';O[K5!E+<H8@
M                   !U+I;J:[VRMM-:U74=?!+2U#4X*L4[%8Y/:4#)FU6
MX5SZ:K7<MI=SL=O%136JKJ*C&;Y::-U72UU)4/Y^5NBHB.5ZJ]-7<.;E=RJW
MB9;4UZ=\4RNZYEG&^N:VN6QUV9R1T]CL]4BMJH+7!RHUTJ*B*BN;'"U-4:J\
MBNTT<T)*P,1W,O62;G9?@59C4UNM6-MC=17U[I%BK>\Y=4:CHFM33F^E>[L
MAM?TA[4W"YW"ZNJ;W!47.JFKJIE/<711+/4/5[U1J,\Z\ 8J@VVZ><>?U 9Q
M9ZV&^08[CO@*NPU[JB:/OY6]U(Y'SJQ$E3FUX:]@7%MH,0#.\7ZZDWZ"I^/-
M"[FB @    ,?[^/=<-U*FB8NKHXJ.F;Z%?&U_P#]PYU_.M^G]!CDT45=M4_;
MR->PQ-@ACA9P9&U&-]AJ:(=%^8S.,XOL(  *IP/I]P?;O/;SN+8JBXRWZ^-J
MF5D=7/%)3(E=4,J9.1C(6.31[$Y=7KP"XK6"
M
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M:WP*YT%)%'!$LCE>]61-1J<SEXJNB<5#%V ,_;O?K%[%?A+_ /B; K0(0
M   !D?J+KGW#<=M!'ZRT5'3TS6)]7*KIOV>\0Y]^<:GZ9W=HY-)S?FF9]7J:
MKLU"ELM%OMK>#:.FAIT3T11HS^H;\1A#\XO5\]RJKC,SY7=*\@
M    "K-Q-@L*W-S&QYOD-3<8KO8&PLHHZ.:*.!R4]0M2WG:^)ZKZRJBZ.3@%
MQ6F$
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M!
M                 ,[Q?KJ3?H*GX\T+N:("     QWF*+>-^98$]?O;U1TN
MGHC=%$OM<ISJ\[GC?J.C_M],B?T53Z9;$.B_+@   QQTZ[DY[DW4;G>,9!D-
M;<<?MT5X6BMU1)SP1+3W.&*-6MTX<K'*U/0&4MCAB
M
M                   S]N]^L7L5^$O_ .)L"M A       &.;OIE>_$D*+S
MQ37R.G<O:BQ4LC8W?Q8SG3\5SQOU&S_]?IF/"C'RQCZVQCHORX
M      9 ZG=Q<[Q3?#;^PXWD%;;++<XJ%:ZAII.2&59+B^)ZN33BKF(C5] 9
M0U^&(
M                           &>NK7\@;>_IO9_L9PL-"A
M                'S(JI&]4X*B+HOT ,A]%>XN=9U>,X@S'(*R]Q6^.A6C;
M6R=XD:R25"/5O!--48W4,I:^#$
M                                         #.\7ZZDWZ"I^/-"[FB
M@    ,=XVY;QOXR=>/>7VIJ$]B*621/:1ISJ<[GC?J.I_M],P_\ UQ'FB&Q#
MHORX   ,']+"I_2KW'X]L-]T_P!;P!E.QO ,0
M
M              &?MWOUB]BOPE__ !-@5H$(     !Q5-1'2TTU5*ND4#'2O
M7]ZQ%<O[0EE33-4Q$;V0]CH'WW=FGN4R<SHDK+A+]<]KFHJ_PI$.=9SK?IO7
M*OE:&:8W\M/V\C8)T7Y@                ,,=7KFIU#[8HJIJD5N54U[$6
MZR<?V RAN<,0
M                                  ,]=6OY V]_3>S_ &,X6&A0@
M                        #XE^]/\ K5_: P[_ /H_W-=?=PU:J*BQ6Y45
M/*G>5092W*&(
M                           &=XOUU)OT%3\>:%W-$!    ^7O;&QSW+H
MUJ*YR^A.(6(Q8_V,;\I[MTE<Y->5*VJ77SOB>W7VWG.LYUOT_KD\FAFG^&//
M'L;".B_+P   A^.W7:RKR*NI,4J[#-ED23?*<-L?1NN#4;*B3=\D*]XFDBM1
M_-]-IKQ F
M                                                &?MWOUB]BOPE
M_P#Q-@5H$(     !%-S+BMJV_P CK6KRO2AFB8[S/G;W3?V7GG<G"F72Z9;^
M9JK=/ZH\V:C^EVW=Y>[_ '56\*>EBIFNT\M1(KUX_P#TC5TT9S+Z[O1<PMT4
M<9F?)_RTV;S\_                $1R:Z;84=[M]-F-78H,CE1GR5%=GTC:
MUR+(J,[A)UYU^Z>YY/IO2!+@
M                                               9ZZM?R!M[^F]G
M^QG"PT*$                            ?BZ:+KV>74")89=-L+C-7-V]
MJ[%4U$:,^4DL3Z1[VHJNY.^\,JJG%'<O-Z0)<
M                                                     #.\7ZZD
MWZ"I^/-"[FB @   >7DU3X/'+Q5ZZ>'H:F77ZR)SOZAC5LEL::GFNT1QJCTL
MR=,])WV=5M2ON::VRJGUTDT34_8U-+3Q\3] [S5X::(XU1Z):O-]^;@  !@_
MI81/Z5>X_P"!OO\ M>G#*=C> 8@
M
M    ,_;O?K%[%?A+_P#B; K0(0     "I^HJX^"VXFID=HZX5=/3Z:Z*J-59
ME_N9KWY^%])W=M\VKB?RQ,^KUO)Z9+<M/A]SN3DT=6UZL:OG93Q,1/XSW&.G
MCX6SWFN8WZ:?RT^F5W&T^2                &&>KU$_I#[8<.V*W(O^M9
MRAN8,0
M                            ,]=6OY V]_3>S_8SA8:%"
M                 /B7[T_ZU?V@,.] "(E]W$1$T1([<B)_]2J#*6Y0Q
M
M             SO%^NI-^@J?CS0NYH@(   $1W2J?";=9++KIK031:_AF]W_
M -(\[GW9=/I=/-J[<?JCS9J7Z6Z977/(ZS3A%!30Z_A7R._Z!K:;;+ZOO15\
M%N.V?5[6EC=? @  !C_IYVLW"Q3J)SG+<BL%1;\<N<=W;0W"58UCE6IN<,T2
M-Y7*OK,:KDX!E+8 8@
M                                                       ,_;O?
MK%[%?A+_ /B; K0(0     #/75)<4;2X[:&KQDDJ*J1/P;61M^S<:>IG9#[?
MNO;^*Y7X(6)LE;DMNV5C8J:25+)*I_I[^5[VK[U6GM9C"B'#ZW<Y]97V9>2%
M@GLX@                R-U+[89_F.]F 9'C%AJ+E8[5'0I7UL*QI'$L5Q?
M*]'<ST7@Q4=V!E#7(8@
M                                         9ZZM?R!M[^F]G^QG"PT
M*$                            ?,B*L;D3M5%1/: R3T9;89_M[=LVJ<
MUL-198KG'0I1.J%C7O%BDJ%>B<CW=B/:&4M<!B
M                                                     !G>+]=2
M;]!4_'FA=S1 0   *WWXJ_"[7WE$X.G6FA3^%41JO["*>-Z?@EWN@T<VLH[,
M9\TH7TN4W+9,@J]/OM5!%K^"C<[_ .X>6FV2ZO>BK^Y;CLGT^Y?AMOC    I
MS;KJ)QK<C<:^[:VRTU])=+"VL?45=3W/AWI053*5_)R/<[UG/14U3L"X+C"
M
M                                     ,_;O?K%[%?A+_\ B; K0(0
M    #)O4I<5J\\IJ!JZMH*")BM3X29[Y%_85IS]1/Q/TGNW;Y=--7YJI\S3V
M-6]+3CMIM:)R^"HZ>G5/3%$UJ_LH;U,81$/S[4W/F7:JN,S/G>H9-<
M          5!N=U"8YM=G&/X+=K575MPR%L#Z:II>Y[F/Q-2ZF:C^=[7<'-U
M71.P+@M\(
M                               !GKJU_(&WOZ;V?[&<+#0H0
M                    !^.=RM5R]B)K[0%1;*]0>-[W5=[H[#:JZVR6)L#J
MA:[N='I4ND:WE[I[^SNUUU"S"W@@
M                                           &=XOUU)OT%3\>:%W-
M$!    I[J3JD@V^A@UT6JN,$>GG1L<LG_1-;4?=?4=VZ<=5,\*9]3YZ:Z5(,
M J)]/6JKC._7T,CB8GV*C3Q\*]Y:\=5$<*8],KC-E\L   &#^EC]:O<?\%??
M]KP!E.QO ,0
M                                                &?MWOUB]BOPE
M_P#Q-@5H$(     !CG,=<JWTGHT7G9-=Z>@]",@=' [VD8ISJ_BN>-^HZ/\
ML=-B>%$U>7&6QCHORX                 ,,]7OZPVV'X*W?[5>&4-S!B
M
M                    !GKJU_(&WOZ;V?[&<+#0H0
M         !\2_>G_ %J_M 8=Z /R[N)^#MW]UJ@REN4,0
M
M,[Q?KJ3?H*GX\T+N:("   !0G5%4\MBL%'K]]JYI=/P42-_^X:FIV0^R[KT_
MW:Y[(]/N3+86E6EVOL[E31U0ZIF7Z-1(U/V&H>MF/@AR^O5\VLK[,/1"R3V<
M$   *"VHZ<*G;3=G)=S9<C9<HL@97L;;&TBP.A\?61U2*LJS/YN7DY?<)KKJ
M%Q7Z$
M                                           9^W>_6+V*_"7_ /$V
M!6@0@    /F21D4;Y9%T8Q%<Y?,B)JH6(QG!CW:"-V1[Q4MRD35O?UERD]E6
MR.3^,YISK6=;]0ZQ/R=!-/933Z&Q#HORX                 *'WBZ=JG=3
M<;%L\BR%EKCQQE,QU ZD6H6;PU6ZIU21)6<O-S<ON5\X6)7P$
M
M            SUU:_D#;W]-[/]C.%AH4(
M _'MYFN;V:HJ:^R!1/3UT[5.QM?D=;/D++Y\O-IFM8RD6D[KPSI7:JJRR\VO
M>^CL"S*]P@
M                         &=XOUU)OT%3\>:%W-$!    S7U2U2NN&-T6
MO".&JF5/PCHV_P#0-+4SG#[WNM3\-RKMCUKDVJIO"[<XU%IIS4,4O\LG>?\
M2-FU]V'RW5:N;5W)_5/FR3 ]'+   #+6QF^VX&>[ZYA@&0STLF/62.Z.HF0T
M[8I46BN$5-'S/155?4>NOG"S#4H0
M
M     !G[=[]8O8K\)?\ \38%:!"     CF?W'Y)PC(+@BZ/AH*CNU[/NCXU8
MS^,J&%<X4RW^GV_F:BW3QJAG_IAMR39/>;HK=4I*)L#5\SJF5%_:B4U-/&<R
M^T[SW,+-%/&K'R1[VHS>?G@                 9@Z@M\<_VYW=PK#L9GI8
M['?HZ-U<R>G2:573USZ=ZM>KDT3D1- L0T^$
M                                                           S
MUU:_D#;W]-[/]C.%AH4(                            ^7JK6.<G:B*J
M?00#,?2?OAGV[USRZDS2>EFBLK*-U'X6G2G5'3OG:_715U^]H%F&G@@
M
M          &=XOUU)OT%3\>:%W-$!    RCU,U??9Q04J=E-;8]?KI)I57]C
M0T-1/Q/T?NS1AIJIXU>J&F,7IO!XS9J333P]#2Q:?60M;_4-VG9#X'55<UZN
M>-4^EZQDU@   P?TL?K5[C_@K[_M> ,IV-X!B
M
M               S]N]^L7L5^$O_ .)L"M A     5?U W%:#;2NA:[E=7ST
M]*GI^Z)*J>U&IX7YPI?0]W[?/K*9_+$SZO6C73!;EAQJ]716Z+5UK(&KYVT\
M2._;E4PT\93+?[SW,;U%/"G'RS[EZFT^/                 ##/5[^L-MA
M^"MW^U7AE#<P8@
M                                    9ZZM?R!M[^F]G^QG"PT*$
M                         ?$OWI_UJ_M 8=Z /R[N)^#MW]UJ@REN4,0
M
M              ,[Q?KJ3?H*GX\T+N:("   !C[?=RW'=BJHFKJK&45*FGD5
M\3'?],YU[.M^G]"CDT,5?Q3Y_<U_'&V*-D3.#&-1K4]")HAT7YC,XSB^@@
M 0O&]I-NL0R6OS#&[##09)=$F;7W".29SY4JI6S2HK7R.:G,]J.X- F@
M
M                                  &?MWOUB]BOPE__ !-@5H$(
M"@>J*XI':,?M*.XSU,U4YOH@8C$7^VJ:FIG*(?:=U[>-RNOA$1Y?^$VV(MWR
M=ME:7*FDE8Z>J?\ _4E<C?XK6GK9C"B')Z[<Y]95V81YED'LX(
M       0S*=I]O,VOUOR?*;%#<;[:FQLM];)),QT3895F8B)&]K5T>JN]9%
MF8
M                         ,]=6OY V]_3>S_8SA8:%"
M              /Q4145%[%X*!#L'VHV]VVEKI\'L4-GEN21MK70OF?WC85<
MK$5)7O1-%>[LT F0
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M!$T155."!E.QN@,0
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MNCTXHBH@90V^&(
M                            *%W(W=SRKW+AV6V:H**HRR.E2X9!?+KS
MNHK;3OY5;JR/BKE1[%UT=[MJ(U55>4KKX?NSN5BFYU#M+O=2VY]9D$3YL7R>
MS(^.EJ7QZJL,K)--'KRZ)HC51W*FCD>C@-!!%7[J7S>BEK[78]HK!;ZU];%-
M+<K[>9',HZ/D<QK&\K'M<Y[M57AS=GN0JJK_ +L[_;'5MJNV\M'9<@V_N-2R
MCK;KC[9F5%%)(BJFK9&Q\VB(YR)W>CM-.=JJ@&HHI8YHF31.1\4C4>QZ=BM<
MFJ*GLH$?8&>NK7\@;>_IO9_L9PL-"A                            'Q
M+][?]:O[0&).@BMK:J^;@MJJF:H;'';N1)I'R::R56NG,J^8,I;>#$
M
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MU5-0SQ7ON:F:"2.)_/=H'-Y7N:B+JB:IQ#*=C<(8@
M
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ME/%;UGJ(*>66)FETD<O,]C51%1.*IJ&4-LAB
M                                                  #+^Q"K4]2>
M^=74IK5Q5%+!$]WNDA1\C41-?)I&SV@LG5@JTV:;(W"F3EN$.4,9#(GNT:^>
MD5S4]"JU 0U $ ,H[NWB?J2S2DV.P)W?8?8ZR.OSW*(N-/%W*N:VFA?[ES^+
MM-->9Z?4L>H9;&JH(8J:&.G@;R0PM;'&Q/(UB:(G'S(@8H;N1<]S[9044FV%
MCM]\N$DSFU\5SJ5I61PHW5KF*BMU57<.T#,N^%[WQN5/@L.Y>+6>RV-N7VE\
M%7;:U:F=U4BR(UBL5Z^JK5>JKIVH@90V@&(
M  #XE^]O^M7]H#%?0?9KQ:KWG[[I;JJA9/';^Y6J@D@1_+)5*NG>-;KIJ@92
MVN&(
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MSNN%#X:IB[M*29L$J]Y+$QCN5[D;ZKEU\G +@G@0
M
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M>>&)[&ZO14]9R>T#!.@
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M(^GEX21N>U%5CM/*W710Q<X&>NK7\@;>_IO9_L9PL-"A
M            'XJHU%5>Q.*@0;;_ 'BVZW2GN--@MY^59K4D;J]OAZFG[M)U
M>C%UGBC1VJL=[G4+@G00
M                                   #.\7ZZDWZ"I^/-"[FB @  \G*
M:GP6,7JLUT\/054NOUD+G?U#&K9+9TM/->HCC5'I9HZ9:3O<XN%4O93VV1$^
MNDFB1/V$4TM/'Q/ON\U>&FICC5ZI:M-]^<     P?TL?K5[C_@K[_M> ,IV-
MX!B
M                                         S]N]^L7L5^$O_XFP*T"
M$   #P\RN*6C$KY<]>5U+0U,C%_?I$[E_9T,:YPB6WH[?S+]%/&J/2SCTRV[
MQ&97&Y.35M%0.:U?,^>1B)_%:XTM/'Q/N^\US#3TT_FJ]$-5&^_.0
M           89ZO?UAML/P5N_P!JO#*&Y@Q
M                                                          SU
MU:_D#;W]-[/]C.%AH4(                            ^)?O3_K5_: P[
MT ?EW<3\';O[K5!E+<H8@
M                                    9WB_74F_05/QYH7<T0$  $.W
M6J?";<Y++KIS4,L6OX;2/_I'G=^[+J=*IYM7;C]4>;-3G2U2JZOR2MTX1PTL
M*+^$=(Y4_B&MIHVOJ>]-7PVZ>V?4TH;KX(    &8-D=@L[V^WQR_<._OH%Q^
M^1W-E&VFG?)4:UM?%4Q\[%C:B>HQ=?6[0LRT^$
M
M                9^W>_6+V*_"7_P#$V!6@0@   5MOQ<?D_;*[-:NDE8Z"
ME9_#E:YW\5KCQO3A1+O=!M\^LI[,9\R%]+MN[NSW^[*WC45,-*UWH@C5Z_W5
M#RTT93+J]Z+F-RBCA$SY?^%^FV^,                  !F??W8C.=RMV<+
MS3''4*6:P1TC:Y*J=\4RK3USJA_(U(W(OJ*FG'M"Q+3 0
M
M       #/75K^0-O?TWL_P!C.%AH4(                            ^7
MHKF.:G:J*B?1 S3TK;$9SLY<\MK,P?0NCO;*1M'X&=\ZZT[YW/YN:-FGWQ-
MLRTP$
M                     SO%^NI-^@J?CS0NYH@(  *UWZJEIMK[NU%T=4/I
MH4^C41N7]AJGC>GX)=[H-'-K*.S'T2A_2[3<MAO]7I]]JXHM?P42N_\ N'EI
MMDNIWHJ_NT1V3Z?<OHVWQH    ,][1]1MUW)W>R?;2KL5/04E@9<'QW"*=\D
MDJT%;'2HCF.:B)S(_F7B%P:$"
M
M   ,_;O?K%[%?A+_ /B; K0(0   *)ZG[BL.-V2UH[1:NM?.J>=*:)6_MRH:
MNHG*(?8]V+>-ZNKA3AY9]R3=/]N6@VTH)7)HZOGJ*I?8618D7VHT,[$84N?W
M@N<^LJC\L1'FQ]:T#W?/                   H#>CJ'NVUFY>*8)16.GN-
M+D3*5\E9-.^*2):FL=3*C6M:J+HC>;M"Q"_P@
M                                                           &
M>NK7\@;>_IO9_L9PL-"A                            'X]W*QSO,BK[
M0% ].74-==\*_):*Y6.GLZ6%E,YCJ>=\_>+4NF:J+SM;IIW8687^$
M
M         SO%^NI-^@J?CS0NYH@(  *<ZE:M(, IJ?7UJJY0LT]#(Y7K^RU#
M6U$_"^I[M48ZJ9X4SZ8??392I!M[+/IHM5<9Y-?.C611_P#1+IX^%.\E6.JB
M.%,>M<!L/EP    8/Z6/UJ]Q_P %??\ :\ 93L;P#$
M
M                   !G[=[]8O8K\)?_P 38%:!"   !ESJ>N*3919[6U=4
MI*)TSD\SJB54_:C0T=1.<0_0^[%O"S75QJ]$>]H# ;=\DX3C]OTT?#04_>)V
M?='QHY_\95-NB,*8?%:^Y\S47*N-4I&9M$                  &&>KW]8;
M;#\%;O\ :KPRAN8,0
M                                       ,]=6OY V]_3>S_8SA8:%"
M                            /B7[T_ZU?V@,.] 'Y=W$_!V[^ZU092W*
M&(
M                 &=XOUU)OT%3\>:%W-$!  !075'4\MEQZDU^^U4\NGX*
M-K?_ +AJ:G9#[/NO3_<N3V1Z?<FVQ%)X7:^RJONIUJ9E_A5$B)^PB'K9CX(<
MGKM?-K*^S#T0L<]G"    !4N =/6&;=;@7K<>RUURGO=];5LJX*N6!]*U*ZI
M952<C60L<FCF(C=7KP\X7%;00
M
M  !G[=[]8O8K\)?_ ,38%:!"   !CO=Z1V2;Q55MC7F:M11VR-$\ZMC:Y/?N
M<<Z[G6_4>D1\G015V55>EL*-C8F-C8FC&(C6IYD1-$.B_+YG&<7T$
M           !5&X_3_AVY^9V+.+]6W*GNN/MA91PT4L+*=Z4]0M2WO&R0R.7
M5SM%Y7)P"XK7"
M                                    9ZZM?R!M[^F]G^QG"PT*$
M                         ?CD1S5:O8J:>V!56S^P&';*55YK,6K;C5R7
MQL+:M+E+#*C4IW2.;R=U#$J:]XNO-J%F5K!
M                                                   ,[Q?KJ3?H
M*GX\T+N:("  #-'5)4JZZ8Y1Z\(J>IFT_"O8W_[9I:G;#[[NO3\%RKMCU^U=
M.UM+X3;O&H5315H(9=/PS>\_Z1LVX^&'RG5*N;5W)_5/FR2X]',    !CCIU
MW)SW)NHW.\8R#(:VXX_;HKPM%;JB3G@B6GN<,4:M;IPY6.5J>@,I;'#$
M
M                                 !G[=[]8O8K\)?\ \38%:!"   !C
MG#>;*M](*Q?79-=ZFOU[41D#I)V_0]5#G4?%<\;]1UG]CILQPHBGRX0V,=%^
M7                    9 ZG=Q<[Q3?#;^PXWD%;;++<XJ%:ZAII.2&59+B
M^)ZN33BKF(C5] 90U^&(
M                                          &>NK7\@;>_IO9_L9PL
M-"A                            'S(JI&]4X*B+HOT ,A]%>XN=9U>,X
M@S'(*R]Q6^.A6C;6R=XD:R25"/5O!--48W4,I:^#$
M                                                        #.\7
MZZDWZ"I^/-"[FB @  R?U,5??9W14R>YIK;$B_7/FE<O[&AH:B?B?I'=JC#3
M3/&J?1#3F-4W@\<M%)IIX>BIHM/K(FM_J&[3LA^?ZFKFNUSQJGTO4,FN
M#!_2PJ?TJ]Q_3#?=/];TX93L;P#$
M
M     !G[=[]8O8K\)?\ \38%:!"  #R\FN"6G'+O=%7E\'1U%0B]G&.)SD_9
M0QJG")EL::W\R[33QJB/.S#TUVY:O.ZJO<FK:"@E>BK\),]D:?L*XT=/'Q/T
M'O+<Y=-%/YJH\S61T'YL                   !AGJ]<W^D/MBFJ:I%;E7T
M)\JR?N!E#<P8@
M                                   9ZZM?R!M[^F]G^QG"PT*$
M                        ?$OWI_UJ_M 8=_\ T?[D=?=PU:J*BQVY45/*
MG>5092W*&(
M                         &=XOUU)OT%3\>:%W-$!  !CW?%WRINW5T+5
MUY?!4B:>=\3':>V\YU[.M^H=#CDT,5?Q3YY]C8#&-C8UC4T:U$:U/0G Z+\P
MF<7T$    !$,>FVMDR*N9BDF/NRQJ3?*;;6ZB6XHB2IWW?)!]U^^:<_/]-IK
MQ EX
M                                          &?MWOUB]BOPE__ !-@
M5H$(  *^WNN/R;ME?'(NDE2R*E9Z>_E8UW\7F/&].%$NWT2WSZRCLQGR0KOI
M<MR-H\BN[DXR24]*QWX-KY')_':>.FC;+N=Z+GQ6Z/#+0IN/B
M         (CDTVU\=[M[,QDL+<C<C/DIMW6C2M5.\T9W'B/NGWSW/)]-Z0)<
M
M                       #/75K^0-O?TWL_P!C.%AH4(
M              _%TT77L\NH$3PV;;"6:N3;V2POJ$1GRE\@K1J]$U=R=]X7
MCV\W+S>D"6@
M                           SO%^NI-^@J?CS0NYH@(  ,=Y&U;QOX^%/
M622_4U.[7ZF*6.-?:1ISJL[GC?J.F_M],Q__ %S/EB9;$.B_+@     ,']+"
M)_2KW']$-]T_UO3AE.QO ,0
M
M&?MWOUB]BOPE_P#Q-@5H$(  *1ZF[BM/B%LMK5T=6UZ2.3SLIXG:_P 9[35U
M$_"^M[LV\;]57"GTR];IVMW@MN(:E6Z.N%745.NFBJC7) G]S,K$84M;O%<Y
MM7,?EB(]?K6P;#YL                   ##/5ZB?TA]L5TXK%;D7V/E60,
MH;F#$
M                           #/75K^0-O?TWL_P!C.%AH4(
M                  ^)?O3_ *U?V@,._P#Z/]$2^[B(B:(D=N1$3R)WE4&4
MMRAB
M                   !G>+]=2;]!4_'FA=S1 0  8ZPU5O&_$,Z^MWMYK*K
M7T1NEF_Z)SJ,[GC?J.L_M],F/T4QZ(;%.B_+@     ,?]/.UFX6*=1.<Y;D5
M@J+?CESCN[:&X2K&L<JU-SAFB1O*Y5]9C5<G ,I; #$
M
M                    !G[=[]8O8K\)?_Q-@5H$(  ,R=4-Q[R^6&TH[A34
MLM2YOIJ)$8G]R-'4SG$/T#NO;PMUU\9B/)_RO';2W+:L QRB5-'MH897IYGS
MM[UW[+U-JW&%,/D.IW/F:JY5^J?-DE1Z.<                   !D;J7VP
MS_,=[, R/&+#47*QVJ.A2OK85C2.)8KB^5Z.YGHO!BH[L#*&N0Q
M
M              SUU:_D#;W]-[/]C.%AH4(
M   ^9$58W(G:J*B>T!DGHRVPS_;V[9M4YK8:BRQ7..A2B=4+&O>+%)4*]$Y'
MN[$>T,I:X#$
M                          #.\7ZZDWZ"I^/-"[FB @!\32M@ADG?[B-K
MGN]AJ:J%IC&<&0M@F.K]U*:L>FKHX:RI=Z%?&K/^F<ZQG6_3NOSR:*8[:8^W
MD; .B_,      *@V]ZB,3W'W$OFVUHMEQI;O86UCZJJJFP)3/2AJ64K^162O
M=Q<]%;JU. 7!;X0
M                                                    !G[=[]8O
M8K\)?_Q-@5H$(  ,?;X3OON[-1;85YEB\);XOKGL:Y4]](ISKV=;]0Z'3\K0
MQ5/ZJOMY&O*:!E+3PTT2:10L;&Q/WK$1$_:.B_,:JIJF9G>Y0Q
M          J3<OJ"Q7:_-;!@UZMMPJ[ED+8'TE11MA= Q*FH6F;SK)*QW!S=
M5Y6KP"X+;"
M                                 9ZZM?R!M[^F]G^QG"PT*$
M                      ?CG<K5<O8B:^T!4NS74%BN]M7>Z/'+;<*"2QM@
M=4NN#86H]*ETC6\G=2R+P[M=== LPML(
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M;P#$
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M0W,&(
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M.WW+XIFH]CD]"HJ*$=@#/75K^0-O?TWL_P!C.%AH4(
M          ^)?O3_ *U?V@,.] 'Y=W$_!V[^ZU092W*&(
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ME\:#(\;UF_-N ^_N7QH,CQO6;\VX#[^Y?&@R/&]9OS;@/O[E\:#(\;UF_-N
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MBP3)[AU$X=N!2TK'XK:++6T%?5K,QLC*B?ON1J1*O,[7G;Q1- JWP@
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M19]^]QLZN%+''C.0TEL@M-2V9CWR/I(&,D1T:+S-T<B^Z0*N (
M    Z-YIIJRSW"DIT1U144TT43571%>^-S6IJO9Q4" =/>'9!@.T&.8EE%.R
MEOMN;5)501RLG:WO:R:5GKL56KJQ[5X*%E9H0             !4/45@F3[@
MXA9+3BE*RKKJ/(+=<JB.29D"-I:;O.\<CI%1%5.9.':%A;P0
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M4EFP;):/J)R7<&HIF-Q6XX]2VRDJTE8LCJJ&:-[FK$B\R(B-7BJ:!5MA
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MLJP2-DY7>9W*JZ*!V0 '4ANELJ:E]'3UL$U7']\IXY6/D;IVZM155 .V
M       .&JK*2AA=4UL\=-3M]U-,]L;$U\[G*B ?<,T-1$R>"1LL,B<S)&*C
MFN1?*BIP5 /L !^<S=>75.9>Q/*!^@          #K37&WTU1%25%7##5S_>
M())&LD?Y/5:JHJ_0 [( #XFFAIXG3U$C8H6)J^21R-:U/.JKP0#CI*ZBKXN_
MH*F*J@[.]@>V1FOLM54 YP          !UJ>XV^LFEIZ2KAGG@72>**1CWL7
M]\C554^B!V0 '4ENML@JF4,];!%6R:<E,^5C97:]FC%75?: [8
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M%JHJ>A=0/T !UH[E;I:M]!%5POKHTUDIFR,65J>EB+JGM =D
M         #K5EPH+<QLEPJH:2-Z\K7SR-B:KO,BN5.('8:YKFHYJHYKDU14X
MHJ+Y4 _0/B66*"-TT[VQ0L3F?(]4:UJ)Y55>" ?%+64E="E30U$=33NX-EA>
MV1BZ>9S55 .8           =9;C;TK$MZU<*5ZIS)2K(WON7MUY->;3Z '9
M =2INELHYHZ:KK8*>HEX112RL8]^OU+7*BK] #M@          #\54:BN<NB
M)Q55[- .O1W"@N#7NH*J&J;&O+(L$C94:[S+RJNB@=D !^.<UJ:N5$3SKP _
M0          !P5=91T$*U-=41TU.U41TLSVQL15[-7.5$ Y(I8IXVS0O;)$]
M.9DC%1S7(OE14X*!]@ .I!=+955#Z2FK8)JJ+[Y!'*Q\C=/JFHJJ@';
M      '6EN-O@J8J*>KABK)OO-.^1C97_6M5=5^@!V0 '7K+A06Z-)KA50TD
M2KRI)/(V)JKYM7*B <L4L4\;9H7MDB>G,R1BHYKD7RHJ<% ^P          !
M^(YJJJ(J*J=J(H'Z  ZK[E;HJME!)5PLKI$UCI72,29R>=&*NJ^T!V@
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M/=5<9[CC-MIH[WB+ZMZR2T])+W2OIT<OD1)V\$T3F8YR(G,H26FP@
M  S1U%7&]9MN3@73_:KA/:[3DZ2W/**BD=W<\ENI^\=W2.\B*V";@J*BNY=4
MT312PBF]FT=BZ>[%:]X=F6SV&Z8[64L-XHDJJB>FN%%42)&K9VRO>JZO5K51
M-$T<JZ<R-5"Q+6MGN=/>[107FDU\)<::&K@U[>[J(TD;K]!P8HQN?MW#N?CL
M6,5EXKK-;EJXJFNDMDB0SU$$37HZG5ZZHC7JY%7@O9V 4-NKTL;2X9MQ>\MQ
M!:S&<GQJBFN=#>XZ^I=(^>F8KVL?SR*B+(J<C5C1JHYR:>92XKFV#RF^9KL_
MB62Y(JOO=;1JE7,Y.5TRP2OA;,J)HFLC6)(NG#B"5CA         !D7&<7M_
M4YN_G=[W ?/7[?X16?(>.8\R>6"E?-&Z1DD[^Y<QVJ]WSKQU7G1%7E8C0RV.
M]B%N=T_]1EOVPL-54.VQSV@EK+;:ZF5\[*"XP)(Y4C<]5=Q[KE_?)(WFU5B*
M$:L"(KN/GUEVRPVZ9G?G?WI;HM8J=JHV2IJ'^K%!'KKZTCE1O9P35R\$4#'^
M"V'+K9U5;?7_ #ZIDDS/,;779#=:)VK8J)*BGKH8*1C5XIW,,3&JUWN5]7CI
MJIEN;J#$         0[=?,G[?;<9+F4+&R55IH99J1C^+%J7:1PHY/J>\<W7
MT 9]VLZ9<.W&VVI<WW1DKKWGV8P?*LE\?5S,GI&U7KP=PUKD9ZK%:[[HQR:K
MHB<NB!EBF72GF&1W*Q91MYE]8^XY!M[=I;,M?*JNDEI$<]D7.KE5RJUT4C45
M5]SRIY DM A&+ZVLQK?G.LMR7=[)4LFRF'7!UBQ^SR5J4%-7UT6O>2O?S-5[
MM$231OKZ/:B*B-7F,EV;.;6;)XU=*K-]GJQLU+6TKK=514-R=<:!461DNKFO
M?*K945B::OX(J\.(25R!         !G;JFR?(7_F3M'BMPDM=SW#NB4-=<(%
M5LL5NC=$R5$5JHJ(Y9D5VB\6M<WL50L(CN_TYXGM1M])N+M"ZMQ_-\-;'7)<
M65<TSZR!DC4F2=LCE9[E5?HUB-=IRJWE7@6):1V[RMN<X+CN8-8D3KU;Z>LE
MA;[F.:2-%D8FNO!K^9J!B\7?&]Y#C>T>7WS%>=M^HK=+)2RQIJ^)-4229OIB
MC5TB?6A84-M=TX;(YKL];LRR>>6Z7Z]4/RA><KEN,S)J6K<U73)JLG=-[AVK
M7=ZQWN=7!<4UZ.<BR;(-JJEN05DUSI+5=JJW6*Z5/,LE1;X61*U>9^KG-:]S
MVM55X(G+]*$EH0(         * WVV(M.;1Y)G5]R2]]Q06>>6BQZEJ4AMS9:
M*GD>CG,5KN;F<B*[33V0L2[W2"JKT^XHJJJJJW#BJZK^4*CS@E>(1F[J=OE]
MON0X#L?C]QFM29S6N6_5]*[EG;;*=6HYC53R.17N<G#7D1J^JKD"PBF]&Q6-
M[)X9%NQLSXK'<KQ"6FEJ9&U4\\==222LAD;.R5[D757HYR-T:YO,U6]FA8EJ
M/$<@@RS%;)E%,WD@O5!37"./77E2JB;+RZ^CFT#%[(
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MLTW)VJWHR5U1109?E5-3XK8GJB,I<?H:BG6![M./>3ND=(OD5%YDX.1$,G]
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MD^YNW]LN<]ZVXQ>Y1P8U7U#^_;$KWS-?!'+[ER(UC55&>KJG,B)S\22U $
M       %7;I[)V_=FY6V>]9+>K99Z"%\4MGM-2E-!4ND<CN>75K]>"<ON>SR
MH%Q5=T1TD5!BF=6^G5RTU)E%33P<[N9R1Q01-;JOE71 2U$$43U79]?\+VYI
MK7B<[Z7)\MN,%CH:N)W)+"R='.E>QW:URHU(T<G%O/JFBHBA80O,NDO",6VT
MK+UA\U=1[G8[1R7:FRF.LJ&U-36TC%FDYF<_(U).5R-Y&HK55%U7CJ,5R;#Y
M]4[F;48WEUP5'7:I@=!<W-1&HZKI)'02/T1$1.=6=YHG!.8$K&"
M          XYYHZ>&2HF=RPQ-=)(Y?(UJ:JOM 8_V<VZLG4S-DF\.[C*B\4E
M7<9[=C%E=4ST]-14,#6JG(D#V+KZZ-[?=-<YVKG:AE.23;'37+:W>O+>G^6O
MJ*_#XZ-E]Q%:QZR24T+N[62G:Y?I?NJIYM8^9$17*$EIX(RIFU _?WJ-J]I[
MW65#-M,&MT=PNUKI97P-KJ^9(G-21S-%X=^U$^I1CN545VH5Y^6XK;>F+=C!
M,CV]?/;\#S&N^0LFQYT\L](CY%8V.=G?.>[F1'J]-5U3DT1>5ZH%VM=AB
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M[=?80$)/LE;JBU;08-05:*VIAL=!WK'=K7/IV.5J^QKH"4\"
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MWW"/<%7[A6&V';_%[;B&,T_AK/;(NZ@:J\SWN55<^21VB<SWN57N73M4(]\
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M1U"*IZ-Z&IHM@L>=4LY/%SU]3"B\%6-U7(UJ_1Y=4] 65]!
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ML+[M"Z];W8UO&EY6!,>MLML^1O#\Z3]\VJ3G[_O$Y?\ "?<]VON>WB%6>$
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M Q79MGB>88A9ZJ@S3,9LTN,U2L\%QGI643HH5C8U(48Q\FJ(YKG:Z_3!$U
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MT3L1$1$0(DX
M
M
M
M
M
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MK4>QR(J(O%%1>('8
M                                                  (/N7NW@VTM
MM@N.97!8'UCG1V^@@8L]95/9IS)%$WM1O,G,YRHU-4U754 K2/K!VY@>QV0V
M')\<H)7(R.XW6U+'3+S=B\T4LCOXH7!H)KFO:U[5U:Y$5%]"A'Z     $&W9
MW)@VJQ%^65%IJKS&RIAI?!4.G?*LZJB.XZ\$T ]3+<_Q+ [;0W;+[BVUT5QJ
M8J"DDDCEEYZJ=KG,CTB8]4U1KEU5-.':![]74)24D]4K%D2"-\JL;[IW(U7:
M)Z5T AVU&X\&ZF'09?3VNIL\4\\U.E%6Z+*BP.Y5=P1."^0";@=.[5Z6JU5U
MT=$Z=M%3RU*PQ^[>D+%?RM]*Z:(!#L!W3M>:[<)N7644]@L[(ZRHJX:U.:6&
M"@<]))'(Q-53EC5W!-= J2XME%AS2P4648S6)7V*XM<^CJVL?&CVL>Z-WJR-
M:Y-'-5.+0CV
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MQB\$>U==-.(1(@
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MI6_5 7:$
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MR\[DY9=^HBT;4X=410V"RV]UWS>=T+9GZ2:+%3M<[W"JCHN*<=)-?I0+M"
M
M                             ,T]7E@O]138%FMNLDF26+#[REPO]DA:
MLBS4ZNA<BNC1':LTB<QR\J\O/JJ<NH6'NXKU>;%Y6L5#57>2Q5=0B1NI+U3N
M@C17<%8^9G>0HB=B\TB(#!.=T=Q;'M#MK6YBVFCGHZ&**&T6ZF5L<4\TZHR"
M-BL14:SCS*K4X,151%[ *NH[#U?7JS,R]^96BRWB>+Q=/@RVR)U.U'(KVT\U
M3(UTK'Z*C7>L[1?IO*#)[V/;W7/,>G_*=Q*2E9:,TQNAND-RH7-62*FNUL@=
M)HC9-55BZL?RNUTUY55=-5&"&8%=^I[>?!+7E]IR>UX52/A<RE5U!%6U%TFA
M>YCYY4DC<V")SD5K&L:KO5UTT5-1DFVR.\=_RO!LKJ,\HXX\RP&JK:"_QT:<
ML<[J)CG\[&\4:Y>1[%1.&K=4T1=$$P@^W=QZC=[<;9N-9MQK5B5JKIIVV_'J
M2U4]Q2)L$KH^2HEG17M<O+KVKJU4=HFN@%EY3?\ <S ]A[]D&25U!4[AV6CJ
M9_E&AAUHY%9,O<O2*1K=%6)6\S=-.;4"K=[+KG>9])]LR[Y6I8(*VST5=EE,
MZE17UJU,E,L:0.1=(>61>9=$XIY@L;4\V2L&\]-:<.N-^S"V5^#+:*5S;+#;
M$AJD@DHF^'9XA'=L:JQ7.T];1>''@27YM3GN?;ALW<MC[A3P77'KY<;+BU5X
M9G)3I%WC8%E:GWQ&N1JNYNT#U^G+<^[;GX ZLRA&1YI9:ZIM.0PL8D/+40OY
MF+W:>YUC<UJ^3F:X$O/VZW(RW<+>G/;;0U$3=L<-[NU1,;"U9:BZJO+([OEX
MJUCHYDT;PTY/.!YFTF>[E[GV#<NECN]'19%9;_56C'J^2C:^&GAA<BIWD;53
MO.&J:K^R!4W3!CV]EQP*Y3X-F=KLMH;?:UE125EK2KD?5-;#WDB/YFZ-<BMT
M;Y- LKNM>Y&56?J)NFU>73Q2X]?+:V[81.V%L4B+$BK/3N<WW:IR3+QXZ1HO
MTP1\[R[DY9:L[P#:S;RHAI\GRFK=4W2JEA;4^%L].B]X_NW\-7(DCFK_ -4J
M>4"[0@
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M00
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MAW%N<U<SFXK';H)'L@C;KQ1O,K]/.Q& EH@(
M
M       BF7;E8/@=?:+=F-Y@LLM\6=MMFK%6.G>ZF[OO$=*J<C-.];]\<U%
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MA28[C^[V.Q\V2;;W*&YHC>V6W2O8RIC73BK=48YWF9S^<$/#Z>9EW:W2SGJ
MJ8I&VERLQO$(JA-'1TD+&/F=RZKHJ^HO!5]9\B:@EIX(
M
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M1.7W/DT[- Q?H
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MQBS4.+2PSXW2T5/#:9J:1LT+Z2.-K8G,D8JM>BM1%YD[>T(]@
M
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@6$$                                    /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>fc_datacuration-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_datacuration-4c.jpg
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M%!04%!04%/_  !$( 5P#Y0,!$0 "$0$#$0'_Q #-  $  @(# 0$
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M+!2PQ6WT+;,GCIF6H^Y%)7MQLC;(.CFO:6-<QS2"/0D)TB! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 00>3Q7QN3B&4X4Z:Y]T9?)3YBU()6"<6;-_[Q<&.V:!G
M=Z ;2=O377J@P.8^&L#S+(9BW:RV5QU7D=:M3Y#C\=/%%!>91+C YY?%)(QS
M0XM=VWM#V]' A$Y:3GOB-N<QHXEB*3I\5R/D?[1\AS%FV(Y,>6OB=,VM&UFY
M_P Q$Q]9K==&A[BXD=$$J\M<2R7,O'N0XM@2(+MJ7']E[935,4=:]7G>Z.1K
M7;'LCC<8^GU@$0Q:WB#!-N-RV4R61RN?^]J><GRUJ2%LTLN,BDAJP.;#%'&V
M"-LK]&,8W5SBXG4DHE\=X@P3LV_(#)Y-F"DR[.22\7;.P8QV89()A.1V^]M,
MS18,/>[1E]^U#+'@\,8O'.CLX//Y?%Y.I:R=C&Y"!]626M6S<K;%ND&S5Y(Y
M*YF;WF"9CWL?U#]!HAERM^&</(R)N/SV<QCWXV+"9>Q6N[[&3HP/>]HM2SLE
M?W099=)XG,D:'N <!IH&95\2<=IY[[\@MW@UN79R*OCC+&:L.0%%^.>YFL?<
MV21.!>UTA]XW#3J"&+7\(\)J87/X2L+<47(,H,Z^TR?;9I7(I6SU_DY T=IE
M>1F^%FA#23Z@D(92;B_%7<<.0L6LQD,YD\G*R:W>R4D9($3!&R.*&".*&)C6
MCTCC&XDN=J2B$A0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%6\WYYSW$\FR
M^'XEB,9<H8#!0\BOSY&S-#+-W)K+#4A;&QP:YS:Q+97DM:>A:?@2CLOF_D]I
MV:S&&PE&;B]+[DIXEEBQ+%D+F2Y/7HS4VR!K'1PPQFZ!,\N<=![1KZC#$Y5Y
M \IP9.AQ%XQ>.Y10Y#QX7;=-\[Z%W%9IUIK&!KVF6-PDJO9*T^K0'-=UT 9.
M \Y9KD^6A^7P@=Q3*V;V/JF"/("_495%AD=RS/\ +BKV97UR"(IBZ/N,ZN(<
M ,-?!Y@YG0XG]YX'#T;.&XUQ7 <FRXRE^W-?F@RE>:62O%,Z-Y?*UL!TFF/N
M)&X=20,)4SRKR"/R<.'Y.E0Q6(GN?)XUF1=;KV[\!A;(RW3LF(TYMSR6?*MD
M$H#23U&U!;B($! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%:<E\14.8<\
MO<ESUF8X2Y@ZV"EQ].U9IOGCCLV9IXK/9>P202MF8TL/7H?@3J2D-KQOPR[3
MS^/M8MDE#DSJ[\M7#WL8YU*"*O7,88X=HQ,@BV&+:6N:'#W=40U7_!SA;\?9
MJ6&WK-^W<J9*QG9[UE^6=;QW_LL@M%^\=ENK6-:0T NZ>YVI.614\4</HYC[
MWK1W&QLGLW:N)^=LG%UKEULC9[$%3?VF2/$TG4-T!>XM +B20YQ^*N$18?(X
M%F/>,7E<31X]>A[\VK\;BXY(:\8=OU!:V5XW [CKU*#X[Q5P^3D3>1R0V7S-
MNMS QS[<[L:,JQH8VZ*I?VQ. /K!NF[W:;_<@FJ @(" @(" @(" @(" @("
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M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0<(IHIV;X9&R,]-S"'#]T(.:
M@(" @ZVV*[I'0ME89F=71AP+A^<>H6$7K,XSQ3B79J%FA\U'TH/NH]$!!\)
M]2@Z77J3+ J/L1-M.&K8"]HD(]=0W77X+'JC.,\673.,XX.X.:>H.H/7]"R8
MONH3((" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @Z[$7?@E
M@UV]QCF;OHW#35!57CS@7DW@^.X_QR7-<=N\<PD,%)SX\1:AR,M:!H9KW?GG
M,$A ZN[9'Y$2U&)\*\R_9+'^-.1<HH6/'-"6)T]6CC98,E>K06?F6UIK$EN1
MC6/<&B4QPASF@M&W<2AEM*WCOR1Q[-<FN<5S> .,Y#EILWVLOB;-JS#+8BBB
M,8EANPM+0(01[->J#/R?B&OFJ/,:U_).CN<DR=;/8K(UHS'8Q62IT:M:&>%V
M_4N9)7[GJW5CC&=03J,MUA/'>*K^.\%X_P"2-CS-3$4J=2:0M= R:6G&U@D#
M&.U;J1NV[NB(9_&^ \0XC8GM\<Q<="Q98(IY(W2.+F-.X#WN=\4&,[ADKO)\
M?D/YT=EF!?@/N_M^XN?<9:[W<W>@#=NW;^75!#<CX=S$O#<7QFIFXYF8_,Y'
M,6Z%IEB+'9&')6[5IM:RVM-')MA=8:]OO+7/C!<P@]"<M3_9[M#C]O QYVM#
M'/3Y32A->AV((ARJ6M,W9")G!K*Y@<UK0[W-(Z@CJ,I%SGP^[F>0S61DR44;
M[]?!"C!8K&Q#'<X]<M6V.G8)&=V&;YDQR1@M.FI#M=- U..\,9O$"ER'$V\+
MC>9XW)OR5&"GCGQ8@5YJ7R$M64"7OR[F$R"=\FYC] UH9[2,IIP_@UW \4RO
M'\UE&Y*_FK>3O7LA!!\JW?EI9)7AD1?(&AG<VM]Q]$0@N,\.<YP>'&/PW)<=
M!<R6 J<5Y!:DQ\LC37Q;9J]2[58;'LL""8MDCD<Z-S]'#0#:XG*:Y?QO7L\;
MX=Q?%7'5*'#[^&MUW3-[TDM?"%H;$X@LT<]K0-_^!!$;?@HGF5_-4I<2_$9?
M,1<@NRY#'&YE8)F.@?+!7D?+V>W*Z %KI(2Z+<[;J=I:,NT^&^13X*]X\L<F
MCA\8SC*"*K6JD962/+&9[8)[$LCV%E:2<O8YD8=)M8'] [>&!RSQKS#)5Y>7
M\LRYRO*,'6I0<>'',>UKHI:F0KWG7GU[,Y$\CGP1F2NV1H[;7-CU>X%!@\;\
M=<MY=RK*\RY#;^5 Y)@\O2EDQ\V/^:KX2A+ ^..I8D=-"PR6'!CYG%[MI.T
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M^>I%*W1P)[;?:_V@@#Z.NB#U;QG!T^/8>''T99+$765T\KS(Z1\G5SM3\#\
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M:]CQZQ@]!\2I&]_L_P#(/^<?.?\ O"'^)0/[/_(/^<?.?^\(?XE!Q?\ A]Y
M]CF?\8^<>X$=<A%IU_\ R4&KL?AEY'(QHJ^:N;U96N#A)'>9KIH1IT:.G50.
MC^S)S7_GUSO_ %UJ"AH_$V?\M>8,3A.%>2^3<KX_X_O?,Y_GN7L,FJ4[C2QW
MRF*>P;I)SMTE<'[&]"=>FXE[GY9@<5G<-:BR<41,,4DE>S-JWL2-:2)-XZM#
M2-2B'B',YG(Y&TZGDF-R-NJ]S_FZ[6Q^W3;OWM&A8.A:[3K\5FP:')0PUYFO
M;N$,S!+&X[>NOKKMZ:@_0@VV QS+[#2DG;4;99N=*X:$M8=[MCORMT'Y?T()
M'A/$N>S>?AQ^"M-D@/VS+P:]L<8;U+7R-!:' ?0>OP43(]I8:B_%XFEC7R"9
M]2". R@$!W;:&ZZ$GZ/I6+-DSP0V&&*Q&V6)PT='( YI'Y0>A6%JQ:,3&83$
MS$YAYMYQ+-0Y!D,+5=\SCC,YE:JUIVQ=03&TN&H+3ZZ=-/BODGS29IW-]=9S
M7/"/)[7LHBVJMIYHK:BW5VV1&6Z.[<FA+VM.FH .G0?I7%Z>&8=&)XXF3%QN
M,S9-=L9=VS(1J!O&T#]TZ_D65(XHO,M]'PJ3)2118*1]MY=VK#&-[A9H="\D
M>@)]=?1=&G86VS6-?O3,\?0J3W=:1/7P\GH'A7')>+8&'$S3-GF:7/D>P$-W
M.^C7J?3XKZC\L[*>TT1KF<SS^MX_N]_QMG5C#?RL9(PQR-#XW AS7#4$?005
MTYA5CF\I^;)9.-<NL4\0^)N)MQ1NFQ,4?LBFE9H206Z-<_ZS-FH^D+QGS7_+
MV]-9X3X/>_)HC;HS>/>B>:J9Z_<I2R&NZ&2J6]V)K@[:UW37335IU'N&NGT+
MA=,S'#P>DBV+1$S'%BXYOV_? /;A+7.?MW-: =22/CT&B5B6>R9Z<3XI3+PE
MV3:7X6P;N5<[?-3A:9GO$ON^S:SW>T'3\JN1VW7'N\9\E&.]C7^N,5CQ>F_#
M/C_(<"P5B')6&RV;[VS.B:T@QM#?:UQ/7<-2"/0+U_RWM+=O2>J?U/!?-N^K
MW6R)K'"K>\]X=E^8U:=?$<LRG$Y*LCI)9\08@^=KFZ!C^ZQ_0>HT76<5!?\
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MKIS]I#V+ V[8I8M&AK"T$N=]*F1ZEXAQ2AP_$MQ./?))#N,A=*03J?@- -
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MOU5SE>[CYIOWTZ;3P3L#1=)R7U 0$! 04K^*[^I/+_R[#_TG6074@(" @("
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MJC4L537R,UF/MQS5)V-<PC5H9W B7JQKMS0[0C4 Z'H1K]*@?4! 0$! 0$!
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MH^#KBOCX^M\^[WN?[C;-O#P]7@E'P5M1?4! 0$! 0$! 0$! 0$! 0$! 0$!
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M?_*?'U<O6L_&IIX:N-OW_P#C'AZ^?J2J...&-D43&QQ1M#&,8 UK6M&@  Z
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MM _8#@G^Z^(_U"M_%H'[ <$_W7Q'^H5OXM _8#@G^Z^(_P!0K?Q:!^P'!/\
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M3?[8NO\ CJGW/O8UQ_-S_ICG^7M7NU]S.V?Y.7]4\OJY^Q)  T!K1HT= !Z
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MXSYSRB?%GME\J93,WSQK#7\CEIF39&OD*I%F,0VPQ[)KA:7.:YC?LA&T#VZ
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MV5=6G4>H0>J^$8:UQSAG'./7G,?>Q.+I4++XB3&9:M=D3RTD EI+3IJ$0WJ
M@(-5R*.'[GO6W5XK%BI6GFK=Z)LP$C8RX: @_$!!5?X<.093R-XS@Y+S;%TV
M9U]RS ]K*+*H$<3@&>PM^@^JD8/A_E.:YAY&\I<=Y)C*0PO%\FVI@"W'MKDP
M&:RPZR$:2=(F=1^?XH/EWE.;@_$KC?&T6+I?L-9PKK\S_D&%_P V&S$#O[=!
M]1O1!>T<;(F-CB:&1L :QC0 T >@ 'HH') 0$!!37!/[Q'ES^;^,?[/94BY5
M (" @(" @(" @(" @(" @(" @(" @(" @(" @I?\5O\ 4;G_ .58C^E:B"Z$
M! 0$! 0$!!'.?<8M\TX;F>*4<O/@I\O7-0Y:H-;$$<A D,?5NCBS<T'7IKJ@
MIWSGP;C'CC\)_,N'\/H,Q^#Q^)+(86=7O>9HR^21YZOD>>KG'J2B4CD\6\9\
MN>!^)\7Y&QT;Q@\78Q65@]MS'WHZ<9BLUW@@M>P_#71PZ'H40M3$T;%'#T<;
M?M.R-JM6BKVKLHT?8DCC#'RN&IT+R"X_G0><N:X/Q9QGS/P7QI!XRXS8Q_+8
MK,UN]+0B^8A= V1PV -VG79\5(^^?<#XK\0\=P>9Q7C+B]^;*YBOB9([E&)C
M&1SQRO+V[&:EP[:"4>5?'/B+Q_X[Y#S.AXXXY;N8:J;,-:?'P-B>X.:W1Q:P
M'X_!0-]X,PG"['"L%Y P'$L3QK,\AQL4MW[IK,@&R4AYCW- <6[F@Z%!:B"N
M//\ _4GSW^9+O^:*"3<"_P# W&/YIH?[-&DB0H" @(" @(" @(" @(" @(""
MC?Q3^,LKY(\<._9RTZIR?!3-O8UPD$;'@D,EC<'$->7LZ!CCH[TZZK/7;$L+
MUSZ7YZ\#YI=X8>7XBOQRC^T&3K,Q/(\5E*_;="UTGR[Y89"]@C(<\/<QVC1K
MU)VA4N[[2G<;=4S-JVI;,=,Q$3..5L^929I6T\)C'CQ:[FWW?A<'B'8F_! ^
MDV2.M7[;K,LL^.F< 1<]@+H3*-&M;IM (+E>I,4F],XQ/5'MCS]<2PM'5%;X
MSF,?5Z/3$M1QGG S#Y*%VC!^TEE[K;;D.Z(7K44;@QDK8W,$3R-=)(P-23N!
MU5K5MSP\?O\ 6K[-$1QSP^Y.. >0<K+R^I@>7QNNLQ-:S6OV'2B2!PF@VND<
M20'/>&L8&G7J!M^*K]YW5JZ\3QMFN/+/5'/'AY^AN[7LZWOF)Z:8GJGQBN)Y
M>G/+TLV;*\(Y%D,I@>27[09>?"VI$^-X>VG%H87,@D+C[0>C&N.K@7'IH%T]
M5-=,Z[3F9G.?.?W?3P<K=?;;IV4B*Q$8B/"L>%?9X^<YE7F9E_8W/-L.E98Q
M/W/#'%%+')!\]$2^%K(VO:=C@-7;G-U:&]/5<BE?AVOCE%K.U-OB5KYS$)!Q
MGC3X:3.)T?F+$EV/[SD9'8;1N.T,;JU6O)T9WBR4NDWEPZZA7M->'1XRH[K\
M>OPCAYQZ<II5\9<<J923'X7'8^U-5O1XVTV>.>W _*%QW0[V.88A%$.X'/.T
MN/Q^'0CMZ]6*X_BYD]W;IS:9XQGRX,SDW%N/P3YG*X_'PQFF(+N,R[6S0VLC
M<K]VM8@EJ$N:[MO<V1[V@- ]#J52^8:ZS7$1^NU8]?.;?<L?+]MXM$VF?=K:
M9CAB.73B?3E*OPZ^&*7/IQ7^Y9<=A(HX69KYRK)"6:MVR&G8>!(3/$3KJ/:7
M:@J;6I37G'O3],MT5V7VQQ]WG_![SX7X_P"%^/,9]S\+PE;#8\[2^.LS1SRW
MH"][B7OT^&YQ7,FTSS=2*Q"2J&0@(" @^$ @@C4'H04$ \@>*\=SB*H(K;\3
M/18\5G5F-V;G$$%S=0-!H>GY4&SX+P+%\)QYA@;'/DI"[YG(]MK)903J XC_
M  _2B,)8[=M.T:NTZ _2B5"Y;*<N$^6?=R6UTK9HI:S/J"-H+ 0 "TN(Z?DT
M^E!!#F8G5HV=L1/CA^7;H-'/;H?KENFHUZ_GZK+ WV%GJ7*L7;M3P967=5L2
M]WM- >W:'DG4'J!HU1,"\^,X[).XC!C,YH;;H71.+])/:1[21Z=/@% I7G,;
M,9+/QNV\BY&Z-QD=J(7,<-6F/X_NJ8D0,QR"?Y=YTVG:6Z]!^A3D2S#S\CQ6
M2HP0X[YZ"9PCB@E9W1-$"-1IK[=/70+$>D[U*/)8N>A8C;V[,)C?&]H<P;FZ
M=1\="L+UBU9B?%G2TUM$QX/(OD:D./OM<4O/:S)Q]HZ@!L!A=[FF)Y:"1_U?
MAZ+PW>T^%,Z_&'T;Y?LG;$;8Y*P<VPV3Y:0D%IV;=>@7)=[AC*8X;*YW"7\?
M7EQ3\M3=_HT->PQ[Q/ XC5D>WJSZ>AU5_3>U+QF.J'.W:==Z6Q;IGSCP]+V[
M2:UM. ,A%9O;;I7: T1]![0!IIIZ+Z#7E'@^5VYSQR[UDQ$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$%-<$_O$>7/YOXQ_L]E2+E4 @(" @(" @(" @(" @(
M" @(" @(" @(" @(""E_Q6_U&Y_^58C^E:B"Z$! 0$! 0$! 04Y^*S^[OY!_
MFP_YZ-!-_%W]6?#/YBQ?^QQ()8@Q9L;CK%N'(6*<$M^L"*]I\;'31AWJ&/(W
M-UU^!0+V-QV3C9%DJD%R*-XDC98C9*UKV^C@'@@$:^J#MM5:UVO)5N0QV*LH
MVRP3-$D;A]#FN!!"!6K5J<$=6I"RO6B:&10Q-#(V-'H&M:  /S(.U!7'G_\
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M$! 0$! 0$! 0$%-<$_O$>7/YOXQ_L]E2+E4 @(" @(" @(" @(" @(" @("
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M?\5O]1N?_E6(_I6H@NA 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MH$/Q?FBI8S7**^2QUNKC\-)B*F.I"C:.8FO96&65T#ZVTG4!C7-<T;=NI+M
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M$,SIR'&661WIW'Z;MOY.G1!OT! 0$! 0$! 0$%+_ (K?ZC<__*L1_2M1!="
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MD:+:5ATCO<UG;[XT&DI'Y5 XYKR9A,+FSA9(Y)I(M!:D8-!$21Z[M >A^E!
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MK)R9GDO$\5ELM*UK)+MVG#/,YL8VM!>]I.@'0(-9_P "/"W^X&!_[NK_ +Q
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M(T/8?5K@"#IU]"@Z:]"E4>^2K6BA?)]=T;&L)U.IUT'T]4&0@(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M-E!G\):$CJ^0KR-B=LD(D;H'>FGJ@V* @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MN#2!TZ(-D    - /0(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M28O="T21.!:03JW4@@E(QRO(T?,C:UG.7<J;>?;0CQ%&]-6N48)J8(BLX:Q
M8)Z#/X;[PKR!_74N.A:B'HI$" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M"",1?L?^W][9_P"./NJE\YN[^W[M^9M?+:;OL-W=^8^K]I_C>W:@DZ#J9\OV
M?L]GR^A^KILT^/IT0<_L^X=-O=VC7TW;=3IK\=-=4')!U_8]WIM[^W\F_9K^
M[IJ@[$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
:0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>fc_discovery-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_discovery-4c.jpg
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M%!04%!04%/_  !$( X8#\P,!$0 "$0$#$0'_Q #0  $  P$  P$!
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M^EXT^2U_]8 .JYQ?TO&GR6O_ *P =5SB_I>-/DM?_6 #JN<7]+QI\EK_ .L
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M_I>-/DM?_6 #JN<7]+QI\EK_ .L '5<XOZ7C3Y+7_P!8 .JYQ?TO&GR6O_K
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M^(@8>?N1R>@^.VYY^23C.:8 SA._?FI?^'+G]JN -'@
M
M                                                          S7
M?7[Z>*_[M5C\60"M* CA7A^PG_YS?XY#MP]V'#G;4^"M1Z!YH
M           %@6-^R7OZPK\1 P\_<CD]!\=MSS\DG&<TP!G"=^_-2_\ #ES^
MU7 &CP
M
M                     9KOK]]/%?\ =JL?BR 5I0$<*\/V$_\ SF_QR';A
M[L.'.VI\%:CT#S0                      + L;]DO?UA7XB!AY^Y')Z#X
M[;GGY).,YI@#.$[]^:E_X<N?VJX T>  ,S<Y>;K[PE;5L56Q'HK,JJ3WXTPY
M<<I)&VVSO222,RTX@K'?M]\PWZ92>[D?& 3C#?.EG&]\K6?:-<ETU5'K-5C0
MIR68*6W#9>7M425$K4CTZ# ?24$
M
M                                   9KOK]]/%?]VJQ^+(!6E 1PKP_
M83_\YO\ '(=N'NPX<[:GP5J/0/-                       L"QOV2]_6%
M?B(&'G[D<GH/CMN>?DDXSFF ,X3OWYJ7_ARY_:K@#1X  H3FCY?*IS!4&@4>
MEUN/1%T:8[+<=DLK?)PG6NK(B)"DZ&0*^=7,1RY5/EZE6_$J=>CUQROMRG6_
M)F'(_4E$4TD]V]2M=W6\-/<!'&Y:_P#K[CG_ )]"_I" ?:D
M
M                                                       !FN^O
MWT\5_P!VJQ^+(!6E 1PKP_83_P#.;_'(=N'NPX<[:GP5J/0/-
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M>2A:DEX5)29%X0$]
M     9KOK]]/%?\ =JL?BR 5I0$<*\/V$_\ SF_QR';A[L.'.VI\%:CT#S0
M                     + L;]DO?UA7XB!AY^Y')Z#X[;GGY).,YI@#.$[]
M^:E_X<N?VJX T>   #YX_P"9;^W,=?U2J?TD4!F3EK_Z^XY_Y]"_I" ?:D
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MZ>*_[M5C\60"M* CA7A^PG_YS?XY#MP]V'#G;4^"M1Z!YH
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MTFT[[Y<;3C0[\M:MQJ@Y 8D)83,AIU-:%+EO$C@:4EIKQ2I72 EUZXYOBO\
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MQ32:$*U5\)*4^$]^TD@-3$6A:>X"
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M;*7^62:4[5:/)X$9^$!=X
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MC>26W%>\G7W0'TL
M
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M16O:5L631V;?M&DQ:+1F#-3<*"TEEO>K3<LR21;E*T\92M5'X3 =D
M
M                                                         !FN
M^OWT\5_W:K'XL@%:4!'"O#]A/_SF_P <AVX>[#ASMJ?!6H] \T
M            "P+&_9+W]85^(@8>?N1R>@^.VYY^23C.:8 SA._?FI?^'+G]
MJN -'@
M
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MK#SO>:%B?+)O;@'UAYWO-"Q/EDWMP#ZP\[WFA8GRR;VX!]8>=[S0L3Y9-[<
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MUAYWO-"Q/EDWMP#ZP\[WFA8GRR;VX!]8>=[S0L3Y9-[< ^L/.]YH6)\LF]N
M?6'G>\T+$^63>W /K#SO>:%B?+)O;@'UAYWO-"Q/EDWMP#ZP\[WFA8GRR;VX
M#FVI8G,+<F?+3RCE2CV_2Z9;M.J%-,J'*=<-29;3FPS0\:S,]ZR+@HBT :B
M<*\/V$__ #F_QR';A[L.'.VI\%:CT#S0       #+W/ TE^R;0869DERN*09
METZ*CJ(]!E9_5#7^-_ZJY/.KD9Q81Z?/]?\ !_Z2'X2_JXOL*>^7Y_LKG=#^
MHY&,6*6E/S_7^)D7^LA^'_ZW#V%/?)_97.Z'(Y.*1%M^[,N4*&M;D6ESXT%A
MQW3K5-1I,UI!KVD1:F2>.A::C\X4:551T[7[^0J]5-$M8#68X       "P+&
M_9+W]85^(@8>?N1R>@^.VYY^23C.:8
M
M                                                   X5X?L)_\
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MW]85^(@8>?N1R>@^.VYY^23C.:8
M
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M5<T^O3@D ^[X@       + L;]DO?UA7XB!AY^Y')Z#X[;GGY).,YI@
M
M
M              #A7A^PG_YS?XY#MP]V'#G;4^"M1Z!YH       !!<I8GM3
M+E(A4B[7I;,&F/KFM+A.ML*WFV:%;U.(66TD\? .:]9IN1_Z['38OU6I_P#/
M:J"D<H> +@AJJ-!K=3J=.0XXRJ9#J$5Y@G&>#B>L0P:?%^^XCCIP[54:Q,NR
MK.O4SI,1'A+SVMRN<O[U68J5K7%+JT^C2&I:FXE4A2R;<8<):>M2RT9DDU)T
M/H_A%HQ;4SPG7Q*\R_$?^J=-?\2GKW+_ &2_EY.9%O3"KA.IF'326GR,YZ$D
MA+^NF_30M=FNF[WN ^_M*?7ZG/[RO]?H6J.UQ        + L;]DO?UA7XB!A
MY^Y')Z#X[;GGY).,YI@"'77EC&=BU%ND7E=M*H54>93*:AU"6U'=4PM2D)<)
M*U$>TU(41'[Q@.%[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX!
M[1F!O6/;W>4?XX![1F!O6/;W>4?XX![1F!O6/;W>4?XX#K6WF7%%X59J@VK>
M='K-:?2M;,"#,9??6EI)K69(0HS/:DC,P$X <*\/V$__ #F_QR';A[L.'.VI
M\%:CT#S0       #.G.3<U9I6/:1;%&>.,=VU+R&<\2C0:HS*"6;1J+B25K6
MC?[J4Z=!C,SJYBF(CM:GQ]$37-4]B(YNI"L&X+M_"]J5!^75KKJ+C$J0LTMN
MOMGL5*2A*"+:VXZMILDZ_!U(S/4Q\+]/ZK<41VOOCU?NNS<F.%,(C=^*U<K]
MYXONBV:W(FU2I2O(ZW'>)*&W5H4RF2ALD$DS9<2\I&U>IEH1ZZ]'SKM?HJIF
M)?:W>]S373,=3=3J20XM!="5&1?Q&-V'GWX%0       !8%C?LE[^L*_$0,/
M/W(Y/0?';<\_))QG-, 97O2T;6O3G4I='N^BPJ[2O1ZI],.HL(DLD\W5722L
MD.$9;B)2B(_?,!;WL\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
M'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B 'L\X)]7%N]V1?B
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M?N1R>@^.VYY^23C.:8 SA._?FI?^'+G]JN -'@
M
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MB%KFT!;Z9:XIDXM*$FZA*249H)*_@EIKH D0
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M H>;Y)6C<D-J@9#0VIYF.RI1P:@VV1J6<8UF:DK0GQE-+4H]OC)4HB5M#3@
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M8]+NJC6M3J9>U>1<UT1TN%4*XW$;IZ9)J=6I!E'9\1&U!I1XO3IKX01(0
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MXO#@7$QGY%$6KE-5+2Q;DWK=5-7'1LEU)(=6@NA*C(OXC&S#$?@5
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MDDHC+B1@."UA_&+%E2,<M6O!39$I:G7J)U>L<W5J)9K(C/4EDHB,E),C(RX
M)#;=M4"SZ)#MNV*<Q2J' 1U<2#%02&D)U,SX>$S,S-2CXF?$^(#U+PL>TL@4
MMNB7G2(]:I33[<QN)*2:D)D-$HD+(B,N)$I1?Q@)  C]XV/:60:05!O2D1ZU
M1TO(DE#E)-39/-$9)7H1EQ(E']T!WTI2A)(26B4D1)(O 1 *^O?!6(<CU$JQ
M>MH4^JU<B2E506A34E:4$1))QUE2%+))%H1+,]" 2BUK1M>R*0W0;0I$2B49
MHS6F'!90PV:U$1&M1)(MRST+52M3/PF XSN)<:2)-QRY-KT^0]=Q(*Y3?9)U
M,[JCW(-U*]4F:3\9)Z:D?$N(#G65@C#^.ZH=;LVSZ?2ZP9*2B>A"G9#9+(R4
M3;CREJ;(R/0]AEJ0"=SZ? JL)^FU2*S-ITI!M28DEM+S+K:N!I6A9&E23\)&
M0"N[:Y>,)6?747-;ECTR%7&5];'EDT;IL.:ZDME+JEI:47@-M)&7@ 2.@XUL
M2V*56*'0*#%@4FON/O5F(TD^KE.2D=6ZIS4SUWI\4_> <*I8!PS5[9IMGU&R
MZ:_;U'ZSYJBFT:51B?<4\X33J3)U)+6M2U$2]#/B8"0V3CNQL<4Y=*L:@0Z%
M!=42WT0VB0MU2==%.N'JMPRU,B-:CT >:+8]I0;NG7[$I$=F\:G&1!GUA*3\
MH>C-[-K:CUTT+JD>#[T@'\H-BVA:]0KM4M^CQZ?4+FD'-KTAE)DN7(,UF;CF
MIGJ>KBSX>Z8#^V=8]I8^I!T&RZ1'HM'4\N2<.*DTMF\Z1$I>AF?$R27W '$I
M^%\4TF[DWW2K0ID&[D+<>158K"6'2=?0IMQ>B-$[EI6HE'MU/4P%$\T2BRSD
M[&O+A3U)=CS9Q7-=ZD[5*8IL)*R2G7B:%.(Z[3HXFCI(P5JYEEJ.TVPPVEIA
MI)(::01)0E"2T)*2+@1$700(_8" WSA+$^2I;51OBTX%7J3)$E$YQLVI)I+0
MB2IYDT+6DM."5*,B\ #SLX=Q;&9MZ/%M.FQV+4DG/MYIAA+*8DLS0HWD$C35
MPS;0:E*U,S+4P'1O7'=C9'IR*5?- AUV"RHUL(F-$M;2U:$:FG"T6V9D1$9H
M46H#TK#Q+C;&*)";"MF%0URB),F1';UD.I(]22MYPU.*21\22:M 'AOO#>+L
MFNLR;[M:!6ID=.QF8\V:)*4=.SKFC0YMUX[35H [-GV-9^/Z25#LJB1*'2B4
M;BH\)I+9+</I6XKX2U:<-RS,] '"OK"F*<ER6YU\6G K%0:+:B:ZV;<K:6A$
ME3S)H<4DM."5*,B =VS[&L^P*45$LNB0Z'2]=ZH\)I+1+7_*<47C+5_I+,S
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M>(S<B/N;-RVS(RT,^K1T^X0#O@
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M=-&U/$G>:2T+Q35IP =
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MT+47@UT 3@
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M_ "MZ,LLQV6X\=M+3#22;::;(DH2A):$E)%P(B+@1$"/V
M
M    #-=]?OIXK_NU6/Q9 *TH".%>'["?_G-_CD.W#W8<.=M3X*U'H'F@
M   'Y==:8:<??<2TPRE3CSSBB0A#:"W*4I2C(B21%J9F),Z<96(U4-=/-E@B
M(](M^8_(N2%KU<GR6"B73UZ=.GE*D)<(O=))E[AC/KS+75,:M&C!O=<</%&;
M<Q=RTYFJ$:ZL7RET2NT>2Q/E4Z&1L[>I>)9=;!D:D2%&6W>PHDEP_@'QHM6K
MLZT\)?:N]?LQI7QB6HUJWK4L^!J,ST_A&LQWY%        %@6-^R7OZPK\1
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M2DK(E:'PU28#P6%9=)QU9U'LBA./O4BB1RBQ'9BTN2%(29JU6I"4),]3\"2
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M/)?9](KER9(S]!IA4ZG755YD&U8NFG54XI!OOK(C(M.L<ZM/#H-M1= *V""
M
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M@
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M>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7M
M#TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ](
M^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/CS
MSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[:
M+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]X
MQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7M
M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ]
M(^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/C
MSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[
M:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]
MXQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7
MM #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0
M](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/
MCSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\
M[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB
M]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,
M7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0
M ](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2
M/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\
M\[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.V
MB]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>
M,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[
M0 ](^//.VB]XQ>T /2/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T /
M2/CSSMHO>,7M #TCX\\[:+WC%[0 ](^//.VB]XQ>T 4%<E<HE>YS,72:'4HE
M3CMVY66W'83[<E"5['ST,VU*(CT,%:C!'"O#]A/_ ,YO\<AVX>[#ASMJ?!6H
M] \T        J[.>0KXQU0*74[$MSZRU"9,5&EQ?)Y,KJF2:-9+VQ3)1:J+3
M57 <>3=KHB/3&KLQK-%R9BJ=%&)YH^8M/P,5FDSX<*95R_\ NQQ>ZN_Q^DN_
MV5C^?UAX[7YM\NW)=\*UCLF$<MR2RS46&H\]4J/'4XE#KBD=:9I)"5:FI2="
M\(E.9<F=-(*\"U33KZI^C92R)*U)2>J2,R(_>&RQ'Y%        %@6-^R7OZ
MPK\1 P\_<CD]!\=MSS\DG&<TP!7U\X.Q/DJK,UV^K7BUJKL1TPVI<@W26F.V
MM;B4?DUI+0E.+/\ C 1GV3.73U?T_P##D=J >R9RZ>K^G_AR.U /9,Y=/5_3
M_P .1VH![)G+IZOZ?^'([4 ]DSET]7]/_#D=J >R9RZ>K^G_ (<CM0#V3.73
MU?T_\.1VH![)G+IZOZ?^'([4 ]DSET]7]/\ PY':@'LF<NGJ_I_X<CM0#V3.
M73U?T_\ #D=J >R9RZ>K^G_AR.U /9,Y=/5_3_PY':@'LF<NGJ_I_P"'([4
M]DSET]7]/_#D=J >R9RZ>K^G_AR.U /9,Y=/5_3_ ,.1VH![)G+IZOZ?^'([
M4 ]DSET]7]/_  Y':@'LF<NGJ_I_X<CM0#V3.73U?T_\.1VH![)G+IZOZ?\
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MET]7]/\ PY':@'LF<NGJ_I_X<CM0#V3.73U?T_\ #D=J >R9RZ>K^G_AR.U
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M2]_6%?B(&'G[D<GH/CMN>?DDXSFF
M
M                                                 .%>'["?_G-_
MCD.W#W8<.=M3X*U'H'F@      4]GJH9LH;5OU_#D5521"5**XJ6EMJ43[:R
M:Z@SCJT<61&2^+)[B'#DS<C2:'=BQ:JUBYX*PIO/!1XE,E,7C9TZ%=T31'D$
M1PDQG7->)*.01.,:%QT-+@YJ<_AQCBZJOCIU_P#-7!Q6KZYJL^1R=L2G(L^S
M)&J2J3#A1$*3KM,CFNZO+,M>),)+^ ?/]EZ]U<(?7]6/8_ZXREE@<F]'HM7B
MW1?UR2K@N",^W,2S#U9C^4-+):3<>>W.N\4\>"!]K>#I.M4OA=^0F8TIC2&G
MU*-2C4?29ZG_ !C49+^"@       "P+&_9+W]85^(@8>?N1R>@^.VYY^23C.
M:8
M
M                       X5X?L)_\ G-_CD.W#W8<.=M3X*U'H'F@
M !!%+VQG861HYL7G08U3<V[6YJDFU-;+30MDAO:X6GN&HR]X?&Y8HKZX?>W?
MKM_\RS]5>5J^K"ENUS =\RZ<\>JCHM0>ZG>6I'L)Y!&RY_ \TDO=,9]6)71Q
MHEI4YM%<:7*7\M_F/RW9=QTRS<W62I#]1DM0HU9CH\C-2WG";)?BDN.\DC/4
M^J-(495RB=*X*L.U73ZK=35RTFA2D'TI,R/^(:S&?P4        6!8W[)>_K
M"OQ$##S]R.3T'QVW//R2<9S3
M
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M9S3 &<)W[\U+_P .7/[5< :/
M
M                                       !FN^OWT\5_P!VJQ^+(!6E
M 1PKP_83_P#.;_'(=N'NPX<[:GP5J/0/-                       L"QO
MV2]_6%?B(&'G[D<GH/CMN>?DDXSFF ,X3OWYJ7_ARY_:K@#1X
M
M
M    ,UWU^^GBO^[58_%D K2@(X5X?L)_^<W^.0[</=APYVU/@K4>@>:
M                 !8%C?LE[^L*_$0,//W(Y/0?';<\_))QG-, 9PG?OS4O
M_#ES^U7 &CP   5OEK.V-<*T]N9?-5)F;)2:X%'BI\HJ$DB/:9MLD9:)(_OU
MJ2CP;M> #(]P_P"94YUYHM6P2\G(ST?JD_QU%X#ZMAK1/YPP'XH/^97))_;=
M%@(.*>FKM-J!DXDM>)['F3)7#P;R :UQ!GW&N;H+TBR:DHZE$23D^B34E'J$
M=!GM)2F]5$I&ID6]M2D\2(SUX +.
M
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M =P
M
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M#I&:&R4HR(U*))Z%[P",W/G'$%F5@[?NF]:32ZTG3K83\I!.M;NCK2(SZO\
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ME 1Q+M0I=#?))&9DI!GH6O E$.S#G2[#BS8UM2K0R,ND>@>:?P5
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MNI6W085J7/;E,E3:'6J(PB ^TJ&PM?5.&P2.L;<22FUDYKXJC/I 4C1R(O\
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M-:RW&K6J5)JE5IU'6M3C5/6_$G-OM,;S4:6E+;-TDZ\#49 -Q@C)'+Y^]AS
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M\*^JJO4VVH+%+75Z73J;%,TH02%*ZOK-#(M%)X:&OI69@/=N:^;!B9?L+(F
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M/"4&EP9,)Y3$ELVW4]*5?]I'X2&S17%4:PPZ[=5$Z3#UA]'R
M     'FCQ7Y3J66$*<<5P2A):F8_%544QK+]TT35.D)M1K/:9VOU31QSI*.7
M%!?SC\/_ &?PC(O9LSPH_P!MNQ@Q'&O_ $E24DDB2DB))%H1%P(B(9C5?T
M9PG?OS4O_#ES^U7 &CP    &<,R<FMAYHO27?-<KM6I]6EL1XQLPE1^H2F,C
M81DEQI2M3+I\8!EO-/()<5A6Y.NZPJZ=S4VELKE5"ER6"CSTQVB-2ULFA2T.
M[4EN-.B%::[=3X ,OX^R'=F+[HA7=9M07!JT-9&>TS-E]K753+Z-2)QM9<%)
M/^$M#(C ?:C&=]4_)E@V_?E+0;42N0VY1L*/4V7>*'FC/P]6XE2-?#H E8
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M^UGFAS_2',7P<<>C6WZH2(]TW%59J)7^[;BZU$<D);-25::&2$J-1<-R2,S
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M+\(![O,WBF^;FMG%-$M6--NJ5;%<A/U>HONMG*6Q':)"Y+ZG%(W*49;E;?"
MZ.7,>7I<',UB"]:-2'9=K6\W**LU)"FR;CFYUFW<2EDH]=2^"DP%I9QH57N?
M#][V[08JIM:JE&FQ($1!I2IU]UI24((UFDB,S/PF"*AAXYSA Y9;%H./ZDY:
MV4+898?D4I]QHF9:6U.=9#>5HM);M4J2>[;J6U1D1ZD5"<H.Y^YC+48Q94\,
M-6M-DOQSJ=WU>6R_%@$RZAQQV%M22R->S:>Q3AF@S3QUU(-B4.FG1:+3:.<A
M<HZ?%8B'*=_UCO4-I;WJZ?&5MU,$>^       #-=]?OIXK_NU6/Q9 *TH"
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M1Y%LVZW3"J<AV4TRXA42J.RG2)M9DI6C:DF6WIZ 5KH$
M      !Z=7I<2MTF?19Y*.#48[T.43:C;6;4A!MKVJ3H:3T4>AET ,K6O9_-
MI@F._9ECLT?)=AH=<=H4FL2SAU&&TXM2NI<-;C9*+4]VA&LOY)I+Q2*E^(,-
MY!7DBH9USC.AR;^E1#IE"H5+-2X-'@J,S4A"U?"69&HN!J+QE&:E*5XH:&!
M                          45S78ON_+./J-;UEL,2*G#N"#5'T27DQT%
M%CM2$+,E*X&9&XG@ O4                       %%6GB^[Z3S37[E6:PP
MFSJ_1(5.ILA+R5/JD1VX:5DIHN*2(V5\3][W0%Z@
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M^:;DG-4FLTW>KR=]F4?5DXI!'IO:,^L0K34M#+H,R,/L$
M
M                                               ,UWU^^GBO^[58
M_%D K2@(      #UIL")4&38EMDXCP&?2D_=(_ /I1<JHG6)?.Y;IKC2J$%K
M5J2H&Y^+K(B%Q,R+\HDO](BZ2]\ALV,NFOA/"6%D855'&.,(X9&72.]G:/X*
M@   #^D1GT"*[M&MF94]KRRZB)T]:HN*B_T"\/\ ".._E4V^'7+NL8E5SCU0
MGM/I<*F-=5$;VZ_#</BM7\)C$N7:KDZRWK5FFW&E,/<'R?8       !G"=^_
M-2_\.7/[5< :/   !#,C8HQ_EBD)HU^T-BK1FMQQ7EZMR8ZEEH:F7VS2X@SX
M:[5:'IQ(P&7*_P#Y;N/9DM3UN7?5J3&5Q*-*98G[>'$B47DYZ?PZ@/6I/^6Q
M93$MMRMWQ4YT)*B-<>+$8AK4DNDNL6I_37^: T[BW".-,-P%P[#HC<*2^DD3
M:HZ9OSY)$>NCKZ]5;=>.Q.B"/H2 L(!GOF!Y2+(SO4(]QN3GK<O!E"8[U6BM
M)D(DQT:[4OLJ4C<I'0A9+2>G ]2).T.5@3DPLK"UPIO*=57KHNJ.A2*;(?83
M%C0S<2:5K;:);AFX:3-.]2^!'P(CX@-,@
M
M                                  #-=]?OIXK_ +M5C\60"M* @
M      C]9M6)4-ST72/+/B>A?DU'[Y%T'[Y#NLY=5'">,,^_ATU\:>$H'.IT
MNGO&S*;-M?@UZ#+W4GX2&U;N4UQK$L*Y:JHG28>H/H^(*/8B0I,UY+$9M3CJ
MNA*?^T_<(?.NN*8UE]*+=5<Z1"<T:T8\3:_4-'Y!<2:Z6TG[_P#*/_R#'O9D
MU<*>$-RQA13QJXRDQ$1%H7 B&<TP          9PG?OS4O\ PY<_M5P!H\
M
M
M             &:[Z_?3Q7_=JL?BR 5I0$          !Z\R%%GLFQ+;)QL_
M=Z2/W2/I(Q^Z*ZJ)UB7SKMTUQI5"#UJTI,+<_"UD12XF1?ZQ!>^1=)>^0V;&
M9%7"KA+#R,*JCC3QAX:-:TNH[7GM8\0^/6*+QE%_HE_]4?J_ETT<(XR_./AU
M7.,\(3N!38=-:ZF(V2"/X2NE2C]TS&-<NU5SK+=MVJ;<:4P]L?)]0
M    &8LKV[FRB<P\#*^,++C7; ;M,K?=3*J#$!+;ZY[LA9D3CB5&9)V?>FGQ
MC\) /8])O.'ZE*5W_%[0%/2;SA^I2E=_Q>T /2;SA^I2E=_Q>T /2;SA^I2E
M=_Q>T /2;SA^I2E=_P 7M #TF\X?J4I7?\7M #TF\X?J4I7?\7M #TF\X?J4
MI7?\7M #TF\X?J4I7?\ %[0 ])O.'ZE*5W_%[0 ])O.'ZE*5W_%[0 ])O.'Z
ME*5W_%[0 ])O.'ZE*5W_ !>T /2;SA^I2E=_Q>T /2;SA^I2E=_Q>T /2;SA
M^I2E=_Q>T /2;SA^I2E=_P 7M #TF\X?J4I7?\7M #TF\X?J4I7?\7M #TF\
MX?J4I7?\7M #TF\X?J4I7?\ %[0 ])O.'ZE*5W_%[0 ])O.'ZE*5W_%[0 ])
MO.'ZE*5W_%[0 ])O.'ZE*5W_ !>T /2;SA^I2E=_Q>T /2;SA^I2E=_Q>T /
M2;SA^I2E=_Q>T /2;SA^I2E=_P 7M #TF\X?J4I7?\7M #TF\X?J4I7?\7M
M#TF\X?J4I7?\7M #TF\X?J4I7?\ %[0 ])O.'ZE*5W_%[0 ])O.'ZE*5W_%[
M0 ])O.'ZE*5W_%[0 ])O.'ZE*5W_ !>T /2;SA^I2E=_Q>T /2;SA^I2E=_Q
M>T /2;SA^I2E=_Q>T /2;SA^I2E=_P 7M #TF\X?J4I7?\7M #TF\X?J4I7?
M\7M #TF\X?J4I7?\7M #TF\X?J4I7?\ %[0 ])O.'ZE*5W_%[0 ])O.'ZE*5
MW_%[0 ])O.'ZE*5W_%[0 ])O.'ZE*5W_ !>T /2;SA^I2E=_Q>T /2;SA^I2
ME=_Q>T /2;SA^I2E=_Q>T /2;SA^I2E=_P 7M #TF\X?J4I7?\7M #TF\X?J
M4I7?\7M #TF\X?J4I7?\7M #TF\X?J4I7?\ %[0 ])O.'ZE*5W_%[0 ])O.'
MZE*5W_%[0 ])O.'ZE*5W_%[0 ])O.'ZE*5W_ !>T /2;SA^I2E=_Q>T /2;S
MA^I2E=_Q>T /2;SA^I2E=_Q>T /2;SA^I2E=_P 7M #TF\X?J4I7?\7M #TF
M\X?J4I7?\7M #TF\X?J4I7?\7M #TF\X?J4I7?\ %[0 ])O.'ZE*5W_%[0 ]
M)O.'ZE*5W_%[0 ])O.'ZE*5W_%[0 ])O.'ZE*5W_ !>T /2;SA^I2E=_Q>T
M/2;SA^I2E=_Q>T /2;SA^I2E=_Q>T /2;SA^I2E=_P 7M #TF\X?J4I7?\7M
M #TF\X?J4I7?\7M #TF\X?J4I7?\7M #TF\X?J4I7?\ %[0 ])O.'ZE*5W_%
M[0 ])O.'ZE*5W_%[0 ])O.'ZE*5W_%[0 ])O.'ZE*5W_ !>T /2;SA^I2E=_
MQ>T /2;SA^I2E=_Q>T /2;SA^I2E=_Q>T /2;SA^I2E=_P 7M #TF\X?J4I7
M?\7M #TF\X?J4I7?\7M #TF\X?J4I7?\7M #TF\X?J4I7?\ %[0 ])O.'ZE*
M5W_%[0 ])O.'ZE*5W_%[0 ])O.'ZE*5W_%[0 ])O.'ZE*5W_ !>T /2;SA^I
M2E=_Q>T /2;SA^I2E=_Q>T /2;SA^I2E=_Q>T /2;SA^I2E=_P 7M #TF\X?
MJ4I7?\7M ''M2@Y]O3F(L[)>1["BVK1;>IE1IKKT6IQIQ*\J:<V&:4.&O7>L
MD\$@C5H
M
M
M
M
M
M
M
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M[4 ])F.//"B=Y1.U /29CCSPHG>43M0#TF8X\\*)WE$[4 ])F.//"B=Y1.U
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M;6I1D1<3X .\ C%\_LEG^LI_$6-' W)Y>3,^1VXY_B5?C<>?
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M*'+MZOJ;]U_M0-3V4.7;U?4W[K_:@:GLH<NWJ^IOW7^U U/90Y=O5]3?NO\
M:@:GLH<NWJ^IOW7^U U/90Y=O5]3?NO]J!J>RAR[>KZF_=?[4#4]E#EV]7U-
M^Z_VH&I[*'+MZOJ;]U_M0-3V4.7;U?4W[K_:@:GLH<NWJ^IOW7^U U/90Y=O
M5]3?NO\ :@:GLH<NWJ^IOW7^U U/90Y=O5]3?NO]J!J>RAR[>KZF_=?[4#4]
ME#EV]7U-^Z_VH&I[*'+MZOJ;]U_M0-3V4.7;U?4W[K_:@:GLH<NWJ^IOW7^U
M U/90Y=O5]3?NO\ :@:GLH<NWJ^IOW7^U U/90Y=O5]3?NO]J!J>RAR[>KZF
M_=?[4#4]E#EV]7U-^Z_VH&I[*'+MZOJ;]U_M0-3V4.7;U?4W[K_:@:GLH<NW
MJ^IOW7^U U/90Y=O5]3?NO\ :@:GLH<NWJ^IOW7^U U/90Y=O5]3?NO]J!J>
MRAR[>KZF_=?[4#4]E#EV]7U-^Z_VH&I[*'+MZOJ;]U_M0-3V4.7;U?4W[K_:
M@:GLH<NWJ^IOW7^U U/90Y=O5]3?NO\ :@:GLH<NWJ^IOW7^U U/90Y=O5]3
M?NO]J!J>RAR[>KZF_=?[4#4]E#EV]7U-^Z_VH&I[*'+MZOJ;]U_M0-3V4.7;
MU?4W[K_:@:GLH<NWJ^IOW7^U U/90Y=O5]3?NO\ :@:GLH<NWJ^IOW7^U U/
M90Y=O5]3?NO]J!J>RAR[>KZF_=?[4#4]E#EV]7U-^Z_VH&I[*'+MZOJ;]U_M
M0-3V4.7;U?4W[K_:@:GLH<NWJ^IOW7^U U/90Y=O5]3?NO\ :@:GLH<NWJ^I
MOW7^U U/90Y=O5]3?NO]J!J>RAR[>KZF_=?[4#4]E#EV]7U-^Z_VH&I[*'+M
MZOJ;]U_M0-3V4.7;U?4W[K_:@:GLH<NWJ^IOW7^U U/90Y=O5]3?NO\ :@:G
MLH<NWJ^IOW7^U U/90Y=O5]3?NO]J!J>RAR[>KZF_=?[4#4]E#EV]7U-^Z_V
MH&I[*'+MZOJ;]U_M0-3V4.7;U?4W[K_:@:GLH<NWJ^IOW7^U U5*>-;$QKSB
M8SIMBT*-0X4N@5B3):C;]''B:?02CWJ4>I)X -? B,7S^R6?ZRG\18T<#<GE
MY,SY';CG^)5^-QY\                      %FVG^P(G^T_I%#SN7NST['
MIL+9CQ^[M#D=H SA._?FI?\ ARY_:K@#1X
M
M                                                 ,UWU^^GBO\
MNU6/Q9 *TH"(Q?/[)9_K*?Q%C1P-R>7DS/D=N.?XE7XW'GP
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M97IF&,].0:NJZ&G7[.O6EL^2M276"W.1GVB2A*5EIH6U):*-)>,2R,@TL"
M S7?7[Z>*_[M5C\60"M* B,7S^R6?ZRG\18T<#<GEY,SY';CG^)5^-QY\
M    ! \BYCL'%+M.9O::_$<JJ'7(1,1G))*2P:4KUV=&AK(<UW(IMSQ=-G'K
MNZ^GL0CVOL$?3,[NY\?#WUM]_87?\'M?8(^F9W=SX>^MGL+O^%BX]R7:&4:5
M*K5F2G9=/A2/(Y"WV%QE$]L2YH25\3+:HN(Z;5ZFY&L.:]9JM3I4EP^[X
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MS8>><GX_R;>]PV-6ZC5W:W;+E,JI4:'5(,YQUXE&M2%H6ZDE)T\;7X1%Q29
M.W?^-<#PKRM/&RKUOS(5SUVH-*C42%7HM29AFTKA)E=:UL;))&H_Y1()1\"Z
M0M7-J>7[(N5*?BW*3$^W+YAP4SK<O)+J*6VZTX>XV(\TUF2E$K?HAUK:2B42
M3W'HH(O8-SW?BOF$MK#-.R(]E*R[C@2'I34]:)=0HIQ6G5MJ5);4O@9-)+:I
M1%M5\ CVF8="@W%0+9YY,C/7'5(M(9FVM3T0W:@\W%;=4E$$S2A;II29D25<
M"/P'[A@-8,/L2F&Y,9Q#T9Y"7&7FU$M"T++5*DJ+4C(R/4C($9<O[]^S%/\
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M5S$3VH/R.$18XN;:7B?/RB29=&A1&>@Q^,#_ )GF^GR7_<<FG1J,H
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MP 6. C5S8^LZ\:K;];N:DMU"J6M*^<*!)<4XE465N0KK$DA22,]6T'HLC+@
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MD1)2DBT(B(N@B!'KU.FP:S39E(JC"95,J##L2;&<+5#K#Z#;<0HO<4DS(P'
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M]5J:NCJU>X8*WI4)L&FP)51J;[<:FQ&G'YDE]1(9;8:2:EK6I7 DI21F9GX
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MBVI9MWV/*OBX[@HMV4TZ.E-8E)DG3HYM/,GY(1IVH,TN\>&GBIX /)6J%CW
M_+P[;%VPYMSXZH4/R*IL]0W*DO1ID@]5K;2;22)*W==R3+81;O!J"JLLSE:L
M*X;;8J>/\L74QA^M-IF+MR%4DIBFTLB6ME;B2\33BEQ"T;T\24>H#T>5:B6]
M[0F8*QCR,PSC6DL0+>I+L,]T53C"4)432]RNLU4PXM3FX]VXE:^,0"U;]Y7[
M:NB[I&0K.N*LX]OB<6E3J=N2/)VYG R4I]G@2EJX:J2HM3XF1JX@.IBCETM#
M%];FWD]4*C=F0:BA3<RZJ^_Y5,)M1ZJ2UP(FR,M",^*M.&[3@".Y1</T6B9B
MN3,S$^4Y6[EI\>ERJ>OJ_)6FXR6$DI&B27N/R=.NJO"8#]9FQ%1LU6DS:%<G
MRJ=#9GQZDF1"ZOK3<BDLB2?6)46A[SUX +# 5QF#"%BYLHT>EW<P\U-IZS>I
M%:@K)B?#=5IJ;3ADHM%;2W)4DTGH1])$9!6E.Y/:#)-*LAWQ<=^E"8<8H<:N
M2NNB05N-+:2^EE6\ENMDK5!J/0C+X)@NJT<;XAMO'6,(N)T*77+;8:EQWRJ:
M6UG(:G/./.H<2E))-)]:I.FG0"*E7R:4RFE+I-D9(NVT[)GK4N5:]/G;HI$X
M>JTM*5Q2D]?O]Y^Z9@JX<>X@L#&-F+L.U:2ANWY*7"J2)/\ O#DU;Z.K=7)4
MHORAK26TRTV[?%(B+@"*<=Y,:- \NI-F9$NNU;&JBUKG6I3YNL,TNGXZ&S66
MJ4F1Z>.2STZ3,%6/4.7^QG<+2L&44GJ+:DIE#*Y$8TKEFM+Z)"GEK<29+<<6
MCQC,O>(B(B(B.+F0L58VP5 M;*5/FUS'<5BG6X\XPP3\AOJ62:8E.&A39MFD
MVB/K$<269$1<= %>T/E.L1RWF'598N2K81-!SV;?.K);HZX9$9Z./M&E/4DG
MX6TD?PD8*\/)9 IDVHYFN2V(I1; K%Q^26PIILFF3AP^OVDTGP)2V\UI_P!^
MH"\L*8>HN$+-79E!GRJE!7-?J!R)W5];OD$A)I_)I26A$@O "/W6,14:LY@M
M[,CT^4W6K=IK])C4]'5^2N-22>(UKU3OW%UZNA7@(!88"B\H<KEH9!NQO(="
MK%4L;(:22EZX+?>ZAR0E!$DC>1PW*(B(MR5),R(B5N(BT",5+DFL*N49]JX;
MDKM:O"9*CRIUXU*0B74E-1E+449OK4J2TRHU[E$GQC,B\;0M 5:V1,/T7(]V
M6'=M3GRHDRP:@NJ4]B-U?52''%,J-+V])GMU83\$RZ3!$SN*C,7';]5MZ4XM
MJ-5H<B \ZUIUB&Y32FE*3J1EJ1*U+4!$+'P_:UFXHAX?D)57[5CQY$-]%22A
M2I#,M]Q]9.$@DEP-T]NW0RT+P\0%01N2NBTI4BCV[DB[Z+C^8YUDNTH<_9'4
MDSW*;)S3X)GTZH-6G29](*L'&W+I8V*+\K%[6<IZ$S5:;&I"*&6SR..S%)HM
MZ%&1N*6M36]:EK,S4I1^$$6\9$9&1EJ1\#(P&;:AR>4.%5JI.QK?5RX]I=<6
MIVK4.AR]L%:W-=QMI/0V]2/0BU42>A.A< 5;&,<0V3B6T5V9:L1:J;(<=?J4
MB<HI$F:^^1)6Y(7M22C-)$G0DDG0N@$5_8?*O;F,[S8N6R[NN.G6\Q)=F%9G
MEN^C*6\A:#2IK:1J26[5.XS5P+4S!4VQSA^BXVN:^[HID^5,EW[4_GBH,R>K
MZMAW>\O8SL21[=7E?",SX$"/[F#"UE9LM]FA7>T\V[!=.32:M"63,V$^9$1K
M:69*+16A;DJ2:3T+PD1D%3/\E]!KU*E4Z_[^N>\G"BG$H;E7E]<U3->'7,LJ
MW)4\2?%)2]2T/X.NAD5;\;$%G*Q1!P[78YURT8=.8I2DS-"=<;C)22'#4ULV
MN)-)*2I&AI5Q($4X7)=3C@E:J\GW@K&Q'H5H^6I\GZG7_4[]NFSP:=6"K\I&
M/[.H5DIQU2J2S'LQ,-VG'2D[NK5&D)4EU*E&>Y1N;U&M1JW&9F>NH(K+%G+-
M2,17,S5[8O.Y7K<C(D(BVC.FD]2F_*DZ&?5I0@C-)^,D]-=?_*'IWURJ6W<E
M[R<C69=%;Q[>%1U^=YEO2.I;EJ5\);C?#1:OOC)6AGXQIW:F97BM?E$L.T[Z
MM?(D*L5>7<]O'(>FSZ@^F5(JLJ2VIHW9;JT[O%2K:A+>TB(BZ3U,PG=.PW1*
M;FFKYM:J$M==K%+11GJ<KJ_)$--]1XZ=$[]WY!/2K3B8(D&0<>VGE"U9MG7G
M 3/HLTB,TZ[767D? >9<+BAQ!GXJB]\CU29D84;2.3.AQO)Z-<&0;KN''T-U
M+L:S)DXT4]24*U2T]U>F]OP&E!(_B!=4^QMR_6OC"D7M1:'.E.0;VD/R9+2T
MLH3$*0VMKJXZ6T$1(0E>B25KT$ [N&\44C"]BQ;#H<Z34:?%??D)E3>KZXU2
M5FXHCZM*4Z$9\. (]G+>-*7EZP:KCZLS)$"G54XYNRH>SKD'&?;D)V]82D\5
M-D1ZET ));M&8MRWZ5;T5Q;L:DPX\!EUW3K%MQ6DM)4K0B+4R3J>@"'8YQ%1
ML;W'?-R4R?*F2K[JIUF>S)ZOJV'5*=7L:V)(]NKI_"U/H ,@XBHV0[ML.[ZE
M/E1)E@SW:E3X\?J^JD./&R9I=WI,]"ZE/P3+P@/1S#@2QLSM0)%?\JIER4@U
M'1[DI#I1:C&W<=I.;5$I&[QMJBX'\$TZGJ$%MWE#MENY(%T9*NVO9*G4E:'*
M5$N*3UL%E3>II-3/C;]#T/12MIZ>,DP5<.1,=6EE.U9=G7K 3/HTO19%KL>8
M?01['F7"XH<1J>BB]\C(TF9&12-(Y-:''5%I5RY NJYK!@.I=AV;/G:4XR;4
M2DMODC3>V6FFU)(!5E8;PC;N%HMQ0[>F2)<:XZDNJO-2$M(0PIPMO5-):0DB
M0DN!$8(@-7Y1*%'K=1K.,+UN'&[596IVJTJ@2=E/<6OI-MKQ>KU]PE&1="2(
MN *L+$&#+'PM3YK%L-R)=9JRTNUJOU)WRFHS7$ZF1N.:)(DD:E&24I(M3U/4
M^((]3'>";?QP5^%3*G,EE?\ .D5&H>4]5_NZY/6[DL[$)X%UIZ;M? "N7;O+
M;;%MX0JV#(M7GO4&K^4==4G.I\L1Y4M*U;=$$CAMX:I +JY;K8NS"M$PA+J\
M]BA4/R3J*BUU/E:_(B42=^Y!HX[CUT2 N*'&1"B1X;9FI$=M#25*Z3)M))(S
M^X"*RQUB>W\'TN]:A3)$^LLU^=+N*?%<;;=>ZQ2%*4RPAM*-VI%HE*N)GX05
M0>.\+XERVU4,@<OV0;DL"FU1YQJX;9I$E,;J734>J%QR49L[R\9'C+1H?B:%
MXI!R;;Q[8MK\XMB6?C USF;/I%3GWG47'/*Y9U"8W)0I<V1H6YY1NLI/P)W$
M6A<2 ;F!                        &:[Z_?3Q7_=JL?BR 5I0$1B^?V2S
M_64_B+&C@;D\O)F?([<<_P 2K\;CSX       "CN97$5=R-1:/<5DN=7?EI/
M*E4Q!*)I<AI2D.&AM9F1$ZA;:7&]QZ=)=)D.#+LS7$54]<-##OQ;F::NJI2N
M:KDR!'K.%<@U:@OS+RIE/.=5:?Y*ZR7ES$P]4.-MIU0:MI&:2TZ> S[M5>M-
M4QQ:-BBCTUTQ/"4SQ#8^3LFY4:SOEV&JD1J8WMMJB.-J85KM436QE9[T,M;U
M.;G/&6L]>/$=%BW7<K]=;FR+MNU;_71V];5 UV.         +-M/]@1/]I_2
M*'G<O=GIV/386S'C]W:'([0!G"=^_-2_\.7/[5< :/      'KSX,2IP9--G
MM$_!F-.1Y3"O@N,NI-"TGIX#(S(!4!<I?+F1$18_I_#W5R3_ /OH+JLRTK0M
MJQ*!%M>T:<W2J!"-PXL%DU&V@WG%.KT-9J/QEK4H]3\(([8"EZ[RF<O=Q5UR
MXJG9$7YQ><4])3&>DQ([KB^)J4RPZAO77B>U):GTZ@+;I%(I5 ID6BT.$Q3J
M1!;2S#@Q6TLL--)Z$H0@B(B+W@'N@         #PRXD6?%?@SF&Y,*2VMF3&
M>0EQIUIQ)I6A:%$9*2HC,C(RT,@&=)_(]@Z5,DOP$UJC4^8LUR*/3:FXU!5K
MTEU:TN*T/W-_\&@+JNZQ[#M+&]N1K4LJEM4FAQ34I$=K52EN+^$XXM9J6M:M
M.*EJ,^@N@B!$C               !SZY0Z/<M(F4"X(3-2HU0:4Q-@R4$XTZ
MVKI)23^Z7N'Q(!GMWD9P:M]PFOGR-1G7#=706:JZ5/T,]=FTR-S;Q_\ $U]\
M%U7_ &U;5!L^APK:MBGLTNA4YLF84&,G:VVC74_?,S,S4I2C,U&9F9F9@CJ@
M                                                         "A;
MQY/\,7?<$FYVXM0MNL3C4NH.6],5 ;D.+,S4M;>U:"4HS/=L2G7I/B"ZIUBS
M"V.\.4Z1 L:E%%?FF2JC4Y"U2)TI23,R-UY>IF1:GHE.B2Z=-3,$6
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M/M_& /GVB?247\^W\8 ^?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?247\^W\8
M^?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?247\^W\8 ^?:)])1?S[?Q@#Y]HGT
ME%_/M_& /GVB?247\^W\8 ^?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?247\^W
M\8 ^?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?247\^W\8 ^?:)])1?S[?Q@#Y]
MHGTE%_/M_& /GVB?247\^W\8 ^?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?247
M\^W\8 ^?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?247\^W\8 ^?:)])1?S[?Q@
M#Y]HGTE%_/M_& /GVB?247\^W\8 ^?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?
M247\^W\8 ^?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?247\^W\8 ^?:)])1?S[
M?Q@#Y]HGTE%_/M_& /GVB?247\^W\8 ^?:)])1?S[?Q@#Y]HGTE%_/M_& /G
MVB?247\^W\8 ^?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?247\^W\8 ^?:)])1
M?S[?Q@#Y]HGTE%_/M_& /GVB?247\^W\8 ^?:)])1?S[?Q@#Y]HGTE%_/M_&
M /GVB?247\^W\8 ^?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?247\^W\8 ^?:)
M])1?S[?Q@#Y]HGTE%_/M_& /GVB?247\^W\8 ^?:)])1?S[?Q@#Y]HGTE%_/
MM_& /GVB?247\^W\8 ^?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?247\^W\8 ^
M?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?247\^W\8 ^?:)])1?S[?Q@#Y]HGTE
M%_/M_& /GVB?247\^W\8 ^?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?247\^W\
M8 ^?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?247\^W\8 ^?:)])1?S[?Q@#Y]H
MGTE%_/M_& /GVB?247\^W\8 ^?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?247\
M^W\8 ^?:)])1?S[?Q@#Y]HGTE%_/M_& /GVB?247\^W\8 ^?:)])1?S[?Q@#
MY]HGTE%_/M_& 9UO&7$F<Z&+'(C[<ALK;K*34TM+A$>Q\]#VF8*TT"(Q?/[)
M9_K*?Q%C1P-R>7DS/D=N.?XE7XW'GP        !5_,=_T+O?^I-_\4R./+VI
M=F'O4G+C_P!"[(_J3G_%/!B;4&9O5+0'8XP        !9MI_L")_M/Z10\[E
M[L].QZ;"V8\?N[0Y': *HR;RWXCR_7X]S7Y1WI]8C1$4]E]J;*BD49MQQU*=
MK#B$GHIU9ZZ:\0$+]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<
M ]AOEN\V97>M0[< ]AOEN\V97>M0[< ]AOEN\V97>M0[<!)\?\K6%\871%O*
MS:(_"K\-#S4>0Y.ER4I3(;-M?B/.K2>J5&70 N0!&+Y_9+/]93^(L:.!N3R\
MF9\CMQS_ !*OQN//@       /%)DQH49Z9-?;C0XZ%.R)+ZTM--MH+52EK69
M)2DO"9F/S,Q$:RL1,\(49=?,ORZ5%B9:E?JJJW2)9$S.0S"DO0W$DHE$1K(D
M&HB41'JCW!P7,JU5&D\8:%O#OQ/JCA*S<=5C'U6M:*C&<N'(M6#JQ'8@*5MC
M&HS6;:VW-'&U&9FK19$9](Z;-5$TZ4=3EO4W(J_]]:5CH?          6;:?
M[ B?[3^D4/.Y>[/3L>FPMF/'[NT.1V@
M
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M
M
M                    !&+Y_9+/]93^(L:.!N3R\F9\CMQS_$J_&X\^
M    HSF6Q'7\B4>C7-8Z]E^6B\J536TK)MQ]E2DN&AM1F1$ZA;:7&]>GB729
M#/R[,U1%5/7#0P[]-$S35U5+'Q56;GN2PZ!5[YBJ@W7*0XFL1ELG$4AUI];6
MJFE$1H-24DHRZ./#@.BS55-$35UN>_333<F*>I0F,K!R;D;-"LS918<I](M]
MUYBVH+S9QC=ZA2VV":85XR64;C=-Q7PU]&NIZ<%FU7<N>NOJAH7[MNW:_71U
MRU.-=C@        "S;3_ &!$_P!I_2*'G<O=GIV/386S'C]W:'([0
M
M
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M[M#D=H SA._?FI?^'+G]JN -'@
M
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MK0ST46O$C >4
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M:=3\!& A=N<VG+W=-910:7>T5-0><)F-Y8S)A,NK5T$EV0TVCB? B4HC,^!
M)YD')UBXJI$>O7_6$4:DRI"84>2XT^\2Y"T+<)!)8;<5\%M1]&G !QZ;F_%-
MRW%2K(H=TL3;FN&#\XTZ'#)U3ODCD8Y*7%J)&UE75>.2'32OH\4!F3E3IF*,
M5UG)5Y0LM%=5+A1NMK#?D,Z,4>*4A2O*Y77)/K7C41H_)$?2H]3W<"J,QQ>5
M&S+S*?7/*U^/TJ/!K469:$%+;\AF2\W4$'#A-))*DLL[2+<9I+774SU,S :#
MLVQ[!8YU:Q<T/**IUV&]4'7+-*',1))QR*HG8SLI1=0IAE*MZ"2?WJ2T\74!
MI+(^:\78E)@K_N2-2)4I"G8L(R<?ENMI,RW)982M>TS(TDHTDG7AJ"/#C?.F
M*<M+>8L*Y8]3GQT$Z_3U)<C3$-GPW=2^E"U)(^!J21D7#4^) .CD3+..\40&
M:C?]?C49F4HT1&G-SLA\TEJ?5LM)6XHB^^42=I:EJ9:D AT#FLP#4;<E74Q>
MD9-)@N,LS=[$I,AE<DS)O='ZDW=JC(RWD@T^Z8"$\R7,O3;+P]2[NQI<4<K@
MNA3<BUG'8CCJ9<-EY"92B0^V1)V)67^L))^X ]SEXYA[;S!8M+M>O74AS+<R
MG37JU&A1W8KS"4.N()U"DM$RE2&E-J+:KI\'2"H3R1V78=MU2^YEE9,^O9OK
MCIE168<N"TRTM;JF7WBE$6]YS:LM4:DDB/B>[@%W7_S)84QE5%T.[[LC1JVW
MH;U.C(>FOM;N@G4QT.=6?AVK,CTXZ B56%DZP<H4UVK6#7XM<A1UDW)..I27
M65JU-).M.$EQ&[0]N]):Z< $<G<Q.%J9<]5LZI7?%A7%1$/N56+);D,H83%0
M3CFKRVB:,R(^!)69J/@G4^ #T[+YF\&9 KS=LVO>$:37)"C;B1'VI$0Y"B^]
M95(;;2M1^!)'N/W '3R5GC%N(JC2:3?M<33)]:/6(R3+SYI:W;#>=ZI"B0V2
MN&Y7\70>@6,A:'$)<;42VUD2DJ2>I&1\2,C(!E_-%\9H=YA[4Q!C&ZXMLPZ[
M;[E3==F4^//1Y1'=EJ49FXA2_&0PE)$1Z KD7ID'F1Y<CI-X9/KE'O\ QM+F
MM4ZM*A0DTVH0>O,S2ZT3:4)5P2KX6[4_%T3J2B#1%:ROCJW*]"MJO7%$IU9J
M$!RKQ&)*E-H53V$K6M\W33U:4$EI9^.LN@$>:R,EV-D>A2KFLNLM52@0GW8D
MFH)2XRTAZ.A+CA&;Z6ST2E:5;O@Z'T@()+YL>7:%5%TA^_Z><QMSJ5J:3(>C
M[R/3A(;:4R9?Z1+T]\!8==OZS;;M%V_:Q6HK-FLMM/+K3:_*(IMR'$--*2MG
M?N):UI2DTZZZ@,]<M/-;0KZH4:CY+NF G(]3K#T&E4UF.MA3T=9H*,1$V@T$
M:E&HB-2O<!5ZW_EG'&+8[$F_KCB41,HS*,R^I2Y#I%TFAEI*W%)+PJ)&A CU
M<?YJQ7E-V1'L&Z(=9F14[WX:.L8DI;UTW]2^AMPT:\#42=/? =V\KZL_'M&7
M<%ZUF+1*0A1(\IEN$C>X?0AM):J6H^G:A)G[P"'V7S&82R%6$4"T;SA3ZT[_
M *B"LGHCKIE]ZT4EMKK%?Z*-3 5ES+<R2<6779=KV[7X42H.U>)]<XLF.I]<
M>BR#29O&>TR26W<>J-5=' %=[*-YXKS5@VZY%%R0=!M2(['CU6ZZ>V^LHKO7
M,J2TXUHTXM#AK0@TI,M=W3T@+4LGYIM_'%OK.OJJM#I]'BK*YJBX2#DQ6XZ5
M%+>6X9;26C\H9J/@728(@;?-GRZ.U(J4G(%/*4;G5$M2)"(V[737RA31,[?]
M+K-OO@+2JURT&AV]*NNJ3VF+<AQCGR*D1]8RF*E.\W2-O=N3MXD:==0%;5KF
MCP%;\6F3*I>\-MJKL)F0$M-R7W%1W%&E+BVVFEK;(S(].L2D^ "P;1O.U;]H
MC-R6;5HU:HD@S2W,B+WI):=-R%%P4A9:\4*(E%X2 =T!6U^9^P[C*J)HE[W=
M#I=9-!.*@:/29"$++5)N-QFW5(W$>J=Y%J7$@'FAYVQ%48]N2H%VPI3%VS#I
M=OK9-QSRB<E3:38,DH,VW"-UOQ7=I^,7N@.E<65<=6E<+5JW/<42DUUZ"Y5T
M1IBC:3Y QUF]Y3JBZM*2ZI?PEET (M:O,W@B]*\Q;%N7K"DUN4OJ8D9U$B*3
M[A]"&ER&FT+49\$I2K51]&H"TITZ%3(;]1J4EJ'3XJ%/29<A:6F6FT%JI:UK
M,DI21<3,S 5/2^:?E]K-::M^GW[3UU-]SJ&2<)]AA;AGH1%(=:0R>I\$^/Q\
M "#<K=Q7-6K_ ,[P;@JTVI,4B['8M-CS7W'T164ORTDVRE9F2$$2$EM3PX$"
MKUR%$BS[#N:'.J[UOPGJ7-3)KD4S2]":ZA>^0@RXZMIU7PX\ 16N'JK86*>7
MVEUV3?KERV)34NN'>,UMY"5H=FJ8)*6CZQQ"$.JZI*#-1E_  Z%?YI, VS,C
MP*Q?,)J7(99DH;91(DFEJ0@G&S<-AIPFS-*B5M7HHB,M2 22OYFQ7;%J0+XK
MEV4Z-:M4+6F5%+W7(E>Z3"6B6MPT_?$A)FGPZ /SCO-&+LKG);L"Y8M9DPTD
MY*B()QF2VV9D6\V7T-KV:F1;B3MUX:@//7\N8UM:X7K5N.Y(E,KT> NL/Q)1
MJ;)$!O7<\IPT["+Q3X;M3\! (_9W,G@Z_JZU;5JWG#FUQ\S3&AN(?BJ>47':
MT<EMLEJ]Q*3,S]P!^+LYF,%617WK8N6]842N15]5+BMH?E=0X72AU<=IQ"%$
M?!25*(R\) +#AW+;]1M]-UT^I1YEMKCJFMU2,XEZ.J,A)J4XE:-2,B(CUT >
MM9MZVOD&@1[HLZI-U:@2E.(8FLI6E"E,K-M9:.)2HM%$9<2 >LK(EEIOA.-E
M5=HKX7%\O31MKG6G%(C/?NV[.@NC=J X%6SWAZ@OW#%K-WP84FU7&F*\R\;B
M5L.R#,FT$G9JXH]I^*UN/@ 8^SUB'*4YVEV+=42J55E)N*@:.QI)MIZ5H:D(
M;4M)>$T$>GAT 2RZKNMBQZ,]<-WU:-1:+',B<FS7$M-[E:[4)UXJ4K3Q4IU4
M?@(! ;4YF<$7M6F+=MN]X,JLRE$W%BO)?B&\X9Z$AM4EII*UF?P4I,S/P +3
ME2HT&,]-FO-QH<9M3TB0\HFVFVFR-2EK4HR)*4D6IF? B 5%"YJ^7JH5EN@Q
M;^IRJ@Z[U#9K)]J,;AGH6DEQI+.AGT*ZS0_= 3ZW+_L^[JO7Z#;E5:J%7M>0
MF'7XK:7$JBR%FLDH4:TI(]3;7Q29EP 1N_,_8=QE4TT2][NATNL&A+BH&CLF
M0A"RU2;C<9MU2-Q'JG>1:EQ(!(+&R-8V2Z6NLV)78M<I[2NK?7%7X[2SXDEU
MM1)6V9EQ(EI+4@' JN?,.T-=Q-5>\(,)ZU'VHE>9>-Q+C$A\U$AM*#1N=4>Q
M7!DEZ:'J _>/<[XDRI+>IUB73%JM380;KD#1V-)ZLCT-:6I"&UJ27A-)&1<-
M>D!"KZM^VIO,IC^KS<C3*-<T:GOE3;"92X;-2:3Y0MQWK$GL02B)1.I4DS63
M9::: JSK\R986,::U5K]K\6API"S;C')49N/+3H:B::02G%[2,MVQ)Z>$$<2
MPL\X@R=4%TBQKMAU6K(2;GD!=;&DJ0DM5*0U(0TM9)+X1H(]/" AMW6Y;4OF
M=LBM2LBS:7=#%*D?-^/VDN&Q/82F2:W=Y'U:4F1*-Q"DF:^K+0RT!4!G<WEN
MTWF)DVS.NZG,XBATEPI,HXSAK16V73;6SUI-FLS+0^!%MT\("_J-F+&EP5^D
MVO1[BCRJ]7:<FM4>$2'4JDT]Q*E$\VI:$I,M$*X:[BVGJ7 $2.Y+DH5GT*=<
MUS3FZ;0J:WUTZ:]KL;;U).I[2,SU,R(B(M3,!^[?K](NFB0+CH,DIE%JC*)4
M"6E*T)=8=+<A9)<2E6AEQ+4@%,7U;]M3>93']7FY&F4:YHU/?*FV$REPV:DT
MGRA;CO6)/8@E$2B=2I)FLFRTTT!4]KN:L56S6:U;]PW3"IE8MZ(W4*Q&E*6T
M;$=[J^K5N4G:I2^M1M0@S6>XM"!'-L7F(PODJK_,%F7?$J%;,E*;@+2]%>=)
M'3U29+;76&1>-HC4]./0 LX          9KOK]]/%?\ =JL?BR 5I0$1B^?V
M2S_64_B+&C@;D\O)F?([<<_Q*OQN//@       *<SG2L]5*10SPK4DT^.VW(
M*M$IZ*SO<4I'4G_O"5:Z$2_@C@R:;LS'H=^+59B)_8J,[6YZC(R^LC?'APET
MTC_HQR>C)Z:.SUXG=])2S"O+K=- O965,MUE-9O-.]4&.AY4LVWG$FV;S[ZR
M(E*2@]K:$>*GIUX$0^V/BU15ZJ^M\<G+IFGT41P:3&HR@        !9MI_L"
M)_M/Z10\[E[L].QZ;"V8\?N[0Y': ,X3OWYJ7_ARY_:K@#1X   /A5DC_J)=
M_P#SJI?\6X UWRN\HN+<RXHC7M=DJL,UAV;+BK13Y3#+&R.LB29)<CN'KH?'
MQ@%S_P#R[\$?I]Q_+HOZF ?_ "[\$?I]Q_+HOZF OC$>);9PM:)67:3TQ^DE
M*>FDNHNH>?ZR1MW%N;;:+:6TM/% 3L      ?/J.POE[Y\41VDJ8M/(R]K2$
MD3;1IKJ^"2(O%T;GHT(O G^$%>2 POF#Y[YDQTCD6EC99[4J43C9%1%]6@DZ
M\#)R<LW-"Z4Z_P (#C\^%RRJUG*RK JD:H3[1I\2).>HM,/_ 'J8[.E.(>\G
M+:HC=4TTEILS2K:>NA<3(PAF5/J#?-FJH5@<NURVI=<4VETRK1(<A9;4*(G$
M24DT:G4J;W>,H]Q*T/734C"2YPJ=W5'DCQL5\Q9D2Y(%P%3GVZDVXS*4U#9G
MM,*<2ZE*]>J2@M5=/3X0&@N5/EJQW9UK67EE*),Z_P"HTINH+J+S[A,M?.D;
M53:&2,D:);<V:J(S\((HKD-H-'N>Z\N6_7X;<^BU&(Q'FPGB,VW6E2GM4JT,
MCT,%<_DGQ]95UY@OUJX:)&GMVZXB90DNDK_='V)ZB;4WHHO@[4].O0 [^.?_
M *16Y/ZQ5O\ @# <3E]M.A\Q_,KD&Y<KL'6FZ;Y1*BTF0M?4:^5%&8;4DCU-
MIAHMJ4:Z:Z:Z^$-'.<E]D4?*5)R?CFL2[*D4QYF1\SP&TO1%K;,R=276+W(;
M>;/JW$%PXGITZ ,YRK<A\PG/-7K7R(^Z_;=$>EQX]-2XIHEQ*.C:W'09<4I<
M69NN;=#/56AD9ZD$AYV^73%U@8Z@7Y8=*;MVHL5!BFRXD9:SCRV)*'%%JAQ2
MM'$*;)1&GI+777@9!Z^5K<H4[D*L.Y9D!I^OT>+"8I=07KUL=N;+(GR09&1?
ME"0DE:D NCD]QE8,##%J9'AT&,S?$ZFSFI=;22O*'$'*>;,E>-MXI;271X &
M<N3&YYUEXYS_ '92T[JG1J/'FPN!&1/LLU!3:C(R,C)*M%'[P(E7)1@/'F5+
M1N#)F2X)736I=7D0$,SG'%-MFAIJ0Z\O:LC6ZZI_BI>NA$6G28*XK%"C<O'/
M)0[7QR\[%M>X784>72>M4ZA,6KEL6PLU'JI+;A$\WO,S3HGB?A#E-8]MK)_/
MI<=JW<RJ50%U*;,E0T+-LGSB1.M0VM2=%$@U$6[:9&9<-0'3YZ,.6#B8K+N_
M&],3;=1F2GV)#,%2D,FN(EMYEY"3,]CB#,^*=->'A(!L"Y,(XWSI2[-NS)-(
M*I5N%!BR$OM.N1B<2\VEY;+J6E))31K,U;?!X#+4]0N!"$-(2VVDD-H(DH0D
MM$DDN!$1%T$0(QEGF=?5.YQL?R\;TJ'6KN1:<@H=/J3QQHRT*=J!.FIPE)T-
M*#49<>D%=FZ\:<R',,ND6KEZ%0K+QM!FMU&KQZ1(5-GSS8X):2HU.)26BE<3
M-.FNXR5H1 .-G6P;>O\ YQ<4V;<+!NVV[;SSLJ DS0AYN N;(0RK:9'U:E-)
M)1>%/ !VN<9N)9>++;QK8T./:]#OBXHM)JOS4RW":**X1J=(TLI26KAI1O/[
MY*32>I&8"]*3@W$='M)NR(UGTMRWD,>3+9D16GG72-.U2W'5)-:G%=)N&K=K
MQ(P10_*E$CT6[\S8%>3\[6#:=8;=H<2>29;;+$MUXU,*)Q)DK0VD*_GDI6FI
MF"O-R(V_0)F(I%6ETJ&_58MR5'R:<[':7(:V$R:=CAI-2=-3TT,!4=H7]3:C
MGC*.0[UQG<>2*O3JP[0[?.ETY%5ATB'"<>:2V:'%)2AU24),CV_RC+BI6H>[
ME"NU&ZKJLZ_<281O2TLBVY58[LBI?,7DL653%;DO,R$QMV\S,TI)2B^ :R,]
M-- LF?0J?EWG6J]OWTVFJ6QCBWXTVA4.01+AJF3"C.*>=:5JE>AR#UW%QVHU
MX)T 6OEOEMQ]E2F06D1D6O<5*DM3*3<=%89CS8ZVE;MNJ4IW)/IT/H41*+B
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M4GL4A9EMZ-=#Z2(!!\]U6MY LKEQQ[5:D\Q2LG/TM=V2&E;79!)CPEJ2:O\
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MC0DH)1FUH6G!Y0#R\SM;1E=6,,(6I+-V-DJ9'K56D,;MR;<AI*2;AEP+:O\
MUB=3Z6M &HH,&)3(4:FP&4QX$-I$>+';+1#;+220A"2]Q*2(B!&6<H?OQ8;_
M .1U+^AG@J/,X^M:_N?2\"NR"W4X5!H$"K1($E).1ERTL0F$+=;5JE9()Y2D
MDHM-VA^ ![_.]9EM6M8MOY0M>F1J)>]N5Z <"JTYI$5XT+WGL6;1)W$2D(4G
M=Q3IPZ3U#7C+ANLMNF6AK2E1E[FI:@CR         ,UWU^^GBO\ NU6/Q9 *
MTH"(Q?/[)9_K*?Q%C1P-R>7DS/D=N.?XE7XW'GP       %,YVK>>*1)H2<+
MTOYQCO-R3K)^3,2=CB5(ZDM7C+;J1JZ!P9-5V)CT-#%HLU1/[%0_7/GF\V/_
M .G0?C#C_9D.W]6+W_64GQU=/-O-OBA1+^H!Q+-=DI369!08C6R/M/4]Z#W)
MXZ<2'TMW+\U1KU/E=MXT4SI/'FDU@5[F$EYMN*EWI339QDUY5Y$Z<=MN(VTA
M1^1JBR"(E.K<+;UA&I7A,R3IP^UJJ]^V8GJ?"[18BU$TS_ZZ=:]QHLX
M  !9MI_L")_M/Z10\[E[L].QZ;"V8\?N[0Y': ,X3OWYJ7_ARY_:K@#1X
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M]/%?]VJQ^+(!6E 1&+Y_9+/]93^(L:.!N3R\F9\CMQS_ !*OQN//@
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MY=GOOUG#=8DJ=ALL*K-MDXK7JB2X293"-?O5&M+J4^#QS\)@-_
M
M                    " 9EQ/0\T6)-LBMONPB=6W*I]2C\78DUC4VGDIU(
ME::FE23,M4F9:D>AD%*QK>YZJ3 3:,:X[1J45M*([%XS$R#J*64IV[W$&V:5
MN$6FIJ;7J?$S5KJ"K6P/A:!A6TY%*^<'*W<]9E+JES5Y\C)R9.=^$9$9J,D)
M^](U&9F9J/BHP1:8           (%FF@7K=F,KAM;'S\6+<U;C'3VI<]Q;+#
M3$DR1(5N;;<5NZHUI3HGX1D?@ >UB;'T'%F.;=L*":5IHT1#4E]'P7I:]7)#
MI:D1Z+=4M1:^ P$S               !FN^OWT\5_P!VJQ^+(!6E 1&+Y_9+
M/]93^(L:.!N3R\F9\CMQS_$J_&X\^        RES8.1:-DG$=UW''5(LN!+4
M50+:;B"-J4R\Z1H\)FWH>W[XDZ#(S.%RF9ZFQ@\;==,=;4L"IT^N0V*M2)C5
M1ILY)/1)L99.M/(5T*0I.I'_ /H0U*:HF-8ZF353-,Z3ULHWU6Z+>/-]CQBS
M'FY\ZB$TS7I\/:XV2HRWWG6U.(U)1M->*L]>&NWI+09%VJ*[\>ELVJ9HQJO5
MVM;#98@*        +-M/]@1/]I_2*'G<O=GIV/386S'C]W:'([0!G"=^_-2_
M\.7/[5< :/   !3L[E5Y?*G.E5*=8D)Z=,><DR7E.RB-;KRC6M1D3Q%Q,S/@
M G%AXVL;&-,D4>PZ(Q1*=*?.7)9C[U=8\:4HW*4XI:C\5)$1:Z$ E0#YO_YD
MT&(U?5D5)M*2G2:5)8?46FXVH\@E-Z_P&ZO0!5')#)D1^92T4L$:DOMU)IXB
M_P##.GR%&9Z>X:2,!]=P     !Z=0JU*I*4+JDZ/!0X>UM4EU#)*,O 1K,M3
M >8Y<4NI,WVR*1IY/XZ?RFI:ELX^-T^ !^CD1TO)C*=04A1;DLFHMYI+PDGI
MT >I"K=%J;[T6G5&+,E1N$AF.^VZXWQT\=*%&:?XP%;9TC9IDT^W4X9K5,HT
MPJHU\^.54FS)R&>G!/6H61I(R_*)01+47P3]TJTUR([3B&7'4(>=_P!6VI1$
MI6GN$9ZF"/68K5&E3G:9&J,9ZI1]>OAMO-K?;TZ=S9*-1:>^0#^U&L4BD):5
M5I\: EY6QDY3S;!+5[B=YEJ?'P /<2I*TDM!DI*BU2HN)&1^$@'JSZI3*4TE
MZJ36(3*CVI<DNH92:O<(UF1:@/(<V&2&7#D-$W(T..O>G1S<6I;#U\;4C\ "
MC+XRI>%"YG\<8MIS[";0N2F3)E586PE;ZG6&Y:D&AT^*2(V4<"]\%7T"/ J;
M#2;Q*D-$<=)KD$:TEU:2+4S7Q\4M/= >*G5:E5=E4BDSH\]A)[5.Q74/H)1>
M U(,RU ?E=:H[=132%U&,FK*(E)@*>;*09&6I&39JW?^0![P#T9E:HU.?;BU
M"HQHDIXB-EE]YMIQ9&>A;4J41GQX< 'O /4GU6F4IM+U4FL065GM0Y)=0RDU
M>X1K,B,P%'<P&6+ML"[,04NTI4=-,O.X6J96#<93(ZV&X[&3^349^+JEU6BD
M^\"K[6M+:5+6HDH21J4I1Z$1%Q,S,P1Z<"LTBJFX5+J$:<;6A.^3/-O;#/HW
M;#/3^,!1O,EEB\L9US%L&U'V&8]U7$U2JP3["7S7%6XR@R0:O@GHXKB0*OJ3
M*C0F%RICR(\9HMSCSJB;;27NJ4HR(@1XX-0@5-@I5-E,S(QF:2>CN)=;W%TE
MN09EJ0#V0'-N&M1;<H=1KLWC&IT9Z4M&XDFLF&U.;4FKAJ>W0@&>.6*Z<PY7
M-.7KWNV&U:%71-:HMA08S*292U)-I+SCW^MU0;:TD2S49EHH].@%:59D,24=
M9'=0\WJ9;VU$I.I=):EJ"!R&$O)CJ=04A9&I#1J(EFDNDR3TF0#\G+B)6XV;
M[9.,IWO(-:=R$=.Y1:\"]\P'@IU8I%80XY2)\:>VTK8ZN*\V^E*O<4;9GH8#
MW0'HPJU1JD\Y'IU1C3)#/%YJ.\VZM!$>GC)0HS+C[H"N<_YF;P;8I7E\U)K;
MQS8T,J;Y2419HD&HC<)1H<^#MZ-O\9 )5>4JXZA9%<]'M0@QKR\A<.DR92D/
M1691HU0;FFY.GN&I)I\)D9< 'IXC:OYC'5!:R?/BU.^4LJ^=9L'9U*U&XLV^
M+24H-26]B5F@MIJ(S(!*'JU1H\Y%,?J,9JI.&1-PUO-I?4:NC1LU;CU\' ![
MIF1$9F>A%Q,S >E*K5&A0SJ$RHQH\ E;#E//-ML[O<WJ42=?XP'LQY$>6PB3
M$=0_&=+<V\THEH4D_"E23,C(!^9<V'3XZI4^0U%BHTWOOK2VVG7@6JE&1$ \
M;54IC\1,]F:PY!7P1)0ZA32CUTX+(]#^Z HOF1RS>.-*WBR%:;[#46Z[B:I=
M7)]E+YKBN.,),D&KX)Z.*XD"K_!'Y<<;9;6\\M+;3:36XXLR2E*4EJ9F9\"(
MB >I#K%(J##DJ!4(TJ,T>CKS#S;K:3]Q2DF9$ ]IIUIYM+K*TN-++5*T&2DF
M7O&7 !ZD2LT>?)=A0:A&DS&-3?CLO-N.HT/0]R4J,RT,].(#W''&V6UNNK)M
MILC4M:C)*4I26IF9GP(B(!ZM/JU*JR%NTJ='G-MGM<7&=0\E)GX#-!GH8#VG
M'&V6UO/+2VTVDUN.+,DI2E):F9F? B(@'J0ZQ2*@PY*@5"-*C-'HZ\P\VZVD
M_<4I)F1 /,4V$?4Z26C\H_U'CI_*:?R./'^(!YP'C9D,2"4J.ZAU*%&A9MJ)
M1$HNDCTZ#+W 'JPZU1ZB^[%I]0C2Y+'%YEAYMUQ&AZ>,E*C,N/#B ]X
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M04E3)&31N[2WF@E:F2===-? "/,
M      #-=]?OIXK_ +M5C\60"M* B,7S^R6?ZRG\18T<#<GEY,SY';CG^)5^
M-QY\       !F#F]N6Z)2[/Q%:RU,O7F^93E(4:.O2;R([$=1EQZLUJ-;GNZ
M$,K-KF9BB.UKX%%,15<GL=NB<F6'J;240:VW/K-7V:2:IY4J+J[X3:::+:E)
M'\$E;CTZ3'[IP:-./6^=7R%R9X::*WL^@5CEOYD*18=+J3U0L2^$-)0R\9$H
MT/FMII3B4^+US#J--Z2+<@_!N,BYJ8FQ=BGLEU5U1D6)JF.-+9@VF$"@
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M=:'&*XTU(DOPGN"XJ9LEV2AE1=)*0EPMR3Z%:EX %Q@.?7:/#N&B5*@5 E'
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MK#,Z87 GI#;:4N.<=/A*(U CWP
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M=#(M0'N    X;5EV<S5CKS-O4QNN&LW3J:(4=,OK#Z5=<2-^I^[N =P
M                               !^7"4I"DH5L69&25Z:Z&9<#T/IT 0
MK$^,:/B2S8]H4>0].VOR)L^IRMI29<R6Z;CCSNPB3KQ)):%\%) )N
M                            #U*I-<IM,FU%J*[.=B,.R$0HQ$I]]32#
M63;9&9$:UZ;4EKT@*$Y4<>W50:/=62,CT]=/R-D*KOU*I1'R)+L:(TM91V33
MIXO%3BR3_)-/#@"M# @
M ,UWU^^GBO\ NU6/Q9 *TH"(Q?/[)9_K*?Q%C1P-R>7DS/D=N.?XE7XW'GP
M      %6Y>K&"Z4_2$YE8@//NMOG1O+XCTLR;2I'7;#:0K:6IIUUZ1QWYM1,
M>MV8]-Z8G]:M/K;R0?H5"[JE]D.7U8SK]&7_ )_W#W:3D3DTH-2C5FB%1Z?5
MH:^MB38],EH=:<(M-R3ZK@?$?JFYCQ.L/S5:RJHTG7_<+:LC+V.<CSY5,LJM
MIJDZ$R4J4TEA]G8R:R;W:NMH(_&,BT(]1V6[]%<Z4RXKF/<MQK5&B;#H<X
M     "S;3_8$3_:?TBAYW+W9Z=CTV%LQX_=VAR.T 9PG?OS4O_#ES^U7 &CP
M
M
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M >GG.GV>:SWS"[( ]/.=/L\UGOF%V0!Z><Z?9YK/?,+L@#T\YT^SS6>^879
M'IYSI]GFL]\PNR /3SG3[/-9[YA=D >GG.GV>:SWS"[( ]/.=/L\UGOF%V0!
MZ><Z?9YK/?,+L@#T\YT^SS6>^879 'IYSI]GFL]\PNR /3SG3[/-9[YA=D >
MGG.GV>:SWS"[( ]/.=/L\UGOF%V0!Z><Z?9YK/?,+L@#T\YT^SS6>^879 'I
MYSI]GFL]\PNR /3SG3[/-9[YA=D >GG.GV>:SWS"[( ]/.=/L\UGOF%V0!Z>
M<Z?9YK/?,+L@#T\YT^SS6>^879 'IYSI]GFL]\PNR /3SG3[/-9[YA=D >GG
M.GV>:SWS"[( ]/.=/L\UGOF%V0!Z><Z?9YK/?,+L@#T\YT^SS6>^879 'IYS
MI]GFL]\PNR /3SG3[/-9[YA=D >GG.GV>:SWS"[( ]/.=/L\UGOF%V0!Z><Z
M?9YK/?,+L@#T\YT^SS6>^879 'IYSI]GFL]\PNR /3SG3[/-9[YA=D >GG.G
MV>:SWS"[( ]/.=/L\UGOF%V0!Z><Z?9YK/?,+L@#T\YT^SS6>^879 'IYSI]
MGFL]\PNR /3SG3[/-9[YA=D >GG.GV>:SWS"[( ]/.=/L\UGOF%V0!Z><Z?9
MYK/?,+L@#T\YT^SS6>^879 (S;Y99R'S*V1D2Y<9U"RZ!0*34J;*?ES(TQ!K
MDM/*;5JUL,M5*).FT^(#5X",7S^R6?ZRG\18T<#<GEY,SY';CG^)5^-QY\
M     !_2(U'H1:F((!4LWX?I$]5,J%[4IJ<A6QQM#YO)0KW%+:2M!&7AU4.:
M<FW$Z:NJG%NS&L4RF=,JE+K<!FJ46='J5,D%JQ-ANH?861?R5H,R_B'WIJBJ
M-8<]5,TSI,:/;'[?D         6;:?[ B?[3^D4/.Y>[/3L>FPMF/'[NT.1V
M@
M
M                     ",7S^R6?ZRG\18T<#<GEY,SY';CG^)5^-QY\
M    !F7FZN^Z4HM3$UH+<9GWJ\:9CC2C;4\T;J&&H^Y/$D+<4:G?=(B+HU&7
MFUSK%$=K6P+=/&NKL>U0N2C%4"CMP[BDU*JUS812ZBQ(3$:)W[[J6B0O1)>#
M>:C%IP*=.,\7YK^1KUX1&B!V'1Z_RW<P]+QNS4G:G8E[);)A+FB=Q/[VV75M
MEJE+[+J-BE)^$C^'0N>B)L78I[)=-RJG(LS5VTMF#:80*        +-M/]@1
M/]I_2*'G<O=GIV/386S'C]W:'([0
M
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MA;,>/W=H<CM
M
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MH:^, ?6"@_2D/Y0U\8 ^L%!^E(?RAKXP!]8*#]*0_E#7Q@#ZP4'Z4A_*&OC
M'U@H/TI#^4-?& /K!0?I2'\H:^, ?6"@_2D/Y0U\8 ^L%!^E(?RAKXP!]8*#
M]*0_E#7Q@#ZP4'Z4A_*&OC 'U@H/TI#^4-?& /K!0?I2'\H:^, ?6"@_2D/Y
M0U\8 ^L%!^E(?RAKXP!]8*#]*0_E#7Q@#ZP4'Z4A_*&OC 'U@H/TI#^4-?&
M/K!0?I2'\H:^, ?6"@_2D/Y0U\8 ^L%!^E(?RAKXP!]8*#]*0_E#7Q@#ZP4'
MZ4A_*&OC 'U@H/TI#^4-?& /K!0?I2'\H:^, ?6"@_2D/Y0U\8 ^L%!^E(?R
MAKXP!]8*#]*0_E#7Q@#ZP4'Z4A_*&OC 'U@H/TI#^4-?& /K!0?I2'\H:^,
M?6"@_2D/Y0U\8 ^L%!^E(?RAKXP!]8*#]*0_E#7Q@#ZP4'Z4A_*&OC 'U@H/
MTI#^4-?& /K!0?I2'\H:^, ?6"@_2D/Y0U\8 ^L%!^E(?RAKXP!]8*#]*0_E
M#7Q@#ZP4'Z4A_*&OC 'U@H/TI#^4-?& /K!0?I2'\H:^, ?6"@_2D/Y0U\8
M^L%!^E(?RAKXP!]8*#]*0_E#7Q@#ZP4'Z4A_*&OC /+'J])ENDQ%GQWWU:FE
MMIY"UF1<3T))F? ![@",7S^R6?ZRG\18T<#<GEY,SY';CG^)5^-QY\
M !EWFR?JET7/C;#\66<"E71.2[4GB/0E*4^B,UJ7WQ-DI:R2? U&7N#*S)FJ
MJFCO:^#$4TU7.Y%,K8GQW9^9L.V=0Z$PB@U%U#-59>W/+G%Y6ELU2%*/51F7
MN:$6O#0?"[9IIN4TQU/O9OUUVJZIGC#H.VI P/S3VE!L9;D>V+X:)F;1E+4M
M#2)+CC"D)-1F:D)<0AUO=J:3X= _4T_IO1Z>J7YBN;^/,U==+7HV6&"@
M   "S;3_ &!$_P!I_2*'G<O=GIV/386S'C]W:'([0!D3*.-++RKSCTJV;ZIO
MSG1DV!Y6B.3SL?1]FJ/I0K<RI"N!+5PUTX@)Q[$O+9YH*[PG]N >Q+RV>:"N
M\)_;@'L2\MGF@KO"?VX![$O+9YH*[PG]N >Q+RV>:"N\)_;@'L2\MGF@KO"?
MVX![$O+9YH*[PG]N >Q+RV>:"N\)_;@'L2\MGF@KO"?VX![$O+9YH*[PG]N
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MH>=R]V>G8]-A;,>/W=H<CM &<)W[\U+_ ,.7/[5< :/
M
M                                                          !F
MN^OWT\5_W:K'XL@%:4!$8OG]DL_UE/XBQHX&Y/+R9GR.W'/\2K\;CSX
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MBUXD?08#V             'K5"?"I4"55*D^B+3H3+DF7)=/:VTRRDUK6H_
M24D9F ]2W;CH5W46)<5LSV:I0YR5+ASXRM[+J4+-"C2?O*29?PD Z@  JZW\
MX4.X<RW%A>/2*BQ6+<AHG/U1YHDPG4JZO4DGKN(ORJ=BE%HOQM.@M0M$
M                      9KOK]]/%?]VJQ^+(!6E 1&+Y_9+/\ 64_B+&C@
M;D\O)F?([<<_Q*OQN//@       ,Z\TV$[RRPBW:I9Q19,B@MRFWZ;)=ZAQX
MI"FUD;:EZ(/3J]#)2D^\,W+L55Z32T\+(HMZQ5VJTL3.3.#9#=OY Q"W:LLM
MJ'*Q2(ZF)3G B4LSEFLW2,N/Y.02?<');O?JG2JEV7<?]T:TUZM+V/FW%^1U
M-,6O<;#M5>+5-)EZQ)QF721-.Z;S+_U9J&G;R:*^J63=QKEOKC@GPZG,
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ME0;ZH<5QJ"KJR,UQY6B4MH5XBMO!*B/3X1+2H@T("
M ,UWU^^GBO\ NU6/Q9 *TH"(Q?/[)9_K*?Q%C1P-R>7DS/D=N.?XE7XW'GP
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MW+5H1=)=)@/9Y\)L*H<N<V1 D-2F/G>GIZUA:7$;DN*U+5)F6I (IGMSZBY
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MB[6R)9=ZU.O4>UJNU4ZC;$GR&NLLI<(HTG<M'5FI24I4>K:R\0SZ 1)P
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M_P"V1D8&O&C_ $A;S+L=Q3+Z#;=0>BD*+0R,:T51,:PQJJ9IG27X'Z?D
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M+1*3/@?N )32JI3JY3(5:I$E$RE5%AJ7!ELGN;>COH);:TGX24DR,@'M@
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M21JVIW)4:%D1FE)[DJ(TEIQ(M(          9KOK]]/%?]VJQ^+(!6E 0
M!_%)2M)I41*2HM#(^)&1@3&J)UJS6GMTBDZ-.])QCX(/^:?@_@Z/X!J6,V8X
M5_[9.1@1/&CA_A"7V'HSJF9#:FW4'HI"BT,AKTU15&L,2JF:9TGK>,?I^0
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M<-X2MS#5/JB:=-F5NY+@D%-N*Y*JYULV:^6XT[C+@24FM9I+B>JC,S,P19H
M         S7?7[Z>*_[M5C\60"M* @       #^&1*(R,M2/@9'T: (K6K.9
MD;I%+T9?Z38/@VK^#^2?_D&G8S9IX5\8961@15QHX3W(1(C/Q'5,26U-/)^$
MA1:&->FJ*HUAB5433.DQI+Q#]OP /9@T^747B8AM&XO[XRX)27NF?01#Y7+E
M-$:U2^MNU5<G2F$]HMIQ*=M?E:29A<2,R_)H/_1(^D_?,8M_+JKX1PAO8^%3
M;XU<92$<+0          !G"=^_-2_P##ES^U7 &CP
M  !4>2^7''66[KI]U7NJI3?F]EF.5%;F*9I;R&'%NI-UE*=349N&2C2LM2T(
M!;+333#2&&$):9:22&VT$24I2DM"(B+@1$700#]@           \$B%#EJ:7
M*CM/KCJZQA3J$K-M9??)-1'H?OD \X                   (%C3$5JXL5<
M,B@.3)E3NFH+JU;J=3>*3+?D.:GH:TH06U)J6:2TUU4?$!/0
M ! LJ8<L',M%9HM\TXY)1%F]3I\=9L38CIZ:J9>3Q+=H6Y)ZI5H6I<"T"LJ/
MR78F@U:#5+@J-PWBS3%$Y!I=R5+RV VI/P?R2&FMQ%_)49I/PD9< 5HE*4H2
M24D24I+1*2X$1%X"!']
M                9KOK]]/%?]VJQ^+(!6E 0          'I5&E0JJSU4MO
M=I\!PN"TG[QC[6KM5N=8?&[9IN1I5" UFV)M*,W4$<B'_P"*DN*2_P!(O!_#
MT#:LY5-SAU2P+^)5;XQQA[-%M&5.VR)^L:)P,D_^D67O$?07OF/Q?S*:.%/&
M7TQ\&JOC5PA.H<*+ 9*/$:)IHO 729^Z9])F,6NNJN=9ENT6Z:(TIC1[ _#Z
M            ,XS4+5SRTTTI,R1CAQ2S(M2(OG99:G[G$R(!HX
M
M
M     &;+Z(_;2Q6>G [:K)$?@U)#X*TF"
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M]F!JDF/N57&N-KS@WW1)E;EUZG-OLQ3J=0.6T2)+:FED:3;(^A1^'IX@B\
M
M
M
M
M
M                                                S(BU/@1 (P[D
MG'3#BF7[NHK;J#T6VNI1$J29> R-S4@'X])V-?/*A]YQ.U /2=C7SRH?><3M
M0';I-<HM>CG,H=2BU.(1[3?A/MR6R5IKIN;4HM0'O@
M
M
M                       #(/\ F%7K<5LXMHM"H<Q<&+<E17'JSC"C0X[%
MCLFYU&XN.Q:C(U^[MTZ#,C#(&+N3[*^7+,AWU:LBCHHLYQ]IE$V6ZT^2HSJF
M5[D(8<(O&2>GC= "8_\ R\\\_I5O?+I'ZJ ?_+SSS^EV]\ND?JH"*<M-9N_$
M_,S2+0CS20MVMKM>XXC#AKAR4$^N*OP%O)"RZQI6FNI%[ID ^NX
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M3QS!_9VJ7?T/L #T\<P?V=JEW]#[  ]/',']G:I=_0^P /3QS!_9VJ7?T/L
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M\<P?V=JEW]#[  ]/',']G:I=_0^P /3QS!_9VJ7?T/L #T\<P?V=JEW]#[
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ME@            &<)W[\U+_PY<_M5P!H\
M
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M!J,1XRWM.I)+>Y)*T/8XD^E*BZ2,!>X            #.$[]^:E_X<N?VJX
MT>                             _A&1ZD1ZF7 _>\(#^@
M  #^$9'J1'J9<#][P@/Z
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MKE;5Q4F[K?I=T4%\I5&K$5F=!?+AN9?02TZEX%$1Z*2?$CX& Z@
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MU62>@E$>I<-#Z0$-?YFL QJP=">R#1RJ!.=2HR?W1R7KIH<A)&R1$?2?6:$
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MHT&9$LDJ+123+B0#K              #-=]?OIXK_NU6/Q9 *TH"
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M*A?(]A*PLMW%=]1OZ$=6A6ZB*F%2EK<;CK>G*?W.N=4I)J-!,Z)3KIXVI]!
MCNUVQZ1@CGBL>BXY6[3:+6)%.=5!ZQ;B6F*HXY%D1R4LS4IM1)-2269Z&?O$
M"H]GJ\Z7=W-K4V,ETJK7'8MI.^01;9HOC/N-1F27M(MR-J'7SWO*29*V>*1\
M$Z!%\O3;!K<FB7#@K&=T6)=5)D)=?>*.Z492&_':=02%NJ0\A9%HI.TC+774
MR(!]3;!K%0N&Q+8K]7;-FJU6DP)TYI2#:-$B3&;=<2:#(C3HI1EM,N (^?UT
MT%/,?SO5*QKWEO-VK0ER(;,%EPT*.'2F=QM-&>NPWW=7'%)XZ&>FG#0KN\Z'
M+-C#'6.HU_8]@';TN-,8IT^ V^\]'EL2=QD9I?6M1.(6E)^*>AEKJ6I$8".9
M>O6M6_R28CM>E/*C1;H)UJJNMJ-)KC0W''.H,RT\5:UI4KW=NG1J BT2;RY'
MC1NTG,.W@_=+D$DJNY#/^]G45M[NO1H]LZLG#\5O9ILZ2,^("9X/I=2NOE5R
MS9V2Z1*D4RR([]<M)JI(DQSBRUP):TFR9[-4MN)-PD<4ZK/4N("P?\O;'5ES
M+#>R7)I+;E\P*S/IT2L&XZ3B(JHD;5LD$OJS_P!:OB:->/2"(=_E]_\ QSE?
M^J-?\2^"H7R/82L++=Q7?4;^A'5H5NHBIA4I:W&XZWIRG]SKG5*2:C03.B4Z
MZ>-J?00([M=L>D8(YXK'HN.5NTVBUB13G50>L6XEIBJ..19$<E+,U*;4234D
MEF>AG[Q J,YNO.DW?S:UGTG4FK7+95IOKIT2V:+JIY;4-LM$Z&M)I;=>,W'E
M),E:'H1]&@1O+<^R*M4:#<^!<;W185T4=\GI#I1W2CF31DMEYO8MU2'4++I+
M0C+IX@+)YD*W<&;,Q8<QA7I3M(I=8I=#DSFB2:";GU[0Y+I-+T+K$(T;;2OX
M)D9<-3 6SS!<H.&K9PQ7;CLNF.4*Y;5IZIT>IIEON*E%'(NM1()U:DJ-U!*(
MMA)T69:>+XIAXN2ZQK;R3RLUZRKMBG+H-6KLUN2TE9MK(T-0W&UH6GBE:%I2
MM)^Z7$C+@ T_BW%EH8>M1JSK*CNL4I#SDIYR0X;S[TA[0EN.+/0C49)2GQ2(
MM"+@"*4Y^_W>9O\ S6G?TB@5QZA#YZ9-A--6]+LA"'*>VF'\T^6-U/JE,D2.
MK7-3U"7--.)F1$?08")4_(%L6#R07%4,1%/I=:A2%4:MG45I.J1JU.D,L2W7
M5((B)75N?DE((M"V]"DF ]7%E[<OMD8^IEMRL-716YST5MRMU69:S4]<V6\V
MDWG">>6:C;-1GU:2T(DZ:%X1!W.5M=4:R#E&S;'I5P6MB:L0OG:U45Z$]%53
M:BZ2&729)Q2D_"<,TEO,S2TG7B1BB'8ZDV?@&VZECKF1Q&^X;\N6J3D%%-16
M8-1:?46BUR3(UHVI,MI-F9ETFE*S5J%R6GC_ !A2^5J[Z?9=;3?EB*AUNLT"
M14FVI)07_(W#)MI*T$;:VEDI?C)2XE:E'PU =;DZM&U&\%6'=#="IR+F5%ED
MJM)B,%.,E3)#9ZR"1UG%!;?A=' $:) 82Y(<,6;==)N/(EXP&:_)AUR;2J'3
MJ@@I,.$E"6WGWD,.:MFZZ;J"W*29I)!:::F"I#S46+;^&JM8^><9PF+:N>'7
MXM+JL:FH*+&J$26A:E(=:;VHU-+*D*VI(U)6>O$DZ!^<ZV)0LD<Y^-[3N9+C
MM DVRZ_4(C:U->4MQ'I[Z65J09'U:UH3O(NE.I<.D!U.;6+!L+&MI8AQS#CV
MG0[^N%BD5,Z6TB*@HKNTGB,D$6IN&;>]1_"2DTGJ1F NN!RZX2@6BU9)612I
M%$0R3"U2(K;DQPRZ7%RMI/&Z9\>L)9*+P: C,&.+[N7#V.>8NPZ14'IT/%LE
MQNS94D^L<BM5)Q]E"=>C\DI"7=NFF_=[H*M?E=P3CB!B&@W/6J'!N.Z;OAMU
MBM5BK,-U%YQ<XC=)M*GTKVI2E9)42?A*U4K4P%93<86[B_GCQO"M!!P;<K$"
MH5)BB(4HXT*0N)-:>*.A1GL;<-M+FTN!*,].&A$%A8_T]N/+?]VZ3_0P 1XN
M?PM<+4G^\]-_HI(#U>82$K)W,9BG!]>>66/Y$:5<E9IS:U(3/=B)?4VT[M,C
M-)%'-/ ]2)Q1].FA5I9&Y:<29!LN1:!6Y3J$X39%2ZM2X3$>5"=;^ M"FTH-
M2? M"E:*+IXZ&1%-\X%E(MOE7CPZ]*1<US4!=-IS-TS(K2)ZV?*4D?C^.I)J
M224KT7X^FJM3,%:3QW:=JV_;]-G4"A4ZDS)U/B',D0(C$5Q[\DE7Y132$FKB
M9GXP(@_-A?%9Q]@6[*_;SRXU96VQ3XLMH]%L>7R&XZW$GTDI*%JVJ+B2M#(!
MZV&, 8HM_%5 IK]K4RKR:I3H\RLU"I16)DB7)F,)<=4IQU"E;=5&2$D>B2Z.
M.IF5QH>-E<KM@98NBRZW(DVZY#FUV@6O(:)4>E3&F7%)ZIQ:UFM!GL)1*3Q2
MA.NIZF8<+E,PM8,K%-*R)=%(BW/?%YD_4ZS6:RTW4'3-Y]PB;1UZ5DDM"U7I
MXRE&>IZ:$05OD7%EKXSYP,0.6<P5,HEP2W)KE#9/2'&F-ZMNN1VO@M)=3U>Y
M*>&J?<T(@Z5W6%;.1.?4J+=T--2HD6W&:@Y37M3CR'([9$VEY)&6]"5*)>P_
M%4:2)1&6I ._SJXRLJW,4(R3:5&AVY>=J5&GOTRJTAAN$\1.2$M;%=022425
M*2M)J+5)IX::GJ'H\Q-1GY6O3!6':M)<AVK>J6ZY<[499M>5=6TEQ+.I=!%M
M<V_Z2DJZ4D ONN\NN&:Y:IVE]3Z;3H;;75P)M/C-1I\1U*=$/LR4))PG4GHK
M<I1[C^%NX@C,G*7&?A\O.<H<I\Y<F/-KC+TI1F9NK12DI4LS,S,S49:\3!7#
M9O.N67_EY4%=O2#ASZY-DT1<Q"C;6TQ+J4M3QI470:D-FV9^XH_" U38/+9A
M^S;%AV@NU*55]T9"*K49\1F5(F/J01..J=<2I1;E:FE*3(D?>Z BBL V'3\:
M<Y&1[.HTAUZA0;:;<I3+[BG51HLI^!(1&)2S4HT,]8:$:GKM(M>(*]CE7L6W
M\RU:^,\Y,A,7+<\RORJ72HU104J-3XD1"%)0TTYN1J27DH3N29I2@M.*E:A'
MN=[#-FVI2;<R)9T%F@29E<A4JN4ZGH*-#FI6EQYAY;#>C?6M&TLMQ)(U$L]=
M=" 2_G2H5"7<^&I[E+AN3JA=\&+4)*X[2G9$9+C1$R\LTZK;T4?B*,T^\ [W
M.#,9Q1@&I0\=P(UMG<M3BTF:NCQFXBNJE)6IY1)82C5:T,]49].U1D @=LWQ
MRV6O:#-E-X.NJ= 0P3$V3.M-M^7*<V;5O.O..FO>H_&U)1;?O="(@$FY*9E8
MI\O(EFQJ17*9C6#4&JC9#=P178S[,6<I[K&-72/738A6B5'QU5TJ/4+^S'2*
M36,77<U5X$>H-1J14)<=N6RA]+<AF(Z;;J"<)1$M!\4J+B7@!%(<LD2@VCRH
MTS)-.H=/^M<"AUN8NIE&:3+?\DDRW$MN/I23BDGU24Z&KH(O<!7K<HF);0N/
M&[&7[YIT6Z[_ +XD39]2JU791-6VA,IQ@FFR>)24E^2W*-*2/QMOP2(B#DWI
M:]*P)S2XRKF.&&J/1,F.2:)<MNQ/R4)Q;:FR2^EE.B4:'(0HB21)(T<"\96H
M<6FXPM#)W/#DV+>L/YTH]'IU/J#=)=4?DK\GR2$RA3Z",B<2A*U&23X:_< ;
M2H]&I%O4R-1:#!CTRD0T=7$@0VD,1VD:F>U#:")*2U/P$"/>
M  &:[Z_?3Q7_ ':K'XL@%:4!        %<Y_?=C8.R.\PK8ZFVZL1*+I+=#<
M(_\ R& ^?_\ E_7'9]K9,N.IW96Z?1.MHOD<!VIR6HA...RV5J0VIY22-6C9
M<"X@/I[ J%/JD5$VF2F9L-S_ %<B,XEYI6GN*09D8#V0 !3G-<PU(Y=L@MO)
M)2"IO6$1_P MIYM:3_B4DC 9/_RU'G$W+D".2OR+D&G.+3[JFWGR2?\ $2U
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M-9DS(]3IG4677Z5"BTBI]>POKGF6X:5IZI*S<3H;2^*T$7 !H0$
M     !FN^OWT\5_W:K'XL@%:4!        %:\PW_ $)R1_=RJ?\ "N /G;R4
M8BL#,-V751,@4LZG"ATMN3#V/OQEM/*D)0:TJ86@S/0]-%:E[P#2E<Y,[GQP
M^[=?+/?52M^NM'UWU?J+Y.0I6WCU9N$DDGKIP3(;<29]*D](":X&YH57I77<
M4Y:IGU/S'3E&PY!>2;,:H+06IFP2S/:X:?&ZO<9+3X[:E)X)#28"H.:?]WG(
M7_*E_P!(@!D?_+5_^*[]_P"7P?Z=T!]%P           9PG?OS4O_#ES^U7
M&CP    %1<S.4_1#AVOW1&=ZNNR4%2Z!IP5\X324A"T^^TDEO?\ F /C,RU)
MG2FV&4JD2Y+A(;06JEN.N*T(B\)F9F ^V&",9L8BQ5;ECI2DI\..3U7=3H?6
M5&3^5D*W%\(B6HT)/^0E("Q@
M                       4=RL8JNO$-@5BW+P*,52FU^;56/(W3?;\FDM,
M(1JHTIT5JVK@ O$
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M6C4].CQ@%HVQ49%7MJC5:622E3X,:4^2"T1UC[*5JVD9GH6I\ '5
M
M   !FN^OWT\5_P!VJQ^+(!6E 0       !6O,-_T)R1_=RJ?\*X Q)_EM?\
M42\O^2M?\4@!])0 !S*];M NJF.T:YJ7$K%)?_UL&>PW)84>AD1FAPE%J6O
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M]"K5KY'RMRMW#595=LBE043*!(E.J.7'IU4;02V"=3HHM424?!T)*TJ4DBW
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MIU1QA5I\2Q*C+B1KDM"=(5-ADKK>LCRHRG=5MN)<22%^,>Y*NG@9&&Y+$_\
M@BVO^50?^&;!$@
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M"2D*(TJ(RCHU(R/B1D".^
M                                #-=]?OIXK_NU6/Q9 *TH"
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MK8A365QYD:DP&9$=TMKC;K<9M*D*+P&DRT,@$A
M
M                       9KOK]]/%?]VJQ^+(!6E 0       !';^M-N^[
M(N&RWI2H35P4^33%S$()Q32932FC62#-)*,MVNFI ,:__+3H'K#F=V-?K !_
M\M.@>L.9W8U^L '_ ,M.@>L.9W8U^L '_P M.@>L.9W8U^L '_RTZ!ZPYG=C
M7ZP NKEUY6J?R]U6N52#<K]=.MQV(RVGHB(I-]0M2]Q&EUS77=IX &@@
M       9PG?OS4O_  Y<_M5P!H\
M
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MBO\ ^S_?/R179 'M17_]G^^?DBNR /:BO_[/]\_)%=D >U%?_P!G^^?DBNR
M/:BO_P"S_?/R179 'M17_P#9_OGY(KL@#VHK_P#L_P!\_)%=D >U%?\ ]G^^
M?DBNR /:BO\ ^S_?/R179 'M17_]G^^?DBNR /:BO_[/]\_)%=D >U%?_P!G
M^^?DBNR /:BO_P"S_?/R179 'M17_P#9_OGY(KL@#VHK_P#L_P!\_)%=D >U
M%?\ ]G^^?DBNR /:BO\ ^S_?/R179 'M17_]G^^?DBNR /:BO_[/]\_)%=D
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M179 'M17_P#9_OGY(KL@#VHK_P#L_P!\_)%=D >U%?\ ]G^^?DBNR /:BO\
M^S_?/R179 'M17_]G^^?DBNR /:BO_[/]\_)%=D >U%?_P!G^^?DBNR /:BO
M_P"S_?/R179 'M17_P#9_OGY(KL@#VHK_P#L_P!\_)%=D >U%?\ ]G^^?DBN
MR /:BO\ ^S_?/R179 'M17_]G^^?DBNR /:BO_[/]\_)%=D >U%?_P!G^^?D
MBNR /:BO_P"S_?/R179 'M17_P#9_OGY(KL@#VHK_P#L_P!\_)%=D >U%?\
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M&=R6=0Z'1ZI3Y<JM1%H8WOLNJ;/K-B4EJ:MNAGQ,$:]
M
M
<                                 '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>lc_bacteria-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_bacteria-4c.jpg
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M="!E;F0](G(B/S[_[0!(4&AO=&]S:&]P(#,N,  X0DE-! 0       \< 5H
M QLE1QP"   "  ( .$))300E       0_.$?B<BWR7@O-&(T!UAWZ__N  Y!
M9&]B90!DP     '_VP"$  0# P,# P0# P0&! ,$!@<%! 0%!P@&!@<&!@@*
M" D)"0D("@H,# P,# H,# T-# P1$1$1$104%!04%!04%!0!! 4%" <(#PH*
M#Q0.#@X4%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%/_  !$( U\#Z ,!$0 "$0$#$0'_Q "O  $  @(# 0$
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M5JTU+>QB?526;-;)SO;8*4^SKDMZFE2G2+P\%=- &N<RFON*IRUN;*(]D$[
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ML9_7F_\ .+_& U&.I2K'JK<1'I'3IK^B8#9F1&9&9:F7@8HXVI,M#(M"\"]
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M#G:1ZEMUUZF1%KK]70@'R1(5X$1D73] !SHGKKIX=?T" "VGZQ:'Z-0'( *
M@G'"O],F(?[JX_ T /:@    #\Z:W]H-?[R3^%O ,H     % 0   % 0  !V
M,?KS?^<7^,!J<=_]O5?[G3_C,!L@     4! %  $   !0$       <EXD UU
M+^U'_P!W3OPE8#8        "C$F?MNK_ '0Y^#.B#+   4!  !0$   !0 !
M !0$        &#._;]/^Z'OP5T49P@"@    ( H  @   * @      H   (,
M"P_;E/\ NM?X*\ SP 4!      !19]1QS265!5YDIR26,(J+"7D)I=03C5G
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MZE_:;_[NG?A*Q!L         &),_;=7^Z'/P9T!E@      * @"@ "
M    "@(   P9W[?I_P!T/?@KHHSA              !0$     4! % 0 &!8
M?MRG_=:_P5X!G@     H  @"C:,Y)>Q\?E8JQ.6C'9SG>E0").Q;FJ3UW:;B
MU-*3,B/T"#*O,TRC)(C,"[L528;*R>2PEMIE*WB3L)USM)3W'-O3>O4P&A !
M0$     !R7C^F SN*\F+$BI[9V,J;!<K%0I\)"R;4]'E,[%$2C(R(R/177X
M&V@<@9E5TB<:@6RVZ%#3D9J&IIAPDL.[MR=RD&KJ2CZZ@/OZ1\[]SMT"+Z0U
M4-,IBH8:)MM1,(3L2WW$I)>A)Z?& ?%3R#F=%4HH:FU5&IVR<2W$[3+B4I=,
MS61&XA1EJ:C](#$8RW)8LVILHUBXU.HX_L=2^E*-68VAEV]-NBDF2C(]VH#8
MXEF\K&\GG95+2[-LIL>8VMYM2&W/:IFA]XS46WHKKIH Z)?(.:SY[]K/N''K
M&3"552'=C:4JA.:&MHD$DDI)1EJ9D6NOI ?%+G66X[7'44]D;%:2E.-,+:9?
M)E:R,E*9-Y"S;,]3ZH,@'=!Y$S>MIFL>@W+S5,REQIN+M;61-.I-*D&I234:
M=#/1)GT] #J@9YF%9.B6,&U<:EP82*F,K8VM!0&CU0PI"DFE:4GU+<1G]4!\
M%F^6E$M('O5U42[?]KM&EI0HG9!FDS<+5/J&>Q.NS3P(!E0N2,YKK&PM8=RZ
MW.M32NP6;;2T.N-I)*%]M2#2E22(B)22(^@#7%E61]E+"K)U;:;$KO5>U:SL
MRZ%(-2B,S5]0^GU &,=U:G='D?M2BO3D^W>VD227[29[NYH1;==?1IH V\;D
M/-(EE87#-JH[.T-I4Y]UIETUKCIV-+2E:#)"FTGHA2"(R ;7AMUV1S5BDB0X
MIZ0\FZ<>><,U+6XN*E2E*,_$S,]3 >T0    'YTUG[0:_P!Y)_"W@&4* @
M           .QC]>;_SB_P 8#4XY_P"WJO\ <Z?\9@-D         "@(  *
M@"@ "    HY+Q(0:ZE_:;_[NG?A*P&P     !0$ !AS/VW5_NAS\&= 9@
M               "@(     H ,&=^WZ?]T/?@KH#.$           !0 ! %
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MW$1Z?!J ^A0$$XX5_IDQ#_=7'X&@![4     ?G36?M!K_>2?PMX!E  H"
M         #L8_7F_\XO\8#48Y_[>JOW.G_&8#9@      * @  H"     *
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M    !V,?KS?^<7^,!J<=_P#;U7^YT_XS ;(4   $     4   $     4! %
M!R7B0@UU+^U'_P!W3OPE8#8"@ "    H"##F?MRK_=#GX,Z S          4
M!  !0$  %  $       8,[]OT_[H>_!70&<     "@(          *  (
M"@( HP+#]N4_[K7^#/"#/% 0<&9)+<HR(OA/H0#/IJBPR"P*JJ4(=GFVM[MN
M.ML))MI.Y1FMPTI+0OJ@,5^/(BLQI$IE<=B8WWX;KJ30EYG7;W&S/XR=>FI
M.DW6B(E&M)$?0C,RT/3X '8VT;SS;;:2-YU26F]="U4XHDI+7T%J8#<.8G?-
M92K"U,-?.1*^V<7OMI1N)ON_KJC).FWKX_4\0&1&P;)I;,&0Q&:-JQ8FRXBC
M>06YFK5MDF9>@TG\4OKO0 U5I4SJ4H)V:$,E8QFYT/:ZV[NCN]4F>Q1[3Z=4
MJZD P#<;))+-:=A]"5J6A_X11M,>HK/*K:/243:)%E*)PV&U.);09,H-:_75
MT+1)&(-9O02^V:B)?4MNO7IT\!0):#))DHC)1Z)/4NI_4$&935DO(+6+2U)(
M>L9KG98;-:4)-PR,]%*/H70@'0^RY'?=C/%H\PXMIPB/4B6VHTJ(C+QZD ZP
M'*?'],4:W'_^ 57[D9_U2$&Q  '!D2B-*B(TGXD?4@'8TT[(>:CL(-Q]Y:6F
M6TEJI2W%$E*2+ZIF S+RHF8[<2Z*S-HK*":4RD,.$\A*E))>FXM.I$?K? ?0
M!KNXWZI;TZJZI+4NI?4 <DM!J-!*+>7BG4M2_P  #;VN/S*:GI+F>ZRAJ_;=
M?@Q24?M"665$DG'$F1$25F?J:&8#3]QO9W-Z>W_E:EI^F VE?16%K56MS )M
MV%2H:>L"[A$Z33ZC0E:$>*DD9>L9> #6&1'H9EJ9=2^H8#D4!  3CA7^F3$/
M]U<?@: 'M0    !^=-9^T&O]Y)_"W@&4 "@(            .QG]>;_SB_Q@
M-3CG_MZK_<Z?\9@-D* @"@(   "@(          * @"CDO$A!KJ7]J/_ +NG
M?A*P&P         8<S]MU?[H<_!G0&8    *     @  H"
MP9W[?I_W0_\ @KH#.    % 0    !0$   !0$  %  $  % 08%A^W*?]UK_!
MG@&>  )?Q8] 8Y"HO>C3+U>^ZY&?1))*F='V5H(U$OIT/334!.)A8_CE#?T\
M H-D6'T3D-RQ-MHU2;RZ>T4I!GJIQ+""VZ^C73IH E=Q/).5Q9-VBIDXQC.,
M.6->VA,8VYDSLDTI!)3J:4&:M&V]-/20#5XB\=G48_EC+%"V=G->>Y!ER6HK
M:(<&&1MLQ&67#U0E:"+JA)F:O6/Q 4DMV$]D1OUS?8K'+(EPFE=-D94DC;(]
M?#1.GZ #T7<)QN=FM9(J?87:].0._.TY/97*5*.)^Q5$M9G^QR+30D]-WU=0
M$6H),1NJQ!)2&4&S39<VI/<0G8:WSV$9:]-2,MOP^@!\N2::G@>\X4.L?EQ.
M/H$EIF0TRZT=@ETSW*0?QG"\3+XQ^D$2*MK:.9:V5\TFM@S9-/0ONS"9B.-H
MDR%K.0VAJ0I#"5/)23:M5$LNAE]4J(8Q)?9\PAOVL!NA4A4Q**]9-,H89]B6
MEDC-L^V>Y.BMR3ZZ@,^NBTJ>-HBZRK:M*UVIEJN5$JN;-JSWJ5W7W'U%))QL
MT^HEOH9?X '-B>#N4$/-YJHFN:(I:JPAH0VV<(FW#.Q>)M):HW)1H9I(C+_"
M WULFOB95C*O=;$:*SD23J+M#E:TU[O4PO[0VB(KN+:T+7>\G4E=#,!YYMC(
M[>R,C(R.9),C+J1EWE]2,@&& Y3X_I@-;C__  "J_<C/^J0#8@   DO':FD<
M@8LI\R)HK2-J9^&XUZ)__6T 6CC%949/DF7X_DW89E8[D;F3KDJ92I;T-IU9
M26%J/0^V>B#T\-# 9F/2Z2WQ5B]B4<>PCVCEH_D]>P=:R3:G7%$P3JY:DNM)
M;:))M=GT^/B T]KCR\BP/'*J(Q%HGI#M=7QZ\DPY/MZGE$:I;$ID^^E1(-2G
MDNEIT,OJ@.]%_4RLXSEYN/#DU>+XXY68]&L$MR(^ZL4DBVI7T5N<)1Z%U,@'
M<28EC-*XHHM2?(5EB$&96QWDQT0U62WU)?4EMP^VEXD;?5/_  ]-0'+B*=O*
M,Q..45LRP9?SF3!V^R)ME;=Q([?J;M2+XO\ CU 4*C78G7QT+7]$!]  H""<
M<*_TR8A_NKC\#0 ]J     /SIK?V@U_O)/X6\ R@  % 0  4!    4  0=C/
MZ\W_ )Q?XP&HQS_V]5_N=/\ C,!LP           !0 !      !0$')>)"C7
M4O[4?_=T[\)6(-@ "@(     HQ)G[;J_W0Y^#.B#+     !0 !    4!  !0
M$       !0$&#._;]/\ NA[\%= 9P *  (      * @  H"      "@(   P
M+#]N4_[K5^#/ ,_4M=NOK::Z>G0 % R(R,C+4C\2,!P24%M,DEZGQ>GA^@(.
M$H:T)24I,O$C(B #0A1[E)(S^$R^ !]?#KZ0'PI+*4D:R222Z$9Z$7Z #Z-"
M#UU2770SZ?!X ."2WKT(M2/4]-.BOU0&ZH\IO,;8E1*AYE,.:MMV7$DQF);"
MW63U0LVWT+(E)]"B 85M9V%]/DVMU(7-L):B7(D/:&:C21$1:$1$1)(B))%T
M(@&%L;5Z^TCUT/=TZZ> #G1!*W:$2U]-?2?U/J@/DFVM-4I3H9:="+30!]_4
M]  *.4^(@UN/_P# *K]R,_ZA -B   #Z0M;:T.-J-#C:DK0M)Z*2I!DI)D?H
M,C+4!O7LUR9^7=3W)J2FY$P46Y?;9:;4\PDB3M+:DMFXB]8T:;O2 CQMMF>I
MH+7P\/07@*,VHM)]!9,W%*^<.SC[R8E-I2:T=U)H5IN(RZI49> @PS(E'JHM
MQZFK4^I[C/4SZ^D!P:$'J1I(R,]Q]/3\(#8PKFSK:NRIH+Q,5MN32;)I*$;G
M4L*-2$[S+<DM3ZDDRU](# % 0  !..%?Z9<0_P!U<?@: 'M0    !^=-9^T&
MO]Y)_"WA1E    "    H"    H"#L8_7F_\ .+_& U..?^WJO]SI_P 9@-D
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M   "@ "  "B<<*_TR8A_NKC\#0(/:@    #\Z:W]H-?[R3^%O ,H % 0
M  4!    4=C/Z\W_ )Q?XQ!J,<_]O5?[G3_C,!LP 4!              !0$
M 4!  <EXD UU+^TW_P!W3OPE8#8    "@( H"#$F?MNK_=#GX,Z RP 4!
M          % 0    !0$   8,W]OT_[H>_!70&<   H"
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M"[.Q4A4M;3+*C;3L3LC-)9;(DZGX)06H*C^/_P# *K]R,_ZI -B "@ "
MH  @  H"   )QPK_ $R8A_NKC\#0 ]J     /SIK/V@U_O)/X6\*,H0   %
M0  4!      =C'Z\W_G%_C :G'/_ &]5_N=/^,P&R     !0$  %   !
M % 0  4<EXD(-=2_M1_]W3OPE8#8   *  (   PYG[;J_P!T.?@SH#, !0$
M         % 0       % 0  !@SOV_3_ +H>_!70&<     "@(   "@(  *
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M!Q"22MA+J6Y!+UZ[DI<0X@TGH9 (V*  ( #DO'],!K<?_P" 57[D9_U2 ;$
M !0$      % 0     $XX5_IDQ#_ '5Q^!H >U     'YTUO[0:_WDG\+> 9
M0H    "  "@ "    H[&/UYO_.+_ !B#4XY_[>J_W.G_ !F V0    H"  "@
M " * @"@(       Y+Q(!KJ7]J/_ +NG?A*P&P         8<S]MU?[H<_!G
M0&8 "@(              * @    "@( #!G?M^G_ '0]^"N@,X
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MC:W+"0TS$V$E1ZJZMK7J7H+4%5KIIT   4!!RGQ%&MQ__@%5^Y&?]4A!L0
M !0$       !0$ 4!!..%?Z9,0_W5Q^!H >U     'YTUO[0:_WDG\+> 90H
M"    H  @  H   (.QC]>;_SB_Q@-3CO_MZK_<Z?\9@-D* @  H"    H"
M"@(   "@(  *.2\2$&NI?VF_^[IWX2L!L!0$      %&),_;=7^Z'/P9T098
M                 *   "      P9W[?I_W0]^"N@,X         %  $
M   % 0    !0$&!8?MRG_=:_P5X!G@ H"    #@TI/J9==-#/ZGP .2(B+0N
MA%X$      &A:D?I+P     !1RGQ :W'_P#@%5^Y&?\ 5(0;$
M     4!!..%?Z9,0_P!U<?@: 'M0    !^=-;^T&O]Y)_"W@&4* @
M   H" *.QC]>;_SB_P 8@U..?^WJO]SI_P 9@-D "@( H  @  H  @"@( H
M @    Y+Q(!KJ7]J/_NZ=^$K ;     4  0 &),_;=7^Z'/P9T!EB@ "  "@
M(              * @"@( #!G?M^G_=#WX*Z S@     4! % 0   % 0!0$
M % 0     &!8?MRG_=:_P5X!G@     H  @"@( H"     * @ .4^/Z8HUN/
M_P# *K]R,_ZA"#8B@( H   (  * @  H" * @G'"O],F(?[JX_ T /:@
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M/[*^._G9>?P#\5 /[*^._G9>?P#\5 /[*^._G9>?P#\5 /[*^._G9>?P#\5
M/[*^._G9>?P#\5 <_P!E?'?SLO/X!^*@(I@'ERHKZJLI+N3W+1Q[JXAI2V4(
MB-,6>\TE1[HRO642=5>C7P 2O^ROCOYV7G\ _%0'']E?'?SLO/X!^*@']E?'
M?SKO/X!^*@']E?'?SLO/X!^*@']E?'?SKO/X!^*@']E?'?SLO/X!^*@']E?'
M?SLO/X!^*@([D/EOH:Z]Q2"C*+I:+.>^PM:O834@D0)#NJ=(Q%J9H(NNO0S
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M?_4!S\R5%I_X].T,B,C)N&9&1^!D9,^ !\RE?+T[[G#^\ 'S)/Y=G?<X?W@
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ML6'W:#^, 'ONW_-BP^[0?Q@ ]]V_YL6'W:#^, 'ONW_-B?\ =H/XP >^[?\
M-BP^[0?Q@!(N+K";,YEPQ,JIDUR4-7*D+D.1UI69PT%M+LN.&1EX]2T >P0
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MN4T[&?C*2M*%Z*2YZ>@"]P             !2_F-_P"$X?\ R@1_Z?, 4^
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M2:RU'GO+?CRT1S,V#=C.&@UMZZF25EHK34] $N      #T*_0/\ Q -)AO\
M[1HOW"Q_J$ W8      T>6Y75X32+R&Z0^JK9>98D+C()Q37M"]B7%D9I]0C
M,M3\>O0@&GM>4<;JK&SJ?9Y\ZRK9L:J;CPF"=.;/F-J=2S&,U$1FA*=737M)
M/3X2 8/TR8N]$JGZN!:VL^W5*2U3PHR%SV3K_P!L$ZVIQ);D:]$H-1J] "P4
MGN2E1$9$I)*(E%M46XM=#(_ R]) .0     !M^/?Z8L(_P RZ_ D /6(
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M\,2(UG,R_%\TK8><Q\QL\RQ^5,93(A-L7,!FODP)+27DJ62VV_UU"DJ3TVZ
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M;^R 4WYAK*NDU6(E'F,.FF_0I1(=0HR+W?,Z]# 5+WX_^W;_ --/ZH!WX_\
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M'';K+G,6$$VZAPR;N3,D*2HR+V-/CH9@/6@    #P]BG_M^'_G2?PIX!N0
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MP!\VN5OS\@?D!/X\ ?-KE;\_('Y 3^/ 'S:Y7_/R!^0$_CP!\VN5_P _('Y
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MGE;W'8T9XTM&I7UVA=-058(      >A7Z!_X@&DP[_VC1?N%C_4(!NP
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M_C&+\.XA.DV%-Q?EBG9$5^M2U/KK*R88@R_U^/':F/.H9;=U/>ELBU(]/B]
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MR2[E%*52XX7_ (G%-O;JZAEQ9);TT+3XP(LB9S+QY U]IM31MQL\W/[0^?\
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MI*R61(^KKX] $[P#+OGQBL7(5Q#KY2W'HLV%NWDU)BKV.$E7I2?B6H"2@
M  !Z%?H'_B :3#O_ &C1?N%C_4(!NP     !JLBR6EQ.L]\Y!).)5D\U&7()
M"G$H<?/:@U[2/:G7Q4?0@&LL^1<0J)=I FSG#GU$B-!E16([S[KDN:@ULL1T
MH2?><-*3,TH^+Z= &,_RI@S%?7629[TEFT[QQ6(D21(E)3$/20IUA"#6V37U
M^XNGHU 3!*DK0EQ![D+22T*+P-*BU(_\)& Y      &WX]_IBPC_ #+K\"0
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MU>ZSV%T-7M$O37[L ^/F1BGR;_")7WX!S\R,4^3?X1*^_ 'S(Q3Y-_A$K[\
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M&O\ *%A^, 4^@;BKY#7^_P"P_& *?0-Q5\AK_?\ 8?C %/H&XJ^0U_E"P_&
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M"/0EH5H?I K?_0-Q5\AK_?\ 8?C %/H&XJ^0U_E"P_& *?0-Q5\AK_*%A^,
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M-2,P'=F.37L:XSO#XTZT?RJTE46/4YDATDLQ&DH0_--:=&T>TN=/55N,U?
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M3<KLYN09#D#+3D:/+N)CA)DFPRZA"D-(-LFFRVET3KIU!%N
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MR /H0Y>_[]C'_F(!]"'+W_?L8_\ ,0#Z$.7O^_8Q_P"8@'T(<O?]^QC_ ,R
M/H0Y>_[]C'_F0##J> >6JJKAU35EC+S<)EN.EU16*5*)M.W<9%J1&8#,^A#E
M[_OV,?\ F(!]"'+W_?L8_P#,@#Z$.7O^_8Q_YD ?0AR]_P!^QC_S( ^A#E[_
M +]C'_F(#IF<#<L3X<F!(G8V4:6TY'?[2[-ISMNI-"MJTZ&D]#Z*+J0#IIO+
MWR?CU7#I:61C$6K@-%'BL$=DK:V1F>AJ/JHS,]3,_$P&?]"O,>NOO'&=>GRC
MZ/#3X 'P?"/+OB<_&"_P61_J 'T'\N_*&,_Z-C^J!#Z#^7?E#&?]&R_5 A]!
M_+ORAC/^C9?J@0^@_EWY0QG_ $;+]4"'T'\N_*&,_P"C8_J@1O,%X;SRCSNF
MRK);&G5 IFII-QZQ$OO.N36DLEJI\]I)21;NG4!?@
M
M
M
M
M
M
M
M
M
M
M
M
M
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MNH#L\>I>
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M_P"3^3N5)'($_D&[CVL6EGQZNL3 89:A]QLG>\XTIM)*4E9);46[X=0'J,
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M7J6JE:&HB!'Z_MMH:0EMM))0@B2E)>!$DM"(!]
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MVUDR8Q'ER=5;2[++BTK7J9:>J1]0&\
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MK.8N3(N5'AF:\?,5>0WM1/N<%C0[9N2W->K6R6NMENJ;2EE\MR-SI:M>MT\
M&9SUF68XQY=KW,Z_7&,X8@5SRFVW&I?L$V5)C-O,DZ:3;<)!N+;[FW:9>L @
MF=>8:_9\NS&04+?L?,-J<K'WJM/:-VON:A#JKAY;:C42416H[SY&HC(B-O7H
MH!$\CY)SA1X_)SG/+KCO%)V*4=CB>75M8W,K)M[+B)<E+MW29>VDEPTZ1S[:
M%(,S-2>FI4WDNY@[S-@%%-S>=)BYSB%H=Y[DEDBH]JBQ64-SJM&Q7:4HW%/)
M7N66NTRZ>(37RL7U[DW"-!<9)9R;BX<D6K#UC.7W9#B(MI*8:WKT+4R0VE.H
M(CV2<VUO'OF!N,>SB]D0\//&*Z760&H4F<V4]R9(2ZY^PV'EI,T)(O7Z'Z %
M9XYRIFO*$V/A%7ET^%59MR1E%?!R*&V46QC8M10&[!$2,;C25L+7NVI6M'<1
MUU 63AW)#W%3O+&,\A9#,O\ 'N-W:N137-@:7[F3&O(G>9A+4DD=]\GB-II1
M^LO<6NA> 13&K?EK)&^9X6?7]A1VS6/5&15U=3N^S+QY4IN;*;A,/&V>KA(C
MMMR5[?75O(O\H!>O!]M9W_#V"7MU*<G6]E15\J=,>/<XZ^['0I:U'Z349ZF
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M6]SN1DL/E0H\*]II4*(Q&B/2ZTY<=Z";*$J;-HRT<)1J)WQ/;Z MC,ZR]H.
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M=H>JJV*Y!KXL)Z0N6]&9;9<E._KCJFT$DW%?])1EJ8#*
M                                                           !
M&.0,0>SC%IF/1+RPQN>Z;;T*[J'39EQI$=9.-J+3HM&Y)$XV?1:=2U+74!5[
M'EZM+]67VO)N8GD6595CB\-38UU<U4,Q*I:E.ZDPEQ[N/&ZKN&M:M"^*DB2
MVN+\,9#67W'N2Y1ER+RWP.OM*@G6JU,!,V-8(9;9-24/K)M3*62W:$K>9_6@
M(I<>6K+%UN3X/B7)+^/\494Y-E2<=]VLRI<9RQ)2GV(\Q;J33&=<5N6WLUVZ
MH)7KJ4 RKWRQ'=T5_3?.DXZKW&<<Q<WTP"5V?FV\3WM!)[Y;N]IILU+9_E*
M3W.N,K'*LRQO-ZC(/<EOC%;>0*]1Q$3"*3=QFV&Y!DMQ*3]G4V3G;-)DOP,R
M!'7R3Q=8<F<.SN+[G(=EM9PH,:QR0HB?MLF&ZR\Z_P"RI<0E/=4T?J)7HG=T
M\ 5%[[RU45QF.=9<S:JBGF-)8546N]G)R/66=S$1"FV;*>XE)NOM,LI<(DI-
M6U6JSW= Z)O!.?0:Z%587R<_55SF/P,8O:ZQK6K: ZW7Q2B>UPX[SR4QG5HW
M;T^NA>OK$>T@&]H^"*S&LHXYNJ2T<;J>/*2;01JY]KNNRDS4-I[RW]Z22HC0
M:C239D9GTVET!6EXQXUSSC6WQ+!HEHN3QIC5;=3[.T0AF.5K<W-FX]'BN1U+
M=<0F*RM:]Z%[5*,M?@(B?0./#A<L6_)_O,UE:TD.B.I[.A(.%(=?)[N[SUU[
MNW;L+3X0%>N>6UQN)<RZG+GZS,GLVLL_QS(68;:SKG[1M++D-QA;AE(84V2D
M.:J1OU+PTT,-K2>7/%GZ>YC\H2#S[(LDLV;N]N);9UY.2X3)QHB6&8SA=EN.
MT9H;3W%::GU\- UM!Y5\#Q;)LOR+'B*#\XJ<J6JCE[0Z=83C#S,EPENR5]_O
M&XE6U:2V[-$GU,!:/'>)?,+!,<PKVOV_YOUT6L]M[?9[WLK26]_;W+V[M-=-
MQ_H@),                         I_*^-.0,FR^VO$\GVV+8E[/%345-&
MF,@VUM(7[4Y(5)8=W;E;31M\.NH*IM64\;(-1+\U]R2D_&2<BL)1:'H9:>Q:
MZ_4 7[P@Y,>P9,B3F[/(41^;,<J\F94VM3L WC)EIY31)3WFB+:YHDM%=- 1
M8X   ,:? AV<1^OL&&Y<"4VMB5$D(2ZR\RZDTK;<0LC2I*B,R4DRT,@$"PS@
MCBKCZU=N\3QY$.S<95$;>>D2II,1G#W+9CHE/.I8;4?BEHDD?AX= '&/<#<4
M8HY"<Q['DP?=MFY>5K2),M3,6P>96PMQEI;RD(2:%J+M)23?IVZD0!F' W%&
M?9 WE.5XZU.O$MH9?DH?DQ4RF6C(T-RVX[K;<E!:%ZKZ5EH6WXO0!S&X&XGA
MUD2FBXZAJL@U=GC\2.F3+VMU=XLW)S!&;VNCJE*]8SW)U]0TD W;W&V%R&,5
MBO5:5,82II>+([KQ%#4Q'.*C31S[9HT>S[;N^'QZ@.:OCC#J;!3XTK:[M8.J
M'(K%52GGW2.'-)9/-F\XXIWU^XOKW-2UZ&0#JB<7X'"N*;((U*TBZQ^I^;M-
M,WNJ<CU6A$4=.Y9D9$1:$M6JRU5ZWK*U".6'ESX:LJ6DQ^1C*6Z_'&G(]*N-
M+FQ9<>.^M3CC)2F'T/J;4I:C-"W#3U,!(8G%F 0',3=@4;$0\&3(3BB(YN,M
MPBFLFP_M0A9)6;B#/<;I*,S];XW4!'6>"\7@YW0Y=4G[!74<NZN_<R.XZB3?
MY E#3\YUQYU>FUM*B0VE.TC5J6FF@";JQ#'EY6UG"X23RMFO73-V6]S<5>X\
MF0IG9NV:&XDE;MN[ZN@#42^*./9[&4QI]$Q+C9JZV_E#,DW'FYCK#:6FUFE:
MS)M2$H3M-K;HHMQ>MU =N \7X)QA!E5^#4[=4S.<)^:Z;CTJ2^XDMJ3=D27'
M75DDM202EF2=3TTU,!LBQ&@3EB\Z*(7SL<KDTB[+>YN.N0^J2EGM[NWH3JC7
MNV[OJZ (/BW!6+X=FE5D="?LF/XY3RJ;&<;(G'68+UG-7-G2TO/.N+-Q\U$W
MI]:DM"Z'H03:+AN.PLIGYM&A$C*;.*Q7S[#>X9NQ8JE+:;V&LT%M-1]4I(S]
M)@.,?PK&L6E7D^B@IBS<DFKM+R0:W'ER9;B20:E&ZI6U))21)0G1"?01:F T
M=%PUQMC)XP=%1IAEACMB_BZ4OR5I@KNB64W82W5$I+N]7JKW)3KZA)Z ,.%P
M+Q'79FKD&#BT5G+%2%SO;"4^;*9CI:+D(BFX<=#RO$W4M$O7KKJ 7? G$>1Y
M:6<76+QI62]QE]Z0:WVV)#T;]9<DQFW$L/K1]:IYM1@.S->#.*N1;B/D&:8V
MQ:W$9M+"92G'V#=90K>EJ0EAQM+[9*ZDAXEI^H R,?XSB4O(N1\B.RRE2[>#
M7TM1")E++=755R5*5&9-*CU2Z\LWE>JG3H1%T ;^EP_',>M[V_J()1K?)7F9
M5Y));BSD/1VB9;4:5K4E.U!::())?X0$3O\ @/B/*<I^>=_C$>;D"G&7I+JG
M)#<>4[%_6ERHK;J8\A2/ C?:7TZ>@!@7_ELX8R>\M,ENL<6]>W:^[:S6K*SB
MK?42226XF)39$1$DM$D6A>@!9M971*BOBU<!!MP83+<:*T:E+-#+*"0A)J6:
ME*T(BZJ,S/T@,H
M
M                =,IMUZ.ZTPZ;#ZT+2T\1$HT+4DR)6A]#T/KH \2NX?EC
M/'4/@ESCI-1R1#L(\ESE-UV#[J;>1.3(.Z1,4X4E<ATB_6-A+];8?J^J!'H;
MA?#[F@N.0<DL*9O%JO*[M,RGQ5A;2T1V(D9N(J8X3!$VAZ<ILY#B$Z[=4[E&
MK< MH!@W-Q6X_53;RYDMPJBN8<ESICQ[6F6&$FM:U'\!)(S :7CS/\>Y0Q"O
MSC%5NN4%IWO9%R&S8=/V=Y;"]R%=2]=M6GPEU 2@
M
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M\LJ<JNW*ZPK9D6-&9-AJ,MT]3;W&>IZ? "O5X(
M
M              CN<Y-,Q'&IEY6T<W)+-K8U!HZQ)*DR9#ZTMH3JKU4((U;G
M'%=$()2NNF@"K&Z?S27[1V=KF&+X(DR);5- JW+OMI5X(D2I3[!&OKHHVD[=
M? !N\,R+FFGRF+A_*-%!M:^P;>579QC!.HA(7'0:^W8Q9!FJ.M9%HA:%J0I6
MB2^H%L+0EQ)I61*2?BDRU(_\!@(]4X)BE'D][F=36HBY-DJ8J+R>E;AG(3 ;
M-I@C0I1H3M2>GJ)3N^NU 0WS,?T \B_Q',_U 5)^*OZ+\)_B"J_ V@1+@
M                                              !5W.ZVHF*U5S[F
MK[N=37,.QK(]O=_-R*U,9)PFWCDF9)6:=QZ,KU2O7P/0!Y-BXSB1SX[OT78N
MAPWVU;RY9DKT4;A'J2/:-#/7J2=!%?H&*@   "@N?/Z4^!?Y3ROP%8+B_00
M
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MDYMR#D<!63..28M=*Q>#"QVQ<;WO*KXEBII+QF39:;]"W;3VJ/H ]F
M
M  \^\\6O"U;DM6GDWD6\PNX7!,X<*FL[&N9>C=Y7VQ:8:%)4K<1IU4>NA?4
M9GE=<7(QW*Y5?:76085(OWEXCD>2O279TZO]F8)2TE)];LH>)QMM>B=^FII(
M]2 7L  *J\S'] /(O\1S/]0!)^*OZ+\)_B&J_ V@$N
M !5//^$WW(V*4F&5,,IE/99'3JRU/M!15(H(LDI,I:%;DJ-7VM"22@]W74O
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M "Z0
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M
M                                     >9/,#>R./\ D:EY#HK9>,7O
MN5=/-N[NHF6F(2X2Y9NMQ)4B 9NQ9+;FYY"MI)4D]#5XD L?@G'HU=CUIE#F
M61,WR',)ZK>]R.L-OW>X_P!EMAJ/&2TM9):CM-H;3N5N/J9Z:[2"U  !57F8
M_H!Y%_B.9_J J3\5_P!%^$_Q#5?@;0(EP      ^'6DO)-"R)2%$:5)46I&1
MEH9&1@-%CF#8=A_M98EC];1%/<[TWW9$9B=YSJ>YSM)3NTU/34!(
M                                 $4Y#S7#<#QURWSNR]U4$A90%RMC
M[AFY)2HDI(HZ'%D9D1]=.@#P^C.*.?AL/R]3.4\47Q&A]B$5TS"MBR=ZL8E(
M>;A^R^S%'1)-1);4Z2NA>MMW /T+     4%SY_2GP+_*>5^ K!<7Z"
M
M                               "E.;).:LVF+5]?FR\-P[(K"-CSCE5
M6MS[J1:V"G#0A+T@^U&8[;9_;DH4M*O1U+0)IQ?Q1B7$5')HL2;D&W/E.6-G
M-FO*D2I<UXB2MYU1Z))1DE):-H2GIX )N  *J\S'] /(O\1S/]0%2?BK^B_"
M?XAJOP-H$2X
M 8E@ZVVSVE2TPW9.L>,\HTZ]YPC)&TE]%*UZDGT@/&J,4Y*>XP@<"-8?709D
M6Q8=^EM%O"5!2XQ.*2=NR@E^UG.<V[=AZ+WJU,]G0#<>U0    %!<^?TI\"_
MRGE?@*P7%^@@
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M7-LSY)RGESA-K.>-7\'C1\D?5$EO6\&T*0M4)9*;V1/609%ZVJN@#U^"
M                     "&<M7^18MQKE628E"]X9)55DF76132;A*>:09DH
MT%U7L^/L+JK33T@/%7DOY^YLY!Y7EXUE5G(R;&9T:5863TAM!E7.(+5MQI;:
M4]M"UZ-$S\3UM4D6@#U=9^9CA:GY!1QA8Y.RSEIO)AN-=MXXK4MP]$L.220;
M2'->AD:O55ZIF1] %M
M                        #1Y=E^/X)1/Y-E,OV"ABK91+G*0MQMGVAU+*
M%.=M*C2C>M)*5IHGQ/0NH"IL[P_E"_Y"H>6>$;G%TL%1N4\UZX.5,CV45Z3[
M2TG6&9I[;:O7;6TM*MRE$9J2>@"%<?M\R\?\H)Q3)LKP*SO\ZM'+R_BM(M7+
MYZ,Q'0E9,I1M98;9CLDW'[R"2>GBI1F"O0?(=?E]KAES68#8QZG,)D93%59S
M"4;,9QPR2IT]B5GN2C<:/5/UM-2T!%.>6[AGD_AQR?6Y7/QV=C\YIV1)F534
MM5U.MG'R64B;*E$1N$2%.IT]!F6A%ZQF5M_,5A.&UW!O(5A QRJC3FZ28MN2
MU C(=2LT'JI*THU)77Q+KJ L7BKIQ?A.GR!5?@;0(EP            "'<J<
MCTW$N!7.?WS3C]?4-)5[,QIW7GGG$LLM),^A;W%I3N/P+J ISRV^;>KY[N;7
M&)6/JQ[(8+"I\9I,GVQB1$2XEM7K]MHTN(-:=4[=#+J1^@!Z4
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M"()NH*0;)'M-PF]=VW7INTT 9H
M                          #IE16)K#L64TA^*^A33[#J2<;<;<+:I*DJ
MU(TF1Z&1^("D)WE<X4<L7SIX\_&)$@E29E=CUQ,K&'&UJT-1Q6GMB$:]/M:$
MI!4YXYXHXTXYBO.X#2QH:[%*5RK8G%S)LM*M%$;DQ];CJT&9;B3OVZ]2($3P
M  55YF/Z >1?XCF?Z@*D_%?]&&$_Q#5_@;0(EP            #19EA]!GV,
MV6'Y3%*;06S)QYL8S-)FG4E)4E23(TJ0HB4E1>!D1@*[X9\M'&O!<FRL<.1,
MDW%F@F'[*T>3(?1&)1+[+?;;:2E!J(E*]74S(M3Z$ N$
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M7IV<?-B>,H"(7?[B5^T:^J26O4[&F[3U"29 /T\
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M\ME)5+D_>;9-)=W[]#66Q+AM[#/T[?6 >A
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MY)-O5[L9+9,(JD,FHR;U)E*$DHNOJ /<0    "@N?/Z4^!?Y3ROP%8+B_00
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M3=2PJ3O]:.E6G3M[S3ZIG]<8>Q
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MKJD;3TU[>P]P#]!P    %!<^%_\ ]2X%5Z"RB27^$X*P5?H(
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M6@#=XEF[N6&\HL8O*..TA*T/WD5$'NFI1EM0WW5N:EIJ>]"2T\#,!+
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MI*2_^@#8@
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MY+I.%:BOY3*2W>-NO>[XMAK[;'K-4E':?W>L2BT6:4J]9*#2D]--""\
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MI\):Z:@,B5RMQ["GO5<K((C5A'MHF.OQU*5O3;V*.Y&BGHGX[B2,R]'0]3Z
M#/*W'LB:S6LY!$7.D7$G&66"4K<JY@IW/Q"U3\=!&6OHZEUZ@.B/S'QE+CU4
MJ-DL-R-=LV4FI=)2MLAFDW'/6CU?!@D*WZ_ >FH#F5S#QI"C^URLDB-1_<C.
M5]Q1KT]QR7"::F%ZO5M:S))>G4_ !]3N7N-:WWM[=DD-CW$JM3;[EJ_8YW:2
M5 )>B3_7TGN1IZ.IZ .USE7CYI]45S((J9*+QK$E-FI6I7SZ=[<+XOZXHO#T
M?5 <P.4^/[69!KZZ_B29ME/FT\%A"E;G;"K0;DMA/J_&:26JM>FFFGB0#$A<
MR\86,&'90LGA/0+"OG7,)]*E;'*^I6;<Q\C-/Q65)42M>O0_@ 13DWS,<;<=
M8<]E")J;V6JOA6U93PE&EZ7$M5FB(Z2EIT0VLTF9J,C-)%\4ST(Q$,X+\Y.&
M\I4-Y8Y9%1ATW'3BG.-Y\Y,-;,]\HS"T.DVE1&;JDH4E2>FI'J9:Z!=#O*O'
MK$M<%[((B);=VSBJV34K<5Y*1O:A_%_7%I(]/1]4!]0N4< L;"#50,@B2;&S
MG3ZF!':6:U/3ZA)KF,IT+3<TDMQZ]#+3374@&)%YDXQFQ8,V)DT-V+9U\VY@
M.I4O1VNJS4F6^GU?BM&E6[7KT/370!T6'.7$E2VR[:9A60T2*EC(H_M#_:4Y
M4ROUF0A*B(U$OZU*2W'\ "#97YP>%L8@3["/.G9 Q5K:8L5T\%YQIAZ42SCH
M6\^3+6KQ-K-K:L]Q)-1="U 1'%/-1:\JU[5K@:,<QJ"_<1L;83ELN6]8.6,\
MC7&0F)!92G[<E#A-ZR>IH/KT 2&K>;R^7"@Y!SG+GNW$R?655=BS$?'VUSZM
M!KF,I=2A^0KLH+74WB^$C/4%?>/U/E34Y!R.+[JOI=C7S;B!:W;LBZ>=@U3B
MBF26UV!O[.TM"M^TDGZIZ=" 6.WRQQ;65QN-Y# C5D2ECY)HWJAIJDE*)+$G
M:E/JH69D24Z;O#H".^?R[QM5N6S5CD<..NA77-7!+4K]C+ND[H)+T2?Z^D]R
M-/1U/0!YJ\XWF5R?"Z>!5<0VK3+WO*959/>1VT/NP9L)MIPH7VU*D(6LG#49
M[3/U-$GT4 FWE2Y\M.0^.J57)DQEO,;.SG4]'(4A++EPFNCHE..I;;22"4VE
M:DK,B2D]OPF MMCF7C"3"A6+&30UP;&NFW<)_<LDN5M69E+D%JGHAK:K=KUZ
M'IX .9/,7&4.(J=)R6&U$13Q\F6ZHUD14TU9-,2OB_$6LR2GT]? !-6'VI+2
M'V5$MEQ)+;6D]4J0HM2,C^ R =@
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M)=WU]'E3'I>0N1WI;,F2MZ,T<1DF$E':4>UHE)+59)^,KJ8(WH
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MZ==P*]@JI*E:.VJ#&4V;*8IH-ELTG'0>J6C+3XA>A/@0(V!$1$1$6A%T(B
M
M'F#S 835\J\FTN 56(T=SFT6C7<RKW*9%DB!#I_:U1T,LQZU]E;KSCYJ/<:B
M2A*>N[4B()9Y8ZRFQFARC"(N,0L5R3&KI43)8E1)E3*R3*=BL/-2XJY;CKJ6
MW6%M_:UJW(,M%=0%Y@ "JO,Q_0#R+_$<S_4!4GXJ_HOPG^(:K\#:!$N
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MLV]=Q)ZEUT 9@
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M6E;/J>S>/_9F1%KH5^G8(
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MD[EJ\5'IXF?I,!V .F5*8A,.RI3B&(K"%.OONJ)MMMMLMREJ4HR(DD1:F9^
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MG7D..*=CJ6:Y*VVE*2CH>Q.OK*Z]--#,/9(
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M/Q,+A <$6FI^D^I@.0
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M*7HN.Q;%MAJ5,L>[[5[I<DK2EI/;[RFDF70DD ]^     *#Y\_I/X&_E3(_
M5@N+\!            $&Y2XAP'F.B:H,]K"GQ8SG?A2&UJ8DQW3+0U-.H,C+
M<7123U2KTET(!Y<\TN49!Y6^.\/P?@J"6+XW9/RO;KMI)2'RD-$VHFS<?)S[
M8]JI:EJ];:C:G0B,@5<7E"Y+SCE7B!C(\];)RU8G2($>T)HF/;XT<D:/FA)$
MG<2E+:4:"(C-'PZ@B^@
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MOW\AN.TY$JM["8C<5E_HXI24K<WN*26W=J1$6O3KT#TR
M     ^7&T.H4VXDEMJ(TK0HM24DRT,C(_$C >9<-X2XBO[C.\ B-WY0\9MJB
M+9,SK$Y$9^OCM'91:E@E$I2*U"Y*EJ8Z*4LB,U'H0#TX  *^Y4Y@QKB:-4>]
MX=C<76023@T-!21O;+&8^@B4LFVS4A.B24G<9J+Q+Q ;'C/DK'.5\6:RW&"D
MM0U//1),.>U[/,BRXRMKK#[>JB2M)Z:Z*,NOB K/GPC/D_@;0O\ ^*9'X"X"
MXOP$             &#;TM1?PEUEY C6=:X9&[#FLMR6%&D]2,T.$I)Z'X=
M'="A1*Z,U"@,-Q84="6H\9A"6FFVT%HE*$)(B21%X$1 ,@
M
M         %#<K9R_*GY+@/(N!SH?"*H#GOOD9-BEF,4;V0I!I2PTCO:J=TBD
ME*MRE'X&1@JK_*8K",HY*R7D3#RIL:JWJ5JCQ[ ZV0PY:>ZX+[9'96C3*E;7
MEJ2A&JM5^MZQGT4LC/YT/S5_1-G/SI+CTL1]US/>!UWOGWA['H>O9[WVON[?
M#=ZNH)E;S 3\X)8)BWN1/&YT_N>O]W^U^_/:?9O9F^UW>WZN_;INV]-? #:D
M.[SJ_P"3QC^G?BIUSN\ZO^3QC^G?@=<:^=7_ ">,?T[X#KG=YU?\CC#]._ Z
MXU\ZO^3QC^G? =0^ZY(\V])R'BW&\QGCQ5[ED>PE5SK*;I4-"*QLG'2?4I1+
M(U$?J;",M?$1>IAKYU?\GC'].^%3KG=YU?\ )XQ_3OP.N-WG5_R>,?T[\#IK
MYU?\GC#]._ ZYW>=7_)XQ_3OP.A'YU=2U3Q@1?#_ ./@=0_CSD;S<<CP[V91
M,<=M-T%W.QV84XKI*E2ZU24NJ:[2E$;1FKU#5ZWPD(O4PW>=7_)XP_3OQ4ZX
MW>=7_)XQ_3OP.F[SK?Y/&/Z=^!TW>=7_ ">,/T[\#KG=YU?\GC']._ ZB')_
M(GFZXKPFQSK(H_'DBIK51D/LUR;IR6HY<AN,C8EU24'HIPC5J?Q== .I>9^=
M770D\8'^7P.N-WG5_P GC']._ Z;O.K_ )/&'Z=^!TW>=7_)XQ_3O@.N=WG5
M_P GC#]._ Z;O.K_ )'&'Z=^"]=6 \B\U)YK^B;EB/C'V_&W,EBRL7*?ZO;F
M(B$A9S%:ZGN49D2?@ZB&/0(*              "N^;<[N^.<"?R7'(46PNO;
M:ZOAQ)ZU,QEN6,UF+ZZT&1IT[GQO O3T 4I-YPQKC^HY'R6)0R,9YTEK@V=Y
M@^3.J-$A;*F*[NP7V=&Y+!-;C)<=1F>W<:2(!ZO 8U@B2Y#?;A/$Q,6VM,=]
M2=Z6W329(6:?223T/3T@/)G(L[S3\<8<] =EO<FYE?R"9J;ZBH&]V.PFVS3*
M>)$=M&]][N()@EZ%ZJCU] *GG#G']3<<%G@]:UFN!$Y+<5.M)ZCH\IDS">1(
M>F[TJ>V)?5ZOB?J:IZ^)D57R[P2Q0YWQ'6'R-GME[]R!Z)[78Y Y(DPML-:^
M[#6;1=ETS]4UEKZNI JW?[,+/];_ "A_.IW[R"']F%G^M_E#^=3OWD _LPL_
MUO\ *'\ZG?O(!_9A9_K?Y0_G4[]Y /[,+/\ 6_RA_.IW[R ?V86?ZW^4/YU.
M_>0$,:\O6<JY3D4CG)7)">+44+<MBY^=#GM2KU4LT+C[MNNPF")6G;TU^N]
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M.IW[R KKG?AVSXPXDR?/,>Y:Y'>N:6.T]$;FY,^['-:Y#31[T);09EHL_KB
M>IL7<=?QNGD/N*=?>@Q7'75GN6I:F4FI2C/Q,SZF8#;
M                                               P;>FJ;^O>J+R#
M'LZF21)DP)K*),9U*5$HB6VX2DJ(E$1]2\0&HH>/<#Q2:[98KB]116+[9L/S
M*ROC0WW&C42C0I;+:%&G<DCVF>FI$ ^>1<,8Y#P:_P (DRUP8]]"=@.3&DDX
MMI+Q:&HDJ,B/3X &RQBC;QG&Z?'&GE26J>#%KFY"R)*W$Q&4M$M1%T(U$G4R
M(!M0     !TKBLK=1(4V@Y#1*)MTTD:TDKQ)*O$B/T@.X       $$XMXRB<
M7P<B@P[%VQ3D-_89(ZMYM+9LN61H-3*229ZI3LZ&?4P$[      '5(CLRFS9
MD-H=:/XS;B26D]#U+4CU+H9:@.T       $#7QC$7S"WR\=B[[<UCRL8*KV(
M[/:7+*6;V_XV[4MNWP 3P               &GR7%J',*TJ?)(2+"L)]B7[,
MX:TI[\1U+[*]4*2>J'$)5X_H@-=G'&^#\DP(]9G-'&NHD1TI$3VA*B=9=29'
MN:=;-+B#/:6[:HMQ=#U(!*0   :;*,LQO"J=W(,LM8M-2L&E+LZ:ZEEHE+/1
M*2-7BI1^"2ZF UK<'!.26,<S-A,+((U:Z=EC5NPYWVVW5I-LW&EH/3735)D?
M@?HU( I.2\!R6_L<5Q_(ZZSR2HW>\JN));=D,[%;%[DI/KL4>U>GQ5=#T,!*
MP             !%)7)> P<NCX#,R2N8S24E*H]$N2VF8K>DUI+MZZ[E)+<E
M)]3+J1 ,29]&O$<:YRRQ=K\7B7TY,NZM)+I1VY,]XMJ5+4M1EO41>!?5,!N<
M3S3%,[K%W.'7$2\J4/*C+FP'DOM$\V25*0:D]-Q$I)Z?5(!O0
M  !#I+_'G+55D.'O/PLDJ8<CW7D=:ASNH;E,J2X;+NPRT4A22/H?0R^$@'S*
MY$XYQ:^K,!L,AK*O(Y;;3=71/26VI"D'ZC24H,]2W;=K9'\;P+4!,P
M                                                          $
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M!QG9Y1;910JQ:FR=A^]DJG/L3YJ&RD$V\OUB;<4X:R;UT+],S*]3@@
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M ,R-1I)H]%FW\)$?70@'Z.Q"?3':*2>L@D([IEX&O:6[_P"H([@
M                                                      :^\I*O
M)*B=07<9$RGLX[L.?$<UV.QWT&A:#T,CZD?B1Z@*=Q_RI\=8W0Y%1PK2_><R
M*"Q3N6\JQ[MC"JXBR6S#A.]LB9929%ZFT^A:'T =F2^5;C'*[Z%?VKUOW&X]
M=$N8+4]2(=VW3["B^]&S09OJ03:?6)2== %VI222T+H1="(NA%H Y
M      4XORS<:N<D?24H[(Y?O/YP'CWMA^XCN]FWW@<3;^V/KMV_37T ,>U\
ML."6]%'J'[G(FI\"YEY%4Y$Q:*;MX,R?M[R8[Y(T2V>Q.B309EXZZ]0%@<=<
M=8QQ;BT;$<286S5QU+><=?6;TF1(>/<Z^^X?5;BSZF?0O01$1$0"5@
M      (;REQGCO+N&3,%RIR4W2SG&'7EP7$LO[HSJ7D:*6APM-R2U]4!KL@X
M8Q'*;^YO+]V?/8O:+YL6%*[)/W8<(W"=[B&221I?)22VNDK5/HT,!A\4<$8;
MQ Y93*"59VMO:HCQY5M>RO;IA0X:=C$9M>Q!):;3T2DD^@BUT(M L\
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MZ),@&X
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M1J:6>FY!F?JJ]) ,P
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M;)YU3I1X_>6XX3#)*[36]9GM(O#P(B?
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M+A@PHM;#CU\%I$>#$:1'C1VD[6VVFDDA"$D7@22(B(@&0
M
M                  Z)D*+81G8<YEN3#?2;;\=]"76G$*Z&E:%$9&1_ 9 /
MMEE##:6FDDAI!$E"$$24I2DM"(B+H1$0#L
M
M
M
M
M
M
M
M
M
M
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M=V@#[K;6LN8WME1-CSX>XT%(B.H?:W)\2W-F9:D S
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MP+@S&,G?9J^+YE3*R66Y8L63U3-MYDJ0[LE%6FF0I26"80@FS]3=KT2I1@C
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M.OBQ+")5NRVEF?>AG8NNNN(0@C(S6>\M^A^&@*]J @
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MC-"E;C#].*5MQJI@MO/O2G4QV4KDR4DA]U1-I(UN)(B(EJ/JHB+Q!&>
M *#JL.\T<FJCS[WE2FI[)Q!KFP&<<8EL1U&H_42^J2WO(BT]8TD ^;?$/-+%
MJ'[#'^4J:\M&TI7"KG\>8AQY![R)2%2$R'=A;=W4DGUZ =7\
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M!.4(,NRP.Z:NH,!XHTMYE#J";>-)+))DZA!^!Z] $N
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M9B&:9;<>5"C3%PG43*V4ZN.^TAYI;;B&U)6A1I-7H(!ZV+70MWQM.NGAJ Y
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MD3D63;PJ?+KR!DTVGYGI,5:L/=L,VBA%!>-PV6U(7V'S4C<I;:M[:]Q)41=
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MO4QK;-*.VM\2B7[^-4&.,VI&DLCL/;9\F6_81F#,D[D---Z::>MKN >S0
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M+T: -'/X>XJM;1%W:X313[AM+*$SI5;&>?VQFTM-$:W$*,^VA"4HU^*1%IX
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M>GZXS,U:F9@-N?'.%G27V-G3L>X\HDRYN00BW]N7)L3W27'#W:[G#ZGM,OJ
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MBM/53YM/FO'T@G3@NS&TF2%>S2%K]F<(U-OMNL'M<;]73JH!Z
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M#0Z\\LT73CBG5/:FO4TFI1F;1_:_#U>A ,ESA[ '9JK%RM4<M>1M9HI???\
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M2DNJEJ,R2A)=5*,B+J8#C#<MJ,ZQ>JR^@4XNEN8Z)D%;R#:<-ISPW(/P,!O
M                                                    $8SW!*/D
M>@5B^2+DG1//LO3HD5]48I;;"R7[.\I'K&RLR+N)29:_" J'DSER-PF^UAO'
M6&0EP:>+ M,E6T2*^NK:RQGIKHY-ML(U=?=7O-*"TT2G4]05N^+*G"LSR2QY
M*BXN>&\CX].L<5RF#"=2EF0\SL67M!LI;;E)-M;+S3JD;BW::F22!%U
M                                                    /)GFSC4;
M=HV\QDI4.5WV/2<>FQIE19VU?+IG927NCE<RZIA]IY.Y"NNXCT,M %@>6BSH
MLGK<LS>'D2<HRB^M&SRBQC5TJHKV94.(U'9AQ&):$N=MAE*$FI>JU*U-74]"
M"\P&CBYAC<W))^'Q+..]E%6PU+L:EMPE2([$C];6XDOB[M2,O3H9'Z2 ;P
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MS#\<XG,Y)R++Z3)8%[(L(-V^A;!*@1DJ:VI01$?K*W=?#0@'J<$
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M-N09WFM_@668))PN_H(,:R>9D6$>PWM3%&ELM6$)(C,BU\3^KH N0
M                                            'F/DSS2U='?JI\!S
M#"$E7J>B7C&4/7,>2U.8=-M2&_8H;J#2G:9&9GX_4!4F\LUE79'7YCF2,IJ\
MER'(KA,N^;QQN2S307FXK3#3,<I2&W%J-M"5NNJ21K4?7PU,BS>1[W(,:PB\
MO<4IG,@R6#$6Y54[)&I4B4>B6RVIZFE)GN42>II(].H#QUY3Y-S3<_Y+ R"@
MR-.4WE#%E978WB&D.MVBU+E/ONH09$TPZLR:BI3UVD6I%KT*MS.3\V6*T>39
M:SE>'KIJ2)/M6XGNV6<A46&VX^EO4U;=YH1M^#4!<?%>16.7\;8CEEP396MY
M3P+*83"30T3TN.AU6Q)F>A:J\ 1+P
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M<=Y.E4\R'R-!LIB*>KBN1GJ*35L(D]KO*=<]H0:7"0M2B(^Y\7U?C!Z#
M              'D_D7E3EFZO2<P>JY-Q&KBM*C/0XV%4MLT^^AQ6LA+TR:2
MR)2=").FG37T@+5\NU8S7X/->.OR6'<6=M+L;V3FD9F%;3K&0EON2>S'6XVA
MDTI0VTE!Z$E&GHU,+; 17.N.<.Y(HGL;S&M385$AUA]YDEK86IR,LG&S-QE2
M%]#+PW=? ^@"4)2E"22DB))$1$1%H1$7H(!0&$_\W/*'\FZ'_K KT""
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M42LJ@UJZ.BJ<<:D)JX4=]Q+TB1OF&;JWWS2E!]$DA"=/6UU(+>
M        'DWG:LXSD\ZU<KG"3)I<"7C7:H[%$F9"A3K1,IQ3[$E^*M.U;#1H
M<:1ZN[<>JE=$@)QY2X<2'QY=E2IE.X<]DMH]B-K8][VNQIE=HF)3G?/=H:B6
MV@]B-R$)4:2,SU"^@   >?<*_P";GE'^3=#_ -8%>@@0
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M_P#-=PQ_%.3_ (,V"K_!
M            'FOS"VE#7Y)!9JLRR.OY,EP$E"PW'ZTLHBSX:'E[7I-/(0<<
MS2K<1/*=:46G170M M+ABUY.N,)8F<LTT:CRCNJ;:C132DW(24([+SS*'7DL
MNK,U;VDN*).GH\""P@   >?L)_YN>4/Y-T/_ %@5Z!!
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M*XW5;+R-KCM:VDU/O-Q_VI7=4E'==C$^?>3%4KM[^IZ^ "[P
M     !2G.,+&JB\X^RR;C=3=9#89-48DW-N&/:CBP+1]:W51D+5L0^1H]1S;
MJ74O !=8   (-S5_0YR'_)FZ_ '@&+P)_0?QQ_)FH_ F@3%A@H
M                         "'<G87A&?8C+H.16R=Q+<B7/)<MV TDHQ[R
M4X\TXT9(2?4]RM %)T7E_P#*%D5BY Q:7$M;AQK<[&J\LG2I2F&C(M5)9GJ6
M:$F?IZ$!7H^FJ(5#50:2M2I%=71VHD1MQ:W5I9802$$I;AJ4HR(B]91F9^D!
MG  #S_R'_P UW#'\4Y/^#-@/0
M                  "KN5T94Q?<<RL8.6S!/)H_SK?A&;;9U2(DK4I:BTU9
M)Q2.BSTW&7IT 6B     \_83_P W/*'\FZ'_ *P*] @@
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MA_R9NOP!X!C<"?T'\<?R9J/P)H$SQ88*
M /*O-_DDQOF+D-6?MY-(H'K!+*;N&W%1*)]3"":);*U.-]I1H2E)ZI66OK?4
M,/2V.4%=BM!58S3H-NIIH<>N@-J/<I,>(TEILC/TGM26I@-H   "D/-93'=\
M6M1Y5:_9XU'NJN7E2("%NV#-(Q()4M^(E![NXA.FID1Z(-9@*RX7IN'7N<H=
MYY=JM;V(1:*;&S"W6F>=>Q*=<8]B;B+G'O\ :EDESVA)>KVR(_C[@,QZ\ ?#
MKK;*#<=4E#9>*U&22+4]"ZF ^P'G_D/_ )KN&/XIR?\ !FP'H
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MLG)^ P^/W6I1)*N@SZVQ1((VTGWE+K/42KZW:OUM"U\ 18X  @W-7]#G(?\
M)FZ_ '@&JX7LH-/P!@-K9R&XE;"Q2KDS)3RB0TTRS ;6M:E'T(DD6I@F>-=Q
M?YF>(^8+^PQG"K9QZY@I4\B/+87%.4P@]%.Q^Y\=):EJD]%D77;IJ"K?
M   !#<JY8XXP>VKJ+,,GKJ6XM=/88<V0EIQ:35M):M?B(,^A+7M29Z]>@"8)
M42BU+P\2]/0P'T                         J7S%Y!>8[Q^Q(J+&11UTR
MWK8&3Y+!3NEU-%*?)$R8R9I7L4E.B.YL/M[M_BD!3?ELSJVMLJH*.BRV;F-,
M=7?(RV++DG8HJC@73Z*:4<LT]7YC"U)4WNU6A!.;=I) >O@'FGS9U?'!P,>N
M,_58Y!.:5*@XIQQ#?4U&N[::A+;:G4-$3GV@U)5W-Y$@NG4U;5!M^.8/+O%_
ME[Q"GIZF/R%GL+[3/A+MF(K3,9YUYW8F8ON(<.,1ML:$9_\ 1/0B 09C(>3,
M@\T7$[G).$L89(8K<D37-Q[5FX]J2J*@W#4;*4DWLT3IK\;7Z@"I//%EW.M+
MRM51,?G7-3AB8T9W'5TZWV&9$XNKRE*CZ&MY*S))(4?JIVZ%ZVIA[?XDE9E.
MXVQ>9R$P<;-7JZ.NZ96DFW"D&GJ;B"Z)<,M#6GT*U+H F@       /S4\WV9
M^8*KY\]AH9MY6TL<HOS*CTQR$,226TV;BDI8Z/.J?-:%I41GX)TVZ:A^AV&/
MWLG$Z*3E+1,9.]71'+IE)$DD3ELI-].A="T6:NA= &] 1V!GF%VM_-Q6KR&M
MFY/7:G.IH\QAV:SM/17<92HUIVGT5J73T@)$
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M$N71U<TK.IQQQA">T^VHULI<DDLS6AI6AD7;(U:$1GXZAZV
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M@H6XZE"GG%.K/<ZI:SW*49]5 *?Y#_YKN&/XIR?\&;!5_F1'IKZ.I?H@CD
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M5H0"XV7FWT)=:4E;2R)3;B#)25)46I&1ET,C(!V
M           I;S!T5QR#QO5.X-3M9LY&NJFZ;HFYD5JNM8D-_N+:?>?632V%
M)ZZ:GJHD]#+4@'7QW9W[%Z])R;A*#QG4L0W7'LH*SI'R1M-)]I10B2X25%U-
M1GM+;U!5V$9*(C(]2/J1E\ (Y  % <A_\UW#'\4Y/^#-@J_P0
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M;B,V9$X]72FI:$FHM2)1M*5H?U# ;<
M                    >5N83J4>8.N58X(OEHUXII\V&H[4I=(2)R])FR9I
M&_9F[M_&)TNS_DF1&%U\0' /%G?=N .<;1O;'=<>=CQ(JEJVH,Y.R&:F_7^+
MJ?7U?T $^   !Y^PG_FYY0_DW0_]8%>@00
M                       8%Q=5./P56=Y.CUM:A3;;DR8ZEAA"WEI;02EK
M,DEN4HDEJ?B8"C^5<<Y'B<O8]R-A.!1,\B1*&733H=E91:]+#CTI+R'(QR$K
MV.F232XO8K<@]O3TA.^/<JOWH_LO(&(U_'=[.E+9IJ5JWAV3EBEIDG7'&O9V
MV=5(+7<@DF9)+<?0!8@  @O-7]#G(?\ )FZ_ '@&-P)_0?QQ_)FG_ F@3/'E
M.@\@5G3<PQ<L>RJ.O *VS1<QD$EU-JHF'O:$,+U23:=%$25.DOPZDDCZ$5[O
M                               !C-5\)B2_,8CM-RY.WVB0AM*77-G1
M.]1%JK3T:@/ /*_GCY'POF^UQFHJ(1X;C5BY52:E]I2I<XF'.VZ[W]2-"EGJ
MIG86TBTW$H!^@4=XI##;Y(4V3B$K)#A;5IW%KHHO09:]0%"^8J':XU"5R(>>
MY;24;'LE:K'\3:@/+<D2'C;0XA$O::UK4M*32E1J\-"\0*C7!N173W)SF.7M
MUR0[8)J7;#W1G,*LA0E1U.-H)]'L[BG%*2H]A;",B/4E: 5ZD   !Y_Y#_YK
MN&/XIR?\&; >@ %?9!PEQED4I-E(Q]BOO6E*=8NZ8UU-BV\KP<*1"4TM2DGU
M+>:BU] #2'@/+F*I_P#R)Y$]]PFTZ,T^;PTS]RC\3.QA>SR"T^MWI< ?:>2>
M2,<2X6<\:3GV&=K96F'R6KUEY?I6F*OV>4A'B?5M1EX -[B_,W&F7RO=U/D,
M5%T3A,JI9YJKK-+WI1[)+2TZ9D?0]J3(!/
M                   $8SW.*WCO'7<JNHDV531'&TV+M;'5,<BQG%;5RG&F
M_7-EKXSIH2I24ZGM/0!3^0TS?(^61^5^'^:ZW&-:=NIFKA0Z^Y;D1VWUR$G(
M]H?225(-S1*5H)3?K%J6XR ;[BOD>+[[7QG89X?*N:-'(GV.0U-9&AU];$T2
M3,>6Y#6IA*U*)9((E*69Z[B21%J%T@   \_83_S<\H?R;H?^L"O0((
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M6%5\EM2HUFF9(750;$U'+C5JB1VFW$K,U(]<G#2A75*3+P\""_@
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M>Y[=9O7;UZE4<KY]HO#E''09-N;-_>Z)?[VTF]OK::E\7< _2@
M         '5(D,Q&'),E:6H[*%./.K/:E"$%N4HS/P(B+J \V\<^=OBWDCD=
MOCRLA6,)<]U<>DMY:&TQI;R",R2:4K-;?<V_:]Q=? ]I] 'I<
M     !0M[Q[Y1L@LG+"\@86JSWJ[ZVY,**I3A*/<;J676R4K7XQK(S!5IX'!
MP*NHBB<;L5$?&VW5))N@*,4,GR(M^OLWJFYX;C/UOA!$G   !Y^PG_FYY0_D
MW0_]8%>@01%<VP*MSAF(4NRMJB; 4XJ%8T=A(K9+9O$25]6E;%D9)(M'$*(O
M0 BI8)RQ0N$K'.2UV4%E/VBLRFKCSC6HC,]')D,XCVA^&[:HR^J ^$Y1SM0[
M$7>"5>3,JU4Y+QBV]F6A)%X>RVC;6JC]!)?,!R7F!PN HD9C7WF%+4OMM*R.
MJDQF%GJ9:IDL$^QH6G4S=+X0%@4648WD["I.-W$&XC(Z*>KY+4I!'\!FTI6@
M#;                KF%P)PU6Y0UF==A%1%R6.Z<F/.9BI1VWSZ]U+:=&R6
M1]262-2/J74!8P                          \@<OT-YC'(,#'J#)N5LE
MN<I;FV[%7CN15S#$)II])+3VGXIFS'0;J4(6XK;X)W&H!9/E@MY-KC^3-39&
M6.3JRX5 F1LZL8UE9QWVF&S4VDH[31M-Z*)226GUM=R3,C 7L  (-S5_0YR'
M_)FZ_ '@&+P)_0?QQ_)FH_ F@3/'@/*O,NQEO.;]=D/&=%,QQRY13O-%#<8R
M-:69!1DN'/8<;=.01%T;/U"^+IKZP-/=1\$U$)1?-;+LLQJ.DCV0X%T_)BDI
M1Z[NU8E++7_] (^DXKSA3)=>KN0:W(%%N]GAW]&A@C(_BDN17/M'ZOPDSU ?
M!Y)SW2DE-C@])DN]1:OT%TJ"I"-#UU9LF$D:M?03V@#Z^FPZY1-95@.6TBD$
MDY4DJSWI";W'U/OUKDDC)/UQ[>@#8U'.O$-V9(A9E6-/&6I,3G_=S_QMOZU,
M)E?C]0!/8DN-.81*AO-R(SA:MO,K2XVHOA)23,C =P
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M+OMD9_Y<8@$NQ3DO LX0A6)9%7VSBTFOV:/(0<I*4^.]A1DZC3_I((!*P
M             '1+B1Y\5Z%,;)Z)(;6R^RKJE;;B32I)_4,CT >8>-/(UQ]Q
MMR4QR!'NIUG'K'E2J&FD(;0B,^>O;4Z\D]SW;(_4]5/70SU](>I0
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MIE#;-=Z(_H:5=%&A:%I/JE:%)4A:?09 )
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M,LBI<PM)F1XDQ7G,583OMAQ)_>;2TVA[:1Z.H4Y]J,]/5U+30]0]Z
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M3'/,#CL^VJ(#U1:U#R(]K52%D\;?>(U-+0ZDDDM"R2KZTC(R/4O S"X
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MDS4?@30)BPP4  'PZTV\DD.H2M!&2MJR)1:I/4CT/X# ?8
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M)6J77Y%A)?0T9N.[B2@TH/7;H>G34+_   !Y^PG_ )N>4/Y-T/\ U@5Z!!
M     1_-,(Q7D/'Y.+9E5LV]%*-*GHCY'IO0>J5H4DTJ0M)^"DF1@,+CWC+!
MN*Z0\>P*G9IZM;G?>0V:W'7GC(DFMUUU2UK5H1%ZRNA="Z ):
M",YWQ]AW)E YC&<5+-O2N+2[V'MR5(=01DEQMQ!I6A9$9EN2HCT,R\#,!S@O
M'^'\:T#6,815,U%(RI3A1V=QJ6ZOXSCCBS4MQ9Z$6Y:C/0B+P(@$E 1C/^/<
M1Y/QJ1B6;5J+.DDF2S94:D+;=1KL=:<0:5(6G7HI)_"7@9D PN,N*,%X@H%8
MW@=6FNKW7#D27%+6](?>,M-[KKAJ4HR(M"+P27@1 (AE7E;X6S3/6N1\@Q\I
M&1)6AV4A+SC<.6\T1$AR0PDR2M1:%KX$O3U]P"XDI)):%X>!$70BT <@
M             #19AAV-Y]CTS$\O@(M,=L"04R"XI:$N=IQ+J/6;4A1&E:$J
M(TJ] "H;WRX>6/&8:;')*F-3P%N)83+L;ZRB,J><UVH);TY*34K0]$ZZF D>
M$<!\)8Q=P<VPNB:1<0/:$5UJBPFSTM&\E<9_9WI+K>IEN;5TU+J0"V  !!N:
MOZ'.0_Y,W7X \ Q>!/Z#^./Y,T_X$T"9XL,%
M            4YYFZ^HF<7.2;;(W<5.JLJ^SK;>'#]XV!6,5\E16H3!+;4J0
MZX9(1M5Z3U]7<8"$<#9ER!>9Q+I,\SF_=L(]<J8UAF5XC78S*D1UK2@IS#T1
MUWN(;5ZBTD?11Z&70#'IH   'G_D/_FMX8_BG)_P9L%>@ 0
M                                     'RM"7"VK(E)])&1&7_U 5CR
M3S5Q]Q;85E1D+,F5<6A(=3!K(OM3D>&N0B+[9*/5"&8_><0WO6HMRCT21Z'H
M$IP;,\7S^F5?XLYW(C4F17RFW&51Y,>7#<-IYAYI9)6VM*B^*HO R/P,@$G
M  !Y^PG_ )N>4/Y-T/\ U@5Z!!
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MA[3JLH+7T:E&;U_Q@+_
M            >5>?\'M,XY#FXS@M[65^97V.5Y75-D;4EN%,JJNV.6Q(A2HY
M&:7V7DJ;>:-)D;;A'H1D1@+GX@P>QPJDMWK^SCVV5Y/;RLBR*77MFS 3.F);
M;-F*A2E*)IIMEMM)N*-:M-RNJM %A@.IV0RRIM#CB$..GM:0I1)-:BZZ)(_$
M_P! !V@//N%?\W/*'\FZ'_K KT$"
M                   \R>86(ZGDG$[#$KO)8_)AU<V+"I<,@PI4IVK4^VMY
M^<]-4VTW&)TFTI)Y1I[FAH3NU,%3GR[W4VZQRY5:Y3=9!=0[)<.SKLG@QJRT
MJ7VFTZQG6HNJ#)1&3J'$J4E1*Z'XD06O9V<"FKY5M:2&X=9":<DS);ZB;:99
M:2:UK6H^A)21:F8(KWCGG_BWE>TFTN$W*IEI!:]J5%?C2(;CL3>3?M#)2&T=
MQK<9%N3X=-=-2 ;3FK^ASD/^3-U^ / ,7@3^@_CC^3-1^!- F+#!0
M                            %.\]0HF30,7Q6!<5T+D [J-?X?2VIJ5&
MM95#K*<CO(;(U]G9KO61>HK:?CH @G%.62.9N9"S&WEX]56V!ULVJ;QR@L5V
MT^2=BZTE]^5*[++3D5I3)$RADEDEQ2C4HNFX/1]S&GS*J=%JIGNZT?CO-0;
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MFU/@&DGF_71ZQ%N+19>JKT B3_2!YL/ZG:?^<S'WL%/G_P";#^IVG_G,Q]@
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M19)SKS]@SE#*SKBZJJJ*XNH%&J8S>HF.)<L'-A&EMMO74B(SU\.@#TZ"
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M(!W8QP[Y@[?&J:TLN=KJJLIT"+*F5;])!4[%?>92M;"S4HC-3:C-"M2UU+J
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M +, ^@SG;_Y"6WY#K_LP*?09SO\ _(2V_(=?]F ?09SM_P#(2V_(=?\ 9@5
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MF4N.+4K359I3T].@":TEW59'50[VCEM3Z:P91)@S8ZB6TZRX6J5),OA ;
M          !0G)-#C7(7,E%AT>%<P,OJZ9ZPM,\QVT72RZNJE.J1'BJ4@E>T
ME)>:7]J47VLB-:3ZJ 2#R[2,=+!IE'18X]BD[';>=4Y'32I)V$A-NVI+KSSD
MP^LDWD.MN]T_$E:%ZI$ ML!4^9^6CA'D/()>59GBC=KD,\FRESERYS*EDPVE
MILMK,A"2VH2E/JD7@ LRJJX5)6PZ>L:)BMKV&HD*.1FHFV&$$VV@C49F>U*2
M+4SU 0*BXUE5',N6<I+L&W8F25E=6-5A-J2XRJ!KN6I>IDHE:]"(@%D@
M   U]71T])[9[G@1X'O"2Y/G>RM(9[\M_3N/.;"+<XO0MRCZF V       QY
M\<Y<&3$2K8<AIQHEZ:Z&M)IUT^IJ @W"''DCBCB['^/9<]%G(I&WT+GM-FRA
MWOR79'1"C49:=S;X^@!8(      PK:HK+ZNDU%U#8L*J8@VI<*4VEYAUM7BE
M:%D9*(_@,!D1HS$1EN-%;2S&90EIEELB2A#:"VI2DBZ$1$6A$ [0     !6W
M-'&4GE*EQZJC63=8JER&MR!;KK1O$XBN6I1M$1*3H:MW17U 7%D@@
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M>936\A<K\0Y!D5CE=?A$JJ=IKJY64B>;5K&6\XT\\1%NVJ26S7ZOHZ CT0
M           Q;*8FNKY4]236F*RZ^:2\3)I!KT+]'0!XFX6Y#Y+;S#AS*,CS
M"QR")S2G(_?=!*6E5? <JG%*C*@-$7VE)$2261=/'ZF@3KS23N6BRW'V<01E
MT7!*JIGVF266'+:C.FYN(DI6X\I*%&TAM2^U\8R5ZOPD5>/#US79!QCBUS4W
M$S(*^77LK:N;0B3/D&DC2I4@BU+NDHC2O0S+4O$_$$3@            !%^0
M59T6+RT<;M07,P>-IF Y;*4F$P3KB4N/N$@C4KM(-2R0DO6,M.H"IO)QDN39
M7P\JURZYE7US[YLV%V,UQ3CJD-.D22+<9FE)==J?!/@0*I+%.5>2Y><8CR?(
MRJ?(J<SY GX7(PMQ1*J(]2C:W'-EDBU2\WKN4Z1ZJ/37Z[<'NX$
M    'E_*^)W,?S:,5_ED&%Q!EF=PLF52NPWW+:=E$C:3%<MY&YHXCCS*7=7$
M:EM)'AU 6]QA@EYBLK+,CRRPC6&69A:>\K#W>VIF"PQ&91#B,-)7ZRC0PTC>
MM752C/QTU,+" 0_EAVRC\7YM(I=_OAF@M7*\V=2=*2F&Z;>S3KNW::?5 >+O
M+?+P['^3, L\4DPH=0WQ<Y/Y&E0W$IC-R&)+BW'IZDGM2\A22W&YZR4Z?6Z
MK6>8FSP_(,^Y>N\@EPI;?S*HIO&4Y]U*M[;[T=9O5JC/UC4XI>JFNNF[T;@'
MO;"562\/Q]=SW/?"JR"=AWM>[[2<=!N[]>N[=KKKZ01O@            $!Y
MO>MHW#V>OT1N%;MX_:*AJ9U[J7"BKT4C3KN+Q+3T@/)? EC@6(\I8?;8M-KJ
MW%FN(X$WD&9%=;;AMV9/IWNSE)/:F5O/17<]?Z@#5^8I>-.<CYQRHUD.&9.B
MEK:!,;![V*]*DRH4E#:R]G<7VT_;2>-Y+D13GJF6[9Z2O>M!+]OI*V;[(J![
M3$CO>PKZ+8[C25=I1:%U1KM\/0"-B             T^4TTS(<>LJ2OM9%',
MGQW(S-O!T*5&-PM.XT:NA+(OBGZ/$!Y=\K!XKQ8YSDU96B8&,8[ERX3MO;R4
M[B;:U82Y(?7M(UK69:GTU4H%4IRL[4OY?RI;2W&3Y;8Y QM&&N[R.V*O-)''
M]C+7?VE-[5?:^A^J9_6@/;]YQ/4Y)R*[F=^IFRI).,NXK,QN7&2\P\EV>W-)
MY:EF9'M[>TD[?JZ@B,8=Y>(V!<B5634&2SW,)IH5A#I<-L%*F-5J[,V>Y['*
M<7W$LZ,)^TN;]#ZDKJ NT  =;S+4ALVGT)<:5\9"TDI)Z'KU(^@#Z-"#62S2
M1K21D2M"U(C\=# <-LM-&LVT)1W%&M>TB3N6?0S/3Q/IX@/L  5QR1S-2<;7
M-%CLJBO<AOLB;EO5M=CL),]\VX!(-Y2DFZWH22<3\(#26WF(IZA>/PG,)S"3
MD.0P9%JQCD6I2[:QHD5\HZURF.^7;]8TZ:&KHHOA 92?,3QXOC_(N0B]X(BX
MFM#&24+\14:[@R''$MH9>B/F@TJ4:RVGNVGUT5T/0,25YBZ&HQ#(<VRC#LMQ
MFDQSV/VGWU5)B/2/;GR83[,GOJ)SMF9*=ZEM3UZ@)5><IXS4M8>N.XJP;SV0
MB'B\J*1.177'XRI3+CB]2-+2T)^,E*CZ^ "KK'S)9#BM5:WV98G$:J*;)V,.
MFG66+DE\Y"B2[(E(0N*C5III1*2C7<HR/4TEU 6%7<OU5OS#*XGJHGM90:%%
M_+OFWB..EUUUDFXJ4$GUU*9?0_O2O0DJ26G4!,Y^24%5+AU]K:0H,^Q5VZ^+
M*DM,O2%ZZ;6D+4E2SU/31)& XN,HQS'UQF[ZW@U3DU1MPT3Y3,4WEEIJELG5
M)WF6I=$@.VYOJ7'8?O&_L8M57DHFSESWVXK)+5KHG>ZI*=3T/0M0'2JWQZ+"
MC/N383-=.]>&ZIYE##^Y*GC-I1F25ZI)2_5]&I@,6=EF&U\>OMK.[JXD6>6E
M3/DRX[3<@G"(]([BU$2R,C(_4,P$@2>H#4L93C<JW>QZ-<07L@CD9OU+<IE<
MQLBZF:F4J-9:?52 @V"\TUG(>?93B6/0FWJ3%E'%?ORGQ5G)GMFUW6F8:%*>
M[2"=(O:%:(-1&DNH";667XM3(>7<W=?7(CNMQY!S);$<FWWT=QMM?<4G:M:"
MW)2?4RZET =\S(*2O;:=L+&)$9?;<?8<D2&FDN,LH[KCB#4HB4E"/74HNA)Z
MGT =$[+\7JTPE6EW7P2L]#K#DS&&2E$K0TFSO67<UW%IMU\0&@N>6\'Q_.Z[
MCJYL6X>16<-RP8[SC+<=+;;B6TH6M;B32XX:_M:=OK== $AD95C<2W8Q^9<0
M8]]*(CC53TIEN8Z2O T,J42U:Z>A(#4PLU=7DF2T]S6IIZ:A5 1$O9,Z*;,U
M=@C7:325]QDT+,FR[Q%O,_5U ;NIR*AO5RVJ6TAV3L!SL3D0Y#4A3#W4MCI-
MJ4:%:D?177H ^:O)*"[=EL4UK"L7X"^U.:A26I"V'#U]5TFU*-!]#Z*T ;4!
M\FA!K)9I(UI(R2K0M2(_'0P'PY&CNM*8<:0IE9ZK;4DC29ZZZF1EH?7J [0
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MP&%:6U720W+&XFQZ^N:T[TR8ZB.PC<9)3N<<,DEJ9Z%U 9A&1]2\/08#D
M !BSK&!6H:<L)3,1MYU$=E<AQ+1+>=/1#:369:J4?1*2ZF R@   4SC?EXKL
M1P.MP/'<MO*V)77Y9(=A$?;CRGU;U+5$>-M!)4PLS]9.G70M06L*H\K6#U')
M*,_:L[1Z!%LY60U>(NO).GAW4\DD]*:;))*(]4DI"=VB3\.FA B\P
M      !Y^R//^->7LXKN-/G YCN68+ET.T9C6#"6T6TBC69N1X3BW"0YJ;A$
MHDGW$^.S3J MS'<WI\GO<GQVN0^F?B4MB!:*>026E/28S<I/:42C-2=CB=3,
MBZ@)*  (I5\9<>T;%Q&IL6J:^/D!.(O&HL%AE$U#I&E:'R2DMZ#)2M4JZ=3Z
M=3 ?$OBWCBP.E.?B=/)/&TH;Q_O0(Z_86VM-B(^Y!]M*3(C2E/0C(C+J0"7
M "!Y]S/QIQ?)@0L\OD5$NT0XY 8-B3)6ZADR):B*.TX9$6I>(#2VGF3X4IH%
M-96>5(8AY#&5/IU>R3EK?BH<-E3G;1'-:"):33ZZ4^ #=*YHXN3@CO)Q9/#=
MP-A26W[I@UOMMNK6ELFUH;2IQ*]RTEL-&XM2Z -37^8[A:SI+#)(N5-%154F
M)!L9S\:9&;9D6"C2PE7?80>BC2>JB]5.GK&0"9W>8T=#8U5',D%\X,@*66/U
MB=>Y-=@,')=0VHRV),D%KJM22 54QYFJ6+&E6&58O:X[50<@C8?/G27(3S3%
MQ(,MZ5]F0H^TRE25+=+IH?JZ@+!8Y-QV3RC*XEC$\]DL&F+()KJ$H.*S'7(0
MPAI:]VXGE;R<).S39UU 3,  ?*DDHM#\/ R\?$!$8/%/&M976]178C3Q*J_5
MNNX3$".VQ,ZZD3Z$IT61&>I)/H7H =DSC#CJQL*FVGXI42;.A;;8I9;L%A;L
M1I@B)I#2E(/:EO3[61?%^MT 2P  0S'>3:'*\NR'$*.+/D.XPLHUM<'&4BI3
M.(DFN&W)49$N0VE:5.(2GU2,NH"9@   TA9;CYY5\R/;FOG;[O\ ?7NG4^][
MM[_LWM'AIM[OJ>.NH#=@(_0Y=#R"XOZ6/7V,1_'I#<61)G1'(T:2IU'<)<1U
M?1Y!>"E)\#_1(!(    1E_CO!),.YKI&-UCM?D;_ +9D$5<-E34^3N)?=DI-
M.CJ]R25N7J>H#Y?XXP*5D$++)&,U;N45J$-0+A<)A4QA#9;4$ATT[BV%T1U]
M7T )0           #RGYG+6NI>8.*K&WR^3@D!$#(FU9/$90^XRMQN,26]KC
M3R/MGAU1Z.@#6S>3\!Q?EOC#/+_-?>>(N85;Q6<PFLK0<Y\IS*#,T,,IT69M
MJZ$V7A^AJ5%>6IGT@XMSAS!CD*7"X^G8_24-=.DQW8AW,J#9)>=L&VG$H<-#
M"%DRA:T^MH>G@9$36RSO+,>R'@O-F,=Y0F<H28=AC3TGVV*TT<%M=M'21$EJ
M,P2TNZ'N)1*\/TR,K)L7NN,^8^+^-HT-;_&LG,59%A$U)ZIK$.1))3ZE22(B
M)"'74OQ?@;4I.JMOJFE\V'!>/V27FI5A)<8D9BWG;[*DLJ;7)0TEE4125(,C
M86E.BB/UNOB"/CCG@7&^,[.NM*>RG2WZ^OGU9G.6AU;Z+"6S();JR22C4RW&
M9C->@FD)+3H \U^9H\*J>3\JL+=J+87-G4US)XUEU7*=;M66$JVIQ>U@]QZ+
M(W*[:TF@D=\R4K5)'M#93I_$N/<AYT_YDJ9W9<4M*G!6\ABO6+ATZ*Y*9,*$
MXDG-DQJ2I27C2I#BG#WI/Q,!\S/F#C6:<=77,=-:1N$VL-.+B$;,V'+%NNNU
M3%+4W8M$3R4OJB=M+7=+0DD22]9'0(K'QBBR6GQ"J53R2X=R#EY"\&J9Z'FB
M70.P'^^;:%[5HB/O>NTVHD^KNU+J8*V'+T"!AG,^4HS/YJT^%+IZJ#@+674$
M^XK$4\:-LE1:M,!:4,.H?U-;:4]TR4DT:%J"+^X4J,X@>6J)51)TM>6JJK%.
M,/6T94&5'[G>]W(=:==>4E+>K>S>X?VO: \WP%<43N/<&POCNE?C>:J!95BY
M9E#DLWL.Z8DM*N)5E*<01JCFDGC,G7%(VJ3ZI:'M"_/+3C./5N5<S3:ZFA0)
MS&;V,!B7'BM,/)@DQ%<*.E:4D9,[]5D@CV[NN@"L;^UX(HO,SS!8\YP(ST!Q
MBAC4]A907;"M:6JG;5(943;;J4RG$$E31J3O-"3)!EU)01_%L$BY-8\ 8OF5
M-)>P"POLXFXS26Y.&^UCB(A2JQF1N,U;?42HD+49*1H75("0W+G">(<D<HQ/
M,C3-R+*R6RU@J9,!Z5&>Q=J,AN+$IR:0:67FG-R%]LVU=PR,CZ*,@T.)4U?A
M>3\$V_/U0RR[+QJPJESKR"4Y7MY3TKJ(\A?96:7V8RFTH-TB-'4NAZ@(+DT9
MR&]GN+YP_0M<GV=]->:9E8]9VF;R'GWM:Y^HFLR&T;"0E'LY-FAM!:I6GKZQ
M4YY7K91T7F*@77=F6*T<7Q[.2ILVW)#J?9D.J/9J6XSW:[5'H"?5G9]@F(X!
MR]B%9A%"]1UF0XAEM9?Q<49)B?-C0HC#L=+1(T2N6E2E&RXOUU+TU5X (%Y8
M).)-<HT5+BT.ONRK<?D1EY)2U\S'K2O8;-)>RY-$,CB2)"UEM0ZVXI?<0I2M
M2,E KW*"                 #R;(YIJ[Z_CVG,V./TV%8AF,]G%,YJ77'ZQ
MJPJW'8"6K9I)+<CFHG-4N*+M+W?6DE1@8O'BGD"1R$WETIQ$3V&CR.9254F"
MX;K4F#&9CNM/FO5234OO'U1ZNFF@"P0       17DY2V^-\P<;<-IQ%'9J0Z
MDS2:5%$=T41EU+3QZ /'_&E%C\3@_(LG@<=W^,95]&\U]W.K":\["L'7J])N
M+CH.8Z25/']N;/LHT3_D@GQO;_ *3B+@"AYWXXF3\>SJJJJ2UG$5A+D0+@YW
MLJ'XLV-)==;4EXW3V=M*5)7M,O %89X_CF2>8#D@LFXYR#.%LW]2W#MJR:ZQ
M$JD.08SAI>0B;'+U%*[BM$*Z%_@!6RXZS2_P#D[/,CNK!;W%>29_<8K:$^:C
M;I+=/:57S"49JV,2>X<9XS)*4*)LS5IT!&9P;07-]Q7Y>+CV!RR3565M(NIK
MQ)>7'9--DRE3BG3-6F]24EIX'H C;_#O+\C!<EP1-;);Q++5W65W47N-IDIM
M*^7*]GKVB(S/;9J37OZDM))2APM/6,!Z,Y2R#D#$>)"M<'JE3\KC,P69#:(Y
MSGHK#AH1*D-PVU(.0ME.Y264J+4_J%H95+UO/O('S55#I<CH<VN+_)JK$<2R
M4X;]2]#D6S;ZWU7%4LD*:5')A7:)!F3NI'UVFD$3;)LUYCX/Q7-,EY DUN<8
MY35:)]#>1HY5$U=DZ^W%*')AMK<2;)+=2YW6U:DDC(]3,MH?"<FYOXQRK!$<
MFWU1E.-YU8HH)L:NKSKI%3;2F7'HY1E$M9R(_P!K4A:W22HNA^G0!6]/Y@.9
M:[@JKYCRBRJ)3^8S(^.8K7,5KQ-1)+LR0RNPG=A3CKADAA>D>.DR/1.FJC,@
M$WX8YGR>^Y%/!+2Z5GF/3J]R="RUK'IV-+AS8JOML.0S(;)I;:T>NTXA>XC]
M56NI:!(\KRWDW,>6;+BCC*W@8I$QFKC6N09%.@E:279-B:_9HT>,MQM';VIW
M.N&9GKT+33U@H[,\@SOF21Q[C623ZR!:4'(5CAN01TUJ+2IF6U3#6ZW8(9D.
M)W-FTYM[#G3>>X]-"2"O0?F(SO-^.\2QF;@9PG<EMLEJ:)MNR;,XCR9YN(-"
MS29&VE2DIU6GJDO $0F^S[F7B7(6,:SJ^J\J9RNAO[''[2'7%7/5MMC\ YRV
MULDXM+T8RZ(49[S/XVGUP:RNY-YX5A/'ZY5K1OYSR^_#1CRDP5MU]'7I@JER
M7W"[AJDR%H)*B;,TH)>I$9IZ ,7D;+>6::DY2X?RK)X4^\C8--S2CS"#7)AO
M.U;"UQ9<-^,ETTM/*/U6GFE>J2M_51:$&ML>7\ZX\Q?C' I>7LL6.24B+VPS
M1VADV+U=4-QV$QXC$&(IXY#ZG#-"WWC(M.IEJ9 .M7,%YF>,UE3E=;!R1=-R
M#C%9$R6=3RJ^%:0+5Y9-S&(<PFU,2FB):%[=4I/PU(P5O)O(G/TVEY4Y$J,B
MI(F-\9W]Y#A8])JS=<M(-(ONNHD24O$IHR:]1I32=5*UWZ=#!,.3>;^2:ZTK
M+&!:1./<*LZ.ON,<M[>H?N:NTLIZ"<7"L)S!Z0$MZI1N[>NFJ]VFA KT_02Y
M-A2UT^:AEN=+BQWY+<1WVB,EUUM*EDTZ1%W$$9GL7IZQ=01L@
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>fc_proteins-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_proteins-4c.jpg
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M;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (  @ X0DE-!"4
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M>CZ\,C S2TNKQOYFPVRW-2PDK7V2VZZ0H(2I?%P)/$']%!SK_,P_\O\ &O\
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M$N'T291>:!/Z.5!3/M^\A(\ ><(>;W" \F-C')F&V"(A-Y,?N!3#I";]5-.
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MC53G2D-EY;+SS(>*0 !W0@._* /FZ"U!Y_R_<PO7O$?DS/-PG\DO%RQ-&.B
M&3(^GA%SM-!1 *U\>*03ZT%<2LE[-O<'NLE$B+EO%&<R*7)2LVZ]#8Q#\LJ!
M4EUM2G6VU+Y%5QVDDCJ>1^8*=<S.3]N_F12/$>[(V>)C9,<MY'%E2861;6$J
M5&>;0MQMT=2VKBI0OU20KT#[+H45H2LI*"H E!]03\#;[*#]4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4&EV[7F-LUG*:[((2G(1UM-ND$]MZW)IRP(-T+"5C]%9Z
M[^-HE$L/Q_GI>QZECLCDT=K,H2J)EF;<2B=$66'P4^J;K05 'X$5EMK%;3$=
MB&PV?%.YS 9#$L.!IZ4T4-K/IR!"@#]QM8U.C9%+Q:?1%HS&%1ZEX^V=&QPY
M&1B&%$Q[R7W7U*20HMFX2WQ))Y?;]E=KD<O7[<Q$YF6O77.5Y5Y]M-4[LVOL
MY 8EW)1T9$GC].7$A?(_LG[#]U71IO-?+$X8^49PVM4LB@4&/.GPL;&7+R$A
MN-%1^)UU00D?=<_&LJTFTXB,RB9P\,?F\1E8RYF.FLR(K?\ :.H6"E-OZ7V?
MKK*^JU9Q,8DB8EZ-Y3&O1G)K,QAR&R"77T.)4VD)%S=0) M432T3B8G)F$><
MV7 [=!R&$P.4;5DWX[J&1\R%&Z2.2>0%Q^BMF--]4Q:\=,L/*+=(5-I^LYE>
MV189;,1_'.\Y:^:.381<$)L3<GTZ?KKL\C=3VIGOEKTK/DU+N#4C858#ZV,5
M?4=CZWN?Y.+GU*OM'Q']+I5\;?D\\3V[>K'QZX;K8M)<@9]6.;RT$B2L*;5*
MD!MU 7_W5)N;_P"&M?3R?*F?&>GW,[4Q/=>.#QHP^'A8L.E[Z1E#7=/[12/7
M]'V5Y_;?SM-OBVHC$85?YEQLOZW'YCD%0@T8W$J 4ESD57"2;D$'U'V=:Z_T
MZ\8FOJHVQZM]XY2UK.G&?FIC4:)*>4^WS<3P0E0  N"1R5:Y K6YF=NW%8S,
M,M?2O5-L;E<;EV/JL7*;EL7L5M*"@#]AMZ']-:%]=J3BT86Q,3V:;?L:O*:G
MD8J'T1R$!WFZH(;(:4%\5J/0 VJ_BW\=L3AC>,PK#Q+"+NT&6)33?TS+@,?G
M9U[F+?*GXI3ZD_HKK\^V->,=U&J.J[Y+/U$9Z/R*.ZA3?,>J>0(N/T7KS]9Q
M.6TYICX)2MA1@/K8W),@,&;W/W!XJ]0K^E]@_I=*]7.WY//$]NS2\>N&YS>D
M.1MB<Q+>6@'ZAPEM<F0$NI#AO^]3Z\NOZZHU<G.OR\9_@RM3K@VC1MAQN7+#
M,9W(QW@VB+)1916$H">!!/0BUK?931RJ6KG."U)B5K8!V)I>JXR%LDYF*^A!
M20XL"RE**N"?MX@VZ5QML3NV3-(ROK\L=4>\GX-_8($#/8B0U(BQDK"D]U"4
M*0Y8\T*40DFXL1>MKA;8UVFEHZRPV5SUAZ^*=8R.(8EY6?Q;$]*$L,)6E9X(
MN>:BDD=2; 7K'G[ZWF*QZ)U5F.J1;[@Y>P:U)@05 20I#R$*(2ESMF_ D]!?
M[36MQ=L:]D3/9G>,P@7BW7,E&S3N9D+;9BQFG&7&T/-N*6I=OQ!"C9(M>YKH
M\[=6:>,=Y4ZZSG*SX&R8'*2EPL=D8\F6W?DTTX%*LGU(MZV^ZN3?3>L9F)B%
M\6B6TJEDC\C=]5BY,XB1DVD3DJ[:TF_!+A-N*EVX@_I-;,<;9-?*(Z,/.,X2
M"M9FHKRMAW86QJR:GVW&L@E*D-<AWD%M(0;I]>/3H:]#P=D6U^..S5VQURP\
M]J[L#5,%DQ.CR$%+W)M#J2/WS@6.T?V^/HNWH:SU;_+9:N)1:N*PGGB77Y>,
MQTK*2EHXY'M]EIM86 AL'YE%)(N>7I\*Y_/VQ:T5CT6ZJXC+>[_@)NQZZY!Q
MY'U;;J)#;:CQ2YV[W1?X7!Z??6MQ-L:]F9[,[US"#^.-)S\#/IS&5C*@QXJ'
M$)0M2>;BW!QL DGY1ZW-=#F<FEJ>-9SE5KI,3F5P5Q&PU4;9=?F3E8R+DH[T
M]!(+"'$E5QZ@?:1]U76TWBOE,3ACY1V?U_9,!&GIQ<C)1V\@L@".IQ(7<^@/
M7H3]AI&F\U\HB<'E'9M*I9(!Y+5^>KPWCID<_P")9'++!)LIO#PB'9))'IW#
MP8%_7F:V-/RYO\/ZHE/6VT-(2TTD(;0 E"$BP"0+  #X"M=+]4"@4"@4"@4"
M@4"@K3SEX:Q'G32V]*S62DXN&W.9R(DPTMJ=*V$.(";. BQ#AH.<_P#Y;7CO
M_P",LU_XN)_]106SX#]JFL> <_E=@P6>GY9_*PQ!=9G(92A"$NI=Y#M)!O=-
MJ"L<M_+J\?Y;*SLJ]N&90[.D/2EH2W%XI4\LK(%T?"]$LC!_RY_$,"5W\UGL
M[EF4VXQ>['BMG_&+;)61_BJ31#J73-(U/Q[@6-8TO$Q\-@XY*T1(R2 5JMR6
MM2B5K6;"ZUJ*C]M!0WF;V8:?YHWR7ON8V3)XV=,9CQU1(B(ZFDB,V&P07$D]
M0+F@@'_RVO'?_P 99K_Q<3_ZB@N?*>V;6\MX'QO@5_-3D8+&N-N(RJ$L_5K[
M<I<JQ!24"Y64^E!G^!/;QK7M_AYR%KF5G91O.NQWGSD.S=LQDK2D([2$>O<-
M[T&Q\X^"-.\]:Y$P.U*?B/XZ1]5C<K"[8E,*4.+J 7$K!0XD#FDCU"3ZI%!H
M_ ?MHU;V^OYY_6\QD,HK/HBHD)R'9LV(9=*>'9;1Z]TWO0790*!0*!0*#GGS
MA[1-,\Z[@QN6P9W*8V='@-8Q,>!]/VBVPZZZ%'NM+-R73?K06Q \=X"-XSC>
M*I_<R6M,X9O77R^KB\_#1&$4E2FPFRU)'JFUCZ4%-^&_9?X[\.;R-]@93(YG
M*1$O(PS4XM);B"0A32UGM(3W'.VLH!-AU)XWM8)-Y\]M.K>X)_ O[)E\ABU:
M^F4B,,?V;."86BKGWFU^G9%K4$P\/>*\1X9T2'H6$FR<ACH3LA]N3-[?>)DN
MJ=4#VTI38%73I08GFSQ!C_-VG(TG+YF;A\29;4R4K'=KN/\ 8"N#2^ZA8X!2
M@OH/Q)%!I_ OMWU'V_X_,P]:F2\E)SCS+TR;/[7=X1DJ2TT.TA XI*UJ_2J@
ML+<]3Q6]:EFM-S:5'%9R&] E%NP<0A]!3S05 @+03R22.B@*"D/"OM!U7P;N
M8W/6=GR\N0N*] EP9?TWT[[#W%5E=MI*OE6A"Q8^HH-=@/9)HFO^48WE2-L>
M7=S$;+KSB8;GTWTQ>6\IXH-F@KC=5OQ7M07AY-T''^4-$S6A964_"Q^;:0P_
M*B\.\@(=0Z"GF%)]46ZB@KCP+[7M3\ 93,977,SD<H[F8[45]O(=CBA+*RL%
M/:;0;F_QH-=YJ]G?B[S-F'-HDKE:]M;_ !$S)8PM\)7 <07V7$J2I0'3FGBH
M]+DVH(G@/Y?_ (BPVNYC%2<AD<EG,LR(S>=D=CN0F^XA:C%9[9;2M03P4M?)
M7$D)*;F@L#P)[8M4]O\ D,UD-<S.1RCF;988?1D.QQ0F.I:@4]IM'4\_C01/
M&^R71,9Y4:\L,[%EUYEG.'8Q"5]-],9"I)E=LV:Y<.1M^*]OC0=%[#GL9JV!
MR>RYIX1\1B(KTZ<^?V&(Z"XL@?$V3T'QH/CYX6T*/YV]P,/$QL8F#K&0R<C-
M93'LW+,3$-/&0M@*]0D@ICH/VJ30?91"$MI2A"0E"0$I2D6  Z  "@I#S7[5
M?%OG"6,UGF)&)VI+:6CG<4I#3[J&P A+Z'$+0Z$@<02GF!TY6 %!5NJ_R[/$
M^&RK.0V+-Y788C"@L8QPM0X[A!OQ=4RDN%)^Q"T'[Z"]_+7A36?+/CMGQI+?
M>P>OQG8KD5.+0TWVFX0*6VD(6A2$H">@ 3TM0:_P-X!UWP#B,OAM=RDW*,9B
M2W+>7D.UR0IMOM@)[2$"Q'VT%<^3O8GX@\A9N3L>,>FZGE9KBGIC>++2H3CJ
MS=2_IW4G@2>O[M24_P!6@]?%'L<\3^,M@B[5,D3=HSF/=2_CCDNTB)'>;-T.
MI8:2.2TGJDN*4 ;$ $ T'3E H% H% H% H% H% H% H% H% H% H%!7^$MK'
MDK-8 @HQFTLC/XWI9 G,\8\YL*)-U*'9>L/M56Q;YM<3_P!>G^$>JP*UTL&'
MF<3D'W8T&<Q)D,_VK33B5J3;IU -66UVK&9B81$Q+--R" ;'X&JTN9\GKN:9
MS[N$D,E>6DOJ[9*D_O2ZLE+G(GXWOUKU=-U)IY1VB&E-9SATC!:>CPHS$A?=
MD--(0ZYZ\EI2 H_K->6M,3,S#<AD5BDH*_\ +.%GY3#1I,1:>S =4[)96M+8
M4E2;!0*B 2GX#[ZZ7 V5K>8GU4[8S"MX&M;&=5RF6B C&O\ :2^PTH*6\TTH
MJ6HI238(]2#UM74ONU^Y%9[J8K.,O73M<SN<QV<8QH4U"?C!!*OE:?D-K2M#
M=STO:]S\+]:CD;J4M69[Y32LS$FLZ?M,C(KD0FC#D8]+BP\7$!0>X*"4)XJ)
MNH]+^E-W(UQ7$]<E:3EJ<!C,V]L,:# ;>CYAIZSBK%*V"#9Q2S\ .M[^M7;;
MTBDS/9C6)RSU^/=M&25BQC7%#N% F#_R8IO?GS^RW7[?AZU7'+U>/EG_ "GP
MG+\9[3]HC9AZ(_"?GOOK_=2FTEQ+XL %<NMNGJ%'I4ZN1KFF8F(_L6I.5]:]
M$EXW!X^#D'.Y,890TZN][J ]+_&WI7G-UHM>9CLVJQB%:^7L-F)61@Y*/'=D
MXYM@LD-)+G;=*R22E-S\P(Z_=75^G[*16:S.)RIVQ*&SM>V.#J\6;/9<9Q7U
M2UMQG.A;4XD .E)] NUA_P#?K>KMUVV3$=\*IK,0FWAW'RXZ,GFGE]G%NI2T
M@*("5K;)*E_[D&U_OK0^HWB<5CNMU1ZI7O\ $DYW4);6&(E.<FW AA07W$-K
M"E)3Q]38>E:?$M&O;'ET67C->BJ/'.-GS=L@OPT*#4%1=EN^B4MV*>)/VJ/2
MU=CF7K75,3ZM?7$Y7Q,6U.C38$5]LS"TXV4)6"I"E)*05 &XZFO/5B:S$S'1
MMRYK9P.9.11AOH7AD@M*"SP5R20;<_3\(_%R]*]3.VGCY9Z-+QG.&SS.G[2W
MF7X+\%^;+?<)3)0DK0_?]OGZ#[[^E5:^1KFD3$Q$,IK.7]V[&['"RZ(^8[S[
MR&VFH;R.:D+2A"0 V1ZD'H;=;TX]]=JYJ7B<]6PVS!;:Y!PF0RD>1)*8:6%@
M)4XXRM*U&S@%SR4DIN:JT;=6;168CJFU;=&%D->VF'JT%<R,\G%&0ZZF)Q)4
MTI20 M:1>P5UM?T_75E-NN=DXGKA$UG"Q/#\+*1,--7,;<9@OO)5":=!3Z)L
MM24GJ HV_N5S/J%JS>,=_5=JB<-UY&BY2=J<MG$!3CI*%/-M'YUL _.D6]>G
MPK7X=JUVQY,MD3,=%.:GA-ARDF:S@TN,<HKK<ESJTVI*D]&B3874>@^SUKN;
M]M*Q$V^+6K$SV>^EX#,R-JAMQV51W,<^ER8LD)[*&S923U]3^&U8\G;2-<Y]
M8Z)I6<N@Q(86ZN.AY!D(%UM!0*T@_$I]17FL3C+<<VY'5L]'S:\&[%4YD'W%
M=FQ!#J5J-E@D^GQ-_2O4TWTFGEGHTIK.<.C,5&>A8R'#D+[K\=AMIURY/)2$
M@$W/WBO,;+1:TS'Q;D=E1>5->S3NP)RT:*[*@R&6VD*927"VM%P4D"Y%[W'P
MKM<'=2*>,SB6OLK.<HYF=1V;%X;'S9[#AAI2X2U^(Q.XN_%8OTY?BZ?HK:U\
MC7:\Q$]?ZL)I,0L[Q1B<GB\ \N>DM-3'N_%8402E!2 56'IR(O7)Y^RMK]/1
M?JB8A.W'&VD*==4$-H!4M:B D >I)/I7/B,K6+ RV,RJ5KQLMJ6EL\7"RL+X
MG[['I65]=J?JC"(F)?S+QY,O%38L)SM2WF'&V'/3BM22 ;_#K4ZYB+1,]LD]
MG/&!P677M$/$M(^GRD62E3I*T@M=E04M7*_6P'P]:]-MVU]N;>DPTZUG.&SS
M6B[,[LTR&PQWW93[C[,DN-I"D+45!:OFN"/T53KY6N-<3,]H932<K\BM.,QF
M675]QUMM*%N']I20 3^LUYVTYG+;031N>R;-L6^NA*X#JQ@]=<!O>! 6H/N
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M<(9#_P O[#?U-_7N\!R]/OKRNS'E..V6['9F5@E57F*#F7_H)<=#CN'80L2
MW<I0Z2+*6!\".@-=CZ?:D9B>ZC;$LSP_"S$7&SG9J%M8U]:%0FW;@D@'FM /
MHD]*P^H6K-HQW]4ZHG#<>3H&3R.J/,8Q"WEI=;<D,-W*W&$D\@ /6QLJWW51
MPKUKLS9ELB9A7OBS$YE.SHG-QW8\!EIQ,MUQ"FT*"A9*/F N>5C]U=+G;*>W
MC/53KB<KMEH><BOMQU<)"VUI:7Z<5E)"3^HUP:S$3&6U+FW&8/8_SV/"C1)#
M>89D)5W%(6 VXA5RXI9%N-^MZ]3?;K\)F9C&&E$3EX3(V<.?>:=;D'85R%'H
M%]XO%70I(^%_0CI:LJS3P]/'")SG[UU[]F\EA=.1&B.I1M.:5'PN+)O;\PG6
M;YW%[=L<W;^GRUYK76+7^Z.OY-WT2/ 82#K>$Q^!QJ>$'',-QF18 D-IMR5;
MU4H_,H_$FJ;6FTS,^J6QK$*!0*!0*!0*!0*!0*!0*"(^2_)6J^)M0F[MN,A3
M&(AE* VRD.2'WW#9MEE!*>2U'T%P +DD $T'-GB#WPN>7_+F&\>P--3BL1E?
MJ;9!^=WI*1'C.O@]M+*4]2W8CD?TT'6.=S,'7,)DMARBE(QF)BOSYJT)*U)8
MBMJ=<(2.I(2D]!0<[_\ 3T]NEO\ UOD/T?ELC_K4'0.J[+B=RUO%;7@G%.X;
M,Q6IT%QQ!;6IA](6@E"NH-CZ&@_.V;/B=+UO)[9GEK:PN'CKF3W6T%Q2&&A=
M:@A-RJPZV'6@HC_IU^V__P"(9G_V,F__ )*@_G_3K]M__P 0S/\ [&3?_P E
M07OL6VZWJ6O2-KV;),XK7HC27I$^4K@VE"[!(^TJ42 E(!43T O0<[/^_P#]
MOK,TQ6W\P^P%<1.;QY#!'](!;B7+?^#O]U!?FA>1-,\G:^UL^C9=G,89Q1;4
MZUR2MIU(!+;K;@2MM8!!XK2#8@^A%!Z;QOFH>-]>?VG=LLSA\''(0J0^22MQ
M5^+;;: I;BS8V0A)5T)M8&@Y^;_F >WU<T15/9EM@JX_7*Q]V /Z5DN%RW_@
M[_=0=$ZGM^L[U@8NSZAE&,O@9H)CS8RN2"4FRDD&RDJ2>BDJ 4#ZB@W=!Y29
M,:''=ES'D1XK*2X\^ZH-MH0D7*E*40 !]IH*NF>YCP# F+@R/(>%^H;5P7VI
M(>;"KV_M&@I'_P!*@L'7]FUW;,<C+ZOEH>9Q3G1$W'OMRF2;7MS:4H7%^H]:
M#:T$2V_RCXZ\?R(L3=MGQN!E34*=B,Y"2VPMQM!"5*2%$$@$VO09VH[QI^^X
M]W+:7FX>>QK#QBO2L>\A]M#Z4I64**";*XK2;?8:#?T%>;?YW\.Z'D%XG;-T
MQ>.RK?\ ;0%/AV2W]SC3(6I!_P 8"@V^E>3_ !YY&:==T;9<?G2P.4AF&^A;
M[2;V!<:N'$@D]"I(H)908N3R4'#XV9E\F^F-C8##LN9)7T0VPP@N.+5]R4@D
MT'R7GY+;_>A[BHT'O.Q</-D+;@LGYD8K 1B5K5Q_#W"@<E?!;R@.@(L'TX95
MXP\#:/C,6]*@:CIF/+<"&N4XB.TI]:5*^9:K<W7.*UK4KYE&ZC09>H>4_'&_
MRY,'2MIQN>FQ&P_)CX^2V^XVTI7$+4E))M?I>@E]! ]C\U^(]0S$C7MHW3$8
MG.10@R<?+EM-/MAU <1S03<<DJ"A?X$&@U^\>??%GCW5<-NVP9KGJ^?<[.)R
M,!IR:T^K@IRZ>PE72R3UH(IJ7O"\$[OLN+U+7<W*D9O,/IB065X^4TE3J_0%
M:VPD#IZDT%->_/V^X_,:X[YJU6$AG8<1P3M+;" GZR 2&TR5!/XG6"4A2K7+
M7J;-IH)![#_.D[R%I\SQUM$I4K9M2;;7 E.JY.R<0L\$<B;E2HZK-E1_94WZ
MFYH.O*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0><AAF4P[%D(#D=Y"
MFW6U>BD+%E _I!J8G JW6<GF,+HNQ:JA:W=ATMQS'L.%([B\>0'83X2+BWTZ
M@!]Z#6]%:VVUF>UOM_5A,S$2@.LYW/0LVW,Q+KLR>_S4\P5*<^H2$E2N8^-O
MQ7^%=O=JI:F+=(_HU:VG+TQ^Z;2C+,9!&2?DONNH"F%**FG0I0'#M_A /H+#
MI6-^-K\9C$01><NC>VVI:75('=2+!1 *@#\ :\QENOW4"BO)V>RK^S.XQ:RS
M#@<%16@!U*DA7=N1<W/0?#I7H>%JK&OR]9:NRTY6;X]S&0SFKQIV3/.5R<:[
MU@GNI;40E=@ .H^RN3R]=:;)BO9?29F.J-^9<A+CXS'8]I7&+-=<^IZ#YNR$
MJ2F_PN3?]5;7TZD3:9]85[9Z*UQNR9S&8:?BX#ZVX$A2"ZM'0M%1(/%0_#W/
MPFNK?32UXM,=84Q:8C"1^*<MDVME;Q3;RUXV0TZM^.25(24)N%@'\)O8??6K
MS]=9U^7K#/5,YPM[893V*P63R,!M/UC+#CJ+)O=:4FQ(^-JXNFL7O$3VRV+3
MB'.^#R^1QV;BY.&Z3-6^GF; ]T/+'-)%K65?X5Z;;KK:DUGLTXF8ET[7DV\Y
MHV7+Y69L<V7/?6F=$D.-LG\)82RX> 2/A;\7Z>M>JTZZQKB(CI,?Q:5IG+)V
M/:MARTB(,FXIAR(RTIIGB$_.4@]X@B]U^OV5CIT4I$^/K]L)M:9;/8=UVB7B
M<&AR4[$$B.MUUYD]I4A2'2@+NFW2R0;"JM/&UQ:W3/7^";7G$,/+;1G<IJ>/
MA9!]3S!E/(7(6 5/!D)4@*5;J4%1Z_'XUGKT4KMF8^")M,U8$'8\[ PDS$0G
MUMXY]:"ZM'0M\KW2%#T#GQ_15EM-+7BTQU1%IB,/? ;!LN-Q^4CXA]WZ1,?N
M/ $D1TE:4EU%_P )ZV_O_"L=NK7:T3:.N?X_<FMIB.C]ZALF:Q&2>D0EN2V.
MP\_-BJ45H6E*">XKU_"2#>HY&FEZXGI\"EIB7\UO:\OB\U]=%:9??FDH=CML
MH3S4L&P;"0"GK;HGUJ=VBMJ8GT*VF):QG-YA&83FD2EG,EWD7A^)2U'B46MZ
M'\''[.E6SJIX>..C'RG.61E]BS\G,O9.9+>C9-AQ02E*BGZ8I/X$I^ 'V?'X
MUCKTTBGC$9C^J9M.6;G]OVF=D$.3)3L%^,ALMQV_W80>"5<[6O=?XNM5ZN/K
MK7I&<IM><L[8]TVF7 PS3LIV(EV('W'&3V3(7W%)YDIL;#B.@Z57IXVN+6Z9
MZ_P3:\XAXYC;-BR.JXN)-?4N,\Y(0[)4!RD=DIXI*K?LA76WK66O1KKLF8^[
M\B;3,/")N^RPM?<Q+3W*$IP-(DN(2X6T\22RDJ!'7UZW(K*W&US?R]?MU1%Y
MQAGXS<=C3JN9AQ3Q^F[*S.CMH:6RV\LI7R* !<]+*]15=^/K]RLSZ^B8O.):
MS5\_LT)Z:G#/O2"8KSC[1470D)3_ &ME7LI/P^VK=^K7:(\H]?M"*VGT>>M9
MW9(^:2]AGW9>1DAPN,J)=[]D%1*P;WM^*]3NU:YIBW2(16TYZ,+'YG,-YIG+
MQ9#CN:<>!#EN3CKBS8H*;=>7X;59?72:>,QT1$SG+8Y#=MI7F7LF9SD>6RZI
M*(X [;02HCM<2#<? WZFJJ<;7X>..C*;SET+CI#LK'Q93[?:?>9;<<:_HJ6D
M$C]1->:O$1:8AMQV4]Y<RF71G6<>I]UC&)90['0A10AQ9)Y*)%KE/I]U=O@4
MKX9]6OMF<HEDL[L<[$8Z)DI+R\6GN&&I9(#W!7$W5^WP_"+^E;E-6NMIF(ZJ
MYM.'K&S.RQM7?CQY#Z,&N4EI4A*B.+A226DJ]0E7J0*B=>N=D3,1Y8,SC[FT
MPN<VEO3<XF%)>,.*Y''U 62XPAQ1[@;5Z@$6*OLJK9JU^[7,=9RRB9\997BS
M*9A6T(AM2'7X+S3BYC2UJ6@ "Z5]2;'E87^^L.=2OMYQU]$ZYG*]*\\VB@_/
M;05API'< L%V%[?9>IR($S_^]/E!U^X<PVE1NPT/@<SD$W<4".A[4>R2#Z%R
MK_TZ_OM_2/\ E"?UKI*!0*!0*!0*!0*!0*#1[CN&N:#K61V[;)R,=@,6UWI<
MIRYL+A*4I2D%2EJ40E"4BZE$ 4'#6V?S)GF\HXSI&D(=P[:E);EYB4I$AX F
MRBRPDI;Z?#N+H+9\"^]W3O+F<C:=LN,.I[9-LWC>3XDP)CY_WIMTI0IMQ7["
M%ILKT"BJP(4-_,'\MS,ML['AS\O#,+7WHV8.22^I1?7)B&R%,\0$\.X;*Y&@
MC7L=\B:MA/(>"T=S1X,[:LW-E*1NTAWE-B,B&M266&U-D)%D+"BA8*N?7H*)
M?2_:L"UM6KYO6'WE1F,W E8UV0V I;:)C*V2M(5T)2%7%Z(?';W(^(,7X/\
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M#D>7K8"@Y1]U&BX'Q+YWS&$T<*Q^*9$/)P([:R3#=D-)>*&U'J E=U(%_E!
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M9&(E>^%*X)"DGR25)*.@*4Y@E9_N T'USH% H% H% H% H% H% H% H% H%
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MBAU-K@!(J-=+<J\S:>D$S%(Z-#*\DP\YJ61;S.*:>FI6TTF+R5V%ETDI7?\
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M=U9<5'[=WDI4;E"57M;X D=*FOU&8KUCJ3JZMUF_(V U.8C HC/R50T(;=[
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M2I*TA:"%(4 4J!N"#Z$&@_M H% H% H% H% H% H% H% H% H% H% H% H%
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MU:_++3DJ1$2;_P#<F>X[T]"I-;$?+KSZV_HCU6!6NDH% H% H% H% H% H%
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MKXL;#JV%O'9=S#%Y, ,H&34T5 !!5TM;]KUOQZ\;_"L]GA-J^7?T1&<3AO\
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M1<-Q493<=/!D\0%!2$_"]^H^VM+F:O#9WSE9KMF'EY*V/(Z[A&EXLAN5+>#
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MO,W Q6-4IIM:+BZ0\Z7'2/O%;&WY8BGP[_C*(6!6NDH% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%!7^/<5K7E+(XA
M9",5M\497'CT2,E!2EB6A( M=;7:=)^)"JV)^;7$^M>GY>B/58%:Z52^7-C*
M9#.N-Q65@-IDNR7D<UI*B0D-$_A]/F5^JNSP-/3SRU]MO1KL5Y#?PFFMLX^!
M':R(E*C)6ALH9*>V%EU0!ZN=;>M6[.)%]N9F<81&S%6/*\F3<KKD_%YF%'E3
M'>"&'>!#5E$W4I-^BDV!18^M95X44V1:LS$(]S,8EJ]-VUK64Y%E^"U+:F,*
M *TW67$CY6U$^K:K_,*NY'']W&)QB?M^;&EL-[XWV&&=F3$<P\..]-#@8DQ6
MU)6TH#EP')2OE(!ZBU:_,TS[>?*>GQ9Z[=>RZ'%I;;6XO\" 5*_0!<UPHC+9
M<SNY3%+V!661BD#%=_NC&\U!)0#\3]I_%Q]+]/2O512WAX^77'=I9C.<)KFO
M+F41DBC ,,)Q;! ;[Z%%;PL/6Q'$?9:M#7]/KX_/,Y63MG/1:V$RC6;Q$/+,
MI*&Y;270@^H)]1^HUQ]M/"TU^#8B<QE4OE_)L/9AC%IB-_41F4K<FJ![MG"2
M&TGTX_$_?79^GTF*3;/?T:^V>N'AC/)+V%U1C&XR"PQE&W5-E800SV[<NZ4W
MZK)-CUK._#B^SRM,X1&S$/WD_(+^=TR3%RD)A[(F0VP'.)[82I"EAT"_18*2
M  :BG$C7MB:S.,?:$S?->K0ZGM4?6F<DT_CF9RIK);:4Z+DJ^#:[^K9]2!\:
MV-^B=DQB<8^W\6%;89VH[O&P$Z1)E8F($O-K[;L5KMNH7:Z4 DJ^11Z'[/6J
M^1QIV5B(M/YIK?'HV6*\N9K\T0<TTPO$O*XO,LH(6TE7Q223RM]A]:JV<"GC
M\N<LHVSGJA[>2QB-A&4.,;_*Q([OY=S5P".5_7UN/Q<?2_3TK=FEO#QSUQW5
MYC.4RR/E_,_FBW,7'8_*&U6:8=2>XZ@?%2@?E)^P#I6E3Z?3Q^:9RLG;.>B=
MR]6UG>HT#/S(RT.OL-N)6VLM+*%#D$+X^MKUSJ[]FB9I$K9K%NJ%^2G=8Q+T
M#"Q\,V[*C,I*7 XXR&F+GBBZ#=5S<]?2M_AQLO$VFW256S$=,/T[Y&9Q.J8Q
MK6<>U!DOJ=;<95=QICLD<B/0K*BH$%7ZZB.'-]L^<YA/N8CH_#'E_)C"/A^,
MRK.)<0AAP!094VH'DM2;]%)MZ7ZU,_3Z^?2?E1[LX^]^H/EG*G Y!4MAI>78
M[28CR$E+1#RBDJ6F_JFWH/6HMP*^<8GHF-LX8FM^5<S&EN#85B;"4VM:2AM+
M;B7$I)2!Q %E'IU]*SW<&DQ\G245VSZMAC/,<EV6IO+XYI$%:5\5,*45I4$D
MI"N5P0;<3:J[_3HB/EGJF-OQ0/&YUN'L36>7CHW:2]WC!2DAEL$_[V+]%)]4
M_?71OJSK\<S^*J+=<O;+9W&2]D=S+>(9,'O%PPU*4E+P!OS6 ;!2O4@=*QUZ
MK1K\?+K\2;1G.'14"2S,@QI<=/!A]I#K22+62M((%OA8&O,7B8F8EN0KSR!Y
M"RNOY1.'P[;27$-H>?D/)*[\R;)2FX%K#J:Z?$XE=E?*RF]YB<0VFLY#'^1]
M?*L_CVG78SQ:=18\.8 (4A7J+@];&J=U+<>_R3W95GSCJE>,Q6.PT5,'%QD1
M8J25!ML6!4?4DGJ3]YK3OLM><VG,K(B([(OY.R4UC7D8'$*MG-G?1A8"A^)L
M2@>^_8$&S+(<<N/0@59IB/+,]HZDI3BL;$PV,A8B DHA0&&XL9!-R&F4!"03
M\3853:9F<REEU 4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@@OE6.]'U]C;83:G,CJ,IO,M(;!YN1VKHEM?+ULIA
M;G3[0*V-$YMXS_[=$2U^S^5VL7,9BX2,B>TIEJ2N2XLH0IN0@.HX "YNA05<
M_;6YQ^#YU\K3A5?9B<-!O&TZSL.*Q605C%NY5]+G$]TM%A+:^*D+4D'F"?06
M^_[JV>-HV:[6C/3^K"]HF(8HV73CI/Y6O"_Y6F1=,0/*N72C_P H[UN5O@1;
M[JL]G;[WEY=,?:,(\J^.,-YX\AZEL>&RF&5C"Q(7VS,YNJ=4M-R6UMK(!3Q-
M^GV_;6OR[;==XMG\&6N(F,)1C?&FJXUF8RAAR1]:T6'')"^:TMJ]0@@#CUZW
M]:T[\W9:8G/99&N(>&'T?7-(7)V%;SSRHS3B@Z^00TU:ZN(2!<V%KUELY.S?
MBGQ1%(KU:K'>8<;-R;<.3CG(L%]P-(E*<2HIYFR2M%A8$GK91M5U_I]JUS$Y
ME$;8F6:YXCUMS*&=W'TQ%++BL>E0#5R;V"K<@F_PO6$<_9XXZ9^*?:C*IMI<
MQ;FQY!6,C*9@)?4A304!R4A7%91TL@$@\1UM79T1;VX\IZX:]L9Z)Y*\K0\0
MS!Q^MXQ+D%EAOGWEE/&Z?[--@;E/Q4:YU>!-YF;SURMG;CLTWD3/8+8HV(R4
M1AU&5?8*EJ*D\&VDK*2VL?M*"@>)'P_35_$U7US:LST8[+1.&L<R.J?P6QCT
MP759T2%K4X7 "E?$#NE0'5!'RA%O^O5L4V^[G/RX8YCQ96-S6I-Z9/Q<W&N*
MR!=;< 2]\[SO4)<0NWR! '5-CZ_?6%]>V=L6B>B8FOCA_-6D:>U@\XK,0G79
MJ6$C^T!*T+7Q2&38<%!7&ZO_ .53OC;-Z^,],_;)7QQ.6/I,W5(>1DG88JW&
MW&74QW7%!;: 4FZ2D 76H=$J^W[/6LN37;-8\)128SU?O5'=,&S13)BS!$6\
M$PA)<;6VA:C9'= 2+B_WFHWQM]N<3&?7_A-?'*Q/^:/7/S3Z_NO_ $G<[OT'
M(=N]^7'E;EQO\+^E<S_?V>..F?BN]J,JWVQG4XNU268R9?Y>V\H3VF.VD)7>
MZTL$_#]/I\*ZFB=LZXF<9]/^5%O'*<9OR9$UMR)A]?@(DPV&&5<UN%"0TM 4
MA"; ]>-KDUS]7"G9FUYQ.5L[,=(1WR'F=<S[.*RD=M]&8D1PM24\."6>1'%R
M_4J"@>-JVN)KV:YM6<8B6%YB>K'S,W3TZ3B8<"&^[-6X\MMQUP(=:=20'5.%
M((4%=+)%9:Z[?>M,ST)FOC# CY;56M0D8QS&.N9MY]*RZ7;7*4GBX%V^5*?0
MMVZWJR=>R=L6S\N&.8\61KV9U.+KF7QV6QSBY<A"%=Q#EU/*2KY$H41^[*3\
MQ_\ N%8[M>V=E9K/2/M^::S&)B6/IV2U?'.3SL$);ZG8SK<=85R390ZMA/2R
MU>B5_P""LN139;'A/JBLQ'=_-/G:U$V-I_*PU" 5*$8N.=Q#!4" 71Q'/H;7
M_O5/(KLG7BL]2DQGJ]\5)T).S,NJA348OO)["7G$*:2KE\I6BW(HO\.1^^L;
MUW>WWC*8FN6/LDC5V]IDKA8]UW&M/J^J8#W!#RTJ^?MV2>*2;]/C]U9:8V3K
MC,]<(MC*?2_,&'A.LQL=CG9$1*$<UI4EH(ND?(E)!OQ]/A7.K]/M/69ZK9VQ
M"09#7-7W^'"S+R%J#C04Q):5VG>VKKP5ZCH?A\#6K3=LX\S5G-8MU;W#87'8
M" WC<6UV8J"56N5*4I7JI1/4DUK[-EMEO*W=G$1$=&?5:5?8L)VOR9D<VI//
M%:<T<1C'+W0K)2P')JQZ?,V@-LG]*JV+?+KB/6W7\O1'JL&M=)0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0?EQ
MM#K:FG4A;:P4K0H7!218@C[Z"B=?\=-95[*ZV)JX62U:68![B"\'L8Z.]!=N
M2/F#*NV;=/DKLUYDZXC,9B?Z^JBVO,IOE/%.+EX:!CH4E<>9 "PF6I(7W>Z>
M2^XGI^UU%O2J*<^T7F9C,2F=481K:=+US4]7;;G2W7<R\_SCR&T#DM018M\;
MV#8'4F][_P!RMO1R=FW9TCY<?;\V%J16&S\.G");GIC..JS:DH5*0Z $!H$A
M/:MZBY^:_6]4_4//IG]++5A8^4R<3#8^1DYZ^$2,@K<4!<_8 !\23T%<NE)O
M:*QWE=,XC*'8;?,%O#DG6Y41V,9C3B&T.E)#K=OFL4_A4!UM6]LXM]&+Q.<*
MXO%NC5X_P[&B9-N3-R2I&.86'4,=L(6O@;@+7>UNG6PJZ_U&9KB(ZL8U=6X7
MY7U5&3./Y/%@+[2IX0/IPJ]KWORXW_:XU1_H;/'/\F7NQE7&\L:HUM4@1'I2
M6E.\LHEA"%)0XJRE%DJ(N3>Y'I?TKJ<:=DZXSC[O^5-\9>.YL:BSD(PU]QXH
M4RR9*$A):2DI%BDJZ]PCJH>EZRXT[9K/FB_CZ,O;!I@P.#&%<D+G)CGMW"1=
MLK//ZB_HOG>P3_@M6&CW?.WEC&?MA-O'$8;77-*UW;=72,9+=8S,9XJEO/(!
M(4M/]F4@@%NPND@WJG=R=FK9\T?++*M(M#][#HN U34WE9&<XYEGW4*C/I;%
MU.I2;-(1?H@]>2B?O^ZHT\J^W;TCI]NJ;4BL(YJ@U16+SC>POO,RG&$]@- '
MY$*"KM7_ !.<K?*?A^NVUO\ =\J^$=,JZXQ.61H&&UG-Y9Z#E7GE/N-N""PI
M(0A=Q;D5 GYTCY@GT_36/+V;*5S7\TTB)E+\3XBC8W*-9#(9,R(,18>0UP#9
M5VS<=Q5R+"US:M'9]0FU<1'65D:L2VB?+6K*R0@#O_3ESM"?P'8N3QY>O+C?
M]KC57^AL\<]/P9>[&4"W*#IB=KEA>3DL(==*L@W'CAQ#3B@"KBLD>IZGH;5T
M>/;;[4=(^[JJO%<IAFO%F,SCL2?B<@J(PIAEM0X!U*VD( 2M)NGYBFWZ:T=?
M.M3,6C/59.N)[(CY(Q& PCF-QV.>6<E%C(:?9(NDM J*5K5TLLDGH!Z5N\/9
M>^9GM,J]D1#PGQ].3HV-=:E2%Y?O/<+(2%ETA)=0M)-@V/EXF_\ A-95G;[T
M](PB?'Q8*8NGJU)Z1]6^G8T/I"6U('S$I_ D V+=NI7Z@_W*L\MONXQ'BC%?
M'[WIK3.GNX7,_G[[S62"$JCEM()2E*AQ+/6REE7125?"HW3MB]?".GV[E?'$
MY?K28.IS94QO8I#J"F,ZIA)'!KBE-U+Y"YYI'5*?\-1R;;8B/"/4I$>K+T_%
MZ3-V)J+)GR)3:E%,./(8[+;RB" %*"B;_8.E_P"]6/(ONKKS$1'QZIK%<I7%
M\-PF<FA]W)..XQM8<3&* '%<3<)4L'T^\"]:5OJ,S7&.JSVNJ"[/+U.5L[\B
M$S*_*U/$S5,J0GN*O9:F4J'RC]/K\*Z.BNV-<1.,^G_*JTQE_=LBZ>QEF_R5
M^1]&XAMR0TTA*DMH4@$=M2R"5$=2E7H:C1;;-?FB,EO'/1/E^1-9U3'XW$8>
M.]/81';6"E24<$+%QR)]5GJ5#X5SO]/9MM-K3CJN]R*QB$XP6;@[#C&<KCRH
MQW;CBL<5I4DV*5#X$&N?MU3KMXRLK.8RQ-SV-K4]8R6><LIR*R?I6E7L[*<(
M;8:Z=?G<4E/ZZC73RM$,GAH>N+U;58&*DD+R929.5>!OW9\E1=D+O\;N*5;[
MK5.V_E:9]$0DE5)*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!00#9$_P .>1-=VE!*(.=0K6LL+DI[JB7X"^(Z
M7[@=;*C\%@5L4^:DU^'7_*/5/ZUTH-Y1Q^%F81J1EII@O1G"8;B4=U2UK%BW
MP!!(-A^BNAP;WB^*QG/=5LB,=6H\28W!M_6Y"'/,O*%*6GF5-EDLMDW%DDDG
MD1^*K^?>_2)C$,=40FFX0(&2UO(1<E)$.(6^:I2O1LH(4E1'QL1Z?&M#CWM7
M9$Q&96WC,*F\80\.K:$/2<BE4M@+_+X_!2 \HI(*P5?8F]D^M=GFVO[>(CIZ
MM?7$97DZVEYI;2K\5I*3;ULH6KS\3B6THY?B'9/S$PDK9.+*[#(%8N&C\>W^
M+E;I;TO\;5Z"/J&OQSZ_!J^U.6NW'$X.)M#D2'ED(CJ*$RUJ;6X(S@2$JY%/
MXO3E9/IZ5;Q]EYUYFO\ RQO$92/*>(Y#ZHTC6YS#L%UIOD7RH?-Q%W$E 5=*
MOQ6^%:M.?$9B\3EG.KX-;N&B0-;AXY?YLRW*+?"2R\%\GG+W+C:4!1"1>W4?
MKJWC\JVR9^7HB],>J<^+,+"QN%>FQ9[<]V>L%Y;%PVWV@0&[*LKD+F]P*Y_.
MV3:^)C&%NN,0VF]:JO;,0F)'>#,V.X'XREW[94 4E*K=;$'U^%4\7?[5LSVE
ME>OE"N?^:Q_'XK(Y'8<C'B%AKE%4A2E-)6"#R</$$@_A"4B]_P"Y74_WHM:(
MI$RI]O$=6!XQQ^.E;*W*F34,N04K?CQC=*G5)!NH*-@$H'S$>O\ ?JSFWM&O
M$1W8ZXC*U6-QU/87G\%$R*%OR$+938%(6%)(/;4H */7X5QYX^W7$6F&QYQ/
M16;?B+9?S(0UK93C$KM]?S!):!]0WZ\K?#TO\:ZL_4-?CGU^"CVIRU>V8S!H
MVR3$C9=#<)UP"2^IM;B8RR % D=%6/7IZ?&KM%[^U$S7K_5C:(SW6RYMVI:E
M'@X21D I;$=I">VE3MFPD!*U\ 0.0ZUQHX^W;,VB/5L>45Z(-Y,Q&)DSH^R1
M<O&0G)-((865+4XE XI<;[85\MK W%=#A;+1$TFL]%6R([Y:C):Q@86GP\JC
M-LO9%YY91VDJ4A[H 6DI_$DHM<J4!]_PJZF^]MLU\>C&:QXYRR->T.)LVNOR
M<9DVW,ZVZDJ84E2$-(L?W:^E[J]0L"U8[N5.K9$6CY4UIF/O;&'X=R:H,Q<Z
M6RC(\0(#;14IH+!N2XH@&Q'0 #[ZJM]0KF,1T]4QJE^M>\29%Q4E>PN(C-EI
M;4=ME7<7W5"P<)%A9/K;XTW<^L8\.I75/JR->\3Y*!FHT_*S&%0H3B7TI9Y\
MW%-FZ;\@.(N+GK6.[GUM28K$YE-=4Q*<1][U27DORAC)-KEJ5VT>H;6OTXI7
M;B3^NN?/%VQ7RF.BWSC.%([#@\;BMC?Q365;,,.D.R"A:C'"C<I<"1\Q3?\
M9KOZ=MKZXMX]?ZM6T1$X;;:\!J..R$)F)FBVVXPR9*4,*D<4E/\ ;<DJ NL=
M>-4Z-NVU9F:_S_DRM6L3W27(>*(>4CP)FN9)"(ZH[25K=25H= ']J"DBRE7Z
MBM2G/FLS%X]?M#.=6>R?:QKT?5\.UB8[A>X%3CKRAQ*W%FY587M^BN=OW3MM
MY2NK7$81;8BG:O(6%U()2[BM?0-AS22"09%RUCVB1TOS[CQ2KU" :FGRTFWK
M/2/[I6#6NDH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H([O6M)V[5,G@P>$MYKN0'KE/:FL$.QW+CJ.+J4D_
M=5FJ_A:)1,/32]A3M6K8O/\  MNRV09+124EN2V2V\BQZCBXE2:;*>-I@A'_
M "K@CE</&FHE,QEX]Q2@F2L--N!T $!1_:Z=/UUN\';X7F,9RKV5S#3^*L'^
M6)G;)-F1Q'6U].E+;R5I0D*"E*<4#9/H+ U?SMOEBD1+'77'5*=E1#W;5LA"
MP4YB0[9*DJ0L%/-M06$J/[/+CZFM33,Z-D3>)AG;YHZ*O\?:U-R&S1I)<::9
MQ3H?D6<0M94CH$I2DFX)]5>E=;E[HKKF/^RC77,KIC;'@9DY6-BY&.]/22"P
MAQ)5=/J!]MONKA6TWB/*8G#9\H%;)@$9$8A>1CC)E7 1BX.?(_LV^W[J>S?Q
M\L3@\HSA1VWZGD,9LC\9*VG6\B\MZ(XMU".CJN5G.1'&Q-KGH:]!Q]];:\_!
MJVK,2N#'2\1IN$Q>'S.289D-LI;27%A/(CU(!ZVOTO7$O6VZ\VK$MF)BL8E$
M/*&JYC-S86;PS7U\<,!A;31!6!R*TK2/VDJY? UN\+?2D36W3JKV5F>L,[Q_
MC5Z3A)D_9WF\<)KJ%)9>6D< @%(OU_$J_H*KY=_>O$4ZX32/&.J;QLWB)D%6
M3BSF78"+]R0E:>";>O(WZ?KKGVU6B?&8ZK<PCNV-1=UU*8S@9K$A;:D/)4EQ
M/#DRKGQ6HGY;@>IK:T3.G;'G$PPM\T=%3ZGJ,[8I,KLR6HR(;3A4ON)*RYQ*
M4IL#?@3^)7I:NSOY$:XCIG+7K29>>IX"7-VF' #S+3D-]+K[B'D$695<]H@_
M.3:PX_IJ=^V*ZYGXP5KF5\?Q+K_YC^4?F4?\R"N'TW<'/G_1_3]U>=]F_CY8
MG#:\HSA0^S:M.Q6R.XI*FG3+=4N&XIU" I+IY#N7/R$7Z\J]%IWQ?7Y?!JVK
M,3A_-GU*?KF09B/O-/B2E!9=[B4DJ( (4%&Z0#T"CTM31OKLKF/1%JXEF;?J
MDS7\=A7Y4EEU2HP86RE8*DK"E.?NQ^TBR^I'Q_36''WQLM:(CU97KB(>,C3,
MDUJL78N^RME:UJ4P'D$):7;BI)O8K)'S)'6ICD5G9-,(\)QE,?&6._AS'3]I
MS<AJ)CI*$-M%2TJ'%"C\QXDV))L$^M:/-O[EHI6,S"W7&(S*P\7LF"S3#LG&
M3VGV6.KZK\. ];J"[$#[S7-OIO2<6A;%HE[8_,XK*MN.XV:S*;:-G5-+"N/Z
M;>E8WUVIWC"8F)8@S&#SZ)F(Q^29>DJ:<:<2RL*6GD"DJ !ZVO\ "L_;OKQ:
M8Z(S$]%)8W1<BO8F\&9L,+CN)+CK<A*E<6S<\$?BYV'X?A7?ORJ^WY8G^#5B
MDYPD6=\3YN1FGWL6^RO'RW5.]Q]2@XUS-SR%CRL?LK5U<^D4B+1UAG;5.>C%
MS_BK/L3FTX5*9L-;;:>ZXXEM2%I397(*_9N+BU_LK/5SJ3'S=)1;7/HMG6L0
MK!8*!B%N=U<5H(6L>A425*M]USTKC;MGN7FWQ;%8Q&&=-F1L=#D9":Z&8<1I
M;\AY7X4--)*E*-O@ +U5$9G$,D-\7Q);^(F;AE!;*;;).5XD +:@J2$0F"1Z
M\&0D_I4:NW3&?&.U>G^40G-4)*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!05_JH.M[]LNI< C&Y8)V;$$!
M1 5(5V9S943:X>"7 E/P<K8O\U(M\.G^$0Q/+6OYG+-P)N.;7*BQ X'XR.JD
ME5K.!/QZ"Q^RMW@;:4S$])E3MK,H5B](VN5KN4?98<98=+"DP%6"I?:622$W
M_8O<7]:W[\G5%XB?X_!7%)PR->TS<!C<XXU%>A?41.PAAS]TY(4%A12$D@CY
M00"?MM6.[DZO*O7/7^":TMB6EU+!9G+Y8L8<JC/LMNAZ2#P#25)*>)(/[1^6
MU7[]M*5S;JPK69GHR,1I&W+S$>,UCWX#[#H5]:M)0TR4'\8<]%6MTX^M8[.3
MJ\9G,3]R8I;+5RL#FD9I>$<CK_.ENE*4$_,I:C<.!5_0_BY5=7;3P\L_*Q\9
MSA(MMTK:W-@?5]$]DOJPV4RVQR03VTI*5*/X>)!]?TUJZ.3J\.^,,[4G+7;=
MK^?Q619&72Y)6ZRRVQ)%W$JX( [23]J#TM^OXU;Q]M+U^7HBU9B>JYO'^.R6
M+U6%#RH4B2GDI+*S=3;:U$H0?L(!]/A7"Y=ZVV3->S9I$Q'5%?+F S&25 R4
M%I4J%%0M#S*.I;4H@ARWQ!'0_96YP-M*YK/295[:S*'P-(VN3K4^2S'<3'=<
M96C'W'.1VR;K";_LWZ7]:W;\G5&R(F?S^"N*3AD8?3=M&O9U:(CT826FDIB+
M'!V1VW I8"/7\-[7]?2L=G(U>=>N<?R3%)Q+3ZOKV?R\J4C#H<84U'>;??ZM
MI^9)'9)Z=5^EJOW[J4B/+X_:6%:S/9^,)K.R2\PS"@PWX4]A=R^M"VDQRG]H
MJMTMZ"U3MW:XIF9B8_J16<L=.NY]67_*40'_ ,T#UK<%6"PJ_<[EK6_:Y7^^
MLO>IX^68PCQG.&YVG3]E.RRF3$7-=G.<V'TD<70I(]23TMZ=:HT<C7[<3G&&
M=J3EB;3KNQ8[*AK)LO3'G6VDM26T+>2X$H2D(! /5/X;5GHW:[5^7HBU9B6Q
MS^F;8WC<+)<B/R^W$#"V&P77(Y"U*"2D7-BE0_1Z55JY&KRM&8CK_%-J3B&-
MDM2VG'ZQ#DS([H@I?=>7"]3'YA(#BTCTY6_5^NLZ<C7;9,1/7'?XHFLQ#VBZ
MCLTO2UR667#%3,$IJ!Z*6WV^*G4I_3_=]:QMR-<;<3WQC*?&?%C8W3MK>Q63
MGL1G&(P9"'&E?(N2@+!4E(OU";<NO2L[\C7%HB9Z_P!$12</[IV"SF59S2\.
M2VCZ%QAPI5Q[JUD%+?KZD)-1R-M*S7R^)2LSG#SU/6]AG9Q",:TY!DPBKO25
M@M]A021Q/QN3TM4[]VNM.O7/\RM9F6!C<%FG-@8Q##*VLTT^"H<@%-*0>2EE
M0/P];U9?;2*>4_IPB*SG#IH @ $W('4_;7E&Z_*W6FRD.+2@K-D!1 )/V"_K
M4Q$R/W4" >37#F/R;QY'<6V]M4DIG.-7!1BH(#\L\A^'N )9%^AYUL:>F;_]
M?Z^B)3U"$-(2VVD(;0 E"$@!(2!8  >@%:Z7ZH% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H(#Y.;7BF\)
MOK%PYJLT.S0E)<4O%S;1YB4I'2X2I+MSZ<*V-/7-?^W]?1$L3S"YD%8."N&I
M2L6IXF:MHW!!2"T21^R3?[O2MSZ=X^<Y[^BK;G#$\,')&-DBLK.(Y-_3\[\>
M]UY\+_"UKVJSZCXYCXHU933=(^2GZMDH^%)5-<:(2EL_.M (YH21\2FXK0XT
MUKLB;=EE\S'13GC_ !>;.VX]V+&?8;C+*ICBT*;0EFQ"DJ*@/7T KN<N]/:G
M,]^S7I$Y=!UYIMN;,OA]D5LLJ(['D.9EV2I3;B4J/,E5T.)5:W$"QO\ "O4Z
M]FOVXG,8PTIB<NCHJ7D164R5<Y"6TAY0]"L <C_=KS%L9Z-U07DQ>43MLS\Q
M+B6/D&/N2&^QQ%N'PO>][=;UZ/A>/M1C\VILSY+=T$Y4ZICSF"LRB@\"[?N=
MFY[?*_6_&WK7$Y?C[L^/9L4SCJB?F8Y(0<=VN?Y3W%_5E%^'<L.WSM\/Q6O6
M[].\<S\5>W.&+X7.3*LEU6<)9'#E?A]3?KPO_5_%;[JS^H^/3_M_9&K*:[^<
MJ-3R'Y/S^JX@+[5^YV2H=SC;K?C?TK0XGC[L>79;?..BIO&GYQ_%D7\O[OT]
ME?F'XNWV+=>=^E[VX_&]=GF^/M3G\FOKSE?]>;;90<R;(,NK8IPR@=.74^H!
M(Y<_7]WV[?"UN/&O6:?'VX\>V&C;.>KHS!_7_DT#\TO^8_3M?5<OQ=WB.5_O
MOZUY?;X^<^/;+=CLSZK2JSS*<J(^.[7/\FY+,DHOQ[W3ASM\+7M>NO\ 3O',
M_%1MR@,56RJU*;],7SKIDM!XCD1SL?P_U/3G;I>U=*WM^[&?U84QGQ^YFZ_#
MV:9J^?CXQ+RL<0PI;0"KN%*SS2U_N?Q >M5[;:XV5FW=-8G$L75L?M!D39F!
M9>;=CQ'@^YQ4BZ5)MP3<"ZSZI'KTK/??7B(OZR5B?1X:D<ZYGV&\"XXG)JYI
M6HE1 24D*+M_A_C?&LM_AX3Y]D5SGH\\;AMB.<CPHT62UF$/I5R4E25(6E5R
MM2_2WQ)O4WV:_"9F8Q@B)RZ83< !1NJW4_?7E&ZY_P#)B<HK;I?UJ72T CZ"
MP5P[7$6X6^-[WMUO7I.%X^U&/S:FS/DN?4?S+^&<7^;\OS#L)[W/\?\ 5Y??
MQM?[ZX7(\?<GQ[9;-<XZHUI)5L>U;)O+AYP0X,!@";6^D@+/U+J".A2[(Y=?
ML0*G9\M8K^<_;\$PG]:Z2@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@QLC BY7'R\7.;[L*:RY&DM'H%-
M/)*%IZ?:":F)F)S B'B^9(=UES6<L>[E=6D.8*:5H">ZW%L([P2;GBZP6U7/
MJ;U?NC%O*/7JB'[\FN9"#J#HPX4RUW&T2BP.*D1E7Y6X^@O8$CX5?PHK;;\W
MVE7LS%>BH]7S.PXQK*.X-QU3"(BUR[$K;:!L [\0%IOTKM;]=+8\OBUZS,=F
MSTK8MJ&5D,P9+\];\:0ZIEY:G4]Q*"I+GS7Z\@/T^E5<G3K\8F8B.L,J6G+7
M:]L6S_Q%#<C39,J>^^A+T=Q:U!T%0YI6@] +?=TJS;IU^W.8B(PQK:<NCZ\N
MW7/^Q[UM2M@G+9R#T)N(^XRU$;/%M*65$#FD_B)M<WKTFGBZ_",QG,-2UYRN
MG!R#G,'C<ED8R!)>90\IM200E9'JGEZ7]:X.V/"\Q$MF.L-O5+)6'EK8,SC%
M0,= <5&A2D+6\^D EQ22!V[D&U@;FNMP-5+9F>LPHVVF$68W'9UZ1-;2\L-Q
MY3,89!L)0M#3J5%2+I ZW ^;[[5N3Q]?O1^'9AYSXM9A-JVF# RC,"4^]'#
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ML&PH5Z&)!< BM$$$*#LGB5#[&S6QK^6LV_*/M^")6#6NDH% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M;A>5"9"7WU$DNR%DN/.$GK\[BE*_74;+^5IE+>56% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M7%1D&%26 2E7SOLA;*!\5+ N/6@WE H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MIKC'-#$@HO;BLA#A3]]JK]5OHII&)]WF=!<EY_5=60KT:A1G9KJ?T]]#J?\
MZ=69HIQLGX+ESN(R69UF9AHV5=Q66EQ2PC,1$CNL/*3;NMI)'4'K:]5Q/5=,
M9A3J/;3/EOMO[#Y7W+)E"DK[:,@6&R4D'\)#@'I\*L\_NA5[7WRM_<-6@;KK
M<_5\F_)C0<BE*'GX+ICR4A#B7!P< -NJ1?IU'2JXG$K9C,857C?:IXTQN1B9
M03,Y)EPGFI3)DY)Q:2\PL+0I0"4WZBL_<E5[4+0T@;4-7@#=E-+VBSOUZH_#
MM7[J^''M@)_L^/I5:Y(*!0*!0*!0*!0*!0*!0:G.:MK&S!A.R86!F$QBHQAD
M8K,L-%=N11WDJXWL+V];4&5BL1B<%!;QF$@1\;C62HM0X;*([""M14KBVV$I
M%R238>M!F4"@4"@4"@4"@4"@4&O_ #[!_FWY#^9Q/SPIYC&=]OZOAQY<NSRY
MVMUO;TH-A0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!01G>F,;(P\)&5R+F,C
MIS.#<:D-)4M2Y+>5BKCL$)!/%]T(94?0)62>E!)J!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0?AUUIAI;[ZTMLMI*W'%D)2E*1<DD]  *#
M5#;=4(!&=QY!Z@_5L>G_ &=!R;[Z<QB,GK>G(QN0BS%MY"45HCOMNJ ,<=2$
M*)M5VKNU]_Z7$M;32*"5^,'6F?)FE//N(:91G\2IQUQ00A*1.9)*E*(  ^)-
M87_3*S5^J'UA_BS5?_UYC_\ ^[9_^KK2=%EP,SB,HIQ&,R$::MH)4ZF,\V\4
M!5^)4$$VO8VO09M H% H% H% H% H% H% H% H%!3.X>X6!A-EG:3J.IYO<=
MOQRPU,AX^,IJ,RM2 L=Q]25<00H'D$%-OC5D4Z9E5.S$XB,I[X^S.X9[6VLE
MO&OIUG.N.NWQ2)")?%@*_=**T$CD4GJ/M^ ]*QF(ST9UF9CJK/(>V/#;3E9>
M2\A[?L&TQGGUNQ<4_,,>$PRI94EL-HN?E%A=*DW];5E[F.ROVL]Y7!K>N8;4
M<'"UO7HWT>%QS?9AQN:W>"+E5N3BE*/4GU-83.5L1B,0V;;3;*$M,H2VVGHE
M" $I ^X"H2_5 H% H% H(9XG8P47Q_AF-:G/Y+"(2_\ 2392.V\X#)=*N22$
MVLHJ2.GH*"9T'%/NM]V7DWPGY.8T[4(F(?Q3N*C9!2\C&?>>[S[KZ%#DW(:'
M&S8L.-!3J/?G[DG$)<;US#+;6 I"TXJ>04D7!!$KJ#0=+I]P/D1OVB/^<9D&
M QO;)5_D;D9]N$ ,L(0)94Z'.K1O_:?BZ^E!RR/YAWGA0)3C=<('J1!EFW_^
M903C0/YC^>1D&(WDW58C^*6H)?R&!+K$AI)(NOL2''4N6_HAQ%!WAK6XZ_NN
MIQ-RU*<WDL%D(ZI,&6W?BH)N"E238I4E0*5H5925 @]10?-QK^8/Y^DR/IHN
M)U]]\DA+34"8XL\>IL$R[GH*"4:5[VO<-G]RUW!937<2UC<IDX4&8XWC)R%I
M8DR$-.%*E25 $)4;$@T%K^[OW1>1_!>[X/7=-BXI^!D<4)[ZLE'>?=#QDNM6
M26WV@$\4#X4%E>UGW#L>>],??RJ(\/>L*X&<[CXP4AI2'"2S)92M2U!M8!20
M5'BM)^!3<*^]WWN:\A^"-FUS$:9&Q;\3+0'9<DY*.\^L.-O=L<2T^T +?:#0
M;'.^8O<%EO;_ *+Y-\;8+'Y39LJT_,VAKL_Y*Q$92Z>;:'9*%#\']-1H*R\"
M>YOW0^8]OQS$+!8F?IL/)0(^V38D7LKBPI;AYK!<E7OVT.*'%*O3TH(L[[]/
M*>$\I/8/.L8A>F8_.N0<@6HCJ9/Y:S++2U)7WB.8;!(/'U^%!97NO]X.V>)M
M]@Z1XW3C9#D>"W,S<B<RN39Z9\[+2.#K?&S7%PGK<.#[*#I;PAN.8\@^)]3W
M3/AD9G-04RI@C(+;/<4I0^5)4H@6'VT$_) %ST H,>+/@S0LPI34D-FSA9<2
MYQ/V'B3:@]@ZVHV2M)/V B] 4XVDV4L _82!0><F9$AMAV7(;CM*(2E;JTH2
M2?0 J(%!Z@A0"DFX/4$>EJ#E+W9>Z+=/ >Q:[B-5Q6*R4;+PWI4E623(6XAQ
MIT( 3V'F@!8_$&@NWPAON2\F^*]8WC-,QHN7S494B3&A\PPA275MC@'%+4!9
M(/51H.(7_9MY\7Y\5M*<BP<.K/?FXW7ZU'?#7U/?Y=GEWN^$_+PX<.73EQZT
M'T?H,=J? ?D.1&)3+DIK^U80XE3B+=/F2#<?KH/;NM@\>:>7I:XO>@_5!BN9
M/',R4PW9C#<M5N,=3J$N&_I9)-^M!E4'Y+K8/$K2#]A(O0>4B9#B<!*D-L%U
M7!KNK2CDK[$\B+F@]Z#\N.-M(4XZH(;2+J6H@) 'Q)-!XQ)\&>E2H,IJ2E!L
MM3+B7 "?@>)-J#(H% H% H% H% H% H%!'-V<9:Q,)3^(_.D',85"8EE'M+7
ME(R4ROE2K_R51$C[/DZD#K02.@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4'X=:;?;6R\A+C+B2AQM8"DJ2H6((/0@B@^?ON>]L8T-Z3Y T
M" E6C.DN9;%M("CBG%'JXVFW_DJB?3_>3_WO\%^N_I+5VZY[PY?"$)-TI2D_
M:  ?[U;#4R_M2% (!%B 1]AZB@D_CSQUL/D[:8FIZM#2]/D_._(6BT>+&20%
MR'U 'BVF_P"E2K)3=1 K"UHK"RE9M+Z?^)/$>J^'=7;U[76@Y+=XNY?+N(2F
M3-D@6*U\?1(O9ML&R$_:;J.G,Y;]:XC"?5#(H% H% H% H% H% H% ].I]*"
M*XOR7H6<VA_3,-L$/(;)&87*?A17.]P;;4E"KN(NCD"L71RY#[*R\9QEC%HF
M<(IY*P/F[9LY'Q&B;%CM5TQ<9*I^8[*I&6^H+B@MMM"ODX\.)2H%!]?F]*FL
MUCNQM%IGIV;GQEXR;\<1<@ES8LMLN3RSC;^0GYF07U%UL%(+:?V 0>O51-AU
MZ5%K936OBG82E)44I *C=1 M<V N?U"L6;^T"@4"@4"@4"@4"@B?C1]<K2,4
M^Y@TZTM:7KX1"%-ICV?<%@E24$<K<_P_M4$LH/EG_,-_U\Q/]'H/^<2J"W]*
M_F#>-M8TS7=:E:OG'I6&QD+'/O-?2=M;D2.AE2D\G@;$IN+B@M;W-[1$W?V>
M9K<8##L:%GL;B,E'CR./>;;ES(CJ4KXDCD JQL:"D?Y::$.2/)*7$)6DMXBX
M4 ?C,^V@LOWP^#M,S7BO*^2<9BXV-W#6BS)7.BM)95+BNO(9=:?X !?$.=Q"
ME?,"FP-E&@KC^71N.1=QN_Z'(=+F,C-,YF V3<-.NA;$BWW+"6O[GWT'*W@'
MR9BO#_E[#^0,U$D3L;B_K4O187#OJ^JBO1T\>XI*>A<!-SZ4'T'\8^^/0?*6
M^8;0<1KF8AY'-..-,2I7TO906F5O$J[;RE>B".@H.=/YD/\ K4U3_1\?Y[(H
M*:T+/[U[7O(FH;TXUW,=G,9$RO897=G)8+)I2MQDGT#B2GT5^!U -B+7"W??
M_LN%W+,^-MJUV4F;@\O@79<&2CT4V[(N 1ZA0_"I)ZI4"#U%!UGX(:=?]H&#
M88;4Z^YK,]#33:2I:UJ$@!*4CJ23T %!4G\NO6-EUK'^0D;'A9^'5)>Q*HXR
M$5Z)W0A$OEP[J4\N-Q>WI<4%):_X.VG=6?/\.7K$YC*M*7F]7DRH3[1>?@Y%
MYU;4<K0.:GF%+0E*2;DB@TK'AGR)E? ^X^2-GP&4R6[97,8G$XMF5$DN9-,"
M"VKO/);*"YP5^Y9!X] V1Z4'T.]L\"=B_ NAX_)Q7H4^/BT(?BR6U,O-J"U]
M%(6 H'](H.'O>]Y^VG9?(>0\3:U/?A:AKZD0\A'B+4A60R*DA3O=*+%3;95V
MDM'IR25=;IL&GP?M9]T7B7!->7]7=:Q>8QK'U[V(A2U'*HC)3S6EY@M]ET!-
M^;/<63Z<2>E!"_9](=>]R^C+6H_/)G**03QZX^4?2]!*??PXXCW"S0E:@/RK
M'= 3;^S50;#)>U[W+^7]*C^6<]D(^1>>@-2L/KDF0XF<<<AE/91&82UV&N38
M24-\TE7JKYR;ALO8CYLVG">2X7BK*Y!^9J.Q-OM0X<A:G$PIT9E;Z%,\B>"5
MI;4VI">A)2?A05_[Q/%VP^/?+N7S>;E1)$3=)V0S>)1%<=6XU&=DJ(2\'$("
M5_,.B"H??07I[)O;IO.'V+5O.4K(XU>H3X$PLP6WI!GCOH<CIY-ED-BRA<_O
M#T^^@HB0M?\ TT5(YJX_\Y Z<C_^NOTT'1GOV]P&RZUD('B'2\@]BS(B#(;+
M/B++<A;;ZE(9B)<392$D(+CO'\04D7MR!"B?&_M$]P^;UF#Y6U%QC#3'&TY'
M!-.3G(67D(5\[;K)2CBCF/F0774<@;^A%!66OYK9<YYUPN4VQ3@V:7M$)>9#
MB.POZSZYL/<VTA(2KF#R  L?A0=O>^OW$['H"<=XMT6<YC,UEXAR&<RT911)
M9A+6IIIEAQ/5"G"A:EJ3902$V/S&@Y\UOV/^9=VT9CR$,ECF\OEF$Y+'82;)
M<^ODLO)#C:ENE);0XZDA24K7\1S*3>P6#['_ '%[<QNT?PQO$]_)8;*)>;P3
MTY:G9$&;'0ITL=Q9*BTXE"DA"B>*PGC8%5!2?NXF2(?N:W>0PH]QB;"<;2;E
M/)$&,H7'Q%Z"9^2/:O[E-@U6=YIWS(,9C+F,K*9+$/2G5Y6/$".ZH!HM!E/;
M1U[#2_E LD7^6@L3^7]YLVJ9M$WQ%L60>R6#=@N3\"92U.N1'HJD]QEM2B2&
MEH65<;V2I'R@<E4%7^Z?R1M_D[SYDO'.8SXP.EXO+-X*&Q*=6QC(R$N):7-E
M!/15R2Z5J!*4=!T%!G93VO>=_$6=PNV>$,TO<&9""\QG]74$!IQHINV\@N+0
MMM05T!4I*Q<*'VA]*/'F9V+8-(P.8V[%+P>TRHC:LQBG $EF8D<'0 %*LA2@
M5(ZD\2+]:"34"@4"@4"@4"@4"@4&BVQK+NXV*G"SF\?+&3Q2WGWE!"5Q$9!A
M4ID$I5\SS(<:2/BI0%QZT&]H% H% H% H-=GL[B-8PL_8L_,;@87&,+E3ICQ
MLAIEH<E*-KD]/0 7)Z#K0<XJ]X4PX]6XQ_$>V/>+$_OCMP90 8:56,E,<^K0
MZJY=VUO4BB71.L;-A-RU_';3K<Q$_!99A$J#+;N MM8^(-B% ]%)(ND@@]:(
M0GSMY@C>#]#5O,O$N9IE,R/!^B9>3'5>25?-S4E8Z<?2U!9$=[ZB.T^!Q#J$
MKXGK;D+VH(WY'V;,Z=HV<V?7\$_LV9QD93\/!1+]Z2L$#BGBE:C8'D0E)40.
M@)H/[X[V3,;AI&"V?/X-_6\SE(J)$S!RK]Z,XJ_RJY)0H7MR 4D* /4 T$GH
M-3M.<1K&L9K97&#*1AH$K(JC)4$*=$1E3Q0%&X!5QM>@CWB'R*SY9\<X/R%'
MQZ\4SFVWG$P''0^IKL2'(_5Q*4@W[?+\(]:";T%8>#_,D;S7@,SGHV'=PR,/
MF).$4P\^F07514-K[H4A*; ]RW&WP]:"SZ!0*!0*!0*!0*!0*!0*!0?AYEF2
MRY'D-I=CNI4VZTXD*0M"A925)-P00;$&@^>WN:]M+WCJ0_O.C1E.: ^KE.@M
MW4K$NK/V>IC*)^4_[V?E/RVK8U[/26IMU>L.9ZV&J4$CT71MD\C;/"U+58OU
M65FFY4JZ6&&$D!Q]]8!X-(O\Q]2;)2"H@'"UO&&=*3:7T]\.>'];\-ZLC!88
M?59224O9K,N("7YD@"UR!?BVBY#38-DC[5%2E:EIF9="M8K&(6)6+(H% H%
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M+)D%">Z!:U@JU_2@]Z#RD18TQOLRV6WV;A7;=2%IN/0V4".E!Z@ "P]*#'3
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M]TG,XO&Y).H9UYW(.+;=Q[;4(RH@0KCSD!4L("5>H[:UFWPH,\;%).R+U_\
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M% H% H% H% H% H% H% H% H.8_??D\GB?"$>9B9+\:8G/8X!49UQE:QQ>/
MJ;4E5B0.EZ)A^&_:6O><8G9?+&];),\F9)H29,O'3?HX.-D.)"A'AQDI4D-L
MJ/$=?GMR^6]!J_#_ )!WM."\S>&/(>8<S>U^.8DL8_9"5"3+Q\B,\6EN+N5=
MQ'%"N145?. 22FY")^TOQ'G?).C:3Y,WW=<V_!UN>Z_J.NQ9/;ACZ.<MQ;LP
MK#BWE./!:2+ILV F_'Y0&YP^*SONW\D;R[G]GR>&\-:3DE8+$:_A'S#5D)C
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MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%!RU[
M_&U.^"XS2%]I:]@QJ4N=?E)2\ >G7I1+U:]TV=T#$-ZOY8\=;+_SFP&A&XX>
M&)V,R[S:>"9$64E0'!XCDI/ E%[?,1:@P/#WCG>V]9\P>8?(V*5BMX\DQ);D
M774A2GX<!F,\&6E)]>XODE/ CE9";V42D!,O9=C<CB?;IJL'*PWX$YMW)%R+
M*:6PZD*R$A224+ (N"".GI1"N<;-V7VE^2MV7D]5R>P>%MXR*L[C\S@6#,>Q
M<U[D76'V019-R$!2E#Y4I*>1Y)22_&?G[5[NMYTW'8?5<KKGA/4\FWG<SG,Z
MR83V2DQA^[8CLDFXZK1R"E6"BH\2D)4&\\].[#X^]P_C[S7_  OE=CTG&8B9
MALHK!1S,E1GI!?"5*:!%DGOIL5$ V(O>P(8WG#5LAY5QWC?W#:1ISVQ/:VX\
MO)Z%G8B&Y<_$2%E#K9C.AU/=04J4A-E7Y\@%%(20BF9\F>-]HQ?\/>'O;N)?
ME"9P89B9G4X,6!CW%D!;LIWB $M_#D4I)_$H4$\\N^'=^3X_\9;3IV/QDOR/
MXIEMYE6NXF,C'XV9W2AV;'B,M\0FZVQQ L5CE;YR!0>69]W>1S>%>U_QSXVV
MM[RS+:,:+B,AC"S&@S5((+DAU2K%MI7S=4IY ?-PZV#;^;M"\K[I[4<AJ^;4
MUG_*:XT.;DF<>TEI#SS$QN2XPPA%@I3;8*$\1^\*>@NJU!X8?RNSY.\$[SJT
M+4]BPF?PFERXLJ+F,<N.EV2<<\QVHR@2IU7-%K<$JZCI\*"2>W'5T9+VP:MJ
M&T076H^0Q$O'Y.!)0IEWLRGGT+2I*P""4JZ7%$.>/#VD[_LGD31O#.ZX:6UJ
M'@[(9C)N9>0TM,7)K$E/Y7P4M(2K@I7-%KW;O]E0E=WNK\4YW;VM0\C:E@HN
MT[!H,U<N1JLUM#C65QDC@9#'%P*"ECMCBDI-[JM=5DF4*MS'E+Q?G,0Y@O&'
MMS<E^5)2.Q'Q.4U*%'B0I*A92Y3I0/D;/7KQO\2CX$NK_%VOY35]"P>&SD3%
MP<ZU'[F4BX&*B#C6Y3RBXXEEEL!( *K%5OF(Y=+VHA+Z!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*"O=&\4PM/W#;MZF9%S-;)M<D+5,D-I;7%@H [<1OB3=*;
M7Z7"4"WRW.4VS&&%:8F96%6+,H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H%!S[[Q](VW?_ !+&P>F8I[,Y=&;@2U1(Y0%AAH.A
M:_G4D6'(?&B70" 0A(/J +T0_5 H% H% H% H% H% H% H% H% H% H% H%
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M3:B4D'XCK1*\/9<H*]M.CD&X")X^WTR4FX_NT0C?C]0/O=\N)N+C7</T_P#
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MMIQI8NE25#U!K6;D3EET2^<6_9C*YW<\YDLRM:YZYCZ%I7?]VEI90EL ^@0
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M5^1XJ2 \-F\D>8_)/G'9O#WBS8L9H<+3(S#L_)Y&(WD,C/>E-H<_<1WKI[2
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M]!8]NOE67N,?8<Q%@S/&Z\@WGHBL?)N''FU-7^GX@) Y67^U?BE0H+%E$?\
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M/Q=RIETI4>VXO]Y\JK*Y!']+J2ZL889BL-QHS:6H[*$MLM( 2A"$"R4I Z
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MTVT?\;-H/Q[@5 >YKV\I)ZF9E"!_N&1_U:"?>Z_<6=+\![E,4]VYN4AG"8]
MOS<D9,_3\4 >I#:EK_0DT0E?A'4W]&\1:7JDM)1.QN)BHFH4.)3)<;#CR2.O
MHXM0H)[0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#3;=GL=J^KYC8LLXZSC<9
M#?E25Q^/?X-H)LUR('</HBY_%:@_6K8+&ZQK>)UW#LKCXS%Q&8D5EVQ=2VT@
M)'<(Z%9M=1^)O0;>@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4$:W^-.
MDZCDCCLRG7I44-3OSAQ2DM,-P7D27>Z4E)[:D-J0YU_"31$I$TZV^TA]E8<9
M<2%MK2;I4E0N""/4$42_= H% H% H% H*9]POAO)>3L3A=@TN:WB?*6ES$Y7
M4\H[<-EQ)2IR,\0%?NW>"?@>J1?Y2JX6-@F<GG=;Q;V^8:'&V$-H=R&.0I,Z
M,S+1<%3+BT]1^TD^H!M0;J3$BS&PU,8;D-!27 AU"5I"T'DE5E BX(N#0?F9
M @Y%GZ;(1FI<?D%]I]M+J.2?0\5@BXH/<    6 Z "@YIW#%95WWM^/,NU D
MN8EC4YK3^02RM49MQ2IUD*= XA7S#H3\1]M$NA(NN:]!R+V7A8F%&RTB_P!1
M/9C--R'.74\W$I"E7^-S1#+F0(.1;2SD(K4ME"PXAM]M+J0M/HH!0(!'P-!D
M4&KR>M:YFGV969Q$+(R8_2.]+C-/N-B]_D4XE13U^R@VGIT'I08<K$XJ<^U*
MG08\F2Q;L//-(<6W8W'%2@2.O7I0>DV#"R45V#D8S4R$\.+T:0A+K2Q>]E(6
M"#U'Q%!YXS$8G"11!PT"/CH045B-#91':Y&USP;"1<V^R@_8Q\!,U613%9&0
M4CM*EAM/>+8_9*[<K?=>@_L>!!ANOO1(K3#TI?<E.--I0IU?])92 5'[S0'H
M$&3(8ER(K3TJ*28S[C:5N-%70E"B"4W^Z@HO=/$VY^6_,F$R>\IBP_#FC.)R
M.$P[3WU$C+Y:PXO2D<0EMIOT""5&P(]'%<25^404"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@C^ZJS8P*F]?@LY'(ORH+"H\E"7&1&=F,HDN+2I200VP7%CKZ
M@>M!(*!0*!00?<O+6E:/+&.S$M;N3("UPHB.\ZA*A<%?5*4W'4 JO;K:U:^S
MD4I.)[N!]0^O<3A6\-ELV^%>L_G\&ST_?=8WJ*Y)UV9WE,6^IC.)+;[7*]N2
M%? VZ$7'WUGKVUO'1M_3_JG'YU9MIMG'>.TQ^22U:ZA0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*##RV/BY;%SL7-9^HA3H[L:3'OQ[C3R"A:+]+<@2+T&H\?Y7'
M9O1]>RF(8=BXN3CXRHD60KF\TV&PE+:U7/)2;<2;]:(A(Z)*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!01
M'?(T64G6FY6<5A"G/8]UCCRO-=9*W!#^52>CH2;WN.G4&I1*75"2@4"@X"W3
M\P_B_._FO/\ ,?KI/U'<ORY=U7V_"WI]WI7F]F?*<_%^=?J/G_M;/<_5Y6S_
M !3GV[_F'_.7%^BY?3?2R?S"U[=CATY?=W>W^NMCB9]SH[_[2\_]^OCV\;>7
MX8_SAV)7<?:R@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@T.F':#K</^,TM)V0%
MX3 QP[=@^X&B.!(ZM\#0;Z@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@B&^81W-+U9;4N-%&,S\+(.?5+
M+?=0TAU/::L#R<45CBGXU*$OJ$E H%! ]N\5:+OLPY#)L%.30 V],A.AMU02
M+!+G1220.@*DWMT]*U]FBFR<SW>>Y_T/A\ZWG>/F^-9Q/YMOI^A:OHL5R-KL
M,,K?M]3)<47'W>-[<EGX"_0"P^ZL]>JM(Z-WZ?\ 2^/P:S&FN,]Y[S/YI+5K
MJ*3]P?D3,ZG"Q^"U]]4.;DTN.R9K9LZVPV0D);/[)42;J'46Z>M:'+W32(B/
M5X3]U_5MO%I75JGQM?,S/K$1\/Q^+GG7_(FXZWDV\I R\E;B5!3K,AU;S+R;
MW*7$*400?M]1\"#7,INO6<Q+YMQ?JW*X^R+UO;\)F9B?QAW'@\HWG,+CLRRD
MH:R$9F4A!ZE(>0%V/Z+VKT%;>41/Q??.-OC=JKLCM>(G^,99]9-@H% H% H%
M H% H% H% H% H% H(AXPBXB'I4!C Y-S,8KO3G&,B\A32W"[-?<6.*@#9"U
M*0.G4"]$0E]$E H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H(;Y(:UM.*Q&4V@R$PL3G,3+BKB\;IG+F-QHQ
M<Y?[WW'DARW7C4HE,JA*D?<'Y&S6JQ\?KVOOJAS,DA;\J:V>+J&4$)2EM7[)
M4;W4.HMT]:Y_+W33$1ZO!_NOZOMXM:ZM4^,WZS/KC[OQ<_ZWY)W+6,HWDX66
MDO<5A3\62\MYAY-^J5H62#<?M>H^!KG4W7K.8E\YX?UCE<;9%ZWF?C$S,Q/X
M_;*Y_/GD3*)P6O8[".NP8F?B#)2W$**'5,K2DH:Y)L0/F/.WKT^%[[W*W3XQ
M$>KW'[I^K;/9U4US-8VU\I^./2/\J P&Q9G6,FSE\)+<B365!7)!/%8!N4K3
MZ*2?BDUS:7FLYA\ZXO+V\;9&S5::VC[=?C#O7 Y/\[P>,S/;[7YA%8E]K^CW
MVTKM^J]>CI;RB)^+]#<7=[VFFS&/.L3_ !C+8UDV59^8_%R_(N,BO8UY$?/8
MTK,8O7#3K;EN3:B 2#=(*56_PW&IR-'N1T[P\K^X/HD_4-<32<7IVSVF)]/\
M*1U_VZ;W/R;;&=::Q6+2L?42N\T\LMCU[2&U*N3\.5A6A3AWF>O2'@^+^T>9
MLV1&V(I7UG,3_"(_NZR@0HV,@QL=#1VXD1I$=A'KQ;:2$)'Z@*[,1B,/L6K7
M772*5[5B(C\(9%2L*!0*!0*!0*!0*!0*!0*!0*!0?EQ:6FUN*OQ0"I5@2; 7
MZ >M!&O'7;.CX)YK"IUU,F*B4<(CE:*J3=Y2#R2DWNLE5T@WHB$GHDH% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MI$N4O99;N??=GI+3Z3/"5-M%HV+89:#;(1ZCCU^:]$0E%$E H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MV8S2UHZRK#VT>V>7NN5.W;_"7'U'%2%LLXYX<59"7'64K01_W!M22E9_:4.
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M ?0CIZFX8VU8^!Y&][N)U3=VD3-:U'6%9?7\/*'.*_/><3S>+:KI6H<K]?\
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M*E#TI;XY.//A+G1Y2[]Q)_"KY>G&P#<>%=7\AP?-GE';]PA8' KV#"!69UW
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M'(SZ$NLN)]%(6 I)'Z0:(>M H% H% H% H% H% H% H% H% H% H% H% H%
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J4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>fc_evxb1-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_evxb1-4c.jpg
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M;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (  @ X0DE-!"4
M !#\X1^)R+?)>"\T8C0'6'?K_^X #D%D;V)E &3      ?_; (0 ! ,# P,#
M! ,#! 8$ P0&!P4$! 4'" 8&!P8&" H("0D)"0@*"@P,# P,"@P,#0T,#!$1
M$1$1%!04%!04%!04% $$!04(!P@/"@H/% X.#A04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@!S0.V P$1
M  (1 0,1 ?_$ +D  0 " @,!               $!@4' @,( 0$!  ,! 0$
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MTT1QGUE\_K_MU5SPI](8$S,SQ,\3/I,QVN$$H
M                 <FW765$ME:FUET*09I/])"LQ$^ZT3,>RX6W<SKSJ*?4
ME9UK]EA\]AFKT)5^7T&/*_9_5B(S4O7_ %/VYF<M?\2MX\MZX      ,?6*J
MS2(:I+A9W#/*RWT&I9_Z"](WT=*=2KA#GU]:-*GC+7<^KU"I+-4IY1I/H:29
MI;+\B2_TCW=/1HHCTA\]J:]>I/K*$-V
M             DPZC-@+)R(^MLRZ4D>*3_*D]AC*O3IKCUAK1JU43QIE<V;I
M-^B29R6TE/BDDG&C,\N*U$DE%Z<-O1^8>35^IPU(I^DO9I_<XZ4U</[H49]U
M<AYQ]P\7'5*6H_M4>)CV:8X1PAX=54U3,S]7 65
M                       7ZRWE.4E;2MI,O*2C^RHB5_69CP_W:>&IQMA[
M_P"A5QT^%DK&.!Z(     P=VO+9HKI(/#>J0V9_89XG^G# =GZ=/'4AP_NU<
M-*;VNA[[YT                                           !]2I2#)
M:#P4D\4F721EM(Q'#BGCP;;CN&]':>/8;B$K,O[1$8^7JCA,P^MIGC$2[158
M     42]GEJJ+$<S]AMG,1?ZRU'C^R0]K]&G^R9O>%_]A5_?$7*R/1>8
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M4ZMRYM&OIEQYM-;M*'&9ISS#2R_>'&E+W1*-OHQ4?3^JHL1?_P!Z>$^[+_\
MGJXQZTWNV[+^U%NO5*7I)I1)A4-5"A-5&Y[FJ;!3%LG(2A3<=E@\R35@XC-C
MTGCM22?:M7JUU5Y*/1&GI:=.GGK]>/M#*VS4=:J.5TT74F)!K%.A4R1-H5ZT
M]#++$AQM@U''D0\Q*Q^W=DGV3(\Q&1B8JU:8F*O7T]U:J=&J:9HGAZ^S4K&L
M%[4+Z5J!J!;Y4^#<;]:53S9B0(S$,V#D2$FA,9M"6DFK(G%24D8YMZJG1B8M
M=<Z%%6O-,^W"U8[[O#ZAM)*3$U*NZJ4*M6SS4=NNVE"B;A41N6>!)8DF6=9H
M/V<YK/VL#P4G$:5UZVG_ '3[6,M/3T-6<M/&)M9C5/66K1;WH^FEBUJCVU,G
M4]-:JUV7&I"8T2(ZG,RTTVZ9)4\LL#P/'[Q$6&U16UOV)FJ*:9B+U=']:,LU
M5Q,W0A6)K#<=/U.IFF=Y730+YA7''<=H=S6\;2%LRF24HX\MI@S0G.2/9V8[
M2VGB9)C2UZHKRU3$\4ZOZ],Z<UTQ-/#Z2VAJUJ'%TKL"JWK)C\X[#)MF#",S
M2EZ7(5D:2I1;221XJ5AMRD>&T=>OJ[=/%R:&EN5Q2U7,F_5/0+)EZB5&L4&>
MXU3W*E*LY,$FG(K"FC<Q:?2GVG6$GG-M2E$>4TXJ/IXYG7BG-Q=D1^O-67A/
MRQ%Q:UZE4[Z?=.]0J7)C/7C<=61"J!N1F29D-J<E))LD8$EO-ND$:DX'T] B
MK7KC2IJX^O'JFC]>B=:JF8](CHR=ZWCK[HXJCWG?-7HEQVA.J#,"N4.G0^57
M!.5F,BC/*(EK)&51)4M1XF19B,CQ$UZFKI\*JIXPBC3T=7C33$Q+!ZK4?423
M]4]HMVY<,"!4Y-*EN6O*D0B?3"BH8?2\AXC2>\4XK>FE7ZI*P&>K%<ZT<)]>
M"^C51X\\8]./JO*[FK=/^HRUK/K"Z<^@[/7,J]73 81*7*:2^;RVI!IWK;*E
M-YMR2LOV#::IIU8B;&--$5:-4QQ_)@[1O+7?6SS*[[!J](LVPH\MV%08]0AE
M.D3^7/VG'U&E1H2>)9C3AAT$1X9CK37JZO&:9X0O7IZ.CPBJ)F7/3?6V]5OZ
MO3M5F(\5G3U#*RI%/0DDMN)WZ7&VWMJG"=4VC(I9GAF$Z7[%7]TU?1&K^M3_
M &11_DK,+5K5JNVT=_Q]2K&HK[K+D^#I_)5&6[R[>92&'GEKWJ7EI3L3F(\3
M+:CH++>U)C-FCX;3H:43ERU3>REY?4+=L_3O3*]=.68T:JW=5SI51I,Q"7F3
MDMJ2TJ/O%X*2A3G0M)DK*HMHO7^S5--,T_52C]2F*JHJ]HAD;FO/7+1RMVU5
M]0JU2+JLFX*FW1ZE&IT+DGH#\C$TFPK*E2TI(E&DUF>;+@9$9D8F=35TYB:I
MXQ*M.GHZL3%$3$P[-3-4[UCZOO:74FZJ1IS38D%J9'K]=C)D%4WWR2>[;6\6
MZ0E)F:.DCQ2K:9X)#5UZ\^6)RFCH4;>:8FIL_2RI:BU&W'/^YD&&Q7(\A342
MITMYEZ%4X6!&W*;)E:R1FVD:=GH/*6. Z]"JN:?[G)KTT15_9_\ "[CI<P
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MWZ6V5J)LTF6!XDG''[N)&9]/Z]5<Q_=BYOV*:(G^SC\6+^.IR@
M    ^'T -M0?Y&-_";_9(?+ZGY3\OK-/\(^$@4:     #7]Z?YPG^ C]I8]S
M]'_7_+P/W_\ 9_"O#O><             /-FNE#?UJU3M[1&$\MNFT:FS+CK
MS[6/[N4\RIJ$E9]!>T;?YG3'E_L?^E<41]'J_K3M:<ZD_6>$+9H'J&B=HBBI
M7*I;51L-F72KC;/!3Z"HZ#4G$CP]HV22G;^L1C7]?5_\_7_%C^SI?^O"/\O;
M^5?LNX/J3U/I"=2;<JE!MR@3'''+<M2;$.2<J.PLT)YB223<1O%)-.<E%ZR)
M)8#*FK6U(S1PB+&M=&AISDF)F;6M]*J_5:9H7KI<CL&,Q66JT_)>ILQEN;%;
M>=4V3C+C3Q+0XE.92?;(_6.?3JF-.N;W3JTQ.K1%S9\K4N[:6W]/D2G/18T.
M^6X[=PQVHC*&UH-F*>5A)%@RDMXO F\,-GJ'3.K5$:?#Z_\ 3DC2IJG4X_X^
MW-9M:;^N6R*[II!MY]MF+<MQ-TNL(=90\;D12V2-*361F@\%J]I.T;:^I535
M3$?667Z^E3735,_2'*S+YNDM;+UTHO"2U(0RRU6K,?0RB.I5,=5@MI1H(MXI
MO.E.8]N*%B-/5JC4FFK^#4TJ=JFNGXE3XNO%;CPM5M3)YMRM-;4EIHEH4Q#2
M6E3:B2TM&XJ02<YH-1I4?3@E>S[HQC]BK^ZKZ1[-I_6I_LH_RGUE]9J'U31;
M.=U*FU2@2L8#E558Q0]TIJ(MHW4Y))%FWS:#)S(I:B/#*9JZ S:^7/Q_A.7]
M?-DX3\L%4];]28OTSVKJ=$EQW;TJM9Y"4ZJ*SNG6=_*;)!-8$A)F32"-1$7Y
MA6=>N-&*N/KQZK4_KT3KS1P].'1E;ZO'Z@='X$'42\ZM0ZY:JYD>/7K7@1#C
MJAHEX^S'D&6=>3#*2U*/VL,246(M7J:NGPJJGTL5T]/1U>--,3$VL%K1 OF=
M]2FFZ[;N"%"?J$20NTGY$/?%"04=9O<P1I/>FZK.I'X,?L&>MFG5CA/PT_7F
MF-">,>WN]/T=FJ1Z1 8KDIN;6FH[2*C-8;W+3TE*2)QQ#?ZJ5*Q,D^@>K3$\
M(X^[R:N'&>'LFBZH                     \Z:_P"ENI-;N=JZM)6&G)]Q
M461:EWI<>:8P@.K0:'?WKB,3RXH,TXJ(DEL/$>;^QHUS5QH^L<)>E^MKT13E
MK^D\8;4J.E]#FZ3N:1M.''HQTE%(9E(3BI#C24J2^:3Z3WJ=ZHO3M'3.C$Z>
M1S1KS&IGO:PME?U/V];<;3%-JTEYR!&\JIVH2ZD@HC4-"3:;>5%+]ZMQM&&7
MV2/869)[1RT[\1DX?RZ:_'JJS\9__57[<^GN\9WT\-6#62;HE_4FO/5^B./.
M-OL[YO!+>\6R;A$EU)JV[32>!F7H%*?UJIT^$^D\6M7[=$:N:/6.'!="KGU1
M78_ HGRO3=/S;>0JMW<N9&JS;K*2/.46'[9D:SVD2LWH+,G:8US:]7".&6]A
ME_7IXSQFJ[V?+KLO4:R=5JAJYIA2(UUQ[B@-0+EMJ3)1 DF[&)M+<AEY>"-I
M-I,R]!YO9/$C2KTZZ*\],<>)1J:=>GDKG+P]F<M=G6RXT7/5;_9AV_29].D0
MK>L>*MB6\V^ZP:2>D34EM,S/ DYL,58F2226-J8U:HF:O2Y2J=&F8R^L_6?^
MFJ']%M23^E^@:;(HZ57G!KI5"53N:C$2(QR'W,^]WF[/ G$F9$LS'/.A7M13
MP]>+JC]C3WYJX^G!MGZD++N/4+2FI6O:40I];D283K48W6V,4,.DI9YWE(3L
M+UF.O]G3JKHX0X_U-2G3KXU>RF:F:-5V1==OZG6[;5)O2=$I#%&N*RZYN=U(
M2PT24O1G7B-M+J?NXG^$L,2-1#GU/UZHF*HCC;#ITOV:>$TU3,>OI+(Z8V'<
M[MY(NNO:<6MIU0*>T?E]'@1($VLNRU$I.^.<P@C92G''V<N/W<NTS%]+3JFK
MC-,4Q_"FMJTY.$535/\ /!?]7M.F=5=/JM9;D@H<F43;]/F+(S0U,C*SM&LB
MVY%;4*PVD2L2'3KZ6Y3P<VAJ[=<5-6RY'U17#9<[3N;9U+ID]RG.4V7>BJDR
MZS)8)C=GN(R%&HGWTEDS&9))2L<$^CCG>FG+P_EUQX]->;C_  Q%9T?U$F:
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M]&EHQIQZ.?6UJM2>,KB-V            "]V0E14Q]1EL4^>!_D0D>+^]/\
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MJ$^K.HR_46KI(_L,]I?H'#^IKQ53EGWAZ'[GZ\T535'M*O#N><"0
M                                 =\.'(GOIC14&MU7H]!%ZS/T$0SK
MKBB.,M***JYX1[MGTR W38+,-L\=V7M*_$L]JC_.8^=U=2:ZIJ?3:.G&G1%,
M)8R;     #HFQ&YT1Z(]_=O)-)F721^@R_(>T7HKFBJ)CZ,]2B*Z9IGZM7U"
MGR:9)5&E)RJ+[BOU5I_$D_4/H]/4IKCC#YC5TJM.KA**-60
M                             ,W;E$=J<I#[B3* RHE.+/H6:=N0O7]H
MX_V=>-.GA'O+N_5_7G4JXS^,-C#P'T0      ,#=%&75(B78Y8RX^)H3^-!]
M*?R[,2';^KK;=7"?:7!^YH3J4\8]X:]4E2%&A9&E23P4DRP,C+T&1CW8GB^?
MF.#X)0                                          @62-;TIJA39;
MC2CEO(03+!%[9-I<2M1F7K/#H'GU?LTSJQ$3Z1T>E1^K5&E55,>L_3^5\4DE
M$:5$1I,L#(]I&1CQ7O,0_:]$?6:SC$A1].[4I!?H(\!U4_M:D?5QU?IZ4_1U
M_*-#[E?$7UBWF:MJO@Z5G,^4:'W*^(OK#S-6T\'2LYGRC0^Y7Q%]8>9JVG@Z
M5G,^4:'W*^(OK#S-6T\'2LYGRC0^Y7Q%]8>9JVG@Z5G,^4:'W*^(OK#S-6T\
M'2LYGRC0^Y7Q%]8>9JVG@Z5G,^4:'W*^(OK#S-6T\'2LYGRC0^Y7Q%]8>9JV
MG@Z5G,^4:'W*^(OK#S-6T\'2LYGRC0^Y7Q%]8>9JVG@Z5G,^4:'W*^(OK#S-
M6T\'2LYGRC0^Y7Q%]8>9JVG@Z5G,^4:'W*^(OK#S-6T\'2LYGRC0^Y7Q%]8>
M9JVG@Z5G,^4:'W*^(OK#S-6T\'2LYGRC0^Y7Q%]8>9JVG@Z5G,^4:'W*^(OK
M#S-6T\'2LYGRC0^Y7Q%]8>9JVG@Z5G,^4:'W*^(OK#S-6T\'2LYGRC0^Y7Q%
M]8>9JVG@Z5G,^4:'W*^(OK#S-6T\'2LYGRC0^Y7Q%]8>9JVG@Z5G,^4:'W*^
M(OK#S-6T\'2LYGRC0^Y7Q%]8>9JVG@Z5G,^4:'W*^(OK#S-6T\'2LYGRC0^Y
M7Q%]8>9JVG@Z5G,^4:'W*^(OK#S-6T\'2LYGRC0^Y7Q%]8>9JVG@Z5G,^4:'
MW*^(OK#S-6T\'2LYGRC0^Y7Q%]8>9JVG@Z5G,*T:&1D>X4?V&XOK#S-6T\+2
MLYLI$@Q(*-W$92R@^G*6!G^4^DQS5ZE5<\9GBZJ-.FB.%,<$@4:        .
MF3$C3&]U*:2\W^%98X'ZR]0O3753/&)X*5T4UQPJCBQ2K2H:C,]PI./H)Q>'
M]8Z8_<U;7+/Z6E9S?/E&A]ROB+ZP\S5M1X.E9S/E&A]ROB+ZP\S5M/!TK.9\
MHT/N5\1?6'F:MIX.E9S/E&A]ROB+ZP\S5M/!TK.9\HT/N5\1?6'F:MIX.E9S
M/E&A]ROB+ZP\S5M/!TK.9\HT/N5\1?6'F:MIX.E9S/E&A]ROB+ZP\S5M/!TK
M.9\HT/N5\1?6'F:MIX.E9S/E&A]ROB+ZP\S5M/!TK.9\HT/N5\1?6'F:MIX.
ME9S/E&A]ROB+ZP\S5M/!TK.9\HT/N5\1?6'F:MIX.E9S/E&A]ROB+ZP\S5M/
M!TK.9\HT/N5\1?6'F:MIX.E9S/E&A]ROB+ZP\S5M/!TK.9\HT/N5\1?6'F:M
MIX.E9S/E&A]ROB+ZP\S5M/!TK.9\HT/N5\1?6'F:MIX.E9S/E&A]ROB+ZP\S
M5M/!TK.9\HT/N5\1?6'F:MIX.E9S/E&A]ROB+ZP\S5M/!TK.9\HT/N5\1?6'
MF:MIX.E9S/E&A]ROB+ZP\S5M/!TK.9\HT/N5\1?6'F:MIX.E9S/E&A]ROB+Z
MP\S5M/!TK.9\HT/N5\1?6'F:MIX.E9S/E&A]ROB+ZP\S5M/!TK.9\HT/N5\1
M?6'F:MIX.E9S/E&A]ROB+ZP\S5M/!TK.9\HT/N5\1?6'F:MIX.E9S<VK6H;*
MLY1LYET$XM2B_09X")_;U9^JU/Z>E'T9="$-I)#:20A)8)2DL"(OL(ARS/'W
M=<1$>D.0A(       "#-HU,J!YY<=*W.C>%BE?O)P,;4:U='M+#4T**_RA!^
M4:'W*^(OK&WF:MK#P=*SF?*-#[E?$7UAYFK:>#I6<SY1H?<KXB^L/,U;3P=*
MSF?*-#[E?$7UAYFK:>#I6<SY1H?<KXB^L/,U;3P=*SF?*-#[E?$7UAYFK:>#
MI6<SY1H?<KXB^L/,U;3P=*SF?*-#[E?$7UAYFK:>#I6<SY1H?<KXB^L/,U;3
MP=*SF?*-#[E?$7UAYFK:>#I6<SY1H?<KXB^L/,U;3P=*SF?*-#[E?$7UAYFK
M:>#I6<SY1H?<KXB^L/,U;3P=*SF?*-#[E?$7UAYFK:>#I6<SY1H?<KXB^L/,
MU;3P=*SF?*-#[E?$7UAYFK:>#I6<SY1H?<KXB^L/,U;3P=*SF?*-#[E?$7UA
MYFK:>#I6<SY1H?<KXB^L/,U;3P=*SF?*-#[E?$7UAYFK:>#I6<SY1H?<KXB^
ML/,U;3P=*SF?*-#[E?$7UAYFK:>#I6<SY1H?<KXB^L/,U;3P=*SF?*-#[E?$
M7UAYFK:>#I6<SY1H?<KXB^L/,U;3P=*SF?*-#[E?$7UAYFK:>#I6<SY1H?<K
MXB^L/,U;3P=*SF?*-#[E?$7UAYFK:>#I6<SY1H?<KXB^L/,U;3P=*SF?*-#[
ME?$7UAYFK:>#I6<SY1H?<KXB^L/,U;3P=*SF?*-#[E?$7UAYFK:>#I6<TN'0
MJ3 63D>,DG2Z'%F:U$?V&HSP_,,J_P!C4K])EMI_K:=$\8AD1@Z
M
M
M
M
M
M
M
M
M
M
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M;E4>],I,>2Q*;WD=9+1C@?H,C+T&1[2/[#&=5,TSPEI37%4<8=HJN
M A'4FUK4W#:<EJ2>52FB(FR,O0:U&E/Z#,;;4QZS/!CNQ,\*8X_\M.:G^ 5Q
M6^L,E/=R,]?;S@YJ?X!7%;ZPR4]W(SU]O.#FI_@%<5OK#)3W<C/7V\X.:G^
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M+H<8+IQ+TFDO:2?YO2-].<W]D_Q\N?4C+_?'T][X_P"F0(\=I= P=
M($W-*?;IJ%&EM:3=E*2>![HCP))&71G/T^HC&U']L9L/G_IAJ?W3%&/Q_P!I
MK;:&D);;22&TE@E*2P(B+T$0RF9GUEM$1$<(<A"0
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M@1AMT           $*'LEU BZ-\@_P YLMC6O\:?C[RQH_*KY^T)HR;
M"%4?O0R]!R48_F)1C;3^OPQU?\?E-&+8      'G_P"HC6*]["J=)HNF\2-4
M:I3H$R\[QCR"(U(MBD+;;>)&)E@MY3BB09;2R&"6<U=OJH1J5I16K-JJF:9=
M-YV]%>D,$DTRZ14D/.*;/,1^PXDD'LP,$)>AUS5^Y9&J"*]/<G)HM]U>D4HG
M"27+T^,Q$4TPG*1>RDW%&6.W: CW!]0$&G7O<&G%NV=<%U7G;Q1')D2EL1RC
M<O-C(E)>5)??;;0DB5D)*O;4O8E)EBH@Y,?499+]I1KJ*%4V755^+:54H,B.
MABJ4VK3'B9)N6TMPB22<Q*-2%JQ3]W$\2!/!=+DO^DVQ=EGV?.CR':C>C\V-
M37F4H-EI=/BJEN&\:EI41&E."<J5;?46T$//^DWU$W.=ES'9]J73?\^CU6KM
M7#5Z5#8-N(TS.=)F.WO7&3DNH8W:C;82K!*BQ/'8"5YGZI?,^H^ALRQZTIZQ
M+U9N.3,;;2242T0Z>AQDG"6G.E3+N;%.PR5B1@AC[(UJH%LZ0VG5W)UR7W6K
MGG5*!;D&1%87<=2D1)DA#I&TPYNDM,$THU.J<)*&R(U8&>4$NVYM<WZII]J9
M3FJ16+%U/MBV*A6F:95FFB>)E,=TF9L1YE;S+S274Y<Q*V+(R,@%MTOU2A7+
M)BV+4TRD7E!MRBUY^3+0A#52BU*,G/)C&E1FHD/$IIW,A."^C'T$+'8&H-)U
M&@U6K4*-);I%.JDRCQYTA*$M3E4]9-.R(QH6O,P;A+0A9X&9I/8 I53^H*"F
MXJQ1;3LRX[RI]LR50+FKM#BLNPHDQO#>QV]X\VN2\SF+?-,(4I.)=)[ %'T@
MU^2QH[%NZZI50NVNUZXJK3+6IM/CD]5*BEN2X;+;#/[K*EME.=:W,J4)+VCQ
MP(R6PZ!KS0I;U=IMZ42JV+<%NTIZX9],K;3:C<I$8C-Z7&=B./-O(;PRK))Y
MB5LP!"/9&OL*[Z[0Z/.L^OVW&NUAR99]5JD=E42HL,LG)/%49UXV%FR6]2A\
MDYD^G' C##R/JBM]$63=$&S[DJ6ED)Y;$O4")$:<IF5EPVG)++6^YAV*VHE$
MM]#.!93P(\-H9NKZ_P!"AWZUIS0[=K5RW _$I]3:=I,=MV$5.J2S3S3CRG4[
MMMLL#4:D[<Q$G';@2U1=FJ\ZTK2=N*F7779D"F:OE1+C?J,=E3Z*;'?-,RGQ
M&XV]4Y&P3@SL)Q6/0G80#:]OZ\PYUTTNU+NM"OV/)N(UIMB77V&$1I[B$Y]P
M:X[SVYD&DLQ,NX&?1][ C(8^J?4?38[]5G4&R[DN:R* \]&K-X4F,PY3T.13
M-,A4=+CS;LEMA25$ZXR@TEE/#,"67NC7BVZ2[;M-M*F5"^KCNN FLT2D4!M"
MUJI2LN$V0[(6TVPP9J)*5N*VK]G#IP(5#2S5>N7[KY=]$>;JE(HE*MZG.NVK
M68Z8LB!4W'UDX9D68E9VS0M*T.*0I*B,C!+T("     !TRB(XKY'M(VUD?NF
M+4?E"M?XRXP#,X,8SVF;3>/ND)U/RGY5T_PCX2!1H     (3.VJ2S]),L$7Y
M,SHUG\(^9^S&G_9/Q'W31DV
M       1)9$<B KTD\K#\[#@UH]JOC[PRK_*GY^TOM-_RZ'_  &_V"$:OYS\
MR:7X1\0E#-J         -0_479MRWQ9M%I=K03J$^)<M%J4ADG&FLL2'*)QY
MS%U2"/*G;@1XGZ",$PQ5_/ZGQ;AK%.JVF4/5>Q9YMO6N33M-C/0'5M;MZ-,1
M4%$1I4HC4E]LCP2>"O01!<=#+0N.PM*+9M*[929=?IL=Q,I2'5OH:2Z^XZU'
M2XX9J4F.VM#"5>DD>H$-(:9VC<=BURI,U[0LJ[5I%UU*K0KV)RA+<9BS9IN,
M/H6\[S"3:0>; O:+T;02SUM.ZMZ9WIJ8=,TNGW/$NJXW:S2*E'JE+AQ5,+C,
M,I)?,/DXC:VHS,T?F 5^]M$]1:CIU<E?JU)8N34N]+HHMPU^VX#S)1&J92'&
MFV:>V[,-MMTVHZ,JUJP):C,B(R(C,,G=]JW%>>B^H]FVEHP5@5BJQ(W)1FET
M5@JF^E])F1G!=RDIM"3VO&73@1@._P"I?1"[KNH[UP:8M)7<M7BP:+>-%-:&
MFZI3(LIJ2P]BXM#?,PW$8MN*/,;2EHQ/!*3#<>KUAJU.TSN:PFI10I%<A+CQ
MI2L30V^DR<:-9%B>3.E.?#;EQ!#0.J;GU$:FZ-U;2UK2GRZOKB1X]6JKM5@*
MI[_*NM+_ /CDI<-:E/;O,DG20EHMBE9L,26U[-LZY:7KM?=W3X)LVW6*+08=
M.F[QI1.R(*7R?1D2HUIR9RVJ21'CLQ :JN#1G4BI6+JK ATA+E8J6HY7A;U/
M<E1VO,:='7"661TUFAI3A-+).^R[2VX%M 6ZOV7>&I>H5LW36K?DVU0IEG7%
M0:\E^3$>D4Y^IK0TVD]RZHEFI!&XE2,4E^L9& H3]T:N4;Z=ZKITS94*H4VB
MVM,I2-18M6AO6U(H<&$XP<ULD+4^ITV48;G=_P!YM49)Q(!#_P"U5;D4O2_4
MZ!;M4NVWY&GM"M^LT.BUEZA5B*N,RW)9E-FE^.B0@R<4VXPI:3)6"R](#(U#
M1:\ZIH]J*FEV.5!NB[YEO>74:56Y%9K#T&AU%ATEU"9-DN,)<)&]6AIDR)",
M$&:E$ W!K19]RW3<.E4R@0CEQ+=NZ-5JTLG&V]Q":COH4Z9.*2:L#61948JV
M] #;@(          !"A_S=0_C(_P6QK7^-/Q]Y8T?E5\_:$T9-@    !"J/W
MH7_$H_94-M/Z_#'5]Z?E-&+8      'FQC2'5F[[^O[4&5=!V+YY(.WJ=2ET
MRG5SF+;IR-VRX:I*G-TF2XMYU;)$726;T8$L32-+=48%@Z>:?3Z:N=_VWU'@
M/1*LI]A)S+3@+><8G&G>JRFA#R6C8QSIR8$1](#:NBEI7#:DC4Q=P0^337[X
MJU;I)[QMS?4Z4Q$0T[^[4K+F-M?LJP46&T@0U;3KHOFT_J'UKJ%JV<Y>5&=<
MMIJK18$J/&J<:0FC-FPXVB4IM#K*B,TK(EYTG[1$98@ETU+174^Z+4O*^:A
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M^P!W5+5W2^C4Z'5JM=U*A4ZHP55:GR)$MIM,F"DTD;S.8RWA8K219,3,SV$
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M);>@!%M+5K3*_*G,HUF793*Y5(!&J3%@R6WG"0E64UI))^V@CV9T8IVEMVD
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M\KSK^GE57)NZN\A*N6'*;F0I!MP&"B1G419S3*R;R8)-:$Y<3+$\3 ;;
M   !6ZW8MO7%<]MW;5FG'ZI:BI;M%1O5%';>G-$RXZMHO96M*",FU*^YB9EM
M 60   &&A79;U1N.JVC"G)>N*B-1I%5@DE9*8:G$I3"E*-))/.2%8$2CZ-H#
M,@ "OO7:PS>D:R3I=37(DT]=4*L(B*524(;=W6Y7*QRI?,_:)O#[NT!8
M         '5)_EGO["OZC%J?>%:O:7"!_(Q?X3?[)"VI^4_*NE^$?"0,V@
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M9^DME2K@N*J7^4RH7C5E5M,*MU)B@16THBQ)<Q6ZC)4;A*>2PE*]RG*D]IF
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M'H+2>LP[@TVM>L0*V_<D273V%-UR8T3$J5E3E-;S9;$N8E@O_6(P0N(
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MJWM;$RV22@_]=@U&9?G)>/YC&WOI_$_U8>VI\Q_3_P"4X8MP
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M>OO/+_M6<VIZ?C'/_ID$(2VA*$))*$D24I+81$6PB(AC,\6\1P](?1"0
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MH;RLKDIUA)+<2T7I-*3(S 9@
M                  8>E75;E<JE7HE(J3$RK4!QMBLPV59G(KKZ36VETO0:
MDD9D S                                                     "
M-4)\*E0)54J+Z(U/@LN29<EP\$-LLI-:UJ/T$E)&9@.FB5NDW'28==H4QN?1
MZ@TE^%-85F:=:7M2I)^DC 3P
M        'G;7G_SI]//_ %FL_P#)- EZ)!
M                            \[:#?^=/J&_ZS1O^2=!+T2"
M                                           %-U<_\47W_P#;U6_Y
M%T!6OIE__7_3K_HD7]D$MK@@
M      %>J%\6Q2KNI5CU*>B+<E<C2)=(BN^R4E$,TD\EM1[#6DEDK)TFG$RQ
M))X!I?7G_P Z?3S_ -9K/_)- ENZO7?;ELRZ/3ZU/;C5"X)B:=1HAGB])DJ+
M,:4(+:9)269:NA)=/26)#-@
M              KEJWU;%Z.UJ-;\Y$B;;M1D4>M0S]E^-+BN*;,EHZ22O+F;
M5T*3]I&1!IG0;_SI]0W_ %FC?\DZ"6[J==]N5>XZS:=-GMRJ];[<5ZLQ6CS'
M&*?O382X9;"6HFE*R8XDG SV*+$AFP
M                   !A;MNFCV1;=2NRX'%,T2DLG)GO-H-Q2&4F1*5E3M/
M*1XF1;?4 KNI53I]9T8O&K4F4U.I<ZV:G(AS(ZR<9=9=@.J0M"TF9&DR/$C(
M!7_INDQH7T[V!,F/(CQ(]!CNR)#JB;;;;;;-2EK4HR)*4D6)F?0"6R+<N*CW
M;0X5R6_)*91:BWOH,M)&E+K1F9$M)*(CP5AB6)= (90
M                         :WUDT;MW6*WFJ?477*7<E,<YRV;FAXHG4V<
M@R4AUM2329I,TEG1F+'#$C)1)40>.-0];[MM/432VEZU424YJ!IM/J3LEZEM
M$MBOQID1+,&3$/V2S/.HW;A$GV3Q/ CQ;22]$:/Z2777[J3KSKH27M1)*#*V
M;:(S.';D!PCRM(0>PY!I5[:CVIQ/]8S,@]#@@
M                           'GC5[2.Z;>NE6O&A*4L:AQD?_ /36UM3"
MN."C UMK06!%((B]A1;5'A^M@9DO.^GFM]VW9J)JE2]%:)*;U U)GTUV,]5&
MB0Q0(T.(IF=)EF68LS+J]VV1I]H\#P,\&U![(T;T<M_1VW':93GG*I<54<YV
MYKDF&:YM2GJQ-3KBE&HR21J5D1F/+B>)FHU*,AL<
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MGP(TJ= 4:X,E]EMQUA2L,3:6HC-!G@7W3(!-
M                              $*)1Z13Y4N= @1HLZ>HESI+#+;;KZD
MXX&ZM)$:S+$_O&8":
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M[\;/5CK>M/"V>"8E*4))*2)*4E@1%L(B(8MHC@^@
M                       B5-DWH3N78ZV6]95^%QOVDG^DAKI5<*H9:M/&
MF;4AEPGF6WD["<2E9%]BBQ&=4<)X+TSQB)<Q"P     @FG?U4B5M1$:):"__
M )'C4G'\R4F7YQM[4?,_T8>^I_\ K']4X8MP
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MV,VS.KGUBNU:-==9A,?)E+KO*,JC$VJ,546GRU69E1\JLT[Q9$9+SK5[>&&
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M_'WEC1^57S]H31DV     $*H_>A?\2C]E0VT_K\,=7WI^4T8M@
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M/>FI%[,WM\Y5.!3*-$J-9*F*8CSU)BLJ)AE<9+9I3D4E3A)PZ< 'M $
M       .J3_+/?V%?U&+4^\*U>TN$#^1B_PF_P!DA;4_*?E72_"/A(&;0
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MRSW]A7]1BU/O"M7M+A _D8O\)O\ 9(6U/RGY5TOPCX2!FT     $)G_-)?\
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MK_&GX^\L:/RJ^?M":,FP     A5'[T(_1S*/Z4J(;:?U^&.K_C\IHQ;
M                                       .J49%%>,^@FU?U&+4?E"M
M?XRX0-D&,1].Z;_9(3J?E/RKI_A'PD"C0     0F?\TE_:RP?_U.C6K\(^9^
MS&G_ &3\1]TT9-@                                           $2
M69%(@%Z3?5A^9AT:T>U7Q]X95^]/S]I=4)90W54QWV2Q4N&H^A;1GB:2^U&.
M&'JP,6KC-&:/Y_Y>IISEG)/\?'_3(#!T
M               Z94EJ(R;SN/3E0A)8J6L^A*2])F+T4S5/"%*ZXICC+K@,
M.,L&I_ I+RU//$6TB4O]4O[)8)_,)U*HF?3VA73IF(]?>?5*&;4     1YT=
M4F,MMM1)>(R6RH^@G$&2DX_9B6T::=66>,^S/4IS4\(]R',1,:S$1H=0>5YE
M7WFUETI/_0?I"NB:9-.N*H2!FT
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M&/9-[6#9;M-7,=ON7,A,S$.DVF*<)E+QJ4@TJ->;-A@1E@ V
M                                           -?V/JC'O:]K^LMJFK
MANV)+APGIBW2<3*.:RIXE)024FC+EPP,SQ ;
M                              8BZZ\BUK7K=SN,');HL"54EQDJR&X4
M-E;QH)1D>!JRX8X ,=IO>;6HEB6_?+$14!FO0FIR(2UDZIHG2QRFLB22L/7@
M0"T                                             /.VO/_G3Z>?^
MLUG_ ))H$O1((
M      'G;0;_ ,Z?4-_UFC?\DZ"7HD$
M                       *;JY_XHOO_P"WJM_R+H"M?3+_ /K_ *=?]$B_
ML@EM<$                                           U1JMK.WI!<M
MKJNFF.)TXKIO0JC=+25+;IE1S(Y8I!%C@TZDUXJPV9<=NT!2=<I#$O6WZ=)4
M5U#\9^K5=UEYI1+;6VN"TI*DJ3B1D9'B1D"5[N;6JE4W4^W](;:B+K]X5%Q+
M]=1&]IFC4M*<ZY$I2<<JU%E2VV9E]XE'TH)9#:0
M                              -2V;K;$JNI5Q:17C!.W+VILF0]0&GS
MRL5FBYU*CR8JE&9*639?O6R,]I*,NA:6PIFALAB)K;]1<J4ZAB,Q5J0Z\\ZH
MD-H;1!=4I2E*P(B(BQ,S!*^:4:RPM7ZS=;ML4]X[#H+L>#2KF<2I#-4F?OCE
MG'(R+%IK!HB5Z<V/J!#:(
M           KM^52XZ)9U:K%HTPJS<D"*Y)IU)49ES3K19MR6!D>*R(R3AZ?
M7T -9JU;M36/Z?[WN2VG%-/M4"K1ZQ1Y'LS:?,3!>SL/HZ2,C(\JNA1;2].!
M+$:7ZE6EI/\ 2I8UX7C,*+38U#B(991@J3*D*0>1B.WB6=Q>&PN@BQ4HR21F
M0;DL2OU2Z;/HUR5JDN4*I56*B8_1WS,W8N^]I+3AJ))YDI,LV*2V^@N@$+"
M                                         ,=7Z!1;IHTVWKB@M5*B
M5%I4>;!D)SM.MJZ2,OZ2,MI'M+: \17=]/WU&V1>]GT?260Q7[$MJ;,F695:
MPXPMR@%5&BCO,R$O*S.M,E^]:R-KVE]W'V02]2Z-Z-4#2"A/1HKSE7NRKN<Y
M=%TS,5SJE-69J4MQ:C4HD$I2LB,QX8XGBHU*,ALD
M                               &MM9-&J!J_0F8TIYRD792'.<M>Z8>
M*)U-FH,E)6VM)I4:#4E.=&8L<,2P425$'EJT?I^^HV][WO"CZM2&*!8ERS8<
MR\ZK1W&$.5\J6T<=EF.EE69IIXOWKN=M&T_NX^R"7MV@4"BVM1H5O6[!:IM$
MIS28\*#'3D::;3T$1?TF9[3/:>T$,B
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M'FD;\#_P[_8#:JNQCJ;U-^$]#S2-^!_X=_L!M578QU-ZF_">AYI&_ _\._V
MVJKL8ZF]3?A/0\TC?@?^'?[ ;55V,=3>IOPGH>:1OP/_  [_ & VJKL8ZF]3
M?A/0\TC?@?\ AW^P&U5=C'4WJ;\)Z'FD;\#_ ,._V VJKL8ZF]3?A/0\TC?@
M?^'?[ ;55V,=3>IOPGH>:1OP/_#O]@-JJ[&.IO4WX3T/-(WX'_AW^P&U5=C'
M4WJ;\)Z'FD;\#_P[_8#:JNQCJ;U-^$]#S2-^!_X=_L!M578QU-ZF_">AYI&_
M _\ #O\ 8#:JNQCJ;U-^$]#S2-^!_P"'?[ ;55V,=3>IOPGH>:1OP/\ P[_8
M#:JNQCJ;U-^$]#S2-^!_X=_L!M578QU-ZF_">AYI&_ _\._V VJKL8ZF]3?A
M/0\TC?@?^'?[ ;55V,=3>IOPGH>:1OP/_#O]@-JJ[&.IO4WX3T/-(WX'_AW^
MP&U5=C'4WJ;\)Z'FD;\#_P ._P!@-JJ[&.IO4WX3T/-(WX'_ (=_L!M578QU
M-ZF_">AYI&_ _P##O]@-JJ[&.IO4WX3T/-(WX'_AW^P&U5=C'4WJ;\)Z'FD;
M\#_P[_8#:JNQCJ;U-^$]#S2-^!_X=_L!M578QU-ZF_">AYI&_ _\._V VJKL
M8ZF]3?A/0\TC?@?^'?[ ;55V,=3>IOPGH>:1OP/_  [_ & VJKL8ZF]3?A/0
M\V@I,MXM3)'^L\VXTG]*TD0;-7T]<#>H^OI\Q,)B5)4DE),C298D9;2,C&+:
M)XOH        ",_/B1E$V\Z1.GM)M.*UX>O*DC/^@:4Z=57K$,ZM2FGTF77Y
MI&_"_P##O]@6VJKL8ZJ[U-^$]#S2-^!_X=_L!M578QU-ZF_">AYI&_ _\._V
M VJKL8ZF]3?A/0\TC?@?^'?[ ;55V,=3>IOPGH>:1OP/_#O]@-JJ[&.IO4WX
M3T/-(WX'_AW^P&U5=C'4WJ;\)Z'FD;\#_P ._P!@-JJ[&.IO4WX3T/-(WX'_
M (=_L!M578QU-ZF_">AYI&_ _P##O]@-JJ[&.IO4WX3T/-(WX'_AW^P&U5=C
M'4WJ;\)Z'FD;\#_P[_8#:JNQCJ;U-^$]#S2-^!_X=_L!M578QU-ZF_">AYI&
M_ _\._V VJKL8ZF]3?A/0\TC?@?^'?[ ;55V,=3>IOPGH>:1OP/_  [_ & V
MJKL8ZF]3?A/0\TC?@?\ AW^P&U5=C'4WJ;\)Z'FD;\#_ ,._V VJKL8ZF]3?
MA/0\TC?@?^'?[ ;55V,=3>IOPGH>:1OP/_#O]@-JJ[&.IO4WX3T/-(WX'_AW
M^P&U5=C'4WJ;\)Z'FD;\#_P[_8#:JNQCJ;U-^$]#S2-^!_X=_L!M578QU-ZF
M_">AYI&_ _\ #O\ 8#:JNQCJ;U-^$]#S2-^!_P"'?[ ;55V,=3>IOPGH>:1O
MP/\ P[_8#:JNQCJ;U-^$]#S2-^!_X=_L!M578QU-ZF_">AYI&_ _\._V VJK
ML8ZF]3?A/0\TC?@?^'?[ ;55V,=3>IOPGH>:1OP/_#O]@-JJ[&.IO4WX3T/-
M(WX'_AW^P&U5=C'4WJ;\)Z'FD;\#_P ._P!@-JJ[&.IO4WX3T/-(WX'_ (=_
ML!M578QU-ZF_">CFU483SA,H=(GCZ&W"4VL_R)61&8K.G5$<>":=6F9X<?5*
M&;5C=WYJ\M3VVG,J-M#/H><0>"E+]:2/82?298GZ!T<=N/3\IY.;AN3Z_C'-
MD4I2DB2DB));"(MA$0YW2^@
M    "'+@DZKF8QDQ/07L/$6Q7^JLB^\D_5^@:T:G#TGUC_GLQKT^/K'I5_SW
M=L.24N.E[+D7M2XV?2E:#RJ3^8R%:Z<L\%Z*\T<7>*+@    #JE2$18[DAPC
M-+98Y2Z3/H(B^TSV$+4TYIX*5U13'&4:+"/.4R=@Y.46./2EHC_5;+T8>D^D
MQI77_C3[?U^6=&G_ )5>M7]/A.&+<
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MF*:L_P!\_*^C'"B/A,&38
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M?L)2G#/^H;3^$?,_9C'^R?B/NFC%L
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MNE^$?"0,V@     A,_YI+_@L?UNC6K\(^9^S&G_9/Q'W31DV
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MJ.L&C6/0-1V8E7J]G5YW<>9TR"IYN [ODQ\L_.I&X/?*W/M=*]A>C$-O
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MQZ975344BZJ0VFJTA3+QOQJI0'W-VW,:-24*0MMS]S(;47LKP-*E$K8&PP
M      '5)_EGO["OZC%J?>%:O:7"!_(Q?X3?[)"VI^4_*NE^$?"0,V@
MA,_YI+_@L?UNC6K\(^9^S&G_ &3\1]TT9-@                !Y[^F&ITN
MCTF\;1N&4S%U0@7-5YMX1I*TMRY"Y<@W8\W!9DI;+D=36[<(LN!; 2R%5U<T
MEMFV=5M2+#:BRJI0B;:KU5AL&F)4:T39M0V.821(D+)QQ#2U(-67.6)@-"Z8
MU1&E=Y:35.1;-ST254H\BT=1:W<-'=I\29/KLDZA'>*0X>"E(GJ6@EKV[I6!
M8$6!AL;3VG:I3M6M8W+$N&DTFCM77'\SB5.G.SGW3Y&.:C;=;D-$@C064B-*
MMH"V6+5J5;OU&ZUQ+AG1Z=-J[%M52E%,=0PJ13(M-7'=<:WAEF;9>2X2S+8D
MSV]((:7N!PIGTKZH7!"/-;UPZC2*K;[Z=C3U,?N:(EMQLMGL*4A9D"7N0$
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M5=+\(^$@9M     !"9_S27_!8_K=&M7X1\S]F-/^R?B/NFC)L
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MX4E6:G1TG]]I!,N%ZEM>PHOTD)UH_OG_ )[HT9_LB[TP31DV
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MM^Z74&>JTR4V'*QNY;]TNH,]5IDIL=B4I065!$E/J(L"$3/%:(X/HA(
M                 -"ZV5NLTW6C0>G4ZHRHE/J=6J[=2B1WG&F9*&X;:D)>
M0A1)<))GB1+(\ 2WT"
M           !H71.MUFI:T:\4ZHU&5+I],JU(;IL20\XZS&0Y#<4M+*%J-+9
M*,L3)!%B"6^@0
M     J6J<J3"TQO2;">7&F1J#5'H\AE1MNMNMPW5)6A23(TJ298D9= "O?3K
M4:A5M#;"J=5EO3JC*H\9V3,E.*>?=<4G:I;BS-2C/UF8#9P
M                              ..=&<VLQ;PBS&C$LV4SPQP]6P!YXUY
M_P#.GT\_]9K/_)- EZ(4I*2Q49$6)%B>S:9X$7YS!#Z
M                                  #@TZT\DULK2X@E*0:D&2B);:C0
MI.)>E*B,C+T& \\Z#?\ G3ZAO^LT;_DG02]$8ECACMZ< 0^@
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MHWY]1E^4O4QY4JV-"[7E*E6E2EENIEP3&R4A,V0D_NL(,S-M/Z-N*B#TT"
M                                                 >7[P>O;Z9KW
MJVHT,Y5S:$75.<J%W4E.+TRWY\Q>9V;&(NF.M9YEI+\A[<%&2HEI:[V;I_?F
MN=W0'TW-,N>KT)%E4>DK)^16),B M3:&202C))9T[Q67V/NX&O!)AOS0VR=1
M*3Y[?VK55YN_KRY5<JC1S+D*/"A[TX\*/@:L31OUFXHCP-1]*CQ6HAM\
M                                              8"][2I]^6C6;-J
MKKK%/K<1V$^_&42'FR=+ EH,R,B4D]I8D \OS=2[PTXM:[]"-=9)2*M)MZK-
MV%?J\41:['3"=2EA]:C,D3$8DDR4K%9[#,U&E3I+"6-JO=M<TJT\T'T+4W(U
M"DV_"7<USD9.0;<@O((S6XM.)<R:3]E'2D_1FZ ]<V):C=C6=1+1:FO5(J/$
M;BJJ$H\7Y#B"]MUSI]I:C-1[3Z>DP0L(
M               --:B_2[H]JC>=/OJZJ0XJM0S1SB8KA,,5%+1ENTS4$DS<
MRX9<4J2HT^RHS21$0;ACQX\2.U$B-(8BL(2TPPTDD-H;065*4I3@1$1%@1$
M[                                                    =<B/'EQ
MW8DMI#\5]"FGV'4DMM;:RRJ2I*L2,C(\#(P&GM.OI=T>TNO.H7U:M(<36IAK
MY-,IPGV*<ETSWB82#21MYL<N*E*42?929),R,-R@
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M5S4A#9@
M
M                                         ";&G+9@38)GBS)2A24^
MIQ#B3Q_.1'B,:M.)JIJL;T:DQ153])ZH0V8
M
M
M
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M]RG)5H3.6.,/0P]5Y8
M
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MT82@\4E'J6!_9E?(ATZO^ZERZ/\ _GK>@AZ;S
M
M
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MU((\=N4RQ$S3$SQX>JL53$<./HF"ZH
M                                         ";5X"Z;4'HJBP02C4T?
MK;4>*3_T##1U(KHB6^OISIUS"$-V
M
M
M   )L: MZGS9ZBP9CI0E*O6XMQ!8%^0C/$85:D1733]9Z-Z-.9HJJ^D=5WN?
MR;E4^:8D[MY<VL#>Q].7'9AZ\=@\C]7<S?V?S8]O]S:R_P!_\6M?.DR2S)A:
MEM^@UI)"OT$I7]8]RGC]7S]7#CZ. LJ
M
M
M   DPRIYN$<];Q-D>U+*$F9E_:4HL/T#*O/P_MX?RUT\G'^[C_#89>1^1GAN
@_)LFWIPPQ_3FS?GQ^T>%_P"NY_\ D^@_\MK_ /!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>lc_postinfection-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_postinfection-4c.jpg
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M%!04%!04%/_  !$( 9,"\ ,!$0 "$0$#$0'_Q #)  $  P # 0$
M    !@<( P0% @$! 0$! 0$! 0$            ! @8%! ,'$  ! P," @,)
M#00%!PD) 0   0(#! 4&$0<A$C$3"$$BTM,4%E87.%%A,I/#E!5UE;5V5QA"
M(]15<8&2,S12<K(D=*0WD;%BHG.T)34VH<&"0V.#LX0F*!$!   #! <%! <'
M!0        $1 D$#4P214H(4!15%(='A5!;P@1(38<'2@]-$-3%1<:$B0@:Q
M,N(C-/_:  P# 0 "$0,1 #\ W\     %-[Y=H"Q[36FMH[9&E[SYM,M5362%
MKYFT\.J)Y36K%_=0-YD7BJ.?P1-$57-+""8Y+N';L+VTGW&R-NE+1VZ&NG@@
MX+)-.UB1PQ\RKHKY'MC;S+W>(16=1NUO'A5-:,QW2QBRT.WEWJ*6GK$M=34R
M76R-KE1D<E=US4BD:U[FMDZK337N]"E2G/-R,MBS:CVNVNME!<<TEH'7FYUU
MZEEBM=OH$DZF-94IT62221_!K&:*B:*O!=4#M[9;CWW(KS?\$SNUT]GW QCJ
M)*V.@E=-;ZRCK&JZ&JI72(C^1=.5S7<6KIJNJJB!980
M
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MUCB/"<E1DMYR]=5</BEV_L^G^V$5O'JN*
M
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M,M?WE6!;%MA       %--]HYWU3\FAY'YSW.YC^@_>?6N4]=PP
M
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M>58%L6V$       4TWVCG?5/R:'D?G/<[F/Z#]Y]:Y3UW#
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M6MT+)XJJ1TJ=5(CIVHC')KT^X$35KFO:CV*CFN35KDXHJ+W4 _0
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MB6%B0HUC51%:O?<SG<0)6            %26WVE\@_!EK^\JP+8ML(
M IIJ?_Z-?[UH^30\C\YLNXC^@_>?6N4]=PX
M                    ?,D;)6.BE:CXWHK7L<B*US53145%Z44"E<+[-^.X
M9G4>?4L])/=)9:^6Y4_T72Q4[O*)$=2>1M;_ (-U,U.1SHM5FU57<0LW'9^S
M5CMGW);N9'4T;[DMPJJJ6WMM%)'1I12L8E+##&FJ0ST[V))Y7'^\D57<WPN
MF^JGLVXU4[CKN6Z:C^E_I2.L\B=:J5U$MN;#ROIEB7@M0Z5>N\M7]XBZ(B:
MF^<I[->/93N([<:IJ:..XQU=#44M"MII):5:>!'^6153'\*F2I5ZN2>1.>)4
M;R?!XB:[VM:QJ,8B-:U-&M3@B(G<0(_0
M                "I+;[2^0?@RU_>58%L6V$       9DR^W+F/:4FPR:HE
MM],ZSLJDKJ1RI/S,C1>7CPY5UXFK_@M%[<;S\=4*IREV2[W5<._R&\REQ\F%
MW373.,>V:;?I\HO2J[?VVGC<MAKU/N]65X-WH/T^47I5=O[;1RV&O4>K*\&[
MT'Z?*+TJNW]MHY;#7J/5E>#=Z#]/E%Z57;^VT<MAKU'JRO!N]!^GRB]*KM_;
M:.6PUZCU97@W>@_3Y1>E5V_MM'+8:]1ZLKP;O0?I\HO2J[?VVCEL->H]65X-
MWH>#C>-/PO>ZU8]!=*RX4CJ"6I<M4]5[]\4R::(NBHG*B]!^-U=?*S,*9QCV
M=[T<YG(9SA%=[&BFB/QPAV0^FEH,]U_-@
M                                                       /%N^7
MXG8*RGM]]OUNM=?5_P"$I:VK@III=5T_=LE>USN*=Q /95S6M5SE1&HFJN7H
M1/= \BS99BV135%/C]\M]VJ*1>6KBH*N&J?$NNFDC8GN5O\ 6![  "I+;[2^
M0?@RU_>58%L6V$       9R;[8S_ *@^20Z+INTU8T:<ZR       H#/LEI\
M.WNH,BKJ6HJJ.GM:1O92M1SU65)F)IS*U.E>/$\+,7L+K,PJC#LEWOZ/PK)U
M9SA%5S3&%,8UV_1\+VOU'8O_ "2[?%0^-/VYG1JU/@]'YC$N],>X_4=B_P#)
M+M\5#XT<SHU:CT?F,2[TQ[C]1V+_ ,DNWQ4/C1S.C5J/1^8Q+O3'N/U'8O\
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MY<Y_C%_EKFJ]JKHC"G]T^Y:1Z3D0
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M1F/_ $W;N>%_I&9_C#ZERGKN&
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MIG7"K:LBL8B)S*C437W@J\0@      #.3?;&?]0?)(=%TW::L:-.=9
M                   !6&XNW.2Y3DMJR3&[O#:JNUP.BBDD:]9$>YSE5R:(
MY--':<3S<SEJ[RN%5,92=9PCB^7RN7KN;ZB-<*XS>3YA[V^GD7Q:^+/RW?,X
MC[.:<(\M'3XGF'O;Z>1?%KXL;OF<0YIPCRT=/B>8>]OIY%\6OBQN^9Q#FG"/
M+1T^)YA[V^GD7Q:^+&[YG$.:<(\M'3XGF'O;Z>1?%KXL;OF<0YIPCRT=/B>8
M>]OIY%\6OBQN^9Q#FG"/+1T^)YA[V^GD7Q:^+&[YG$.:<(\M'3XGF'O;Z>1?
M%KXL;OF<0YIPCRT=/B>8>]OIY%\6OBQN^9Q#FG"/+1T^)YA[V^GD7Q:^+&[Y
MG$.:<(\M'3XGF'O;Z>1?%KXL;OF<0YIPCRT=/B>8>]OIY%\6OBQN^9Q#FG"/
M+1T^)YA[V^GD7Q:^+&[YG$.:<(\M'3XGF'O;Z>1?%KXL;OF<0YIPCRT=/B>8
M>]OIY%\6OBQN^9Q#FG"/+1T^)YA[V^GD7Q:^+&[YG$.:<(\M'3XGF'O;Z>1?
M%KXL;OF<0YIPCRT=/B>8>]OIY%\6OBQN^9Q#FG"/+1T^)YA[V^GD7Q:^+&[Y
MG$.:<(\M'3XGF'O;Z>1?%KXL;OF<0YIPCRT=/B>8>]OIY%\6OBQN^9Q#FG"/
M+1T^)YA[V^GD7Q:^+&[YG$.:<(\M'3XGF'O;Z>1?%KXL;OF<0YIPCRT=/B[5
MMPG>2GN-)45F<134<4S'U$75<W/&UR*YNBQHBZIPZ3=-QF(1A&-?8_*^XEPJ
MJBJ%.7C",8=G;;I6V>HXP                 /B5JOB>Q.ES51-?=5- *T[
M/^W5[VJVOM>%9#/35-THIJN266A=)) J5%0^5O*Z1D;N".X]Z%BD&Z.+W#-M
MN\FQ*U20PW&\V^>BI9:E7-A;),WE17JQKW(G]#5"*JQRP]K#&\9M&)6]^ 1T
M-HHJ:V4U=(Z[RU"0TD386R.;R-8Y_*W7H1NO<T"]CFB[-%._:JMPVOR"67-Z
M^\NR^3+&1HQT>1JJ*D\<6O!B)WBIKJJ*YR<JKP$W*M-VMZBA7'IJG#:>1Z+"
M_+8?+75#8E33K64JL1G7:<433DU[F@.Q9FV> VO;#!K/@UHE?/1VF)S'5,J:
M/FFE>Z::1415TYY'N<C=5Y4X=P(E@               "I+;[2^0?@RU_>58
M%L6V$       9R;[8S_J#Y)#HNF[35C1ISK(
M
M             "I+;[2^0?@RU_>58%L6V$       9R;[8S_ *@^20Z+INTU
M8T:<ZR
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MSK(
M                           !U$N%L^DW6I*J#Z8ZA*EU%UC/*?)N=6)(
ML>O-R<VK4=IIKP AFZ>>7;#**RT&,6R*[Y=D]P9:;)254WDU(V58I)WRSR=*
M,8R-R\K>^<NB(%1C'\^W9Q_,[#B.[MHL7496ZI@LMWQB>I='%5TD#JE8:B&L
M1'Z/C8[ED9P141%3CJ@7(C6HJJB(BN75RHG%5TTX_P!01^@       5);?:7
MR#\&6O[RK MBVP@      #.3?;&?]0?)(=%TW::L:-.=9
M
M          *PWBQK:>OH:7(=Q;C%C5PH%6.SY7#6?15TI9%U7EIJAJHYR\7+
MU:H]O2O*%@J>ZSWC*,4\DO3J??+:^EJ65%/D.+RLI<MM53 BK'*Z"![6S2QH
MJ-:L+F2NU57,5%T F6R>)[-UUP7-<0R*XYAD= R2E;49%7S5MRM;9>]EB2GG
M1CJ=SM.15='JJ:HBZ*NHBO4(        5);?:7R#\&6O[RK MBVP@      #
M.3?;&?\ 4'R2'1=-VFK&C3G60
M                                                 "C]W<1R9=P<
M>W'MN(T^X=GM5MJ;7-B]3-!#+25%3/'*E?3)5-=&]ZM9U3TX.TTT]XKYVDQ'
M)EW%OVY%RQ"GV[LUQM=/:8<9IYJ>:6MJ(9WS+7U*4J-C8]K7=4Q.+N55U[FH
M637;<X7<,LM^=2VF*++K8KE@N]/K!4/8^-8W,F=&K>N9RN71LO,B=S0(E(
M!1R;F[M9[7WJJV<L5DEQ&P5DUM6YY%45,<MUJZ3A.VB;3)RL8UW>-EE7E<ON
M=]RE=^KWX;0[04>XU;C=;2Y)<*AEHHL0J46"JEO4LRP,IFOD8FK%<USTDY?[
MM->7F[T$G3I-S-U,-R?'+5O%9;)3V'+ZM+7:[OCT]3(VCN4S5=!2U;:I$YG2
MZ.:U\7>ZI[@%W! "I+;[2^0?@RU_>58%L6V$       9R;[8S_J#Y)#HNF[3
M5C1ISK(
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MSYHXG(_FYD5J-TT1% OD(       SDWVQG_4'R2'1=-VFK&C3G60
M
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MV^TOD'X,M?WE6!;%MA       &<F^V,_Z@^20Z+INTU8T:<ZR
M
M              0G.=HMN-RJJDK,WL,-XJJ"-T-))+)-&K(Y%1SD_=2,UU5.
MZ!E'(*WLLVJ[5M#9MF[SD5MHKBEC=?+<RI6WRW-7]6E/%*^J3F<KN#>CF[FJ
M*BJ:[4WV*J]K*G=%]NPO9ZZ8??[72R/N-TNSY():2*H8J,1U/-*]R]<K5:BZ
M!(M6A        "I+;[2^0?@RU_>58%L6V$       9R;[8S_ *@^20Z+INTU
M8T:<ZR
M                                ,?-Q?+F;+9WL=#8*^#-<2JY+_8KI
MU*OI;I3MNWTA#+32M^%,YC71]7\+71/A:M::2C$=R:'>??+#LCP:U5]'28Y9
MKK3YK6UE,M.C?+6P]10/>OPWQ3L63EZ.E4Z%"-,A        "I+;[2^0?@RU
M_>58%L6V$       9R;[8S_J#Y)#HNF[35C1ISK(
M
M      HFLP??S ZJJN.W^:4V66%TLE0N-9@QR2Q,>]SU9!7Q+S\$71B2<K&Z
M!79VP[15LSC+Y=N+Y8IK!GM/&^:HI8*FFNEO<D3>9ZLJZ5ZIKIW'-3W-54$E
MVA        "I+;[2^0?@RU_>58%L6V$       9R;[8S_J#Y)#HNF[35C1IS
MK(
M                          !'[GG&*V?)K1AURN<=/DM];*^TV]S7J^=L
M#5<]45K5:FB-7X3D]X#)EQO.T&5W:M7>S?"JR&G94S,\U;;'5VJSQ-;(K4BD
M;3Q<TW*B:<^K5]]>E32[MI<Z[.BUT>&[155KAN,\;Y$HZ"DE@EF9"G,YSY9(
MFK(J)Q[]ZJ$7*$        *DMOM+Y!^#+7]Y5@6Q;80      !G)OMC/^H/D
MD.BZ;M-6-&G.L@
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MOMC/^H/DD.BZ;M-6-&G.L@
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MT\C)F(Y+E6:M56*J(OO*%7&$       9R;[8S_J#Y)#HNF[35C1ISK(
M
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MT0PK%L:P_M#Y%:<4M%)9;8_$;9424E!"RGA=,ZX5;5D5C$1.94:B:^\%7B$
M      9R;[8S_J#Y)#HNF[35C1ISK(
M                                                        INI[
M.'9XJJJ:JJ<5M[ZF>1\LSEJJA-9'N5SET2=$3BO0%F@6-X7MEMEVE,?L^W5!
M1R^<%HKY;G21R.JI;1)2-UCJ(I'O>Z-M2CGQ/C5=."*F@&H0@       !4EM
M]I?(/P9:_O*L"V+;"       ,Y-]L9_U!\DAT73=IJQHTYUD
M
M             AFY.Z6'[4V:*\Y;5/8E7*E-;J"EC6>LJYUX]7#$FFJIW554
M:G#5=534,][E[<=EG#[#:LRO6#7&OO>92,ELV/TU5<DNE755C6S*SJ$JT1BM
M61J2)^RY4:B*JH@:[4P[.CMFZ"\WFP8C@]9@.X5-3MENEGOC9G7%]"][=)(9
M:B25SH5=R<R-5J<W+JGP5"1:'"        %26WVE\@_!EK^\JP+8ML(
M  SDWVQG_4'R2'1=-VFK&C3G60
M                                                  #/VX]1;+=V
MFML*_*GQPV1UINL%DJ*IR-IV7A5;KWS^]1[HU8UONN5NG'0*Z,-32;E=K:*H
MH98Z^P;96%R/GB<DT#;Q<G.:K4<W5O/U;_ZG1+W4X"QWK_74-W[6^&T5DD9/
M<K#CMS?DKH%1RQ4U1WM/%,K>A4D>C^1>CG1>Z"QH$(        5);?:7R#\&
M6O[RK MBVP@      #.3?;&?]0?)(=%TW::L:-.=9
M
M      (YFN!8AN+9EL&:6F&[VI7I*R*;F:Z.5$5J/CDC5KV.T54YF.1=%T Z
MF([88-@6/U6,X;:([-:ZU'^5>3OD6>1SV*SF=/(Y\CG(B]ZKG+R]P#I[:[08
M+M/255/B% Z.KN#DDN-SJI'5-;4N155.LE?QT35=&M1&Z\=-550)T
M  J2V^TOD'X,M?WE6!;%MA       &<F^V,_Z@^20Z+INTU8T:<ZR
M
M                               J2V^TOD'X,M?WE6!;%MA       &<
MF^V,_P"H/DD.BZ;M-6-&G.L@
M                                                       %+W?<
M3='*LXR#"]HK;9H:;$E@AOE_R=:M:>2LJ8^M2GI8:3E>[D;ISO<[3WO@JXKF
MQ/>]RV#.I-QK='9LGVV7_P#IJ6@D6HII8I(734\M*Y_*JI.UJHQC^.NFJ\>
MDC-1N[O9CF-4>[&7XS9&;8U*4]56VB@FJWY#;[=6N8V.>1TFD$KFH]KI(V-:
MO^;WW*&A()X:J"*IIWI+3S,;)%(U=6N8]-6JB^XJ*$<@%26WVE\@_!EK^\JP
M+8ML(       SDWVQG_4'R2'1=-VFK&C3G60
M
M       "MMS]V*;!I*3&L?H'Y'N9>VK] 8Q2_P!X_I;Y14NX)#3L5%YGN5-=
M%TZ'*TJG=Q=LKWA?9OW,NN0UJ7;<;+%I[OE-? BMA1T=5"J4\"*B+U,$7,UN
MOO\ 0FC4"S=Z*F@7LXY/4M5OD,N.+Y.NJ(U>MA:D6B^^KFZ>Z"":8!%7TNVN
M+PN8CKG#8Z!BLF56HL[*2--'JB*J=\G'@$0]+MVD^[C.(:_6U?\ P05X&WU1
MF=3V@,BDSNAMUOO:8E;4BAL]1-5T[J?Z0JU:YSYHXG(_FYD5J-TT1% OD(
M     SDWVQG_ %!\DAT73=IJQHTYUD
M
M  HJL[/5^7.,CSRR[EW>T7C))46K6"EHY%931*O44['R-54CB;HU---=$5VJ
MA9IIBVVUTMUIOUCSC+:[.K7?8$I)::ZQ00LB@<R2.9C?)VM5>M;(B.U7ARII
MH!"X.SE5S4M#B60Y_=KYM3:Y89*/#*F"F8CXJ5R/@IZFLC:DLT$:M;I&J(FC
M4TTT3037HB(B(B)HB<$1 C] J2V^TOD'X,M?WE6!;%MA       &<F^V,_Z@
M^20Z+INTU8T:<ZR
M                                                     J2V^TOD
M'X,M?WE6!;%MA       &<F^V,_Z@^20Z+INTU8T:<ZR
M
M                      J2V^TOD'X,M?WE6!;%MA       &<F^V,_Z@^2
M0Z+INTU8T:<ZR
M                                                   J2V^TOD'X
M,M?WE6!;%MA       &<F^V,_P"H/DD.BZ;M-6-&G.L@
M
M                     *DMOM+Y!^#+7]Y5@6Q;80      !G)OMC/^H/DD
M.BZ;M-6-&G.L@
M                                              !X3<VPQ]^7%F9%
M;'9,W7FLR5D"UR*G2BP<_6?]4#W0 %26WVE\@_!EK^\JP+8ML(       SDW
MVQG_ %!\DAT73=IJQHTYUD
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MER_$JZHCI**_6ZIJI51L4$-7!)(YR]"-:UZJJ@>T
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M45K:+S<R*WY%)SQK+UT=OZS6%-'-Y5?S_"XZ>X!,P
M
M
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M/_<$<H      *\WX_P""V??4-P_[N\+!Z>TZHNUF#JG%%Q^U:+_^E$$BF
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M*B]&@$6L>V>WF,W>6_X]BUKM=[FYDDKZ.CAAFTD^&C7,:BM1W[2-TU[H$J
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MS(7V^F=?HZ=:*.Z+"Q:MM*KN=84ETYT8KN^Y==-0.^
M
M
M
M
M                     "$;OYE<MO=M<BS.T005-RL],D]/!5(]8'.61C._
M1CFN5-'=QR @KJVY#VL;A9J+(J:T8)6T5;315L-!#/=(:M\4\:2-8CI?W37Z
M+IQ=IJ%[$_VFW/HMTL=J+DE!+9K]:JN6UY#8JE=9Z&X4^B21JNC>9O'5KM$]
MS1%140)12Y/C5=<'VFBO-#4W6/5)*&&IADJ&JWIUC:Y7)IIQX!'?@K*2IDFB
MIIXYI:9W5U#(WM>Z-^FO*]$55:NG<4#Y\OH4EG@6JBZ^E8DE5'UC>>)CD54<
M]-=6HJ(O%0.M:K_8KZV1UDNE)<FPKRS+1U$50C'>X[JW.T7^D#NU%1!2PR5-
M5*R"GB:KY9I7(QC6ITJYSM$1$ Z:7ZQNN:65MSI%O#F)*VWI/'Y2L:IS(Y(N
M;GTTXZZ <UQN=MM%*ZNNU9!043-$?4U4K((FJO1J]ZHB?\H'U15U#<J6.MMU
M3%64<J:Q5%/(V6)Z=&K7L547^H#J4^18_5W*6S4MVHY[O#KUUOBJ(GU+.7IY
MHFN5R:=W5 (?3[JVZIW<K-KD;3L\BM,=R=<'54:ODJIJCJ4I6PI^TU$<YVKN
M;H[W3B%2+.:_([7B=TK\290/R*"-KJ!MWD6"@Y^=J.ZY[7-5$1JNT[Y..@1W
MV7>DIJ-C[O64E-5Q4S*JN;US6QQM5$1S]7JFD?-JB.4#\3(K%):9;[37*EJ+
M1$U7.K8JB)U/WO<ZU'<G3P^$!4^PVXNX6Z-))FN02X_28=713/MEEMSIY+O2
MN94+%&M7(]ZQZ*V-Z\&IKP7AQ0+%;5LR"PWI\T=FNE)<7TZ\M0VDJ(IUC7W'
MI&YW*O\ 2$?MUOMDL<<<M[N5+;8IG<D3ZR>.G:]WN-61S=5X]P"%[H;K4&W,
M6+?NX*V;*+W066+GJHX&005SEYZMVNJNCC:U>C1-535R!7M6^[Y-59S6T+OH
MN3"$MM/56ZH@G5]S?52O[Y7QHY6]2K?@.1.GNKW"/87(L?;=$LCKM1I>EZ+<
MM1$E4O#7^ZYN?H]X#M35U%3/ZJHJ8H9>K?/R2/:UW51Z<[]%5.];KQ7H0#AM
MEYL][@=4V:X4UQIFNY'34<T=0Q')W%=&KDU [P
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MSV?S9_7VZVK;/)TQ^[R3Q\JTU1-3,1DKD7OHTY47FT57+WH%Q=H7CLAGFO\
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M]]Q">KNELH4ZFCEJ*:N1D<O4M[QKFMX:M1.[[KM26-$!
M
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MT_7K(KOA<VO#3H")D
M                                           C47_K>?\ \F_P;?@?
M^>=*?#_^C[GO@24 !U;E_@*C^X^ O^+_ +C_ .Y_T?= Y:;_  T/P/@-_NO[
MOH3X'_1]P#E
1                   #_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>lc_abcessarea-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_abcessarea-4c.jpg
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M%!04%!04%/_  !$( K$"!P,!$0 "$0$#$0'_Q #.  $  @(# 0$
M    !@<%" ,$"0(! 0$!  (# 0$              0($!08' P@0   % P("
M!08("0@&!@H#   ! @,$$04&$@<A,4%1$Q0(82*U-E88<8$RDI/3%79"4M(C
M4W2T%C=B<C-4E-1U%Y'1@H,DE:&Q-#55AL&R0V-SA"5E5SC5EG<1 0 " 0($
M P0&"0('  ,    ! @,1!"$Q$@5!47%A@9&QH=$B$S0&\,'A,D)R,Q054F+Q
MDJ+"(U,6TN)#_]H # ,!  (1 Q$ /P#?X
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ME)FO0V'R0>EQQ"$%J3VB-23)*BKQ2!HL,$
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M
M
M
M
M
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MW&P?<)N6[A5\C7IN ;:9AQ5&?9&[J-&HC(C+5H53X 1*
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ML4(N!?\ =K@*M\$
M        %2[I_P 2]G/\<N/HB4"K:!                            %0
M[>_QTWF_\L>C7 5;P(
M           *EW3_ (E[.?XY<?1$H%6T"
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MK9>A.MOO0+I:YB21*A3XJM+T=Y)<E).A^5)D?#D"):
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MNCN/E4Y#16;)OL3[)6AS4ZK[.AK8?[1%"T469:>)U(%6$"
M         HG<O:#<O,-S+;G5ER*SM6VPQR:L%HN\%R<S&DN4-V5HUD@WC41:
M%_@D2>DJ@J5XIC>[QS9<;<O([-?<7EPWHSD"W6]R&\IQ[2FIN&X?FZ-9&7E
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M%UU!$W  %2^'SU7R7[WY)Z2=!96T"
M                                                     *E\/GJO
MDOWOR3TDZ"RMH$
M                                      5+X?/5?)?O?DGI)T%E;0(
M                                            -0MW?%O=;??)>.[;
M,QRBP'%,/WR2CMS>=;,TJ[!!F2"01EP6K5JYD1%S[;LNRUM2+9=>/A];*(8#
M;_QB9;"NK$;<%ABZ6-Y24/S(K)1Y;!&=#626Z(61=*=)'U&/ON>QXYKKBX3]
M"Z-UHDN-/BL3H3J7X<EM#T=]L]2%M.))25),N9&1U(=,M6:SI/.&#F$
M                            !4OA\]5\E^]^2>DG065M @
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M[UZ<<=/M\5U;.$1$5"X$7(AUIB
M"I?#YZKY+][\D]).@LK:!
M                                             %2^'SU7R7[WY)Z2
M=!96T"
M                              *E\/GJODOWOR3TDZ"RMH$
M
M               5+X?/5?)?O?DGI)T%E;0(
M
MJ7P^>J^2_>_)/23H+*V@0
M                                            !4OA\]5\E^]^2>DG
M065M @
M                             "I?#YZKY+][\D]).@LK:!
M
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MY:= (G8  J7P^>J^2_>_)/23H+*V@0
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M%W-IIBYJRG(3G,1EJ=CMR#N#G:):6HB4I!*J25&1&9 2N$$
M                                'RM:&T&MQ1(0DJJ4HZ$1%TF9@/EE
M]F0V3L=Q+K1\EMJ)23^,N LQ,<QR"  TP\1/B,R=O)YV#8).7:;?:'%1KE<H
MQZ94B4C@XA#G-M#:O,\VBC41\:4'<>U]KIT1DR1K-N4>&C*(4KB^]NZ.)W!%
MPM^33I)$K4[$N#[DR,Z722VWE*Y]::*ZC(<SFV&#+&DUCW<)9:/0K;#/86Y6
M%6S+8;?8+EI-$R)75V$IH]#K=>DJE5)]*3(QT#=[:=OEFD^'R82EXU$
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MHPE=8X9                            %2^'SU7R7[WY)Z2=!96T"
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MA4?H                            "I?#YZKY+][\D]).@LK:!
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M;S!'U2\5Q^+;YJB-)RR)3T@DGS(G7E+61'TD1C//O,V:-+VF875,1IH
M                             "I?#YZKY+][\D]).@LK:!
M                              $,R[:?;K.Y!3,JQZ-/G$DD=\\]F0:4
M\")3K*D+41=!*,Z#<P;W-AC2EIB%U=_$L PS!6'(^)66-:DO?TSC*:O.$7(E
MNK-2U$702E#YYMSES3K>TRB2#7
M      %2^'SU7R7[WY)Z2=!96T"
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M!9BWDG9+J&6S.(THM3BB27!#ZE'Q/\%)GU$);LF>(F=:_']B:+]' H
M                        "I?#YZKY+][\D]).@LK:!
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M,^A+K+B>*5(61*2HO(9&".4           %2^'SU7R7[WY)Z2=!96T"
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MZB91_A$_]F<&QMOZM/YH^9"MO"C_  4L_P"LSOVIP<CWG\3;TCY+*ZQPR
M_"(BK0J5XG3K ?H            #IW:*_.M4Z%&D'$DR8[K+,M/RFEN(-*7"
MY<4F=0&FFV>>^%'%,0A8MG5HL[F864W(-ZF_9)WQN7*8<4A<EJ8U'>)QMVFM
M'G<".E. ,N+8K9O*=G,H@W5[9^)$B0H[S2;H4*VKM25.J09MFI*F6=9Z2/C0
MZ DK-!            %2^'SU7R7[WY)Z2=!96T"
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M,]31:UZB*E#/H!$V!            %2^'SU7R7[WY)Z2=!96T"
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M(0I%NN$UAF'J*A*5%;7VJD]95<2FO61ET#IG?[Q.2M8YQ'S8V;1#K+$
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M9[-:\?M<6RV6(W!M4)LF8L5DM*$(+JZS,^)F?$SXGQ'7;WM>TVM.LRQ=X8
M      #J754]%KFKM24+NB8[IPD.'1"I!(/LR49\B-5*@-3]I-HMM\SQ!G)[
M_G%X_?2ZNO2LLC1KNFUFQ=UN*[RVN*R2-"DKJ7G%YWRBX&0,I; ;9X!C&!QK
MBSC-XGW=J<XVN0NXW%5S-M3:3))(-1GHK4Z]?Q Q3L  :Z>(?Q!W;![5?K-M
MU;Y$S)+'W4\@ORX^JVV=$Q3/9$M3I:'7W2>02&TUIJU'\DT@L0M7=G,9&![7
MY-F,52"N%LMSKL)3I:F^]N$3;&I/27:+3PZ01 <9M'B6EN6N9>,XQ\F3[K(N
MUJ3:S3);:<TK<9-1*\U6FJ2.A<>(*[>59;N'F6YERVMVRNT3&FL:@1IV39+*
MAIN3R)$_SXT5B.M:$><V7:*6H_@I3S@89NW>K5&W"L.Z?=UY+MHR4^X7"W(-
MIBX6MZ,J4P^VTHSTN&E!I6@CH2J$0"(+R[Q$,[?)WT<N=H59>YE?7-O"@F1)
MLQ_GZE<-?:]N4?SSJC37HZ &P^/WN#DMAM>16Q1KMMWB,3XBCX&;,EM+J*ET
M'115!&1 5+X?/5?)?O?DGI)T%E;0(
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MV2PV;++KY7!PEK;;,S-"5*XI34Z$!*X00
M               &J^Y_@_8OUYDWW;^Y,6KOBU/2+1-2LHR'5G51LN-DHT),
M_P  T&1=!D5"+M&T[W-*Q7+&NGC'/WLHE\;:>#QFRWB->]P;G'NC<-:7F;/"
M2LX[CB>)=NXZ234DCYH)'G=)TJ1W=]\F]9KBC37QG]1,MB<_]0\H_P (G_LS
M@Z]MOZM/YH^;&%;>%'^"EG_69W[4X.1[S^)MZ1\EET-Y?#+8]S+DO)K+.*QY
M,ZDBF*-OM8LHTD1)4XDC2:5T*AK36O25>(^FQ[M;;UZ+1U5^F")5]A_@K4Q<
MVI.<7]J5;&E$I=OMB'$J>H==*GG-)H2?3I17J,N8W\_?M:Z8ZZ3YRNK;2%"B
M6V''MT!E$:#$;0Q&CM$26VVFDDE"$D7(B(J$.JVM-IF9YRQ<XQ
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MB2E)42DN!$1=! C] 5+X?/5?)?O?DGI)T%E;0(
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M*/\ ")_[,X-C;?U:?S1\R%;>%'^"EG_69W[4X.1[S^)MZ1\EE=8X9
M          !2^ZN.YMC^=V7>C;VUED-QM]O=L&28V3A-/S+0X]WE"HRU<"=:
M=JO30S5R+J,K$^\\[+24&T;5YK*R11FC[,>MA1FTK*ORWS6HDIX?*T :)/LI
MA>668\HSK<%#,?.<YG-3KA;HRB<:@Q(C781(NLC,EJ;174HN''II4Q*UP0
M         !4OA\]5\E^]^2>DG065M @
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M5H5=)"5I@@           "I?#YZKY+][\D]).@LK:!
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M$\%.$DSU4\G(ZD0E;X(            J7P^>J^2_>_)/23H+*V@0
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MP(!/P0           !4OA\]5\E^]^2>DG065M @
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M7I4-HUSGD5TKE/J-UTTUH9I)2C2G^21#S?>;C[_-:_G\F$IF--
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MY[++A<%-MN)2I)$=$ZZ)\V@)*^00           !4OA\]5\E^]^2>DG065M
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M$            5+X?/5?)?O?DGI)T%E;0(
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M9$?9LHJ23453KQ!%C@@           "I?#YZKY+][\D]).@LK:!
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M6.6TJWFLS/LVIJ5J4TD_Q26VI=.M1CI7?<5:Y*VCG:./N8RV9'6V(
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M)))):J5#-MM/ C_E&9GU#Z[?8TQ3KSEJ=T_,>XWM?N^%*>,1X^LK('(.K@
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M](6BX.$IUQ*"))*6?G*))4KR E<((
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M0VW$6E*2\A$5!TO!,SFK,\^J/FQ5YX4?X*6?]9G?M3@Y#O/XFWI'R)76.&0
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M_P!W0%U6@" "I?#YZKY+][\D]).@LK:!
M                 !'<_P#43*/\(G_LS@V-M_5I_-'S(5MX4?X*6?\ 69W[
M4X.1[S^)MZ1\EE=8X9                 !PRY4>#%?FRW":BQFUO/NJY);
M;2:E*/X"(!JI;LIQK&L;:W1PK:J'9\[W)O2;'AD5]XB7.AS]*RF/$@R*,VX9
M*4MMNGX)FK2>H&2S/#W*MUJME_VW+%8>'Y'A\MI-YM=M>7*B/%<62>CRT/NF
M;B^U0FGYQ2E%HH9]!$E<H(            J7P^>J^2_>_)/23H+*V@0
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MX:>/49T'G%<?W>YBG^F^GTL$0\*/\%+/^LSOVIP;?>?Q-O2/D2NL<,@
M            Z5Y*XJM%P39S2F['&>* I=-)2#;/LS.O"FJ@#2G!KOMA:'-E
M'8TJ%:\L@7>Y'N$[<W&X]T;N?<'TR5SG'S)S2IW42#6>FE"Y\ 9+H\.YV61E
M.Z5RP)M+6U4NZPOW=3'2;<)<]J)HN;D9)D1=FISLZ&GS>'F\.!$E?8(
M       J7P^>J^2_>_)/23H+*V@0
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MB;#B<'%Y628YDR\UGY-).=>\L>,B>F2FTDV2#;+BREI):4,G\@$E:8(
M       J7P^>J^2_>_)/23H+*V@0
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M?)?O?DGI)T%E;0(
M   Z%XL=FR&$NVWZWQKG;U\519C2'VC/E72LC*I=8^E,EJ3K69B?8,9C^ X3
MBCRY&-8_;[5)<*BWXD9MITTGT:TIU4\E1],NYRY(TO:9]XD0UP
M    $3SC<7 =NX17'-[W$M31I-3+;ZM<ATBY]DR@E.+Y?@),!1V3>(O-+R[9
MX6UV!/18&1W!NRVC+,L:7!@N2Y"%K0;4=!&XM&E"U$NM.%-/0"Z+?VOQ//\
M&XURE[BY>>57NZ.-.$VS'1$@P4M)4GLHR$TJ1UXJ-*3.A5*M3,)\"
M     *E\/GJODOWOR3TDZ"RMH$
M                                !6&Y&RMKSZ_VW-8-YG8YG5F8.+:[
MU"[)Y"&C4M>ER.^A:%E5Q1\-)^4%U5+GME\1UME8C*R2VP=P[)B-\CWXKG8$
M=RO+R(S3K1MN0UJ)LU*[35^8(^0"\-M-UL:W2ASWK&S.@W"TN-L7>TW6,N),
MBNNI-24N(54N)$?R5&")R             J7P^>J^2_>_)/23H+*V@0
M                                        :P[N^+1C$[W*QG!+>Q=9
ML!:F)UTF&ONJ7T'13;2&S2I>D^!JUD52X5+B.R[+LLY*Q?).D3RB.;*(8#;[
MQERI-UCV[<6UQH]ND*)M5VMI.([ U'0E.,N+<U(+\(TJJ1=!\AL;GL4177%,
MZ^4FC;MIUMYM#S*TN,N));;B#)25)452,C+@9&0ZG,:,7T(
M      ^2;;2M3B4$3BZ$M9$1*,D\JGTTJ ^@            %2^'SU7R7[WY
M)Z2=!96T"                                            .E>.^_9
M$_[.K]H=V>[I3GVW9GHI_M4&=-.J->6H\EG->M7:U[2IZ]5=6JO&M>D>K/H^
M0'ISL?\ :'^4>'?:>KO7V8Q37\KL:?F>?_N] \U[AI_<7T\_^+"4_&@@
M                             J7P^>J^2_>_)/23H+*V@0
M                                   :Q;N>$MC+;Y*R?!KBQ:9L]:GI
MULF)7W53ZSJMQM;9*4C4=3-.A15Y4+@.R[+O4XJQ3)&L1RF.;*)8' /!G(B7
M9BX;AW:-*MT=9.':;;VJB?-)U)+CSB6S2D_PB2FIE^$0^^Y[[$UTQ1,3YR:M
MN6VVV6T,LH2VTVDD-MH(DI2E)4(B(N!$1#JDSJQ?0@
M               *E\/GJODOWOR3TDZ"RMH$
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M)!CH)N/&80EIIM"2H24(21$DBZ"(@'.  *E\/GJODOWOR3TDZ"RMH$
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MI;:4U/HJ8[)3>8KSI$\9>39^P;[!CG)?'I6O/C6?E*;#<<"
M        *@W.\..!;FSUWN3V]HR%PB)^X0#21/Z2H1O-K(TJ,BX:BHKK,Z#E
M]IW3+MXZ8^U7RE8EB, \*>WN%79F^37I.07**LG8:9NA$9IQ/%*^R07G*(^)
M:U&732H^NY[QFRUZ8TK$^1JO8<&@
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M?)>T3X3:=&;'V:
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MF/76(^4MPQVQXD
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M&T_4N <JZ2
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M3R6U+5YQHY!6(
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M*]//@KY1%T$8[AMLWWN.+>+PCN^P_LMU;%'&.<>D\OJ2H;+B
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M&^JJ6S+K2@DDKRU';]GBG'BB)YO"OS!O:;O>WO3C6-*Q[HY^^=93P;KKP
M            "H=S_$9@6V,Y5DE&]=\A01&_;H!(/L-1:D]LXM1)29D==):E
M=94,ARVT[7EW$=4?9KYS^I8AA\ \5>WN;75BQS6I./W.4LFHASM"HSKBCHE!
M/(/S5&?+6E)=%:C[;GL^;%7JC2T1Y<S1>PX-
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M@1&? BJ?D&#83G;K;.^9S=HZ>[.Q[ A:53KBM)H;[(C\Y+:C+SEGR(BK3F?
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M)                                 !4OA\]5\E^]^2>DG065M @
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M;&VF8RUT\X<5W>E;;/+%N71:?A&L?2WH(B(J%P(N1#NC\^@
M      !D1E0^)'S(!HUN]X5<NM-]F7?;R%]KXU,=4\U;V5)3*A]H9F;6A9IU
MMI,Z(-)FJG RX5/NVR[QCM2*Y9Z;1X^$LXE@, \+&Y&479A.2P%XYCZ%D<R7
M*-!2#;+B:662-2C4?(C61)+GQY#8W/>,..OV)ZK&K?BTVN#8[7"LUL:)BW6]
MAN+$93Q)#+*20A/'G0B'1+WF]IM/.6#N#
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M'.7;S,]/&:SY>R?U+^'./.
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MYZ>6O!SC)\P
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MX[M^:<FZQSBQ5Z*SSX\9CR]D>:X1RSI(
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M                          ZMSBKG6V9":,DN26'64*5722G$&DC.G1Q
M1W;#%IV$;>XUB-R>:D3[+;V(4AZ.:C96XRG29H-:4JI\*2 2P
M
M
M    &N>[<:^91O\ 8;@4?+[[C%@N%BFS)7[OSS@.+>CN+-)F>E:3K0B.J3X
MJ36S84[?<H5P_P U\]FG$?:D=SE7Q#L=[LEDOLW4=W+4A5-*DUXD!JZ^)WN_
M8MXA,MV_O]SE3K%E,%K)L0*8ZIU,=32C:F1&349Z2U&:TMIX)0DNOB'+O3>[
MY=,OV^VHQ6Y2;9<,AN)W6_38#JF'V;%:D]H\G6@R4CMU'H2?2::=($,;G%^R
M79;<Z+FUQN<NX[.9>\U;K]'EO*>:L%R5YK,IG69]E&</^D(O-(]1\^S2 YL,
MON0[T;CO9G;+E*MVSN(O/0;&U$>4RC(+FGS'I+N@R[2(T?!I)^:I5#_'207J
M"-2]J<+OV[*LYO-]W/S.TN6O++K9X4*TWGNT9$2.;;C=$.-N&1EVIIX&14(J
M$"K V.ON4,9OGVW%RR)[-,;Q9<%5JR>5H<DI<F,FMV&^\WYKJVS+G\HN.JE2
M2D2BVYFX6ZLW.\#;CVR3B.W*LVM]D6Z\^;-SO+A/+JOLF_DP5);5YJS_ #E4
MG2G @V=!                 !3'BKO]\QG8_(+SCMQDVJ[,.P"9G0G5L/H)
MR:RA1)6@R,JI,R/CR!88USP_7=NV'.@;Q9Y%N26.V9>GW=$B(VYIU5>9-E&I
M!?A)UE\(&JL+YNEG.;>'/ +^]>YEFR*ZY;$L%UO5F=."[)CDY)84ZA2*$6LD
MI4JA:=:>5. *E&YV"WS:##;CN!CN\.4NWFT$AZ);\DN35S@35]HDBC&P;2-2
MG/DII4P1(M\-P,HMF';?H^T%X+'S*=#B91D.DC<M#3\?MG&DJ7P;6I6I':*^
M3I,^',A#H7#:;,<:M+&9;&[AW[)[]%=9<.SWV\-72U75@W$DZA:G-"$*T&:B
M6E710J&9&0;%,J<6RVMYOLG5)2;C525H495--2X'0^%01]@
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M?N,2AEV,IUE*G6Z'^*LS2#%E0
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M^A*D)65#+B25J+XP$4MWA\V3M4QJ?"P:U)E,J);2G&">)*DG4C)+IJ34CY<
M75.KU8[-DELD66_P(]SM,I.B1"EMI>961<2JE9&7 ^)'T&"(+CWA]V9Q:[MW
MZQX= CW9E9.,2%DY([)PN)*;2^M:4*+H-*2,N@%U64"
M
5                        #__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>lc_halfmaxtiter-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_halfmaxtiter-4c.jpg
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M%!04%!04%/_  !$( =$!]@,!$0 "$0$#$0'_Q #!  $!  ,! 0$!
M    !P4&" 0# @$! 0$  @,! 0             !!08" P<$"!   00! P("
M!0D$! @)#0$   $" P0%$08'(1(Q$T$B% @846$RTY2U-E9V<2,5%H&10A>A
M8M(S4Y,D5[%2<H*2U"55E?#!T:*R@S1$5'2T=28W$0$  @(! @0#!@0#" ,
M     0(1 P0A!3%!41)A$P;P<8&1H2+1,E(5P>$4L6*2HM(C4Q9#-%3_V@ ,
M P$  A$#$0 _ ._@         #&YG<. VY!':W#E:>)K2O2**:_8BJQOD=X,
M:Z5S45R_(@&08]DK&R1N1\;T1S'M75JM7JBHJ>**!^@
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M@+/&6'BVW3MXS'47VJ+\1D9W6[-"Q6M2QS55F<JJYD+T<R)?]&C?#P!*BA
M
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MQ]/)35:U*1T,E&O85%CJL8SHZ1W7Q!*JA
M                                     #5>2MFKR%L3.[*2[_#ES59:
MOMOE^?Y6KD=W>7W,[O#P[D _64V)B-P; ?QYG];F(L8Z/%VI&HD;W)'&UB2L
MU[D:]KFH]OCHY$\0)C%P;OK-PX?:_(F_4W%QU@YX)X\1'CF5;F12DJ.K1W['
MF/[V,5K>]&M_>::N];JA<KL$  $EXD_'7+_ZE@^ZJ@65:"
M                                                         $EX
MD_'7+_ZE@^ZJ@65:"
M                            $EXD_'7+_P"I8/NJH%E6@@
M
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M:^JL4O2)F,=(G'E,.KS9WCH
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MV)Q/Q<IK+=C*.(!\+EN"A4L7K3NRM6C?-,_QT9&U7.7^I#C>T5K-I\($#O\
M.&YI;[IL=!6KX]KOW5>5BR.<Q%_MN[DZK_BZ&HW[SMFV:Q$0[O9"Q[+W3!N_
M!19:*/R94<L-J#75&3,1%5$7THJ*BI^TV3B<F-^N+1T]75,8; ?8@
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MQ8Y':.R*2][.Q/2D>B/5?F5$_;Z3 1VS;G&8P]2M]7\.-?NB+3;^G'^/@O\
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M)YT2:LD3N35.WHO7JAFJ6BT1,>$O.=^J^G9;7>,6K.)>OX(L!_O W+_KHO\
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MAW+IHU/'7YC&<33;9LC'A$MN[YSM7&XM_?,9M68B/.<QC\O5VN;@\'
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M"B]51D348W_ @1Z  $EXD_'7+_ZE@^ZJ@65:"
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MZ           )+Q)^.N7_P!2P?=50+*M!
M                 !\WUZ\DC9I(F/E9]"1S45S?V*O5#C-8F<X'T.0
M     'RLQ.GKS0-<C'2,<QKU:CT:KD5->UW1=/D4#CK;6"I[5W9%Q#M'WA;L
M&?L6+",P6/PT4]*M.B/GFC8J*^"OHK7JL3'-1JZIHBAR7K@Z2?(;<L9]O(\G
M)&+R4C?8K\E6&E[,L**V2)8XT1R.5517-D1%3ITZA)5 (         )+Q)^.
MN7_U+!]U5 LJT$
M           /#F8+UG#Y"MBYO9\G-6FCI3KT2.=\;DC=_0Y44#BC;>^>.=L)
MPOM_(R1;5W!LS*7X]]T,BQU>Q#>_A\L<EF9ZM7S&SR*BL>CG?21OHZ');_=]
MDI9O<_)N^=JU'TN-]QY*BNW&+"ZK%9GIU5BO7(HG(W1D\JM];3UE:NO75$)*
M[!         !)>)/QUR_^I8/NJH%E6@@
M                            !H/)^;Y0PE*"7CC;-3<BR1SI>;8O)1GK
MN:U%B?&CV.;(B^MJW5%UT\=>A46V]D>>-P[8P-[<_"V%W+E&TH>[+YR[2@OR
MKV_3D@G@[H7+XJSIH!6N)*O*SK.Y,SR9#7Q-?(356;>VO3GCM0XZK5@\M_;)
M&U$7S7*CM-?%/0G0"FA         !)>)/QUR_P#J6#[JJ!95H(
M                                               2CDW.\<;&W/CM
MY;VW3=PN0DQMS'XW&MLSQX^RQ/6D=Y4;'-6=JRM[7JJ*GJ_(%<]X&_[N.8PM
M#*Y/F#=V)R%R%DUG&6-P6I)J\CTU=&]S*^BJU>BJ@58_=PRVT;]O>]'8^3SF
M?V]C;=*&+<6<R$F0BMR/@<^1*R21QK&D:KVO3KW>JOAH$E> @         DO
M$GXZY?\ U+!]U5 LJT$
M                /'DL3B\Q76IEJ<-VLNO[JQ&V5J=S5:JHCD71=%5-4 P^
M(X_V3@L73PV,P%&+'4(FUZL;H&2N;'&FB(KY$<YR_.YRJH&=J4J="%*U&O%5
MKHJJV&!C8V(J^*HUJ(@'W          )+Q)^.N7_ -2P?=50+*M!
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M6&Q&DC%<UVBM7M<FJ+X >T"2\2?CKE_]2P?=50+*M!
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M59"
M'BS&-BS&)OXB9RLAOUYJDCV_2:V=BQJJ?.B*!S3_ "SROB./-E)+M/SMT</9
MJLR"O1L1R)G,)%6?5EEJ>EKWQ2-56/ZZM7IJO:%;]PI6W5E-T\A<C;@P-O:M
M#=EK&MQ6!R.C;C6XNHM>2Q*QO1JS*K4T\=&>E-%42LH0  3+WB?_ /#M^?\
MZBQ_P(%A/^<<?;R/NCJE*+SY:F'P5V2+376&K)4EE5?F:QKG+\R CQ;%[R&X
M,99]W?<.2JRLL5\[2J18E(_76P_(30^2D2)U<JH[O3M]":^@$*74VW5N;(@V
MAGH$L4I\4S%9.OW*U)(GUD@F9W,5%3N17)JU0C]V]F[:O;238MN@V7:B5(\;
M_#E?(C?9(&M8R/O:Y']$:B:]VH$\^%G@/\FP_:[W_6 N7BX!V[A=I9[E/;FW
M:C:&$Q^XH8Z=1CGR-C:[&57+ZTCG.7555>K@2MH0
M                                     \>6?D(\5>?B6-DRC:\KJ,;^
MC'6$8JQH[7T*[34#E[C7C';&_=H4-S[SY)W,[>MOO_F.JN;=CGU,BQZLFK.J
MJB+"L3D[.U43HFJ>JJ!5RXTV)MW8]?(Q;?S^2SS+LD;[$F5R3LHZ)T:.1$8J
M_0U[EU^7^@#>P@  Q.YMN8C=^ R&V,]"MC#92%U:["U[HG/B?XHCV*CD_:B@
M?>MA<95PL.W6UVR8:&JV@VI,GG,=59&D7EO1^O<BL3M7NUU]($YP?NZ\7;?S
M-+,4Z%N=N)G6WA<7<O6K6-H6%<KO,K5I9',8Y%75O1>U>J:*%RJH0  27B3\
M=<O_ *E@^ZJ@65:"
M             'BS+;;L1D&T+#*EY:TR5K4O2.*58U['NU]#5T50.->*<5[H
MV6V91M<@W<78W\O>FYK.<R<OM,N1:]4FD;(LZ,DC>[UHWQJJ.:J:KKJ'+JZ,
MX?QG"F-J95O#+\8^I))#_%UQ-E;2>8C7>5YBK))IT5VG](25+"         "
M2\2?CKE_]2P?=50+*M!
M                #\O8R1CHY&H^-Z*U[')JBHO145%\44"!<M8G9^S-P<;8
MO#;-VTVKNC<4&(R:3X>G(JU9&ZJD:]B=KOD7J%A:L)MG;>VHY8MN8>CB(K"H
MZ=F/K0U6R.:FB*Y(FM151%Z:A&5          )+Q)^.N7_U+!]U5 LJT$
M                                                      (GR?MO
MEZAR SD3C)E++5Y=O2;?R&#OV9ZOEO;9?:9:@2/5KI%[NSJFO33T]"M-V?=]
MY?(;/VM+E]A8#,7*%>"S4O[BN2MRK;",Z32,F8KHIU3Z6FCD M7'N1Y.R->^
M[DO"8W#6(WQICF8JT^VV2-6KWJ]7HG:J+II\H1N@         !)>)/QUR_\
MJ6#[JJ!95H(
M        3OD'B+"\@9*OF<GN'/X>2G7]G2/"Y23'UU8U[I.][&HJ*[UE];Y-
M/D"N7)\WP.^^VM1W5RGEVV))XZ-VA;MSP7/9/\\ZNY6M=(UGBY4;T3JH5=/=
MJR6T,OB<_=V5-NNYB/:HH'WMWSNG\R:)K^]E75SM$9K^\\.JI\@25S"
M    "2\2?CKE_P#4L'W54"RK00
M                       \&<QSLQA,EB6R>2Z_5GJMF3KV+/&YG=_1KJ!R
MS5=NG;W'O'>4GV?DZ.<X8S4./W+3@@\Q]G%RTY*MNW05B_[0Q[9&2.[=/[6J
MZ)J')1N!\E:W/NGDG?.-QUS%;#W%?Q\V K7X%J/FM5Z:0W[;85\$F>D?K?VE
M:JKZVH25O"         "2\2?CKE_]2P?=50+*M!
M                                    "9\D[1Y=W#EJEKCW?\.TL7%7
M\JU1DQD-]9;'>YWF]\JZHG:K6]J?)\X5&=M4?>5W)OO>^QX^6X*\NRW8QDMU
M<)3>VS_%:JVD[6=J*SL1.U>JZ@7CC3;?(^W:V0CY%WA'N^S8DC=0FBH18_V=
MC6JCVJD71W<NB]? (WH          DO$GXZY?_4L'W54"RK00
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MR+UU\>NH)5 (DO$GXZY?_4L'W54"RK00
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M[_X94T\KVC]YIVZ:]WIU] )6T(
M                              8/>N)MY[9NX<'C^SV_)XR[2J^:Y61^
M=9KOC9W.1%T3N<FJZ :KM3CAS.$\;Q9NSL5ZX),'E5JO[VHKH%A>Z)[FIU37
M5JZ>(5,W;$]X');"BX1R;<+#ME*\>&M;\ALROM286+2/M915FJ6'0M2-RND[
M>J]=?6 Z%Q&*I8+$T,)C8_*QV-KPTZD7CVPUV)&QO]#6H$>T !)>)/QUR_\
MJ6#[JJ!95H(
M                      27B3\=<O\ ZE@^ZJ@65:"
M                                                      $EXD_'
M7+_ZE@^ZJ@65:"
M                         $EXD_'7+_ZE@^ZJ@65:"
M                                                        $EXD
M_'7+_P"I8/NJH%E6@@
M                            !)>)/QUR_P#J6#[JJ!95H(
M
M 27B3\=<O_J6#[JJ!95H(
M                          /XUS7M1S%1S5\%1=4 =[>[L[D[].[MUZZ>
M&N@&B;SWENJAN'';.V-MYF8S]ZK+D;-[)3R4<32J0O;%K).R&9SY7O=VLAC;
MW::N71J!7IXXWW+OBAE69'&KA]Q[>R,V&SN.25+,3+<#&2=T,R(WS(GLD8]K
ME:U>NBIT"-S DO$GXZY?_4L'W54"RK00
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MUOL]SZ@&#XIN OSK6^SW/J 8/BFX"_.M;[/<^H!@^*;@+\ZUOL]SZ@&#XIN
MOSK6^SW/J 8?U?>EX"1$7^=:O7T)!<5?Z42#H##^?%-P%^=:WV>Y]0#!\4W
M7YUK?9[GU ,'Q3<!?G6M]GN?4 P?%-P%^=:WV>Y]0#!\4W 7YUK?9[GU ,'Q
M3<!?G6M]GN?4 P?%-P%^=:WV>Y]0#!\4W 7YUK?9[GU ,'Q3<!?G6M]GN?4
MP?%-P%^=:WV>Y]0#!\4W 7YUK?9[GU ,'Q3<!?G6M]GN?4 P?%-P%^=:WV>Y
M]0##^I[TO :ZJF]*W3JO^SW/V?Z &%?"      8/>BHFSMPJJZ(F,NJJK_\
M;O C?'FW;6\/=#H;8QZHM_+;7M5*:*J(BV)&2MC15]"*_1%"^;7J_.FR8_=N
M;B'92-.0(L!_+'\J:_\ ;"YMM;^'I%['_GM%F377M^C\_0&%JXLV>NU>-=I;
M;S%>-^4Q>*J5KB/:V3LG;$BRL1W75&O5R($;G#!!7:K((F1-5=5:QJ-15^7H
M!]                 "3<V*J9;B=/1_/%'_ / OA85D(
M        )-QLJKR[S-K_ -Y8/[EKA59"                      'Y>QDC
M'1R-1\;T5KV.35%1>BHJ+XHH'XK5:U*O'5IPQUZL2=L4$+4CC8WY&M:B(B?L
M Q_\K[:7,?S"N&H_Q_3M_BOLL/MFGR>=V]__ *P&5
M#6]U[,Q^[K.W+-^>:%^V<M#G::0*U$DL00S0M9)W-=ZBI,Y5[=%Z)U V0
M                     UO [,Q^W]R[IW15GFDN[LGJ6;T4JM6*)U&JRHQ(
MD1J*B*UB*[N5>H&R
M &L;ZW]MKCG$U\[NNP^IB+%R#'NMM8KXXI+2JC7RJGT8TT]9WH V2&:*Q%'8
MKR-E@E:CXI6*CF.8Y-4<U4Z*BIX*!^P                      &-S^?PV
MUL-=W#N&[%C\+CXEGN7)U[6,8W^M555Z-:B*KET1$55 TOBC>^\.0X,ING*X
M2/![(N21KLR.?O;E;%-&JC[-IBJK&-E7M="C>O;KKW)VN<51@@
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M/2*I5:ZY+5IPLT2S=>KNYD:JG;WNU5R]?E4#>0@
M                    "9[P]X#B?8FY&;4W+GVULSK&EMD<,T\5/ST18UM2
M1L<R+N145.Y==.JZ-ZA<,=OK?V]\ENW$<><446NR%J.#+YG=U^%TN(IXES]4
M\I45$L2S:*UJ,=T3P7Q=&%/S&'Q>X,5;PF;J1WL3?B=7N5)V]T<D;TT5JI_Y
M:!'QVWMW#[1P./VUM^O[)A<9"VM2K][Y.R-G@G=(KG+^U5 R@
M         (]RKNKD7C3<%/D&HQ<_Q-#62KNG;]:!GM]!.]7+DX'IZTJ-1422
M-5T:U-?2KV%:-1YLXWQ7.>XLMN+=->/;F=V[A5VS:F622H^!ZSR3-:J-5(M7
M.17MD[5U\? &&)7%[AV3G[6=]U7*XC=.U=TO<S)[/9<BL4\5?G7L9D8&Q2?N
MX6NT\UB::>&BM[?+*M?%'%%/CJG<R.1N/SN_LZ]+.Y]SV4UGM3KU[&:_0A9X
M1QIT1/\  110@                                        &@[TY*V
M7C'W-GIOK$;<WO:@?#CUN302OK696Z0OD@D>U%ZJCD8]4[@J4\&V,='/O+AO
MEK&5HN2<S?O9C,1SL:ZGN"G?<K_:*KG(B/8Q-6I&GT&MZ(BH]&"6X<8;&W[Q
M7NFSLNE*F:X8FADMX.U;G3V_#S=W_P #H[5TT3M=6+_93Q77Z060(
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M(U,K2AB2.5U5LZM5'+#KY4C7(K>J:(G8W0.IF-[6M;JKNU$3N=XKIZ5"/Z
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MW1N&RY5EN7$1=.UJKHR./N5L;$\$ H(0
M           &%R>[MM8;-XC;>4R<%7.YYTK<10D=^^L+ SOD[437HU/2NB>C
MQ -W!@,KE,KM*CF(?YCH0,??IUY6+<JLM-7RY%8O=HNBHYNK5]&OBFH<RY7
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M\1C*>)J+(M2A!%5@6:1\TJQPL1C>^217.>[1.KG*JJO50CU@
M      !\I[->LC'69F0MD>V*-9'(Q'22+VM:FJIJYR]$3T@:!S'QM#R-MF*.
M'+S;?W#@ITRV SL,KHVU+L#55LDJ(J(YFFJ.UZHG5/G*YSVSNA.<;$&4P>2J
M;;]YW9S)64<K65$Q>Y*-9[HWHBZ(DT$G8[5-/4^DWU-4:5L='.;]Y+WQ0W_Q
M^W%X?EK:N-FVQO/86ZO/;%69+-YJ6JSH45ZL<_3UVZ:LT;JO]HB\\:;&L;(P
MUM,OD%S&ZLY=ES&XLLK?+9-?L-8QR1,Z]D,;(V11L]#6_.$;H
M                             &J[XY%VEQQ6QMW=]U<?2RMV+&U[3HWN
MA9/,BJBRO:BMC8G;ZSWJB(!M"+'+&BHJ/B>FJ*FCFN:Y/\**!QEO78VT=B[Z
MFY"V'"S=_'&T\O[9OOCNG.Z2+#9-\?:N1KU4=Y3EC;JJQN32-6JFJ-1?*.3K
MC;&Y\#O+!4MR;9O19+"WXTEK6H5U:J>"M<B]6N:OJN:Y$<U>BIJ'%EP
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MG<&6=GLU3KLANYA\38'696IHKU8U51-?VJJ^*]0,R
M                     $^Y5Y5QO&N-JPPU7YK>F:>M7;&V*JZVKUI>B=$U
M[(F*J+)(J:-3Y55$"M9P>*78FP=Q;D]X;<L61=N9S9=Q4[;EDPM)DS?)92IU
M]'>JC7(QW:BJ]4UZZ=RA/;%.+@"]7PN\*<>[?=MS,J-Q-_(0-R,NW)K2^K#-
MYC7J^H]5]5WH_P"5TD"@YGW8/=_WC69=BVM4@CLL26M=PLTE2-S)$1S7L2N]
M(G-5.J+V*FG@#*KX#!8S;&$Q^W<+"M?$XNO'3I0*]TBLAA:C&-5SU<Y=$3Q5
M=0C(@
M          &E<A<L[#XOK5IMXY5M2Q=56T,?"Q]FY85%1%\N&)'/5$5417:=
MOS@0G/Y#;G+>X(>7_=[ST?\ ?+M:!8KFW<BU\#LACF*J/JRU[':K5]96MEC]
M75W:YR+VN:5[.*Y/B.W99Y!Y!?%#5V=<6KA>-%>YZXV['ZKK>19(R-7S*YKD
MB[F=K=%]**@/!N[.0+/+6][6R-H8FEFN*<8V>COO/Y!KI*EN:2-6I2H=J]LC
MV*J.D>NK=/D]57A5=O;?PVU,+2V[MZHRAA<=&D%*I&KE;'&G735RJY>JZJJJ
MJJ$9,
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MJY55574(RP
M               !.N9^6L;Q!M1N;LUG7\M?F;0P>/1?+CGNRHJL269VC(HT
MT[G.<O@G3J%AI>V]NXCB3%9;G'FS,0Y#?]Z%'Y#*]'P4H7I^ZQV,CZ].O:G9
MUD7Y@/SGMD97FO:N"Y3P^.L<<\O8YK[.V[=A[7S^SHYWEP748U.Z&=BZJQ[-
M8^Y4T5%<UX:U#G.4_>(@3C7-8"QL; XN1*O)^35?6N30N15H8UVJ^I,B(]\F
MKNUCD35S=/-'@Z8Q]"GBJ%7%XZ!E;'TH8ZU2M&FC(X86HQC&IZ$:U$1 CT
M
M     #$;GVQ@MY8&]MG<M*/(87(QK%:JRIT5/%%14T5KFJB.:YJHK535.H')
M'\H)Q!REM3#<SY*[N+A_'O=!QME;KF.QV-OR.[HX\DWM362-J=L,CU5C6IW-
M1K4<D9R4[/[GW#SQN&SL+C7(SXGC?$6$BWCORD]8YK4T2HY<?BY4]/AYL[>B
M)_BZ)*1?88_)ACA1SGI&U&=\B]SW=J::N5?%5]*A'[
M                                                   !B=S;8P&\
ML%=VUN>A'DL'D(_*MU)M>US?%%1S51S7-5.YKVJCFKU144#];<VY@]HX2EMO
M;=&/'83'1I#3IPHO:QB=>JN57.<JJKG.<JN<JJJJJJ!E
M
K                                                     #__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>lc_kidneys-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_kidneys-4c.jpg
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M%!04%!04%/_  !$( <0!W@,!$0 "$0$#$0'_Q "V  $  @,  P$
M    !P@$!08! @,) 0$!  ,!                 0($!0,0   % P(# @<,
M!P,("04!   ! @,$$04&$@<A$P@Q%$$BLQ5UM3=18;$R=)34-E9V%SAQ0B-4
ME188TC/3@9'14B2TEE=B<I)#I"4U90F"<S2$1281 0$  @ $! 4# @<
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MUFQ>'OT+R+@+5B-]?8QG_H"Y?[LL$BIVT1E_1'N3Q[)LXC_3R80+S3-T1T_
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M<'$;'"LD5TR4\W 8;8YBD]AK-!$:C*O:HS ;T
M
M
M
M
M
M
M
M
M
M                   >#.A&?N>X B&X=1F'VAA,N[X_E=NB*=;CID2\=N##
M1O/*T-H)2VR(U+4=$I[3,%PE\CJ1'[ON@@
M                                               K1,WBW!R7=K;F
M);[1-Q;;2\7*?&;5<DE'N-W5$BK4:U1UD:VHZ3-)H)5#774?@(BNYW=RW*SR
MO#-J<&N";+?,O7+D7&_FTB0Y!M=N:YCIM-N$:>:Z9Z&U*(R3_E(R#5X[=LRV
MSW9LNV>4Y+(RW&<R@S)..W&Y-M(N,6?;$D[(8<<92A+C:FCUDI2:D=$EP[0V
M+Y?B%OPNV2OVN,[6Q(TXXBJZ'<DO"%J8=4DZI7W:(1J;X50MW40"3[YD-@QB
M#YSR6ZP[-;=:6N^7&0U$8YB_BIYCRDIJ=.!5!'-?C+L__P P<:_C,#_& =5:
M;S:+_ :NMBN$:Z6Q_5R9L)YN2PO09I5I<;-23H9&1T/M 9H
M JQU/=4\_:N[(P7!H[#^5<E$BYW"4GFM0T/%J;;0V1EJ=4GQSU>*E)IX*,_%
M+(A;;;KBW#M>01F]Q^1?<8?<)$UUB,W%F1T*.G,:Y)(0O1VFA2?&["47:"X?
MH7%DQYL9F9$<2]%D(2\PZ@ZI6VX1*2HC]PR.H,7U
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MG;VUX(<T[;<[Q<>_\OF%>;G)N9(Y.JG**0M1(KJ\;3V\*]A CK@
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MW>]QWID=AMM];+%UD-M-J<(M1I0E*4I36A$1 M3:"
M                                         (EZ</9H?IS(/6\H%J6@
M0              $2].'LT/TYD'K>4"U+0(
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ML=P[(V[I>5-+D%%1'E-'RFJ:E:GF4)X5+A4#"1@0
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M8"P?PV-_8 R?@5LQ]@+!_#8W]@#)^!6S'V L'\-C?V ,GX%;,?8"P?PV-_8
MR\EL7LP1D98!8*E_[;&_L 91IL1M!M?>MORG7O"K/,F^=[XR3\J RXX;4>ZR
M6FTZEI,]*$H)"2\!%0"U)7X%;,?8"P?PV-_8 R?@5LQ]@+!_#8W]@#)^!6S'
MV L'\-C?V ,GX%;,?8"P?PV-_8 R?@5LQ]@+!_#8W]@#*!L4QVP8MULSK/C5
MLBVBU-XYK1"@M(CLDI;3)J,D((BJ9]H+R6Z!B
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M3PT40,&>     JQ"_/5<?NTGR+(+R6G!
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M9_\ 520,&<     JQ"_/5<?NTGR+(+R6G!
M                          $2].'LT/TYD'K>4"U+0(     *W=<7L.7Z
M7@_ Z"Q/>+_5FS?(8OD4@C;      ")NG):E[:56HU'Y[R#M.O;>)9_"8+4L
M@@     JQ"_/5<?NTGR+(+R6G!
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M>G#V:'Z<R#UO*!:EH$     %;NN+V'+]+P?@=!8GO%_JS9OD,7R*01M@
M !$O3A[-#].9!ZWE M2T"     "K$+\]5Q^[2?(L@O):<$
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M<BY79I,9$9DW4I-:FTIYBC25"[*]E0L0"   B7IP]FA^G,@];R@6I:!
M!6[KB]AR_2\'X'06)[Q?ZLV;Y#%\BD$;8      1+TX>S0_3F0>MY0+4M @
M    JQ"_/5<?NTGR+(+R6G!                                    &
MFD99CL7)8>'2+@VWDT^,Y-AVT]7-<C-&9+67"E",C\(#<@        /!$22H
MDJ%[A /(   (EZ</9H?IS(/6\H%J6@0     5NZXO8<OTO!^!T%B>\7^K-F^
M0Q?(I!&V      $2].'LT/TYD'K>4"U+0(     *L0OSU7'[M)\BR"\EIP0
M                                :6^9AB6,NLLY)?K=9WI"5+CMW"8Q
M$4XE)D2C03RTFHB,^- &J_%;:[[;V#^*PO\ % 1+*R3'<EZJL,DXY=X5XCLX
MQ<VWG;?):EH0LW3/2I32E$1TXT,%Y+$@@             B7IP]FA^G,@];R
M@6I:!     !6[KB]AR_2\'X'06)[Q?ZLV;Y#%\BD$;8      1+TX>S0_3F0
M>MY0+4M @     JQ"_/5<?NTGR+(+R6G!
M      !R&8[6[?;@2(LO,\>B7F3"0IJ*[*2HU-H6>HTE0RX&8"L#[NQ]PN5R
MCX%L!<<QLULE.0';Y;HQE#=D,'1PFE&I6HB/P\/T4H#)WNS<7%VLXCJM6Q-S
MP.9W=_3D4QK0RVG3Q;,S/M7\4@2K(@@         T=XS#&[!>+)C]VN"(]ZR
M-UV/981DI3DA<=OFN4))'1*$_&4JB>)%6ID W@  B7IP]FA^G,@];R@6I:!
M    !6[KB]AR_2\'X'06)[Q?ZLV;Y#%\BD$;8      1+TX>S0_3F0>MY0+4
MM @     JQ"_/5<?NTGR+(+R6G!
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MY_L1_P#]2)\X:_M (UZ;U)5MEJ0HE).]W\TJ29*29'=Y7$C+@9 M2V"
M"MW7%[#E^EX/P.@L3WB_U9LWR&+Y%((VP    #X3)D.WQG)L^0W%ALEJ>D/K
M2TTA/952E&1$7Z0$0=,UWM$_;MV+ N$:7)9O-\=>98>0ZXAMZZR5MJ4E)F9$
MM)DI)GVD9&0+4S @     JQ"_/5<?NTGR+(+R6G!
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M$14!@^P    "K$+\]5Q^[2?(L@O):<$
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MLMN\"W.OVY)[O;PI@VVXV^ NU8SC%L<Y[41I\ZO/.NU42G%%5/BJ56O@)*2
M3H"             ")>G#V:'Z<R#UO*!:EH$     %;NN+V'+]+P?@=!8GO%
M_JS9OD,7R*01M@     !$O3A[-#].9!ZWE M2T"     "K$+\]5Q^[2?(L@O
M):<$                                 $)9G<KDSU+[96QF:^U;95IO
M:Y,)#JTQW5MLF:36V1Z5&D^RI< 7DVEUS+)(W478,%9FZ<5FXS*N<F!RFCU2
MVI*FTN<PT\PJ)(BTDJGO )9!       <5D&Z>(XYFV.;>RY"G\KR5;B8D&-H
M<4RTTVISG2*J(T(5H-*.!FH^PJ$HR#*S_<3&]M[2S=<A4^XY,D(A6RV0652I
M\V6[\1F.RCBM9T]XO? :G MW\>SR[3L;*WW3',MM[*9<G'L@B]QG=T6K0E]"
M24M*V]5"U(6=*E6E2!41YI$N.W]ZQUV1F%ZF;LWF]Q7'[RZY+AXIYNDRU)5"
M?9=6N$TT3"5(;:2HWU.Z5$?C$ LZ" ")>G#V:'Z<R#UO*!:EH$     %;NN+
MV'+]+P?@=!8GO%_JS9OD,7R*01M@     !$O3A[-#].9!ZWE M2T"     "K
M$+\]5Q^[2?(L@O):<$                                 $);O;:;G9
M%G^+9_MG=K1;+ECL*;$4=Y2\XD^^T29I2VTX1EIKVF5 5PDG:GJED9M#W'>R
MS$/Y@@6YRU,/<B23!0W7.<JJ>[4K7]:O8!P25MU;NH5N_P >;N!D>-77#W&'
M%*;LS+R9"W%)+E*0M32$Z:\3/5V )>!     !5W)=LL6VZWCV<78VGI%WO%X
MO,B\WRXNG+N4QQ,'Q3>?7Q,DDHR2E)$DO<K4P5V&;)3/ZGML8DL]4>VV:]W"
M&VKXI274)84HB[*D@@'IN:9P.HW92;$HF5<6LCM\TDD9*=BMPD.I2HR[4H6H
MUD7N@,?(MO\ >;,,4E;19/)M=PQ>:^E,W/77U>=';8B44A*/-Z8R6DRB)*6^
M9S=!4U4U )?RVVY3<[043#KXSCUW)U"O.$F$5S1RDD>I')4ZR55</&U</<!'
M!_R7OY_S5MO_  LU]/!7RZ9T26]JF6YCR9$Q%XOJ9$A"":0XZ5VE$I:6R,R2
M2CXDFO "I?!     !6[KB]AR_2\'X'06)[Q?ZLV;Y#%\BD$;8      1+TX>
MS0_3F0>MY0+4M @     JQ"_/5<?NTGR+(+R6G!
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MAQ-"YJR\6E".A\4ITE4)V!             !$O3A[-#].9!ZWE M2T"
M"MW7%[#E^EX/P.@L3WB_U9LWR&+Y%((VP      B7IP]FA^G,@];R@6I:!
M   !5B%^>JX_=I/D607DM."
M               (EZ</9H?IS(/6\H%J6@0     5NZXO8<OTO!^!T%B>\7^
MK-F^0Q?(I!&V      $2].'LT/TYD'K>4"U+0(     *L0OSU7'[M)\BR"\E
MIP0                                           !ZJ6A!I)2B2:CT
MIJ=*GVT+_, ]@'JA:'$DMM1+0?8I)U(_\I (.G;W9G:["YN;<\/:@[2LR28>
M7*E/,9&B(J444IJH*XY()!J,E$R;O,T\07"<P0 1+TX>S0_3F0>MY0+4M @
M    K=UQ>PY?I>#\#H+$]XO]6;-\AB^12"-L      (EZ</9H?IS(/6\H%J6
M@0     58A?GJN/W:3Y%D%Y+3@@
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M[2E:7$'Q2HJT4GP&!4P @     K=UQ>PY?I>#\#H+$]XO]6;-\AB^12"-L
M    (EZ</9H?IS(/6\H%J6@0     58A?GJN/W:3Y%D%Y+3@@
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MTX>S0_3F0>MY0+4M @     JQ"_/5<?NTGR+(+R6G!
M                                  $2].'LT/TYD'K>4"U+0(     *
MW=<7L.7Z7@_ Z"Q/>+_5FS?(8OD4@C;      ")>G#V:'Z<R#UO*!:EH$
M  %6(7YZKC]VD^19!>2TX(
M          ULS(+);[O;;!-G,LWJ\$^JUP5JH](3$03CQH3VF2$F1J,!L@ !
M$O3A[-#].9!ZWE M2T"     "MW7%[#E^EX/P.@L3WB_U9LWR&+Y%((VP
M   B7IP]FA^G,@];R@6I:!     !5B%^>JX_=I/D607DM."
M                               *^R.HPLAW3PS$, BJF89=;A*A73*W
MF%E$E/18RW%1X*U:27H,B-QPB,NPD\#J9<.TW6W#R#'+IB^"X+$BR\^S)]]N
MW*N)K[C$B06^;)E/DT9*5H29:$$9:CK[E##58CG6X%@W&C;7;JG;9TN]P7KC
MB^0VAMR,W).'3O,9YAU2]+J$GS"-!Z='OGP#17K#;;C74AMY?(\B7-O.1M90
MY<IL]]3ZR98CQUL1F4G1#3#/-7RT(27;51J/B L " ")>G$C+;0R/M*^9!ZW
ME M2T"     "MW7%[#E^EX/P.@L3WB_U9LWR&+Y%((VP      B7IP]FA^G,
M@];R@6I:!     !5B%^>JX_=I/D607DM."
M                  ()W9C1XF\&Q,:(RAB.W<KREMEI)(0DNX)X$E)$1 KZ
M9D91NJ';-Z25&9MCOD6"H^PY#24NN$7ODV!R>FZ"3E]16Q\>*6J5$3DLJ2HC
MXMQE0&T$:B]Q2B-)'[H"4[MAEIO.68YF4M;Z;MBZ)[5N0VM*6%)NC;;3W-2:
M3-5":3IHHJ>^"/?,,*QG/K/Y@RV#YPM)NHD=WYKS'[5JNE6IA;:N%3X:J .
M+I?V,(ZEBO'TA<OI0+EZ],L2/ VH8@0T<J'%N]]8CM5-6EMN[2DI351F9T(N
MTSJ!4P @     K=UQ>PY?I>#\#H+$]XO]6;-\AB^12"-L      (EZ</9H?I
MS(/6\H%J6@0     58A?GJN/W:3Y%D%Y+3@@
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MA[-#].9!ZWE M2T"     "K$+\]5Q^[2?(L@O):<$
M                                 1+TX>S0_3F0>MY0+4M @     K=
MUQ>PY?I>#\#H+$]XO]6;-\AB^12"-L      (EZ</9H?IS(/6\H%J6@0
M 58A?GJN/W:3Y%D%Y+3@@
M    #F+]N!BV.9+C^(7.9IR/)G'&K5 ;2;CBDLH4XMQ9%\1LM--2NT^!=AT#
MZ9MG>+;>6;S[ED\H4%;J(T9)(6\_(DNUT,LM-DI;CBJ'1*2]\^!&8#4X)NWA
MFX;\^WV1^1&O=K2ERXV6Z1G8%P9:7\5PV7DI,T'P\9-2*I5I4@5"1Y9GK>TZ
M>I=>37#O9OIN2L+U,^9/,:IY1NZDWR]7.Y!\SGZ]6OAV +2D9*(E%Q(^)&"/
M(")>G#V:'Z<R#UO*!:EH$     %;NN+V'+]+P?@=!8GO%_JS9OD,7R*01M@
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M>4\N,\RZ9&9+025<%%VD9*(:7<]O>CM]MN6_VO<SKZ?=)AT@U6V
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M5L7"./<^X$P24IU$GF<S7XA?]Y0#+O>3U2?OF ?-;S]) .3U2?OF ?-;S])
M.3U2?OF ?-;S]) .3U2?OF ?-;S]) .3U2?OF ?-;S]) .3U2?OF ?-+S])
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MD Y/5)^^8!\UO/TD Y/5)^^8!\UO/TD )GJCXUF8#[W^RWGM^<@)>!
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MV[?7H:?;'0C6;0
M
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M-;*7F8ZFF5J;KI7I;69$2R-/'L[ &OZ9R(BW;(B(B+<;("(B*A$1=W(B(B[
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MN6Z"IK*K=.L#-B3;R0KGI=9D\_F&NNG32I4I4%2""
M
*          #_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>fc_ngo265-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_ngo265-4c.jpg
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M;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (  @ X0DE-!"4
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M 0$! 0$! 0<CQ7'0\R@X77! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MR](J-51]_3REH_\ ';/.$LX%N[MUN:PC#;[#65K&]<MLF#J:N8T:ZGR)0'.
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MV'V2DLM'*0Z=M)'TOE<WD99':O>1X=;CHK]>JM/AAGV;;7G-IRSJM5" @("
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M! 0$! 0$&PX8QS[TUPY,B>YWR'1O]E8.]G^G^;T.PC.W\DC+P7T8@(" @("
M@(" @(""'ZUCHJRHC=[S)7M/RAQ"^II.:Q/L?(;(Q:8]KX*Q6(" @(" @("
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MM/2QB*%O)H]/I)\2O*O>;SF7L4I6D8K&(?=03$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$!!KV<9MCFW.*W#,\MJG4>/6ML;JVI9&^=S1-*R%FC(PYQU>]HX!!"T
M??)VUR/:PY5.P'Z3K9< T?+I 4$E[8[U;;;Q1W.3;R\&[,L[H6W$FFJ:;RS5
M!YCX5$<>O5Y;_=UY(-_0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$ =Z_\
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M"=S'Q.?!,WJ:XL> YNH\"$&60$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MD5^<VUW8-I[OII$\<(Y]/0/!WJ\?#T+Z+M.]C9[MN%OWH3#?5ZC@@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MQ5\O;'L\X\/P6!6]^?B @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MYY75Y?R2:+Y[9Z?NI/+/X-U;Y9;'+C29C3/K<3D^^J*-P8ZIH@Z6'J(U #]
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M43VVL:6U=%*^FJ&N&A\R%Q8>'KTU7QEHF)Q+^FZ;:[:QLI\-XBT?A/%T44Q
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M2#V98W.8-2UWA\G)?H5^VU]QJK%X\/S>/%YI:<-)N.!W:E)?;GMKH/!I(CF
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M?#" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MEA^!J/:UX^92F(D\?I:JJ=596QMM'BA;)^SK&</;)E&VNX%SVXKH/;CJ*^L
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M:Y'0W:WRM]YE1$1^L M/:VZ=M)_ZH5[(S64T.&CB/02OTEXCJ@B?N'WA&S>
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M2(O6<$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M\989>4N$! 0$!!F,4N3K1DEMKFG1@F;'-_@Y?8=^(K5VNSHV1/M0LL@OL4!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MU2BOMRVCOT]RG[@-W7.KMS\G::FV4U0W3[KHIFZ,(8?V<KX]&L8/V47L\W.
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MT <%MB,,4B."#D DZ#B3R""HN[=XOO<CNJ>WS"ZQU'M[C<C:K<"^P\1)-3O
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M>R623.K;315F)W,\63V6H+86OUUZA!.)&CY&%JHG1$\FBO<6CFU9O;]W&X$
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M<<%VB8B>*.L [K=D]M\8I<6QO;[(+)34[0*FG9!3RS33M&AEGF+V.ED<?I.
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M@_,2L_<6Z==I]@K<WD%\;*V'*XZ(" @("#:]O:@QW>JI=?8J*?JT_*B<#K^
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M -AV%PU@HZ2)Q$50&.Y-9Q%/K[SNJ8\2TK-KI-IZI:MMXK'3"UG/B>:V,3A
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M9GP;5<\PVG[5=N;1BEVN+&&TT@926BD#9+I<:D^U-.(=1T^;(7/,DA:P<M>
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M8::GC:&LCBC :QC6C@ UH  "OB,0HF<R[+K@@(" @(" @(" @(" @(" @("
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M8='"K@(T]/F-5^C^Y7\81LLROM%8@(" @(" @(" @(" @(" @(" @(" @("
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M:D^UY%SN)?H1PX.$SX^D?R$9(T+UB_N6]C;_ &Z>V5P2=3K^(<!\RVL3A'!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0=Q'(X=36.(](!(3,.X=6N+2'-X$<D%0
M-P</R?M<SBIWJVKHW5^U]WD:W.<082(Z8/?KYD8 /1'U.+H9 /L7GH/V;M%B
MM6=<YCDVUM&R,3S6>PW,L7W(Q2ERC%ZIERQVZQECF2-:2UVFDM/41'4![->E
M['</$:M(*U5M%X9;5FDHESWM!V@S.K?=[32U&'9 X];:ZP/$,/F:Z]1IG L!
MX_Q7EJJVB)Y+:[[1S??:'MJHML<QJL]O&6W',LGDI#;J.KN+3'\/3N :[4NF
MF<]W2 QNK@&MUX>A33B<R7W=48B,)@;DF-ON[L>9>K>[(&'1]I%7 :UITUT,
M'7Y@.G'3I5W77.,J>B<9PRA!!T/ CF%)!4O?*FK]@]Y[)W%6"G?+B60O;9L_
MH8=="Z0 &70<-9&,$C-?XZ/C[ZQ[(Z+9AMUSUUZ96#S+!]O]Y,2@MV24D-\Q
MROA;66FOB/3-$VIC#HZFEF ZF.+2#Z'<G C@KYK%X9ZVM25:&-WM[0Y2QC)M
MR=A6DEH&K:RTQN?ZNLP$:\?>@?\ D./#-[VN?8U>[M]DM>RO=S;^^]P.U>[V
MT]Q?47B^5$5@RVQR0O@K?*ED92M,S"',<70RE@+'N'V;2HS:)M$PE%)BDQ*]
M3V]+W-YZ$C7Y%Z#SW5''*!RX'F@Q63PUU1B]^I[6YS+I-;*Z.A>PD/%0^FD$
M9:1R/41HH7^&4Z?%&5 MF=CJS--G*7=#:6Z5-EWKQ6YUL+VQSEK*[RNB:.'1
MW".0QR=+=?8DXM>..HPUI,QF'H7O$6Q*V/;UOI2;Q6":GNL+;7N-CY$&3V-S
M3$X/8[H-1%&_VA&YPZ7L/&)_LG@6DZM6SJC$\V3;KZ9S')\[Q2.H+Q7T;A^S
MF>6^MKSU-/X"OS_N]?T]UJ^W_EZ6JV:Q+QK(M$! 0$!!L&#4#KAEMLB U;#*
M*F0^ ;#[?'YP MO9TZMM?U_1"RQ"^N0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$&-OMZH\?MD]TK3]G$-&1CWGR'W6-]9/_ *U3NVQKK-I%
M>K[?;AD=>^X7%_4XZB&$>Y&S7@UH]'\*^2W[[;;9E9$,<LZ0@("#O3S"EJ(Z
MGR8ZAL9U=!,.J-X\00K==^FT3B)]DH6KF$MV1UGJJ*&X6JEBABE')L;0]CQ[
MS20-=05]]V?T;TB^NL1^3R=G5$XF63)).IXE;U+A!4[*;O:L%[X+=?\ *JR&
MTV*]8P8X+E6/$-,US*62+VI': >W 6\?$CTA8IX;&ZOO:^#%T<LG=WO;3W-D
M3SL-MO+K 96N8RZU[B'#5ITXS.:TN:>+(&\>ESTX[+>P_MU]JX[G%SBYW,\2
MMK$JY9(S<._+*)3Q%IQ>,-UYCJIJ1G#_ 'TK'$?U&N9_I0WSN:W:DVHVVG?9
MWN_?;)'.M&,PQ:F9LL@ FJ&!O'6%CO8T_C',5NZ^(PKTTZI9#MXVECV?VUH+
M%5,'[TW(BYY-4<'/=73-X0]7,M@;]F/RNIWTEW53IAS=?JE&5J8:_OTO[V<6
MVK%F"0CPZJ2F9Q_WY4Q']1;,_P!):(EK07/<UC&@N>]Y#6M:T:ESB>0 XDK9
M,X9(A3BW43^\'>2MO%S,KM@=OY336^B#S&RZ5Q^D2-#]MIYDA'%D/0S@Y^JQ
M1'U+>QMF?I5]K-[-V:VX#W>;HX-CE.R@QJLLT%Q@MU..B"%[?A)FM:WP#342
M!OH#EW7'3?".RW5KB5K%L8VG;D[I81M+8F9!G%Q^"I9WF&BI8FF:KJI6@%S8
M8@07=((ZG$AK>&IXA5WV17FLI2;3P=-L=U\)W>L,N0X36OJ*:FE^&K:6HC\B
MJIY2.IHECU=H'-XM<UQ:>/'4$!39%N1?7->:'N^.VW6NV>M]714[ZJU6J^TM
M9?(8FESA2>3-&'G3DT/>&DGQ<%5W')=V_P 35<EW]S;?R9NV?;1:*VVVZ>-D
M-[S.N9\(VBI"T-<R-S"\0 -X%_497<HV@\35.R;\*K(UQ3C9.^R^RN*;)XT;
M+80:R\5G3)?+],T-J*R9O(>/1$PD^7&#PYG5Q)6G7KBK/LV3:6O=U^<G!=C\
MAEIY#'=,@#,?M_2='%U=KYY'CP@;+R\2%'=;%4M%<V;1L;@XVYVDQ3$WQB.N
MIZ)E5<AIH?C:[^<3!WK:7]'Z*EJKBJ&VV;/3NONQB.SN+29/EDY^T+HK7:X2
M/BZZI:-?+B:>0&H\R0^RP>L@'NS9%8->N;RJ_?;AW7YYA5\WJK,C_P!FV)VB
MADN]BQBDZXIZJFA'6"\ =9#V\GU!]OZ+ PK),WM&6N(I6>EN.?[\W]G:/9<W
M?TQYWG, L,#Z9O0?B)'S0U-1&QH]DNBA<0&^Z]XTY!3MLGH5UUQ]3V0F'8K:
M^DVBVSL^)1QM;=WL%?D$X'M2W*I:TRZGCJ(P&PM]3?6K]5.F%.V_59(RM4B
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M89_#X>E>OVG8S:>J_+]Z$RF=K6L:&, :QH :T#0 #D %]&BY0$! 0$! 0$!
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M8^*[D^X"O?\ M(ZUE.->?2:R4?\ Y06/5'ORV[9]R#NDR>\9UD..]LF"S?\
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MTFA]Q0V3UVQ"6N.BO5*VEOHZ2@AH[;;X&TUOI&14U'2QC1D4$+0R-C1Z&M
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MO-<.!:X>!!X%?6Z]D;*Q:.4H/:K 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$$&[HV9UMR,W!C=*6YM$@=X"5@#7C^!WSKYGU'5T[.KPLE66DKR
ME@@(" @(.T^)MS+&LKMD\0EI)++7P!KAJ#43TTC80/6'>T/D7L^EZ)OLZO"L
M?MEGVWQAC.RN]S7C8"TTTS^M]EKZ^VM](9Y@J6@_)Y^B^QT3[K#W$8LD_=K.
MX]L]M<ESAQ;\3:J-QM['Z:/KYR(:9NAYCS7M)'H!5FRV*J]=>JV$6=I^UE+:
MMFYJ_)8//ONYK)ZV_P \H/G24%8U\4$3R>8+'OF^614ZZ>[F5VV_O8CP87LA
MKZJEPK,L!K'%TN(9#-!%U>\V.I:6N;I_A('GYTT3S@[B.4K0-&I )#1XN/
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M\ /$J[5JMLM%:QF90M:*QF4OX_:*>R4<%OC(?J[6IETT\R1_!Q^33@/4OO\
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M'\HRTC /S@L<ST[&R(ZM7X/'OW*W>;?S MA;>[S[+C\WW]F98=6Q^R)'1O\
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M&1[^'/I5&^N:M&BV+(*W WXG[@-O,(V7VX;/59WF#:.+,26/;'1MHM!*USR
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M:(#D6B&H#PS]#I7(M,<G;4B><+8[1=]EJO\ <*6P;K6R"QU%26PQY%;R_P"
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M5[%D-JR.D^+MDW6!PEB=[,L9/@YOA\O(KW=.^FV,UE%E%>" @(" @(" @("
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M)K#S[WGJEN\-@Q^FE944UGH(*B,]44T5)!'(QWI:YK 0?6"K8I$*^N604D!
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M.&#%N^+;^ZM!#,HL<E!5MY:R-BJJ<?+[D2[;$;(ERN9URM$0""UP#FN!#FN
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M?'&]U*G#:N;HMN8TCJ>)KG:-%PH@Z:G/HU<WS8QZW!1TVQ9/=7-7Z0+T'FB
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M3RCZ==/,/][UZO4H_4KG#OT[8SAM!!!T/ CF%8K<M'4X-]) _"@I3C>V./\
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M2:9Q>]YTD U<XD\%3.FJZ-UH>?\ JU;!_P"H%K_!/_C4^C5WZUC^K3L&?_[
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M6N8WDR9[=)F?H2![?F5VNV84WKTSA7VT1F[=^60S<'LL.+L:T_5+Z6FCT_\
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MBWQ-IZ*CAU$<4+.#6-U).@^52B(B,0Y,S,YE[%U$0$! 0$! 0$! 0$! 0$!
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MP<T\6G@0"ME;1,9ACM68G$O:NHB @(" @(" @(" @(" @(" @(" @(" @("
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M3L.X^G?IGE*N83LOIT1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MI:E@!DIIVCW9&:_(X:.;JT@K16T6AFO2:RK[VFQC%MPM[=M 3\/:;XVMHAR
MC,U1 >'A[(B5&GA:8:-_&L2M.M;&UG-MNL&W(M\5KSJQ4M[I('%],9PYDT+G
M<_*FB<R1FOB&NT/BH6I%N:RMYKR??#<'Q';VRMQW"K1!9K.V1TQIX.IQ?*\
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MTN:-? '10FE;)1:U67HJ:EMM/!1VVGBHZ*E:V.EI:>-L4,4;/=:R-@#6M'H
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M\6QL^'7^*T_/@.)/(+8QJ4]YVXV-7BZXYAV'?%7G<C"KDZ\5/W?%\12T<<3
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MX2MWU\8\5B#[(:YQ#6N/2TN(:"[T#734K3EF<N8]G![2TGEJ-$R.J." @("
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M$?FD^*:J]-7-M^JR,>Q-A.TV0U0_9U&3U;X_3H*6F'%1[?DGW'Q)&[B=V?\
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M8X2(Q_*3:>"Q[)Z[8AMUQT5FTI>[G+K/9]@\]K:/6*22@91-\OATQUE1%3O
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M 7<-/,A)X-E:-/!P:[@M&O;%F?9JFK1>\/!*G*-JOWNLQ=%D^ 5+;[;ZB/\
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MN&HTXJ=ME;51KJM2S9NS_(KKD>P6.R7;J=+:Y:NTTL[]29*2DD'DG4\PP/\
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MZI:MEHI7IAUW/I3OAW18]M/5^W@>W=)]_P"31$@Q2SN9'.YLAX -<'T\'$\
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M4+>K:FHPVYRWZRP%V*5K^K1@U%',\\8W:<F$G[,_H\]-?)WZ>B<QR?KW^/\
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M!U57U<FK@R)GH U+G$D-:T<7.( 7+6BL9*UFTXA5<;K]PW<143T^Q]K;@^W
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MN2[@[?0/,<^7V.*0<V/NE&#P]7FJ/U*^:?T[>3JW<C;H.!9F=BZO#2ZT8/\
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MD9C5YLI@?<CF)SZU;9;U8%+A>17\]%CKX#(ZDJ)22UK"R0O]ESATB2.5P#M
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M!RB_4QI<;L(:8C16Z1H8'O8>+!Y0$<3'^T07/?Q<%#529GJE9MO$1TPD+?\
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M5;V*P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M"J[6I/-.M;QR5]V"OMHP[N*.VVRV2U67[/WREJ*VY4\\<HBMD\<3Y/,8^1C
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M"7.W#=.\[P[7TN79#0QT5XBJY[;5/@:64]4ZF:QWGQL.O2'=?2YH.@<#IH.
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MKP.GVQV[QW!('-DDL]*&5LS/=EK9G&:I>/497NZ?R=%?KKBK/LMU6RV]6*Q
M0$&I;B2M;9J6!S6N,U4US2X EIB:3JW7D?:YA>!ZWLQJBOG/[FOMH][*/%\8
M]00$! 0$!!->TE:ZHQF2E<=?@ZE[&?F/ ?\ PER^G]-OG5CRE5+?5ZC@@("
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M>Y;M_P#L-WL?&X>!0'I&76IVM5'$"0'2RM9Z-.%5$TG^^*J+WIS6S2E^2?\
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ML-Z05]=V>OHU1$\YXJFS+8" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(""/]V+V^@LL5J@=TSW)Q$A'/R(]"X?.2T?
M)JO*]1V]-.F/YOW.PA<<."^:6BX" @("#SUU1?:2BJZG&*UMNR%L$HMU8]C)
MHV3EOL"1CP6N8XCI<#X+3VVZ=.R+QX?N\5=ZQ,<4+[I;Q[KY[M[==HLWV7N=
M/FEY^'915M!%4/HO.BF9(V:*-T4OU7 =$[FZ'GHON;;)M&,,E-=:SF)6TVML
M=ZQG;3$,<R-_7?K5:*.CN&CO,Z9HH@TQ]7'JZ!HS7QT6S7$Q7BQ[)B;3AMBL
M5B @Y!+2'-.CAQ!]81U47=7#<C[<<^EW_P!J:(U.#7)P9N!B46K86,E?JZ9C
M6@AL;G'J8X#["3TQO+1BO6:3F&VEHV1TSS6;PK-<;W#QB@S#$JP5MDN+.J)Q
MT;+%(WWX9F GHEC/!S?G&H(*U4O%HRR7I-9Q+8&O>S7I<1KST\?E4\(O)2VR
MV4,TE30T%+2U,P+9IZ>"*&1[2=2'/8T$@D>)48K$.S:9>E21$'+7%I#FG1PX
M@A'5:]S^V:NI\B_VJ]OMP&'[E4[G3SVV)S8;;<"[0O:UI!CB=)I[<;QY,GT@
MWB3DOIQQJU4W9C%F3V:[EZ7+[P-M=T+:<,W<I7_#24%2UU/25TXY"#S#K'*[
MPB<2'\/+<[7I$M>[PES9IQQCDL"00=#P(Y@K2S.$<:GE.Z.VV$3FDR[++59Z
MT<315-5&*D @$:PL+I!P/BU5SLK"RNNT\H:J>YK8$/Z#G]MZN X-JB./K$.B
MA]>J?T+/H>Y78-K7:[@6OI((</MR"T\P1Y7$'T).ZDN_1NJ5OKDNQ=%D5GSK
MMSO<M%NY'6QEM%CE).R@J_-<0XN8]D;6R.)Z2R)KFR@EKF<=5EO-<YJU4BV,
M67\M4U?4VFWU-VIQ27:>EIY;A2-]V&JDB:Z:,<3P:\N:M]9F8XO/M$1/![-3
MTN9S8\=+VGBUP/@0>!"E,9<1?F7;ILIG?FR7W#Z*&NE'&X6P&VU.NNO5K3%C
M7'\]CE3;365M=UH1'/VF9U@,\ET[?=R[E9JEI+X[#=GEU)+I[08Y\33&[4_W
MVGT])5,Z9KQB5\;HMPM#<MA-ZLOS'),CVHW3M,-LW/Q*/SJR:B+/A:JG:]D;
MB6QN>QLC3)&[[-W0\.X!NFBGJV3,XE7NUQ'&$]+2SHFR'MDV&R>HFK+EA-'#
M63N+Y9K=)/;]7NXEW132,CU/YBIG35=&Z\>+57]E';X]VK;-<&#ZK;G/I_;:
ME0^A"?W%GDJ^R'M_\B:=U-=:.")IDFG^\PV.)C1J7.=+&0&@<27%<G16/%V-
M]I\$(XA36G!.XC%<.[:<PNV3VF6J#,RHIW-J+/%;V2,\_2:,,CF:R,R'S/+
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MTO5\H7I=EVWU+9GX8_UA7,IZ7U*(@(" @(" @(" @(" @(" @(" @(" @("
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M>GS_ $8_-2W%>@" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M1-<9]'5=2.1(Y-;KQZ1^/FOJNU[:--?;XJVR+8" @(" @(" @(" @(" @("
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MFR/*.,H6E81?6H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MNX*\OI[':[!$[3[RJ3/4@$@F&D < ?49'-_ LGJ>S%8KYO>_P;M(OW&S?/\
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M 1]7[29WM2O(^L[Q^3DO:TZ*:HQ6$655X(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MQ_\ 'A_LW97/$$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!
M@LGQ2V932""M;Y=3'K\/5L \R,G^%I\6E9NX[>NZ,3S\Q"M_PJ_XZ]SJBG-1
M1 ^S60 O9I^5XM_27S6_L]FOG'#S3BS7>H>E8\)9-1Z4,OO1T=9<)A34%/)4
MSNY1Q-+C^)3IKM:<1&7,I0Q':TQ/CN.3AKW-T=';FD.:#_*D<#^:.'I/@O<[
M;T_'O;/T_BA,N-Y*;2"SU31HR-TT)TY#J#"W^Y*>J5X5G\2$5+Y]:(" @("
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M+T'YV(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
-@(" @(" @(" @(/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>lc_postinfections-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_postinfections-4c.jpg
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M="!E;F0](G(B/S[_[0!(4&AO=&]S:&]P(#,N,  X0DE-! 0       \< 5H
M QLE1QP"   "  ( .$))300E       0_.$?B<BWR7@O-&(T!UAWZ__N  Y!
M9&]B90!DP     '_VP"$  0# P,# P0# P0&! ,$!@<%! 0%!P@&!@<&!@@*
M" D)"0D("@H,# P,# H,# T-# P1$1$1$104%!04%!04%!0!! 4%" <(#PH*
M#Q0.#@X4%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%/_  !$(!!(#Z ,!$0 "$0$#$0'_Q #=  $!  ,! 0$! 0
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M YIW@>&M19DS6@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M0GX0X%!7;X'6L-&3<58 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M^%NO_>1:S &V_65_9-8_=6/]M%06IDRKT0_V<<8_^2S_ .=N5F6I%&Z\T_\
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% ?F_Y@
M9<+/\;VJ\O\ =:;?LT!SME>F_P!4//\ F]HNW.4IBW6*UJ\EQY:F 410X%.(
MCQHVQ6Z![ZOJ[CM4ZI:&#HC'CM16&HS"0AAE"6FD#HE"!H /L%0,GZT H!0"
M@% * 4 H!0"@% * 4 H!0"@(TY&]//.N29_D=_Q^]-,62XS7)$!I5Q>:*&5]
M 4)20G3Z*E4C0T9QKQ?R-G609!9L,N+<6[6<@79Q4I<<.DN*1LI()7[0/6LF
M#9?_  O^HW_SUG_6CW_9K%11G\.>D_GRYI$.ZWJ*Y!61YB7K@\\C;Q*.S?2E
M10K;AKC1CB?!8F)-RS/DH<<E3IG;V)7(?.JNQ.^B1H *B21L"AD4 H!0"@%
M* 4 H!0$:>IGTV<F\K<T8[G.)MP%6&V1H+,E4J5Y+H7&E+>7HCM.H[5#2I)T
M,%E*2%;'<>(._6HF2&^6_0W?_P"F,G/^!\A%AN4I]4LVEUUR%\N\X>Y1BR6
M2E!.I[%)VZ:Z;5+J,4,11Z-/4KR3<8L?F#.TFQ1UA7>]/D79Q(UT/E,J[$!1
M'1152J0+GXVX[QKBO#K=A.*,%FTVY!'>O0O//+.KCSJ@!JM:MS^ ;"HF3+*
M4 H!0"@% <VOUDO]8>&?H5W^=+J<06/Z6O[/7'OZ):_AJJ+!MZL 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MDJ0\^RJ(TI2DI#*^T'58!WK#,HV%6#(H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0'-K]9+_6'AGZ%=_G2ZG$%C^EK^SUQ[^B6OX:JBP;>K % * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M]"N_SI=3B"Q_2U_9ZX]_1+7\-518-O5@"@% * 4 H!0"@% * 4 H!0"@% *
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MD_G.T+4"4Z_X1DK4/I"4U)F#HM4#)SM]=.07#DCE_"N$<=)>D1"UYS:!K_\
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M&48WYQM+K,=AI<A'E+46&PA2NW4Z D;:[UWWX['E8LJ$M=IYIM-[#6-; B*
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MZE6J8E+J-0ULR H!0&;</?UJ8=^EX?\ WJ:\>;_HG_\ EDH:HZIU\U/4* 4
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M7S4]0H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M \KQI\.PI$>8A]A1'G1WTJ:[FG4C=*AX?C#<;5+\/9E:ZXRXHC<W$W5T!4*
M4!FW#W]:F'?I>'_WJ:\>;_HG_P#EDH:HZIU\U/4* 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MNLEQ(\4,H"ED?7VZ4H#%L4]4/ ^9W!NU63-8(N+RNQAB85P2XKP2@R$M@D^
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M94B6PMMM#:4J]K4JU)Z ;T0,#]"%@NEC]/\ ;W;HRM@7:?+N,)"_BBN]B$+
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M8H4W%BQX3#42(TAB*PA+3##20VVVV@=J4I2G0  ; "HF31_J[R_,\'X8G7_
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M0H'4$5T$IRDJ-U1H_P#T7?ZF>FF##3DB\R2P@9>XS\LN^@:3E,  >67>O;H
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MEM7[%L951N*M23% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M6'TR^['1Z^_S++<ME"JZYDM% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M..)3N['U'4+'NC\8"O9^,S/L7=O;+7]R,XU1./I'Y67B>4N<>7MU2++D#O\
MF0<)"8]S [0-#T\T (/_ $@FM_\ F</[EO[D>Z/U7D56Y;B\ZXD] H!0"@%
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MD^(^NNI_&).S\359V(KOJ7<OJ99%E1YD=BX0)"),*0@/19;*NYMQ!W"DD?\
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M_)8G_GNT7:]J_;X%T951MFM62% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MCA*0E9^(H(T"OH-8DMYXOR..H24EI+F65C;D>_8M'9G-)D1W&5194=U(6A:
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M(X;<^T34%#\=P?@4DC=*DG=*AN#6NM796Y=471DCG-ROQ1F?IXS*)?;#+?\
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * T1S=ZF<>XGDG'K=%_/68% <<AA?9'BI6-4E]
M8WU(W"$[Z?164C#9H'_B]YRF$RX=@@_*'520S"E.-]IZ>V5$_LUFA&IFW'_K
M:9DSV[7R994VU*UAM5UMO>6FCTU>9=)6!K[RDG;Z*4,U*W@SHERB,3X#R)$*
M2VEZ/(:4%(<;6-4J21U!%1)'T4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0'-K]9+_6'AGZ%=_G2ZG$%C^EK^SUQ[^B6OX:JBP;>K % * U/R7J+XR?_
M (P-#]YKI?QO^I^\Y3\I_N^!.?,7#[&;L.9#CS26LP93^5:&B43VTCHKP#P'
MNJ^+H:VT94V,QAYGV_3+MY&H.)^6)_'=P5CN1)=<QAQTIDQU ^=!>UT4XVD[
M]??1X_;5DHU-GE8BO+JCW<RM(DJ-,C1Y\!]$B'(0EZ+*9.J%H5N%)/\ RTJD
MYF46G1ZFE^9^&$9$V_EN),!&0H!<N5N1HE,M(&[C8\'1\2?B^WK.,MS-MAYO
M1Z)Z;GP,%X:YD<Q1Q&)98XM6-K7V192P2[ =)T((.Y:)]Y/P]14I1K[SV9F'
M]SUP[N94[;@T;?8<2M"P'&GFR%(4E0U"DD;$$54<XT3US5PJA:).:87&"2D%
MV\V9H?OGXZ?H\5H'3J-JLC*NQZF\PLW^2?P9\'"W-7R/R^&YG(*K<>UFTW5P
M[Q_ ,O'Q;_%/P_9691K[_'U)YN%U>N&N]%*D=NJ5 $*&A!T4E25#\!20?OJH
MT!K.T<;MX3R.WD^+M!&,WEAZ)=K<D_\ LCRP%H6V#U:4M(V^'[*LK5.NO,V$
M\G[MKIEW+1FZ<8Y/LN(7FV8AD2C$8R!;AM=R60(XEIT!8<)]PK&Z#T\*TN?B
MRN+KCJM4;+\3<],H^TW+,AQKA%>A36D2(<A"F7V'4A:%MN#M4E23L00=#7.I
MM.JU-\<^_49Z=)W&4Y>;X0AQ>%K=2M;;:E*?MKY.HWZ^5W>XOX3L? GJ\+-5
MY=,N[F5RC0W3Z:?4NWFS<;!,[D);S) \NVW)>B47%"1LE9Z!\:?]?]UUUV=@
M=%9PTWKAY<C,95*4O%GMF06N59;S%;FVJ<TIB7$>3W-N-K&X/_,1N.HWK3PF
MX24HNC1,YV<Z\%9!P?D+&68H\^K$5R4NVJYM*/S$"0#WI:=4G30@CV%_$!]-
M=;B9<<B-'W;T5-4*<].7J-A\H0V\8RAQN-GT9!.H ;:GM('\8V.@< ]] ^T;
M;#2YV#]KU1[>1-2J;MRC%['F=BF8WD<1$ZT3D>6^PO\ "%)(W2I)W2H;@UKK
M5V5N2E'4D<Y^6.*,Q]/&9Q+]89;PL_S!>QZ^M>^A2#KY+V@T"P-B#[*Q]X'6
MX^1#)AS7C<5-4+$X Y_M/+MH$">6X6<P6P;A;P>U#Z$[%]@'JD_$GJD_56@S
M<)V75=O(FG4V/G>"8YR+CDK&,GC"1;I(U2L:!UET>ZZTKX5I\/P'4;5X[-Z5
MJ75$D<ZLTPSD/TR\AQ;E;92VTH<4[8[TT/R$N.#[3;J>FNA[76U?M:&NLM7;
M>5;]F]</&YE33B7-PCS=C_,>/_-1>V%D\)"1>;,5>TVH[>:UKNII1Z'X>A^O
MF\O$E8EQB]&6)U/>Y.XPQGE7&7<;R1KZ7($]L#YB)(TT#C9/X%).RA]Q%6/D
MRLRZH_%<0U4YJ\@\<99Q/DTG%LA2I+3P\R++:*OE9L=*CV.(^G0]4G=)V-=O
MA7HW?5'^!1)4,6K:E8K)@4 K*U#.N>+_ /Q-6;_P$7_N4U\MO=\O>SVGK52!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M<[2 *[@\XH!0"LK4PSKGB_\ \35F_P# 1?\ N4U\NO=\O>SVGK52!0"@% *
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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ML]IZU4@4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!Y
MF0V.#DUCN&/W-)5;[E'<BR />"'4]NHU\1U% 1')]''*]EGOM8KD,9RW=Y\F
M2B0]#=4V/=\Q"?B V-2J0HS6G''%7(6<9+DM@Q*ZHB7>Q+[+L]\VXR'5>8I&
MH6C=?M [F@-E_P#"QZ@_]HT?ZSD4J9HQ_P +'J#_ -HT?ZSD4J*,J?@S#LFP
M3CZ)CF72Q-O;+[[CKZ7E2 4.+U2.]>^PJ)E&R*&10"@% * 4 H!0"@% * 4
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M_D1C-\80B/!N+;T7(+6GV$)\Y.J9#(Z:=X25H\.HJ?55;=3VO)<[71+5:/\
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@-7XUZ@^*\GN+]ECWQN!>8[ZXRX-Q!BK*VSVGL4OV5#[%
M5FABILYMQ#J XA04A0U2I)U!'U$5@R?U0"@% * 4 H!0"@% * 4!BW)&(KS[
M \APMN:;<N^P7H"9Z4EPLEY/;W]H4G73Z.X4!RHY7X;F<"<OXIAZLC7?3*-O
MN!E)95#"/-E%HH"/-=Z=G7N\:L3J1H=;<COL#%[!=,CNJBBW6F*].E*'7RHZ
M"XK3ZR!M59(YG8QC?*_KJY"O=WO-^79,#M+@T00IV-":=4?(C1XR5H2MTI25
M+6I7UD[@5/0P9#RIZ(\MX<QV1R3Q;F$NYS; @S)L=MDP9S<=GVW'F7&75=_8
M!W*00/9'CTHI5!4GI$YNG<U\9F9D*TN9A8'Q;KRZA(1YX[ MF04C8%Q.H5I\
M2346C)(N><D9+E?J+7G/(_'U\OV(X=(?B8OCD.*Z&.Z*]^2<>4MM06%*3YJ]
M![7LI]T5*FPB?OZI/4M-Y;XVCXQ*X^O.,!%S8F)N5R0I+!\IMU/E@EM/M'OU
MZ^%%$R6#Z:N7I'*&+KAO8K<,;1CD6WPFW+BDI^;!C@>8UJE/L^QKX[$5%J@-
MXU@R* 4!S:_62_UAX9^A7?YTNIQ!8_I:_L]<>_HEK^&JHL&WJP!0"@-2\D.-
MKOZ$)6E3C;"?,0""I(43H2/#7PKI?QO^KXG*_E?]R]QICDOC2U<CVKRGBF+D
M$5!%KN9'0]?*=TZMG^]K;1E3W'EQLF5F7LWHFG%<KRSA;+9-ON$9:6TK#5XL
M[IT0\V#LM!Z=VFZ%C]JK&DT;Z[:ADPJO@RNL?R"SY59X]^L,CYFV21[).SC:
MQ[S;B?A6GQ_"*I::.9N6Y6Y=,M3#.5^*8/(L'YR'V1<OBHTB3%>RB0A/1A\_
MP%^'0[5*,J;-QZ\3+=ET?:: X\Y"R#B6_P FRWF,Z;0I[RKS:'=0XTM)T+C6
MO18'W*%6-5-UD8\<B-5KN975KNENO=MC7BSR4R[9+3YD:2CH1X@CJ%).R@>E
M4TH<S.#@Z/4UCS!P\QG##F06!"6<Q92.]H:(;GH3\*O .@>ZKXNAJ494V,V.
M'F?;],NWD:=XIY7N/'-Q7CN0H=7C#CQ1,BK!\^$\#VJ<:2>FA]]'C]M62C4V
M>5BJ\NJ/=S*VB2XTV-'N%OD(DP9*$OQ);)U0XVK<*2?^6E4G,RBTZ/4TQS-P
MRG)4/Y9B; 3D207+C;FP$IEH2-W&QX.C3=/Q?;UG&6YFVPLSH]$]-SX& \-\
MR.8B\WBF5N+5C"UE+,E0*G8#IVZ=2WK[R?#J*E*-?>>S,P_N>J'=S*O@S#&D
M1;C%="DI+<AA]H]R5H.B@I)'4*%42CU)Q>\YZ,G"2>],UGZE?32F6R_R=QK$
MU+R?FKY86!MH1W*D1TC\+C8_=#Q%:S"S=OV[FJT?Z,[GN74MYY7IG]32[$J)
MQYR'*ULJB&;/>GR>Z*>B67E'^2\$J/N>/L])9V#U^N'=PX^9F,BXB&I+12H)
M<8<3H0=%(6A0_ 017-:%A"_J8],[F-.2N0N/8REV!:E/WBTLC54(GVB\R!OY
M7XP^#]STZ?!SON>B?=N]OF5RB9)Z9?4Y\U\IQUR-, D^RQ8[Z^K3S/A3'D*/
MCX(</V'P-4YV!6L[:]Z_5&8R+"DQH\V.[$F,H?BO)4V^PZD.-N-K&BDJ2K4$
M$;$&N>3:=43.?_J.].,SC>:YG6"-NN8:MP.R&6M2[:WBKV=P>[R2=.Q?PGV3
MX$]5A9JO+IEW<RN4:&X_31ZF&\U;C8'GDA+>8(2&[7<EZ)1<4I&R%GH'P/W_
M .ZZZ_.P.CUPTWKAY<C,95*6N]HMM^MDJS7F*W-M4UM3$N(\GN;<;6-""/VC
MX=:T\)N#4DZ-$SG;SOP1?N$K^SE>*.ON8@Y(#MMN3:C\Q D ]R6G5)W!&GL+
M^+[:ZW$RXY$:/NWK]2IJA2_IQ]1T/DV(WBV4N(C9['1L= VU/;0-W&_ . >^
MC[QMJ!IL[!^UZH]O(FG4WCD^,6/,K',QS(HB)MIG(['V%_L*2>J5).Z5#<5K
M;5V5N2E%[42.<W+7$V8>GG,H=_L$IXV7YCS\?OS6RVUI/=Y+VFP6!U!]E8^\
M#K<?(ADP]N]>-Q4U0L'T^^H&U<NVD6RYEN%G<%H&?"'LMR4)V+[&OA^.CX3]
M5:#-PG9=5V\B:=39F<8-CG(F.2L7RB*)-ME#4$:)=:='NNM+(/:M/@?N.H)%
M>*S>E:EU1)'-/ESA[(N',H_-ES29-CF*6;/=TC1N0RD]%::]KB=1WH/VC8@U
MVV#E1NT:^*X%$HT*(]#V4GS,GPQY9(*6KI$23L.T^2[H/K[FZU_YZUVS^!FT
M]Q8]<F7"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!I
MKFWU+8%P/-M%ORZ//E2[RTZ_'1;VD.]C;*DI)65K1IJ5;:5E(&JA^L1X5U'_
M ,&7W3Z?EF/\O2C!MCBCU.<1\R3E6?$KJMJ_A)<3:+BV8LEQ"1JI30)*7.T=
M>U1(HT#<58 H!0"@% * 4!+/J ]:F*\0WI["\:MARC-(I"9[7F>3!B+5H0VX
MX I2W-#NA"=NA.NU92J#4$7]8?G%KFQ7,RXW;C69]7M+9=DQWU-_2V9""A1K
M/2"U>,N3,4Y9Q*)F6'2OF;7*U0XTX A^.^CWV7D:GM6G\!&XU!!J(,PH#%N1
M.0\5XMQ2;F>8S/D[+"T"BE/>ZZZO9#32![RUGH/O.@!- 1+._6'YE=+A)_H/
MQNB79V3JA<ER1(D=GTN",CM0?O/VU+I,&T^!?6[C/*=_8PO+[5_1;+9B_)MQ
M2Z7H,E[4@,A2@E3;AT]D*&A.VNNFIJ@*IFS(MOB/SYSR(\*,VMZ3(=4$-MM-
MI*EK4H[ ) U)-1,D1YU^L,B1\B?L?%>'KR6,PXMM-SE.N-B0$;=[+#3:E]A/
M0J(.GA4E$P?[@?ZPN#*R%BQ<JXBO&([[B6S=(SKCJ8_=MW/,.MI7V:]5))(^
MBCB"W(DN/.C-3(;J'XDA"76'VE!;;C;@[DJ2H;$$'4$5$R3#SYZTL6XEOKF%
M8O:SEN:,$-S66WO*AQ'E$ ,N+2E:EN_2A VZ$@[5E*H-4M^O[D6PRHTC/>*U
MP+$^K^.09<1TI/BV9+78L_5J*ETF"S.->2L4Y8Q.'F6'2Q*M<H=KB%>R_'?2
M!WLO(^%:==_IZC4$&H&3#>>?41A/ ME8EY %W&_W#N_--@BJ"9#X00%.+4K9
MMI.NZU=3LD$UE*H)B8]=O--PB*OMKXA\_&]"L3&T7!YKL'B9"&@C;Z>VI=)B
MIOST\>JW$.>"_9!#78,WAM>>]97W0ZA]I.@6Y&=T25A)/M)*0H==QO46J&2@
M:P!0"@% * 4 H!0"@):S[T5XU?YDR[XG?9-IN$MQ<AR-,2)493BSJ0".U:!K
M^ZK-2-#5G]!O57PBX7L>=EW6S,G7M@.?G&(H?]**X2M*1]@K.PQM,SP[UK/Q
M7TVWDW&G(CR3V/3[>E:5)[=BI<9[16NOXJJQ0S4I+"^5L Y!82[B=\C3G2/;
MA]X;E(/713*]%;>.@K!FIF=#(H!0"@% * 4 H!0"@.:_KB_M,89_X.U_S]VI
MQ,%;>L*X.6[TZ9LIH]JI$=F*2#H>UZ2TE0^\:BHK4,PC]7[:X\/@1-P;;2F1
M<;O-<>< T4H,E#203XZ=IH]3)44Z&Q<(4F!)2%QI32V'D*&H4AU)2H$'KJ#6
M <]OU=LMVV\B<BXNE1^55$:>*"3IWPI2V0=/L=-3D8.B%0,FC_5)POD/.G'\
M/$<;N$.W3(]Q:GN/7 NAI3;3;B"D%I#A[M5Z]*RF8-MXU;GK/CUILTEQ+LBW
M0HT1YU&H0M;#26U*3KOH2G;6L&37GJ+Y9N/"G&<K/+7;F;K+CRHT5,22M;;9
M$E?85$HWVK*501S_ .I1F_\ L/:O]*D?W*ET@_W_ -2C-_\ 8>U?Z5(_N4Z0
M3_Z@>?KKS_?+/?+M9HUF>M$1<)#41UQU+B5NESN)< TTUTK*5 =/_2R=?3UQ
M[^B6_P"&NH,&WJP!0"@(;]4&;7OC_G>!?+0>Y*[1';EQ'-?(E,>8YW(4/NV4
M.AKJOQFVS1Z5/'E6(W8]+_@9[B.76/-[(W?;"[WQU:(E1ED>=&>TW;<'\%71
M0K8--'(WK,K4NF1XO)?&EJY&M09=*8F014'\V7+3H>OE.^);)_>]:1E0NQ<E
MV9>S>B:<5RK+N%,MDV^X15I;2L-7BS.DAMYO79QLC;NTW;6/VJM:31OKMJ&3
M"J^#*ZQ_(+/E5HCWZPR!*MDG9*NCC:Q[S;B?A6GZ/O&U4M-',W+<K<NF6IA?
M*_%$'D2!\["[(F71&R(DH@)1*2G<,/'^ OP\=JE&5-CT/7B9;LNC[>1H'CSD
M/(.);_)LUZC/*M!=\J[V=W5*V7 ="ZT#T6/P*%6-5\>-ANLC'C?C5:[F5U;+
MI;KW;X]WL\E$RV2T]\:2V=E#Q!'5*DG923N*II34YF<'%T>IK'F#A]C-XZ[_
M &!M+.8,(U6TD!*)Z4_"H[ .@>ZKXNAJ<94V,V&'F.V^F7;R-/\ %/*UQXXN
M2\=R-MY>,N/%$N(X#Y\%X'13C:3N-#[Z/'[:FU4VF5BJ\NJ/=S*TB2XTV,Q<
M+?(1)@R4!Z)+85W-N(/122/^0JDYJ46G1ZFF.9N&$Y(A_*\1CA.0H'?/MC20
ME,Q(ZN-@:?E1XI^+[:G&6YFUPLSH]$]./ ^+TTY//F0[QB-Q>6X+8E$JW-ND
M]S2"OL=; .X )!T\*3)?DK234UOU+@P:;\[C<4DZK8[F%$]?8.VOW5R6=#IO
M/V[3;?C[G797LV$J^ISTR=_SG(W'$/VMW[[8(Z.OBJ1'2G\+C8^T>(K:8&=6
MD)O;N?Z,]THGC^F;U,JL:HG'?(DLFS$I8LUZ?4=8IZ)8?4?Y+P2H^YT/L^[/
M.P>OUPUWKCYB,BX2&I+1!"7&'$Z$'12%H4/P$$5S6U$R%_4QZ9W,:<E<@\>Q
M5+Q]1+MVL["250CU+S0&_E>*A\'[GIT^#G?<]$^[GYE<HF2^F3U-B4(G'7(T
MP"5[+%COLA6GF ;)CR%J^+P0L]>A\*HSL"M9P7O7ZHS&18$F-&GQGH<QE$B(
M^A33[#J0MMQ"P0I*DG8@@[@USZ;3JB9S]]1GIRG<:S7,XP9MUW"UN!QYMLDO
M6QXJVW'M>5K[B_A/LGP)ZO"S5>73+NYE<HT-S>FCU+LYHU&P3/)*6LP;2EJV
M7)PZ)N24C0(63L)  _\ KG[KKKL_!Z/7#3>N'ER,QE4I:[6BVWZVRK/>(K<V
MUS6U,RXCR>YMQM?4$?\ +2M/";@TTZ-$SG9SOP1?^$[^UE>*.R',/<?2[;;F
MTHB1 D:]R6G5)T(((]ASHK[:ZW$RXWXT?=O14U0ICTY>HZ#R;#;Q?*7&XF>1
MF]$_ W<&VQNXV.@<TW6C[QMJ!IL[!=I]4>WEY$TZF\<GQBR9C8YF.9%$1-M$
MY!;?86/IZ*2>J5).Z5#H:UMJ[*W)2CJ2.<W+?$>8^GO,8M^L,J1^8_F/.L%_
M9]E;:T^T&7BG8+ VWV6.GB!UN/D0R(>W>O&XJ:H6'Z?_ % 6GEVTBWW$M0<Y
MA('SUO"NU,A"1N^P#U2?B1U3]E:#-PG9=5V\B:=39&=X-C_(>-R\9R.*B3#D
MI/E+(_*,/ 'L=:5U2M)\1]AV)%>.Q?E9FI1,M5( X/N<GC+GJW6ZX'RPF>]8
M9_F'L 2\HL=Q^Q7:JN[SX*_BMKAU+F>>&R5#I)7ST](H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% <V_5:E7(GK Q' #H_"879[8MG3
M4?YX^'GM?#W%C6IK0PR]G>*^,'D*;=PJPK0L:*2JUPR"/\54#)SE]1.'V#B/
MU3XPGBM M4F0]:[C^;89(3&F/R>PH;3OVI<2 >SI[1TVJ:VHP=1TE1 [AHK0
M:CZZ@9,.Y0Y-QGB+$9&:Y:9'YFC.LL.?*-^<[WR%A"-$ZI\3OO0&B?\ U ^
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M=I\&'_RS?[*EBM+^;M=%_J_J1.VZHH6M"6"@% * 4 H!0"@% * 4 H!0"@%
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M;\GN\Y7=IV]RNGVT,HSRL&10"@% * 4 H!0"@% >)=,.Q.]SFKG>;%;[C<6
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M<,9=61'OD):FD:Z)^8B'S =/I*.\4_.6NJRI?TOF8MO;0O2N(+Q0"@% * 4
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M)?45]GTA*03](HY LR]6(R,2N&-6-X6A3]N>MMM>8'8F(5L%EI2 G30-Z@I
M^BHF2#(GZN7.H4UNY0^1XD>XM+\UN6S%DH>2YU[@M+H4#]>M3ZC![)]"7,A)
M)YD=).Y)^?\ _EBL]0-J>G[TR\@<09P[E.3\@KR>WN0G8:;<KYG3S'%)*7/R
MSJQ[(2>GTU%NHH;5YLX.PWG/%QC^4H6Q+BJ4[:;O'T^9AO+ !4G7925: +0K
M8_4=",)T,DFQO0OSC8X[MBQGEI$3&'"H&*V[<(J2A?O=S#2E(U/C[6]2ZB-#
M?'IU])V*\$K>O\B:K(,[E-J8<N[C?E,QV5Z%2([1*B.[3VUJ45'IL-=8MU,E
M#U@R* 4 H!0"@% * _EQM#K:VG!JVM)2L?2"-#0$1<6W.'Z;^;,CQ7,UB-C6
M0@"UWH'N8[$NE;"U$:Z A2D+_%54M2*V%D1\JQF4VEZ/>8+K2P"E:)3*@0?K
M"JB2/U_I#8/_ #6'_I#7_:H#[(LN--:#\1YM]D[!QI:7$$CKNDD4!^U * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4!S:_62_UAX9^A7?YTNIQ!8_I:_L]
M<>_HEK^&JHL&WJP!0"@-$\\X?9,X6+%?6NYE3(7%DH'Y:,]N XV?X2?B%=-^
M,=+3]YS>=>E:R%*/ AF;"S7@W-6W6U^7*;U5&DI!,6=$4=P0=BD]%).Z36ZV
M->PV$96\JWXV%58%GEEY"LHNMJ/E2V>U-RMRCJY'=/[:"?=55+5#G,C'E9E1
M_!G^9[@5EY"LIM=U'DS& I5LN21JY'=5]/XS:C[R?O&]$Z#'R)6956F]$K09
MV:\&YJXTXCRY+>B)456JHDZ(HZ@@]%)/5*ANDU;L:]AT<HV\FWXV%:XAE]DS
MBR-WZQ.:L$A$J*LCSHSVFI;< _O5=%"JFJ',WK,K4NF1XO)?&MJY&M09>*8N
M0Q4D6RZ$;CQ\EW3=39/[VD94]Q=C9,K,O9O1-.)Y7EO"N6R8$^,M+(6&KS9G
M20V^V.BT'H%:;H6/VJM:3-]=M0R857P97>/W^T959X]^L4@2;;)&RMN]MS3V
MFG4CW5I\1]]4M49S-RW*W+IEJ87ROQ3!Y$@_.0NR+E\5&D28KV4R4)&S+Q_@
M+\.G2I1E38]#UXF6[+H]L>1/_'O(60<29!)L]YC/&TEWRKQ9G/9<;<3MYK8/
M18_ H58U4W61CQR(U6NYE=6NZ6Z^6Z-=[/)1+MDM/?'D-G8_2DCX5)Z*2>E4
MM4.9G!P='J:SYAX?9SEA=_L"$,Y>RG5U'NIGH2-DJ^AT?"KXNAJ<94V,V&'F
M?:],NWD8KZ:+Y/:>O^$7);B#%0)L2$]J%,N(7V/I .Z=B"169GH_)6TU&:]Q
M<V!SOG<<CI4=5QBIA0^@)W3^P17)9\.FZ_;M-G^.N==E>S83WZF?3.UEC<K/
M\!BI;REM*WKO:V@0+@!N7&TC8/CQ'Q_NO>]F!G]-(3TW/AY<CWRC4U+Z</4?
M+X[EM8)GCKKF&K<\F+(<U+MK>4K<$'?R22>Y/P]1X@^_-PE=75'NY^9B,MQ?
M\>0Q+9;DQ74/1GDI<9>:4%H6A8U"DJ3J""-P17*M-.C+".?4WZ8TN)F<C<<0
MP%@*D7VPQTGVM^Y<B.A/X7&P/K'B*Z+!SZTA<>W<_P!&0E$\+TS>IA5A5%X[
MY#E%5E44L66[O'_V0]$LO*/\E^*H^Y^YZ69V#U^N'=O]OF8C+B7*0A]&A"5M
M+&X.BDJ2H?@((KF="PA7U,>F=>,KE<A<>Q2<=42]=[0R"50U$ZEUD#^1^D?!
M^YZ=/@YWW/1/NY^97*)DOID]30E?)\<\C2_\Y':Q8;X^K3O ]E,>0H_%X-K/
M7H? U3GX-:S@O>OU1F,BPI,=B9'>B2VD/17T*:?8=2%MK;6.U25).Q!!((-<
M\FTZHF<_O4=Z<9G&TQS.<&;<7A:W X\PV5*>MCRCMN-RR5>XOJGW3X$]5@YJ
MO+IEW<RJ43<7IG]2Z,S;CX%GLD)R] #=JN;A"4W!"1H&UG;\N-/_ *Y^ZZZ_
M/P>CUPTWKAY<B<95*8NUIMM^MLJSWB*W-M<UM3$N*\GN;<;6-""/^6E:>$W!
MJ471HD<[>=^";]PE?V<LQ-Z0O$5R [;+FT5"1;Y 5W(:=6G<$'^+<^+[:ZS$
MRXY$:/NWHJ:H4OZ</4;#Y,@MXME#K<;/(C8T42E#=P;0-W&QMHX -5H'[H;:
MZ:?.P?M/JCV\B:=3>.38S8\PLDO'<BAHG6B<@MR([@_ I)ZI4D[I4-P:UENY
M*W+JBZ,D<X?EG^$.=VXZ%K4QCMW0EMUSV5.0G"-"K]TTNOH*:RL7_P#4?J>;
MMD=,VW$/-I=;4%-K 4A0Z%*AJ"*^=M4/2?U6 * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4!&=Y]%.1WB[3[@K,H_ERI#K[;3D=U?
M8EU15VC5?[52J1Z3X$^A2_IV1F,1(^A,5P?M*I4=)_O_  +9#_MG&_T9W_MT
MJ8Z2F.%N.I/%F"1</EST7)^.\\\J4VA3:3YRNX#11)VJ))(V%0R* 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4!S:_62_UAX9^A7?YTNIQ!8_I:_L]<>_HE
MK^&JHL&WJP!0"@--<BW>V/YBJQM24&\183<I^%KHZ&%J(#@!ZIUV.G2NF_&I
M_9K[3E_RL)?=4J;*&O<OQ&R9Q8W;#?6]6%>W&E( +\9[P<;)_OD]%"MHG0UU
MF]*U+JB27.@9KP;FK;K:_+?;)7$E)!,2?$)T((\4J&RDG=)JW8U[#I(RMY-O
MQL*GP'/K+R%91=+60S-9 %SMBE:NQG#^RIM1]U7W'>JFJ'/9&/*S*CT/ZSS
M[+R%93:;L/)E,ZKMUR0D%V,Z?X3:OB1]XWHG0QCY$K,JHE:#-S;@S-5MN-^6
M^C1,F*LDQ)\0G8@C8I(W2H;I-7;&O8=%*-O*M^-A6F(9?9,XLC5]L3O<RK1$
MJ*L@O17M-VW!_!5T4*I:H<U>LRM2Z9'C<E<:VGD>TAB04Q+_ !4G\V773=/C
MY3NFZFC_ 'IW'T43H78V3*R_9O1-&+93EW"F6R8-PBK2TE8;O%F=)#;[8.RT
M'<=VF[;@_:JUI-&^NVH9,*KX,KK'LAL^5V>/?K#($FVR1L=@XTY\33J?A6G]
MGJ-JI:H<U<MRMRZ9:F&\K<4P.18/S<0HB9=$1I#F'1*)*$C9A\_P%_#X[5*,
MJ;'H>K$RW9='V\B?N/N0<AXCR"39[Q%>-I+OEWBS.ZI<;<&WFM:[!8_ H58U
M4W61CQR(U6NYE=6JZVV^6Z/>+-)1,MDM(7'D-^(\4J'5*DG923N*IT.9G!P=
M'J>-*PV K,X&=V\B)>F4KC70)3^3G1'4%.B].CB3H0OQ\:RGLHRU7W]MVWM6
M[V'HW3EZ5Q#<;)<+@S\U@ET?7#O80DE^,\0"U(;TZ^R%=Z/$#;>O%E8BOQKI
M):>9M?Q-RCE%^\I&TW:W7VW1KO:)+<RV36TOQ);*@MMQM8U!!KE9P<&T]C1T
M9,OJ7],[>8-RL^P*,$9:@%VZVIH!*+@E(U+C8'1\>(_E/W7O;G SNFD)Z;GP
M\N1"4:FH/3CZCY?',MK!,[<<7ABW2VQ(<"E/6QY1W&G4LD^\CJD^T/$'WYV$
MKJZH]W,Q&6XZ 1I+$R.U+BNH>BOH2ZP^TH+;<;6.Y*DJ&H((.H(KE6FG1EA'
M?J<],GG?.<C<<P_R_M2+]8F$^\!NN1'0/'Q<;'VI\170X&=6EN;V[G^C(2B>
M#Z9_4VJP&+Q[R)+)L1(:M%[?42J(>B67B=?R7@E1]SQ]GW;<[!Z_7#NX<?,Q
M&1<A#4AK0]KC#B?J4A:%#\!!%<SH6$,^ICTS.8\Y*Y#X\BJ78UJ4_>+.RGVH
M9]XO,I'\E^,D>Y^Y]WIL'.^YZ)]W/SYE<HF0^F7U-B0(?'/(\L!X!+%CO\A?
MO[Z(CR%*\?!#A/U'Z:JSL"M9P7O7ZHS&18DF-'F,.Q9;2'XKR%-O,.I#C:T+
M&A2I*M001L0:YY-IU1,Y_P#J-].$SCB6YG>!MO.8<MSSI+#>I>M;Q5JD@C<L
MDGV%]4G97@3U6%FJ\NF7=S\RJ4=YMWTS^IAK+FXV Y])2WE;:4LVJZN*T%Q
MV#;A.P?^@_RG[KWO!G8/3ZX:;UP\N1.+J4W=K3;;];9-GO$5N;:YK:F9<1](
M6VXVKJ"#_P A6FA-P:E%T:)'.[GC@>_<)WYG+,2=D.8BN0';=<FB1(MT@*[D
M-.K3N-#_ !;GQ?;768F7'(C1]V]%35"E/3CZD(7)<1O%<K=;B9Y&; 0LD(;N
M*$#=;8Z!T#WT#KU3MJ!I\[!^WZH]O+R)J533GK6Q55NSJU96RVH1[W"#+[AZ
M&3#/;I_BRBM]^"O=5IP_I?T?F575O*GX(RL9EQ3C=W4OOE-Q4PI9_P#C\/\
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M H!0"@% * 4 H!0'-K]9+_6'AGZ%=_G2ZG$%C^EK^SUQ[^B6OX:JBP;>K %
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MQT [%3R>YK7_ *Z4U[_RUK[F,WPVE<'21TAKY^>D4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H"'.4^,N2N#.0IG*/%*'7<=GN+?>
M;C-EX1?-/<XQ(9&ZF21JA7A]M2(4H?3 ]=-]C,!J]XA&5,2-.]F2XPDGZ2AQ
M"B/PTH9J8CEG,',OJ-6WA&,V,Q;1*6GYB# #BFW %:A4J2X  VD[D;"E*&*U
M+'X8XV8XJP*WXJ'4R;@GNDW24@:)<EO'593KOVI]U/V5ADDC8-8,B@% * 4
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M/K@MF]</+D3C*IXWKAQ4KC8SFC+9/DEVU3'/ )5^69'X?-KW_@;VV5OX_O\
MH5W5LJ;-])N6)R3B&WP7%]TS'WG;8\-=3V)/FM?WBPG[JU_YBS]O(;W2VDX.
MJ-Y5I28H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * _)^.U
M):4P^A+K#B2AQIQ(4A25#0@@[$&@/#&!X.  ,:M6@_\ R&/_ -BABAAO(-WX
M2XPM[=PS"V6B)Y^HB1$0&'9+Y'7RVPC4Z?2=!]=9!I)[U3<!(>*&>/\ S&-3
M^45;X2%:?3VZ']NLT,5-@<?\M^G3D.:U:;?:[=;+T^0EB!=+=&C*<4?!M?:I
M"B? =P)\!6!L-[6^VP+5&3#MD5F'#2241XS:66P3N2$H &]8)'U4 H!0"@%
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MKU:Q9YKBHR[>*<I.:<<XUDJU%<B=!:^:43J3(9'E/$_:XA5<9F6?M7I0X/\
M@>A.J,QKR&10"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M.,&NO"'(\L!^Y0'(.-WY]6FKP0?(8D+5MJ%A/EN']R?"IWL;[=V-Z"T=6N=
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M H!0'\N=W:>SKH=/MTVH#F1RMREZWN)4(N6:WM^T6BY2WXUL=#=H?"BC582
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M*)98JM/.5';_ "SVG0NNJU<7UV[E'2HF3+: 4 H!0"@% * 4 H!0$0?K)_\
MXB<)_2LC^;U*)C>;[Q9E<CTL6V,T"77<%0A '4J5:M!I]YK#U"T)I_5JR&TL
M<@Q"0'^^W.]OCV@/I_;K,AO+ZJ)DYS6EI5S_ %C\E<75:(]RD+=*? 1[,I"]
M?L4-#5E?3XXF#HS59D4 H#7W,_$]IYIP:1@MZG2+=!D/L2528@070J.KN2 %
M@C0FLIT!-O\ Z;O&O^UMZ_>1?\G6>HQ0?^F[QK_M;>OWD7_)TZA0E7U6\"X[
MP%DU@L6/7.9<VKK 7-?<G!L*2M#RFP$^6E.V@\:DG44.C_I9&GIZX]_1+?\
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M*VN'4BJ.R5#I'7ST](H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MH:$'9QIU.G>TZGX5IUW'WC8BN2O696I=,M2TUIZ@/3]:>7;2;E;@W"SJ"V1
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M/]\GHH5A.A59O2M2ZHFG.(<<OG&G)ERPZ])[XEXA+7;Y[8/D2/ESYB%)/@=
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M1?ZOZD2MNJ*(K0%@H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M81\I"CH/F8BN].Q\2DKKJ/SEGJLJ2_E?,HM/:7K7$'H% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% ?PIII1[E(25'Q(!- ?YY#/^#3^]% 2%
MC>_K]R<$ @XZD'8=/*9J7\I#>5[Y#/\ @T_O1429_26FT'5"$I/T@ 4!_5 *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H"!(;['IT];%]
MOF<CY#"<^1+7;+^Z@B*@W!;<CVEZ$ -O(+*_Q00HZ)J6J,%YPIT.XQFYEOD-
M2X;J0IJ1'<2ZVM)&H*5))!!'T&HF3Z* 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@.;7ZR7^L/#/T*[_.EU.(+']+7]GKCW]$M?PU5%@V]6 * 4!J
MCDDE-^84DZ*#*2"/IU-=+^-_U/WG*?E/]WP)0YJX63<$2<RPV,!-2"[=K.PG
M0.@;J?92/B\5H'7J*W$95V,MPLVE(3^#,>X7YG-D+&'Y@^38U$-VVY.DE4-1
MV#:SU\HG]Y]E2E&OOY^9?FX?5ZX:\RGDJ*=%I(4" I*@0I*DJ&Q!W!20?L(J
MDYXFWFKA40Q(S/#(W^8ZER[6AE/\1KU>9 _D]?>2/=^SI9&53?X6;7T3UW,^
MSA3FE*TQ\+S25H1VM6:\/*Z>"6'U'P_$6>G0[5F4:[5J5YN%_/#XHH5:- XR
M\A*D+26WF7 %(6A0T4E0.Q2151I"6.9.&G,56YEN)-K7C2EA4N*C4N0'5'8C
M3<M$^ZKX>AJV,J^\Z/#S/N>B?=S,XX8YG3D*8^(Y=("+ZD):MES<.@EI T#3
MI/\ *_BJ/O=#O491WH\>9A='KAIO7 W7*BQY<=^#.81(AR$*9E17D]R'$*V*
M5 U U,9-.J)+Y:XFG<>STY'CBGEXPXZ%1Y"2?.@OZZI;6H;Z:^XOQ^VK8RK[
MSIL3*5Y=,N[F;<X=YA9S9EO'LB<0UE[2=&'3[*9Z$CJ/ / =1\74;U&4=Z-9
MF8;M^J/;R-I7.V6^\V^3:+M&1+MLM!;DQG!JE0\"/H4GJE0W!J!KH3<75:DB
M\C<<W[B>^Q[U9)#ZK(70Y:+PW[+C+HW\ITI]U8_ H5=&53IL?(C?C1Z[T;\X
MGY8@\B0OD)Y;BYA&3K)BI]E$I"1N\R/I_'1X=1M5<HTVK0TN7B.RZKMY&;WZ
MPVG*+/)L-\CB3;)0T4G;O;7\+C:OA6GP/W5%.AY+=R5N75'4D3+\0RSA?*XU
MQMTEP10X7++>FAVH>0.K;@&P4!LM!Z_95R:9TUF]#)A1_%%-\:9_$Y%QW\[M
MM)BW2,L1[I"024H=(U2M&OP+\/H.U5.-#096.[,Z;MQF-8/(?C*DL0HDF=*<
M2S%BM.2'W5G1*6VDE1)_!1&4FW1:F>\%\F8=R)B2'<866)D-2DW.VOJ29+3A
M)T6H#3N2L>ZH?9U%<S^0M3C<;EM3T9VV-95JVHKPST^6N),:Y<QI=DOB U/:
M"EVJZH2"_%>.FZ?I0K0!:-=Q]>A'GQLF5F55IO1Z&JD 0YG)7I>Y+6A:"S):
M/:^PKN,&Z0"K8@_$E6GLJ]Y"OH((KJ6K>5;XI_-/]RK:F="N,>3L9Y5QEG),
M<>^A$^ X1\Q$D::EMP#^]5T4-Q7*Y&/*S+IE\'Q+4ZG@<V\(X_S%8/E97;"R
M:&DFSWH)U6VKKY3NFZFE'J/A/M#QULQ,N5B7&+U7C>&JD,X7F?(7IFY#DVZY
MQ'&T-N);O=C=40Q+8!/:ZTK<:Z'N:=3^R-172W;5O*M\GX^J*DZ'1;!<ZQSD
M7'(N3XQ*3)M\E/MHV#K+H'M-.I^%:?$?>-00:Y.]9E:ETR+C6OJ!]/\ :>7;
M2;C;@W!SJ$V1;YQ':B0E.X8?(ZI/PJ^$_5M7LPLUV71]O(BU4CWB;EG,O3SF
M4NP7V(]^9B_Y-_L+^J5-K2="\SKL' .A&RT_<1O\C'ADPK\GXW$$Z'1G&,GL
M>8V.)D>.3$3K1.0'&)#9_"E0.Z5).RDG<&N1N6Y6Y=,EM+32'J-].4+DZ$YE
M&,-HBY]%;Z#1#=P;0-FW3L X!LA9_<G;0IV>#G?:?3+MY$7&I,O!/.N0<(9
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M@X,X_P"9\'-Y_P![.?HS-F7Y7YL:2VO6,I'=YBBXXE!T4"!V :;:T!NBL 4
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M:)J MA]LZ_:E0ZI4D[*2=Q7)7;4K<NF2VEIH[U&^G*%R;#<RC%VVXN>16SJ
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ME:,SQUTNV:\QD2HJECM6D*V4A8\%(4"E0^D5$R9!0"@% * 4 H!0"@% * 4
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MM^8YNI1'B3])K /=H!0"@% * \K)_P#XFKS_ .!D_P#<JH"8_P!7C_4/,_\
MGAG?S>)4I:@K&H@4 H!0"@% * 4 H!0"@% * 4 H!0"@(]QK^W]DW_SNI_[I
MFI?RD-Y851)B@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H" >&(<.]^O?D2;D 2[<[8N[.VA#WMD.-.-1FU(U\4L*/;] J6XP?5^L'
M_P#BQXJ_^3O?SB/1&2DO53:[-=?3_G3=[2W\M'MRI4=UQ(7Y<IA25,J3KT5W
MZ)&GTUA:F&:]] ,F6_Z?V6Y*E*98N\]N*5$G1O5M1 ^H*4JCU!4E8,B@% *
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M^>BU,:2I?;V&1*=)<>=T_P"DLG3Z!H*BS)G-8 H!0"@% * 4 H!0"@% * 4
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M1L?#3=?B,J2NQMO:GI["N:JB%*[<\XH!0"LF&=0N ?ZF<+_1K7[:J^<_DO\
MZ9^\]<=$;'K7$A0"@/-R+_XG[M_X.1_W2JMM=Z]Z!R+>_CG/W2OVZ^I'C/XK
M % * OOT6_U53/TJ_P#]VU7$_G/]Z_\ RCT6^THZN?+!0"@% * 4 H!0"@%
M* 4 H#G)ZL5K1SE?NU1&K$#H2/\ \3:KZ!^(_P#EC\>9YKG<:4\Y[_"*_?&M
MO4@?YWK[N_N/>>JM=_PT!_OG/?X17[XTJ#?_ *.5K5S&GN45?_!<SJ2?%NM)
M^;_^;_\ DBRWJ=!ZX,] H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M*/O#Q+1/0_#T-6QE7WG18>9U^B?=S,SX8YH1?4Q\1RY\)O8"6K7<W#HF2 -
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MZ*; 5W'+Y9;^9"1([4^:&]>SOT]KMUWTUZ:U$R?K0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H"8O5-Z4(?.3;.48Q(9M?(<%D,!V1JF-/CHW2T\4@E*TZGL7H
M?H.VA&4Z&";+?&_6!<;QTXQ;HUYFP& &8RD(C79I"1L.QX^80/M54M@/1Q#T
MB<\<SY9%RKU!W61 M#929"9<A#]R>:UU++#314VP"=B3IIU"32J6@.AM@L-I
MQ>RP,=L,5$*RVQAN)!B-#1#;+2>U('T_63N:@9/2H!0"@% * 4 H!0"@% *
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M#776+\,FWS7CZ,J:HRU^".=K)S!8R%=D+,("$_G:UZZ:^'G,:G53:C]Z3L?
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MPJ^'[*]>%F.RZ/M?T#52.^*.6LU]/&8RK#?8K_YF2_Y5^Q][92%#8O,ZG0+
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MXA0Z*2=P:X2Y;E;DXR5&CTGIU6!0"@(X]$'_ ,6G//\ \\J/YQ<*RP6/6 *
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M/M7C85M4VHN[@CG2T\MV7Y:241,S@-I-SMXV2X![/GLZ]4$]1\)V^@UQGY#
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M\3GX$L:?&+T?Z/VGHC*IMBM62% 1OZF/[57 '_BO_MQNLK0P]"R*P9% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#1'K!Q+'\GX#RR5>HS3DRQ13<[
M3+6D>9'E-*3NVKJ.\>PH#J#65J#S/1%EMVRW@"S*O#JGY%FDR;0R^X5*6J-&
M*2T"5$D]B5A ^I(H]0456 * 4 H!0"@% * 4 H"//UBJ4HX=L80D)"K^T3H
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MA^^1_P!FG_.QOZ$.N7$QB_7#-\V3<,UOJYU[3"\EFX75T*=;8\S5+2%J [4
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M&E=R%H5NE25#J#5)S;5-C-$<T<+)NJ9.88='";DD%V[6EH:!\#=3S"1\?BM
MZ]14XRW,W.%FT]$]-S,8X8YG./EC$,O>4JPDANW7!>ZX2B?<7XEDD_\ 5^RI
MRCU>_GYE^9A=?KAKS*A2HI*5MJ!! 4A:2%)4E0U!!W!!!^^J3GB<.:N%!'3)
MS/#(VD3=V[VAH$EKQ4\R/Q/%2?AZ].ED9<3?86;7T3UW,_7A7FI($;"\TD_D
M_99LUX>.S8Z)8?5^+X(6?=\=NF91KM6O/S(YN%_/#XHHI:>WO:=0%)4"AQM8
M"D*0H:%*@=BD@U2:,EGF;AA6,J>RW$FE*QHJ"YL-)*G(+BC[P\2R3T/P]#5T
M95]YT6'F=?HGW<S:G!&;W+,\2D-7E[S[K9'6XWS/\HY&6C\FI?TJ3VE/=X[:
MU&25379]A6Y^G1E?V]N%DN+LQ[DPB5!G1?(F1G4A2'$*3V+2H'Z:XV\G:NNF
MRC.FQKGW+49>P@7U!>GNZ\2709EAQ><PIQY+D=YM2C(MK^NJ4+4-^W4?DW/N
M._7I,/-5Y4?<62C0H#TV^I2/R"PQA>:/(9SAI/;$E$!#=Q;0-=?H#P'O)^+J
M/$5J\[ Z/7#MWKAY$XRJ4)?K#:<GL\RP7V*B;:)[2F)<5T:I6A7[((.X(W!W
M%:B$Y0DI1V-$CG5S5PKD_ V41LHQF0^<85)#UCO+2B'XCZ3WI9>4D#18T]E7
M18'TZBNMQ<J.1&CUWKQN*FJ%7^GCU#VWEFW)L=\4W"S^$WK)C#1#<UM W?8'
MT_X1OPZCV>FDS<)V7U1[>1.+J;:S'#L?SS'IF,9-$3,M,U/:X@[+0L>ZXVKJ
ME:3NE0_:K7VKLK4NJ.I(YS<D<;YWZ;L[AWBTRW4P$O%['<@:&B74IW+3PZ!8
M!T6A6RATU%==8OPR;?-%35&6MP1SQ8^8;+Y:NR#F4) -UM.N@(&@\]C7WFR3
MTZI.Q\">=S,-V75;8^-C+$ZF:\B<=XWR=C4C&,FC^9%=]IB0C0/QW@/9=:4>
MBA^ C8UYK%^5F75$-5.=N18YR/Z8N1H\V*\6G6EJ<M5S0"8D^)KHI"T^.HV<
M;.X_ :ZR%RWDV^*>J*]J+RX9YGQSF''A<;:H1;[%2E-XLZSJY'<.W<G\9M1'
MLJ^X[US.7B2L2XQ>C\;RQ.I]O+7$V-\N8TNQ7U'ES6@IRU71L?EHKY'O#Z4G
M0!:.A'UZ$0QLF5F55IO0:J<_XTGDOTN\EJ2I/DRVO9>:/<8-S@%6NQVU2K38
M^\A7T$5U+5O*M\4_FG^Y5MBSH3Q?RAC/*V,M9)CCNFFC<^WN$?,1)&FI;< _
M"E0V4/O Y7(QY69=+^#XEJ=3PN;>$\?YBQ\1)?;#R:&A1LUY"?::4=_+=TW4
MTH]1X=1OULQ,N5B7&+U7C>&JD+X=F'(?IEY%DV^XQEMAMQ+5[LKA_(3(P)[7
M&E=-="5-.)_:U%=+=M6\JW[-SX>-Z*TVF=%<#SS&^1\<BY/B\H2+?)&BVSH'
MF'1[S3J-^U:?V>HU&AKD[UF5J73(L1KOG[@*T<O6@S8?EP<XA-D6ZXD=J7D)
MU/D/Z=4G7V5=4GZM17KPLUV71]O(PU4CCBKE/,_3KFLNPWZ&\FSE\-9#871H
ML%.WG,ZG0+ W20>U8^K0CH,C'AD0K\GXW$$Z'1C%<JL6:6*'DF-RTS;1.1WL
M/(Z_0I*DG=*DG923TKDKMJ5N3C+4M-*>HWTYPN482\EQI#<7/XK8"5$AMJ>T
MV-FG3T#@&R%_]56VA3L<'.^T^F7;R\B,E4F'@SG/(>#LB?Q3*F7U8BN2IN[6
MMQ)$B#(![%/,I.A!&GMHZ*'UZ&MSEXD<B-5W;GXW$$Z'12S7BV9!:XE[LLIN
M;:IS:7XDMD]R'&UC8C_G!W!V.]<G.#@W&2HT6DV^I;TT-9PU(SK!8Z6\S;27
M+E;D:)1<4(&ZDCH'P/W_ .ZZ[C!S^CT3TW/AY<B$HU-)>G7U%3N,)R<)S9;J
M\)<=4A*EI)?MCY5N0D^T6R??1X=1OJ%;'-PE>75'NYD8RH=!H<R+<(K,Z$ZB
M1"D(2]'D-*"VW&W!W)4E0V((.H-<HTTZ/4M)$]3?ID_./S?(O'43_P"$?:?O
MMD9&@= &JY$=(^/Q6@=>HWV/08&?I;F_<_T9"43#_31ZEUXHY&X_Y!DJ5C2E
M>5:KJZ2505DZ!ITG?R2>A^#]STOSL'[GKAW<_,Q&1=R5MOMI<;4E;+B0I*DD
M*2I*AJ""-B"*YC0L(A]37IF7:ES.1N.HA-K45R+Y961O&/O*?82/Y/Q6@>[U
M'L^[TN#G=?HF]NY\?,KE$ECO6YHXXHK<4-5*4=23]9-=='M1YV*D!0"@+$]%
M5N@WC'<ZM-TCHEVR8N*S*B/#N;<;6VZ"% _4:Y7\[)QG;:V-5+K6AJOG_@"\
M</7A.88>IYS#7)"78DIM2OF+;(U[D(<4-]-?XMS[COUGAYD;ZH^[GXWF6J%#
M^F[U)1N1(S.'9@\AC.V$:,25:(;N+:!U3IL'@/>3\74>(&ISL'[?KAV\O(G%
MU-_Y!C]HRFSR[!?HC<ZT3FRU*BNC5*TGZQH001J"-P=Q6JMW)0DI1=&B1SGY
MEX:RO@+*XN2XW)?..F0'[%?&CH]&=2>Y++Q  "QX'HL?>!UN-DPR(4>N]>-Q
M4U0K3T\^H:V\LVT62]*;AY]":[I<4:(;F-HV+[ ^GQ<;^'J/9Z:+-PG9?5'M
MY$TZFV,RPW'L^QZ7C&3Q$S+3,3HM!V6A8]UQM75*TG=)'[6HKPV;TK4NJ.I(
MYS\A<>Y[Z:\^AW>TRW!$2\I['K^T/R;S:3NT\GH%A)[7&SL1TU!KK;-ZWDVW
M]5X^C*6J,MG@KG6Q\PV/X86806TF\6G7[O.9UU*FE'[TG8^!/.9F&[,MG:]"
MU.IF/(W'.-<H8T_C.3Q_,CK_ "D:2C0/QGP-$NM*\"/$="-C7GQ\B5F75'^(
M:J<[;Y8^2/3#R0Q*CO>5):*G+=<$ JAW"&3HI*D^((V6@[I/W&NLC*WE6^*?
MT*MJ9>W#G,F.<P8Z+I:C\O>8J4(O%H6?RD=U0ZI_&;40>Q7X=ZYC*Q96);=-
MS+4ZGU<M<3XURWC*[%?D>7-:[W+5<VQ^6BOD:!0^E!V[T=%#Z" 1'&R96)56
MF]!JISCR3',KX9RB=B>5PP[$D!(E1M3\K.BZGL>97ILH=4+'M)5L?$5U]J[&
MXE.#*FJ;#^;/?KIQ]D-NS'"+H1VJ+L)_4>9V@Z.1Y+0/T>RM)]E0W%;%J&1;
M<9K9O\BNG2ZHWI_QP9]_LY9__P Y_P K6G_X-K^J7T)_=]AJ[/N;K]R!R+A/
M)%QMT.+=,'=\Z##C^88[Y\U+NCO>LJTU3I[)I_P;7]4OH/N>PVE_QP9]_LY9
M_P#\Y_RM/^#:_JE]!]WV&0X'ZO\ -LLS2PXU,L-J9BW6:S$>>:^8\Q*'5=I*
M>YPC4?6*HO\ X6W;MRDI2V*NXRKE72A8]<F7"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0&!9Z.(L.M<S,^0X=D@P$J!E72X1(ZW''%;)2-6U..+.FR4ZJ-9!
M+MV]9WI9A3%1[;@*[G'2KM,M-HM["% ?$A+A"M/W24FI49@W%POZE. ^1)2+
M!A#K6/7Z01Y=CF16K:\^H#HT6M6G#]"4K[OJJ+0J;]K!D4 H!0"@% * 4 H!
M0"@(]_6,?U/6+]/,_P V?J40;A]+*4K]._'Z%C5*K2D*!Z$%Q>M8>H(TX%R"
M!Z=_5CEN%YD\FWVF\/2;4W<)'Y)I/G/IDPW%$[!#@('>=AW5)[48.CUSO%LL
MUMD7F[3&85HBME^3.?<2VRAI(U*E+)  J!DYV\)3#SSZV;MR?;VG%XQ9G)-Q
M:>4G0",Q'^0A=P.NBE^RYV_4?HJ;V(P=(*@9% * 4 H!0'-K]9+_ %AX9^A7
M?YTNIQ!8_I:_L]<>_HEK^&JHL&WJP!0"@-!^H#![)GRT6:\I\M:60N#/0 7H
MSV_M ^*3\2?&NF_&.EI^\YS.ORM9":X:$/H5FW!F; J3Y<IL;I.JHD^&H_5L
MI*OPI/UUNDTU[/'U/<U;RK?BJ96.%YI9,\LB+U9'-T]J9\)1_*Q7R-T*^E)^
M%7C]M52C0YN]9E:ETR_B?!R+QU9^1K.(,XB-=HH4;7= -5M*(_BU^*FE'J/#
MJ*PG0LQLF5F55IO1+]BON9\(9D_%EQRAU&C=RMCI)CRF#N%)(V.H]I"QT_"*
MNV-;=#H+ENWDVZKX,KC&,GLN8V9F_6%_SH3OLN(5_&L.Z:J:<'@H?@/452TT
MSF;MJ5N73(Q?E'BVW<C6X.M%$3*8B"($\@ .I V8>/BD_"KX?LI&5/<>G%RG
M9?\ :R=<&SC)N'<FDVRZ17?D/,\J]61T]NXZ.M^ 6!NE0V(^JK6DU1F\OV(9
M$*KX,KRS7FU9%:HU[LDE,NURT]S+R>H/Q(6/A6GHI)JEIIT9S$X2@^F6IKWE
MSB.+G\15WM(1'S&,C1M>R4S4)&S;IV]L::(6?L-2C*A[L3+=IT?;R-(<8\FW
MCBZ\/V&_L/*L"GBW<K:X"'8KP.A=:2>BA\2?B%6M)K;X\C;96+&_'JCKN?$K
MB#.A7.%'N=KDHEVZ4D.Q9;1U0M/TCZ"#U'4&J&J;&<S*+BZ/4U'S+PVC+VW<
MHQ=E+>5-I*ID- "4ST)&I4/_ (\/[_[:G&6YFTP\S[?IEV\O(UAQ#R])P>2,
M8R8N+Q9QPI/<"7H#Q.A4E)W[=??1]XWZSE&OO-AEXBNKJCW<RL&'VGFF9<1Y
M+T=Y*7HTAH]R%H4-4K21U!JDYMJFQFB.:>%DW1,G,L.C@7(!3UWM+0 #P&ZG
MF4CXO%:!UZBIQEN9N<+-IZ)_!F,<,<SJQ\LXAE[Y./D]EON"]5+A+)]Q?B62
M?WGV5.4>KW\_,OS</K]<->94()04K0H'4!2%I(4E25#4$'H00?OJDYXF_FKA
M41Q)S/#8W^:;O7>TM#^)).JGF4CX/QDCW?LJR,J[#?86;7T3UW,_7A7FI*4Q
ML,S.3HT EFS7=T^YX)8?4?A\$*/3H=NF91KM6O/S(YN%_/#XHHM:2DK:=0%
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M6'-;%$R3&YB)UHFH[V7T>!&RD*2=TJ2=E)/2N2NVI6Y=,EM+32OJ-].D'E"
MYDV--HBY[$;T1IVH;GMHZ-.G;18'N+/[D[:$;'!S7:?3+MY$6JDP\&<YY%P=
MD3^*94Q(7B:Y):NUK>"@_ ?2KM6ZRE710^-'Q?;H:W67B1R(U7=N9!.AT3LU
MYM>0VN+>K+*;G6J<VE^)+95W-N-JZ$']@@[@[&N2G!PDXR5&BTFWU+>FEK.&
M9&=8+'2WFC2>^X6YL!*+BA/521L ^!^_Z>]UW&!G]'HGIN?#RY$)1J:2].GJ
M)G\87%&$YJMU>&.O%OO="R];'B="0D[^7W>^C3;J-]0=CFX2O+JCW<R,94.@
MT.9%N$5F=!?;DPY"$NQY#*@XVXVL:I4E2=B"/HKE7%Q='J6DB>IOTRBX)E\B
M\=0__A :O7NQ1T !X#=<AA*?C\5H'7J-^N_P,ZO^.X_<_P!&0E$Q#TT>I=S$
MW(W'_(,E2L:4H,VNZO$E4%1V#3I/\CKT/P?N>E^=@_<]<.[GYF(R+M0MN0TE
M:"EQEQ(4E22%(6A0V(/0@BN8>PL.3&;M-,YE?VF6TM-(N$D(;0 E*0'5; #H
M*^H676W'W(\DM6>#5I@4 H"IO1ER#C6.WF[X?>9'RETR!QA5J<<T#+KC(6DM
M=W@M7=[.O7IUTUYK\Y9E-1DOY:U+K;+8N=M@7B!)M=TCMR[=+;4S*BO)"VW&
MUC0I4#X&N0C)Q=5L:+CGCZ@> +OP]>$9?B*GUX8Z^ER)+;4?F+=([M4MN*&A
M U_BW/N._7K</,5]4?<52C0H?TW>I*-R)&9P[,7D1\Y81VQGSHANXMH'4> >
M ]Y/Q=1XBM3G8/V_7#MY>1.,JF_\@Q^T939Y=@OT1N;:9S99DQG1JE23]'T$
M'=)&X.XK56[DH24HNC1(YT<S<-95P'E<7)<;DR#CADAZQ7QHE+T9Y)[@R\4]
M%C38]%C[P.MQLF&1"CUWKQN*FJ%:>GGU"VSEFV)LU[4U"S^$WK*B)]AN8VCJ
M^P#_ '[8]WJ/9Z:+-PG9?5'MY$TZFU\SPS'\^QV9B^314R[5,3HI.P<;6/==
M;5H>U:3NE7_-J*\-F]*U)2CJ2.<_(?'F>^FO/HEVM,MU$-+Q=Q^_M#1#[:?>
M9>2-0% 'M<;5LH?2#76V;UO*M\UX^C*FFBV>"N=K'S#8_P"3A9A"0#=K0">F
MNGG,]VZFU$_:D['P)YS+PW9?]O$L3J9AR/QSC7)^-2,9R5CO8<]N+*0!Y\9\
M>ZZTH@Z$>(Z$;&J,?(E9EU1_B&JG.Z^V/D;TP\DL28SJF7V5*<ML]&OREQA]
MVA2L Z$$;+0=TG[C75QE;RK?%/Z%>C+VX<YDQSF#'$W.UJ3'O<5*4WBT*5J[
M'=/B-?>;41[*ON.]<QE8LK$J;MS+$ZGT\M<2XURYC2['>T!F>T"NUW5"07XK
MQ\1]*#H.]&NX^O0UC%R96)56F]!JIS6S;C[)>,\CEXSD\8LRFCWQWTZEF2P2
M0EUI7BDZ?<=CO7=X5V-R+E%[#SS5#'Z]Y 4 H#.>&/ZV,-_2L7^&*\F;_HG_
M /EDH]R.J%?-#U"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0'-CF1K*O5-ZK5
M\/Q;BN#B.+O/0Q\;49J&D?/2NP:!3KC@\M&O_0&NFM36Q&"ML<](/I[QVU,V
MS^AD6ZN-IT=GW,KE275>*E*4K0:_0@ #P%1JS)-7JS](N,X-C,CEKB5#MF%F
M<;?NUG:=6IM#:G$I$B,M2BMLMJ()2%::;ITTWDF8*=]*O)MQY7X7LF1WMPO7
M^*7+7=9*M.YY^&0D.G3Q6@I4KZ]:BS)NFL 4 H!0"@% * 4 H!0&D?4]P==N
M>L)MV*VB[Q[._"N*+@M^6VMU"TH:<;[0$;@ZKUK*8,WX@P>7QMQGC>"3I;<^
M78H@B.S&4E#;A"U*U2E6X&_C1@UWZ@O2MA///R]UE2%V',HC?DLWR*VESSF0
M#VM26B4^8E)/LJ[@H=-=-J)T,$Z-_J[,XDEJWW3DUI=C;4"64Q9+A"0=^UI;
MX0#ITWJ74"N>$^#<,X+QE=@Q1#C\J6M+UUN\G0RI;J!HDJ[0 E*=^Q"=AJ?$
MDU%LR;-K % * 4 H!0'-K]9+_6'AGZ%=_G2ZG$%C^EK^SUQ[^B6OX:JBP;>K
M % * T]R+<(+^5&V-2$*N46(V_(B _E4-.*(2OM_%)VUKIOQJ?V:^TY;\K%J
MZGNH:SS?"+)GUD79KRD(<3JJ!<$I!>BNGXD_2D_$GQK:)T/!8ORM2JOXDHH7
MFW!F;$$%N0V?:3N8=PB$_@4E0^])^NKDTU[/'U.CI;RK?BJ96&%YI9,]L;=[
MLCG:1HF= 6K5Z*]XH7]*3\*_$?754HT.;O696I=,OXGP<B<=6?D6S_(SNV+=
MXP)MEU"=5LJ_$7INII7B/#J*Q%T)X^3*S*JTWHF"PW[,N$<Q?B2V%-E"@BYV
MQPGY>7'UV6D]#J-T+']T5=L:.AN6[>3;JO@RN,8R:S9A96+]8GO-A/C1;:B/
M-8=^)IT#HH?L]15+5&<S=M2MRZ9:F+<H\6VWD:W!QHHB95%3I N*AH'$CHP\
M1U2?A5U3]E%*AZ<7*=E_VDZ8/G&3\/9-)MESC._(>;Y5ZLCOLZE.WF-Z[!8&
MZ5#90^JK:)JC-Y?L0R(53V[F5Y9KS:LBM4:]V.2F7:Y:>YEY/O _$A8^%:3L
MI)JEIIT9S%R#A+IEJ:_Y;XCBY_%5=K0E$;,(Z/8</LIFH2-FG#^/M["S]AJ4
M94/=B9;M.C[>1H[C'D^\<7W=ZQ7YAY>/*=*+C;%@I>BO:Z%UH*Z*'Q)Z*JQI
M-4?CR-ME8L;\>J.O'B5S!G0KE#CW.UR42[=*0'8LMDZH6D^(^@CQ!W!JFE-C
M.:E%Q='J:CYDX;:RYI[)\892WE3:>Z7"0 E$]"1N0!L'@/WWVU.,MS-GAYGV
M_3+MY>1K#B'E^7@TH8QDWF.8PXZ4'O!+T!TG0J2#OVZ^^C[QO4Y1K[S89>(K
MJZH]W,J]A]I]IF7#>2]'>2EV-):4%(6A6Z5)4.H-4G-M4V,T3S3PLBZ(DYCA
MT8)N20IV[6EE.@> W4\RD?%XK0.O45.,MS-SA9M/1/3<S&.&.:%8^IG$,O?4
MK'U*[(%P<)4N"LGW%^)9)_>_94Y1ZO?S\R_,PNOUPUYE0I/;VK0H*2H!2%I(
M4A:%#8@C4*21^&J#GFB<.:N%A'$G,\,C?YKN[=[2R/XGQ+S('P?C)'N_95L9
M5V&^PLVOHGKN9^W"O-2=(^&9K*T1LU:+T^KW-!HEA]1^'P2L].AVK,HUVK7G
MYD<W"_G@O>BB5)4A12H:*'454:,T_P"HO'IMVPZ#>K:RX[*L$HO/*922MN,^
MD!3A[=PE*D)W\-:E%T-M^,G2XX\5R,U],WJ:3D*8O'W(4L)OR0&K1>GUZ"8
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M#'];&&_I6+_#%>3-_P!$_P#\LE'N1U0KYH>H4 H!0"@% * 4 H!0"@% * 4
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M&<TM:$IN\5(" ZGW4R6T_BJ/O >ZK;H17&?D<!XT]G8]/V+XRJC<=:DF* 4
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M3>W<^/F5RB?1Z8_4WY/R?&_(TO\ );,6*_R5Z=G@B-)4KP\&W"=O=.VA$<_
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M3@DP3F(;3BW&Y1#K3W8M2M"D:M ;?2:I_P"##^M_(?<]AM@^N7)M=L3@Z?\
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M\18E9ZXRXHQ<>A.== 4B@% 9=Q9_63B?Z5B?]\FO/E?Z9^YF8ZHZMU\Q/6*
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M.ZD*;<0HD%*@>H-=+^-_U?$Y7\FVKZ:X$/<N\0R\$E?TFQDNN8PMP+"DD^=
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M?$?744Z$;%^5J58DGD9MP9FP(T;EMCZU1)\11\?QDJ'WI/UU>J->SQ]3H_\
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M@C8@BN5:IL+2*O4WZ9!"^;Y&XXB:0P%/WZQL ZMG754B,@?#XN-CIU&VPZ+
MSNKT3UW,A*(],GJ;5#,/CCD>9K#/9&L%\?(_)?"F/(6KX.@0L^[T/LZ=LL_
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M+WJ-D<>-0^..09KDG$TDM0+O([E/0'%*]Q?4^1J>G5'V:UMLG\<I1K#N7_\
MEYD%+B7ZTZW):0\RM+C#B0MMQ!"T+0H:@@C8@BN::HRPBSU-^F,Q?G.1^.(9
M,8]\F_V-@#\E\2I$9 ^'J7&Q[O4;:@=%@Y_52$]=S(2B?SZ9/4X(0A\<\CR]
M(0"8]BOKQ.K9)T3'D+)]SP0L^[T/LZ:2SL'KK.&N]<?:O:8C(M5YEJ0TXQ(;
M2XPXE2'6E@*0M"AH4J!U!!&Q%<VG30L((]2GIKD8._(S_ 8ZW,3<67KC :U*
M[:LG7O1IN6">A^#H=MZZG!SON^F7=S\RN43'[MZCEY7Z=,RXXSJ03D3<!M%E
MNJ]3\XAMYL^2Z?\ "@#V5?%X[]?'GX2C_DAIO7ZHS&17?IT@0KIZ<\"MUQ8;
ME0)5ACM28SR0MMQM:2"E23L0:TO4XRJM22)+]0?IZNO$US_IEAOGNX8MX.MO
MMD^?;'RO5*%J3OV:Z>6Y]QWZ]3AYJO*DN[F5R5#??IL]2L?/68^$YL^AC-FD
M!$*:LA#=R2D=/H#X'4?'U&^U:W.P.CUPTWKAY<B<95*)OECM.2VF78[Y$;G6
MF<VIF5%>3W(6A7[1'4$;@[C>M/"<H24HNC1(YT\U\*9-P+E$7)\6DR%8P9"7
MK->FR0_#D)/<EEY2>BA\*NBQ]>H'6XN5'(C1Z[UXW%35"K?3QZB+=RQ;D6&^
MJ;A\@0V]9$<:(:FMH&[[ Z=VF[C?AU'L]-)FX3LOJCV\B:=3;F7XAC^=X_+Q
MG)HB9EIFI[7&U;*0H>ZXVKJE:3NE0K7VKLK4NJ.I(YS\D\:YSZ<,ZAWJSRG?
MS>EXOX]D#0T2L).I9>'0+ V6@[*'TBNNL7X9,.:*FJ%I<#<\67F"RAEWLA9G
M!;!NMLUT"P-O.8U))03U'5).A\">=S,-V75=K)IU,XY#X]QODS&I.,Y-'\V(
MZ.]A].@>CO >RZTKP4/P$;&O-8ORLRZHF6CG;DN,\C>F/D:/.AOJ:=:4IRTW
M5 )B3HIV4A:>AU&SC9W'X#766[EO)M\4]454:+OX7YHQWF''OG[<1%O\1*$W
MFT*5[;+A'OHUW4TH^ZK[CO7,Y>)*Q+C%Z/QO+4ZGI<K<4XURUC2[!?T>7(;U
M<MMR:2//BOZ:!22>J3\:.BA]>A$,;)E9E5:;T&JG/UI?)GI<Y+!6GRI;0]I!
M)5 N<!2OJT[DG3]TA0\"*ZG_ !Y5OBG\T_W*ML6=!N+>4L9Y7QIK(<==T<2$
MMW*W+(\^'((U+:QXCKV+&RA]X'*Y&-*S*C^#XEJ=3Q^:N%,>YBQ[Y*=I#R*&
ME2K-=TI]MI9'\6YINII1]Y/AU&_6S$RY6)<8O5>-X:J0EBF5\B^F/D63"G1E
M-.MD-7>SNDF-,C$ZI<;4-CM[3;B?[HKIKENWDV_9N?CZHK6PZ*X#G^-<DXY'
MR?&)(D07O8>;.SS#P *FG4^"DZ_?U&U<E?L2M2Z9%I@'/G EHY?LWS47LAYK
M ;5^;+CH$I='7R'R!J4$^Z?A/U:UZ\/,=ET?:S#52,^+N4,V].F;R[+?(;XM
M?G!K(,?>]D[='F==@X =4J&RA]6AKH+]B&3#D_&XK3H=&,3RRPYO8HF28U,1
M-M$Q(4T\@[A7Q(6GJE:3LI)Z5R5VU*W+IDMI:::]1?IU@<IP%Y'CJ&XF>PVM
M&UZ!#<]M V9>/@L#9MP_8=O=V.#G.T^F7;R(N-27>#^;\DX(R:3BF61I"L65
M(+-XM#J2)$&0D]JGF4JTT4/C1T6/KT-;G*Q8Y$:K7<_&X@G0Z)V6]6K(K5$O
M=DEMSK3.;#T26R>YMQ"O$?@T(.X.QWKDYPE"3C)4:+2<?4KZ:6<Z8D9S@\=+
M6:,H*Y]O; 0BY(3U4.@#X'C\?0[UN,'.Z/1/MW/AY<B$HU-&>GCU#7+BJY_T
M*S4NN8:MXM*2Z%%^V/\ =HHI2=^S7^,1X=1OJ#LLW"5Y=4>[F1C(Z#P9T.Z0
MV+A;WVY,&2VEZ-(94%MN-K&J5)4-B"*Y247%T>I:25ZF_3*+J)G(G'<0"Z>T
M_>[(R- ^!NI]A(^/Q6@>]U&_7?8&?I";]S_1D)1,']-/J6<PUR/@'($A2L6*
M@U:[D[J5P'"K^+</7R=3_P!3[.GISL'[OKAW<_,Q&1>3;C<AM+C2DK9<2%(6
MDA25)4-001L017+Z%A$_J:],BK>9G(O',36 >Z1?+&P-V23JI^.@#W/%:![O
M4>SKV])@Y_52$WMW/CYE<HGT>F/U.)CB'QQR/+T9';'L%]>/N?"F-)4?#P;<
M/3HK;0B.?@=59P6W>C,9%H/,M2&EL/H2XPXDH=:6D*0I*AH4D'8@@Z$5SJ="
M9 WJ3]-DC!)#^?8"PM>(+5YT^"T27+:X3[R?$LD]#\'0[:&NIP<[[OIEW<_,
MKE'>C97IF]3*,A1$X]Y E)1?T!$>R7=TZ"8![*67E';S>@2KX_'VNOCSL&E9
MP^*,QE4JFXVZ#=H4BVW*.W*M\MM3,F,\D+;<;6-%)4D[$$5HXR<75:DSGCZ@
M?3Y=N(KH,OP\ONX6MU+C$E"C\Q;I!5JE"U)T/;K_ !;GW'?KUN'F*^J/NYE3
MC0H+TV^I2/R!'9PS-'T,9PRD(AR5:(1<FT)Z_0'@![2?BZCQ%:G.P>CUP[=Z
MX>1.,JE"WVQ6G)K1,L-]BMS;3/:4S*C.C5*T*'[!'5)&X.XWK4PG*$E*+HT2
M.<O)>'Y7Z9N5&KIA\J2Q;"1)L-T=2"EYE0'FQGM/97VGV%I/4:'0:UUUB['*
MM>I+VKQ]"IJC+8X2YLQ_F+'OFXG;#R:&E(O-G*O::6=O-:UW4TH]#X=#OUYS
M+Q)6)<8O1EB=3W>3^+\9Y6QEW&\D:.VKD"X-@?,1)&F@<;)_ I)V4/N(KQ\B
M5F74OBN(:J<]9L+DOTO<DI6VOR)K0)8D)!5!N4%2MP0=.Y)T]I/O(5]! -=4
MG;RK?%/YI_N5;8LVES5?9OJ+M6*9-QW:)5Q?M[#[%^ML=!=>@25J00ES3X%Z
M'RU]%:>!VJ/XZ,<5SC<DE73VB:KH:?\ ]RW+/^QUT_T=5;G_ -EC^M?,KZ9<
M#RCQUG:;^G%58].3D:V3)1;5,J#ZF4@DK2DC=(TZBI_^FUT]74J<1TO@>K_N
M6Y9_V.NG^CJJ'_LL?UKYCIEP,FXZXCY.MN?8U/G8I<H\./<HKK[[C"@A"$.I
M*E*/@ *\^3EV7:DE-:,S&+J=**^>'I% * 4 H!0"@% * 4!S_P"))\+#_7OG
M]NR<IC3;ZY<F;.])(1W.S'&9;"4E6VKC0T3].P'6I/0P?9^L'_\ BRXJ_P#D
M[W\XCT1DHSU7Y%9,=X"S1=[6V$W&"JW0H[BNTORY)"6T('4D>_MX))K"U,,P
MCT#6V= ]/T1^8A3;5PNDZ5$"AIW,ZH:[A]14VJCU"*?K!D4 H!0"@% * 4 H
M!0"@(B]=G%O'6,\5NY98<9@0,GGWN.J7=F&@B2X7PXIS57_2(U-239@WAZ0O
M[.& _P#@Y'\\?K#U,DA<DVZ7ZG_66OCV7,<:Q+'G7+<L-J_BH=L3WRRV.@6\
M]JCN^M/T5+1&"VAZ<N"A9/Z/?[O[+^;.SR__ &1'S.FFFOS/\=W?]+S.[ZZC
M5BA$7'L";Z7_ %ELX# DN*Q#(Y#5O0TXO7S(%TU^4+G@5,ND#N^H_2:EJ@5I
MZR_[.F8__(XW\Y;J*U#/9]*W]GGCW]%I_P"\71F3<%8 H!0'-O\ 62@_[P\,
M/@;*[O\ _P TNIQ!8WI:_L]<>_HEK^&JHL&WJP!0"@-3\E:&^-!20I"H_:M"
M@%)4E1(((.Q!'45TOXW_ %?$Y3\I_N7N(MYGX7./E[+\094JP*/F7"WMZE4)
M9/OH\2T3^]^RMS&5?>>W"S>OT3UY^9D_"W-*;JF-AV8R0FY)"6;3=G5:!\#9
M++RC\7@A9Z]#24:[4>;-PNGUPTWHWN^PT\T]$ELI>CO)4U)CNI[D+0K925)/
M4&J33IM.J)/Y>XAE8-*.3XR'',66X%:H)+T!XG5*5$;]FON+^X[U=&1TF)EJ
MZNF7=S-H<-<R-Y>TUC&4/);RMM(1#EK/:F>D#0)).P>']_\ ;6)1WHUV9A_;
M?5'MY>1MJ? A72%(M=TC(EV^4@M2HKPU2M)_:(\#U!JLUL9.+JM21^3.,KSQ
M;=V;]8GGEX^IT+MUT;)2[%>!U#3I3[JAI[*OB%6QD=-C9,;\>F6N]&\>).7(
MF?Q4VF[*1&S&.@=[0/:F:A(W=:'X^VJT?>*C*--JTY&HR\1VG5=O(V!>K+:L
MCM4FR7J,F7;):>UUI0W2?!:#\*TG<$5!.AXH3E"75'4D3.<'R?AW)HUSM<IW
M\W^9YEFO;7LZD;EIS38+ V4D[*'U5=&1TUB_#)@TUMWHHKB[E*V\C6XMNA$/
M*8J=9UO!T#B1U?9!ZI/Q)^'[*KE&FU:&CRL5V7_:91D^+V7,;,]8K\P'H;VJ
MFG !YK#NF@=:/@H?@/C44Z'FM796Y=421[[8LRX1S%B7$?4VM!*[9=&P?(EL
M'WD*'0ZC9:#5R:9TT)V\FWM^*X%0<=\B6?D:SF=!"8UWC "Z6KNU6TH_RB-=
MU-*/0^'0U7*-/<<]DX\K,J/3<S[LUPJRY[8UV6]("5)U7 GI&KT5X_$D^*3\
M2?&L)T(6+\K4NJ/\24",VX,S;7=J0WT.YAW"&3^!25?A2?KJU-->/%3I/\>5
M;\53*NPG-K)GUD3>K*OL6G1$^ I6KT5T_"H>*3\*O'[:JE&ASE^Q*U*C/DY#
MX\L_(MG^0G]L:Z1P3;+H$ZK94=^Q6FZFU'WD_>*RG0ECY$K,JK3>B7;-><SX
M0S-Z-)94VX@A%QMSA/RTR-KLI)Z$$;H6.GX15NQKV'0SA;R;=5\'P*XQ?*++
MF5E9OUA?\V$[[+K2OXUA[34M.#P4/IZ$;BJ6J,YJ[:E;ETR,9Y0XOMG(MM"T
ME$3)XB"+?<"- L#<,O'Q0?A/P_92+H>C%RG9?]I.6%9KE'#642K9<HKGR?F!
MJ]65XD!02=G&_ + W0L;$?55K2>QF\OV89$*I[=S*\LE[M626F-?+')3+M<L
M:M.C925#WD+3U2M/B#5+33HSF)VY0?3+4P'EOB6)R!$-TM:41\QC(T:=.B43
M$)Z-.G\;\1?W&I1E0]N)ENTZ/MY'Q>GF;-1A]QQJXMN1KICMQ6TZPZ"'&TR$
M]P!!W&BD*K,MQ/\ (Q76I+22+2Q^<FXV6%,20KO:2%:'7VDCM.OUZBN*R(=%
MR4?:=+C7.NU&7%$7?K ^)\:8PQGE*W($*_?G&/#N3;20&I8?2YHXL#HXGMW5
M\0ZU:LF3M?;>U;O87TVF%>F[U$7'BQ^-A^7EU["9!;00[W%VVNJ "EH2=3Y9
M)]M'WC?77H,K#5Z"DNZGS\<2"E34Z'P+A"NL)BXVV0W+@2FTO1I+*@MMQM8U
M2I*AL017*RBXNCV,L)0]3/ID%\3*Y"X\B 7M(\V\62.@ 2@-U/LI'\K^,D>_
MU'M==Y@YU/1-^YD)1J:]]-?J4?PA]C <^?6O$UK\NWW%XDN6U9V[%ZZGR"?#
MX.O2O9G8/W?5#NY^9B,N)>K3K,ME#[*TNQW4A;3B"%H6A8U"DD:@@@[&N6::
M9819ZF_3(8AF<C\<0]8I*G[[88R- UH.Y<F.E/P^+C8]WJG;4#HL#.ZJ0F]N
MYE<HG^^F+U,"+\IQOR+,_P W)#-BOTA?\7X)C2%*^'P;6?=Z';0C.?@]59PU
MWKC[?>(R+2=:9E,K9?0EV.ZDH<;6 M"T+&A!!V((KG$VM"PYX>L#TV*P>RW3
M/,'8*\/=6VJXVY U-N6IQ/M)^EE1.WXIVZ:5O8YRN6)1GW4^?F0Z=IL7T;^H
MFW/XM8.*\O6W#FQ(Z(V/W!1"&GVT^['<)V#@Z(/Q=.O6B]@O[2N0X;5^IE/<
M6+<+?"NT)^VW*.W*@2FU,RHSR0MMQM8T4E23L016JC)Q=5J2.>WJ$]/=TXGN
MG],\,\YS#''_ #6G&BKS[8]W=R4J4-^S7^+<^X[[GJ\+,5Y4?=S*VJ&^?35Z
ME&,]CL83F\A+.;,H"(4Y9"$7)"!]P#X'4?'U&^U:W/P>CUP7IWKAY<B495*)
MOMBM.36B78;[$;G6B>V6945Y/<A:%?M$'<$;@[C>M/";A)2BZ-$CG3S7PID_
M ^3Q\FQB1)5BZI =LM[:)2_$?![DLO*3IHL:>RKHL?7J*ZW%RHY$:/7>O&XJ
M:H5;Z=_4/;^5[:FPWY34//X3>K\<'L1-:0-WV0?BTW<;'3J/9Z:3.PG9?5'M
MY$TZFW<OQ"P9UC\S&<FB)F6F:CM<;5[R%CW7&U=4K2=TJ%:^U=E:EU1U)'.?
MDOC3.?3CG,2\6>6\+<'B]C^0,CM"PG<LN@;!8&RT'90^JNNL7X9,.:*FJ%I<
M#\\V7E^R^4\6X.9P4 W2U Z=P&WGL:[J;)ZCJD['P)YW,PW9=5MB_%":=3.>
M0N/<;Y,QJ3C&31P]$>'<P^D#SH[X'LNM*/10_9&QVKS6+\K,NJ))[3G9DV,\
MC>F/D>--B/K:6RM3EJNK8/RL^*#HI"QKH=1LXV=Q^ UUENY;R;?%/5<"JC1>
M'#',^.\P8Z+C;RF)?XJ0F[V92]7&%].].NA4TKX5?<=ZYG+Q)6)<8O1^-Y8G
M4]'E;BG&>6<9=Q^_MAJ2G5=MNB$!4B(_X*03IJD]%H)T4/KT(KQLF5F55IO0
M:J<_$+Y+]+O)?M)4S)9/M(/=\A=('=]W<A6G[I"OH(KJO\>5;XI_-/\ <JVQ
M9T&XMY2QKE?&&<BQ]T)= 2BY6U:@9$.01NVX-M0=-4+TT4/O Y7)QI694?P?
M$M3J>1S5PKCW,6/&#.[8>11 56>\I1JXRKKY:]-U-*/O)\.HWJS$RY6)<8O5
M>-X:J0EBF5\B^F7D21"GQG&E-+#=VLSJB(TV-OVN(4-0=O:;<3_=%=-<MV\F
MW[-S\?5%56F=%< S_&^2<;C9-C,I+\-\ /,DCSH[VFJFG4_"I/[/4;5R5^Q*
MU+ID7)FO^?. [/R]9OFH@;@YM!0?S=<^W0.I&I\A\C<H.OLJZI/U:@^O#S'9
M='V\C#52,^+N4<W].F:R[->HCXM8>\F_X\\>W4IV\YG78+ W2H;*'U5T&1CP
MR8<GXW%:=#HSB>66'-[##R7&I:)MHFH"VG4^\D_$A:>J5I.RDGI7)7;4K<NF
M6I::;]17IU@<IV]60XXAJ'GL-!['= A$]M"=F7CT"QIHVX?L.WN[#!S7:?3+
MMY$6JDM<'\XY)P5D;^+Y3'DKQ53ZFKM9W0I+\*1J$J>92KHH:>VCHH?7H:W>
M5B1R(U6NY^-Q!.AT5LMZM616N+>[)+;G6F<VEZ)+95W(<;5T(^CZ"#N#L=ZY
M*<)0;C)4:+2<O4KZ:F,[8D9Q@\=+.:,I+D^ V E-R2D=0-@'P!L?CZ'>MQ@Y
MW1Z)Z;GP\N1"4:FC/3OZA[EQ7<AA.:EU>&./%LAX++]L?)(44I._EZ^^C3;J
M-]0=EFX2O+JCW<S$94.@\*;$N41B?;WT284EM+T>2RH+;<;<&J5)4-B"*Y24
M7%T>I825ZF_3*+L)7(G'</2[>T]>[(PD 2 -U/L)'\IXK0/>ZC?KOL#._DF_
M<_T9"4:F"^FKU*NX:['P#D"2I6+*5Y=MNCQ4I=O6HZ!MS74^23^\^RO3G8/W
M?5#NY^9B,B\VW&I#:76E)<9<2%(6DA25)4-001L017+M4+")_4WZ93;S+Y&X
MYAZP#W2+[8XZ=/(^)4B.D?!XK0/=ZCV=>WI,#.ZJ0F]NY\?,KE$_?TR>IOY?
MY/CCD:9HQ[+%AOTA1]@]$1I"E?#X-N'W>BMMQC/P>JLX+;O7ZB,BT'F6I+3D
M>0VEUAU*FW6G$A:%H6-%)4D[$$;$&N<3IM1801ZD_39)P22]GV L.+Q-;A>G
MP602Y;'"=>Y.F_DD]#\'0[:&NIP<U7?3+NY^97*.\V3Z9O4TC(41>/N0I81?
MT -6>\OKT^<WT2RZH_RO@E1/M]/>Z^/.P*5G!>]&8RJ53<;=!NT)^VW..W+M
M\I"FI,5] <;<;4-"E23L16CC)Q=5L9,YY^H+T^W;B*[IS'#3(<PUQX/,2&BK
MS[8_W:H0M:3KVZZ>6Y]QWZ]9AYBOJC[N?C>BJ2IM1O\ ]-GJ4C9_&8PO-'T1
M\VCH2W#EN*"4W)*1X:[!X ;I^+J/&M7G8/1ZX=N]</(G&53>.>X'CG)&-RL8
MR>,)$"0.YMP:!UAX#V76E?"I.OW]#M6LL7Y6I=421SKS'#>1/3+R'&N5MD.-
MH:<4Y9+VVD_+S(_Q-.)Z:Z'M=:5^UH:ZRU=MY5OFN'C<RIKI+FX3YOQWF*PB
M3$*863PT)%XLI5JMM73S6M=UM*/0_#T5OUYK+Q)6)<8O1EB=3(.3N,,:Y6QE
M[&\D:VW<@3VP/F(LC30.-D_@4GHH?AJO'R)69=4?BN(:J<])43DSTN\DH<22
MS):)+#P[E0+G!*M-"-NY)\4GVD*^@BNJ3MY5OBG\T_W*]L67[Q'R]C7+N.(O
M-D7Y5Q8"476U+4/.C/$;ZCQ03[B_'[=17+9.+*S*CTW,L3J9C)L5HF7:#?9,
M1MR\6U+J(,TI_*MH?3VN)"A\*AX&O.KDE%Q3V,R>C4 * 4 H!0"@% * 4 H!
M0"@):]5?I37S&[&SG!Y3=LY(MS:6R75%IF>TT>YI*G$[MNMG^+7]QZ C*9@C
M[D?"/6'DDBQP,]QZ[WM_%7%_FF:8[4HDJ6A6I?9U\T:H3IW$U+8#9EF]//J6
M]2.40;WS[/DV3$X:ROR)/EM/]BNWN;B0VO9;*]-"XL#3_I=*Q5+0'0;&\=M&
M)6&W8S8(R8=EM3#<2#%1T0TT- -?$GJ3XG>HF3U* 4 H!0"@% * 4 H!0"@)
M0_6$?U%,?IJ'_ =J4=3!L+TA?V<,!_\ !R/YX_6'J9).](7^?>KG.ITO>6&[
MTH%77N7-0%?L5*6A&)T>J!(YQ>LG_,?5;@$^(>V8IJS**D[*U1<%A-3CH8H7
M[FN%XYR%CDS$\LB?/6&>$B5%[UM]W8H+3[392H:$ [&H&3]\3Q6QX1CMOQ3&
MHWR=BM;7D08O<ISL;U*M.Y94H[DG<T!J/U<V[.[IPS.A\<-7![)U389:1:%+
M3*\D.?E-"V0K33KI65J89SX_H1ZQ?_<,S_QLO_MU.J,#^A'K%_\ <,S_ ,;+
M_P"W2J!K?DRS\KV>? ;Y79NS-R=84JW"]K=6X8X60?+\TD]O=KT\:RJ&4=9?
M2S_9ZX]_1+?\-=5O4R;?K % * F?EWE&W8]R]&P[(?+BVV;;V'H-SW_)R'%J
M3V/>'8>W97@>NU=1^,C6SLUJ:+\EBN;ZXZI:'WJ24%2%I!!!2I"@%(4E0W!'
M0@BM@<X2]S/PO^8"_E^'LJ-@)+EQMZ-U0EJ/OH\2R3^]^RK8RK[SHL/,Z_1/
M7GYF3\+<TINB8V'9E)";BD)9M%V=.@? V2P^H_%X(6>O0_324:[4>?-PZ>N&
MF]&]WF6W6WHLII+K#J5-2([J>Y"T*V4E23U!JHTR;6U$H<O\0R<&E?TGQ<.K
MQ=QP*U227H#Q.H2HC?LU]Q?W&KHR.DQ,M75TR[N9L_AOF1O,&VL8RAY+>5MI
M[8DQ9"43T)&P)Z!X#]_]O7$H[T:_,P_M^J/;R\C;<Z#"N<*3:[I&1+MTM!:E
MQ'1JA:/H/B"#T(W!JLUD9.+JG1DC\G<87?BZ[L7^P/O+QU;P<MMR02'XCP/<
MEITIZ*'PJZ*JV,CI<;)C?CTRUWKB;OXCY=BY_%3:+N4Q\QCHU<2-$MS4)ZNM
MCP7^.C[QX@1E&FU:<O(U.9B.TZKMY&PKS9K5D5JDV2^1DR[5+3VO,JV((Z+0
M>J5IZI4*AH>*W<E"75'4D/.<&R;AW)HMUM4IWY#S?-LE[:]DZI_DW--@L#92
M3LH?55RE4Z:Q?AD0H]=Z**XLY1M_(UM4VX$1,IAH"KA 3LAQ(V+[(_%/Q)^$
M_55<HTVK0T>5BNT_[3*<FQBRYC97K!?V/.@/>TA:=G670/9=:5X*'[(V-1K0
M\]J[*W+JB2-?K#F7"&91Y<1\MNH)=M=S;&K$I@G0I6#MN-EH-7)IKV'2PG;R
M;='\5P*@XZY$M'(UG,Z"!&N\5*1=;63[32SMWMZ[J:4>A\.AJN4:>XY[(QY6
M94>FYGH9IAEDSVQKL=\00E)+D&:@?EHKY&G>CZ4GXT=#]M13H0LWY6I=4?XD
MFK1F_!>; @AN8V/94-5PY\-9_ODJ ^U)^@U<FFO9X^ITG^/*M^*IE7X1F]CS
M^R)O5E44+1VHN$!9U=BO$;I/TH/P+\?MJIQH<Y?L2M2HSY.0N/;-R+9_S?<=
M(]TC!2K5= /;86?A7^,TH^\GPZBB="6-D2LRJM-Z)<LMZS/A#,GXLECRWD:-
MW*VN$F-+CDZA22.H(]I"QN/PBK=C7L.AG"WDPJO@RN,6RFRYG96;]87O-A.^
MRZTK9YA[3533H\%#Z>A&XJIIHYJ[:E;ETR,<Y0XPMO(UL!U3%R:&@BVW$[!0
MZ^2\?%!/0]4GZJ1="_%RG9?]I.&%YIE/#64RK9<HR_E/,#-[LKIT"@D[.-GH
M%@;H6.OV5:TFJ,WMZS#)@FM=S*\LE[M.2VF/?;'($NU2QJTZ-E)4/>;<3\*T
M]"/^:JFFG1G,W+<H2Z9:GZ(MD!NZR+VVR$726RB-,D)V+S;)U1Y@\5)Z!773
M:L5V4,.;Z>G<C!+IS#=>#^4F)<L.3<"RIAIZYP 2I3$AG\BY(C@D +VU6GHO
MQWT(\V3BQOPX26C_ $?L.C_%W?\ 'T\&>QZZ+Y:LD]-,6^V.6W.M,^[VYZ)*
M9/<A:%(>/V@CH0=P=CO7*2A*$G&2HT;H_;F7TW-<AX59\XPQE+6<,VJ&N;$3
MHE%R0F.C[@^![I^+H? UM<'.^WZ)]N[V>1!QJ:<]/GJ%NO$US_H;F7G.X6MX
MM.,N)5\Q;'RK12T)._9K_&-_>-]0=IF8:OJJ[N?C<R*E0Z&0)\.Z0V+C;GT2
MH$IM+T:2RH+;<;6-4J2H=017)RBXNCU1:2EZFO3*B_)E\A\>Q0F^I"GKU9F1
MHF6!NIYE(Z.^*D_'U'M>]O,#.IZ)_!D)1-<^FSU*/X-(8P#/WUN8BM89M\]W
M4N6UPG3L7KN6">H^#J-M17MS<'[JZX]W/S,1D7PTZW(;0^PM+C#B0MMQ!"DJ
M2H:A0(V((KE6J:EA%7J<],PA_.<D<<0](0"I%_L; _BB-U2(R!\/BXV/=]X;
M:A/1X&=U4A-[=S*Y1'ID]3?RGR?''(TO_-/8C6"^/'^*.O:F/)63[G0(</N]
M%>SNG.=@]59P6W>N/N]HC(W9ZNB?^'7._#_,V]?](;KFT6$6WC@2ZVGAG"N6
M,5#LNRSK1$DWV/KW/PY*@ IY/:!JRI6_TH/7:NGP,M27VWL:T]OF5R6\H;TR
M^IL7SY3CSD*4!>_98L=X<V$D :)9?5_A?!"_CZ'VO>\V?@:W(?%?JC,9%83X
M$.Z0W[=<&$28$IM3,F,ZD+;<;<&BDJ!V((K11DXNJU)G/7U#>GFX\4W(YGAG
MFKPIQY*VU(4HR+;(*M4I4H>UV:_Q;GAT.^A/5X6:KRZ9=W,JE$WSZ:O4HSGK
M#.$YO(0UFS2>V#-5HA%Q;0/'P#X W'Q]1OK6MS\'H]<%Z=ZX>7(E&52BKY8[
M5DEIEV.^1&YUIG-J9EQ7AW(6A7AX$$=01N#N-ZT\)RA)2BZ-$SG5S;PEDO ^
M31LHQ:3(5BRI"7;->6E$/PY ]H,O*3IHH:>RKHL?7J!UN)EQR(T>N]>-Q4U0
MJGT[>HBW\K6]-@OZFX>?PV]7F![#<YI W?9'3N&FKC?AU'L^[I,[!=I]4>WD
M3BZFX<NQ&P9SC\S&<EB)F6F:CM=;5LI*A[JT*ZI6D[I4*U]J[*U)2CJ2.<O)
MG&N<>G'.HEYLLMY-M#Q>QW(&MN\)W++P&P6!LM!V4/JKKK%^&3#FBIJA:' O
M/=FY@LWR[_9"S6"V#<[8"0E:1MY[&NI*#J-1U2=CX$\[F8;LNJVQ9-.IGG(/
M'V-\EXU)QC)HX>AOCN9?3H'H[P'LNM*\%)_ >AVKS6+\K,NJ)(YUY/C/(WIB
MY&8F09"FW&U*<M-V;23%G1"=%(<2=MQ[+C9Z'IX&NLMW+>5;XIZHI>PN_A?F
MC'N8<=_.%OTB7^(E*;Q:%*U6RX?C1KNII1]U7W'>N9R\25B7&+T?C>6IU/3Y
M5XJQGEG&G,?R%KMD("EVRY-@>?$?(V6@^*3H.]!V4/KT(KQLF5F55IO7$-5.
M?85R7Z7.2U)!\J6ULKWE0+I *M?J[DJT_=(5]!%=5_CRK?%/YI_N5;8LZ#<6
M<I8SRQC+>18ZYVNIT;N5M<4/F(DC3="P.H/5"^BA]>H'*Y.-*S*C^#XEJ=3R
M>:>%L=YAQXP9X3$R&(E1L]Y2G5;*SOV+TW4TH^\GPZC>K,3+E8E_:]4&JD(X
MKE7(OIDY&DP)L=32VEI;O%I<)^6G1024N-JZ'4'N;<3T_"*Z:Y;MY-OV;GX^
MJ*DVF=%< S_&^2L;C91B\GSX+_L.M+]EYAY/O-.IW[5)U^_J-JY*_8E9ETR+
M4S >>^!+-R_9C)C=D+-H+9%KN1V2X!OY#^FNJ">AZI.XVU!]6'F.RZ/M8:J1
MCQCR=F_IRSB99+S$=%L#X8R*P.GKV'3SF3KH%@'5"A[*AUVKHK]B&3#DRM.A
MT9Q++;#G%@AY-C4M,RT3D=[+J=E)(V4A:3NE:3LI)KD;MJ5J3C+4M-.^HGTZ
MV_E: O(<?2B)R!$; 9>)"&IS38V9>/0* V;<\.BO9W3L,+.=I],NWD1:J2QP
MCS?DO!62OXKE##ZL45*4U>;.ZD_,0I"3V+=92HC10T]M'18'TZ&MWE8L<B-5
MKN?C<03H=%+'>[7DEIB7RR2FYMIGMI?B2FCJAQM70_2".A!W!V.]<E.#A)QD
MJ-%I.?J5]-3.>,R,XPAA+>;-)[IT!&B&[BA ZCP#X'0_'T.];?!SNCT3[=SX
M>7(C*-31?IW]1%RXLN(PO-%.N86X\6E!P*+]L>*B%*2D[^7K_&-^'4;Z@[/-
MPE>75'NYD8RH="(,Z)<X;%PM[Z),&4VEZ-(:4%MN-K'<E22-B"#7*2BXNCU+
M"3?4UZ9$WE,OD/CN(!>1J]>[*R $R$@:J?82/Y3Q4@>]U'M==[@9^D)OW/\
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M*]5MGIYK6NZF5'H?A/LGP)YK+Q)6)<8O1EB=3(>3>,<9Y5QE[&\D9VT*X$]
M'S$21IH'&R?[Y/10V-58^1*S+JC\5Q#53GI<+?R5Z7N2D.-.>5+9U5%E)"C!
MN4%2MP0=-4G312?>0KZ]#75IV\JWQ3^:95MBR_.(N7<;Y=QM-ZLRO)N+ 2B[
M6I:@7HSQ'33Q0K?L7X_;J*Y?)QI694>FYEJ=38=>,R* 4 H!0"@% * 4 H!0
M'F7'([!9W4,7BZP[>\ZGO:;ER&F%J2#IJ XI)(U\10$:\:<LWZ7ZSLYL5YS1
MUS (T><JWPI-P'YK04&-Y?E)4OR]1W*T[=^M3:V&"OOZ=83_ +2VK_3H_P#V
MZ@9-2^I?EG'<=X4RN9CV80X>3.1DLV9=OG-?.F2MU _(^4LKU[==2GH*R@?/
MZ,<BRC*N";5?,NN4N[W:1-G 3K@ZM]];+;Q2@=ZR20--J/4% U@"@% * 4 H
M!0"@% * 4!*'ZPC^HIC]-0_X#M2CJ8-A>D+^SA@/_@Y'\\?K#U,DE\;2H?$'
MKPR"U9"ZFWV^]3+A#BO.J"&R+L$RHA).@'>2A ^LU)[481TAJ!DYN\IS8O+_
M *Z\;LEC5\_!LDVW0):VR%( M2U2YA!&Q[/;!^L5-;$19TBJ!(4 H!0"@.;7
MZR7^L/#/T*[_ #I=3B"Q_2U_9ZX]_1+7\-518-O5@"@% 1=ZR>,KM?+ZQFUC
M[IBX<%#-QMR1JXEEM2E!YO3=0'=[0\.M=1^+?^*GM-?=RHQN_;ELJC6_"G-(
MC_+X9F<G_,]F[1=WE;M'HEEY1^#\51]W[.FWE'JVK7GY\S69N%_/#XHH]2=.
MY"TA25 I6A0"D*0H:$$'8I(/WU2:(F#F?AA5@4]F&'L*785J+EQM[8U5!6=^
M]&FY9)_>?95D9?,Z+#S.OT3UYF3<*\T(N:8^'9C)"+BD!NTW9Y6@? V2P\H_
M%X(6>O0TE&NU'GS,*GKAIO1O:0PT^T]$ELI>CO)4S)CNI[D+0H:*2I)Z@U6:
M9-K:B4.7N(9>#2_Z38P'',6<<"P4$EZ \3J$J(W[-?<7]QWJV,OF=+B9:NKI
MEW<S:'#?,C68--8OD[R6LK;2$0Y:O91/0D=">@>']_\ ;UQ*.]&NS,/[?JCV
M\O(VU/@0KG"D6RZ1T2K=*06I45T:H6@^!^@CP/4&JS61DXNJU)(Y.XPN_%]X
M9OUA>>7CJW@NVW)!(>BO ]P:=*>BA\*NBA5L9'38V3&_'IEKO1O#B/ER-G\0
M6B[J1'S*,C5QL:(1,;2-W&Q^.![Z/O'U1E&FU:<O(T^7B.TZKMY&P;S9K7D5
MKDV2]QDR[7+3VO,*V((Z+0KX5IZI4*AH>*W.4)=4=20\XP?)N'<FBW.V273;
MR[YMDO37LD]IU\IW38. ;*2=E#ZJNC*IT]F]#(A1KWHHOBWE&W<C6TMN>7$R
MJ(CNGVY.P<2-O.9!ZI/Q)^'[*KE&FFAH\K%=E_VF49/C%FS&ROV&_,^;!>]I
M#B=/-9='1QI1Z*'[/2HIT/-:NRMRZHDC7ZP9CPEF+$N*\I"D*+EKN:!^0EQP
M=TJ'3<;+0:N4DSIH3MY-NC^*X%0<=<BV?D:S_.PNV->8R1^=;5K[3*CMWHUW
M4TH]#X=#]=<HT]QSV1C2LRH]-S/OS3"[)GMD78[VDI )7"G-@%Z,]X+1KU2?
MB3XUA.A"Q?E:EU1_B2<M&;<&9LDD>7*:W0K=4.?$4=/J"DJ'WI/UU:FFO9X^
MITG^/*M^-A5V$9O9,^LB+S9E]CJ E-Q@*.KL5XC=)^E)^!?C]M5RC0YR_8E:
ME1GR<A<>67D6SBWW B-=(X)MEU2G5;*NO8OQ4TH^\GPZBL)T)8V1*S*JTWHE
MVRWK,^$,R>C2F"V\V0BXVUPDQID?7922-B"-T+'2K=C7L.AG;MY,*KX/@5QB
MV4V7,[*S?K"]YL-W1+S2B/-CO::EIU/@1X'HH;BJFFF<U=LRMRZ9&-\G\7VS
MD:V@@HB9-$21;[B1H%@=&7CXH)Z'X?LI&5"_%RG9?]N\G'"\TRGAK*)-MN45
MT1 YY=YLCQ*0H#8.-^ 6!NA8ZCZJMV-49O;]B&1"J>W<RN[)>[3DMICWRQ24
MR[7*&K3J=E)4/>;<3\*T^*3^U5+36QG,W+<H2Z9:F/\ (G$BN7+.+?;I CY3
M:FW9-E2O0,R2>WOCK4?=[@-4*Z ]=JINWOM)2>E=OL]IL_Q<J7''BN1%.?9+
MF>-X-=.++MYL>UJNC+\NTRTD+C38H6"I 5N@J&RP-E;?0*\GY&$)VE-:\?8=
M)%[:'6KCNYV^[X)C=PM<EN9!>MD3RI#*@M"NUE*5:$>((((\#M7-3BXNC5&6
MFC/4IZ:V,^8?S7"6$LYLR@KFPD (;N2$#\ ? Z'X^AWWK;8.=T>B?;N]GD1E
M&IH3T]^H2Z<2W3^AN9!Y>%K>4V\TXE1D6R03HI2$G?L[OXQO[QOJ#M<S#5]5
M7=S\;B$94.A=ON$*ZPH]RMK[<JWRFTO19+*@MMQM8U2I)&Q!%<G*+BZ/5%I*
M7J:],R+\B5R%Q[$";\D*>O5F9  E@#53S*1_*^*DCW^H]KKO,'.IZ)_!D)1J
M:[]-?J4?P9YC ,^?6K$5+\JWW!W4N6YQ2M.Q>N_D:G<?!X;;5[,[!^[ZX]W/
MS,1D7JTXU):0\PM+L=U(6VX@A:%H6-001L017+--%A%?J:],BH9E\C\<PRJ&
MHKD7VQL)'Y'XE2(Z!\'4K0/=ZC;73H\'/ZO1-[=SX^97*)J*5ZAID[T_9?Q5
MFKCDEU<!#>.78ZN.:H?;4(SYZE/:#Y:_#W3MIIC\AAJGW8_%?J(RW%N>FMEI
M_P!/?'S+Z$N,N6..AQM8"DJ0I!!2H'8@CK7/-T9-$O\ J4]-<C"7Y&?X!'6O
M%5++USM[6[EM<)U[V]-RQJ?^IX[5T^#G?<],N[GYD)1-@^F;U.(O28G'O(DM
M*+P@(8LMZ>4=)7@EE]1_E>@2L^]T/M>]YL_ UG;7O7ZHS&16$^!#N<1ZWW!A
MN5!DH4U)C/)"VW&UC0I4D[$$5H8R<75:DSGMZA?3W=.)KH,RPL/N8:MU+R'F
MR2_;)'=JE*E)W[-=/+<^X[Z$]7AYJO*DN[F5.-#?/IL]2L?/8[&%9L^AC-F4
MA$*:LA"+DA(T'U!\#J/CZC?:M;G8'1ZX=N]</+D24JE$7VQ6G);3*L=]B-SK
M3-;+4J*\GN0M!_:(.X(W!W%:>$Y0DI1=&B9SJYKX3R?@?)X^48O(DJQ<R$O6
M:]LDI>AR >Y++RD]%#X5=%CZ]176XN5'(C1Z[UXW%35"J_3OZB;;RM;D6"_K
M:A9_";'G,:A#<YM W>8'XWBXV.G4>S[NDS<%VGU1[>1-.IM_+L1L&<V"7C62
MQ$3;3,24N-J'M(5\+C:NJ5I.Z5"M?:NRMRZHZDCG-R7QGG/IPSF)>;-+>%M2
M]YN/Y"R.T+TW++P&P6!LM!V4/JKKK%^&3#FBIJA:' W/=DY?L_D2/+@9K"0/
MSE:^[0. #3SV-=R@GJ.J?'P)YW,PW9=5MCXV,L3J9WR%Q[C7)F-R,9R:-YT1
M[VF'TZ!Z.\![+K2B#HH?@(V.U>:Q?E9EU1#1SLR;&.1O3'R-'G0WU-N-*4Y:
M;J@'Y6=%)T4A:>AU&SC9Z?@-=9;N6\FWQ3U7CF5THR\.&.:<=YAQT3[>4Q<@
MB)2F\V<J]MAPCWT:[J:4?=5]QWKF<O$E8EQB]'XWEB=3T>5>*<:Y9QI>/Y W
MV/H[G+;<FT@OQ'R- M)/5)^-&NBA]>A$,;)E9E5:;T&JG/Q*N3/2YR7J4^3+
M:V(/<J!<X"C]W<DZ?ND*^@BNI_QY5OBG\T_W*ML6=!N+.4\9Y8QIO(L==[74
M=K=RMSA'GQ)!&I0L>(._8OHH?7J!RN3C2LRH_@^):G4\CFKA;'N8<>^1G!,3
M(8B5*LUX2GVV5G?L7INII1]Y/AU&]68F7*Q+^UZKQO#52$L3RSD7TR<B2(5P
MBK:<;(;N]F=4?EID8GV7&U#4';VFW$]/PBNFN6[>5;]FY^/JBK:F=%< Y QK
MDK'(^2XO*$B$\ EYH[/,/: J:=3\*DZ_8>HVKDK]B5F73(M1@//G MFY?LWS
M,;LA9K!;5^;+B  '0!J&'SIJ4$]%=4]?I!]>'F.RZ/M9AJI&7&/)V<>G+-YE
MEO<-X6WS@SD&/O$C4 [/,GH%@;I6-E#ZJZ"_8ADPY,@G0Z,8EEM@SBPQ,DQF
M8B=:)B>YIU'5*A[R%IZI6D[*2:Y*[:E:ETR6TM--^HKT[6_E.WKR+'THB9_#
M:T97HE#<]M'1IX[>T![CA^P[=-A@YKM/IEV\B+526N$.;<EX(R:3BN4QY!Q9
M<GR;S:'@0_!?2KM4\RE6FBA\:.BQ]>AK=Y6+'(C5:[GXW$$Z'12R7NTY):HE
M\L<MN=:)S8>B2V3W(<0=M1]!!&A!W!V.]<E.#@W&2HT6DX^I;TTLYTQ(SG!X
MZ6LT907)]O; 0BY(3U4.@#X'0_'T.];C!S^CT3TW/AY<B$HU-&^GCU#7'BJY
M?T*S8O+PQ;Q:4ET*+]KD=Q"E)2=_+U_C&]-1U&^H.RS<)7EU1[N?C<8C*AT(
M@3X=TAL7"W/MRH$E"78\EE06VXVL:A25)U!!KE)1<71ZEA)?J:],HO E<A\=
MQ/\ X7 +UYL;" !)'53["1_*>*T#WNHWZ[[!S](7'[G^C(2B8+Z:O4J]A;T?
MC_D"0I6+K7Y-NN3VI7;UDZ>6YKOY.O[S[*].=@_=]4>[GYF(R+R;<:DM(>96
MEUAU(6VX@A:%H6-001L017+M4+")_4WZ956]4OD7CF'K;SW/WRQL)T\@C=3\
M= ^#Q6@>[U&W3I,'.ZO1-[=SX^97*)]'IC]3?D?)\<<CS &/8CV"_2%>Y\*(
MTE9^'P;</N^ZK;0B.?@=59P6W>OU1F,BT'V&I+2V'T)=9<2I#K3B0M"T+&BD
MJ!V((V(KG4Z;29 WJ3]-C^"OOY[@+"UXBM?FW" UJIRVN*.O<C3<L$]#\'0[
M:&NIP<[[OIEW<_,KE$V1Z9?4TB_HB\>\A2PF_)"6++>'CH):0-$LO*/\K^*H
M^_T][WO'GX-*S@O>OU1F,JE67"WPKK"?MUR81*@2FU,R8SR0MMQM8T4E23L0
M16CC)Q=5J3.<W-_&=_X Y%CY-A2I,'''G4R;!<TJ[BP^!JY'6K_HG70*]Y'T
M[UUV+?61;I*E=Z*FJ%;>G_GZT\NV@0)_EPLZ@M@W& /90^A.WGL:]4GXD]4G
MZM#6AS<)V75=O(L3J;'SO!,<Y&QR5B^41A)MLD:I4/9=9=3[CK2OA6G78_<=
M02*\EF]*U+JB9.=6:X5R%Z9N0HMRMDM:$MK4[8[XTG\A*8Z*:=2=1KH>UQM7
M[(T-=9:NV\JWS7CZ,I:HRY>$.;;!S%CYE1NV%D\)*1>;.5>TVH[>:UJ=5,J/
M0]4]%>!/-9>)*Q+C%Z/QO+4ZF0\F\98SRIC3N-Y*S[)U<@SFP/F(LC39QHG^
M^3T4-C5>/D2LRZH_%<0U4DW@3CC*N)/4>C%K_P!R67[?-7$ELDB-.C)02A:?
MIT(W2=TJK?9=V%[&<H\5\""5&7-7+E@H!0"@% * 4 H!0"@% 3-ZD_2@]Z@L
MFLV0M92+#^:H)@*CJAF5YFKRG>\*#S>GOZ::&I)T,$:XQZ.LHOW-5^XLE3YE
MNLMG;?<CY<[:WOE)19\OM2@%:4:J\P]'3[IJ75LJ#;__ *:<S_Z(K?\ JM7_
M ,M5CK8H?7;?U:L9,QM5ZY!<=MX/Y5N);@T\1]"5N/N)'V]IIUL4+;PO#K#Q
M_BUKP[&8YC6.T,)C1&BHK60-2I:U'=2EJ)4H^)-0,GO4 H!0"@% * 4 H!0"
M@% 3SZRN.<RY/XF9QS!K8;K>4W2-)5%2XTR?);2L*5W/*0G;N'C64#,O3;BF
M08/PCA^*Y3#-OO\ ;8SK<V&I:'"VM<EUP J;4I)]E0Z$T8-;>J7TH-\WN1,M
MQ2<S:.0;>T&/-D!28\UALE3:'%MA2D+03["^T[;'P(RG0P:#_P!W'ZPE,7^B
M8OL[\T]GD?.?G.)_%^[I\Q_[1T^O6LU0-\^EGTH)X3>EYCF$YF\<A7%KR4N1
MPI<>"TY[3J6W' %...'WW.T;#0=23ANH*@J)D4 H!0"@.;7ZR7^L/#/T*[_.
MEU.(+']+7]GKCW]$M?PU5%@V]6 * 4!JCDE13?F5).A# _;-=+^-_P!3]YRG
MY3_=\"0N:N%4H3(S3"XVC0U=N]G92?8\5/L)'P^*T^'45N(RXGHPLW^2?P?Z
M'Y<*\U?+_+89F<G_ #0Z-6F[/*_B?!++Q/P>"5'W?LZ2E'JVK7GYC-PM9P^*
M*/4G3N0L!25)*5I4 I"D*&X(W!21^&J#1$P<T<,&P%[,,084JPJ5WS[<T"50
ME'^41IN6B?WOV5=&5?>=#AYG7Z)Z\S)N%>:$W-$?#LRE!-Q2 U:+L\K0/#HE
MAY1^+P0L]>AI*-=J//FX5/7#3>C>S[#3[3T26REZ,\DM2([J>Y"T*V*5 ^!J
MHTZ;3JB4.7N(9>"ROZ3XSYCF+K<"@I!/G0'B=0E1&_;K[B_N.]6QD=)B9:NK
MIEW<S9_#?,C67M,XQD[R6LJ;2$0YBSVIGH2-@HG8/#^_^WKB4=Z-=F8?V_5'
MMY>1MN? A7.%)M=TCHE6^4@M2HKHU2I)_:(\#U%5FMC)Q=5J21R=QC=^+KPS
M?K"\\O'G'@NVW)!(>BO ZAITIZ*'PJ^(5=&1TN-DQOQZ9:[UQ-W\1\N1<_BI
MM%W4B/F,=/MM^ZB:A(W<;'X_XZ?O%1E'>M.1J,O$=IU7;R-@WJRVK([5)LE[
MC)EVR4GM=95U"O!:#U2M/PJ%5K8>.W<E"75'4D/.,'R?AW)HURM<I[Y#S/,L
MU\:!1J1N6W--@L#923L1]571E4Z:S>AD0HUMWHHSB[E*V\C6[RW>R)E,5/\
MGUO!T#J4C=]D'JD_$GX?LJ$HTVK0T65BNR_[3)\GQBS9A97[%?6 ]">U+;@
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M%#X5=%CZ]176XN5'(C1Z[UXW%35"J_3MZB+=RM;46"_K;A9_":'GLZA#<YM
MW?9'XW^$;\.H]GW=)G83M/JCV\B:E4V_EV(V#.;#+QK)H:)MHF)[76E^\E0]
MU:%=4K2=TJ%:^U=E;EU1>TD<Y^2^,\Y].&<Q+Q9Y;WYN2Z7K!D#(*0H [LO
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MZI.Q\">?S,-V75=I-.IG?(/'F-<F8Y(QK)XP>B.@J8?2 'X[VGLNM*(]E0_
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MVKIN#JVXGI^$5TURW;RK?%;GP\<"M53.B?'_ "!C?)6-Q\GQB3YT)\=KK*]
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MM T^FLK4PS7GH >EN^G]E$@J++-WGHBE1)T;_)J('U=Q51Z@J2L&10"@% *
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MDV##N,21;;G&1+M\E):E1'AJA:3X$>!'@>H-5FMC)Q=5J2/RAQA=N+[NS?K
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M/3I:@ KR^J6TZ:GHDJTI1('0KB?CRU<58!9,"M"R]'M# 0]*4 E3\APE;SQ
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M7:CSYN'3UPTWHWL^PV\T]$ELI>CO)4U(CNI[D+0H:*2I)Z@U2:9.FU$H\O\
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MM?96A6A!U'M-N)Z?A%=-<MV\FW[-SX>-Z*]J9T4X_P"0,;Y*QN-DV,R0_$?
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MHR6IJ$MO!<=7:K4(4L::]/:K ,YH!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M=A\^)/\ S3= ->S\D3Y+Y T2X!]RNH\0-]?RXWL9[GLJO&X@HT97]<Z3% *
M4 H!0"@% * 4 H!0'.?!\I@<4>O/,AFSJ8$/(9<^&Q/D:-MM_G1;<N(M2U:
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M/@?$*'0@[@U2TTZ,YF47%T>IJWF+AUG-67,BQUM+.7LI*GV0 E%P0D=#X!X
M;'XNAWJ494V,V6'F?;],NWD:CXFY8G<>SU8YDB'G,8<=*'XZ@?/@OZZ%QM*M
M]-??1X_;5C75[S99>(KRZH]W,K2+*CRX[$^ ^B1#D(2[%E,J[FW$*W"DD52<
MU*+3HS27-'"Z+ZB1E^(1PF]I!<N=K: "921NIUH#HX/B3\74;U*,MS-OA9G3
MZ)Z;F89PSS*O%W&\1RYU2L<6OLB3'-2Y <)Z$=2T3[R?AZCQJR2ZO>>K,PNO
MUP[N94B%[(>:6E:%I#C3J"%(6A0U"DD:@@BJ3G2>.:^%0H2<TPN-MN]>+.RG
MW?%3["1X>*T#IU%3C+B;S"S=(3?N9\O"G-(AB/AN92?\P_B[3=G3J6#X,NG_
M  9^%7P_9TG*/5M6O/S)9N%7UP^**2(*24J ((T4D@*2I*AT(W!21^&J#0DP
M\T<,&Q*>S##V%*L:U%RXVYH$JA*._F(TW+)/[W[*MC+YG18>9U^B>O,R+A7F
ME-Q3'PW,I(3/2 W:;P^K0.@;)8>4?B\$+/V'PK,HUVH\^;A4]<--Z-\/L-/-
MNQ9;*7H[J2U(CNI[D+0K8I4D]0:J-,G3:B4N7^()6$2CE&+AQS&''.\A&OFV
M]TG5*5$;]FON+^XU;&1TF)EJZNF7=S-F<-<R-98TSBV4/):RAI(3#G.*"4ST
MIZ)43L'@/W_V]<2CO1KLS#^WZH]O+R-NS8,*XQ'[;<XR)=ODI+4J(\-4+0>H
M(\"/ ]159K(R<75/:21RAQ?=N,+LU?K \\O'5NARWW%O4/1'M=0TZI/10^%7
MQ5;&1T^-DQOQZ9:[UQ-V<0\NQL\BILUY6B/F$9 !!(2F<A(W<;'^$&GMI'7J
M*C*--J_AY&HS,1VG5=O(V)>+/:\AMDBRWN*F9:Y0[7F%]=1T6@]4K3U2H5#0
M\,)RA+JCJ2'G6"Y+P_DL:Z6N4Z;?YGFV6]M I(*3_%NZ;!P#923LH?55T95.
MGLWX9$*/7>BB>+.4[=R+;BR]V1,KB(!GP = \D=7V1X@_$GX?LJN4:;5H:/*
MQ79>SM,KR7&K+E]F?L5^8#\![="A_&LNZ:!UH^"A^SXU%.AYK5V5N75'4D7(
M<>S'A+,&)<20I!02Y:[JT#Y$EGQ2H';ILM!JZ+J=-;N6\FW1_%%/\<\C6?D>
MT&9""8MYB@"Z6HJU4TH_RC>NZFE'H?AZ'ZZY1I[CGLG&E9E1Z;F>CF6&6/.[
M(Y8[XWHG=4*:@:O17CT<1](_&3T(K"="%F]*U+JC_$DUQK-N#<V20?+DM'5M
M8U,.?$)_ODJ'4=4GZZN337L\?4Z3_'E6_%4RKL'SBRY_9$7BSJ#;R-$W"WJ.
MKL9T^!^E!^%7C]M52C0YR_8E:E1_Q/FY!X^LO(EG_-URTCW)@*-LNB4ZN,+/
MPJ\5-J/O)^\5A.A+'R)6956F]$M6F[YIPAF;L>2R6GVB$3[>LDQID<G922-B
M"-T+'2KMC7L.BG"WDV]G\"N,5RNR9I96;]87O,BN:)?841YT=[34M.@="/ ]
M%#<52U1G,WK,K4NF1CW)W&-LY&M>A*(F21$G\W7$C0*^AEX]2@^!^&BE0OQ<
MEV9?V[R;L-S'*N&<JDV^Y17!&"PU>;*Z2D+2/Y1L] L#="QU^RKMC5&;V]9A
MDPJG[F5Y8[Y:<FM,>^6*2F7:I0U:=&RDJ'O-N)ZI6GH0?VJH::=&<S<MRA+I
MEJ8'RSQ)#Y!AFY6P(BYC&0?(?([43$I&S+I_&_$7]QJ2E0]F)ENRZ/MY&B>-
MN2KWQ7>W[)?([R[&ITMW.TNZI=CN@Z%UH*Z*'B.BA5K55M\>1N,G&C?CU1UW
M,KFWW&!=H,>Z6J2B7;920Y&E-'5*A_S$>(.X-4--;&<S*+BZ/4U3S%PXSF3+
MN28VTEK+64E4B,D!*+@E._V!X#H?CZ'>I1E38S9X>9]OTR[>7D:HXEY;G8!.
M.-Y*'7,8<=\MUE8/G0'N[12T).^FOOH_YZLE&OO-CEXBNKJCW<RLH\B/+CLS
M(;R),.0@.QI+*@MMQM7122/"J3FFFG1F*9*WDN.*<R3$F?SG 0"Y><763JZ@
M;J?AJW*'0/>1T5]%3JFJ/YGJM=$_3/8]TOT?L/9X\Y/M61-"YX?<2B8@:S+6
M]HF2UIU2ZT?>&H]Y.HJB[9C-4DJHRXWL655LY,WCCV=P+N$QIP3#N!V"5'\D
MX?\ HJ/0_4:Y[(P)6]L=J-]B_D8W-DO3+Z,DCFWT_P!JR7)7+[QL&[-)DK7^
M>;-.'R\=+^O\;'*.\#N/O(T !W'70;[$<U&EQUX-?J5S_)6DZ4=39?$MWY%Q
M;#;AA'(3\:ZP4PW8UCN,5XOR6N]!0EE[N2G5L:^RKJGIN--/'F8,;CZK;H]^
M[XA?E;7!GQ>ERRO<+<72\'S-#<V?)NDJ<H0=),8QY+++02HN!&I/EJ[D]O0U
MX%^.NUJFC/\ U;7!FJ^4O3O#N^2KO7%CS5NM4LEU^U3U%CY9_77\@I/?JVKJ
M!U3TZ5O\>4U&EQ[>*WD'^3M<&;:X1YTEV2^CAKE.Z1I.20^R/;;ZTZ7&G5Z#
M2*^XH)_+)]T*/4['VNNJS\!?[+?Q7ZHVEB\KD>HIF=!AW.&_;[@PW)@R4*9D
M1GDA;;C:QHI*DG8@BM!&3BZK4]!SX]0WIYN7%=R.:X4'EX8X\'$K:*O/MCY5
MJE*E#?R]?<<\.AWT)ZO#S5>73+NYE3C0WIZ:O4JQG3$?!\XD(9S1E*6X$]PA
M*;DE(Z$] ^--Q\?4;UK<_ Z*S@MF]</+D2C*I1MZLEJR*URK)?(C<ZTS6U,R
MHCZ>YM:%#30_01U!&X.XK3PG*#K%T:)G.OG#@_)>"LD8RG%I$A>*+?#MIO#)
M*7X4C7N2R\I/10T]A?18^O45UN)EQR(T>N]%35"I?3MZBK=RI;T8]D2VX6?1
M&P%M:]C<]M"=WF1T"]M7&_O3MKVZ7.P7:?5'MY$XNIN3+,3L.;V&7C>2PT3;
M3-1VNM+'M)/PK0KJE:3NE0Z5KK5V5N75'4D<Y>3>,<Y].6;1+S99CXMH=\VP
M9$R.S7KJR\!J L#92#LH?5776,B&3#FBIJA9W O/EFY?L_RTGRX&:0D#\XVS
MN #H2!J^P#N4$]4]4^.VAKGLS"=EU6V/+WDTZF>\@8!C?).-R<9R:*E^(^DE
MEX >='>TT2ZTKX5)_9Z':O)8ORM2ZHDFCG9E6*\B^F3D5B=;Y+C7E+*[1>&T
MD1IT;4%3;B3J#M[+C9Z?@-=;;N6\FW['JO'T94U0NWA;FK'N8L>$Z"4P\BB)
M N]F4H%QE?3S$>*FE'W5>'0[US.7B2L2XQ>C\;RQ.IZW*?%F-<L8T]CV0M!+
MP!7;;DA(,B(^>BT';4'312.BA]Q%>-DRLRJM-ZXAJISZ6CDOTN\E@@J:D-'V
M5CN^0NL#O^[N2K3]TA7T$5U7^/*M\4_FG^Y5MBSH)Q5RKC7+6,MY#8'/+?1H
MW<K8M05(B/\ XBP--0>J%@:*'U@@<KDXTK,J/3<^):G4\KFCA?'>8,=-OG!,
M3((J5&S7@)U<8<._8O3=32C[R?#J-ZLQ,N5B7&+U7C>&JD(XSD_(OICY&D0I
MD=;:VEAJZVIPGY6?%U]EQM70ZC=MP=/PBNFN6[>5;XK<^'C>BNK1T3X^Y"QO
MDS&XV38S(#T1X=K["B ]'> ]IIU(Z*'X"-QM7)W[$K,NF188-SQP+9.8++YS
M'EP,SA(/YLNI&@6!OY#^FY03T/5)W'B#Z</,=ET>V(:J1;QIR7G7IPSF79[Q
M$>%N#P9R#'WCVA82= \R3L%@;H6-E#;I717[$,F')E:=#HSB&7V#.K!$R;&9
M:9MIFI[FW$^\A0]YMQ/5*TG9237(W;4K4NF6I::>]1/IVM_*MN5D%@2W#SZ$
MT0R\0$(GMH&S+QZ=P&S:STZ'V>FPPLUVGTR[>1%JI*_"?-F3<#Y/)Q;*8T@X
MPJ06;S9G@4OPGTJ[5/,I5T4-/:3T6/KT-;O*Q8Y$:K7<_&X@G0Z*V.^6G)+5
M%OEBEMS[3-;#L66PKN;6@_1T((.Q!W!V.]<E.$H/IDJ-%I.OJ4]-3.>L/YMA
M,=+6;,H*YL% "$7%"?'P ? Z'X^AWWK;X.=T>B?;N?#R(RC4T-Z>O4)<^)[I
M_0S,P\YAKK_E.MO!7GVQ_N[5*2D[]FO\8W]XWU!V>;AJ\NJ/=S(J5-AT)MUQ
M@W:$Q<K;(;E6^4VEZ-)94%MN-K&J5)(Z@URDHN+H]2PBGU8\ W")<Y?*F'14
MKM3X2N^V^,CM7'>2-#)2E/5"] 7--PK?H=NC_'9:DOMR>W=[2N2/;],?J;$P
M1..>198^< 2Q8KX\=/- ]E,>0H_%X(6>O0[[U7GX%:S@O>OU1F,BOY42/.C.
MPYC2'XDA"FI$=U(6VXVL:*2I)V((.]<^FTZHF<_?4;Z<9G&TMS.,&;<7A:W$
MK>80I2G[:\H[;]2T3[J^J3L? GJ\+-5Y=,N[F52C0W'Z9_4NC-$1L"SV2$9>
MD!NUW->B4W!"4[(</@^-/_KG[KWM=G8'1ZX:;UP\N1*,JE,7:TVZ^VV59[O&
M;FVN:VIB7$>2%MN-K&A!!K3PFX-2BZ-$R9./_3Y/XE]0,*]61#DS I\6<(LD
M^TY#=4T2&'C]'XB_B^VMW>S8WL9I[);-GZHBHT95%:$D* 4 H!0"@% * 4 H
M!0$$^HJ%'OGK:XMM-S0E^!V6P%E8[D$)E/.Z$'_I"IK0CO+LN,2/.@2H4ML.
MQ9++C+[2QJE;;B"E22#U!!TJ!(@W]7=98$3*^3Y#38^8@JC0([IW4F.7WR4Z
M_66T:_94Y$44OZL(K$OT[Y^A] 6ENV^<C4 Z+:>;6DC["*BB1AWH/?=>].MG
M#JBH-3[BVWKX)$@D#]FLRU!2U1 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MQ9;B5*2%$O0'B=0"1N4:^XO[C5D9'28F8KJZ9=W,V;PWS,WER&<6REY+>5(
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M+IIW/7FS,)Z>*I#"1\/XZ!TZC:IQEN9O,+-_DF_<_P!#X^%>:4PQ'PW,I/\
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ME.Z;!P#923LH?5778^1#)AS7C<5-4+,X#Y\L_+UG^5E>7!S:"VG\Y6[4)2\
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M=Q6JOV__ #W%TRVHVF)D._#J:HB!><>#\DX*R2/E6*OR%8FJ2';/=VB1(A2
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M1.YWZUB@/;_X^/4/_P"8VO\ U<U_=IT@?\?'J'_\QM?^KFO[M.D#_CX]0_\
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M\7_)T _W>8!_LI9_]7Q?\G0#_=Y@'^REG_U?%_R= /\ =Y@'^REG_P!7Q?\
M)T!(/ZPS&L;L7%^,.V2S0+:\[?@EQV'%9CK4D0WSVE3:4G37PJ<3#/;] V*X
MO>^#9,N\V2WW&4F_36P_+B,ON!"6(Q">YQ"CH"3M6&9*C_W>8!_LI9_]7Q?\
MG40/]WF ?[*6?_5\7_)T _W>8!_LI9_]7Q?\G0#_ '>8!_LI9_\ 5\7_ "=
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M2UPBYP9QHW8KHMI[*[J\;C?WF=5-I?6A*4,)5K[0:0.W4;%7<1UJ+=3)NZL
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M^_B=AD2E^9)=MT-;R]-.YQ3""HZ#Z2:U#;;JS=))*B/:K!D4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0'R
MW)M;MNEM-)[G%L.I0D=2HH( H#G%Z5^!>8<)Y\L^495B,VUV!@3P_/?" TGS
M67$(Z*)W)&FU62:(HZ3U62% * 4 H!0"@% <SH/ /,K?JF3FJ\/G)Q89@NY&
MZ$(\GY,S"Z'=>[7M[3KTJQM4(HZ8U62% * 4 H!0"@% <X/6+P/R_GW-]RR3
M#L2FWBQO08+34V,&RVI;3(2L>TH'4':IQ>P'0C%(LB#B]DA2VRU*C0(K+[1Z
MI<;90E23]A%0!Z] * 4 H!0"@% 1+Z\>).2.3;MA4C \=E7QFW1Y[<U47L/E
M*>6R4!7<I/4(-3BS&\H#TR8U?L/X+P[&LF@N6V^V^,^B9!>T\QI2Y3SB0K0D
M;I4#4&9-M4 H!0"@% * 4!+/KIXYS?DKCS';5@ME?O=PB7D2I,>-VE:&?EGF
M^X]Q&W<H"I19AGL>B;!,OX[X=D6#-K2]9;PN]2Y28<GM\PL.,QTI7[)(T)0K
M\%89DHZL 4 H!0"@% * U7ZDL<OF7<'9GCF-PG+C?+A"0U"@LZ>8ZL/MJ(3J
M0-= 365J"=_0=Q'R3QG>\SDYYCLJQ,7"+";A+E!(\U;3CJE!/:I70*%2DS&\
MMRH&10"@% * 4 H#&^0H$RZ8)DMLMS*I$^9:YD>*PCWENN,*2E(^LDT!"WHJ
MX/Y9X[Y=>OV:XK,LMG5:I+ ER0@(\UQ2"E/LJ5N=#4VU0QO.AM0,B@% * 4
MH!0"@.9&#^GWF>V^IZW9E.PZ<QC#67N7%VYK\OR4PS-6[YNH63V]IUZ5/<#I
MO4 * 4 H!0"@% * YN>K3@;F#.>=KIDN)8C-NMB>9@I:G,!'E*4TTE*ANH'8
MC?:K(M(B]&=$[$R[&LEMCOH+;[,5AMU!ZI6EM((/V$562/0H!0"@% * 4 H#
MFUZQN%.6LWYQG9!B.'W*\65<*$VW.B,EQI2VTD* 4/$'K5D70BSH=BC#\3&+
M+$E-EJ5'@16GVE;*0XAE*5)/U@C2JR1Z] * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M>2\SS?'^%,.@SSCTA,9ZY/1F'RQ)F3'"A ==;!!::3HHCP))/05)4,&Q\:]
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MF+!:;7=GIG&>9%E#K4C<JB2'2P4O)3HDNQG"%)< W3]&I%9U0.D(.M1,G^T
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M0MB*T7%  !(*5A"$  ;^.II%F&=+;-#_ #=:8%N_]SC,Q_\ %-A'_-4"1]U
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M0"@% * 4 H!0"@% * 4 H!0"@.;?KT@1KES[A5NE@F+-A0X\CL/:LMNS5(4
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M=K % * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MD)"9!2DNA.Z0O3V@/JUJ)D_6@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M)BO)<822"222E83_ -&LQU!@OZNWCIY<')>7KP%/3)[@LMID/'O<\MGM<DN
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M%C,PXS,2.D(CL(2TRV.B4( 2D?<!43)^M * 4 H!0"@% * 4 H!0"@% * 4
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@.=UQ_MZ)_
M^9'_ ,WHO_S3_P#;?_96OXK_ *?^ _ZM3_E(+4Z(U F* 4!SV]4G]KK"/_F;
M_P#V+_VK_P!H_P#;5]/_ *C_ *561T(LZ$U62% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
;H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>lc_auccfu-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_auccfu-4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    1@  _^$#@&AT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@-RXR+6,P,# @-SDN9&5E,V$W-S S+" R,#(R+S X+S$X+3$V.C4P
M.C,P(" @(" @(" B/B \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N
M=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B \<F1F.D1E<V-R
M:7!T:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+VUM+R(@>&UL;G,Z<W12968](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B('AM;&YS.GAM
M<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(@>&UP34TZ3W)I9VEN
M86Q$;V-U;65N=$E$/2)U=6ED.F8X,S%A.&(T+3<U8C4M,S4T,BTX8S-F+6,U
M,S@R-31A,&5D92(@>&UP34TZ1&]C=6UE;G1)1#TB>&UP+F1I9#HT-$4Y,#1&
M,3E!-$$Q,45&.30Q1D$X-T)&,T)#,4-#-2(@>&UP34TZ26YS=&%N8V5)1#TB
M>&UP+FEI9#HT-$4Y,#1&,#E!-$$Q,45&.30Q1D$X-T)&,T)#,4-#-2(@>&UP
M.D-R96%T;W)4;V]L/2)!9&]B92!);&QU<W1R871O<B R-BXU("A-86-I;G1O
M<V@I(CX@/'AM<$U-.D1E<FEV961&<F]M('-T4F5F.FEN<W1A;F-E240](GAM
M<"YI:60Z,3<R.3(U930M9#8W-BTT.#8T+6$V,C4M8CDT86-F9C$V8V,R(B!S
M=%)E9CID;V-U;65N=$E$/2)X;7 N9&ED.C4X8C!F,61C+30X,#$M-&0Q-2UB
M9#,U+6$Y9C1E9C(U96,V."(O/B \+W)D9CI$97-C<FEP=&EO;CX@/"]R9&8Z
M4D1&/B \+W@Z>&UP;65T83X@/#]X<&%C:V5T(&5N9#TB<B(_/O_N  Y!9&]B
M90!DP     '_VP"$  0# P,# P0# P0&! ,$!@<%! 0%!P@&!@<&!@@*" D)
M"0D("@H,# P,# H,# T-# P1$1$1$104%!04%!04%!0!! 4%" <(#PH*#Q0.
M#@X4%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%/_  !$( TX"PP,!$0 "$0$#$0'_Q #9  $!  (# 0$!
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M8>]I;N\)+7G:>CM-1J**.B" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M$! 0$! 0$!!\[V;S'N'F ;BS7KH>FNGLZ()5PIS3^F"+)976%UB;CE=]'/\
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MO'&,95E-_BXVY'S6XX);LZ:S)Z"#R6F"]2W/H"]S)8FM,S6GRQ("TN&W:'$
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MBCLB:Q5ZBBB @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M:[RMNTD?N>W7KVHC+D! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 03SE7/>->-8;-E?(<;&OCJ)*
M6S5ONAK)H)YH]TAC+6N=&7-CZN&GL16 _P!M'@+ZZK/_ "^J_P!!"CL47K'X
M K*AM.[(IJ7?T$M105C8P?A+8G:?;0HM-DOEFR2UTU[L%?!<[15MWTU;22-E
MA>WL.CFDC4'H1W'H41]4EFM%!75MTH:"GIKC<O+-QJH8F1RU!A!$9E<T O+0
MX@%W<@[R @(" @(" @\7*<OQG";4;WEES@M-I$C(/>ZEVV/S)-=K==#U.A01
M_"LTQ7//4==;SAUU@O-J@PFDHYJNE<71MJ&W:HD,9) Z[7M/VT5>D00$!!K5
MSYZ4*'E&[29AB=?%9LLG:UMPAJ6N-%6%C=K7N,8+HY-  YP:X.T'374G=9DI
MP<^3%U<823#O0GEL]TB?G=]H:.RQO!FBM3I:FJE8#U:UTL4;&:_?'=I]ZLYR
MQR:XP3S63G_F"B]/&&6/"\ HH(;Y4P>1:87MWPT-#3 ,,SFGJ][B=&;OC.W.
M=KIH[79;U366W)?T12&E1Y_YJ-P^DSG-W]YW;]@J7"GU_P!0/DM/@V:+HZ([
M')WEW:S;D?FF\<Z\9V7'[K3^?G]AN-155#:.$M95VYEOGD=4AHZ-?&(W>8QH
MTT\0[P-?1TW1+=WG59='.B!+>YF4\:V"Y91R!C5AM#'/N%9<:9L99U+&LD$D
MDAT[HV-<]Q[@"L;II"VQ68;->HCU8Y33Y/<,(XSJQ:[=:97T=PO4;6OJ:BJB
M=ME;"YX(9&QP+=S1N<1J#HM5F.*5ET9,LUI"3X9ZJN9<3NL5;5WZ7(+=N'O5
MLNI$S)&:C4-DT\R-VG86NT]H/8LYQQ+7;ENA_1S!<QM/(&(VG,;(3]'7: 3Q
ML?IOC>"621/TZ;HWM<QVG>%R3%)H[K9K%60J,A 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0>;><
M=Q_(X(Z7(;51W:FA?YL4-?3Q53&2:%NYK96N .A(U"#Q?T7<9?\ !=B_\KH_
MX)!T;IPMQ%>*=]+<,'L;XGC:71V^GAD _8R1,8]I^%K@BU0OT_VY_%GJ"Y&X
M4M=1++APHXK_ &FGF>9/(<\4Q+03W[:D1N=VN\MI*++:Y&(@(" @(" @(/E\
M;)&[9&A[?8X C]=!(J6..+U05[8F!C3@5$2&@ :_3-5[$7DKZ((" @("#0GU
MVXE=J;,K%FCW2U-DN%%]',+VQNBIJFE>Z0Q-/EG:)&R>8 XDDA^G0:#HQ>>C
MESTB8K;$^=J5L'WK?^;'_!K=2>V7-U6_1:V*])/$ERSW+*_)8[K<<=HL<B_B
MMYM'N\4_O]4#$(VNE@D81Y+I=XV_=-]O73E\]73@G6D1$+M</0AQY5R/GAR6
M\1U,LADE?+';Y&DN.KM&LI8@.I^Q\"U]Y=VMG<V?3'J9'B'I%QO JR:Y8CFN
M1VBXU$7N\]52FV-D=%N#BT%U"X@$M!Z%8S?,ZRSMQVVZ1$- ^0<=NF)YQD&.
MWKS#<J"OJ(YI)OCRASR]DO8-1(US7@]X.J[8FL/.NBDRQM5']/\ TI8_<\=X
M/QV"[,=#45QJ+C% \$.93U<SGQ=#]^S23_*7'DFMST,44M6E:VT0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$&!<J<O8CP[::*]9A[U[G<*GW.G]SA$[_-\MTG4%S=!HTHJ4_P!N
M3A#_ /S'S)O\,A1U+AZZ^'X('&VT%[N-81\C3MI88@YYZ!I<^?IK\#3]A"C]
M]-..YMD^<YES_GML?9:S*8XZ"QVR5KFR,H&&,[MKPUP8&PPL8X@%^CG: $:B
M6SJ((" @(" @("#S;YD-@QBA-TR2ZT=FM@>V,UMQJ(J2 /?\5OF3.:W4Z=!J
M@D&,Y+CF5^I2YW+%KQ0WRW18-1T\M9;*F*L@9.+O4O,;GPN>T/#7-=M)UT(1
M5Q1! 0$! 0>/E&*X]FEEJ<=RFWQ7.S50 FI9P2-6]0YK@0YK@>K7-(([BK$T
M28B>$M>*OT2\-457->JR[7:ELE.UU144LM73QT\<3!N<73.@WM8 -22_73[I
M;>]EH[BU\VSU2>G+C.EBPS#J2N=8J%Q8R:UT8-,7DZ.>7U$L<LA/:7EKMWM*
M=W=/&2,MEO"%XP/D;#>2[/\ 3>&72.XT;'!E0P QSP2$:[)8G@.8?9J-#W:A
M:YMF-6ZVZ+M&4K%DEG+'I^X]Y?,=7D--+1WZ%@BAO5O<V*J\L:D,DW->R1H)
MZ;VZCN(6=M\VM=^.+M6!X3Z+N+<6ND5VO$]9DTM.\204E>8V4>YO4%\4309-
M/8YVT][2LIRS+"W#;#8YK6M:&M #0- !T  6IO?J @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @()
M5SAR19>.:#&Y+UCD>1PWR[PVJ&&9T;6P23-<?-^5CD!( (TZ?91899>K/@..
MV>X7^[V:VT]JM=--6UT_N,3_ "Z>G89)';61EQT:TG0#5$<>$SX!E%DH,QPN
MBHGVJX-=)15T-&VF>YK'NC)T=&Q[='-(ZA!EJ @("#$^2\_M'%^$7;-[TUTM
M);(P64T9 DGGE<(XHFDZZ%[W $Z>$:GN00O'Z_U@<A6*#.+7<<<Q:WW",5EH
MQZJIW2RR4T@W1>;(Z.8MWMT(\8/7J&]B+P9QP-S1=^1GW_$,XM;+)R3B,PI[
MU10D^[RM+BP31:N=IXFD.&YPZM<UQ#M )AB=WY6Y:Y1Y$ON!\%.MUJL>)/\
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M*&TF20S1GM8YK8J1A!_9[A\!0JV*XVXSQ/BC&8L6Q"E,%$QQFJ:B4A]34SN
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M1L :UH'L &B]Z(B(I#\YOOF^Z;KIK,\9<JK 0$! 0$! 0$! 0$! 0$! 0$!
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M<!Y6RE<7-Z$NW'IT7AL6<(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MTU(TT"NH@@(" @(" @()'!_>AK_S!HOQS5HO)7$00$! 0$! 0$! 0$! 0$!
M0$! 0$!!(JS^\]:?S&K_ ,;4J*KJ((" @(" @(" @(" @(" @(" @(" @("
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M[S3)>=>3Z 62]Y%31VNQV @B6CMD3FO^4:[Q-+C&SH[1Q(<XM&X!"6PJ(("
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M>=8BLM/^/,BJL=Y6R*^M<Z1\3K:ZI!.IECDBE$@.O:2">WOZKYB-Q.+'@O\
M+?7^[BV4K5N]2U,%;30UE*\24U0QLL,C>QS'C<TC[(*^RMNBZ(F-):G*L@0$
M! 0$! 0$!!T;W726NS7&YQ,$DM%2S5+(W$AKG0QN> 2.XZ+/';U71';(UR/J
M<R( GZ#HN@^_E_QKZ+\IL^J65&$<:\[WG&H,G936FEF^ELCNUWF+WR#;+65)
M+F-T/Q6[1HN?#X=;?U<9X73'J*+[Q+RK<^1*VYTM?004;*&*.1CH'/<7&1Q:
M0=Q/L7-O=G;@B)B:U2855>6@@(" @(" @("#P,RAOL]BJ(\?>&UA'R@&HE=%
MH=S8SW./_P!G5=6UG'&2.O3]M7/GB^;)Z=6NL[7-:]K@6N;T(/0@@]A7UO)\
M]S8AQ1_5YCO^Y0?Y@7+M/N;?-^]T;G[V[SMG>+X;_%9R;D=+6_0V^.37S0#V
MD>QA[@?LCIV^-XA..;_AUYO2V<7Q;QTY,[7EN\0$! 0$! 03KF"MY@H;+;W\
M-V^@N-[=5;:^*YN8R-M+Y;CJW?+"-V_;W_:14=^G_75_POC7[[#^'(<#Z?\
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MGO.CX+M/<\_<[;J^*W5-/35@!K^/,8OE[C_B!H8'T=*[KYW@&CW_ +#V#O\
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MXC3XIU0AS\*\T8_S3C4EXM4+[?=[?(*>]V:9VZ6EG<"6^+0;HWZ'8_0:Z$$
M@A"84M$$! 0$! 0$! 02.#^]#7_F#1?CFK1>2N(@@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @C',LV07FLIK#:K;65%NI )ZB:&"1\<D[QHT
M M:0=C3^JX^Q?,^+SDR719;;,Q''2=6RUKYC^.9!)G>8TT=JJWU$#+69X6P2
M%[-\,I;N:&ZC<!J->U>=FV^2=OBB+9K'7RGZF43QEMCQ7<+M48VRV7NCJ*6M
MMA$#'5,3XO,@T^3(+P-=H&PZ>P>U?1>&9+YQ=-\3$V\./9R:[M6<KU6(@("
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ML:V:-SM---X>"!NVL>TDZMT&K;U&*1P?WH:_\P:+\<U:+R5Q$$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&&\E9<_$L?,](\-NU6\0T((#M"-"]Y
M![0UOZY"\SQ'=]QBK'S3HRMBKW<;OE-DEDH[S2Z;*F,.>P'79(WPO8?VK@0N
MO;YHS8XOCFDQ1ZJZ$$$?X]_KYYG_ -7BWXOG1695&>4%/G,&'.+=98?'/K\6
MJ=H]D1[NK.OV2 O-NWUL;B,/D]O9ZEIPJRY>DQ2OFO*3;;5!CM')MK;@1-4%
MIT<RGB=J.SJ-[QT_:E?/^,;KHLC'$\;O<SMAF&"Y*S*\;I+F7 UC1Y%<P?<U
M$8&[IW;@0\? 5Z6RW,9\47<])\[&8I+)%W((" @(" @XJJF@K:::CJHQ+35#
M'131.['1R M<T_ 058F8FL##_P!$7&VFGY.TNG_U/])=GXW-]4K5,.%..<(N
M]-G1N-DIZ@T.:7^@I"[?\G305(\N,:.[&[CHL+=WEMK2[6:BSV##,7Q:6:?'
M[9%02U#6LF=%NU<UI) .XGO*PR9\F3YIJCW5H! 0$! 0$! 0$!!Q5/\ )YOV
MCO\  4$P]-G]16"_T:S_ #WHLJHB/ RO*Z'%Z'SIM):V4$4M*#XGN]I]C1WE
M=6VVUV:ZD:<Y<^;-&./*PS#>2I9ZQU!DDC0VHD+J>KT#6QN<?W-WL;]Z>[OZ
M=GI;K81$=6/ER<>#=UFEZI+PWJ" @(" @F_,>;9]@]DM]?Q]B$F87&IJO(JJ
M*+S-88/+<[S#Y;7'XP#?MHJ,_P!H/U+?^QU5_P#FOX-"D..;U,\]V9IK<AX/
MN#+7'HZHD@][:6L[SN]WD T'M"+1;^(.8\3YGQV2^XTZ2"II'B"Z6JIT%32S
M.!+0[:2',< 2QXZ'0]A! )10T00$! (!&AZ@]H003U<TE+0^G3)*.B@CIJ2%
MUN;#!"QL<;&BX4_1K6@ #["+"H<7_P!6F&?T%;/YG$B('Z*!K;>1WS?RYV2R
M^\?:9T_7+D67QZZ7B+"<,E#7.E9D<+FB,;I#I3S'1H'4GL0A3O[0%J_X$SG_
M /;5;_B0HQW!,O@S;U%W6[TUJNMFC@PJDI32WVBEMM4XMNU1)YC(I>IC._0/
M[-P([D%^1! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&,<AX31\BX=
M=,,N%94V^CNC8FRUE"YK*A@AF9,-A<'#J6:'4=FJ#1?(>",3H;S645FR2^U-
MOIW^5'4354.Z0LZ.<-L(&TNUV_ OE]QXQ=;DF++8F(;8M>O@/IQP[*+T;-=L
MHO\ 22S,+J.2&IA(=(SJYCMT)[6]1]A=.Q\3G-DZ+HB.RB3%%1_L,X2/_P#L
M\E^<4_\  +WV%7C8]Z0>,\I@J:BTYKDY923OI9=]32DN=&>CVZ0?$>.K5R[?
M<V9HF;>4T6>#"J3TR833YIR7:;GE%]BMN&0V:6GJ(9X&U-2^YTTDI9(XQ$$A
M[0QF@&FO59Y\T8K)OGDK$OT)6CZ^O.O^]1_P2^7_ #O)]-OM9]*NX]Z0^.;]
MC4.2?EKDE/3B)SZUKJFF(ADA'RH)\CL!!(_8Z+Z/;[FW+BC)IPX^3M83JD]5
MPEC_ +S-[G?KY[F'N]W\VJB,GEZG;NTA UT[=%\]=XU?6:6Q1GTO;PC@#$;M
MDM';[MDM]I8JAP9!/#51:B<'6-KMT/8X^'IWD+IVGBTY,D67Q$1/O28H_H$O
MI&H0$!!*^>\@O>-XG0UMBKI:"JDN$<3Y83HYT9AE<6GH>FH!7J>'8K<F28NB
ML46&N_Z5N1O^(ZS_ )X_Q+Z#\'A^F&5#]*W(W_$=9_SQ_B3\'A^F"C:#AR[W
M.^\?VVYW>J?65\KZD25$IU>X,G>UNI^ #1?,[ZRVS-,6Q2.'N8RSQ<*)%P%_
M)>1?S]R3^<M195U$2C*N><?Q3(*['JRV5D]30N:R26(Q;'%S&OZ;G@]CEZN'
MPZ_)9%T3'%:/'_M-8M]3W#]6'_36W\IR?5"T=^Q^H7'+[>;?9:>TUT<]QJ(J
M6.1YAV-=,\,!=H_70:]5AD\,OLMFZ9CA"46!>0@@(" @\V^7R@Q^WR7"X/VL
M;TCC'QY']S6CO)6[#ANRW=-K5DR19%9?MDO5!?[?'<+>_=$_H]A^/&_O8X=Q
M"9<5V.[IN7'DB^*P]%:6QQ5/\GF_:._P%!,/39_45@O]&L_SWHLJ+>Z^HMEJ
MJJ^EI75D\#"YE.SM<?;]@=ITZK;BLB^^(F:-62Z;;9F(JUTNMUKKS72W"X2F
M6IE/4_<M;W-:.X#N"^NQX[<=O3;H^=OOF^:RZ:V,%<XNR2[5['V:KB?44E*P
M&*M_ZH=T;R>W7[GO^UV>#XA@LM^*.$SR>OL\MUWPSI'-2EXSTA 0$! 0$!!J
MSQE24UA]97)]EL3&PV:LLT%PKJ:'I$VMD]QD+B!T#BZ>5W^447DVF1! 0$!!
M"_6"US_3[E#6-+G&2W=&@D_^(4_L184GC $<:8:""#]!6S4$:$?Q.+M!1&MM
MMR%OI9YBS-F94-2SBS/JH7:TW^FA?40TM47/>^&1K 2-#*YA U=HUC@-"=#+
M5\9'DD/JJY3PVR8-254W&.&5OTQD.0U$+X*>>9A8YL,8D .I#/+:#HX[W.V[
M6ZD:-P$8I'!_>AK_ ,P:+\<U2+R5Q$$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0=.[4=1<+;54-+4FCGJ(W1-JFMWNCW]"0-1UT[.JU9;)OLFV)I,
M\R$G_0#2_7LGS9O\*OG_ ,CCZ_9_%LZW/1<'"WU<%?1Y#)%54TC989!3-\+V
M'4']U]H6=G@W1=%T7\8\G\3K9#RME!QW%WT\,FESNFM+ 6]"UA'RKQ]AIT'P
MN"[/$]SW6&D?-=P^UC;%92/B?*/R=R:.GJ'[;;=-M-4:GPMD)^2>?L..W[#B
MOG?#-SW66DZ7</L;+HK#EK\7O.7\O\I6JQRT\3(9,=J+E[PY['/=]&O;  6M
M<"T#S#H>\KZ'Q':Y<]L6V3%.=?9^]A$T=S]!N7_]XH?WV3^"7B?DV?MM]<_8
MRZX9M@G'M]L=/<K)DAIJS';DUKI((9I=PF81H>C6=' >+KW!>ILMADQQ=9DI
M-EWEG5C-S(OT78%]31_OLW\(NW\MV_T>_P"U.J7ZWC#!&.:]EG8U[2"UPEG!
M!'4$?*)^6[?Z??\ :=4LN7HL1 0$$#]6MTKK5Q[:ZBWVZ6YS.N\3'00':YK3
M3U!W'PNZ=-%W[++=COF;;>K@L--?RSR;_A&M_?!_!+V/QV;_ &I]OV,C\L\F
M_P"$:W]\'\$GX[-_M3[?L%TXX]07*F-XA16BT\,WB]T,#YS'<H7S^7(7S.>0
M/+HY&^$G:='=R\/=Y+K\DW3'3/8E&5_VG^9?_82^?\ZK_ 5R)1@W&7/O*&/0
M96VU<.W:\MN>3W:YUCH'5&E)5U<H=+2/VTC_ !PGPNUT/P!%HSG^T_S+_P"P
ME\_YU7^ HE$#SSDO,[]EUTN]RP&XVFMJ9&F:W2O(DA+8V- =O@8[J!NZM':O
M?VV[R68XB,<S';^T*QS\L\F_X1K?WP?P2Z/QV;_:GV_8K,>)LIOU;R;B-)58
MW5T=/+=J1LE3(\%C!YK3J1Y8_P *U9MYENLNB<<Q$Q/;]B2_HJOG6(@("#S;
MY?+?C] ^X7"3:QO2.,?'D?W-:.\E;L.&[+=TVM63)%D5E LCR.OR6O=6UKML
M;=6T].T^")GL'M)[SWKZK!@MQ6TAX.7+.2:R^L:R6OQFO%72'?"_1M33..C)
M&#N/L([CW*9\%N6VDF'-..:POEEO5!?Z".X6^3?$_H]AZ/C?WM<.XA?+9<5V
M.[IN>_CR1?%8=RI_D\W[1W^ K2V)AZ;/ZBL%_HUG^>]%E5$1+<_P#=YM]L47
MBZOK*-@[>\R1@?\ WF_;"]O9;W^2_P!$O+W.V_FM8/B^+UV3UPIJ8>72QZ&J
MJB-6QM/^%Q[A_P B]/<;BW#;6=>4.'#AG)-(7RT6BAL=#';[?'Y<$?:>USW'
MM<X]Y*^6RY;LEW5<]ZRR+(I#O+4V" @("";\QY/RCB]DM]7Q5C,.47>:J\JM
MI:@D-BIO+<[S!I+%UW!H[45&?TO>L;_VBM__ #G_ (:AP?$O)/K6O#30V[C2
MUVF:7PBME<W2/7[KY:M+>GPM/V$.#/\ T\\)WSC87[+\]N3;QR1EDHFNU5&X
MOCAC#B_RFO(;N<YSMSR&AO1K6C1NI$RN2((" @(/QS6O!:\!S3V@C4(/T  :
M#H!V!!QST]/51.@JHF30/Z/BD:'L/V0=04'Y3TU-21-@I(600-^+%$T,8/L!
MH 0>-E^86/!K.;[D+YX[<V5D!=2TU16R;Y=0WY.F9(_3IV[=$$?P7-L?S_U%
MW6]8U)424%/A5)1RNJZ2IH)/.;=JB0@1U4<3RW:\>(-V]VNH15^1! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$$Y%Q[.LLR2>K@L\YME-_%J$
M%T8!C8>K]-WW;M7?8T7R6_P;C/EF8MFD<(;;9B(8G^C3.QU%EFU_;1_Z:\[\
MNW'T2O5#->&/I)W)_)LU[B=!>W4F+LKX7N#G[X:2JC$AVD@>8UH=I[=5]IM9
MOG%;UQ2[G^WE:Y7)=3$0$! 0$! 02KGS'KSDF)4-%8Z"6X54=PCE?%"W<YL8
MAE:7$>S4@+U/#<MN/),W33@L-=?T4<A?\-5G[U_\U]#^,P_5#*I^BCD+_AJL
M_>O_ )I^,P_5!5M'PW:+E8N/K9;+M2OHJZ%]29*>4;7M#YWN&H^$'5?,;Z^V
M_-,VS6.'N8RSQ<*)'P%_)>1?S]R3^<M195Q$:5\S-:>3<A) )\Z+_81K[+8_
M<6_MS9PP38S[T?J+N5D_'+6C/L8( _\ %*/N_P"V:N;=?<W>:4EO0OB& @("
M#PLIQ>BRB@]VJ/DZJ+5U)4@:F-Y[>G>TZ=0NK;[B[#=6-.;1FPQDBDH'=K37
M62NDM]PC\NHC/V6N:>QS3W@KZG'DMR6]5NCP+[)LFDOJSV>OOM?';[?'YD\G
M4D]&L:.USCW )ERVX[>JXQXYOFD+YC&,T6,6\4E+\I/)HZJJ#T=(\?!W :]
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M,)I*2:KI';XVU#;M42&,G0=0U[3]M%7I$$! 0$! 0$! 0$! 0$! 0$! 0$!
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M7S.[VDXIK'RO<V^XC)%)U9@O/=@@(" @(,8S'CO!N0*3W+,K#1WB)HTC?4Q
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MP6CFDIZ*&.FB=*;Q4M+RV-K07: #7MT"+R6M$$! 0$! 0$! 0$! 0$! 0$!
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MIVX2TD\=1$,#HVE\3@]H=],51T):2->J+R6)$$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 08!=.(<9O-QJ;I7U-=)5U<AEE<)F::GL !C.@ Z
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M$$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M$:-:.TGO<X]Y/>4R9+K[NJ[4LLBV*0[:ULQ 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$!!(X/[T-?^8-%^.:M%Y*XB" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @\;+B!BE])Z 6ZKU_>'K=@^\M\\#0I
M?=-@@O7IAT^E\@]ONT'^T<O"\6^6WSL9;*+YQB(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(/!R_&9,LL[K1%?+GCSS*R7Z1LD[*:L'EG78'R
M1RC:[[H;4$?P3%9<.]1=UM<M_NV2.FPJDJ17WZHCJJM@==JAGE,?'%$!&-NX
M-V_&)ZHJ_(@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(/F2-DK'12M#XW@M>QP!:YI&A!![04B:#R_R7QGZFH?FL/\
MHK;WU_U3ZQ^_DOC7U-0_-8?]%.^O^J?6.S16FU6USWVZAIZ1\@ D=3Q,B+@.
MP$L UT6-U]UVLS([BP! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MAK_S!HOQS5HO)7$00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MG>#@K+JZ;!./K=/N?15.L-7?)XG Q!K^K )NVG!.W3Q>*3:P&39[(,@P#@S
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M^T4$9FJZRH<&1QQM[R3^H!VD]!U0:SW/UKVH2U%PQC +[?<,I'%M5DC6&G@
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M;K*1**7SNKH('=FOW+WM_:MT8.HF5Q1! 0$! 0$!!\O>R-CI)'!D; 7.<XZ
M =222@Q6+E+C2>X?1,.8V22YZ[?=&7&E,I=]Z&B34GKV(,;Y8XGGY,O>!U[K
MDV"U8I>67>X6R1I+:MD8#FZ.'4.:YFT#L+7NZZ@(K!N=>"KO<+O#S%P[-]#\
ML6?Y>2.#:R.Z1L;H6/!\)E+?#XO#(WP/[B!$LLX*YUL_,-GFI:J$6C/K1\ED
M./2ZLDCD8=CI8FO\1C+NA!\4;O"[N+A,/=K.#.'[A>_RBK,*M,UW+_-?,ZE9
ML?)KKN?$-(W.U'4N:4*L^CCCAC9%$QL<4;0QC& -:UK1H  .@ "(^D! 0$!
M0?$LL4$3YYWMBAC:7R2/(:UK6C4DD]  $&+T?*'&UQN'T309A9:FY[M@I(;C
M2OE+M=- ULA).I[ @QOD3BBISSD+CS+9;DV*S8765%?46I[#K-.YC702,>/N
MF2Q,U#NFW73KVE3OF_A#(*+(&\W\(.-NY(MQ,UUM4(^1NT/;)\F- Z5P'C9_
MTO\ K-"X1+/^$N;<=YHQU\\#!0910 0Y!C\Q^5IY?BES0[0NB<0=KM.GQ7=4
M)AZ3N">''7K\H3A-H-VW^;YONK/+\P'=O\K]SW:]==FJ%5! #0&M #0- !T
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MT>TZM[2ZMC\KX,XUS7-[1R!D%H;47^T?M13U>T#RO>XRT^;Y)&L>I'L=N:
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M#C=&+?CUKI+30 [O=J&".FBW>W;$UHU^%$>B@(" @(" @(" @(" @(" @("
M@(" @(" @(" @("#SKW8+'DMNDM&16VFNMKF_=*.MA940N.A .V0$:C7H4&&
MV+@GA[&[BV[V7"[73W%CO,BJ'0"9T;_;'YI>&$=VW1%JH:((" @(" @Q3/\
MDC#.,+*+_FUS9;;>^5L$.K72S2RO/Q8XHPY[R!XG;6]!U*#Q<>Y[X:RDM99L
MUM;YG_%@J9Q1S'IKTCJ?+<?U$6CP^;^$,>YLL,%=;ZF.WYK;&^;CN24[NK'M
M.]L4KX^KHB[J"/%&[Q-[VN$2GO%?*<>;^_\ IX]15KB9G-.WW0QW!H$%VB8
MYCFN&@\_0!['QGQ]'L.J#BF]&)LE?/-QER5?<.MM4XNGH(7/EZ$:$"2&>F)
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MBO#+=AE@W24M$'/GJI=/-J*F4[I9GZ=[CV#[ENC>Y$9>@(" @(" @(" @("
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M$8LM0$! 0$! 0$! 08%RWQ)BW,6+2XWDD7EU$>Z2U76)H-315)&@>PG35IT
MDC)T>/80""H+QIR7>N/,D9P!ZC88:MH(CQ7**YHGI*RG<2R)DDDP(<UWQ62.
MZM/@?H458LB]-G!V3^8ZX870032:DS6YK[<\$]-?XJZ(?JA$JPVP^C+B/&\Q
MM>76R6Z?_I4[:N"URU0=3&>(AT3BYK&RZ,<-VWS/%W]-015L.B" @(" @("
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M155! #YIG@#<]VGV -&M : $1ER @(" @(" @(" @(" @(" @(" @(" @("
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MH- S:W1K=-&G1PZA"JE4L I::&E$DDHAC;&)9G&25^P ;GN/5SCIJ3WE$<J
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M6Q,)(8W[904=$$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M1$>P@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @U9NT^9>I;D;)L-LN156*\1X5/\
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M]SNUSB=3V#V !$9(@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MYK9(R?D]0]IV%%U>QZT:Y^.Q\8YI-2OJ[7C^21U57%&=A>6;)VQAQ! +VP/
M)")#YXOXNRCF?*X><^<:<MHP?,PK"Y=33TM,3NCEF8X#4=C@'#60^-WAVM0;
M4H@@(" @(" @(""'>H3E;)<4=8>.>-86U/*&:2N@M;G!KFT5,WH^I<' C4==
MI<-H#7N/Q="6&!N]$MMO5$+IE^>WVX\@2CS9;TV5CX&3N&IVQRM=*YH/?YS2
M?V/8A5LAC^+T=DQ*AQ"IEEO%%243:"IFN;O>I*MFS9(9_,W;O,U.YIZ==.Q$
M:G9AA^7>DG+YN3.-(9;IP_=96#)L:+G.]S#G:#J=2&@N^0G[6D['Z@@O,M6U
M6"YYC'(^-TF58E6MK;75MZCH)H90/%#,S4EDC>]I^R-0028LD0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0>??;[9\9M%9?[_ %L5NLU!&9JRLJ';(XV#IU/>22 T
M#J3T'4H-;:SUBSW2>>7C?C'(,NL-,XMDO$<<L$3MG:6MBIZC0?MRT^T!%HZM
M5RAQ-ZL,7KN*[SY^)YQ([S+3271K?,BN, <&.@D&@>1J621.V/<TN '>!HY>
M%.<[OA=V;P;STXVG+[7MIK)?ZIW\5N%-\6$/F=H"X@:1S'I)\5VD@.X3"@>J
MJV8Q<N#<H?DSHF-HH15VB:0@/;<HSI3B,G[IY=Y9T[6N<A#V.++2W,.%L'@Y
M MT5RJ3;;=5RP7",2ZRT[6OIY7M>#X]&L<=>\G7O04]$$! 0$! 0$! 0$&IW
M)]VI\$]8F!Y9DSA%CEWM#K31UTG2*"H>:B$ZN.@ #YX][M?"V34HRY-L48L5
MY,MLUWX]R>WT]PGM-1+;*HPW&DE=!-#(R)SVN#VD$#5OBT/5NH02CTA76KRS
M@.WT>0L%=3TT]=:M*H"5L]&'ZACP_4.:!(8]#]R-$65<P?C_ !#C>RG'\+M<
M=KM;II*F2*,N>]\TIU+GR/+GN(&C6[G'1H#1T 1&2H" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(-5^?(YN4^=\ X)JYY(L0\E^0Y#!$XL]Y$0F<R-Q&AZ-@<T:=GF
M$]H&A8;/6VVV^S4%-:K32Q45MHXVPTM)3L;%#%&P:!K&M   1$-]2/ %IY+Q
M^IRG'H!;^2[+&:NV7*F^2EJC3C>*>5S-"YQV_)/^,Q^G7;J$6)>/Q?3XCZK>
M%+;)R9;V7#(+1+):ZVXQGR:R.KIVM(FCE9H6F6-T;Y&Z;"[7PZ (:.YC_H\P
M"V72CJ\@O=[RNTVQXDMEBO%4V6@B+?B[HV,:' ?>]&GL((Z(5;#@!H#6C1HZ
M #L 1'Z@(" @(" @(" @()OS9P[8N:<.DQNZ/]TN5.XU-FNS6[Y*6J TU(U&
MZ-X\,C->HZ]'!I!8EK]CG-?,'IYBCPSF_%JV_P"-T(\BV9;;/EW.A9H&-,K]
ML<H [/,='*/NM46CMY%S%R%ZE*&7C_AG&:^R8U=-:;(<QO#1%'%12>&6-GEE
M[07C5I#7N>YO0-'5P&C9?CO!K/QMAEHPJQZNH+5#Y?G/ $DTKW%\LK].FZ1[
MG./LUT'1&+)T! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0=2YW.VV6@J+K=ZN&@ME(P
MRU594R-AAB8.USWO( 'V4$CI_5=P%4W?Z&9F$+)MVP54M/5149=_KWQ",#]D
M7;?A1:)UZH[5D.$9EAGJ/Q"G-<W&PVAO\#-='4,KG['.+0=&/;-+"Y_W)<PH
M0V$P#D'%N3,:I<IQ*M;5V^I:/,B) GIYM/%#.P$ECVGM'?V@EI!)'SR-G]AX
MSQ"Y9?D-0R&EHHG&GA<X"2IJ2T^5!$.USWN&G3L&I.@!*"3>CC#KIC'$?TK>
M874]=E=?-?&4[AM+*:9D<<)V]P>V/S&_L7!%EL&B" @(" @(" @()AR-Z@^*
M>+*YMIRN]@7IP:YULHXWU=3&QPU#I&Q@B/4=0'D$CJ 46CW,3Y(QKDS&*N^<
M:76DNL\<;V0LG\V)L-66$QLJH]HEC:3IKX>HU+=41Y7"LO,$V*SOYFBHH<B]
M\G%(RCV;_= \[?-$1,?;KY>P_N>W=XM465(1 @$:'L0  !H!H!V (" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @("#4J^4U=ZH^:+SA-75S4W#/',S8[K2TSS&;G=0Y
MS"U[F]VYDC01KM8PENUTFH,M%RJ>%N%Z6T14]5AECIK7:]M4V=]+#$8O=_E/
M,?/H'D#35Y>_0CXVH1*H7>?658),Y?;Y+ ZX<&R/?8[EDSZ>25DM;*W5S@UP
M,;X1'KK"1YCF$O\ 8PEH[]7Z3[<*X9MP'G];AD5UC;4,BHI'U5!-#(-S?*DB
MEC=Y9#M6M>9![-$2KV<;]*3:R^4>2\S9E<.1:^@.^CMU;O9;HW @C=&^24O'
M34M&UKONFN"%6QS6M:T-: UK1H .@ '<$1^H" @(" @(" @QW/KY6XS@V2Y'
M;8?/N-IM=;74D.F[=-30/D8".\:MZH(CZ3\*PZY\9P<@7"&GR'-<IGJZG(KQ
M7,955/G^\2-,),@<6  !SF_=$[NS;H66.X_8*+BOUE#'L4A%OQK-K%)75-K@
M&RECFC;*\EC!T&CZ9SFZ?%\QP&@Z(O)MDC%+<4YE.4<L93Q?^2]SH!C<;)!>
MJB/2GEU.A+QH/+;)KNICJ[S6ASO#IHBT5)$$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0=:XW"BM-OJKK<IVTUNH89*FKJ)#HR.&%I>][C[&M!)08WQWR5A_*=A_*/
M#*\5M V5\$['-,<\,K#\66-WB82-'-U[6D%!KCP5>(>+/4)R5Q3D[A2S93</
MI?':N7P,J-[Y9F1M<>A=)%-T_9,<WXV@1E+8CE/CNCY3PRMPRX7*LM5)6NC=
M)4V^39(1$\.V/!U:]CONF.Z=_: C%,N=+7QMQ+Z<+SC#+52LLONOT=8[=* ]
MTMSJ-?*FU/B=,QVM0Y^N[P$HL,D],F(U^%\)8M:KJ)&7&H@?<9X9==T7O\CI
MV1[3\4M8]H<WN=JA*N(@@(" @(" @(""+\P^H:T\;W2DPS'+7-E_)=RVBCQR
M@)+H@\:L=.YC7ENH\36!I<6]3M;HY%B&,<?>I"_73.J?B[F/"I,/O]Y81:7O
M+I*6JWM.D3FR#[O0M:YKG-+O"="A1:L&P#$>-[*<?PRV1VNUNFDJ9(HRY[I)
MI2-SWO>7.<= &C4]&@ = $1":[;</7!;B>@L^)/=J=!U>9AK^I.B\G8K^<LT
MY)Y6H<#X'935&/6"I9/F655<?G4#X6DM=3Q.':UVC@US#OD>/ 1&USW"C9(-
M:'%X W$ %VG4@=G^%$?J @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#\<UKFEK@"TC
M0@]004&HW)W&.5^G_*I^;^$(/,QR3QYEAC-?=S3Z[GR1L;KI$-2[PC6 ^)OR
M>YK3)DN58CQYZP,$MN:8A<3:<RM0VT5P'2JHJAORAHZQK"';0[Q,>T^'X[-0
M7!Q-&/VO,/6A@D#<;NV%4.;.A:(J._-F:72 = 97LFBW=G;)&QY[7$]J+P>M
MBO!?)')674'(?J0KZ>=EI>)K'@]"6OH(']#K-M+F$:M!+0^0OT&]^T;"2K9]
M$$! 0$! 0$! 03[FS(,^QCCB\7CC:U-NV3P1_)QGQO@A(/F3QPZ'SGQCJV+O
M]CM-KBPBGHPHN/+M9+IFE-<9+WRU72O.5U=R(=74_G.+@V+<2?*D(W&0'QNZ
M.TVAK2R\'F3,[WS'S%BN+<(6^GOEXX\JI;E6W^HZVZ"K+F -=*"!Y<;HANT)
M\Q_1H.WJ(>I3<S\Z<.9_9,;Y\AM]SQ/)9A34>16QC8V4\CG!FH<QD6K6%[?,
M9)&';?$TG30BC]YXX2Y/S+FZ@NN!UDEKL.461UER6],.C*:EAD_C$<@!#B)8
MS&&,:1O(<"0W<0(EL1QQQQBW%F+TN*8G2^110>.HJ'Z&HJJAP ?-,\ ;GNT^
MP!HUH#0 C%EJ @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""&>J'C7/N1,)A/']ZJ:.
MZ6:1U:ZR4\GD-N.C1HWS&EKA)'H3$"[82>O7:X%AK;PE+SWF5OJ:? N6GP9A
M97/;=<.RCS9)H6L?LW1FICJ@]FOA=X6F-W1VFK2XLJR[D'UEX:"S)./K;EU"
MT=:FU.'GO [?#!,X]G_\NB<&NE9RI=^)^3(\_P )PJYX']($MRC#KF)!:Z@[
M]7-@+H87,:=2YHV?)/\ B> [$9/Z-X=DL>8XM:<HBH:JVQW6F95-H:^/R:F(
M2#L>W]<'O&A[T8/<0$! 0$! 0$! 0<,-725$L\%//'+-2O$=5&Q[7.B>YH>&
MO .K26N:[0]Q!0<R#3[U'^G:^6RHN?+/"<E3;+U44\\>462V/?"^JIJAOR\M
M.V,C5SAUEA'Q_C-\?QC*)9YZ0K[Q97<916W 810WBB#79325+FNKW5CAH9Y'
MC3?$_0^4X>%H\.@((1)8'R1=V>J/E.Q\:8.WWK <+K6W++,H:-:=TC=6>53O
M';J ^.,CX[B7 ;&;B71N"C$0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!KESSP
M-=KE=HN8>'939^5[0?>)(Z?:QES8P:%K@?"92WP^+PR-\#^X@L2RS@;GFT\P
MVF6AKHA9^0;0/+O]@DW,>U[#L=-"U_B,9=T<T^*-WA=]RYPF%=GIZ>JB=!51
M,F@?\:.1H>PZ>T'4(CD0$! 0$! 0$! 0$&LGI7K*F@S;FG#:Z=\U5;LFDK0^
M5Q>][:F2>+>7.ZDD0L19; 9?EMBP7&[CEF2U!I;+;(O.JI0TO=H2&M:UK=27
M.<0UH]I1$%X6R+F'F//).6J^KFQCB2&.6BL6,N:'_249)'FO#NFK7 .,[>\>
M6SP[T67F\P^E"MR#,&9=Q/=_R4J;^Y]#F5/$^2"&2BJ_Y1-&V(C<7@?*0'1D
MAT=JT[B1$KUQQQQBW%F+TN*8G2^10P>.HJ'Z.J*FH< 'S3/ &Y[M/L :-: T
M (C+4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!-J[@W ZSE*W\NLIYJ/*J%
MCQ**23R*>JE<W8R6H:P N>UI+>T!W3?NT"+52400$! 0$! 0$!!/L^RG)Y[=
M>,?XC=:[KR+;Q![W1UU2&-H(JMKW1RR, .YS@P[&.+?OCTZ.*B/Z6_5_B8V9
M3Q52WZ&/MGLY<^1[?;_%IZGK_P#2'V$."183ZB*#CWGC,LXS+%+M8J'*Z6$5
MEC# ^KI:MGE'S'-J!3;F.+9#V ^+O1:-D+=ZM/3SEE)-;;G>_=*>KC=#44-X
MH9A%)%(-KF/(CDB+2#H0YR)16,-R[!<IMP9@EWMMSMMO9%!Y-JFBDCIF;=(X
MS'$?DQM;HUI Z#HB,D0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$!!J9FK#P5ZHK)GL9,.$<FL-KOIU^2AN!+&%[M>C1O\F;<>XRZ=$9
M<FV:,6JG*;&6#U@<97F9K74.16R6S54<@#HY"34Q!I!Z'K-$B\ENOO"7$62%
MSKSA5GGE=KNG91Q03'7VR0AC_P#[R%7LX3@.'<<V?Z!PJT0VBUF1TTD4.Y[Y
M)7]KY))'.>\Z= 7N.@T Z (C)$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$$YY@SS,<'QAUWP+$Y<RND4XCK*6G>"*:%@#WN?''K*]Q:=
M&MC:=-=QZ#0EAAW&WJRXNSR5EINM0_$<HW>5+:KT1$PR@Z%L=0=&..O31^QQ
M/W*%&2>H3C5G*_%5XL%+&);S P7.PO&A/OU*TN8UI_[5I=%K^SU0AQ>G'D@\
MG<46>\5DA??[<#:;Z'?']]HP&E[M>^5A9*?A=IW(2Q_GKC#)\[SKBF]XK&UE
M1C=WDJ[C<93I%3TD;H*C5VAW.+C!L8UHZN=UT&I A>$00$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M])EXQS%\_P FQ'DF@GMW/%;52B:[7:3S9:R-VDCH87NZ->X_*>$GSFZ.#B
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$ @__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>lc_immunizations-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_immunizations-4c.jpg
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M%!04%!04%/_  !$( C4"AP,!$0 "$0$#$0'_Q "^  $!  (# 0$!
M    !P8( P0% @$) 0$!  (# 0$              0(&! 4' P@0  $# P("
M!04-!P %"0D!   ! @,$!081!R$2,4$3-P@BPQ1UM5%AL3)R,[,5A19VAD=Q
M@4(CU)97D=%28I/20U,T5"56%QC!@I)C1(2T)C8X$0$  0,!!@$+! (" P$
M     1$" P0A,4%A$@51\'&!D;'!(C)"$P:AT5)BX7(S%/&"%<+_V@ , P$
M A$#$0 _ -_@
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MW5O&VC(8HUL]NIJ]]P=4,59IZJ16]BR)$U\A&ZN57:Z]76I6?!
M
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M*OE.ZP<&QX0
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MKFZK[FG$*I80
M                                   !UW4%"^L9<74L3KA&U8V52QM6
M9K%Z6H_3F1./1J!V
M
M
M
M                                                 >?>[Y:L=ML]
MWO52RDM].FLDS]5XKP1$1-5557H1$U/GDR6V6]5TTAR=-ILFHR1CQQU72[-%
M6TEQI(:^@F944=2Q)8)XUYF/8Y-45%0RMNBZ*QN?+)CNQW39=%)C?#G,GS
M$4W)W*W-MFZEEVQVYMMDJJNZVB6[NJ;Z^JC8WL)GL<U%IU7J:FGDKQ"NY:*W
MQ/.NU V^VO"F61:F%+F^CJ;DZI;2*].U6%'LY5D1FO)S<->D&QZ>VVY%VR?+
ML]P;)Z.GH<@P^XL93-IN=&U-IK&=I1SJDCG+SN:FK^5=$U0#DW&W%NN-9;@>
M#XU205M_R^XO94I4\ZLIK/1,[2LJ$2-S5YVM5.SYEY574#HX;NG=YMR;]M1N
M!14UKR6GYKCB]32K(VENMF<J\KXTE5R]M'HO:M1W4[1-&*H')A>YUWW#W OE
M#BU'32;88WS6^KR*3M'2UUY;HKXJ-6N1BPPHO\QZHNJZ<O!R*!EFXN2U6&X%
MDN64,,=1662VU5P@@GYNR?)31.D:U_*J+HJIQT4(D..9MXH\FQ>U9C:\>PRI
MMEVHX;E2425=?#5OAJ(TD8S5^L;7Z+UNT10NQ[">(FW2[.T^YM-8ZF2]U58E
MCI\6YT29;XZ98$IEEY=$;S)S\_+\3^'F\D%'1N.Y^\VW-1:+ONS8L?=A5WKJ
M>VU%5CE15OJ[7)6.Y8GU+:IO)*Q':->L6GO:\$<%Z"
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M9<J>>J8L55DEPI%7LG,C=HYE&QVJZN3R_<U^;&YL0$
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M/1(%9I2QVFVQ1]G&J?RT1K41K=$TX)P M(0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M /+MF2XY>JBHH[->**XU=+PJH*2IBGDB5%T\ML;G*WBO6!Z@
M
M                   $*\4F3Q6C$\>QNKNRV.RY9>Z:V9%=6O6)\-E8U\]9
MR/:BJCGM8C-$3RD56]86&#65=C+GG>%TN+X_=]J,GH:QDV.72ILZV>&_TC&<
MLM)VCU7MFSM5/*G1)%Z&KJ[12MJY)8X6+),]L<;>E[U1K4UX=*ABX/K*W?\
M;(/^(S_6!SQ30SLYX)&R,UTYF*CDU_:@'V
M                                _'.:QJN<J-:B:JJ\$1$ UVW:WRG;
M5+C^"5?(RFD1:V\0Z.YY(UU[.%5U16(J>4[^+H3R?C=!K-?->G'/I>F]A_&8
MZ?NZJW?&RR>'.[GX1P\^ZA[6[K6W/J%M'5NCI,HIV:U5%KHV5K=$6:%%756Z
MJG,WI:OO:*O8:35QFBD_-#6>^=COT%_5;\6*Z=D^']9Y^WUJ.<]K
M                  (CXF,4N-YQW&,JMEKDODF#Y!0Y!76:%B2S5=NIG+Z3
M'&Q>#G::+R]:(H6&';C;@XKOW/A6$[7R3WF]4^06Z^72N92U$#++14#GK++/
M),QB,EX\C&=*KJG3R\P;%Y'C=BRZSU&/Y+017.RU?)Z315#>:)_9/;(S5/><
MUKD]] C _P#TY;&?^!+5_P %?^4%J\;PX6R@LELW"LUIIVTEJM^<WNEH:2/5
M(X8(T@1K&(NNB(G0@)6D(
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MY@+*O!                                          #5%UTZND
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M/7D<NBM?')RM>L;VKT.1')JAM6/)%]L71NEXMJ]+DTV6[%DBEUL[7L'T<4
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M+8DY;H0                            "0["?J=^/[]Y@+*O!
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M]6Y3]%0!5:"                             $AV$_4[\?W[S 65>"
M                                       )5MS33Q;K[PSR1JV&HN-E
M= ]>AZ,L\#'*GNZ.14_:8Q=$S2.#Z78[K;8F8F(G=S\RJF3Y@
M 2'PO]Q>*_:'M*J"RY/$IW17+UE8?;5$"%:")+FG?YM5ZMRGZ*@"JT$
M                        )#L)^IWX_OWF LJ\$
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MS^(^*6?:6XQPL=)(MRL6C&(KEX7JBZD!"KA$ES3O\VJ]6Y3]%0!5:"
M                       $AV$_4[\?W[S 65>"
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M<I^BH#MVBJT$                             )#L)^IWX_OWF LJ\$
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M\G<,E/EQQ\MOOGG[/77Q,T[_ #:KU;E/T5 <YKJM!
M          "0["?J=^/[]Y@+*O!
M       0W?Z.^7^_X-M]9ZA($R+ZXG>QZJD<LUJIHZB)C].I=7)JO0JH[J.'
MJ\$YK*1-&P]A[E9H=3UWV]5L[)\;>=OEMC8UZI\8O]5?TQ>&@E6_+*L"T2MT
M>UZ=/-KP1$3BKEX:<>@U2,5\W]%-KVF_6X;</WYNC[=*U4G;[!\ZM&1[@V2S
M;AMQ"#&IK8EVJ*>UT5=%4/J+;'5ND?)7-5R)$DG9-5--6M153J3;-/B^SCI,
MO$^[:W_Z.KF_'93JI$1&^>$3/]I_QS9-B#-Q,Y;6K8=\:[M*![F2PSXW962N
M8BZ-F8U&*JQOZM=%3^)$4RPZFS+7IG<^7<>TZC0]/W8V71OC;%?"><>KPF5(
MV/R>]9GM/BN49%.E5>KE1I-6U#6,B1\B2/;KR1HUJ<$ZD.2Z>5 "
M  !(?"_W%XK]H>TJH+*O! "2YIW^;5>K<I^BH JM!
M       1JP[[0Y1OC5[6V*B9/C]OM]3-47]W/I-<*.6..:*G_A<R)7\CW?[:
M+IP1%4M%E" $AV$_4[\?W[S 65>"
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M268:S&^7<]T[YGU\6VW[+;>$;IGQGW>#P_#/W#X-ZO\ .R'-=#*KA
M    D/A?[B\5^T/:54%E7@@!)<T[_-JO5N4_14 56@@
M   ">YCNQ38QD<>(6G&[SE>1^AMN57262")[*6DDD=%&^:6HEA8U9',>C&(J
MN7E5>"=)7JX3F=TRU:Y+EB-XQ;T/LNR6\MIF^D=KSZ]EZ//-\3E3FYM/C)IK
MQ",M  835;=PU.ZU!NBMP>V>ALLMA2U]DU6.;-4>D=KVG-JBHO#EY?W@9L
MD.PGZG?C^_>8"RKP0                                       $AW"
M[]-F?S/[-C"J\$27;7O=WG]96/V+3A57E^:?\E?@")7X9^X?!O5_G9 LJN$
M         "0^%_N+Q7[0]I5065>" $ES3O\ -JO5N4_14 56@@
M          #7S<GZXDWMIH+5F]'MI.N-M6*[ST]-5R7E/3).:G<RM>V'2DT1
M[-$[3^<[35NNA5"VQ@R"#ZT^O-R:?<+F[#L/1Z.WT7H6G:<W-Z"YW-VO#3GZ
M.7AU@4$(    "0["?J=^/[]Y@+*O!
M         2'<+OTV9_,_LV,*KP1)=M>]W>?UE8_8M.%5>7YI_P E?@")7X9^
MX?!O5_G9 LJN$          "0^%_N+Q7[0]I5065>" $ES3O\VJ]6Y3]%0!5
M:"                     (3N9:J_.=SV8=:,9Q"JK+;9(;I4WO,;7];3OB
MGJIH8X*2-'1JC(W,<Z1W.J(KT31-=5*R[:K KQA"W9;K;\3H/3O1TA^Z%G6S
M*_L>TYO2=9).TTYT[/HY?*]T"D!     2'83]3OQ_?O,!95X(
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M5%+7/5[6J]LS'M5B.16HCE7@"5F"     D.PGZG?C^_>8"RKP0
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M00ZQ-IT:^1S'QN=VCE<Y7:\$)*OA     2'83]3OQ_?O,!95X(
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M14%KB26:F@C@D>^=JN=-)(]:A>?F7ET;R@E5P@    )#L)^IWX_OWF LJ\$
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M     2'83]3OQ_?O,!95X(
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M$3@B E:0@     $AV$_4[\?W[S 65>"
M           D.X7?ILS^9_9L85VMX-J9<ZI4NUJJIDOU%'I3T4LKEI)6)Q<U
M&.7E9(O4].GH=[J==K=+.:W9OAM7X[WFW09)MOCX+Z5GC%./FV[8],<];<4P
M+(<LR%<=HZ9]/4T[U;<9)VJUM*UJ\KED1>**B\$;TJIKN'3WY+^F(\_)ZKKN
MZX-)@^]=-8GY:?5YOW;BXGBM)AF.16&CJJBKAIV?.U<BR.U1C6JC$7@QGDZH
MQO!#;L6.,=L6QP>&:[5W:K/?FNB(F^:TCR_\[V$^&?N'P;U?YV0^KARJX0
M        )#X7^XO%?M#VE5!95X( 27-._P VJ]6Y3]%0!5:"
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MLN]2O-4RVJZT_I-(R9W\4D;4<USOV)T("5G"      2'83]3OQ_?O,!95X(
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MEZ>:)'*]--/< ]8 !(=A/U._']^\P%E7@@
M             )#N%WZ;,_F?V;&%5X( ?$OS3_DK\ $K\,_</@WJ_P [(%E5
MP@          2'PO]Q>*_:'M*J"RKP0 DN:=_FU7JW*?HJ *K00
M               ,=SVPWG*,.O..X_=W6&[W.F=2T]W8Q9'T_::(]S4:]B\R
MLYFHYKD5JKJG% ->=\-K=I-M=H(**R66GI-PD?24>'7*WQ]G?ZN])+&C'LFC
M_G2.555S]7*B=7'E"PV7M#Z^GL5O=D$D;;JRE@2Y2HK6Q^D]FU)51>":*_70
M(Y_K*W?]L@_XC/\ 6!*M@G->W<U[%1S'9]?5:Y%U147L.A4"RKX0
M                               $AW"[]-F?S/[-C"J\$ /B7YI_R5^
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MV;@V6U4[*2U6[.+W2T-)$FD<,$20(UC4ZD1 2M 0
M                   $AW"[]-F?S/[-C"J\$ /B7YI_R5^ "5^&?N'P;U?Y
MV0+*KA           D/A?[B\5^T/:54%E7@@!)<T[_-JO5N4_14 56@@
M                        !(=A/U._']^\P%E7@@
M                     )#N%WZ;,_F?V;&%5X( ?$OS3_DK\ $K\,_</@WJ
M_P [(%E5P@          2'PO]Q>*_:'M*J"RKP0 DN:=_FU7JW*?HJ *K00
M                            D.PGZG?C^_>8"RKP0
M                        $AW"[]-F?S/[-C"J\$ /B7YI_P E?@ E?AG[
MA\&]7^=D"RJX0          )#X7^XO%?M#VE5!95X( 27-._S:KU;E/T5 %5
MH(                             2'83]3OQ_?O,!95X(
M                           "0[A=^FS/YG]FQA5>" 'Q+\T_Y*_ !*_#
M/W#X-ZO\[(%E5P@          2'PO]Q>*_:'M*J"RKP0 DN:=_FU7JW*?HJ
M*K00                             D.PGZG?C^_>8"RKP0
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MJ_SL@657"          !(?"_W%XK]H>TJH+*O! "2YIW^;5>K<I^BH JM!
M                           "0["?J=^/[]Y@+*O!
M         DWB(15P:V(B:JN2X[HB>M:<+#M9KO;CF'W^EL79K<'I)RW>6!R*
ME*Q>&G7SR(O%S>I/?.NSZZS%?%N_QY-K[;^-9]7@NRUZ-GP5^K]HYJ-;[A17
M6B@N-NG94T-2Q)()XUYFN:[K0Y]MT716-S6,N*_%?-E\4NC?#LF3Y
M   !(=PN_39G\S^S8PJO! #XE^:?\E?@ E?AG[A\&]7^=D"RJX0
M )#X7^XO%?M#VE5!95X( 27-._S:KU;E/T5 %5H(
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M                             2'83]3OQ_?O,!95X(
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M<(          $A\+_<7BOVA[2J@LJ\$ )+FG?YM5ZMRGZ*@"JT$
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MPNYHVL=\9%U^,Y%17=?#1#5LNLRWS.VD3P>S:/L.DT]ML=$776U^*=\S._\
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M:"              /B7YI_R5^ "5>&9478?!E1=4^K].'NI-(@658"
M        (_N(]C=]MEV.<B/?]Z.5JKQ72VQZZ(%6 (               1_P
MN/9)L3BCXW(]B_6&CFKJB_\ >55UH%E8 @
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M@Y#E-@Q>5]:W$Y*6GKKDSD=1S35;955L#VN57]FL2M>JHB:_%U3B!FX
M         $<N?B,QR"X72GQ[&,DRRT6.9]->;_8;>E3;H)8OG6-D?+&LJQ]+
M^S:J(G'54"T4O%<IL6:X]093C-8VNL=SB[:DJ6(J:IJK7-<UR(K7-<BM<U4U
M:Y%10CV              8?N%N5CNVUOHZJ],JJVX72=*.S62V0K57&NJ537
MLZ>%%3543I5RHU.''54U#S,&W?L6:WRLQ.HM=TQG,:*!*V2P7^F2EJI*-SN1
M)X58^1DD?,O*JM?P7J"J&$
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M[66:IM^ TEMD2LMM0C56:M2>K\EZU#6\O*Q8VLT_WE3F*V6"
M                            ^)8HYXGP3-1\,C59(QR:HYKDT5%3WT U
MULF';\[<8S7;3X3;[3=,862JBQC+ZVO=!/;:&MD?)RU-+V3G32PK([D=&[EZ
M.&GDA5EVXPB@VXP>QX1;9%FIK/3) M0YO(LLSE62:7EU73GD<Y^FO#70(R@
M             "8X#@U_QW=+='+;DV%+/EL]GEM"QR<\JI04CX9NT9HG+Y3D
MY>*ZA5."             <54^>.FF?2QI-5-8YT$3G<C7R(BJUJNT71%7AKH
M!JWA6$^(K%K]=LUN6*8U?\]O4KUJL@KKI4=M#2.TY*2FC2-6PPQZ::,XN_B5
M=$#)L1A=5F598HY\[M]%;,A621)*6VSOJJ=(D7R'(][6KJJ=*!BR$
M      $RW2Q?<*LNN.9KMM<FI>L<DG2KQJNJ)8+7=:.J8C'LDY-4;,S36%[F
MJB*O'H"L<M>%[D[@;DX[N#N;;Z'&;/AK*EV/XU0U?UE42UU;&D4D]34-CC9R
M-:B<C6)KJG'KU"X!
M
M
M
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M'T6LC[.1T:I)%J[EU5NJ<>*:*![H
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M^5K\@I*I%3LYHD;! _LG:\KTE:B-ZM5Z"2V "
M                                          #AJZ2EKZ6>AKH8ZFBJ
M8WPU-/,U)(I(I&JU['M<BHYKD545%Z0-5W^&E:O:FIM$N%V:ESG(LD=67"HC
MCHTEM5HFNB2N92U#4X,92QM8V.)W0]41-0RJV5QW$<5Q"":EQ2QT%CIJAZ2U
M$-MI8:1DDB)RHYS86M15TX:J&*899ANX&)[F5FZ^V5OI,A2_4$%NR?%ZVJ2W
MRS/HN%/4TU2YKV-<UG\MS9$TT]U5\DKK8WM[G^099D>Z>X5/1VS(:ZQ28WC6
M,T51Z7'0T<BNE>L]3R-:^5\J_&8W1&Z^\B!F6R.)WG!=JL9Q+(61QWFU4SH:
MMD$G:QHY9I'IH]$37@Y 2\.Z;?9)5;ZUN?PQPKCTV#RXW&]9427ZP?7K4(BL
MTU1G(OQ@/)QK:_+;9X7Y]JJR*!N7OLESMK8F3(ZG[>K?.L7\W1$T5)&ZKIP!
MQ?FX>U^79)X;[9MI;(:=V64MNL5+-%).C*=)K:ZF=.B2\O%$[)VBZ<0<628[
MA&06W>_-,[JHXDQZ^6RV45OD;+S3++1M5).:/3R4U7AQ ;8X3?\ %LPW*O-X
MCB90Y/>H[A:712]HYT#8$C57MT3E75.@"9-V+S__ ,I8['3NH:?-+)F<F:66
MGFE62CJ.RJ'RQ12O8W5O,V1>KI1-=-=4%7?OV,;Z[E91@&0Y%CUJQFRXE?Z6
MOJK/'<O3ZN9C=>UJEF9&V-&L:B-CB;JYRN7F5-$ S[:K",@Q/)-R+G>HXF4F
M39 ^Z6I8I>T<ZF=$UB*]-$Y7<.@"77;8[/JO;?<C&:>"E6[9/GL^46ICJA&Q
MNMTE533-5[N5>5_+$[R= 5=[*<5WNK]WY<YJ,3M>46*Q<T."T%3=THZ>B5RI
MSUCX>Q?SU,B)P<[YOJU5&N0.?<7$=Y]V\2@I;_C-GM5;C]ZMMZI+"ZY+6T-[
M@INU[>DJG)$Q(V\6*WFYD=Q1=-.8#HY?AF]>X=+BRQX?9L)LN*WZW7S[N17"
M*LJ*R2CDXN2:GABAB8QCG:,T<KE7JT0#*V81N!9=[<OR2VV^CN&%9]0T-/7U
M[JKL:NW26VBDIVHD*M7M4>]45=.I>G@NH8E8]D=Q<8P3:^\6'T%FZ&W*7"*6
MUU$RK05]#<YI.VIUG8WR7]FJ+&[31KE77J4%63TV*[H;GYUB^4;D62BP_%\,
MGDN-!8*>O;=JRMN;F=G'++-$R.-D<7QFHB<VO!>GR0R39#",@P6SY119%'%'
M477)KK>:/L)>V1:2M>QT:N5$31W!=6@E@F*[;[TX1MK;:/%JRBI<JM>05UVK
M+)-*U]#=+=5SO>M.^?LU=&]4<BM<FFB]/O!S8]MUF>5[M8[N;D>&VO;J'&8Z
MQ)H+=60W"XW::MB6%$GEIHHF)%&BJY.?5VJJG7Y(;"!
M
M                                                        '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>bc_splenocytes-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_splenocytes-4c.jpg
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M%!04%!04%/_  !$( 28#[@,!$0 "$0$#$0'_Q #"  $  P$! 0$!
M    !08'! @# @$! 0$  P$!               ! @0%!@,0   & 0,!!0$,
M!P0$" L) 0 ! @,$!081$@<A,4$B$P@446$R0K-T%;46-G8W([34=9875W&!
M4C.18M.4H7)S)#355CC!X8*2TD.#DR4U5=&RHV2$E28G=Q@1 0 " 0," P4&
M!04! 0     ! @,1$@0A,4%1!?!A<3(3@:&QP=$BD4)2(Q3A\8(S%6)R_]H
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M+"I%<A+DF*^S*<=42B;5YB'"61&1:::]@:X"
M
M
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MI[IF D@
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M9@
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M?\BH!><4^Z])\PB_(H 2X
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MM][T"/-O4
M            \X^H9WBVPR.!76O'CW(W(=9!59E"A..1$Q*MI2C)<Z2A24DT
M:]VQMQ*R,]>A;BW%@JLPXYMN0.,<WR3#7JVWRJ@BQ\4R(W%2*J%+?4\I-:E)
M$AM#^T_ YY>Y1*)):%J ]' @          ,O]1_Y"<C?N"?\BH!><4^Z])\P
MB_(H 2X
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M\1D:_P"P?+)S,6&=DZS,?CY/MCX.;/&^-*Q/X>:S_87'\(YCXR:IH^V8_69
MS/GJ,_.DDTW%6GS-#T,B4M1I+3H/-\C/;-?=;_9ZCC\>N"FVO^[=1\&P
M                                                          #S
MCR:C*N-<YS3,8>,V&4X?G]''KY[U,W[5/K+"O8>CM:L:D9QW$N[E*2?0]?<(
ME%4W 7LKY0Q;BKC>NQ*UIJ/"I53:Y1DUU&.&P;E,6XHT(E'N<4XOP[RT-)=J
M= 5[ !B          #+_ %'_ )"<C?N"?\BH!><4^Z])\PB_(H 2X
M
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MHC/3OT/0B >@@0          &7^H_P#(3D;]P3_D5 +SBGW7I/F$7Y% "7
M
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M1G)<I&NA+D-NJ)M*NJ4=.I&1@JXY3>9WC6+T-UR=A>-?R:8E5J',=AKDN6U
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M<C?N"?\ (J 7G%/NO2?,(OR* $N
M                                             ,WYP^YL#\1XS]>0
MP&D  ##_ $L_</(OQADOUDX"RW $9?F'YV\8_,<D^1A@-0
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M0 EP
M                     !F_.'W-@?B/&?KR& T@  8?Z6?N'D7XPR7ZR<!9
M;@",OS#\[>,?F.2?(PP&H                                  "OW>"
M8/DTM-ADF,U5Q/0V3*)5A!C2WB:29J)!+>;4HDD:C/373J8#BC<5\80Y#,R'
MA5#'EQUI>COM5<-#C;C9DI*T*2T1I4DRU(R[ %M      $%>X5AN4/-2<FQV
MLNI$=)ML/6,*/+6V@SU-*5/(49$9]=" 1B.)N*VEI<;P;'T.(,E(6FIA$I*D
MGJ1D9-=#(P%P                 8EGV*<C8?G4_E?BU59-1<PX\/+<>NGC
MAM/G )28TEF3J24+2E9MF2S).GNF?0J'KJGEKF>ZQ^7GT>EQW!,:LV+I=;3S
MDVLRPGPC-4=#CS1FTAE"O$HNT^S3O2'H4$          !E_J/_(3D;]P3_D5
M +SBGW7I/F$7Y% "7
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M"2X2=3TW;= 'UR_DS ,!<BLYED4&F?F_]%9EO$AQ:==#42"U5L(^AK,MI>Z
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M^81?D4 )<
M                           9OSA]S8'XCQGZ\A@-(  &'^EG[AY%^,,E
M^LG 66X C+\P_.WC'YCDGR,,!J                    *]GI:X/DA'V'63
M/D%C8XW_ &U^,?B/*6-8[23Z2++F1"=DN;][AJ66NU9D70C(NP>IRY;1:8B6
M:3J*FNJN1L,37L$PEV<TIPB4I6II=3I\(S'SR7FV&^OD2]=CR3  >)L">LN+
M)N1<WU9/R<7<R^ZH^1JU!J<TKRFF<6P:;(OA1ENF2R+4S2KIIJI1&32+3*"I
M>8N3LTIU(FI@<=1K>O<;,G&GB9-]]I23+HI*M"ZEVD")[A6MQ+C_ (3K>0[A
MOVBRN:]&0Y1?&PJ;82G[ B?7O-M"W5[?,V$E)=--=-=3,2K%%GG$E0YRIE_$
M<R8UDBL>?R&=CCL%^!6I>KF5DF6VR_':(EK6I/FFE7B[=-=3 7[T]X30TO%>
M/VQ16I=]E%>Q<Y!;OI2_+FRK-LI+AO/*(U+(C<VD1GIT]W4"5<Q2OB\>>I:[
MPK%VT0\6RW&D9._4LEMCQK2/+.(IUII.B4)=07CVZ;E:>X0"#K\$<PSU)X-+
MM+R;DN4W5-=NW-W/-*/-\DFR:;9CMZ-L-(W*VH1[H"1SBBY#L^=YU]28'$R*
ML@XW'J:V;?R&X]2AUV4J6^XA)M/+<=/PM%M2G;H>IZ=H3&/<UT%1AN1/2\4^
MSN:X]8MTTW"87E*=EW4Q)%#;B+801.E)Z;%DC4DI4K0TIU,:*?QSBESC7J6C
M2LJE>WYMD&$R;G)I2%&;"9CUFRTF/'29JVLQVVT,-]?$2=Q]H#X<=93QCA1<
MD8YR[[.QGEC>V+MU#LXQR)-O EKUAE%0:%*?96V9):9;UT/XI;@5?_2G8SYW
M"U0Q8$\ARKE6%8RU*,S?:CQ);B&F5Z][2-&].XDD0)*L^H+FR?0ULFAI*3+:
MVR@V]:VK((U:ZW7/LE*:4ZVS*)6B_-09MI3IXU>$"(;)@F>,YY$F2V<?O,?*
M&ZEDV<BKUUKKNY.[<TE9GN2789^Z",*YUPB5GO.>-5=3.=K,H@8O/M<9L65D
M@F+:%,;<CJ<U2K5LSU0LM.P]>X%ASYWR.CDGB_"K";&^C<JJ\\HZO*:5?1R%
M:19*D/(VF9GM4?C0>I^$]-=2,!:L4JZ_D3U#\A765,-V",!;K*;%Z^2DG68O
MMC"I,B23:B-/FN+3HES37;T[B <G(N<\"VN<T:;RPL*7.,2O&41+6#62V7%2
M$.&RJ&Y*.*I"X[QGM61*T478>@#KPNJ@<@\_\C9'E,=NQ5@ZZ^CQ6')23K4)
M#S!OR'TMJU3YCJ]#2YIN(M2UT ?WU-54#%Z*IYAHX[<+-L4MJ];4^.DFGY<.
M4^F,_#>4G0W&UI<^"K730]--3U$.WB:!!R/DKF')KF.W-L473>.,*D(2[Y5;
M!B-Z,M[R/:APW#4XE/19]3U 5GBGC^DS?'LGP&\4_P#9/ >1[%=-5L+3[([$
MAK3(9A2$+2LG&$K?4I;?3KIU 2EK)J,ZY[Q=_!(R%Q>-VYZLQR6$@DLE[1&-
MEFJ0X@M'EDKQK1V-EV&2MQ ,QXHR7)+?B.WNXO%AYG6Y"[83<^NI<UF%)LGG
MWG%/-P6%H=<>1&9-*$'N07F)4ELMVH*MM] F9-&X1>XFQ5S+N/JJ)-FLL7$A
M+41M1Q"BPT3'G2>,CCFIPS02%&9I)*?=!%DILMNGY&2<;/\ &E)6<JQ846SB
MU1N-'26M8N8VRJ23Z6"426%&9FVM!JW$6G7L#T " #SKZBIO!OTY41<VL+:N
MY%8CJ<J9V)D^5VS#4I6NJV4+239JW&DG"_Q&GM4"PI'%-OP979Y3V)R<WRS-
MY#R*^GM\LCRI:8BYBB:U09H2ALNO5:B/:6O4B!7L$&( Y["?"JH$JTLI"(M=
M":<DRY3RB0VTRRDUK6M1]"2E)&9F \Y\?9_G&8\_Q)]E(>K\$O<7F6>+XX:G
M$'[ U-998FRFS(D^=(\;J.TT-J2G7M!4C35F0\XY'G5Q(S&]QJBQFZDXQC4#
M'Y?L*"?K$H\^9(-*3]H-;JO A?@))&6AZZD$(URSG61\9X=C;5@4'D+(LF<P
MFZOHR$DMANN<=*7,809&DG5,MI,O"1$I9FG31("SPV;KA_E7#L5;R6XR3#L\
M:L(CK.12SL9$*SK6$R&W69#A$O8\G<A37P25XO<(@W<$?E:T-H4XXHD-I+52
ME'H1$7>9F RCU%V->]P/R*VU+86X=!/T2EU!F?Z%79U :%BOW7I/F$7Y% "7
M
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M7L=B+EV)V3RHC4\X231'DQY!)63;Z$GY?C3L-.O> C)6)<J\PV]&?)M3!P[
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MZG_[%("7
M                          &;\X?<V!^(\9^O(8#2  !A_I9^X>1?C#)?
MK)P%EN (R_,/SMXQ^8Y)\C# :@
M                             ##.2^0.2+'*+W!^*7(%6>(U:+?*\DLF
MSDFRJ2TX[&BQF"(R4XM#9K-2R-.GOEXBHFGY7Y'JZOB;,[XXEI@F:1*NHOUI
M;)F?&O+(U^7++RR2CR%F:$*21>'N+J ]$@@  /YH6NNG7LU[P'S>C1I"FU/L
MH=4RKS&5+22C0LOC)U+H?OD ^H#Y1XT:(@VHK*&&C,U&AI)(3N5U,]$D74P'
MU  &7^H_\A.1OW!/^14 O.*?=>D^81?D4 )<
M                                                      9OSA]S
M8'XCQGZ\A@-(  &'^EG[AY%^,,E^LG 66X C+\P_.WC'YCDGR,,!J
M                                                        _AF2
M2U4>A>Z8##^3N-\]/);7.N)K&M38Y%5E393C]P:TQ)K;25H8D-NM>)#[27%(
M+=X=/[]2JOQ]Q)RS:,8-0\H2JFLP;CY<276TM0XN1+L;"N3MCNRW5>%*$&>_
M:CHH^AI[#(/3((          #+_4?^0G(W[@G_(J 7G%/NO2?,(OR* $N
M                          SWDCDAK%&DT].DIF5S"),:.DM_D[^A+67>
M9_%3_>?3MZ7#X<Y9W6Z5AR^;S8PQMKUO/W,WJ,HS7CZ:U;7TIVYI9YE]+,FX
MIU4=U1]J34>A*+7M+PJ^#[AEULW&QYJZ5C;,=G&P\K+@MNM.Z)[M^JK6!=5[
M%I6/ID09*=[3J.PR[R,NTC(^AD?4C'FKTM2VVW27J<>2MZQ:LZQ+L&#Z
M                                        ,WYP^YL#\1XS]>0P&D
M##_2S]P\B_&&2_63@++< 1E^8?G;QC\QR3Y&& U
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ML)9R'SCJ0A6\DMQS7Y2=#^.2-Y]Y]P\URL_UK[GJ>)QXP8XKW7P:K;
M                                      9OSA]S8'XCQGZ\A@-(  &'
M^EG[AY%^,,E^LG 66X C+\P_.WC'YCDGR,,!J
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M^3/DR1$6G71KXN/CQ3,TC35LX^#8
M             &;\X?<V!^(\9^O(8#2 &-\D\CSIDU>"X,LUVCAFU9V39Z)C
MI+X:$+[E$7PU_%["\79W.%PHT^ID[>$>;@<[G3K]+%W\9\O]?P^*GT-I><13
MVWT+7:8A,-)6+*2T-MXRT-Q!&?A5[G<LNA^(;^?#7DQY6CM[>VCG<?/?BV_J
MI/?]8]NKT156M?>5T>UJGTR8$I!.,O([#(_^$C+L,C[!Y>]+4M-;1I,/6X\E
M;UBU9UB6=YA^=O&/S')/D88P9M0
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M+\IDMJW%K5IJ9)0V2C/0NT].@^^'!?+.E8U%1_GWQ=_]87_NLG_9C:_\[/\
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MNU
M      &0<F<!PN0;F9=0,GM,7=NH2*G*&*PT&U9P&C/8AU*R/19)4I&_KX3V
MZ::ZEU=TWA2LG9'A\MVVE)PG!F(GT#AB"24(K& 2T,3'7-36XI"%))*3[%)U
MU\2B,:M1!           9?ZC_P A.1OW!/\ D5 +SBGW7I/F$7Y% "7
M                         &,<"_>#F;\>S?JVO ;.
M              ,+]224JBXJE1$:3G.$9'U(R,F]2';]*[W^#*%+7551+5_S
M"/VG_P"J1_\ 8-[?;SE5>I<+3D*>0;"+D-]C4C'(<B9#/&[%VJ)Q:6W5I2^3
M1?I$)-LMJ3Z%J8U/4_DI/Q_))1KF,/PN,^,\[M,KR*_M<I@0)]BU?VKUC$9>
M?CLR'51FG>C1&I9]GQ="[AAZ5'[K? A<%7M&:S/Z2C::G_ZPO=&_].WE*K7Z
M=W&W<CS5UI9+:6N.I"TGJ2DFM[0R]X:GJD?LI]OY)+T . Q      !F_.'W-
M@?B/&?KR& T@!^5H0XA3;B26VLC2M"BU(R/H9&1]I& Q/TN+6[@V0..J-;B,
MLR".E2NIDS'GN-M((S^*A)$E!=A%T+H,[Y+7G6TS/Q84QTI&E8B/@VX8,V7Y
MA^=O&/S')/D88#4
M                 !79V?8/6U4^\GY'6L4]7)5 L9JY;/DL3$$1JCK42M"=
M+<7Z/X77L =&,9=B^:5I6^)V\2YK=QMJD0GD/)2X1$9H7M,S2HB,CVJT,!-
M            ,O\ 4?\ D)R-^X)_R*@%YQ3[KTGS"+\B@!+@
M                 #&.!?O!S-^/9OU;7@-G
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M'YCDGR,,!J
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MR+\89+]9. LMP!&7YA^=O&/S')/D88#4
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M=>AH;01GVJ6HB(!Z0Q4C+&*4C[2@12/_ -RD!+
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M!,A):329Y?DBBU+35*K%PR,O>,@TT-=6W@,OS#\[>,?F.2?(PP&H
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M1C29D?V?L"U+IT-A1&7]Y +QBGW7I/F$7Y% "7
M       8!R7=6639J6$3I!U5#&4E1(/5*I:MI*(R,^AFK71'<7;VCTG!Q5IC
M^I'6T_<\OZAFMDR_3GI6/O1F34%;"KFK:M<333J<D^QR$&:-VP]4MF9=369_
M!5VZ]O0;E+3,Z3UB6E>L5C='28;'QIDUEEF*1[6V8\F82U,*<(MJ7B;T_2I+
ML+4ST/3IJ1Z>X/-\S#7%DFM9Z/3\+/;+BBUHZ_BMXTV\
M    S?E9/)JH>F&^Q?9[V9WZ8(O.^F#7J6WV;;^CV;==^OC_ ,(W>%L^K&_M
M^?@T>=]3Z,[._P"7BSC E4OT,95?2676T\[;YN_3M5W>7I\'N]WJ/1YM=>OV
M/,8=NWI]KBQ@\N/)[,^&BC%^C+S_ *6\WZ'WZ_'\G])MUU\O;XM==/#J-;G;
M?H_O^;P\VUZ?N^O_ &_E_F\GIEGS?*;\_;Y^TO-V:[-^G7;KUTU[!YAZM^P
M!F^=?F;Q5\_N/J>2 T@!E_)/(F#NX=EU U>Q'+ERKL(3<-#A*<5)7&<0ELM.
MFXU&2>WM&W'#S3&L5E=$%P;GN&4G$N 8U;7D2'>PZ2M@RX3SFQQJ4B.A"FUZ
MZ$1I5X3#_#S::[9-&VD9&6I=@U$9Q5?GKE'X9I/UVS :.       #-^</N;
M_$>,_7D,!HDB0Q$8=E2G4,16$*=??=42&T-H+<I2E*T(B(BU,S 8GG_),K*)
M!X;QZ^EYA]/_ ,2O&%ZL^4HNJ6G$ZEMT/Q.)/KV)]T=[A<.*Q&3)]D?F\]SN
M;-IG%C_Y3^4?FK-5*O.);!NSK%KL\7D;$6L0RVF2B+3>1=B3_P "N_X*O=&_
MFQUY-=+=+>$N=@RVXEM:]:SWAON/99CN51SD4-BQ--M#:Y##;B3?8\TC-)/-
MD>YLST/0E$78/+9,=L=IK;O#UV+)7)6+5[2I&8?G;QC\QR3Y&&/F^C4
M                                                         !7,
MZQRTRO%YU)2WTO&K9]*50[F 9$\RZVHE)U(_A(,RT6G4C-/89 /-_&.!\IY@
MU<U&3\K971YIC,Q4&Y@I)"XKB5FI4>3%=6DO,9>;+5)GXM2/4M--2M-HN%<X
MJ;NNM9G+V26D2%)9D/ULDF?(DMM+)2F7--? LBVJT[C U;,"           R
M_P!1_P"0G(W[@G_(J 7G%/NO2?,(OR* $N
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M/D^K4
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MJ)T>?'2K8IV*ZAY!+(M=IF@S(CZ]@^5Z6I.EHF!VC
M                                   %<SIO.'<9EHXZ=KF<M-37L3ER
M3IPB3YB?-W^22EZ^7NVZ%\+0!D7L7K-_^I8#_P"99?[(%Z.>-G?)V-97C6+>
MH/&Z"=29%/1!H,FI26['8M_A1VW6I1&I*UJ+P+2E.A]FNAZ!Z(!
M  9?ZC_R$Y&_<$_Y%0"\XI]UZ3YA%^10 EP
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MZS-ND> _>76$"5'K&XDIF0LIS1J0VLEGM/IU(NX3#68F=8\![-'CF
M                                             #-N>,\LN->,K3+Z
MB'%GSH;T)IN+/2M<=129;3"MQ(4D^A+,RZ]H+#KY(S.GXZBX])DTJ;!.07L'
M'6TM$TWY+EAOVO*W)/5*=G5)=>H"^(0AM)(;22$%T)*2T(O[B!'Z
M   !E_J/_(3D;]P3_D5 +SBGW7I/F$7Y% "7
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MTK474@MZAGF--WX&KTP-!
M             &/^I_'K[*>&;NEQJN>M;AY^O<8@Q4[W5DS.9<7H7O)29@L,
MFY4SKE/D2)B\:/PWD4+[/Y'6Y"\;BFU^:U7&LU-)T1T4K?T4?8"M.H>;.0;>
M\K:J;P[D-7"G2F8TBSD.-&S&:=625/.%M+PH(]RNO80)HVL$          !E
M_J/_ "$Y&_<$_P"14 O.*?=>D^81?D4 )<
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MR'$'N4,GAYCBF963-%/\B"U!>J;2<1G'\E31)\UDU)-*E+26A%V$?:'HT$
M        !E_J/_(3D;]P3_D5 +SBGW7I/F$7Y% "7
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MR,,!J   Q#TA?]WO%/\ EKGZZF@-O   !BOJV_[O6:?\G ^LHH#:@
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MM0
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MR.3<F"_:-4Y-,:M&;I.NM/$H]Q)3LV]^NO0<_P!0_P"BOQ_5):/_ #&]1O\
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M^;<> S9M7"76"0DR=-UIIDDF:C4G9M[M=>H"U
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MC?W-PFSG36"C%L0:>AK2LU*-74S\!$6@T>7S*YJQ6L:1"3+4QRT
M     !G7/6)WF=</9?B.-,)DWMO 5&@L..)92IPUI/0UK,DET(^TP&@1D*;C
M,MK+1:$)2HNWJ1$1@/J                       #+\&PW(J3F+E?+K*.V
MW093]GOH.0EU*UN_1M>MB1O;+JC:LR(MWPNT@&H
M   S7GC$+[.>.G\>QIA$FU79TTM+3CB&4FU!M(TIX]RS(NC;2CT[^X!I0
M
M
M
M
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MT,NTC!=&HUEE!N:V'<5CR9-;8,-2X<A&I)<8?03C:RU(CT4DR/J".H
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M:%),R4E1'J1EV@CZ@
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M;?FFC0^S33N EO0(
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MNDD^\D[B1N^-MU[P):""
M
M                                            */G] JZ>@*3E.2X[
MY*72V8RTEU#VXT]7]T&9H:=/#U3VGV]P4W["N?U-Y'_W9'_4H*UFAC'#I8$4
MYDNP-EA"/;K(MLU[:G3>^1-M:+/M5^C3U[B!$B      *)GV/JNI<)Q.5Y/C
MOE-K3Y.--)<:=U41[GM8$O11=B?$GIW JH'@KFGYF\C_ .[(_P"I0&NT[!Q:
MF#&.5)G&S':;.9.(DRWMJ"+S'B)#1$XKM7^C3U[B[ 1V@
=                                    _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>bc_killing-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_killing-4c.jpg
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M;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (  @ X0DE-!"4
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MN-L75EMC<^U8U31OT->Y8=9.CO-+Y.@M:()+U:HB*J::BJZ"NJ!B+6S-W/\
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M_MG;V*4&UK=FR.&@$^+7$)(V]Q=6Z*&(J;3G"7 Z&H%HO"JZ8%DP& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M.3B:!!ZPD^**N=*\/<3N96TY/S9GR<?C*TJJBFF9GX*\O,RT0E'[!9U1=/:
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M$<(4Z-5[JC^K*[_#_P#7Y./QX+/YO_'B@3YEVC9D!4#7$*J*_P#B =U.C_\
M1R;_ -?/[O\ 9 _[#+_"5LVQN!=PU9V#L;R,VGWXSK*N(Z*%&<5M50T0=473
M7N9 SLK_ !U?+S3LNN*Z8JCXO#\>[&[OXGJ=%_\ SXW_ -3'^#,_;/Y2^_FA
M)UES3W31OTUA&L66BX''(CS;XB>B%PJK:DB+HJ+IGQ5153SC@<76KS2+HK@H
MJ=U-4SYX.OT3 _B$A:=W1=<X/K 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8&2\_:"LG[;JKV6T;UC3W=(M
M;_$=ZIER1;PVS=ZD20"/@4@0S%5%%+335<.PS[F0Y41[#F_3VS:+O2_=H%V=
M',?\9,%&&&H?D(KX1]1-!XCZKZ,M3+A1=<#YCG5K-K-MM '_ *GL\SY%E.C
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M.:"&5AH'*_V?==IKZG%R@O\ 4C!H[+2CV^+,:OV57^CM_!E]')19VI5C*_\
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M347N7315$4QP]W>5O:9DYF7QGFK<?=N\9+12)-S*B/F_*$XC(5YM-=3*=:0
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MMGJQU6WF;[7HO1;+YT3*[;OJZ+'</",5!M/9-CZ,]\Q<N)Y*C)U*<8:=S/\
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M?AS00RL- Y7^S[KM-?4XN4%_J1@T=EI1[?%F-7[*K_1V_@R^CDHL[4JQE?\
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M_P L?:][Z+7?/EY3[C]/5;[?X3BJ$OVC:]J6/K;F65OITX0KKS5GV^"?Y?\
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M67 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M@(:JNG[Q*G3@6_ 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M=S;WA KW3B08]D^VQ&8)6VFP1>@1$51$3I[B9MK/)RYR:9FF.7X0^>#^E/\
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MYV-MS=NY:^KI95-%K2VO:MFR])>-+&A:>1N5*KT'J_\ %Q)<1]&VD<("%MQ
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M'FQM$CRQ$Q#117@4RPZOO**M<A[>LXK<:7'V@5F^>T8-H)#)9J5%OA'@=_B
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M1(?X+;&FG"X/0=?T^D&$DTK)(S26)-HP4M 'KE:1>) 4].+AUZ>'73#CHP&
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MD739.1J3<Y,W\+;\EO1ZKDV+:/S&.LU\(">)74'@'A,C[RHB'%XP& P& P&
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MRU4NTHFW50X:MO<)0YL,RZEU!ZL)L=6T(O"4Q.M/F.[0Y,0!CP6[.NI]SS7
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M-\\Q;';%I75]+3'=O2&7K HK)"CTZ+#XAE,5Y<7"<UGB!Y&'.'K6T- +B%=
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M7:-/LR%(K* 76*EZ2Y+CUY.*<>)UVBFU%!?HF>)%,6A\$5)>%$31$.)W 8#
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M$;1.F(*W(<BNHCC#XBV\G&::EQ*2'6J;7VU4[/H86VJ,'&ZBO$FXC3SSD@P
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MK!1)[5J)#U[O5M^ TKW5M&X4=P1-P5/@'C+#K7L.& P& P& P& P& P& P&
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A# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>fc_identification-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_identification-4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    1@  _^$#_FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@-RXR+6,P,# @-SDN9&5E,V$W-S S+" R,#(R+S X+S$X+3$V.C4P
M.C,P(" @(" @(" B/B \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N
M=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B \<F1F.D1E<V-R
M:7!T:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+VUM+R(@>&UL;G,Z<W12968](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B('AM;&YS.GAM
M<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(@>&UL;G,Z9&,](FAT
M=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(B!X;7!-33I/<FEG:6YA
M;$1O8W5M96YT240](G5U:60Z-C5%-C,Y,#8X-D-&,3%$0D$V13)$.#@W0T5!
M0T(T,#<B('AM<$U-.D1O8W5M96YT240](GAM<"YD:60Z-#="-S)%.4$Y1$4Q
M,3%%1D(V041$1C(P-39$,#,P03(B('AM<$U-.DEN<W1A;F-E240](GAM<"YI
M:60Z-#="-S)%.3DY1$4Q,3%%1D(V041$1C(P-39$,#,P03(B('AM<#I#<F5A
M=&]R5&]O;#TB061O8F4@26QL=7-T<F%T;W(@,C8N-2 H36%C:6YT;W-H*2(^
M(#QX;7!-33I$97)I=F5D1G)O;2!S=%)E9CII;G-T86YC94E$/2)X;7 N:6ED
M.F9B-S@U-&8P+64P,V8M-&4X-"TX9&8R+3-B-# R8C<T8V%E."(@<W12968Z
M9&]C=6UE;G1)1#TB>&UP+F1I9#IF8C<X-31F,"UE,#-F+31E.#0M.&1F,BTS
M8C0P,F(W-&-A93@B+SX@/&1C.G1I=&QE/B \<F1F.D%L=#X@/')D9CIL:2!X
M;6PZ;&%N9STB>"UD969A=6QT(CY796(\+W)D9CIL:3X@/"]R9&8Z06QT/B \
M+V1C.G1I=&QE/B \+W)D9CI$97-C<FEP=&EO;CX@/"]R9&8Z4D1&/B \+W@Z
M>&UP;65T83X@/#]X<&%C:V5T(&5N9#TB<B(_/O_M $A0:&]T;W-H;W @,RXP
M #A"24T$!       #QP!6@ #&R5'' (   (  @ X0DE-!"4      !#\X1^)
MR+?)>"\T8C0'6'?K_^X #D%D;V)E &3      ?_; (0 ! ,# P,#! ,#! 8$
M P0&!P4$! 4'" 8&!P8&" H("0D)"0@*"@P,# P,"@P,#0T,#!$1$1$1%!04
M%!04%!04% $$!04(!P@/"@H/% X.#A04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@!>P.V P$1  (1 0,1
M ?_$ -8  0 " @,! 0             &!P0% 0,( @D! 0 " P$!
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M5\8^W2B [9\_RBOC'VZ40':2-.+C7PC>>(Z5BB,@//G^45\8^W6:(P.V?/\
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M80XZA0>.CSG2CA&SIK:LQ2>9JWIMJC5"\P2""#H1M!%;9JEEX]=1=8"5K/\
M>FM$/CQ]"O5KS^YL^'+H9Z3:WO$ATK,VU:IMB@% 0KF/^90ORJON:W=IFR43
MSES0Y0L\SY=KE.Y!+LAMC3K(1$;#@=[985Q*U6C0C32MR<*D+EK73%H\SV3E
MRJ[\X)W*U>0368D21-CINR>)3RA":+@46BX$CBTT/6V50EB:,;=;CA5EZ2+
MUZ/O*K+I<6^2+Q.N:D-VYZ6@-+;F2&S';2C1:]P*G-?@U8UI1MT\*#QJ4-@%
MQOG+3*L&S*[O/?05_2XK5;BW Y;G'E0WE*"B1Q CM!XM#5:=&:EMN#BWDSTM
MZ116SREO?9N*0M+\,!QM12=.\)W*20=#5]S(W;_<9YXMW+F!+Y02N9JLODPK
MY$+Y;LRWP$.EEY+:4((=#H6L'4:)/K5KFFK7]/75U+OY&YO=WN4%QR;+GWI\
M>P.S>[S'E%3[\2(TEP(*SM5PK);"CK]2KH2HC:L3;A5\"K<-Q[+O20OEUO\
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MOKKF^4ICZEGG?<$E:BGMYO5*CP_@?!KI7(M_7]9HQ^N^TNNNN;HH!0"@% *
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MX@_/M5;<R+KWTY=1#/19(/+:;I^N9/\ 4LU&UD5;;N=I=M7FR* 4 H!0"@%
M* 4 H!0"@% 6MAM\^EK:&'U:SH@"'-=ZD>Y5]8^/RUR=Q;TRJLF0:))6L8%
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MX- <A"R0 DZD:@:;QX:5!SV3OO%>L:50H<*0I&G$DIUW:C2@/FLF!0"@% *
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MF_I*N,O<EKP_&6'8SSUN=8=3M"VW)"%(4/$00:OO.L"BPJ3+:M?YO;_R$?\
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MKX]#MK-AU;9BPT]37/X&3DO^]&"?Y?<_N55F7U$9G]6/4RQZVB\4 H!0"@%
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M#1R_PYK,E\PFK6EO,7$%IVY)<<'&E3?9**F^+@*B@:%7#KZM1\.-:F?$E2G
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MHG(W*\GUQ0P>A#O-:9XP5DP* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M=7WP&^MJW?X,U+ECC$L/G+@6<\QT67&;'>6+7@\IWBRDC7O*VT]=M2=-CK9
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MNFVE@?'I=I",PL2!N39W@-?%*749YF-YFNIGI7#?]&8W_E4#_#(K8AD;ZR1
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M2,DQ&Q9#+0VW*NL)F8\VQKV25NIU(1Q$G3P:FKXNJ-^+K%/F;NIDA0"@% *
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M^;6M9DY3E7@4VYN4I<D3:MPN% * Y&Y7D^N* ]"'>:TSQ@K)@4 H!0"@% *
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M1I12K0Z[1J-]4O<13*'N()T^!L6\QL>;83D=QL*GEQ8\29'=+[195VG=E*V
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M4!2/I$_F^/?9R_89KM>69R[/B2B4/7<)"@% * 4 H!0"@% * 4 H!0"@% *
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M#EK@5LFQKG;K!&CSHJTO19".TXD+&Y0U61K5RM16-"U6H)U21*JN+#B@% *
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M*4.X1-J4DCSE> 5S+_>.=N>_V(]/I\Q'V*?8%=)'2.:R8% * 4 H!0"@% *
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MZ_/99::5I[Y" D_5%;4%2*1<=]2 H!0'(W*\GUQ0'H0[S6F>,%9,"@% * 4
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MZ'8_2[205HF^* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MHP*Y9DFKH$10"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M3]WO]'J&A#]]&;_C(WS ]NG[O?Z/4-"'[Z,W_&1OF![=/W>_T>H:$/WT9O\
MC(WS ]NG[O?Z/4-"'[Z,W_&1OF![=/W>_P!'J&A#]]&;_C(WS ]NG[O?Z/4-
M"'[Z,W_&1OF![=/W>_T>H:$<CG/FYU^5C;!^('MT_=[_ $>H:$2X[S7UX\4*
MR8% * @V8Q)4[,<7B0IKENE.,R^SFLI"EMZ:DZ D#:-E4RS+8O!D@L-FN]M>
M?5<;[(O*7T!MEN0A* VK7SD\).I.ZI*-"#:Y%7\JE)9R]UAS8ZN-);3K[Y"@
M5#U@:A',NGD3*-"C9)GEZ>NZ!(CX\&8UNA.CB:2IP<2G2D["21TUE8LA6B,K
M.K#;7[!+NK#3<*[6IOO<&<PE+*T+:(/"2@#4&LR1B+Q/JZWVUMXY:+Y>;8BX
MW*>VPF%#[)#CKDEU()2DJ2=$Z];U:5P"3J=MIRJ6_=F[!D%H79;F^T78">,.
M,NH0-J4D;E #=ZE(R#CQ1$><KK?'9F=G:!$AT^'@)2D?5!K$R5LEL6T7&?B=
MBBQ+K(L\AF,RMQZ, I:TJ;V(5Q$;!KK6:51!O%FF@6R=:N9%L9GW5^[NN6R6
MM#\D!*T)VC@&A.S4:U&E&3K6)8%7E(H!0"@% * 4 H!0"@% * 4!VQI+L20W
M)8/"ZTH*2?)X?$:A**DJ,G"3BTUFBTK?.:N,-J6SYK@VIZ4J&\'R&O-W+;A)
MIGJ+5Q7(J2,JJRT4 H",9I^:Q?RBO8KG;WNHE$HKG?F%\P/EQ.R?&W&FKO'E
M1&6EOM)?;"'W"E>J%;"=-U:FTM1N7%&65&1O2<8U13>,9SZ6.9V2/D>-0+=-
MLLI3B&)/=X37$IE10L<*UA0T(TW5T+EG:6Y:9-I]IKQG>DJJA86>YOS(P;D9
M"RJZB-#YCHD18]U0IEIZ.A3[SJ5 -I)1YB4;CLK5LVK=R^XKN<"VY.485XE;
M6_F9Z4,[#?WC08MKG8DVV[(<=1&BEX,QEEMU2F$K#O"DI.NG1MW5N2L;53\-
MU4NTI5R[35A0L#&>>,W-.3679K BLVS+\7CJ$EA(+\3MU)"V7D)<VE"T\6J%
M$Z$;ZU+FT5N]&#QC(MC>U0;XHT&#<RN=?,#E5=+[C*84_.8E\8ALH[O'89%N
M+':.DH<4E!4%$:'76K;UBQ:NI2JHT]I&%R<H-K.I"LGYT>D=AM\AXUDJ;;"O
M<]#3D2,(D5T+1(<+39XVU%(U6"-IK9M[7;7(ZHU:72RJ5VY%T="WL"OG/.V7
M.[7'G9&A6S"[9;9$IV7&1%"T2&%)5_(+4H]0+T&XG2N?>A8:2LU<F^DV(.XF
M]=*$ M?.'GOS?N]P3RDMD&T8_;BGB>G(9<4E+FO9A]Z3JGM5@:]FVG8/7K;E
MM=O82\5MM^G I5VY-_+D;;!^>^;6;/6^67.FWQXESD.MQF+M'0ECLWGQ\@7$
MMDM+8=U 2ZC337;J*KN[.$K?B6GAR].)*%Z2EIF=G/\ YO\ ,#E]G-GQK$7X
MC,>XP675-RHK;ZC*>DK8'77YHV)%-EMK=VVY2X,S>NRC))&BR/G!Z0_*:=!?
MYFV2V2[1-<6VEN.EE(<+.A<0V_%6>!P).H"TD>I5EO;;:^GX;=?3F0E=N0[R
M1*N>O.?(,/QG"LGP*0RU!R=M^4XJ9&1(5V 9:=;&BMB5)XR%:=-4;/:QN2E&
M><2R]=<4FN)I8M\],B?"C7"%:;:Y$F,M28SG8P!Q,O)#B%:%S4:I.NAJUQV2
M=&W[2-;_ $'I-DN%EHO;'BV@O ;NTX1QZ>KK7'9N'W6 * 4 H!0"@% * 4 H
M"58C=.%1M;RMBM5QR?#O4GZ]=/9W?R/L(R1+ZZA 4 H!0% S/SN1^47]T:\7
M/O,N/-&0<U.;TCFI?.7^%=SD.1IK\>VQ78S/&6H[8<5Q.N$ D#4ZFO06MGME
MMXW;E<4F\7Q-&5V;FXQ)WR_E<^7LE0CF+ B1L8[N\5NL)C)<[P$CLAJTLJT)
MUUV5H;E;-0_I-N5>G+B76_%K\V1!K[S2YNR^:U[Y>X8Y <7&FR(]M8DQV4GL
MH[8</&ZX0"0-=^^MZUL]LMO&[<KBDWB^/052NS<W&-#(MG.KF)B.:0\1YLVN
M*VU-6R@RHJ4MN-(DJX&WD*:4IMUOBV*&_P!6L3\OLW;3G8;P^'#'%!7IQE2:
M-QFO,_,+!SQM> 07HZ,=E.VMN2TN.A;Q$S\-HZ=H\7@JC;;2U<VCNNNKYN/+
M(G.[)7%'A@=&;Y!Z1%BN&0W.V0X*<,MKK[\24XW%6X(#1U2I0*^,G3Q:U+;V
MME.,4V];ISS,3E=3;5*$7Q7F/Z1><0)-QQ1BWSHL1P1WG%1XK/"ZI/&!HXM)
M.RMJ]M=E9:4ZJO2RN-R[)55";<R^<UVP"V6.PLPFIG,:XPH[]Q;6.*/$== 0
M?DVSUUK<XNS0#PZ;=NRM+:;"-^4I5I;3=.;+;MYP27$C5YRSTF,*M8RO)(MN
MD61HH5-B!F.I3"7"  \(Y#B!J>$J"CPG?6S;L["]+1!NO#%^RN#*Y2O1572A
M8T'F>UE'*>\9YCZ!$NMNB22]#>T>$:='2%<)UT"T'4*2>D5SI;-V]Q&U/%-^
MM&PKNJ#DBJ\2YB>D5G%LEW?%VK;/BP7 S(3V$9ITN<':<*&UJ!42-VGDKJW]
MKLK,E&=57I9K0N79*JH3[DQSAF<Q57.RWZ$U$R.UL&5VL8*2R^R%=FK5M1)0
MXA>G$D'0@]%<_?[%;>DHNL6Z=1=9O:ZIYHK7$>:W/_.Y,V)BB($^1 0'I2.[
M1V>!I:RA)U<4-=3LV5T[^RV=E)SJJ]+*(7;L\J%U<LW^:[Z+K^]*)'BN)4Q]
M$B,EE/$DA?:\78J5N/#IK7%W:VZIX+KSS[,S:MZ\=9/*T"X4 H!0"@% * 4
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M"@*!F?G<C\HO[HUXN?>9<>.+G8+SE'I&Y%8\?NJK)=Y-SFEBYM]IQ-!J/QJ
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M(=;5'81([4R4H20H+4G33@K<VVY=ANBK4INVE,K-7H@6\H*!G]W2DC0 ,I
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MDAIN4)LN)PL)*$=G&6$I.A)VZ';5OF.VAM[VB%::8O'IJ1M3<HU?,E%<XN%
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MQ&W[G:R?5Q#8% * 4 H!0"@% * 4!R-RO)]<5D%X'>:^['AQ63 H!0"@% *
M4!]!QQ(T2L@#< 36* Y[5WWZO7-*('Q60* 4 _\ T!6 26WV^/9H_P!*W8?W
MC^08V$I)&P:=*S]K7*NW97I>';RXOTX>\[%FS&Q'Q+F?!>G'W$=?<#S[CR6T
MM)<45!I'FIUZ!73A'2DJU.5.6J3=*5/BID!0'!&HTH#9W>ZHN8CA#2FNP24G
MB(5KKIX/)6IM[#M5QK4W-SN%=IA2AK:VS3% * W5CEP"V[:Y[20W).QX[-5=
M"5'HT]R:Y^ZMSJIQ>7#T]ITMI<MT=N:[W'T]AB76U/6M[A5JN,L_(O>'X*O
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M52N#LM3(()'#JK=IOUJ[?;K[F]XE-."5.JI&U#1&F9(:T2T4 H!0"@% * 4
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MRUUO+]QIEH>3]Y&2-3S]_ 6'[.5[#55^=Y0[?@(%)5Y<M% * 4 H!0"@% *
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M[S>SX;5,F>FV=[Q(8YHTE>?-X4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@-SC5S[A.#3ATC2-$+UW)5[E7MUM[:[HE1Y,PT0&9LF2
M=X=7]T:X\^\^LD=%0 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M26N$MAOAX5\6NH4=:Y/F7FKWD8QT:=+KG7A3D;%C;^$VZUJ2.N&;8H!0"@%
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MAMJ7=X#,U]MC7L4K>3J0CB)/#X-37!O04)N*X,Z$):HIF^JHD* 4 H!0"@%
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M=JT^D&FT.(+84LMA7RB4\2>))&J=1Z]7W+$[:3DJ5(1G&63)0E*EJ2A.U2B
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MU>N::(\A4=HY[]7KFFB/(5':.>_5ZYIHCR%1VCGOU>N::(\A4^:D!0"@% *
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MN)6.L2=QU.T5H0W^XA=\53;G2E7C@^C(ME:@XZ:8&V;;:9;0RPA+3#8"6VD
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MI.@TU16S'=78QTJ5%V>_,@X1;J24DJ)*CJ3M)/AK6)G% * Y2E2U!*1JHG0
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MKV:@%:Z*K8VOF.W5Z%+$(8KYJY=.1"Y9GI?S-X$638+\H:BUROFE>U7M7O\
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MN%<7<[N]N6G=EJIET&U"W&'=5#.K4+!0"@% <C<KR?7%9!>!WFONQX<5DP*
M4 H!0"@% * 4 H!0"@% ;>S7HP-8LH%RWKU!3IQ%&N_0=*3TBM'<[;Q/FCA(
MZ&UW7A_++&/N-8^IE;[BHS9:CE1+;9.I2GP:UMP345J=6:4W%R>E41UU,@*
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M.#A*E;N#776N;N;_ (T]5*84-FU;T*A/ZU2T4 H!0"@% * 4 H!0"@% * 4
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M/%7C=WYKN-RM,VE']*6'XG3M[>%O%9\S=URC8% <ZGPFL40.-3X:S0"@% *
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M8L>Y2V8HN5H2([4AU#0"D1]0$)4$Z'7;LKTNTBGMUAP9S;K?B9\CW'* $IX
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MLLMQV4,,IX6FTA*1XA7H(Q25$5'94@* 4!0,S\[D?E%_=&O%S[S+CHJ % *
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M@% * 4 H!0"@% * 4 H!0'(W*\GUQ607@=YK[L>'%9,"@% * 4 H!0"@% *
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MOZ:U]_YC=WDJRPBLHK+KZ7[B=FS&VL,^9N*YA>* 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4!R-RO)]<5D%Z'@U/F_;U]U/$X''4^!]M0Q@.I\#[:@P'4^
M!]M08#J? ^VH,!U/@?;4& ZGP/MJ# =3X'VU!@.I\#[:@P'4^!]M08#J? ^V
MH,!U/@?;4& ZGP/MJ# =3X'VU!@.I\#[:@P'4^!]M08#J? ^VH,!U/@?;4&
MZGP/MJ# =3X'VU!@.I\#[:@P'4^!]M08#J? ^VH,!U/@?;4& ZGP/MJ# =3X
M'VU!@.I\#[:@P)GA/#V$OA[+7B3KP\7:;CYVNS3WNGCKD[[-9G9\OR>1*ZYA
MU10"@% 1G,M.[1==/PBM^OO?%7/WN2)1(?U/@_;5RB8ZGP?MJ =3X/VU .I\
M'[:@'4^#]M0#J?!^VH!U/@_;4 ZGP?MJ =3X/VU .I\'[:@'4^#]M0#J?!^V
MH!U/@_;4 ZGP?MJ =3X/VU .I\'[:@'4^#]M0#J?!^VH!U/@_;4 ZGP?MJ =
M3X/VU .I\'[:@'4^#]M0#J?!^VH#NB<'>F=>RTXT_A>/@W^ZTZ*E"FI9 M"O
M1E0H!0"@% 4++[/O3_F?A%[^/WQKQLZ:F7'5\G\#[>H8 ?)_ ^WI@!\G\#[>
MF 'R?P/MZ8 ?)_ ^WI@!\G\#[>F 'R?P/MZ8 ?)_ ^WI@!\G\#[>F 'R?P/M
MZ8 ?)_ ^WI@!\G\#[>F 'R?P/MZ8 ?)_ ^WI@!\G\#[>F 'R?P/MZ8 ?)_ ^
MWI@!\G\#[>F 'R?P/MZ8 ?)_ ^WI@!\G\#[>F 'R?P/MZ8 ?)_ ^WI@!\G\#
M[>F ++Y;\'T9*X.Q_##B[/C[77A]WQ='O=/'TUW_ "WN/+,KD32NL1% * 4!
M3O/G@[&P\?#YTK3CX]-S7O:\WYUE#M^!9 I?Y'^9_I:\UAT>TL'R/\S_ $M,
M.CV@?(_S/]+3#H]H'R/\S_2TPZ/:!\C_ #/]+3#H]H'R/\S_ $M,.CV@?(_S
M/]+3#H]H'R/\S_2TPZ/:!\C_ #/]+3#H]H'R/\S_ $M,.CV@?(_S/]+3#H]H
M'R/\S_2TPZ/:!\C_ #/]+3#H]H'R/\S_ $M,.CV@?(_S/]+3#H]H'R/\S_2T
MPZ/:!\C_ #/]+3#H]H'R/\S_ $M,.CV@?(_S/]+3#H]H'R/\S_2TPZ/:!\C_
M #/]+3#H]H'R/\S_ $M,.CV@?(_S/]+3#H]H'R/\S_2TPZ/:#D=CM_!;OY[P
'BF'1[0?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>bc_sarsgenome-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_sarsgenome-4c.jpg
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M%!04%!04%!04%!04%/_  !$( 74#* ,!$0 "$0$#$0'_Q #5  $  @,  P$
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M5>UVDM17>)VUA5QGICBBP-UW(1&[@1$1<S#F?_4")34
M                                                     <9;8ZOU
M7J#5%152]9SC<O%:I@73+-RY.EL(8[2420_ <:258A@D)-MYIY9K5DQ(B6>!
MDZ=VHO[/56V>D=1W*3*VM*F'*F*,B3G><92:G"(L"(EGUR+S#!BF
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M:,IF2LR/3$D1XFC%1=4L0$@
M                    8-G45]Q73JJ>SG@V+#D28A!J:4MEY!H6G.@TJ+%)
MF6)'B ^\*%$K8<>N@,HCP8C2(\:.V65#;3220A"2+H))$1$ ^X
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M3-(%5W @
M
M
M
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M3'==7,RZ;LDUDGM:%H2@C=6KF-<L^JDLJL3X@+:!
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M&M$\[*U[;;6E(JZO7][65\RNF1+ZMBS[!J"Z4B&XHV'B2IQ!J22TJZ<4G@9
M3=$<[1Z+^8QG6TVWT9J"KFZMO.T$42-;HF&1/K[7**+&YRTM\U:.<]RD%F4G
M,?0!%\3SK5!D
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MT
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MN]"2::>U<]'?/5\.NA2B<(HR*N4]+;4WE+$UJ>88,E8^ B/ZH,HKSMV#(
M
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MVIJ0I)>,$LL3(RZ:*R_>$XDHC+"S!I>@
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MMNRQ$O5AXV)AQ,67W6US73'9+6?LZ[0?H)_X5M?SL8^1A^&.J&SZS>/Y+_\
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M6NRK5K=@N2[2RFH:<=:6PI:6Y,EQ&8VW%IQR]!@19$)H#,
M
M
M
M
M
M
M
M
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M&1F)K ]Q(
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MFS9&''TUY76,L>.4L$EX"(<'%Q[\6:W2WQ;$)J-#(
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M[#UP/JK_ ..[U>TIZ3QIM?DQ8_V'K@?57_QW>KVE/2>--K\F+'^P]<#ZJ_\
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M7S-#16;)-_7D:YB7JV8S';:Q<2APY"VB:R.FTLFE9L%Y3RX@A,
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M$+[^2WW8];?;AQ&5TDVVVTVEII)(:01)0A)$24I(L"(B+H(ARVU[
M                            @%O],^E/\O7WMNJ 3\           &#-
MB4\B7!?L6(SL^.M2JUR0AM3S;BDX*-DUEF2HRZ<G@!'(S@2
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MYW7=+1T^G*UBGH8#%;5QBRL1(K:66DEYR4D18GX3Z3'&NNFZ:S-9;Z,\8@
M                                   K"35*A;\4UB=C-E)L=/W2DP9+
MJ5Q(O*DU*?\ 9FR0DT9^ES%2L3\P$K/!           *AW5IK:QW-VDGP*^1
M+A5MG/<L)3#2W&HR'(Z$I4ZI)&2"49<#4(EJOCWH6\);0
M                         !ZDVA*U.$DB<61$I9$6)DG'#$_.Q >P
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MRXK,@1,Q#=@D
M                         >JVVW,N=)*RF2DYB(\%%T&6/A >P
M                                    *PDPK2/OQ32IMJJ;7RM/W1U]
M:<=II,(D2:DG,'4==WF'Q],]#X 2L\$           KC<#1%WJ776W6HJTV.
M[M+SIDJTYJS0YRY#"6T<M))/,>)'CQ(0UW6S,Q*QQ+8
M
M                                    -+JV,[*TY8I9>E,O-,K?;5 D
M%#D*4P7,)"7C)1(SFG*9F708"![,S-423M_&!Z5+C+1$>ARGU2GHQ\Q+AF3#
MT@B2Z2DY%YFL2+'*K!1&0)E:P( $ M_IGTI_EZ^]MU0"?@           KG<
M[=^EVLM-+Q=0,DFJU"_)8DVBG#2F&B,VA6<VTMK4YF-9)P+# 1,M=]\6TJW%
MON?H.AFT==;734:;J0FE4C1H=4<E+ZDH;-)H09%F-:2+,9!5,WQ#UE[I: @Z
MP;T!+NVF]7NK;;;JS0Z;AK?03B"S$@T$:DF1\5!4UXK3G3 2S
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MM27U'J6RC'WQI^0<N!(95RC-PTDCTW L5I(BX$8(FV)FJ3@R
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M9>4KO(Z]-CRT/DO*E1M*)7)6WB22/%><L@"U 0
M"-ZBUO1Z8L*^ML^><BQ/%!LLJ<0TV;K;',<470GF/-IX8GQQPP(S(-*K=[2I
M-N*:8L'I&<NQ0VH:U2)L91.J[5&1_K&,K#JL_#@GHZR<Q*;0)T2S@QK* Z3\
M&8TW(C/)QRK:=22T*+' \#(R,$,@
M                               &-8Q3G0)4%+ZXRY3+C"9#1Y76S<0:
M<Z#^Z3CB0" [94M=33KEF-J<K^SP8;M4)):"*4R;B%.Y%NND19<K"2;X))K*
M9J7F,$M]N,J>C1=J=;8.U,LT-I*R88>E.1VS=03CA-Q_3,"1FQ4CT)=;P A5
M=1?ZQDW].DUVC#JY$)NDC$<IV#/JR>D(G3'CD$I65:.6XGGJYC:>7D]%UB6_
MKG-<.;R:=\=(U3'46GKSL1T[\F1FQEU>?F]H9:PPZN7+CX<?  MX$
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M:6$0HBS:-*T&GK)4DE8EX0(6A3J4NHKU+,U*5&9-2CXF9FV7$P0S0
M                                                      !&]=U-
MG=Z;D5U2U'>EN+:/)*+$B0E9*4;9GP2Z1%BVH^!* 8>A]&.Z52^_)?:D39[;
M*IJR;S.E)(C-W"0K!2VU+,U)2I.)&9F9F9@)@  (!;_3/I3_ "]?>VZH!/P
M            !#M8: CZNU#I'4#TYR*YI*:Y8,L(0E:9"G$$C*HS/%)%ATD(
M876UF)S)B)9@                                            "';M
M_19K?WAL_:C@)A(Z7W&KO8S/J:00S@
M                                     5?(FV\C?BGBSJKL5;%H+HJV
MQ[2V]VTER*E3A\E!$MGEJZO7/K> $K0!              JO=+4]]1ZYVOJZ
MF<N+ N[=^-:L(2DTOLH9)1)4:DF9$1GX,!$M5\S$PM02V@
M                              "';M_19K?WAL_:C@)A(Z7W&KO8S/J:
M00S@
M           0"W^F?2G^7K[VW5 )^              -+=:ETW265-674MN/
M973ZHU,TXA2E//H3F4E)I29)/ ^DS($3,0W0)
M                      $.W;^BS6_O#9^U' 3"1TON-7>QF?4T@AG
M
M   K&592)>^])!=K)41B#I^Z)FP?Y79IG,DU2E<C(XM?I?0OF(1YV()6<"
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MDNJ@S9#4>4^W*AKY>1I:LRC4:B3@G'K< (6/3$94]>1E@91F2,C_ *-((9P
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M"83"E]QJ[V,SZFD$,X      5_ ^FR]_RQ4^W[$$K !
M          *]TQ]+FX/L#3WWLX$K"!          Q+&TK*>*J?;S6($%!DE<
MF4ZAAHC4>!$:W#(BQ/@7$!B5FJ-,W4E4.GNH-C+0CFKCQ)3+[B6\2+.:6U*,
MD]8N/G@-L                 K"5<1I^_%+5M,2FY%9IZZ)]U^,ZS&<YTFJ
M4GD/+22'L/M^69Y3Z02L\$                (GK&?H2'8Z8:UBAA=C*LVV
MM,<]A;RBLS+J&V:4J)"L.A2L"\\0QNIR52P2R
M              'S?98DL.QY+:'H[J%(>:<22T+0HL%)4D\2,C+@9& H[;&-
M/B7\!>FI$&NH;.$4]C3O8TNDFJ;D&T9HL$Y'^:@UMY6749"2?#CCE)7J" !#
MMV_HLUO[PV?M1P$PD=+[C5WL9GU-((9P      K^!]-E[_EBI]OV()6 "
M                        5[ICZ7-P?8&GOO9P)6$"         !B6-767
M$54"WA,3X*S)2XTII#[1FD\2,T.$9'@?$N "N=C=/T%?I-=E7U,*'8.6=ZPN
M5&C,L.FRBYE$ELU-I2>4B2DB3T%@7F F5H@@               ! ;<S^>;2
MA>#Q>O\ VW4@)\                 B>L=%T.J[+3%A<RWHTG3MFW:5:&7&
MVTO2FRP)"R6E1J3AX$X'YXAC=;$T2P2R
M          ^@!2NR]?,;O;:V1$=8AV+!NS[11.*C7,Q3V9,V+FBL$PWE-9<I
M*C(R4DR(\N=9,KJ!  AV[?T6:W]X;/VHX"82.E]QJ[V,SZFD$,X      5_
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M>N>)RXJ4P6996+1.(4;9NN*)36*4J1BDC]%CX 3,3,\DI<)9@
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MRX>?:/MDER(TVEADW3/,VR^9F?1AE&W"PYQ+M6&K%Q8P[=:5>UU]N)7:LO\
M5*:6E<5>1Z^.J-WE++E=W$^6;-V \V?G=&4L,/"/9]!?GAX?R.'FE:&W^J9N
ML-.][V,)J!.;F3H+\:.\J0T2H$IR,:DN+;:,R5R\W%!#P7VZLS&9T;+HNMB8
MYTI&+(         5_LS\1O\ Y>^_7,P$RL $                (#;F?SS:
M33CU2T]?F1>><NI 3X
M              !X625)-*N*3+CB6(#GG9N;9OZR655,KI$%^*ZY<RFRG\VP
M=0XG.\HGI#J$R6#<;0Z1)2G%U22/J94$K)UYN7"TA>:>T\AV&FQMYD8I?;GN
M0EJO>D)CJ<;\+CJG%I0V@O/4K@GB$7C[IZRFR:RJ9AUC-GJ"$FYJGG>><:-"
M-J4Z;$G!9*4]A'21+0:4]99Y?2\%!]-S]Q:EW:&S=EP[%$G4>E9$V.B)7S9T
M=KML)9I2[)CLJ:1E-7$W%)P+K'P 6K3$::BO2?249DCPXE^+($,T    !K[>
M^H]/L(E7UG$JXKB^4V_.?;C-J<,C5E)3JDD9X$9X *NA:^T&G>&ZGJU33E"<
MTW5,HD'81>6;B)U@I2"5S,#41*29EX",O-!*U:NWJKN(FPI9T>Q@*-24RH;R
M)#)J0>"B);9J3B1]/$$(+OS]$>I_Z!KVPT"86,"    %<[O_ -WT7_F^D]7,
M$PL8$        *]V,^B/2/L!/WR@3*P@0K63O141KQ6G5:9U.NW)+CJ&&Z=]
M7,CLNDRM]!D>!MDI2>MYY FBR@0  "K=V/=_1/LF?[4,>S<]K'2\._;&>CM:
M\^@QWU=E(-F?BA*]_+S]:2!6L;:7:96K V=NB%A#2W         "O]F?B-_\
MO??KF8"96 "               0^TW"KZO4S>G50WWFD.18]A9(R<B+(LL_9
M6UI-1+5GR'F4DL$8IQZ3P"&6FXFWSF[>F)Z-6TJH3-#>-.R"L8IM(<<E59H2
MI9.8$I1(4:2,^.4_,!*;_.CME\M*+X4A^N@BCS\Z&VF&/CG18%TGWG#]= >/
MG1VR^6E%\*0_70*//SH;:&1F6LZ+ ND^\X?KH#Q\Z.V7RTHOA2'ZZ!1Y+=#;
M0R,RUG1&1=)]YP_70'CYT=LOEI1?"D/UT"CR6Z&VAD9EK.BP+I/O.'ZZ \?.
MCME\M*+X4A^N@4>?G0VT,C,M9T6!=/\ S.'ZZ \?.CME\M*+X4A^N@4>2W0V
MT/HUG1'AT_\ ,X?KH#Q\Z.V7RTHOA2'ZZ!1Y+=#;0^C6=$>'3_S.'ZZ \?.C
MME\M*+X4A^N@4>2W0VT/HUG1'ATX6</UT!X^=';+Y:47PI#]= H\ENAMHKHU
MG1'ATX6</UT!X^=';+Y:47PI#]= H\ENAMH?1K.B/#I_YG#]= >/G1VS^6E%
M\*0_70*/);H;:'T:SHC_ /DX?KH#Q\Z.V?RTHOA2'ZZ!1Y+=#;,^!:SHC/WS
MA^N@/'SH[9_+2B^%(?KH%'DMT-M#/ M9T1GYUG#]= >/G1VS^6E%\*0_70*/
M);H;:&>!:SHC/SK.'ZZ \?.CMG\M*+X4A^N@4>[>YNV[SB&6=8T;CKBB0VVB
MSB*4I2CP(B(G<3,S 2D                !@W%BNIJY5DB*[-5&0;G98Y$;
MJR+I))*,BQ(N/2 TVBK:@OJU-I41H<9]1**0S#<CO*;)QQ3I9E,=&<U*<P41
M'B9F98@-_+@0IZ6D38[<A++K;[).I)>1UE1+0M./0I*B(R,!'W-N-"NQ)L%=
M#$.+822FRV\F&=].."L2/%)=9?53@GK*X=96(8>ZK;<?:?6;+""::;T_9(;;
M01)2E*8;A$1$7 B(N& )A)J7W&KO8S/J:00S@    %,^4(VAR-HY+B24D[A[
M@?'_ -LF#F<3F8W>ZGH[89V955=BB?S*?K"EZ]V>>N6^BY]@$I1HF6E!$DN]
MY_ N'VY"][E-<"SY8['GNRL[?GZ(]3_T#7MAH>Q$+&!    "N=W_ .[Z+_S?
M2>KF"86,"        %>[&?1'I'V G[Y0)E80(5[(^G*N_P IS_UE#!*P@0
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M/R5G\$$,"PV^T;9RZN;*I8G.IY*IL/(PTA/-7'=C'G(DX*3D>7U3X9L%=)$
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M$:W VTJM6Z.M=.U,*OKK"<VA#$U<1LTMJ0ZAS'!!)5T)X8&"4[!
M       "/:Z@L66D+F%)C3)C#L9>>)6FV4UW+ULC)/&EM2U&6!(6>57H5<#
M0W;'3LR-:+U#8UTZ&\] 2Q&=DPJFK;-AU2',BV*YUQPW2RE^.PY?%*2(U*Q)
M6F" !#MV_HLUO[PV?M1P$PD=+[C5WL9GU-((9P    "F_* _N^C??A[]63!S
M.*?;7=';#.S*J\4AO7#L%\2IGOO/]4(7[<MA9\L=CSW96;OSQVCU/_0->V&A
M[$0L8$    *YW?\ [OHO_-])ZN8)A8P(      !3>L_*5T/H?5-EI&TK;:18
MU:FD2'8K40V#4\PW(+(;TII1X)=3CU>D>G"W;%Q8K;%8317FUGE*Z)TWH[3.
MCK&JM^](S34)UQI$)QGF*6>)D92\QI(CQ/J8^<,[]SQK+9NFWDA,PZG'C8J]
MD?3G7?Y3G_K*&"5A A"MSYFKZC2MCJ+25G#@.TD*;8RF)T)<U,DHS!NH;2:)
M#!M\4&1JZW3T< &?H;QJ=I&9VJ[2)9RIS;,E@X4)4!#3;K25&@R4^^:SQ/T6
M*?J (GNQ[OZ)]DS_ &H8]FY[6.EX=^V,]':UY]!COJ[*0;,_%"5[^7GZTD"M
M8VTNTRM6!L[=$+"&EN  ! -MR,KO<8S+#'4ZL/@JO!*?@@  '*^[GTK6_L.#
M]XH</B66WI7_ /JOP8NFW_9 -2_%ZU]AR?45CFX.TMTQVK1O_P!MB?)=V.WJ
M[W/B_P!"W]Z0MSXPR0               5/<+U<6Z+28IV'*[97=A0WS>[.Y
MCC/=X&YAZ3GYN7BOTS-R\O $K8!           *MW$>U#&UC12ZE<N8AAMHF
M*!IB8F+,>=F-)=6J7&=0VVMEDE+RR$*1EQX89@2M($           J7<!C6C
M&HKB532[9RL>HF"2Q#(R884W8M%(..3:2,Y*HYNF1XJ7@19, 2E>VYV1Z??[
M:<@X/;YI4:IING*.JYZNS&X;_IA]7T!N=?)ES<00EX          KO7;&IT:
MDK)E--LDP%55TT]'A-\Z,U(*.E4=Y3:"2;CV?@TE3F'22<#,S!+[[3+LBH)4
M2<X]-CQ))-0;J2B8P[8-\AI2WE,3W''6S)TUM&6;*9I-22+$!/00
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M])=I)<N?M?H^;/D.RYLBHA.2)4A:G7G'%,I-2EK69J4HSZ3,\3'SV<K!,A
M.5]W/I6M_8<'[Q0X?$LMO2O_ /5?@Q=-O^R :E^+UK[#D^HK'-P=I;ICM6C?
M_ML3Y+NQV]7>Y\7^A;^](6Y\89(
M                                         B&Z*5JT%=&W.*M>0VVX
MS+-#SN5QMY"T)Y<8R=7G41(RM]8\V! ([MEJG4\^ZM=/ZED1)/)<FOQ),5B>
MTEY;4PTR6VG99FE:(BW4QUDG#*HB+ $K1!  AV[?T6:W]X;/VHX"82.E]QJ[
MV,SZFD$,X    !3?E ?W?1OOP]^K)@YG%/MKNCMAG9E5>*0WKAV"^)4SWWG^
MJ$+]N6PL^6.QY[LJB--^X\;ZA_9%/W[[B_3W0W6Y$DTE])FA??*5^I[ >[@V
MVGY>^&-^1U,+<T@".Z_^(FJ/>B?[6< ?GVW^+1_%+[ H&+\<Z72C(N7R8/I3
ME?Y?F^W8 [_!\EW1WO/C\SL$6!Y0  5=JS5^Z--K&ITW4U5!(B:A=EMU$F5-
MF-N(3"C=H4<A"(RR(U$1I+(HP2LN&<LXD<[!+:)YMH.4EA2ELD]E+.2%*)*C
M3FQRF9$> (<![_?37K#^GA_JR$+/PK93\W=#*$#K/=JI]F-?Z1[-\V%^CO2[
M,\K'Z)G/9['J;HK&Y;>S2QAQ5@7F"YLG8'D>?$'4'O\ +_5T$5#B&WNZ.QC*
MV]T?HRUI[Q6GM-T<]$-MI?XLTOL"+ZBD! ]V/=_1/LF?[4,>S<]K'2\._;&>
MCM:\^@QWU=E(-F?BA*]_+S]:2!6L;:7:96K V=NB%A#2W #BKRV?C5IKV"?J
MKHLW -I?\O><\:>YRXKH^M]D7-NE^H&S/T3:*]Y8/J"1\GG*TIP( !RONY]*
MUO[#@_>*'#XEEMZ5_P#ZK\&+IM_V0#4OQ>M?8<GU%8YN#M+=,=JT;_\ ;8GR
M7=CMZN]SXO\ 0M_>D+<^,,D                            !@W-K&HJ>
MPNYI+.'6QGID@FDYG#:CMFXK*G$L3P3P(!&X6YFGG"EHNVY.FY<-##SD6X2V
MRXMB42^6ZT;3CJ%H]+62LJS-&4\Q$ VLS6FDH$9$N7=0VH[JW&V5F\@^8MA1
M(<2@B,S4:3468BZ 'TFZMTQ72H,*=;Q&)5FDG*]I;R"4^VI24DM''BDU+2G-
MT8J(NDR 8R->Z+<+,B]A*(I/8>#R3_V@BS9>GS..;T.''' !CL;BZ2D5+%\F
M>ANE??EQ53I!E&::7 -TGC<YQH,DD;*BQ(C\!]'$!B'NOH?O=JH;L4N\R"JS
M5.1@<5#)2.RD@UXXFZITE))M*35U3QP 9=KN3H:F6VU-NXQONN16FV65D^XI
M4Y:6V3)+>;$CSI49_:I,E'@D\0'T+<+1B6E.2KJ'$6U';F2&7Y#25M-/9,N?
M*M2<?3$<"4?HD_=%B&\KK*!;P6;*KDMRX$A.9F0RHEH41&9'@9>$C(R,O ?
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M<6ZA^9,GJ4YAB3D^2Y*6DL"+@2G#(O.!#9
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M7XO6OL.3ZBL<W!VENF.U:-_^VQ/DN[';U=[GQ?Z%O[TA;GQAD@
M
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MQ/DN[';U=[GQ?Z%O[TA;GQAD@
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M?]D U+\7K7V')]16.;@[2W3':M&__;8GR7=CMZN]SXO]"W]Z0MSXPR0
M
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M;^](6Y\89(
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MS!TVW3(-*);D*9/<DDTE.&+:'8J4F>.'!2_W1U503D$
M
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M6JQ2%OR%J90ZE!N&\E1$KJ];%Q:.)@46PA1+0E:>*5$1D9&1E@?'I+@"'L
M
M                    *DH_F?[9K3NCD][=DF^,G+Y/;.1VB7VK)DZ^/,SY
MO_T_.!*R=/=@\7ZKNK-W7V./V'F8Y^S\I/+S8\<<N&((0G<GYL.^:#YP>S]L
MS?\ *NU\GE?WN)GQYOVN?E9_X&;P8@EA[3]Q=[:C[@\9>7VN3WAW]_=.W=H5
MSN5FZ^?HPS_ZK)EZN "PM0]@[@M>]<>Z^QR.W9?1=GY2N9ACX<N((4E)^9;N
M#_D/>'<'.E]]>+OXCL/*9[5WCR.KV3E\OT76RXY?M@2OQKE\M')PY64N7E]#
MEPX8>=@"%9ZM^:/Q^B>./8O&;L[7*[Q[/R>S<J;ES\[[3#G8X_;9?.!+;[;_
M #:Y;_YMNQ=F[P+O;N[)R>U=F9RY<G#+R\F7#ATX AMM=^+?BK/\;\OBYBQV
M_/ER9.>WESYN&7-ES8^ !643YJN9ION?O/Q<YK.?N_'N'M7;U=E[QY?I?-[5
MZ##K8Y<_5R@E=X(4UJ/YD_&C4O?W(\9NS2.],W*[3AR86'(P],YV7D\G+UL<
MV'$$IGMGW!XO/=Q=MYO;'^^.]_=/O'J\WM7_ *F7)T<,F7#@"#<OQ,[@9\>\
MO<?:VL.;DY?:,J^7FS\.GH_A8 ,?17B'W@QXJ9>=W#6]DY>7D]T\V1R>5EZN
M/,YG-P\.7$!.@%%S_F2[3J'L>;QJ[>WS>Z^3WUWGWC)R]CR];F<_/F\&3+FZ
MH)6?M_W!XH5GBQS>Y\KN3M6;M//YR^T<_-QYW.YG-Q^WQ!"/;L?-MV>M^<CE
M]D_VGL//Y?+SY$\S#F<,V3H\[$$O32WB=X_V?8.\.^.2YV#MN'=_9\6>?W?X
M<F/)Q\&&&3JX@-]N+XI>+9^.V3N#M47F<W)R^=SD\G/S.&&?*"$65\T_<6EL
MN'BYW-:=U<C^[=V]D3V[G<KAFY?HO#GQ\();[;'N7N69W7WKVWM:N]_&'-WM
MVGDM9.T9N/XCD\O^!E\.((:NH^:[YT9_8^S_ #A_[3VCF<GG8\N+S,GV^/+Y
M>'\'-YX)?>@\1NY=#=U]I[N[<_XM\S-G[3V>9S.;CX,G.PQ\. #SNW\W?=,+
MYQLO=G,?[+S.7EYW9G,V&?[;EY\N'A AH]R/FV[NM^\N\>1XO1.?XNYLW<?;
MTY.1R>KDS_C,.KR<<>J GNA\GBO Y?>?+P<R=^9>\,O-7AS,G5P^XPX9,H(5
MOI_YDO%+5O<'+[L[ GQB[-R^V]DY)_S76^ZQ_AY@2W<#Q,^=1W/WMW[FD]V=
MNYG<_;.0WVOL&?ASN5AS,O5PSY?M@'TW&^:_Q@HO'[D=X]3NKM?)Y6';(^./
M-\',Y>?^#CYX#X:L^:/-K#QU[/R<8_>W>>3E<_NY?*[)S?\ 6]FS_B^MT@)6
MYXK_ #>KY6'B7W,>3DX8=U]EX9,>'XKH!"(:>^:3Q:1XL\KN?Q@@Y^P9,W>G
M;&>R\SD_:9^7AC]H"65H3Q1\<+GL'?'?W*7V7OWFY>[>TJS]W<[K=FYV'3_
MPZN4![:@^:[YRZKQA[-X[X1N[>U<GHRS.1ES\?1<W+A]ODPXX ([JKYLN1-[
M3WQG[UMN].[.9SN5E9[UYN'^Y9>3S?\ Z<O6P 7+%[-V5CL>3L?+1V?EX9.7
ME++EPX88= (?8
7                           ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>bc_antibody-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_antibody-4c.jpg
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M%!04%!04%/_  !$( ?$!,0,!$0 "$0$#$0'_Q "C  $  @,! 0$
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M *YJY]*ZZ[5V,'O.Z<-HI!$XVXVOHI"S,S+KV%J86N"
M                           *=\2.26]9@L;$<9<[K*<^L8V+5CI:ZLIG
MF9/O=.I$EHE)W%[TU$?D!88/->*0</\ ##DF)8TR;5=3TS<=A">BC:9<;-U:
M].U2B):UGY3,S C_ %L^1GX*O#/?OMF1PG,/<..9&6ADY T:T/R]32 K?C9J
M3%YBXH19DHG%<31&&=Y_^K;=:4Z77RDCM 3/,R[WQ0\9(C]76*2]=F$1]C"T
M)0@S+W-X'196:-<B.Q8I<>2J:+,)Q7IJKYB5(;-K3S2;**ZT9*U[=VH(@\IO
MQ,1(KTI=M@QH8;4ZK_\ GVW8@C4?_K#]P%]$RXMRF?F_'6,Y=:--,V-S7L3)
M348E)92XZG4R02U*41>YJHP1+@
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M!/#W[$<#^IHOP 65E @
M      # N_H6Q_=7_BU ()X>_8C@?U-%^ "RLH$
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MA.L/I;=1KH>FY!:Z'IV )4 P+OZ%L?W5_P"+4 @GA[]B.!_4T7X +*R@0
M                !!>:_8YR#ZN6_P#!.@0W. _[%QCZI@?PS8"0@
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M^W);D=U"=:&W(M5(,BZG%(B_I!:-YX>RTX1P/ZFB?  E90(
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MTI4>IGU+RD07D",&Z,TT]@I)F2BC/&1ET,C)M0"!^'OV(X']31?@ LK*!
M                 $%YK]CG(/JY;_P3H$-S@/\ L7&/JF!_#-@)"
M                  P+OZ%L?W5_XM0"">'OV(X']31?@ LK*!
M          $%YK]CG(/JY;_P3H$-S@/^Q<8^J8'\,V D(
M         # N_H6Q_=7_ (M0"">'OV(X']31?@ LK*!
M   $%YK]CG(/JY;_ ,$Z!#<X#_L7&/JF!_#-@)"
M    P+OZ%L?W5_XM0"">'OV(X']31?@ LK*!                    $%YK
M]CG(/JY;_P $Z!#<X#_L7&/JF!_#-@)"                 Y>Y;R9BSYIF
M8Y=\FSN.\-QV@BNR'*ZP1!=DVT^2M2$;5[N\T8+<>U!F6GD(%3&KLX'%G$F5
M\B5.=6')$!N(N=7R[:<W/:2^R@T-LH<:(MJ5.*23A=I?K 0RYQ+DK%>+2YK:
MY#O)G(<* UD5K4RY*5X\ZR:4R)$-, DDA"$MFI*5(,E:EJ6W7S0DF7YE<\G9
M3Q_QYB5S,QJGRFD5E]_:5JR:LRJU(24=B.]H?=J6XK1:R+4M"T\I&&3B+^0<
M8<QQ>*Y^0V.38AD]2_:4$B\?],L8<Z"Y^WC^D&1*<:4V>]._WO0B\IF%[ C!
MNB,Z:Q(BU,XSQ$1?_C4 @?A[]B.!_4T7X +*R@0                   !!
M>:_8YR#ZN6_\$Z!#<X#_ +%QCZI@?PS8"0@         #7WQR"H[,XDDH4HH
MC_<3#0;A,N=VK:YL3J:MI^=H7: YLXL\5>(U^$5E7R#)N7\K@)7'GV2JZ3);
MF*0XK:^TMMI)FA233IWB$J+REY3+1>''G*.)\GQ9TS%%REL5SB&9!S(C\,]S
MB346TGDIW="ZZ=@(F8  J"C3PW?<Q9E$5CS3?*$!J(5K*MFD+7+BK8)+;L,G
M''"-M+:4(<4A"/ZN[4%4;8XXS<H\2E)QFRE>"G#@NL1H!;H1W<1DI$QN(E&J
M=Q[%)<2W_6VEV;05:N>\@8W/\*TZ_C3V76;S&RK(3:%)6XY/FQBC>CI01F9N
MI6LR4@NJ=#U[ 3JCU'6.<;\P\0ED:TPV)O'Z,/0^\9);*TKC:D*:-9Z$2E>]
M06OG'T+J D]V^SDGBHQ*)5+3)/#<?LYEVMHR4F.NS-,=EIQ1:Z.*]^2#Z[>O
M8!T6=FN"5>=1HL6TG6<%$-Q3K:ZB?(K5J-2=IDM4=2347N$8(@5IX?\ $F*R
M:\5]E:C;CNKVJR*R,CVH,]#(W3(P6K=^'OKPC@?U-$^ !*R@0
M        !!>:_8YR#ZN6_P#!.@0W. _[%QCZI@?PS8"0@         ##M[.-
M2U4ZYF[BAUT=Z7(-!:J[IA!N*T+RGHD!S5CV<\TV>9\79-D-[%@8GR*Y/<@X
M;!BM+3&A?-SDJ(X_+61N..&1MK4E.TOU:FDBK,X<S#+[*;EF <@O1YV981+C
M,2K>$V3+$Z'8L>DQ7C;(B)#AIU):4EH0$K5! !#,XXFXYY(7'=S;'8MO(B%L
MCR7"6V^A&NNPG65(7LU/7;NT_0 WV.8SC^(5#%#C%;'J:>/KW,.(V3;9&H]5
M*,B[5&?4U'U/R@(E X,XBJ\H+,H&(5[&1I=](;E);/8AXSU[Q#)J-I"R/J2D
MH(R/KV@M4GRO#L7SFH<H<NJH]O4N*)PXTI&XDN)U(EH46BD*(C,B4DR/J",3
M"N/,*XZKW:O":6/30WUDY(2P2C<=61:$;CBS4M>A=FY1Z>0!)@&!=_0MC^ZO
M_%J 03P]^Q' _J:+\ %E90(                    @O-?L<Y!]7+?^"= A
MN<!_V+C'U3 _AFP$A          &HR&VQVOKY360RHS4-R.\;\>0XA)NL$DR
M<(D*,C41ETZ .4ZWCW+7&\,O.,^4*1["Z$W;/"XF3-D<^!&M(QM>CN&@S-PF
MT.'L)S:I)].FTB!Z6[P+'QVOEYK61\A>RW/6K"._FV2.-(:8D2Y#&K+<;NS4
MDFF4)V$DC\T]>PM"(DKF!         !@7?T+8_NK_P 6H!!/#W[$<#^IHOP
M65E @                   ""\UD9\.<@Z?ANW_ ()T"&YP+I@N,$?;\TP/
MX9L!(0         !5')N-8CGF1Q,4S# )F018]7)L(>2MM)]&C.J-2%14.DM
M*B>7W:5$DRVGYI_J*H&MQ;BVMKHM>OPW9?8+BM(95/F125)?-M))-QTVWT(-
M:M-5;4D6O81 KH'@Q-#'I+*'CW'-AQU!:DI6J)9L)8<EN.(ZN$9+6I6TDDGS
MCZ=- 25J @         P+OZ%L?W5_P"+4 @GA[]B.!_4T7X +*R@0
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MZI/W=#T"S 1@7?T+8_NK_P 6H!!/#W[$<#^IHOP 65E @
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M?$2=;,)_&<2[DV'>\TN)^NW8>O\ Z(O)^D@5M_#WI^2.!Z?^S1?@ 2LH$
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M^<I:SU\G8 M0$8%W]"V/[J_\6H!!/#W[$<#^IHOP 65E @
M "D<F]OCOJC%^\I(W8ETZ,&9;&J2#I.6      ",X-[?,@]4Z[[QF#EY=^SK
M8?CW7@,;:     *HY=XBQ+-"D9E>JN'9]-6.I9@U5@]"0\B-WL@D;&]2WJ4H
MT[M->SW"!55<,>'/ LNXWILMN[NWMK"_C%.6J-;26F(:GM3]';)"]34Q_=K-
MPU&:TGV=@+,IAX=*>OQ+(N3\%JY4FW@4%M#2Q?2I*Y*GDRHA.G&5JHT$Y%5N
M;<-LD[M2W)(R!)7X"         # N_H6Q_=7_BU ()X>_8C@?U-%^ "RLH$
M               4CDWM\=]48OWE)&[$NG1@S+8U20=)RP      1G!O;YD'
MJG7?>,P<O+OV=;#\>Z\!C;0    !\N.(:0IUU1(:01J6M1D24I(M3,S/L(@'
M$5CCM/F%I8Y%PYQCE<G"YDAU;MC3Y G&ZVP<2I2'78T-Y"S4VI1&1;-ON;4]
M@/3HO@&RP*3A"ZK!*-_&4TTMV'=X_/2I%A%L4DDW/236:E.*66TR<,SU+ITV
M[2)*U 0         8%W]"V/[J_\ %J 03P]^Q' _J:+\ %E90(
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M;=0XB:>Q44=K4HSQEYB?_+5^@!"O#W[$<#^IHOP 65E @
M"D<F]OCOJC%^\I(W8ETZ,&9;&J2#I.6      ",X-[?,@]4Z[[QF#EY=^SK8
M?CW7@,;:     *[Y6C\Q.U[1\3R:5M9LR463%RB3WQZH_9*BN1U$1.:[BT66
MFNAZ]H*K'#HOC#BXG21WI6')=;A,)45Z=H[:]$$7^+6A2DJ>_P#,,C]\!Z+'
MXFQ7D6D>R2]Y,OHMK>Y!*8>;@5:Y"JR S&9[HD1TR#U3O[5D1==-=3,!98(
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MFB_ !964"                *1R;V^.^J,7[RDC=B73HP9EL:I(.DY8
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M$YMR(YLD1'S92E+GFGWB5[2/R?J"[ 1@7?T+8_NK_P 6H!!/#W[$<#^IHOP
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M:+\ "5E @               "D<F]OCOJC%^\I(W8ETZ,&9;&J2#I.6
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MZ\!C;0                   &!=_0MC^ZO_ !:@$$\/?L1P/ZFB_ !964"
M               *1R;V^.^J,7[RDC=B73HP9EL:I(.DY8      (S@WM\R#
MU3KOO&8.7EW[.MA^/=> QMH                   # N_H6Q_=7_BU ()X>
M_8C@?U-%^ "RLH$                4CDWM\=]48OWE)&[$NG1@S+8U20=)
MRP      1G!O;YD'JG7?>,P<O+OV=;#\>Z\!C;0           $7S_D#&.-,
M9F95E4Q$6!%0HVFC47?27B(S2PP@S+>XL^A%_2>A$9@/7&LQKL@P:LSUXOFV
MIL*QJY<])6G2/'=8)]7>++IYB3\XP%7L^)FH]'B9)88A?5W&4]]$:+F\IAI,
M+1USNVWW6B<-YMA:M-KJD>4NG4%HG7(G*-/QZW4QEPI=YDF0/'&H,?JD)=F2
MUH22G%IW*2E+;:3)3CBCT20(Q>/^686:W%GB=G2S\6S:H:;E3*"U2WWJXCI[
M4R&'&E*0ZUN/8:DGT5T,%6&","[^A;']U?\ BU ()X>_8C@?U-%^ "RLH$
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M.!_4T3X $K*!                %(Y-[?'?5&+]Y21NQ+IT8,RV-4D'2<L
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M=4DC6WO3H2MIZIW%T,$9     "D<F]OCOJC%^\I(W8ETZ,&9;&J2#I.6
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M("+91QQA>$9;QE98I6*K9LO*&XDEQ$N6Z2V/0I+AH-+SRTZ&I*3[/(!#HH
M %(Y-[?'?5&+]Y21NQ+IT8,RV-4D'2<L      $9P;V^9!ZIUWWC,'+R[]G6
MP_'NO 8VT               !Y2),>&PY*EO(8C-%N=>=42$)27E4I1D1$ ^
M(-A LXR)M;*9F0W/[N1'<2\TK3W%(,R,!D ,"[^A;']U?^+4 @GA[]B.!_4T
M7X +*R@0 5=S)_\ N\9^NE=_"S $U!'X      *ZY1^G^*O6]O[OE L+B
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M22T*(TJ2HM2,CZ&1D8#\999CMI98;2TRCHAM!$E)%^@BZ$ ^P
M0_CS!U8+"O(BYI3OGF]L[XEDWW7=%9OF\36FY6NS73=TU]P@$P
M !H<XQQ6889D.)ID%$5>ULRL*6:.\)HYC"V=^S5.[;NUTU+4!FX_5G1T-72F
M[WYUL./#-_;LWG':2WNVZGIKMUTU ;$
M                  #LZF _$J)1$I)D:3+4C+J1D8#]
M                  %5Y#XB^)<7RM6'W%V;4]EU,6?,0RZY7PY*_>LR)*4F
MVA?NEKYO];;H8+1:2%H=0EQM1+;61*0M)ZI-)]2,C+M(P1]            Y
MTY2OTYYR_C_!63%88YALMN3.F/D[Z*WD1MLMG'BL/M*W)0E9N]\V9DI1I3V&
M:05C2(=YX6;%-C6JF7GA]FK2BQ@.*7+FXV\LR23S)GJI<51GYZ>U/_>]^/\
M71T27'GQ&)T19.Q)+:'F'2U(E-N))25%KH?4C!'L
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M7'*1_%Z"Y@P::AJ9;?H\V5&KR/\ QLEG_P ,S+:VRE7G=V773IJ1=@(
M #Y<<;9;4Z\M+;2"-2UK,DI2DNTS,^A$ YYROE#D?*8E_/Q+CR%E7$58_*JK
M9J8^?SC<-15FS,7!8+5!MH,EI3N)1N;?-+7S2*T54T5"37.GAM8^><%NC3_.
M?'45)-+[QLB);L1A.I,RVB/SV2Z++JG4C(!8G%>)%99#.YA=H;' [3(4/,6&
M*.2$&Q-2APCCV$N.2"[J4:342D:ZEJ9GJ:C,PD..\(\6XIE4O-J/'&&,GF.N
M/N6#CCTA2'7S,W%LI><6EI2]Q[C;2G773L JL $
M        %)<[<F3:*;CW&5)*E4&09M-B06<J4R7HD6(^\;<DV'E'M.4E)$24
M'V;TJU(] 6$:M\>S3P[N*R:HLK;/^(Y"=N8T-R\5C9PD*+1<Z*M24[T$6IO-
M:$6G4^GG-AF83Q3*;L(&1\,<B.5G"MU*;NW<=B,HD%WJ%&;C,1UTC-EEU1;7
M6C3JDR-)EY""_:^NKZF(U7U<1F# 9(R9BQFTLLH(S-1[4((DEJ9F?0@1D@
M     \I,F/"C/3)CJ(\2.A3K[[JB0VVVV1J4I2E:$1$1:F9@.=<F\06-7M<M
MO+,%M%<$WZSJEYM+_9QGB>,T)=]%21/)CJ,M4/;B5Y23KT!://![AWPZ386#
M9)-^<>%;U]3N#9KN2XU"<FJ-[T*<XCS20LU&MI\O-/4S][KW8_U:M#Q/0XQR
M%;9_CLJ36IOH^RXH(ZDIK),TE[BF*:TZ/:&9&:="/4S[35J$^!
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MY 1R]RUCL:EM:N/'A8CCS4OTUZ"3#KKRY,A]@TMK<6IW1*"U2E/:6[J N\$
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M#U(2J'!G*5JZ[&69FI"%EH7=$6TOU$DDA8X(
M      #DR?S)7\.<I7=++RB5F/&EU,=5>K_Q,J7B]C(425H]*0CNS8,ST[E"
M][>G1.Y)]X6C9MRV.)6$X9GCZ<O\->8EW=!DTI?IA5GII[T19KI&>Z.LSW,2
M-?,[==/>A-^-^-\HQ1=UQO<.QLJX+EPC7CK\]PGIL=J0K:JN<3H9.LD@S4AS
M4M"T(NW1 6]65E?2UT2HJ8S<.L@,HC0XK*=K;3+222A"2+L(B+0$98
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M5(W)K9+];*U8F,]62==)D]%H66KC;:S/9K^K0+9!
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M[Q"(C>FX^?=8WB$0R57LR6?,78OI)2TN/.*3N:+4R0G0^W0DAT "
M                     #\41FDR2>U1D9$KMT/W>H#G*KSC+^/,AD\1<W7#
M[M3DIR&<-Y+CFF&MPY.I>CO+06UB0V:_V:NQ)Z?U=I@KXXLL9_!65SN*.27S
M?A959OVF*9T]KW=I*E$@G(TQ:C/;+\U.FX_/["/WFX)KC_#3V%9]/LL.G1XW
M&&2-/KRC")+)NQ?37$;4O0D^\;2YKH\@RV[2TT,MO=A:-965U+7QJFHB-0:R
M&VEF)#C(2TRTV@M$I0A)$1$7Z 1E@
M             .=%9IF7 6:N5O)MG)R'B3)YBETN92?/?J)<@S5Z)--)$1-?
M\"B(DD74M")24%7'G.(8GR-B$W'\I::EX].9[WTC<DNZT2:D2&7>I)4C7<E?
M9[NI&9 BH^$*F)S#P(WC?)+99/2,39=97V3^]#DR%7/FW&E(<(R6E9:&@EI5
MN\WJ9ZJU++H".PU%8:C,)VL,H2VVG4U:(06A%J9F9]"\H(]
M                                 !KKZAILHIYN/Y!":L::P:-B9#?+
M<VXA7_W(R,M4J+JD]#(R,@%%M>%^8W%/$CY+R!7%)JT_D_5!*]'W:^C'-(]_
M<&7FFV2"Z>77J"U7Q3T]9C]7#I*6*W!J8#2(\.(R6UMMILM$I(@1F@
M
M
4                       #_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>tm2427973d4_ex5-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2427973d4_ex5-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ *<# 2(  A$! Q$!_\0
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M[?CTKS7PW#XN@M;F_M-(M+E=3;S7DN' 9@<\8W#CD_G0!Z)HFJQZUHUMJ$7
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MC_[[?_&KUKX<TBSL+BQM[)8[:X_UL89L-V]:U** (+.SM]/M([6UC$<$8PB
MDX'XU6L=#TW3;F>>SM5ADN/];M)PW.>F<5H44 8%SX)\.7<QFETJ(.3D^6S(
M#^"D"M.'2;"VTU].@M8X[1U9&B48!!&#GOSZU<HH YW_ (03PS_T"H_^^W_Q
MK0L/#^EZ9;7%M9VBQ0W Q*H9CN&,=SZ&M*B@"M86%KIEFEI9PB*!,[4!)QDY
E/7W-1'1]/;5EU4VJ?;E7:)AD'&,?0\5>HH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>62
<FILENAME>tm2427973d4_ex5-1img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2427973d4_ex5-1img02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  % "4# 2(  A$! Q$!_\0
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K^1-[1--N=+LW@NM1EOG:0N)9<Y P!CDGTS^-%%%;1BHJR..<W.3E+=G_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
